PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, C; Shi, LC; Xu, XL; Li, H; Xing, H; Liang, D; Jiang, K; Pang, XH; Song, JY; Chen, SL				Liu, Chang; Shi, Linchun; Xu, Xiaolan; Li, Huan; Xing, Hang; Liang, Dong; Jiang, Kun; Pang, Xiaohui; Song, Jingyuan; Chen, Shilin			DNA Barcode Goes Two-Dimensions: DNA QR Code Web Server	PLOS ONE			English	Article							GENOMIC SEQUENCE; ALGORITHMS; SPACER	The DNA barcoding technology uses a standard region of DNA sequence for species identification and discovery. At present, "DNA barcode" actually refers to DNA sequences, which are not amenable to information storage, recognition, and retrieval. Our aim is to identify the best symbology that can represent DNA barcode sequences in practical applications. A comprehensive set of sequences for five DNA barcode markers ITS2, rbcL, matK, psbA-trnH, and CO1 was used as the test data. Fifty-three different types of one-dimensional and ten two-dimensional barcode symbologies were compared based on different criteria, such as coding capacity, compression efficiency, and error detection ability. The quick response (QR) code was found to have the largest coding capacity and relatively high compression ratio. To facilitate the further usage of QR code-based DNA barcodes, a web server was developed and is accessible at http://qrfordna.dnsalias.org. The web server allows users to retrieve the QR code for a species of interests, convert a DNA sequence to and from a QR code, and perform species identification based on local and global sequence similarities. In summary, the first comprehensive evaluation of various barcode symbologies has been carried out. The QR code has been found to be the most appropriate symbology for DNA barcode sequences. A web server has also been constructed to allow biologists to utilize QR codes in practical DNA barcoding applications.	[Liu, Chang; Shi, Linchun; Xu, Xiaolan; Pang, Xiaohui; Song, Jingyuan; Chen, Shilin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Xing, Hang; Liang, Dong] Beijing Univ Aeronaut, Sch Comp Sci & Engn, Beijing, Peoples R China; [Jiang, Kun] Pidit Inc, Edison, NJ USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Beihang University	Liu, C (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu@implad.ac.cn; slchen@implad.ac.cn	Liu, Chang/A-1148-2014		Chinese Academy of Medical Sciences [PUMC20112569]	Chinese Academy of Medical Sciences	This work was supported by the "Xiehe Scholar" start-up fund to C. Liu from the Chinese Academy of Medical Sciences (Grant No. PUMC20112569). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chen X, 2002, BIOINFORMATICS, V18, P1696, DOI 10.1093/bioinformatics/18.12.1696; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Golomb SW, 1965, IEEE T INFORM THEORY, V12, P317; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HUFFMAN DA, 1952, P IRE, V40, P1098, DOI 10.1109/JRPROC.1952.273898; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar NP, 2008, COMPUT METH PROG BIO, V90, P187, DOI 10.1016/j.cmpb.2007.12.011; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Ledford H, 2008, NATURE, V451, P616, DOI 10.1038/451616b; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Soliman Taysir H A, 2009, Int J Bioinform Res Appl, V5, P593, DOI 10.1504/IJBRA.2009.029040; Tembe W, 2010, BIOINFORMATICS, V26, P2192, DOI 10.1093/bioinformatics/btq346; Wang C, 2011, NUCL ACIDS RES	23	29	33	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35146	10.1371/journal.pone.0035146	http://dx.doi.org/10.1371/journal.pone.0035146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574113	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800009
J	Regev, T; Myers, N; Zarivach, R; Fishov, I				Regev, Tomer; Myers, Nadav; Zarivach, Raz; Fishov, Itzhak			Association of the Chromosome Replication Initiator DnaA with the Escherichia coli Inner Membrane In Vivo: Quantity and Mode of Binding	PLOS ONE			English	Article							FUNCTIONAL INTERACTION; ACIDIC PHOSPHOLIPIDS; AMPHITROPIC PROTEINS; STRUCTURAL BASIS; LIPID DOMAINS; E. COLI; NUCLEOTIDE; SITE; IDENTIFICATION; MECHANISMS	DnaA initiates chromosome replication in most known bacteria and its activity is controlled so that this event occurs only once every cell division cycle. ATP in the active ATP-DnaA is hydrolyzed after initiation and the resulting ADP is replaced with ATP on the verge of the next initiation. Two putative recycling mechanisms depend on the binding of DnaA either to the membrane or to specific chromosomal sites, promoting nucleotide dissociation. While there is no doubt that DnaA interacts with artificial membranes in vitro, it is still controversial as to whether it binds the cytoplasmic membrane in vivo. In this work we looked for DnaA-membrane interaction in E. coli cells by employing cell fractionation with both native and fluorescent DnaA hybrids. We show that about 10% of cellular DnaA is reproducibly membrane-associated. This small fraction might be physiologically significant and represent the free DnaA available for initiation, rather than the vast majority bound to the datA reservoir. Using the combination of mCherry with a variety of DnaA fragments, we demonstrate that the membrane binding function is delocalized on the surface of the protein's domain III, rather than confined to a particular sequence. We propose a new binding-bending mechanism to explain the membrane-induced nucleotide release from DnaA. This mechanism would be fundamental to the initiation of replication.	[Regev, Tomer; Myers, Nadav; Zarivach, Raz; Fishov, Itzhak] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Regev, T (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	fishov@bgu.ac.il	FISHOV, ITZHAK/F-2264-2012; ZARIVACH, RAZ/F-1671-2012	ZARIVACH, RAZ/0000-0001-6543-0296; Fishov, Itzhak/0000-0002-2125-0012				Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Aranovich A, 2006, J BIOL CHEM, V281, P12526, DOI 10.1074/jbc.M510266200; Aranovich A, 2007, FEBS LETT, V581, P4439, DOI 10.1016/j.febslet.2007.08.019; ATLUNG T, 1993, J BACTERIOL, V175, P6537, DOI 10.1128/jb.175.20.6537-6545.1993; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bipatnath M, 1998, J BACTERIOL, V180, P265, DOI 10.1128/JB.180.2.265-273.1998; Blaesing F, 2000, MOL MICROBIOL, V36, P557, DOI 10.1046/j.1365-2958.2000.01881.x; Boeneman K, 2009, MOL MICROBIOL, V72, P645, DOI 10.1111/j.1365-2958.2009.06674.x; CASTUMA CE, 1993, J BIOL CHEM, V268, P24665; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Cronan JE, 1987, ESCHERICHIA COLI SAL, P31; Epand RM, 2009, BBA-BIOMEMBRANES, V1788, P289, DOI 10.1016/j.bbamem.2008.08.023; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Erzberger JP, 2002, EMBO J, V21, P4763, DOI 10.1093/emboj/cdf496; Fujikawa N, 2003, NUCLEIC ACIDS RES, V31, P2077, DOI 10.1093/nar/gkg309; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; FUTAI M, 1974, J MEMBRANE BIOL, V15, P15, DOI 10.1007/BF01870079; Garner J, 1998, J BIOL CHEM, V273, P5167, DOI 10.1074/jbc.273.9.5167; Garner J, 1996, EMBO J, V15, P2313, DOI 10.1002/j.1460-2075.1996.tb00585.x; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; HANSEN FG, 1991, J BACTERIOL, V173, P5194, DOI 10.1128/jb.173.16.5194-5199.1991; Hase M, 1998, J BIOL CHEM, V273, P28651, DOI 10.1074/jbc.273.44.28651; HELMSTETTER CE, 1996, ESCHERICHIA COLI SAL, P1627; Herrick J, 1996, MOL MICROBIOL, V19, P659, DOI 10.1046/j.1365-2958.1996.432956.x; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kitagawa R, 1998, GENE DEV, V12, P3032, DOI 10.1101/gad.12.19.3032; Kitagawa R, 1996, MOL MICROBIOL, V19, P1137, DOI 10.1046/j.1365-2958.1996.453983.x; Kitchen JL, 1999, BIOCHEMISTRY-US, V38, P6213, DOI 10.1021/bi982733q; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Leonard AC, 2009, GENE DEV, V23, P1145, DOI 10.1101/gad.1809909; Li ZY, 2005, J BIOL CHEM, V280, P9796, DOI 10.1074/jbc.M413923200; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Makise M, 2000, J BIOL CHEM, V275, P4513, DOI 10.1074/jbc.275.6.4513; Makise M, 2002, BIOCHEM J, V362, P453, DOI 10.1042/0264-6021:3620453; Makise M, 2001, J BIOL CHEM, V276, P7450, DOI 10.1074/jbc.M009643200; Matsumoto K, 2006, MOL MICROBIOL, V61, P1110, DOI 10.1111/j.1365-2958.2006.05317.x; Messer W, 1999, BIOCHIMIE, V81, P819, DOI 10.1016/S0300-9084(00)87165-5; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mileykovskaya E, 2005, CURR OPIN MICROBIOL, V8, P135, DOI 10.1016/j.mib.2005.02.012; Molt KL, 2009, GENETICS, V183, P39, DOI 10.1534/genetics.109.104760; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Newman G, 2000, J BACTERIOL, V182, P2604, DOI 10.1128/JB.182.9.2604-2610.2000; Nozaki S, 2009, J BACTERIOL; OSBORN MJ, 1972, J BIOL CHEM, V247, P3962; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Roth A, 1998, MOL MICROBIOL, V28, P395, DOI 10.1046/j.1365-2958.1998.00813.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seitz H, 2000, MOL MICROBIOL, V37, P1270, DOI 10.1046/j.1365-2958.2000.02096.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7136; Simmons LA, 2003, MOL MICROBIOL, V49, P849, DOI 10.1046/j.1365-2958.2003.03603.x; SKARSTAD K, 1989, MOL GEN GENET, V218, P50, DOI 10.1007/BF00330564; Skarstad K, 2000, MOL MICROBIOL, V36, P1319, DOI 10.1046/j.1365-2958.2000.01943.x; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skovgaard O, 2005, MICROBIOL-SGM, V151, P963, DOI 10.1099/mic.0.27630-0; Soufo CD, 2008, DEV CELL, V15, P935, DOI 10.1016/j.devcel.2008.09.010; Weigel C, 1999, MOL MICROBIOL, V34, P53, DOI 10.1046/j.1365-2958.1999.01568.x; XIA WM, 1995, P NATL ACAD SCI USA, V92, P783, DOI 10.1073/pnas.92.3.783; Yamaguchi Y, 1999, BIOCHEM J, V340, P433, DOI 10.1042/0264-6021:3400433; Yamamoto K, 2008, J BIOCHEM, V143, P759, DOI 10.1093/jb/mvn025; YUNG BYM, 1988, P NATL ACAD SCI USA, V85, P7202, DOI 10.1073/pnas.85.19.7202; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak A, 2003, J MOL BIOL, V334, P933, DOI 10.1016/j.jmb.2003.10.018; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zheng WD, 2001, EMBO J, V20, P1164, DOI 10.1093/emboj/20.5.1164	68	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36441	10.1371/journal.pone.0036441	http://dx.doi.org/10.1371/journal.pone.0036441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574163	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800059
J	Ni, WY; Le Guiner, C; Moullier, P; Snyder, RO				Ni, Weiyi; Le Guiner, Caroline; Moullier, Philippe; Snyder, Richard O.			Development and Utility of an Internal Threshold Control (ITC) Real-Time PCR Assay for Exogenous DNA Detection	PLOS ONE			English	Article							LEBERS CONGENITAL AMAUROSIS; DIRECT GENE-TRANSFER; SKELETAL-MUSCLE; HOUSEKEEPING GENES; PLASMID DNA; FACTOR-IX; VECTOR; THERAPY; SAFETY; BIODISTRIBUTION	Sensitive and specific tests for detecting exogenous DNA molecules are useful for infectious disease diagnosis, gene therapy clinical trial safety, and gene doping surveillance. Taqman real-time PCR using specific sequence probes provides an effective approach to accurately and quantitatively detect exogenous DNA. However, one of the major challenges in these analyses is to eliminate false positive signals caused by either non-targeted exogenous or endogenous DNA sequences, or false negative signals caused by impurities that inhibit PCR. Although multiplex Taqman PCR assays have been applied to address these problems by adding extra primer-probe sets targeted to endogenous DNA sequences, the differences between targets can lead to different detection efficiencies. To avoid these complications, a Taqman PCR-based approach that incorporates an internal threshold control (ITC) has been developed. In this single reaction format, the target sequence and ITC template are co-amplified by the same primers, but are detected by different probes each with a unique fluorescent dye. Sample DNA, a prescribed number of ITC template molecules set near the limit of sensitivity, a single pair of primers, target probe and ITC probe are added to one reaction. Fluorescence emission signals are obtained simultaneously to determine the cycle thresholds (Ct) for amplification of the target and ITC sequences. The comparison of the target Ct with the ITC Ct indicates if a sample is a true positive for the target (i.e. Ct less than or equal to the ITC Ct) or negative (i.e. Ct greater than the ITC Ct). The utility of this approach was demonstrated in a nonhuman primate model of rAAV vector mediated gene doping in vivo and in human genomic DNA spiked with plasmid DNA.	[Ni, Weiyi; Moullier, Philippe; Snyder, Richard O.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Le Guiner, Caroline; Moullier, Philippe; Snyder, Richard O.] IRT UN, INSERM UMR1089, Lab Therapie Gen, Nantes, France; [Snyder, Richard O.] Univ Florida, Ctr Excellence Regenerat Hlth Biotechnol, Alachua, FL USA	State University System of Florida; University of Florida; Institut National de la Sante et de la Recherche Medicale (Inserm); State University System of Florida; University of Florida	Ni, WY (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	rsnyder@cerhb.ufl.edu			World Anti-Doping Agency; United States Anti-Doping Agency; Agence Francaise de Lutte contre le Dopage; The Partnership for Clean Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	World Anti-Doping Agency; United States Anti-Doping Agency; Agence Francaise de Lutte contre le Dopage; The Partnership for Clean Competition; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project was funded by the World Anti-Doping Agency (RS and PM), United States Anti-Doping Agency (RS), Agence Francaise de Lutte contre le Dopage (PM), and The Partnership for Clean Competition (RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baoutina A, 2007, MOL THER, V15, P1751, DOI 10.1038/sj.mt.6300278; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Ciron C, 2009, HUM GENE THER, V20, P350, DOI 10.1089/hum.2008.155; Damen M, 2008, J CLIN MICROBIOL, V46, P3997, DOI 10.1128/JCM.00563-08; Doroudchi MM, 2011, MOL THER; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Favre D, 2001, MOL THER, V4, P559, DOI 10.1006/mthe.2001.0494; Flotte TR, 2007, HUM GENE THER, V18, P245, DOI 10.1089/hum.2006.113; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002715; Gonin P, 2004, GENE THER, V11, pS98, DOI 10.1038/sj.gt.3302378; Hagstrom JE, 2004, MOL THER, V10, P386, DOI 10.1016/j.ymthe.2004.05.004; JIAO SS, 1992, HUM GENE THER, V3, P21, DOI 10.1089/hum.1992.3.1-21; Lai LH, 2002, HUM GENE THER, V13, P2027, DOI 10.1089/10430340260395884; Lefevre J, 2003, J VIROL METHODS, V114, P135, DOI 10.1016/j.jviromet.2003.09.003; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Murphy RM, 2003, PHYSIOL GENOMICS, V12, P163, DOI 10.1152/physiolgenomics.00060.2002; Ni W, 2011, GENE THER, V18, P709, DOI 10.1038/gt.2011.19; Paulson DS., 2008, BIOSTATISTICS MICROB; Ponder KP, 2011, MOL THER, V19, P427, DOI 10.1038/mt.2011.13; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Provost N, 2005, MOL THER, V11, P275, DOI 10.1016/j.ymthe.2004.09.022; Ryan KJ., 2004, SHERRIS MED MICROBIO; Saulnier P, 2003, J VIROL METHODS, V114, P55, DOI 10.1016/j.jviromet.2003.08.012; Schenk-Braat EAM, 2007, J GENE MED, V9, P910, DOI 10.1002/jgm.1096; Stocher M, 2004, J CLIN VIROL, V29, P171, DOI 10.1016/S1386-6532(03)00121-5; Stocher M, 2002, J CLIN VIROL, V25, pS47; Stroes ES, 2008, ARTERIOSCL THROM VAS, V28, P2303, DOI 10.1161/ATVBAHA.108.175620; Su LT, 2005, CIRCULATION, V112, P1780, DOI 10.1161/CIRCULATIONAHA.105.534008; Templeton KE, 2003, J CLIN MICROBIOL, V41, P4016, DOI 10.1128/JCM.41.9.4016-4021.2003; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Ursi D, 2003, J MICROBIOL METH, V55, P149, DOI 10.1016/S0167-7012(03)00131-3; Verdier F, 1999, TOXICOL SCI, V47, P9, DOI 10.1093/toxsci/47.1.9; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Vigen KK, 2007, HUM GENE THER, V18, P257, DOI 10.1089/hum.2006.115; Wells DJ, 2008, BRIT J PHARMACOL, V154, P623, DOI 10.1038/bjp.2008.144; WOLFF JA, 1991, BIOTECHNIQUES, V11, P474; Wooddell CI, 2011, HUM GENE THER, V22, P889, DOI 10.1089/hum.2010.160; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	47	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36461	10.1371/journal.pone.0036461	http://dx.doi.org/10.1371/journal.pone.0036461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570718	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343400034
J	Stern, ER; Fitzgerald, KD; Welsh, RC; Abelson, JL; Taylor, SF				Stern, Emily R.; Fitzgerald, Kate D.; Welsh, Robert C.; Abelson, James L.; Taylor, Stephan F.			Resting-State Functional Connectivity between Fronto-Parietal and Default Mode Networks in Obsessive-Compulsive Disorder	PLOS ONE			English	Article							BRAIN NETWORKS; TASK; ACTIVATION; CORTEX; BOLD; PSYCHOPATHOLOGY; HYPERACTIVITY; ORGANIZATION; FLUCTUATIONS; ARCHITECTURE	Background: Obsessive-compulsive disorder (OCD) is characterized by an excessive focus on upsetting or disturbing thoughts, feelings, and images that are internally-generated. Internally-focused thought processes are subserved by the "default mode network" (DMN), which has been found to be hyperactive in OCD during cognitive tasks. In healthy individuals, disengagement from internally-focused thought processes may rely on interactions between DMN and a frontoparietal network (FPN) associated with external attention and task execution. Altered connectivity between FPN and DMN may contribute to the dysfunctional behavior and brain activity found in OCD. Methods: The current study examined interactions between FPN and DMN during rest in 30 patients with OCD (17 unmedicated) and 32 control subjects (17 unmedicated). Timecourses from seven fronto-parietal seeds were correlated across the whole brain and compared between groups. Results: OCD patients exhibited altered connectivity between FPN seeds (primarily anterior insula) and several regions of DMN including posterior cingulate cortex, medial frontal cortex, posterior inferior parietal lobule, and parahippocampus. These differences were driven largely by a reduction of negative correlations among patients compared to controls. Patients also showed greater positive connectivity between FPN and regions outside DMN, including thalamus, lateral frontal cortex, and somatosensory/motor regions. Conclusions: OCD is associated with abnormal intrinsic functional connectivity between large-scale brain networks. Alteration of interactions between FPN and DMN at rest may contribute to aspects of the OCD phenotype, such as patients' inability to disengage from internally-generated scenarios and thoughts when performing everyday tasks requiring external attention.	[Stern, Emily R.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Stern, Emily R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Fitzgerald, Kate D.; Welsh, Robert C.; Abelson, James L.; Taylor, Stephan F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Welsh, Robert C.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stern, ER (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	emily.stern@mssm.edu	Fitzgerald, Kate D./AAV-7278-2020; Welsh, Robert/ABH-3526-2021	Taylor, Stephan/0000-0001-8777-4292	National Institute of Mental Health (NIMH) [R01 MH071821, F32 MH082573, K23 MH082176]; Brain and Behavior Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH082176, R01MH071821, F32MH082573] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain and Behavior Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this research comes from National Institute of Mental Health (NIMH) R01 MH071821 awarded to SFT, NIMH F32 MH082573 and Brain and Behavior Foundation (formerly NARSAD) Young Investigator Award to ERS, and NIMH K23 MH082176 awarded to KDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson ML, 2010, SPRINGER SER OPTIM A, V38, P31, DOI 10.1007/978-0-387-88630-5_2; Anderson ML, 2010, BEHAV BRAIN SCI, V33, P245, DOI 10.1017/S0140525X10000853; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; First M.B., 2014, STRUCTURED CLIN INTE; Fitzgerald KD, 2011, J AM ACAD CHILD PSY, V50, P938, DOI 10.1016/j.jaac.2011.06.011; Fitzgerald KD, 2010, BIOL PSYCHIAT, V68, P1039, DOI 10.1016/j.biopsych.2010.08.018; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grigg O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013311; Gu BM, 2008, BRAIN, V131, P155, DOI 10.1093/brain/awm277; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Harrison BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001794; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Harrison BJ, 2009, ARCH GEN PSYCHIAT, V66, P1189, DOI 10.1001/archgenpsychiatry.2009.152; Hasson U, 2009, P NATL ACAD SCI USA, V106, P10841, DOI 10.1073/pnas.0903253106; Jang JH, 2010, NEUROSCI LETT, V474, P158, DOI 10.1016/j.neulet.2010.03.031; Jung WH, 2011, ACTA PSYCHIAT SCAND, V123, P376, DOI 10.1111/j.1600-0447.2010.01659.x; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Menzies L, 2008, NEUROSCI BIOBEHAV R, V32, P525, DOI 10.1016/j.neubiorev.2007.09.005; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; O'Connor K, 2003, PSYCHOL REP, V93, P227, DOI 10.2466/PR0.93.5.227-232; Olvet DM, 2008, CLIN PSYCHOL REV, V28, P1343, DOI 10.1016/j.cpr.2008.07.003; Overbeek T, 2002, J CLIN PSYCHIAT, V63, P1106, DOI 10.4088/JCP.v63n1204; Page LA, 2009, PSYCHIAT RES-NEUROIM, V174, P202, DOI 10.1016/j.pscychresns.2009.05.002; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch S L, 2001, Adv Neurol, V85, P207; Rauch SL, 2007, BIOL PSYCHIAT, V61, P330, DOI 10.1016/j.biopsych.2005.12.012; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Rotge JY, 2008, J PSYCHIATR NEUROSCI, V33, P405; Roth RM, 2007, BIOL PSYCHIAT, V62, P901, DOI 10.1016/j.biopsych.2006.12.007; Sakai Y, 2011, EUR PSYCHIAT, V26, P463, DOI 10.1016/j.eurpsy.2010.09.005; Sanislow CA, 2010, J ABNORM PSYCHOL, V119, P631, DOI 10.1037/a0020909; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Schienle A, 2005, INT J PSYCHOPHYSIOL, V57, P69, DOI 10.1016/j.ijpsycho.2004.12.013; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shapira NA, 2003, BIOL PSYCHIAT, V54, P751, DOI 10.1016/S0006-3223(03)00003-9; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smallwood J, 2012, BRAIN RES, V1428, P60, DOI 10.1016/j.brainres.2011.03.072; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stawarczyk D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016997; Stern ER, 2011, BIOL PSYCHIAT, V69, P583, DOI 10.1016/j.biopsych.2010.09.048; Stern ER, 2012, HUM BRAIN MAPP; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; Ursu S, 2009, NEUROPSYCHOLOGIA, V47, P2145, DOI 10.1016/j.neuropsychologia.2009.03.018; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Whitfield-Gabrieli S, 2011, NEUROIMAGE, V55, P225, DOI 10.1016/j.neuroimage.2010.11.048; Yang YH, 2002, MAGN RESON MED, V48, P278, DOI 10.1002/mrm.10196; Zhang TJ, 2011, J PSYCHIATR NEUROSCI, V36, P23, DOI 10.1503/jpn.100006	74	153	159	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36356	10.1371/journal.pone.0036356	http://dx.doi.org/10.1371/journal.pone.0036356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570705	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400021
J	Harholt, J; Sorensen, I; Fangel, J; Roberts, A; Willats, WGT; Scheller, HV; Petersen, BL; Banks, A; Ulvskov, P				Harholt, Jesper; Sorensen, Iben; Fangel, Jonatan; Roberts, Alison; Willats, William G. T.; Scheller, Henrik Vibe; Petersen, Bent Larsen; Banks, Ann; Ulvskov, Peter			The Glycosyltransferase Repertoire of the Spikemoss Selaginella moellendorffii and a Comparative Study of Its Cell Wall	PLOS ONE			English	Article							CELLULOSE-SYNTHASE-LIKE; SUSPENSION-CULTURED CELLS; ARABIDOPSIS-THALIANA; MONOCLONAL-ANTIBODY; GLUCURONOXYLAN BIOSYNTHESIS; FUNCTIONAL IDENTIFICATION; BIOINFORMATICS APPROACH; RHAMNOGALACTURONAN-II; VASCULAR PLANTS; GENE FAMILIES	Spike mosses are among the most basal vascular plants, and one species, Selaginella moellendorffii, was recently selected for full genome sequencing by the Joint Genome Institute (JGI). Glycosyltransferases (GTs) are involved in many aspects of a plant life, including cell wall biosynthesis, protein glycosylation, primary and secondary metabolism. Here, we present a comparative study of the S. moellendorffii genome across 92 GT families and an additional family (DUF266) likely to include GTs. The study encompasses the moss Physcomitrella patens, a non-vascular land plant, while rice and Arabidopsis represent commelinid and non-commelinid seed plants. Analysis of the subset of GT-families particularly relevant to cell wall polysaccharide biosynthesis was complemented by a detailed analysis of S. moellendorffii cell walls. The S. moellendorffii cell wall contains many of the same components as seed plant cell walls, but appears to differ somewhat in its detailed architecture. The S. moellendorffii genome encodes fewer GTs (287 GTs including DUF266s) than the reference genomes. In a few families, notably GT51 and GT78, S. moellendorffii GTs have no higher plant orthologs, but in most families S. moellendorffii GTs have clear orthologies with Arabidopsis and rice. A gene naming convention of GTs is proposed which takes orthologies and GT-family membership into account. The evolutionary significance of apparently modern and ancient traits in S. moellendorffii is discussed, as is its use as a reference organism for functional annotation of GTs.	[Harholt, Jesper; Sorensen, Iben; Fangel, Jonatan; Willats, William G. T.; Petersen, Bent Larsen; Ulvskov, Peter] Univ Copenhagen, Dept Plant Biol & Biotechnol, VKR Res Ctr Pro Active Plants, Frederiksberg, Denmark; [Sorensen, Iben] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Roberts, Alison] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Scheller, Henrik Vibe] Joint Bioenergy Inst, Feedstocks Div, Emeryville, CA USA; [Scheller, Henrik Vibe] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Banks, Ann] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	University of Copenhagen; Cornell University; University of Rhode Island; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harholt, J (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, VKR Res Ctr Pro Active Plants, Frederiksberg, Denmark.	ulvskov@life.ku.dk	Scheller, Henrik/AAH-4770-2020; Scheller, Henrik V/A-8106-2008; Petersen, Bent/H-9437-2014; Harholt, Jesper/F-6865-2014; Ulvskov, Peter/I-1228-2014	Scheller, Henrik/0000-0002-6702-3560; Scheller, Henrik V/0000-0002-6702-3560; Petersen, Bent/0000-0002-2004-9077; Harholt, Jesper/0000-0002-7984-0066; Ulvskov, Peter/0000-0003-3776-818X; Willats, William/0000-0003-2064-4025; Sorensen, Iben/0000-0002-9768-620X	Villum-Kann Rasmussen grant; Danish Research Council [FTP-09-066624]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DEAC02-05CH11231]; Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture [2007-35318-18389]; Villum Fonden [00007173] Funding Source: researchfish	Villum-Kann Rasmussen grant; Danish Research Council(Det Frie Forskningsrad (DFF)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Agriculture and Food Research Initiative Competitive grant from the USDA National Institute of Food and Agriculture; Villum Fonden(Villum Fonden)	This work was supported by a Villum-Kann Rasmussen grant to the Pro-Active Plant Centre (www.proactiveplants.life.ku.dk), by the Danish Research Council (FTP-09-066624 to PU), by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DEAC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy and by Agriculture and Food Research Initiative Competitive grant no. 2007-35318-18389 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anders N, 2012, P NATL ACAD SCI USA, V109, P989, DOI 10.1073/pnas.1115858109; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bernal AJ, 2007, PLANT J, V52, P791, DOI 10.1111/j.1365-313X.2007.03281.x; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bouton S, 2002, PLANT CELL, V14, P2577, DOI 10.1105/tpc.004259; Bown L, 2007, J EXP BOT, V58, P1813, DOI 10.1093/jxb/erm040; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; BURKE D, 1974, PLANT PHYSIOL, V54, P109, DOI 10.1104/pp.54.1.109; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104; Dhugga KS, 2001, CURR OPIN PLANT BIOL, V4, P488, DOI 10.1016/S1369-5266(00)00205-3; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Egelund J, 2004, PLANT PHYSIOL, V136, P2609, DOI 10.1104/pp.104.042978; Egelund J, 2008, FEBS LETT, V582, P3217, DOI 10.1016/j.febslet.2008.08.015; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Friedman WE, 2000, PHILOS T R SOC B, V355, P857, DOI 10.1098/rstb.2000.0620; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Gunl M, 2011, PLANTA, V233, P707, DOI 10.1007/s00425-010-1330-7; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; HAYASHI T, 1989, ANNU REV PLANT PHYS, V40, P139, DOI 10.1146/annurev.pp.40.060189.001035; Izumi Y, 2003, PLANT CELL PHYSIOL, V44, P183, DOI 10.1093/pcp/pcg028; Jensen JK, 2008, PLANT CELL, V20, P1289, DOI 10.1105/tpc.107.050906; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; KATO Y, 1982, PLANT CELL PHYSIOL, V23, P351, DOI 10.1093/oxfordjournals.pcp.a076357; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar M, 2009, TRENDS PLANT SCI, V14, P248, DOI 10.1016/j.tplants.2009.02.004; LABAVITCH JM, 1978, PHYTOCHEMISTRY, V17, P933, DOI 10.1016/S0031-9422(00)88649-5; Lao NT, 2003, PLANT MOL BIOL, V53, P687, DOI 10.1023/B:PLAN.0000019074.60542.6c; Li XM, 2004, PLANT PHYSIOL, V134, P940, DOI 10.1104/pp.103.036285; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Machida M, 2006, P NATL ACAD SCI USA, V103, P6753, DOI 10.1073/pnas.0510693103; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Manfield IW, 2004, PLANT J, V40, P260, DOI 10.1111/j.1365-313X.2004.02208.x; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsunaga T, 2004, PLANT PHYSIOL, V134, P339, DOI 10.1104/pp.103.030072; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MCDOUGALL GJ, 1994, J PLANT PHYSIOL, V143, P591, DOI 10.1016/S0176-1617(11)81143-0; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Moller I, 2007, PLANT J, V50, P1118, DOI 10.1111/j.1365-313X.2007.03114.x; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Nairn CJ, 2005, NEW PHYTOL, V166, P907, DOI 10.1111/j.1469-8137.2005.01372.x; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; Nobles DR, 2001, PLANT PHYSIOL, V127, P529, DOI 10.1104/pp.010557; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Oikawa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015481; Ordaz-Ortiz JJ, 2009, MOL PLANT, V2, P910, DOI 10.1093/mp/ssp049; Orfila C, 2005, PLANTA, V222, P613, DOI 10.1007/s00425-005-0008-z; Park S, 2011, NAT CELL BIOL, V13, P973, DOI 10.1038/ncb2294; Pena MJ, 2008, GLYCOBIOLOGY, V18, P891, DOI 10.1093/glycob/cwn078; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Popper ZA, 2003, ANN BOT-LONDON, V91, P1, DOI 10.1093/aob/mcg013; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Qu YM, 2008, PLANT MOL BIOL, V68, P43, DOI 10.1007/s11103-008-9351-3; RAVEN JA, 1993, BIOL REV, V68, P337, DOI 10.1111/j.1469-185X.1993.tb00735.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roberts AW, 2007, PLANT MOL BIOL, V63, P207, DOI 10.1007/s11103-006-9083-1; Roberts A, 2007, CHEM IND-LONDON, P17, DOI 10.1007/978-1-4020-5380-1_2; Roberts E, 2009, J PHYCOL, V45, P203, DOI 10.1111/j.1529-8817.2008.00626.x; Sadowski PG, 2008, PROTEOMICS, V8, P3991, DOI 10.1002/pmic.200800217; Sarria R, 2001, PLANT PHYSIOL, V127, P1595, DOI 10.1104/pp.010596; Saxena IM, 2000, CURR OPIN PLANT BIOL, V3, P523, DOI 10.1016/S1369-5266(00)00125-4; Scheller HV, 2007, PHYSIOL PLANTARUM, V129, P283, DOI 10.1111/j.1399-3054.2006.00834.x; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seifert GJ, 2007, ANNU REV PLANT BIOL, V58, P137, DOI 10.1146/annurev.arplant.58.032806.103801; Singh SK, 2005, PLANT J, V43, P384, DOI 10.1111/j.1365-313X.2005.02455.x; Sorensen I, 2008, PLANT J, V54, P510, DOI 10.1111/j.1365-313X.2008.03453.x; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Sterling JD, 2006, P NATL ACAD SCI USA, V103, P5236, DOI 10.1073/pnas.0600120103; Stone BA, 2010, PLANT POLYSACCHARIDE, P09; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tounou Eiichirou, 2002, Cytologia (Tokyo), V67, P429, DOI 10.1508/cytologia.67.429; TSEKOS I, 1994, J PHYCOL, V30, P300, DOI 10.1111/j.0022-3646.1994.00300.x; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Wang WM, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-10; Wende G, 1997, PHYTOCHEMISTRY, V44, P1019, DOI 10.1016/S0031-9422(96)00649-8; Weng JK, 2008, P NATL ACAD SCI USA, V105, P7887, DOI 10.1073/pnas.0801696105; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Wu YY, 2010, J BIOL CHEM, V285, P13638, DOI 10.1074/jbc.M110.102715; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Xu ZY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S11-S3; Yin L, 2011, MOL PLANT, V4, P1024, DOI 10.1093/mp/ssr026; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; Yin YB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-99; Yokoyama R, 2004, PLANT CELL PHYSIOL, V45, P1111, DOI 10.1093/pcp/pch151; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zhou YH, 2009, PLANT J, V57, P446, DOI 10.1111/j.1365-313X.2008.03703.x	111	53	53	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35846	10.1371/journal.pone.0035846	http://dx.doi.org/10.1371/journal.pone.0035846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567114	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500032
J	Mishra, P; Das, S; Panicker, L; Hosur, MV; Sharma, S; Hosur, RV				Mishra, Pushpa; Das, Sudipta; Panicker, Lata; Hosur, Madhusoodan V.; Sharma, Shobhona; Hosur, Ramakrishna V.			NMR Insights into Folding and Self-Association of Plasmodium falciparum P2	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; SECONDARY STRUCTURE PREDICTION; DENATURED STATE ENSEMBLE; GTPASE-ASSOCIATED CENTER; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; INITIATION-SITES; SACCHAROMYCES-CEREVISIAE; STRUCTURAL GENOMICS; NONNATIVE PROTEIN	The eukaryotic 60S-ribosomal stalk is composed of acidic ribosomal proteins (P1 and P2) and neutral protein P0, which are thought to be associated as a pentameric structure, [2P1, 2P2, P0]. Plasmodium falciparum P2 (PfP2) appears to play additional non-ribosomal functions associated with its tendency for homo-oligomerization. Recombinant bacterially expressed PfP2 protein also undergoes self-association, as shown by SDS-PAGE analysis and light scattering studies. Secondary structure prediction algorithms predict the native PfP2 protein to be largely helical and this is corroborated by circular dichroism investigation. The H-1-N-15 HSQC spectrum of native P2 showed only 43 cross peaks compared to the expected 138. The observed peaks were found to belong to the C-terminal region, suggesting that this segment is flexible and solvent exposed. In 9 M urea denaturing conditions the chain exhibited mostly non-native beta structural propensity. N-15 Relaxation data for the denatured state indicated substantial variation in ms-mu s time scale motion along the chain. Average area buried upon folding (AABUF) calculations on the monomer enabled identification of hydrophobic patches along the sequence. Interestingly, the segments of slower motion in the denatured state coincided with these hydrophobic patches, suggesting that in the denatured state the monomeric chain undergoes transient hydrophobic collapse. The implications of these results for the folding mechanism and self-association of PfP2 are discussed.	[Mishra, Pushpa; Hosur, Ramakrishna V.] Tata Inst Fundamental Res, Dept Chem Sci, Bombay 400005, Maharashtra, India; [Das, Sudipta; Sharma, Shobhona] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Panicker, Lata; Hosur, Madhusoodan V.] Bhabha Atom Res Ctr, Dept Solid State Phys Div, Bombay 400085, Maharashtra, India; [Hosur, Ramakrishna V.] UM DAE Ctr Excellence Basic Sci, Bombay, Maharashtra, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Bhabha Atomic Research Center (BARC); UM-DAE Centre for Excellence in Basic Sciences	Mishra, P (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	hosur@tifr.res.in		Hosur, Madhusoodan/0000-0003-1012-0906; DAS, SUDIPTA/0000-0002-8644-7342	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	The work was supported by the Department of Atomic Energy, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; Beaucage G, 2008, BIOPHYS J, V95, P503, DOI 10.1529/biophysj.107.121855; Bhavesh NS, 2001, BIOCHEMISTRY-US, V40, P14727, DOI 10.1021/bi015683p; BUSHUEV VN, 1989, J BIOL CHEM, V264, P4498; Chakraborty S, 2011, J MOL BIOL, V405, P1202, DOI 10.1016/j.jmb.2010.11.050; Chatterjee A, 2002, BIOCHEM BIOPH RES CO, V293, P427, DOI 10.1016/S0006-291X(02)00240-1; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chugh J, 2007, BIOCHEMISTRY-US, V46, P11819, DOI 10.1021/bi701280p; Chugh J, 2009, ARCH BIOCHEM BIOPHYS, V481, P169, DOI 10.1016/j.abb.2008.11.002; Chugha P, 2007, BIOCHEMISTRY-US, V46, P1141, DOI 10.1021/bi061371g; Claes P. D. M., 1992, LASER LIGHT SCATTERI, P66; Dadlez M, 1999, ACTA BIOCHIM POL, V46, P487, DOI 10.18388/abp.1999_4126; Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; Dyson HJ, 2001, METHOD ENZYMOL, V339, P258; Ecroyd H, 2008, IUBMB LIFE, V60, P769, DOI 10.1002/iub.117; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Freund SMV, 1996, P NATL ACAD SCI USA, V93, P10600, DOI 10.1073/pnas.93.20.10600; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; Goswami A, 1997, J BIOL CHEM, V272, P12138, DOI 10.1074/jbc.272.18.12138; Grela P, 2008, J BIOCHEM, V143, P169, DOI 10.1093/jb/mvm207; GUDKOV AT, 1978, EUR J BIOCHEM, V90, P313, DOI 10.1111/j.1432-1033.1978.tb12606.x; Hagiya A, 2005, J BIOL CHEM, V280, P39193, DOI 10.1074/jbc.M506050200; Hass MAS, 2006, MAGN RESON CHEM, V44, P761, DOI 10.1002/mrc.1845; Ilag LL, 2005, P NATL ACAD SCI USA, V102, P8192, DOI 10.1073/pnas.0502193102; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; Justice MC, 1999, J BIOL CHEM, V274, P4869, DOI 10.1074/jbc.274.8.4869; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Kumar A, 2006, BIOPHYS J, V90, P2498, DOI 10.1529/biophysj.105.071746; Le Duff CS, 2006, J MOL BIOL, V364, P824, DOI 10.1016/j.jmb.2006.09.037; Lee JP, 2002, BIOPHYS J, V82, p304A; Lee KM, 2010, NUCLEIC ACIDS RES, V38, P5206, DOI 10.1093/nar/gkq231; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; LEIJONMARCK M, 1987, J MOL BIOL, V195, P555, DOI 10.1016/0022-2836(87)90183-5; Lin K, 2005, BIOINFORMATICS, V21, P152, DOI 10.1093/bioinformatics/bth487; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; MEILER J, JUFO SECONDARY STRUC; Naganuma T, 2007, GENES CELLS, V12, P501, DOI 10.1111/j.1365-2443.2007.01067.x; OTZEN DE, 1994, P NATL ACAD SCI USA, V91, P10422, DOI 10.1073/pnas.91.22.10422; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Palmer AG, 1997, CURR OPIN STRUC BIOL, V7, P732, DOI 10.1016/S0959-440X(97)80085-1; Penkett CJ, 1997, J MOL BIOL, V274, P152, DOI 10.1006/jmbi.1997.1369; Permi P, 2004, PROG NUCL MAG RES SP, V44, P97, DOI 10.1016/j.pnmrs.2003.12.001; PTITSYN OB, 1975, BIOPHYS CHEM, V3, P1, DOI 10.1016/0301-4622(75)80033-0; PTITSYN OB, 1987, J PROTEIN CHEM, V6, P273; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryabov Y, 2011, J AM CHEM SOC, V133, P6154, DOI 10.1021/ja201020c; SAENZROBLES MT, 1990, BIOCHIM BIOPHYS ACTA, V1050, P51, DOI 10.1016/0167-4781(90)90140-W; Sagle LB, 2009, J AM CHEM SOC, V131, P9304, DOI 10.1021/ja9016057; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Stumpe MC, 2009, BIOPHYS J, V96, P3744, DOI 10.1016/j.bpj.2009.01.051; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Tchorzewski M, 2000, INT J BIOCHEM CELL B, V32, P737, DOI 10.1016/S1357-2725(00)00017-0; Tchorzewski M, 2003, BIOCHEMISTRY-US, V42, P3399, DOI 10.1021/bi0206006; Tchorzewski M, 2000, BBA-MOL CELL RES, V1499, P63, DOI 10.1016/S0167-4889(00)00108-7; Tozawa K, 2005, BIOCHEMISTRY-US, V44, P11496, DOI 10.1021/bi0503596; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; Uchiumi T, 1997, J BIOL CHEM, V272, P3302, DOI 10.1074/jbc.272.6.3302; Wahl MC, 2000, EMBO J, V19, P174, DOI 10.1093/emboj/19.2.174; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wishart DS, 1994, NUCL MAGNETIC RESO C, P363; Zurdo J, 2000, BIOCHEMISTRY-US, V39, P8929, DOI 10.1021/bi000362j	80	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36279	10.1371/journal.pone.0036279	http://dx.doi.org/10.1371/journal.pone.0036279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567147	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500066
J	Raymond, JA; Kim, HJ				Raymond, James A.; Kim, Hak Jun			Possible Role of Horizontal Gene Transfer in the Colonization of Sea Ice by Algae	PLOS ONE			English	Article							DIATOM FRAGILARIOPSIS-CYLINDRUS; ANTIFREEZE PROTEINS; BINDING PROTEINS; MICROBIAL COMMUNITIES; MCMURDO-SOUND; BACTERIA; ANTARCTICA; EVOLUTION; GENOME; MICROORGANISMS	Diatoms and other algae not only survive, but thrive in sea ice. Among sea ice diatoms, all species examined so far produce ice-binding proteins (IBPs), whereas no such proteins are found in non-ice-associated diatoms, which strongly suggests that IBPs are essential for survival in ice. The restricted occurrence also raises the question of how the IBP genes were acquired. Proteins with similar sequences and ice-binding activities are produced by ice-associated bacteria, and so it has previously been speculated that the genes were acquired by horizontal transfer (HGT) from bacteria. Here we report several new IBP sequences from three types of ice algae, which together with previously determined sequences reveal a phylogeny that is completely incongruent with algal phylogeny, and that can be most easily explained by HGT. HGT is also supported by the finding that the closest matches to the algal IBP genes are all bacterial genes and that the algal IBP genes lack introns. We also describe a highly freeze-tolerant bacterium from the bottom layer of Antarctic sea ice that produces an IBP with 47% amino acid identity to a diatom IBP from the same layer, demonstrating at least an opportunity for gene transfer. Together, these results suggest that the success of diatoms and other algae in sea ice can be at least partly attributed to their acquisition of prokaryotic IBP genes.	[Raymond, James A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Kim, Hak Jun] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea; [Kim, Hak Jun] Univ Sci & Technol, Dept Polar Sci, Inchon, South Korea	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Raymond, JA (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	raymond@unlv.nevada.edu			NSF [0088000]; National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF); Korea Polar Research Institute (KOPRI) [PG11010, PE11100]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF); Korea Polar Research Institute (KOPRI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Collections of sea ice and diatom samples in McMurdo Sound, Antarctica, were supported by NSF grant 0088000 to JR. The Pyramimonas studies and part of the F. frigoris studies were supported by the National Agenda Project from The Korea Research Council of Fundamental Science & Technology (KRCF) and the Korea Polar Research Institute (KOPRI) (Grant nos. PG11010 and PE11100 to HJK). Additional material support was provided by the University of Nevada Las Vegas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2011, J MOL MICROB BIOTECH, V20, P83, DOI 10.1159/000324505; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001138; Bayer-Giraldi M, 2011, CRYOBIOLOGY, V63, P210, DOI 10.1016/j.cryobiol.2011.08.006; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; Belbahri L, 2008, GENE, V408, P1, DOI 10.1016/j.gene.2007.10.019; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Collins RE, 2011, POLAR BIOL, V34, P1831, DOI 10.1007/s00300-011-1008-z; Collins RE, 2011, POLAR BIOL, V34, P1819, DOI 10.1007/s00300-011-1041-y; Derelle E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002250; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Goldenfeld N, 2007, NATURE, V445, P369, DOI 10.1038/445369a; Gosink JJ, 1998, INT J SYST BACTERIOL, V48, P223, DOI 10.1099/00207713-48-1-223; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; GROSSI SM, 1984, MICROBIAL ECOL, V10, P231; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Horner R., 1985, P147; Hoshino T, 2003, CAN J BOT, V81, P1175, DOI [10.1139/b03-116, 10.1139/B03-116]; Hwang YS, 2008, BIOCHEM BIOPH RES CO, V367, P635, DOI 10.1016/j.bbrc.2007.12.176; Janech MG, 2006, J PHYCOL, V42, P410, DOI 10.1111/j.1529-8817.2006.00208.x; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Kiko R, 2010, POLAR BIOL, V33, P543, DOI 10.1007/s00300-009-0732-0; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; Krembs C, 2011, P NATL ACAD SCI USA, V108, P3653, DOI 10.1073/pnas.1100701108; Kropuenske LR, 2010, J PHYCOL, V46, P1138, DOI 10.1111/j.1529-8817.2010.00922.x; Lee JK, 2010, CRYOBIOLOGY, V60, P222, DOI 10.1016/j.cryobiol.2010.01.002; MCFADDEN GI, 1982, PHYCOLOGIA, V21, P103, DOI 10.2216/i0031-8884-21-2-103.1; Mock T, 2004, J PHYCOL, V40, P732, DOI 10.1111/j.1529-8817.2004.03224.x; Monier A, 2009, GENOME RES, V19, P1441, DOI 10.1101/gr.091686.109; Morgan-Kiss RM, 2006, MICROBIOL MOL BIOL R, V70, P222, DOI 10.1128/MMBR.70.1.222-252.2006; Park S, 2010, PLANTA, V231, P349, DOI 10.1007/s00425-009-1044-x; Parker MS, 2008, ANNU REV GENET, V42, P619, DOI 10.1146/annurev.genet.42.110807.091417; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Rampen SW, 2009, J PHYCOL, V45, P444, DOI 10.1111/j.1529-8817.2009.00657.x; RAYMOND JA, 1994, POLAR BIOL, V14, P71; Raymond JA, 2003, CRYOBIOLOGY, V46, P203, DOI 10.1016/S0011-2240(03)00026-9; Raymond JA, 2001, CRYOBIOLOGY, V43, P63, DOI 10.1006/cryo.2001.2341; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Raymond JA, 2007, FEMS MICROBIOL ECOL, V61, P214, DOI 10.1111/j.1574-6941.2007.00345.x; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Raymond JA, 2009, CRYOBIOLOGY, V58, P151, DOI 10.1016/j.cryobiol.2008.11.009; SULLIVAN CW, 1984, APPL ENVIRON MICROB, V47, P788, DOI 10.1128/AEM.47.4.788-795.1984; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Wenzl P, 2005, MOL BIOL EVOL, V22, P308, DOI 10.1093/molbev/msi018; Yu Y, 2009, POLAR BIOL, V32, P1539, DOI 10.1007/s00300-009-0654-x	50	68	69	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35968	10.1371/journal.pone.0035968	http://dx.doi.org/10.1371/journal.pone.0035968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567121	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500039
J	Cao, L; Lim, T; Jun, SM; Thornburg, T; Avci, R; Yang, XH				Cao, Ling; Lim, Timothy; Jun, SangMu; Thornburg, Theresa; Avci, Recep; Yang, Xinghong			Vulnerabilities in Yersinia pestis caf Operon Are Unveiled by a Salmonella Vector	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; PNEUMONIC PLAGUE; POLYMYXIN-B; ANTIGEN; VACCINE; MACROPHAGES; PROTECTION; IDENTIFICATION; PHAGOCYTOSIS	During infection, Yersinia pestis uses its F1 capsule to enhance survival and cause virulence to mammalian host. Since F1 is produced in large quantities and secreted into the host tissues, it also serves as a major immune target. To hold this detrimental effect under proper control, Y. pestis expresses the caf operon (encoding the F1 capsule) in a temperature-dependent manner. However, additional properties of the caf operon limit its expression. By overexpressing the caf operon in wild-type Salmonella enterica serovar Typhimurium under a potent promoter, virulence of Salmonella was greatly attenuated both in vitro and in vivo. In contrast, expression of the caf operon under the regulation of its native promoter exhibited negligible impairment of Salmonellae virulence. In-depth investigation revealed all individual genes in the caf operon attenuated Salmonella when overexpressed. The deleterious effects of caf operon and the caf individual genes were further confirmed when they were overexpressed in Y. pestis KIM6+. This study suggests that by using a weak inducible promoter, the detrimental effects of the caf operon are minimally manifested in Y. pestis. Thus, through tight regulation of the caf operon, Y. pestis precisely balances its capsular anti-phagocytic properties with the detrimental effects of caf during interaction with mammalian host.	[Cao, Ling; Avci, Recep] Montana State Univ, Dept Phys, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Cao, L (corresponding author), Montana State Univ, Dept Phys, Imaging & Chem Anal Lab, Bozeman, MT 59717 USA.	yangxh@montana.edu	Yang, Xinghong/A-5473-2012		National Institute of Allergy and Infectious Diseases [R21 AI-080960]; National Center for Research Resources [RR020185-09]; National Institute of General Medical Sciences from the National Institutes of Health [GM103500-09]; M.J. Murdock Charitable Trust, Montana Agricultural Station; U.S. Department of Agriculture Formula Funds; Office of Navy Research Award [N00014-10-1-0946]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); M.J. Murdock Charitable Trust, Montana Agricultural Station; U.S. Department of Agriculture Formula Funds(United States Department of Agriculture (USDA)); Office of Navy Research Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by grants from National Institute of Allergy and Infectious Diseases (R21 AI-080960), National Center for Research Resources (RR020185-09), and the National Institute of General Medical Sciences (GM103500-09) from the National Institutes of Health. It is supported in part by an equipment grant from the M.J. Murdock Charitable Trust, Montana Agricultural Station, and U.S. Department of Agriculture Formula Funds. It is also supported in part by Office of Navy Research Award (N00014-10-1-0946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Alvarez ML, 2010, BIOTECHNOL ADV, V28, P184, DOI 10.1016/j.biotechadv.2009.11.006; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; Bearden SW, 2008, CURR PROC MICROBIOL; CHARNETZKY WT, 1985, INFECT IMMUN, V47, P234, DOI 10.1128/IAI.47.1.234-241.1985; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Douglass II W. C., 2003, HYDROGEN PEROXIDE ME; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Goto S, 1995, J INFECT CHEMOTHER, V1, P133, DOI [10.1007/BF02348758, DOI 10.1007/BF02348758]; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Karasova D, 2009, VACCINE, V27, P5265, DOI 10.1016/j.vaccine.2009.06.060; Meka-Mechenko TV, 2003, ADV EXP MED BIOL, V529, P379; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Pascual DW, 2002, INFECT IMMUN, V70, P4273, DOI 10.1128/IAI.70.8.4273-4281.2002; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PERRY RD, 1990, J BACTERIOL, V172, P5929, DOI 10.1128/jb.172.10.5929-5937.1990; Perry RD, 2011, MICROBES INFECT, V13, P808, DOI 10.1016/j.micinf.2011.04.008; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Prouty AM, 2002, J BACTERIOL, V184, P1270, DOI 10.1128/JB.184.5.1270-1276.2002; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Ramos-Morales F, 2003, J BACTERIOL, V185, P5328, DOI 10.1128/JB.185.17.5328-5332.2003; Robinson LS, 2006, MOL MICROBIOL, V59, P870, DOI 10.1111/j.1365-2958.2005.04997.x; Runco LM, 2008, J BACTERIOL, V190, P3381, DOI 10.1128/JB.01840-07; RUSSELL P, 1995, VACCINE, V13, P1551, DOI 10.1016/0264-410X(95)00090-N; SCHMIDT G, 1987, J CLIN MICROBIOL, V25, P1993, DOI 10.1128/JCM.25.10.1993-1998.1987; Sebbane F, 2009, INFECT IMMUN, V77, P1222, DOI 10.1128/IAI.00950-08; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Soliakov A, 2010, VACCINE, V28, P5746, DOI 10.1016/j.vaccine.2010.05.074; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Suo ZY, 2009, LANGMUIR, V25, P4588, DOI 10.1021/la8033319; Urakawa H, 2010, BIOORG MED CHEM LETT, V20, P1771, DOI 10.1016/j.bmcl.2010.01.040; Vaara M, 2010, CURR OPIN MICROBIOL, V13, P574, DOI 10.1016/j.mib.2010.09.002; Walters N, 2005, INFECT IMMUN, V73, P317, DOI 10.1128/IAI.73.1.317-324.2005; Weening EH, 2011, INFECT IMMUN, V79, P644, DOI 10.1128/IAI.00981-10; Williamson ED, 2009, VACCINE, V27, pD56, DOI 10.1016/j.vaccine.2009.07.068; WU SG, 1995, INFECT IMMUN, V63, P4933, DOI 10.1128/IAI.63.12.4933-4938.1995; Yang XH, 2007, J IMMUNOL, V178, P1059, DOI 10.4049/jimmunol.178.2.1059; Yang XH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/632396; Yang XH, 2012, VIRULENCE, V3, P29, DOI 10.4161/viru.3.1.18447; Zhang SS, 2008, J BIOL CHEM, V283, P31511, DOI 10.1074/jbc.M804646200	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36283	10.1371/journal.pone.0036283	http://dx.doi.org/10.1371/journal.pone.0036283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558420	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200061
J	Schrouff, J; Kusse, C; Wehenkel, L; Maquet, P; Phillips, C				Schrouff, Jessica; Kusse, Caroline; Wehenkel, Louis; Maquet, Pierre; Phillips, Christophe			Decoding Semi-Constrained Brain Activity from fMRI Using Support Vector Machines and Gaussian Processes	PLOS ONE			English	Article							COGNITIVE STATES; CLASSIFICATION; SELECTION; INVENTORY	Predicting a particular cognitive state from a specific pattern of fMRI voxel values is still a methodological challenge. Decoding brain activity is usually performed in highly controlled experimental paradigms characterized by a series of distinct states induced by a temporally constrained experimental design. In more realistic conditions, the number, sequence and duration of mental states are unpredictably generated by the individual, resulting in complex and imbalanced fMRI data sets. This study tests the classification of brain activity, acquired on 16 volunteers using fMRI, during mental imagery, a condition in which the number and duration of mental events were not externally imposed but self-generated. To deal with these issues, two classification techniques were considered (Support Vector Machines, SVM, and Gaussian Processes, GP), as well as different feature extraction methods (General Linear Model, GLM and SVM). These techniques were combined in order to identify the procedures leading to the highest accuracy measures. Our results showed that 12 data sets out of 16 could be significantly modeled by either SVM or GP. Model accuracies tended to be related to the degree of imbalance between classes and to task performance of the volunteers. We also conclude that the GP technique tends to be more robust than SVM to model unbalanced data sets.	[Schrouff, Jessica; Kusse, Caroline; Maquet, Pierre; Phillips, Christophe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Schrouff, Jessica; Wehenkel, Louis; Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Wehenkel, Louis] Univ Liege, Giga R, Liege, Belgium; [Maquet, Pierre] Liege Univ Hosp, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Schrouff, J (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	jschrouff@doct.ulg.ac.be	Phillips, Christophe/M-3025-2017	Phillips, Christophe/0000-0002-4990-425X; , Pierre/0000-0003-3106-3357; Schrouff, Jessica/0000-0003-4992-3183	F.R.S.; Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; BIAL foundation; F.N.R.S. (Belgium) [FC86538, FC86292]	F.R.S.(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Research Fund of ULg; PAI/IAP Interuniversity Pole of Attraction; BIAL foundation(Bial Foundation); F.N.R.S. (Belgium)(Fonds de la Recherche Scientifique - FNRS)	This study was supported by the Belgian Fonds National de la Recherche Scientifique (F.R.S.-F.N.R.S.), the Fondation Medicale Reine Elisabeth, the Research Fund of ULg, the PAI/IAP Interuniversity Pole of Attraction and the BIAL foundation. JS and CK are funded by F.N.R.S. (Belgium) - Fonds pour la Recherche Industrielle et Agronomique (FRIA) grants FC86538 and FC86292, PM and CP are supported by F.N.R.S. (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, APPL SOFT COMPUT, V6, P119, DOI 10.1016/j.asoc.2004.12.002; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bishop C. M, 2006, PATTERN RECOGNITION; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chadwick M.J., 2010, CURR BIOL, P1; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Dietterich TG, 1994, J ARTIF INTELL RES, V2, P263; Formisano E, 2008, MAGN RESON IMAGING, V26, P921, DOI 10.1016/j.mri.2008.01.052; Frackowiak R, 2004, HUMAIN BRAIN FUNCTIO; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hassabis D, 2009, CURR BIOL, V19, P546, DOI 10.1016/j.cub.2009.02.033; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Spiridon M, 2002, NEURON, V35, P1157, DOI 10.1016/S0896-6273(02)00877-2; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443	33	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35860	10.1371/journal.pone.0035860	http://dx.doi.org/10.1371/journal.pone.0035860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563410	Green Published, gold			2022-12-27	WOS:000305349100036
J	Takahara, T; Minamoto, T; Yamanaka, H; Doi, H; Kawabata, Z				Takahara, Teruhiko; Minamoto, Toshifumi; Yamanaka, Hiroki; Doi, Hideyuki; Kawabata, Zen'ichiro			Estimation of Fish Biomass Using Environmental DNA	PLOS ONE			English	Article							CARP CYPRINUS-CARPIO; COMMON CARP; BENTHIVOROUS FISH; LAKE; WATER; TEMPERATURE; COMMUNITIES; STRESS; PONDS	Environmental DNA (eDNA) from aquatic vertebrates has recently been used to estimate the presence of a species. We hypothesized that fish release DNA into the water at a rate commensurate with their biomass. Thus, the concentration of eDNA of a target species may be used to estimate the species biomass. We developed an eDNA method to estimate the biomass of common carp (Cyprinus carpio L.) using laboratory and field experiments. In the aquarium, the concentration of eDNA changed initially, but reached an equilibrium after 6 days. Temperature had no effect on eDNA concentrations in aquaria. The concentration of eDNA was positively correlated with carp biomass in both aquaria and experimental ponds. We used this method to estimate the biomass and distribution of carp in a natural freshwater lagoon. We demonstrated that the distribution of carp eDNA concentration was explained by water temperature. Our results suggest that biomass data estimated from eDNA concentration reflects the potential distribution of common carp in the natural environment. Measuring eDNA concentration offers a non-invasive, simple, and rapid method for estimating biomass. This method could inform management plans for the conservation of ecosystems.	[Takahara, Teruhiko; Minamoto, Toshifumi; Kawabata, Zen'ichiro] Res Inst Human & Nat, Kyoto, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Fac Sci & Technol, Dept Environm Solut Technol, Otsu, Shiga 52021, Japan; [Takahara, Teruhiko; Doi, Hideyuki] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan	Research Institute for Humanity & Nature (RIHN); Ryukoku University; Hiroshima University	Takahara, T (corresponding author), Res Inst Human & Nat, Kyoto, Japan.	takahara@hiroshima-u.ac.jp	Doi, Hideyuki/D-2012-2010; Minamoto, Toshifumi/C-6453-2009	Doi, Hideyuki/0000-0002-2701-3982; Minamoto, Toshifumi/0000-0002-5379-1622	RIHN [C-06]	RIHN	This research project has been funded by RIHN C-06. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy. Dr. Y. Iseri is working for a private company (the West Japan Engineering Consultants, Inc.). The RIHN possessed all the data and materials, because the RIHN and his company were making a contract of research support. Thus, this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Barus V., 2002, FRESHWATER FISHES EU, P85; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BEITINGER TL, 1990, J GREAT LAKES RES, V16, P495, DOI 10.1016/S0380-1330(90)71443-8; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Engelsma MY, 2003, FISH SHELLFISH IMMUN, V15, P397, DOI 10.1016/S1050-4648(03)00006-8; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Mabuchi Kohji, 2010, Japanese Journal of Ichthyology, V57, P1; Matsui K, 2001, AQUAT MICROB ECOL, V26, P95, DOI 10.3354/ame026095; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Minamoto T, 2012, LIMNOLOGY, V13, P193, DOI 10.1007/s10201-011-0362-4; Minamoto T, 2012, RES VET SCI, V93, P508, DOI 10.1016/j.rvsc.2011.06.004; Minamoto T, 2009, APPL ENVIRON MICROB, V75, P6900, DOI 10.1128/AEM.01411-09; Mittelbach G.G., 1987, P315; Person-Le Ruyet J, 2004, AQUACULTURE, V237, P269, DOI 10.1016/j.aquaculture.2004.04.021; PITT T. K., 1956, CANADIAN JOUR ZOOL, V34, P555, DOI 10.1139/z56-055; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roberts J, 1995, MAR FRESHWATER RES, V46, P1171, DOI 10.1071/MF9951171; Takahara T, 2011, HYDROBIOLOGIA, V675, P65, DOI 10.1007/s10750-011-0796-z; Titus JE, 2004, AQUAT BOT, V79, P33, DOI 10.1016/j.aquabot.2003.11.006; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Venables W. N., 2002, STAT COMPLEMENTS MOD; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Zambrano L, 2001, OIKOS, V94, P344, DOI 10.1034/j.1600-0706.2001.940215.x; Zambrano L, 1999, HYDROBIOLOGIA, V408, P131, DOI 10.1023/A:1017085129620	29	410	459	33	371	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35868	10.1371/journal.pone.0035868	http://dx.doi.org/10.1371/journal.pone.0035868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563411	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100037
J	Huang, ZF; Zhu, GH; Sun, CC; Zhang, JG; Zhang, Y; Zhang, YT; Ye, CH; Wang, XJ; Ilghari, D; Li, XK				Huang, Zhifeng; Zhu, Guanghui; Sun, Chuanchuan; Zhang, Jingui; Zhang, Yi; Zhang, Youting; Ye, Chaohui; Wang, Xiaojie; Ilghari, Dariush; Li, Xiaokun			A Novel Solid-Phase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1	PLOS ONE			English	Article							POLYETHYLENE-GLYCOL; CHEMICAL-MODIFICATION; MONO-PEGYLATION; ORAL MUCOSITIS; HEPATITIS-C; STABILITY; AGGREGATION; PALIFERMIN; RATS; INTERFERON-ALPHA-2B	Keratinocyte growth factor 1 (KGF-1) has proven useful in the treatment of pathologies associated with dermal adnexae, liver, lung, and the gastrointestinal tract diseases. However, poor stability and short plasma half-life of the protein have restricted its therapeutic applications. While it is possible to improve the stability and extend the circulating half-life of recombinant human KGF-1 (rhKGF-1) using solution-phase PEGylation, such preparations have heterogeneous structures and often low specific activities due to multiple and/or uncontrolled PEGylation. In the present study, a novel solid-phase PEGylation strategy was employed to produce homogenous mono-PEGylated rhKGF-1. RhKGF-1 protein was immobilized on a Heparin-Sepharose column and then a site-selective PEGylation reaction was carried out by a reductive alkylation at the N-terminal amino acid of the protein. The mono-PEGylated rhKGF-1, which accounted for over 40% of the total rhKGF-1 used in the PEGylation reaction, was purified to homogeneity by SP Sepharose ion-exchange chromatography. Our biophysical and biochemical studies demonstrated that the solid-phase PEGylation significantly enhanced the in vitro and in vivo biostability without affecting the over all structure of the protein. Furthermore, pharmacokinetic analysis showed that modified rhKGF-1 had considerably longer plasma half-life than its intact counterpart. Our cell-based analysis showed that, similar to rhKGF-1, PEGylated rhKGF-1 induced proliferation in NIH 3T3 cells through the activation of MAPK/Erk pathway. Notably, PEGylated rhKGF-1 exhibited a greater hepatoprotection against CCl4-induced injury in rats compared to rhKGF-1.	[Huang, Zhifeng; Sun, Chuanchuan; Zhang, Jingui; Zhang, Yi; Ye, Chaohui; Wang, Xiaojie; Li, Xiaokun] Wenzhou Med Coll, Key Lab Biotechnol & Pharmaceut Engn Zhejiang Pro, Wenzhou, Peoples R China; [Zhu, Guanghui; Zhang, Youting] Wenzhou Med Coll, Affiliated Hosp 2, Med Ctr, Wenzhou, Peoples R China; [Ilghari, Dariush] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Li, Xiaokun] Jilin Univ, Normal Bethune Med Coll, Changchun 130023, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; New York University; Jilin University	Huang, ZF (corresponding author), Wenzhou Med Coll, Key Lab Biotechnol & Pharmaceut Engn Zhejiang Pro, Wenzhou, Peoples R China.	Dariush.Ilghari@nyumc.org; proflxk@163.com	Zhu, Guangshan/E-2024-2013		Natural Science Foundation [81102486]; Natural Science Foundation of Zhejiang Province of China [Y4100067]; Key Grant of Wenzhou Department of Science and Technology [Y20100004]; Zhejiang Provincial Key Research Group [2010R50042]; China Postdoctoral Science Foundation Project [20110491431]	Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Key Grant of Wenzhou Department of Science and Technology; Zhejiang Provincial Key Research Group; China Postdoctoral Science Foundation Project(China Postdoctoral Science Foundation)	This study was supported, in part, by grants from Natural Science Foundation, 81102486 (to ZH); Natural Science Foundation of Zhejiang Province of China, Y4100067 (to ZH); Key Grant of Wenzhou Department of Science and Technology, Y20100004 (to ZH); Zhejiang Provincial Key Research Group, 2010R50042 (to XL) and China Postdoctoral Science Foundation Project, 20110491431 (to ZH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSPACH FB, 1995, J CHROMATOGR A, V711, P129; Balan S, 2007, BIOCONJUGATE CHEM, V18, P61, DOI 10.1021/bc0601471; Basu A, 2006, BIOCONJUGATE CHEM, V17, P618, DOI 10.1021/bc050322y; Beaven AW, 2006, EXPERT OPIN PHARMACO, V7, P2287, DOI 10.1517/14656566.7.16.2287; Berg T, 2007, HEPATOLOGY, V46, P1187, DOI 10.1002/hep.21814; Blijlevens N, 2007, ANN ONCOL, V18, P817, DOI 10.1093/annonc/mdl332; Bohm F, 2010, GASTROENTEROLOGY, V139, P1385, DOI 10.1053/j.gastro.2010.06.069; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Cai YQ, 2011, J CHROMATOGR A, V1218, P6953, DOI 10.1016/j.chroma.2011.07.107; Caliceti P, 2003, ADV DRUG DELIVER REV, V55, P1261, DOI 10.1016/S0169-409X(03)00108-X; CHEN BL, 1994, J PHARM SCI, V83, P1657, DOI 10.1002/jps.2600831204; Chen BL, 1996, J PHARM SCI, V85, P419, DOI 10.1021/js9504393; CHEN BL, 1994, PHARMACEUT RES, V11, P1581, DOI 10.1023/A:1018905720139; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DeSantis G, 1999, CURR OPIN BIOTECH, V10, P324, DOI 10.1016/S0958-1669(99)80059-7; George S, 2008, CANCER CHEMOTH PHARM, V62, P347, DOI 10.1007/s00280-007-0594-5; Hsu E, 2006, PROTEIN ENG DES SEL, V19, P147, DOI 10.1093/protein/gzj013; Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706; Huang ZF, 2007, TOXICOL LETT, V170, P146, DOI 10.1016/j.toxlet.2007.03.001; Huang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020669; Huang Z, 2009, J BIOTECHNOL, V142, P242, DOI 10.1016/j.jbiotec.2009.05.004; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kaido T, 1996, BIOCHEM BIOPH RES CO, V218, P1, DOI 10.1006/bbrc.1996.0001; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; KUAN CT, 1994, J BIOL CHEM, V269, P7610; Lee BK, 2007, BIOCONJUGATE CHEM, V18, P1728, DOI 10.1021/bc060245m; Lee H, 2003, PHARMACEUT RES, V20, P818, DOI 10.1023/A:1023402123119; Lin JH, 1997, PHARMACOL REV, V49, P403; Luo YD, 2004, PROTEIN EXPRES PURIF, V33, P326, DOI 10.1016/j.pep.2003.10.013; Marti Guy P., 2008, V423, P383, DOI 10.1007/978-1-59745-194-9_30; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; MIKI T, 1991, SCIENCE, V251, P72, DOI 10.1126/science.1846048; Niall H D, 1973, Methods Enzymol, V27, P942; Nie YJ, 2006, BIOCONJUGATE CHEM, V17, P995, DOI 10.1021/bc050355d; Niu JG, 2007, J BIOL CHEM, V282, P6001, DOI 10.1074/jbc.M606878200; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4; Slavica A, 2007, BIOTECHNOL BIOENG, V96, P9, DOI 10.1002/bit.21181; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Tamai H, 2011, HEPATOL RES, V41, P1137, DOI 10.1111/j.1872-034X.2011.00879.x; TSUBOI R, 1993, J INVEST DERMATOL, V101, P49, DOI 10.1111/1523-1747.ep12358892; Tsutsumi Y, 2000, P NATL ACAD SCI USA, V97, P8548, DOI 10.1073/pnas.140210597; Wu XP, 2010, J CELL MOL MED, V14, P351, DOI 10.1111/j.1582-4934.2008.00506.x; Xiao JP, 2008, BIOCONJUGATE CHEM, V19, P1113, DOI 10.1021/bc800063k; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812	48	19	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36423	10.1371/journal.pone.0036423	http://dx.doi.org/10.1371/journal.pone.0036423			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574160	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800056
J	Kumsta, C; Hansen, M				Kumsta, Caroline; Hansen, Malene			C. elegans rrf-1 Mutations Maintain RNAi Efficiency in the Soma in Addition to the Germline	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN EXTENSION; GENETIC INTERFERENCE; GATA-FACTOR; PATHWAYS; PROTEIN; DAF-16; DIFFERENTIATION; MORPHOGENESIS; LOCALIZATION	Gene inactivation through RNA interference (RNAi) has proven to be a valuable tool for studying gene function in C. elegans. When combined with tissue-specific gene inactivation methods, RNAi has the potential to shed light on the function of a gene in distinct tissues. In this study we characterized C. elegans rrf-1 mutants to determine their ability to process RNAi in various tissues. These mutants have been widely used in RNAi studies to assess the function of genes specifically in the C. elegans germline. Upon closer analysis, we found that two rrf-1 mutants carrying different loss-of-function alleles were capable of processing RNAi targeting several somatically expressed genes. Specifically, we observed that the intestine was able to process RNAi triggers efficiently, whereas cells in the hypodermis showed partial susceptibility to RNAi in rrf-1 mutants. Other somatic tissues in rrf-1 mutants, such as the muscles and the somatic gonad, appeared resistant to RNAi. In addition to these observations, we found that the rrf-1(pk1417) mutation induced the expression of several transgenic arrays, including the FOXO transcription factor DAF-16. Unexpectedly, rrf-1(pk1417) mutants showed increased endogenous expression of the DAF-16 target gene sod-3; however, the lifespan and thermo-tolerance of rrf-1(pk1417) mutants were similar to those of wild-type animals. In sum, these data show that rrf-1 mutants display several phenotypes not previously appreciated, including broader tissue-specific RNAi-processing capabilities, and our results underscore the need for careful characterization of tissue-specific RNAi tools.	[Kumsta, Caroline; Hansen, Malene] Dell E Webb Neurosci Aging & Stem Cell Res Ctr, Sanford Burnham Med Res Inst, Program Dev & Aging, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Kumsta, C (corresponding author), Dell E Webb Neurosci Aging & Stem Cell Res Ctr, Sanford Burnham Med Res Inst, Program Dev & Aging, La Jolla, CA USA.	mhansen@sanfordburnham.org	Kumsta, Caroline/AAU-9147-2020		American Association for Cancer Research -Astellas Pharma Global Development Inc. [11-40-28-KUMS]; National Insititutes of Health/National Insititute on Aging [1 R01 AG038664-01A1, 1 R01 AG039756]; Ellison Medical Foundation New Scholar in Aging [AG-NS-0481-08]; American Association for Cancer Research; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE ON AGING [R01AG039756, R01AG038664] Funding Source: NIH RePORTER	American Association for Cancer Research -Astellas Pharma Global Development Inc.; National Insititutes of Health/National Insititute on Aging; Ellison Medical Foundation New Scholar in Aging(Lawrence Ellison Foundation); American Association for Cancer Research; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	CK is funded by an American Association for Cancer Research -Astellas Pharma Global Development Inc. Fellowship in Basic Cancer Research Grant (Grant Number: 11-40-28-KUMS - http://www.aacr.org/home/scientists/aacr-research-funding.aspx). MH is funded by National Insititutes of Health/National Insititute on Aging (Grant numbers: 1 R01 AG038664-01A1 and 1 R01 AG039756). MH is also an Ellison Medical Foundation New Scholar in Aging (Grant number: AG-NS-0481-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CK was funded by the American Association for Cancer Research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We would like to thank all members of the Hansen Lab for fruitful discussions, and Drs. Anne Brunet, Sean Curran, Andrew Fire, and Anne O'Rourke for feedback on the manuscript. We are grateful to Joyce Chu for repeating the lifespan experiment, and to Sara Gelino, Binnan Ong and Andrew Davis, who generated some of the strains used in this study. We thank the Kenyon lab, the Tuck lab, and the Desai lab for providing strains, and the Dillin lab and Moribe lab for providing the gfp and tsp-15 RNAi clones, respectively. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center (CGC), which is funded by the NIH National Center for Research Resources (NCRR).	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Currie E, 2007, GENETICS, V177, P1569, DOI 10.1534/genetics.107.080689; Deshpande R, 2005, DEV BIOL, V278, P118, DOI 10.1016/j.ydbio.2004.10.020; Drabikowski K, 2005, DEV BIOL, V282, P27, DOI 10.1016/j.ydbio.2005.02.017; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fischer SEJ, 2008, NATURE, V455, P491, DOI 10.1038/nature07274; Fischer SEJ, 2010, INT J BIOCHEM CELL B, V42, P1306, DOI 10.1016/j.biocel.2010.03.006; FRANCIS R, 1995, GENETICS, V139, P579; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; GAO DL, 1995, P NATL ACAD SCI USA, V92, P9839, DOI 10.1073/pnas.92.21.9839; Govindan JA, 2009, DEVELOPMENT, V136, P2211, DOI 10.1242/dev.034595; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; HAWKINS MG, 1995, J BIOL CHEM, V270, P14666, DOI 10.1074/jbc.270.24.14666; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Hurd D, 2003, DEV BIOL, V253, P54, DOI 10.1006/dbio.2002.0866; Ito S, 2010, CURR BIOL, V20, P333, DOI 10.1016/j.cub.2009.12.032; Jose AM, 2007, ANNU REV GENET, V41, P305, DOI 10.1146/annurev.genet.41.110306.130216; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimble Judith, 2005, WormBook, P1; Koh K, 2001, DEVELOPMENT, V128, P2867; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Maciejowski J, 2005, GENETICS, V169, P1997, DOI 10.1534/genetics.104.040121; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; Maine Eleanor M., 2008, Briefings in Functional Genomics & Proteomics, V7, P184, DOI 10.1093/bfgp/eln019; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Murphy CT, 2006, EXP GERONTOL, V41, P910, DOI 10.1016/j.exger.2006.06.040; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ono K, 2008, J CELL SCI, V121, P2662, DOI 10.1242/jcs.034215; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; Praitis V, 2001, GENETICS, V157, P1217; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Reece-Hoyes JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2168-8-27; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Samuelson AV, 2007, COLD SPRING HARB SYM, V72, P489, DOI 10.1101/sqb.2007.72.068; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; THACKER C, 1995, GENE DEV, V9, P956, DOI 10.1101/gad.9.8.956; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Voutev R, 2006, DEV BIOL, V298, P45, DOI 10.1016/j.ydbio.2006.06.011; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836	61	85	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35428	10.1371/journal.pone.0035428	http://dx.doi.org/10.1371/journal.pone.0035428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574120	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800016
J	Umbach, JA; Adams, KL; Gundersen, CB; Novitch, BG				Umbach, Joy A.; Adams, Katrina L.; Gundersen, Cameron B.; Novitch, Bennett G.			Functional Neuromuscular Junctions Formed by Embryonic Stem Cell-Derived Motor Neurons	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; AMYOTROPHIC-LATERAL-SCLEROSIS; DIRECTED DIFFERENTIATION; NEUROTRANSMITTER RELEASE; SYNAPTIC VULNERABILITY; MOTONEURONS; DISEASE; TRANSPLANTATION; DIVERSITY; MOUSE	A key objective of stem cell biology is to create physiologically relevant cells suitable for modeling disease pathologies in vitro. Much progress towards this goal has been made in the area of motor neuron (MN) disease through the development of methods to direct spinal MN formation from both embryonic and induced pluripotent stem cells. Previous studies have characterized these neurons with respect to their molecular and intrinsic functional properties. However, the synaptic activity of stem cell-derived MNs remains less well defined. In this study, we report the development of low-density co-culture conditions that encourage the formation of active neuromuscular synapses between stem cell-derived MNs and muscle cells in vitro. Fluorescence microscopy reveals the expression of numerous synaptic proteins at these contacts, while dual patch clamp recording detects both spontaneous and multi-quantal evoked synaptic responses similar to those observed in vivo. Together, these findings demonstrate that stem cell-derived MNs innervate muscle cells in a functionally relevant manner. This dual recording approach further offers a sensitive and quantitative assay platform to probe disorders of synaptic dysfunction associated with MN disease.	[Umbach, Joy A.; Gundersen, Cameron B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Adams, Katrina L.; Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Adams, Katrina L.; Novitch, Bennett G.] Univ Calif Los Angeles, Mol Biol Interdisciplinary Grad Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Umbach, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	bnovitch@ucla.edu	Adams, Katrina/GLV-6737-2022	Adams, Katrina/0000-0001-5290-4245; Gundersen, Cameron/0000-0002-1552-6086; Novitch, Bennett/0000-0002-2696-3708	Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles; California Institute for Regenerative Medicine [RB1-01367]; Muscular Dystrophy Association [92901]; University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award [GM007185]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Muscular Dystrophy Association(Muscular Dystrophy Association); University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Broad Center for Regenerative Medicine and Stem Cell Research at the University of California Los Angeles, and grants to BGN from the California Institute for Regenerative Medicine (RB1-01367) and the Muscular Dystrophy Association (92901). KLA was also supported by the University of California Los Angeles Cellular and Molecular Biology Training Program, Ruth L. Kirschstein National Research Service Award GM007185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6; di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; FATT P, 1951, J PHYSIOL-LONDON, V115, P320, DOI 10.1113/jphysiol.1951.sp004675; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Guo XF, 2010, TISSUE ENG PART C-ME, V16, P1347, DOI [10.1089/ten.tec.2010.0040, 10.1089/ten.TEC.2010.0040]; Karumbayaram S, 2009, DIS MODEL MECH, V2, P189, DOI 10.1242/dmm.002113; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Patani R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1216; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Poage RE, 1999, J NEUROPHYSIOL, V82, P50, DOI 10.1152/jn.1999.82.1.50; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SINGH RN, 2005, EXP NEUROL, V196, P224, DOI DOI 10.1016/J.EXPNEUROL.2005.06.021; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; Vande Velde Christine, 2011, F1000 Biol Rep, V3, P18, DOI 10.3410/B3-18; Wee CD, 2010, CURR OPIN NEUROL, V23, P450, DOI 10.1097/WCO.0b013e32833e1765; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle H, 2008, CURR PROTOC STEM CEL, V1, P9; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yohn DC, 2008, J NEUROSCI, V28, P12409, DOI 10.1523/JNEUROSCI.1761-08.2008	37	66	79	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36049	10.1371/journal.pone.0036049	http://dx.doi.org/10.1371/journal.pone.0036049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574134	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800030
J	Steg, PG; Ferrari, R; Ford, I; Greenlaw, N; Tardif, JC; Tendera, M; Abergel, H; Fox, KM				Steg, Ph Gabriel; Ferrari, Roberto; Ford, Ian; Greenlaw, Nicola; Tardif, Jean-Claude; Tendera, Michal; Abergel, Helene; Fox, Kim M.		CLARIFY Investigators	Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; I-F INHIBITOR; EXTERNAL VALIDITY; SUBGROUP ANALYSIS; DOUBLE-BLIND; RISK-FACTOR; TASK-FORCE; ANGINA	Background: Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD). However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice. The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR. Methods and Findings: CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable CAD, defined as prior myocardial infarction or revascularization procedure, evidence of coronary stenosis of >50%, or chest pain associated with proven myocardial ischemia. A total of 33,438 patients from 45 countries in Europe, the Americas, Africa, Middle East, and Asia/Pacific were enrolled between November 2009 and July 2010. Most of the 33,177 patients included in this analysis were men (77.5%). Mean (SD) age was 64.2 (10.5) years, HR by pulse was 68.3 (10.6) bpm, and by electrocardiogram was 67.2 (11.4) bpm. Overall, 44.0% had HR >= 70 bpm. Beta-blockers were used in 75.1% of patients and another 14.4% had intolerance or contraindications to beta-blocker therapy. Among 24,910 patients on beta-blockers, 41.1% had HR >= 70 bpm. HR >= 70 bpm was independently associated with higher prevalence and severity of angina, more frequent evidence of myocardial ischemia, and lack of use of HR-lowering agents. Conclusions: Despite a high rate of use of beta-blockers, stable CAD patients often have resting HR >= 70 bpm, which was associated with an overall worse health status, more frequent angina and ischemia. Further HR lowering is possible in many patients with CAD. Whether it will improve symptoms and outcomes is being tested.	[Steg, Ph Gabriel; Abergel, Helene] INSERM, U698, Paris, France; [Steg, Ph Gabriel; Abergel, Helene] Univ Paris Diderot, Paris, France; [Steg, Ph Gabriel; Abergel, Helene] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Ferrari, Roberto] Univ Ferrara, Salvatore Maugeri Fdn, IRCCS, Dept Cardiol, Lumezzan, Italy; [Ferrari, Roberto] Univ Ferrara, Salvatore Maugeri Fdn, IRCCS, LTTA Ctr, Lumezzan, Italy; [Ford, Ian; Greenlaw, Nicola] Univ Glasgow, Glasgow, Lanark, Scotland; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Tendera, Michal] Med Univ Silesia, Katowice, Poland; [Fox, Kim M.] Royal Brompton Hosp, ICMS, NHLI Imperial Coll, London SW3 6LY, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Istituti Clinici Scientifici Maugeri IRCCS; University of Ferrara; Istituti Clinici Scientifici Maugeri IRCCS; University of Ferrara; University of Glasgow; Universite de Montreal; Medical University Silesia; Imperial College London; Royal Brompton Hospital	Steg, PG (corresponding author), INSERM, U698, Paris, France.	gabriel.steg@bch.ap-hop-paris.fr	Marchionni, Niccolò/ABE-3977-2020; chioncel, ovidiu/K-8425-2019; Gowdak, Luis Henrique Wolff/M-7153-2017; Dženkevičiūtė, Vilma/AAB-6975-2021; Bogdański, Paweł/ABB-2938-2020; FERRARI, ROBERTO/ABD-5169-2020; Tendera, Michal/AAA-1875-2022; Chioncel, Ovidiu/R-7556-2017; Widimsky, Petr/P-8088-2016; Makarenkova, Kseniia/AAB-5482-2019; Colquhoun, David M/F-9078-2013; Georgescu, Catalina Arsenescu/R-5709-2017; Kaab, Stefan/H-3915-2012; Hairullina, Adelya/AAF-6013-2019; Prunier, Fabrice/A-5210-2011; Lukina, Yulia/J-9925-2017; Ford, Ian/ABE-6145-2020; Gowdak, Luis Henrique Wolff/C-4844-2012; Sosner, Philippe/I-6119-2019; Díaz, José Luis JLDD Díaz/Q-2523-2015; Christodorescu, Ruxandra Maria/AAB-4653-2021; STEG, Philippe Gabriel/Z-1567-2019; Nastari, Luciano/C-8528-2012; Idoate, Miguel-Ángel/D-8502-2019; Ushakov, Alexei V/P-4465-2015; Gruchala, Marcin/S-8407-2018; Hernandez Afonso, Julio/I-2223-2017	Marchionni, Niccolò/0000-0002-8101-4695; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Dženkevičiūtė, Vilma/0000-0003-1471-9131; Bogdański, Paweł/0000-0002-0563-1624; Chioncel, Ovidiu/0000-0002-3197-3628; Widimsky, Petr/0000-0001-5686-7752; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Hairullina, Adelya/0000-0002-7832-2267; Lukina, Yulia/0000-0001-8252-3099; Gowdak, Luis Henrique Wolff/0000-0002-6785-7506; Sosner, Philippe/0000-0002-5771-8174; Christodorescu, Ruxandra Maria/0000-0001-8267-5404; Nastari, Luciano/0000-0002-7959-3827; Idoate, Miguel-Ángel/0000-0002-1596-1192; Ushakov, Alexei V/0000-0002-7020-4442; Gomez Doblas, Juan Jose/0000-0002-9020-639X; STEG, Philippe Gabriel/0000-0001-6896-2941; Cziraki MD.PhD. Professor., Attila/0000-0002-8231-3312; Nicolino, Antonio/0000-0001-9667-703X; Aboyans, Victor/0000-0002-0322-9818; GALINIER, Michel/0000-0003-1735-3390; Aksutina, Natal'a/0000-0002-4856-2729; Walker, David/0000-0002-3541-8955; al suwaidi, MB, ChB, FACC, FESC, FSCAI, jassim/0000-0002-5299-9106; Florescu, Cristina/0000-0001-8597-3407; Freitas, Joao/0000-0001-7478-3042; Gruchala, Marcin/0000-0003-4901-2291; Phrommintikul, Arintaya/0000-0003-3986-1951; Ferrari, Roberto/0000-0003-2046-9175; Manzur, Fernando/0000-0001-6679-5609; Hernandez Afonso, Julio/0000-0002-0982-1759; Bryl, Wieslaw/0000-0003-0135-409X; Wongcharoen, Wanwarang/0000-0002-2418-329X; Shiels, Paul/0000-0002-7577-9843; gosse, philippe/0000-0002-5840-7749; Bravo Baptista, Sergio/0000-0002-4546-5261; Tendera, Michal/0000-0002-0812-6113; jourdain, patrick/0000-0002-5202-6902	Servier, France; Servier; Amgen; Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo/Eli Lilly alliance; Eisai; GlaxoSmithKline; Medtronic; Merck Sharpe and Dohme; Pfizer; Roche; sanofi-aventis; Medicines Company; Menarini; TIMI Group; National Institute for Health Research [NF-SI-0611-10149] Funding Source: researchfish	Servier, France(Servier); Servier(Servier); Amgen(Amgen); Astellas(Astellas Pharmaceuticals); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo/Eli Lilly alliance(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); Medtronic(Medtronic); Merck Sharpe and Dohme(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); sanofi-aventis(Sanofi-Aventis); Medicines Company; Menarini(Menarini Group); TIMI Group; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by research grants from Servier, France (http://www.clarify-registry.com). The study was designed and conducted by the investigators and funded via grants from Servier, including a grant to the academic statistical center. The sponsor provided assistance for study set-up and management in each country, and funded editorial assistance in the preparation of the manuscript, tables, and figures by Sophie Rushton-Smith. The sponsor was sent the manuscript before submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This study was supported by research grants from Servier, France. PGS: has received research grants from Servier; consultancy fees/honoraria from Amgen, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo/Eli Lilly alliance, Eisai, GlaxoSmithKline, Medtronic, Merck Sharpe and Dohme, Pfizer, Roche, sanofi-aventis, Servier, and The Medicines Company; and has equity ownership in Aterovax. RF: Speaker's bureau: Servier, Roche and Boehringer Ingelheim; Research Grant: Servier, Boehringer Ingelheim and Roche; Advisory Board: Servier, Bayer, Roche and Boehringer Ingelheim. IF: Research grants, honoraria for committee membership, and support for conference attendance from Servier. NG: none. J-CT: Research grants and honoraria from Servier. MT: Fees, honoraria, and research grants from Amgen, Bayer, Menarini, Servier and TIMI Group. HA: none. KMF: Fees, honoraria, and research grants from Servier. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Anderson GF, 2007, NEW ENGL J MED, V356, P209, DOI 10.1056/NEJMp068182; Antoni ML, 2012, EUR HEART J, V33, P96, DOI 10.1093/eurheartj/ehr293; Bagnall AJ, 2010, CIRC-CARDIOVASC QUAL, V3, P530, DOI 10.1161/CIRCOUTCOMES.109.919415; Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7; Borer JS, 2003, CIRCULATION, V107, P817, DOI 10.1161/01.CIR.0000048143.25023.87; CLAUSEN JP, 1976, PROG CARDIOVASC DIS, V18, P459, DOI 10.1016/0033-0620(76)90012-8; Daly CA, 2010, POSTGRAD MED J, V86, P212, DOI 10.1136/pgmj.2009.084384; Diaz A, 2005, EUR HEART J, V26, P967, DOI 10.1093/eurheartj/ehi190; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X; Fox K, 2007, J AM COLL CARDIOL, V50, P823, DOI 10.1016/j.jacc.2007.04.079; Fox K, 2009, EUR HEART J, V30, P2337, DOI 10.1093/eurheartj/ehp358; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; HJALMARSON A, 1990, AM J CARDIOL, V65, P547, DOI 10.1016/0002-9149(90)91029-6; Ho JE, 2010, AM J CARDIOL, V105, P905, DOI 10.1016/j.amjcard.2009.11.035; Hsia J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b219; Kolloch R, 2008, EUR HEART J, V29, P1327, DOI 10.1093/eurheartj/ehn123; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Rambihar S, 2010, CIRCULATION, V122; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Steg PG, 2007, ARCH INTERN MED, V167, P68, DOI 10.1001/archinte.167.1.68; Steg PG, 2009, EUR HEART J SUPPL, V11, pD13, DOI 10.1093/eurheartj/sup017; Tardif JC, 2005, EUR HEART J, V26, P2529, DOI 10.1093/eurheartj/ehi586; Tardif JC, 2009, EUR HEART J, V30, P540, DOI 10.1093/eurheartj/ehn571; Waters DD, 2010, EUR HEART J, V31, P801	30	80	83	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36284	10.1371/journal.pone.0036284	http://dx.doi.org/10.1371/journal.pone.0036284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570699	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400015
J	Suzuki, K; Matsui, Y; Higashimoto, M; Kawaguchi, Y; Seki, S; Motomura, H; Hori, T; Yahara, Y; Kanamori, M; Kimura, T				Suzuki, Kayo; Matsui, Yoshito; Higashimoto, Mami; Kawaguchi, Yoshiharu; Seki, Shoji; Motomura, Hiraku; Hori, Takeshi; Yahara, Yasuhito; Kanamori, Masahiko; Kimura, Tomoatsu			Myxoid Liposarcoma-Associated EWSR1-DDIT3 Selectively Represses Osteoblastic and Chondrocytic Transcription in Multipotent Mesenchymal Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE; BINDING-PROTEIN; DNA METHYLATION; POSTCONFLUENCE INHIBITION; GENE-TRANSCRIPTION; FUSION PROTEIN; PPAR-GAMMA; IN-VITRO; CHOP; COLLAGEN	Background: Liposarcomas are the most common class of soft tissue sarcomas, and myxoid liposarcoma is the second most common liposarcoma. EWSR1-DDIT3 is a chimeric fusion protein generated by the myxoid liposarcoma-specific chromosomal translocation t(12;22)(q13;q12). Current studies indicate that multipotent mesenchymal cells are the origin of sarcomas. The mechanism whereby EWSR1-DDIT3 contributes to the phenotypic selection of target cells during oncogenic transformation remains to be elucidated. Methodology/Principal Findings: Reporter assays showed that the EWSR1-DDIT3 myxoid liposarcoma fusion protein, but not its wild-type counterparts EWSR1 and DDIT3, selectively repressed the transcriptional activity of cell lineage-specific marker genes in multipotent mesenchymal C3H10T1/2 cells. Specifically, the osteoblastic marker Opn promoter and chondrocytic marker Col11a2 promoter were repressed, while the adipocytic marker Ppar-gamma 2 promoter was not affected. Mutation analyses, transient ChIP assays, and treatment of cells with trichostatin A (a potent inhibitor of histone deacetylases) or 5-Aza-2'-deoxycytidine (a methylation-resistant cytosine homolog) revealed the possible molecular mechanisms underlying the above-mentioned selective transcriptional repression. The first is a genetic action of the EWSR1-DDIT3 fusion protein, which results in binding to the functional C/EBP site within Opn and Col11a2 promoters through interaction of its DNA-binding domain and subsequent interference with endogenous C/EBP beta function. Another possible mechanism is an epigenetic action of EWSR1-DDIT3, which enhances histone deacetylation, DNA methylation, and histone H3K9 trimethylation at the transcriptional repression site. We hypothesize that EWSR1-DDIT3-mediated transcriptional regulation may modulate the target cell lineage through target gene-specific genetic and epigenetic conversions. Conclusions/Significance: This study elucidates the molecular mechanisms underlying EWSR1-DDIT3 fusion protein-mediated phenotypic selection of putative target multipotent mesenchymal cells during myxoid liposarcoma development. A better understanding of this process is fundamental to the elucidation of possible direct lineage reprogramming in oncogenic sarcoma transformation mediated by fusion proteins.	[Suzuki, Kayo; Matsui, Yoshito; Higashimoto, Mami; Kawaguchi, Yoshiharu; Seki, Shoji; Motomura, Hiraku; Hori, Takeshi; Yahara, Yasuhito; Kimura, Tomoatsu] Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 930, Japan; [Kanamori, Masahiko] Toyama Univ, Fac Med, Dept Human Sci, Toyama 930, Japan	University of Toyama; University of Toyama	Suzuki, K (corresponding author), Toyama Univ, Fac Med, Dept Orthopaed Surg, Toyama 930, Japan.	m-yoshito@umin.ac.jp	Yahara, Yasuhito/AAO-7487-2020		KAKENHI [22591683]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-Aid for Scientific Research (C) 22591683 (KAKENHI). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelmant G, 1998, J BIOL CHEM, V273, P15574, DOI 10.1074/jbc.273.25.15574; Antonescu C, 2002, PATHOLOGY GENETICS T, P40; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Carbone R, 2006, MOL CELL BIOL, V26, P1288, DOI 10.1128/MCB.26.4.1288-1296.2006; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Conyers Rachel, 2011, Sarcoma, V2011, P483154, DOI 10.1155/2011/483154; CRAIG AM, 1991, GENE, V100, P163, DOI 10.1016/0378-1119(91)90362-F; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; Gonzalez I, 2007, J MOL MED, V85, P1015, DOI 10.1007/s00109-007-0202-5; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Hata K, 2005, MOL CELL BIOL, V25, P1971, DOI 10.1128/MCB.25.5.1971-1979.2005; Illich DJ, 2011, STEM CELLS, V29, P555, DOI 10.1002/stem.611; Jalagadugula G, 2010, BLOOD, V116, P6037, DOI 10.1182/blood-2010-06-289850; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMURA T, 1989, J BIOL CHEM, V264, P13910; Krishnan B, 2008, CLIN ORTHOP RELAT R, V466, P2131, DOI 10.1007/s11999-008-0342-0; Kubo T, 2006, BIOCHEM BIOPH RES CO, V340, P476, DOI 10.1016/j.bbrc.2005.12.042; Kubo T, 2010, ANTICANCER RES, V30, P661; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Mai A, 2006, J MED CHEM, V49, P6897, DOI 10.1021/jm060601m; Matsui Y, 2003, J BIOL CHEM, V278, P11369, DOI 10.1074/jbc.M300164200; Matsui Y, 1998, CANCER LETT, V124, P143, DOI 10.1016/S0304-3835(97)00468-0; Matsui Y, 2006, BIOCHEM BIOPH RES CO, V348, P437, DOI 10.1016/j.bbrc.2006.07.085; Mohseny AB, 2011, STEM CELLS, V29, P397, DOI 10.1002/stem.596; Nguyen CT, 2002, CANCER RES, V62, P6456; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; Panagopoulos I, 1996, ONCOGENE, V12, P489; PARK JS, 1992, GENE, V116, P259, DOI 10.1016/0378-1119(92)90523-R; Perez-Mancera PA, 2005, SEMIN CANCER BIOL, V15, P206, DOI 10.1016/j.semcancer.2005.01.006; Perez-Mancera PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002569; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Robertson KD, 2000, NAT GENET, V25, P338, DOI 10.1038/77124; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rubio R, 2010, CANCER RES, V70, P4185, DOI 10.1158/0008-5472.CAN-09-4640; Secchiero P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011140; Shi XM, 2000, J CELL BIOCHEM, V76, P518, DOI 10.1002/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M; Shirakawa K, 2006, MOL CELL BIOL, V26, P6105, DOI 10.1128/MCB.02429-05; Strunnikova M, 2005, MOL CELL BIOL, V25, P3923, DOI 10.1128/MCB.25.10.3923-3933.2005; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Suzuki K, 2011, ONCOL LETT IN PRESS; Suzuki K, 2010, ANTICANCER RES, V30, P4679; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Tenbrock K, 2005, J IMMUNOL, V175, P5975, DOI 10.4049/jimmunol.175.9.5975; Tezuka KI, 1996, J BIOL CHEM, V271, P22713, DOI 10.1074/jbc.271.37.22713; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; Turriziani M, 2006, PHARMACOL RES, V53, P317, DOI 10.1016/j.phrs.2005.12.001; Valen E, 2011, TRENDS GENET, V27, P475, DOI 10.1016/j.tig.2011.08.001; Weiss SW, 2001, ENZINGER WEISSS SOFT, P641; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zohar R, 1997, J CELL PHYSIOL, V170, P88	78	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36682	10.1371/journal.pone.0036682	http://dx.doi.org/10.1371/journal.pone.0036682			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570737	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343400053
J	Chu, H; Wang, JJ; Qi, ML; Yoon, JJ; Wen, XY; Chen, XM; Ding, LM; Spearman, P				Chu, Hin; Wang, Jaang-Jiun; Qi, Mingli; Yoon, Jeong-Joong; Wen, Xiaoyun; Chen, Xuemin; Ding, Lingmei; Spearman, Paul			The Intracellular Virus-Containing Compartments in Primary Human Macrophages Are Largely Inaccessible to Antibodies and Small Molecules	PLOS ONE			English	Article							PLASMA-MEMBRANE; HIV-1 ASSEMBLES; SURFACE-CHARGE; TYPE-1; TRAFFICKING; CELLS; REPLICATION; ENDOSOMES; INFECTION; VIRIONS	HIV-1 assembly and release occurs at the plasma membrane of human T lymphocytes and model epithelial cell lines, whereas in macrophages intracellular sites of virus assembly or accumulation predominate. The origin of the intracellular virus-containing compartment (VCC) has been controversial. This compartment is enriched in markers of the multivesicular body, and has been described as a modified endosomal compartment. Several studies of this compartment have revealed the presence of small channels connecting to the plasma membrane, suggesting that instead of an endosomal origin the compartment is a modified plasma membrane compartment. If the compartment is accessible to the external environment, this would have important implications for antiviral immune responses and antiviral therapy. We performed a series of experiments designed to determine if the VCC in macrophages was open to the external environment and accessible to antibodies and small molecules. The majority of VCCs were found to be inaccessible to exogenously-applied antibodies to tetraspanins in the absence of membrane permeabilization, while tetraspanin staining was readily observed following membrane permeabilization. Cationized ferritin was utilized to stain the plasma membrane, and revealed that the majority of virus-containing compartments were inaccessible to ferritin. Low molecular weight dextrans could access only a very small percentage of VCCs, and these tended to be more peripheral compartments. We conclude that the VCCs in monocyte-derived human macrophages are heterogeneous, but the majority of VCCs are closed to the external environment.	[Chu, Hin] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA USA	Emory University; Children's Healthcare of Atlanta (CHOA)	Chu, H (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.	paul.spearman@emory.edu	CHU, HIN/ABU-1193-2022	CHU, HIN/0000-0003-2855-9837	National Institutes of Health (NIH) [AI058828, AI40338]; Children's Healthcare of Atlanta; flow cytometry/cell sorting core of Children's Healthcare of Atlanta; Emory Center for AIDS Research [P30 AI050409]; Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409, R01AI040338, R29AI040338, R01AI058828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Healthcare of Atlanta; flow cytometry/cell sorting core of Children's Healthcare of Atlanta; Emory Center for AIDS Research; Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) AI058828 and NIH AI40338 and by funds from Children's Healthcare of Atlanta. The work was partly supported by the flow cytometry/cell sorting core of Children's Healthcare of Atlanta, by the Emory Center for AIDS Research (P30 AI050409), and by the Robert P. Apkarian Integrated Electron Microscopy Core Laboratory of Emory University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaroch P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-29; Bennett AE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000591; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; BURRY RW, 1979, J CELL BIOL, V82, P726, DOI 10.1083/jcb.82.3.726; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; Crowe SM, 2006, CURR OPIN HIV AIDS, V1, P129, DOI 10.1097/01.COH.0000209583.89952.9d; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Groot F, 2008, BLOOD, V111, P4660, DOI 10.1182/blood-2007-12-130070; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Koppensteiner H, 2011, J VIROLOGY; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17, DOI 10.1002/jlb.44.1.17; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; ORENSTEIN JM, 1988, J VIROL, V62, P2578, DOI 10.1128/JVI.62.8.2578-2586.1988; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Pelchen-Matthews A, 2012, TRAFFIC, V13, P273, DOI 10.1111/j.1600-0854.2011.01306.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Thole AA, 1999, J SUBMICR CYTOL PATH, V31, P131; Varthakavi V, 1999, J VIROL, V73, P10329, DOI 10.1128/JVI.73.12.10329-10338.1999; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; Welsch S, 2011, J VIROL, V85, P7922, DOI 10.1128/JVI.00834-11; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	34	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35297	10.1371/journal.pone.0035297	http://dx.doi.org/10.1371/journal.pone.0035297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567100	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500018
J	Ehlers, K; Oster, G				Ehlers, Kurt; Oster, George			On the Mysterious Propulsion of Synechococcus	PLOS ONE			English	Article							BACTERIAL GLIDING MOTILITY; LOW REYNOLDS-NUMBER; CILIARY PROPULSION; SWIMMING MOTILITY; ELECTROPHORESIS; CYANOBACTERIA; LOCOMOTION; MECHANICS; ROTATION; MOTOR	We propose a model for the self-propulsion of the marine bacterium Synechococcus utilizing a continuous looped helical track analogous to that found in Myxobacteria [1]. In our model cargo-carrying protein motors, driven by proton-motive force, move along a continuous looped helical track. The movement of the cargo creates surface distortions in the form of small amplitude traveling ridges along the S-layer above the helical track. The resulting fluid motion adjacent to the helical ribbon provides the propulsive thrust. A variation on the helical rotor model of [1] allows the motors to be anchored to the peptidoglycan layer, where they drive rotation of the track creating traveling helical waves along the S-layer. We derive expressions relating the swimming speed to the amplitude, wavelength, and velocity of the surface waves induced by the helical rotor, and show that they fall in reasonable ranges to explain the velocity and rotation rate of swimming Synechococcus.	[Ehlers, Kurt] Truckee Meadows Community Coll, Dept Math, Reno, NV USA; [Ehlers, Kurt] Nevada Syst Higher Educ, Desert Res Inst, Dept Atmospher Sci, Reno, NV USA; [Oster, George] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Oster, George] Univ Calif Berkeley, ESPM, Berkeley, CA 94720 USA	Nevada System of Higher Education (NSHE); Truckee Meadows Community College; Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ehlers, K (corresponding author), Truckee Meadows Community Coll, Dept Math, Reno, NV USA.	goster@berkeley.edu			NSF [DMS 0414039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104979] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GO was supported by NSF Grant DMS 0414039. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE JR, 1971, J FLUID MECH, V46, P199, DOI 10.1017/S002211207100048X; BLAKE JR, 1971, J FLUID MECH, V49, P209, DOI 10.1017/S0022112071002027; BLAKE JR, 1974, BIOL REV, V49, P85, DOI 10.1111/j.1469-185X.1974.tb01299.x; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; Brahamsha B., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P59; Chan B, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2102927; Chen XB, 2000, BIOPHYS J, V78, P1036, DOI 10.1016/S0006-3495(00)76662-8; Childress S, 1978, MECH SWIMMING FLYING; Cortez R, 2004, COMPUT SCI ENG, V6, P38, DOI 10.1109/MCISE.2004.1289307; Ehlers KM, 1996, P NATL ACAD SCI USA, V93, P8340, DOI 10.1073/pnas.93.16.8340; Ehlers KM, 2011, REGUL CHAOTIC DYN, V16, P623, DOI 10.1134/S1560354711060050; FAIR MC, 1989, J COLLOID INTERF SCI, V127, P388, DOI 10.1016/0021-9797(89)90045-3; Happel, 2012, LOW REYNOLDS NUMBER; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; Koiller J, 1996, J NONLINEAR SCI, V6, P1432; Leshansky AM, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/145; LIGHTHILL MJ, 1952, COMMUN PUR APPL MATH, V5, P109, DOI 10.1002/cpa.3160050201; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; McBride MJ, 2001, ANNU REV MICROBIOL, V55, P49, DOI 10.1146/annurev.micro.55.1.49; McCarren J, 2007, J BACTERIOL, V189, P1158, DOI 10.1128/JB.01500-06; McCarren J, 2005, J BACTERIOL, V187, P224, DOI 10.1128/JB.187.1.224-230.2005; Nan BY, 2011, P NATL ACAD SCI USA, V108, P2498, DOI 10.1073/pnas.1018556108; PITTA TP, 1995, J BACTERIOL, V177, P5701, DOI 10.1128/jb.177.19.5701-5703.1995; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Samuel A D, 2001, BMC Microbiol, V1, P4, DOI 10.1186/1471-2180-1-4; SHAPERE A, 1989, J FLUID MECH, V198, P557, DOI 10.1017/S002211208900025X; Spagnolie SE, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3469786; Stone HA, 1996, PHYS REV LETT, V77, P4102, DOI 10.1103/PhysRevLett.77.4102; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Swan JW, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3594790; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; WATERBURY JB, 1985, SCIENCE, V230, P74, DOI 10.1126/science.230.4721.74	32	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36081	10.1371/journal.pone.0036081	http://dx.doi.org/10.1371/journal.pone.0036081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567124	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500042
J	Ishitani, Y; Ujiie, Y; de Vargas, C; Not, F; Takahashi, K				Ishitani, Yoshiyuki; Ujiie, Yurika; de Vargas, Colomban; Not, Fabrice; Takahashi, Kozo			Phylogenetic Relationships and Evolutionary Patterns of the Order Collodaria (Radiolaria)	PLOS ONE			English	Article							COLONIAL RADIOLARIAN; FINE-STRUCTURE; ANTARCTIC GLACIATION; MAXIMUM-LIKELIHOOD; GLOBAL CLIMATE; DNA-SEQUENCES; OCEAN; SEA; EOCENE; ZOOXANTHELLAE	Collodaria are the only group of Radiolaria that has a colonial lifestyle. This group is potentially the most important plankton in the oligotrophic ocean because of its large biomass and the high primary productivity associated with the numerous symbionts inside a cell or colony. The evolution of Collodaria could thus be related to the changes in paleo-productivity that have affected organic carbon fixation in the oligotrophic ocean. However, the fossil record of Collodaria is insufficient to trace their abundance through geological time, because most collodarians do not have silicified shells. Recently, molecular phylogeny based on nuclear small sub-unit ribosomal DNA (SSU rDNA) confirmed Collodaria to be one of five orders of Radiolaria, though the relationship among collodarians is still unresolved because of inadequate taxonomic sampling. Our phylogenetic analysis has revealed four novel collodarian sequences, on the basis of which collodarians can be divided into four clades that correspond to taxonomic grouping at the family level: Thalassicollidae, Collozoidae, Collosphaeridae, and Collophidae. Comparison of the results of our phylogenetic analyses with the morphological characteristics of each collodarian family suggests that the first ancestral collodarians had a solitary lifestyle and left no silica deposits. The timing of events estimated from molecular divergence calculations indicates that naked collodarian lineages first appeared around 45.6 million years (Ma) ago, coincident with the diversification of diatoms in the pelagic oceans. Colonial collodarians appeared after the formation of the present ocean circulation system and the development of oligotrophic conditions in the equatorial Pacific (ca. 33.4 Ma ago). The divergence of colonial collodarians probably caused a shift in the efficiency of primary production during this period.	[Ishitani, Yoshiyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan; [Ujiie, Yurika] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi, Japan; [de Vargas, Colomban; Not, Fabrice] Stn Biolog, UMR CNRS Evolut Plancton & PaleOceans 7144, Roscoff, France; [Takahashi, Kozo] Kyushu Univ, Dept Sci, Higashi Ku, Fukuoka 812, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kochi University; UDICE-French Research Universities; Sorbonne Universite; Kyushu University	Ishitani, Y (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Yokosuka, Kanagawa, Japan.	Ishitani@jamstec.go.jp		Takahashi, Kozo/0000-0001-8660-4371; Ishitani, Yoshiyuki/0000-0001-8941-6990; Ujiie, Yurika/0000-0001-7627-7979; Not, Fabrice/0000-0002-9342-195X	JSPS [17310009]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was entirely supported by a JSPS Grant-in-Aid for Scientific Research (B) Project No. 17310009 (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson O.R., 2002, 2 ILLUSTRATED GUIDE, P994; ANDERSON OR, 1983, MAR BIOL, V77, P265, DOI 10.1007/BF00395815; Anderson OR, 1999, MAR MICROPALEONTOL, V36, P81, DOI 10.1016/S0377-8398(98)00029-2; ANDERSON OR, 1976, MAR MICROPALEONTOL, V1, P81, DOI 10.1016/0377-8398(76)90006-2; ANDERSON OR, 1978, J ULTRA MOL STRUCT R, V62, P181, DOI 10.1016/S0022-5320(78)90031-X; ANDERSON OR, 1976, TISSUE CELL, V8, P195, DOI 10.1016/0040-8166(76)90046-X; Anderson OR, 1980, BIOCH PHYSL PROTOZOA; BARRON JA, 1989, LIFE SCI R, V44, P341; BJORKLUND KR, 1979, J PALEONTOL, V53, P1293; Carter L, 2004, MAR GEOL, V205, P9, DOI 10.1016/S0025-3227(04)00016-7; Cault JP, 1991, P OCEAN DRILLING PRO, V19, P513; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; De Wever P., 2001, RADIOLARIANS SEDIMEN; Diekmann B, 2004, GLOBAL PLANET CHANGE, V40, P295, DOI 10.1016/j.gloplacha.2003.09.001; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.1111/j.1558-5646.1984.tb00255.x; Fenner J, PLANKTON STRATIGRAPH, P713; Funakawa S, 2006, PALAEOGEOGR PALAEOCL, V230, P183, DOI 10.1016/j.palaeo.2005.07.014; Griffith E, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2010PA001932; Haeckel E., 1862, RADIOLARIEN RHIZOPOD, V2; Haeckel E, 1887, REPORTS SCI RESULTS; Harwood DM, SILICEOUS MICROFOSSI, P81; Huber M, 2003, SCIENCE, V299, P877, DOI 10.1126/science.1078766; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Ishitani Y, 2012, DEEP-SEA RES PT II, V61-64, P172, DOI 10.1016/j.dsr2.2011.12.005; Jobb G, 2008, TREEFINDER VERSION O; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; KHMELEVA NN, 1967, DOKL AKAD NAUK SSSR+, V172, P1430; Kunitomo Y, 2006, EUR J PROTISTOL, V42, P143, DOI 10.1016/j.ejop.2006.04.001; Lazarus DB, 2009, P NATL ACAD SCI USA, V106, P9333, DOI 10.1073/pnas.0812979106; MALIVA R G, 1989, Palaios, V4, P519, DOI 10.2307/3514743; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Miller KG, 2008, GEOL SOC AM BULL, V120, P34, DOI 10.1130/B26105.1; MOORE TC, 1969, GEOL SOC AM BULL, V80, P2103, DOI 10.1130/0016-7606(1969)80[2103:RCISWA]2.0.CO;2; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Nikolaev VA, P 16 INT DIAT S, P127; Nylander JAA., 2004, BIOINFORMATICS; Polet S, 2004, PROTIST, V155, P53, DOI 10.1078/1434461000164; Rabosky DL, 2009, NATURE, V457, P183, DOI 10.1038/nature07435; Riedel W.R., 1967, FOSSIL RECORD S DOCU, P291; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevenell AE, 2007, DEEP-SEA RES PT II, V54, P2308, DOI 10.1016/j.dsr2.2007.07.018; Stoecker DK, 2009, AQUAT MICROB ECOL, V57, P279, DOI 10.3354/ame01340; Strelkov AA, 1971, EXPLORATIONS FAUNA S, V9, P295; SWANBERG NR, 1980, DEEP-SEA RES, V27, P715, DOI 10.1016/0198-0149(80)90024-2; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor F.J.R., 1990, P323; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	51	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35775	10.1371/journal.pone.0035775	http://dx.doi.org/10.1371/journal.pone.0035775			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567112	Green Published, gold			2022-12-27	WOS:000305341500030
J	Nishiyama, A; Dey, A; Tamura, T; Ko, M; Ozato, K				Nishiyama, Akira; Dey, Anup; Tamura, Tomohiko; Ko, Minoru; Ozato, Keiko			Activation of JNK Triggers Release of Brd4 from Mitotic Chromosomes and Mediates Protection from Drug-Induced Mitotic Stress	PLOS ONE			English	Article							N-TERMINAL KINASE; BROMODOMAIN PROTEIN BRD4; CELL-DEATH; TRANSCRIPTION FACTOR; HISTONE H3; S-PHASE; P-TEFB; MITOSIS; PHOSPHORYLATION; PROGRESSION	Some anti-cancer drugs, including those that alter microtubule dynamics target mitotic cells and induce apoptosis in some cell types. However, such drugs elicit protective responses in other cell types allowing cells to escape from drug-induced mitotic inhibition. Cells with a faulty protective mechanism undergo defective mitosis, leading to genome instability. Brd4 is a double bromodomain protein that remains on chromosomes during mitosis. However, Brd4 is released from mitotic chromosomes when cells are exposed to anti-mitotic drugs including nocodazole. Neither the mechanisms, nor the biological significance of drug-induced Brd4 release has been fully understood. We found that deletion of the internal C-terminal region abolished nocodazole induced Brd4 release from mouse P19 cells. Furthermore, cells expressing truncated Brd4, unable to dissociate from chromosomes were blocked from mitotic progression and failed to complete cell division. We also found that pharmacological and peptide inhibitors of the c-jun-N-terminal kinases (JNK) pathway, but not inhibitors of other MAP kinases, prevented release of Brd4 from chromosomes. The JNK inhibitor that blocked Brd4 release also blocked mitotic progression. Further supporting the role of JNK in Brd4 release, JNK2-/- embryonic fibroblasts were defective in Brd4 release and sustained greater inhibition of cell growth after nocodazole treatment. In sum, activation of JNK pathway triggers release of Brd4 from chromosomes upon nocodazole treatment, which mediates a protective response designed to minimize drug-induced mitotic stress.	[Nishiyama, Akira; Dey, Anup; Ozato, Keiko] NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA; [Nishiyama, Akira; Tamura, Tomohiko] Yokohama City Univ, Dept Immunol, Grad Sch Med, Kanazawa Ku, Yokohama, Kanagawa 232, Japan; [Nishiyama, Akira; Ko, Minoru] NIA, Sect Dev Genom & Aging, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Yokohama City University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Nishiyama, A (corresponding author), NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov	Ko, Minoru S. H./B-7969-2009	Ko, Minoru S. H./0000-0002-3530-3015	National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008815, ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000662] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23659492] Funding Source: KAKEN	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Intramural Program of National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Delcuve GP, 2008, J CELL BIOCH; Dey A, 2000, BROMODOMAIN PROTEIN, P6537; Dey A, 2003, DOUBLE BROMODOMAIN P, P8758; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Fan MY, 2000, CANCER RES, V60, P6403; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kim JA, 2010, ONCOGENE, V29, P1702, DOI 10.1038/onc.2009.464; Kolomeichuk SN, 2008, FEBS J, V275, P1889, DOI 10.1111/j.1742-4658.2008.06349.x; Lee K, 2008, CELL CYCLE, V7, P216, DOI 10.4161/cc.7.2.5155; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MacCorkle RA, 2004, J BIOL CHEM, V279, P40112, DOI 10.1074/jbc.M405481200; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mikhailov A, 2002, CURR BIOL, V12, pR331, DOI 10.1016/S0960-9822(02)00833-3; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Mochizuki K, 2008, J BIOL CHEM, V283, P9040, DOI 10.1074/jbc.M707603200; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Oktay K, 2008, CELL CYCLE, V7, P533, DOI 10.4161/cc.7.4.5660; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sorger PK, 1997, CURR OPIN CELL BIOL, V9, P807, DOI 10.1016/S0955-0674(97)80081-6; Takenaka K, 1998, SCIENCE, V280, P599, DOI 10.1126/science.280.5363.599; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang TH, 1998, J BIOL CHEM, V273, P4928, DOI 10.1074/jbc.273.9.4928; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wolf F, 2007, CELL CYCLE, V6, P1408; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yujiri T, 1999, J BIOL CHEM, V274, P12605, DOI 10.1074/jbc.274.18.12605	59	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34719	10.1371/journal.pone.0034719	http://dx.doi.org/10.1371/journal.pone.0034719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567088	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500006
J	da Silva, CF; Baldo, MVC				da Silva, Carolina Feher; Chrysostomo Baldo, Marcus Vinicius			A Simple Artificial Life Model Explains Irrational Behavior in Human Decision-Making	PLOS ONE			English	Article							PROBABILITY; PERSPECTIVE	Although praised for their rationality, humans often make poor decisions, even in simple situations. In the repeated binary choice experiment, an individual has to choose repeatedly between the same two alternatives, where a reward is assigned to one of them with fixed probability. The optimal strategy is to perseverate with choosing the alternative with the best expected return. Whereas many species perseverate, humans tend to match the frequencies of their choices to the frequencies of the alternatives, a sub-optimal strategy known as probability matching. Our goal was to find the primary cognitive constraints under which a set of simple evolutionary rules can lead to such contrasting behaviors. We simulated the evolution of artificial populations, wherein the fitness of each animat (artificial animal) depended on its ability to predict the next element of a sequence made up of a repeating binary string of varying size. When the string was short relative to the animats' neural capacity, they could learn it and correctly predict the next element of the sequence. When it was long, they could not learn it, turning to the next best option: to perseverate. Animats from the last generation then performed the task of predicting the next element of a non-periodical binary sequence. We found that, whereas animats with smaller neural capacity kept perseverating with the best alternative as before, animats with larger neural capacity, which had previously been able to learn the pattern of repeating strings, adopted probability matching, being outperformed by the perseverating animats. Our results demonstrate how the ability to make predictions in an environment endowed with regular patterns may lead to probability matching under less structured conditions. They point to probability matching as a likely by-product of adaptive cognitive strategies that were crucial in human evolution, but may lead to sub-optimal performances in other environments.	[da Silva, Carolina Feher; Chrysostomo Baldo, Marcus Vinicius] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Roberto Vieira Lab Sensory Physiol, Sao Paulo, Brazil	Universidade de Sao Paulo	da Silva, CF (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Roberto Vieira Lab Sensory Physiol, Sao Paulo, Brazil.	carolina.feher.silva@usp.br	Feher da Silva, Carolina/GVS-8900-2022; Baldo, Marcus VC/A-4659-2012	Feher da Silva, Carolina/0000-0002-4137-0847; Baldo, Marcus VC/0000-0003-1791-8638	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation), http://www.fapesp.br/ and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development), http://www.cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna DE, 2012, PLOS COMPUTATIONAL B, V6; [Anonymous], 1998, NEURAL NETWORKS COMP; BARHILLEL M, 1991, ADV APPL MATH, V12, P428, DOI 10.1016/0196-8858(91)90029-I; BEHREND ER, 1961, AM J PSYCHOL, V74, P542, DOI 10.2307/1419664; BLISS JP, 1995, ERGONOMICS, V38, P2300, DOI 10.1080/00140139508925269; Falk R, 1997, PSYCHOL REV, V104, P301, DOI 10.1037/0033-295X.104.2.301; Fantino E, 2002, CAN J EXP PSYCHOL, V56, P58, DOI 10.1037/h0087385; Gaissmaier W, 2008, COGNITION, V109, P416, DOI 10.1016/j.cognition.2008.09.007; GRAF V, 1964, J EXP ANAL BEHAV, V7, P151, DOI 10.1901/jeab.1964.7-151; Green CS, 2010, P NATL ACAD SCI USA, V107, P16401, DOI 10.1073/pnas.1001709107; Hardy-Vallee B, 2007, ARTIFICIAL LIFE NATU; Haselton MG, 2009, SOC COGNITION, V27, P733, DOI 10.1521/soco.2009.27.5.733; HEALY AF, 1981, J EXP PSYCHOL-HUM L, V7, P344, DOI 10.1037/0278-7393.7.5.344; Hindmoor Andrew, 2006, RATIONAL CHOICE; Koehler DJ, 2009, COGNITION, V113, P123, DOI 10.1016/j.cognition.2009.07.003; Miller Michael B, 2005, Brain Cogn, V57, P165, DOI 10.1016/j.bandc.2004.08.038; Niv Y, 2002, ADAPT BEHAV, V10, P5, DOI 10.1177/10597123020101001; PARDUCCI A, 1958, J COMP PHYSIOL PSYCH, V51, P492, DOI 10.1037/h0040097; Sabes PN, 1996, ADV NEUR IN, V8, P1080; Seth AK, 2001, ADAPT BEHAV, V9, P67, DOI 10.1177/105971230200900204; Seth AK, 2007, PHILOS T R SOC B, V362, P1545, DOI 10.1098/rstb.2007.2052; Shanks DR, 2002, J BEHAV DECIS MAKING, V15, P233, DOI 10.1002/bdm.413; Unturbe J, 2007, NEUROPSYCHOLOGY, V21, P621, DOI 10.1037/0894-4105.21.5.621; Vulkan N, 2000, J ECON SURV, V14, P101, DOI 10.1111/1467-6419.00106; Wolford G, 2004, CAN J EXP PSYCHOL, V58, P221, DOI 10.1037/h0087446; Wolford G, 2000, J NEUROSCI, V20, part. no.; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871	27	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34371	10.1371/journal.pone.0034371	http://dx.doi.org/10.1371/journal.pone.0034371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UN	22563454	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700003
J	Kariya, Y; Sato, H; Katou, N; Kariya, Y; Miyazaki, K				Kariya, Yoshinobu; Sato, Hiroki; Katou, Naoko; Kariya, Yukiko; Miyazaki, Kaoru			Polymerized Laminin-332 Matrix Supports Rapid and Tight Adhesion of Keratinocytes, Suppressing Cell Migration	PLOS ONE			English	Article							JUNCTIONAL EPIDERMOLYSIS-BULLOSA; CHAIN SHORT ARM; EXTRACELLULAR-MATRIX; BIOLOGICAL-ACTIVITY; RECOMBINANT LAMININ-5; PLASMINOGEN-ACTIVATOR; BASEMENT-MEMBRANES; ALPHA-3B CHAIN; SCATTER FACTOR; HUMAN TISSUES	Laminin-332 (alpha 3 beta 3c2) (Lm332) supports the stable anchoring of basal keratinocytes to the epidermal basement membrane, while it functions as a motility factor for wound healing and cancer invasion. To understand these contrasting activities of Lm332, we investigated Lm332 matrices deposited by normal human keratinocytes and other Lm332-expressing cell lines. All types of the cells efficiently deposited Lm332 on the culture plates in specific patterns. On the contrary, laminins containing laminin beta 1 and/or gamma 1 chains, such as Lm511 and Lm311, were not deposited on the culture plates even if secreted into culture medium. The Lm332 deposition was not inhibited by function-blocking antibodies to the alpha 3 and alpha 6 integrins but was inhibited by sodium selenate, suggesting that sulfated glycosaminoglycans on cell surface, e. g. heparan sulfate proteoglycans, might be involved in the process. HEK293 cells overexpressing exogenous Lm332 (Lm332-HEK) almost exclusively deposited Lm332 on the plates. The deposited Lm332 matrix showed a mesh-like network structure as analyzed by electron microscopy, suggesting that Lm332 was highly polymerized. When biological activity was analyzed, the Lm332 matrix rather suppressed the migration of keratinocytes as compared with purified Lm332, which highly promoted the cell migration. The Lm332 matrix supported adhesion of keratinocytes much more strongly and stably than purified Lm332. Integrin alpha 3 beta 1 bound to the Lm332 matrix at a three times higher level than purified Lm332. Normal keratinocytes prominently showed integrin alpha 6 beta 4-containing, hemidesmosome-like structures on the Lm332 matrix but not on the purified one. These results indicate that the polymerized Lm332 matrix supports stable cell adhesion by interacting with both integrin alpha 6 beta 4 and alpha 3 beta 1, whereas unassembled soluble Lm332 supports cell migration.	[Kariya, Yoshinobu; Kariya, Yukiko; Miyazaki, Kaoru] Yokohama City Univ, Div Cell Biol, Kihara Inst Biol Res, Yokohama, Kanagawa 232, Japan; [Kariya, Yoshinobu] Kihara Mem Yokohama Fdn Adv Life Sci, Yokohama, Kanagawa, Japan; [Sato, Hiroki; Katou, Naoko; Kariya, Yukiko; Miyazaki, Kaoru] Yokohama City Univ, Grad Sch Integrated Sci, Yokohama, Kanagawa 232, Japan	Yokohama City University; Yokohama City University	Kariya, Y (corresponding author), Fukushima Med Univ, Sch Med, Dept Biochem, Fukushima, Japan.	miyazaki@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17014077, 23300351, 23112517]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding came from the Ministry of Education, Culture, Sports, Science and Technology of Japan: 17014077, 23300351, and 23112517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Arimura A, 1991, Hum Cell, V4, P67; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baker SE, 1996, J CELL SCI, V109, P2509; Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-9; DIETRICH CP, 1988, FASEB J, V2, P56, DOI 10.1096/fasebj.2.1.2961646; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Gagnoux-Palacios L, 2001, J CELL BIOL, V153, P835, DOI 10.1083/jcb.153.4.835; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Hirosaki T, 2000, J BIOL CHEM, V275, P22495, DOI 10.1074/jbc.M001326200; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263; Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350; Kariya Y, 2004, EXP CELL RES, V297, P508, DOI 10.1016/j.yexcr.2004.03.044; Kariya Y, 2004, J BIOL CHEM, V279, P24774, DOI 10.1074/jbc.M400670200; Kariya Y, 2009, MINI-REV MED CHEM, V9, P1284, DOI 10.2174/138955709789878114; Kariya Y, 2008, J MOL HISTOL, V39, P435, DOI 10.1007/s10735-008-9183-0; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; KIKKAWA Y, 1994, J BIOCHEM-TOKYO, V116, P862, DOI 10.1093/oxfordjournals.jbchem.a124608; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Lohi J, 2001, INT J CANCER, V94, P763, DOI 10.1002/ijc.1539; MIYAZAKI K, 1993, P NATL ACAD SCI USA, V90, P11767, DOI 10.1073/pnas.90.24.11767; Miyazaki K, 2006, CANCER SCI, V97, P91, DOI 10.1111/j.1349-7006.2006.00150.x; Mizushima H, 1996, J BIOCHEM-TOKYO, V120, P1196; Mori T, 2010, J BIOL CHEM, V285, P35068, DOI 10.1074/jbc.M110.146126; Nakashima Y, 2005, J BIOCHEM, V138, P539, DOI 10.1093/jb/mvi153; Nakashima Y, 2007, J CELL BIOCHEM, V100, P545, DOI 10.1002/jcb.21032; Nguyen BP, 2000, CURR OPIN CELL BIOL, V12, P554, DOI 10.1016/S0955-0674(00)00131-9; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; Ogawa T, 2004, J CELL BIOCHEM, V92, P701, DOI 10.1002/jcb.20112; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; PULKKINEN L, 1994, GENOMICS, V24, P357, DOI 10.1006/geno.1994.1627; PYKE C, 1995, CANCER RES, V55, P4132; ROUSSELLE P, 1994, J CELL BIOL, V125, P205, DOI 10.1083/jcb.125.1.205; RYAN MC, 1994, J BIOL CHEM, V269, P22779; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Sigle RO, 2004, J CELL SCI, V117, P4481, DOI 10.1242/jcs.01310; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; Tsubota Y, 2005, J BIOL CHEM, V280, P14370, DOI 10.1074/jbc.M413051200	49	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35546	10.1371/journal.pone.0035546	http://dx.doi.org/10.1371/journal.pone.0035546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563463	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700012
J	Sluder, A; Shah, S; Cassayre, J; Clover, R; Maienfisch, P; Molleyres, LP; Hirst, EA; Flemming, AJ; Shi, M; Cutler, P; Stanger, C; Roberts, RS; Hughes, DJ; Flury, T; Robinson, MP; Hillesheim, E; Pitterna, T; Cederbaum, F; Worthington, PA; Crossthwaite, AJ; Windass, JD; Currie, RA; Earley, FGP				Sluder, Ann; Shah, Sheetal; Cassayre, Jerome; Clover, Ralph; Maienfisch, Peter; Molleyres, Louis-Pierre; Hirst, Elizabeth A.; Flemming, Anthony J.; Shi, Min; Cutler, Penny; Stanger, Carole; Roberts, Richard S.; Hughes, David J.; Flury, Thomas; Robinson, Michael P.; Hillesheim, Elke; Pitterna, Thomas; Cederbaum, Fredrik; Worthington, Paul A.; Crossthwaite, Andrew J.; Windass, John D.; Currie, Richard A.; Earley, Fergus G. P.			Spiroindolines Identify the Vesicular Acetylcholine Transporter as a Novel Target for Insecticide Action	PLOS ONE			English	Article							GROWTH-HORMONE SECRETAGOGUE; CAENORHABDITIS-ELEGANS; GENETIC-ANALYSIS; RESISTANCE; RECEPTORS; MUTANTS; MONOAMINE; DISCOVERY; RESIDUES; VESICLES	The efficacy of all major insecticide classes continues to be eroded by the development of resistance mediated, in part, by selection of alleles encoding insecticide insensitive target proteins. The discovery of new insecticide classes acting at novel protein binding sites is therefore important for the continued protection of the food supply from insect predators, and of human and animal health from insect borne disease. Here we describe a novel class of insecticides (Spiroindolines) encompassing molecules that combine excellent activity against major agricultural pest species with low mammalian toxicity. We confidently assign the vesicular acetylcholine transporter as the molecular target of Spiroindolines through the combination of molecular genetics in model organisms with a pharmacological approach in insect tissues. The vesicular acetylcholine transporter can now be added to the list of validated insecticide targets in the acetylcholine signalling pathway and we anticipate that this will lead to the discovery of novel molecules useful in sustaining agriculture. In addition to their potential as insecticides and nematocides, Spiroindolines represent the only other class of chemical ligands for the vesicular acetylcholine transporter since those based on the discovery of vesamicol over 40 years ago, and as such, have potential to provide more selective tools for PET imaging in the diagnosis of neurodegenerative disease. They also provide novel biochemical tools for studies of the function of this protein family.	[Sluder, Ann; Clover, Ralph] Cambria Biosci, Woburn, MA USA; [Shah, Sheetal; Hirst, Elizabeth A.; Flemming, Anthony J.; Shi, Min; Cutler, Penny; Stanger, Carole; Roberts, Richard S.; Hughes, David J.; Robinson, Michael P.; Worthington, Paul A.; Crossthwaite, Andrew J.; Windass, John D.; Currie, Richard A.; Earley, Fergus G. P.] Syngenta Crop Protect Res, Bracknell, Berks, England; [Cassayre, Jerome; Maienfisch, Peter; Molleyres, Louis-Pierre; Flury, Thomas; Hillesheim, Elke; Pitterna, Thomas; Cederbaum, Fredrik] Syngenta Crop Protect AG, Stein, Switzerland	Syngenta; Syngenta	Sluder, A (corresponding author), Scynexis Inc, Res Triangle Pk, NC USA.	fergus.earley@syngenta.com	Sluder, Ann/AAS-3102-2020; Currie, Richard/N-6074-2017	Roberts, Richard/0000-0003-2343-6301; Currie, Richard/0000-0002-6528-3326				ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bondensgaard K, 2004, J MED CHEM, V47, P888, DOI 10.1021/jm0309452; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bravo DT, 2005, BIOCHEMISTRY-US, V44, P7955, DOI 10.1021/bi047442y; Brittain RT, 1969, BRIT J PHARMACOL, V36, P173; Cheng Y, 1997, TETRAHEDRON LETT, V38, P1497, DOI 10.1016/S0040-4039(97)00139-1; CLARKSON ED, 1992, J NEUROCHEM, V59, P695, DOI 10.1111/j.1471-4159.1992.tb09424.x; Eiden LE, 1998, J NEUROCHEM, V70, P2227; Elbert A., 2008, IRAC INSECTICIDE RES, P753; EVANS BE, 1988, J MED CHEM, V31, P2235, DOI 10.1021/jm00120a002; Fliri AF, 2005, P NATL ACAD SCI USA, V102, P261, DOI 10.1073/pnas.0407790101; Griswold CM, 2002, DROSOPHILA INF SERV, V85, P129; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; HENRY JP, 1989, BIOCHEM PHARMACOL, V38, P2395, DOI 10.1016/0006-2952(89)90082-8; Horti AG, 2010, LIFE SCI, V86, P575, DOI 10.1016/j.lfs.2009.02.029; HUGHES DJ, 2003, Patent No. 2003106457; Jerome C., 2005, [No title captured], Patent No. [WO 2005058897, 2005058897, 058897]; Jeschke P, 2010, PEST MANAG SCI, V66, P10, DOI 10.1002/ps.1829; Kaufman PE, 2010, PEST MANAG SCI, V66, P290, DOI 10.1002/ps.1872; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khare P, 2009, BIOCHEMISTRY-US, V48, P8965, DOI 10.1021/bi900759v; Kim MH, 1999, J BIOL CHEM, V274, P673, DOI 10.1074/jbc.274.2.673; Lind RJ, 2001, INSECT BIOCHEM MOLEC, V31, P533, DOI 10.1016/S0965-1748(00)00153-3; Maligres PE, 1997, TETRAHEDRON, V53, P10983, DOI 10.1016/S0040-4020(97)00359-1; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; NGUYEN M, 1995, GENETICS, V140, P527; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ojeda AM, 2004, BIOCHEMISTRY-US, V43, P11163, DOI 10.1021/bi049562b; Oyarzun MP, 2008, MED VET ENTOMOL, V22, P188, DOI 10.1111/j.1365-2915.2008.00733.x; PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001; RAND JB, 1984, GENETICS, V106, P227; RAND JB, 1989, GENETICS, V122, P73; Acevedo GR, 2009, PARASITOL RES, V105, P489, DOI 10.1007/s00436-009-1425-x; Schafer WR, 2002, J NEUROBIOL, V53, P535, DOI 10.1002/neu.10154; Thompson GD, 2000, PEST MANAG SCI, V56, P696, DOI 10.1002/1526-4998(200008)56:8<696::AID-PS182>3.0.CO;2-5; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Varoqui H, 1998, METHOD ENZYMOL, V296, P84; Zhu HM, 2001, J BIOL CHEM, V276, P41580, DOI 10.1074/jbc.M103550200	40	24	25	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34712	10.1371/journal.pone.0034712	http://dx.doi.org/10.1371/journal.pone.0034712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563457	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700006
J	Gebhard, LG; Kaufman, SB; Gamarnik, AV				Gebhard, Leopoldo G.; Kaufman, Sergio B.; Gamarnik, Andrea V.			Novel ATP-Independent RNA Annealing Activity of the Dengue Virus NS3 Helicase	PLOS ONE			English	Article							YELLOW-FEVER VIRUS; DEAD-BOX PROTEIN; WEST-NILE-VIRUS; STIMULATED NUCLEOSIDE TRIPHOSPHATASE; TYPE-2 NONSTRUCTURAL PROTEIN-3; VIRAL REPLICATION; IN-VITRO; CRYSTAL-STRUCTURE; HELICASE/NUCLEOSIDE TRIPHOSPHATASE; CATALYTIC DOMAIN	The flavivirus nonstructural protein 3 (NS3) bears multiple enzymatic activities and represents an attractive target for antiviral intervention. NS3 contains the viral serine protease at the N-terminus and ATPase, RTPase, and helicase activities at the C-terminus. These activities are essential for viral replication; however, the biological role of RNA remodeling by NS3 helicase during the viral life cycle is still unclear. Secondary and tertiary RNA structures present in the viral genome are crucial for viral replication. Here, we used the NS3 protein from dengue virus to investigate functions of NS3 associated to changes in RNA structures. Using different NS3 variants, we characterized a domain spanning residues 171 to 618 that displays ATPase and RNA unwinding activities similar to those observed for the full-length protein. Interestingly, we found that, besides the RNA unwinding activity, dengue virus NS3 greatly accelerates annealing of complementary RNA strands with viral or non-viral sequences. This new activity was found to be ATP-independent. It was determined that a mutated NS3 lacking ATPase activity retained full-RNA annealing activity. Using an ATP regeneration system and different ATP concentrations, we observed that NS3 establishes an ATP-dependent steady state between RNA unwinding and annealing, allowing modulation of the two opposing activities of this enzyme through ATP concentration. In addition, we observed that NS3 enhanced RNA-RNA interactions between molecules representing the ends of the viral genome that are known to be necessary for viral RNA synthesis. We propose that, according to the ATP availability, NS3 could function regulating the folding or unfolding of viral RNA structures.	[Gebhard, Leopoldo G.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina; [Kaufman, Sergio B.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; University of Buenos Aires	Gebhard, LG (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Buenos Aires, DF, Argentina.	agamarnik@leloir.org.ar		Kaufman, Sergio Benjamin/0000-0002-8763-4086	NIH [1R01AI095175-01]; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT-2010-2092]; CONICET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants to AVG from NIH (1R01AI095175-01) and Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) PICT-2010-2092. AVG is a member of the Argentinean Council of Investigation (CONICET). LG was funded by a CONICET fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; [Anonymous], VECT BORN VIR INF; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; CHAMBERS TJ, 1993, J VIROL, V67, P6797, DOI 10.1128/JVI.67.11.6797-6807.1993; CHAMBERS TJ, 1995, J VIROL, V69, P1600, DOI 10.1128/JVI.69.3.1600-1605.1995; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Ding SC, 2011, J VIROL, V85, P4343, DOI 10.1128/JVI.02130-10; Dreher TW, 1999, ANNU REV PHYTOPATHOL, V37, P151, DOI 10.1146/annurev.phyto.37.1.151; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; EAGLES RM, 1994, EUR J BIOCHEM, V224, P677, DOI 10.1111/j.1432-1033.1994.t01-1-00677.x; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Frick DN, 2006, HCV HELICASE STRUCTU; Ghosh A, 2010, WIRES RNA, V1, P152, DOI 10.1002/wrna.19; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huang YL, 2002, J BIOL CHEM, V277, P12810, DOI 10.1074/jbc.M200182200; Huang ZS, 2010, FEBS LETT, V584, P2356, DOI 10.1016/j.febslet.2010.04.020; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kadare G, 1997, J VIROL, V71, P2583; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Liu WJ, 2002, J VIROL, V76, P10766, DOI 10.1128/JVI.76.21.10766-10775.2002; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001; McKnight KL, 1998, RNA, V4, P1569, DOI 10.1017/S1355838298981006; Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; SHUMAN S, 1992, P NATL ACAD SCI USA, V89, P10935, DOI 10.1073/pnas.89.22.10935; Sikora B, 2008, J BIOL CHEM, V283, P11516, DOI 10.1074/jbc.M708125200; SONG CZ, 1995, J MOL BIOL, V254, P6, DOI 10.1006/jmbi.1995.0594; SUZICH JA, 1993, J VIROL, V67, P6152, DOI 10.1128/JVI.67.10.6152-6158.1993; Uhlmann-Schiffler H, 2006, NUCLEIC ACIDS RES, V34, P10, DOI 10.1093/nar/gkj403; Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410; Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008; WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993; WARRENER P, 1995, J VIROL, V69, P1720, DOI 10.1128/JVI.69.3.1720-1726.1995; WENGLER G, 1991, J GEN VIROL, V72, P851, DOI 10.1099/0022-1317-72-4-851; WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M; Wu BD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000323; Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Yu E, 2000, NUCLEIC ACIDS RES, V28, P3926, DOI 10.1093/nar/28.20.3926	77	55	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36244	10.1371/journal.pone.0036244	http://dx.doi.org/10.1371/journal.pone.0036244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558403	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200054
J	Koper, A; Schenck, A; Prokop, A				Koper, Andre; Schenck, Annette; Prokop, Andreas			Analysis of Adhesion Molecules and Basement Membrane Contributions to Synaptic Adhesion at the Drosophila Embryonic NMJ	PLOS ONE			English	Article							SULFATE PROTEOGLYCAN SYNDECAN; ATYPICAL CADHERIN FLAMINGO; CELL-ADHESION; NEUROMUSCULAR-JUNCTIONS; EXTRACELLULAR-MATRIX; GLUTAMATE RECEPTORS; POSTSYNAPTIC SPECIALIZATIONS; IMMUNOGLOBULIN SUPERFAMILY; PRESYNAPTIC DEVELOPMENT; CAENORHABDITIS-ELEGANS	Synapse formation and maintenance crucially underlie brain function in health and disease. Both processes are believed to depend on cell adhesion molecules (CAMs). Many different classes of CAMs localise to synapses, including cadherins, protocadherins, neuroligins, neurexins, integrins, and immunoglobulin adhesion proteins, and further contributions come from the extracellular matrix and its receptors. Most of these factors have been scrutinised by loss-of-function analyses in animal models. However, which adhesion factors establish the essential physical links across synaptic clefts and allow the assembly of synaptic machineries at the contact site in vivo is still unclear. To investigate these key questions, we have used the neuromuscular junction (NMJ) of Drosophila embryos as a genetically amenable model synapse. Our ultrastructural analyses of NMJs lacking different classes of CAMs revealed that loss of all neurexins, all classical cadherins or all glutamate receptors, as well as combinations between these or with a Laminin deficiency, failed to reveal structural phenotypes. These results are compatible with a view that these CAMs might have no structural role at this model synapse. However, we consider it far more likely that they operate in a redundant or well buffered context. We propose a model based on a multi-adaptor principle to explain this phenomenon. Furthermore, we report a new CAM-independent adhesion mechanism that involves the basement membranes (BM) covering neuromuscular terminals. Thus, motorneuronal terminals show strong partial detachment of the junction when BM-to-cell surface attachment is impaired by removing Laminin A, or when BMs lose their structural integrity upon loss of type IV collagens. We conclude that BMs are essential to tie embryonic motorneuronal terminals to the muscle surface, lending CAM-independent structural support to their adhesion. Therefore, future developmental studies of these synaptic junctions in Drosophila need to consider the important contribution made by BM-dependent mechanisms, in addition to CAM-dependent adhesion.	[Koper, Andre; Prokop, Andreas] Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Manchester, Lancs, England; [Schenck, Annette] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Donders Inst Brain Cognit & Behav,Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Manchester; Radboud University Nijmegen	Koper, A (corresponding author), Sch Translat Med, Manchester, Lancs, England.	Prokop@manchester.ac.uk	Schenck, Annette/E-4514-2012	Schenck, Annette/0000-0002-6918-3314; Prokop, Andreas/0000-0001-8482-3298	BBSRC [BB/E009085/1]; Wellcome Trust VIP funding [092403/Z/10/Z]; FP7 Gencodys [Health-241995]; NWO VIDI grants; University of Manchester Strategic Fund; Wellcome Trust [087742/Z/08/Z]; Biotechnology and Biological Sciences Research Council [BB/E009085/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust VIP funding(Wellcome Trust); FP7 Gencodys; NWO VIDI grants; University of Manchester Strategic Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded through a grant by the BBSRC (www.bbsrc.ac.uk)(BB/E009085/1) and Wellcome Trust (www.wellcome.ac.uk) VIP funding (092403/Z/10/Z) to AP, and FP7 Gencodys (Health-241995)(http://cordis.europa.eu/fetch?CALLER=FP7_PROJ_EN&ACTION=D&DOC=1&CAT=PROJ&RCN=94690) and NWO VIDI grants (http://www.nwo.nl/nwohome.nsf/pages/nwop_5vtgqw_eng) to AS. The EM Facilities used for this project are supported by grants from the BBSRC, The Wellcome Trust and the University of Manchester Strategic Fund. The Drosophila core facility is supported by the Wellcome Trust (www.wellcome.ac.uk)(087742/Z/08/Z). The publication costs were paid for by The Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Al-Anzi B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-31; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Astigarraga S, 2010, CURR OPIN GENET DEV, V20, P400, DOI 10.1016/j.gde.2010.04.001; Ataman B, 2006, INT REV NEUROBIOL, V75, P181, DOI 10.1016/S0074-7742(06)75009-7; Aumailley Monique, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000123; Banovic D, 2010, NEURON, V66, P724, DOI 10.1016/j.neuron.2010.05.020; Bao H, 2007, MOL CELL NEUROSCI, V34, P662, DOI 10.1016/j.mcn.2007.01.007; Bate Michael, 1993, P1013; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bodily KD, 2001, J NEUROSCI, V21, P3113, DOI 10.1523/JNEUROSCI.21-09-03113.2001; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; Broadie K, 2011, DEV NEUROBIOL, V71, P1102, DOI 10.1002/dneu.20935; Budnik V, 2006, INT REV NEUROBIOL, V75, P323, DOI 10.1016/S0074-7742(06)75015-2; BUNCH TA, 1992, GENETICS, V132, P519; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; Butler SJ, 1997, DEVELOPMENT, V124, P781; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Carlson SS, 2010, J NEUROCHEM; Chen K, 2005, J NEUROSCI, V25, P6667, DOI 10.1523/JNEUROSCI.1527-05.2005; Chen KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011115; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Christoforou CP, 2008, DEV BIOL, V313, P519, DOI 10.1016/j.ydbio.2007.09.044; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; Devenport D, 2004, DEVELOPMENT, V131, P5405, DOI 10.1242/dev.01427; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Egles C, 2007, MOL CELL NEUROSCI, V34, P288, DOI 10.1016/j.mcn.2006.11.004; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Ferguson K, 2009, J NEUROSCI, V29, P14151, DOI 10.1523/JNEUROSCI.2497-09.2009; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Friedrich MVK, 2000, EUR J BIOCHEM, V267, P3149, DOI 10.1046/j.1432-1327.2000.01337.x; Fung S, 2009, DEV BIOL, V332, P371, DOI 10.1016/j.ydbio.2009.06.005; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; GUTZEIT HO, 1991, J CELL SCI, V100, P781; HENCHCLIFFE C, 1993, DEVELOPMENT, V118, P325; Hill E, 2001, J MOL BIOL, V305, P1011, DOI 10.1006/jmbi.2000.4361; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Jonkman MF, 1999, J DERMATOL SCI, V20, P103, DOI 10.1016/S0923-1811(99)00017-1; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kuppers-Munther B, 2004, DEV BIOL, V269, P459, DOI 10.1016/j.ydbio.2004.01.038; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Lardi-Studler B, 2007, NEUROSCIENTIST, V13, P115, DOI 10.1177/1073858406296803; Latefi NS, 2007, NEUROCHEM RES, V32, P303, DOI 10.1007/s11064-006-9181-0; Latvanlehto A, 2010, J NEUROSCI, V30, P12230, DOI 10.1523/JNEUROSCI.5518-09.2010; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Lin YC, 2010, ANNU REV NEUROSCI, V33, P349, DOI 10.1146/annurev-neuro-060909-153204; Long H, 2009, DEVELOPMENT, V136, P3475, DOI 10.1242/dev.040220; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Matsuno M, 2009, P NATL ACAD SCI USA, V106, P310, DOI 10.1073/pnas.0807665106; McMahon SA, 2011, CURR OPIN NEUROBIOL, V21, P221, DOI 10.1016/j.conb.2010.12.005; Melom JE, 2011, CURR OPIN GENET DEV, V21, P256, DOI 10.1016/j.gde.2011.01.002; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Owald D, 2009, CURR OPIN NEUROBIOL, V19, P311, DOI 10.1016/j.conb.2009.03.003; Pastor-Pareja JC, 2011, DEV CELL, V21, P245, DOI 10.1016/j.devcel.2011.06.026; Piechotta K, 2006, CELL TISSUE RES, V326, P617, DOI 10.1007/s00441-006-0267-4; Pielage J, 2008, NEURON, V58, P195, DOI 10.1016/j.neuron.2008.02.017; Pielage J, 2006, J CELL BIOL, V175, P491, DOI 10.1083/jcb.200607036; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Prokop A, 1999, CELL TISSUE RES, V297, P169, DOI 10.1007/s004410051345; Prokop A, 2006, INT REV NEUROBIOL, V75, P71, DOI 10.1016/S0074-7742(06)75004-8; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; RAKIC P, 1975, COLD SPRING HARB SYM, V40, P333, DOI 10.1101/SQB.1976.040.01.033; Rawls AS, 2003, DEVELOPMENT, V130, P1877, DOI 10.1242/dev.00411; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Rohrbough J, 2007, GENE DEV, V21, P2607, DOI 10.1101/gad.1574107; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmid A, 2006, J NEUROSCI, V26, P11267, DOI 10.1523/JNEUROSCI.2722-06.2006; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; Singhal N, 2011, DEV NEUROBIOL, V71, P982, DOI 10.1002/dneu.20953; Slovakova J, 2011, DEVELOPMENT, V138, P1563, DOI 10.1242/dev.056192; Sone M, 2000, DEVELOPMENT, V127, P4157; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Steinel MC, 2009, DEV BIOL, V327, P447, DOI 10.1016/j.ydbio.2008.12.026; Sudhof TC, 2001, SYNAPSES, P275; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Sun MK, 2012, SCI CHINA LIFE SCI, V55, P20, DOI 10.1007/s11427-012-4273-3; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Thomas U, 2010, J NEUROGENET, V24, P109, DOI 10.3109/01677063.2010.493589; Tsai PI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-26; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Urbano JM, 2009, DEVELOPMENT, V136, P4165, DOI 10.1242/dev.044263; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Vogel C, 2003, DEVELOPMENT, V130, P6317, DOI 10.1242/dev.00848; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wheeler SR, 2009, DEVELOPMENT, V136, P1147, DOI 10.1242/dev.030254; Wolfstetter G, 2012, CELL MOL LIFE SCI, V69, P267, DOI 10.1007/s00018-011-0652-3; YEE GH, 1993, DEVELOPMENT, V118, P845; Yonekura S, 2007, DEV BIOL, V304, P759, DOI 10.1016/j.ydbio.2007.01.030; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	114	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36339	10.1371/journal.pone.0036339	http://dx.doi.org/10.1371/journal.pone.0036339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558441	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200068
J	Girard, C; Renaud, S				Girard, Catherine; Renaud, Sabrina			Disparity Changes in 370 Ma Devonian Fossils: The Signature of Ecological Dynamics?	PLOS ONE			English	Article							MORPHOLOGICAL DISPARITY; BRACHIOPOD FAUNAS; CONODONT; EXTINCTION; EVOLUTION; PALMATOLEPIS; INDICATE; RECOVERY; EVENTS; STRATEGIES	Early periods in Earth's history have seen a progressive increase in complexity of the ecosystems, but also dramatic crises decimating the biosphere. Such patterns are usually considered as large-scale changes among supra-specific groups, including morphological novelties, radiation, and extinctions. Nevertheless, in the same time, each species evolved by the way of micro-evolutionary processes, extended over millions of years into the evolution of lineages. How these two evolutionary scales interacted is a challenging issue because this requires bridging a gap between scales of observation and processes. The present study aims at transferring a typical macro-evolutionary approach, namely disparity analysis, to the study of fine-scale evolutionary variations in order to decipher what processes actually drove the dynamics of diversity at a micro-evolutionary level. The Late Frasnian to Late Famennian period was selected because it is punctuated by two major macro-evolutionary crises, as well as a progressive diversification of marine ecosystem. Disparity was estimated through this period on conodonts, tooth-like fossil remains of small eel-like predators that were part of the nektonic fauna. The study was focused on the emblematic genus of the period, Palmatolepis. Strikingly, both crises affected an already impoverished Palmatolepis disparity, increasing risks of random extinction. The major disparity signal rather emerged as a cycle of increase and decrease in disparity during the inter-crises period. The diversification shortly followed the first crisis and might correspond to an opportunistic occupation of empty ecological niche. The subsequent oriented shrinking in the morphospace occupation suggests that the ecological space available to Palmatolepis decreased through time, due to a combination of factors: deteriorating climate, expansion of competitors and predators. Disparity changes of Palmatolepis thus reflect changes in the structure of the ecological space itself, which was prone to evolve during this ancient period where modern ecosystems were progressively shaped.	[Girard, Catherine] Univ Montpellier 2, Inst Sci Evolut, CNRS, Montpellier, France; [Renaud, Sabrina] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Girard, C (corresponding author), Univ Montpellier 2, Inst Sci Evolut, CNRS, Montpellier, France.	Catherine.Girard@univ-montp2.fr	Renaud, Sabrina/AAV-3141-2020; Girard, Catherine/ABB-3841-2021; Renaud, Sabrina/D-4247-2009	Renaud, Sabrina/0000-0002-8730-3113; Renaud, Sabrina/0000-0002-8730-3113	CNRS "Morphologie et Evolution des Formes'' [GDR 2474]	CNRS "Morphologie et Evolution des Formes''	This study has been supported by the GDR 2474 CNRS "Morphologie et Evolution des Formes''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo T.J., 1995, GEOL SURV AM TODAY, V5, P65; Balter V, 2008, GEOLOGY, V36, P907, DOI 10.1130/G24989A.1; Bambach Richard K., 2002, Paleontological Society Papers, V8, P319; BECKER RT, 1989, CR ACAD SCI II, V309, P259; Borsa P, 2002, BIOL J LINN SOC, V75, P261, DOI 10.1111/j.1095-8312.2002.tb01426.x; Bottjer D.J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSATG8A.1; Buggisch W, 2008, PALAEOGEOGR PALAEOCL, V268, P273, DOI 10.1016/j.palaeo.2008.03.043; Cardini A, 2007, ZOOMORPHOLOGY, V126, P121, DOI 10.1007/s00435-007-0036-2; Chen ZQ, 2005, PALAEOGEOGR PALAEOCL, V224, P232, DOI 10.1016/j.palaeo.2005.04.014; Chen ZQ, 2005, PALAEOGEOGR PALAEOCL, V224, P270, DOI 10.1016/j.palaeo.2005.03.037; Corradini C., 2003, PALAEONTOGRAPH ITAL, V89, P65; Dzik J, 2002, ACTA PALAEONTOL POL, V47, P565; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Friedman M, 2010, P ROY SOC B-BIOL SCI, V277, P1675, DOI 10.1098/rspb.2009.2177; Gerber S, 2007, EVOL DEV, V9, P472, DOI 10.1111/j.1525-142X.2007.00185.x; Ginter Michal, 2002, Acta Geologica Polonica, V52, P169; Girard C, 2004, GEOBIOS-LYON, V37, P404, DOI 10.1016/j.geobios.2003.07.002; Girard C, 2004, CR PALEVOL, V3, P1, DOI 10.1016/j.crpv.2003.09.008; GIRARD C., 1994, WILLI ZIEGLER FESTSC, V168, P299; Girard C, 2005, DEV PALAEONTOL STRAT, V20, P181; Girard C, 2007, PALAEOGEOGR PALAEOCL, V250, P114, DOI 10.1016/j.palaeo.2007.03.007; Girard C, 2007, J MICROPALAEONTOL, V26, P61, DOI 10.1144/jm.26.1.61; Girard Catherine, 1996, Revue de Micropaleontologie, V39, P261, DOI 10.1016/S0035-1598(96)90110-5; Girard C, 2011, CR PALEVOL, V10, P107, DOI 10.1016/j.crpv.2010.10.009; Girard C, 2010, ACTA PALAEONTOL POL, V55, P675, DOI 10.4202/app.2009.0098; Girard C, 2008, LETHAIA, V41, P383, DOI 10.1111/j.1502-3931.2008.00095.x; Godderis Y, 2004, PALAEOGEOGR PALAEOCL, V202, P309, DOI 10.1016/S0031-0182(03)00641-2; Hallam A., 1997, MASS EXTINCTIONS THE; Helms J., 1963, Geologie, V12, P449; Helms JJ, 1981, CONODONTA TREATISE W, P202; Jacobsen ND, 2011, PALAEOGEOGR PALAEOCL, V308, P200, DOI 10.1016/j.palaeo.2010.04.024; Janevski GA, 2009, PALEOBIOLOGY, V35, P553, DOI 10.1666/0094-8373-35.4.553; Joachimski MM, 2009, EARTH PLANET SC LETT, V284, P599, DOI 10.1016/j.epsl.2009.05.028; Joachimski MM, 2002, GEOLOGY, V30, P711, DOI 10.1130/0091-7613(2002)030<0711:CAOSIC>2.0.CO;2; Johansson F, 2006, ICHTHYOL RES, V53, P63, DOI 10.1007/s10228-005-0316-0; Kaiser SI, 2008, GEOL J, V43, P241, DOI 10.1002/gj.1111; Kassahn KS, 2003, MAR BIOL, V143, P947, DOI 10.1007/s00227-003-1141-5; Kaufmann B, 2006, EARTH-SCI REV, V76, P175, DOI 10.1016/j.earscirev.2006.01.001; KLAPPER G, 1993, J PALEONTOL, V67, P1; KLAPPER G, 1986, CAN J EARTH SCI, V23, P1214, DOI 10.1139/e86-117; Klug C, 2010, LETHAIA, V43, P465, DOI 10.1111/j.1502-3931.2009.00206.x; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Linde M, 2004, J EVOLUTION BIOL, V17, P941, DOI 10.1111/j.1420-9101.2004.00763.x; Long JA, 2010, ANNU REV EARTH PL SC, V38, P255, DOI 10.1146/annurev-earth-040809-152416; McGhee G.R., 1996, LATE DEVONIAN MASS E; Morrow Jared R., 2000, Courier Forschungsinstitut Senckenberg, V219, P1; Muller KJ, 1956, GESELLSCHAFT, V494, P1; Nicoll RS, 1977, J AUSTR GEOLOGY GEOP, V2, P217; Price SA, 2011, ECOL LETT, V14, P462, DOI 10.1111/j.1461-0248.2011.01607.x; PURNELL MA, 1995, NATURE, V374, P798, DOI 10.1038/374798a0; Purnell MA, 2000, J PALEONTOL, V74, P113, DOI 10.1666/0022-3360(2000)074<0113:OAANIC>2.0.CO;2; Racki G, 2005, DEV PALAEONTOL STRAT, V20, P5; RAUP DM, 1986, SCIENCE, V231, P833, DOI 10.1126/science.11542060; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Renaud S, 1999, PALAEOGEOGR PALAEOCL, V146, P19, DOI 10.1016/S0031-0182(98)00138-2; Renaud S, 1996, PALEOBIOLOGY, V22, P255, DOI 10.1017/S0094837300016201; Renaud S, 2007, ZOOL SCR, V36, P525, DOI 10.1111/j.1463-6409.2007.00297.x; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Saltzman MR, 2005, GEOLOGY, V33, P573, DOI 10.1130/G21535.1; Sandberg CA, 2002, GEOL SOC AM SPEC PAP, V356, P473; Sandberg CA., 1976, GEOLOGICAL ASS CANAD, V15, P171; Scheckler S.E., 1986, ANN SOC GEOL BELG, V109, P209; Schulke I., 1995, EVOLUTIVE PROZESSE B; SCOTESE CR, 1990, GEO SOC MEM, V12, P1, DOI 10.1144/GSL.MEM.1990.012.01.01; Sepkoski J.J. Jr, 1982, Geological Society of America Special Paper, P283; Sepkoski J.J. Jr, 1986, Life Sciences Research Report, P277; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sepkoski Jr J.J., 1996, GLOBAL EVENTS EVENT, P35, DOI DOI 10.1007/978-3-642-79634-0_4; Stigall AL, 2012, GEOLOGICAL SOC AM TO, V22, P4, DOI DOI 10.1130/G128A.1; Svanback R, 2004, FUNCT ECOL, V18, P503, DOI 10.1111/j.0269-8463.2004.00858.x; Sweet W.C, 1971, J PALEONTOL, V45, P869; van den Boogaard, 1979, SCRIPTA GEOLOGICA, V49, P1; Viguier B, 2000, CR ACAD SCI III-VIE, V323, P573, DOI 10.1016/S0764-4469(00)00148-7; Villier L, 2004, SCIENCE, V306, P264, DOI 10.1126/science.1102127; Ziegler W., 1990, Courier Forschungsinstitut Senckenberg, V121, P1; Ziegler W., 1984, Geological Society of America Special Paper, P179; Ziegler W, 2000, COUR FORSCH I SENCKE, V225, P335	77	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36230	10.1371/journal.pone.0036230	http://dx.doi.org/10.1371/journal.pone.0036230			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558396	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000163
J	Jacobs, SA; Tsien, JZ				Jacobs, Stephanie A.; Tsien, Joe Z.			Genetic Overexpression of NR2B Subunit Enhances Social Recognition Memory for Different Strains and Species	PLOS ONE			English	Article							LONG-TERM-MEMORY; NMDA RECEPTOR; SYNAPTIC PLASTICITY; CYTOTOXIC LESIONS; SPATIAL MEMORY; ENVIRONMENTAL ENRICHMENT; OLFACTORY MEMORY; RAT HIPPOCAMPUS; TRANSGENIC MICE; MEDIAL AMYGDALA	The ability to learn and remember conspecifics is essential for the establishment and maintenance of social groups. Many animals, including humans, primates and rodents, depend on stable social relationships for survival. Social learning and social recognition have become emerging areas of interest for neuroscientists but are still not well understood. It has been established that several hormones play a role in the modulation of social recognition including estrogen, oxytocin and arginine vasopression. Relatively few studies have investigated how social recognition might be improved or enhanced. In this study, we investigate the role of the NMDA receptor in social recognition memory, specifically the consequences of altering the ratio of the NR2B:NR2A subunits in the forebrain regions in social behavior. We produced transgenic mice in which the NR2B subunit of the NMDA receptor was overexpressed postnatally in the excitatory neurons of the forebrain areas including the cortex, amygdala and hippocampus. We investigated the ability of both our transgenic animals and their wild-type littermate to learn and remember juvenile conspecifics using both 1-hr and 24-hr memory tests. Our experiments show that the wild-type animals and NR2B transgenic mice preformed similarly in the 1-hr test. However, transgenic mice showed better performances in 24-hr tests of recognizing animals of a different strain or animals of a different species. We conclude that NR2B overexpression in the forebrain enhances social recognition memory for different strains and animal species.	[Jacobs, Stephanie A.] Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA; Georgia Hlth Sci Univ, Dept Neurol, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Jacobs, SA (corresponding author), Georgia Hlth Sci Univ, Brain & Behav Discovery Inst, Med Coll Georgia, Augusta, GA USA.	jtsien@georgiahealth.edu			National Institute of Mental Health [MH060236]; National Institute on Aging [AG024022, AG034663, AG025918]; Georgia Research Alliance; USAMRA00002; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024022, R01AG025918, R01AG034663] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; USAMRA00002; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute of Mental Health (MH060236), National Institute on Aging (AG024022, AG034663 & AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2002, EXP BRAIN RES, V142, P395, DOI 10.1007/s00221-001-0938-z; Bannerman DM, 2001, EXP BRAIN RES, V138, P100, DOI 10.1007/s002210100687; BERTAINA V, 1995, COGNITIVE BRAIN RES, V2, P269, DOI 10.1016/0926-6410(95)90018-7; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; BLUTHE RM, 1993, BRAIN RES, V604, P205, DOI 10.1016/0006-8993(93)90370-3; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Celerier A, 2011, BIOL LETTERS, V7, P807, DOI 10.1098/rsbl.2011.0340; Choleris E, 2009, FRONT NEUROENDOCRIN, V30, P442, DOI 10.1016/j.yfrne.2009.05.003; CORKIN S, 1984, ARCH NEUROL-CHICAGO, V41, P975, DOI 10.1001/archneur.1984.04050200081022; Coudereau JP, 1996, PROG NEURO-PSYCHOPH, V20, P827, DOI 10.1016/0278-5846(96)00062-0; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; Cui ZZ, 2005, EUR J NEUROSCI, V22, P755, DOI 10.1111/j.1460-9568.2005.04257.x; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DANTZER R, 1987, PSYCHOPHARMACOLOGY, V91, P363, DOI 10.1007/BF00518192; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; Engelmann M, 2009, NEUROBIOL LEARN MEM, V91, P58, DOI 10.1016/j.nlm.2008.08.009; ESSMAN WB, 1966, ANIM BEHAV, V14, P406, DOI 10.1016/S0003-3472(66)80037-4; FALKENBERG T, 1992, NEUROSCI LETT, V138, P153, DOI 10.1016/0304-3940(92)90494-R; Feinberg LM, 2012, NEUROBIOL LEARN MEM, V97, P7, DOI 10.1016/j.nlm.2011.08.008; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gao XM, 2009, PHARMACOL BIOCHEM BE, V92, P236, DOI 10.1016/j.pbb.2008.11.016; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hlinak Z, 2002, NEUROSCI LETT, V330, P227, DOI 10.1016/S0304-3940(02)00802-9; HLINAK Z, 1991, PHYSIOL RES, V40, P59; Holmes A, 2002, GENES BRAIN BEHAV, V1, P55, DOI 10.1046/j.1601-1848.2001.00005.x; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kasahara M, 2011, BEHAV BRAIN RES, V218, P357, DOI 10.1016/j.bbr.2010.12.029; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; KONISHI M, 1989, NEURON, V3, P541, DOI 10.1016/0896-6273(89)90264-X; KUHL PK, 1994, CURR OPIN NEUROBIOL, V4, P812, DOI 10.1016/0959-4388(94)90128-7; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; Letty S, 1997, NEUROPHARMACOLOGY, V36, P681, DOI 10.1016/S0028-3908(96)00169-4; Li SJ, 2010, BRAIN RES, V1351, P165, DOI 10.1016/j.brainres.2010.06.004; Maaswinkel H, 1996, PHYSIOL BEHAV, V60, P55, DOI 10.1016/0031-9384(95)02233-3; Macbeth AH, 2009, GENES BRAIN BEHAV, V8, P558, DOI 10.1111/j.1601-183X.2009.00506.x; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Noack J, 2010, NEUROBIOL LEARN MEM, V94, P568, DOI 10.1016/j.nlm.2010.09.013; Penka LL, 2004, STRESS, V7, P63, DOI 10.1080/10253890410001677231; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Popik Piotr, 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P315; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Richter K, 2005, LEARN MEMORY, V12, P407, DOI 10.1101/lm.97505; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rudy JW, 1996, BEHAV NEUROSCI, V110, P238, DOI 10.1037/0735-7044.110.2.238; Samuelsen CL, 2011, NEUROSCIENCE, V180, P96, DOI 10.1016/j.neuroscience.2011.02.030; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; SCHELLINCK HM, 1995, PHYSIOL BEHAV, V57, P1005, DOI 10.1016/0031-9384(94)00353-7; SEKIGUCHI R, 1991, PHYSIOL BEHAV, V50, P1253, DOI 10.1016/0031-9384(91)90591-B; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SINGH PB, 1987, NATURE, V327, P161, DOI 10.1038/327161a0; Spiteri T, 2010, BEHAV BRAIN RES, V210, P211, DOI 10.1016/j.bbr.2010.02.033; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; Squires AS, 2006, NEUROBIOL LEARN MEM, V85, P95, DOI 10.1016/j.nlm.2005.08.012; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; THOR DH, 1982, J COMP PHYSIOL PSYCH, V96, P1000, DOI 10.1037/0735-7036.96.6.1000; THOR DH, 1981, ANIM LEARN BEHAV, V9, P561, DOI 10.3758/BF03209791; Tonegawa S, 1996, COLD SPRING HARB SYM, V61, P225; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van der Staay FJ, 2011, BEHAV BRAIN RES, V220, P215, DOI 10.1016/j.bbr.2011.01.052; Vann SD, 2000, J NEUROSCI, V20, P8144; Vann SD, 2000, J NEUROSCI, V20, P2711; Wang DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007486; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; White TL, 2004, BRAIN RES, V1021, P1, DOI 10.1016/j.brainres.2004.05.114; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817	79	34	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36387	10.1371/journal.pone.0036387	http://dx.doi.org/10.1371/journal.pone.0036387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558458	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000203
J	Liang, JA; Sun, LM; Su, KP; Chang, SN; Sung, FC; Muo, CH; Kao, CH				Liang, Ji-An; Sun, Li-Min; Su, Kuan-Pin; Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin; Kao, Chia-Hung			A Nationwide Population-Based Cohort Study: Will Anxiety Disorders Increase Subsequent Cancer Risk?	PLOS ONE			English	Article							BREAST-CANCER; PSYCHOSOCIAL FACTORS; LIFE EVENTS; STRESS; DEPRESSION; METAANALYSIS; OUTPATIENTS; PREVALENCE; NONSMOKERS; SMOKERS	Background: The aim of this study was to evaluate a possible association between malignancy and anxiety disorders (AD) in Taiwan. Methods: We employed data from the National Health Insurance system of Taiwan. The AD cohort contained 24,066 patients with each patient randomly frequency matched according to age and sex with 4 individuals from the general population without AD. Cox's proportional hazard regression analysis was conducted to estimate the influence of AD on the risk of cancer. Results: Among patients with AD, the overall risk of developing cancer was only 1% higher than among subjects without AD, and the difference was not significant (hazard ratio [HR] = 1.01, 95% confidence interval [ 95% CI] = 0.95-1.07). With regard to individual types of cancer, the risk of developing prostate cancer among male patients with AD was significantly higher (HR = 1.32, 95% CI = 1.02-1.71). On the other hand, the risk of cervical cancer among female patients with AD was marginally significantly lower than among female subjects without AD (HR = 0.72, 95% CI = 0.51-1.03). Limitations: One major limitation is the lack of information regarding the life style or behavior of patients in the NHI database, such as smoking and alcohol consumption. Conclusions: Despite the failure to identify a relationship between AD and the overall risk of cancer, we found that Taiwanese patients with AD had a higher risk of developing prostate cancer and a lower risk of developing cervical cancer.	[Liang, Ji-An] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Liang, Ji-An; Su, Kuan-Pin; Kao, Chia-Hung] China Med Univ, Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Liang, Ji-An; Su, Kuan-Pin; Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Sun, Li-Min] Zuoying Armed Forces Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Su, Kuan-Pin] China Med Univ Hosp, Dept Gen Psychiat, Taichung, Taiwan; [Su, Kuan-Pin] China Med Univ Hosp, Mind Body Interface Lab, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Chang, Shih-Ni; Sung, Fung-Chang; Muo, Chih-Hsin] China Med Univ, Inst Environm Hlth, Coll Publ Hlth, Taichung, Taiwan; [Chang, Shih-Ni] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Chang, Shih-Ni] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Liang, JA (corresponding author), China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan.	A17776@mail.cmuh.org; d10040@mail.cmuh.org.tw	Su, Kuan-Pin/P-5284-2015	Su, Kuan-Pin/0000-0002-4501-2502	Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH101-TD-C-111-005];  [DMR-99-105];  [DMR-98-050]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; ; 	This work was supported by the study projects (DMR-99-105 and DMR-98-050) in our hospital and Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH101-TD-B-111-004), and Taiwan Department of Health Cancer Research Center for Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown LF, 2009, PSYCHOSOMATICS, V50, P440, DOI 10.1176/appi.psy.50.5.440; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; CHEN CN, 1993, ARCH GEN PSYCHIAT, V50, P125; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; COX T, 1982, SOC SCI MED, V16, P381, DOI 10.1016/0277-9536(82)90048-X; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; EYSENCK HJ, 1994, ADV BEHAV RES THER, V16, P167, DOI 10.1016/0146-6402(94)00001-8; FARAVELLI C, 1989, ACTA PSYCHIAT SCAND, V79, P308, DOI 10.1111/j.1600-0447.1989.tb10263.x; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; Geyer S, 2000, WIEN KLIN WOCHENSCHR, V112, P986; Ginsberg A, 1996, EUR J CANCER, V32A, P2049, DOI 10.1016/S0959-8049(96)00275-4; GROSS J, 1989, SOC SCI MED, V28, P1239, DOI 10.1016/0277-9536(89)90342-0; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x; Jadoon NA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-594; Khuwaja AK, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-72; Liang JA, 2012, RHEUMATOL INT, V32, P773, DOI 10.1007/s00296-010-1684-y; Lillberg K, 2001, INT J CANCER, V91, P888, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1138>3.0.CO;2-D; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Masmoudi Jawaher, 2010, Tunis Med, V88, P223; McKenna MC, 1999, HEALTH PSYCHOL, V18, P520, DOI 10.1037/0278-6133.18.5.520; Morissette SB, 2008, ADDICT BEHAV, V33, P1425, DOI 10.1016/j.addbeh.2008.06.012; Morissette SB, 2006, J ANXIETY DISORD, V20, P597, DOI 10.1016/j.janxdis.2005.08.003; Papadimitriou GN, 2005, INT REV PSYCHIATR, V17, P229, DOI 10.1080/09540260500104524; Protheroe D, 1999, BRIT MED J, V319, P1027, DOI 10.1136/bmj.319.7216.1027; Reynaert C, 2000, B CANCER, V87, P655; Ritz T, 2000, PSYCHOSOM MED, V62, P401, DOI 10.1097/00006842-200005000-00014; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Schwarz S, 2007, MED KLIN, V102, P967, DOI 10.1007/s00063-007-1128-y; Taiwan Cancer Registry, CABC STAT; WITTCHEN HU, 1994, ARCH GEN PSYCHIAT, V51, P355	31	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36370	10.1371/journal.pone.0036370	http://dx.doi.org/10.1371/journal.pone.0036370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558450	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000198
J	van Dooremalen, C; Gerritsen, L; Cornelissen, B; van der Steen, JJM; van Langevelde, F; Blacquiere, T				van Dooremalen, Coby; Gerritsen, Lonne; Cornelissen, Bram; van der Steen, Jozef J. M.; van Langevelde, Frank; Blacquiere, Tjeerd			Winter Survival of Individual Honey Bees and Honey Bee Colonies Depends on Level of Varroa destructor Infestation	PLOS ONE			English	Article							JACOBSONI OUD; OXALIC-ACID; POPULATION; ACARI; HYMENOPTERA; LONGEVITY; LIFE; PHYSIOLOGY; DECLINES; SEASON	Background: Recent elevated winter loss of honey bee colonies is a major concern. The presence of the mite Varroa destructor in colonies places an important pressure on bee health. V. destructor shortens the lifespan of individual bees, while long lifespan during winter is a primary requirement to survive until the next spring. We investigated in two subsequent years the effects of different levels of V. destructor infestation during the transition from short-lived summer bees to long-lived winter bees on the lifespan of individual bees and the survival of bee colonies during winter. Colonies treated earlier in the season to reduce V. destructor infestation during the development of winter bees were expected to have longer bee lifespan and higher colony survival after winter. Methodology/Principal Findings: Mite infestation was reduced using acaricide treatments during different months (July, August, September, or not treated). We found that the number of capped brood cells decreased drastically between August and November, while at the same time, the lifespan of the bees (marked cohorts) increased indicating the transition to winter bees. Low V. destructor infestation levels before and during the transition to winter bees resulted in an increase in lifespan of bees and higher colony survival compared to colonies that were not treated and that had higher infestation levels. A variety of stress-related factors could have contributed to the variation in longevity and winter survival that we found between years. Conclusions/Significance: This study contributes to theory about the multiple causes for the recent elevated colony losses in honey bees. Our study shows the correlation between long lifespan of winter bees and colony loss in spring. Moreover, we show that colonies treated earlier in the season had reduced V. destructor infestation during the development of winter bees resulting in longer bee lifespan and higher colony survival after winter.	[van Dooremalen, Coby; Gerritsen, Lonne; Cornelissen, Bram; van der Steen, Jozef J. M.; Blacquiere, Tjeerd] Bees Wur, Plant Res Int, Wageningen, Netherlands; [van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands	Wageningen University & Research	van Dooremalen, C (corresponding author), Bees Wur, Plant Res Int, Wageningen, Netherlands.	coby.vandooremalen@wur.nl	Cornelissen, Bram ACM/B-3440-2013	van Dooremalen, Coby/0000-0002-1525-0171; Van Langevelde, Frank/0000-0001-8870-0797	Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands; European Union [NP11/2.1, NL08/2.1, BO-06-012-001, BO-12.03-007-001]; Food Quality (LNV) of the Netherlands	Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands; European Union(European Commission); Food Quality (LNV) of the Netherlands(Netherlands Government)	The project was funded by Ministry of Agriculture, Nature Conservation and Food Quality (LNV) of the Netherlands and by the European Union (project numbers NP11/2.1, NL08/2.1, BO-06-012-001, and BO-12.03-007-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol E, 2008, ITAL J ANIM SCI, V7, P237; Aliano NP, 2009, EXP APPL ACAROL, V48, P303, DOI 10.1007/s10493-009-9240-8; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Amdam GV, 2002, J THEOR BIOL, V216, P209, DOI 10.1006/jtbi.2002.2545; BOOT WJ, 1995, APIDOLOGIE, V26, P109, DOI 10.1051/apido:19950204; Branco MR, 2006, APIDOLOGIE, V37, P452, DOI 10.1051/apido:2006010; Currie RW, 2006, CAN ENTOMOL, V138, P238; DEJONG D, 1983, J ECON ENTOMOL, V76, P766, DOI 10.1093/jee/76.4.766; Delaplane KS, 1997, J APICULT RES, V36, P125, DOI 10.1080/00218839.1997.11100938; Ellis JD, 2010, J APICULT RES, V49, P134, DOI 10.3896/IBRA.1.49.1.30; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; FUKUDA HIROMI, 1966, JAP J ECOL, V16, P206; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; KOVAC H, 1988, J APICULT RES, V27, P230, DOI 10.1080/00218839.1988.11100808; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; Martin SJ, 1997, J APICULT RES, V36, P113, DOI 10.1080/00218839.1997.11100937; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rademacher E, 2006, APIDOLOGIE, V37, P98, DOI 10.1051/apido:2005063; Rademacher E, 2001, APIDOLOGIE, V32, P488; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; SCHNEIDER P, 1987, APIDOLOGIE, V18, P101, DOI 10.1051/apido:19870108; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; WOYKE J, 1984, J APICULT RES, V23, P148, DOI 10.1080/00218839.1984.11100624; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720	27	95	99	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36285	10.1371/journal.pone.0036285	http://dx.doi.org/10.1371/journal.pone.0036285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558421	Green Published, gold			2022-12-27	WOS:000305336000179
J	Caruso, T; Powell, JR; Rillig, MC				Caruso, Tancredi; Powell, Jeff R.; Rillig, Matthias C.			Compositional Divergence and Convergence in Local Communities and Spatially Structured Landscapes	PLOS ONE			English	Article							NEUTRAL THEORY; SPECIES ABUNDANCE; MULTIPLE SAMPLES; ECOLOGICAL DATA; MODEL; NICHE; DISPERSAL; DIVERSITY; FRAMEWORK	Community structure depends on both deterministic and stochastic processes. However, patterns of community dissimilarity (e.g. difference in species composition) are difficult to interpret in terms of the relative roles of these processes. Local communities can be more dissimilar (divergence) than, less dissimilar (convergence) than, or as dissimilar as a hypothetical control based on either null or neutral models. However, several mechanisms may result in the same pattern, or act concurrently to generate a pattern, and much research has recently been focusing on unravelling these mechanisms and their relative contributions. Using a simulation approach, we addressed the effect of a complex but realistic spatial structure in the distribution of the niche axis and we analysed patterns of species co-occurrence and beta diversity as measured by dissimilarity indices (e.g. Jaccard index) using either expectations under a null model or neutral dynamics (i.e., based on switching off the niche effect). The strength of niche processes, dispersal, and environmental noise strongly interacted so that niche-driven dynamics may result in local communities that either diverge or converge depending on the combination of these factors. Thus, a fundamental result is that, in real systems, interacting processes of community assembly can be disentangled only by measuring traits such as niche breadth and dispersal. The ability to detect the signal of the niche was also dependent on the spatial resolution of the sampling strategy, which must account for the multiple scale spatial patterns in the niche axis. Notably, some of the patterns we observed correspond to patterns of community dissimilarities previously observed in the field and suggest mechanistic explanations for them or the data required to solve them. Our framework offers a synthesis of the patterns of community dissimilarity produced by the interaction of deterministic and stochastic determinants of community assembly in a spatially explicit and complex context.	[Caruso, Tancredi; Powell, Jeff R.; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Berlin, Germany; [Powell, Jeff R.] Univ Western Sydney, Hawkesbury Inst Environm, Richmond, NSW, Australia	Free University of Berlin; Western Sydney University	Caruso, T (corresponding author), Free Univ Berlin, Inst Biol, Berlin, Germany.	tancredi.caruso@fu-berlin.de	Rillig, Matthias C./B-3675-2009; Caruso, Tancredi/H-1103-2012; Powell, Jeff R/A-5076-2010; Rillig, Matthias C./AAE-6980-2019	Rillig, Matthias C./0000-0003-3541-7853; Caruso, Tancredi/0000-0002-3607-9609; Powell, Jeff R/0000-0003-1091-2452; Rillig, Matthias C./0000-0003-3541-7853	Freie Universitat Berlin; Marie Curie International Incoming Fellowship; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft; University of Western Sydney	Freie Universitat Berlin; Marie Curie International Incoming Fellowship(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Western Sydney	Funded by Freie Universitat Berlin (http://www.fu-berlin.de/), a Marie Curie International Incoming Fellowship (http://cordis.europa.eu/mariecurieactions/iif/home.html), an Alexander von Humboldt Foundation Fellowship (http://www.humboldt-foundation.de/web/home.html), the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp), and the University of Western Sydney (http://www.uws.edu.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Allouche O, 2009, ECOL LETT, V12, P1287, DOI 10.1111/j.1461-0248.2009.01379.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borenstein M., 2009, INTRO METAANALYSIS; Caruso T, 2012, J ANIM ECOL, V81, P214, DOI 10.1111/j.1365-2656.2011.01886.x; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chave J, 2006, NATURE, V441, pE1, DOI 10.1038/nature04826; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; Chave J, 2002, THEOR POPUL BIOL, V62, P153, DOI 10.1006/tpbi.2002.1597; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014717; Etienne RS, 2009, ECOLOGY, V90, P847, DOI 10.1890/08-0750.1; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, P NATL ACAD SCI USA, V107, P5030, DOI 10.1073/pnas.0914089107; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2003, ECOLOGY, V84, P532, DOI 10.1890/0012-9658(2003)084[0532:SAINMA]2.0.CO;2; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Jabot F, 2011, AM NAT, V178, pE37, DOI 10.1086/660829; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Legendre P., 1998, DEV ENV MODELLING, V20; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Munkemuller T, 2012, ECOGRAPHY, V35, P468, DOI 10.1111/j.1600-0587.2011.07259.x; Nee S, 2003, TRENDS ECOL EVOL, V18, P433, DOI 10.1016/S0169-5347(03)00196-4; Petzoldt T, 2007, J STAT SOFTW, V22, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Rejou-Mechain M, 2011, AM NAT, V177, P589, DOI 10.1086/659627; Ruokolainen L, 2009, ECOL LETT, V12, P909, DOI 10.1111/j.1461-0248.2009.01346.x; Sokol ER, 2011, AM NAT, V177, P630, DOI 10.1086/659625; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D., 1982, Monographs in Population Biology, pi; Volkov I, 2004, NATURE, V427, P696, DOI 10.1038/427696a; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883	50	47	49	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35942	10.1371/journal.pone.0035942	http://dx.doi.org/10.1371/journal.pone.0035942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563423	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100049
J	He, WM; Montesinos, D; Thelen, GC; Callaway, RM				He, Wei-Ming; Montesinos, Daniel; Thelen, Giles C.; Callaway, Ragan M.			Growth and Competitive Effects of Centaurea stoebe Populations in Response to Simulated Nitrogen Deposition	PLOS ONE			English	Article							INVASION BIOGEOGRAPHIC DIFFERENCES; EXOTIC PERENNIAL GRASSES; BROMUS-TECTORUM; NUTRIENT LIMITATION; PLANT-COMMUNITIES; SOIL-NITROGEN; IMPACTS; MECHANISMS; FEEDBACKS; MACULOSA	Increased resource availability can promote invasion by exotic plants, raising concerns over the potential effects of global increases in the deposition of nitrogen (N). It is poorly understood why increased N favors exotics over natives. Fast growth may be a general trait of good invaders and these species may have exceptional abilities to increase growth rates in response to N deposition. Additionally, invaders commonly displace locals, and thus may have inherently greater competitive abilities. The mean growth response of Centaurea stoebe to two N levels was significantly greater than that of North American (NA) species. Growth responses to N did not vary among C. stoebe populations or NA species. Without supplemental N, NA species were better competitors than C. stoebe, and C. stoebe populations varied in competitive effects. The competitive effects of C. stoebe populations increased with N whereas the competitive effects of NA species decreased, eliminating the overall competitive advantage demonstrated by NA species in soil without N added. These results suggest that simulated N deposition may enhance C. stoebe invasion through increasing its growth and relative competitive advantage, and also indicate the possibility of local adaptation in competitive effects across the introduced range of an invader.	[He, Wei-Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Montesinos, Daniel] Ctr Invest Desertificac CIDE CSIC UV GV, Albal, Spain; [Thelen, Giles C.; Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE); University of Montana System; University of Montana	He, WM (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	weiminghe@ibcas.ac.cn	Montesinos, Daniel/A-9070-2012	Montesinos, Daniel/0000-0003-2893-0878	National Natural Science Foundation of China [31170507]; State Key Laboratory of Vegetation and Environmental Change [2011zyts02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Vegetation and Environmental Change	Two grants supported this work: No. 1. The National Natural Science Foundation of China (31170507, www.nsfc.gov.cn). No. 2. The State Key Laboratory of Vegetation and Environmental Change (2011zyts02, www.ibcas.ac.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JK, 2009, PLANT ECOL, V201, P445, DOI 10.1007/s11258-008-9467-1; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2005, J ECOL, V93, P576, DOI 10.1111/j.1365-2745.2005.00994.x; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; CHAPIN FS, 1986, AM NAT, V127, P48, DOI 10.1086/284466; Crutsinger GM, 2008, ECOL LETT, V11, P16, DOI 10.1111/j.1461-0248.2007.01118.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fridley JD, 2007, J ECOL, V95, P908, DOI 10.1111/j.1365-2745.2007.01256.x; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Grime J. P., 2001, PLANT STRATEGIES VEG; He WM, 2011, ECOGRAPHY, V34, P1059, DOI 10.1111/j.1600-0587.2011.06835.x; He WM, 2010, BIOL INVASIONS, V12, P3591, DOI 10.1007/s10530-010-9753-4; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Hebel CL, 2009, APPL SOIL ECOL, V42, P150, DOI 10.1016/j.apsoil.2009.03.004; Knochel DG, 2010, BIOL INVASIONS, V12, P3771, DOI 10.1007/s10530-010-9769-9; Knochel DG, 2010, ECOL APPL, V20, P1903, DOI 10.1890/09-1944.1; Kolb A, 2002, J ECOL, V90, P871, DOI 10.1046/j.1365-2745.2002.00719.x; Kourtev P.S., 1999, Biological Invasions, V1, P237, DOI 10.1023/A:1010048909563; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lowe PN, 2003, PLANT ECOL, V167, P247, DOI 10.1023/A:1023934515420; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; MILCHUNAS DG, 1995, ECOL APPL, V5, P452, DOI 10.2307/1942035; Nybakken L, 2009, GLOBAL CHANGE BIOL, V15, P2247, DOI 10.1111/j.1365-2486.2009.01853.x; Ortega YK, 2005, ECOL APPL, V15, P651, DOI 10.1890/04-0119; Peltzer DA, 2010, GLOBAL CHANGE BIOL, V16, P732, DOI 10.1111/j.1365-2486.2009.02038.x; Penuelas J, 2009, SCIENCE, V324, P887, DOI 10.1126/science.1173004; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Reinhart KO, 2011, PLANT ECOL, V212, P821, DOI 10.1007/s11258-010-9867-x; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; ROCHE CT, 1988, NORTHWEST SCI, V62, P242; Siguenza C, 2006, PLANT SOIL, V286, P153, DOI 10.1007/s11104-006-9034-2; Thomsen MA, 2006, PLANT ECOL, V186, P23, DOI 10.1007/s11258-006-9109-4; Thorpe AS, 2011, J ECOL, V99, P729, DOI 10.1111/j.1365-2745.2011.01802.x; Tilman D., 1982, Monographs in Population Biology, pi; Tomassen HBM, 2004, J APPL ECOL, V41, P139, DOI 10.1111/j.1365-2664.2004.00870.x; van der Wal R, 2003, ECOL LETT, V6, P141, DOI 10.1046/j.1461-0248.2003.00407.x; Vasquez E, 2008, INVAS PLANT SCI MANA, V1, P287, DOI 10.1614/IPSM-08-062.1; Vellend M, 2006, ECOLOGY, V87, P304, DOI 10.1890/05-0173; Vitousek P. M., 1997, ISSUES ECOL, V1, P1; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; WEIR TL, 2010, ANN REV PLANT BIOL	46	15	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36257	10.1371/journal.pone.0036257	http://dx.doi.org/10.1371/journal.pone.0036257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563451	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100076
J	Todd, JD; Curson, ARJ; Sullivan, MJ; Kirkwood, M; Johnston, AWB				Todd, Jonathan D.; Curson, Andrew R. J.; Sullivan, Matthew J.; Kirkwood, Mark; Johnston, Andrew W. B.			The Ruegeria pomeroyi acuI Gene Has a Role in DMSP Catabolism and Resembles yhdH of E. coli and Other Bacteria in Conferring Resistance to Acrylate	PLOS ONE			English	Article							PROPIONYL-COENZYME-A; DIMETHYL SULFIDE; RHIZOBIUM-LEGUMINOSARUM; ESCHERICHIA-COLI; DIMETHYLSULFONIOPROPIONATE LYASE; MARINE-BACTERIA; COA DEHYDROGENASE; SULFUR-COMPOUNDS; GENOME SEQUENCE; ENZYME	The Escherichia coli YhdH polypeptide is in the MDR012 sub-group of medium chain reductase/dehydrogenases, but its biological function was unknown and no phenotypes of YhdH(-) mutants had been described. We found that an E. coli strain with an insertional mutation in yhdH was hyper-sensitive to inhibitory effects of acrylate, and, to a lesser extent, to those of 3-hydroxypropionate. Close homologues of YhdH occur in many Bacterial taxa and at least two animals. The acrylate sensitivity of YhdH(-) mutants was corrected by the corresponding, cloned homologues from several bacteria. One such homologue is acuI, which has a role in acrylate degradation in marine bacteria that catabolise dimethylsulfoniopropionate (DMSP) an abundant anti-stress compound made by marine phytoplankton. The acuI genes of such bacteria are often linked to ddd genes that encode enzymes that cleave DMSP into acrylate plus dimethyl sulfide (DMS), even though these are in different polypeptide families, in unrelated bacteria. Furthermore, most strains of Roseobacters, a clade of abundant marine bacteria, cleave DMSP into acrylate plus DMS, and can also demethylate it, using DMSP demethylase. In most Roseobacters, the corresponding gene, dmdA, lies immediately upstream of acuI and in the model Roseobacter strain Ruegeria pomeroyi DSS-3, dmdA-acuI were co-regulated in response to the co-inducer, acrylate. These observations, together with findings by others that AcuI has acryloyl-CoA reductase activity, lead us to suggest that YdhH/AcuI enzymes protect cells against damaging effects of intracellular acryloyl-CoA, formed endogenously, and/or via catabolising exogenous acrylate. To provide "added protection" for bacteria that form acrylate from DMSP, acuI was recruited into clusters of genes involved in this conversion and, in the case of acuI and dmdA in the Roseobacters, their co-expression may underpin an interaction between the two routes of DMSP catabolism, whereby the acrylate product of DMSP lyases is a co-inducer for the demethylation pathway.	[Todd, Jonathan D.; Curson, Andrew R. J.; Sullivan, Matthew J.; Kirkwood, Mark; Johnston, Andrew W. B.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Todd, JD (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England.	a.johnston@uea.ac.uk	Sullivan, Matthew J/C-3857-2009; Todd, Jonathan/B-8967-2009; Johnston, Andrew W B/D-1859-2009; Curson, Andrew RJ/B-8964-2009	Sullivan, Matthew J/0000-0003-2276-3132; Todd, Jonathan/0000-0003-0777-9312; 	BBSRC; Natural Environment Research Council (NERC) of the United Kingdom; Biotechnology and Biological Sciences Research Council [BB/H002642/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC) of the United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC and the Natural Environment Research Council (NERC) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Burgmann H, 2007, ENVIRON MICROBIOL, V9, P2742, DOI 10.1111/j.1462-2920.2007.01386.x; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; Curson ARJ, BIOGEOCHEMI IN PRESS; DESOUZA MP, 1995, APPL ENVIRON MICROB, V61, P21, DOI 10.1128/AEM.61.1.21-26.1995; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gonzalez JM, 2003, INT J SYST EVOL MICR, V53, P1261, DOI 10.1099/ijs.0.02491-0; Gonzalez JM, 1997, INT J SYST BACTERIOL, V47, P773, DOI 10.1099/00207713-47-3-773; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P3810; Hedlund J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-534; Herrmann G, 2005, FEBS J, V272, P813, DOI 10.1111/j.1742-4658.2004.04518.x; Hetzel M, 2003, EUR J BIOCHEM, V270, P902, DOI 10.1046/j.1432-1033.2003.03450.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jornvall H, 2010, BIOCHEM BIOPH RES CO, V396, P125, DOI 10.1016/j.bbrc.2010.03.094; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Otte ML, 2004, J EXP BOT, V55, P1919, DOI 10.1093/jxb/erh178; PATEL SS, 1987, J BIOL CHEM, V262, P7132; Pati A, 2010, STAND GENOMIC SCI, V2, P300, DOI 10.4056/sigs.912121; Raina JB, 2010, TRENDS MICROBIOL, V18, P101, DOI 10.1016/j.tim.2009.12.002; Reisch CR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00172; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; ROSSEN L, 1985, EMBO J, V4, P3369, DOI 10.1002/j.1460-2075.1985.tb04092.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schneider K, 2012, J BACTERIOL, V194, P225, DOI 10.1128/JB.05959-11; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; SHAW L, 1985, BIOCHEM J, V230, P723, DOI 10.1042/bj2300723; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Sullivan MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015972; Sulzenbacher G, 2004, ACTA CRYSTALLOGR D, V60, P1855, DOI 10.1107/S0907444904020220; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapiolas DM, 2010, CORAL REEFS, V29, P621, DOI 10.1007/s00338-010-0608-3; TAYLOR BF, 1991, APPL ENVIRON MICROB, V57, P3581, DOI 10.1128/AEM.57.12.3581-3584.1991; Teufel R, 2009, J BACTERIOL, V191, P4572, DOI 10.1128/JB.00068-09; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1376, DOI 10.1111/j.1462-2920.2009.01864.x; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Todd JD, 2010, ENVIRON MICROBIOL, V12, P327, DOI 10.1111/j.1462-2920.2009.02071.x; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; van Niel CB, 1944, BACTERIOL REV, V8, P1; Wexler M, 2001, MOL MICROBIOL, V41, P801, DOI 10.1046/j.1365-2958.2001.02556.x; WOOD WB, 1966, J MOL BIOL, V16, P118, DOI 10.1016/S0022-2836(66)80267-X; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34	59	35	43	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35947	10.1371/journal.pone.0035947	http://dx.doi.org/10.1371/journal.pone.0035947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563425	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100051
J	Walker, MB; King, BL; Paigen, K				Walker, Michael B.; King, Benjamin L.; Paigen, Kenneth			Clusters of Ancestrally Related Genes That Show Paralogy in Whole or in Part Are a Major Feature of the Genomes of Humans and Other Species	PLOS ONE			English	Article							PROTOCADHERIN-ALPHA; SCOP DATABASE; PROTEINS; FAMILY; EVOLUTION; COMPLEX; IDENTIFICATION; IMMUNOGLOBULIN; PROMOTER	Arrangements of genes along chromosomes are a product of evolutionary processes, and we can expect that preferable arrangements will prevail over the span of evolutionary time, often being reflected in the non-random clustering of structurally and/or functionally related genes. Such non-random arrangements can arise by two distinct evolutionary processes: duplications of DNA sequences that give rise to clusters of genes sharing both sequence similarity and common sequence features and the migration together of genes related by function, but not by common descent [ 1,2,3]. To provide a background for distinguishing between the two, which is important for future efforts to unravel the evolutionary processes involved, we here provide a description of the extent to which ancestrally related genes are found in proximity. Towards this purpose, we combined information from five genomic datasets, InterPro, SCOP, PANTHER, Ensembl protein families, and Ensembl gene paralogs. The results are provided in publicly available datasets (http://cgd.jax.org/datasets/clustering/paraclustering.shtml) describing the extent to which ancestrally related genes are in proximity beyond what is expected by chance (i.e. form paraclusters) in the human and nine other vertebrate genomes, as well as the D. melanogaster, C. elegans, A. thaliana, and S. cerevisiae genomes. With the exception of Saccharomyces, paraclusters are a common feature of the genomes we examined. In the human genome they are estimated to include at least 22% of all protein coding genes. Paraclusters are far more prevalent among some gene families than others, are highly species or clade specific and can evolve rapidly, sometimes in response to environmental cues. Altogether, they account for a large portion of the functional clustering previously reported in several genomes.	[Walker, Michael B.; King, Benjamin L.; Paigen, Kenneth] Jackson Lab, Bar Harbor, ME 04609 USA; [King, Benjamin L.] Mt Desert Isl Biol Lab, Salsbury Cove, ME USA	Jackson Laboratory; Mount Desert Island Biological Laboratory	Walker, MB (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	kenneth.paigen@jax.org	King, Benjamin/AAI-1492-2019	King, Benjamin/0000-0001-6463-1336	United States National Institutes of Health [GM 076468]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States National Institutes of Health grant GM 076468. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000953; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Barrow AD, 2008, IMMUNOL REV, V224, P98, DOI 10.1111/j.1600-065X.2008.00653.x; Bretaudeau A, 2010, DGD DUPLICATED GENE; Cao H, 2009, IMMUNOGENETICS, V61, P401, DOI 10.1007/s00251-009-0372-0; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Despons L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-56; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605; Fisher R.A, 1930, GENETIC THEORY NATUR; Force A, 1999, GENETICS, V151, P1531; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Lanave C, 2004, GENE, V333, P71, DOI 10.1016/j.gene.2004.02.017; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Makino T, 2008, MOL BIOL EVOL, V25, P1855, DOI 10.1093/molbev/msn137; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Mayor LR, 2004, J MOL BIOL, V340, P991, DOI 10.1016/j.jmb.2004.05.036; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Minguillon C, 2005, INT J BIOL SCI, V1, P19; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NEI M, 1967, GENETICS, V57, P625; Nei M, 2003, HEREDITY, V90, P411, DOI 10.1038/sj.hdy.6800287; Nei M, 2007, P NATL ACAD SCI USA, V104, P12235, DOI 10.1073/pnas.0703349104; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pan D, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/545269; Patel S, 2003, MAMM GENOME, V14, P140, DOI 10.1007/s00335-002-2205-4; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Ribich S, 2006, P NATL ACAD SCI USA, V103, P19719, DOI 10.1073/pnas.0609445104; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; ROZWARSKI DA, 1994, STRUCTURE, V2, P159, DOI 10.1016/S0969-2126(00)00018-6; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Shiina T, 2001, GENOME RES, V11, P789, DOI 10.1101/gr.175801; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; Song G, 2010, J COMPUT BIOL, V17, P1227, DOI 10.1089/cmb.2010.0094; Suzuki ST, 2000, EXP CELL RES, V261, P13, DOI 10.1006/excr.2000.5039; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trowsdale J, 2002, GENOME BIOL, V3; Tzifi F, 2012, ADV HEMATOL, P524308; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204	54	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35274	10.1371/journal.pone.0035274	http://dx.doi.org/10.1371/journal.pone.0035274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563380	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100009
J	Henson, BJ; Zhu, W; Hardaway, K; Wetzel, JL; Stefan, M; Albers, KM; Nicholls, RD				Henson, Brian J.; Zhu, Wan; Hardaway, Kelsey; Wetzel, Jaime L.; Stefan, Mihaela; Albers, Kathryn M.; Nicholls, Robert D.			Transcriptional and Post-Transcriptional Regulation of SPAST, the Gene Most Frequently Mutated in Hereditary Spastic Paraplegia	PLOS ONE			English	Article							RESPIRATORY FACTOR-I; MICROTUBULE DYNAMICS; AXON OUTGROWTH; MUTATIONS; PROTEIN; ACTIVATION; EXPRESSION; PROMOTER; SOX11; SPG4	Hereditary spastic paraplegias (HSPs) comprise a group of neurodegenerative disorders that are characterized by progressive spasticity of the lower extremities, due to axonal degeneration in the corticospinal motor tracts. HSPs are genetically heterogeneous and show autosomal dominant inheritance in similar to 70-80% of cases, with additional cases being recessive or X-linked. The most common type of HSP is SPG4 with mutations in the SPAST gene, encoding spastin, which occurs in 40% of dominantly inherited cases and in similar to 10% of sporadic cases. Both loss-of-function and dominant-negative mutation mechanisms have been described for SPG4, suggesting that precise or stoichiometric levels of spastin are necessary for biological function. Therefore, we hypothesized that regulatory mechanisms controlling expression of SPAST are important determinants of spastin biology, and if altered, could contribute to the development and progression of the disease. To examine the transcriptional and post-transcriptional regulation of SPAST, we used molecular phylogenetic methods to identify conserved sequences for putative transcription factor binding sites and miRNA targeting motifs in the SPAST promoter and 3'-UTR, respectively. By a variety of molecular methods, we demonstrate that SPAST transcription is positively regulated by NRF1 and SOX11. Furthermore, we show that miR-96 and miR-182 negatively regulate SPAST by effects on mRNA stability and protein level. These transcriptional and miRNA regulatory mechanisms provide new functional targets for mutation screening and therapeutic targeting in HSP.	[Henson, Brian J.; Hardaway, Kelsey; Wetzel, Jaime L.; Stefan, Mihaela; Nicholls, Robert D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet,Birth Defects Labs, Pittsburgh, PA USA; [Zhu, Wan; Nicholls, Robert D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Albers, Kathryn M.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Henson, BJ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Med Genet,Birth Defects Labs, Pittsburgh, PA USA.	robert.nicholls@chp.edu	Mandak, Kelsey/AAH-2106-2019	Albers, Kathryn/0000-0003-4597-9323	National Institutes of Health [NS049417]; Spastic Paraplegia Foundation (SPF); Research Administration Committee, Children's Hospital of Pittsburgh of UPMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059003, R01NS049417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spastic Paraplegia Foundation (SPF); Research Administration Committee, Children's Hospital of Pittsburgh of UPMC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by research grants from the National Institutes of Health (NS049417) and the Spastic Paraplegia Foundation (SPF) to RDN. WZ was supported in part by a graduate fellowship from the Research Administration Committee, Children's Hospital of Pittsburgh of UPMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez V, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-89; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beauloye C, 2011, CARDIOVASC RES, V90, P224, DOI 10.1093/cvr/cvr034; Beetz C, 2006, NEUROLOGY, V67, P1926, DOI 10.1212/01.wnl.0000244413.49258.f5; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger J, 2000, EUR J HUM GENET, V8, P771, DOI 10.1038/sj.ejhg.5200528; Butler R, 2010, DIS MODEL MECH, V3, P743, DOI 10.1242/dmm.004002; Canbaz D, 2011, J NEUROCHEM, V117, P724, DOI 10.1111/j.1471-4159.2011.07243.x; Chang WT, 2005, BIOCHEM BIOPH RES CO, V334, P199, DOI 10.1016/j.bbrc.2005.06.079; CHAU CMA, 1992, J BIOL CHEM, V267, P6999; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; David MD, 2010, J NEUROSCI RES, V88, P3011, DOI 10.1002/jnr.22464; de Bot ST, 2010, J NEUROL NEUROSUR PS, V81, P1073, DOI 10.1136/jnnp.2009.201103; Depienne C, 2007, CURR OPIN NEUROL, V20, P674, DOI 10.1097/WCO.0b013e3282f190ba; Depienne C, 2007, J MED GENET, V44, P281, DOI 10.1136/jmg.2006.046425; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058; Fazio IK, 2001, J BIOL CHEM, V276, P18710, DOI 10.1074/jbc.M100080200; Fink JK, 2009, GENEREVIEWS; Goodman M, 2009, P NATL ACAD SCI USA, V106, P20824, DOI 10.1073/pnas.0911239106; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Jalvy-Delvaille S, 2012, NUCLEIC ACIDS RES, V40, P1356, DOI 10.1093/nar/gkr843; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jensen KP, 2011, NUCLEIC ACIDS RES, V39, P701, DOI 10.1093/nar/gkq798; Jing XT, 2012, EXP NEUROL, V233, P221, DOI 10.1016/j.expneurol.2011.10.005; Juhila J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021495; Kalil K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00062; Kasher PR, 2009, J NEUROCHEM, V110, P34, DOI 10.1111/j.1471-4159.2009.06104.x; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Lee S, 2011, J NEUROIMMUNOL, V235, P56, DOI 10.1016/j.jneuroim.2011.02.007; Lehnert S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004456; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Lin PF, 2008, AM J HUM GENET, V83, P752, DOI 10.1016/j.ajhg.2008.11.003; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Magariello A, 2010, J NEUROL SCI, V288, P96, DOI 10.1016/j.jns.2009.09.025; Mancuso G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-31; McCorquodale DS, 2011, CLIN GENET, V79, P523, DOI 10.1111/j.1399-0004.2010.01501.x; Pantakani DVK, 2008, J NEUROCHEM, V106, P613, DOI 10.1111/j.1471-4159.2008.05414.x; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Rainier S, 2003, AM J HUM GENET, V73, P967, DOI 10.1086/378817; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Rodriguez-Jato S, 2005, NUCLEIC ACIDS RES, V33, P4740, DOI 10.1093/nar/gki786; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shoukier M, 2009, EUR J HUM GENET, V17, P187, DOI 10.1038/ejhg.2008.147; Smith KT, 2004, HUM MOL GENET, V13, P1611, DOI 10.1093/hmg/ddh172; Solowska JM, 2010, HUM MOL GENET, V19, P2767, DOI 10.1093/hmg/ddq177; Stefan M, 2005, GENOMICS, V85, P630, DOI 10.1016/j.ygeno.2005.02.004; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Tarrade A, 2006, HUM MOL GENET, V15, P3544, DOI 10.1093/hmg/ddl431; Thein DC, 2010, J NEUROCHEM, V115, P131, DOI 10.1111/j.1471-4159.2010.06910.x; Valdmanis PN, 2007, AM J HUM GENET, V80, P152, DOI 10.1086/510782; Vinson C, 2011, SUBCELL BIOCHEM, V52, P205, DOI 10.1007/978-90-481-9069-0_10; Wei HG, 2010, INT J DEV NEUROSCI, V28, P545, DOI 10.1016/j.ijdevneu.2010.04.007; Wharton SB, 2003, J NEUROPATH EXP NEUR, V62, P1166, DOI 10.1093/jnen/62.11.1166; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xin N, 2011, DEVELOPMENT, V138, P4955, DOI 10.1242/dev.068890; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yu W., 2007, J ENV BIOMED, V1, P1; Yun H, 2011, EXPERT OPIN THER PAT, V21, P983, DOI 10.1517/13543776.2011.577069	89	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36505	10.1371/journal.pone.0036505	http://dx.doi.org/10.1371/journal.pone.0036505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574173	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000305349800070
J	Liang, S; Fang, L; Zhou, RC; Tang, T; Deng, SL; Dong, SS; Huang, YL; Zhong, CR; Shi, SH				Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Zhong, Cairong; Shi, Suhua			Transcriptional Homeostasis of a Mangrove Species, Ceriops tagal, in Saline Environments, as Revealed by Microarray Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; NA+/H+ ANTIPORTER; ARABIDOPSIS-THALIANA; SALT TOLERANCE; STRESS; ADAPTATION; DROUGHT; ASSIMILATION; SPECIATION; HALOPHYTE	Background: Differential responses to the environmental stresses at the level of transcription play a critical role in adaptation. Mangrove species compose a dominant community in intertidal zones and form dense forests at the sea-land interface, and although the anatomical and physiological features associated with their salt-tolerant lifestyles have been well characterized, little is known about the impact of transcriptional phenotypes on their adaptation to these saline environments. Methodology and Principal findings: We report the time-course transcript profiles in the roots of a true mangrove species, Ceriops tagal, as revealed by a series of microarray experiments. The expression of a total of 432 transcripts changed significantly in the roots of C. tagal under salt shock, of which 83 had a more than 2-fold change and were further assembled into 59 unigenes. Global transcription was stable at the early stage of salt stress and then was gradually dysregulated with the increased duration of the stress. Importantly, a pair-wise comparison of predicted homologous gene pairs revealed that the transcriptional regulations of most of the differentially expressed genes were highly divergent in C. tagal from that in salt-sensitive species, Arabidopsis thaliana. Conclusions/Significance: This work suggests that transcriptional homeostasis and specific transcriptional regulation are major events in the roots of C. tagal when subjected to salt shock, which could contribute to the establishment of adaptation to saline environments and, thus, facilitate the salt-tolerant lifestyle of this mangrove species. Furthermore, the candidate genes underlying the adaptation were identified through comparative analyses. This study provides a foundation for dissecting the genetic basis of the adaptation of mangroves to intertidal environments.	[Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Liang, Shan; Fang, Lu; Zhou, Renchao; Tang, Tian; Deng, Shulin; Dong, Suisui; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Liang, Shan] S China Normal Univ, Guangdong Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Zhong, Cairong] Hainan Dongzhai Harbor Natl Nat Reserve, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; South China Normal University	Liang, S (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.	lssssh@mail.sysu.edu.cn		Huang, Yelin/0000-0002-2514-0144; Deng, Shulin/0000-0002-7231-3415	National Natural Science Foundation of China [41130208, 40976081, 31170213, 31170308, 31070290, 31171994]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC2011A06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of the State Key Laboratory of Biocontrol	This study is supported by grants from the National Natural Science Foundation of China (41130208, 40976081, 31170213, 31170308, 31070290, 31171994), and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC2011A06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz I, 2001, AQUAT BOT, V70, P259, DOI 10.1016/S0304-3770(01)00160-7; Bohnert HJ, 2005, PLANT FUNCTIONAL GEN, P451; Bressan RA, 2001, PLANT PHYSIOL, V127, P1354, DOI 10.1104/pp.010752; CRAWFORD DL, 1992, MOL BIOL EVOL, V9, P806; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Feller I.C., 1996, MANGROVE ECOLOGY WOR; Fu XH, 2004, PLANT MOL BIOL REP, V22, p197a; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hruz T, 2008, ADV BIOINFORMATICS, V47, P5; Jiang YQ, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-25; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lexer C, 2005, J EVOLUTION BIOL, V18, P893, DOI 10.1111/j.1420-9101.2005.00901.x; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Nadon R, 2002, TRENDS GENET, V18, P265, DOI 10.1016/S0168-9525(02)02665-3; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Olsen KM, 2004, GENETICS, V167, P1361, DOI 10.1534/genetics.103.024950; Ouborg NJ, 2007, J ECOL, V95, P8, DOI 10.1111/j.1365-2745.2006.01197.x; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Pigliucci M, 2003, EVOLUTION, V57, P1455; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCHOLANDER PF, 1962, PLANT PHYSIOL, V37, P722, DOI 10.1104/pp.37.6.722; SCHOLANDER PF, 1968, PHYSIOL PLANTARUM, V21, P251, DOI 10.1111/j.1399-3054.1968.tb07248.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shimada M, 2010, POPUL ECOL, V52, P5, DOI 10.1007/s10144-009-0187-8; Soensen JG, 2003, ECOL LETT, V6, P1025; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tomlinson P.B., 2016, BOT MANGROVES, DOI [10.1017/CBO9781139946575, DOI 10.1017/CBO9781139946575]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103; Whitehead A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r13; Wong CE, 2005, PLANT MOL BIOL, V58, P561, DOI 10.1007/s11103-005-6163-6; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; Zheng WJ, 1999, J EXP MAR BIOL ECOL, V233, P247, DOI 10.1016/S0022-0981(98)00131-2; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	53	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36499	10.1371/journal.pone.0036499	http://dx.doi.org/10.1371/journal.pone.0036499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574172	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800068
J	Suspene, R; Meyerhans, A				Suspene, Rodolphe; Meyerhans, Andreas			Quantification of Unintegrated HIV-1 DNA at the Single Cell Level In Vivo	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RETROVIRAL DNA; CYTIDINE DEAMINASES; GERMINAL-CENTERS; INFECTED-CELLS; WHITE PULPS; T-CELLS; RECOMBINATION; INTEGRATION; EVOLUTION	In the nucleus of HIV-1 infected cells, unintegrated HIV-1 DNA molecules exist in the form of one and two LTR circles and linear molecules with degraded extremities. In tissue culture they are invariably more numerous than the provirus, the relative proportion of integrated to unintegrated forms varies widely from,1:1 to 1:10 and even over 1:100. In vivo, this ratio is unknown. To determine it, single nuclei from two infected patients with a known provirus copy number were microdissected, HIV DNA was amplified by nested PCR, cloned and individual clones sequenced. Given the extraordinary sequence complexity, we made the assumption that the total number of distinct sequences approximated to real number of amplifiable HIV-1 DNA templates in the nucleus. We found that the number of unintegrated DNA molecules increased linearly with the proviral copy number there being on average 86 unintegrated molecules per provirus.	[Suspene, Rodolphe; Meyerhans, Andreas] Univ Saarland, Inst Med Microbiol, Dept Virol, D-6650 Homburg, Germany	Saarland University	Suspene, R (corresponding author), Inst Pasteur, Paris, France.	rodolphe.suspene@pasteur.fr	Meyerhans, Andreas/S-2559-2019; t, lf/AAJ-4924-2020; Meyerhans, Andreas/D-3382-2014	Meyerhans, Andreas/0000-0003-0620-5317; Meyerhans, Andreas/0000-0003-0620-5317	EMBO Long Term Fellowship; Deutsche Forschungsgemeinschaft; Spanish Ministry of Science and Innovation [SAF2010-21336]	EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	RS was supported by an EMBO Long Term Fellowship. AM was supported by grants from the Deutsche Forschungsgemeinschaft and the Spanish Ministry of Science and Innovation (SAF2010-21336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; Bell P, 2001, J VIROL, V75, P7683, DOI 10.1128/JVI.75.16.7683-7691.2001; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; BROWN PO, 1989, P NATL ACAD SCI USA, V86, P2525, DOI 10.1073/pnas.86.8.2525; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; Carr JK, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-39; CHEYNIER R, 1994, CELL, V78, P373, DOI 10.1016/0092-8674(94)90417-0; Cheynier R, 2001, J GEN VIROL, V82, P1613, DOI 10.1099/0022-1317-82-7-1613; DELASSUS S, 1992, J VIROL, V66, P5642, DOI 10.1128/JVI.66.9.5642-5645.1992; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Dumaurier MJ, 2005, J GEN VIROL, V86, P3369, DOI 10.1099/vir.0.81133-0; FARNET CM, 1991, J VIROL, V65, P6942, DOI 10.1128/JVI.65.12.6942-6952.1991; FUJIWARA T, 1988, CELL, V54, P497, DOI 10.1016/0092-8674(88)90071-2; GOODENOW M, 1989, J ACQ IMMUN DEF SYND, V2, P344; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Gratton S, 2000, P NATL ACAD SCI USA, V97, P14566, DOI 10.1073/pnas.97.26.14566; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoelscher M, 2001, AIDS, V15, P1461, DOI 10.1097/00002030-200108170-00002; Hosmalin A, 2001, BLOOD, V97, P2695, DOI 10.1182/blood.V97.9.2695; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kils-Hutten L, 2001, J GEN VIROL, V82, P1621, DOI 10.1099/0022-1317-82-7-1621; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; LI YX, 1991, J VIROL, V65, P3973, DOI 10.1128/JVI.65.8.3973-3985.1991; McCutchan FE, 2000, AIDS, V14, pS31; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Plikat U, 1997, J VIROL, V71, P4233, DOI 10.1128/JVI.71.6.4233-4240.1997; ROBERTSON DL, 1995, NATURE, V374, P124, DOI 10.1038/374124b0; Rousseau CM, 2007, J VIROL, V81, P4492, DOI 10.1128/JVI.02050-06; Schwartz O, 1998, J VIROL, V72, P3845, DOI 10.1128/JVI.72.5.3845-3850.1998; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vandegraaff N, 2001, J VIROL, V75, P11253, DOI 10.1128/JVI.75.22.11253-11260.2001; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wain-Hobson S, 2003, J GEN VIROL, V84, P885, DOI 10.1099/vir.0.18894-0; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wooley DP, 1997, J VIROL, V71, P9650, DOI 10.1128/JVI.71.12.9650-9653.1997; Xu HZ, 2007, VIROLOGY, V360, P247, DOI 10.1016/j.virol.2006.10.036; Zhang Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010498, 10.1371/journal.pone.0015300, 10.1371/journal.pone.0015570, 10.1371/journal.pone.0012559]	45	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36246	10.1371/journal.pone.0036246	http://dx.doi.org/10.1371/journal.pone.0036246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574142	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800038
J	Walsh, MC; Buzoianu, SG; Rea, MC; O'Donovan, O; Gelencser, E; Ujhelyi, G; Ross, RP; Gardiner, GE; Lawlor, PG				Walsh, Maria C.; Buzoianu, Stefan G.; Rea, Mary C.; O'Donovan, Orla; Gelencser, Eva; Ujhelyi, Gabriella; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			Effects of Feeding Bt MON810 Maize to Pigs for 110 Days on Peripheral Immune Response and Digestive Fate of the cry1Ab Gene and Truncated Bt Toxin	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; ENDOGENOUS PLANT DNA; RECOMBINANT-DNA; FRAGMENTS; RAPESEED; PROTEIN; INGESTION; NUTRITION; TISSUES; SHEEP	Background: The objective of this study was to evaluate potential long-term (110 days) and age-specific effects of feeding genetically modified Bt maize on peripheral immune response in pigs and to determine the digestive fate of the cry1Ab gene and truncated Bt toxin. Methodology/Principal Findings: Forty day old pigs (n = 40) were fed one of the following treatments: 1) isogenic maize-based diet for 110 days (isogenic); 2) Bt maize-based diet (MON810) for 110 days (Bt); 3) Isogenic maize-based diet for 30 days followed by Bt maize-based diet for 80 days (isogenic/Bt); and 4) Bt maize-based diet (MON810) for 30 days followed by isogenic maize-based diet for 80 days (Bt/isogenic). Blood samples were collected during the study for haematological analysis, measurement of cytokine and Cry1Ab-specific antibody production, immune cell phenotyping and cry1Ab gene and truncated Bt toxin detection. Pigs were sacrificed on day 110 and digesta and organ samples were taken for detection of the cry1Ab gene and the truncated Bt toxin. On day 100, lymphocyte counts were higher (P<0.05) in pigs fed Bt/isogenic than pigs fed Bt or isogenic. Erythrocyte counts on day 100 were lower in pigs fed Bt or isogenic/Bt than pigs fed Bt/isogenic (P<0.05). Neither the truncated Bt toxin nor the cry1Ab gene were detected in the organs or blood of pigs fed Bt maize. The cry1Ab gene was detected in stomach digesta and at low frequency in the ileum but not in the distal gastrointestinal tract (GIT), while the Bt toxin fragments were detected at all sites in the GIT. Conclusions/Significance: Perturbations in peripheral immune response were thought not to be age-specific and were not indicative of Th 2 type allergenic or Th 1 type inflammatory responses. There was no evidence of cry1Ab gene or Bt toxin translocation to organs or blood following long-term feeding.	[Walsh, Maria C.; Buzoianu, Stefan G.; Lawlor, Peadar G.] Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; O'Donovan, Orla; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] Teagasc Moorepk Food Res, Fermoy, Cork, Ireland; [Rea, Mary C.; Ross, R. Paul] Univ Coll, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gelencser, Eva; Ujhelyi, Gabriella] Cent Food Res Inst, Budapest, Hungary	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Walsh, MC (corresponding author), Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; walsh, maria/H-3662-2013; Gelencser, Eva/A-2842-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; O' Donovan, Orla/0000-0003-3980-8835	European Union's Seventh Framework Programme [211820]; Teagasc Walsh Fellowship programme	European Union's Seventh Framework Programme; Teagasc Walsh Fellowship programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Alexander TW, 2006, BRIT J NUTR, V96, P997, DOI 10.1017/BJN20061935; Buzoianu SG, 2012, ANIMAL 1 VIEW, P1; Buzoianu SG, 2012, PLOS ONE IN PRESS; Chowdhury EH, 2004, J FOOD PROTECT, V67, P365, DOI 10.4315/0362-028X-67.2.365; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Deaville ER, 2005, J AGR FOOD CHEM, V53, P10268, DOI 10.1021/jf051652f; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Feldman B. F., 2000, SCHALMS VET HEMATOLO; Festi D, 2011, DIGEST DIS, V29, P518, DOI 10.1159/000332975; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flachowsky G, 2005, ARCH ANIM NUTR, V59, P1, DOI 10.1080/17450390512331342368; Guertler P, 2008, EUR J WILDLIFE RES, V54, P36, DOI 10.1007/s10344-007-0104-4; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Krzyzowska M, 2010, POL J VET SCI, V13, P423; Lawlor PG, 2003, ANIM SCI, V76, P401, DOI 10.1017/S1357729800058628; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; Nemeth A, 2004, J AGR FOOD CHEM, V52, P6129, DOI 10.1021/jf049567f; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Phipps RH, 2000, J ANIM FEED SCI, V9, P543; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Reuter T, 2003, EUR FOOD RES TECHNOL, V216, P185, DOI 10.1007/s00217-002-0642-7; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sharma R, 2006, J AGR FOOD CHEM, V54, P1699, DOI 10.1021/jf052459o; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; THORN CE, 2000, SCHALMS VET HEMATOLO, P1089; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wiedemann S, 2009, MAMM BIOL, V74, P193, DOI 10.1016/j.mambio.2008.07.002; Yonemochi C, 2010, ANIM SCI J, V81, P94, DOI 10.1111/j.1740-0929.2009.00718.x	32	26	30	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36141	10.1371/journal.pone.0036141	http://dx.doi.org/10.1371/journal.pone.0036141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574138	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800034
J	Ohrmalm, L; Wong, M; Aust, C; Ljungman, P; Norbeck, O; Broliden, K; Tolfvenstam, T				Ohrmalm, Lars; Wong, Michelle; Aust, Carl; Ljungman, Per; Norbeck, Oscar; Broliden, Kristina; Tolfvenstam, Thomas			Viral Findings in Adult Hematological Patients with Neutropenia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; RESPIRATORY VIRUS-INFECTIONS; REAL-TIME PCR; CANCER; CYTOMEGALOVIRUS; DIAGNOSIS; CHILDREN; FEBRILE; FEVER; DNA	Background: Until recently, viral infections in patients with hematological malignancies were concerns primarily in allogeneic hematopoietic stem cell transplant (HSCT) recipients. During the last years, changed treatment regimens for non-transplanted patients with hematological malignancies have had potential to increase the incidence of viral infections in this group. In this study, we have prospectively investigated the prevalence of a broad range of respiratory viruses in nasopharyngeal aspirate (NPA) as well as viruses that commonly reactivate after allogeneic HSCT. Methodology/Principal Findings: Patients with hematological malignancies and therapy induced neutropenia (n = 159) were screened regarding a broad range of common respiratory viruses in the nasopharynx and for viruses commonly detected in severely immunosuppressed patients in peripheral blood. Quantitative PCR was used for detection of viruses. A viral pathogen was detected in 35% of the patients. The detection rate was rather similar in blood (22%) and NPA (18%) with polyoma BK virus and rhinovirus as dominating pathogens in blood and NPA, respectively. Patients with chronic lymphocytic leukemia (CLL) (p<0.01) and patients with fever (p<0.001) were overrepresented in the virus-positive group. Furthermore, viral findings in NPA were associated with upper respiratory symptoms (URTS) (p<0.0001). Conclusions/Significance: Both respiratory viral infections and low titers of viruses in blood from patients with neutropenia were common. Patients with CLL and patients with fever were independently associated to these infections, and viral findings in NPA were associated to URTS indicating active infection. These findings motivate further studies on viruses' impact on this patient category and their potential role as causative agents of fever during neutropenia.	[Ohrmalm, Lars; Wong, Michelle; Aust, Carl; Norbeck, Oscar; Broliden, Kristina; Tolfvenstam, Thomas] Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit,Ctr Mol Med, Stockholm, Sweden; [Ljungman, Per] Karolinska Inst, Div Hematol, Dept Med, Stockholm, Sweden; [Ljungman, Per] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ohrmalm, L (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Med, Infect Dis Unit,Ctr Mol Med, Stockholm, Sweden.	lars.ohrmalm@ki.se	Ljungman, Per/M-4946-2019	Tolfvenstam, Thomas/0000-0003-3549-8083	Stockholm County Council/Karolinska Institutet; Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; Swedish Childhood Cancer Foundation	Stockholm County Council/Karolinska Institutet(Stockholm County Council); Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; Swedish Childhood Cancer Foundation(European Commission)	Grants were received from the Stockholm County Council (www.sll.se)/Karolinska Institutet (www.ki.se), the Swedish Society of Medicine (www.sls.se), the Clas Groschinsky foundation (www.groschinsky.org), Karolinska Institutet Infection Network (www.ki.se) and from The Swedish Childhood Cancer Foundation (www.barncancerfonden.se) for method development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROLA M, 1995, PEDIATR INFECT DIS J, V14, P690, DOI 10.1097/00006454-199508000-00008; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chemaly RF, 2006, MEDICINE, V85, P278, DOI 10.1097/01.md.0000232560.22098.4e; Englund JA, 1999, CURR CLIN TOPICS INF, V19, P30; Englund J, 2011, BIOL BLOOD MARROW TR, V17, pS2, DOI 10.1016/j.bbmt.2010.11.008; Engstrand M, 2003, CLIN EXP IMMUNOL, V132, P96, DOI 10.1046/j.1365-2249.2003.02098.x; Erard V, 2005, BLOOD, V106, P1130, DOI 10.1182/blood-2004-12-4988; Fairchok MP, 2010, J CLIN VIROL, V49, P16, DOI 10.1016/j.jcv.2010.06.013; Gustafson I, 2008, J CLIN VIROL, V43, P79, DOI 10.1016/j.jcv.2008.04.014; Haines HL, 2011, BIOL BLOOD MARROW TR, V17, P1512, DOI 10.1016/j.bbmt.2011.02.012; Hakim H, 2009, J PEDIAT HEMATOL ONC, V31, P623, DOI 10.1097/MPH.0b013e3181b1edc6; Hakki M, 2003, BLOOD, V102, P3060, DOI 10.1182/blood-2002-11-3472; Hughes WT, 2002, CLIN INFECT DIS, V34, P730, DOI 10.1086/339215; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Koskenvuo M, 2008, PEDIATR INFECT DIS J, V27, P974, DOI 10.1097/INF.0b013e31817b0799; LAWSON RD, 1984, AM J MED SCI, V287, P16, DOI 10.1097/00000441-198401000-00004; Lindblom A, 2010, J CLIN VIROL, V47, P234, DOI 10.1016/j.jcv.2009.11.026; Ljungman P, 2005, SCAND J INFECT DIS, V37, P121, DOI 10.1080/00365540410020794; Ljungman P, 2001, BONE MARROW TRANSPL, V28, P479, DOI 10.1038/sj.bmt.1703139; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Martin ET, 2011, INFLUENZA OTHER RESP; Ng AP, 2005, HAEMATOLOGICA, V90, P1672; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Persson L, 2003, CLIN MICROBIOL INFEC, V9, P640, DOI 10.1046/j.1469-0691.2003.00578.x; PIZZO PA, 1993, NEW ENGL J MED, V328, P1323; Terlizzi ME, 2009, J VIROL METHODS, V160, P172, DOI 10.1016/j.jviromet.2009.04.039; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Viscoli C, 2006, CLIN MICROBIOL INFEC, V12, P212, DOI 10.1111/j.1469-0691.2005.01297.x; WHIMBEY E, 1987, AM J MED, V82, P723, DOI 10.1016/0002-9343(87)90007-6	31	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36543	10.1371/journal.pone.0036543	http://dx.doi.org/10.1371/journal.pone.0036543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570724	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400040
J	Platt, NJ; Gispert, S; Auburger, G; Cragg, SJ				Platt, Nicola J.; Gispert, Suzana; Auburger, Georg; Cragg, Stephanie J.			Striatal Dopamine Transmission Is Subtly Modified in Human A53T alpha-Synuclein Overexpressing Mice	PLOS ONE			English	Article							TONICALLY ACTIVE NEURONS; ALPHA-SYNUCLEIN; MIDBRAIN DOPAMINE; RELEASE; LACKING; RECEPTORS; REWARD; INHIBITION; MUTATION; CELLS	Mutations in, or elevated dosage of, SNCA, the gene for alpha-synuclein (alpha-syn), cause familial Parkinson's disease (PD). Mouse lines overexpressing the mutant human A53T alpha-syn may represent a model of early PD. They display progressive motor deficits, abnormal cellular accumulation of alpha-syn, and deficits in dopamine-dependent corticostriatal plasticity, which, in the absence of overt nigrostriatal degeneration, suggest there are age-related deficits in striatal dopamine (DA) signalling. In addition A53T alpha-syn overexpression in cultured rodent neurons has been reported to inhibit transmitter release. Therefore here we have characterized for the first time DA release in the striatum of mice overexpressing human A53T alpha-syn, and explored whether A53T alpha-syn overexpression causes deficits in the release of DA. We used fast-scan cyclic voltammetry to detect DA release at carbon-fibre microelectrodes in acute striatal slices from two different lines of A53T alpha-syn-overexpressing mice, at up to 24 months. In A53T alpha-syn overexpressors, mean DA release evoked by a single stimulus pulse was not different from wild-types, in either dorsal striatum or nucleus accumbens. However the frequency responsiveness of DA release was slightly modified in A53T alpha-syn overexpressors, and in particular showed slight deficiency when the confounding effects of striatal ACh acting at presynaptic nicotinic receptors (nAChRs) were antagonized. The re-release of DA was unmodified after single-pulse stimuli, but after prolonged stimulation trains, A53T alpha-syn overexpressors showed enhanced recovery of DA release at old age, in keeping with elevated striatal DA content. In summary, A53T alpha-syn overexpression in mice causes subtle changes in the regulation of DA release in the striatum. While modest, these modifications may indicate or contribute to striatal dysfunction.	[Platt, Nicola J.; Cragg, Stephanie J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Gispert, Suzana; Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, Sch Med, Frankfurt, Germany	University of Oxford; Goethe University Frankfurt	Platt, NJ (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	Nicola.platt@dpag.ox.ac.uk		Cragg, Stephanie/0000-0001-9677-2256	MRC (Medical Research Council) doctoral training grant; BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz); NGFNplus Parkinson programs; MRC [MR/J004324/1, G0700932] Funding Source: UKRI; Medical Research Council [MR/J004324/1, G0700932] Funding Source: researchfish; Parkinson&quot;s UK [G-1103, G-0803, H-1003, G-0808] Funding Source: researchfish	MRC (Medical Research Council) doctoral training grant; BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz); NGFNplus Parkinson programs; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	The authors are grateful for financial support from an MRC (Medical Research Council) doctoral training grant, and from the BMBF (Bundesministerium fur Bildung und Forschung) in the NGFN2 (Das Nationale Genomforschungsnetz) and NGFNplus Parkinson programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Anwar S, 2011, J NEUROSCI, V31, P7264, DOI 10.1523/JNEUROSCI.6194-10.2011; Apicella P, 2011, J NEUROSCI, V31, P1507, DOI 10.1523/JNEUROSCI.4880-10.2011; Apicella P, 2009, EUR J NEUROSCI, V30, P515, DOI 10.1111/j.1460-9568.2009.06872.x; Benoit-Marand M, 2001, J NEUROSCI, V21, P9134, DOI 10.1523/JNEUROSCI.21-23-09134.2001; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; Cragg SJ, 2003, J NEUROSCI, V23, P4378; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Exley R, 2008, BRIT J PHARMACOL, V153, pS283, DOI 10.1038/sj.bjp.0707510; Exley R, 2008, NEUROPSYCHOPHARMACOL, V33, P2158, DOI 10.1038/sj.npp.1301617; Fernagut PO, 2004, NEUROBIOL DIS, V17, P123, DOI 10.1016/j.nbd.2004.07.001; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; GRACE AA, 1984, J NEUROSCI, V4, P2877; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2011, J NEURAL TRANSM, P1; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schmitz Y, 2002, J NEUROSCI, V22, P8002; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; THOMSON AM, 1993, J NEUROPHYSIOL, V70, P2354, DOI 10.1152/jn.1993.70.6.2354; Threlfell S, 2010, J NEUROSCI, V30, P3398, DOI 10.1523/JNEUROSCI.5620-09.2010; Tozzi A, 2011, NEUROBIOLOGY AGING; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243; Zhang H, 2003, J NEUROSCI, V23, P10585; Zhou FM, 2001, NAT NEUROSCI, V4, P1224, DOI 10.1038/nn769	47	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36397	10.1371/journal.pone.0036397	http://dx.doi.org/10.1371/journal.pone.0036397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570709	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400025
J	Gollamudi, S; Johri, A; Calingasan, NY; Yang, LC; Elemento, O; Beal, MF				Gollamudi, Seema; Johri, Ashu; Calingasan, Noel Y.; Yang, Lichuan; Elemento, Olivier; Beal, M. Flint			Concordant Signaling Pathways Produced by Pesticide Exposure in Mice Correspond to Pathways Identified in Human Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; TRANSCRIPTIONAL ANALYSIS; HEME OXYGENASE-1; GENE-EXPRESSION; ALPHA-SYNUCLEIN; PROTEIN SACSIN; RODENT MODELS; NEURODEGENERATION; PARAQUAT; ROLES	Parkinson's disease (PD) is a neurodegenerative disease in which the etiology of 90 percent of the patients is unknown. Pesticide exposure is a major risk factor for PD, and paraquat (PQ), pyridaben (PY) and maneb (MN) are amongst the most widely used pesticides. We studied mRNA expression using transcriptome sequencing (RNA-Seq) in the ventral midbrain (VMB) and striatum (STR) of PQ, PY and paraquat+maneb (MNPQ) treated mice, followed by pathway analysis. We found concordance of signaling pathways between the three pesticide models in both the VMB and STR as well as concordance in these two brain areas. The concordant signaling pathways with relevance to PD pathogenesis were e. g. axonal guidance signaling, Wnt/beta-catenin signaling, as well as pathways not previously linked to PD, e. g. basal cell carcinoma, human embryonic stem cell pluripotency and role of macrophages, fibroblasts and endothelial cells in rheumatoid arthritis. Human PD pathways previously identified by expression analysis, concordant with VMB pathways identified in our study were axonal guidance signaling, Wnt/beta-catenin signaling, IL-6 signaling, ephrin receptor signaling, TGF-beta signaling, PPAR signaling and G-protein coupled receptor signaling. Human PD pathways concordant with the STR pathways in our study were Wnt/beta-catenin signaling, axonal guidance signaling and G-protein coupled receptor signaling. Peroxisome proliferator activated receptor delta (Ppard) and G-Protein Coupled Receptors (GPCRs) were common genes in VMB and STR identified by network analysis. In conclusion, the pesticides PQ, PY and MNPQ elicit common signaling pathways in the VMB and STR in mice, which are concordant with known signaling pathways identified in human PD, suggesting that these pathways contribute to the pathogenesis of idiopathic PD. The analysis of these networks and pathways may therefore lead to improved understanding of disease pathogenesis, and potential novel therapeutic targets.	[Gollamudi, Seema; Johri, Ashu; Calingasan, Noel Y.; Yang, Lichuan; Beal, M. Flint] Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA; [Elemento, Olivier] Cornell Univ, Inst Computat Biomed, Weill Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Gollamudi, S (corresponding author), Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA.	fbeal@med.cornell.edu			National Institute of Health NIH [R01 ES017295-01]; National Institute of Environmental Health Sciences (NIEHS) [ES017295]; Parkinson's Disease Foundation; NSF [1054964]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017295] Funding Source: NIH RePORTER	National Institute of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Parkinson's Disease Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the National Institute of Health NIH grant R01 ES017295-01. MFB would like to acknowledge funding from the National Institute of Environmental Health Sciences (NIEHS) grant ES017295 and the Parkinson's Disease Foundation. OE would like to acknowledge receipt of NSF Career grant 1054964. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuirmeileh A, 2007, EUR J NEUROSCI, V26, P417, DOI 10.1111/j.1460-9568.2007.05653.x; Ali F, 2010, CARDIOVASC RES, V85, P701, DOI 10.1093/cvr/cvp365; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Austin PJ, 2010, BRIT J PHARMACOL, V160, P1741, DOI 10.1111/j.1476-5381.2010.00820.x; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Bartus RT, 2011, NEUROBIOL DIS, V44, P38, DOI 10.1016/j.nbd.2011.05.026; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bezard E, 2011, MOVEMENT DISORD, V26, P993, DOI 10.1002/mds.23696; Bjorklund A, 2010, PROG BRAIN RES, V184, P17, DOI 10.1016/S0079-6123(10)84002-6; Blakely BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018373; Braak H, 2000, J NEUROL, V247, P3; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Caricasole A, 2005, BIOSCIENCE REP, V25, P309, DOI 10.1007/s10540-005-2893-6; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chang SC, 2009, MOL MEMBR BIOL, V26, P104, DOI 10.1080/09687680802706432; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Cory-Slechta DA, 2005, ENVIRON HEALTH PERSP, V113, P1263, DOI 10.1289/ehp.7570; Cotter D, 1998, NEUROREPORT, V9, P1379, DOI 10.1097/00001756-199805110-00024; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Deng QL, 2011, DEVELOPMENT, V138, P3399, DOI 10.1242/dev.065482; Edwards YJK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016917; Goetz CG, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a008862; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; Guerreiro S, 2008, MOL PHARMACOL, V74, P980, DOI 10.1124/mol.108.048207; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hurley MJ, 2012, PHARM THER; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Inzelberg R, 2007, NEUROLOGY, V69, P1542, DOI 10.1212/01.wnl.0000277638.63767.b8; Lenzken SC, 2011, HUM MUTAT, V32, P168, DOI 10.1002/humu.21394; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; Miller RM, 2006, NEUROBIOL DIS, V21, P305, DOI 10.1016/j.nbd.2005.07.010; Moran LB, 2006, NEUROGENETICS, V7, P1, DOI 10.1007/s10048-005-0020-2; Morgan AR, 2007, AM J MED GENET B, V144B, P762, DOI 10.1002/ajmg.b.30509; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro A, 2010, J BIOENERG BIOMEMBR, V42, P405, DOI 10.1007/s10863-010-9309-4; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Patel S, 2008, MOL BIOTECHNOL, V40, P59, DOI 10.1007/s12033-008-9060-9; Rawal N, 2009, BIOCHEM BIOPH RES CO, V388, P473, DOI 10.1016/j.bbrc.2009.07.014; RIESS O, 1994, GENOMICS, V19, P298, DOI 10.1006/geno.1994.1061; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Sherer TB, 2007, J NEUROCHEM, V100, P1469, DOI 10.1111/j.1471-4159.2006.04333.x; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Si W, 2010, J NEUROCHEM, V115, P475, DOI 10.1111/j.1471-4159.2010.06947.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Thiruchelvam M, 2000, BRAIN RES, V873, P225, DOI 10.1016/S0006-8993(00)02496-3; Thrash Bessy, 2007, Proc West Pharmacol Soc, V50, P31; Tremblay L, 2010, B ACAD NAT MED PARIS, V194, P1321, DOI 10.1016/S0001-4079(19)32211-3; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vogt IR, 2006, EXP NEUROL, V199, P465, DOI 10.1016/j.expneurol.2006.01.008; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yin LN, 2011, NEUROTOXICOL TERATOL, V33, P415, DOI 10.1016/j.ntt.2011.02.012; Zhang J, 2003, J NEUROCHEM, V84, P336, DOI 10.1046/j.1471-4159.2003.01525.x; Zhang YL, 2005, AM J MED GENET B, V137B, P5, DOI 10.1002/ajmg.b.30195; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	67	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36191	10.1371/journal.pone.0036191	http://dx.doi.org/10.1371/journal.pone.0036191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563483	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700032
J	Mancuso, G; Barth, E; Crivello, P; Rugarli, EI				Mancuso, Giuseppe; Barth, Esther; Crivello, Pietro; Rugarli, Elena I.			Alternative Splicing of Spg7, a Gene Involved in Hereditary Spastic Paraplegia, Encodes a Variant of Paraplegin Targeted to the Endoplasmic Reticulum	PLOS ONE			English	Article							M-AAA PROTEASE; MITOCHONDRIAL METALLOPROTEASE; UBIQUITIN-LIGASE; MUTATIONS; PROTEINS; MEMBRANE; DEGENERATION; IMPAIRMENT; PROTECTION; MECHANISM	Background: Hereditary spastic paraplegia defines a group of genetically heterogeneous diseases characterized by weakness and spasticity of the lower limbs owing to retrograde degeneration of corticospinal axons. One autosomal recessive form of the disease is caused by mutation in the SPG7 gene. Paraplegin, the product of SPG7, is a component of the m-AAA protease, a high molecular weight complex that resides in the mitochondrial inner membrane, and performs crucial quality control and biogenesis functions in mitochondria. Principal Findings: Here we show the existence in the mouse of a novel isoform of paraplegin, which we name paraplegin-2, encoded by alternative splicing of Spg7 through usage of an alternative first exon. Paraplegin-2 lacks the mitochondrial targeting sequence, and is identical to the mature mitochondrial protein. Remarkably, paraplegin-2 is targeted to the endoplasmic reticulum. We find that paraplegin-2 exposes the catalytic domains to the lumen of the endoplasmic reticulum. Moreover, endogenous paraplegin-2 accumulates in microsomal fractions prepared from mouse brain and retina. Finally, we show that the previously generated mouse model of Spg7-linked hereditary spastic paraplegia is an isoform-specific knockout, in which mitochondrial paraplegin is specifically ablated, while expression of paraplegin-2 is retained. Conclusions/Significance: These data suggest a possible additional role of AAA proteases outside mitochondria and open the question of their implication in neurodegeneration.	[Mancuso, Giuseppe; Barth, Esther; Rugarli, Elena I.] Univ Cologne, Inst Zool, Cologne, Germany; [Crivello, Pietro] Natl Neurol Inst Carlo Besta, Milan, Italy; [Rugarli, Elena I.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Rugarli, Elena I.] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany	University of Cologne; IRCCS Istituto Neurologico Besta; University of Cologne; University of Cologne	Mancuso, G (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	Elena.Rugarli@uni-koeln.de	Crivello, Pietro/AFO-1225-2022	Rugarli, Elena/0000-0002-5782-1067	Spastic Paraplegia Foundation	Spastic Paraplegia Foundation	This study was supported by a grant from the Spastic Paraplegia Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; Hansen JJ, 2002, AM J HUM GENET, V70, P1328, DOI 10.1086/339935; HARDING AE, 1993, SEMIN NEUROL, V13, P333, DOI 10.1055/s-2008-1041143; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Koppen M, 2009, MOL BIOL CELL; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Kremmidiotis G, 2001, GENOMICS, V76, P58, DOI 10.1006/geno.2001.6560; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Pedrazzini E, 2000, J CELL BIOL, V148, P899, DOI 10.1083/jcb.148.5.899; Pierson TM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002325; Pirozzi M, 2006, J CLIN INVEST, V116, P202, DOI 10.1172/JCI26210; Reid E, SCRIVERS ONLINE META; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Zhao JL, 2008, J NEUROSCI, V28, P13938, DOI 10.1523/JNEUROSCI.4668-08.2008	36	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36337	10.1371/journal.pone.0036337	http://dx.doi.org/10.1371/journal.pone.0036337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563492	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700041
J	Moran, EV; Clark, JS				Moran, Emily V.; Clark, James S.			Between-Site Differences in the Scale of Dispersal and Gene Flow in Red Oak	PLOS ONE			English	Article							SEED DISPERSAL; MICROSATELLITE MARKERS; QUERCUS-SALICINA; POLLEN DISPERSAL; MATING PATTERNS; ACORN DISPERSAL; BUR OAK; POPULATION; FOREST; PLANT	Background: Nut-bearing trees, including oaks (Quercus spp.), are considered to be highly dispersal limited, leading to concerns about their ability to colonize new sites or migrate in response to climate change. However, estimating seed dispersal is challenging in species that are secondarily dispersed by animals, and differences in disperser abundance or behavior could lead to large spatio-temporal variation in dispersal ability. Parentage and dispersal analyses combining genetic and ecological data provide accurate estimates of current dispersal, while spatial genetic structure (SGS) can shed light on past patterns of dispersal and establishment. Methodology and Principal Findings: In this study, we estimate seed and pollen dispersal and parentage for two mixed-species red oak populations using a hierarchical Bayesian approach. We compare these results to those of a genetic ML parentage model. We also test whether observed patterns of SGS in three size cohorts are consistent with known site history and current dispersal patterns. We find that, while pollen dispersal is extensive at both sites, the scale of seed dispersal differs substantially. Parentage results differ between models due to additional data included in Bayesian model and differing genotyping error assumptions, but both indicate between-site dispersal differences. Patterns of SGS in large adults, small adults, and seedlings are consistent with known site history (farmed vs. selectively harvested), and with long-term differences in seed dispersal. This difference is consistent with predator/disperser satiation due to higher acorn production at the low-dispersal site. While this site-to-site variation results in substantial differences in asymptotic spread rates, dispersal for both sites is substantially lower than required to track latitudinal temperature shifts. Conclusions: Animal-dispersed trees can exhibit considerable spatial variation in seed dispersal, although patterns may be surprisingly constant over time. However, even under favorable conditions, migration in heavy-seeded species is likely to lag contemporary climate change.	[Moran, Emily V.] Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA; [Clark, James S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University of Tennessee System; University of Tennessee Knoxville; Duke University	Moran, EV (corresponding author), Univ Tennessee, Natl Inst Math & Biol Synth, Knoxville, TN 37996 USA.	moranev@nimbios.org		Moran, Emily/0000-0003-4624-1910	Duke Biology Department; Duke Center for Theoretical and Mathematical Sciences; Association for Women in Science; National Science Foundation; US Department of Homeland Security; USDA, NSF [EF 0832858]; University of Tennessee; Division Of Environmental Biology [0823293] Funding Source: National Science Foundation	Duke Biology Department; Duke Center for Theoretical and Mathematical Sciences; Association for Women in Science; National Science Foundation(National Science Foundation (NSF)); US Department of Homeland Security(United States Department of Homeland Security (DHS)); USDA, NSF; University of Tennessee; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding sources include the Duke Biology Department (http://www.biology.duke.edu), the Duke Center for Theoretical and Mathematical Sciences (http://ctms.phy.duke.edu/wp), and the Association for Women in Science (http://www.awis.org). Part of this work was conducted while Moran was a postdoctoral fellow at the National Institute for Mathematical and Biological Synthesis; NIMBioS is an institute sponsored by the National Science Foundation, US Department of Homeland Security, and the USDA, NSF Award # EF 0832858, with additional support from the University of Tennessee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich PR, 2005, J HERED, V96, P627, DOI 10.1093/jhered/esi115; Aldrich PR, 2003, SILVAE GENET, V52, P176; Aldrich PR, 2003, CAN J FOREST RES, V33, P2228, DOI 10.1139/X03-160; Aldrich PR, 2002, MOL ECOL NOTES, V2, P472, DOI 10.1046/j.1471-8286.2002.00282.x; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Asuka Y, 2005, MOL ECOL, V14, P2565, DOI 10.1111/j.1365-294X.2005.02585.x; Bacles CFE, 2005, EVOLUTION, V59, P979, DOI 10.1111/j.0014-3820.2005.tb01037.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Burczyk J, 2006, GENETICS, V173, P363, DOI 10.1534/genetics.105.046805; Burczyk J., 2004, FOREST GENETIC, V11, P1, DOI DOI 10.1080/10623320490432434; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Chybicki IJ, 2010, MOL ECOL, V19, P2137, DOI 10.1111/j.1365-294X.2010.04632.x; Clark J. S., 2010, OXFORD HDB APPL BAYE, P431; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Clark JS, HIERARCHICAL MODELLI; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cousens R, 2008, DISPERSAL IN PLANTS: A POPULATION PERSPECTIVE, P1; Craft KJ, 2007, FOREST ECOL MANAG, V239, P13, DOI 10.1016/j.foreco.2006.11.005; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; DARLEYHILL S, 1981, OECOLOGIA, V50, P231, DOI 10.1007/BF00348043; Dodd RS, 2004, EVOLUTION, V58, P261, DOI 10.1111/j.0014-3820.2004.tb01643.x; Dow BD, 1996, MOL ECOL, V5, P615, DOI 10.1111/j.1365-294X.1996.tb00357.x; Ducousso A., 1993, ANN SCIENC FOR VOL, V50, p91s, DOI 10.1051/forest:19930708; DYER JM, 1995, ECOL MODEL, V79, P199, DOI 10.1016/0304-3800(94)00038-J; Epperson BK, 1997, EVOLUTION, V51, P275, DOI 10.1111/j.1558-5646.1997.tb02409.x; Fernandez-Manjarres JF, 2006, J HERED, V97, P451, DOI 10.1093/jhered/esl022; Gaino APSC, 2010, CONSERV GENET, V11, P1631, DOI 10.1007/s10592-010-0046-3; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; Gerwein JB, 2006, RHODORA, V108, P1, DOI 10.3119/05-9.1; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Gonzalez-Martinez SC, 2002, THEOR APPL GENET, V104, P1290, DOI 10.1007/s00122-002-0894-4; Goto S, 2006, MOL ECOL, V15, P2985, DOI 10.1111/j.1365-294X.2006.02976.x; Grace SL, 2004, CASTANEA, V69, P207, DOI 10.2179/0008-7475(2004)069&lt;0207:EOSDIA&gt;2.0.CO;2; GUTTMAN SI, 1989, CAN J BOT, V67, P339, DOI 10.1139/b89-050; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hardesty BD, 2006, ECOL LETT, V9, P516, DOI 10.1111/j.1461-0248.2006.00897.x; Hein EW, 1997, ENVIRON MANAGE, V21, P943, DOI 10.1007/s002679900078; Herrera CM, 2010, ECOLOGY, V91, P422, DOI 10.1890/09-0849.1; HEYWOOD JS, 1986, AM NAT, V127, P851, DOI 10.1086/284529; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Iverson LR, 2004, LANDSCAPE ECOL, V19, P787, DOI 10.1007/s10980-005-3990-5; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JENSEN RJ, 1977, TAXON, V26, P399, DOI 10.2307/1220040; JOHNSON WC, 1989, J BIOGEOGR, V16, P561, DOI 10.2307/2845211; Johnson WC, 1997, AM MIDL NAT, V138, P357, DOI 10.2307/2426828; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones FA, 2008, J ECOL, V96, P642, DOI 10.1111/j.1365-2745.2008.01400.x; Jones FA, 2006, MOL ECOL, V15, P851, DOI 10.1111/j.1365-294X.2005.02830.x; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; Li HJ, 2003, FOREST ECOL MANAG, V176, P387, DOI 10.1016/S0378-1127(02)00286-4; Little Jr EL, 1980, NATL AUDUBON SOC FIE; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Matlack GR, 2005, J ECOL, V93, P50, DOI 10.1111/j.1365-2745.2004.00947.x; McShea WJ, 2007, J WILDLIFE MANAGE, V71, P1717, DOI 10.2193/2006-169; McShea WJ, 2000, ECOLOGY, V81, P228, DOI 10.1890/0012-9658(2000)081[0228:TIOACO]2.0.CO;2; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Moran EV, 2012, AM J BOT, V99, P92, DOI 10.3732/ajb.1100023; Moran EV, 2011, MOL ECOL, V20, P1248, DOI 10.1111/j.1365-294X.2011.05019.x; Nakanishi A, 2004, SILVAE GENET, V53, P258, DOI 10.1515/sg-2004-0048; Nakanishi A, 2009, HEREDITY, V102, P182, DOI 10.1038/hdy.2008.101; Oddou-Muratorio S, 2008, MOL ECOL, V17, P2743, DOI 10.1111/j.1365-294X.2008.03783.x; Oddou-Muratorio S, 2010, FOREST ECOL MANAG, V259, P2151, DOI 10.1016/j.foreco.2010.03.001; Oosting H. J., 1942, American Midland Naturalist, V28, P1, DOI 10.2307/2420696; Purves DW, 2007, ECOL MONOGR, V77, P77, DOI 10.1890/05-1923; Rushton B., 1993, ANN FOREST SCI, V50, P73, DOI DOI 10.1051/FOREST:19930707; Sato T, 2006, HEREDITY, V96, P79, DOI 10.1038/sj.hdy.6800748; Schnabel A, 1998, MOL ECOL, V7, P819, DOI 10.1046/j.1365-294x.1998.00397.x; SCHWARZMANN JF, 1991, FOREST SCI, V37, P1376; Sezen UU, 2005, SCIENCE, V307, P891, DOI 10.1126/science.1105034; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; SORK VL, 1984, ECOLOGY, V65, P1020, DOI 10.2307/1938075; STAPANIAN MA, 1986, J MAMMAL, V67, P326, DOI 10.2307/1380886; Streiff R, 1999, MOL ECOL, V8, P831, DOI 10.1046/j.1365-294X.1999.00637.x; Thomas L, 2010, J APPL ECOLOGY; Tomlinson PT, 2000, AM MIDL NAT, V143, P154, DOI 10.1674/0003-0031(2000)143[0154:DWTSCI]2.0.CO;2; Tramer EJ, BREEDING BIRD CENSUS; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Yang S, 2008, MOL ECOL, V17, P731, DOI [10.1111/j.1365-294X.2007.03625.x, 10.1111/j.1365-294X.2008.03976.x]	92	30	32	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36492	10.1371/journal.pone.0036492	http://dx.doi.org/10.1371/journal.pone.0036492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563504	Green Published, gold			2022-12-27	WOS:000305340700053
J	Muller-Redetzky, HC; Kummer, W; Pfeil, U; Hellwig, K; Will, D; Paddenberg, R; Tabeling, C; Hippenstiel, S; Suttorp, N; Witzenrath, M				Mueller-Redetzky, Holger Christian; Kummer, Wolfgang; Pfeil, Uwe; Hellwig, Katharina; Will, Daniel; Paddenberg, Renate; Tabeling, Christoph; Hippenstiel, Stefan; Suttorp, Norbert; Witzenrath, Martin			Intermedin Stabilized Endothelial Barrier Function and Attenuated Ventilator-induced Lung Injury in Mice	PLOS ONE			English	Article							MECHANICAL VENTILATION; ADRENOMEDULLIN; PEPTIDE; INFLAMMATION; ENDOTOXEMIA; ADULT; CELLS	Background: Even protective ventilation may aggravate or induce lung failure, particularly in preinjured lungs. Thus, new adjuvant pharmacologic strategies are needed to minimize ventilator-induced lung injury (VILI). Intermedin/Adrenomedullin-2 (IMD) stabilized pulmonary endothelial barrier function in vitro. We hypothesized that IMD may attenuate VILI-associated lung permeability in vivo. Methodology/Principal Findings: Human pulmonary microvascular endothelial cell (HPMVEC) monolayers were incubated with IMD, and transcellular electrical resistance was measured to quantify endothelial barrier function. Expression and localization of endogenous pulmonary IMD, and its receptor complexes composed of calcitonin receptor-like receptor (CRLR) and receptor activity-modifying proteins (RAMPs) 1-3 were analyzed by qRT-PCR and immunofluorescence in non ventilated mouse lungs and in lungs ventilated for 6 h. In untreated and IMD treated mice, lung permeability, pulmonary leukocyte recruitment and cytokine levels were assessed after mechanical ventilation. Further, the impact of IMD on pulmonary vasoconstriction was investigated in precision cut lung slices (PCLS) and in isolated perfused and ventilated mouse lungs. IMD stabilized endothelial barrier function in HPMVECs. Mechanical ventilation reduced the expression of RAMP3, but not of IMD, CRLR, and RAMP1 and 2. Mechanical ventilation induced lung hyperpermeability, which was ameliorated by IMD treatment. Oxygenation was not improved by IMD, which may be attributed to impaired hypoxic vasoconstriction due to IMD treatment. IMD had minor impact on pulmonary leukocyte recruitment and did not reduce cytokine levels in VILI. Conclusions/Significance: IMD may possibly provide a new approach to attenuate VILI.	[Mueller-Redetzky, Holger Christian; Hellwig, Katharina; Will, Daniel; Tabeling, Christoph; Hippenstiel, Stefan; Suttorp, Norbert; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany; [Kummer, Wolfgang; Pfeil, Uwe; Paddenberg, Renate] Univ Giessen, Inst Anat & Cell Biol, D-35390 Giessen, Germany; [Kummer, Wolfgang; Pfeil, Uwe; Paddenberg, Renate] Univ Giessen, Marburg Lung Ctr, D-35390 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Justus Liebig University Giessen; Justus Liebig University Giessen	Muller-Redetzky, HC (corresponding author), Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany.	martin.witzenrath@charite.de		Suttorp, Norbert/0000-0002-3958-1151; Hippenstiel, Stefan/0000-0002-5146-1064; Tabeling, Christoph/0000-0001-9189-4318; Kummer, Wolfgang/0000-0002-3946-0683	German Research Foundation [SFB/TR84, HI-789/6-1, OP-87/1]; Excellence Cluster Cardio-Pulmonary System; German Federal Ministry of Education and Research	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary System(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study is supported in part by grants from the German Research Foundation (http://www.dfg.de/index.jsp) to ACH, SH, NS, MW (SFB/TR84) and SH (HI-789/6-1) and MW (OP-87/1), the Excellence Cluster Cardio-Pulmonary System to UP and WK, and the German Federal Ministry of Education and Research (http://www.bmbf.de/) to SH, NS (Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis PROGRESS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam M, 2011, BR J PHARM; BANKSTON PW, 1991, EUR J CELL BIOL, V54, P187; Bell D, 2008, BRIT J PHARMACOL, V153, pS247, DOI 10.1038/sj.bjp.0707494; Brell B, 2005, CRIT CARE MED, V33, P819, DOI 10.1097/01.CCM.0000159194.53695.7A; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Fujisawa Y, 2007, EUR J PHARMACOL, V558, P128, DOI 10.1016/j.ejphar.2006.11.043; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1921, DOI 10.2353/ajpath.2006.051104; Hagner S, 2001, NEUROPEPTIDES, V35, P58, DOI 10.1054/npep.2000.0844; Hippenstiel S, 2002, CIRC RES, V91, P618, DOI 10.1161/01.RES.0000036603.61868.F9; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; Korner C, 2011, PNEUMOLOGIE, V65, P114, DOI DOI 10.1055/s-0030-1270376; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; Muller HC, 2011, PULM PHARMACOL THER, V24, P377, DOI 10.1016/j.pupt.2011.01.017; Muller HC, 2010, THORAX, V65, P1077, DOI 10.1136/thx.2010.135996; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Paddenberg R, 2009, ADV EXP MED BIOL, V648, P361, DOI 10.1007/978-90-481-2259-2_41; Paddenberg R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-93; Pfeil U, 2009, AM J PHYSIOL-LUNG C, V297, pL837, DOI 10.1152/ajplung.90608.2008; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Takei Y, 2004, PEPTIDES, V25, P1643, DOI 10.1016/j.peptides.2004.06.026; Temmesfeld-Wollbruck B, 2007, THROMB HAEMOSTASIS, V98, P944, DOI 10.1160/TH07-02-0128; Temmesfeld-Wollbruck B, 2007, INTENS CARE MED, V33, P703, DOI 10.1007/s00134-007-0561-y; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Verbrugge SJC, 2007, CLIN PHYSIOL FUNCT I, V27, P67, DOI 10.1111/j.1475-097X.2007.00722.x; Witzenrath M, 2006, EUR RESPIR J, V28, P370, DOI 10.1183/09031936.06.00080105; Witzenrath M, 2006, CRIT CARE MED, V34, P1947, DOI 10.1097/01.CCM.0000220496.48295.A9; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Yang JH, 2005, BIOCHEM BIOPH RES CO, V327, P713, DOI 10.1016/j.bbrc.2004.12.071	30	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35832	10.1371/journal.pone.0035832	http://dx.doi.org/10.1371/journal.pone.0035832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563471	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700020
J	Spiegel, DP; Hansen, BC; Byblow, WD; Thompson, B				Spiegel, Daniel P.; Hansen, Bruce C.; Byblow, Winston D.; Thompson, Benjamin			Anodal Transcranial Direct Current Stimulation Reduces Psychophysically Measured Surround Suppression in the Human Visual Cortex	PLOS ONE			English	Article							CROSS-ORIENTATION SUPPRESSION; CAT STRIATE CORTEX; HUMAN MOTOR CORTEX; RECEPTIVE-FIELD; PHOSPHENE THRESHOLDS; SPATIAL-DISTRIBUTION; MOTION PERCEPTION; BRAIN PLASTICITY; INHIBITION; MODULATION	Transcranial direct current stimulation (tDCS) is a safe, non-invasive technique for transiently modulating the balance of excitation and inhibition within the human brain. It has been reported that anodal tDCS can reduce both GABA mediated inhibition and GABA concentration within the human motor cortex. As GABA mediated inhibition is thought to be a key modulator of plasticity within the adult brain, these findings have broad implications for the future use of tDCS. It is important, therefore, to establish whether tDCS can exert similar effects within non-motor brain areas. The aim of this study was to assess whether anodal tDCS could reduce inhibitory interactions within the human visual cortex. Psychophysical measures of surround suppression were used as an index of inhibition within V1. Overlay suppression, which is thought to originate within the lateral geniculate nucleus (LGN), was also measured as a control. Anodal stimulation of the occipital poles significantly reduced psychophysical surround suppression, but had no effect on overlay suppression. This effect was specific to anodal stimulation as cathodal stimulation had no effect on either measure. These psychophysical results provide the first evidence for tDCS-induced reductions of intracortical inhibition within the human visual cortex.	[Spiegel, Daniel P.; Thompson, Benjamin] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Hansen, Bruce C.] Colgate Univ, Dept Psychol, Hamilton, NY 13346 USA; [Hansen, Bruce C.] Colgate Univ, Neurosci Program, Hamilton, NY 13346 USA; [Byblow, Winston D.] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand	University of Auckland; Colgate University; Colgate University; University of Auckland	Spiegel, DP (corresponding author), Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand.	b.thompson@auckland.ac.nz	Byblow, Winston/D-3579-2009; Hansen, Bruce/E-8516-2010	Byblow, Winston/0000-0001-8347-6730; Hansen, Bruce/0000-0002-8898-1688; Thompson, Benjamin/0000-0002-3902-2712	Health Research Council of New Zealand Emerging Researcher Grant [09/150]; University of Auckland Faculty Development Research Fund Grant [3622919]	Health Research Council of New Zealand Emerging Researcher Grant; University of Auckland Faculty Development Research Fund Grant	This study was supported by a Health Research Council of New Zealand Emerging Researcher Grant (09/150) to BT and WDB and a University of Auckland Faculty Development Research Fund Grant (3622919) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; Akasaki T, 2002, NEUROSCI RES, V43, P207, DOI 10.1016/S0168-0102(02)00038-X; Angelakis E., 2011, THE J, V15, P337, DOI [10.1080/10874208.2011.623092, DOI 10.1080/10874208.2011.623092]; Antal A, 2003, EXP BRAIN RES, V150, P375, DOI 10.1007/s00221-003-1459-8; Antal A, 2006, BRAIN RES BULL, V68, P459, DOI 10.1016/j.brainresbull.2005.10.006; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2003, NEUROPSYCHOLOGIA, V41, P1802, DOI 10.1016/S0028-3932(03)00181-7; Antal A, 2001, NEUROREPORT, V12, P3553, DOI 10.1097/00001756-200111160-00036; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Antal A, 2008, PERCEPTION, V37, P367, DOI 10.1068/p5872; Baroncelli L, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/286073; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Bex PJ, 2007, J VISION, V7, DOI 10.1167/7.11.12; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Bonin V, 2005, J NEUROSCI, V25, P10844, DOI 10.1523/JNEUROSCI.3562-05.2005; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Chatrian G. E., 1985, American Journal of EEG Technology, V25, P83; Darrien JH, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-13; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DUFFY FH, 1985, BRAIN RES, V339, P257, DOI 10.1016/0006-8993(85)90090-3; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Fu Y, 2010, NEUROSCIENCE, V169, P874, DOI 10.1016/j.neuroscience.2010.05.015; Gonzalez-Burgos G, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/723184; Halko MA, 2011, NEUROIMAGE, V57, P885, DOI 10.1016/j.neuroimage.2011.05.026; HEGGELUND P, 1983, EXP BRAIN RES, V52, P235; Huang SY, 2010, J NEUROSCI, V30, P16636, DOI 10.1523/JNEUROSCI.4384-10.2010; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kraft A, 2010, EXP BRAIN RES, V207, P283, DOI 10.1007/s00221-010-2453-6; Lang N, 2007, INVEST OPHTH VIS SCI, V48, P5782, DOI 10.1167/iovs.07-0706; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Leventhal AG, 2003, SCIENCE, V300, P812, DOI 10.1126/science.1082874; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; Li G, 2008, NEUROSCIENCE, V155, P914, DOI 10.1016/j.neuroscience.2008.06.032; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ohtani Y, 2002, VISION RES, V42, P1825, DOI 10.1016/S0042-6989(02)00103-7; Osaki H, 2011, EUR J NEUROSCI, V33, P923, DOI 10.1111/j.1460-9568.2010.07572.x; Petrov Y, 2005, J NEUROSCI, V25, P8704, DOI 10.1523/JNEUROSCI.2871-05.2005; Petrov Y, 2006, J VISION, V6, P224, DOI 10.1167/6.3.4; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Rokem A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00127; Saint-Amour D, 2005, EUR J NEUROSCI, V21, P1107, DOI 10.1111/j.1460-9568.2005.03914.x; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00010; Sengpiel F, 2006, CEREB CORTEX, V16, P1750, DOI 10.1093/cercor/bhj110; Smith MA, 2006, J NEUROSCI, V26, P4826, DOI 10.1523/JNEUROSCI.5542-06.2006; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Thompson B, 2008, CURR BIOL, V18, P1067, DOI 10.1016/j.cub.2008.06.052; Thompson B, 2012, DEV PSYCHOBIOL, V54, P263, DOI 10.1002/dev.20509; Tyler CW, 1997, SPATIAL VISION, V10, P369, DOI 10.1163/156856897X00294; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Yoon JH, 2010, J NEUROSCI, V30, P3777, DOI 10.1523/JNEUROSCI.6158-09.2010; Yoon JH, 2009, SCHIZOPHRENIA BULL, V35, P1078, DOI 10.1093/schbul/sbp064; Yu C, 2002, J VISION, V2, DOI 10.1167/2.3.4	68	41	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36220	10.1371/journal.pone.0036220	http://dx.doi.org/10.1371/journal.pone.0036220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563485	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700034
J	Brissette, MJ; Lepage, S; Lamonde, AS; Sirois, I; Groleau, J; Laurin, LP; Cailhier, JF				Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Sirois, Isabelle; Groleau, Jessika; Laurin, Louis-Philippe; Cailhier, Jean-Francois			MFG-E8 Released by Apoptotic Endothelial Cells Triggers Anti-Inflammatory Macrophage Reprogramming	PLOS ONE			English	Article							CHRONIC TRANSPLANT VASCULOPATHY; FIND-ME; SELECTIVE DEPLETION; GROWTH-FACTOR; TGF-BETA; CLEARANCE; PHAGOCYTOSIS; INFLAMMATION; NUCLEOTIDES; ACTIVATION	Apoptotic endothelial cells are an important component of the "response to injury" process. Several atherosclerosis risk factors such as hyperglycemia and oxidized low-density lipoproteins, and immune injuries, such as antibodies and complement, induce endothelial cell apoptosis. While endothelial cell apoptosis is known to affect neighboring vascular wall cell biology, its consequences on macrophage reprogramming are ill defined. In this study, we report that apoptosis of human and mouse endothelial cells triggers the release of milk fat globule-epidermal growth factor 8 (MFG-E8) and reprograms macrophages into an anti-inflammatory cells. We demonstrated that MFG-E8 is released by apoptotic endothelial cells in a caspase-3-dependent manner. When macrophages were exposed to conditioned media from serum-starved apoptotic endothelial cells, they adopt a high anti-inflammatory, low pro-inflammatory cytokine/chemokine secreting phenotype that is lost if MFG-E8 is absent from the media. Macrophage treatment with recombinant MFG-E8 recapitulates the effect of conditioned media. Finally, we showed that MFG-E8-mediated reprogramming of macrophages occurs through increased phosphorylation of signal transducer and activator of transcription-3 (STAT-3). Taken together, our study suggests a key role of MFG-E8 release from apoptotic endothelial cells in macrophage reprogramming and demonstrates the importance of the apoptotic microenvironment in anti-inflammatory macrophage responses.	[Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Sirois, Isabelle; Groleau, Jessika; Laurin, Louis-Philippe; Cailhier, Jean-Francois] Univ Montreal, CRCHUM, Montreal, PQ, Canada; [Brissette, Marie-Joelle; Lepage, Stephanie; Lamonde, Anne-Sophie; Cailhier, Jean-Francois] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada; [Laurin, Louis-Philippe; Cailhier, Jean-Francois] Univ Montreal, Dept Med, CHUM, Div Nephrol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Brissette, MJ (corresponding author), Univ Montreal, CRCHUM, Montreal, PQ, Canada.	jf.cailhier@umontreal.ca			Kidney Foundation of Canada; Fonds de la recherche en sante du Quebec (FRSQ); Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM); l'Institut du Cancer de Montreal; J.-L. Levesque Foundation; CHUM Renal Division	Kidney Foundation of Canada; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM); l'Institut du Cancer de Montreal; J.-L. Levesque Foundation; CHUM Renal Division	This work was funded in part by research grants from the Kidney Foundation of Canada, the Fonds de la recherche en sante du Quebec (FRSQ), the Foundation from the Centre hospitalier de l'Universite de Montreal (CHUM), and from l'Institut du Cancer de Montreal. JFC was the recipient of a Kidney Foundation of Canada scholarship and is now a FRSQ clinician-scientist scholar. The authors thank the J.-L. Levesque Foundation and the CHUM Renal Division for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Aziz MM, 2009, J IMMUNOL, V182, P7222, DOI 10.4049/jimmunol.0803711; Aziz M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027685; BAUMGARTNERPARZER SM, 1995, DIABETES, V44, P1323, DOI 10.2337/diabetes.44.11.1323; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Cailhier JFO, 2006, AM J RESP CRIT CARE, V173, P540, DOI 10.1164/rccm.200504-538OC; Chekeni FB, 2011, J MOL MED, V89, P13, DOI 10.1007/s00109-010-0673-7; Chen WJ, 2001, IMMUNITY, V14, P715, DOI 10.1016/S1074-7613(01)00147-9; Cornell LD, 2008, ANNU REV PATHOL-MECH, V3, P189, DOI 10.1146/annurev.pathmechdis.3.121806.151508; Cui TP, 2010, AM J RESP CRIT CARE, V181, P238, DOI 10.1164/rccm.200804-625OC; De Meyer I, 2012, BRIT J CLIN PHARMACO, V74, P246, DOI 10.1111/j.1365-2125.2012.04211.x; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Golpon HA, 2004, FASEB J, V18, P1716, DOI 10.1096/fj.04-1853fje; Hamet P, 2001, CAN J CARDIOL, V17, p26A; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Kitchens WH, 2007, AM J TRANSPLANT, V7, P2675, DOI 10.1111/j.1600-6143.2007.01997.x; Kluth DC, 2004, KIDNEY INT, V66, P542, DOI 10.1111/j.1523-1755.2004.00773.x; Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740; Laplante P, 2010, CELL DEATH DIFFER, V17, P291, DOI 10.1038/cdd.2009.124; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lepage S, 2009, TRANSPL P, V41, P3311, DOI 10.1016/j.transproceed.2009.08.035; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Martinet W, 2007, TRENDS CARDIOVAS MED, V17, P69, DOI 10.1016/j.tcm.2006.12.004; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje; Rovere P, 1998, J IMMUNOL, V161, P4467; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scannell M, 2007, J IMMUNOL, V178, P4595, DOI 10.4049/jimmunol.178.7.4595; Schaub FJ, 2000, NAT MED, V6, P790, DOI 10.1038/77521; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Sirois I, 2011, CELL DEATH DIFFER, V18, P549, DOI 10.1038/cdd.2010.126; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852	47	47	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36368	10.1371/journal.pone.0036368	http://dx.doi.org/10.1371/journal.pone.0036368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558449	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200071
J	Jansen, C; Parchi, P; Capellari, S; Ibrahim-Verbaas, CA; Schuur, M; Strammiello, R; Corrado, P; Bishop, MT; van Gool, WA; Verbeek, MM; Baas, F; van Saane, W; Spliet, WGM; Jansen, GH; van Duijn, CM; Rozemuller, AJM				Jansen, Casper; Parchi, Piero; Capellari, Sabina; Ibrahim-Verbaas, Carla A.; Schuur, Maaike; Strammiello, Rosaria; Corrado, Patrizia; Bishop, Matthew T.; van Gool, Willem A.; Verbeek, Marcel M.; Baas, Frank; van Saane, Wesley; Spliet, Wim G. M.; Jansen, Gerard H.; van Duijn, Cornelia M.; Rozemuller, Annemieke J. M.			Human Prion Diseases in The Netherlands (1998-2009): Clinical, Genetic and Molecular Aspects	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PROTEASE-SENSITIVE PRIONOPATHY; FATAL FAMILIAL INSOMNIA; VARIANT; PRPSC; CLASSIFICATION; COOCCURRENCE; PHENOTYPE; STRAINS; PATIENT	Prion diseases are rare and fatal neurodegenerative disorders that can be sporadic, inherited or acquired by infection. Based on a national surveillance program in the Netherlands we describe here the clinical, neuropathological, genetic and molecular characteristics of 162 patients with neuropathologically confirmed prion disease over a 12-year period (1998-2009). Since 1998, there has been a relatively stable mortality of Creutzfeldt-Jakob disease (CJD) in the Netherlands, ranging from 0.63 to 1.53 per million inhabitants per annum. Genetic analysis of the codon 129 methionine/valine (M/V) polymorphism in all patients with sporadic CJD (sCJD) showed a trend for under-representation of VV cases (7.0%), compared with sCJD cohorts in other Western countries, whereas the MV genotype was relatively over-represented (22,4%). Combined PrP Sc and histopathological typing identified all sCJD subtypes known to date, except for the VV1 subtype. In particular, a "pure" phenotype was demonstrated in 60.1% of patients, whereas a mixed phenotype was detected in 39.9% of all sCJD cases. The relative excess of MV cases was largely accounted for by a relatively high incidence of the MV 2K subtype. Genetic analysis of the prion protein gene (PRNP) was performed in 161 patients and showed a mutation in 9 of them (5.6%), including one FFI and four GSS cases. Iatrogenic CJD was a rare phenomenon (3.1%), mainly associated with dura mater grafts. Three patients were diagnosed with new variant CJD (1.9%) and one with variably protease-sensitive prionopathy (VPSPr). Post-mortem examination revealed an alternative diagnosis in 156 patients, most commonly Alzheimer's disease (21.2%) or vascular causes of dementia (19.9%). The mortality rates of sCJD in the Netherlands are similar to those in other European countries, whereas iatrogenic and genetic cases are relatively rare. The unusual incidence of the VV2 sCJD subtype compared to that reported to date in other Western countries deserves further investigation.	[Jansen, Casper; van Saane, Wesley; Spliet, Wim G. M.; Rozemuller, Annemieke J. M.] Univ Med Ctr Utrecht, Dutch Surveillance Ctr Prion Dis, Utrecht, Netherlands; [Parchi, Piero; Capellari, Sabina; Strammiello, Rosaria; Corrado, Patrizia] Univ Bologna, Ist Sci Neurol, Bologna, Italy; [Parchi, Piero; Capellari, Sabina; Strammiello, Rosaria; Corrado, Patrizia] Univ Bologna, Dipartimento Sci Neurol, Bologna, Italy; [Ibrahim-Verbaas, Carla A.; Schuur, Maaike] Erasmus Univ, Dept Neurol, Med Ctr, Rotterdam, Netherlands; [Ibrahim-Verbaas, Carla A.; van Duijn, Cornelia M.] Erasmus Univ, Dept Epidemiol, Med Ctr, Dutch Natl Prion Dis Registry, Rotterdam, Netherlands; [Bishop, Matthew T.] Univ Edinburgh, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh, Midlothian, Scotland; [van Gool, Willem A.; Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Donders Inst Brain Cognit & Behav,Alzheimer Ctr N, NL-6525 ED Nijmegen, Netherlands; [Verbeek, Marcel M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Donders Inst Brain Cognit & Behav,Alzheimer Ctr N, NL-6525 ED Nijmegen, Netherlands; [Baas, Frank] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Jansen, Gerard H.] Publ Hlth Agcy Canada, Prion Dis Program, Creutzfeldt Jakob Dis Surveillance Syst, Ottawa, ON, Canada; [Rozemuller, Annemieke J. M.] Netherlands Brain Bank, Amsterdam, Netherlands; [Rozemuller, Annemieke J. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; University of Bologna; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Agency of Canada; Vrije Universiteit Amsterdam	Jansen, C (corresponding author), Univ Med Ctr Utrecht, Dutch Surveillance Ctr Prion Dis, Utrecht, Netherlands.	c.jansen@umcutrecht.nl	Rozemuller, Annemieke/ABA-7093-2021; Van Gool, Willem A/G-5985-2012; Rozemuller, Annemieke/C-2084-2008; Verbeek, Marcel M/D-1971-2010; Parchi, Piero/L-9833-2015; Baas, Frank/F-9574-2010; capellari, sabina/F-5545-2012	Verbeek, Marcel M/0000-0003-4635-7876; Parchi, Piero/0000-0002-9444-9524; Baas, Frank/0000-0003-3912-5428; capellari, sabina/0000-0003-1631-1439; Ibrahim-verbaas, Carla/0000-0002-4325-0857; Van Gool, Willem/0000-0003-3174-8233; Van Duijn, Cornelia/0000-0002-2374-9204				Aguzzi A, 2007, NAT REV MOL CELL BIO, V8, P552, DOI 10.1038/nrm2204; Alperovitch A, 1999, LANCET, V353, P1673, DOI 10.1016/S0140-6736(99)01342-2; Bishop MT, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-146; Bishop MT, 2010, P NATL ACAD SCI USA, V107, P12005, DOI 10.1073/pnas.1004688107; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Croes EA, 2003, ANN NEUROL, V54, P275, DOI 10.1002/ana.10658; Croes EA, 2002, J NEUROL NEUROSUR PS, V72, P792, DOI 10.1136/jnnp.72.6.792; Dyrbye H, 2008, EUR J EPIDEMIOL, V23, P23, DOI 10.1007/s10654-007-9197-z; Ferrer I, 2007, BRAIN PATHOL, V17, P297, DOI 10.1111/j.1750-3639.2007.00073.x; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Ghetti B, 2003, CLIN LAB MED, V23, P65, DOI 10.1016/S0272-2712(02)00064-1; Ghetti B, 2003, CLIN LAB MED, V23, pviii; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; Jansen C, 2011, NEUROPATH APPL NEURO, V37, P549, DOI 10.1111/j.1365-2990.2010.01126.x; Jansen C, 2010, J NEUROL NEUROSUR PS, V81, P1052, DOI 10.1136/jnnp.2009.175646; Jansen C, 2009, J NEUROL NEUROSUR PS, V80, P1386, DOI 10.1136/jnnp.2008.169359; Jansen C, 2011, J NEUROPATH EXP NEUR, V70, P698, DOI 10.1097/NEN.0b013e3182270c54; Jansen C, 2011, ACTA NEUROPATHOL, V121, P59, DOI 10.1007/s00401-010-0656-3; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Kobayashi A, 2011, AM J PATHOL, V178, P1309, DOI 10.1016/j.ajpath.2010.11.069; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, BRAIN PATHOL, V12, P1; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; Lewis V, 2005, NEUROLOGY, V65, P113, DOI 10.1212/01.wnl.0000167188.65787.a0; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Nozaki I, 2010, BRAIN, V133, P3043, DOI 10.1093/brain/awq216; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Parchi P, 2010, BRAIN, V133, P3030, DOI 10.1093/brain/awq234; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Parchi P, 2009, BRAIN PATHOL, V19, P384, DOI 10.1111/j.1750-3639.2008.00187.x; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Sanchez-Juan P, 2007, J NEUROL, V254, P958, DOI 10.1007/s00415-006-0360-3; Schoch G, 2006, PLOS MED, V3, P236, DOI 10.1371/journal.pmed.0030014; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Will RG, 1998, ANN NEUROL, V43, P763, DOI 10.1002/ana.410430611; Yull HM, 2009, BIOLOGICALS, V37, P210, DOI 10.1016/j.biologicals.2009.01.009; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zimmermann K, 1999, ACTA NEUROPATHOL, V97, P355, DOI 10.1007/s004010050998; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	52	40	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36333	10.1371/journal.pone.0036333	http://dx.doi.org/10.1371/journal.pone.0036333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558438	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200067
J	Schreur, PJW; van Weeghel, C; Rebel, JMJ; Smits, MA; van Putten, JPM; Smith, HE				Schreur, Paul J. Wichgers; van Weeghel, Christian; Rebel, Johanna M. J.; Smits, Mari A.; van Putten, Jos P. M.; Smith, Hilde E.			Lysozyme Resistance in Streptococcus suis Is Highly Variable and Multifactorial	PLOS ONE			English	Article							PENICILLIN RESISTANCE; ANTIBIOTIC TOLERANCE; MURMN OPERON; PGDA GENE; VIRULENCE; DEACETYLASE	Background: Streptococcus suis is an important infectious agent for pigs and occasionally for humans. The host innate immune system plays a key role in preventing and eliminating S. suis infections. One important constituent of the innate immune system is the protein lysozyme, which is present in a variety of body fluids and immune cells. Lysozyme acts as a peptidoglycan degrading enzyme causing bacterial lysis. Several pathogens have developed mechanisms to evade lysozyme-mediated killing. In the present study we compared the lysozyme sensitivity of various S. suis isolates and investigated the molecular basis of lysozyme resistance for this pathogen. Results: The lysozyme minimal inhibitory concentrations of a wide panel of S. suis isolates varied between 0.3 to 10 mg/ml. By inactivating the oatA gene in a serotype 2 and a serotype 9 strain, we showed that OatA-mediated peptidoglycan modification partly contributes to lysozyme resistance. Furthermore, inactivation of the murMN operon provided evidence that additional peptidoglycan crosslinking is not involved in lysozyme resistance in S. suis. Besides a targeted approach, we also used an unbiased approach for identifying factors involved in lysozyme resistance. Based on whole genome comparisons of a lysozyme sensitive strain and selected lysozyme resistant derivatives, we detected several single nucleotide polymorphisms (SNPs) that were correlated with the lysozyme resistance trait. Two SNPs caused defects in protein expression of an autolysin and a capsule sugar transferase. Analysis of specific isogenic mutants, confirmed the involvement of autolysin activity and capsule structures in lysozyme resistance of S. suis. Conclusions: This study shows that lysozyme resistance levels are highly variable among S. suis isolates and serotypes. Furthermore, the results show that lysozyme resistance in S. suis can involve different mechanisms including OatA-mediated peptidolycan modification, autolysin activity and capsule production.	[Schreur, Paul J. Wichgers; van Weeghel, Christian; Rebel, Johanna M. J.; Smits, Mari A.; Smith, Hilde E.] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Schreur, Paul J. Wichgers; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Smits, Mari A.] Wageningen UR, Wageningen Livestock Res, Lelystad, Netherlands	Wageningen University & Research; Utrecht University; Wageningen University & Research	Schreur, PJW (corresponding author), Wageningen UR, Cent Vet Inst, Lelystad, Netherlands.	hilde.smith@wur.nl	smits, mari/J-4892-2013	smits, mari/0000-0002-3493-291X; van Putten, Jos/0000-0002-4126-8172; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs, Agriculture and Innovation	Dutch Ministry of Economic Affairs, Agriculture and Innovation	This project was financially supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINE E, 1984, ACTA OPHTHALMOL, V62, P932; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; BUNGENER W, 1989, EUR J CLIN MICROBIOL, V8, P306, DOI 10.1007/BF01963457; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Cole AM, 2002, J IMMUNOL, V169, P6985, DOI 10.4049/jimmunol.169.12.6985; COTTAGNOUD P, 1993, J INFECT DIS, V167, P684, DOI 10.1093/infdis/167.3.684; CRAMER EM, 1987, J LEUKOCYTE BIOL, V41, P242, DOI 10.1002/jlb.41.3.242; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; Davis KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000241; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Filipe SR, 2002, P NATL ACAD SCI USA, V99, P1550, DOI 10.1073/pnas.032671699; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JACQUES M, 1990, J BACTERIOL, V172, P2833, DOI 10.1128/jb.172.6.2833-2838.1990; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; Markart P, 2004, AM J RESP CRIT CARE, V169, P454, DOI 10.1164/rccm.200305-669OC; PEETERMANS WEC, 1989, J INFECT DIS, V159, P595, DOI 10.1093/infdis/159.3.595; PEREZMARTINEZ G, 1992, MOL GEN GENET, V234, P401, DOI 10.1007/BF00538699; Rae CS, 2011, INFECT IMMUN, V79, P3596, DOI 10.1128/IAI.00077-11; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schreur PJW, 2011, J BACTERIOL, V193, P5073, DOI 10.1128/JB.05305-11; Schreur PJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022299; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Smith HE, 1999, INFECT IMMUN, V67, P1750; SMITH HE, 1995, MICROBIOL-UK, V141, P181, DOI 10.1099/00221287-141-1-181; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; WELSH IRH, 1971, INFECT IMMUN, V4, P97, DOI 10.1128/IAI.4.2.97-102.1971; Wichgers Schreur PJ, 2009, VET MICROBIOL; Wichgers Schreur PJ, 2011, PLOS ONE IN PRESS; Zhang AD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-523; Zhu HD, 2011, MICROB PATHOGENESIS, V51, P442, DOI 10.1016/j.micpath.2011.08.002	39	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36281	10.1371/journal.pone.0036281	http://dx.doi.org/10.1371/journal.pone.0036281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558419	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200060
J	Lin, RH; Xie, ZY; Zhang, JF; Xu, HW; Su, H; Tan, XR; Tian, DP; Su, M				Lin, Runhua; Xie, Zeyu; Zhang, Jianfa; Xu, Hongwu; Su, Hang; Tan, Xuerui; Tian, Dongping; Su, Min			Clinical and Immunopathological Features of Moyamoya Disease	PLOS ONE			English	Article							EPIDEMIOLOGIC FEATURES; UNITED-STATES; AUTOPSY; S100A4; BRAIN; JAPAN; CELLS	Background: Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive stenosis or occlusion of the terminal portion of internal carotid arteries and the formation of a vascular network at the base of the brain. The pathogenesis of MMD is still unclear. Methodology/Principal Findings: We retrospectively analyzed clinical data for 65 consecutive patients with MMD in our institutions and evaluated the histopathological and immunohistochemical findings of intracranial vessels from 3 patients. The onset age distribution was found to have 1 peak at 40-49 year-old age group, no significant difference was observed in the female-to-male ratio (F/M=1.2). Intracranial hemorrhage was the predominant disease type (75%). Positive family history was observed in 4.6% of patients. Histopathological findings were a narrowed lumen due to intimal fibrous thickening without significant inflammatory cell infiltration, and the internal elastic lamina was markedly tortuous and stratified. All 3 autopsy cases showed vacuolar degeneration in the cerebrovascular smooth muscle cells. Immunohistochemical study showed the migration of smooth muscle cells in the thickened intima, and aberrant expression of IgG and S100A4 protein in vascular smooth muscle cells. The Complement C3 immunoreactivity was negative. Conclusion/Significance: This study indicated that aberrant expression of IgG and S100A4 protein in intracranial vascular wall of MMD patients, which suggested that immune-related factors may be involved in the functional and morphological changes of smooth muscle cells, and finally caused the thickened intima. A possible mechanism is that deposits of IgG in the damaged internal elastic lamina may underlie the disruption of internal elastic lamina, which facilitated S100A4 positive SMCs migrated into intima through broken portions of the internal elastic lamina, resulting in lumen stenosis or occlusion, leading to compensatory small vessels proliferation.	[Lin, Runhua; Su, Hang; Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China; [Lin, Runhua; Su, Hang; Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China; [Xie, Zeyu; Xu, Hongwu] Shantou Univ, Coll Med, Affiliated Hosp 2, Shantou, Guangdong, Peoples R China; [Zhang, Jianfa; Tan, Xuerui] Shantou Univ, Coll Med, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Tian, Dongping; Su, Min] Shantou Univ, Coll Med, Judicial Crit Ctr, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Lin, RH (corresponding author), Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China.	dp_tian@163.com; minsu@stu.edu.cn			National Natural Science Foundation of China [31171226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grant from National Natural Science Foundation of China (31171226, www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2008, J NEUROL NEUROSUR PS, V79, P900, DOI 10.1136/jnnp.2007.130666; Battistella PA, 1997, CLIN NEUROL NEUROSUR, V99, pS54, DOI 10.1016/S0303-8467(97)00041-3; Borota L, 1997, CLIN NEUROL NEUROSUR, V99, pS49, DOI 10.1016/S0303-8467(97)00040-1; Brisset AC, 2007, CIRC RES, V100, P1055, DOI 10.1161/01.RES.0000262654.84810.6c; Burke GM, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08310; Chen D, 2012, WORLD J GASTROENTERO, V18, P915, DOI 10.3748/wjg.v18.i9.915; Chiu D, 1998, STROKE, V29, P1347, DOI 10.1161/01.STR.29.7.1347; Duan L, 2012, STROKE, V43, P56, DOI 10.1161/STROKEAHA.111.621300; Graham JF, 1997, CLIN NEUROL NEUROSUR, V99, pS31, DOI 10.1016/S0303-8467(97)00037-1; Grigorian M, 2008, CURR MOL MED, V8, P492, DOI 10.2174/156652408785747942; Han DH, 2000, ACTA NEUROCHIR, V142, P1263, DOI 10.1007/s007010070024; He YT, 2010, AM J FOREN MED PATH, V31, P77, DOI 10.1097/PAF.0b013e3181c215e2; Hosoda Y, 1997, CLIN NEUROL NEUROSUR, V99, pS203, DOI 10.1016/s0303-8467(97)00044-9; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Kuroda S, 2005, STROKE, V36, P2148, DOI 10.1161/01.STR.0000182256.32489.99; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; Mishra S.K., 2011, CANC METASTASIS REV; Numaguchi Y, 1997, CLIN NEUROL NEUROSUR, V99, pS26, DOI 10.1016/S0303-8467(97)00060-7; OKA K, 1981, VIRCHOWS ARCH A, V392, P247, DOI 10.1007/BF02155663; Reid AJ, 2010, J NEUROSURG-PEDIATR, V6, P244, DOI 10.3171/2010.5.PEDS09505; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Takekawa Y, 2004, NEUROPATHOLOGY, V24, P236, DOI 10.1111/j.1440-1789.2004.00550.x; Takeuchi K., 1957, BRAIN NERVE, V9, P37; Wakai K, 1997, CLIN NEUROL NEUROSUR, V99, pS1, DOI 10.1016/S0303-8467(97)00031-0; YAMASHITA M, 1983, STROKE, V14, P50, DOI 10.1161/01.STR.14.1.50	27	40	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36386	10.1371/journal.pone.0036386	http://dx.doi.org/10.1371/journal.pone.0036386			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558457	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000202
J	Ambarus, CA; Santegoets, KCM; van Bon, L; Wenink, MH; Tak, PP; Radstake, TRDJ; Baeten, DLP				Ambarus, Carmen A.; Santegoets, Kim C. M.; van Bon, Lenny; Wenink, Mark H.; Tak, Paul P.; Radstake, Timothy R. D. J.; Baeten, Dominique L. P.			Soluble Immune Complexes Shift the TLR-Induced Cytokine Production of Distinct Polarized Human Macrophage Subsets towards IL-10	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FC-GAMMA-RECEPTORS; COLONY-STIMULATING FACTOR; BLOOD MONONUCLEAR-CELLS; FACTOR-ALPHA PRODUCTION; RHEUMATOID-ARTHRITIS; HUMAN MONOCYTES; CROSS-LINKING; ALTERNATIVE ACTIVATION; CITRULLINATED PROTEINS	Background: Costimulation of murine macrophages with immune complexes (ICs) and TLR ligands leads to alternative activation. Studies on human myeloid cells, however, indicate that ICs induce an increased pro-inflammatory cytokine production. This study aimed to clarify the effect of ICs on the pro-versus anti-inflammatory profile of human polarized macrophages. Materials and Methods: Monocytes isolated from peripheral blood of healthy donors were polarized for four days with IFN-gamma, IL-4, IL-10, GM-CSF, M-CSF, or LPS, in the presence or absence of heat aggregated gamma-globulins (HAGGs). Phenotypic polarization markers were measured by flow cytometry. Polarized macrophages were stimulated with HAGGs or immobilized IgG alone or in combination with TLR ligands. TNF, IL-6, IL-10, IL-12, and IL-23 were measured by Luminex and/or RT-qPCR. Results: HAGGs did not modulate the phenotypic polarization and the cytokine production of macrophages. However, HAGGs significantly altered the TLR-induced cytokine production of all polarized macrophage subsets, with the exception of M Phi(IL-4). In particular, HAGGs consistently enhanced the TLR-induced IL-10 production in both classically and alternatively polarized macrophages (M1 and M2). The effect of HAGGs on TNF and IL-6 production was less pronounced and depended on the polarization status, while IL-23p19 and IL-12p35 expression was not affected. In contrast with HAGGs, immobilized IgG induced a strong upregulation of not only IL-10, but also TNF and IL-6. Conclusion: HAGGs alone do not alter the phenotype and cytokine production of in vitro polarized human macrophages. In combination with TLR-ligands, however, HAGGs but not immobilized IgG shift the cytokine production of distinct macrophage subsets toward IL-10.	[Ambarus, Carmen A.; Tak, Paul P.; Baeten, Dominique L. P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Santegoets, Kim C. M.; van Bon, Lenny; Wenink, Mark H.; Radstake, Timothy R. D. J.] Radboud Univ Nijmegen, Dept Rheumatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	Ambarus, CA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.a.ambarus@amc.nl	Santegoets, Kim/S-4267-2017		The Netherlands Organization for Scientific Research (NWO); Dutch Arthritis Foundation	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Arthritis Foundation	This research is supported by a VIDI grant from The Netherlands Organization for Scientific Research (NWO) and by a grant from the Dutch Arthritis Foundation (Reumafonds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Anderson CF, 2002, J LEUKOCYTE BIOL, V72, P101; Anderson CF, 2002, J IMMUNOL, V168, P3697, DOI 10.4049/jimmunol.168.8.3697; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Berger S, 1996, EUR J IMMUNOL, V26, P1297, DOI 10.1002/eji.1830260618; Berger S, 1997, EUR J IMMUNOL, V27, P2994, DOI 10.1002/eji.1830271136; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; BONNEY RJ, 1979, PROSTAGLANDINS, V18, P605, DOI 10.1016/0090-6980(79)90027-3; Boross P, 2006, SPRINGER SEMIN IMMUN, V28, P339, DOI 10.1007/s00281-006-0049-9; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; DiMartino SJ, 2008, CLIN IMMUNOL, V127, P56, DOI 10.1016/j.clim.2007.11.014; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Ephrem A, 2005, CLIN EXP MED, V5, P135, DOI 10.1007/s10238-005-0079-y; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Gupta S, 2010, BIOCHEM BIOPH RES CO, V402, P301, DOI 10.1016/j.bbrc.2010.10.020; HERRMANN F, 1992, EUR J IMMUNOL, V22, P1681, DOI 10.1002/eji.1830220703; Hogger P, 1998, J IMMUNOL, V161, P1883; Ji JD, 2003, J EXP MED, V197, P1573, DOI 10.1084/jem.20021820; KIM JW, 1991, AM J RESP CELL MOL, V5, P249, DOI 10.1165/ajrcmb/5.3.249; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; KRUTMANN J, 1990, J IMMUNOL, V145, P1337; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Mullazehi M, 2006, ARTHRITIS RHEUM-US, V54, P1759, DOI 10.1002/art.21892; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Nimmerjahn F, 2007, J EXP MED, V204, P11, DOI 10.1084/jem.20061788; POLAT GL, 1993, IMMUNOLOGY, V80, P287; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P1556, DOI 10.1136/ard.2003.016550; Radstake TRDJ, 2004, ANN RHEUM DIS, V63, P696, DOI 10.1136/ard.2003.010033; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Ronnelid J, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.1.37; SHANLEY TP, 1995, J IMMUNOL, V154, P3454; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; TRIPP CS, 1995, J CLIN INVEST, V95, P1628, DOI 10.1172/JCI117837; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; VIRGIN HW, 1984, ANN NY ACAD SCI, V437, P16, DOI 10.1111/j.1749-6632.1984.tb37118.x; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818; Vos ACW, 2011, GASTROENTEROLOGY, V140, P221, DOI 10.1053/j.gastro.2010.10.008; Wenink MH, 2009, J IMMUNOL, V183, P4509, DOI 10.4049/jimmunol.0900153; Wernersson S, 1999, J IMMUNOL, V163, P618; Wijngaarden S, 2004, ARTHRITIS RHEUM-US, V50, P3878, DOI 10.1002/art.20672; Yuan WJ, 2011, ARTHRITIS RHEUM-US, V63, P212, DOI 10.1002/art.30083	57	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35994	10.1371/journal.pone.0035994	http://dx.doi.org/10.1371/journal.pone.0035994			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563430	Green Published, gold			2022-12-27	WOS:000305349100056
J	He, ZY; Gao, Y; Deng, YX; Li, W; Chen, YM; Xing, SP; Zhao, XY; Ding, J; Wang, XR				He, Zhengyu; Gao, Yuan; Deng, Yuxiao; Li, Wen; Chen, Yongming; Xing, Shunpeng; Zhao, Xianyuan; Ding, Jia; Wang, Xiangrui			Lipopolysaccharide Induces Lung Fibroblast Proliferation through Toll-Like Receptor 4 Signaling and the Phosphoinositide3-Kinase-Akt Pathway	PLOS ONE			English	Article							LAMINA PROPRIA FIBROBLASTS; HUMAN GINGIVAL FIBROBLASTS; IN-VITRO; NEGATIVE REGULATION; PULMONARY-FIBROSIS; INJURY; PTEN; PHOSPHATASE; ACTIVATION; HYPOXIA	Pulmonary fibrosis is characterized by lung fibroblast proliferation and collagen secretion. In lipopolysaccharide (LPS)-induced acute lung injury (ALI), aberrant proliferation of lung fibroblasts is initiated in early disease stages, but the underlying mechanism remains unknown. In this study, we knocked down Toll-like receptor 4 (TLR4) expression in cultured mouse lung fibroblasts using TLR4-siRNA-lentivirus in order to investigate the effects of LPS challenge on lung fibroblast proliferation, phosphoinositide3-kinase (PI3K)-Akt pathway activation, and phosphatase and tensin homolog (PTEN) expression. Lung fibroblast proliferation, detected by BrdU assay, was unaffected by 1 mug/mL LPS challenge up to 24 hours, but at 72 hours, cell proliferation increased significantly. This proliferation was inhibited by siRNA-mediated TLR4 knockdown or treatment with the PI3K inhibitor, Ly294002. In addition, siRNA-mediated knockdown of TLR4 inhibited the LPS-induced up-regulation of TLR4, down-regulation of PTEN, and activation of the PI3K-Akt pathway (overexpression of phospho-Akt) at 72 hours, as detected by real-time PCR and Western blot analysis. Treatment with the PTEN inhibitor, bpV(phen), led to activation of the PI3K-Akt pathway. Neither the baseline expression nor LPS-induced down-regulation of PTEN in lung fibroblasts was influenced by PI3K activation state. PTEN inhibition was sufficient to exert the LPS effect on lung fibroblast proliferation, and PI3K-Akt pathway inhibition could reverse this process. Collectively, these results indicate that LPS can promote lung fibroblast proliferation via a TLR4 signaling mechanism that involves PTEN expression down-regulation and PI3K-Akt pathway activation. Moreover, PI3K-Akt pathway activation is a downstream effect of PTEN inhibition and plays a critical role in lung fibroblast proliferation. This mechanism could contribute to, and possibly accelerate, pulmonary fibrosis in the early stages of ALI/ARDS.	[He, Zhengyu; Gao, Yuan; Deng, Yuxiao; Li, Wen; Chen, Yongming; Xing, Shunpeng; Zhao, Xianyuan; Ding, Jia; Wang, Xiangrui] Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	He, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China.	xiangruiwang@gmail.com	GAO, YUAN/AFF-0781-2022; gao, yuan/GWM-8846-2022	He, Zhengyu/0000-0001-7354-850X	National Natural Science Foundation of China (NSFC) [81000025]; Science and Technology Commission of Shanghai Municipality Foundation [10411951600]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality Foundation(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by a grant from the National Natural Science Foundation of China (NSFC) (No. 81000025) and the Science and Technology Commission of Shanghai Municipality Foundation (No. 10411951600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANKEY P, 1989, J TRAUMA, V29, P972, DOI 10.1097/00005373-198907000-00011; Brass DM, 2007, J ALLERGY CLIN IMMUN, V120, P121, DOI 10.1016/j.jaci.2007.03.051; Cai XJ, 2010, CELL BIOL INT, V34, P163, DOI 10.1042/CBI20090013; Cai XJ, 2010, MOL ENDOCRINOL, V24, P218, DOI 10.1210/me.2009-0128; Chakravortty D, 1999, BBA-MOL BASIS DIS, V1453, P261, DOI 10.1016/S0925-4439(98)00106-9; Chakravortty D, 1997, BIOCHEM BIOPH RES CO, V240, P458, DOI 10.1006/bbrc.1997.7680; CHEN B, 1992, J CLIN INVEST, V90, P1778, DOI 10.1172/JCI116052; Chen XH, 2008, BASIC CLIN PHARMACOL, V103, P278, DOI 10.1111/j.1742-7843.2008.00287.x; Churg A, 2007, AM J SURG PATHOL, V31, P277, DOI 10.1097/01.pas.0000213341.70852.9d; Dzierzewicz Z, 2010, ARCH ORAL BIOL; Fagone E, 2011, EXP LUNG RES, V37, P162, DOI 10.3109/01902148.2010.524722; Gerasimovskaya EV, 2005, J APPL PHYSIOL, V98, P722, DOI 10.1152/japplphysiol.00715.2004; Gutierrez-Venegas G, 2006, EUR J PHARMACOL, V541, P95, DOI 10.1016/j.ejphar.2006.03.069; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; He ZY, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-126; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Howell DCJ, 2006, THORAX, V61, pII51; Kim CS, 2007, MOL CELLS, V24, P424; Krick S, 2005, FASEB J, V19, P857, DOI 10.1096/fj.04-2890fje; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Lai JP, 2007, BRIT J PHARMACOL, V152, P1172, DOI 10.1038/sj.bjp.0707501; LAYMAN DL, 1987, J PERIODONTOL, V58, P387, DOI 10.1902/jop.1987.58.6.387; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Qureshi ST, 2006, J IMMUNOL, V176, P4950, DOI 10.4049/jimmunol.176.8.4950; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; SUBRAMONIAM A, 1985, P SOC EXP BIOL MED, V178, P50; Susilowati Heni, 2002, Journal of Microbiology Immunology and Infection, V35, P203; Suzuki S, 2003, ARTHRITIS RHEUM, V48, pS355; Takemura A, 1998, J PERIODONTAL RES, V33, P400; Takeuchi R, 2011, ARCH ORAL BIOL; Tasaka Sadamoto, 2005, Nihon Naika Gakkai Zasshi, V94, P1106; Tian J, 2011, ANESTH ANALG, V113, P112, DOI 10.1213/ANE.0b013e3182159c15; Tsugawa K, 2002, FRONT BIOSCI-LANDMRK, V7, pE245, DOI 10.2741/tsugawa; White ES, 2006, AM J RESP CRIT CARE, V173, P112, DOI 10.1164/rccm.200507-1058OC; Wu WKK, 2007, WOUND REPAIR REGEN, V15, P221, DOI 10.1111/j.1524-475X.2007.00208.x; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Yang H, 2002, PHYTOTHER RES, V16, P43, DOI 10.1002/ptr.912; Zhang J, 2011, CYTOKINE, V54, P289, DOI 10.1016/j.cyto.2011.02.018	40	67	76	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35926	10.1371/journal.pone.0035926	http://dx.doi.org/10.1371/journal.pone.0035926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563417	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349100043
J	Rutti, S; Sauter, NS; Bouzakri, K; Prazak, R; Halban, PA; Donath, MY				Rutti, Sabine; Sauter, Nadine S.; Bouzakri, Karim; Prazak, Richard; Halban, Philippe A.; Donath, Marc Y.			In Vitro Proliferation of Adult Human Beta-Cells	PLOS ONE			English	Article							MASS; REPLICATION; APOPTOSIS	A decrease in functional beta-cell mass is a key feature of type 2 diabetes. Glucagon-like peptide 1 (GLP-1) analogues induce proliferation of rodent beta-cells. However, the proliferative capacity of human beta-cells and its modulation by GLP-1 analogues remain to be fully investigated. We therefore sought to quantify adult human beta-cell proliferation in vitro and whether this is affected by the GLP-1 analogue liraglutide. Human islets from 7 adult cadaveric organ donors were dispersed into single cells. Beta-cells were purified by FACS. Non-sorted cells and the beta-cell enriched ("beta-cells'') population were plated on extracellular matrix from rat (804G) and human bladder carcinoma cells (HTB9) or bovine corneal endothelial ECM (BCEC). Cells were maintained in culture+/-liraglutide for 4 days in the presence of BrdU. Rare human beta-cell proliferation could be observed either in the purified beta-cell population (0.051 +/- 0.020%; 22 beta-cells proliferating out of 84'283 beta-cells counted) or in the non-sorted cell population (0.055 +/- 0.011%; 104 proliferating beta-cells out of 232'826 beta-cells counted), independently of the matrix or the culture conditions. Liraglutide increased human beta-cell proliferation on BCEC in the non-sorted cell population (0.082 +/- 0.034% proliferating beta-cells vs. 0.017 +/- 0.008% in control, p<0.05). These results indicate that adult human beta-cell proliferation can occur in vitro but remains an extremely rare event with these donors and particular culture conditions. Liraglutide increases beta-cell proliferation only in the non-sorted cell population and only on BCEC. However, it cannot be excluded that human beta-cells may proliferate to a greater extent in situ in response to natural stimuli.	[Rutti, Sabine; Bouzakri, Karim; Halban, Philippe A.] Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland; [Sauter, Nadine S.; Prazak, Richard; Donath, Marc Y.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Sauter, Nadine S.; Prazak, Richard; Donath, Marc Y.] Univ Basel Hosp, Div Endocrinol Diabet & Metab, CH-4031 Basel, Switzerland	University of Geneva; University of Basel; University of Basel	Rutti, S (corresponding author), Univ Geneva, Dept Genet Med & Dev, Geneva, Switzerland.	sabine.rutti@unige.ch			Novo Nordisk	Novo Nordisk(Novo Nordisk)	The study was supported by Novo Nordisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The study was supported by Novo Nordisk who provided Liraglutide for this study. There are no other patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLos ONE policies on sharing data and materials, as detailed online in the guide for authors.	Banerjee M, 2012, MOL CELL ENDOCRINOL; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; In't Veld P, 2010, DIABETES, V59, P1702, DOI 10.2337/db09-1698; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; Maedler K, 2006, DIABETES, V55, P2455, DOI 10.2337/db05-1586; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Reers C, 2009, EUR J ENDOCRINOL, V160, P185, DOI 10.1530/EJE-08-0596; Rolin B, 2002, AM J PHYSIOL-ENDOC M, V283, pE745, DOI 10.1152/ajpendo.00030.2002; Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9	14	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35801	10.1371/journal.pone.0035801	http://dx.doi.org/10.1371/journal.pone.0035801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563404	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100031
J	Elamin, E; Jonkers, D; Juuti-Uusitalo, K; van IJzendoorn, S; Troost, F; Duimel, H; Broers, J; Verheyen, F; Dekker, J; Masclee, A				Elamin, Elhaseen; Jonkers, Daisy; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Duimel, Hans; Broers, Jos; Verheyen, Fons; Dekker, Jan; Masclee, Ad			Effects of Ethanol and Acetaldehyde on Tight Junction Integrity: In Vitro Study in a Three Dimensional Intestinal Epithelial Cell Culture Model	PLOS ONE			English	Article							PARACELLULAR PERMEABILITY; LIVER-DISEASE; ALCOHOL-CONSUMPTION; INDUCED INCREASE; MOLECULAR-BASIS; LEAKY GUT; BARRIER; TISSUE; MONOLAYER; COMPLEX	Background: Intestinal barrier dysfunction and translocation of endotoxins are involved in the pathogenesis of alcoholic liver disease. Exposure to ethanol and its metabolite, acetaldehyde at relatively high concentrations have been shown to disrupt intestinal epithelial tight junctions in the conventional two dimensional cell culture models. The present study investigated quantitatively and qualitatively the effects of ethanol at concentrations detected in the blood after moderate ethanol consumption, of its metabolite acetaldehyde and of the combination of both compounds on intestinal barrier function in a three-dimensional cell culture model. Methods and Findings: Caco-2 cells were grown in a basement membrane matrix (Matrigel (TM)) to induce spheroid formation and were then exposed to the compounds at the basolateral side. Morphological differentiation of the spheroids was assessed by immunocytochemistry and transmission electron microscopy. The barrier function was assessed by the flux of FITC-labeled dextran from the basal side into the spheroids' luminal compartment using confocal microscopy. Caco-2 cells grown on Matrigel assembled into fully differentiated and polarized spheroids with a central lumen, closely resembling enterocytes in vivo and provide an excellent model to study epithelial barrier functionality. Exposure to ethanol (10-40 mM) or acetaldehyde (25-200 mu M) for 3 h, dose-dependently and additively increased the paracellular permeability and induced redistribution of ZO-1 and occludin without affecting cell viability or tight junction-encoding gene expression. Furthermore, ethanol and acetaldehyde induced lysine residue and microtubules hyperacetylation. Conclusions: These results indicate that ethanol at concentrations found in the blood after moderate drinking and acetaldehyde, alone and in combination, can increase the intestinal epithelial permeability. The data also point to the involvement of protein hyperacetylation in ethanol- and acetaldehyde-induced loss of tight junctions integrity.	[Elamin, Elhaseen; Jonkers, Daisy; Juuti-Uusitalo, Kati; van IJzendoorn, Sven; Troost, Freddy; Dekker, Jan; Masclee, Ad] Top Inst Food & Nutr, Wageningen, Netherlands; [Elamin, Elhaseen; Jonkers, Daisy; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, Div Gastroenterol Hepatol, Maastricht, Netherlands; [Elamin, Elhaseen; Jonkers, Daisy; Troost, Freddy; Masclee, Ad] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Juuti-Uusitalo, Kati; van IJzendoorn, Sven] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Duimel, Hans; Broers, Jos; Verheyen, Fons] Maastricht Univ, Med Ctr, Dept Mol Cell Biol, Maastricht, Netherlands; [Duimel, Hans; Verheyen, Fons] Maastricht Univ, Med Ctr, Electron Microscopy Unit, Maastricht, Netherlands; [Dekker, Jan] Wageningen Univ, Dept Anim Sci, Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University; University of Groningen; Maastricht University; Maastricht University; Wageningen University & Research	Elamin, E (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.	d.jonkers@maastrichtuniversity.nl	Troost, Freddy/B-2782-2015	Juuti-Uusitalo, Kati/0000-0003-2275-5562	Top Institute Food and Nutrition	Top Institute Food and Nutrition	This study was funded by Top Institute Food and Nutrition. Both funders and providers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; ARTURSSON P, 1993, PHARMACEUT RES, V10, P1123, DOI 10.1023/A:1018903931777; Atkinson KJ, 2001, AM J PHYSIOL-GASTR L, V280, pG1280, DOI 10.1152/ajpgi.2001.280.6.G1280; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Banan A, 1998, AM J PHYSIOL-GASTR L, V274, pG111, DOI 10.1152/ajpgi.1998.274.1.G111; Bentrup KHZ, 2006, MICROBES INFECT, V8, P1813, DOI 10.1016/j.micinf.2006.02.020; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; BJARNASON I, 1984, LANCET, V1, P179; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Collett A, 1996, PHARMACEUT RES, V13, P216, DOI 10.1023/A:1016082829111; Dufour MC, 1999, ALCOHOL RES HEALTH, V23, P5; Eckardt MJ, 1998, ALCOHOL CLIN EXP RES, V22, P998, DOI 10.1111/j.1530-0277.1998.tb03695.x; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Forsyth CB, 2011, ALCOHOL CLIN EXP RES; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Forsyth CB, 2010, ALCOHOL CLIN EXP RES, V34, P19, DOI 10.1111/j.1530-0277.2009.01061.x; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Geetha S, 2009, GASTROENTEROLOGY S1, V136, pA; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Itoh M, 1999, J CELL BIOL, V147, P1351, DOI 10.1083/jcb.147.6.1351; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2008, J CELL SCI, V121, P1803, DOI 10.1242/jcs.015842; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Juuti-Uusitalo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022967; Kannarkat GT, 2006, J HEPATOL, V44, P963, DOI 10.1016/j.jhep.2005.07.007; KESHAVARZIAN A, 1994, AM J GASTROENTEROL, V89, P2205; Keshavarzian A, 1999, AM J GASTROENTEROL, V94, P200; Keshavarzian A, 2009, J HEPATOL, V50, P538, DOI 10.1016/j.jhep.2008.10.028; Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Lindfors K, 2000, BIOCHEM BIOPH RES CO, V276, P660, DOI 10.1006/bbrc.2000.3480; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; MILLAN MS, 1980, DIGEST DIS SCI, V25, P513, DOI 10.1007/BF01315213; Nickerson CA, 2001, INFECT IMMUN, V69, P7106, DOI 10.1128/IAI.69.11.7106-7120.2001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Ohata A, 2005, NUTRITION, V21, P838, DOI 10.1016/j.nut.2004.12.004; Ohmori T, 1998, EXP CELL RES, V245, P350, DOI 10.1006/excr.1998.4261; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Polevoda B, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-5-reviews0006; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Rao RK, 1998, ALCOHOL CLIN EXP RES, V22, P1724, DOI 10.1097/00000374-199811000-00015; ROBINSON GM, 1981, DIGEST DIS SCI, V26, P971, DOI 10.1007/BF01314757; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Services USDoAUSDoHaH, 1990, SERV USDOAUSDOHAH B; Seth A, 2004, AM J PHYSIOL-GASTR L, V287, pG510, DOI 10.1152/ajpgi.00058.2004; Shepard BD, 2010, ALCOHOL CLIN EXP RES, V34, P280, DOI 10.1111/j.1530-0277.2009.01091.x; Sheth P, 2004, ALCOHOL CLIN EXP RES, V28, P797, DOI 10.1097/01.ALC.0000125358.92335.90; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; TUMA DJ, 1991, ANN NY ACAD SCI, V625, P786, DOI 10.1111/j.1749-6632.1991.tb33920.x; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Van Itallie CM, 2004, PHYSIOLOGY, V19, P331, DOI 10.1152/physiol.00027.2004; WERCH CE, 1987, J DRUG EDUC, V17, P261, DOI 10.2190/KQDE-YYW2-7H4N-QQGJ; Willner IR, 2005, CURR OPIN GASTROEN, V21, P323; WORTHINGTON BS, 1978, AM J DIG DIS, V23, P23, DOI 10.1007/BF01072571; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zakhari S, 2006, ALCOHOL RES HEALTH, V29, P245; Zhong W, 2010, AM J PHYSIOL-GASTR L, V299, pG643, DOI 10.1152/ajpgi.00515.2009	67	82	88	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2012	7	4							e35008	10.1371/journal.pone.0035008	http://dx.doi.org/10.1371/journal.pone.0035008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TL	22563376	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336200020
J	Austin, D; Baer, A; Lundberg, L; Shafagati, N; Schoonmaker, A; Narayanan, A; Popova, T; Panthier, JJ; Kashanchi, F; Bailey, C; Kehn-Hall, K				Austin, Dana; Baer, Alan; Lundberg, Lindsay; Shafagati, Nazly; Schoonmaker, Annalise; Narayanan, Aarthi; Popova, Taissia; Panthier, Jean Jacques; Kashanchi, Fatah; Bailey, Charles; Kehn-Hall, Kylene			p53 Activation following Rift Valley Fever Virus Infection Contributes to Cell Death and Viral Production	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; NSS PROTEIN; DOWN-REGULATION; PHOSPHORYLATION; TRANSCRIPTION; APOPTOSIS; REPLICATION; INHIBITION; PROMOTES; PATHOGENESIS	Rift Valley fever virus (RVFV) is an emerging viral zoonosis that is responsible for devastating outbreaks among livestock and is capable of causing potentially fatal disease in humans. Studies have shown that upon infection, certain viruses have the capability of utilizing particular cellular signaling pathways to propagate viral infection. Activation of p53 is important for the DNA damage signaling cascade, initiation of apoptosis, cell cycle arrest and transcriptional regulation of multiple genes. The current study focuses on the role of p53 signaling in RVFV infection and viral replication. These results show an up-regulation of p53 phosphorylation at several serine sites after RVFV MP-12 infection that is highly dependent on the viral protein NSs. qRT-PCR data showed a transcriptional up-regulation of several p53 targeted genes involved in cell cycle and apoptosis regulation following RVFV infection. Cell viability assays demonstrate that loss of p53 results in less RVFV induced cell death. Furthermore, decreased viral titers in p53 null cells indicate that RVFV utilizes p53 to enhance viral production. Collectively, these experiments indicate that the p53 signaling pathway is utilized during RVFV infection to induce cell death and increase viral production.	[Austin, Dana; Baer, Alan; Lundberg, Lindsay; Shafagati, Nazly; Schoonmaker, Annalise; Narayanan, Aarthi; Popova, Taissia; Kashanchi, Fatah; Bailey, Charles; Kehn-Hall, Kylene] George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA; [Panthier, Jean Jacques] Inst Pasteur, Paris, France	George Mason University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Austin, D (corresponding author), George Mason Univ, Sch Syst Biol, Natl Ctr Biodefense & Infect Dis, Manassas, VA USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; PANTHIER, Jean-Jacques/I-4366-2014	PANTHIER, Jean-Jacques/0000-0002-7966-0663; Kehn-Hall, Kylene/0000-0001-8036-7213	USA Department of Energy grant [DE-FC52-04NA25455]	USA Department of Energy grant	This work was supported by the USA Department of Energy grant DE-FC52-04NA25455 (to CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer A, 2012, J BIOL CHEM, V287, P7399, DOI 10.1074/jbc.M111.296608; Billecocq A, 2004, J VIROL, V78, P9798, DOI 10.1128/JVI.78.18.9798-9806.2004; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Blakqori G, 2007, J VIROL, V81, P4991, DOI 10.1128/JVI.01933-06; Bouloy M, 2001, J VIROL, V75, P1371, DOI 10.1128/JVI.75.3.1371-1377.2001; Bouloy Michele, 2010, Open Virol J, V4, P8, DOI 10.2174/1874357901004020008; CHEN XB, 1993, GENE DEV, V7, P1837, DOI 10.1101/gad.7.10.1837; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Devireddy LR, 1999, J VIROL, V73, P3778, DOI 10.1128/JVI.73.5.3778-3788.1999; Di Lello P, 2008, P NATL ACAD SCI USA, V105, P106, DOI 10.1073/pnas.0707892105; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Habjan M, 2009, J VIROL, V83, P4365, DOI 10.1128/JVI.02148-08; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006; Ikegami T, 2005, J VIROL, V79, P5606, DOI 10.1128/JVI.79.9.5606-5615.2005; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ikegami T, 2009, ANN NY ACAD SCI, V1171, pE75, DOI 10.1111/j.1749-6632.2009.05054.x; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; Kalveram B, 2011, J VIROL, V85, P6234, DOI 10.1128/JVI.02255-10; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kurihara A, 2007, GENES CELLS, V12, P853, DOI 10.1111/j.1365-2443.2007.01097.x; Lazo PA, 2011, REV MED VIROL; Le May N, 2004, CELL, V116, P541, DOI 10.1016/S0092-8674(04)00132-1; Mansuroglu Z, 2010, J VIROL, V84, P928, DOI 10.1128/JVI.01165-09; MEEK DW, 1994, SEMIN CANCER BIOL, V5, P203; Milczarek GJ, 1996, LIFE SCI, V60, P1, DOI 10.1016/S0024-3205(96)00479-1; Moll UM, 2003, MOL CANCER RES, V1, P1001; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Myskiw C, 2011, J VIROL; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pepin M, 2010, VET RES, V41, P40; Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033; Pise-Masison CA, 2005, FRONT BIOSCI-LANDMRK, V10, P919, DOI 10.2741/1586; Popova TG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013805; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Steegenga WT, 1996, J MOL BIOL, V263, P103, DOI 10.1006/jmbi.1996.0560; Tabakin-Fix Y, 2006, CARCINOGENESIS, V27, P673, DOI 10.1093/carcin/bgi274; Thakur VS, 2010, CANCER LETT, V296, P225, DOI 10.1016/j.canlet.2010.04.012; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Verbruggen P, 2011, J BIOL CHEM, V286, P3681, DOI 10.1074/jbc.M110.154799; Vialat P, 1997, VIRUS RES, V52, P43, DOI 10.1016/S0168-1702(97)00097-X; Vialat P, 2000, J VIROL, V74, P1538, DOI 10.1128/JVI.74.3.1538-1543.2000; WANG P, 1994, MOL CELL BIOL, V14, P5182, DOI 10.1128/MCB.14.8.5182; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07; Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06; Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x; Zamoto-Niikura A, 2009, J VIROL, V83, P12779, DOI 10.1128/JVI.01310-09; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	55	41	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36327	10.1371/journal.pone.0036327	http://dx.doi.org/10.1371/journal.pone.0036327			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574148	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800044
J	Pereira, CA; Silber, AM				Alejandro Pereira, Claudio; Silber, Ariel Mariano			On the Evolution of Hexose Transporters in Kinetoplastid Potozoans	PLOS ONE			English	Article							GLUCOSE-TRANSPORTER; FUNCTIONAL EXPRESSION; SEQUENCE; FAMILY; FACILITATORS; GENES; GLUT1	Glucose, an almost universally used energy and carbon source, is processed through several well-known metabolic pathways, primarily glycolysis. Glucose uptake is considered to be the first step in glycolysis. In kinetoplastids, a protozoan group that includes relevant human pathogens, the importance of glucose uptake in different phases of the life cycles is well established, and hexose transporters have been proposed as targets for therapeutic drugs. However, little is known about the evolutionary history of these hexose transporters. Hexose transporters contain an intracellular N- and C-termini, and 12 transmembrane spans connected by alternate intracellular and extracellular loops. In the present work we tested the hypothesis that the evolutionary rate of the transmembrane span is different from that of the whole sequence and that it is possible to define evolutionary units inside the sequence. The phylogeny of whole molecules was compared to that of their transmembrane spans and the loops connecting the transmembrane spans. We show that the evolutionary units in these proteins primarily consist of clustered rather than individual transmembrane spans. These analyses demonstrate that there are evolutionary constraints on the organization of these proteins; more specifically, the order of the transmembrane spans along the protein is highly conserved. Finally, we defined a signature sequence for the identification of kinetoplastid hexose transporters.	[Alejandro Pereira, Claudio] Inst Invest Med Alfredo Lanari, Buenos Aires, DF, Argentina; [Silber, Ariel Mariano] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Pereira, CA (corresponding author), Inst Invest Med Alfredo Lanari, Buenos Aires, DF, Argentina.	cpereira@retina.ar; asilber@usp.br	Pereira, Claudio A/F-5382-2012; 4, INCT/H-4499-2013; Inbeqmedi, Inct/I-1929-2013; Silber, Ariel/O-6951-2015	Pereira, Claudio A/0000-0001-7874-1894; Silber, Ariel/0000-0003-4528-4732	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [0685]; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT) [2008-1209]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50631-1]; Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI)	This work was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP Grant # 0685 to CAP), and Agencia Nacional de Promocion Cientifica y Tecnologica (FONCYT PICT Grant #2008-1209 to CAP), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP grants #11/50631-1 to AMS) and Instituto Nacional de Biologia Estrutural e Quimica Medicinal em Doencas Infecciosas (INBEQMeDI). CAP is a member of the career of scientific investigator of CONICET (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barrett MP, 1995, BIOCHEM J, V312, P687, DOI 10.1042/bj3120687; Barrett MP, 1998, MOL BIOCHEM PARASIT, V91, P195, DOI 10.1016/S0166-6851(97)00192-8; Bouvier LA, 2004, BIOCHEM BIOPH RES CO, V321, P547, DOI 10.1016/j.bbrc.2004.07.002; BRINGAUD F, 1994, MOL BIOL EVOL, V11, P220; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Burchmore RJS, 1998, J BIOL CHEM, V273, P29118, DOI 10.1074/jbc.273.44.29118; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; CAZZULO JJ, 1994, J BIOENERG BIOMEMBR, V26, P157, DOI 10.1007/BF00763064; CAZZULO JJ, 1992, FASEB J, V6, P3153, DOI 10.1096/fasebj.6.13.1397837; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Krishna S, 2000, PARASITOL TODAY, V16, P516, DOI 10.1016/S0169-4758(00)01762-2; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Landfear SM, 2008, ADV EXP MED BIOL, V625, P22; Landfear SM, 2011, EUKARYOT CELL, V10, P483, DOI 10.1128/EC.00287-10; LANGFORD CK, 1995, BIOCHEMISTRY-US, V34, P11814, DOI 10.1021/bi00037a020; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Rodriguez-Contreras D, 2007, MOL BIOCHEM PARASIT, V153, P9, DOI 10.1016/j.molbiopara.2007.01.010; Silber AM, 2009, MOL BIOCHEM PARASIT, V168, P102, DOI 10.1016/j.molbiopara.2009.07.006; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetaud E, 1996, BIOCHEM J, V317, P353, DOI 10.1042/bj3170353; Tetaud E, 1997, BIOCHEM J, V325, P569, DOI 10.1042/bj3250569; TETAUD E, 1994, P NATL ACAD SCI USA, V91, P8278, DOI 10.1073/pnas.91.17.8278; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Vedrenne C, 2000, EUR J BIOCHEM, V267, P4850, DOI 10.1046/j.1432-1327.2000.01543.x; Waitumbi JN, 1996, EUR J BIOCHEM, V237, P234, DOI 10.1111/j.1432-1033.1996.0234n.x	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36303	10.1371/journal.pone.0036303	http://dx.doi.org/10.1371/journal.pone.0036303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567148	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500067
J	Goncalves, JP; Aires, RS; Francisco, AP; Madeira, SC				Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.			Regulatory Snapshots: Integrative Mining of Regulatory Modules from Expression Time Series and Regulatory Networks	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; TGF-BETA; TOOL; IDENTIFICATION; ASSOCIATIONS; VERSATILITY; METASTASIS; ALGORITHMS; ACTIVATION	Explaining regulatory mechanisms is crucial to understand complex cellular responses leading to system perturbations. Some strategies reverse engineer regulatory interactions from experimental data, while others identify functional regulatory units (modules) under the assumption that biological systems yield a modular organization. Most modular studies focus on network structure and static properties, ignoring that gene regulation is largely driven by stimulus-response behavior. Expression time series are key to gain insight into dynamics, but have been insufficiently explored by current methods, which often (1) apply generic algorithms unsuited for expression analysis over time, due to inability to maintain the chronology of events or incorporate time dependency; (2) ignore local patterns, abundant in most interesting cases of transcriptional activity; (3) neglect physical binding or lack automatic association of regulators, focusing mainly on expression patterns; or (4) limit the discovery to a predefined number of modules. We propose Regulatory Snapshots, an integrative mining approach to identify regulatory modules over time by combining transcriptional control with response, while overcoming the above challenges. Temporal biclustering is first used to reveal transcriptional modules composed of genes showing coherent expression profiles over time. Personalized ranking is then applied to prioritize prominent regulators targeting the modules at each time point using a network of documented regulatory associations and the expression data. Custom graphics are finally depicted to expose the regulatory activity in a module at consecutive time points (snapshots). Regulatory Snapshots successfully unraveled modules underlying yeast response to heat shock and human epithelial-to-mesenchymal transition, based on regulations documented in the YEASTRACT and JASPAR databases, respectively, and available expression data. Regulatory players involved in functionally enriched processes related to these biological events were identified. Ranking scores further suggested ability to discern the primary role of a gene (target or regulator). Prototype is available at: http://kdbio.inesc-id.pt/software/regulatorysnapshots.	[Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.] INESC ID, Knowledge Discovery & Bioinformat Grp KDBIO, Lisbon, Portugal; [Goncalves, Joana P.; Aires, Ricardo S.; Francisco, Alexandre P.; Madeira, Sara C.] Univ Tecn Lisboa, Inst Super Tecn, P-1096 Lisbon, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Goncalves, JP (corresponding author), INESC ID, Knowledge Discovery & Bioinformat Grp KDBIO, Lisbon, Portugal.	jpg@kdbio.inesc-id.pt; smadeira@kdbio.inesc-id.pt	Gonçalves, Joana/GSI-9858-2022; Francisco, Alexandre/B-9429-2009; Gonçalves, Joana/B-2330-2009; Madeira, Sara/AAR-3658-2020; Madeira, Sara/C-5494-2008	Francisco, Alexandre/0000-0003-4852-1641; Gonçalves, Joana/0000-0001-6072-9627; Madeira, Sara/0000-0002-1459-8096; Madeira, Sara/0000-0002-1459-8096	Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds [SFRH/BD/36586/2007, PTDC/SAU-MII/100964/2008, PTDC/EIA-EIA/111239/2009]	Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT) via: INESC-ID multiannual funding through the PIDDAC program funds; doctoral grant SFRH/BD/36586/2007 to J.P.G.; project grants PTDC/SAU-MII/100964/2008 to PneumoSys and PTDC/EIA-EIA/111239/2009 to NEUROCLINOMICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires RS, 2011, ADV INTEL SOFT COMPU, V93, P49; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Andersen R, 2006, P 15 INT C WORLD WID, P223, DOI DOI 10.1145/1135777.1135814; Androulakis IP, 2007, ANNU REV BIOMED ENG, V9, P205, DOI 10.1146/annurev.bioeng.9.060906.151904; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Bozdag S, 2010, BIOINFORMATICS, V26, P1792, DOI 10.1093/bioinformatics/btq275; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brynildsen MP, 2006, BIOPHYS J, V91, P2749, DOI 10.1529/biophysj.106.082560; Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chung F., 1999, ELECTRON J COMB, V6, pR12; Chung F, 2007, P NATL ACAD SCI USA, V104, P19735, DOI 10.1073/pnas.0708838104; Coleman CB, 2008, BIOTECHNOL BIOENG, V100, P334, DOI 10.1002/bit.21748; Costa IG, 2005, BIOINFORMATICS, V21, P2544, DOI 10.1093/bioinformatics/bti311; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Garber K, 2008, J NATL CANCER I, V100, P232, DOI 10.1093/jnci/djn032; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goncalves JP, 2011, BIOINFORMATICS, V27, P3149, DOI 10.1093/bioinformatics/btr546; Goncalves Joana P, 2009, BMC Res Notes, V2, P124, DOI 10.1186/1756-0500-2-124; Goncalves JP, 2010, WORKSH DYN NETW KNOW; Gusfield D., 1997, COMPUTER SCI COMPUTA; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hiyama Keiko, 2009, TELOMERES TELOMERASE; Ji LP, 2005, BIOINFORMATICS, V21, P509, DOI 10.1093/bioinformatics/bti026; Kasabov NK, 2004, LECT NOTES COMPUT SC, V3316, P1344; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Kreizenbeck GM, 2008, CANCER EPIDEM BIOMAR, V17, P949, DOI 10.1158/1055-9965.EPI-07-2729; Ksienzyk A, 2011, CANC RES; Kundaje A, 2005, IEEE ACM T COMPUT BI, V2, P194, DOI 10.1109/TCBB.2005.34; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Li S, 2006, BIOINFORMATICS, V22, P2143, DOI 10.1093/bioinformatics/btl363; Madeira SC, 2010, IEEE ACM T COMPUT BI, V7, P153, DOI 10.1109/TCBB.2008.34; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng J, 2009, BIOINFORMATICS, V25, P1521, DOI 10.1093/bioinformatics/btp235; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Nam H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S3-S6; Novershtern N, 2011, BIOINFORMATICS, V27, pI177, DOI 10.1093/bioinformatics/btr222; Ramakrishnan N, 2010, P NATL ACAD SCI USA, V107, P12511, DOI 10.1073/pnas.1006283107; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Segal E, 2005, J MACH LEARN RES, V6, P557; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Van Dyck F, 2007, INT J ONCOL, V30, P765; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Wu Z, 2011, ONCOGENE, V30, P3979, DOI 10.1038/onc.2011.129; Xue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027748; Yang H., 2007, P 30 ANN INT ACM SIG, P431; Yeang C, 2003, 3 IEEE S BIOINFORMAT, V14, P755; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhang YJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-203; Zhang YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S15	61	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35977	10.1371/journal.pone.0035977	http://dx.doi.org/10.1371/journal.pone.0035977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563474	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340700023
J	Miki, K; Maekura, R; Nagaya, N; Nakazato, M; Kimura, H; Murakami, S; Ohnishi, S; Hiraga, T; Miki, M; Kitada, S; Yoshimura, K; Tateishi, Y; Arimura, Y; Matsumoto, N; Yoshikawa, M; Yamahara, K; Kangawa, K				Miki, Keisuke; Maekura, Ryoji; Nagaya, Noritoshi; Nakazato, Masamitsu; Kimura, Hiroshi; Murakami, Shinsuke; Ohnishi, Shunsuke; Hiraga, Toru; Miki, Mari; Kitada, Seigo; Yoshimura, Kenji; Tateishi, Yoshitaka; Arimura, Yasuji; Matsumoto, Nobuhiro; Yoshikawa, Masanori; Yamahara, Kenichi; Kangawa, Kenji			Ghrelin Treatment of Cachectic Patients with Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							GROWTH-HORMONE; UNDERWEIGHT PATIENTS; HEALTH SURVEY; CACHEXIA; EXERCISE; SF-36; MEN; REHABILITATION; SAFETY	Background: Pulmonary cachexia is common in advanced chronic obstructive pulmonary disease (COPD), culminating in exercise intolerance and a poor prognosis. Ghrelin is a novel growth hormone (GH)-releasing peptide with GH-independent effects. The efficacy and safety of adding ghrelin to pulmonary rehabilitation (PR) in cachectic COPD patients were investigated. Methodology/Principal Findings: In a multicenter, randomized, double-blind, placebo-controlled trial, 33 cachectic COPD patients were randomly assigned PR with intravenous ghrelin (2 mg/kg) or placebo twice daily for 3 weeks in hospital. The primary outcomes were changes in 6-min walk distance (6-MWD) and the St. George Respiratory Questionnaire (SGRQ) score. Secondary outcomes included changes in the Medical Research Council (MRC) scale, and respiratory muscle strength. At pre-treatment, serum GH levels were increased from baseline levels by a single dose of ghrelin (mean change, +46.5 ng/ml; between-group p<0.0001), the effect of which continued during the 3-week treatment. In the ghrelin group, the mean change from pre-treatment in 6-MWD was improved at Week 3 (+40 m, within-group p = 0.033) and was maintained at Week 7 (+47 m, within-group p = 0.017), although the difference between ghrelin and placebo was not significant. At Week 7, the mean changes in SGRQ symptoms (between-group p = 0.026), in MRC (between-group p = 0.030), and in maximal expiratory pressure (MEP; between-group p = 0.015) were better in the ghrelin group than in the placebo group. Additionally, repeated-measures analysis of variance (ANOVA) indicated significant time course effects of ghrelin versus placebo in SGRQ symptoms (p = 0.049) and MEP (p = 0.021). Ghrelin treatment was well tolerated. Conclusions/Significance: In cachectic COPD patients, with the safety profile, ghrelin administration provided improvements in symptoms and respiratory strength, despite the lack of a significant between-group difference in 6-MWD.	[Miki, Keisuke; Maekura, Ryoji; Hiraga, Toru; Miki, Mari; Kitada, Seigo; Yoshimura, Kenji; Tateishi, Yoshitaka] Toneyama Natl Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka, Japan; [Nagaya, Noritoshi; Ohnishi, Shunsuke; Yamahara, Kenichi] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Regenerat Med, Suita, Osaka, Japan; [Nakazato, Masamitsu; Arimura, Yasuji; Matsumoto, Nobuhiro] Miyazaki Univ, Fac Med, Dept Neurol Respirol Endocrinol & Metab, Miyazaki, Japan; [Kimura, Hiroshi; Murakami, Shinsuke; Yoshikawa, Masanori] Nara Med Univ, Dept Internal Med 2, Kashihara, Nara 634, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; University of Miyazaki; Nara Medical University; National Cerebral & Cardiovascular Center - Japan	Miki, K (corresponding author), Toneyama Natl Hosp, Natl Hosp Org, Dept Internal Med, Toyonaka, Osaka, Japan.	mikisuke@toneyama.go.jp	Ohnishi, Shunsuke/A-5982-2012	Ohnishi, Shunsuke/0000-0003-1194-4149	Research Grant from the Ministry of Health, Labour and Welfare in Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Takeda Scientific Foundation in Japan; Health and Labour Sciences Research Grants, Clinical Research [H20-translational research-general-002]	Research Grant from the Ministry of Health, Labour and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation); Takeda Scientific Foundation in Japan; Health and Labour Sciences Research Grants, Clinical Research	Funding was from the Research Grant from the Ministry of Health, Labour and Welfare in Japan; the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; the Takeda Scientific Foundation in Japan; and Health and Labour Sciences Research Grants, Clinical Research, H20-translational research-general-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamizu T, 2004, EUR J ENDOCRINOL, V150, P447, DOI 10.1530/eje.0.1500447; Anawalt BD, 2001, ENDOCRIN METAB CLIN, V30, P647, DOI 10.1016/S0889-8529(05)70206-1; Belloni AS, 2004, INT J MOL MED, V14, P165; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Burdet L, 1997, AM J RESP CRIT CARE, V156, P1800, DOI 10.1164/ajrccm.156.6.9704142; Calverley PMA, 2003, CHEST, V124, P1350, DOI 10.1378/chest.124.4.1350; Cassoni P, 2006, J ENDOCRINOL INVEST, V29, P781, DOI 10.1007/BF03347371; Creutzberg EC, 2003, CHEST, V124, P1733, DOI 10.1378/chest.124.5.1733; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Ghe C, 2002, ENDOCRINOLOGY, V143, P484, DOI 10.1210/en.143.2.484; Itoh T, 2004, AM J RESP CRIT CARE, V170, P879, DOI 10.1164/rccm.200310-1404OC; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; Koehler F, 2007, INT J CARDIOL, V119, P83, DOI 10.1016/j.ijcard.2006.07.088; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Liu H, 2007, ANN INTERN MED, V146, P104, DOI 10.7326/0003-4819-146-2-200701160-00005; Lutter M, 2009, F1000 BIOL REP, V1; Matsumura K, 2002, HYPERTENSION, V40, P694, DOI 10.1161/01.HYP.0000035395.51441.10; Murata M, 2002, J BIOL CHEM, V277, P5667, DOI 10.1074/jbc.M103898200; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Nagaya N, 2004, CIRCULATION, V110, P3674, DOI 10.1161/01.CIR.0000149746.62908.BB; Nagaya N, 2001, AM J PHYSIOL-REG I, V280, pR1483, DOI 10.1152/ajpregu.2001.280.5.R1483; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Papadakis MA, 1996, ANN INTERN MED, V124, P708, DOI 10.7326/0003-4819-124-8-199604150-00002; Puhan MA, 2005, THORAX, V60, P367, DOI 10.1136/thx.2004.033274; Rabinovich RA, 2006, RESPIRATION, V73, P757, DOI 10.1159/000094395; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Wagner PD, 2008, EUR RESPIR J, V31, P492, DOI 10.1183/09031936.00074807; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILSON DO, 1989, AM REV RESPIR DIS, V139, P1435, DOI 10.1164/ajrccm/139.6.1435; Zaloga GP, 2005, CHEST, V128, P1084, DOI 10.1378/chest.128.3.1084; Zinna EM, 2003, CURR OPIN CLIN NUTR, V6, P87, DOI 10.1097/00075197-200301000-00013	35	83	87	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35708	10.1371/journal.pone.0035708	http://dx.doi.org/10.1371/journal.pone.0035708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563468	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700017
J	Skoog, EC; Sjoling, A; Navabi, N; Holgersson, J; Lundin, SB; Linden, SK				Skoog, Emma C.; Sjoling, Asa; Navabi, Nazanin; Holgersson, Jan; Lundin, Samuel B.; Linden, Sara K.			Human Gastric Mucins Differently Regulate Helicobacter pylori Proliferation, Gene Expression and Interactions with Host Cells	PLOS ONE			English	Article							LEWIS-B; ADHESION; INFECTION; BINDING; MUC5AC; GROWTH; GLAND; IDENTIFICATION; GLYCOSYLATION; EPITHELIUM	Helicobacter pylori colonizes the mucus niche of the gastric mucosa and is a risk factor for gastritis, ulcers and cancer. The main components of the mucus layer are heavily glycosylated mucins, to which H. pylori can adhere. Mucin glycosylation differs between individuals and changes during disease. Here we have examined the H. pylori response to purified mucins from a range of tumor and normal human gastric tissue samples. Our results demonstrate that mucins from different individuals differ in how they modulate both proliferation and gene expression of H. pylori. The mucin effect on proliferation varied significantly between samples, and ranged from stimulatory to inhibitory, depending on the type of mucins and the ability of the mucins to bind to H. pylori. Tumor-derived mucins and mucins from the surface mucosa had potential to stimulate proliferation, while gland-derived mucins tended to inhibit proliferation and mucins from healthy uninfected individuals showed little effect. Artificial glycoconjugates containing H. pylori ligands also modulated H. pylori proliferation, albeit to a lesser degree than human mucins. Expression of genes important for the pathogenicity of H. pylori (babA, sabA, cagA, flaA and ureA) appeared co-regulated in response to mucins. The addition of mucins to co-cultures of H. pylori and gastric epithelial cells protected the viability of the cells and modulated the cytokine production in a manner that differed between individuals, was partially dependent of adhesion of H. pylori to the gastric cells, but also revealed that other mucin factors in addition to adhesion are important for H. pylori-induced host signaling. The combined data reveal host-specific effects on proliferation, gene expression and virulence of H. pylori due to the gastric mucin environment, demonstrating a dynamic interplay between the bacterium and its host.	[Skoog, Emma C.; Sjoling, Asa; Navabi, Nazanin; Lundin, Samuel B.; Linden, Sara K.] Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Skoog, Emma C.; Navabi, Nazanin; Linden, Sara K.] Univ Gothenburg, Dept Biomed Chem & Cell Biol, Sahlgrenska Acad, Gothenburg, Sweden; [Sjoling, Asa; Lundin, Samuel B.] Univ Gothenburg, Sahlgrenska Acad, Dept Microbiol & Immunol, Gothenburg, Sweden; [Holgersson, Jan] Univ Gothenburg, Dept Clin Chem & Transfus Med, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg	Skoog, EC (corresponding author), Univ Gothenburg, Mucosal Immunobiol & Vaccine Ctr, Sahlgrenska Acad, Gothenburg, Sweden.	sara.linden@gu.se	Lindén, Sara K/A-3271-2011	Lindén, Sara K/0000-0002-7751-9586; Skoog, Emma/0000-0002-2543-6412; Sjoling, Asa/0000-0003-1529-1720	Swedish Research Council [K2008-58X-20693-01-4]; Swedish Cancer Foundation; Royal Swedish Academy of Sciences; Mucosal Immunobiology and Vaccine Center; Jeansson Foundation; Ake Wibergs Foundation; Magnus Bergvall Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Royal Swedish Academy of Sciences; Mucosal Immunobiology and Vaccine Center; Jeansson Foundation; Ake Wibergs Foundation; Magnus Bergvall Foundation	The work was supported by the Swedish Research Council (grant number: K2008-58X-20693-01-4, http://www.vr.se), the Swedish Cancer Foundation (http://www.cancerfonden.se), The Royal Swedish Academy of Sciences (http://kva.se), Mucosal Immunobiology and Vaccine Center (www.mivac.se), the Jeansson Foundation (www.jeanssonsstiftelser.se), Ake Wibergs Foundation (http://www.ake-wiberg.com) and the Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado M, 1998, GASTROENTEROLOGY, V114, P462, DOI 10.1016/S0016-5085(98)70529-3; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backstrom M, 2003, BIOCHEM J, V376, P677, DOI 10.1042/BJ20031130; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Byrd JC, 1997, GASTROENTEROLOGY, V113, P455, DOI 10.1053/gast.1997.v113.pm9247464; Cole SP, 2004, J BACTERIOL, V186, P3124, DOI 10.1128/JB.186.10.3124-3132.2004; Cooke CL, 2009, GASTROENTEROLOGY, V137, P1061, DOI 10.1053/j.gastro.2009.04.014; Fox JT, 2009, J ANIM SCI, V87, P1304, DOI 10.2527/jas.2008-1166; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gustafsson A, 2011, GLYCOBIOLOGY; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; HESSEY SJ, 1990, GUT, V31, P134, DOI 10.1136/gut.31.2.134; HO SB, 1995, CANCER RES, V55, P2681; Holgersson J, 2006, GLYCOBIOLOGY, V16, P584, DOI 10.1093/glycob/cwj090; Ishijima N, 2011, J BIOL CHEM; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; Jiang XP, 2000, J CLIN MICROBIOL, V38, P1984, DOI 10.1128/JCM.38.5.1984-1987.2000; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; KLEIN A, 1993, EUR J BIOCHEM, V211, P491, DOI 10.1111/j.1432-1033.1993.tb17575.x; Linden S, 2002, GASTROENTEROLOGY, V123, P1923, DOI 10.1053/gast.2002.37076; Linden S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040002; Linden SK, 2008, HELICOBACTER, V13, P81, DOI 10.1111/j.1523-5378.2008.00587.x; Linden SK, 2007, HELICOBACTER, V12, P341, DOI 10.1111/j.1523-5378.2007.00509.x; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Liu JN, 2003, XENOTRANSPLANTATION, V10, P149, DOI 10.1034/j.1399-3089.2003.01144.x; Lofling J, 2008, GLYCOBIOLOGY, V18, P494, DOI 10.1093/glycob/cwn030; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Nakajima K, 2003, J HISTOCHEM CYTOCHEM, V51, P1689, DOI 10.1177/002215540305101213; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Nordman H, 2002, BIOCHEM J, V364, P191, DOI 10.1042/bj3640191; Odenbreit S, 2009, INFECT IMMUN, V77, P3782, DOI 10.1128/IAI.00364-09; Park SA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-96; SAKAMOTO J, 1989, CANCER RES, V49, P745; Skoog EC, 2011, HELICOBACTER, V16, P9, DOI 10.1111/j.1523-5378.2010.00810.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tsai CJ, 2006, CANCER EPIDEM BIOMAR, V15, P272, DOI 10.1158/1055-9965.EPI-05-0632; Tu QV, 2008, J MED MICROBIOL, V57, P795, DOI 10.1099/jmm.0.47752-0; Van den Brink GR, 2000, GUT, V46, P601, DOI 10.1136/gut.46.5.601; Wickstrom C, 1998, BIOCHEM J, V334, P685, DOI 10.1042/bj3340685; Yokozaki H, 2000, PATHOL INT, V50, P767, DOI 10.1046/j.1440-1827.2000.01117.x; Zambon CF, 2003, J CLIN PATHOL, V56, P287, DOI 10.1136/jcp.56.4.287	42	66	69	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36378	10.1371/journal.pone.0036378	http://dx.doi.org/10.1371/journal.pone.0036378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563496	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700045
J	Xie, GQ; Zhang, HT; Du, GP; Huang, QL; Liang, XH; Ma, J; Jiao, RJ				Xie, Gengqiang; Zhang, Hongtao; Du, Guiping; Huang, Qinglei; Liang, Xuehong; Ma, Jun; Jiao, Renjie			Uif, a Large Transmembrane Protein with EGF-Like Repeats, Can Antagonize Notch Signaling in Drosophila	PLOS ONE			English	Article							CELL FATE DECISIONS; WING FORMATION; SERRATE; DELTA; BOUNDARY; MELANOGASTER; ACTIVATION; SUPPRESSOR; EXPRESSION; HAIRLESS	Background: Notch signaling is a highly conserved pathway in multi-cellular organisms ranging from flies to humans. It controls a variety of developmental processes by stimulating the expression of its target genes in a highly specific manner both spatially and temporally. The diversity, specificity and sensitivity of the Notch signaling output are regulated at distinct levels, particularly at the level of ligand-receptor interactions. Methodology/Principal Findings: Here, we report that the Drosophila gene uninflatable (uif), which encodes a large transmembrane protein with eighteen EGF-like repeats in its extracellular domain, can antagonize the canonical Notch signaling pathway. Overexpression of Uif or ectopic expression of a neomorphic form of Uif, Uif*, causes Notch signaling defects in both the wing and the sensory organ precursors. Further experiments suggest that ectopic expression of Uif* inhibits Notch signaling in cis and acts at a step that is dependent on the extracellular domain of Notch. Our results suggest that Uif can alter the accessibility of the Notch extracellular domain to its ligands during Notch activation. Conclusions/Significance: Our study shows that Uif can modulate Notch activity, illustrating the importance of a delicate regulation of this signaling pathway for normal patterning.	[Xie, Gengqiang; Zhang, Hongtao; Du, Guiping; Huang, Qinglei; Liang, Xuehong; Jiao, Renjie] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Xie, Gengqiang; Zhang, Hongtao; Du, Guiping] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Xie, Gengqiang; Ma, Jun] Cincinnati Childrens Res Fdn, Div Biomed Informat, Cincinnati, OH USA; [Ma, Jun] Cincinnati Childrens Res Fdn, Div Dev Biol, Cincinnati, OH USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation	Xie, GQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	jun.ma@cchmc.org; rjiao@sun5.ibp.ac.cn	Jiao, Renjie/AAE-8902-2019; XIE, Gengqiang/R-9285-2016; Ma, Jun/GLT-4809-2022	XIE, Gengqiang/0000-0002-2064-4757; Ma, Jun/0000-0002-1609-3294	973 program [2009CB918702]; NSFC [31071087]; NIH; NSF	973 program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was supported in part by grants from the 973 program (2009CB918702) and the NSFC (31071087) (to RJ) and from NIH and NSF (to JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Ahmed A, 2003, DEVELOPMENT, V130, P6295, DOI 10.1242/dev.00796; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Callebaut I, 2000, PROTEIN SCI, V9, P1382, DOI 10.1110/ps.9.7.1382; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Couso JP, 1995, CURR BIOL, V5, P1437, DOI 10.1016/S0960-9822(95)00281-8; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; deCelis JF, 1997, DEVELOPMENT, V124, P3241; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Escudero LM, 2003, DEVELOPMENT, V130, P6305, DOI 10.1242/dev.00869; Fiuza UM, 2010, DEV DYNAM, V239, P798, DOI 10.1002/dvdy.22207; Gho M, 1996, DEVELOPMENT, V122, P1673; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Hori K, 2004, DEVELOPMENT, V131, P5527, DOI 10.1242/dev.01448; Huang H, 2011, DEVELOPMENT, V138, P2477, DOI 10.1242/dev.061770; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; KANE WH, 1988, BLOOD, V71, P539; Kim IM, 2010, CIRC RES, V106, P1233, DOI 10.1161/CIRCRESAHA.109.213785; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Koles K, 2007, GLYCOBIOLOGY, V17, P1388, DOI 10.1093/glycob/cwm097; Kucherenko MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002418; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Li Yanxia, 2004, BMC Dev Biol, V4, P5, DOI 10.1186/1471-213X-4-5; Lieber T, 2002, GENE DEV, V16, P209, DOI 10.1101/gad.942302; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Liu JY, 2011, J GENET GENOMICS, V38, P225, DOI 10.1016/j.jgg.2011.05.002; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Miller AC, 2009, CURR BIOL, V19, P1378, DOI 10.1016/j.cub.2009.06.042; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Pi HW, 2001, DEVELOPMENT, V128, P2699; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Prout M, 1997, GENETICS, V146, P275; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Sun X, 1996, DEVELOPMENT, V122, P2465; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tien AC, 2009, J CELL BIOL, V184, P621, DOI 10.1083/jcb.200811141; Wang SW, 1997, DEVELOPMENT, V124, P4435; Xu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006107; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	53	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36362	10.1371/journal.pone.0036362	http://dx.doi.org/10.1371/journal.pone.0036362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558447	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200070
J	Ioannoni, R; Beaudoin, J; Lopez-Maury, L; Codlin, S; Bahler, J; Labbe, S				Ioannoni, Raphael; Beaudoin, Jude; Lopez-Maury, Luis; Codlin, Sandra; Bahler, Jurg; Labbe, Simon			Cuf2 Is a Novel Meiosis-Specific Regulatory Factor of Meiosis Maturation	PLOS ONE			English	Article							MEMBRANE COPPER TRANSPORTER; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; SEXUAL-DIFFERENTIATION; GENOME SEQUENCE; DNA-BINDING; RECOMBINATION; SPORULATION; IDENTIFICATION	Background: Meiosis is the specialized form of the cell cycle by which diploid cells produce the haploid gametes required for sexual reproduction. Initiation and progression through meiosis requires that the expression of the meiotic genes is precisely controlled so as to provide the correct gene products at the correct times. During meiosis, four temporal gene clusters are either induced or repressed by a cascade of transcription factors. Principal Findings: In this report a novel copper-fist-type regulator, Cuf2, is shown to be expressed exclusively during meiosis. The expression profile of the cuf2(+) mRNA revealed that it was induced during middle-phase meiosis. Both cuf2(+) mRNA and protein levels are unregulated by copper addition or starvation. The transcription of cuf2(+) required the presence of a functional mei4(+) gene encoding a key transcription factor that activates the expression of numerous middle meiotic genes. Microscopic analyses of cells expressing a functional Cuf2-GFP protein revealed that Cuf2 co-localized with both homologous chromosomes and sister chromatids during the meiotic divisions. Cells lacking Cuf2 showed an elevated and sustained expression of several of the middle meiotic genes that persisted even during late meiosis. Moreover, cells carrying disrupted cuf2 Delta/cuf2 Delta alleles displayed an abnormal morphology of the forespore membranes and a dramatic reduction of spore viability. Significance: Collectively, the results revealed that Cuf2 functions in the timely repression of the middle-phase genes during meiotic differentiation.	[Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada; [Lopez-Maury, Luis; Codlin, Sandra; Bahler, Jurg] UCL, Dept Genet Evolut & Environm, London, England	University of Sherbrooke; University of London; University College London	Ioannoni, R (corresponding author), Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Simon.Labbe@USherbrooke.ca	Bahler, Jurg/B-4572-2009; Lopez-Maury, Luis/B-3715-2015	Bahler, Jurg/0000-0003-4036-1532; Lopez-Maury, Luis/0000-0002-3510-0621; Labbe, Simon/0000-0002-4947-523X	Canadian Institutes of Health Research (CIHR) [MOP-3645, MOP-114986]; Foundation of Stars for Children's Health Research; Cancer Research UK grant (CUK) [C9546/A6517]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Cancer Research UK grant (CUK)	This work was supported in part by grants MOP-3645 and MOP-114986 from the Canadian Institutes of Health Research (CIHR), and by a grant from the Foundation of Stars for Children's Health Research awarded to SL. This study was also supported by a Cancer Research UK grant (CUK C9546/A6517) to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, GENETICS, V154, P1497; Amorim MJ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.38; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, EUKARYOT CELL, V5, P277, DOI 10.1128/EC.5.2.277-292.2006; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2003, J BIOL CHEM, V278, P14565, DOI 10.1074/jbc.M300861200; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2007, EUKARYOT CELL, V6, P764, DOI 10.1128/EC.00002-07; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Davis L, 2001, P NATL ACAD SCI USA, V98, P8395, DOI 10.1073/pnas.121005598; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; Jbel M, 2009, EUKARYOT CELL, V8, P649, DOI 10.1128/EC.00001-09; Jensen LT, 1998, EMBO J, V17, P5400, DOI 10.1093/emboj/17.18.5400; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Klutstein M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-478; Koch KA, 1996, MOL CELL BIOL, V16, P724; Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Li YF, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-125; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nevitt T, 2012, BIOCH BIOPH IN PRESS; Pak J, 2002, MOL CELL BIOL, V22, P6417, DOI 10.1128/MCB.22.18.6417-6429.2002; Pelletier B, 2002, J BIOL CHEM, V277, P22950, DOI 10.1074/jbc.M202682200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Shigehisa A, 2010, MOL BIOL CELL, V21, P1955, DOI 10.1091/mbc.E09-12-0997; Shimoda C, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P311; Staub C, 2001, J ANDROL, V22, P911; Turner RB, 1998, NAT STRUCT BIOL, V5, P551, DOI 10.1038/805; Winge DR, 1998, PROG NUCLEIC ACID RE, V58, P165; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yamamoto M, 2003, MOLECULAR BIOLOGY OF SCHIZOSACCHAROMYCES POMBE, P297; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200; Zhu ZW, 1998, J BIOL CHEM, V273, P1277, DOI 10.1074/jbc.273.3.1277	54	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36338	10.1371/journal.pone.0036338	http://dx.doi.org/10.1371/journal.pone.0036338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558440	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000192
J	Kuo, HC; Wang, TY; Hsu, HH; Chen, PP; Lee, SH; Chen, YM; Tsai, TJ; Wang, CK; Ku, HT; Lee, GB; Chen, TY				Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Peng-Peng; Lee, Szu-Hsien; Chen, Young-Mao; Tsai, Tieh-Jung; Wang, Chien-Kai; Ku, Hsiao-Tung; Lee, Gwo-Bin; Chen, Tzong-Yueh			Nervous Necrosis Virus Replicates Following the Embryo Development and Dual Infection with Iridovirus at Juvenile Stage in Grouper	PLOS ONE			English	Article							LARVAL STRIPED JACK; SALMON SALMO-SALAR; VERTICAL TRANSMISSION; PSEUDOCARANX-DENTEX; VIBRIO-ANGUILLARUM; MARINE FISH; HBV DNA; NODAVIRUS; PROTEINS; SEQUENCE	Infection of virus (such as nodavirus and iridovirus) and bacteria (such as Vibrio anguillarum) in farmed grouper has been widely reported and caused large economic losses to Taiwanese fish aquaculture industry since 1979. The multiplex assay was used to detect dual viral infection and showed that only nervous necrosis virus (NNV) can be detected till the end of experiments (100% mortality) once it appeared. In addition, iridovirus can be detected in a certain period of rearing. The results of real-time PCR and in situ PCR indicated that NNV, in fact, was not on the surface of the eggs but present in the embryo, which can continue to replicate during the embryo development. The virus may be vertically transmitted by packing into eggs during egg development (formation) or delivering into eggs by sperm during fertilization. The ozone treatment of eggs may fail to remove the virus, so a new strategy to prevent NNV is needed.	[Kuo, Hsiao-Che; Wang, Ting-Yu; Hsu, Hao-Hsuan; Chen, Peng-Peng; Chen, Young-Mao; Tsai, Tieh-Jung; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Mol Genet Lab, Inst Biotechnol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Res Ctr Ocean Environm & Technol, Tainan 70101, Taiwan; [Kuo, Hsiao-Che; Hsu, Hao-Hsuan; Chen, Young-Mao; Chen, Tzong-Yueh] Natl Cheng Kung Univ, Agr Biotechnol Res Ctr, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Inst Nanotechnol & Microsyst Engn, Tainan 70101, Taiwan; [Lee, Szu-Hsien; Lee, Gwo-Bin] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 70101, Taiwan; [Wang, Chien-Kai] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Miaoli, Taiwan; [Ku, Hsiao-Tung] Taiwan Inst Econ Res, Res Div 1, Taipei, Taiwan; [Ku, Hsiao-Tung] Natl Sci Council, Off Energy Strategy Dev, Taipei, Taiwan; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Health Research Institutes - Taiwan; National Tsing Hua University	Kuo, HC (corresponding author), Natl Cheng Kung Univ, Mol Genet Lab, Inst Biotechnol, Tainan 70101, Taiwan.	gwobin@pme.nthu.edu.tw; ibcty@mail.ncku.edu.tw	Lee, Gwo-Bin Vincent/D-3032-2012	Lee, Gwo-Bin Vincent/0000-0001-6910-9133; Wang, Chien-Kai/0000-0002-9162-6820	Sanfong Technology Co. Ltd.; Council of Agriculture, Taiwan [97AS-14.3.1-BQ-B6, 98AS-5.4.2-BQ-B1, 99AS-5.3.1-ST-aC]	Sanfong Technology Co. Ltd.; Council of Agriculture, Taiwan	This research was funded and supported by Sanfong Technology Co. Ltd. and the Council of Agriculture, Taiwan (97AS-14.3.1-BQ-B6, 98AS-5.4.2-BQ-B1, 99AS-5.3.1-ST-aC to TYC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BA, 2005, MOL REPROD DEV, V70, P30, DOI 10.1002/mrd.20185; Arimoto M, 1996, AQUACULTURE, V143, P15, DOI 10.1016/0044-8486(96)01261-6; Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; Chen YM, 2006, FISH SHELLFISH IMMUN, V20, P58, DOI 10.1016/j.fsi.2005.04.001; Chou HY, 1998, FISH PATHOL, V33, P201, DOI 10.3147/jsfp.33.201; Emmy E, 1987, AQUACULTURE, V67, P15; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Gomez DK, 2004, J FISH DIS, V27, P603, DOI 10.1111/j.1365-2761.2004.00577.x; Grotmol S, 2000, DIS AQUAT ORGAN, V39, P89, DOI 10.3354/dao039089; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Huang TH, 2005, WORLD J GASTROENTERO, V11, P2869, DOI 10.3748/wjg.v11.i19.2869; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Kai YH, 2010, VACCINE, V28, P996, DOI 10.1016/j.vaccine.2009.10.132; Kanthong N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-14; Kuo HC, 2011, J CLIN MICROBIOL, V49, P1090, DOI 10.1128/JCM.01016-10; Larochelle N, 2011, TRANSGENIC RES, V20, P123, DOI 10.1007/s11248-010-9401-x; Leong JAC, 1998, IMMUNOL REV, V166, P349, DOI 10.1111/j.1600-065X.1998.tb01275.x; Lien KY, 2009, MICROFLUID NANOFLUID, V7, P795, DOI 10.1007/s10404-009-0438-1; MEIER E, 1988, J VIROL, V62, P2386, DOI 10.1128/JVI.62.7.2386-2393.1988; Melville KJ, 1999, DIS AQUAT ORGAN, V38, P231, DOI 10.3354/dao038231; MORI KI, 1992, VIROLOGY, V187, P368, DOI 10.1016/0042-6822(92)90329-N; MULCAHY D, 1984, SCIENCE, V225, P333, DOI 10.1126/science.6740314; Munday BL, 1997, WORLD J MICROB BIOT, V13, P375, DOI 10.1023/A:1018516014782; MUNDAY BL, 1994, AUST VET J, V71, P384, DOI 10.1111/j.1751-0813.1994.tb00937.x; MYHR E, 1991, APPL ENVIRON MICROB, V57, P2750, DOI 10.1128/AEM.57.9.2750-2757.1991; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Nylund A, 2007, ARCH VIROL, V152, P151, DOI 10.1007/s00705-006-0825-9; Ohta T, 2011, FISH SHELLFISH IMMUN, V30, P1064, DOI 10.1016/j.fsi.2011.02.003; Pakingking R, 2005, FISH PATHOL, V40, P125, DOI 10.3147/jsfp.40.125; Samuelsen OB, 2006, DIS AQUAT ORGAN, V71, P239, DOI 10.3354/dao071239; Skliris GP, 2001, VIRUS RES, V75, P59, DOI 10.1016/S0168-1702(01)00225-8; SONG YL, 1988, FISH PATHOL, V23, P185, DOI 10.3147/jsfp.23.185; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Wang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028586; Williams T, 2005, ADV VIRUS RES, V65, P173, DOI 10.1016/S0065-3527(05)65006-3	37	31	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36183	10.1371/journal.pone.0036183	http://dx.doi.org/10.1371/journal.pone.0036183			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563447	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100072
J	Swietach, P; Hulikova, A; Patiar, S; Vaughan-Jones, RD; Harris, AL				Swietach, Pawel; Hulikova, Alzbeta; Patiar, Shalini; Vaughan-Jones, Richard D.; Harris, Adrian L.			Importance of Intracellular pH in Determining the Uptake and Efficacy of the Weakly Basic Chemotherapeutic Drug, Doxorubicin	PLOS ONE			English	Article							TUMOR ACIDITY; CELL-LINES; TRANSPORTER SLC22A16; BREAST-CANCER; DNA-ADDUCTS; IN-VITRO; ADRIAMYCIN; DAUNORUBICIN; FLOW; ACCUMULATION	Low extracellular pH (pH(e)), that is characteristic of many tumours, tends to reduce the uptake of weakly basic drugs, such as doxorubicin, thereby conferring a degree of physiological resistance to chemotherapy. It has been assumed, from pH-partition theory, that the effect of intracellular pH (pH(i)) is symmetrically opposite, although this has not been tested experimentally. Doxorubicin uptake into colon HCT116 cells was measured using the drug's intrinsic fluorescence under conditions that alter pH(i) and pH(e) or pH(i) alone. Acutely, doxorubicin influx across the cell-membrane correlates with the trans-membrane pH-gradient (facilitated at alkaline pH(e) and acidic pH(i)). However, the protonated molecule is not completely membrane-impermeant and, therefore, overall drug uptake is less pH(e)-sensitive than expected from pH-partitioning. Once inside cells, doxorubicin associates with slowly-releasing nuclear binding sites. The occupancy of these sites increases with pH(i), such that steady-state drug uptake can be greater with alkaline cytoplasm, in contradiction to pH-partition theory. Measurements of cell proliferation demonstrate that doxorubicin efficacy is enhanced at alkaline pH(i) and that pH-partition theory is inadequate to account for this. The limitations in the predictive power of pH-partition theory arise because it only accounts for the pH(i)/pH(e)-sensitivity of drug entry into cells but not the drug's subsequent interactions that, independently, show pH(i)-dependence. In summary, doxorubicin uptake into cells is favoured by high pH(e) and high pH(i). This modified formalism should be taken into account when designing manoeuvres aimed at increasing doxorubicin efficacy.	[Swietach, Pawel; Hulikova, Alzbeta; Vaughan-Jones, Richard D.] Dept Physiol Anat & Genet, Oxford, England; [Patiar, Shalini; Harris, Adrian L.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford	Swietach, P (corresponding author), Dept Physiol Anat & Genet, Oxford, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020; Harris, Adrian L/ABA-3343-2020	Swietach, Pawel/0000-0002-9945-9473; Harris, Adrian L/0000-0003-1376-8409	Royal Society; Medical Research Council; British Heart Foundation; Cancer Research UK; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Cancer Research UK [11359] Funding Source: researchfish; Medical Research Council [G0700698] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish; MRC [G0700698] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This works was supported by the Royal Society (PS), Medical Research Council (PS), British Heart Foundation (RDV-J) and Cancer Research UK (ALH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BYRN SR, 1978, J PHARM SCI, V67, P688, DOI 10.1002/jps.2600670532; CULLINANE C, 1994, NUCLEIC ACIDS RES, V22, P2296, DOI 10.1093/nar/22.12.2296; Cutts SM, 2005, IUBMB LIFE, V57, P73, DOI 10.1080/15216540500079093; DURAND RE, 1981, CANCER RES, V41, P3489; Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024; Gerweck LE, 1999, BRIT J CANCER, V79, P838, DOI 10.1038/sj.bjc.6690134; Gerweck LE, 1996, CANCER RES, V56, P1194; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Huber V, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-57; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Karukstis KK, 1998, BIOPHYS CHEM, V73, P249, DOI 10.1016/S0301-4622(98)00150-1; Lee CM, 2006, BRIT J CANCER, V94, P863, DOI 10.1038/sj.bjc.6603010; LONG BH, 1991, CANCER RES, V51, P5275; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; LUK CK, 1989, JNCI-J NATL CANCER I, V81, P55, DOI 10.1093/jnci/81.1.55; Mahoney BP, 2003, BIOCHEM PHARMACOL, V66, P1207, DOI 10.1016/S0006-2952(03)00467-2; NOEL G, 1978, EUR J CANCER, V14, P363, DOI 10.1016/0014-2964(78)90206-2; Okabe M, 2005, BIOCHEM BIOPH RES CO, V333, P754, DOI 10.1016/j.bbrc.2005.05.174; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Raghunand N, 2003, BIOCHEM PHARMACOL, V66, P1219, DOI 10.1016/S0006-2952(03)00468-4; Raghunand N, 2002, ACAD RADIOL, V9, pS481, DOI 10.1016/S1076-6332(03)80270-2; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Schindler M, 1996, BIOCHEMISTRY-US, V35, P2811, DOI 10.1021/bi952234e; SCHNEIDER YJ, 1979, CANCER CHEMOTH PHARM, V2, P7; SMALLEY RV, 1983, BREAST CANCER RES TR, V3, P209, DOI 10.1007/BF01803563; Stubbs M, 2000, MOL MED TODAY, V6, P15, DOI 10.1016/S1357-4310(99)01615-9; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; VAUPEL P, 1989, CANCER RES, V49, P6449; WU L, 1992, CANCER RES, V52, P3029	34	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35949	10.1371/journal.pone.0035949	http://dx.doi.org/10.1371/journal.pone.0035949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563426	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100052
J	Hugo, S; Van Rensburg, BJ; Van Wyk, AE; Steenkamp, Y				Hugo, Sanet; Van Rensburg, Berndt J.; Van Wyk, Abraham E.; Steenkamp, Yolande			Alien Phytogeographic Regions of Southern Africa: Numerical Classification, Possible Drivers, and Regional Threats	PLOS ONE			English	Article							SPECIES RICHNESS; PLANT INVASIONS; DISTRIBUTIONS; CONSERVATION; MANAGEMENT; MODEL; CONSEQUENCES; DIVERSITY; PATTERNS; GRASSES	The distributions of naturalised alien plant species that have invaded natural or semi-natural habitat are often geographically restricted by the environmental conditions in their new range, implying that alien species with similar environmental requirements and tolerances may form assemblages and characterise particular areas. The aim of this study was to use objective numerical techniques to reveal any possible alien phytogeographic regions (i.e. geographic areas with characteristic alien plant assemblages) in southern Africa. Quarter degree resolution presence records of naturalised alien plant species of South Africa, Lesotho, Swaziland, Namibia and Botswana were analysed through a divisive hierarchical classification technique, and the output was plotted on maps for further interpretation. The analyses revealed two main alien phytogeographic regions that could be subdivided into eight lower level phytogeographic regions. Along with knowledge of the environmental requirements of the characteristic species and supported by further statistical analyses, we hypothesised on the main drivers of alien phytogeographic regions, and suggest that environmental features such as climate and associated biomes were most important, followed by human activities that modify climatic and vegetation features, such as irrigation and agriculture. Most of the characteristic species are not currently well-known as invasive plant species, but many may have potential to become troublesome in the future. Considering the possibility of biotic homogenization, these findings have implications for predicting the characteristics of the plant assemblages of the future. However, the relatively low quality of the dataset necessitates further more in-depth studies with improved data before the findings could be directly beneficial for management.	[Hugo, Sanet; Van Rensburg, Berndt J.] Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence Invas Biol, ZA-0002 Pretoria, South Africa; [Van Rensburg, Berndt J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Van Wyk, Abraham E.] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa; [Steenkamp, Yolande] S African Natl Biodivers Inst, Biosystemat Res & Biodivers Collect Div, Pretoria, South Africa	National Research Foundation - South Africa; University of Pretoria; University of Queensland; University of Pretoria; South African National Biodiversity Institute	Hugo, S (corresponding author), Univ Pretoria, Dept Zool & Entomol, DST NRF Ctr Excellence Invas Biol, ZA-0002 Pretoria, South Africa.	shugo@zoology.up.ac.za	van Wyk, Abraham Erasmus/A-2181-2008; van Rensburg, Berndt/A-4154-2009	van Wyk, Abraham Erasmus/0000-0002-0437-3272; Hugo, Sanet/0000-0001-8636-3985; van Rensburg, Berndt/0000-0002-5274-5536	University of Pretoria; DST-NRF Centre of Excellence for Invasion Biology	University of Pretoria; DST-NRF Centre of Excellence for Invasion Biology(Department of Science & Technology (India))	This study was funded by the University of Pretoria (www.up.ac.za) and the DST-NRF Centre of Excellence for Invasion Biology (http://academic.sun.ac.za/cib/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackburn T.M., 2003, MACROECOLOGY CONCEPT; Chown SL, 2003, ECOL APPL, V13, P1233, DOI 10.1890/02-5105; COBLENTZ BE, 1990, CONSERV BIOL, V4, P261, DOI 10.1111/j.1523-1739.1990.tb00287.x; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Ebach Malte, 2003, Biologist (London), V50, P48; Evans KL, 2006, P ROY SOC B-BIOL SCI, V273, P1779, DOI 10.1098/rspb.2006.3487; Feenstra KR, 2008, PAC SCI, V62, P161, DOI 10.2984/1534-6188(2008)62[161:BAIOPI]2.0.CO;2; Gaston Kevin J., 2003, P345; GATES CT, 1972, AUST J BOT, V20, P261, DOI 10.1071/BT9720261; GAUCH HG, 1981, J ECOL, V69, P537, DOI 10.2307/2259682; Gotelli NJ, 1996, NULL MODELS ECOLOGY; Hawkins BA, 2001, TRENDS ECOL EVOL, V16, P470, DOI 10.1016/S0169-5347(01)02197-8; Henderson L, 2007, BOTHALIA, V37, P215, DOI 10.4102/abc.v37i2.322; Higgins SI, 1999, CONSERV BIOL, V13, P303, DOI 10.1046/j.1523-1739.1999.013002303.x; Higgins SI, 2000, ECOL APPL, V10, P1833, DOI 10.1890/1051-0761(2000)010[1833:UADLMF]2.0.CO;2; Hill M.O., 1979, TWINSPAN FORTRAN PRO; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Irish J, 1994, RES NAT MUS BLOEMFON, V10, P550; Kent M, 2006, PROG PHYS GEOG, V30, P399, DOI 10.1191/0309133306pp489pr; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Lawesson JE, 2002, PLANT ECOL, V158, P113, DOI 10.1023/A:1014757324453; Le Maitre DC, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P295; Le Maitre DC, 2000, WATER SA, V26, P397; Linder HP, 2004, BIOL SKIFTER COPENHA, V55, P229; Marais C., 2001, ENVIRON DEV SUSTAIN, V3, P145, DOI [DOI 10.1023/A:1011668417953, 10.1023/A:1011668417953]; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Milton S. J., 1998, Diversity and Distributions, V4, P175, DOI 10.1046/j.1472-4642.1998.00024.x; Milton SJ, 2004, S AFR J SCI, V100, P69; Mucina I., 2006, STRELITZIA, V19; Mucina L, 2006, STRELETZIA; Mucina Ladislav, 2006, V19, P2; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nel JL, 2004, S AFR J SCI, V100, P53; NELSON G, 1978, Journal of the History of Biology, V11, P269, DOI 10.1007/BF00389302; Neter J., 1996, APPL LINEAR STAT MOD; Ojeda F, 1998, J BIOGEOGR, V25, P165, DOI 10.1046/j.1365-2699.1998.251141.x; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; Parker-Allie F, 2009, CLIMATIC CHANGE, V94, P87, DOI 10.1007/s10584-009-9549-7; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2005, ECOSCIENCE, V12, P391, DOI 10.2980/i1195-6860-12-3-391.1; Richardson DM, 2004, S AFR J SCI, V100, P45; Richardson DM, 2004, P 10 MEDECOS C APR 2; Ringrose S, 2002, ENVIRON MANAGE, V30, P98, DOI 10.1007/s00267-002-2486-0; Robertson MP, 2003, S AFR J SCI, V99, P37; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Rutherford MC, 2006, STRELETZIA; Saiz JCM, 1998, J BIOGEOGR, V25, P179, DOI 10.1046/j.1365-2699.1998.251118.x; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schulze R.E., 1997, TT8296 WRC; Steenkamp Y., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P253; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Stohlgren TJ, 2003, FRONT ECOL ENVIRON, V1, P11; Stromberg J.C., 1993, Journal of the Arizona-Nevada Academy of Science, V27, P111; Thompson M, 1996, S AFR J SCI, V92, P34; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; Van Rooy J, 2010, J BRYOL, V32, P80, DOI 10.1179/037366810X12578498136039; van Wilgen BW, 2008, J ENVIRON MANAGE, V89, P336, DOI 10.1016/j.jenvman.2007.06.015; van Wyk AE., 2001, REGIONS FLORISTIC EN; White F., 1993, Bulletin du Jardin Botanique National de Belgique, V62, P225, DOI 10.2307/3668279; Wolmarans R, 2010, J BIOGEOGR, V37, P1797, DOI 10.1111/j.1365-2699.2010.02325.x	61	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36269	10.1371/journal.pone.0036269	http://dx.doi.org/10.1371/journal.pone.0036269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574145	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800041
J	Undurraga, EA; Zebrowitz, L; Eisenberg, DTA; Reyes-Garcia, V; Godoy, RA				Undurraga, Eduardo A.; Zebrowitz, Leslie; Eisenberg, Dan T. A.; Reyes-Garcia, Victoria; Godoy, Ricardo A.		TAPS Bolivia Study Team	The Perceived Benefits of Height: Strength, Dominance, Social Concern, and Knowledge among Bolivian Native Amazonians	PLOS ONE			English	Article							FACTORS INFLUENCING PREFERENCES; LABOR-MARKET OUTCOMES; REPRODUCTIVE SUCCESS; SEXUAL-DIMORPHISM; VARIABLE PREFERENCES; NUTRITIONAL-STATUS; PHYSICAL STATURE; CHILDRENS HEIGHT; HEALTH; WOMEN	Research in industrial countries suggests that, with no other knowledge about a person, positive traits are attributed to taller people and correspondingly, that taller people have slightly better socioeconomic status (SES). However, research in some non-industrialized contexts has shown no correlation or even negative correlations between height and socioeconomic outcomes. It remains unclear whether positive traits remain attributed to taller people in such contexts. To address this question, here we report the results of a study in a foraging-farming society of native Amazonians in Bolivia (Tsimane')-a group in which we have previously shown little association between height and socioeconomic outcomes. We showed 24 photographs of pairs of Tsimane' women, men, boys, and girls to 40 women and 40 men >16 years of age. We presented four behavioral scenarios to each participant and asked them to point to the person in the photograph with greater strength, dominance, social concern, or knowledge. The pairs in the photographs were of the same sex and age, but one person was shorter. Tsimane' women and men attributed greater strength, dominance, and knowledge to taller girls and boys, but they did not attribute most positive traits to taller adults, except for strength, and more social concern only when women assessed other women in the photographs. These results raise a puzzle: why would Tsimane' attribute positive traits to tall children, but not tall adults? We propose three potential explanations: adults' expectations about the more market integrated society in which their children will grow up, height as a signal of good child health, and children's greater variation in the traits assessed corresponding to maturational stages.	[Undurraga, Eduardo A.; Reyes-Garcia, Victoria; Godoy, Ricardo A.] Brandeis Univ, Heller Sch Social Policy, Waltham, MA 02254 USA; [Zebrowitz, Leslie] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA; [Eisenberg, Dan T. A.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA; [Eisenberg, Dan T. A.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, ICREA, E-08193 Barcelona, Spain; [Reyes-Garcia, Victoria] Univ Autonoma Barcelona, Inst Ciencia Tecnol & Ambientals, E-08193 Barcelona, Spain; [TAPS Bolivia Study Team] TAPS, San Borja, Beni, Bolivia	Brandeis University; Brandeis University; Northwestern University; University of Washington; University of Washington Seattle; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona	Undurraga, EA (corresponding author), Brandeis Univ, Heller Sch Social Policy, Waltham, MA 02254 USA.	eundurra@brandeis.edu	Reyes-Garcia, Victoria/C-4552-2008; Eisenberg, Dan T.A./D-7691-2011; Undurraga, Eduardo/I-3739-2014	Reyes-Garcia, Victoria/0000-0002-2914-8055; Eisenberg, Dan T.A./0000-0003-0812-1862; Undurraga, Eduardo/0000-0002-4425-1253	NSF; NSG GRF grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	NSF(National Science Foundation (NSF)); NSG GRF grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); ICREA(ICREA)	The Cultural Anthropology Programs of NSF provided funding. DTAE is funded by an NSG GRF grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akachi Y, 2007, ANN HUM BIOL, V34, P397, DOI 10.1080/03014460701452868; BOOTH ND, 1990, J SOC PSYCHOL, V130, P609, DOI 10.1080/00224545.1990.9922952; BRACKBILL Y, 1981, MERRILL PALMER QUART, V27, P429; Brown JL, 1996, SCI AM, V274, P38, DOI 10.1038/scientificamerican0296-38; Byron E., 2003, MARKET INTEGRATION H; Case A, 2008, J POLIT ECON, V116, P499, DOI 10.1086/589524; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Chu S, 2005, PERS INDIV DIFFER, V38, P1927, DOI 10.1016/j.paid.2004.10.004; Cinnirella F, 2011, EC HUMAN BI IN PRESS; Cronk L., 2004, MUKOGODO MAASAI ETHN; Deady DK, 2006, PERS INDIV DIFFER, V40, P17, DOI 10.1016/j.paid.2005.06.014; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Deaton A, 2009, ECON HUM BIOL, V7, P133, DOI 10.1016/j.ehb.2009.06.001; Dinda S, 2006, ECON HUM BIOL, V4, P342, DOI 10.1016/j.ehb.2005.10.003; EISENBERG N, 1984, SEX ROLES, V11, P719, DOI 10.1007/BF00288123; EKWO F, 1991, AM J HUM BIOL, V3, P181, DOI 10.1002/ajhb.1310030212; Ellis R, 1996, THESIS ST ANDREWS U; Fink B, 2007, PERS INDIV DIFFER, V43, P2249, DOI 10.1016/j.paid.2007.07.014; Godoy RA, 2004, HUM ECOL, V32, P339, DOI 10.1023/B:HUEC.0000028085.47707.08; Godoy R, 2008, EVOL HUM BEHAV, V29, P201, DOI 10.1016/j.evolhumbehav.2007.12.003; Godoy R, 2008, FIELD METHOD, V20, P26, DOI 10.1177/1525822X07309356; Godoy R, 2010, AM J HUM BIOL, V22, P336, DOI 10.1002/ajhb.20996; Godoy R, 2010, ECON HUM BIOL, V8, P88, DOI 10.1016/j.ehb.2009.08.002; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; HADDAD LJ, 1991, OXFORD B ECON STAT, V53, P45, DOI 10.1111/j.1468-0084.1991.mp53001004.x; HENSLEY WE, 1993, PSYCHOLOGY, V30, P40; Hersch J, 2008, J LABOR ECON, V26, P345, DOI 10.1086/587428; Huanca Tomas, 2008, TSIMANE ORAL TRADITI; Hunt L, 2000, HORM RES, V53, P129, DOI 10.1159/000023561; Irons W, 1979, EVOLUTIONARY BIOL HU, P284; JACKSON LA, 1992, J SOC PSYCHOL, V132, P433, DOI 10.1080/00224545.1992.9924723; Judge TA, 2004, J APPL PSYCHOL, V89, P428, DOI 10.1037/0021-9010.89.3.428; Leatherman T, 1998, SOC SCI MED, V47, P1031, DOI 10.1016/S0277-9536(98)00160-9; LEE PDK, 1987, PEDIATR CLIN N AM, V34, P851; Lee RB, 1979, KUNGSAN MEN WOMEN WO; Leonard WR, 2008, ECON HUM BIOL, V6, P299, DOI 10.1016/j.ehb.2008.04.001; Long J.S., 2006, REGRESSION MODELS CA; Martel LF., 1987, STATURE STIGMA BIOPS; Martorell R, 1986, HUMAN GROWTH COMPREH, V3, P241; MONTEPARE JM, 1995, J NONVERBAL BEHAV, V19, P31, DOI 10.1007/BF02173411; Nettle D, 2002, HUM NATURE-INT BIOS, V13, P473, DOI 10.1007/s12110-002-1004-7; Nettle D, 2002, P ROY SOC B-BIOL SCI, V269, P1919, DOI 10.1098/rspb.2002.2111; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Persico N, 2004, J POLIT ECON, V112, P1019, DOI 10.1086/422566; Reyes-Garcia V, 2008, J DEV STUD, V44, P217, DOI 10.1080/00220380701789901; Reyes-Garcia Victoria, 2001, INDIGENOUS PEOPLE ET; Ringhofer L, 2010, FISHING, FORAGING AND FARMING IN THE BOLIVIAN AMAZON, P1, DOI 10.1007/978-90-481-3487-8; ROTH K, 1983, J GENET PSYCHOL, V143, P45, DOI 10.1080/00221325.1983.10533532; Salska I, 2008, PERS INDIV DIFFER, V44, P203, DOI 10.1016/j.paid.2007.08.008; Sear R, 2010, HOMONOVUS HUMAN ILUS; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Seckler D., 1982, NEWER CONCEPTS NUTR, P127; SHEPPERD JA, 1989, PERS SOC PSYCHOL B, V15, P617, DOI 10.1177/0146167289154014; Sorokowski P, 2012, J CROSS CULT PSYCHOL, V43, P32, DOI 10.1177/0022022110395140; Spears D, 2011, EC HUMAN BI IN PRESS; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Strauss J, 1998, J ECON LIT, V36, P766; Swami V, 2008, PERS INDIV DIFFER, V45, P395, DOI 10.1016/j.paid.2008.05.012; Tanner S, 2009, AM J HUM BIOL, V21, P651, DOI 10.1002/ajhb.20944; Tanner S, 2005, THESIS U MICHIGAN; Tanner S, 2011, SOC SCI MED, V72, P701, DOI 10.1016/j.socscimed.2010.12.012; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; UNDERWOOD LE, 1991, ACTA PAEDIATR SCAND, P3; Undurraga EA, 2010, MED ANTHROPOL Q, V24, P522, DOI 10.1111/j.1548-1387.2010.01121.x; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074	66	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35391	10.1371/journal.pone.0035391	http://dx.doi.org/10.1371/journal.pone.0035391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574118	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800014
J	Van Klinken, JB; van den Berg, SAA; Havekes, LM; Van Dijk, KW				Van Klinken, Jan Bert; van den Berg, Sjoerd A. A.; Havekes, Louis M.; Van Dijk, Ko Willems			Estimation of Activity Related Energy Expenditure and Resting Metabolic Rate in Freely Moving Mice from Indirect Calorimetry Data	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIVITY THERMOGENESIS; ADAPTIVE-CHANGES; OBESITY; IDENTIFICATION; DETERMINANTS; RESISTANCE; MODELS; GAIN	Physical activity (PA) is a main determinant of total energy expenditure (TEE) and has been suggested to play a key role in body weight regulation. However, thus far it has been challenging to determine what part of the expended energy is due to activity in freely moving subjects. We developed a computational method to estimate activity related energy expenditure (AEE) and resting metabolic rate (RMR) in mice from activity and indirect calorimetry data. The method is based on penalised spline regression and takes the time dependency of the RMR into account. In addition, estimates of AEE and RMR are corrected for the regression dilution bias that results from inaccurate PA measurements. We evaluated the performance of our method based on 500 simulated metabolic chamber datasets and compared it to that of conventional methods. It was found that for a sample time of 10 minutes the penalised spline model estimated the time-dependent RMR with 1.7 times higher accuracy than the Kalman filter and with 2.7 times higher accuracy than linear regression. We assessed the applicability of our method on experimental data in a case study involving high fat diet fed male and female C57Bl/6J mice. We found that TEE in male mice was higher due to a difference in RMR while AEE levels were similar in both groups, even though female mice were more active. Interestingly, the higher activity did not result in a difference in AEE because female mice had a lower caloric cost of activity, which was likely due to their lower body weight. In conclusion, TEE decomposition by means of penalised spline regression provides robust estimates of the time-dependent AEE and RMR and can be applied to data generated with generic metabolic chamber and indirect calorimetry set-ups.	[Van Klinken, Jan Bert; van den Berg, Sjoerd A. A.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Havekes, Louis M.; Van Dijk, Ko Willems] Leiden Univ, Med Ctr, Dept Gen Internal Med, Leiden, Netherlands; [Havekes, Louis M.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Havekes, Louis M.] Netherlands Org Appl Sci Res Qual Life, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research	Van Klinken, JB (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	J.B.van_Klinken@lumc.nl	van den Berg, Sjoerd A/R-9541-2018; van den Berg, Sjoerd AA/B-1994-2009; van Dijk, Ko Willems/AAT-4681-2021; van Dijk, Ko Willems/A-1798-2008	van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505	Netherlands Consortium for Systems Biology (NCSB); Center of Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO); TSE systems (Bad Homburg, Germany)	Netherlands Consortium for Systems Biology (NCSB); Center of Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); TSE systems (Bad Homburg, Germany)	This work was supported by grants from the Netherlands Consortium for Systems Biology (NCSB) and the Center of Medical Systems Biology (CMSB) established by The Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (NGI/NWO). Funding has also been received from TSE systems (Bad Homburg, Germany) in the form of indirect calorimetry equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Blaxter K, 1989, ENERGY METABOLISM AN; Bursztein S., 1989, ENERGY METABOLISM IN; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cooper CE, 2010, PHYSIOL BIOCHEM ZOOL, V83, P385, DOI 10.1086/605612; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; DAUNCEY MJ, 1990, CAN J PHYSIOL PHARM, V68, P17, DOI 10.1139/y90-002; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; DULLOO AG, 1990, AM J CLIN NUTR, V52, P415, DOI 10.1093/ajcn/52.3.415; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; EVEN PC, 1993, BRIT J NUTR, V70, P421, DOI 10.1079/BJN19930136; Fuller W.A., 2009, MEASUREMENT ERROR MO; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; GREEN PJ, 1987, INT STAT REV, V55, P245, DOI 10.2307/1403404; Institute for Laboratory Animal Research, 2011, GUID CAR US LAB AN; Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Levine JA, 1999, SCIENCE, V283, P212, DOI 10.1126/science.283.5399.212; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lighton JRB, 2011, COMP BIOCHEM PHYS A, V158, P265, DOI 10.1016/j.cbpa.2010.11.026; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lusk G, 1928, ELEMENTS SCI NUTR; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Morton GJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE392, DOI 10.1152/ajpendo.00546.2010; NAKAMURA T, 1990, BIOMETRIKA, V77, P127; Nonogaki K, 2003, DIABETES, V52, P315, DOI 10.2337/diabetes.52.2.315; Novak CM, 2006, AM J PHYSIOL-ENDOC M, V290, pE396, DOI 10.1152/ajpendo.00293.2005; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Proakis J.G., 1992, DIGIT SIGNAL PROCESS; RAVUSSIN E, 1986, J CLIN INVEST, V78, P1568, DOI 10.1172/JCI112749; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ruppert D, 2002, J COMPUT GRAPH STAT, V11, P735, DOI 10.1198/106186002853; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Stepien M, 2010, J NUTR, V140, P939, DOI 10.3945/jn.109.120139; Tataranni PA, 2003, INT J OBESITY, V27, P1578, DOI 10.1038/sj.ijo.0802469; Tokuyama K, 2009, J APPL PHYSIOL, V106, P640, DOI 10.1152/japplphysiol.90718.2008; Tou JCL, 2002, EXP BIOL MED, V227, P587, DOI 10.1177/153537020222700806; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; VanMilgen J, 1997, BRIT J NUTR, V78, P397, DOI 10.1079/BJN19970159; Weinsier RL, 2002, AM J CLIN NUTR, V75, P499, DOI 10.1093/ajcn/75.3.499; Zhong XP, 2002, ANN I STAT MATH, V54, P595, DOI 10.1023/A:1022467212133	46	41	41	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36162	10.1371/journal.pone.0036162	http://dx.doi.org/10.1371/journal.pone.0036162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574139	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800035
J	Singh, B; Tai, KR; Madan, S; Raythatha, MR; Cady, AM; Braunlin, M; Irving, LR; Bajaj, A; Lucci, A				Singh, Balraj; Tai, Karen; Madan, Simran; Raythatha, Milan R.; Cady, Amanda M.; Braunlin, Megan; Irving, LaTashia R.; Bajaj, Ankur; Lucci, Anthony			Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic State	PLOS ONE			English	Article							DISSEMINATED TUMOR-CELLS; MOUSE MAMMARY-TUMOR; GENOMIC INSTABILITY; STEM-CELLS; GROWTH; SUPPRESSION; EXPRESSION; GENES; MODEL; COX-2	A small subpopulation of highly adaptable breast cancer cells within a vastly heterogeneous population drives cancer metastasis. Here we describe a function-based strategy for selecting rare cancer cells that are highly adaptable and drive malignancy. Although cancer cells are dependent on certain nutrients, e.g., glucose and glutamine, we hypothesized that the adaptable cancer cells that drive malignancy must possess an adaptable metabolic state and that such cells could be identified using a robust selection strategy. As expected, more than 99.99% of cells died upon glutamine withdrawal from the aggressive breast cancer cell line SUM149. The rare cells that survived and proliferated without glutamine were highly adaptable, as judged by additional robust adaptability assays involving prolonged cell culture without glucose or serum. We were successful in isolating rare metabolically plastic glutamine-independent (Gln-ind) variants from several aggressive breast cancer cell lines that we tested. The Gln-ind cells overexpressed cyclooxygenase-2, an indicator of tumor aggressiveness, and they were able to adjust their glutaminase level to suit glutamine availability. The Gln-ind cells were anchorage-independent, resistant to chemotherapeutic drugs doxorubicin and paclitaxel, and resistant to a high concentration of a COX-2 inhibitor celecoxib. The number of cells being able to adapt to non-availability of glutamine increased upon prior selection of cells for resistance to chemotherapy drugs or resistance to celecoxib, further supporting a linkage between cellular adaptability and therapeutic resistance. Gln-ind cells showed indications of oxidative stress, and they produced cadherin11 and vimentin, indicators of mesenchymal phenotype. Gln-ind cells were more tumorigenic and more metastatic in nude mice than the parental cell line as judged by incidence and time of occurrence. As we decreased the number of cancer cells in xenografts, lung metastasis and then primary tumor growth was impaired in mice injected with parental cell line, but not in mice injected with Gln-ind cells.	[Singh, Balraj; Tai, Karen; Madan, Simran; Raythatha, Milan R.; Cady, Amanda M.; Braunlin, Megan; Irving, LaTashia R.; Bajaj, Ankur; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Singh, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	alucci@mdanderson.org	Singh, Balraj/AHD-5938-2022	Lucci, Anthony/0000-0003-4039-174X	United States Army Medical Research and Material Command [DAMD17-03-1-0669 W81XWH-09-1-0590]; National Institutes of Health, HostGator [CA16672]; Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center; Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Health, HostGator; Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center; Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants DAMD17-03-1-0669 W81XWH-09-1-0590 from the United States Army Medical Research and Material Command (AL), CA16672 (Core) from the National Institutes of Health, HostGator (AL), Breast Cancer Micrometastasis Research Program at MD Anderson Cancer Center (AL), and Morgan Welch Inflammatory Breast Cancer Multi-Disciplinary Research Program at MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barry M, 2009, IRISH J MED SCI, V178, P201, DOI 10.1007/s11845-009-0335-3; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guo LX, 2011, AM J PATHOL, V178, P2357, DOI 10.1016/j.ajpath.2011.01.047; Hall C, 2012, CANCER-AM CANCER SOC, V118, P342, DOI 10.1002/cncr.26202; Janni W, 2011, CLIN CANCER RES, V17, P2967, DOI 10.1158/1078-0432.CCR-10-2515; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lev DC, 2003, CLIN EXP METASTAS, V20, P515; LI LM, 1989, JNCI-J NATL CANCER I, V81, P1406, DOI 10.1093/jnci/81.18.1406; Li YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017421; Lu X, 2010, J BIOL CHEM, V285, P9317, DOI 10.1074/jbc.C110.104448; Lucci A, 2009, BREAST CANCER RES TR, V117, P61, DOI 10.1007/s10549-008-0135-x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Mustafa A, 2008, CLIN CANCER RES, V14, P4935, DOI 10.1158/1078-0432.CCR-08-0958; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; NICOLSON GL, 1982, SCIENCE, V215, P176, DOI 10.1126/science.7053568; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Pan QT, 2003, MOL CANCER RES, V1, P701; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Pishvaian MJ, 1999, CANCER RES, V59, P947; POSTE G, 1980, CANCER RES, V40, P1636; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2005, INT J ONCOL, V26, P1393; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Singh B, 2008, J SURG RES, V147, P240, DOI 10.1016/j.jss.2008.02.026; Singh B, 2007, J SURG RES, V140, P220, DOI 10.1016/j.jss.2007.01.039; Singh B, 2011, J SURG RES, V168, pE39, DOI 10.1016/j.jss.2010.03.003; Singh B, 2010, J SURG RES, V163, P235, DOI 10.1016/j.jss.2010.04.061; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; TALMADGE JE, 1982, SCIENCE, V217, P361, DOI 10.1126/science.6953592; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vlashi E, 2011, P NATL ACAD SCI USA, V108, P16062, DOI 10.1073/pnas.1106704108; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; Zhang DW, 2009, CLIN CANCER RES, V15, P6639, DOI 10.1158/1078-0432.CCR-09-0951	51	15	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36510	10.1371/journal.pone.0036510	http://dx.doi.org/10.1371/journal.pone.0036510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570721	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343400037
J	Cummings, JR; Muchlinski, MN; Kirk, EC; Rehorek, SJ; DeLeon, VB; Smith, TD				Cummings, Joshua R.; Muchlinski, Magdalena N.; Kirk, E. Christopher; Rehorek, Susan J.; DeLeon, Valerie B.; Smith, Timothy D.			Eye Size at Birth in Prosimian Primates: Life History Correlates and Growth Patterns	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; TARSIUS-BANCANUS; BRAIN GROWTH; LORISES; ENUCLEATION; EVOLUTION; ORBIT; SHAPE	Background: Primates have large eyes relative to head size, which profoundly influence the ontogenetic emergence of facial form. However, growth of the primate eye is only understood in a narrow taxonomic perspective, with information biased toward anthropoids. Methodology/Principal Findings: We measured eye and bony orbit size in perinatal prosimian primates (17 strepsirrhine taxa and Tarsius syrichta) to infer the extent of prenatal as compared to postnatal eye growth. In addition, multiple linear regression was used to detect relationships of relative eye and orbit diameter to life history variables. ANOVA was used to determine if eye size differed according to activity pattern. In most of the species, eye diameter at birth measures more than half of that for adults. Two exceptions include Nycticebus and Tarsius, in which more than half of eye diameter growth occurs postnatally. Ratios of neonate/adult eye and orbit diameters indicate prenatal growth of the eye is actually more rapid than that of the orbit. For example, mean neonatal transverse eye diameter is 57.5% of the adult value (excluding Nycticebus and Tarsius), compared to 50.8% for orbital diameter. If Nycticebus is excluded, relative gestation age has a significant positive correlation with relative eye diameter in strepsirrhines, explaining 59% of the variance in relative transverse eye diameter. No significant differences were found among species with different activity patterns. Conclusions/Significance: The primate developmental strategy of relatively long gestations is probably tied to an extended period of neural development, and this principle appears to apply to eye growth as well. Our findings indicate that growth rates of the eye and bony orbit are disassociated, with eyes growing faster prenatally, and the growth rate of the bony orbit exceeding that of the eyes after birth. Some well-documented patterns of orbital morphology in adult primates, such as the enlarged orbits of nocturnal species, mainly emerge during postnatal development.	[Cummings, Joshua R.; Rehorek, Susan J.] Slippery Rock Univ, Dept Biol, Slippery Rock, PA 16057 USA; [Muchlinski, Magdalena N.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY USA; [Kirk, E. Christopher] Univ Texas Austin, Dept Anthropol, Austin, TX 78712 USA; [DeLeon, Valerie B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD USA; [Smith, Timothy D.] Slippery Rock Univ, Sch Phys Therapy, Slippery Rock, PA 16057 USA; [Smith, Timothy D.] Univ Pittsburgh, Dept Anthropol, Pittsburgh, PA 15260 USA	Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania; University of Kentucky; University of Texas System; University of Texas Austin; Johns Hopkins University; Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cummings, JR (corresponding author), Slippery Rock Univ, Dept Biol, Slippery Rock, PA 16057 USA.	timothy.smith@sru.edu		Kirk, Chris/0000-0001-9439-3041; Rehorek, Susan/0000-0003-2550-905X	Pennsylvania State System of Higher Education and Slippery Rock University; NSF [BCS-0923791, BCS-0959438]; National Evolutionary Synthesis Center [EF-0905606]; Division Of Behavioral and Cognitive Sci [0959438] Funding Source: National Science Foundation	Pennsylvania State System of Higher Education and Slippery Rock University; NSF(National Science Foundation (NSF)); National Evolutionary Synthesis Center; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was supported by grants from the Pennsylvania State System of Higher Education and Slippery Rock University. For training in phylogenetic comparative methods, we thank the AnthroTree Workshop which is supported by the NSF (BCS-0923791) and the National Evolutionary Synthesis Center (NSF grant EF-0905606). The CT scan was made possible by NSF grant # BCS-0959438 (MRI-R2 Acquisition: Establishment of a Core Facility for the Hierarchical Analysis of Bone). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atzeva M, 2007, J HUM EVOL, V52, P231, DOI 10.1016/j.jhevol.2006.08.009; Barathi A, 2002, CELLS TISSUES ORGANS, V171, P276, DOI 10.1159/000063123; CARTMILL M, 1974, SCIENCE, V184, P436, DOI 10.1126/science.184.4135.436; Cartmill M., 1972, FUNCTIONAL EVOLUTION, P97, DOI DOI 10.4324/9781315132129; Castenholz A., 1984, P303; DEROUSSEAU CJ, 1981, EXP EYE RES, V32, P407, DOI 10.1016/S0014-4835(81)80020-6; Fitch-Snyder H, 2003, ZOO BIOL, V22, P15, DOI 10.1002/zoo.10072; Fledelius HC, 1996, BRIT J OPHTHALMOL, V80, P918, DOI 10.1136/bjo.80.10.918; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Godfrey Laurie R., 2003, P177; Harvey P.H., 1987, P181; Hintschich C, 2001, BRIT J OPHTHALMOL, V85, P205, DOI 10.1136/bjo.85.2.205; Hoyte DAN, 1997, FUNDAMENTALS CRANIOF, P225; Jeffery N, 2007, J ANAT, V210, P703, DOI 10.1111/j.1469-7580.2007.00725.x; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kappeler P M, 2003, PRIMATE LIFE HIST SO; Kirk EC, 2006, J HUM EVOL, V51, P159, DOI 10.1016/j.jhevol.2006.02.004; Kurta A., 1987, Symposia of the Zoological Society of London, P79; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LEIGH SR, 2007, PRIMATES PERSPECTIVE, P396; Lindenfors P, 2002, J EVOLUTION BIOL, V15, P595, DOI 10.1046/j.1420-9101.2002.00422.x; Martin R.D., 1983, HUMAN BRAIN EVOLUTIO; Martin R.D., 1990, PRIMATE ORIGINS EVOL; MARTIN RD, 1985, NATURE, V313, P220, DOI 10.1038/313220a0; Martin RD, 2007, YEARB PHYS ANTHROPOL, V50, P59, DOI 10.1002/ajpa.20734; Moore Persuad, 2008, DEV HUMAN; Nash Leanne T., 1993, P119; Norrby A., 1958, ACTA OPHTHALMOL, V49, P5; NORTON TT, 1992, VISION RES, V32, P833, DOI 10.1016/0042-6989(92)90026-F; O'Mara MT, 2012, AM J PHYS ANTHROPOL, V147, P11, DOI 10.1002/ajpa.21600; ORAHILLY R, 1975, EXP EYE RES, V21, P93, DOI 10.1016/0014-4835(75)90075-5; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PEREIRA M, 1993, JUVENILE PRIMATES; Pereira Michael E., 2003, P149; RASMUSSEN DT, 1988, AM J PHYS ANTHROPOL, V75, P357, DOI 10.1002/ajpa.1330750307; Riordan-Eva P, 2008, VAUGHAN ASBURYS GEN; ROBERTS M, 1994, INT J PRIMATOL, V15, P1, DOI 10.1007/BF02735232; Rosenberger AL, 2010, INT J PRIMATOL, V31, P1032, DOI 10.1007/s10764-010-9447-x; Ross C, 2001, INT J PRIMATOL, V22, P749, DOI 10.1023/A:1012065332758; Ross CF, 2007, J HUM EVOL, V52, P294, DOI 10.1016/j.jhevol.2006.09.006; ROSS CF, 1995, J HUM EVOL, V29, P201, DOI 10.1006/jhev.1995.1057; Ross CF, 2009, EVOLUTIONARY NEUROSC, P819; SARNAT BG, 1972, ACTA ANAT, V82, P497; Scammon RE, 1925, J COMP NEUROL, V38, P165, DOI 10.1002/cne.900380203; Schmechel DE, 1996, EXP NEUROL, V142, P111, DOI 10.1006/exnr.1996.0183; Schultz AH, 1940, AM J PHYS ANTHROPOL, V26, P389, DOI 10.1002/ajpa.1330260138; Smith RJ, 1998, J HUM EVOL, V34, P173, DOI 10.1006/jhev.1997.0190; Smith TD, 2011, AM J PHYS ANTHROPOL, V144, P392, DOI 10.1002/ajpa.21421; St Clair EM, 2007, INT J PRIMATOL, V28, P1109, DOI 10.1007/s10764-007-9198-5; Tecot SR, 2010, INT J PRIMATOL, V31, P715, DOI 10.1007/s10764-010-9423-5; TIGGES M, 1990, INVEST OPHTH VIS SCI, V31, P1035; TROILO D, 1993, VISION RES, V33, P1311, DOI 10.1016/0042-6989(93)90039-Y; Tuntivanich N, 2007, VET OPHTHALMOL, V10, P2, DOI 10.1111/j.1463-5224.2007.00481.x; van Limborgh J, 1982, Prog Clin Biol Res, V101, P1; Washburn SL, 1943, AM J PHYS ANTHROP-NE, V1, P171, DOI 10.1002/ajpa.1330010211; Weisenseel KA, 1998, FOLIA PRIMATOL, V69, P321, DOI 10.1159/000052720; WILKINSON F, 1986, BEHAV BRAIN RES, V19, P59, DOI 10.1016/0166-4328(86)90048-3	57	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36097	10.1371/journal.pone.0036097	http://dx.doi.org/10.1371/journal.pone.0036097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567127	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500045
J	Morena, M; Jaussent, I; Halkovich, A; Dupuy, AM; Bargnoux, AS; Chenine, L; Leray-Moragues, H; Klouche, K; Vernhet, H; Canaud, B; Cristol, JP				Morena, Marion; Jaussent, Isabelle; Halkovich, Aurore; Dupuy, Anne-Marie; Bargnoux, Anne-Sophie; Chenine, Leila; Leray-Moragues, Helene; Klouche, Kada; Vernhet, Helene; Canaud, Bernard; Cristol, Jean-Paul			Bone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-23; PERIPHERAL VASCULAR CALCIFICATION; SERUM OSTEOPROTEGERIN LEVELS; ARTERY CALCIFICATION; COMPUTED-TOMOGRAPHY; RENAL-DISEASE; FGF23; RISK; HYPOPHOSPHATEMIA; ATHEROSCLEROSIS	Background: Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker of CAC: FGF23? OPG? Methodology/Principal Findings: 195 ND-CKD patients (112 males/83 females, 70.8 [27.4-94.6] years) were enrolled in this cross-sectional study. All underwent chest multidetector computed tomography for CAC scoring. Vascular risk markers including FGF23 and OPG were measured. Logistic regression analyses were used to study the potential relationships between CAC and these markers. The fully adjusted-univariate analysis clearly showed high OPG (>= 10.71 pmol/L) as the only variable significantly associated with moderate CAC ([100-400[) (OR = 2.73 [1.03; 7.26]; p = 0.04). Such association failed to persist for CAC scoring higher than 400. Indeed, severe CAC was only associated with high phosphate fractional excretion (FEPO4) (>= 38.71%) (OR = 5.47 [1.76; 17.0]; p = 0.003) and high FGF23 (>= 173.30 RU/mL) (OR = 5.40 [1.91; 15.3]; p = 0.002). In addition, the risk to present severe CAC when FGF23 level was high was not significantly different when OPG was normal or high. Conversely, the risk to present moderate CAC when OPG level was high was not significantly different when FGF23 was normal or high. Conclusions: Our results strongly suggest that OPG is associated to moderate CAC while FGF23 rather represents a biomarker of severe CAC in ND-CKD patients.	[Morena, Marion; Halkovich, Aurore; Dupuy, Anne-Marie; Bargnoux, Anne-Sophie; Cristol, Jean-Paul] CHRU Montpellier, Biochim Lab, Montpellier, France; [Morena, Marion; Canaud, Bernard] Inst Rech & Format Dialyse, Montpellier, France; [Morena, Marion; Bargnoux, Anne-Sophie; Klouche, Kada; Canaud, Bernard; Cristol, Jean-Paul] Univ Montpellier I, UMR 204, Montpellier, France; [Jaussent, Isabelle] INSERM, U1061, Montpellier, France; [Chenine, Leila; Leray-Moragues, Helene; Canaud, Bernard] CHRU Montpellier, Serv Nephrol Hemodialyse & Soins Intensifs, Montpellier, France; [Vernhet, Helene] CHRU Montpellier, Serv Radiol, Montpellier, France; [Klouche, Kada] CHRU Montpellier, Serv Reanimat Metabol, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Morena, M (corresponding author), CHRU Montpellier, Biochim Lab, Montpellier, France.	jp-cristol@chu-montpellier.fr		dupuy, anne marie/0000-0001-6538-3944; MORENA CARRERE, Marion/0000-0001-9563-5217; Jaussent, Isabelle/0000-0002-8205-7590	Ministere de la Sante [PHRC-UF 7853]	Ministere de la Sante	This work was partly supported by a grant from Ministere de la Sante (PHRC-UF 7853). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anand DV, 2006, J AM COLL CARDIOL, V47, P1850, DOI 10.1016/j.jacc.2005.12.054; Avignon A, 2005, DIABETES CARE, V28, P2176, DOI 10.2337/diacare.28.9.2176; Brindis RG, 2005, J AM COLL CARDIOL, V46, P1587, DOI 10.1016/j.jacc.2005.08.029; Chiu YW, 2010, KIDNEY INT, V77, P1107, DOI 10.1038/ki.2010.70; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Haas MH, 2010, KIDNEY INT, V77, P1057, DOI 10.1038/ki.2010.92; Inaba M, 2006, OSTEOPOROSIS INT, V17, P1506, DOI 10.1007/s00198-006-0154-6; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P948, DOI 10.1093/ndt/gfn571; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Maimoun L, 2005, CALCIFIED TISSUE INT, V76, P404, DOI 10.1007/s00223-004-0048-6; Mikami S, 2008, HYPERTENS RES, V31, P1163, DOI 10.1291/hypres.31.1163; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Morena M, 2009, NEPHROL DIAL TRANSPL, V24, P3389, DOI 10.1093/ndt/gfp301; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Nitta K, 2004, NEPHROL DIAL TRANSPL, V19, P1886, DOI 10.1093/ndt/gfh263; Nitta K, 2003, AM J KIDNEY DIS, V42, P303, DOI 10.1016/S0272-6386(03)00655-3; Olauson H, 2010, NEPHROL DIAL TRANSPL, V25, P3033, DOI 10.1093/ndt/gfq191; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Russo D, 2010, KIDNEY INT, V78, P818, DOI 10.1038/ki.2010.307; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; Strewler GJ, 2001, P NATL ACAD SCI USA, V98, P5945, DOI 10.1073/pnas.11154898; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Weber TJ, 2003, J BONE MINER RES, V18, P1227, DOI 10.1359/jbmr.2003.18.7.1227	36	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36175	10.1371/journal.pone.0036175	http://dx.doi.org/10.1371/journal.pone.0036175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567137	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500056
J	Panzer, S; Piombino-Mascali, D; Zink, AR				Panzer, Stephanie; Piombino-Mascali, Dario; Zink, Albert R.			Herniation Pits in Human Mummies: A CT Investigation in the Capuchin Catacombs of Palermo, Sicily	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; FEMORAL-NECK; OSTEOARTHRITIS; HIP; ETIOLOGY; HEAD; ASSOCIATION; PREVALENCE; DISEASE	Herniation pits (HPs) of the femoral neck were first described in a radiological publication in 1982 as round to oval radiolucencies in the proximal superior quadrant of the femoral neck on anteroposterior radiographs of adults. In following early clinical publications, HPs were generally recognized as an incidental finding. In contrast, in current clinical literature they are mentioned in the context of femoroacetabular impingement (FAI) of the hip joint, which is known to cause osteoarthritis (OA). The significance of HPs in chronic skeletal disorders such as OA is still unclear, but they are discussed as a possible radiological indicator for FAI in a large part of clinical studies. In this paleoradiological study we examined a sample of mummies from the Capuchin Catacombs of Palermo, Sicily, by a mobile computed tomography (CT) scanner. Evaluation of the CT examinations revealed HPs in six out of 16 (37.5%) adult male mummies. The first aim of this study was to compare the characteristics of HPs shown in our mummy collection to the findings described in clinical literature. Thereby CT evaluation revealed that their osseous imaging characteristics are in accordance, consisting of round to oval subcortical lesions at the anterior femoral neck, clearly demarcated by a sclerotic margin. The second aim was to introduce HPs to the paleoradiological and paleopathological methodology as an entity that underwent a renaissance from an incidental finding to a possible radiological indicator of FAI in the clinical situation. As FAI plays an important role in the development of OA of the hip, which is a very common finding in human skeletal remains, HPs should always be considered in paleoradiological evaluation of hip joint diseases.	[Panzer, Stephanie] Trauma Ctr Murnau, Dept Radiol, Murnau, Germany; [Piombino-Mascali, Dario; Zink, Albert R.] EURAC Inst Mummies & Iceman, Bolzano, Italy	European Academy of Bozen-Bolzano	Panzer, S (corresponding author), Trauma Ctr Murnau, Dept Radiol, Murnau, Germany.	stephanie.panzer@bgu-murnau.de	Piombino-Mascali, Dario/ACG-0789-2022; Zink, Albert/P-4024-2015	Zink, Albert/0000-0002-1461-747X	Foundation Sudtiroler Sparkasse	Foundation Sudtiroler Sparkasse	This study was supported by Dr. Dariusch Rafiy, 3W Production, Munich, Germany (http://www.3w-production.com) and the Foundation Sudtiroler Sparkasse (http://www.stiftungsparkasse.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J BONE JOINT SURG AM, V91A, P305, DOI 10.2106/JBJS.G.01198; Aufderheide A, 1998, CAMBRIDGE ENCY HUMAN, pXV; Aufderheide A.C., 2003, SCI STUDY MUMMIES, P195; Beall DP, 2005, SKELETAL RADIOL, V34, P691, DOI 10.1007/s00256-005-0932-9; Borody C, 2005, J MANIP PHYSIOL THER, V28, P449, DOI 10.1016/j.jmpt.2005.06.003; Bredella Miriam A, 2005, Magn Reson Imaging Clin N Am, V13, P653, DOI 10.1016/j.mric.2005.08.001; Buikstra JE, 1994, ARCHAEOLOGICAL SURVE, V44, P122; Chhem Rethy K., 2008, P1, DOI 10.1007/978-3-540-48833-0_1; CRABBE JP, 1992, AM J ROENTGENOL, V159, P1038, DOI 10.2214/ajr.159.5.1414772; Daenen B, 1997, AM J ROENTGENOL, V168, P149, DOI 10.2214/ajr.168.1.8976938; Fadul DA, 2009, J BONE JOINT SURG AM, V91A, P138, DOI 10.2106/JBJS.H.01449; Filigenzi JM, 2008, APPL RADIOL, P12; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Ganz R, 2008, CLIN ORTHOP RELAT R, V466, P264, DOI 10.1007/s11999-007-0060-z; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; Hedvabny Z, 1993, Acta Chir Orthop Traumatol Cech, V60, P351; Jager M, 2004, J ORTHOP SCI, V9, P256, DOI 10.1007/s00776-004-0770-y; James SLJ, 2007, CLIN RADIOL, V62, P472, DOI 10.1016/j.crad.2006.11.022; James SLJ, 2006, AM J ROENTGENOL, V187, P1412, DOI 10.2214/AJR.05.1415; Jurmain R., 1999, STORIES SKELETON BEH; JURMAIN RD, 1977, AM J PHYS ANTHROPOL, V46, P353, DOI 10.1002/ajpa.1330460214; Kassarjian A, 2006, SEMIN MUSCULOSKEL R, V10, P208, DOI 10.1055/s-2006-957174; Kavanagh EC, 2011, CLIN RADIOL, V66, P742, DOI 10.1016/j.crad.2011.02.014; KELLGREN JH, 1958, ANN RHEUM DIS, V17, P388, DOI 10.1136/ard.17.4.388; Klaus HD, 2009, AM J PHYS ANTHROPOL, V139, P204, DOI 10.1002/ajpa.20973; Konig W., 1896, 14 PHOTOGRAPHIEN RON; Larsen C. S., 1997, BIOARCHAEOLOGY INTER, P160; LARSEN CS, 1995, ANTHR PAPERS, V77, P107; Lee L, 2000, J RHEUMATOL, V27, P2278; LERAIS JM, 1995, J RADIOL, V76, P593; Leunig M, 2005, RADIOLOGY, V236, P237, DOI 10.1148/radiol.2361040140; Leunig M, 2009, CLIN ORTHOP RELAT R, V467, P616, DOI 10.1007/s11999-008-0646-0; Lieverse AR, 2007, AM J PHYS ANTHROPOL, V132, P1, DOI 10.1002/ajpa.20479; MURRAY RO, 1965, BRIT J RADIOL, V38, P810, DOI 10.1259/0007-1285-38-455-810; NOKES SR, 1989, RADIOLOGY, V172, P231, DOI 10.1148/radiology.172.1.2740509; Notzli HP, 2002, J BONE JOINT SURG BR, V84B, P556, DOI 10.1302/0301-620X.84B4.12014; Ortner D. J., 2003, IDENTIFICATION PATHO, P545; Panzer S, 2010, ROFO-FORTSCHR RONTG, V182, P565, DOI 10.1055/s-0029-1245347; Panzer S, 2008, EUR RADIOL, V18, P1869, DOI 10.1007/s00330-008-0952-7; Panzer S, 2010, RADIOGRAPHICS, V30, P1123, DOI 10.1148/rg.304095174; Panzer S, 2010, SKELETAL RADIOL, V39, P645, DOI 10.1007/s00256-009-0792-9; Pfirrmann CWA, 2006, RADIOLOGY, V240, P778, DOI 10.1148/radiol.2403050767; Piombino-Mascali D., 2010, MUMMIES WORLD DREAM, P357; Piombino-Mascali D., 2009, MAESTRO SONNO ETERNO; PITT MJ, 1982, AM J ROENTGENOL, V138, P1115, DOI 10.2214/ajr.138.6.1115; POLGER M, 1993, ARTHRITIS RHEUM, V36, P572, DOI 10.1002/art.1780360420; Reijman M, 2005, ARTHRITIS RHEUM-US, V52, P787, DOI 10.1002/art.20886; Resnick D., 1988, DIAGNOSIS BONE JOINT; Roberts C, 1995, ARCHAEOLOGY DIS, P1; Rothschild BM, 1997, AM J PHYS ANTHROPOL, V104, P529, DOI 10.1002/(SICI)1096-8644(199712)104:4<529::AID-AJPA7>3.0.CO;2-M; Schedel H, 1994, Bildgebung, V61, P20; Steinbock RT, 1976, PALEOPATHOLOGICAL DI, P277; Stulberg SD, 1975, HIP, P212; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Tannast M, 2007, J ORTHOP RES, V25, P122, DOI 10.1002/jor.20309; THOMASON CB, 1983, CLIN NUCL MED, V8, P304, DOI 10.1097/00003072-198307000-00004; Villotte Sebastien, 2009, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V21, P95; Waldron T, 2009, CAMB MAN ARCHAEOL, P1; Walker P., 1989, INT J ANTHR, V4, P171, DOI DOI 10.1007/BF02446239; Weiss E, 2007, INT J OSTEOARCHAEOL, V17, P437, DOI 10.1002/oa.889; WELLS C, 1963, J BONE JOINT SURG BR, V45, P790, DOI 10.1302/0301-620X.45B4.790; Woods R. J., 1995, THESIS OHIO STATE U	62	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36537	10.1371/journal.pone.0036537	http://dx.doi.org/10.1371/journal.pone.0036537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567164	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500084
J	Vidwan, NK; Regi, A; Steinhoff, M; Huppert, JS; Staat, MA; Dodd, C; Nongrum, R; Anandan, S; Verghese, V				Vidwan, Navjyot K.; Regi, Annie; Steinhoff, Mark; Huppert, Jill S.; Staat, Mary Allen; Dodd, Caitlin; Nongrum, Rida; Anandan, Shalini; Verghese, Valsan			Low Prevalence of Chlamydia trachomatis Infection in Non-Urban Pregnant Women in Vellore, S. India	PLOS ONE			English	Article							PACE 2 ASSAY; CLEARVIEW; TESTS; CULTURE	Objective: To determine the prevalence and risk factors for Chlamydia trachomatis (CT) infection in pregnant women and the rate of transmission of CT to infants. Methods: Pregnant women (>= 28 weeks gestation) in Vellore, South India were approached for enrollment from April 2009 to January 2010. After informed consent was obtained, women completed a socio-demographic, prenatal, and sexual history questionnaire. Endocervical samples collected at delivery were examined for CT by a rapid enzyme test and nucleic acid amplification test (NAAT). Neonatal nasopharyngeal and conjunctival swabs were collected for NAAT testing. Results: Overall, 1198 women were enrolled and 799 (67%) endocervical samples were collected at birth. Analyses were completed on 784 participants with available rapid and NAAT results. The mean age of women was 25.8 years (range 18-39 yrs) and 22% (95% CI: 19.7-24.4%) were primigravida. All women enrolled were married; one reported. one sexual partner; and six reported prior STI. We found 71 positive rapid CT tests and 1/784 (0.1%; 95% CI: 0-0.38%) true positive CT infection using NAAT. Conclusions: To our knowledge, this is the largest study on CT prevalence amongst healthy pregnant mothers in southern India, and it documents a very low prevalence with NAAT. Many false positive results were noted using the rapid test. These data suggest that universal CT screening is not indicated in this population.	[Vidwan, Navjyot K.; Steinhoff, Mark; Huppert, Jill S.; Staat, Mary Allen; Dodd, Caitlin] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Regi, Annie; Nongrum, Rida; Anandan, Shalini; Verghese, Valsan] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Cincinnati Children's Hospital Medical Center; Christian Medical College & Hospital (CMCH) Vellore	Vidwan, NK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.	nkvidwan@gmail.com			Fogarty International Center, National Institutes of Health [R24TW007988]; Cincinnati Children's Hospital Medical Center Infectious Diseases Department; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Cincinnati Children's Hospital Medical Center Infectious Diseases Department; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Fogarty International Center, National Institutes of Health (R24TW007988, the Fogarty International Clinical Research Scholars Support Center), and Cincinnati Children's Hospital Medical Center Infectious Diseases Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER R, 1993, GENITOURIN MED, V69, P240; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; BLANDING J, 1993, J CLIN MICROBIOL, V31, P1622, DOI 10.1128/JCM.31.6.1622-1625.1993; Brabin L, 1998, B WORLD HEALTH ORGAN, V76, P277; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Chen Chun-Jen, 2007, Journal of Microbiology Immunology and Infection, V40, P255; El Qouqa IA, 2009, INT J INFECT DIS, V13, P334, DOI 10.1016/j.ijid.2008.07.013; HAMMERSCHLAG MR, 1989, J PEDIATR-US, V114, P727, DOI 10.1016/S0022-3476(89)80128-3; Hislop J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14290; Horner P, 2005, J CLIN MICROBIOL, V43, P2065, DOI 10.1128/JCM.43.5.2065-2069.2005; Joyee A G, 2005, Indian J Med Microbiol, V23, P37; Joyee AG, 2004, INT J STD AIDS, V15, P51, DOI 10.1258/095646204322637272; KLUYTMANS JAJW, 1993, J CLIN MICROBIOL, V31, P3204, DOI 10.1128/JCM.31.12.3204-3210.1993; Lauderdale TL, 1999, J CLIN MICROBIOL, V37, P2223, DOI 10.1128/JCM.37.7.2223-2229.1999; Livengood CH, 2001, J CLIN MICROBIOL, V39, P2928, DOI 10.1128/JCM.39.8.2928-2932.2001; Malik A, 2009, FERTIL STERIL, V91, P91, DOI 10.1016/j.fertnstert.2007.05.070; Mania-Pramanik J, 2001, SEX TRANSM INFECT, V77, P141, DOI 10.1136/sti.77.2.141; Paul VK, 1999, NATL MED J INDIA, V12, P11; Rastogi S, 2003, INT J GYNECOL OBSTET, V80, P129, DOI 10.1016/S0020-7292(02)00371-5; Rosenman MB, 2003, ARCH PEDIAT ADOL MED, V157, P565, DOI 10.1001/archpedi.157.6.565; Saison F, 2007, J CLIN MICROBIOL, V45, P4011, DOI 10.1128/JCM.01343-07; SINGH V, 1995, OBSTET GYNECOL, V85, P215, DOI 10.1016/0029-7844(94)00367-M; Singh V, 2003, J CLIN MICROBIOL, V41, P2700, DOI 10.1128/JCM.41.6.2700-2702.2003; Sturm AW, 1998, AM J PUBLIC HEALTH, V88, P1243, DOI 10.2105/AJPH.88.8.1243; Tang YJ, 2009, SE ASIAN J TROP MED, V40, P1038; The Inverness Medical Group of Companies, 2006, CLEARV CHAL MF; US Preventive Services Task Force, 2007, ANN INTERN MED, V147, P128, DOI 10.7326/0003-4819-147-2-200707170-00172; Wessel H F, 1998, Afr J Reprod Health, V2, P32; World Health Organization, 2010, SEX TRANSM DIS CHAL; Yin YP, 2006, SEX TRANSM INFECT, V82, pV33, DOI 10.1136/sti.2006.022475	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34794	10.1371/journal.pone.0034794	http://dx.doi.org/10.1371/journal.pone.0034794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567090	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500008
J	Ho, D; Chen, L; Zhao, X; Durham, N; Pannirselvam, M; Vatner, DE; Morgans, DJ; Malik, FI; Vatner, SF; Shen, YT				Ho, David; Chen, Li; Zhao, Xin; Durham, Nicquanna; Pannirselvam, Malar; Vatner, Dorothy E.; Morgans, David J.; Malik, Fady I.; Vatner, Stephen F.; Shen, You-Tang			Smooth Muscle Myosin Inhibition: A Novel Therapeutic Approach for Pulmonary Hypertension	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; NITRIC-OXIDE; NITROPRUSSIDE; VASODILATION; GUIDELINES; DIAGNOSIS; PIGLETS	Objective: Pulmonary hypertension remains a major clinical problem despite current therapies. In this study, we examine for the first time a novel pharmacological target, smooth muscle myosin, and determine if the smooth muscle myosin inhibitor, CK-2019165 (CK-165) ameliorates pulmonary hypertension. Materials and Methods: Six domestic female pigs were surgically instrumented to measure pulmonary blood flow and systemic and pulmonary vascular dynamics. Pulmonary hypertension was induced by hypoxia, or infusion of the thromboxane analog (U-46619, 0.1 mu g/kg/min, i.v.). In rats, chronic pulmonary hypertension was induced by monocrotaline. Results: CK-165 (4 mg/kg, i.v.) reduced pulmonary vascular resistance by 22 +/- 3 and 28 +/- 6% from baseline in hypoxia and thromboxane pig models, respectively (p<0.01 and 0.01), while mean arterial pressure also fell and heart rate rose slightly. When CK-165 was delivered via inhalation in the hypoxia model, pulmonary vascular resistance fell by 17 +/- 6% (p<0.05) while mean arterial pressure and heart rate were unchanged. In the monocrotaline model of chronic pulmonary hypertension, inhaled CK-165 resulted in a similar (18.0 +/- 3.8%) reduction in right ventricular systolic pressure as compared with sildenafil (20.3 +/- 4.5%). Conclusion: Inhibition of smooth muscle myosin may be a novel therapeutic target for treatment of pulmonary hypertension.	[Ho, David; Chen, Li; Zhao, Xin; Vatner, Dorothy E.; Vatner, Stephen F.; Shen, You-Tang] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Vatner, Stephen F.; Shen, You-Tang] CV Dynam Inc, N Brunswick, NJ USA; [Durham, Nicquanna; Pannirselvam, Malar; Morgans, David J.; Malik, Fady I.] Cytokinetics Inc, San Francisco, CA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Ho, D (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA.	vatnersf@umdnj.edu			National Institutes of Health [HL033107-27, HL069020-10, HL101420-01, HL093481-02, HL102472-01, HL069752-08, AG027211-04]; Cytokinetics; CV Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101420, T32HL069752, R01HL102472, R01HL093481, R01HL106511, P01HL069020, R01HL033107, R37HL033107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytokinetics; CV Dynamics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by National Institutes of Health (grants HL033107-27, HL069020-10, HL101420-01, HL093481-02, HL102472-01, HL069752-08, AG027211-04), and a grant from Cytokinetics and CV Dynamics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 1998, J APPL PHYSIOL, V84, P435, DOI 10.1152/jappl.1998.84.2.435; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gomberg-Maitland M, 2011, J AM COLL CARDIOL, V57, P1053, DOI 10.1016/j.jacc.2010.11.020; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Meadow W, 1998, PEDIATR RES, V44, P181, DOI 10.1203/00006450-199808000-00007; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morano S, 2000, Minerva Med, V91, P117; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; Safdar Z, 2011, RESP MED, V105, P818, DOI 10.1016/j.rmed.2010.12.018; Schutte H, 1997, J PHARMACOL EXP THER, V282, P985; Yu XQ, 1999, PEDIATR RES, V45, P255, DOI 10.1203/00006450-199902000-00017; Zhao X, 2011, J PHARMACOL EXP THER, V339, P307, DOI 10.1124/jpet.111.182402	15	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36302	10.1371/journal.pone.0036302	http://dx.doi.org/10.1371/journal.pone.0036302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563487	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700036
J	Dark, MJ; Lundgren, AM; Barbet, AF				Dark, Michael J.; Lundgren, Anna M.; Barbet, Anthony F.			Determining the Repertoire of Immunodominant Proteins via Whole-Genome Amplification of Intracellular Pathogens	PLOS ONE			English	Article							ANAPLASMA-MARGINALE; ANTIGENIC VARIATION; GENE CONVERSION; DIVERSITY; GENERATION; SURFACE; PHAGOCYTOPHILUM; SUPERINFECTION; TRANSMISSION; CONSERVATION	Culturing many obligate intracellular bacteria is difficult or impossible. However, these organisms have numerous adaptations allowing for infection persistence and immune system evasion, making them some of the most interesting to study. Recent advancements in genome sequencing, pyrosequencing and Phi29 amplification, have allowed for examination of whole-genome sequences of intracellular bacteria without culture. We have applied both techniques to the model obligate intracellular pathogen Anaplasma marginale and the human pathogen Anaplasma phagocytophilum, in order to examine the ability of phi29 amplification to determine the sequence of genes allowing for immune system evasion and long-term persistence in the host. When compared to traditional pyrosequencing, phi29-mediated genome amplification had similar genome coverage, with no additional gaps in coverage. Additionally, all msp2 functional pseudogenes from two strains of A. marginale were detected and extracted from the phi29-amplified genomes, highlighting its utility in determining the full complement of genes involved in immune evasion.	[Dark, Michael J.; Lundgren, Anna M.; Barbet, Anthony F.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Dark, Michael J.; Barbet, Anthony F.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Dark, MJ (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	darkmich@ufl.edu	Dark, Michael/AAB-4603-2021	Dark, Michael/0000-0002-6547-1298	National Institutes of Health [RO1GM081714]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was received from University-provided startup funds to MJD and National Institutes of Health grant RO1GM081714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Barbet AF, 2000, INFECT IMMUN, V68, P6133, DOI 10.1128/IAI.68.11.6133-6138.2000; Barbet AF, 2001, INFECT IMMUN, V69, P3057, DOI 10.1128/IAI.69.5.3057-3066.2001; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2002, MOL MICROBIOL, V43, P1151, DOI 10.1046/j.1365-2958.2002.02792.x; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Dark MJ, 2011, VACCINE, V29, P4923, DOI 10.1016/j.vaccine.2011.04.131; Dark MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-16; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Felsheim RF, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-42; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Futse JE, 2005, MOL MICROBIOL, V57, P212, DOI 10.1111/j.1365-2958.2005.04670.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hongoh Y, 2011, METHODS MOL BIOL, V733, P25, DOI 10.1007/978-1-61779-089-8_2; Lew AE, 2003, VET MICROBIOL, V92, P145, DOI 10.1016/S0378-1135(02)00352-8; Meeus PFM, 2003, MOL MICROBIOL, V47, P633, DOI 10.1046/j.1365-2958.2003.03331.x; Palmer GH, 2011, FEMS IMMUNOL MED MIC; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Rurangirwa FR, 2000, INFECT IMMUN, V68, P3023, DOI 10.1128/IAI.68.5.3023-3027.2000; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; Sperling U, 2011, BOVINE ANAPLASMOSIS, p[59, 94]; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102	24	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36456	10.1371/journal.pone.0036456	http://dx.doi.org/10.1371/journal.pone.0036456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558468	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200081
J	Li, JY; Sun, XD; Wang, ZZ; Chen, L; Li, DW; Zhou, J; Liu, M				Li, Jingyu; Sun, Xiaodong; Wang, Zaizhu; Chen, Li; Li, Dengwen; Zhou, Jun; Liu, Min			Regulation of Vascular Endothelial Cell Polarization and Migration by Hsp70/Hsp90-Organizing Protein	PLOS ONE			English	Article							MICROTUBULE-BINDING PROTEIN; STRESS-INDUCIBLE PROTEIN-1; TUMOR-SUPPRESSOR CYLD; CANCER GENE-THERAPY; CO-CHAPERONE HOP; TARGETING ANGIOGENESIS; CYCLE KINASES; IN-VITRO; AURORA-B; HSP90	Hsp70/Hsp90-organizing protein (HOP) is a member of the co-chaperone family, which directly binds to chaperones to regulate their activities. The participation of HOP in cell motility and endothelial cell functions remains largely unknown. In this study, we demonstrate that HOP is critically involved in endothelial cell migration and angiogenesis. Tube formation and capillary sprouting experiments reveal that depletion of HOP expression significantly inhibits vessel formation from endothelial cells. Wound healing and transwell migration assays show that HOP is important for endothelial cell migration. By examination of centrosome reorientation and membrane ruffle dynamics, we find that HOP plays a crucial role in the establishment of cell polarity in response to migratory stimulus. Furthermore, our data show that HOP interacts with tubulin and colocalizes with microtubules in endothelial cells. These findings indicate HOP as a novel regulator of angiogenesis that functions through promoting vascular endothelial cell polarization and migration.	[Li, Jingyu; Sun, Xiaodong; Wang, Zaizhu; Chen, Li; Li, Dengwen; Zhou, Jun] Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Min] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Minist Educ, Basic Med Coll, Tianjin, Peoples R China	Nankai University; Tianjin Medical University	Li, JY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Coll Life Sci, Tianjin 300071, Peoples R China.	minliu@tijmu.edu.cn	Li, Jingyu/GSD-1924-2022; Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260	National Basic Research Program of China [2012CB945002, 2010CB912204]; National Natural Science Foundation of China [30825022]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Basic Research Program of China (2012CB945002 and 2010CB912204) and the National Natural Science Foundation of China (30825022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-20; AUERBACH R, 1979, J IMMUNOL, V123, P751; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen QR, 2001, MOL GENET METAB, V74, P120, DOI 10.1006/mgme.2001.3223; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fonseca Ana-Violeta, 2011, Commun Integr Biol, V4, P201, DOI 10.4161/cib.4.2.14419; Gao JM, 2008, J BIOL CHEM, V283, P8802, DOI 10.1074/jbc.M708470200; Gao JM, 2010, BLOOD, V115, P4130, DOI 10.1182/blood-2009-10-248526; Gardlik R, 2011, BRATISL MED J, V112, P428; Huo LH, 2011, J BIOL CHEM, V286, P9280, DOI 10.1074/jbc.M110.208884; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li DW, 2011, PROTEIN CELL, V2, P150, DOI 10.1007/s13238-011-1015-4; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Liu CC, 2006, WORLD J GASTROENTERO, V12, P6941, DOI 10.3748/wjg.v12.i43.6941; Liu M, 2010, J PATHOL, V221, P221, DOI 10.1002/path.2706; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Longshaw VM, 2000, BIOL CHEM, V381, P1133, DOI 10.1515/BC.2000.139; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; McKenna LB, 2007, CELL MOL LIFE SCI, V64, P2723, DOI 10.1007/s00018-007-7247-z; NICOLET CM, 1989, MOL CELL BIOL, V9, P3638, DOI 10.1128/MCB.9.9.3638; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shi XJ, 2011, J BIOL CHEM, V286, P33401, DOI 10.1074/jbc.M111.252262; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Skalnikova H, 2011, J PROTEOME RES, V10, P404, DOI 10.1021/pr100468w; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Sun L, 2010, J PATHOL, V221, P425, DOI 10.1002/path.2723; Sun XD, 2011, ACTA PHARMACOL SIN, V32, P1543, DOI 10.1038/aps.2011.130; Sun XD, 2012, J PATHOL, V226, P666, DOI 10.1002/path.3026; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; Tandle Anita, 2004, J Transl Med, V2, P22, DOI 10.1186/1479-5876-2-22; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Walsh N, 2011, CANCER LETT, V306, P180, DOI 10.1016/j.canlet.2011.03.004; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Whitfield C, 2010, STRUCTURE, V18, P151, DOI 10.1016/j.str.2010.01.006; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	51	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36389	10.1371/journal.pone.0036389	http://dx.doi.org/10.1371/journal.pone.0036389			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558459	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200075
J	Cox, PG; Rayfield, EJ; Fagan, MJ; Herrel, A; Pataky, TC; Jeffery, N				Cox, Philip G.; Rayfield, Emily J.; Fagan, Michael J.; Herrel, Anthony; Pataky, Todd C.; Jeffery, Nathan			Functional Evolution of the Feeding System in Rodents	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; 2 MURID RODENTS; APODEMUS-SPECIOSUS; ONYCHOMYS-LEUCOGASTER; MASTICATORY MUSCLES; MANDIBULAR MOVEMENT; GUINEA-PIG; BITE-FORCE; MORPHOLOGY; MECHANICS	The masticatory musculature of rodents has evolved to enable both gnawing at the incisors and chewing at the molars. In particular, the masseter muscle is highly specialised, having extended anteriorly to originate from the rostrum. All living rodents have achieved this masseteric expansion in one of three ways, known as the sciuromorph, hystricomorph and myomorph conditions. Here, we used finite element analysis (FEA) to investigate the biomechanical implications of these three morphologies, in a squirrel, guinea pig and rat. In particular, we wished to determine whether each of the three morphologies is better adapted for either gnawing or chewing. Results show that squirrels are more efficient at muscle-bite force transmission during incisor gnawing than guinea pigs, and that guinea pigs are more efficient at molar chewing than squirrels. This matches the known diet of nuts and seeds that squirrels gnaw, and of grasses that guinea pigs grind down with their molars. Surprisingly, results also indicate that rats are more efficient as well as more versatile feeders than both the squirrel and guinea pig. There seems to be no compromise in biting efficiency to accommodate the wider range of foodstuffs and the more general feeding behaviour adopted by rats. Our results show that the morphology of the skull and masticatory muscles have allowed squirrels to specialise as gnawers and guinea pigs as chewers, but that rats are high-performance generalists, which helps explain their overwhelming success as a group.	[Cox, Philip G.] Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Rayfield, Emily J.] Univ Bristol, Dept Earth Sci, Bristol, Avon, England; [Fagan, Michael J.] Univ Hull, Dept Engn, Kingston Upon Hull HU6 7RX, N Humberside, England; [Herrel, Anthony] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Pataky, Todd C.] Shinshu Univ, Dept Bioengn, Ueda, Nagano, Japan; [Jeffery, Nathan] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England	University of Hull; University of York - UK; University of Bristol; University of Hull; Museum National d'Histoire Naturelle (MNHN); Shinshu University; University of Liverpool	Cox, PG (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England.	philip.cox@hyms.ac.uk	Rayfield, Emily/F-5038-2010; Herrel, Anthony/C-3712-2013	Rayfield, Emily/0000-0002-2618-750X; Herrel, Anthony/0000-0003-0991-4434; Pataky, Todd/0000-0002-8292-7189; Jeffery, Nathan/0000-0001-5166-2029; Cox, Philip Graham/0000-0001-9782-2358	Natural Environment Research Council (NERC) [NE/G001952/1]; NERC [NE/G001952/1, NE/G002207/1, NE/G001979/1] Funding Source: UKRI; Natural Environment Research Council [NE/G002207/1, NE/G001979/1, NE/G001952/1] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a grant from the Natural Environment Research Council (NERC grant NE/G001952/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; [Anonymous], 1999, WALKERS MAMMALS WORL; Becht G., 1953, Proceedings of the Koninklijke Nederlandse Akademie van Wetenschappen, V56C, P508; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; BRANDT J.F., 1855, MEM ACAD IMP SCI S 6, V7, P1; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; BYRD KE, 1981, J MORPHOL, V170, P147, DOI 10.1002/jmor.1051700203; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Cox PG, 2011, ANAT REC, V294, P915, DOI 10.1002/ar.21381; Curtis N, 2011, ANAT REC, V294, P1178, DOI 10.1002/ar.21415; Druzinsky RE, 2011, INTEGR COMP BIOL, V51, P224, DOI 10.1093/icb/icr067; Druzinsky RE, 2010, CELLS TISSUES ORGANS, V192, P50, DOI 10.1159/000284930; Druzinsky RE, 2010, CELLS TISSUES ORGANS, V191, P510, DOI 10.1159/000284931; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Eng CM, 2009, J EXP BIOL, V212, P4040, DOI 10.1242/jeb.029983; GORNIAK GC, 1977, J MORPHOL, V154, P427, DOI 10.1002/jmor.1051540305; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; HIIEMAE K, 1971, ZOOL J LINN SOC-LOND, V50, P111, DOI 10.1111/j.1096-3642.1971.tb00754.x; HIIEMAE KM, 1968, J ZOOL, V154, P139; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Macdonald D, 2001, NEW ENCY MAMMALS; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meng J, 2003, B AM MUS NAT HIST, P1; Meng Jin, 2005, P145; Miller G.S., 1918, J WASH ACAD SCI, V8, P431, DOI DOI 10.5962/BHL.PART.6490; Pataky TC, 2010, J BIOMECH, V43, P1976, DOI 10.1016/j.jbiomech.2010.03.008; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; ROBINS MW, 1977, ARCH ORAL BIOL, V22, P43, DOI 10.1016/0003-9969(77)90138-8; Satoh K, 1999, J MORPHOL, V240, P1; Satoh K, 1998, J MORPHOL, V236, P49, DOI 10.1002/(SICI)1097-4687(199804)236:1<49::AID-JMOR3>3.0.CO;2-J; Satoh K, 1997, J MORPHOL, V231, P131; Satoh K, 2006, J MORPHOL, V267, P987, DOI 10.1002/jmor.10443; Satoh K, 2009, ZOOMORPHOLOGY, V128, P339, DOI 10.1007/s00435-009-0094-8; Satoh Kazuhiko, 2008, Mammal Study, V33, P35, DOI 10.3106/1348-6160(2008)33[35:MMAIAM]2.0.CO;2; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; VANSPRONSEN PH, 1989, J DENT RES, V68, P1765, DOI 10.1177/00220345890680120901; WEIJS WA, 1975, J MORPHOL, V146, P1, DOI 10.1002/jmor.1051460102; WILLIAMS KR, 1984, BIOMATERIALS, V5, P347, DOI 10.1016/0142-9612(84)90033-4; Williams SH, 2009, J MORPHOL, V270, P1338, DOI 10.1002/jmor.10761; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WOOD AE, 1965, EVOLUTION, V19, P115, DOI 10.2307/2406300	51	121	130	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36299	10.1371/journal.pone.0036299	http://dx.doi.org/10.1371/journal.pone.0036299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558427	gold, Green Accepted, Green Published			2022-12-27	WOS:000305336000182
J	Lee, HS; Daniels, BH; Salas, E; Bollen, AW; Debnath, J; Margeta, M				Lee, Han S.; Daniels, Brianne H.; Salas, Eduardo; Bollen, Andrew W.; Debnath, Jayanta; Margeta, Marta			Clinical Utility of LC3 and p62 Immunohistochemistry in Diagnosis of Drug-Induced Autophagic Vacuolar Myopathies: A Case-Control Study	PLOS ONE			English	Article							COLCHICINE MYOPATHY; SKELETAL-MUSCLE; CHLOROQUINE; DISEASE; MICE	Background: Some patients treated with chloroquine, hydroxychloroquine, or colchicine develop autophagic vacuolar myopathy, the diagnosis of which currently requires electron microscopy. The goal of the current study was to develop an immunohistochemical diagnostic marker for this pathologic entity. Methodology: Microtubule-associated protein light chain 3 (LC3) has emerged as a robust marker of autophagosomes. LC3 binds p62/SQSTM1, an adapter protein that is selectively degraded via autophagy. In this study, we evaluated the utility of immunohistochemical stains for LC3 and p62 as diagnostic markers of drug-induced autophagic vacuolar myopathy. The staining was performed on archival muscle biopsy material, with subject assignment to normal control, drug-treated control, and autophagic myopathy groups based on history of drug use and morphologic criteria. Principal Findings: In all drug-treated subjects, but not in normal controls, LC3 and p62 showed punctate staining characteristic of autophagosome buildup. In the autophagic myopathy subjects, puncta were coarser and tended to coalesce into linear structures aligned with the longitudinal axis of the fiber, often in the vicinity of vacuoles. The percentage of LC3- and p62-positive fibers was significantly higher in the autophagic myopathy group compared to either the normal control (p<0.001) or the drug-treated control group (p<0.05). With the diagnostic threshold set between 8% and 15% positive fibers (depending on the desired level of sensitivity and specificity), immunohistochemical staining for either LC3 or p62 could be used to identify subjects with autophagic vacuolar myopathy within the drug-treated subject group (p <= 0.001). Significance: Immunohistochemistry for LC3 and p62 can facilitate tissue-based diagnosis of drug-induced autophagic vacuolar myopathies. By limiting the need for electron microscopy (a time consuming and costly technique with high specificity, but low sensitivity), clinical use of these markers will improve the speed and accuracy of diagnosis, resulting in significantly improved clinical care.	[Lee, Han S.; Daniels, Brianne H.; Salas, Eduardo; Bollen, Andrew W.; Debnath, Jayanta; Margeta, Marta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Daniels, Brianne H.] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA	University of California System; University of California San Francisco; Touro University California	Lee, HS (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	Marta.Margeta@ucsf.edu		Debnath, Jayanta/0000-0002-8745-4069; Margeta, Marta/0000-0001-6889-2488	NCI NIH HHS [R01 CA126792] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA126792] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdel-Hamid H, 2008, MUSCLE NERVE, V38, P1206, DOI 10.1002/mus.21091; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Casado E, 2006, ANN RHEUM DIS, V65, P385, DOI 10.1136/ard.2004.023200; Chen N, 2010, FEBS LETT, V584, P1427, DOI 10.1016/j.febslet.2009.12.034; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Estes M L, 1987, Am J Med, V82, P447, DOI 10.1016/0002-9343(87)90444-X; Fernandez C, 2002, ACTA NEUROPATHOL, V103, P100; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; KUMAMOTO T, 1993, MUSCLE NERVE, V16, P819, DOI 10.1002/mus.880160803; Kuncl RW, 2003, EXP CELL RES, V285, P196, DOI 10.1016/S0014-4827(03)00034-X; KUNCL RW, 1987, NEW ENGL J MED, V316, P1562, DOI 10.1056/NEJM198706183162502; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; Malicdan MC, 2008, NEUROMUSCULAR DISORD, V18, P521, DOI 10.1016/j.nmd.2008.04.010; MARKAND ON, 1971, ARCH NEUROL-CHICAGO, V24, P72, DOI 10.1001/archneur.1971.00480310100010; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Nishino Ichizo, 2006, Semin Pediatr Neurol, V13, P90, DOI 10.1016/j.spen.2006.06.004; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Siddiqui AK, 2007, CHEST, V131, P588, DOI 10.1378/chest.06-1146; STAUBER WT, 1981, EXP NEUROL, V71, P295, DOI 10.1016/0014-4886(81)90090-X; Stein M, 2000, J RHEUMATOL, V27, P2927; Temiz P, 2009, J NEUROL SCI, V278, P25, DOI 10.1016/j.jns.2008.11.010; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Wilbur K, 2004, PHARMACOTHERAPY, V24, P1784, DOI 10.1592/phco.24.17.1784.52334; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278	37	55	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36221	10.1371/journal.pone.0036221	http://dx.doi.org/10.1371/journal.pone.0036221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558391	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000160
J	Dorokhov, YL; Komarova, TV; Petrunia, IV; Kosorukov, VS; Zinovkin, RA; Shindyapina, AV; Frolova, OY; Gleba, YY				Dorokhov, Yuri L.; Komarova, Tatiana V.; Petrunia, Igor V.; Kosorukov, Vyacheslav S.; Zinovkin, Roman A.; Shindyapina, Anastasia V.; Frolova, Olga Y.; Gleba, Yuri Y.			Methanol May Function as a Cross-Kingdom Signal	PLOS ONE			English	Article							ENZYME PECTIN METHYLESTERASE; TUBE MASS-SPECTROMETRY; MODIFIED CITRUS PECTIN; TRANSDUCED HELA-CELLS; MOSAIC-VIRUS MOVEMENT; ADENOSYL-L-METHIONINE; U-SHAPED CURVE; PROTEIN CARBOXYMETHYLASE; S-ADENOSYLMETHIONINE; ALZHEIMERS-DISEASE	Recently, we demonstrated that leaf wounding results in the synthesis of pectin methylesterase (PME), which causes the plant to release methanol into the air. Methanol emitted by a wounded plant increases the accumulation of methanol-inducible gene mRNA and enhances antibacterial resistance as well as cell-to-cell communication, which facilitates virus spreading in neighboring plants. We concluded that methanol is a signaling molecule involved in within-plant and plant-to-plant communication. Methanol is considered to be a poison in humans because of the alcohol dehydrogenase (ADH)-mediated conversion of methanol into toxic formaldehyde. However, recent data showed that methanol is a natural compound in normal, healthy humans. These data call into question whether human methanol is a metabolic waste product or whether methanol has specific function in humans. Here, to reveal human methanol-responsive genes (MRGs), we used suppression subtractive hybridization cDNA libraries of HeLa cells lacking ADH and exposed to methanol. This design allowed us to exclude genes involved in formaldehyde and formic acid detoxification from our analysis. We identified MRGs and revealed a correlation between increases in methanol content in the plasma and changes in human leukocyte MRG mRNA levels after fresh salad consumption by volunteers. Subsequently, we showed that the methanol generated by the pectin/PME complex in the gastrointestinal tract of mice induces the up- and downregulation of brain MRG mRNA. We used an adapted Y-maze to measure the locomotor behavior of the mice while breathing wounded plant vapors in two-choice assays. We showed that mice prefer the odor of methanol to other plant volatiles and that methanol changed MRG mRNA accumulation in the mouse brain. We hypothesize that the methanol emitted by wounded plants may have a role in plant-animal signaling. The known positive effect of plant food intake on human health suggests a role for physiological methanol in human gene regulation.	[Dorokhov, Yuri L.; Komarova, Tatiana V.; Zinovkin, Roman A.; Shindyapina, Anastasia V.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Dorokhov, Yuri L.; Komarova, Tatiana V.; Petrunia, Igor V.; Frolova, Olga Y.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; [Kosorukov, Vyacheslav S.] Russian Acad Med Sci, NN Blokhin Natl Canc Res Ctr, Moscow, Russia; [Gleba, Yuri Y.] Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany	Lomonosov Moscow State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences	Dorokhov, YL (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Komarova, Tatiana V./D-5824-2012; Dorokhov, Yuri L/D-3565-2012; Zinovkin, Roman/J-2500-2013; Kosorukov, Viacheslav S/A-3901-2014	Komarova, Tatiana V./0000-0001-6558-8755; Dorokhov, Yuri L/0000-0002-4066-8940; Zinovkin, Roman/0000-0001-5337-4346; Kosorukov, Viacheslav S/0000-0002-8462-2178; Gleba, Yuri/0000-0003-4675-7474; Shindyapina, Anastasia/0000-0002-7336-3086	Russian Fund of Basic Research [11-04-01152-a]	Russian Fund of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by grant (11-04-01152-a) from Russian Fund of Basic Research (http://grant.rfbr.ru). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altorf-van Der Kuil W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012102; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Attar N, 2010, ADV ENZYME REGUL, V50, P216, DOI 10.1016/j.advenzreg.2009.10.002; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Bergman M, 2010, BIOMED PHARMACOTHER, V64, P44, DOI 10.1016/j.biopha.2009.03.004; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Boyle R, SCEPTICAL CHYMIST CH; Brent J, 2010, CLIN TOXICOL, V48, P401, DOI 10.3109/15563650.2010.495347; Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; Brown L, 1999, AM J CLIN NUTR, V69, P30; BYERS JA, 1992, J CHEM ECOL, V18, P2385, DOI 10.1007/BF00984957; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Datta NJ, 2003, DRUG ALCOHOL DEPEN, V71, P87, DOI 10.1016/S0376-8716(03)00066-8; De Gouw JA, 2000, ENVIRON SCI TECHNOL, V34, P2640, DOI 10.1021/es991219k; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Diachenko L., 1996, P NATL ACAD SCI USA, V93, P6025; DICKSON D, 1981, NATURE, V292, P283, DOI 10.1038/292283b0; DILIBERT.EJ, 1974, P NATL ACAD SCI USA, V71, P1701, DOI 10.1073/pnas.71.5.1701; DILIBERTO EJ, 1976, P NATL ACAD SCI USA, V73, P4050, DOI 10.1073/pnas.73.11.4050; DILIBERTO EJ, 1976, J NEUROCHEM, V26, P1159, DOI 10.1111/j.1471-4159.1976.tb07001.x; Divol F, 2005, PLANT MOL BIOL, V57, P517, DOI 10.1007/s11103-005-0338-z; Dorokhov YL, 1999, FEBS LETT, V461, P223, DOI 10.1016/S0014-5793(99)01447-7; Dorokhov YL, 2006, FEBS LETT, V580, P3872, DOI 10.1016/j.febslet.2006.06.013; Dorokhov YL, 2006, FEBS LETT, V580, P3329, DOI 10.1016/j.febslet.2006.04.090; Dorokhov YL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002640; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; DWYER JT, 1988, AM J CLIN NUTR, V48, P712, DOI 10.1093/ajcn/48.3.712; Ehlting J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-154; Enderby B, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/036001; ERIKSEN SP, 1963, SCIENCE, V141, P639, DOI 10.1126/science.141.3581.639; Ewen R, 2005, RAPID DIAGNOSIS GAST; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Fisher JW, 2000, TOXICOL SCI, V53, P185, DOI 10.1093/toxsci/53.2.185; Fosu-Nyarko J, 2009, MOL PLANT PATHOL, V10, P237, DOI 10.1111/j.1364-3703.2008.00526.x; Francies KE, 2007, PLANT PHYSIOL, V142, P1004; Frenkel C, 1998, J BIOL CHEM, V273, P4293, DOI 10.1074/jbc.273.8.4293; Fuso A, 2012, NEUROBIOL A IN PRESS, DOI [10.1016/j.bbr.2011.03.031, DOI 10.1016/J.BBR.2011.03.031]; GAGNON C, 1978, LIFE SCI, V22, P2155, DOI 10.1016/0024-3205(78)90566-0; Gallaher CM, 2009, BRIT J NUTR, V101, P233, DOI 10.1017/S0007114508995684; Galli A, 1999, HEPATOLOGY, V29, P1164, DOI 10.1002/hep.510290420; Gasanova TV, 2008, MOL BIOL+, V42, P421, DOI 10.1134/S0026893308030102; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Goren JL, 2004, PHARMACOTHERAPY, V24, P1501, DOI 10.1592/phco.24.16.1501.50943; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Haffner HT, 1997, FORENSIC SCI INT, V86, P69, DOI 10.1016/S0379-0738(97)02119-1; Hansen JM, 2005, BIRTH DEFECTS RES A, V73, P72, DOI 10.1002/bdra.20094; Hasunuma T, 2004, J BIOTECHNOL, V111, P241, DOI 10.1016/j.jbiotec.2004.04.015; Hasunuma T, 2003, J BIOTECHNOL, V106, P45, DOI 10.1016/j.jbiotec.2003.07.008; Heil M, 2010, TRENDS ECOL EVOL, V25, P137, DOI 10.1016/j.tree.2009.09.010; Holopainen JK, 2010, TRENDS PLANT SCI, V15, P176, DOI 10.1016/j.tplants.2010.01.006; Hoog JO, 2011, CHEM-BIOL INTERACT, V191, P2, DOI 10.1016/j.cbi.2011.01.028; Hovda KE, 2008, HUM EXP TOXICOL, V27, P539, DOI 10.1177/0960327108095992; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Martin-Subero JI, 2011, ADV EXP MED BIOL, V711, P162; Jacobsen D, 1997, J TOXICOL-CLIN TOXIC, V35, P127, DOI 10.3109/15563659709001182; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Jenkins J, 2001, J MOL BIOL, V305, P951, DOI 10.1006/jmbi.2000.4324; Jolie RP, 2010, CARBOHYD RES, V345, P2583, DOI 10.1016/j.carres.2010.10.002; JONES AW, 1987, PHARMACOL TOXICOL, V60, P217, DOI 10.1111/j.1600-0773.1987.tb01737.x; Key TJ, 1999, AM J CLIN NUTR, V70, p516S, DOI 10.1093/ajcn/70.3.516s; Kimura M, 2011, PSYCHIAT CLIN NEUROS, V65, P213, DOI 10.1111/j.1440-1819.2011.02190.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Korner E, 2009, J EXP BOT, V60, P2631, DOI 10.1093/jxb/erp106; Kostic MA, 2003, J TOXICOL-CLIN TOXIC, V41, P793, DOI 10.1081/CLT-120025344; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; Lagaert S, 2009, SEMIN CELL DEV BIOL, V20, P1064, DOI 10.1016/j.semcdb.2009.05.008; Ledochowski M, 2005, BREATH ANALYSIS: FOR CLINICAL DIAGNOSIS AND ATHERAPEUTIC MONITORING, P375, DOI 10.1142/9789812701954_0026; Lee ES, 2008, LIFE SCI, V83, P821, DOI 10.1016/j.lfs.2008.09.020; LESTER D, 1962, Q J STUD ALCOHOL, V23, P17; Lindinger W, 1997, ALCOHOL CLIN EXP RES, V21, P939; Linnebank M, 2010, NEURODEGENER DIS, V7, P373, DOI 10.1159/000309657; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu HY, 2008, WORLD J GASTROENTERO, V14, P7386, DOI 10.3748/wjg.14.7386; Liu JR, 2009, J AGR FOOD CHEM, V57, P297, DOI 10.1021/jf801826w; Liu L, 2010, CARCINOGENESIS, V31, P1822, DOI 10.1093/carcin/bgq070; Louvet R, 2006, PLANTA, V224, P782, DOI 10.1007/s00425-006-0261-9; LUKYANOV SA, 1994, BIOORG KHIM+, V20, P701; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Markovic O, 2004, CARBOHYD RES, V339, P2281, DOI 10.1016/j.carres.2004.06.023; Markovic O, 2002, CELL MOL LIFE SCI, V59, P513, DOI 10.1007/s00018-002-8442-6; MARMOT M, 1991, BMJ-BRIT MED J, V303, P565, DOI 10.1136/bmj.303.6802.565; Matsumoto M, 2011, ALCOHOL CLIN EXP RES, V35, P28, DOI 10.1111/j.1530-0277.2010.01319.x; Megarbane B, 2005, INTENS CARE MED, V31, P189, DOI 10.1007/s00134-004-2521-0; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Miura K, 2004, AM J EPIDEMIOL, V159, P572, DOI 10.1093/aje/kwh085; Monte W. C., 1984, Journal of Applied Nutrition, V36, P42; Monte WC, 2010, MED HYPOTHESES, V74, P493, DOI 10.1016/j.mehy.2009.09.059; Nakao H, 2003, J PHARMACOL SCI, V91, P83, DOI 10.1254/jphs.91.83; Nangia-Makker P, 2002, JNCI-J NATL CANCER I, V94, P1854, DOI 10.1093/jnci/94.24.1854; Nassirpour R, 2007, CHANNELS, V1, P331, DOI 10.4161/chan.5191; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; Neuthouser ML, 2006, CANCER EPIDEM BIOMAR, V15, P1755, DOI 10.1158/1055-9965.EPI-06-0728; Oyama Y, 2002, CELL BIOL TOXICOL, V18, P43, DOI 10.1023/A:1014419229301; Panza F, 2009, THESCIENTIFICWORLDJO, V9, P373, DOI 10.1100/tsw.2009.48; Pelletier S, 2010, NEW PHYTOL, V188, P726, DOI 10.1111/j.1469-8137.2010.03409.x; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Penuelas J, 2005, NEW PHYTOL, V167, P851, DOI 10.1111/j.1469-8137.2005.01459.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potter JD, 1996, IARC SCI PUBL, P61; Preston CA, 1999, PLANTA, V209, P87, DOI 10.1007/s004250050609; Raiola A, 2011, MOL PLANT MICROBE IN, V24, P432, DOI 10.1094/MPMI-07-10-0157; Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90; San Jose B, 1999, J STUD ALCOHOL, V60, P725, DOI 10.15288/jsa.1999.60.725; Schapira Matthieu, 2011, Curr Chem Genomics, V5, P85, DOI 10.2174/1875397301005010085; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; SMITH RJ, 1981, SCIENCE, V213, P986, DOI 10.1126/science.7268411; SNYDER SH, 1967, NATURE, V215, P773, DOI 10.1038/215773b0; STASSEWOLTHUIS M, 1980, AM J CLIN NUTR, V33, P1745, DOI 10.1093/ajcn/33.8.1745; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; TAUCHER J, 1995, ALCOHOL CLIN EXP RES, V19, P1147, DOI 10.1111/j.1530-0277.1995.tb01593.x; TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5; Tian GW, 2006, DEV BIOL, V294, P83, DOI 10.1016/j.ydbio.2006.02.026; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Trocho C, 1998, LIFE SCI, V63, P337, DOI 10.1016/S0024-3205(98)00282-3; Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402; Turner C, 2006, PHYSIOL MEAS, V27, P637, DOI 10.1088/0967-3334/27/7/007; van Weering JRT, 2010, SEMIN CELL DEV BIOL, V21, P371, DOI 10.1016/j.semcdb.2009.11.009; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Voglesonger KM, 2001, CHEM GEOL, V180, P129, DOI 10.1016/S0009-2541(01)00310-2; von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x; Walley JW, 2010, J INTEGR PLANT BIOL, V52, P354, DOI 10.1111/j.1744-7909.2010.00940.x; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; WESTERN O C, 1949, U S Nav Med Bull, V49, P574; Williams LB, 2005, GEOLOGY, V33, P913, DOI 10.1130/G21751.1; Williams LB, 2011, EARLIEST LIFE ON EARTH: HABITATS, ENVIORNMENTS AND METHODS OF DETECTION, P79, DOI 10.1007/978-90-481-8794-2_4; WOLF ME, 1985, J NEUROCHEM, V44, P291, DOI 10.1111/j.1471-4159.1985.tb07143.x; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; XIAO Q, 1995, J CLIN INVEST, V96, P2180, DOI 10.1172/JCI118272; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; ZATMAN LJ, 1946, BIOCHEM J, V40, P67	144	23	24	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36122	10.1371/journal.pone.0036122	http://dx.doi.org/10.1371/journal.pone.0036122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563443	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100068
J	Lee, ST; Chu, K; Jung, KH; Kim, JM; Moon, HJ; Bahn, JJ; Im, WS; Sunwoo, J; Moon, J; Kim, M; Lee, SK; Roh, JK				Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jeong-Min; Moon, Hye-Jin; Bahn, Jae-Jun; Im, Woo-Seok; Sunwoo, Junsang; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu			Circulating CD62E(+) Microparticles and Cardiovascular Outcomes	PLOS ONE			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VITRO; PLATELET MICROPARTICLES; MYOCARDIAL-INFARCTION; HEART-DISEASE; CELLS; DYSFUNCTION; ATHEROSCLEROSIS; ACTIVATION; PREDICTION	Background: Activated endothelial cells release plasma membrane submicron vesicles expressing CD62E (E-selectin) into blood, known as endothelial microparticles (EMPs). We studied whether the levels of endothelial microparticles expressing CD62E(+), CD31(+)/Annexin-V+, or CD31(+)/CD42(-) predict cardiovascular outcomes in patients with stroke history. Methods/Principal Findings: Patients with stroke history at least 3 months prior to enrolment were recruited. Peripheral blood EMP levels were measured by flow cytometry. Major cardiovascular events and death were monitored for 36 months. Three hundred patients were enrolled, of which 298 completed the study according to protocol. Major cardiovascular events occurred in 29 patients (9.7%). Nine patients died, five from cardiovascular causes. Cumulative event-free survival rates were lower in patients with high levels of CD62E(+) microparticles. Multivariate Cox regression analysis adjusted for cardiovascular risk factors, medications and stroke etiologic groups showed an association between a high CD62E(+) microparticle level and a risk of major cardiovascular events and hospitalization. Levels of other kinds of EMPs expressing CD31(+)/Annexin-V+ or CD31(+)/CD42(-) markers were not predictive of cardiovascular outcomes. Conclusion: A high level of CD62E(+) microparticles is associated with cardiovascular events in patients with stroke history, suggesting that the systemic endothelial activation increases the risk for cardiovascular morbidities.	[Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Jeong-Min; Moon, Hye-Jin; Bahn, Jae-Jun; Im, Woo-Seok; Sunwoo, Junsang; Moon, Jangsup; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea; [Lee, Soon-Tae; Chu, Kon; Jung, Keun-Hwa; Kim, Manho; Lee, Sang Kun; Roh, Jae-Kyu] Seoul Natl Univ, Coll Med, Program Neurosci, Neurosci Res Inst,Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, ST (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Dept Neurol, Seoul 110744, South Korea.	rohjk@snu.ac.kr	Kim, Manho/J-2738-2012; Roh, Jae Kyu/J-5459-2012; Lee, Soon-Tae/C-4663-2013; Lee, Sang Kun/J-5578-2012	Kim, Jeong-Min/0000-0001-7213-5527; Moon, Jangsup/0000-0003-1282-4528; Sunwoo, Jun-Sang/0000-0001-8834-0568; Lee, Soon-Tae/0000-0003-4767-7564; Chu, Kon/0000-0001-5863-0302	Stem Cell Research Center [SC4120]; National Research Foundation of Korea [2009-0080355]; Ministry of Education, Science and Technology, South Korea	Stem Cell Research Center; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant (SC4120) from Stem Cell Research Center of the 21st Century Frontier Research Program, and the Original Technology Research Program for Brain Science (2009-0080355) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Amabile N, 2010, SEMIN THROMB HEMOST, V36, P907, DOI 10.1055/s-0030-1267044; Amabile N, 2009, J HEART LUNG TRANSPL, V28, P1081, DOI 10.1016/j.healun.2009.06.005; Arteaga RB, 2006, AM J CARDIOL, V98, P70, DOI 10.1016/j.amjcard.2006.01.054; Bernal-Mizrachi L, 2003, AM HEART J, V145, P962, DOI 10.1016/S0002-8703(03)00103-0; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Brogan PA, 2004, ARTHRITIS RHEUM, V50, P927, DOI 10.1002/art.20199; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; De Caterina R, 2010, ANN NY ACAD SCI, V1207, P23, DOI 10.1111/j.1749-6632.2010.05784.x; Ferreira AC, 2004, CIRCULATION, V110, P3599, DOI 10.1161/01.CIR.0000148820.55611.6B; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Jung KH, 2009, ANN NEUROL, V66, P191, DOI 10.1002/ana.21681; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Kushak RI, 2005, THROMB RES, V116, P409, DOI 10.1016/j.thromres.2005.01.013; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rossig L, 2000, J AM COLL CARDIOL, V36, P2081, DOI 10.1016/S0735-1097(00)01002-0; Sabatier F, 2002, DIABETES, V51, P2840, DOI 10.2337/diabetes.51.9.2840; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yun CH, 2010, J CLIN NEUROL, V6, P89, DOI 10.3988/jcn.2010.6.2.89; ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984	33	55	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35713	10.1371/journal.pone.0035713	http://dx.doi.org/10.1371/journal.pone.0035713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563392	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100020
J	Murray, TS; Okegbe, C; Gao, Y; Kazmierczak, BI; Motterlini, R; Dietrich, LEP; Bruscia, EM				Murray, Thomas S.; Okegbe, Chinweike; Gao, Yuan; Kazmierczak, Barbara I.; Motterlini, Roberto; Dietrich, Lars E. P.; Bruscia, Emanuela M.			The Carbon Monoxide Releasing Molecule CORM-2 Attenuates Pseudomonas aeruginosa Biofilm Formation	PLOS ONE			English	Article							ANTIMICROBIAL ACTION; LIPOPOLYSACCHARIDE; RESPIRATION; INFECTIONS; TARGETS; OXYGEN	Chronic infections resulting from biofilm formation are difficult to eradicate with current antimicrobial agents and consequently new therapies are needed. This work demonstrates that the carbon monoxide-releasing molecule CORM-2, previously shown to kill planktonic bacteria, also attenuates surface-associated growth of the Gram-negative pathogen Pseudomonas aeruginosa by both preventing biofilm maturation and killing bacteria within the established biofilm. CORM-2 treatment has an additive effect when combined with tobramycin, a drug commonly used to treat P. aeruginosa lung infections. CORM-2 inhibited biofilm formation and planktonic growth of the majority of clinical P. aeruginosa isolates tested, for both mucoid and non-mucoid strains. While CORM-2 treatment increased the production of reactive oxygen species by P. aeruginosa biofilms, this increase did not correlate with bacterial death. These data demonstrate that CO-RMs possess potential novel therapeutic properties against a subset of P. aeruginosa biofilm related infections.	[Murray, Thomas S.; Bruscia, Emanuela M.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Okegbe, Chinweike; Dietrich, Lars E. P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Motterlini, Roberto] Univ Paris Est, INSERM, U955, Creteil, France	Yale University; Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Murray, TS (corresponding author), Quinnipiac Univ Frank H Netter MD, Sch Med, Dept Basic Sci, Hamden, CT 06518 USA.	emanuela.bruscia@yale.edu	Motterlini, Roberto/Q-1890-2019	Motterlini, Roberto/0000-0003-2684-2612; Kazmierczak, Barbara/0000-0002-8162-803X; Dietrich, Lars/0000-0003-2049-1137	United States National Institutes of Health [R01 HL093004, P30 DK072442, K08 AI071074]; Charles Hood Foundation; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075051, K08AI071074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles Hood Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the United States National Institutes of Health (R01 HL093004 to E. M. B.; P30 DK072442 to the Yale Center of Excellence in Molecular Hematology; and K08 AI071074 to T.S.M.). T.S.M. is also supported by a Charles Hood Foundation Award. C.O. has a Gilliam Fellowship from the Howard Hughes Medical Institute. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathoorn E, 2007, EUR RESPIR J, V30, P1131, DOI 10.1183/09031936.00163206; Bilban M, 2008, J MOL MED, V86, P267, DOI 10.1007/s00109-007-0276-0; Burmolle M, 2010, FEMS IMMUNOL MED MIC, V59, P324, DOI 10.1111/j.1574-695X.2010.00714.x; Chhikara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008139; Davidge KS, 2009, J BIOL CHEM, V284, P4516, DOI 10.1074/jbc.M808210200; Desmard M, 2011, ANTIOXID REDOX SIGNA; Desmard M, 2007, ANTIOXID REDOX SIGN, V9, P2139, DOI 10.1089/ars.2007.1803; Desmard M, 2009, FASEB J, V23, P1023, DOI 10.1096/fj.08-122804; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Megias J, 2007, BRIT J PHARMACOL, V150, P977, DOI 10.1038/sj.bjp.0707184; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mizuguchi S, 2009, AM J PHYSIOL-HEART C, V297, pH920, DOI 10.1152/ajpheart.00305.2009; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Motterlini R, 2005, EXPERT OPIN INV DRUG, V14, P1305, DOI 10.1517/13543784.14.11.1305; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Murray TS, 2010, J MED MICROBIOL, V59, P511, DOI 10.1099/jmm.0.017715-0; Nobre LS, 2007, ANTIMICROB AGENTS CH, V51, P4303, DOI 10.1128/AAC.00802-07; Nobre LS, 2009, MICROBIOL-SGM, V155, P813, DOI 10.1099/mic.0.023911-0; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rau MH, 2010, ENVIRON MICROBIOL, V12, P1643, DOI 10.1111/j.1462-2920.2010.02211.x; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Smith H, 2011, IUBMB LIFE, V63, P363, DOI 10.1002/iub.476; Tavares AF, 2011, J BIOL CHEM; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006	33	39	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35499	10.1371/journal.pone.0035499	http://dx.doi.org/10.1371/journal.pone.0035499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563385	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100014
J	Bharath, SR; Bisht, S; Harijan, RK; Savithri, HS; Murthy, MRN				Bharath, Sakshibeedu R.; Bisht, Shveta; Harijan, Rajesh K.; Savithri, Handanahal S.; Murthy, Mathur R. N.			Structural and Mutational Studies on Substrate Specificity and Catalysis of Salmonella typhimurium D-Cysteine Desulfhydrase	PLOS ONE			English	Article							D-SERINE DEHYDRATASE; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; 3-DIMENSIONAL STRUCTURE; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURES; IDENTIFICATION; CEPHAMYCIN; MECHANISM; INSIGHT; COMPLEX	Salmonella typhimurium DCyD (StDCyD) is a fold type II pyridoxal 5' phosphate (PLP)-dependent enzyme that catalyzes the degradation of D-Cys to H2S and pyruvate. It also efficiently degrades beta-chloro-D-alanine (beta CDA). D-Ser is a poor substrate while the enzyme is inactive with respect to L-Ser and 1-amino-1-carboxy cyclopropane (ACC). Here, we report the X-ray crystal structures of StDCyD and of crystals obtained in the presence of D-Cys, beta CDA, ACC, D-Ser, L-Ser, D-cycloserine (DCS) and L-cycloserine (LCS) at resolutions ranging from 1.7 to 2.6 angstrom. The polypeptide fold of StDCyD consisting of a small domain (residues 48-161) and a large domain (residues 1-47 and 162-328) resembles other fold type II PLP dependent enzymes. The structures obtained in the presence of D-Cys and beta CDA show the product, pyruvate, bound at a site 4.0-6.0 angstrom away from the active site. ACC forms an external aldimine complex while D- and L-Ser bind non-covalently suggesting that the reaction with these ligands is arrested at C alpha proton abstraction and transimination steps, respectively. In the active site of StDCyD cocrystallized with DCS or LCS, electron density for a pyridoxamine phosphate (PMP) was observed. Crystals soaked in cocktail containing these ligands show density for PLP-cycloserine. Spectroscopic observations also suggest formation of PMP by the hydrolysis of cycloserines. Mutational studies suggest that Ser78 and Gln77 are key determinants of enzyme specificity and the phenolate of Tyr287 is responsible for C alpha proton abstraction from D-Cys. Based on these studies, a probable mechanism for the degradation of D-Cys by StDCyD is proposed.	[Bharath, Sakshibeedu R.; Bisht, Shveta; Harijan, Rajesh K.; Murthy, Mathur R. N.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Savithri, Handanahal S.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bharath, SR (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mm@mbu.iisc.ernet.in	Harijan, Rajesh K./AAY-3277-2021	Bisht, Shveta/0000-0002-5566-3472; Harijan, Rajesh/0000-0003-1503-5057	Department of Science and Technology, Government of India; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Department of Science and Technology (DST); ESRF Grenoble	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); ESRF Grenoble	This work supported by: (1) Department of Science and Technology, Government of India and (2) Department of Biotechnology, Government of India and (3) Council of Scientific and Industrial Research, Government of India. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The diffraction data were collected using the X-ray facility at Molecular Biophysics Unit, Indian Institute of Science, supported by the Department of Science and Technology (DST) and the Department of Biotechnology (DBT), Government of India and at ESRF Grenoble. We thank the staff at the X-ray laboratory in MBU and beam line scientists at BM14, ESRF for their cooperation during data collection.	ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bharath SR, 2011, FEBS J, V278, P2879, DOI 10.1111/j.1742-4658.2011.08210.x; Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Davis L, ENZYMES, P33; DeLano W.L., PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5372; Fujino A, 2004, J MOL BIOL, V341, P999, DOI 10.1016/j.jmb.2004.06.062; Gallagher DT, 1998, STRUCTURE, V6, P465, DOI 10.1016/S0969-2126(98)00048-3; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; GRABOWSKI R, 1993, TRENDS BIOCHEM SCI, V18, P297, DOI 10.1016/0968-0004(93)90040-T; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; INOUYE S, 1984, ANTIMICROB AGENTS CH, V26, P722, DOI 10.1128/AAC.26.5.722; INOUYE S, 1984, J ANTIBIOT, V37, P1403, DOI 10.7164/antibiotics.37.1403; Ito T, 2008, BIOCHEM J, V409, P399, DOI 10.1042/BJ20070642; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karthikeyan S, 2004, BIOCHEMISTRY-US, V43, P13328, DOI 10.1021/bi048878g; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; NAGASAWA T, 1985, EUR J BIOCHEM, V153, P541, DOI 10.1111/j.1432-1033.1985.tb09335.x; Ose T, 2003, J BIOL CHEM, V278, P41069, DOI 10.1074/jbc.M305865200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavelka A, 2009, NUCLEIC ACIDS RES, V37, pW376, DOI 10.1093/nar/gkp410; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Sharif S, 2007, J AM CHEM SOC, V129, P6313, DOI 10.1021/ja070296+; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Simanshu DK, 2006, J BIOL CHEM, V281, P39630, DOI 10.1074/jbc.M605721200; Smith MA, 2010, J BIOL CHEM, V285, P12873, DOI 10.1074/jbc.M109.050062; Todorovic B, 2008, PLANTA, V229, P193, DOI 10.1007/s00425-008-0820-3; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yao M, 2000, J BIOL CHEM, V275, P34557, DOI 10.1074/jbc.M004681200	39	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36267	10.1371/journal.pone.0036267	http://dx.doi.org/10.1371/journal.pone.0036267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574144	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305349800040
J	Gronroos, NN; Chamberlain, AM; Folsom, AR; Soliman, EZ; Agarwal, SK; Nettleton, JA; Alonso, A				Gronroos, Noelle N.; Chamberlain, Alanna M.; Folsom, Aaron R.; Soliman, Elsayed Z.; Agarwal, Sunil K.; Nettleton, Jennifer A.; Alonso, Alvaro			Fish, Fish-Derived n-3 Fatty Acids, and Risk of Incident Atrial Fibrillation in the Atherosclerosis Risk in Communities (ARIC) Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ARTERY-BYPASS SURGERY; PREVENTION; OMEGA-3-FATTY-ACIDS; CONSUMPTION; DIET; ASSOCIATION; ARRHYTHMIAS; WHITES	Background: Results of observational and experimental studies investigating the association between intake of long-chain n-3 polyunsaturated fatty acids (PUFAs) and risk of atrial fibrillation (AF) have been inconsistent. Methods: We studied the association of fish and the fish-derived n-3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) with the risk of incident AF in individuals aged 45-64 from the Atherosclerosis Risk in Communities (ARIC) cohort (n = 14,222, 27% African Americans). Intake of fish and of DHA and EPA were measured via food frequency questionnaire. Plasma levels of DHA and EPA were measured in phospholipids in a subset of participants (n = 3,757). Incident AF was identified through the end of 2008 using ECGs, hospital discharge codes and death certificates. Cox proportional hazards regression was used to estimate hazard ratios of AF by quartiles of n-3 PUFAs or by fish intake. Results: During the average follow-up of 17.6 years, 1,604 AF events were identified. In multivariable analyses, total fish intake and dietary DHA and EPA were not associated with AF risk. Higher intake of oily fish and canned tuna was associated with a nonsignificant lower risk of AF (p for trend = 0.09). Phospholipid levels of DHA+EPA were not related to incident AF. However, DHA and EPA showed differential associations with AF risk when analyzed separately, with lower risk of AF in those with higher levels of DHA but no association between EPA levels and AF risk. Conclusions: In this racially diverse sample, dietary intake of fish and fish-derived n-3 fatty acids, as well as plasma biomarkers of fish intake, were not associated with AF risk.	[Gronroos, Noelle N.; Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Chamberlain, Alanna M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Soliman, Elsayed Z.] Wake Forest Univ, Sch Med, EPICARE, Epidemiol Cardiol Res Ctr EPICARE, Winston Salem, NC 27109 USA; [Agarwal, Sunil K.] Univ N Carolina, Chapel Hill, NC USA; [Nettleton, Jennifer A.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Wake Forest University; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Gronroos, NN (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	alonso@umn.edu	Soliman, Elsayed Z/AAD-7135-2020; Alonso, Alvaro/A-4917-2010	Soliman, Elsayed Z/0000-0001-5632-8150; Alonso, Alvaro/0000-0002-2225-8323; Chamberlain, Alanna/0000-0003-1888-9584	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C]; NHLBI [RC1HL099452]; American Heart Association [09SDG2280087]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099452] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute (NHLBI) contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). This work was additionally funded by grant RC1HL099452 from NHLBI and 09SDG2280087 from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Anselmi CV, 2010, J INTERV CARD ELECTR, V27, P95, DOI 10.1007/s10840-009-9466-8; Berry JD, 2010, AM J CARDIOL, V105, P844, DOI 10.1016/j.amjcard.2009.11.039; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Breslow JL, 2006, AM J CLIN NUTR, V83, p1477S, DOI 10.1093/ajcn/83.6.1477S; Brouwer IA, 2006, AM HEART J, V151, P857, DOI 10.1016/j.ahj.2005.07.029; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Freedman LS, 2010, AM J EPIDEMIOL, V172, P836, DOI 10.1093/aje/kwq194; Frost L, 2005, AM J CLIN NUTR, V81, P50; Gronroos NN, 2010, CIRC J, V74, P2029, DOI 10.1253/circj.CJ-10-0820; He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B; Heidarsdottir R, 2010, EUROPACE, V12, P356, DOI 10.1093/europace/eup429; Huxley RR, 2011, CIRCULATION, V123, P1501, DOI [10.1161/circulationaha.110.009035, 10.1161/CIRCULATIONAHA.110.009035]; Kang JX, 1996, EUR J PHARMACOL, V297, P97, DOI 10.1016/0014-2999(95)00701-6; Kowey PR, 2010, JAMA-J AM MED ASSOC, V304, P2363, DOI 10.1001/jama.2010.1735; Leaf A, 2003, CIRCULATION, V107, P2646, DOI 10.1161/01.CIR.0000069566.78305.33; MA J, 1995, AM J CLIN NUTR, V62, P564, DOI 10.1093/ajcn/62.3.564; Mariscalco G, 2010, ANGIOLOGY, V61, P643, DOI 10.1177/0003319710370962; Mayyas F, 2011, CARDIOVASC RES, V89, P852, DOI 10.1093/cvr/cvq380; Mozaffarian D, 2006, AM J CARDIOL, V97, P216, DOI 10.1016/j.amjcard.2005.08.025; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Mozaffarian D, 2008, AM J CLIN NUTR, V87, p1991S, DOI 10.1093/ajcn/87.6.1991S; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Nodari S, 2011, CIRCULATION, V124, P1100, DOI 10.1161/CIRCULATIONAHA.111.022194; Patel Dimpi, 2009, Indian Pacing Electrophysiol J, V9, P292; RIBOLI E, 1987, CANCER SURV, V6, P685; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Saravanan P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P46, DOI 10.1161/CIRCEP.109.899633; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Willett WC, 2008, MODERN EPIDEMIOLOGY, P1188; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu JHY, 2012, CIRCULATION, V125, P1084, DOI 10.1161/CIRCULATIONAHA.111.062653; Xiao YF, 1997, P NATL ACAD SCI USA, V94, P4182, DOI 10.1073/pnas.94.8.4182	40	28	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36686	10.1371/journal.pone.0036686	http://dx.doi.org/10.1371/journal.pone.0036686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570739	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400055
J	Rios, FJO; Koga, MM; Ferracini, M; Jancar, S				Rios, Francisco J. O.; Koga, Mariana M.; Ferracini, Matheus; Jancar, Sonia			Co-Stimulation of PAFR and CD36 Is Required for oxLDL-Induced Human Macrophages Activation	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED MACROPHAGES; FOAM CELL-FORMATION; OXIDIZED LDL; GENE-EXPRESSION; PPAR-GAMMA; CARDIOVASCULAR-DISEASE; FACTOR RECEPTOR; INTERLEUKIN-8; ATHEROSCLEROSIS	The oxidative process of LDL particles generates molecules which are structurally similar to platelet-activating factor (PAF), and some effects of oxidized LDL (oxLDL) have been shown to be dependent on PAF receptor (PAFR) activation. In a previous study, we showed that PAFR is required for upregulation of CD36 and oxLDL uptake. In the present study we analyzed the molecular mechanisms activated by oxLDL in human macrophages and the contribution of PAFR to this response. Human adherent monocytes/macrophages were stimulated with oxLDL. Uptake of oxLDL and CD36 expression were determined by flow cytometry; MAP kinases and Akt phosphorylation by Western blot; IL-8 and MCP-1 concentration by ELISA and mRNA expression by real-time PCR. To investigate the participation of the PI3K/Akt pathway, G alpha i-coupled protein or PAFR, macrophages were treated with LY294002, pertussis toxin or with the PAFR antagonists WEB2170 and CV3988, respectively before addition of oxLDL. It was found that the addition of oxLDL to human monocytes/macrophages activates the PI3K/Akt pathway which in turn activates the MAPK (p38 and JNK). Phosphorylation of Akt requires the engagement of PAFR and a G alpha i-coupled protein. The upregulation of CD36 protein and the uptake of oxLDL as well as the IL-8 production are dependent on PI3K/Akt pathway activation. The increased CD36 protein expression is dependent on PAFR and G alpha i-coupled protein. Transfection studies using HEK 293t cells showed that oxLDL uptake occurs with either PAFR or CD36, but IL-8 production requires the co-transfection of both PAFR and CD36. These findings show that PAFR has a pivotal role in macrophages response to oxLDL and suggest that pharmacological intervention at the level of PAFR activation might be beneficial in atherosclerosis.	[Rios, Francisco J. O.; Koga, Mariana M.; Ferracini, Matheus; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo	Rios, FJO (corresponding author), Univ Sao Paulo, Dept Immunol, Inst Biomed Sci, Sao Paulo, Brazil.	fjorios@usp.br	Jancar, Sonia/C-5153-2012; Ferracini, Matheus/E-3820-2010; Rios, Francisco J./C-6059-2012	Jancar, Sonia/0000-0001-7983-3459; Ferracini, Matheus/0000-0003-1523-6457; Rios, Francisco/0000-0002-8194-0787; Koga, Marianna/0000-0003-3244-9059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/03982-5, 2009/05290-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: 2006/03982-5; 2009/05290-1), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Brocheriou I, 2000, CIRCULATION, V102, P2569; D'Archivio M, 2008, FEBS LETT, V582, P2291, DOI 10.1016/j.febslet.2008.05.029; Dentan C, 1996, EUR J BIOCHEM, V236, P48, DOI 10.1111/j.1432-1033.1996.00048.x; Dobreva I, 2006, J BIOL CHEM, V281, P199, DOI 10.1074/jbc.M508857200; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2007, INT J BIOCHEM CELL B, V39, P2012, DOI 10.1016/j.biocel.2007.03.012; Fremont L, 1999, LIFE SCI, V64, P2511, DOI 10.1016/S0024-3205(99)00209-X; Fritz JM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-76; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; Ketelhuth DFJ, 2011, CIRCULATION, V124, P2433, DOI 10.1161/CIRCULATIONAHA.111.051599; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marathe GK, 2001, TRENDS CARDIOVAS MED, V11, P139, DOI 10.1016/S1050-1738(01)00100-1; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Prieto P, 2010, CELL DEATH DIFFER, V17, P1179, DOI 10.1038/cdd.2009.220; Riazy M, 2011, BIOCHEM CELL BIOL, V89, P387, DOI 10.1139/O11-035; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rios FJO, 2011, CELL PHYSIOL BIOCHEM, V27, P363, DOI 10.1159/000327962; Rios FJO, 2008, CELL PHYSIOL BIOCHEM, V22, P549, DOI 10.1159/000185539; SAKAI H, 1982, AM J CLIN PATHOL, V78, P58, DOI 10.1093/ajcp/78.1.58; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Subbanagounder G, 1999, CIRC RES, V85, P311, DOI 10.1161/01.RES.85.4.311; Svensjo E, 2003, INFLAMM RES, V52, P215, DOI 10.1007/s000110300074; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Carvalho MDT, 2010, J ATHEROSCLER THROMB, V17, P844, DOI 10.5551/jat.3905; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x	32	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36632	10.1371/journal.pone.0036632	http://dx.doi.org/10.1371/journal.pone.0036632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570732	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400048
J	Wallington-Beddoe, CT; Don, AS; Hewson, J; Qiao, Q; Papa, RA; Lock, RB; Bradstock, KF; Bendall, LJ				Wallington-Beddoe, Craig T.; Don, Anthony S.; Hewson, John; Qiao, Qiao; Papa, Rachael A.; Lock, Richard B.; Bradstock, Kenneth F.; Bendall, Linda J.			Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; LYMPHOCYTIC-LEUKEMIA; PRECLINICAL ACTIVITY; ORAL FINGOLIMOD; STROMAL CELLS; PROLIFERATION; RECEPTOR-1; INHIBITORS; APOPTOSIS; SURVIVAL	Most patients with acute lymphoblastic leukemia (ALL) respond well to standard chemotherapy-based treatments. However a significant proportion of patients, particularly adult patients, relapse with the majority dying of leukemia. FTY720 is an immunosuppressive drug that was recently approved for the treatment of multiple sclerosis and is currently under preclinical investigation as a therapy for a number of hematological malignancies. Using human ALL xenografts in NOD/SCID gamma c(-/-) mice, we show for the first time that three Ph+ human ALL xenografts responded to FTY720 with an 80 +/- 12% (p = 0.048) reduction in overall disease when treatment was commenced early. In contrast, treatment of mice with FTY720 did not result in reduced leukemia compared to controls using four separate human Ph- ALL xenografts. Although FTY720 reactivated PP2A in vitro, this reactivation was not required for death of Ph- ALL cells. The plasma levels of FTY720 achieved in the mice were in the high nanomolar range. However, the response seen in the Ph+ ALL xenografts when treatment was initiated early implies that in vivo efficacy may be obtained with substantially lower drug concentrations than those required in vitro. Our data suggest that while FTY720 may have potential as a treatment for Ph+ ALL it will not be a useful agent for the treatment of Ph- B-ALL.	[Wallington-Beddoe, Craig T.; Hewson, John; Bendall, Linda J.] Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia; [Don, Anthony S.; Qiao, Qiao] Univ New S Wales, Fac Med, Lowy Canc Res Ctr, Prince Wales Clin Sch, Sydney, NSW, Australia; [Papa, Rachael A.; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Lowy Canc Res Ctr, Sydney, NSW, Australia; [Bradstock, Kenneth F.] Westmead Hosp, Dept Hematol, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of Sydney	Wallington-Beddoe, CT (corresponding author), Univ Sydney, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia.	linda.bendall@sydney.edu.au	Lock, Richard/G-4253-2013; Don, Anthony Simon/AAE-9687-2021	Don, Anthony Simon/0000-0003-1655-1184; Wallington-Gates, Craig Thomas/0000-0002-7457-5937; Lock, Richard/0000-0002-3436-9071	Leukemia Foundation of Australia PhD Scholarship (Clinical); Cancer Institute NSW Research Scholar Award [10/RSA/1-34]; Cancer Institute NSW Early Career Fellowship [08/ECF/1-03]; Royal College of Pathologists of Australasia Research Award; NHMRC [511965, 568703]	Leukemia Foundation of Australia PhD Scholarship (Clinical); Cancer Institute NSW Research Scholar Award; Cancer Institute NSW Early Career Fellowship; Royal College of Pathologists of Australasia Research Award; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the following grants: Leukemia Foundation of Australia PhD Scholarship (Clinical) (www.leukaemia.org.au), Cancer Institute NSW Research Scholar Award No. 10/RSA/1-34, Cancer Institute NSW Early Career Fellowship 08/ECF/1-03 (www.cancerinstitute.org.au), Royal College of Pathologists of Australasia Research Award (www.rcpa.edu.au), NHMRC CDA2 No. 511965 and NHMRC Senior Research Fellowship No. 568703 (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gaundar SS, 2009, CELL CYCLE, V8, P2975; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Hung JH, 2008, CANCER RES, V68, P1204, DOI 10.1158/0008-5472.CAN-07-2621; Jary E, 2010, MOL PHARMACOL, V78, P685, DOI 10.1124/mol.110.064873; Juarez J, 2003, LEUKEMIA, V17, P1294, DOI 10.1038/sj.leu.2402998; Juarez J, 2007, HAEMATOLOGICA, V92, P450, DOI 10.3324/haematol.10621; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Liao AJ, 2011, BLOOD, V118, P2793, DOI 10.1182/blood-2011-01-331447; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Liu Q, 2008, BLOOD, V111, P275, DOI 10.1182/blood-2006-10-053884; Liu Q, 2010, CLIN CANCER RES, V16, P3182, DOI 10.1158/1078-0432.CCR-09-2484; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Meno-Tetang GML, 2005, BASIC CLIN PHARMACOL, V96, P182, DOI 10.1111/j.1742-7843.2005.pto960307.x; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Nikolova Z, 2001, TRANSPL IMMUNOL, V8, P267, DOI 10.1016/S0966-3274(01)00031-4; Roberts KG, 2010, CANCER RES, V70, P5438, DOI 10.1158/0008-5472.CAN-09-2544; Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Wallington-Beddoe CT, 2011, AUTOPHAGY, V7, P707, DOI 10.4161/auto.7.7.15154; Yasui H, 2005, CANCER RES, V65, P7478, DOI 10.1158/0008-5472.CAN-05-0850	32	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36429	10.1371/journal.pone.0036429	http://dx.doi.org/10.1371/journal.pone.0036429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570713	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000305343400029
J	Lunde, K; Egelandsdal, B; Skuterud, E; Mainland, JD; Lea, T; Hersleth, M; Matsunami, H				Lunde, Kathrine; Egelandsdal, Bjorg; Skuterud, Ellen; Mainland, Joel D.; Lea, Tor; Hersleth, Margrethe; Matsunami, Hiroaki			Genetic Variation of an Odorant Receptor OR7D4 and Sensory Perception of Cooked Meat Containing Androstenone	PLOS ONE			English	Article							SENSITIVITY; PLASTICITY; PHEROMONE; ABILITY; TAINT; FAT	Although odour perception impacts food preferences, the effect of genotypic variation of odorant receptors (ORs) on the sensory perception of food is unclear. Human OR7D4 responds to androstenone, and genotypic variation in OR7D4 predicts variation in the perception of androstenone. Since androstenone is naturally present in meat derived from male pigs, we asked whether OR7D4 genotype correlates with either the ability to detect androstenone or the evaluation of cooked pork tainted with varying levels of androstenone within the naturally-occurring range. Consistent with previous findings, subjects with two copies of the functional OR7D4 RT variant were more sensitive to androstenone than subjects carrying a nonfunctional OR7D4 WM variant. When pork containing varying levels of androstenone was cooked and tested by sniffing and tasting, subjects with two copies of the RT variant tended to rate the androstenone-containing meat as less favourable than subjects carrying the WM variant. Our data is consistent with the idea that OR7D4 genotype predicts the sensory perception of meat containing androstenone and that genetic variation in an odorant receptor can alter food preferences.	[Lunde, Kathrine; Skuterud, Ellen] Norwegian Meat Res Ctr, Oslo, Norway; [Lunde, Kathrine; Egelandsdal, Bjorg; Skuterud, Ellen; Lea, Tor; Hersleth, Margrethe] Univ Life Sci, Inst Chem Biotechnol & Food Sci, As, Norway; [Hersleth, Margrethe] Nofima Mat, As, Norway; [Mainland, Joel D.; Matsunami, Hiroaki] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol & Neurobiol, Durham, NC USA	Norwegian University of Life Sciences; Nofima; Duke University	Lunde, K (corresponding author), Norwegian Meat Res Ctr, Oslo, Norway.	kathrine.lunde@animalia.no	Mainland, Joel/C-5171-2009	Mainland, Joel/0000-0002-5056-4598	Norwegian Research Council [63164]; United States National Institutes of Health (NIH)-NRSA; NIH [DC005782, DC010857];  [DC011373]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008932, R01DC005782, R01DC010857, R03DC011373] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); United States National Institutes of Health (NIH)-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Norwegian Research Council for its grant to this activity through project number 63164, "Boar meat-consumer aspects and exploitation of resources." JM is supported by a United States National Institutes of Health (NIH)-NRSA fellowship and DC011373 and HM is supported by the NIH (DC005782 and DC010857). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRESEN O, 1974, ACTA ENDOCRINOL-COP, V76, P377; Banon S, 2003, MEAT SCI, V63, P381, DOI 10.1016/S0309-1740(02)00097-9; Beets M. G. J., 1970, TASTE SMELL VERTEBRA, P313; Dorries KM, 1997, BRAIN BEHAV EVOLUT, V49, P53, DOI 10.1159/000112981; Dotson CD, 2010, APPETITE, V54, P93, DOI 10.1016/j.appet.2009.09.011; Font I, 2000, J SENS STUD, V15, P393; GIBIS M, 1994, THESIS U HOHENHEIM G; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kline JP, 2007, BIOL PSYCHOL, V74, P405, DOI 10.1016/j.biopsycho.2006.10.003; Lunde K, 2010, MEAT SCI, V86, P706, DOI 10.1016/j.meatsci.2010.06.009; Lunde K, 2009, FOOD QUAL PREFER, V20, P304, DOI 10.1016/j.foodqual.2009.02.001; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Oliver MA, 2009, STUDY IMPROVED METHO; PATTERSON RL, 1968, J SCI FOOD AGR, V19, P31, DOI 10.1002/jsfa.2740190107; Pause BM, 1999, PHYSIOL BEHAV, V68, P129, DOI 10.1016/S0031-9384(99)00158-4; Shahidi F, 1998, FLAVOR MEAT MEAT PRO, V2nd; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Tuomola M, 1997, J AGR FOOD CHEM, V45, P3529, DOI 10.1021/jf9702398; VOLD E, 1970, Meldinger fra Norges Landbrukshogskole, V49, P1; Wang LW, 2004, J PHYSIOL-LONDON, V554, P236, DOI 10.1113/jphysiol.2003.054726; Weiler U, 1997, EAAP PUBLICATION, V92, P147; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; WYSOCKI CJ, 1984, P NATL ACAD SCI-BIOL, V81, P4899, DOI 10.1073/pnas.81.15.4899	25	52	52	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35259	10.1371/journal.pone.0035259	http://dx.doi.org/10.1371/journal.pone.0035259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567099	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500017
J	Nahirya-Ntege, P; Cook, A; Vhembo, T; Opilo, W; Namuddu, R; Katuramu, R; Tezikyabbiri, J; Naidoo-James, B; Gibb, D				Nahirya-Ntege, Patricia; Cook, Adrian; Vhembo, Tichaona; Opilo, Wilfred; Namuddu, Rachel; Katuramu, Richard; Tezikyabbiri, Jessica; Naidoo-James, Bethany; Gibb, Diana		ARROW Trial Team	Young HIV-Infected Children and Their Adult Caregivers Prefer Tablets to Syrup Antiretroviral Medications in Africa	PLOS ONE			English	Article							FIXED-DOSE COMBINATION; PEDIATRIC-PATIENTS; ADHERENCE; THERAPY; PHARMACOKINETICS; NEVIRAPINE; LAMIVUDINE; SURVIVAL	Background: Provision of anti-retroviral therapy (ART) for HIV-infected children is complicated using syrup formulations, which are costlier than tablets, harder to transport and store and difficult for health-workers to prescribe and caregivers to administer. Dispersible/crushable tablets may be more appropriate. We studied the acceptability of syrups and scored tablets among young children who used both in the AntiRetroviral Research fOr Watoto (ARROW) trial. Methods: ARROW is an ongoing randomized trial of paediatric ART monitoring and treatment strategies in 1206 children in Uganda and Zimbabwe. 405 children initially received syrups of combination ART including Nevirapine, Zidovudine, Abacavir and Lamivudine before changing, when reaching the 12-<15 kg weightband, to scored adult-dose tablets prescribed according to WHO weightband tables. Caregiver expectations and experiences were collected in questionnaires at their last visit on syrups and after 8 and 24 weeks on tablets. Results: Questionnaires were completed by caregivers of 267 children (median age 2.9 years (IQR 2.5, 3.4)). At last visit on syrups, 79% caregivers reported problems with syrups, mostly related to number, weight, transportation and conspicuousness of bottles. Difficulties taking tablets were expected by 127(48%) caregivers; however, after 8 and 24 weeks, only 26% and 18% reported their children had problems with tablets and no problems were reported with transportation/conspicuousness. Taste, swallowing or vomiting were reported as problems 'sometimes/often' for 14%, 9%, 22% children on syrups and 16%, 9%, 8% on tablets. At last visit on syrups, 74% caregivers expected to prefer tablets but only 27% thought their child would. After 8/24 weeks, 94%/97% caregivers preferred tablets and 57%/59% reported their child did. Conclusions: Most children at about 3 years can take tablets; caregivers and children themselves generally prefer tablets to liquid formulations of HIV medications above this age. Preferences of caregivers and children should be considered when designing and licensing paediatric drug formulations.	[Nahirya-Ntege, Patricia; Katuramu, Richard] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Cook, Adrian; Naidoo-James, Bethany; Gibb, Diana] MRC Clin Trials Unit, London, England; [Vhembo, Tichaona] Univ Zimbabwe, Sch Med, Harare, Zimbabwe; [Opilo, Wilfred; Tezikyabbiri, Jessica] Joint Clin Res Ctr, Kampala, Uganda; [Namuddu, Rachel] Mulago Hosp, Baylor Uganda Paediat Infect Dis Clin, Kampala, Uganda	Medical Research Council Clinical Trials Unit; University of Zimbabwe; Joint Clinic Research Center - United Arab Emirates; Baylor College of Medicine; Mulago National Referral Hospital	Nahirya-Ntege, P (corresponding author), MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda.	adc@ctu.mrc.ac.uk	; Bwakura-Dangarembizi, Mutsa/D-5686-2018	Gibb, Diana/0000-0002-9738-5490; Thomason, Margaret/0000-0003-3590-0140; Kasirye, Phillip/0000-0001-6620-483X; Bwakura-Dangarembizi, Mutsa/0000-0001-7751-6177	UK Medical Research Council; UK Department for International Development [G0300400]; MRC [MC_EX_G0300400] Funding Source: UKRI; Medical Research Council [MC_EX_G0300400] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The main trial was funded by the UK Medical Research Council, www.mrc.ac.uk and the UK Department for International Development, www.dfid.gov.uk. Grant number G0300400. First-line drugs were provided by GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagenda A, 2011, ANN TROP PAEDIATR, V31, P235, DOI 10.1179/1465328111Y.0000000025; Bagenda A, 2010, 18 INT AIDS C 2010 V; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Calmy A, 2004, LANCET, V364, P329, DOI 10.1016/S0140-6736(04)16716-0; Chokephaibulkit K, 2005, AIDS, V19, P1495, DOI 10.1097/01.aids.0000183625.97170.59; Eldridge K, 2000, Int J Paediatr Dent, V10, P19, DOI 10.1046/j.1365-263x.2000.00168.x; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Garvie PA, 2007, PEDIATRICS, V119, pE893, DOI 10.1542/peds.2006-1488; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Kasirye P, 2012, CLIN PHARMACOL THER, V91, P272, DOI 10.1038/clpt.2011.225; King JR, 2004, HIV CLIN TRIALS, V5, P288, DOI 10.1310/GRQX-761M-DPB1-V9CG; Livshits Z, 2011, CLIN TOXICOL, V49, P747, DOI 10.3109/15563650.2011.602081; Mulenga V, 2010, CLIN INFECT DIS, V51, P1081, DOI 10.1086/656628; Musiime V, 2010, ANTIVIR THER, V15, P1115, DOI 10.3851/IMP1695; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Pujari SN, 2004, JAIDS-J ACQ IMM DEF, V37, P1566, DOI 10.1097/00126334-200412150-00005; Shingadia D, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e80; Sohn AH, 2007, CURR OPIN HIV AIDS, V2, P426, DOI 10.1097/COH.0b013e3282ced12c; Swan J, 2007, PEDIATRICS, V119, P838, DOI 10.1542/peds.2007-0273; Temple ME, 2001, ANN PHARMACOTHER, V35, P414; Thomson SA, 2009, PEDIATRICS, V123, pE235, DOI 10.1542/peds.2008-2059; UNICEF, 2004, IMPR ACC APPR PAED A; UNICEF WHO, 2010, SOURC PRIC SEL MED C; Walker AS, 2009, AIDS BEHAV, V13, P33, DOI 10.1007/s10461-008-9382-4; World Health Organization, 2010, ANT THER HIV INF INF; Yeung VW, 2005, PHARM WORLD SCI, V27, P399, DOI 10.1007/s11096-005-7911-z	27	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36186	10.1371/journal.pone.0036186	http://dx.doi.org/10.1371/journal.pone.0036186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567139	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500058
J	O'Loghlen, AL; Rothstein, SI				O'Loghlen, Adrian L.; Rothstein, Stephen I.			When Less Is Best: Female Brown-Headed Cowbirds Prefer Less Intense Male Displays	PLOS ONE			English	Article							MOLOTHRUS-ATER; SEXUAL PREFERENCES; VOCAL DEVELOPMENT; WILD POPULATIONS; SONG PREFERENCES; COURTSHIP SONGS; ZEBRA FINCHES; OLDER MALES; MATE CHOICE; SIGNAL	Sexual selection theory predicts that females should prefer males with the most intense courtship displays. However, wingspread song displays that male brown-headed cowbirds (Molothrus ater) direct at females are generally less intense than versions of this display that are directed at other males. Because male-directed displays are used in aggressive signaling, we hypothesized that females should prefer lower intensity performances of this display. To test this hypothesis, we played audiovisual recordings showing the same males performing both high intensity male-directed and low intensity female-directed displays to females (N = 8) and recorded the females' copulation solicitation display (CSD) responses. All eight females responded strongly to both categories of playbacks but were more sexually stimulated by the low intensity female-directed displays. Because each pair of high and low intensity playback videos had the exact same audio track, the divergent responses of females must have been based on differences in the visual content of the displays shown in the videos. Preferences female cowbirds show in acoustic CSD studies are correlated with mate choice in field and captivity studies and this is also likely to be true for preferences elucidated by playback of audiovisual displays. Female preferences for low intensity female-directed displays may explain why male cowbirds rarely use high intensity displays when signaling to females. Repetitive high intensity displays may demonstrate a male's current condition and explain why these displays are used in male-male interactions which can escalate into physical fights in which males in poorer condition could be injured or killed. This is the first study in songbirds to use audiovisual playbacks to assess how female sexual behavior varies in response to variation in a male visual display.	[O'Loghlen, Adrian L.; Rothstein, Stephen I.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	O'Loghlen, AL (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	ologhlen@lifesci.ucsb.edu			National Science Foundation [IOS-0446371]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a National Science Foundation (www.nsf.gov) grant (IOS-0446371) to SIR and ALO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bird CD, 2008, ANIM BEHAV, V76, P679, DOI 10.1016/j.anbehav.2008.04.014; Bradbury Jack W., 1998, pi; Brazas ML, 2002, ANIM COGN, V5, P91, DOI 10.1007/s10071-002-0136-9; Byers J, 2010, ANIM BEHAV, V79, P771, DOI 10.1016/j.anbehav.2010.01.009; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Candolin U, 1999, ANIM BEHAV, V58, P1261, DOI 10.1006/anbe.1999.1259; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooper BG, 2004, SCIENCE, V303, P544, DOI 10.1126/science.1091099; DUFTY AM, 1992, J FIELD ORNITHOL, V63, P16; DUFTY AM, 1986, BEHAV ECOL SOCIOBIOL, V19, P49, DOI 10.1007/BF00303842; DUFTY AM, 1982, ANIM BEHAV, V30, P1043, DOI 10.1016/S0003-3472(82)80194-2; Fleishman L.J., 2000, Acta Ethologica, V3, P15, DOI 10.1007/s102110000025; Freeberg TM, 2001, J COMP PSYCHOL, V115, P201, DOI 10.1037/0735-7036.115.2.201; Freeberg TM, 2006, INT J COMP PSYCHOL, V19, P206; Friedmann H., 1929, COWBIRDS STUDY BIOL; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; Galoch Z, 2007, BEHAV PROCESS, V74, P21, DOI 10.1016/j.beproc.2006.09.002; Gorney-Labinger E, 2002, CONDOR, V104, P866, DOI 10.1650/0010-5422(2002)104[0866:BHCIEA]2.0.CO;2; Gorney-Labinger E, THESIS U CALIFORNIA; Hansen TF, 1995, J EVOLUTION BIOL, V8, P759, DOI 10.1046/j.1420-9101.1995.8060759.x; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hill JA, 1999, BEHAV ECOL, V10, P91, DOI 10.1093/beheco/10.1.91; Hosken D, 2005, AM NAT, V165, pS1, DOI 10.1086/429355; Hosoi SA, 2005, AUK, V122, P82, DOI 10.1642/0004-8038(2005)122[0082:SPOFBC]2.0.CO;2; Hunt KE, 2004, GEN COMP ENDOCR, V137, P248, DOI 10.1016/j.ygcen.2004.03.015; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P2109, DOI 10.1098/rspb.1999.0895; Maddocks SA, 2001, GEN COMP ENDOCR, V124, P315, DOI 10.1006/gcen.2001.7718; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Moller AP, 1998, AM NAT, V151, P236, DOI 10.1086/286114; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; O'Loghlen AL, 2010, CONDOR, V112, P615, DOI 10.1525/cond.2010.090216; O'Loghlen AL, 2010, ANIM BEHAV, V79, P1285, DOI 10.1016/j.anbehav.2010.03.001; O'Loghlen AL, 2004, AUK, V121, P824, DOI 10.1642/0004-8038(2004)121[0824:DSRTDC]2.0.CO;2; O'Loghlen AL, 2003, BEHAV ECOL SOCIOBIOL, V53, P102, DOI 10.1007/s00265-002-0551-6; O'Loghlen AL, 2002, ANIM BEHAV, V64, P609, DOI 10.1006/anbe.2002.3081; O'Loghlen AL, 2002, CONDOR, V104, P761, DOI 10.1650/0010-5422(2002)104[0761:VDICWA]2.0.CO;2; O'Loghlen AL, 2002, ANIM BEHAV, V63, P475, DOI 10.1006/anbe.2001.1951; OLOGHLEN AL, 1993, ANIM BEHAV, V46, P293, DOI 10.1006/anbe.1993.1190; OLOGHLEN AL, 1995, BEHAV ECOL SOCIOBIOL, V36, P251, DOI 10.1007/s002650050147; OLoghlen AL, 1997, ANIM BEHAV, V53, P835, DOI 10.1006/anbe.1996.0348; Ophir AG, 2005, J COMP PSYCHOL, V119, P3, DOI 10.1037/0735-7036.119.1.3; Ortega CP, 1996, J FIELD ORNITHOL, V67, P542; Partan SR, 2005, AM NAT, V166, P231, DOI 10.1086/431246; Patricelli GL, 2002, NATURE, V415, P279, DOI 10.1038/415279a; Proulx SR, 2002, P ROY SOC B-BIOL SCI, V269, P2291, DOI 10.1098/rspb.2002.2129; RATCLIFFE L, 1987, ANIM BEHAV, V35, P1260, DOI 10.1016/S0003-3472(87)80188-4; Rothstein S.I., 1986, Current Ornithology, V3, P127; ROTHSTEIN SI, 1988, ANIM BEHAV, V36, P73, DOI 10.1016/S0003-3472(88)80251-3; Searcy WA, 1997, CONDOR, V99, P826, DOI 10.2307/1370497; SELANDER ROBERT K., 1960, CONDOR, V62, P202, DOI 10.2307/1365603; SULLIVAN MS, 1994, ANIM BEHAV, V47, P141, DOI 10.1006/anbe.1994.1016; West MJ, 2006, ETHOLOGY, V112, P1095, DOI 10.1111/j.1439-0310.2006.01264.x; West MJ, 1998, ETHOLOGY, V104, P250; WEST MJ, 1981, ANIM BEHAV, V29, P490, DOI 10.1016/S0003-3472(81)80110-8; Wilkie SE, 1998, BIOCHEM J, V330, P541; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yokel D. A., 1986, NATURAL HIST WHITE I, V1, P164; YOKEL DA, 1991, BEHAV ECOL SOCIOBIOL, V29, P39, DOI 10.1007/BF00164293	65	17	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36130	10.1371/journal.pone.0036130	http://dx.doi.org/10.1371/journal.pone.0036130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567131	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500049
J	O'Reilly, PF; Hoggart, CJ; Pomyen, Y; Calboli, FCF; Elliott, P; Jarvelin, MR; Coin, LJM				O'Reilly, Paul F.; Hoggart, Clive J.; Pomyen, Yotsawat; Calboli, Federico C. F.; Elliott, Paul; Jarvelin, Marjo-Riitta; Coin, Lachlan J. M.			MultiPhen: Joint Model of Multiple Phenotypes Can Increase Discovery in GWAS	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; LOCI; PLEIOTROPY; VARIANTS; RISK	The genome-wide association study (GWAS) approach has discovered hundreds of genetic variants associated with diseases and quantitative traits. However, despite clinical overlap and statistical correlation between many phenotypes, GWAS are generally performed one-phenotype-at-a-time. Here we compare the performance of modelling multiple phenotypes jointly with that of the standard univariate approach. We introduce a new method and software, MultiPhen, that models multiple phenotypes simultaneously in a fast and interpretable way. By performing ordinal regression, MultiPhen tests the linear combination of phenotypes most associated with the genotypes at each SNP, and thus potentially captures effects hidden to single phenotype GWAS. We demonstrate via simulation that this approach provides a dramatic increase in power in many scenarios. There is a boost in power for variants that affect multiple phenotypes and for those that affect only one phenotype. While other multivariate methods have similar power gains, we describe several benefits of MultiPhen over these. In particular, we demonstrate that other multivariate methods that assume the genotypes are normally distributed, such as canonical correlation analysis (CCA) and MANOVA, can have highly inflated type-1 error rates when testing case-control or non-normal continuous phenotypes, while MultiPhen produces no such inflation. To test the performance of MultiPhen on real data we applied it to lipid traits in the Northern Finland Birth Cohort 1966 (NFBC1966). In these data MultiPhen discovers 21% more independent SNPs with known associations than the standard univariate GWAS approach, while applying MultiPhen in addition to the standard approach provides 37% increased discovery. The most associated linear combinations of the lipids estimated by MultiPhen at the leading SNPs accurately reflect the Friedewald Formula, suggesting that MultiPhen could be used to refine the definition of existing phenotypes or uncover novel heritable phenotypes.	[O'Reilly, Paul F.; Calboli, Federico C. F.; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Hoggart, Clive J.] Univ London Imperial Coll Sci Technol & Med, Dept Pedeatr, London, England; [Pomyen, Yotsawat] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, MRC HPA Ctr Environm & Hlth, London, England; [Coin, Lachlan J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Pomyen, Yotsawat] Chulabhorn Res Inst, Translat Res Unit, Bangkok, Thailand	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Finland National Institute for Health & Welfare; University of Oulu; Chulabhorn Research Institute	O'Reilly, PF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	paul.oreilly@imperial.ac.uk; l.coin@imperial.ac.uk	Coin, Lachlan JM/A-9001-2014; Coin, Lachlan/O-4976-2019	Coin, Lachlan JM/0000-0002-4300-455X; Coin, Lachlan/0000-0002-4300-455X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Pomyen, Yotsawat/0000-0002-1070-3047; O'Reilly, Paul/0000-0001-7515-0845; Elliott, Paul/0000-0002-7511-5684	European Network for Genetic and Genomic Epidemiology Consortium [P12892]; National Institute for Health Research (NIHR) Imperial College Health Care NHS Trust Biomedical Research Centre; European Union [HEALTH-2007-201550]; Academy of Finland [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; ENGAGE project; Medical Research Council, UK; European Community [223367];  [HEALTH-F4-2007-201413]; Medical Research Council [G0801056, G0801056B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RL1MH083268, R01MH063706] Funding Source: NIH RePORTER; MRC [G0801056] Funding Source: UKRI	European Network for Genetic and Genomic Epidemiology Consortium; National Institute for Health Research (NIHR) Imperial College Health Care NHS Trust Biomedical Research Centre; European Union(European Commission); Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE project(General Electric); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Network for Genetic and Genomic Epidemiology Consortium (grant number P12892 DFHM to PFO), the National Institute for Health Research (NIHR) Imperial College Health Care NHS Trust Biomedical Research Centre (to PFO and PE), the European Union (grant HEALTH-2007-201550 to CJH), the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE to MRJ), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617 to MRJ), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01 to MRJ), NIH/NIMH (5R01MH63706:02 to MRJ), ENGAGE project and grant agreement HEALTH-F4-2007-201413 (to MRJ), the Medical Research Council, UK (PrevMetSyn/SALVE to MRJ) and the European Community's Seventh Framework Programme (grant number 223367, MultiMod, to LJMC). PE is a NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Medland S, 2010, EUR J HUM GENET, V18, P233, DOI 10.1038/ejhg.2009.133; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pendergrass SA, 2011, GENET EPIDEMIOL, V35, P410, DOI 10.1002/gepi.20589; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; SIDAK Z, 1968, ANN MATH STAT, V39, P1425, DOI 10.1214/aoms/1177698122; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497	23	231	232	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34861	10.1371/journal.pone.0034861	http://dx.doi.org/10.1371/journal.pone.0034861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567092	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500010
J	Das, K; De la Garza, G; Maffi, S; Saikolappan, S; Dhandayuthapani, S				Das, Kishore; De la Garza, Georgina; Maffi, Shivani; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian			Methionine Sulfoxide Reductase A (MsrA) Deficient Mycoplasma genitalium Shows Decreased Interactions with Host Cells	PLOS ONE			English	Article							PATHOGEN ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MYCOIDES SMALL COLONY; TOLL-LIKE RECEPTORS; NF-KAPPA-B; EPITHELIAL-CELLS; STREPTOCOCCUS-GORDONII; VIRULENCE DETERMINANT; EXTRACELLULAR-MATRIX; HELICOBACTER-PYLORI; CYTOKINE SECRETION	Mycoplasma genitalium is an important sexually transmitted pathogen that affects both men and women. In genital-mucosal tissues, it initiates colonization of epithelial cells by attaching itself to host cells via several identified bacterial ligands and host cell surface receptors. We have previously shown that a mutant form of M. genitalium lacking methionine sulfoxide reductase A (MsrA), an antioxidant enzyme which converts oxidized methionine (Met(O)) into methionine (Met), shows decreased viability in infected animals. To gain more insights into the mechanisms by which MsrA controls M. genitalium virulence, we compared the wild-type M. genitalium strain (G37) with an msrA mutant (MS5) strain for their ability to interact with target cervical epithelial cell lines (HeLa and C33A) and THP-1 monocytic cells. Infection of epithelial cell lines with both strains revealed that MS5 was less cytotoxic to HeLa and C33A cell lines than the G37 strain. Also, the MS5 strain was more susceptible to phagocytosis by THP-1 cells than wild type strain (G37). Further, MS5 was less able to induce aggregation and differentiation in THP-1 cells than the wild type strain, as determined by carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling of the cells, followed by counting of cells attached to the culture dish using image analysis. Finally, MS5 was observed to induce less proinflammatory cytokine TNF-a by THP-1 cells than wild type G37 strain. These results indicate that MsrA affects the virulence properties of M. genitalium by modulating its interaction with host cells.	[Das, Kishore; De la Garza, Georgina; Maffi, Shivani; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX 78541 USA; [Das, Kishore; De la Garza, Georgina; Saikolappan, Sankaralingam; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, Edinburg, TX USA; [Maffi, Shivani] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Edinburg, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Das, K (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX 78541 USA.	dhandayutha@uthscsa.edu			NIH [AI08346]; ERAHC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI008346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERAHC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH AI08346 and ERAHC research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamuri P, 2004, MOL MICROBIOL, V53, P1397, DOI 10.1111/j.1365-2958.2004.04190.x; AUSUBEL F, 1989, CURRENT PRTOCOLS MOL; Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; BASEMAN JB, 1995, MICROB PATHOGENESIS, V19, P105, DOI 10.1006/mpat.1995.0050; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Campbell P, 1994, MEASUREMENT BACTERIA, P1451; Cao P, 1998, INFECT IMMUN, V66, P2984, DOI 10.1128/IAI.66.6.2984-2986.1998; Clanchy FIL, 2006, J LEUKOCYTE BIOL, V79, P757, DOI 10.1189/jlb.0905522; Cohen CR, 2002, LANCET, V359, P765, DOI 10.1016/S0140-6736(02)07848-0; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Dhandayuthapani S, 1999, P NATL ACAD SCI USA, V96, P5227, DOI 10.1073/pnas.96.9.5227; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Dumke R, 2011, MICROBIOL-SGM, V157, P2328, DOI 10.1099/mic.0.048298-0; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Falk L, 2005, SEX TRANSM INFECT, V81, P73, DOI 10.1136/sti.2004.010439; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gaydos C, 2009, SEX TRANSM DIS, V36, P598, DOI 10.1097/OLQ.0b013e3181b01948; Giomarelli B, 2006, FEMS MICROBIOL LETT, V265, P172, DOI 10.1111/j.1574-6968.2006.00479.x; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; He J, 2009, CLIN VACCINE IMMUNOL, V16, P1750, DOI 10.1128/CVI.00281-09; Herzberg MC, 2005, J PERIODONTOL, V76, P2101, DOI 10.1902/jop.2005.76.11-S.2101; JENSEN JS, 1994, INT J EXP PATHOL, V75, P91; Kuboniwa M, 2006, MOL MICROBIOL, V60, P121, DOI 10.1111/j.1365-2958.2006.05099.x; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lowther WT, 2002, NAT STRUCT BIOL, V9, P348, DOI 10.1038/nsb783; Mavedzenge SN, 2009, AIDS, V23, P611, DOI 10.1097/QAD.0b013e328323da3e; McGowin CL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-139; McGowin CL, 2009, INFECT IMMUN, V77, P1175, DOI 10.1128/IAI.00845-08; Medina E, 2011, CURRENT PROTOC IMMUN, V19, P1; Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x; Mintz KP, 2002, MICROBIOL-SGM, V148, P3695, DOI 10.1099/00221287-148-11-3695; MOSKOVITZ J, 1995, J BACTERIOL, V177, P502, DOI 10.1128/jb.177.3.502-507.1995; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nathan C., 2004, TUBERCULOSIS, V84, P215; Pich OQ, 2008, MICROBIOL-SGM, V154, P3188, DOI 10.1099/mic.0.2008/020636-0; Pilo P, 2005, J BACTERIOL, V187, P6824, DOI 10.1128/JB.187.19.6824-6831.2005; Razin S, 1983, METHODS MYCOPLASMOLO, P22; REDDY SP, 1995, J BACTERIOL, V177, P5943, DOI 10.1128/jb.177.20.5943-5951.1995; Rey P, 2005, PLANT J, V41, P31, DOI 10.1111/j.1365-313X.2004.02271.x; Reyes L, 1999, INFECT IMMUN, V67, P3188, DOI 10.1128/IAI.67.7.3188-3192.1999; Rodrigo MJ, 2002, MOL GENET GENOMICS, V267, P613, DOI 10.1007/s00438-002-0692-3; Saikolappan S, 2009, J BACTERIOL, V191, P6675, DOI 10.1128/JB.01066-08; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Short VL, 2010, SEX TRANSM INFECT, V86, P29, DOI 10.1136/sti.2009.037721; Short VL, 2009, CLIN INFECT DIS, V48, P41, DOI 10.1086/594123; Singh VK, 2001, FEMS MICROBIOL LETT, V199, P79, DOI 10.1016/S0378-1097(01)00163-X; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; SOMERSON NL, 1965, SCIENCE, V150, P226, DOI 10.1126/science.150.3693.226; Taylor-Robinson D, 2004, INT J STD AIDS, V15, P21, DOI 10.1258/095646204322637209; Vattanaviboon P, 2005, J BACTERIOL, V187, P5831, DOI 10.1128/JB.187.16.5831-5836.2005; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Vilei EM, 2000, MICROBIOL-UK, V146, P477, DOI 10.1099/00221287-146-2-477; Vilei EM, 2001, CLIN DIAGN LAB IMMUN, V8, P85, DOI 10.1128/CDLI.8.1.85-92.2001; Ward J, 2001, INFECT IMMUN, V69, P2748, DOI 10.1128/IAI.69.4.2748-2752.2001; Wayne KJ, 2010, J BACTERIOL, V192, P4388, DOI 10.1128/JB.00578-10; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Weissbach H, 2005, BBA-PROTEINS PROTEOM, V1703, P203, DOI 10.1016/j.bbapap.2004.10.004; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Wu YM, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/195427; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x; Zeng YH, 2008, CAN J MICROBIOL, V54, P150, DOI [10.1139/W07-125, 10.1139/w07-125]; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	75	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36247	10.1371/journal.pone.0036247	http://dx.doi.org/10.1371/journal.pone.0036247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558404	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200055
J	Delhaes, L; Monchy, S; Frealle, E; Hubans, C; Salleron, J; Leroy, S; Prevotat, A; Wallet, F; Wallaert, B; Dei-Cas, E; Sime-Ngando, T; Chabe, M; Viscogliosi, E				Delhaes, Laurence; Monchy, Sebastien; Frealle, Emilie; Hubans, Christine; Salleron, Julia; Leroy, Sylvie; Prevotat, Anne; Wallet, Frederick; Wallaert, Benoit; Dei-Cas, Eduardo; Sime-Ngando, Telesphore; Chabe, Magali; Viscogliosi, Eric			The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community-Implications for Therapeutic Management	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; ASPERGILLUS-FUMIGATUS; RESPIRATORY-TRACT; CANDIDA-ALBICANS; BRONCHOALVEOLAR LAVAGE; SPUTUM SAMPLES; ADULT PATIENTS; DNA; INFECTIONS; DIVERSITY	Background: Given the polymicrobial nature of pulmonary infections in patients with cystic fibrosis (CF), it is essential to enhance our knowledge on the composition of the microbial community to improve patient management. In this study, we developed a pyrosequencing approach to extensively explore the diversity and dynamics of fungal and prokaryotic populations in CF lower airways. Methodology and Principal Findings: Fungi and bacteria diversity in eight sputum samples collected from four adult CF patients was investigated using conventional microbiological culturing and high-throughput pyrosequencing approach targeting the ITS2 locus and the 16S rDNA gene. The unveiled microbial community structure was compared to the clinical profile of the CF patients. Pyrosequencing confirmed recently reported bacterial diversity and observed complex fungal communities, in which more than 60% of the species or genera were not detected by cultures. Strikingly, the diversity and species richness of fungal and bacterial communities was significantly lower in patients with decreased lung function and poor clinical status. Values of Chao1 richness estimator were statistically correlated with values of the Shwachman-Kulczycki score, body mass index, forced vital capacity, and forced expiratory volume in 1 s (p = 0.046, 0.047, 0.004, and 0.001, respectively for fungal Chao1 indices, and p = 0.010, 0.047, 0.002, and 0.0003, respectively for bacterial Chao1 values). Phylogenetic analysis showed high molecular diversities at the sub-species level for the main fungal and bacterial taxa identified in the present study. Anaerobes were isolated with Pseudomonas aeruginosa, which was more likely to be observed in association with Candida albicans than with Aspergillus fumigatus. Conclusions: In light of the recent concept of CF lung microbiota, we viewed the microbial community as a unique pathogenic entity. We thus interpreted our results to highlight the potential interactions between microorganisms and the role of fungi in the context of improving survival in CF.	[Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] Inst Pasteur, CIIL, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] INSERM U1019, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] UMR CNRS 8402, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo; Chabe, Magali; Viscogliosi, Eric] Univ Lille Nord France, EA4547, Dept Parasitol Mycol, Fac Pharm, Lille, France; [Delhaes, Laurence; Frealle, Emilie; Dei-Cas, Eduardo] Lille Hosp, Fac Med, Dept Microbiol, Lille, France; [Monchy, Sebastien; Sime-Ngando, Telesphore] Clermont Univ, LMGE, UMR CNRS 6023, Aubiere, France; [Monchy, Sebastien] ULCO, Univ Lille Nord France, LOG, UMR CNRS 8187, Wimereux, France; [Salleron, Julia] Lille Hosp, Fac Med, Dept Biostat, Lille, France; [Leroy, Sylvie; Prevotat, Anne; Wallaert, Benoit] Calmette Hosp, CRCM Adulte, Dept Pneumol & Immunoallergol, Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Delhaes, L (corresponding author), Inst Pasteur, CIIL, BP 245, Lille, France.	Laurence.delhaes@pasteur-lille.fr	Leroy, Sylvie SL/A-6903-2017; Sime-Ngando, Télesphore/M-4134-2019; Fréalle, Emilie/AAF-5162-2020; Delhaes, Laurence/AAD-6930-2020; Chabe, Magali/H-6045-2017	Leroy, Sylvie SL/0000-0002-3465-8180; Sime-Ngando, Télesphore/0000-0002-7240-5803; Frealle, Emilie/0000-0003-3129-979X; Viscogliosi, Eric/0000-0002-5805-7179; MONCHY, Sebastien/0000-0001-5808-4700; Chabe, Magali/0000-0002-6732-6772	French Ministry of Health and Research (PHRC) [2006/1902]; Pfizer France Pharmaceutical Division [2006/158]; Lille-Nord-de-France University; Pasteur Institute of Lille	French Ministry of Health and Research (PHRC); Pfizer France Pharmaceutical Division; Lille-Nord-de-France University; Pasteur Institute of Lille	This work was part of a study supported by the French Ministry of Health and Research (PHRC No 2006/1902), and Pfizer France Pharmaceutical Division (No 2006/158). The authors also thank the Lille-Nord-de-France University, the Pasteur Institute of Lille for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from Pfizer France pharmaceutical Division (No 2006/158). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguero-Chapin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026638; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Balajee SA, 2006, EUKARYOT CELL, V5, P1705, DOI 10.1128/EC.00162-06; Balajee SA, 2005, EUKARYOT CELL, V4, P625, DOI 10.1128/EC.4.3.625-632.2005; Bandara HMHN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-125; Bearchell SJ, 2005, P NATL ACAD SCI USA, V102, P5438, DOI 10.1073/pnas.0501596102; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Borman AM, 2010, MED MYCOL, V48, pS88, DOI 10.3109/13693786.2010.511287; Bouchara JP, 2009, J CLIN MICROBIOL, V47, P142, DOI 10.1128/JCM.01668-08; Casagrande BF, 2006, J INVEST DERMATOL, V126, P2414, DOI 10.1038/sj.jid.5700431; Chabe M, 2011, FEMS YEAST RES, V11, P2, DOI 10.1111/j.1567-1364.2010.00698.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chotirmall SH, 2010, CHEST, V138, P1186, DOI 10.1378/chest.09-2996; Cimerman M, 1999, J CLIN MICROBIOL, V37, P1532, DOI 10.1128/JCM.37.5.1532-1535.1999; Cimon B, 2001, J MED MICROBIOL, V50, P367, DOI 10.1099/0022-1317-50-4-367; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Delhaes L, 2008, EMERG INFECT DIS, V14, P282, DOI 10.3201/eid1402.070920; Dumitru R, 2004, ANTIMICROB AGENTS CH, V48, P2350, DOI 10.1128/AAC.48.7.2350-2354.2004; Dumitru R, 2007, EUKARYOT CELL, V6, P465, DOI 10.1128/EC.00316-06; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; European Commission Health & Consumers Directorate-General Phlebiopsis gigantea, SANCO16308REV3 EUR C; Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557; FEGAN M, 1991, J CLIN MICROBIOL, V29, P2151, DOI 10.1128/JCM.29.10.2151-2157.1991; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Friaza V, 2010, J MICROBIOL METH, V82, P98, DOI 10.1016/j.mimet.2010.03.026; Gammelsrud KW, 2011, CLIN MICROBIOL INFEC, V17, P1875, DOI 10.1111/j.1469-0691.2011.03528.x; Gilgado F, 2008, J CLIN MICROBIOL, V46, P766, DOI 10.1128/JCM.01122-07; Gomez-Lopez A, 2010, DIAGN MICR INFEC DIS, V66, P116, DOI 10.1016/j.diagmicrobio.2009.06.007; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Grinwis ME, 2010, J CLIN MICROBIOL, V48, P395, DOI 10.1128/JCM.01807-09; Guarro J, 1999, CLIN MICROBIOL REV, V12, P454, DOI 10.1128/CMR.12.3.454; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Hall RA, 2011, EUKARYOT CELL, V10, P1034, DOI 10.1128/EC.05060-11; HARRIES MG, 1985, LANCET, V1, P1063; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hirooka Y, 2011, STUD MYCOL, P35, DOI [10.3114/sim.2011.68.02, 10.3114/sim.2011.68.03]; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hogan DA, 2004, MOL MICROBIOL, V54, P1212, DOI 10.1111/j.1365-2958.2004.04349.x; Horre R, 2010, MED MYCOL, V48, pS1, DOI 10.3109/13693786.2010.529304; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Lachance MA, 2003, FEMS YEAST RES, V4, P253, DOI 10.1016/S1567-1356(03)00113-2; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; Leclair LW, 2010, MED MYCOL, V48, pS125, DOI 10.3109/13693786.2010.521522; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; McAlester G, 2008, J MED MICROBIOL, V57, P563, DOI 10.1099/jmm.0.47705-0; Merget R, 2008, RESPIRATION, V76, P109, DOI 10.1159/000097137; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; Montes-Cano MA, 2007, CLIN MICROBIOL INFEC, V13, P1008, DOI 10.1111/j.1469-0691.2007.01789.x; Moore JE, 2002, MYCOPATHOLOGIA, V154, P25, DOI 10.1023/A:1015236422992; Mortensen KL, 2011, EUR J CLIN MICROBIOL, V30, P1355, DOI 10.1007/s10096-011-1229-7; Mowat E, 2010, FEMS MICROBIOL LETT, V313, P96, DOI 10.1111/j.1574-6968.2010.02130.x; Muthig M, 2010, MED MYCOL, V48, P56, DOI 10.3109/13693780802716532; Nagano Y, 2010, MED MYCOL, V48, P166, DOI 10.3109/13693780903127506; Nagano Y, 2008, J CYST FIBROS, V7, P566, DOI 10.1016/j.jcf.2008.06.007; Nahimana A, 2000, J EUKARYOT MICROBIOL, V47, P368, DOI 10.1111/j.1550-7408.2000.tb00062.x; Neuveglise C, 1997, EUR J CLIN MICROBIOL, V16, P747, DOI 10.1007/BF01709257; Perkins SD, 2010, INT J MED MICROBIOL, V300, P503, DOI 10.1016/j.ijmm.2010.02.005; Peterson SW, 2008, MYCOLOGIA, V100, P205, DOI 10.3852/mycologia.100.2.205; Pihet M, 2009, MED MYCOL, V47, P387, DOI 10.1080/13693780802609604; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Reihill JA, 2011, J CYST FIBROS, V10, P401, DOI 10.1016/j.jcf.2011.06.006; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2010, GUT MICROBES, V1, P85, DOI 10.4161/gmic.1.2.11350; Rogers GB, 2010, J CLIN MICROBIOL, V48, P78, DOI 10.1128/JCM.01324-09; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; SAMSON RA, 1978, MYCOPATHOLOGIA, V64, P13, DOI 10.1007/BF00443082; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Seidler MJ, 2008, ANTIMICROB AGENTS CH, V52, P4130, DOI 10.1128/AAC.00234-08; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Sibley CD, 2011, CAN J MICROBIOL, V57, P69, DOI [10.1139/W10-105, 10.1139/w10-105]; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Sudfeld CR, 2010, J CYST FIBROS, V9, P110, DOI 10.1016/j.jcf.2009.11.010; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tre-Hardy M, 2010, ANTIMICROB AGENTS CH, V54, P4409, DOI 10.1128/AAC.00372-10; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Vanhee LME, 2008, EUR J CLIN MICROBIOL, V27, P1005, DOI 10.1007/s10096-008-0527-1; Vilela DM, 2010, FOOD MICROBIOL, V27, P1128, DOI 10.1016/j.fm.2010.07.024; Willner D, 2012, ISME J, V6, P471, DOI 10.1038/ismej.2011.104; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Wolcott RD, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-226; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Zemanick ET, 2011, CURR OPIN PEDIATR, V23, P319, DOI 10.1097/MOP.0b013e32834604f2; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	104	247	251	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36313	10.1371/journal.pone.0036313	http://dx.doi.org/10.1371/journal.pone.0036313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558432	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000187
J	Zhu, M; Li, WW; Lu, CZ				Zhu, Min; Li, Wenwei; Lu, Chuanzhen			Role of Alpha-Synuclein Protein Levels in Mitochondrial Morphology and Cell Survival in Cell Lines	PLOS ONE			English	Article							PARKINSON-DISEASE; TRANSGENIC MICE; COMPLEX-I; NEURONS; EXPRESSION; DYNAMICS; FISSION; FUSION; MUTANT; FRAGMENTATION	alpha-Synuclein is highly associated with some neurodegeneration and malignancies. Overexpressing wild-type or mutant alpha-synuclein promotes neuronal death by mitochondrial dysfunction, the underlying mechanisms of which remain poorly defined. It was recently reported that alpha-synuclein synuclein expression could directly lead to mitochondrial fragmentation in vitro and in vivo, which may be due to alpha-synuclein localization on mitochondria. Here, we applied a double staining method to demonstrate mitochondrial morphogenetic changes in cells overexpressed with alpha-synuclein. We show that mitochondrial localization of alpha-synuclein was increased following its overexpression in three distinct cell lines, including HeLa, SH-SY5Y, and PC12 cells, but no alteration in mitochondrial morphology was detected. However, alpha-synuclein knockdown prevents MPP+-induced mitochondrial fragmentation in SH-SY5Y and PC12 cells. These data suggest that alpha-synuclein protein levels hardly affect mitochondrial morphology in normal cell lines, but may have some influence on that under certain environmental conditions.	[Zhu, Min; Li, Wenwei] Fudan Univ, Lab Neurol Inst Integrat Med, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei; Lu, Chuanzhen] Fudan Univ, Inst Neurol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei; Lu, Chuanzhen] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Min; Li, Wenwei] Fudan Univ, State Key Lab Med Neurobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhu, M (corresponding author), Fudan Univ, Lab Neurol Inst Integrat Med, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	wenweili2000@yahoo.com.cn; czlu@shmu.edu.cn			China Postdoctoral Foundation [20080430076, 200902205]; Ph.D. Programs Foundation from the China Ministry of Education [200802461038]; Shanghai Natural Science Foundation [10ZR1406100]; Opening Foundation from Institutes of Brain Science of Fudan University	China Postdoctoral Foundation(China Postdoctoral Science Foundation); Ph.D. Programs Foundation from the China Ministry of Education; Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Opening Foundation from Institutes of Brain Science of Fudan University	This work was supported by the China Postdoctoral Foundation (20080430076 & 200902205), Ph.D. Programs Foundation from the China Ministry of Education (200802461038), and the Shanghai Natural Science Foundation (10ZR1406100). The imaging was performed at the Institutes of Brain Science of Fudan University, in part, supported by Opening Foundation from Institutes of Brain Science of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Andringa G, 2003, J NEUROPATH EXP NEUR, V62, P1060, DOI 10.1093/jnen/62.10.1060; Baltic S, 2004, J MOL NEUROSCI, V22, P199, DOI 10.1385/JMN:22:3:199; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bruening W, 2000, CANCER-AM CANCER SOC, V88, P2154, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2154::AID-CNCR23>3.0.CO;2-9; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chang DTW, 2006, NEUROSCIENCE, V141, P727, DOI 10.1016/j.neuroscience.2006.01.034; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Fung KM, 2003, ACTA NEUROPATHOL, V106, P167, DOI 10.1007/s00401-003-0718-x; HEIKKILA RE, 1984, NATURE, V311, P467, DOI 10.1038/311467a0; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Kamp F, 2010, EMBO J, V29, P3571, DOI 10.1038/emboj.2010.223; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Raghavan R, 2004, PEDIATR DEVEL PATHOL, V7, P506, DOI 10.1007/s10024-003-7080-9; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steidl JV, 2003, NEUROREPORT, V14, P219, DOI 10.1097/00001756-200302100-00012; Stichel CC, 2007, HUM MOL GENET, V16, P2377, DOI 10.1093/hmg/ddm083; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2003, J BIOMOL STRUCT DYN, V21, P211, DOI 10.1080/07391102.2003.10506918; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; von Bohlen und Halbach O, 2004, PROG NEUROBIOL, V73, P151, DOI 10.1016/j.pneurobio.2004.05.002; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wirdefeldt K, 2004, NEUROLOGY, V63, P305, DOI 10.1212/01.WNL.0000129841.30587.9D; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105	48	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36377	10.1371/journal.pone.0036377	http://dx.doi.org/10.1371/journal.pone.0036377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558453	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000200
J	Ma, FF; Li, YL; Jia, LX; Han, YL; Cheng, JZ; Li, HH; Qi, YF; Du, J				Ma, Feifei; Li, Yulin; Jia, Lixin; Han, Yalei; Cheng, Jizhong; Li, Huihua; Qi, Yongfen; Du, Jie			Macrophage-Stimulated Cardiac Fibroblast Production of IL-6 Is Essential for TGF beta/Smad Activation and Cardiac Fibrosis Induced by Angiotensin II	PLOS ONE			English	Article							TRANSFORMING GROWTH FACTOR-BETA(1); RECEPTOR; INTERLEUKIN-6; HYPERTROPHY; DYSFUNCTION; INFLAMMATION; MECHANISMS; PRECURSORS; EXPRESSION; INDUCTION	Interleukin-6 (IL-6) is an important cytokine participating in multiple biologic activities in immune regulation and inflammation. IL-6 has been associated with cardiovascular remodeling. However, the mechanism of IL-6 in hypertensive cardiac fibrosis is still unclear. Angiotensin II (Ang II) infusion in mice increased IL-6 expression in the heart. IL-6 knockout (IL-6-/-) reduced Ang II-induced cardiac fibrosis: 1) Masson trichrome staining showed that Ang II infusion significantly increased fibrotic areas of the wild-type mouse heart, which was greatly suppressed in IL-6-/- mice and 2) immunohistochemistry staining showed decreased expression of alpha-smooth muscle actin (alpha-SMA), transforming growth factor beta 1 (TGF-beta 1) and collagen I in IL-6-/- mouse heart. The baseline mRNA expression of IL-6 in cardiac fibroblasts was low and was absent in cardiomyocytes or macrophages; however, co-culture of cardiac fibroblasts with macrophages significantly increased IL-6 production and expression of alpha-SMA and collagen I in fibroblasts. Moreover, TGF-beta 1 expression and phosphorylation of TGF-beta downstream signal Smad3 was stimulated by co-culture of macrophages with cardiac fibroblasts, while IL-6 neutralizing antibody decreased TGF-beta 1 expression and Smad3 phosphorylation in co-culture of macrophage and fibroblast. Taken together, our results indicate that macrophages stimulate cardiac fibroblasts to produce IL-6, which leads to TGF-beta 1 production and Smad3 phosphorylation in cardiac fibroblasts and thus stimulates cardiac fibrosis.	[Ma, Feifei; Li, Yulin; Jia, Lixin; Han, Yalei; Cheng, Jizhong; Qi, Yongfen; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Du, Jie] Minist Educ, Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China; [Li, Huihua] Capital Med Univ, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Ma, FF (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China.	yongfenqi@163.com; jdu@bcm.edu	Li, yulin/AGZ-5611-2022		Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Brewster UC, 2003, AM J MED SCI, V326, P15, DOI 10.1097/00000441-200307000-00003; Castrillo A, 2001, J EXP MED, V194, P1231, DOI 10.1084/jem.194.9.1231; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; Euler-Taimor G, 2006, CARDIOVASC RES, V69, P15, DOI 10.1016/j.cardiores.2005.07.007; Hafizi S, 1998, CIRCULATION, V98, P2553, DOI 10.1161/01.CIR.98.23.2553; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Haugen Espen, 2008, Exp Clin Cardiol, V13, P19; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Lijnen PJ, 2001, J RENIN-ANGIO-ALDO S, V2, P117, DOI 10.3317/jraas.2001.012; Marvar PJ, 2010, CIRC RES, V107, P263, DOI 10.1161/CIRCRESAHA.110.217299; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mollmann H, 2010, CARDIOVASC RES, V87, P395, DOI 10.1093/cvr/cvq186; Moustakas Aristidis, 2002, Journal of Cell Science, V115, P3355; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Ruiz-Ortega M, 2003, CURR HYPERTENS REP, V5, P73, DOI 10.1007/s11906-003-0014-0; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Schrader LI, 2007, ARTERIOSCL THROM VAS, V27, P2576, DOI 10.1161/ATVBAHA.107.153080; Seong GJ, 2009, MOL VIS, V15, P2123; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Staufenberger S, 2001, J CELL PHYSIOL, V187, P326, DOI 10.1002/jcp.1079; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; Wang WS, 2006, CIRC RES, V98, P1032, DOI 10.1161/01.RES.0000218782.52610.dc; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628; Zhang XL, 2005, J BIOL CHEM, V280, P12239, DOI 10.1074/jbc.M413284200	38	194	207	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35144	10.1371/journal.pone.0035144	http://dx.doi.org/10.1371/journal.pone.0035144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574112	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800008
J	Suzuki, S; Ishida, T; Kurokawa, K; Akiyama, Y				Suzuki, Shuji; Ishida, Takashi; Kurokawa, Ken; Akiyama, Yutaka			GHOSTM: A GPU-Accelerated Homology Search Tool for Metagenomics	PLOS ONE			English	Article							READ ALIGNMENT; PROTEIN; DATABASE; BLAST; SEQUENCES; KEGG	Background: A large number of sensitive homology searches are required for mapping DNA sequence fragments to known protein sequences in public and private databases during metagenomic analysis. BLAST is currently used for this purpose, but its calculation speed is insufficient, especially for analyzing the large quantities of sequence data obtained from a next-generation sequencer. However, faster search tools, such as BLAT, do not have sufficient search sensitivity for metagenomic analysis. Thus, a sensitive and efficient homology search tool is in high demand for this type of analysis. Methodology/Principal Findings: We developed a new, highly efficient homology search algorithm suitable for graphics processing unit (GPU) calculations that was implemented as a GPU system that we called GHOSTM. The system first searches for candidate alignment positions for a sequence from the database using pre-calculated indexes and then calculates local alignments around the candidate positions before calculating alignment scores. We implemented both of these processes on GPUs. The system achieved calculation speeds that were 130 and 407 times faster than BLAST with 1 GPU and 4 GPUs, respectively. The system also showed higher search sensitivity and had a calculation speed that was 4 and 15 times faster than BLAT with 1 GPU and 4 GPUs. Conclusions: We developed a GPU-optimized algorithm to perform sensitive sequence homology searches and implemented the system as GHOSTM. Currently, sequencing technology continues to improve, and sequencers are increasingly producing larger and larger quantities of data. This explosion of sequence data makes computational analysis with contemporary tools more difficult. We developed GHOSTM, which is a cost-efficient tool, and offer this tool as a potential solution to this problem.	[Suzuki, Shuji; Ishida, Takashi; Akiyama, Yutaka] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan; [Kurokawa, Ken] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 227, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Suzuki, S (corresponding author), Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Meguro Ku, Tokyo 152, Japan.	akiyama@cs.titech.ac.jp	Akiyama, Yutaka/D-2048-2015	Akiyama, Yutaka/0000-0003-2863-8703	HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan; National Cancer Center, Japan; CUDA COE Program by NVIDIA; Grants-in-Aid for Scientific Research [22380176] Funding Source: KAKEN	HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan; National Cancer Center, Japan(National Cancer Center - Japan); CUDA COE Program by NVIDIA; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by HPCI Strategic Program Computational Life Science and Application in Drug Discovery and Medical Development by MEXT of Japan, Cancer Research Development funding by National Cancer Center, Japan, and the CUDA COE Program by NVIDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WG, 2011, IEEE ACM T COMPUT BI, V8, P1678, DOI 10.1109/TCBB.2011.33; Liu Yongchao, 2010, BMC Res Notes, V3, P93, DOI 10.1186/1756-0500-3-93; Liu Yongchao, 2009, BMC Res Notes, V2, P73, DOI 10.1186/1756-0500-2-73; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vouzis PD, 2011, BIOINFORMATICS, V27, P182, DOI 10.1093/bioinformatics/btq644; Walters JP, 2009, INT PARALL DISTRIB P, P1010; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X	25	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36060	10.1371/journal.pone.0036060	http://dx.doi.org/10.1371/journal.pone.0036060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574135	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800031
J	Cardaci, A; Papasergi, S; Midiri, A; Mancuso, G; Domina, M; Cariccio, VL; Mandanici, F; Galbo, R; Lo Passo, C; Pernice, I; Donato, P; Ricci, S; Biondo, C; Teti, G; Felici, F; Beninati, C				Cardaci, Angela; Papasergi, Salvatore; Midiri, Angelina; Mancuso, Giuseppe; Domina, Maria; Cariccio, Veronica Lanza; Mandanici, Francesca; Galbo, Roberta; Lo Passo, Carla; Pernice, Ida; Donato, Paolo; Ricci, Susanna; Biondo, Carmelo; Teti, Giuseppe; Felici, Franco; Beninati, Concetta			Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library	PLOS ONE			English	Article							HYPERVARIABLE REGION; PNEUMOCOCCAL DISEASE; EPITHELIAL-CELLS; VIRULENCE FACTOR; BINDING PROTEIN; LAMBDA-DISPLAY; VACCINATION; DISSECTION; INFECTION; ADHERENCE	There is considerable interest in pneumococcal protein antigens capable of inducing serotype-independent immunoprotection and of improving, thereby, existing vaccines. We report here on the immunogenic properties of a novel surface antigen encoded by ORF spr1875 in the R6 strain genome. An antigenic fragment encoded by spr1875, designated R4, was identified using a Streptococcus pneumoniae phage displayed genomic library after selection with a human convalescent serum. Immunofluorescence analysis with anti-R4 antisera showed that Spr1875 was expressed on the surface of strains belonging to different serotypes. Moreover, the gene was present with little sequence variability in 27 different pneumococcal strains isolated worldwide. A mutant lacking Spr1875 was considerably less virulent than the wild type D39 strain in an intravenous mouse model of infection. Moreover, immunization with the R4 recombinant fragment, but not with the whole Spr1875 protein, induced significant protection against sepsis in mice. Lack of protection after immunization with the whole protein was related to the presence of immunodominant, non-protective epitopes located outside of the R4 fragment. In conclusion, our data indicate that Spr1875 has a role in pneumococcal virulence and is immunogenic. As the R4 fragment conferred immunoprotection from experimental sepsis, selected antigenic fragments of Spr1875 may be useful for the development of a pneumococcal protein-based vaccine.	[Cardaci, Angela; Papasergi, Salvatore; Midiri, Angelina; Mancuso, Giuseppe; Domina, Maria; Cariccio, Veronica Lanza; Mandanici, Francesca; Biondo, Carmelo; Teti, Giuseppe; Beninati, Concetta] Univ Messina, Elie Metchnikoff Dept, Messina, Italy; [Galbo, Roberta; Lo Passo, Carla; Pernice, Ida] Univ Messina, Dipartimento Sci Vita M Malpighi, Messina, Italy; [Donato, Paolo] Novartis Vaccines & Diagnost, Messina, Italy; [Ricci, Susanna] Univ Siena, Dipartimento Biotecnol, I-53100 Siena, Italy; [Felici, Franco] Univ Molise, Dipartimento STAT, Pesche, IS, Italy	University of Messina; University of Messina; University of Siena; University of Molise	Cardaci, A (corresponding author), Univ Messina, Elie Metchnikoff Dept, Messina, Italy.	cbeninati@unime.it	ricci, susanna/R-4184-2018; Felici, Franco/H-5693-2012; papasergi, salvatore/AAE-8818-2021; Biondo, Carmelo/AAA-3391-2019; GALBO, Roberta/AAR-8424-2021; Domina, Maria/K-7883-2016	ricci, susanna/0000-0002-2279-6391; Felici, Franco/0000-0003-2205-5195; GALBO, Roberta/0000-0002-2880-3871; Pernice, Ida/0000-0001-8328-2776; Mancuso, Giuseppe/0000-0001-5454-3228; Lo Passo, Carla/0000-0001-5531-6748; BENINATI, Concetta/0000-0001-8305-1337; Domina, Maria/0000-0002-0445-8356; Midiri, Angelina/0000-0002-4128-9678	Progetti di Ricerca di Rilevante Interesse Nazionale from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy [287/2005, 1407/2008]	Progetti di Ricerca di Rilevante Interesse Nazionale from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy	This study was supported by grants Progetti di Ricerca di Rilevante Interesse Nazionale 2005 (DM n. 287/2005) and 2008 (DM n. 1407/2008) from the Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Bogaert D, 2004, VACCINE, V22, P2209, DOI 10.1016/j.vaccine.2003.11.038; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Downer R, 2002, J BIOL CHEM, V277, P243, DOI 10.1074/jbc.M107621200; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Garibaldi M, 2010, VACCINE, V28, P3609, DOI 10.1016/j.vaccine.2010.01.009; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Lannergard J, 2011, CELL HOST MICROBE, V10, P147, DOI 10.1016/j.chom.2011.06.011; Maione D, 2005, SCIENCE, V309, P148, DOI 10.1126/science.1109869; Martin D, 2002, INFECT IMMUN, V70, P4897, DOI 10.1128/IAI.70.9.4897-4901.2002; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; Oggioni MR, 2003, MOL MICROBIOL, V49, P795, DOI 10.1046/j.1365-2958.2003.03596.x; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Pearce BJ, 2002, RES MICROBIOL, V153, P243, DOI 10.1016/S0923-2508(02)01312-8; Rehm SJ, 2009, POSTGRAD MED, V121, P101, DOI 10.3810/pgm.2009.11.2069; Stalhammar-Carlemalm M, 2007, CELL HOST MICROBE, V2, P427, DOI 10.1016/j.chom.2007.10.003; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Waldemarsson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007279	25	23	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36588	10.1371/journal.pone.0036588	http://dx.doi.org/10.1371/journal.pone.0036588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570729	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400045
J	Cuddapah, S; Roh, TY; Cui, KR; Jose, CC; Fuller, MT; Zhao, KJ; Chen, X				Cuddapah, Suresh; Roh, Tae-Young; Cui, Kairong; Jose, Cynthia C.; Fuller, Margaret T.; Zhao, Keji; Chen, Xin			A Novel Human Polycomb Binding Site Acts As a Functional Polycomb Response Element in Drosophila	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP PROTEINS; DEVELOPMENTAL REGULATORS; SILENCING MECHANISMS; CHROMATIN DOMAINS; CELLULAR MEMORY; TARGET GENES; DNA-BINDING; COMPLEX; METHYLATION	Polycomb group (PcG) proteins are key chromatin regulators implicated in multiple processes including embryonic development, tissue homeostasis, genomic imprinting, X-chromosome inactivation, and germ cell differentiation. The PcG proteins recognize target genomic loci through cis DNA sequences known as Polycomb Response Elements (PREs), which are well characterized in Drosophila. However, mammalian PREs have been elusive until two groups reported putative mammalian PREs recently. Consistent with the existence of mammalian PREs, here we report the identification and characterization of a potential PRE from human T cells. The putative human PRE has enriched binding of PcG proteins, and such binding is dependent on a key PcG component SUZ12. We demonstrate that the putative human PRE carries both genetic and molecular features of Drosophila PRE in transgenic flies, implying that not only the trans PcG proteins but also certain features of the cis PREs are conserved between mammals and Drosophila.	[Cuddapah, Suresh; Jose, Cynthia C.] NYU, Dept Environm Med, Sch Med, New York, NY 10016 USA; [Roh, Tae-Young; Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Chen, Xin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Fuller, Margaret T.] Stanford Univ, Dept Dev Biol & Genet, Sch Med, Stanford, CA 94305 USA	New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Stanford University	Cuddapah, S (corresponding author), NYU, Dept Environm Med, Sch Med, 550 1St Ave, New York, NY 10016 USA.	Suresh.Cuddapah@nyumc.org; xchen32@jhu.edu	Cuddapah, Suresh/AAU-4288-2021	Roh, Tae-Young/0000-0001-5833-0844; Cuddapah, Suresh/0000-0002-4556-2029; Fuller, Margaret T/0000-0002-3804-4987	Leukemia and Lymphoma Society [LLS-3598-06]; National Institutes of Health (NIH) [K99/R00 HD055052, 1R01HD065816, 1R01GM61986]; National Heart, Lung and Blood Institute (NHLBI), NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K99HD055052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061986] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung and Blood Institute (NHLBI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Leukemia and Lymphoma Society Special Fellowship (grant LLS-3598-06), National Institutes of Health (NIH) grants K99/R00 HD055052 Pathway to Independence Award and 1R01HD065816 to XC, NIH grant 1R01GM61986 to MTF, and National Heart, Lung and Blood Institute (NHLBI), NIH intramural grants to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Cui KR, 2004, MOL CELL BIOL, V24, P4476, DOI 10.1128/MCB.24.10.4476-4486.2004; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Hur MW, 2002, DEVELOPMENT, V129, P1339; Jacobs JJL, 1999, SEMIN CELL DEV BIOL, V10, P227, DOI 10.1006/scdb.1999.0304; Kassis JA, 2002, ADV GENET, V46, P421; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Moschetti R, 2004, MOL GENET GENOMICS, V271, P394, DOI 10.1007/s00438-004-1007-7; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Przybyla-Zawislak BD, 2005, ANN NY ACAD SCI, V1053, P162, DOI 10.1196/annals.1344.014; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2004, COLD SPRING HARB SYM, V69, P301, DOI 10.1101/sqb.2004.69.301; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Simon JA, 2003, CURR BIOL, V13, pR79, DOI 10.1016/S0960-9822(03)00028-9; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Su YL, 2011, EPIGENETICS-US, V6, P9, DOI 10.4161/epi.6.1.13298; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707	65	22	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36365	10.1371/journal.pone.0036365	http://dx.doi.org/10.1371/journal.pone.0036365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570707	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343400023
J	Hoose, SA; Duran, C; Malik, I; Eslamfam, S; Shasserre, SC; Downing, SS; Hoover, EM; Dowd, KE; Smith, R; Polymenis, M				Hoose, Scott A.; Duran, Camille; Malik, Indranil; Eslamfam, Shabnam; Shasserre, Samantha C.; Downing, S. Sabina; Hoover, Evelyn M.; Dowd, Katherine E.; Smith, Roger, III; Polymenis, Michael			Systematic Analysis of Cell Cycle Effects of Common Drugs Leads to the Discovery of a Suppressive Interaction between Gemfibrozil and Fluoxetine	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; G1; LOVASTATIN; INITIATION; DIVISION; RECEPTOR	Screening chemical libraries to identify compounds that affect overall cell proliferation is common. However, in most cases, it is not known whether the compounds tested alter the timing of particular cell cycle transitions. Here, we evaluated an FDA-approved drug library to identify pharmaceuticals that alter cell cycle progression in yeast, using DNA content measurements by flow cytometry. This approach revealed strong cell cycle effects of several commonly used pharmaceuticals. We show that the antilipemic gemfibrozil delays initiation of DNA replication, while cells treated with the antidepressant fluoxetine severely delay progression through mitosis. Based on their effects on cell cycle progression, we also examined cell proliferation in the presence of both compounds. We discovered a strong suppressive interaction between gemfibrozil and fluoxetine. Combinations of interest among diverse pharmaceuticals are difficult to identify, due to the daunting number of possible combinations that must be evaluated. The novel interaction between gemfibrozil and fluoxetine suggests that identifying and combining drugs that show cell cycle effects might streamline identification of drug combinations with a pronounced impact on cell proliferation.	[Hoose, Scott A.; Duran, Camille; Malik, Indranil; Eslamfam, Shabnam; Shasserre, Samantha C.; Downing, S. Sabina; Hoover, Evelyn M.; Dowd, Katherine E.; Polymenis, Michael] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Smith, Roger, III] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Hoose, SA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	polymenis@tamu.edu	Smith III, Roger/C-8685-2013; Polymenis, Michael/AAJ-3389-2021	Duran, Camille/0000-0002-7614-3265; Smith, Roger/0000-0001-5645-8422	National Science Foundation [MCB-0818248]; Direct For Biological Sciences [0818248] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (MCB-0818248) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Blank HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008018; Blank HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000047; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Escriva H, 2000, BIOESSAYS, V22, P717; Formenti LR, 2011, J MOL MICROB BIOTECH, V20, P191, DOI 10.1159/000329068; Haase SB, 1997, METHOD ENZYMOL, V283, P322; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Huggins DJ, 2011, ACS CHEM BIOL, V6, P208, DOI 10.1021/cb100420r; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; KELLER HU, 1995, J LEUKOCYTE BIOL, V58, P519, DOI 10.1002/jlb.58.5.519; KEYOMARSI K, 1991, CANCER RES, V51, P3602; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Wiens M, 2003, J EXP BIOL, V206, P3261, DOI 10.1242/jeb.00541; WONG DT, 1974, LIFE SCI, V15, P471, DOI 10.1016/0024-3205(74)90345-2	22	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36503	10.1371/journal.pone.0036503	http://dx.doi.org/10.1371/journal.pone.0036503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567160	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500080
J	Letnic, M; Fillios, M; Crowther, MS				Letnic, Mike; Fillios, Melanie; Crowther, Mathew S.			Could Direct Killing by Larger Dingoes Have Caused the Extinction of the Thylacine from Mainland Australia?	PLOS ONE			English	Article							INVASIVE MESOPREDATOR; MAMMALIAN CARNIVORES; PREDATORY BEHAVIOR; FEEDING-BEHAVIOR; ABUNDANCE; ECOLOGY; BIODIVERSITY; CONVERGENCE; POPULATIONS; VERTEBRATES	Invasive predators can impose strong selection pressure on species that evolved in their absence and drive species to extinction. Interactions between coexisting predators may be particularly strong, as larger predators frequently kill smaller predators and suppress their abundances. Until 3500 years ago the marsupial thylacine was Australia's largest predator. It became extinct from the mainland soon after the arrival of a morphologically convergent placental predator, the dingo, but persisted in the absence of dingoes on the island of Tasmania until the 20th century. As Tasmanian thylacines were larger than dingoes, it has been argued that dingoes were unlikely to have caused the extinction of mainland thylacines because larger predators are rarely killed by smaller predators. By comparing Holocene specimens from the same regions of mainland Australia, we show that dingoes were similarly sized to male thylacines but considerably larger than female thylacines. Female thylacines would have been vulnerable to killing by dingoes. Such killing could have depressed the reproductive output of thylacine populations. Our results support the hypothesis that direct killing by larger dingoes drove thylacines to extinction on mainland Australia. However, attributing the extinction of the thylacine to just one cause is problematic because the arrival of dingoes coincided with another the potential extinction driver, the intensification of the human economy.	[Letnic, Mike] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Fillios, Melanie] Univ Sydney, Dept Archaeol, Sydney, NSW 2006, Australia; [Crowther, Mathew S.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Letnic, M (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	m.letnic@unsw.edu.au	Crowther, Mathew/M-7406-2013; Fillios, Melanie/D-7473-2018	Crowther, Mathew/0000-0001-8968-1161; Fillios, Melanie/0000-0002-7889-0061; Letnic, Michael/0000-0003-4191-8427	Asia Pacific Science Foundation [APSF 10/6]	Asia Pacific Science Foundation	Funding was provided by a grant APSF 10/6 from the Asia Pacific Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; ARCHER M, 1974, Journal of the Royal Society of Western Australia, V57, P43; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Berger KM, 2007, J ANIM ECOL, V76, P1075, DOI 10.1111/j.1365-2656.2007.01287.x; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Corbett L. K., 1995, DINGO AUSTR ASIA; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Dawson L., 1982, CARNIVOROUS MARSUPIA, P517; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gale SJ, 2009, QUAT GEOCHRONOL, V4, P391, DOI 10.1016/j.quageo.2008.12.003; Glen AS, 2005, BIOL REV, V80, P387, DOI 10.1017/S1464793105006718; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Johnson, 2006, AUSTRALIAS MAMMAL EX; Johnson CN, 2009, J APPL ECOL, V46, P641, DOI 10.1111/j.1365-2664.2009.01650.x; Johnson CN, 2011, P ROY SOC B-BIOL SCI, V278, P3748, DOI 10.1098/rspb.2011.0343; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Jones M, 1997, ECOLOGY, V78, P2569; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; KENDRICK G W, 1973, Journal of the Royal Society of Western Australia, V56, P116; Kovacs EK, OECOLOGIA IN PRESS; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2011, GLOBAL ECOL BIOGEOGR, V20, P343, DOI 10.1111/j.1466-8238.2010.00600.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOWRY J W J, 1972, Journal of the Royal Society of Western Australia, V55, P19; Luckett PW, 1993, MAMMAL PHYLOGENY MES, P182; Macintosh N.W.G., 1975, P87; Macintosh N. W. G., 1964, Proceedings of the Royal Society of Victoria, V77, P507; Mcnab BK, 2005, REV CHIL HIST NAT, V78, P183, DOI 10.4067/S0716-078X2005000200002; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Paddle R., 2000, LAST TASMANIAN TIGER; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Ride W. D. L., 1964, Journal of the Royal Society of Western Australia, V47, P97; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; ROSS A, 1985, Archaeology in Oceania, V20, P81; Ryan Lyndall., 1996, ABORIGINAL TASMANIAN; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Savidge J, 1997, ECOLOGY, V68, P660; Switalski TA, 2003, CAN J ZOOL, V81, P985, DOI 10.1139/Z03-080; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; THOMSON PC, 1992, WILDLIFE RES, V19, P531, DOI 10.1071/WR9920531; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wroe S, 2002, AUST J ZOOL, V50, P1, DOI 10.1071/ZO01053; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Yom-Tov Y, 2011, BIOL REV, V86, P531, DOI 10.1111/j.1469-185X.2010.00168.x	47	34	36	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34877	10.1371/journal.pone.0034877	http://dx.doi.org/10.1371/journal.pone.0034877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567093	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500011
J	Montiel, R; Solorzano, E; Diaz, N; Alvarez-Sandoval, BA; Gonzalez-Ruiz, M; Canadas, MP; Simoes, N; Isidro, A; Malgosa, A				Montiel, Rafael; Solorzano, Eduvigis; Diaz, Nancy; Alvarez-Sandoval, Brenda A.; Gonzalez-Ruiz, Mercedes; Pau Canadas, Mari; Simoes, Nelson; Isidro, Albert; Malgosa, Assumpcio			Neonate Human Remains: A Window of Opportunity to the Molecular Study of Ancient Syphilis	PLOS ONE			English	Article							TREPONEMA-PALLIDUM; CONGENITAL-SYPHILIS; TUBERCULOSIS; SEQUENCES; LESIONS; LIMITS	Ancient DNA (aDNA) analysis can be a useful tool in bacterial disease diagnosis in human remains. However, while the recovery of Mycobacterium spp. has been widely successful, several authors report unsuccessful results regarding ancient treponemal DNA, casting doubts on the usefulness of this technique for the diagnosis of ancient syphilis. Here, we present results from an analysis of four newborn specimens recovered from the crypt of "La Ermita de la Soledad'' (XVI-XVII centuries), located in the province of Huelva in the southwest of Spain. We extracted and analyzed aDNA in three independent laboratories, following specific procedures generally practiced in the aDNA field, including cloning of the amplified DNA fragments and sequencing of several clones. This is the most ancient case, reported to date, from which detection of DNA from T. pallidum subspecies pallidum has been successful in more than one individual, and we put forward a hypothesis to explain this result, taking into account the course of the disease in neonate individuals.	[Montiel, Rafael; Alvarez-Sandoval, Brenda A.] Inst Politecn Nacl CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico; [Solorzano, Eduvigis; Diaz, Nancy; Gonzalez-Ruiz, Mercedes; Isidro, Albert; Malgosa, Assumpcio] Univ Autonoma Barcelona, Unitat Antropol, Dept Biol Anim Biol Vegetal & Ecol, Bellaterra, Spain; [Pau Canadas, Mari] Gen Lab, Dept Biol Mol, Barcelona, Spain; [Simoes, Nelson] Univ Azores, Res Ctr Nat Resources CIRN, Dept Biol, Ponta Delgada, Azores, Portugal; [Isidro, Albert] Hosp Univ Sagrat Cor, Serv Cirurgia Ortoped & Traumatol COT, Barcelona, Spain	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Autonomous University of Barcelona; Universidade dos Acores	Montiel, R (corresponding author), Inst Politecn Nacl CINVESTAV IPN, Lab Nacl Genom Biodiversidad, Ctr Invest & Estudios Avanzados, Guanajuato, Mexico.	Assumpcio.Malgosa@uab.cat	Simões, Nelson/K-3843-2013; Isidro, Albert/L-6218-2014; Montiel, Rafael/A-6774-2008; Malgosa, Assumpció/K-2406-2014	Simões, Nelson/0000-0003-3612-6759; Isidro, Albert/0000-0001-8784-2945; Montiel, Rafael/0000-0001-8052-0679; Malgosa, Assumpció/0000-0003-1723-3671	Ministerio de Educacion y Ciencia, Spain (MEC) [CGL2008-00800]; Generalitat de Catalunya [PR2009-0128]; Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG) [08-03-K662-076 A04]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2008-01-105481]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) [SFRH/BPD/32473/2006]; CONACYT	Ministerio de Educacion y Ciencia, Spain (MEC)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors acknowledge the following grants: Ministerio de Educacion y Ciencia, Spain (MEC; www.educacion.gob.es) grant No. CGL2008-00800 to Dr. Malgosa; Generalitat de Catalunya (www.gencat.cat), grant No. PR2009-0128 to the Grup de Recerca en Antropologia Biologica (GREAB); Consejo de Ciencia y Tecnologia del Estado de Guanajuato, Mexico (CONCYTEG; www.concyteg.gob.mx) grant No. 08-03-K662-076 A04 to Dr. Montiel; Consejo Nacional de Ciencia y Tecnologia (CONACYT; www.conacyt.gob.mx) grant No. CB-2008-01-105481) to Dr. Montiel. Dr. Montiel received a postdoc grant (SFRH/BPD/32473/2006) from the Fundacao para a Ciencia e a Tecnologia, Portugal (FCT; www.fct.pt). Dr. Alvarez-Sandoval is supported by CONACYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduc-Le Bagousse A, 1988, NOTES MONOGRAPHIES T, V24, P81; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Armangil D, 2009, TURKISH J PEDIATR, V51, P169; Barnes I, 2006, P ROY SOC B-BIOL SCI, V273, P645, DOI 10.1098/rspb.2005.3339; BAUER MF, 1967, BRIT J VENER DIS, V43, P175; Bauer WH, 1944, AM J PATHOL, V20, P297; Blondiaux J, 1994, ORIGIN SYPHILIS EURO; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; Centurion-Lara A, 1998, J INFECT DIS, V177, P1036, DOI 10.1086/515247; Centurion-Lara A, 2006, J CLIN MICROBIOL, V44, P3377, DOI 10.1128/JCM.00784-06; DISMUKES WE, 1976, JAMA-J AM MED ASSOC, V236, P2646, DOI 10.1001/jama.236.23.2646; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063; Garcia C, 1999, ERMITA SOLEDAD TRAVE, P57; HANSEN K, 1984, BRIT J VENER DIS, V60, P265; Henneberg M, 1994, ORIGIN SYPHILIS EURO; Hershkovitz I, 1995, ORIGIN SYPHILIS EURO, P81; Hershkovitz I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003426; Ho EL, 2011, J CLIN INVEST, V121, P4584, DOI 10.1172/JCI57173; Hudson MM, 1996, LANCET, V348, P1495, DOI 10.1016/S0140-6736(96)08170-6; Jaffe H., 1972, METABOLIC DEGENERATI; Je GC, 1979, SEOUL J MED, V20, P297; Kolman CJ, 1999, J INFECT DIS, V180, P2060, DOI 10.1086/315151; Liu H, 2007, J MED MICROBIOL, V56, P715, DOI 10.1099/jmm.0.46943-0; LUGER A, 1993, SEX TRANSM DIS, V20, P110, DOI 10.1097/00007435-199303000-00010; Malgosa A., 2005, Recent Research Developments in Microbiology, Vol. 9, Part II, P213; Malgosa A, 1996, INT J OSTEOARCHAEOL, V6, P388, DOI 10.1002/(SICI)1099-1212(199609)6:4<388::AID-OA286>3.3.CO;2-1; Marangoni A, 2008, CLIN MICROBIOL INFEC, V14, P1065, DOI 10.1111/j.1469-0691.2008.02066.x; Montiel R, 2003, FEMS MICROBIOL LETT, V226, P413, DOI 10.1016/S0378-1097(03)00617-7; Montiel R, 2001, HUM BIOL, V73, P689, DOI 10.1353/hub.2001.0069; Montiel R, 2001, THESIS U AUTONOMA BA; Montiel R., 1997, J ANCIENT BIOMOL, V1, P221; OHTSUKI F, 1977, AM J PHYS ANTHROPOL, V46, P141, DOI 10.1002/ajpa.1330460118; Palfi G, 1992, INT J OSTEOARCHAEOL, V2, P245; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Roberts C, 1994, ORIGIN SYPHILIS EURO; Safont S, 1996, SALUD ENFERMEDAD MUE, P41; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Shen Hui-jun, 2009, Zhonghua Er Ke Za Zhi, V47, P871; Stirland A, 1991, ORIGIN SYPHILIS EURO; SUNDICK RI, 1978, HOMO, V29, P228; von Hunnius TE, 2007, J ARCHAEOL SCI, V34, P2091, DOI 10.1016/j.jas.2007.02.007	44	20	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36371	10.1371/journal.pone.0036371	http://dx.doi.org/10.1371/journal.pone.0036371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567153	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500072
J	Norberg, AL; Poder, U; Ljungman, G; von Essen, L				Norberg, Annika Lindahl; Poder, Ulrika; Ljungman, Gustaf; von Essen, Louise			Objective and Subjective Factors as Predictors of Post-Traumatic Stress Symptoms in Parents of Children with Cancer - A Longitudinal Study	PLOS ONE			English	Article							CHILDHOOD-CANCER; DISORDER; MOTHERS; SATISFACTION; SURVIVORS; DISTRESS	Background: Parents of children with cancer report post-traumatic stress symptoms (PTSS) years after the child's successful treatment is completed. The aim of the present study was to analyze a number of objective and subjective childhood cancer-related factors as predictors of parental PTSS. Methods: Data were collected from 224 parents during and after their child's cancer treatment. Data sources include self-report questionnaires and medical records. Results: In a multivariate hierarchical model death of the child, parent's perception of child psychological distress and total symptom burden predicted higher levels of PTSS. In addition, immigrants and unemployed parents reported higher levels of PTSS. The following factors did not predict PTSS: parent gender, family income, previous trauma, child's prognosis, treatment intensity, non-fatal relapse, and parent's satisfaction with the child's care. Conclusions: Although medical complications can be temporarily stressful, a parent's perception of the child's distress is a more powerful predictor of parental PTSS. The vulnerability of unemployed parents and immigrants should be acknowledged. In addition, findings highlight that the death of a child is as traumatic as could be expected.	[Norberg, Annika Lindahl; Poder, Ulrika; von Essen, Louise] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Norberg, Annika Lindahl] Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Ljungman, Gustaf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Uppsala University	Norberg, AL (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	Annika.Lindahl.Norberg@pubcare.uu.se		Ljungman, Gustaf/0000-0002-4949-2494	Swedish Cancer Society [02 0274, 03 0228]; Swedish Research Council [K2008-70X-20836-01-3]; Swedish Children's Cancer Foundation [02/004, 05/030, 08/006]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Children's Cancer Foundation	This work was supported by The Swedish Cancer Society, grants numbers 02 0274 and 03 0228. http://www.cancerfonden.se/sv/Information-inEnglish/. The Swedish Research Council, grant number K2008-70X-20836-01-3. http://vetenskapsradet.wordpress.com/in-english/. The Swedish Children's Cancer Foundation, grant numbers 02/004, 05/030, and 08/006. http://www.barncancerfonden.se/Om-oss/In-English/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barakat LP, 1997, J PEDIATR PSYCHOL, V22, P843, DOI 10.1093/jpepsy/22.6.843; Bredart A, 1998, SUPPORT CARE CANCER, V6, P518, DOI 10.1007/s005200050207; Brewin Chris R., 2000, J CONSULTING CLIN PS, V68; Brown RT, 2003, J TRAUMA STRESS, V16, P309, DOI 10.1023/A:1024465415620; Butow PN, 2011, SUPPORT CARE CANCER, V19, P281, DOI 10.1007/s00520-010-0817-x; Collins JJ, 2000, J PAIN SYMPTOM MANAG, V19, P363, DOI 10.1016/S0885-3924(00)00127-5; Cull A., 1998, EORTC QUALITY LIFE S; Duffey-Lind Eileen C, 2006, J Pediatr Oncol Nurs, V23, P335, DOI 10.1177/1043454206293267; Elklit A, 2010, J PSYCHOSOC ONCOL, V28, P399, DOI 10.1080/07347332.2010.488142; Horowitz MJ, 1997, AM J PSYCHIAT, V154, P904; Jurbergs N, 2009, J PEDIATR PSYCHOL, V34, P4, DOI 10.1093/jpepsy/jsm119; Kazak AE, 2005, J CLIN ONCOL, V23, P7405, DOI 10.1200/JCO.2005.09.110; Kazak AE, 1998, J AM ACAD CHILD PSY, V37, P823, DOI 10.1097/00004583-199808000-00012; Lazarus R.S., 1991, EMOTION ADAPTATION; Libova BG, 2002, PSYCHOL HEALTH, V17, P501, DOI 10.1080/0887044022000004975; Magal-Vardi O, 2004, J NERV MENT DIS, V192, P872, DOI 10.1097/01.nmd.0000146881.00129.ec; Nandi A, 2004, J OCCUP ENVIRON MED, V46, P1057, DOI 10.1097/01.jom.0000141663.22902.0a; NOPHO, 1999, CHILDH CANC NORD COU; Norberg AL, 2009, EUR J CANCER CARE, V18, P371, DOI 10.1111/j.1365-2354.2008.00976.x; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; Pelcovitz D, 1996, PSYCHOSOMATICS, V37, P116, DOI 10.1016/S0033-3182(96)71577-3; Poder U, 2008, PSYCHO-ONCOLOGY, V17, P430, DOI 10.1002/pon.1263; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Schwartz SJ, 2010, AM PSYCHOL, V65, P237, DOI 10.1037/a0019330; Steele RG, 2004, J PEDIATR PSYCHOL, V29, P507, DOI 10.1093/jpepsy/jsh053; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Yeh CH, 2003, APPL NURS RES, V16, P245, DOI 10.1016/S0897-1897(03)00054-5	31	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36218	10.1371/journal.pone.0036218	http://dx.doi.org/10.1371/journal.pone.0036218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567141	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500060
J	Szwedowski, TD; Taylor, WR; Heller, MO; Perka, C; Muller, M; Duda, GN				Szwedowski, Tomasz D.; Taylor, William R.; Heller, Markus O.; Perka, Carsten; Mueller, Michael; Duda, Georg N.			Generic Rules of Mechano-Regulation Combined with Subject Specific Loading Conditions Can Explain Bone Adaptation after THA	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; X-RAY ABSORPTIOMETRY; MINERAL DENSITY; REMODELING SIGNAL; PROXIMAL FEMUR; DESIGN; STEMS; PROSTHESIS; SIMULATION; RESORPTION	Bone adaptation after total hip arthroplasty is associated with the change in internal load environment, and can result in compromised bone stock, which presents a considerable challenge should a revision procedure be required. Under the assumption of a generic mechano-regulatory algorithm for governing bone adaptation, the aim of this study was to understand the contribution of subject specific loading conditions towards explaining the local periprosthetic remodelling variations in patients. CT scans of 3 consecutive THA patients were obtained and used for the construction of subject specific finite element models using verified musculoskeletal loading and physiological boundary conditions. Using either strain energy density or equivalent strain as mechano-transduction signals, predictions of bone adaptation were compared to DEXA derived BMD changes from 7 days to 12 months post-implantation. Individual changes in BMD of up to 33.6% were observed within the 12 month follow-up period, together with considerable inter-patient variability of up to 26%. Estimates of bone adaptation using equivalent strain and balanced loading conditions led to the best agreement with in vivo measured BMD, with RMS errors of only 3.9%, 7.3% and 7.3% for the individual subjects, compared to errors of over 10% when the loading conditions were simplified. This study provides evidence that subject specific loading conditions and physiological boundary constraints are essential for explaining inter-patient variations in bone adaptation patterns. This improved knowledge of the rules governing the adaptation of bone following THA helps towards understanding the interplay between mechanics and biology for better identifying patients at risk of excessive or problematic periprosthetic bone atrophy.	[Szwedowski, Tomasz D.; Taylor, William R.; Heller, Markus O.; Perka, Carsten; Mueller, Michael; Duda, Georg N.] Charite, Julius Wolff Inst JWI, Ctr Musculoskeletal Surg CMSC, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Szwedowski, TD (corresponding author), Charite, Julius Wolff Inst JWI, Ctr Musculoskeletal Surg CMSC, Ctr Sports Sci & Sports Med Berlin CSSB, D-13353 Berlin, Germany.	bill.taylor@charite.de	Perka, Carsten/ABG-6505-2021; Müller, Michael/L-2732-2019; Duda, Georg N/H-2085-2016; Taylor, William R./F-8692-2010; Heller, Markus O/F-8437-2010	Müller, Michael/0000-0002-8934-9676; Duda, Georg N/0000-0001-7605-3908; Taylor, William R./0000-0003-4060-4098; Heller, Markus O/0000-0002-7879-1135; Perka, Carsten/0000-0002-0993-581X	Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America); Deutsche Forschungsgemeinschaft DFG [SFB 760]	Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was financially supported by Zimmer Orthopaedics Inc. (Warsaw, Indiana, United States of America) and the Deutsche Forschungsgemeinschaft DFG SFB 760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005; Bryan JM, 1996, J ORTHOP RES, V14, P762, DOI 10.1002/jor.1100140513; Duda GN, 1998, J BIOMECH, V31, P841, DOI 10.1016/S0021-9290(98)00080-3; Dunbar M J, 2001, Instr Course Lect, V50, P197; ENGH CA, 1993, CLIN ORTHOP RELAT R, P177; Epari DR, 2006, CLIN BIOMECH, V21, P646, DOI 10.1016/j.clinbiomech.2006.01.003; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Heller MO, 2005, J BIOMECH, V38, P1155, DOI 10.1016/j.jbiomech.2004.05.022; Heller MO, 2003, LANGENBECK ARCH SURG, V388, P291, DOI 10.1007/s00423-003-0406-2; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; HUISKES R, 1995, CLIN ORTHOP RELAT R, P64; Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118; HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3; HUISKES R, 1992, CLIN ORTHOP RELAT R, P124; HUISKES R, 1987, ACTA ORTHOP SCAND, V58, P620; HUISKES R, 1989, ORTHOPEDICS, V12, P1255; Kainmueller D, 2009, C P IEEE ENG MED BIO, V2009, P6345; Kerner J, 1999, J BIOMECH, V32, P695, DOI 10.1016/S0021-9290(99)00041-X; KILGUS DJ, 1993, J BONE JOINT SURG BR, V75, P279, DOI 10.1302/0301-620X.75B2.8444950; Kiratli BJ, 1996, J ARTHROPLASTY, V11, P184; KIRATLI BJ, 1992, J ORTHOP RES, V10, P836, DOI 10.1002/jor.1100100613; Kleemann RU, 2003, J ORTHOP RES, V21, P767, DOI 10.1016/S0736-0266(03)00040-8; LES CM, 1994, J ORTHOP RES, V12, P822, DOI 10.1002/jor.1100120610; MIKIC B, 1995, J BIOMECH, V28, P465, DOI 10.1016/0021-9290(94)00085-I; Perka C, 2005, CLIN ORTHOP RELAT R, P153; Rosenbaum TG, 2006, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000223981.21584.35; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; Scannell PT, 2009, MED ENG PHYS, V31, P477, DOI 10.1016/j.medengphy.2008.11.007; Schmitz MJ, 2004, P I MECH ENG H, V218, P417, DOI 10.1243/0954411042632162; Smart RC, 1996, J ARTHROPLASTY, V11, P445, DOI 10.1016/S0883-5403(96)80035-0; Speirs AD, 2007, J BIOMECH, V40, P2318, DOI 10.1016/j.jbiomech.2006.10.038; Speirs AD, 2007, CLIN BIOMECH, V22, P431, DOI 10.1016/j.clinbiomech.2006.12.003; Stulpner MA, 1997, J BIOMECH, V30, P1063, DOI 10.1016/S0021-9290(97)00074-2; SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202; Taylor W. R., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P131, DOI 10.1080/10255840410001712108; Taylor WR, 2004, J ORTHOP RES, V22, P625, DOI 10.1016/j.orthres.2003.09.003; Taylor WR, 2003, P I MECH ENG H, V217, P349, DOI 10.1243/095441103770802513; Turner AWL, 2005, J ORTHOP RES, V23, P705, DOI 10.1016/j.orthres.2005.02.002; VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U; WEINANS H, 1993, J ORTHOPAED RES, V11, P500, DOI 10.1002/jor.1100110405; Wilkinson JM, 2003, J ORTHOP RES, V21, P691, DOI 10.1016/S0736-0266(02)00237-1; Wolff J, 2010, CLIN ORTHOP RELAT R, V468, P1056, DOI 10.1007/s11999-010-1239-2; Wolff J, 2010, CLIN ORTHOP RELAT R, V468, P1052, DOI 10.1007/s11999-010-1240-9	45	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36231	10.1371/journal.pone.0036231	http://dx.doi.org/10.1371/journal.pone.0036231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567143	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000305341500062
J	Thomas, NA; Loetscher, T; Clode, D; Nicholls, MER				Thomas, Nicole A.; Loetscher, Tobias; Clode, Danielle; Nicholls, Michael E. R.			Right-Wing Politicians Prefer the Emotional Left	PLOS ONE			English	Article							RIGHT-HEMISPHERE; LATERALITY; EXPRESSION; VALENCE; GENDER; WOMEN; TRANSMISSION; ORIENTATIONS; PERCEPTION; ATTITUDES	Physiological research suggests that social attitudes, such as political beliefs, may be partly hard-wired in the brain. Conservatives have heightened sensitivity for detecting emotional faces and use emotion more effectively when campaigning. As the left face displays emotion more prominently, we examined 1538 official photographs of conservative and liberal politicians from Australia, Canada, the United Kingdom and the United States for an asymmetry in posing. Across nations, conservatives were more likely than liberals to display the left cheek. In contrast, liberals were more likely to face forward than were conservatives. Emotion is important in political campaigning and as portraits influence voting decisions, conservative politicians may intuitively display the left face to convey emotion to voters.	[Thomas, Nicole A.; Loetscher, Tobias; Nicholls, Michael E. R.] Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia; [Clode, Danielle] Flinders Univ S Australia, Sch Humanities, Adelaide, SA 5001, Australia	Flinders University South Australia; Flinders University South Australia	Thomas, NA (corresponding author), Flinders Univ S Australia, Sch Psychol, Adelaide, SA 5001, Australia.	nicole.thomas@flinders.edu.au	Loetscher, Tobias/I-1865-2019	Loetscher, Tobias/0000-0003-1967-2926; Nicholls, Mike/0000-0002-7072-3744; Thomas, Nicole/0000-0002-1112-9024				Adolphs R, 2001, NEUROPSYCHOLOGY, V15, P516, DOI 10.1037//0894-4105.15.4.516; Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; Brader T, 2005, AM J POLIT SCI, V49, P388, DOI 10.1111/j.0092-5853.2005.00130.x; Dolan K, 2010, POLIT BEHAV, V32, P69, DOI 10.1007/s11109-009-9090-4; Eaves LJ, 2008, BEHAV GENET, V38, P247, DOI 10.1007/s10519-008-9205-4; EYSENCK HJ, 1975, BRIT J SOC CLIN PSYC, V14, P323, DOI 10.1111/j.2044-8260.1975.tb00188.x; Fowler JH, 2008, SCIENCE, V322, P912, DOI 10.1126/science.1158188; Fridkin KL, 2009, POLIT BEHAV, V31, P53, DOI 10.1007/s11109-008-9065-x; Fusar-Poli P, 2009, NEUROSCI LETT, V452, P262, DOI 10.1016/j.neulet.2009.01.065; Hatemi PK, 2009, J POLIT, V71, P1141, DOI 10.1017/S0022381609090938; Helzer EG, 2011, PSYCHOL SCI, V22, P517, DOI 10.1177/0956797611402514; Huber GA, 2007, AM J POLIT SCI, V51, P957, DOI 10.1111/j.1540-5907.2007.00291.x; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; Lawless JL, 2009, POLIT GENDER, V5, P70, DOI 10.1017/S1743923X09000051; Lawless JL, 2004, POLIT RES QUART, V57, P479, DOI 10.1177/106591290405700312; Lenz GS, 2011, AM J POLIT SCI, V55, P574, DOI 10.1111/j.1540-5907.2011.00511.x; Marcus GE, 2000, ANNU REV POLIT SCI, V3, P221, DOI 10.1146/annurev.polisci.3.1.221; MCMANUS IC, 1973, NATURE, V243, P271, DOI 10.1038/243271a0; Nicholls MER, 2002, BRAIN COGNITION, V48, P480, DOI 10.1006/brcg.2001.1402; Nicholls MER, 2002, NEUROPSYCHOLOGIA, V40, P1662, DOI 10.1016/S0028-3932(02)00024-6; Nicholls MER, 1999, P ROY SOC B-BIOL SCI, V266, P1517, DOI 10.1098/rspb.1999.0809; Powell WR, 2009, LATERALITY, V14, P545, DOI 10.1080/13576500802680336; Rodway P, 2003, BRAIN COGNITION, V53, P452, DOI 10.1016/S0278-2626(03)00217-3; Rule NO, 2010, SOC COGN AFFECT NEUR, V5, P349, DOI 10.1093/scan/nsp046; Settle JE, 2010, J POLIT, V72, P1189, DOI 10.1017/S0022381610000617; Smith KB, 2011, POLIT PSYCHOL, V32, P369, DOI 10.1111/j.1467-9221.2010.00821.x; Vidal G., 1977, MATTERS FACT FICTION; Vigil JM, 2010, GROUP PROCESS INTERG, V13, P547, DOI 10.1177/1368430209356930; Westen D., 2007, PUBLIC AFFAIRS	33	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36552	10.1371/journal.pone.0036552	http://dx.doi.org/10.1371/journal.pone.0036552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567166	Green Published, Green Accepted, gold			2022-12-27	WOS:000305341500086
J	Wan, XW; Liu, YH; Zhang, B				Wan, Xuanwu; Liu, Yinghong; Zhang, Bin			Invasion History of the Oriental Fruit Fly, Bactrocera dorsalis, in the Pacific-Asia Region: Two Main Invasion Routes	PLOS ONE			English	Article							MULTIPLE INTRODUCTIONS; POPULATION-GENETICS; DIPTERA; POLYMORPHISM; INHERITANCE; DIVERSITY; PATTERNS	The oriental fruit fly, Bactrocera dorsalis, was initially recorded in Taiwan Island in 1912, and has dispersed to many areas in the Pacific-Asia region over the last century. The area of origin of the species may be confidently placed in South-East China. However, routes of range expansion to new areas and underlying population processes remain partially unclear, despite having been the subject of several studies. To explore the invasion history of this species, a partition of the cox1 gene of mitochondrial DNA was used to investigate genetic diversity, haplotype phylogeny and demographic history of 35 populations, covering China and South-East Asia and including marginal populations from Pakistan and Hawaii. Based on neighbor-joining tree analysis and the distribution of haplotypes, two main invasion routes are inferred: one from South-East China to Central China, another from South-East China to South-East Asia, with both routes probably coinciding in Central China. Populations in Taiwan Island and Hainan Island might have originated in South-East China. The marginal populations in Pakistan and Hawaii might have undergone founding events or genetic bottlenecks. Possible strategies for the control of this species are proposed based on the invasion history and reconstructed expansion routes.	[Wan, Xuanwu; Liu, Yinghong; Zhang, Bin] Southwest Univ, Coll Plant Protect, Chongqing Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wan, XW (corresponding author), Southwest Univ, Coll Plant Protect, Chongqing Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	yhliu@swu.edu.cn	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		National Basic Research Program of China [2009CB125903]; Innovation Fund for graduate student in Southwest University of China	National Basic Research Program of China(National Basic Research Program of China); Innovation Fund for graduate student in Southwest University of China	This study was supported by the National Basic Research Program of China (2009CB125903) and by the Innovation Fund for graduate student in Southwest University of China: Invasion History of the Fruit Flies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aketarawong N, 2007, MOL ECOL, V16, P3522, DOI 10.1111/j.1365-294X.2007.03409.x; Avise John C., 1994, pi; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; [陈鹏 CHEN Peng], 2007, [生态学报, Acta Ecologica Sinica], V27, P2468; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; di Castri F., 1989, SCOPE, V37, P1; Downie DA, 2002, MOL ECOL, V11, P2013, DOI 10.1046/j.1365-294X.2002.01584.x; Durka W, 2005, MOL ECOL, V14, P1697, DOI 10.1111/j.1365-294X.2005.02521.x; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; FULLAWAY DT, 1953, P ENTOMOLOGY SOC WAS, V51, P181; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; HARDY D E, 1973, Pacific Insects Monograph, V31, P1; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li Wei-Feng, 2007, Acta Entomologica Sinica, V50, P1255; Li Y, 2012, J APPL ENTOMOL, V136, P241, DOI 10.1111/j.1439-0418.2011.01636.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nakahara S, 2008, APPL ENTOMOL ZOOL, V43, P457, DOI 10.1303/aez.2008.457; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Pinero JC, 2009, J ECON ENTOMOL, V102, P1123, DOI 10.1603/029.102.0334; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rollins LA, 2011, MOL ECOL, V20, P2307, DOI 10.1111/j.1365-294X.2011.05101.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Shi W, 2005, ENVIRON ENTOMOL, V34, P977, DOI 10.1603/0046-225X-34.4.977; Shi W, 2010, GENETICA, V138, P377, DOI 10.1007/s10709-009-9429-0; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wan X, 2011, PLOS ONE, V10	51	53	67	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36176	10.1371/journal.pone.0036176	http://dx.doi.org/10.1371/journal.pone.0036176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567138	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500057
J	Chen, YZ; Wang, Y; Zhuang, YL; Zhou, FL; Huang, LL				Chen, Yuezhou; Wang, Yan; Zhuang, Yaling; Zhou, Feng; Huang, Lili			Mifepristone Increases the Cytotoxicity of Uterine Natural Killer Cells by Acting as a Glucocorticoid Antagonist via ERK Activation	PLOS ONE			English	Article							NK CELLS; PROGESTERONE-RECEPTOR; GRANZYME-B; PERFORIN EXPRESSION; CONTRACEPTIVE DRUG; SIGNALING PATHWAYS; CUSHINGS-SYNDROME; IN-VITRO; T-CELLS; RU-486	Background: Mifepristone (RU486), a potent antagonist of progesterone and glucocorticoids, is involved in immune regulation. Our previous studies demonstrated that mifepristone directly augments the cytotoxicity of human uterine natural killer (uNK) cells. However, the mechanism responsible for this increase in cytotoxicity is not known. Here, we explored whether the increased cytotoxicity in uNK cells produced by mifepristone is due to either anti-progesterone or anti-glucocorticoid activity, and also investigated relevant changes in the mitogen-activated protein kinase (MAPK) pathway. Methodology/Principal Findings: Uterine NK cells were isolated from decidual samples and incubated with different concentrations of progesterone, cortisol, or mifepristone. The cytotoxicity and perforin expression of uNK cells were detected by mitochondrial lactate dehydrogenase-based MTS staining and flow cytometry assays, respectively. Phosphorylation of components of the MAPK signaling pathway was detected by Western blot. Cortisol attenuated uNK cell-mediated cytotoxicity in a concentration-dependent manner whereas progesterone had no effect. Mifepristone alone increased the cytotoxicity and perforin expression of uNK cells; these effects were blocked by cortisol. Furthermore, mifepristone increased the phosphorylation of ERK1/2 in a cortisol-reversible manner. Specific ERK1/2 inhibitor PD98059 or U0126 blocked cortisol-and mifepristone-induced responses in uNK cells. Conclusions/Significance: These results suggest that mifepristone acts as a glucocorticoid antagonist to augment uNK cell-mediated cytotoxicity via ERK activation, which may be caused by increased perforin expression. These observations may reveal an important mechanism by which mifepristone upregulates the cytotoxicity of uNK cells.	[Chen, Yuezhou; Zhuang, Yaling; Zhou, Feng; Huang, Lili] Zhejiang Univ, Womens Reprod Hlth Lab Zhejiang Prov, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yan] Hubei Med Univ, Taihe Hosp, Dept Gastroenterol, Shiyan, Hubei, Peoples R China	Zhejiang University	Chen, YZ (corresponding author), Zhejiang Univ, Womens Reprod Hlth Lab Zhejiang Prov, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	fbhuanglili@163.com	Chen, Yuezhou/E-5206-2011	Chen, Yuezhou/0000-0002-9138-7081	National Natural Science Foundation of China [81070525]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81070525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruvito L, 2008, J IMMUNOL, V180, P5746, DOI 10.4049/jimmunol.180.8.5746; BAGCHI MK, 1990, NATURE, V345, P547, DOI 10.1038/345547a0; Boomsma CM, 2007, COCHRANE DATABASE SY; Check JH, 2010, ANTICANCER RES, V30, P119; Chen XY, 2010, FERTIL STERIL, V93, P2615, DOI 10.1016/j.fertnstert.2009.09.015; Chen YZ, 2011, AM J REPROD IMMUNOL, V65, P589, DOI 10.1111/j.1600-0897.2010.00955.x; Chien CH, 2009, HUM REPROD, V24, P1968, DOI 10.1093/humrep/dep099; Chiossone L, 2007, BLOOD, V109, P3767, DOI 10.1182/blood-2006-07-037846; Clark AR, 2003, CURR OPIN PHARMACOL, V3, P404, DOI 10.1016/S1471-4892(03)00073-0; Colucci F, 2003, NAT REV IMMUNOL, V3, P413, DOI 10.1038/nri1088; DARMON AJ, 1995, NATURE, V377, P446, DOI 10.1038/377446a0; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; Dosiou C, 2005, ENDOCR REV, V26, P44, DOI 10.1210/er.2003-0021; ELASHRY D, 1989, MOL ENDOCRINOL, V3, P1545, DOI 10.1210/mend-3-10-1545; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fukui A, 1999, AM J REPROD IMMUNOL, V41, P413; Ge NL, 2003, WORLD J GASTROENTERO, V9, P2182; Gonzalez R, 2010, REPROD TOXICOL, V29, P198, DOI 10.1016/j.reprotox.2009.10.009; Grossman WJ, 2003, CURR OPIN IMMUNOL, V15, P544, DOI 10.1016/S0952-7915(03)00099-2; HANSEN KA, 1992, AM J OBSTET GYNECOL, V166, P87, DOI 10.1016/0002-9378(92)91835-X; Henderson TA, 2003, J CLIN ENDOCR METAB, V88, P440, DOI 10.1210/jc.2002-021174; Imasato A, 2002, J BIOL CHEM, V277, P47444, DOI 10.1074/jbc.M208140200; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Johanssen S, 2007, EUR J ENDOCRINOL, V157, P561, DOI 10.1530/EJE-07-0458; Kitaya K, 2003, FERTIL STERIL, V79, P730, DOI 10.1016/S0015-0282(02)04818-5; Lachapelle MH, 1996, J IMMUNOL, V156, P4027; Lash GE, 2011, J REPROD IMMUNOL, V88, P156, DOI 10.1016/j.jri.2011.01.003; LAUE L, 1988, J CLIN ENDOCR METAB, V66, P290, DOI 10.1210/jcem-66-2-290; Li AM, 2005, FERTIL STERIL, V84, P202, DOI 10.1016/j.fertnstert.2005.01.126; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; LIN MF, 1995, PROSTATE, V26, P194, DOI 10.1002/pros.2990260405; Lu CC, 2010, J CELL PHYSIOL, V223, P343, DOI 10.1002/jcp.22043; Lu S, 2001, Zhonghua Fu Chan Ke Za Zhi, V36, P625; Mattarollo SR, 2007, CANCER IMMUNOL IMMUN, V56, P1285, DOI 10.1007/s00262-007-0279-2; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Quenby S, 2005, FERTIL STERIL, V84, P980, DOI 10.1016/j.fertnstert.2005.05.012; Rambal AA, 2009, LEUKEMIA, V23, P1744, DOI 10.1038/leu.2009.80; Ribeiro-Dias F, 2000, J IMMUNOL METHODS, V241, P121, DOI 10.1016/S0022-1759(00)00206-4; Sarkar NN, 2002, INT J CLIN PRACT, V56, P140; Sartor O, 1996, CLIN OBSTET GYNECOL, V39, P506, DOI 10.1097/00003081-199606000-00024; SPITZ IM, 1993, NEW ENGL J MED, V329, P404; Spitz IM, 1998, HUM REPROD UPDATE, V4, P584, DOI 10.1093/humupd/4.5.584; Spitz IM, 2006, CURR OPIN INVEST DR, V7, P882; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Tuckerman E, 2010, J REPROD IMMUNOL, V87, P60, DOI 10.1016/j.jri.2010.07.001; VANVOORHIS BJ, 1989, J CLIN ENDOCR METAB, V69, P1195; Verma S, 2000, BIOL REPROD, V62, P959, DOI 10.1095/biolreprod62.4.959; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wei S, 1998, J EXP MED, V187, P1753, DOI 10.1084/jem.187.11.1753; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Zhang T, 2009, BLOOD; Zhou F, 2011, FERTIL STERIL, V96, P649, DOI 10.1016/j.fertnstert.2011.06.074; Zhu HX, 2009, AM J REPROD IMMUNOL, V61, P68, DOI 10.1111/j.1600-0897.2008.00664.x	55	27	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36413	10.1371/journal.pone.0036413	http://dx.doi.org/10.1371/journal.pone.0036413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563497	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340700046
J	Mansouri, S; Kutky, M; Hudak, KA				Mansouri, Sheila; Kutky, Meherzad; Hudak, Katalin A.			Pokeweed Antiviral Protein Increases HIV-1 Particle Infectivity by Activating the Cellular Mitogen Activated Protein Kinase Pathway	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEINS; SARCIN/RICIN LOOP; P38 MAPK; CELLS; RNA; TRICHOSANTHIN; APOPTOSIS; INHIBITION; MUTATIONS; RICIN	Pokeweed antiviral protein (PAP) is a plant-derived N-glycosidase that exhibits antiviral activity against several viruses. The enzyme removes purine bases from the messenger RNAs of the retroviruses Human immunodeficiency virus-1 and Human T-cell leukemia virus-1. This depurination reduces viral protein synthesis by stalling elongating ribosomes at nucleotides with a missing base. Here, we transiently expressed PAP in cells with a proviral clone of HIV-1 to examine the effect of the protein on virus production and quality. PAP reduced virus production by approximately 450-fold, as measured by p24 ELISA of media containing virions, which correlated with a substantial decline in virus protein synthesis in cells. However, particles released from PAP-expressing cells were approximately 7-fold more infectious, as determined by single-cycle infection of 1G5 cells and productive infection of MT2 cells. This increase in infectivity was not likely due to changes in the processing of HIV-1 polyproteins, RNA packaging efficiency or maturation of virus. Rather, expression of PAP activated the ERK1/2 MAPK pathway to a limited extent, resulting in increased phosphorylation of viral p17 matrix protein. The increase in infectivity of HIV-1 particles produced from PAP-expressing cells was compensated by the reduction in virus number; that is, virus production decreased upon de novo infection of cells over time. However, our findings emphasize the importance of investigating the influence of heterologous protein expression upon host cells when assessing their potential for antiviral applications.	[Mansouri, Sheila; Kutky, Meherzad; Hudak, Katalin A.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Mansouri, S (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	hudak@yorku.ca			Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship in Science and Technology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship in Science and Technology	This work was supported by a Discovery Grant to KAH from the Natural Sciences and Engineering Research Council of Canada. MK is the recipient of an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; AGUILARCORDOVA E, 1994, AIDS RES HUM RETROV, V10, P295, DOI 10.1089/aid.1994.10.295; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Bukrinskaya AG, 1996, P NATL ACAD SCI USA, V93, P367, DOI 10.1073/pnas.93.1.367; Cartier C, 1999, J BIOL CHEM, V274, P19434, DOI 10.1074/jbc.274.27.19434; Cartier C, 2003, J BIOL CHEM, V278, P35211, DOI 10.1074/jbc.M301257200; Cartier C, 1997, J VIROL, V71, P4832, DOI 10.1128/JVI.71.6.4832-4837.1997; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4; FOATOMASI L, 1982, ARCH VIROL, V71, P323, DOI 10.1007/BF01315062; GESSNER SL, 1980, J BIOL CHEM, V255, P3251; Giroud C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-71; Huang H, 2006, LIFE SCI, V79, P1287, DOI 10.1016/j.lfs.2006.03.047; Hui EKW, 2002, CELL MOL LIFE SCI, V59, P920, DOI 10.1007/s00018-002-8479-6; HUR Y, 1995, P NATL ACAD SCI USA, V92, P8448, DOI 10.1073/pnas.92.18.8448; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; IRVIN JD, 1975, ARCH BIOCHEM BIOPHYS, V169, P522, DOI 10.1016/0003-9861(75)90195-2; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Korcheva V, 2005, AM J PATHOL, V166, P323, DOI 10.1016/S0002-9440(10)62256-0; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; Mansouri S, 2006, RNA, V12, P1683, DOI 10.1261/rna.70306; Mansouri S, 2009, J BIOL CHEM, V284, P31453, DOI 10.1074/jbc.M109.046235; Miyake T, 2010, MOL CELL BIOL, V30, P722, DOI 10.1128/MCB.01005-09; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Narayanan S, 2004, BIOCHEM J, V377, P233, DOI 10.1042/BJ20030797; NILSSON L, 1986, EUR J BIOCHEM, V161, P111, DOI 10.1111/j.1432-1033.1986.tb10130.x; Poon DTK, 1996, J VIROL, V70, P6607, DOI 10.1128/JVI.70.10.6607-6616.1996; Rajamohan F, 1999, BIOCHEM BIOPH RES CO, V260, P453, DOI 10.1006/bbrc.1999.0922; SADAIE MR, 1992, VIROLOGY, V187, P604; Tung KWC, 2008, INT J BIOCHEM CELL B, V40, P2452, DOI 10.1016/j.biocel.2008.04.021; Wang P, 2010, MOL BIOL REP, V37, P1891, DOI 10.1007/s11033-009-9629-9; Wang YY, 2005, BIOCHEM BIOPH RES CO, V331, P1075, DOI 10.1016/j.bbrc.2005.03.230; ZARLING JM, 1990, NATURE, V347, P92, DOI 10.1038/347092a0	34	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36369	10.1371/journal.pone.0036369	http://dx.doi.org/10.1371/journal.pone.0036369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563495	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340700044
J	Merino, S; Bouamama, L; Knirel, YA; Senchenkova, SN; Regue, M; Tomas, JM				Merino, Susana; Bouamama, Lamiaa; Knirel, Yuriy A.; Senchenkova, Sofya N.; Regue, Miguel; Tomas, Juan M.			Aeromonas Surface Glucan Attached through the O-Antigen Ligase Represents a New Way to Obtain UDP-Glucose	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIPOPOLYSACCHARIDE; BIOSYNTHESIS; POLYSACCHARIDE; ADHESIN	We previously reported that A. hydrophila GalU mutants were still able to produce UDP-glucose introduced as a glucose residue in their lipopolysaccharide core. In this study, we found the unique origin of this UDP-glucose from a branched alpha-glucan surface polysaccharide. This glucan, surface attached through the O-antigen ligase (WaaL), is common to the mesophilic Aeromonas strains tested. The Aeromonas glucan is produced by the action of the glycogen synthase (GlgA) and the UDP-Glc pyrophosphorylase (GlgC), the latter wrongly indicated as an ADP-Glc pyrophosphorylase in the Aeromonas genomes available. The Aeromonas glycogen synthase is able to react with UDP or ADP-glucose, which is not the case of E. coli glycogen synthase only reacting with ADP-glucose. The Aeromonas surface glucan has a role enhancing biofilm formation. Finally, for the first time to our knowledge, a clear preference on behalf of bacterial survival and pathogenesis is observed when choosing to produce one or other surface saccharide molecules to produce (lipopolysaccharide core or glucan).	[Merino, Susana; Bouamama, Lamiaa; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Knirel, Yuriy A.; Senchenkova, Sofya N.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Moscow, Russia; [Regue, Miguel] Univ Barcelona, Fac Farm, Dept Microbiol & Parasitol Sanitarias, E-08028 Barcelona, Spain	University of Barcelona; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; University of Barcelona	Merino, S (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Knirel, Yuriy A/E-2058-2014; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain); Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants; Spanish government	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain); Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte, Spain) and from Generalitat de Catalunya (Centre de ReferAncia en Biotecnologia) grants. These are competitve grants from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atlas R. M., 2004, Handbook of microbiological media; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GRANT WD, 1969, J BACTERIOL, V100, P1187, DOI 10.1128/JB.100.3.1187-1193.1969; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Kumari J, 2006, J FISH DIS, V29, P95, DOI 10.1111/j.1365-2761.2006.00691.x; Leontein K., 1993, METHODS CARBOHYDR CH, V9, P87; Lou J, 1997, APPL ENVIRON MICROB, V63, P4355, DOI 10.1128/AEM.63.11.4355-4359.1997; Merino S, 1996, FEMS MICROBIOL LETT, V139, P97, DOI 10.1016/0378-1097(96)00068-7; Merino S, 2011, J BACTERIOL, V193, P1943, DOI 10.1128/JB.01441-10; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; PREISS J, 1984, ANNU REV MICROBIOL, V38, P419, DOI 10.1146/annurev.mi.38.100184.002223; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Rodriguez I, 2009, FISH SHELLFISH IMMUN, V27, P369, DOI 10.1016/j.fsi.2009.02.007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; SOWOKINOS JR, 1976, PLANT PHYSIOL, V57, P63, DOI 10.1104/pp.57.1.63; STROBEL HJ, 1993, APPL ENVIRON MICROB, V59, P40, DOI 10.1128/AEM.59.1.40-46.1993; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vilches S, 2007, MICROBIOL-SGM, V153, P2393, DOI 10.1099/mic.0.2007/006437-0; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Westphal O, 1965, METHODS CARBOHYDR CH, V5, P83; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	37	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35707	10.1371/journal.pone.0035707	http://dx.doi.org/10.1371/journal.pone.0035707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563467	Green Published, gold			2022-12-27	WOS:000305340700016
J	Vegh, A; Farkas, A; Kovesdi, D; Papp, K; Cervenak, J; Schneider, Z; Bender, B; Hiripi, L; Laszlo, G; Prechl, J; Matko, J; Kacskovics, I				Vegh, Attila; Farkas, Anita; Koevesdi, Dorottya; Papp, Krisztian; Cervenak, Judit; Schneider, Zita; Bender, Balazs; Hiripi, Laszlo; Laszlo, Gloria; Prechl, Jozsef; Matko, Janos; Kacskovics, Imre			FcRn Overexpression in Transgenic Mice Results in Augmented APC Activity and Robust Immune Response with Increased Diversity of Induced Antibodies	PLOS ONE			English	Article							I-RELATED RECEPTOR; DENDRITIC CELLS; THERAPEUTIC ANTIBODIES; MEDIATED PRESENTATION; IGG; ANTIGEN; EXPRESSION; COMPLEXES; EPITOPE; SERUM	Our previous studies have shown that overexpression of bovine FcRn (bFcRn) in transgenic (Tg) mice leads to an increase in the humoral immune response, characterized by larger numbers of Ag-specific B cells and other immune cells in secondary lymphoid organs and higher levels of circulating Ag-specific antibodies (Abs). To gain additional insights into the mechanisms underlying this increase in humoral immune response, we further characterized the bFcRn Tg mice. Our Western blot analysis showed strong expression of the bFcRn transgene in peritoneal macrophages and bone marrow derived dendritic cells; and a quantitative PCR analysis demonstrated that the expression ratios of the bFcRn to mFcRn were 2.6- and 10-fold in these cells, respectively. We also found that overexpression of bFcRn enhances the phagocytosis of Ag-IgG immune complexes (ICs) by both macrophages and dendritic cells and significantly improves Ag presentation by dendritic cells. Finally, we determined that immunized bFcRn mice produce a much greater diversity of Ag-specific IgM, whereas only the levels, but not the diversity, of IgG is increased by overexpression of bFcRn. We suggest that the increase in diversity of IgG in Tg mice is prevented by a selective bias towards immunodominant epitopes of ovalbumin, which was used in this study as a model antigen. These results are also in line with our previous reports describing a substantial increase in the levels of Ag-specific IgG in FcRn Tg mice immunized with Ags that are weakly immunogenic and, therefore, not affected by immunodominance.	[Vegh, Attila; Cervenak, Judit; Bender, Balazs; Kacskovics, Imre] ImmunoGenes Kft, Budakeszi, Hungary; [Farkas, Anita; Koevesdi, Dorottya; Schneider, Zita; Laszlo, Gloria; Matko, Janos; Kacskovics, Imre] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Papp, Krisztian; Prechl, Jozsef] Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary; [Hiripi, Laszlo] Agr Biotechnol Ctr, H-2101 Godollo, Hungary	Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences	Vegh, A (corresponding author), ImmunoGenes Kft, Budakeszi, Hungary.	ikacsko@elte.hu	Prechl, József/B-2094-2009; Kacskovics, Imre/J-8449-2013; Matko, Janos/C-9008-2013; Papp, Krisztián/B-2251-2009; Hiripi, Laszlo/AAL-8243-2021	Prechl, József/0000-0003-3859-4353; Kacskovics, Imre/0000-0002-0402-3862; Matko, Janos/0000-0001-9434-934X; Papp, Krisztián/0000-0003-0619-8233; Hiripi, Laszlo/0000-0002-1023-0112; Schneider, Zita/0000-0001-8188-5952	National Office for Research, Hungary [OM-00117-119/2008]; National Development Agency, Hungary [TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Technology and National Development Agency, Hungary [KMOP-1.1.1-08]; Hungarian Scientific Research Fund [K101364]; EEA Grant; Norway Grant; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Office for Research, Hungary; National Development Agency, Hungary; Technology and National Development Agency, Hungary; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EEA Grant; Norway Grant; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the grants OM-00117-119/2008 from the National Office for Research, Hungary, TAMOP 4.2.1./B-09/1/KMR-2010-0003 from National Development Agency, Hungary, KMOP-1.1.1-08 from the Technology and National Development Agency, Hungary and K101364 from Hungarian Scientific Research Fund. Dr. Kovesdi is a Magyary Zoltan Postdoctoral Fellow supported by the EEA and Norway Grants, and Dr. Papp is supported by Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 1996, J IMMUNOL, V157, P2779; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Bender B, 2007, TRANSGENIC RES, V16, P613, DOI 10.1007/s11248-007-9108-9; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Cervenak J, 2011, J IMMUNOL, V186, P959, DOI 10.4049/jimmunol.1000353; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Chappell CP, 2006, J IMMUNOL, V176, P4706, DOI 10.4049/jimmunol.176.8.4706; COULIE PG, 1985, EUR J IMMUNOL, V15, P793, DOI 10.1002/eji.1830150810; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Garrity RR, 1997, J IMMUNOL, V159, P279; Getahun A, 2006, IMMUNOL LETT, V104, P38, DOI 10.1016/j.imlet.2005.11.005; Goins CL, 2010, J IMMUNOL, V184, P6293, DOI 10.4049/jimmunol.0902530; Golestani R, 2007, HYBRIDOMA, V26, P296, DOI 10.1089/hyb.2007.0510; Henry Kevin A, 2011, Bioeng Bugs, V2, P275, DOI 10.4161/bbug.2.5.16559; Hesselgesser J, 1998, J IMMUNOL, V160, P877; HIBBS ML, 1985, IMMUNOGENETICS, V22, P335, DOI 10.1007/BF00430917; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kacskovics I, 2006, INT IMMUNOL, V18, P525, DOI 10.1093/intimm/dxh393; Kacskovics I, 2011, MABS-AUSTIN, V3, P431, DOI 10.4161/mabs.3.5.17023; KUNKL A, 1981, IMMUNOLOGY, V43, P371; LAISSUE J, 1971, J IMMUNOL, V107, P822; Lemos APC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028869; Liu XD, 2011, J IMMUNOL, V186, P4674, DOI 10.4049/jimmunol.1003584; Lu W, 2007, IMMUNOLOGY, V122, P401, DOI 10.1111/j.1365-2567.2007.02654.x; Maletto BA, 2006, BLOOD, V108, P3094, DOI 10.1182/blood-2006-04-016659; Mi WT, 2008, J IMMUNOL, V181, P7550, DOI 10.4049/jimmunol.181.11.7550; Mine Y, 2007, BBA-PROTEINS PROTEOM, V1774, P200, DOI 10.1016/j.bbapap.2006.12.003; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Onisk D, 2011, MABS UNPUB; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Schneider Z, 2011, IMMUNOL LETT, V137, P62, DOI 10.1016/j.imlet.2011.02.018; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Soehnlein O, 2009, TRENDS IMMUNOL, V30, P511, DOI 10.1016/j.it.2009.07.002; Tobin GJ, 2008, VACCINE, V26, P6189, DOI 10.1016/j.vaccine.2008.09.080; Vegh A, 2011, MABS-AUSTIN, V3, P173, DOI 10.4161/mabs.3.2.14462; Vidarsson G, 2006, BLOOD, V108, P3573, DOI 10.1182/blood-2006-05-024539; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; WESTERWOUDT RJ, 1986, METHOD ENZYMOL, V121, P3; Zhu XP, 2001, J IMMUNOL, V166, P3266, DOI 10.4049/jimmunol.166.5.3266	46	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36286	10.1371/journal.pone.0036286	http://dx.doi.org/10.1371/journal.pone.0036286			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558422	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200062
J	Zalcman, SS; Patel, A; Mohla, R; Zhu, YH; Siegel, A				Zalcman, Steven S.; Patel, Ankur; Mohla, Ruchika; Zhu, Youhua; Siegel, Allan			Soluble Cytokine Receptors (sIL-2R alpha, sIL-2R beta) Induce Subunit-Specific Behavioral Responses and Accumulate in the Cerebral Cortex and Basal Forebrain	PLOS ONE			English	Article							INTERLEUKIN-2 RECEPTOR; IL-2; SCHIZOPHRENIA	Soluble cytokine receptors are normal constituents of body fluids that regulate peripheral cytokine and lymphoid activity. Levels of soluble IL-2 receptors (sIL-2R) are elevated in psychiatric disorders linked with autoimmune processes, including ones in which repetitive stereotypic behaviors and motor disturbances are present. However, there is no evidence that sIL-2Rs (or any peripheral soluble receptor) induce such behavioral changes, or that they localize in relevant brain regions. Here, we determined in male Balb/c mice the effects of single peripheral injections of sIL-2R alpha or sIL-2R beta (0-2 mu g/male Balb/c mouse; s.c.) on novelty-induced ambulatory activity and stereotypic motor behaviors. We discovered that sIL-2R alpha increased the incidence of in-place stereotypic motor behaviors, including head up head bobbing, rearing/sniffing, turning, and grooming behavior. A wider spectrum of behavioral changes was evident in sIL-2R beta-treated mice, including increases in vertical and horizontal ambulatory activity and stereotypic motor movements. To our knowledge, this is the first demonstration that soluble receptors induce such behavioral disturbances. In contrast, soluble IL-1 Type-1 receptors (0-4 mu g, s.c.) didn't appreciably affect these behaviors. We further demonstrated that sIL-2R alpha and sIL-2R beta induced marked increases in c-Fos in caudate-putamen, nucleus accumbens and prefrontal cortex. Anatomical specificity was supported by the presence of increased activity in lateral caudate in sIL-2R alpha treated mice, while sIL-2R beta treated mice induced greater c-Fos activity in prepyriform cortex. Moreover, injected sIL-2Rs were widely distributed in regions that showed increased c-Fos expression. Thus, sIL-2R alpha and sIL-2R beta induce marked subunit- and soluble cytokine receptor-specific behavioral disturbances, which included increases in the expression of ambulatory activity and stereotypic motor behaviors, while inducing increased neuronal activity localized to cortex and striatum. These findings suggest that sIL-2Rs act as novel immune-to- brain messengers and raise the possibility that they contribute to the disease process in psychiatric disorders in which marked increases in these receptors have been reported.	[Zalcman, Steven S.; Patel, Ankur; Mohla, Ruchika; Zhu, Youhua; Siegel, Allan] UMDNJ New Jersey Med Sch, Dept Psychiat, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zalcman, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Psychiat, Newark, NJ USA.	dr.ankur@yahoo.com			National Institutes of Health (NIH) [R01 MH74689]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074689] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institutes of Health (NIH) grant R01 MH74689 (to SSZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bien E, 2008, BIOMARKERS, V13, P1, DOI 10.1080/13547500701674063; Bresee C, 2009, INT J NEUROPSYCHOPH, V12, P861, DOI 10.1017/S1461145709000315; CARUSO C, 1993, MEDIAT INFLAMM, V2, P3, DOI 10.1155/S0962935193000018; Ebrinc S, 2002, J INT MED RES, V30, P314, DOI 10.1177/147323000203000313; Ellery JM, 2002, IMMUNOL CELL BIOL, V80, P351, DOI 10.1046/j.1440-1711.2002.01097.x; Fulop T, 2006, MECH AGEING DEV, V127, P526, DOI 10.1016/j.mad.2006.01.025; Hanisch UK, 1995, BRAIN RES REV, V21, P246, DOI 10.1016/0165-0173(95)00015-1; HONDA M, 1990, J IMMUNOL, V145, P4131; Kowalski J, 2000, World J Biol Psychiatry, V1, P190, DOI 10.3109/15622970009150591; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; LICINIO J, 1993, AM J PSYCHIAT, V150, P1408; MAES M, 1995, J PSYCHIAT RES, V29, P141, DOI 10.1016/0022-3956(94)00049-W; Novick D, 2007, CYTOKINE GROWTH F R, V18, P525, DOI 10.1016/j.cytogfr.2007.06.024; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rapaport MH, 1997, SCHIZOPHR RES, V25, P123, DOI 10.1016/S0920-9964(97)00008-X; Rapaport MH, 1997, PROG NEURO-PSYCHOPH, V21, P817, DOI 10.1016/S0278-5846(97)00082-1; RAPAPORT MH, 1994, ACTA PSYCHIAT SCAND, V90, P311, DOI 10.1111/j.1600-0447.1994.tb01599.x; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Suh CH, 2008, EXPERT REV MOL DIAGN, V8, P189, DOI 10.1586/14737159.8.2.189; Taylor JM, 2007, J NEUROIMMUNOL, V183, P118, DOI 10.1016/j.jneuroim.2006.11.027; Tsai SYM, 2001, J AFFECT DISORDERS, V64, P185, DOI 10.1016/S0165-0327(00)00252-4; Zalcman SS, 2002, BRAIN RES, V944, P157, DOI 10.1016/S0006-8993(02)02740-3; Zalcman SS, 2001, BRAIN RES, V899, P1, DOI 10.1016/S0006-8993(01)02090-X	23	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36316	10.1371/journal.pone.0036316	http://dx.doi.org/10.1371/journal.pone.0036316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558434	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000189
J	Tallent, J; Goodall, S; Hortobagyi, T; Gibson, AS; French, DN; Howatson, G				Tallent, Jamie; Goodall, Stuart; Hortobagyi, Tibor; Gibson, Alan St Clair; French, Duncan N.; Howatson, Glyn			Repeatability of Corticospinal and Spinal Measures during Lengthening and Shortening Contractions in the Human Tibialis Anterior Muscle	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; SOLEUS H-REFLEX; POST-ACTIVATION DEPRESSION; TEST-RETEST RELIABILITY; INPUT-OUTPUT PROPERTIES; SILENT PERIOD; SKELETAL-MUSCLE; V-WAVE; EXCITABILITY	Elements of the human central nervous system (CNS) constantly oscillate. In addition, there are also methodological factors and changes in muscle mechanics during dynamic muscle contractions that threaten the stability and consistency of transcranial magnetic stimulation (TMS) and perpherial nerve stimulation (PNS) measures. Purpose: To determine the repeatability of TMS and PNS measures during lengthening and shortening muscle actions in the intact human tibialis anterior. Methods: On three consecutive days, 20 males performed lengthening and shortening muscle actions at 15, 25, 50 and 80% of maximal voluntary contraction (MVC). The amplitude of the Motor Evoked Potentials (MEPs) produced by TMS was measured at rest and during muscle contraction at 90 degrees of ankle joint position. MEPs were normalised to Mmax determined with PNS. The corticospinal silent period was recorded at 80% MVC. Hoffman reflex (H-reflex) at 10% isometric and 25% shortening and lengthening MVCs, and V-waves during MVCs were also evoked on each of the three days. Results: With the exception of MEPs evoked at 80% shortening MVC, all TMS-derived measures showed good reliability (ICC = 0.81-0.94) from days 2 to 3. Confidence intervals (CI, 95%) were lower between days 2 and 3 when compared to days 1 and 2. MEPs significantly increased at rest from days 1 to 2 (P = 0.016) and days 1 to 3 (P = 0.046). The H-reflex during dynamic muscle contraction was reliable across the three days (ICC = 0.76-0.84). V-waves (shortening, ICC = 0.77, lengthening ICC = 0.54) and the H-reflex at 10% isometric MVC (ICC = 0.66) was generally less reliable over the three days. Conclusion: Although it is well known that measures of the intact human CNS exhibit moment-to-moment fluctuations, careful experimental arrangements make it possible to obtain consistent and repeatable measurements of corticospinal and spinal excitability in the actively lengthening and shortening human TA muscle.	[Tallent, Jamie; Goodall, Stuart; Gibson, Alan St Clair; French, Duncan N.; Howatson, Glyn] Northumbria Univ, Sch Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Hortobagyi, Tibor] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Howatson, Glyn] Univ Johannesburg, Ctr Aquat Res, Gauteng, South Africa	Northumbria University; University of Groningen; University of Johannesburg	Tallent, J (corresponding author), Northumbria Univ, Sch Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.	glyn.howatson@northumbria.ac.uk	Howatson, Glyn/AAE-9508-2021	Howatson, Glyn/0000-0001-8494-2043; Goodall, Stuart/0000-0001-9029-2171				Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; BARKER AT, 1985, LANCET, V1, P1106; Cacchio A, 2011, J NEUROL SCI, V303, P90, DOI 10.1016/j.jns.2011.01.004; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Carroll TJ, 2011, ACTA PHYSIOL, V202, P119, DOI 10.1111/j.1748-1716.2011.02271.x; Carroll TJ, 2001, J NEUROSCI METH, V112, P193, DOI 10.1016/S0165-0270(01)00468-X; Chen YS, 2010, J ELECTROMYOGR KINES, V20, P980, DOI 10.1016/j.jelekin.2009.11.003; Christie A, 2004, CLIN NEUROPHYSIOL, V115, P116, DOI 10.1016/S1388-2457(03)00306-7; Christie AD, 2005, J CLIN NEUROPHYSIOL, V22, P204; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; CRONE C, 1989, EXP BRAIN RES, V78, P28, DOI 10.1007/bf00230683; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; Darling WG, 2006, EXP BRAIN RES, V174, P376, DOI 10.1007/s00221-006-0468-9; Daskalakis ZJ, 2003, CLIN NEUROPHYSIOL, V114, P938, DOI 10.1016/S1388-2457(03)00038-5; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Dragert K, 2011, EXP BRAIN RES, V208, P217, DOI 10.1007/s00221-010-2472-3; Duchateau J, 2008, J PHYSIOL-LONDON, V586, P5853, DOI 10.1113/jphysiol.2008.160747; Duclay J, 2011, J PHYSIOL-LONDON, V589, P2901, DOI 10.1113/jphysiol.2011.207472; Duclay J, 2009, J ELECTROMYOGR KINES, V19, P948, DOI 10.1016/j.jelekin.2008.04.011; Ellaway PH, 1998, ELECTROMYOGR MOTOR C, V109, P104, DOI 10.1016/S0924-980X(98)00007-1; Enoka RM, 1996, J APPL PHYSIOL, V81, P2339, DOI 10.1152/jappl.1996.81.6.2339; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Field-Fote EC, 2006, NEUROSCI LETT, V410, P37, DOI 10.1016/j.neulet.2006.09.058; Fimland MS, 2009, EUR J APPL PHYSIOL, V107, P21, DOI 10.1007/s00421-009-1096-4; Fritz C, 1997, ELECTROMYOGR MOTOR C, V105, P235, DOI 10.1016/S0924-980X(97)96675-3; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hebbal GV, 2006, PERCEPT MOTOR SKILL, V102, P163, DOI 10.2466/PMS.102.1.163-164; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Herwig U, 2001, BIOL PSYCHIAT, V50, P58, DOI 10.1016/S0006-3223(01)01153-2; Hoffman P., 1910, ARCH F PHYSL, V1, P223; Hwang IS, 2002, J ELECTROMYOGR KINES, V12, P361, DOI 10.1016/S1050-6411(02)00034-2; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kasai T, 1997, BRAIN RES, V744, P147, DOI 10.1016/S0006-8993(96)01101-8; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; Lee M, 2005, J NEUROSCI METH, V149, P95, DOI 10.1016/j.jneumeth.2005.03.016; Magistris MR, 1999, BRAIN, V122, P265, DOI 10.1093/brain/122.2.265; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Minassian K, 2007, MUSCLE NERVE, V35, P327, DOI 10.1002/mus.20700; Mynark RG, 2005, CLIN NEUROPHYSIOL, V116, P1400, DOI 10.1016/j.clinph.2005.02.001; Palmieri RM, 2004, J ATHL TRAINING, V39, P268; Palmieri TM, 2002, INT J NEUROSCI, V112, P841, DOI 10.1080/00207450290025851; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Robertson CT, 2004, MED SCI SPORT EXER, V36, pS164, DOI 10.1097/00005768-200405001-00784; Rosler KM, 2001, NEWS PHYSIOL SCI, V16, P297; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rothwell JC, 2007, J PHYSIOL-LONDON, V584, P363, DOI 10.1113/jphysiol.2007.143677; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Sekiguchi H, 2003, BRAIN RES, V977, P169, DOI 10.1016/S0006-8993(03)02621-0; Sekiguchi H, 2007, EXP BRAIN RES, V178, P374, DOI 10.1007/s00221-006-0743-9; Selvanayagam VS, 2011, J APPL PHYSL; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Simonsen EB, 2011, HUM MOVEMENT SCI, V30, P333, DOI 10.1016/j.humov.2010.02.009; Solstad GM, 2011, J CLIN NEUROPHYSIOL, V28, P217, DOI 10.1097/WNP.0b013e31821215cf; Tallent J, 2012, J CLIN NEUROSCI, DOI [10.1016/j.jocn.2012.1001.1022, DOI 10.1016/J.JOCN.2012.1001.1022]; Troni W, 1996, MUSCLE NERVE, V19, P595, DOI 10.1002/(SICI)1097-4598(199605)19:5<595::AID-MUS7>3.3.CO;2-4; van Hedel HJA, 2007, J NEUROL, V254, P1089, DOI 10.1007/s00415-006-0493-4; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Yahagi S, 1998, ELECTROMYOGR MOTOR C, V109, P409, DOI 10.1016/S0924-980X(98)00041-1; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5; Ziemann U, 1996, ANN NEUROL, V40, P367, DOI 10.1002/ana.410400306	63	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35930	10.1371/journal.pone.0035930	http://dx.doi.org/10.1371/journal.pone.0035930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563418	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000305349100044
J	Arguello, RJ; Albareda, MC; Alvarez, MG; Bertocchi, G; Armenti, AH; Vigliano, C; Meckert, PC; Tarleton, RL; Laucella, SA				Argueello, Rafael J.; Albareda, Maria C.; Alvarez, Mari G.; Bertocchi, Graciela; Armenti, Alejandro H.; Vigliano, Carlos; Meckert, Patricia C.; Tarleton, Rick L.; Laucella, Susana A.			Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease	PLOS ONE			English	Article							INTERFERON-GAMMA; VIRAL-INFECTION; CTLA-4; LYMPHOCYTES; EXHAUSTION; MOLECULES; DIFFERENTIATION; PHENOTYPE; SUBSETS; PROGRESSION	We had formerly demonstrated that subjects chronically infected with Trypanosoma cruzi show impaired T cell responses closely linked with a process of T cell exhaustion. Recently, the expression of several inhibitory receptors has been associated with T cell dysfunction and exhaustion. In this study, we have examined the expression of the cytotoxic T lymphocyte antigen 4 (CTLA-4) and the leukocyte immunoglobulin like receptor 1 (LIR-1) by peripheral T. cruzi antigen-responsive IFN-gamma (IFN-gamma)-producing and total T cells from chronically T. cruzi-infected subjects with different clinical forms of the disease. CTAL-4 expression was also evaluated in heart tissue sections from subjects with severe myocarditis. The majority of IFN-gamma-producing CD4(+) T cells responsive to a parasite lysate preparation were found to express CTLA-4 but considerably lower frequencies express LIR-1, irrespective of the clinical status of the donor. Conversely, few IFN-gamma-producing T cells responsive to tetanus and diphtheria toxoids expressed CTLA-4 and LIR-1. Polyclonal stimulation with anti-CD3 antibodies induced higher frequencies of CD4(+)CTAL-4(+) T cells in patients with severe heart disease than in asymptomatic subjects. Ligation of CTLA-4 and LIR-1 with their agonistic antibodies, in vitro, reduces IFN-gamma production. Conversely, CTLA-4 blockade did not improved IFN-gamma production in response to T. cruzi antigens. Subjects with chronic T. cruzi infection had increased numbers of CD4(+)LIR-1(+) among total peripheral blood mononuclear cells, relative to uninfected individuals and these numbers decreased after treatment with benznidazole. CTLA-4 was also expressed by CD3(+) T lymphocytes infiltrating heart tissues from chronically infected subjects with severe myocarditis. These findings support the conclusion that persistent infection with T. cruzi leads to the upregulation of inhibitory receptors which could alter parasite specific T cell responses in the chronic phase of Chagas disease.	[Argueello, Rafael J.; Albareda, Maria C.; Laucella, Susana A.] Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina; [Vigliano, Carlos; Meckert, Patricia C.] Hosp Univ Fdn Favaloro, Dept Patol, Buenos Aires, DF, Argentina; [Tarleton, Rick L.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	University of Buenos Aires; University System of Georgia; University of Georgia	Arguello, RJ (corresponding author), Inst Nacl Parasitol Dr Mario Fatala Chaben, Buenos Aires, DF, Argentina.	slaucella@yahoo.com	Tarleton, Rick/AES-8572-2022	Tarleton, Rick/0000-0002-9589-5243; Arguello, Rafael J/0000-0001-9785-3883	National Council for Scientific and Technical Research, Argentina (CONICET PIP) [5686]; National Institutes of Health, United States of America [P01AI044979]; Ministerio de Salud de la Nacion, Argentina; Ministerio de Salud de la Provincia de Buenos Aires, Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044979] Funding Source: NIH RePORTER	National Council for Scientific and Technical Research, Argentina (CONICET PIP); National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Salud de la Nacion, Argentina; Ministerio de Salud de la Provincia de Buenos Aires, Argentina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Council for Scientific and Technical Research, Argentina (CONICET PIP No5686) to SAL; The National Institutes of Health, United States of America (P01AI044979) to RLT; Ministerio de Salud de la Nacion, Argentina, and Ministerio de Salud de la Provincia de Buenos Aires, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Albareda MC, 2006, INT IMMUNOL, V18, P465, DOI 10.1093/intimm/dxh387; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; [Anonymous], 2002, WHO TECHN REP SER; Antrobus RD, 2005, J INFECT DIS, V191, P1842, DOI 10.1086/429927; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3; Bank/WHO UW UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 1995, 12 PROGR REP UNDP WO, P125; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2007, J VIROL, V81, P945, DOI 10.1128/JVI.01354-06; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Blackburn SD, 2010, J VIROL, V84, P2078, DOI 10.1128/JVI.01579-09; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Cella M, 2000, CURR TOP MICROBIOL, V251, P161; Chapman TL, 1999, IMMUNITY, V11, P603, DOI 10.1016/S1074-7613(00)80135-1; Chen YQ, 2006, ALLERGY, V61, P15, DOI 10.1111/j.1398-9995.2006.01008.x; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; EDWARDS WD, 1981, MAYO CLIN PROC, V56, P479; Graefe SEB, 2004, PARASITE IMMUNOL, V26, P19, DOI 10.1111/j.0141-9838.2004.00679.x; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Gutierrez FRS, 2011, INFECT IMMUN, V79, P1873, DOI 10.1128/IAI.01047-10; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Hermann E, 2010, IMMUNOLOGY, V129, P418, DOI 10.1111/j.1365-2567.2009.03194.x; Higuchi MD, 1997, AM J TROP MED HYG, V56, P485; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Ince MN, 2004, IMMUNOLOGY, V112, P531, DOI 10.1046/j.1365-2567.2004.01907.x; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Jimenez-Martinez MC, 2004, IMMUNOLOGY, V111, P100, DOI 10.1111/j.1365-2567.2004.01785.x; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kumar S, 2001, J IMMUNOL, V166, P4596, DOI 10.4049/jimmunol.166.7.4596; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laguens RP, 1999, MEDICINA-BUENOS AIRE, V59, P63; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Laucella SA, 2009, CLIN INFECT DIS, V49, P1675, DOI 10.1086/648072; Marinova E, 2007, J IMMUNOL, V178, P5010, DOI 10.4049/jimmunol.178.8.5010; Martins GA, 2004, J IMMUNOL, V172, P4893, DOI 10.4049/jimmunol.172.8.4893; Merlo A, 2001, INFECT IMMUN, V69, P6022, DOI 10.1128/IAI.69.10.6022-6029.2001; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Northfield J, 2005, IMMUNOL CELL BIOL, V83, P182, DOI 10.1111/j.1440-1711.2005.01321.x; Olivera GC, 2010, MICROBES INFECT, V12, P359, DOI 10.1016/j.micinf.2010.01.011; Radziewicz H, 2007, WORLD J GASTROENTERO, V13, P4848, DOI 10.3748/wjg.v13.i36.4848; Raziorrouh B, 2011, GASTROENTEROLOGY, V141, P1422, DOI 10.1053/j.gastro.2011.07.004; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Saverino D, 2004, J IMMUNOL, V172, P5629, DOI 10.4049/jimmunol.172.9.5629; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; Schlotmann T, 2000, J INFECT DIS, V182, P367, DOI 10.1086/315690; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Souza PEA, 2007, INFECT IMMUN, V75, P1886, DOI 10.1128/IAI.01931-06; TARLETON RL, 1994, INFECT IMMUN, V62, P1820, DOI 10.1128/IAI.62.5.1820-1829.1994; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Vandenborre K, 1998, AM J PATHOL, V152, P963; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Wagner CS, 2007, J IMMUNOL, V178, P3536, DOI 10.4049/jimmunol.178.6.3536; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wizel B, 1998, J CLIN INVEST, V102, P1062, DOI 10.1172/JCI3835; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; Zammit DJ, 2006, MICROBES INFECT, V8, P1108, DOI 10.1016/j.micinf.2005.12.002; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	69	41	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35966	10.1371/journal.pone.0035966	http://dx.doi.org/10.1371/journal.pone.0035966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574131	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800027
J	Nishiyama, T; Miyawaki, K; Ohshima, M; Thompson, K; Nagashima, A; Hasebe, M; Kurata, T				Nishiyama, Tomoaki; Miyawaki, Kaori; Ohshima, Masumi; Thompson, Kari; Nagashima, Akitomo; Hasebe, Mitsuyasu; Kurata, Tetsuya			Digital Gene Expression Profiling by 5 '-End Sequencing of cDNAs during Reprogramming in the Moss Physcomitrella patens	PLOS ONE			English	Article							SHOOT DEVELOPMENT; ARABIDOPSIS-THALIANA; AUXIN BIOSYNTHESIS; HISTONE H4R3; GENOME; TRANSCRIPTOME; PROTEINS; KINASE; LAND; ROOT	Stem cells self-renew and repeatedly produce differentiated cells during development and growth. The differentiated cells can be converted into stem cells in some metazoans and land plants with appropriate treatments. After leaves of the moss Physcomitrella patens are excised, leaf cells reenter the cell cycle and commence tip growth, which is characteristic of stem cells called chloronema apical cells. To understand the underlying molecular mechanisms, a digital gene expression profiling method using mRNA 5'-end tags (5'-DGE) was established. The 5'-DGE method produced reproducible data with a dynamic range of four orders that correlated well with qRT-PCR measurements. After the excision of leaves, the expression levels of 11% of the transcripts changed significantly within 6 h. Genes involved in stress responses and proteolysis were induced and those involved in metabolism, including photosynthesis, were reduced. The later processes of reprogramming involved photosynthesis recovery and higher macromolecule biosynthesis, including of RNA and proteins. Auxin and cytokinin signaling pathways, which are activated during stem cell formation via callus in flowering plants, are also activated during reprogramming in P. patens, although no exogenous phytohormone is applied in the moss system, suggesting that an intrinsic phytohormone regulatory system may be used in the moss.	[Nishiyama, Tomoaki; Miyawaki, Kaori; Ohshima, Masumi; Thompson, Kari; Nagashima, Akitomo; Hasebe, Mitsuyasu; Kurata, Tetsuya] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okazaki, Aichi, Japan; [Nishiyama, Tomoaki] Kanazawa Univ, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 444, Japan; [Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi, Japan	Japan Science & Technology Agency (JST); Kanazawa University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Nishiyama, T (corresponding author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okazaki, Aichi, Japan.	tomoakin@staff.kanazawa-u.ac.jp; mhasebe@nibb.ac.jp; tekurata@bs.naist.jp		Hasebe, Mitsuyasu/0000-0001-7425-8758; Nishiyama, Tomoaki/0000-0003-1279-7806	Japan Science and Technology Agency under Exploratory Research for Advanced Technology program; Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 22128008, 21370107, 22128002]	Japan Science and Technology Agency under Exploratory Research for Advanced Technology program; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Science and Technology Agency under the Exploratory Research for Advanced Technology program, and the Ministry of Education, Culture, Sports, Science and Technology [KAKENHI 22128008 to TN, 21370107 and 22128002 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bao YH, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-132; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bibikova M, 2008, CELL STEM CELL, V2, P123, DOI 10.1016/j.stem.2008.01.005; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Chopra RN, 1988, BIOL BRYOPHYTES; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Eklund DM, 2010, DEVELOPMENT, V137, P1275, DOI 10.1242/dev.039594; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hashimoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004108; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Ishikawa M, 2011, PLANT CELL, V23, P2924, DOI 10.1105/tpc.111.088005; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kulpa D, 1997, EMBO J, V16, P856, DOI 10.1093/emboj/16.4.856; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Ludwig-Muller J, 2009, NEW PHYTOL, V181, P323, DOI 10.1111/j.1469-8137.2008.02677.x; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Moon J, 2007, PLANT PHYSIOL, V143, P684, DOI 10.1104/pp.106.091439; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishiyama T, 2000, DNA RES, V7, P9, DOI 10.1093/dnares/7.1.9; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Prigge MJ, 2010, DEVELOPMENT, V137, P3535, DOI 10.1242/dev.049023; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Sakakibara K, 2003, DEVELOPMENT, V130, P4835, DOI 10.1242/dev.00644; Sakakibara K, 2008, EVOL DEV, V10, P555, DOI 10.1111/j.1525-142X.2008.00271.x; Schaefer DG, 1997, PLANT J, V11, P1195, DOI 10.1046/j.1365-313X.1997.11061195.x; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Su N, 2007, PLANT MOL BIOL, V63, P337, DOI 10.1007/s11103-006-9092-0; Sugimoto K, 2010, DEV CELL, V18, P463, DOI 10.1016/j.devcel.2010.02.004; Sugiura C, 2003, NUCLEIC ACIDS RES, V31, P5324, DOI 10.1093/nar/gkg726; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Toronen P, 1999, FEBS LETT, V451, P142, DOI 10.1016/S0014-5793(99)00524-4; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Turner BM, 2002, CHROMATIN GENE REGUL; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; WILLIAMS EG, 1986, ANN BOT-LONDON, V57, P443, DOI 10.1093/oxfordjournals.aob.a087127; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356; Zhao Z, 2010, NATURE, V465, P1089, DOI 10.1038/nature09126; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	65	18	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36471	10.1371/journal.pone.0036471	http://dx.doi.org/10.1371/journal.pone.0036471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574165	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800061
J	Rowell, JT; Servedio, MR				Rowell, Jonathan T.; Servedio, Maria R.			Vocal Communications and the Maintenance of Population Specific Songs in a Contact Zone	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; GEOGRAPHIC-VARIATION; BIRD SONG; ZEBRA FINCHES; HYBRID ZONE; DIALECTS; EVOLUTION; DISPERSAL; DIVERGENCE; BARRIERS	Bird song has been hypothesized to play a role in several important aspects of the biology of songbirds, including the generation of taxonomic diversity by speciation; however, the role that song plays in speciation within this group may be dependent upon the ability of populations to maintain population specific songs or calls in the face of gene flow and external cultural influences. Here, in an exploratory study, we construct a spatially explicit model of population movement to examine the consequences of secondary contact of populations singing distinct songs. We concentrate on two broad questions: 1) will population specific songs be maintained in a contact zone or will they be replaced by shared song, and 2) what spatial patterns in the distribution of songs may result from contact? We examine the effects of multiple factors including song-based mating preferences and movement probabilities, oblique versus paternal learning of song, and both cultural and genetic mutations. We find a variety of conditions under which population specific songs can be maintained, particularly when females have preferences for their population specific songs, and we document many distinct patterns of song distribution within the contact zone, including clines, banding, and mosaics.	[Rowell, Jonathan T.; Servedio, Maria R.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Rowell, JT (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	jtrowell@email.unc.edu	Servedio, Maria R/A-9743-2008	Servedio, Maria R/0000-0002-3965-4445	National Science Foundation [DEB 0614166]	National Science Foundation(National Science Foundation (NSF))	Funding for both authors was provided by National Science Foundation grant DEB 0614166 to MRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armsworth PR, 2005, AM NAT, V165, P449, DOI 10.1086/428595; Baker M.C., 1985, Evolution, V39, P1177, DOI 10.1111/j.1558-5646.1985.tb00461.x; BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; BAKER MC, 1975, EVOLUTION, V29, P226, DOI 10.1111/j.1558-5646.1975.tb00203.x; BAKER MC, 1981, EVOLUTION, V35, P189, DOI 10.1111/j.1558-5646.1981.tb04872.x; BAKER MC, 1987, ANIM BEHAV, V35, P395, DOI 10.1016/S0003-3472(87)80263-4; BAKER MC, 1978, EVOLUTION, V32, P712, DOI 10.1111/j.1558-5646.1978.tb04624.x; BAKER MC, 1983, BEHAV ECOL SOCIOBIOL, V12, P309, DOI 10.1007/BF00302898; BAKER MC, 1982, AM ZOOL, V22, P561; Baker MC, 2008, AUK, V125, P651, DOI 10.1525/auk.2008.07111; Baker MC, 2010, J AVIAN BIOL, V41, P50, DOI 10.1111/j.1600-048X.2009.04801.x; BAPTISTA LF, 1982, AUK, V99, P537; Baptista LF, 1975, U CALIFORNIA PUBL ZO, V105, P1; Bee MA, 2000, BEHAV ECOL, V11, P169, DOI 10.1093/beheco/11.2.169; Beecher MD, 2000, ANIM BEHAV, V59, P29, DOI 10.1006/anbe.1999.1304; Bell DA, 1998, ANIM BEHAV, V55, P939, DOI 10.1006/anbe.1997.0644; Bradbury Jack W., 1998, pi; Catchpole CK, 1995, BIRD SONG BIOL THEME; CLAYTON NS, 1990, PHILOS T R SOC B, V330, P351, DOI 10.1098/rstb.1990.0205; CYNX J, 1992, P NATL ACAD SCI USA, V89, P1368, DOI 10.1073/pnas.89.4.1368; Doutrelant C, 2000, BEHAV ECOL SOCIOBIOL, V48, P119, DOI 10.1007/s002650000220; Ellers J, 2003, ANIM BEHAV, V65, P671, DOI 10.1006/anbe.2003.2081; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; GOODFELLOW DJ, 1986, ANIM BEHAV, V34, P1579, DOI 10.1016/S0003-3472(86)80233-0; Grant BR, 1996, EVOLUTION, V50, P2471, DOI 10.1111/j.1558-5646.1996.tb03633.x; Grant PR, 1997, BIOL J LINN SOC, V60, P317; Grant PR, 1997, AM NAT, V149, P1, DOI 10.1086/285976; Haavie J, 2004, J EVOLUTION BIOL, V17, P227, DOI 10.1111/j.1420-9101.2003.00682.x; HAFNER DJ, 1985, EVOLUTION, V39, P687, DOI 10.1111/j.1558-5646.1985.tb00405.x; Irwin DE, 2008, J EVOLUTION BIOL, V21, P435, DOI 10.1111/j.1420-9101.2007.01499.x; Irwin DE, 2000, EVOLUTION, V54, P998; JENKINS PF, 1978, ANIM BEHAV, V26, P50, DOI 10.1016/0003-3472(78)90007-6; Koetz AH, 2007, ANIM BEHAV, V74, P1019, DOI 10.1016/j.anbehav.2006.11.035; Lachlan RF, 1999, P ROY SOC B-BIOL SCI, V266, P701, DOI 10.1098/rspb.1999.0692; Lachlan RF, 2003, J EVOLUTION BIOL, V16, P1084, DOI 10.1046/j.1420-9101.2003.00624.x; Lachlan RF, 2004, EVOLUTION, V58, P2049; Liu IA, 2008, CONDOR, V110, P102, DOI 10.1525/cond.2008.110.1.102; LOUGHEED SC, 1993, CONDOR, V95, P889, DOI 10.2307/1369426; LOUGHEED SC, 1992, EVOLUTION, V46, P1443, DOI 10.1111/j.1558-5646.1992.tb01135.x; LYNCH A, 1989, AM NAT, V133, P634, DOI 10.1086/284942; MacDougall-Shackleton EA, 2001, EVOLUTION, V55, P2568, DOI 10.1111/j.0014-3820.2001.tb00769.x; MARLER P., 1962, CONDOR, V64, P368, DOI 10.2307/1365545; Martens Jochen, 1996, P221; MILLER DB, 1979, NATURE, V280, P389, DOI 10.1038/280389a0; MUNDINGER P, 1975, CONDOR, V77, P407, DOI 10.2307/1366088; Mundinger PC., 1982, ACOUSTIC COMMUNICATI, Vvol. 2, P147; MUNN CA, 1986, NATURE, V319, P143, DOI 10.1038/319143a0; Nelson DA, 2004, ANIM BEHAV, V68, P395, DOI 10.1016/j.anbehav.2003.08.027; Nelson DA, 2000, ANIM BEHAV, V60, P887, DOI 10.1006/anbe.2000.1560; NOTTEBOHM F, 1969, CONDOR, V71, P299, DOI 10.2307/1366306; Olofsson H, 2011, EVOL IN PRESS; Olofsson H, 2008, BEHAV ECOL, V19, P594, DOI 10.1093/beheco/arn002; Patten MA, 2004, EVOLUTION, V58, P2144; PETRINOVICH L, 1981, Z TIERPSYCHOL, V57, P1; PETRINOVICH L, 1981, EVOLUTION, V35, P180, DOI 10.1111/j.1558-5646.1981.tb04871.x; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Ribot RFH, 2009, ANIM BEHAV, V77, P581, DOI 10.1016/j.anbehav.2008.10.029; Riebel K, 2000, P ROY SOC B-BIOL SCI, V267, P2553, DOI 10.1098/rspb.2000.1320; Rowell JT, 2010, AM NAT, V176, P638, DOI 10.1086/656494; Rowell JT, 2009, THEOR POPUL BIOL, V75, P216, DOI 10.1016/j.tpb.2009.03.001; Sattler GD, 2007, AUK, V124, P926, DOI 10.1642/0004-8038(2007)124[926:AAOSAA]2.0.CO;2; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1992, NATO ADV SCI I A-LIF, V228, P175; Searcy WA, 2002, AM NAT, V159, P221, DOI 10.1086/338509; Searcy WA, 1997, CONDOR, V99, P651, DOI 10.2307/1370477; Secondi J, 2003, BIOL J LINN SOC, V80, P507, DOI 10.1046/j.1095-8312.2003.00248.x; Sewall KB, 2011, BEHAV ECOL SOCIOBIOL, V65, P157, DOI 10.1007/s00265-010-1022-0; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Soha JA, 2004, BEHAV ECOL, V15, P636, DOI 10.1093/beheco/arh055; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; THIELCKE G, 1970, Zeitschrift fuer Zoologische Systematik und Evolutionsforschung, V8, P309; WEISMAN R, 1994, BEHAVIOUR, V128, P15, DOI 10.1163/156853994X00028; WILLIAMS JM, 1990, J THEOR BIOL, V145, P487, DOI 10.1016/S0022-5193(05)80483-7; Wilson PL, 2000, CONDOR, V102, P355, DOI 10.1650/0010-5422(2000)102[0355:SASTSI]2.0.CO;2; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Wright TF, 2005, MOL ECOL, V14, P1197, DOI 10.1111/j.1365-294X.2005.02466.x; Wright TF, 2001, ETHOLOGY, V107, P111, DOI 10.1046/j.1439-0310.2001.00632.x; Wright TF, 2001, P ROY SOC B-BIOL SCI, V268, P609, DOI 10.1098/rspb.2000.1403; Wright TF, 2008, ANIM BEHAV, V76, P1017, DOI 10.1016/j.anbehav.2008.03.025	79	12	12	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35257	10.1371/journal.pone.0035257	http://dx.doi.org/10.1371/journal.pone.0035257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574116	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800012
J	Tung, EKK; Wong, BYC; Yau, TO; Ng, IOL				Tung, Edmund Kwok-Kwan; Wong, Betty Yin-Chi; Yau, Tai-On; Ng, Irene Oi-Lin			Upregulation of the Wnt Co-Receptor LRP6 Promotes Hepatocarcinogenesis and Enhances Cell Invasion	PLOS ONE			English	Article							BETA-CATENIN MUTATIONS; HEPATOCELLULAR-CARCINOMA; MOLECULAR PATHOGENESIS; SIGNALING PATHWAY; EXPRESSION; OVEREXPRESSION; TARGET; VIRUS; GENES; ACTIVATION	Background: Activation of the Wnt/beta-catenin signaling pathway plays a crucial role in hepatocellular carcinoma (HCC). Low-density lipoprotein (LDL) receptor-related protein-6 (LRP6) is one of the co-receptors of the Wnt/beta-catenin pathway and forms a signaling complex with Wnt ligand and Frizzled receptor to activate downstream signaling. However, the role of LRP6 in hepatocarcinogenesis is unclear. In this study, we examined its expression and roles in human HCC. Methodology/Principal Findings: Using real-time quantitative RT-PCR, we found that LRP6 was frequently (45%) overexpressed in human HCCs (P = 0.003). In vitro studies showed that ectopic expression of LRP6 increased the protein level of beta-catenin. Moreover, overexpression of the full-length and constitutively active LRP6, respectively, activated the WNT/beta-catenin signaling pathway, as shown by the TCF/beta-catenin reporter assay. With regard to the effects of LRP6 overexpression in HCC cells, stable overexpression of the constitutively active LRP6 in BEL-7402 HCC cells enhanced cell proliferation, cell migration, and invasion in vitro as well as tumorigenicity in nude mice. Conclusions/Significance: Our findings indicate that overexpression of LRP6 contributes to the hyperactivation of the Wnt/beta-catenin signaling pathway in human HCCs and suggest it may play a role in hepatocarcinogenesis.	[Tung, Edmund Kwok-Kwan; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China; [Tung, Edmund Kwok-Kwan; Wong, Betty Yin-Chi; Yau, Tai-On; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tung, EKK (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Pokfulam, Hong Kong, Peoples R China.	iolng@hku.hk		Ng, Irene Oi-lin/0000-0001-7532-2029	Research Grants Council (RGC) General Research Fund [HKU 7615/06M]; National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant [N_HKU 716/06]; RGC Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09]	Research Grants Council (RGC) General Research Fund; National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant(National Natural Science Foundation of China (NSFC)); RGC Collaborative Research Fund(Hong Kong Research Grants Council)	The study was supported by the Research Grants Council (RGC) General Research Fund (HKU 7615/06M), a National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme grant (N_HKU 716/06), and the RGC Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beagle B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011821; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bjorklund P, 2007, PLOS MED, V4, P1829, DOI 10.1371/journal.pmed.0040328; Brennan K, 2004, ONCOGENE, V23, P4873, DOI 10.1038/sj.onc.1207642; Chan DW, 2006, GASTROENTEROLOGY, V131, P1218, DOI 10.1053/j.gastro.2006.07.020; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Devereux TR, 2001, MOL CARCINOGEN, V31, P68, DOI 10.1002/mc.1041; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Hu L, 2004, CANCER GENET CYTOGEN, V148, P80, DOI 10.1016/S0165-4608(03)00206-1; Huang H, 1999, AM J PATHOL, V155, P1795, DOI 10.1016/S0002-9440(10)65496-X; Ishizaki Y, 2004, INT J ONCOL, V24, P1077; Janssens N, 2004, TUMOR BIOL, V25, P161, DOI 10.1159/000081098; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kim YD, 2008, J GASTROEN HEPATOL, V23, P110, DOI 10.1111/j.1440-1746.2007.05250.x; Kirikoshi H, 2001, INT J ONCOL, V19, P767; Li YH, 2004, ONCOGENE, V23, P9129, DOI 10.1038/sj.onc.1208123; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Merle P, 2005, J HEPATOL, V43, P854, DOI 10.1016/j.jhep.2005.05.018; Merle P, 2004, GASTROENTEROLOGY, V127, P1110, DOI 10.1053/j.gastro.2004.07.009; Mi KH, 2005, J CELL BIOCHEM, V95, P328, DOI 10.1002/jcb.20400; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Park JY, 2005, LIVER INT, V25, P70, DOI 10.1111/j.1478-3231.2004.0995.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Takigawa Y, 2008, CURR DRUG TARGETS, V9, P1013, DOI 10.2174/138945008786786127; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teufel A, 2007, WORLD J GASTROENTERO, V13, P2271, DOI 10.3748/wjg.v13.i16.2271; Tommasi S, 2007, CURR PHARM DESIGN, V13, P3279, DOI 10.2174/138161207782360663; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wong CM, 2008, LIVER INT, V28, P160, DOI 10.1111/j.1478-3231.2007.01637.x; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Zender L, 2008, ONKOLOGIE, V31, P550, DOI 10.1159/000151586; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhang Z, 2006, NEUROPATH APPL NEURO, V32, P615, DOI 10.1111/j.1365-2990.2006.00770.x	41	47	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36565	10.1371/journal.pone.0036565	http://dx.doi.org/10.1371/journal.pone.0036565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570728	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400044
J	Sauermann, H; Roach, M				Sauermann, Henry; Roach, Michael			Science PhD Career Preferences: Levels, Changes, and Advisor Encouragement	PLOS ONE			English	Article							JOB	Even though academic research is often viewed as the preferred career path for PhD trained scientists, most U.S. graduates enter careers in industry, government, or "alternative careers.'' There has been a growing concern that these career patterns reflect fundamental imbalances between the supply of scientists seeking academic positions and the availability of such positions. However, while government statistics provide insights into realized career transitions, there is little systematic data on scientists' career preferences and thus on the degree to which there is a mismatch between observed career paths and scientists' preferences. Moreover, we lack systematic evidence whether career preferences adjust over the course of the PhD training and to what extent advisors exacerbate imbalances by encouraging their students to pursue academic positions. Based on a national survey of PhD students at tier-one U.S. institutions, we provide insights into the career preferences of junior scientists across the life sciences, physics, and chemistry. We also show that the attractiveness of academic careers decreases significantly over the course of the PhD program, despite the fact that advisors strongly encourage academic careers over non-academic careers. Our data provide an empirical basis for common concerns regarding labor market imbalances. Our results also suggest the need for mechanisms that provide PhD applicants with information that allows them to carefully weigh the costs and benefits of pursuing a PhD, as well as for mechanisms that complement the job market advice advisors give to their current students.	[Sauermann, Henry] Georgia Inst Technol, Atlanta, GA 30332 USA; [Roach, Michael] Univ N Carolina, Chapel Hill, NC USA	University System of Georgia; Georgia Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Sauermann, H (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	henry.sauermann@mgt.gatech.edu		Roach, Michael/0000-0002-9781-8567	Georgia Research Alliance/Kauffman Foundation; Georgia Institute of Technology (College of Management)	Georgia Research Alliance/Kauffman Foundation; Georgia Institute of Technology (College of Management)	The Georgia Research Alliance/Kauffman Foundation has provided partial funding for this study (http://www.gra.org/). The Georgia Institute of Technology (College of Management) has provided partial funding for this study (http://www.mgt.gatech.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2010, ADV STUD ENTREP INNO, V21, P139, DOI 10.1108/S1048-4736(2010)0000021009; [Anonymous], 2011, NATURE, V472, P259, DOI 10.1038/472259b; [Anonymous], 2010, ECONOMIST; Antony JS., 2002, HIGHER ED HDB THEORY, P349, DOI DOI 10.1007/978-94-010-0245-5_8; Beshears J, 2008, J PUBLIC ECON, V92, P1787, DOI 10.1016/j.jpubeco.2008.04.010; Cyranoski D, 2011, NATURE, V472, P276, DOI 10.1038/472276a; Fox MF, 2001, SOC STUD SCI, V31, P109, DOI 10.1177/030631201031001006; Freeman R, 2001, SCIENCE, V294, P2293, DOI 10.1126/science.1067477; Freeman Richard B, 2009, SCI ENG CAREERS US A, P19, DOI [DOI 10.7208/CHICAGO/9780226261904.003.0002, 10.7208/chicago/9780226261904.003.0002]; Fuhrmann CN, 2011, CBE-LIFE SCI EDUC, V10, P239, DOI 10.1187/cbe.11-02-0013; Golde C., 2001, CROSS PURPOSES WHAT; Grimaldi R, 2011, RES POLICY, V40, P1045, DOI 10.1016/j.respol.2011.04.005; Hamilton BH, 2000, J POLIT ECON, V108, P604, DOI 10.1086/262131; HUBER GP, 1985, STRATEGIC MANAGE J, V6, P171, DOI 10.1002/smj.4250060206; Kristof-Brown AL, 2005, PERS PSYCHOL, V58, P281, DOI 10.1111/j.1744-6570.2005.00672.x; LEVIN SG, 1991, AM ECON REV, V81, P114; Mangematin V, 2000, RES POLICY, V29, P741, DOI 10.1016/S0048-7333(99)00047-5; Matthews KRW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029738; Mendoza P, 2007, J HIGH EDUC, V78, P71, DOI 10.1353/jhe.2007.0004; Mervis J, 2008, SCIENCE, V321, P1622, DOI 10.1126/science.321.5896.1622; MOORMAN RH, 1992, J OCCUP ORGAN PSYCH, V65, P131, DOI 10.1111/j.2044-8325.1992.tb00490.x; National Science Board, 2010, SCI ENG IND 2010; National Science Foundation, 2009, SURV EARN DOCT; Roach M, 2010, RES POLICY, V39, P422, DOI 10.1016/j.respol.2010.01.004; Sauermann H, 2005, J VOCAT BEHAV, V66, P273, DOI 10.1016/j.jvb.2004.10.001; Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003; Schwarz N., 2007, SCI REAL TIME DATA C, P11; Slaughter JE, 2006, ORGAN RES METHODS, V9, P285, DOI 10.1177/1094428105279936; Stephan P, 2005, AM ECON REV, V95, P71, DOI 10.1257/000282805774669619; Stephan P, EC SHAPES SCI; Taylor MC, 2011, NATURE, V472, P261, DOI 10.1038/472261a; Thursby JG., 2001, J TECHNOL TRANSFER, V26, P109, DOI DOI 10.1023/A:1007884111883; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26	33	178	180	2	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36307	10.1371/journal.pone.0036307	http://dx.doi.org/10.1371/journal.pone.0036307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567149	Green Published, gold			2022-12-27	WOS:000305341500068
J	Matsui, K; Sugimoto, K; Mano, J; Ozawa, R; Takabayashi, J				Matsui, Kenji; Sugimoto, Kohichi; Mano, Jun'ichi; Ozawa, Rika; Takabayashi, Junji			Differential Metabolisms of Green Leaf Volatiles in Injured and Intact Parts of a Wounded Leaf Meet Distinct Ecophysiological Requirements	PLOS ONE			English	Article							HYDROPEROXIDE LYASE PATHWAY; ARABIDOPSIS-THALIANA; DEFENSE GENES; PLANTS; ALDEHYDES; PRODUCT; INSECTICIDES; PEROXIDATION; ACETATE; LEAVES	Almost all terrestrial plants produce green leaf volatiles (GLVs), consisting of six-carbon (C6) aldehydes, alcohols and their esters, after mechanical wounding. C6 aldehydes deter enemies, but C6 alcohols and esters are rather inert. In this study, we address why the ability to produce various GLVs in wounded plant tissues has been conserved in the plant kingdom. The major product in completely disrupted Arabidopsis leaf tissues was (Z)-3-hexenal, while (Z)-3-hexenol and (Z)-3-hexenyl acetate were the main products formed in the intact parts of partially wounded leaves. 13 C-labeled C6 aldehydes placed on the disrupted part of a wounded leaf diffused into neighboring intact tissues and were reduced to C6 alcohols. The reduction of the aldehydes to alcohols was catalyzed by an NADPH-dependent reductase. When NADPH was supplemented to disrupted tissues, C6 aldehydes were reduced to C6 alcohols, indicating that C6 aldehydes accumulated because of insufficient NADPH. When the leaves were exposed to higher doses of C6 aldehydes, however, a substantial fraction of C6 aldehydes persisted in the leaves and damaged them, indicating potential toxicity of C6 aldehydes to the leaf cells. Thus, the production of C6 aldehydes and their differential metabolisms in wounded leaves has dual benefits. In disrupted tissues, C6 aldehydes and their alpha,beta-unsaturated aldehyde derivatives accumulate to deter invaders. In intact cells, the aldehydes are reduced to minimize self-toxicity and allow healthy cells to survive. The metabolism of GLVs is thus efficiently designed to meet ecophysiological requirements of the microenvironments within a wounded leaf.	[Matsui, Kenji; Sugimoto, Kohichi] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan; [Sugimoto, Kohichi; Ozawa, Rika; Takabayashi, Junji] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Mano, Jun'ichi] Yamaguchi Univ, Ctr Sci Res, Yamaguchi, Japan; [Matsui, Kenji; Sugimoto, Kohichi] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Yamaguchi, Japan	Yamaguchi University; Kyoto University; Yamaguchi University; Yamaguchi University	Matsui, K (corresponding author), Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan.	matsui@yamaguchi-u.ac.jp	Sugimoto, Koichi/N-2302-2014; Mano, Jun'ichi/K-7437-2019; Takabayashi, Junji/G-2212-2010	Sugimoto, Koichi/0000-0002-8335-1396; Takabayashi, Junji/0000-0002-3575-9952; Mano, Jun'ichi/0000-0001-5030-8845	Japan Society for the Promotion of Science [18580105, 23580151, 19101009]; Core-to-Core Program from Japan Society for the Promotion of Science; Research Support Program of Sekisui Chemical Company, Tokyo, Japan; Yamaguchi University; Grants-in-Aid for Scientific Research [19101009] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core-to-Core Program from Japan Society for the Promotion of Science; Research Support Program of Sekisui Chemical Company, Tokyo, Japan; Yamaguchi University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by Grants-in-Aid for Scientific Research (18580105, 23580151 to KM and 19101009 to JT) and by the Core-to-Core Program (20004) from Japan Society for the Promotion of Science; the Research Support Program of Sekisui Chemical Company, Tokyo, Japan; and Yamaguchi University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmann S, 2010, SCIENCE, V329, P1075, DOI 10.1126/science.1191634; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Barakat A, 2011, PLANT SCI, V181, P249, DOI 10.1016/j.plantsci.2011.05.012; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; Farmer EE, 2007, CURR OPIN PLANT BIOL, V10, P380, DOI 10.1016/j.pbi.2007.04.019; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Hammond DG, 2000, J AGR FOOD CHEM, V48, P4410, DOI 10.1021/jf000233+; Heil M, 2008, J CHEM ECOL, V34, P601, DOI 10.1007/s10886-008-9464-9; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471; Kallenbach M, 2011, NEW PHYTOL, V191, P1054, DOI 10.1111/j.1469-8137.2011.03767.x; Kasai H, 2008, MUTAT RES-REV MUTAT, V659, P56, DOI 10.1016/j.mrrev.2008.02.003; Kawai K, 2006, MUTAT RES-GEN TOX EN, V603, P186, DOI 10.1016/j.mrgentox.2005.11.012; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; Liu ZQ, 2004, PEST MANAG SCI, V60, P434, DOI 10.1002/ps.816; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Matsui K, 1996, FEBS LETT, V394, P21, DOI 10.1016/0014-5793(96)00924-6; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Nakamura S, 2002, J AGR FOOD CHEM, V50, P7639, DOI 10.1021/jf025808c; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Nyambura MC, 2011, J PLANT INTERACT, V6, P185, DOI 10.1080/17429145.2010.544777; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Reinecke A, 2002, NATURWISSENSCHAFTEN, V89, P265, DOI 10.1007/s00114-002-0314-2; Riahi Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE879, DOI 10.1152/ajpendo.00508.2010; Shimoda T, 2010, EXP APPL ACAROL, V50, P9, DOI 10.1007/s10493-009-9275-x; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Shiojiri K, 2006, J CHEM ECOL, V32, P969, DOI 10.1007/s10886-006-9047-6; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Wei JN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000852; Yamauchi Y, 2011, J BIOL CHEM, V286, P6999, DOI 10.1074/jbc.M110.202226	38	108	112	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36433	10.1371/journal.pone.0036433	http://dx.doi.org/10.1371/journal.pone.0036433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558466	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200080
J	Ganel, T; Freud, E; Chajut, E; Algom, D				Ganel, Tzvi; Freud, Erez; Chajut, Eran; Algom, Daniel			Accurate Visuomotor Control below the Perceptual Threshold of Size Discrimination	PLOS ONE			English	Article							VISUAL ILLUSIONS; DISSOCIATION; REAL; HANDEDNESS	Background: Human resolution for object size is typically determined by psychophysical methods that are based on conscious perception. In contrast, grasping of the same objects might be less conscious. It is suggested that grasping is mediated by mechanisms other than those mediating conscious perception. In this study, we compared the visual resolution for object size of the visuomotor and the perceptual system. Methodology/Principal Findings: In Experiment 1, participants discriminated the size of pairs of objects once through perceptual judgments and once by grasping movements toward the objects. Notably, the actual size differences were set below the Just Noticeable Difference (JND). We found that grasping trajectories reflected the actual size differences between the objects regardless of the JND. This pattern was observed even in trials in which the perceptual judgments were erroneous. The results of an additional control experiment showed that these findings were not confounded by task demands. Participants were not aware, therefore, that their size discrimination via grasp was veridical. Conclusions/Significance: We conclude that human resolution is not fully tapped by perceptually determined thresholds. Grasping likely exhibits greater resolving power than people usually realize.	[Ganel, Tzvi; Freud, Erez] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Ganel, Tzvi; Freud, Erez] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Chajut, Eran] Open Univ Israel, Dept Educ & Psychol, Raanana, Israel; [Algom, Daniel] Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel	Ben Gurion University; Ben Gurion University; Open University Israel; Tel Aviv University	Ganel, T (corresponding author), Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel.	tganel@bgu.ac.il	Ganel, Tzvi/B-9344-2011	Ganel, Tzvi/0000-0003-0658-0598; Freud, Erez/0000-0003-3758-3855	Israel National Science Foundation [830/07]	Israel National Science Foundation(Israel Science Foundation)	This study was supported by an Israel National Science Foundation grant 830/07 to T.G. http://www.isf.org.il/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird JC, 1978, FUNDAMENTALS SCALING; Bruno N, 2001, TRENDS COGN SCI, V5, P379, DOI 10.1016/S1364-6613(00)01725-3; Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Carey DP, 2001, TRENDS COGN SCI, V5, P109, DOI 10.1016/S1364-6613(00)01592-8; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Cohen NR, 2009, NEUROPSYCHOLOGIA, V47, P1553, DOI 10.1016/j.neuropsychologia.2008.12.034; Culham JC, 2003, EXP BRAIN RES, V153, P180, DOI 10.1007/s00221-003-1591-5; Falmagne JC, 2001, ELEMENTS PSYCHOPHYSI; Franz VH, 2001, J EXP PSYCHOL HUMAN, V27, P1124, DOI 10.1037//0096-1523.27.5.1124; Ganel T, 2003, NATURE, V426, P664, DOI 10.1038/nature02156; Ganel T, 2008, CURR BIOL, V18; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; Ganel T, 2008, PSYCHOL SCI, V19, P221, DOI 10.1111/j.1467-9280.2008.02071.x; Gescheider G. A., 1976, PSYCHOPHYSICS METHOD; Glover SR, 2001, J EXP PSYCHOL HUMAN, V27, P560, DOI 10.1037/0096-1523.27.3.560; Gonzalez CLR, 2007, EXP BRAIN RES, V182, P275, DOI 10.1007/s00221-007-1090-1; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodale MA, 2010, VISION RES; Haffenden AM, 2000, VISION RES, V40, P1597, DOI 10.1016/S0042-6989(00)00056-0; Hollands JG, 2010, PSYCHON B REV, V17, P135, DOI 10.3758/PBR.17.1.135; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; Marks LE, 1998, MEASUREMENT JUDGMENT, Vxviii, P81; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Stevens SS, 1975, PSYCHOPHYSICS INTRO; TEGHTSOONIAN R, 1971, PSYCHOL REV, V78, P71, DOI 10.1037/h0030300; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518	29	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36253	10.1371/journal.pone.0036253	http://dx.doi.org/10.1371/journal.pone.0036253			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558407	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000171
J	Tao, X; Gu, YH; Wang, HY; Zheng, W; Li, X; Zhao, CW; Zhang, YZ				Tao, Xiang; Gu, Ying-Hong; Wang, Hai-Yan; Zheng, Wen; Li, Xiao; Zhao, Chuan-Wu; Zhang, Yi-Zheng			Digital Gene Expression Analysis Based on Integrated De Novo Transcriptome Assembly of Sweet Potato [Ipomoea batatas (L.) Lam.]	PLOS ONE			English	Article							RNA-SEQ DATA; SEQUENCING ANALYSIS; GENOME SEQUENCE; CODON USAGE; SHORT READS; GENERATION; PROTEIN; TOOL; DISCOVERY; ALIGNMENT	Background: Sweet potato (Ipomoea batatas L. [Lam.]) ranks among the top six most important food crops in the world. It is widely grown throughout the world with high and stable yield, strong adaptability, rich nutrient content, and multiple uses. However, little is known about the molecular biology of this important non-model organism due to lack of genomic resources. Hence, studies based on high-throughput sequencing technologies are needed to get a comprehensive and integrated genomic resource and better understanding of gene expression patterns in different tissues and at various developmental stages. Methodology/Principal Findings: Illumina paired-end (PE) RNA-Sequencing was performed, and generated 48.7 million of 75 bp PE reads. These reads were de novo assembled into 128,052 transcripts (>= 100 bp), which correspond to 41.1 million base pairs, by using a combined assembly strategy. Transcripts were annotated by Blast2GO and 51,763 transcripts got BLASTX hits, in which 39,677 transcripts have GO terms and 14,117 have ECs that are associated with 147 KEGG pathways. Furthermore, transcriptome differences of seven tissues were analyzed by using Illumina digital gene expression (DGE) tag profiling and numerous differentially and specifically expressed transcripts were identified. Moreover, the expression characteristics of genes involved in viral genomes, starch metabolism and potential stress tolerance and insect resistance were also identified. Conclusions/Significance: The combined de novo transcriptome assembly strategy can be applied to other organisms whose reference genomes are not available. The data provided here represent the most comprehensive and integrated genomic resources for cloning and identifying genes of interest in sweet potato. Characterization of sweet potato transcriptome provides an effective tool for better understanding the molecular mechanisms of cellular processes including development of leaves and storage roots, tissue-specific gene expression, potential biotic and abiotic stress response in sweet potato.	[Tao, Xiang; Gu, Ying-Hong; Wang, Hai-Yan; Zheng, Wen; Li, Xiao; Zhao, Chuan-Wu; Zhang, Yi-Zheng] Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol,Ctr Funct G, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Tao, X (corresponding author), Sichuan Univ, Key Lab Bioresources & Ecoenvironm, Minist Educ,Coll Life Sci, Sichuan Key Lab Mol Biol & Biotechnol,Ctr Funct G, Chengdu 610064, Sichuan, Peoples R China.	yizzhang@scu.edu.cn	GU, Yinghong/D-2433-2010	GU, Yinghong/0000-0002-9364-1389	National Science & Technology Pillar Program of China [2007BAD78B03]; "Eleventh-Five'' Key Project of Sichuan Province, China [07SG111-003-1]	National Science & Technology Pillar Program of China; "Eleventh-Five'' Key Project of Sichuan Province, China	This work was supported by funds from the National Science & Technology Pillar Program of China (No. 2007BAD78B03, http://kjzc.jhgl.org/) and the "Eleventh-Five'' Key Project of Sichuan Province, China (No. 07SG111-003-1, http://www.scst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blankenberg D, 2010, GALAXY WEB BASED GEN; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; CAMPBELL WH, 1990, PLANT PHYSIOL, V92, P1, DOI 10.1104/pp.92.1.1; Carpena A. L., 2009, P27, DOI 10.1007/978-1-4020-9475-0_4; Chen Jen-Chih, 1997, Taiwania, V42, P34; CIP, 2010, FACTS FIG SWEETP; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ekblom R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-219; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Fernie AR, 2002, TRENDS PLANT SCI, V7, P35, DOI 10.1016/S1360-1385(01)02183-5; Firon N., 2009, P13, DOI 10.1007/978-1-4020-9475-0_3; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; HABIB, 2007, BIOTECH MOL BIOL REV, V2, P68; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Loebenstein G., 2009, P105, DOI 10.1007/978-1-4020-9475-0_8; Loebenstein G., 2009, P9, DOI 10.1007/978-1-4020-9475-0_2; Low J., 2009, P359, DOI 10.1007/978-1-4020-9475-0_16; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Mbanzibwa DR, 2011, PLANT DIS, V95, P224, DOI 10.1094/PDIS-10-10-0707; McGregor CE, DIFFERENTIAL EXPRESS; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Padmaja G., 2009, P189, DOI 10.1007/978-1-4020-9475-0_11; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Qin YF, 2011, GENOMICS, V97, P364, DOI 10.1016/j.ygeno.2011.02.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P9; Robischon M, 2011, PLANT PHYSIOL, V155, P1214, DOI 10.1104/pp.110.167007; Rodriguez MCS, 2010, PLANT J, V63, P212, DOI 10.1111/j.1365-313X.2010.04243.x; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Srinivas T., 2009, P235, DOI 10.1007/978-1-4020-9475-0_12; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thottappilly G., 2009, P503, DOI 10.1007/978-1-4020-9475-0_23; Varshney RK, 2010, TRENDS BIOTECHNOL, V28, P452, DOI 10.1016/j.tibtech.2010.06.007; Wang HC, 2004, MOL BIOL EVOL, V21, P90, DOI [10.1093/molbev/msh003, 10.1093/molbev/msg003]; Wang HC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S6; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang QM, 2010, CROP PROT, V29, P110, DOI 10.1016/j.cropro.2009.11.002; Wang RL, 2008, ARCH VIROL, V153, P1765, DOI 10.1007/s00705-008-0180-0; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh KW, 1997, PLANT MOL BIOL, V33, P565, DOI 10.1023/A:1005764702510; You MK, 2003, FEBS LETT, V536, P101, DOI 10.1016/S0014-5793(03)00035-8; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang L., 2009, P325, DOI 10.1007/978-1-4020-9475-0_15; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	82	150	166	5	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36234	10.1371/journal.pone.0036234	http://dx.doi.org/10.1371/journal.pone.0036234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558397	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000164
J	Ge, Y; Wu, JY; Xia, YJ; Yang, M; Xiao, JF; Yu, J				Ge, Yan; Wu, Jiayan; Xia, Yingjie; Yang, Ming; Xiao, Jingfa; Yu, Jun			Molecular Dynamics Simulation of the Complex PBP-2x with Drug Cefuroxime to Explore the Drug Resistance Mechanism of Streptococcus suis R61	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; ACID SUBSTITUTION MATRICES; ANTIBIOTIC-RESISTANCE; SUBSTRATE-BINDING; FREE-ENERGIES; PNEUMONIAE; SUSCEPTIBILITY; IDENTIFICATION; PBP2X	Drug resistance of Streptococcus suis strains is a worldwide problem for both humans and pigs. Previous studies have noted that penicillin-binding protein (PBPs) mutation is one important cause of beta-lactam antibiotic resistance. In this study, we used the molecular dynamics (MD) method to study the interaction differences between cefuroxime (CES) and PBP2x within two newly sequenced Streptococcus suis: drug-sensitive strain A7, and drug-resistant strain R61. The MM-PBSA results proved that the drug bound much more tightly to PBP2x in A7 (PBP2x-A7) than to PBP2x in R61 (PBP2x-R61). This is consistent with the evidently different resistances of the two strains to cefuroxime. Hydrogen bond analysis indicated that PBP2x-A7 preferred to bind to cefuroxime rather than to PBP2x-R61. Three stable hydrogen bonds were formed by the drug and PBP2x-A7, while only one unstable bond existed between the drug and PBP2x-R61. Further, we found that the Gln569, Tyr594, and Gly596 residues were the key mutant residues contributing directly to the different binding by pair wise energy decomposition comparison. By investigating the binding mode of the drug, we found that mutant residues Ala320, Gln553, and Thr595 indirectly affected the final phenomenon by topological conformation alteration. Above all, our results revealed some details about the specific interaction between the two PBP2x proteins and the drug cefuroxime. To some degree, this explained the drug resistance mechanism of Streptococcus suis and as a result could be helpful for further drug design or improvement.	[Ge, Yan] China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China; [Wu, Jiayan; Yang, Ming; Xiao, Jingfa; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Xia, Yingjie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Revolut, Kunming, Peoples R China; [Xia, Yingjie; Yang, Ming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ge, Y (corresponding author), China Agr Univ, Coll Biol Sci, Beijing 100094, Peoples R China.	xiaojingfa@big.ac.cn; junyu@big.ac.cn		wu, jia yan/0000-0001-6048-405X	National Basic Research Program (973 Program) [2010CB126604]; Special Foundation Work Program [2009FY120100]; Ministry of Science and Technology of the People's Republic of China; National Science Foundation of China [31071163]; Scientific Research Foundation, State Education Ministry	National Basic Research Program (973 Program)(National Basic Research Program of China); Special Foundation Work Program; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation, State Education Ministry	This study was supported by a grant from the National Basic Research Program (973 Program) (No. 2010CB126604), the Special Foundation Work Program (No. 2009FY120100), the Ministry of Science and Technology of the People's Republic of China and grant from the National Science Foundation of China (No. 31071163). The Project Sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDER BJ, 1959, J CHEM PHYS, V31, P459, DOI 10.1063/1.1730376; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Escudero JA, 2007, ANTIMICROB AGENTS CH, V51, P777, DOI 10.1128/AAC.00972-06; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; CANTIN M, 1992, J VET DIAGN INVEST, V4, P170, DOI 10.1177/104063879200400209; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang YT, 1999, PROTEINS, V34, P403, DOI 10.1002/(SICI)1097-0134(19990215)34:3<403::AID-PROT12>3.0.CO;2-D; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gordon E, 2000, J MOL BIOL, V299, P477, DOI 10.1006/jmbi.2000.3740; Hakenbeck R, 1998, J BACTERIOL, V180, P1831, DOI 10.1128/JB.180.7.1831-1840.1998; HAKENBECK R, 1995, BIOCHEM PHARMACOL, V50, P1121, DOI 10.1016/0006-2952(95)00158-V; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024988; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; KELL CM, 1993, FEMS MICROBIOL LETT, V106, P171; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeszczynskiJerzy, 2005, COMPUTATIONAL CHEM R, V9, P54; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Martel A, 2001, VET MICROBIOL, V83, P287, DOI 10.1016/S0378-1135(01)00426-6; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mouz N, 1998, P NATL ACAD SCI USA, V95, P13403, DOI 10.1073/pnas.95.23.13403; Nienhaus Gerd Ulrich, 2005, PROTEIN LIGAND INTER, P54; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Payne VA, 1999, PROTEINS, V37, P176, DOI 10.1002/(SICI)1097-0134(19991101)37:2<176::AID-PROT4>3.0.CO;2-8; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Princivalli MS, 2009, EUROSURVEILLANCE, V14, P15; Pucci MJ, 1997, J BACTERIOL, V179, P5632, DOI 10.1128/jb.179.17.5632-5635.1997; RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405; Sakata Hiroshi, 2011, Kansenshogaku Zasshi, V85, P26; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; Takamatsu D, 2003, PLASMID, V49, P143, DOI 10.1016/S0147-619X(02)00149-X; Walker Ross, 2010, AMBER TUTORIALS TUTO; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; WASTESON Y, 1994, VET MICROBIOL, V41, P41, DOI 10.1016/0378-1135(94)90134-1; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Willenburg KS, 2006, NEW ENGL J MED, V354, P1325, DOI 10.1056/NEJMc053089; Zhang CP, 2008, VET MICROBIOL, V131, P386, DOI 10.1016/j.vetmic.2008.04.005	53	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35941	10.1371/journal.pone.0035941	http://dx.doi.org/10.1371/journal.pone.0035941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563422	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100048
J	Midha, M; Prasad, NK; Vindal, V				Midha, Mohit; Prasad, Nirmal K.; Vindal, Vaibhav			MycoRRdb: A Database of Computationally Identified Regulatory Regions within Intergenic Sequences in Mycobacterial Genomes	PLOS ONE			English	Article							BINDING-SITES; CONTROLS TRANSCRIPTION; ESCHERICHIA-COLI; TUBERCULOSIS; PREDICTION; DNA; FAMILY; GENES; EXPRESSION; PROTEIN	The identification of regulatory regions for a gene is an important step towards deciphering the gene regulation. Regulatory regions tend to be conserved under evolution that facilitates the application of comparative genomics to identify such regions. The present study is an attempt to make use of this attribute to identify regulatory regions in the Mycobacterium species followed by the development of a database, MycoRRdb. It consist the regulatory regions identified within the intergenic distances of 25 mycobacterial species. MycoRRdb allows to retrieve the identified intergenic regulatory elements in the mycobacterial genomes. In addition to the predicted motifs, it also allows user to retrieve the Reciprocal Best BLAST Hits across the mycobacterial genomes. It is a useful resource to understand the transcriptional regulatory mechanism of mycobacterial species. This database is first of its kind which specifically addresses cis-regulatory regions and also comprehensive to the mycobacterial species. Database URL: http://mycorrdb.uohbif.in.	[Midha, Mohit; Prasad, Nirmal K.; Vindal, Vaibhav] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Midha, M (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India.	vvls@uohyd.ernet.in	Midha, Mohit/AAD-9858-2019; midha, mohit/F-4848-2015	Midha, Mohit/0000-0001-7554-4086; midha, mohit/0000-0001-7554-4086	RGYI scheme from Department of Biotechnology, Government of India	RGYI scheme from Department of Biotechnology, Government of India	Research in VV's laboratory is supported under RGYI scheme from Department of Biotechnology, Government of India. VV acknowledges the Bioinformatics Infrastructure Facility, University of Hyderabad, to host the database.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BERGH S, 1994, MOL MICROBIOL, V12, P517, DOI 10.1111/j.1365-2958.1994.tb01039.x; Brooks PC, 2001, J BACTERIOL, V183, P4459, DOI 10.1128/JB.183.15.4459-4467.2001; Bulyk ML, 2004, GENOME RES, V14, P201, DOI 10.1101/gr.1448004; Catanho M, 2006, GENET MOL RES, V5, P115; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; Dullaghan EM, 2002, MICROBIOL-SGM, V148, P3609, DOI 10.1099/00221287-148-11-3609; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Fulton DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-270; Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x; Haydel SE, 2002, J BACTERIOL, V184, P2192, DOI 10.1128/JB.184.8.2192-2203.2002; He HJ, 2005, J BACTERIOL, V187, P202, DOI 10.1128/JB.187.1.202-212.2005; Jacques PE, 2005, BIOINFORMATICS, V21, P2563, DOI 10.1093/bioinformatics/bti321; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2010, MICROBIOL-SGM, V156, P1362, DOI 10.1099/mic.0.034538-0; Lee SA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S11; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Movahedzadeh F, 1997, J BACTERIOL, V179, P3509, DOI 10.1128/jb.179.11.3509-3518.1997; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Ranjan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S9; Ranjan S, 2006, NUCLEIC ACIDS RES, V34, pW584, DOI 10.1093/nar/gkl202; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rodriguez G. Marcela, 1999, Tubercle and Lung Disease, V79, P287; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Sala C, 2003, J BACTERIOL, V185, P5357, DOI 10.1128/JB.185.18.5357-5362.2003; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Thieffry D, 1998, BIOINFORMATICS, V14, P391, DOI 10.1093/bioinformatics/14.5.391; Vindal V, 2008, FEBS LETT, V582, P1117, DOI 10.1016/j.febslet.2008.02.074; Vindal V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-289; Vishnoi A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-373; Young DB, 2001, NAT MED, V7, P11, DOI 10.1038/83250; Zhu XX, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-40	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36094	10.1371/journal.pone.0036094	http://dx.doi.org/10.1371/journal.pone.0036094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563442	gold, Green Published			2022-12-27	WOS:000305349100067
J	Shi, HY; Lee, KT; Lee, HH; Ho, WH; Sun, DP; Wang, JJ; Chiu, CC				Shi, Hon-Yi; Lee, King-Teh; Lee, Hao-Hsien; Ho, Wen-Hsien; Sun, Ding-Ping; Wang, Jhi-Joung; Chiu, Chong-Chi			Comparison of Artificial Neural Network and Logistic Regression Models for Predicting In-Hospital Mortality after Primary Liver Cancer Surgery	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TRANSPLANTATION; RISK	Background: Since most published articles comparing the performance of artificial neural network (ANN) models and logistic regression (LR) models for predicting hepatocellular carcinoma (HCC) outcomes used only a single dataset, the essential issue of internal validity (reproducibility) of the models has not been addressed. The study purposes to validate the use of ANN model for predicting in-hospital mortality in HCC surgery patients in Taiwan and to compare the predictive accuracy of ANN with that of LR model. Methodology/Principal Findings: Patients who underwent a HCC surgery during the period from 1998 to 2009 were included in the study. This study retrospectively compared 1,000 pairs of LR and ANN models based on initial clinical data for 22,926 HCC surgery patients. For each pair of ANN and LR models, the area under the receiver operating characteristic (AUROC) curves, Hosmer-Lemeshow (H-L) statistics and accuracy rate were calculated and compared using paired T-tests. A global sensitivity analysis was also performed to assess the relative significance of input parameters in the system model and the relative importance of variables. Compared to the LR models, the ANN models had a better accuracy rate in 97.28% of cases, a better H-L statistic in 41.18% of cases, and a better AUROC curve in 84.67% of cases. Surgeon volume was the most influential (sensitive) parameter affecting in-hospital mortality followed by age and lengths of stay. Conclusions/Significance: In comparison with the conventional LR model, the ANN model in the study was more accurate in predicting in-hospital mortality and had higher overall performance indices. Further studies of this model may consider the effect of a more detailed database that includes complications and clinical examination findings as well as more detailed outcome data.	[Shi, Hon-Yi; Lee, King-Teh; Ho, Wen-Hsien] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lee, King-Teh] Kaohsiung Med Univ Hosp, Dept Surg, Kaohsiung, Taiwan; [Lee, Hao-Hsien; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Surg, Liouying, Taiwan; [Sun, Ding-Ping; Chiu, Chong-Chi] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Chiu, Chong-Chi] Taipei Med Univ, Dept Surg, Taipei, Taiwan; [Chiu, Chong-Chi] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Taipei Medical University; Chia Nan University of Pharmacy & Science	Shi, HY (corresponding author), Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan.	chiuchongchi@yahoo.com.tw			National Science Council, Taiwan, Republic of China [NSC 99-2320-B-037-026-MY2, NSC 99-2314-B-037-069-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by the National Science Council, Taiwan, Republic of China, under grant numbers NSC 99-2320-B-037-026-MY2 and NSC 99-2314-B-037-069-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Cazzaniga M, 2009, EUR J GASTROEN HEPAT, V21, P681, DOI 10.1097/MEG.0b013e328317f4da; Chen HY, 1999, THER DRUG MONIT, V21, P50, DOI 10.1097/00007691-199902000-00008; Chen MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027186; Cucchetti A, 2010, J HEPATOL, V52, P880, DOI 10.1016/j.jhep.2009.12.037; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Dvorchik I, 2007, CURR PHARM DESIGN, V13, P1527, DOI 10.2174/138161207780765846; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fan ST, 2011, ANN SURG, V253, P745, DOI 10.1097/SLA.0b013e3182111195; Guo X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028404; Han YF, 2011, WORLD J GASTROENTERO, V17, P4258, DOI 10.3748/wjg.v17.i38.4258; Haykin S, 1999, P842; Ho WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029179; Ho WH, 2011, EXPERT SYST APPL, V38, P13050, DOI 10.1016/j.eswa.2011.04.109; Ho WH, 2011, EXPERT SYST APPL, V38, P6319, DOI 10.1016/j.eswa.2010.11.110; Huang Y, 2010, STAT MED, V29, P1391, DOI 10.1002/sim.3876; Jarnagin WR, 2010, ANN SURG ONCOL, V17, P1226, DOI 10.1245/s10434-010-0978-3; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018776; Livingston EH, 2010, JAMA-J AM MED ASSOC, V304, P95, DOI 10.1001/jama.2010.905; Marsh JW, 1997, HEPATOLOGY, V26, P444, DOI 10.1002/hep.510260227; Sighoko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018415; Tsai JT, 2006, IEEE T NEURAL NETWOR, V17, P69, DOI 10.1109/TNN.2005.860885; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Zou Jinming, 2008, V458, P15	23	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35781	10.1371/journal.pone.0035781	http://dx.doi.org/10.1371/journal.pone.0035781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563399	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100027
J	Walsh, RK; Bradley, C; Apperson, CS; Gould, F				Walsh, Rachael K.; Bradley, Caitlin; Apperson, Charles S.; Gould, Fred			An Experimental Field Study of Delayed Density Dependence in Natural Populations of Aedes albopictus	PLOS ONE			English	Article							FEEDING-BEHAVIOR; INTERSPECIFIC COMPETITION; DYNAMICS; DIPTERA; MOSQUITO; AEGYPTI; CULICIDAE; DETRITUS; SURVIVAL; CYCLES	Aedes albopictus, a species known to transmit dengue and chikungunya viruses, is primarily a container-inhabiting mosquito. The potential for pathogen transmission by Ae. albopictus has increased our need to understand its ecology and population dynamics. Two parameters that we know little about are the impact of direct density-dependence and delayed density-dependence in the larval stage. The present study uses a manipulative experimental design, under field conditions, to understand the impact of delayed density dependence in a natural population of Ae. albopictus in Raleigh, North Carolina. Twenty liter buckets, divided in half prior to experimentation, placed in the field accumulated rainwater and detritus, providing oviposition and larval production sites for natural populations of Ae. albopictus. Two treatments, a larvae present and larvae absent treatment, were produced in each bucket. After five weeks all larvae were removed from both treatments and the buckets were covered with fine mesh cloth. Equal numbers of first instars were added to both treatments in every bucket. Pupae were collected daily and adults were frozen as they emerged. We found a significant impact of delayed density-dependence on larval survival, development time and adult body size in containers with high larval densities. Our results indicate that delayed density-dependence will have negative impacts on the mosquito population when larval densities are high enough to deplete accessible nutrients faster than the rate of natural food accumulation.	[Walsh, Rachael K.; Apperson, Charles S.; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Bradley, Caitlin] Univ N Carolina, Chapel Hill, NC USA; [Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Walsh, RK (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	rskatz@ncsu.edu			National Institutes of Health (US) (NIH) [R01-AI54954-0IA2]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054954, R01AI091980] Funding Source: NIH RePORTER	National Institutes of Health (US) (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (US) (NIH) grant R01-AI54954-0IA2 and a grant to the Regents of the University of California from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2005, POPUL ECOL, V47, P257, DOI 10.1007/s10144-005-0232-1; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Aspbury AS, 1998, OECOLOGIA, V115, P137, DOI 10.1007/s004420050500; Bowman J, 2006, J MAMMAL, V87, P480, DOI 10.1644/05-MAMM-A-202R2.1; Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2; Cooke BJ, 2006, FOREST ECOL MANAG, V226, P110, DOI 10.1016/j.foreco.2006.01.034; FISH D, 1982, ECOLOGY, V63, P283, DOI 10.2307/1938943; Friedenberg NA, 2008, ENVIRON ENTOMOL, V37, P650, DOI 10.1603/0046-225X(2008)37[650:TEDDAS]2.0.CO;2; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gotelli NJ, 2001, PRIMER ECOLOGY; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; HARRISON S, 1986, OECOLOGIA, V69, P354, DOI 10.1007/BF00377056; HAUKIOJA E, 1980, OIKOS, V35, P202, DOI 10.2307/3544428; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; HAWLEY WA, 1985, J ANIM ECOL, V54, P955, DOI 10.2307/4389; HO BC, 1989, J MED ENTOMOL, V26, P615, DOI 10.1093/jmedent/26.6.615; Hunter MD, 1998, ECOL ENTOMOL, V23, P216, DOI 10.1046/j.1365-2311.1998.00123.x; Kesavaraju B, 2007, J MED ENTOMOL, V44, P215, DOI 10.1603/0022-2585(2007)44[215:IAIDIF]2.0.CO;2; LEATHER SR, 1987, ECOL ENTOMOL, V12, P275, DOI 10.1111/j.1365-2311.1987.tb01006.x; Little RC, 2006, SAS MIXED MODELS; Lord CC, 1998, J MED ENTOMOL, V35, P825, DOI 10.1093/jmedent/35.5.825; MAY RM, 1974, J ANIM ECOL, V43, P747, DOI 10.2307/3535; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; MORI A, 1979, Tropical Medicine, V21, P85; O'GOWER A. K., 1957, PROC LINN SOC N S WALES, V82, P285; Ott R., 2008, INTRO STAT METHODS D; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pedraza-Garcia M, 2008, ENVIRON BIOL FISH, V82, P111, DOI 10.1007/s10641-007-9260-3; Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2; Solow AR, 2001, ECOLOGY, V82, P3263, DOI 10.1890/0012-9658(2001)082[3263:OEATDO]2.0.CO;2; Stenseth NC, 1999, OIKOS, V87, P427, DOI 10.2307/3546809; TURCHIN P, 1990, NATURE, V344, P660, DOI 10.1038/344660a0; Turchin P, 2000, ECOL ENTOMOL, V25, P119, DOI 10.1046/j.1365-2311.2000.00228.x; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Yee DA, 2006, FRESHWATER BIOL, V51, P448, DOI 10.1111/j.1365-2427.2005.01504.x; Yee DA, 2004, J VECTOR ECOL, V29, P315; Yee DA, 2004, ANN ENTOMOL SOC AM, V97, P720, DOI 10.1603/0013-8746(2004)097[0720:IDIFBA]2.0.CO;2; Yee DA, 2007, J MED ENTOMOL, V44, P580, DOI 10.1603/0022-2585(2007)44[580:DAIEOA]2.0.CO;2	42	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35959	10.1371/journal.pone.0035959	http://dx.doi.org/10.1371/journal.pone.0035959			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563428	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100054
J	Kopera, E; Belczyk-Ciesielska, A; Bal, W				Kopera, Edyta; Belczyk-Ciesielska, Agnieszka; Bal, Wojciech			Application of Ni(II)-Assisted Peptide Bond Hydrolysis to Non-Enzymatic Affinity Tag Removal	PLOS ONE			English	Article							CATALYZED PROTEIN CLEAVAGE; C-TERMINAL TAIL; HISTONE H2A; RECOMBINANT PROTEINS; FUSION; PURIFICATION; COPPER(II); COMPLEX; SITE; NICKEL(II)	In this study, we demonstrate a non-enzymatic method for hydrolytic peptide bond cleavage, applied to the removal of an affinity tag from a recombinant fusion protein, SPI2-SRHWAP-His(6). This method is based on a highly specific Ni(II) reaction with (S/T) XHZ peptide sequences. It can be applied for the protein attached to an affinity column or to the unbound protein in solution. We studied the effect of pH, temperature and Ni(II) concentration on the efficacy of cleavage and developed an analytical protocol, which provides active protein with a 90% yield and similar to 100% purity. The method works well in the presence of non-ionic detergents, DTT and GuHCl, therefore providing a viable alternative for currently used techniques.	[Kopera, Edyta; Belczyk-Ciesielska, Agnieszka; Bal, Wojciech] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Kopera, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wbal@ibb.waw.pl		Bal, Wojciech/0000-0003-3780-083X	Polish National Center for Research and Development [KB/138/13749/IT1-B/U/08]	Polish National Center for Research and Development	This study was financed by Polish National Center for Research and Development, grant no. KB/138/13749/IT1-B/U/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1996, INT J PEPT PROT RES, V48, P265; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Baker RT, 1996, CURR OPIN BIOTECH, V7, P541, DOI 10.1016/S0958-1669(96)80059-0; Bal W, 1998, CHEM RES TOXICOL, V11, P1014, DOI 10.1021/tx980051y; Bal W, 2000, CHEM RES TOXICOL, V13, P616, DOI 10.1021/tx000044l; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dou F, 2000, PREP BIOCHEM BIOTECH, V30, P69, DOI 10.1080/10826060008544946; Humphreys DP, 1999, PROTEIN ENG, V12, P179, DOI 10.1093/protein/12.2.179; Humphreys DP, 2000, PROTEIN ENG, V13, P201, DOI 10.1093/protein/13.3.201; JENCKS WP, 1960, J BIOL CHEM, V235, P3608; Jeon JW, 2003, BIOORGAN MED CHEM, V11, P2901, DOI 10.1016/S0968-0896(03)00216-5; Karaczyn AA, 2003, CHEM RES TOXICOL, V16, P1555, DOI 10.1021/tx0300277; Kludkiewicz B, 2005, PROTEIN EXPRES PURIF, V43, P94, DOI 10.1016/j.pep.2005.06.011; Kopera E, 2010, INORG CHEM, V49, P6636, DOI 10.1021/ic1005709; Krezel A, 2006, ACTA BIOCHIM POL, V53, P721, DOI 10.18388/abp.2006_3299; Krezel A, 2010, J AM CHEM SOC, V132, P3355, DOI 10.1021/ja907567r; Kurowska E, 2011, METALLOMICS, V3, P1227, DOI 10.1039/c1mt00081k; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Milovic NM, 2003, CHEM-EUR J, V9, P5097, DOI 10.1002/chem.200304772; Mylonas M, 2002, J CHEM SOC DALTON, P4296, DOI 10.1039/b206585a; Nirmala X, 2001, EUR J BIOCHEM, V268, P2064, DOI 10.1046/j.1432-1327.2001.02084.x; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Perler FB, 1998, NAT STRUCT BIOL, V5, P249, DOI 10.1038/nsb0498-249; Sadilkova L, 2008, PROTEIN SCI, V17, P1834, DOI 10.1110/ps.035733.108; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Surovtsev VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P531, DOI 10.1023/A:1010211019260; YASHIRO M, 1997, J INORG BIOCHEM, V67, P225	27	25	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36350	10.1371/journal.pone.0036350	http://dx.doi.org/10.1371/journal.pone.0036350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574150	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800046
J	Wong, KL; Chen, WQ; Balakrishnan, T; Toh, YX; Fink, K; Wong, SC				Wong, Kok Loon; Chen, Weiqiang; Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja; Wong, Siew-Cheng			Susceptibility and Response of Human Blood Monocyte Subsets to Primary Dengue Virus Infection	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CHEMOKINE RECEPTOR EXPRESSION; CELL-DEATH APOPTOSIS; DIFFERENTIAL REGULATION; TNF-ALPHA; T-CELLS; PERMEABILITY; SUBPOPULATIONS; MACROPHAGES; ENHANCEMENT	Human blood monocytes play a central role in dengue infections and form the majority of virus infected cells in the blood. Human blood monocytes are heterogeneous and divided into CD16(-) and CD16(+) subsets. Monocyte subsets play distinct roles during disease, but it is not currently known if monocyte subsets differentially contribute to dengue protection and pathogenesis. Here, we compared the susceptibility and response of the human CD16(-) and CD16(+) blood monocyte subsets to primary dengue virus in vitro. We found that both monocyte subsets were equally susceptible to dengue virus (DENV2 NGC), and capable of supporting the initial production of new infective virus particles. Both monocyte subsets produced anti-viral factors, including IFN-alpha, CXCL10 and TRAIL. However, CD16(+) monocytes were the major producers of inflammatory cytokines and chemokines in response to dengue virus, including IL-1 beta, TNF-alpha, IL-6, CCL2, 3 and 4. The susceptibility of both monocyte subsets to infection was increased after IL-4 treatment, but this increase was more profound for the CD16(+) monocyte subset, particularly at early time points after virus exposure. These findings reveal the differential role that monocyte subsets might play during dengue disease.	[Wong, Kok Loon; Chen, Weiqiang; Balakrishnan, Thavamalar; Toh, Ying Xiu; Fink, Katja; Wong, Siew-Cheng] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Wong, KL (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore.	wong_kok_loon@immunol.a-star.edu.sg	Fink, Katja/AAI-1881-2021	Fink, Katja/0000-0002-3571-0390; Chen, Weiqiang/0000-0002-8840-1823	Biomedical Research Council, ASTAR, Singapore	Biomedical Research Council, ASTAR, Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Biomedical Research Council, ASTAR, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x; Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bosch I, 2002, J VIROL, V76, P5588, DOI 10.1128/JVI.76.11.5588-5597.2002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Campbell JJ, 2001, J IMMUNOL, V166, P6477, DOI 10.4049/jimmunol.166.11.6477; Carr JM, 2003, J MED VIROL, V69, P521, DOI 10.1002/jmv.10340; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671; Dewi BE, 2004, J VIROL METHODS, V121, P171, DOI 10.1016/j.jviromet.2004.06.013; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Fahy RJ, 1999, J IMMUNOL, V163, P1755; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Fink K, 2009, EUR J IMMUNOL, V39, P2809, DOI 10.1002/eji.200939389; Frankenberger M, 1996, BLOOD, V87, P373; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Kumar-Sinha C, 2002, J BIOL CHEM, V277, P575, DOI 10.1074/jbc.M107795200; KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lyons PA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-64; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MANGAN DF, 1991, J IMMUNOL, V147, P3408; MANGAN DF, 1991, J IMMUNOL, V146, P1541; McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Spain-Santana TA, 2001, J MED VIROL, V65, P324, DOI 10.1002/jmv.2037; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Thein S, 1997, AM J TROP MED HYG, V56, P566, DOI 10.4269/ajtmh.1997.56.566; Wang L, 2007, AM J TROP MED HYG, V77, P297, DOI 10.4269/ajtmh.2007.77.297; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08; Zawada AM, 2011, BLOOD; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	62	52	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36435	10.1371/journal.pone.0036435	http://dx.doi.org/10.1371/journal.pone.0036435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574162	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800058
J	Naidoo, R; Du Preez, P; Stuart-Hill, G; Jago, M; Wegmann, M				Naidoo, Robin; Du Preez, Pierre; Stuart-Hill, Greg; Jago, Mark; Wegmann, Martin			Home on the Range: Factors Explaining Partial Migration of African Buffalo in a Tropical Environment	PLOS ONE			English	Article							PREDATION RISK; BEHAVIOR; MIGRANT; ECOLOGY; FORAGE; NDVI; SIZE	Partial migration (when only some individuals in a population undertake seasonal migrations) is common in many species and geographical contexts. Despite the development of modern statistical methods for analyzing partial migration, there have been no studies on what influences partial migration in tropical environments. We present research on factors affecting partial migration in African buffalo (Syncerus caffer) in northeastern Namibia. Our dataset is derived from 32 satellite tracking collars, spans 4 years and contains over 35,000 locations. We used remotely sensed data to quantify various factors that buffalo experience in the dry season when making decisions on whether and how far to migrate, including potential man-made and natural barriers, as well as spatial and temporal heterogeneity in environmental conditions. Using an information-theoretic, non-linear regression approach, our analyses showed that buffalo in this area can be divided into 4 migratory classes: migrants, non-migrants, dispersers, and a new class that we call "expanders". Multimodel inference from least-squares regressions of wet season movements showed that environmental conditions (rainfall, fires, woodland cover, vegetation biomass), distance to the nearest barrier (river, fence, cultivated area) and social factors (age, size of herd at capture) were all important in explaining variation in migratory behaviour. The relative contributions of these variables to partial migration have not previously been assessed for ungulates in the tropics. Understanding the factors driving migratory decisions of wildlife will lead to better-informed conservation and land-use decisions in this area.	[Naidoo, Robin] WWF US, Conservat Sci Program, Washington, DC USA; [Du Preez, Pierre; Jago, Mark] Minist Environm & Tourism, Directorate Sci Serv, Windhoek, Namibia; [Stuart-Hill, Greg] World Wildlife Fund WWF Namibia, Windhoek, Namibia; [Wegmann, Martin] Univ Wurzburg, Dept Remote Sensing, Wurzburg, Bavaria, Germany	World Wildlife Fund; University of Wurzburg	Naidoo, R (corresponding author), WWF US, Conservat Sci Program, Washington, DC USA.	robin.naidoo@wwfus.org		Wegmann, Martin/0000-0003-0335-9601	WWF-US; WWF-Germany; Game Products Trust Fund; Ministry of Environment and Tourism, Namibia [1537/2010, 1339/2008, 1184/2007]	WWF-US; WWF-Germany; Game Products Trust Fund; Ministry of Environment and Tourism, Namibia	The work was funded by WWF-US and by WWF-Germany, as well as by the Game Products Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Erica Rieder, Carol Murphy, Julie Taylor, Ortwin Aschenborn, Vincent Guillemin, Simon Mayes, Beavan Munali, Hans Swartbooi, Bollen Zingolo, Shadrich Siloka, Jannie du Preez, Carl-Heinz Moelle, Piet Beytell, Lise Hansen, Euan Anderson, Andrea Capobianco, Scott Loarie, Ally Thompson, Sylvia Thompson, Russell Taylor, Chris Weaver, Dave Ward, Raymond Peters, Jo Tagg, and Bucker assisted with field work and/or data interpretation and analysis. Comments from Mark Boyce and two anonymous reviewers greatly improved an earlier manuscript draft. The research was conducted under permits 1537/2010, 1339/2008, and 1184/2007 from the Ministry of Environment and Tourism, Namibia, whom we thank for their support.	Ball JP, 2001, WILDLIFE BIOL, V7, P39, DOI 10.2981/wlb.2001.007; BERTHOLD P, 1981, SCIENCE, V212, P77, DOI 10.1126/science.212.4490.77; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Bolger DT, 2008, ECOL LETT, V11, P63; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; Bunnefeld N, 2011, J ANIM ECOL, V80, P466, DOI 10.1111/j.1365-2656.2010.01776.x; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chase MJ, 2009, AFR J ECOL, V47, P223, DOI 10.1111/j.1365-2028.2008.01017.x; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Beer Y, 2008, J ARID ENVIRON, V72, P2017, DOI 10.1016/j.jaridenv.2008.07.002; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Geremia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016848; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Grayson KL, 2011, ECOLOGY, V92, P1236, DOI 10.1890/11-0133.1; Halley DJ, 2004, S AFR J WILDL RES, V34, P105; Halley DJ, 2002, AFR J ECOL, V40, P97, DOI 10.1046/j.0141-6707.2001.00336.x; Hansen BB, 2010, CAN J ZOOL, V88, P1202, DOI 10.1139/Z10-086; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jahn AE, 2010, J ANIM ECOL, V79, P983, DOI 10.1111/j.1365-2656.2010.01713.x; Lindsey PA, 2007, BIOL CONSERV, V134, P455, DOI 10.1016/j.biocon.2006.09.005; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Martin RB, 2002, TRANSBOUNDARY SPECIE; McLoughlin PD, 2000, ECOSCIENCE, V7, P123, DOI 10.1080/11956860.2000.11682580; Mendelsohn J., 1997, ENV PROFILE ATLAS CA; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; R Core Team, 2018, R LANG ENV STAT COMP; Redfern JV, 2005, J ARID ENVIRON, V63, P406, DOI 10.1016/j.jaridenv.2005.03.016; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Rivrud IM, 2010, J ANIM ECOL, V79, P1280, DOI 10.1111/j.1365-2656.2010.01731.x; Robillard MM, 2011, BIOL CONSERV, V144, P1931, DOI 10.1016/j.biocon.2011.03.022; Robinson BG, 2010, OECOLOGIA, V164, P265, DOI 10.1007/s00442-010-1620-6; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Sekercioglu CH, 2010, J ANIM ECOL, V79, P933, DOI 10.1111/j.1365-2656.2010.01739.x; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Taylor JJ, 2008, GEOFORUM, V39, P1766, DOI 10.1016/j.geoforum.2008.04.001; Traill LW, 2007, AFR J ECOL, V45, P347, DOI 10.1111/j.1365-2028.2006.00717.x; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Yackulic CB, 2011, J ANIM ECOL, V80, P1088, DOI 10.1111/j.1365-2656.2011.01851.x	55	50	52	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36527	10.1371/journal.pone.0036527	http://dx.doi.org/10.1371/journal.pone.0036527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570722	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305343400038
J	Hassan, I; Chibber, S; Khan, AA; Naseem, I				Hassan, Iftekhar; Chibber, Sandesh; Khan, Aijaz A.; Naseem, Imrana			Riboflavin Ameliorates Cisplatin Induced Toxicities under Photoillumination	PLOS ONE			English	Article							INDUCED NEPHROTOXICITY; OXIDATIVE STRESS; NITRIC-OXIDE; APOPTOSIS; CANCER; INHIBITION; CYTOTOXICITY; MODULATION; KINASE; REPAIR	Background: Cisplatin is an effective anticancer drug that elicits many side effects mainly due to induction of oxidative and nitrosative stresses during prolonged chemotherapy. The severity of these side effects consequently restricts its clinical use under long term treatment. Riboflavin is an essential vitamin used in various metabolic redox reactions in the form of flavin adenine dinucleotide and flavin mononucleotide. Besides, it has excellent photosensitizing property that can be used to ameliorate these toxicities in mice under photodynamic therapy. Methods and Findings: Riboflavin, cisplatin and their combinations were given to the separate groups of mice under photoilluminated condition under specific treatment regime. Their kidney and liver were excised for comet assay and histopathological studies. Furthermore, Fourier Transform Infrared Spectroscopy of riboflavin-cisplatin combination in vitro was also conducted to investigate any possible interaction between the two compounds. Their comet assay and histopathological examination revealed that riboflavin in combination with cisplatin was able to protect the tissues from cisplatin induced toxicities and damages. Moreover, Fourier Transform Infrared Spectroscopy analysis of the combination indicated a strong molecular interaction among their constituent groups that may be assigned for the protective effect of the combination in the treated animals. Conclusion: Inclusion of riboflavin diminishes cisplatin induced toxicities which may possibly make the cisplatin-riboflavin combination, an effective treatment strategy under chemoradiotherapy in pronouncing its antineoplastic activity and sensitivity towards the cancer cells as compared to cisplatin alone.	[Hassan, Iftekhar; Chibber, Sandesh; Naseem, Imrana] Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India; [Khan, Aijaz A.] Aligarh Muslim Univ, Dept Anat, Jawaharlal Nehru Med Coll, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Hassan, I (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Biochem, Aligarh 202001, Uttar Pradesh, India.	imrananaseem2009@gmail.com	Hassan, Iftekhar/AAX-5261-2021	Hassan, Iftekhar/0000-0001-6993-9954	University Grant Commission (UGC), New Delhi under SAP-DRS II Program; UGC-BSR fellowship; department of Biochemistry; Aligarh Muslim University	University Grant Commission (UGC), New Delhi under SAP-DRS II Program(University Grants Commission, India); UGC-BSR fellowship; department of Biochemistry; Aligarh Muslim University	This work was financially supported by the University Grant Commission (UGC), New Delhi under SAP-DRS II Program, UGC-BSR fellowship and the facilities provided by the department of Biochemistry, Aligarh Muslim University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2006, J PHOTOCH PHOTOBIO B, V82, P21, DOI 10.1016/j.jphotobiol.2005.08.004; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Bareford LM, 2008, MOL PHARMACEUT, V5, P839, DOI 10.1021/mp800046m; Boulikas T, 2003, ONCOL REP, V10, P1663; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Chirino YI, 2008, TOXICOL LETT, V176, P48, DOI 10.1016/j.toxlet.2007.10.006; Chirino YI, 2009, EXP TOXICOL PATHOL, V61, P223, DOI 10.1016/j.etp.2008.09.003; De Souza AC, 2006, APOPTOSIS, V11, P1761, DOI 10.1007/s10495-006-9549-2; Queiroz KCD, 2007, CANCER LETT, V258, P126, DOI 10.1016/j.canlet.2007.08.024; Dobrosz-Teperek K, 1998, J MOL STRUCT, V471, P115, DOI 10.1016/S0022-2860(98)00395-0; Edwards AM, 2001, J PHOTOCH PHOTOBIO B, V63, P126, DOI 10.1016/S1011-1344(01)00209-3; Furuta T, 2002, CANCER RES, V62, P4899; Hassan I, 2010, FOOD CHEM TOXICOL, V48, P2052, DOI 10.1016/j.fct.2010.05.004; Ho JW, 2006, RECENT PAT ANTI-CANC, V1, P129, DOI 10.2174/157489206775246485; Hodeify R, 2010, AM J PHYSIOL-RENAL, V299, pF112, DOI 10.1152/ajprenal.00151.2010; Husain E, 2008, PHOTODERMATOL PHOTO, V24, P301, DOI 10.1111/j.1600-0781.2008.00380.x; Jazzar MM, 1996, FREE RADICAL BIO MED, V21, P7, DOI 10.1016/0891-5849(95)02156-6; Jiang M, 2008, J PHARMACOL EXP THER, V327, P300, DOI 10.1124/jpet.108.139162; Kart A, 2010, EXP TOXICOL PATHOL, V62, P45, DOI 10.1016/j.etp.2009.02.066; Kim HJ, 2010, J NEUROSCI, V30, P3933, DOI 10.1523/JNEUROSCI.6054-09.2010; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Mohamed Yousif Ibrahim, 2009, Research Journal of Biological Sciences, V4, P777; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; Munoz MA, 2011, J PHOTOCH PHOTOBIO B, V103, P57, DOI 10.1016/j.jphotobiol.2011.01.012; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pathmamanoharan C, 1996, LANGMUIR, V12, P4372, DOI 10.1021/la960350s; PRABHU AL, 1989, CANCER LETT, V48, P89, DOI 10.1016/0304-3835(89)90042-6; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Shacter E, 2000, BLOOD, V96, P307, DOI 10.1182/blood.V96.1.307.013k47_307_313; Shin JS, 2010, INT J ONCOL, V36, P1445, DOI 10.3892/ijo_00000630; Tang CH, 2004, J BIOL CHEM, V279, P288, DOI 10.1074/jbc.M310821200; Webster RP, 1996, CANCER LETT, V98, P129; Wu W, 2010, MUTAT RES-FUND MOL M, V691, P1, DOI 10.1016/j.mrfmmm.2010.06.002; Yang J, 2008, FREE RADICAL RES, V42, P492, DOI 10.1080/10715760802112791; Zhang JG, 1996, TOXICOL LETT, V89, P11, DOI 10.1016/S0378-4274(96)03776-9; Zhang YZ, 2009, PHOTOCHEM PHOTOBIOL, V85, P943, DOI 10.1111/j.1751-1097.2009.00547.x; Zhu XY, 2006, P NATL ACAD SCI USA, V103, P3581, DOI 10.1073/pnas.0600251103	39	46	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36273	10.1371/journal.pone.0036273	http://dx.doi.org/10.1371/journal.pone.0036273			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567145	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500064
J	Lutz, JA; Larson, AJ; Swanson, ME; Freund, JA				Lutz, James A.; Larson, Andrew J.; Swanson, Mark E.; Freund, James A.			Ecological Importance of Large-Diameter Trees in a Temperate Mixed-Conifer Forest	PLOS ONE			English	Article							YOSEMITE-NATIONAL-PARK; GENERAL QUANTITATIVE THEORY; NORTHERN FLYING SQUIRRELS; OLD-GROWTH; SPATIAL-PATTERNS; PRESCRIBED FIRE; CLIMATE-CHANGE; SIERRA-NEVADA; NEST TREES; MORTALITY	Large-diameter trees dominate the structure, dynamics and function of many temperate and tropical forests. Although both scaling theory and competition theory make predictions about the relative composition and spatial patterns of large-diameter trees compared to smaller diameter trees, these predictions are rarely tested. We established a 25.6 ha permanent plot within which we tagged and mapped all trees >= 1 cm dbh, all snags >= 10 cm dbh, and all shrub patches >= 2 m(2). We sampled downed woody debris, litter, and duff with line intercept transects. Aboveground live biomass of the 23 woody species was 507.9 Mg/ha, of which 503.8 Mg/ha was trees (SD = 114.3 Mg/ha) and 4.1 Mg/ha was shrubs. Aboveground live and dead biomass was 652.0 Mg/ha. Large-diameter trees comprised 1.4% of individuals but 49.4% of biomass, with biomass dominated by Abies concolor and Pinus lambertiana (93.0% of tree biomass). The large-diameter component dominated the biomass of snags (59.5%) and contributed significantly to that of woody debris (36.6%). Traditional scaling theory was not a good model for either the relationship between tree radii and tree abundance or tree biomass. Spatial patterning of large-diameter trees of the three most abundant species differed from that of small-diameter conspecifics. For A. concolor and P. lambertiana, as well as all trees pooled, large-diameter and small-diameter trees were spatially segregated through inter-tree distances,10 m. Competition alone was insufficient to explain the spatial patterns of large-diameter trees and spatial relationships between large-diameter and small-diameter trees. Long-term observations may reveal regulation of forest biomass and spatial structure by fire, wind, pathogens, and insects in Sierra Nevada mixed-conifer forests. Sustaining ecosystem functions such as carbon storage or provision of specialist species habitat will likely require different management strategies when the functions are performed primarily by a few large trees as opposed to many smaller trees.	[Lutz, James A.] Univ Washington, Coll Environm, Seattle, WA 98195 USA; [Larson, Andrew J.] Univ Montana, Dept Forest Management, Missoula, MT 59812 USA; [Swanson, Mark E.] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Freund, James A.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Montana System; University of Montana; Washington State University; University of Washington; University of Washington Seattle	Lutz, JA (corresponding author), Univ Washington, Coll Environm, Seattle, WA 98195 USA.	jlutz@uw.edu	Lutz, James/AAA-9574-2019; Lutz, James/B-3785-2012	Lutz, James/0000-0002-2560-0710	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Direct For Biological Sciences [1046113] Funding Source: National Science Foundation	Smithsonian Institution Center for Tropical Forest Science; University of Washington College of the Environment; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was received from the Smithsonian Institution Center for Tropical Forest Science (http://www.ctfs.si.edu/) and the University of Washington College of the Environment (http://coenv.washington.edu/). In-kind support was received from the University of Washington, the University of Montana, Washington State University, the US Geological Survey, and Yosemite National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Baishya R, 2009, TROP ECOL, V50, P295; Baumgartner K, 2001, MYCOLOGIA, V93, P821, DOI 10.2307/3761748; BONNICKSEN TM, 1981, FOREST ECOL MANAG, V3, P307; BROWN IF, 1995, FOREST ECOL MANAG, V75, P175, DOI 10.1016/0378-1127(94)03512-U; Brown J. K., 1974, USDA Forest Service General Technical Report, Intermountain Forest and Range Experiment Station; Bunnel LH, 1880, DISCOVERY YOSEMITE I; Busing RT, 2005, ECOLOGY, V86, P73, DOI 10.1890/04-0410; Busing RT, 2002, J VEG SCI, V13, P785, DOI 10.1111/j.1654-1103.2002.tb02108.x; Carolin V.M., 1977, MISCELLANEOUS PUBLIC, P1; Chao KJ, 2009, J VEG SCI, V20, P260, DOI 10.1111/j.1654-1103.2009.05755.x; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; CLARK DB, 1991, J ECOL, V79, P447, DOI 10.2307/2260725; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Das A, 2011, FOREST ECOL MANAG, V261, P1203, DOI 10.1016/j.foreco.2010.12.035; Diggle P., 2003, STAT ANAL SPATIAL PO; Edmonds RL, 2000, FOREST HLTH PROTECTI; Elsasser AB, 1978, HDB N AM INDIANS, V8, P37; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Gholz, 1979, EQUATIONS ESTIMATING; Gilbert GS, 2010, J VEG SCI, V21, P388, DOI 10.1111/j.1654-1103.2009.01151.x; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Hall CM, 2011, J HERIT TOUR, V6, P309, DOI 10.1080/1743873X.2011.620116; Hammer TE, 1995, ECOLOGY CONSERVATION; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harmon M. E, 2008, NRS29 USDA FOR SERV, DOI DOI 10.2737/NRS-GTR-29; Harmon M.E., 1996, GUIDELINES MEASUREME; HARMON ME, 1987, CAN J FOREST RES, V17, P1265, DOI 10.1139/x87-196; Hawksworth, 1996, AGR HDB, P410; Hickman JC, JEPSON MANUAL HIGHER; Hiskes G, 2009, DISCOVERY YOSEMITE 1; Jenkins J. C., 2004, NE319 USDA FOR SERV, DOI [10.2737/NE-GTR-319, DOI 10.2737/NE-GTR-319]; Jenkins JC, 2003, FOREST SCI, V49, P12; Jennings MD, 2009, ECOL MONOGR, V79, P173, DOI 10.1890/07-1804.1; Keeler-Wolf T, YOSEMITE NA IN PRESS; Keeton WS, 2011, FOREST SCI, V57, P489; Keeton WS, 2005, ECOL MONOGR, V75, P103, DOI 10.1890/03-0626; Knight FR, 2003, STEM MAPPING METHODO; Larson AJ, 2012, FOREST ECOL MANAG, V267, P74, DOI 10.1016/j.foreco.2011.11.038; Larson AJ, 2010, CAN J FOREST RES, V40, P2091, DOI 10.1139/X10-149; Larson AJ, 2008, CAN J FOREST RES, V38, P2814, DOI 10.1139/X08-123; Larson JA, 2006, J VEG SCI, V17, P489, DOI 10.1111/j.1654-1103.2006.tb02470.x; Levy R., 1978, HDB N AM INDIANS, V8, P398; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Lutz JA, 2009, FOREST ECOL MANAG, V257, P2296, DOI 10.1016/j.foreco.2009.03.009; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Lutz JA, 2011, FIRE ECOL, V7, P51, DOI 10.4996/fireecology.0702051; Lutz JA, 2010, J BIOGEOGR, V37, P936, DOI 10.1111/j.1365-2699.2009.02268.x; Makana JR, 2011, J TROP ECOL, V27, P447, DOI 10.1017/S0266467411000265; Martin TA, 2001, FOREST ECOL MANAG, V152, P211, DOI 10.1016/S0378-1127(00)00604-6; Meador AJS, 2009, J VEG SCI, V20, P79, DOI 10.1111/j.1654-1103.2009.05464.x; Means J. E., 1994, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Meyer MD, 2007, SOUTHWEST NAT, V52, P157, DOI 10.1894/0038-4909(2007)52[157:NTONFS]2.0.CO;2; Meyer MD, 2005, J MAMMAL, V86, P275, DOI 10.1644/BEH-110.1; MORRISON ML, 1993, ECOL APPL, V3, P322, DOI 10.2307/1941835; Muir J., 1911, MY 1 SUMMER SIERRA; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; NADKARNI NM, 1989, CONDOR, V91, P891, DOI 10.2307/1368074; Nesmith JCB, 2010, FIRE ECOL, V6, P97, DOI 10.4996/fireecology.0603097; North M, 2004, FOREST SCI, V50, P299; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; NRCS (Natural Resource Conservation Services), 2007, SOIL SURV GEOGR SSUR; Omura H, 2004, MT RES DEV, V24, P179, DOI 10.1659/0276-4741(2004)024[0179:TFARIJ]2.0.CO;2; Parker A.J., 2002, FIRE NATIVE PEOPLES, P233; PIELOU EC, 1962, J ECOL, V50, P357, DOI 10.2307/2257448; Pierson ED, 2006, BAT USE GIANT SEQUOI; PRISM, 2004, 800 M CLIM NORM 1971; R Core Team, 2016, R FDN STAT COMP; Rambo TR, 2009, FOREST ECOL MANAG, V257, P435, DOI 10.1016/j.foreco.2008.09.029; Rizzo DM, 2001, FOREST ECOL MANAG, V146, P159, DOI 10.1016/S0378-1127(00)00455-2; Roberts S. L., 2008, Fire Ecology, V4, P83; Roberts SL, 2011, BIOL CONSERV, V144, P610, DOI 10.1016/j.biocon.2010.11.002; Scholl AE, 2010, ECOL APPL, V20, P362, DOI 10.1890/08-2324.1; Sillett SC, 2007, ECOL MONOGR, V77, P335, DOI 10.1890/06-0994.1; Stephens SL, 2004, NORTHWEST SCI, V78, P93; Stephenson NL, 2011, ECOL MONOGR, V81, P527, DOI 10.1890/10-1077.1; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Sugihara NG, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P1; SWETNAM TW, 1993, SCIENCE, V262, P885, DOI 10.1126/science.262.5135.885; Tarnay LW, 2011, PARK SCI, V28, P48; Taylor AH, 2004, ECOL APPL, V14, P1903, DOI 10.1890/02-5257; Thode AE, 2011, INT J WILDLAND FIRE, V20, P223, DOI 10.1071/WF09060; USDI National Park Service, 2003, FIR MON HDB; van Mantgem PJ, 2004, ECOL APPL, V14, P1590, DOI 10.1890/03-5109; Van Pelt R, 2000, CAN J FOREST RES, V30, P1231, DOI 10.1139/cjfr-30-8-1231; Van Pelt R., 2001, FOREST GIANTS PACIFI; Van Pelt R, 2008, ECOL MONOGR, V78, P283, DOI 10.1890/07-0158.1; van Wagtendonk JW, 2010, FOREST ECOL MANAG, V259, P2122, DOI 10.1016/j.foreco.2010.02.024; van Wagtendonk JW, 2007, FIRE ECOL, V3, P34; Wang XG, 2011, J ECOL, V99, P1382, DOI 10.1111/j.1365-2745.2011.01857.x; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; Westman WE, 1998, J FOREST RES, V17, P311, DOI DOI 10.1139/X87-052; Winter LE, 2002, CAN J FOREST RES, V32, P1057, DOI 10.1139/X02-030	101	144	150	9	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36131	10.1371/journal.pone.0036131	http://dx.doi.org/10.1371/journal.pone.0036131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567132	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500050
J	Ray, S; Pyne, S				Ray, Surajit; Pyne, Saumyadipta			A Computational Framework to Emulate the Human Perspective in Flow Cytometric Data Analysis	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; TRANSFORMATIONS; DISPLAY	Background: In recent years, intense research efforts have focused on developing methods for automated flow cytometric data analysis. However, while designing such applications, little or no attention has been paid to the human perspective that is absolutely central to the manual gating process of identifying and characterizing cell populations. In particular, the assumption of many common techniques that cell populations could be modeled reliably with pre-specified distributions may not hold true in real-life samples, which can have populations of arbitrary shapes and considerable inter-sample variation. Results: To address this, we developed a new framework flowScape for emulating certain key aspects of the human perspective in analyzing flow data, which we implemented in multiple steps. First, flowScape begins with creating a mathematically rigorous map of the high-dimensional flow data landscape based on dense and sparse regions defined by relative concentrations of events around modes. In the second step, these modal clusters are connected with a global hierarchical structure. This representation allows flowScape to perform ridgeline analysis for both traversing the landscape and isolating cell populations at different levels of resolution. Finally, we extended manual gating with a new capacity for constructing templates that can identify target populations in terms of their relative parameters, as opposed to the more commonly used absolute or physical parameters. This allows flowScape to apply such templates in batch mode for detecting the corresponding populations in a flexible, sample-specific manner. We also demonstrated different applications of our framework to flow data analysis and show its superiority over other analytical methods. Conclusions: The human perspective, built on top of intuition and experience, is a very important component of flow cytometric data analysis. By emulating some of its approaches and extending these with automation and rigor, flowScape provides a flexible and robust framework for computational cytomics.	[Ray, Surajit] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Pyne, Saumyadipta] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pyne, Saumyadipta] MIT, Broad Inst, Cambridge, MA 02139 USA; [Pyne, Saumyadipta] Harvard Univ, Cambridge, MA 02138 USA	Boston University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Ray, S (corresponding author), Boston Univ, Dept Math & Stat, Boston, MA 02215 USA.	sray@math.bu.edu; spyne@broad.mit.edu	Ray, Surajit/H-4633-2019	Ray, Surajit/0000-0003-3965-8136				Aghaeepour N, 2010, RAPID CELL POPULATIO; Baudry JP, 2010, J COMPUT GRAPH STAT, V19, P332, DOI 10.1198/jcgs.2010.08111; Brinkman RR, 2007, BIOL BLOOD MARROW TR, V13, P691, DOI 10.1016/j.bbmt.2007.02.002; Cheng MY, 1998, J R STAT SOC B, V60, P579, DOI 10.1111/1467-9868.00141; Cheng MY, 1999, ANN STAT, V27, P1294; Cheng MY, 2004, IMS LECT NOTES MONOG, V45, P237; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ellis B, 2011, FLOWCORE FLOWCORE BA; Finak G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-546; Finak Greg, 2009, Advances in Bioinformatics, V2009, P247646, DOI 10.1155/2009/247646; Hahne F, 2010, FLOWSTATS STAT METHO; HAHNE F, 2009, BMC BIOINFORMATICS, V10; Hahne F, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r77; Hartigan J. A., 1988, Classification and Related Methods of Data Analysis. Proceedings of the First Conference of the International Federation of Classification Societies (IFCS), P229; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Li J, 2007, J MACH LEARN RES, V8, P1687; Lin TI, 2009, J MULTIVARIATE ANAL, V100, P257, DOI 10.1016/j.jmva.2008.04.010; Lin TI, 2010, STAT COMPUT, V20, P343, DOI 10.1007/s11222-009-9128-9; Lindsay B, 2011, DEGREES FREEDOM QUAD; Lindsay BG, 2008, ANN STAT, V36, P983, DOI 10.1214/009053607000000956; Lo K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-145; Lugli E, 2010, CYTOM PART A, V77A, P705, DOI 10.1002/cyto.a.20901; Luta G, 2011, CYTOM PART A, V79A, P3, DOI 10.1002/cyto.a.20988; Maier LM, 2007, P NATL ACAD SCI USA, V104, P18607, DOI 10.1073/pnas.0706409104; Marchette DJ, 1997, J COMPUT GRAPH STAT, V6, P143; McLachlan G, 2000, WILEY SERIES PROBABI, DOI [10.1002/0471721182, DOI 10.1002/0471721182]; Minnotte MC, 1998, J COMPUT GRAPH STAT, V7, P239, DOI 10.2307/1390816; Novo D, 2008, CYTOM PART A, V73A, P685, DOI 10.1002/cyto.a.20592; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Pyne S, 2009, P NATL ACAD SCI USA, V106, P8519, DOI 10.1073/pnas.0903028106; Ray S, 2005, ANN STAT, V33, P2042, DOI 10.1214/009053605000000417; Ray S, THESIS PENNSYLVANIA; Sarkar D, 2008, BIOINFORMATICS, V24, P878, DOI 10.1093/bioinformatics/btn021; Scheuermann R, 2009, J IMMUNOL, V42, P182; SILVERMAN BW, 1981, J ROY STAT SOC B MET, V43, P97; Silverman BW, 1983, PROBABILITY STAT ANA, V79, P248; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Trotter J, ALTERNATIVES LOG SCA, DOI [10.1002/0471142956.cy1016s42, DOI 10.1002/0471142956.CY1016S42]; Zare H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-403	44	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35693	10.1371/journal.pone.0035693	http://dx.doi.org/10.1371/journal.pone.0035693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563466	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700015
J	Thompson, DA; Khan, NW; Othman, MI; Chang, B; Jia, L; Grahek, G; Wu, ZJ; Hiriyanna, S; Nellissery, J; Li, TS; Khanna, H; Colosi, P; Swaroop, A; Heckenlively, JR				Thompson, Debra A.; Khan, Naheed W.; Othman, Mohammad I.; Chang, Bo; Jia, Lin; Grahek, Garrett; Wu, Zhijian; Hiriyanna, Suja; Nellissery, Jacob; Li, Tiansen; Khanna, Hemant; Colosi, Peter; Swaroop, Anand; Heckenlively, John R.			Rd9 Is a Naturally Occurring Mouse Model of a Common Form of Retinitis Pigmentosa Caused by Mutations in RPGR-ORF15	PLOS ONE			English	Article							RPGR EXON ORF15; ONSET RETINAL DEGENERATION; CONE OPSIN MISLOCALIZATION; GTPASE REGULATOR RPGR; PHOTORECEPTOR DEGENERATION; DISEASE EXPRESSION; NEGATIVE RESPONSE; B-WAVE; A-WAVE; GENE	Animal models of human disease are an invaluable component of studies aimed at understanding disease pathogenesis and therapeutic possibilities. Mutations in the gene encoding retinitis pigmentosa GTPase regulator (RPGR) are the most common cause of X-linked retinitis pigmentosa (XLRP) and are estimated to cause 20% of all retinal dystrophy cases. A majority of RPGR mutations are present in ORF15, the purine-rich terminal exon of the predominant splice-variant expressed in retina. Here we describe the genetic and phenotypic characterization of the retinal degeneration 9 (Rd9) strain of mice, a naturally occurring animal model of XLRP. Rd9 mice were found to carry a 32-base-pair duplication within ORF15 that causes a shift in the reading frame that introduces a premature-stop codon. Rpgr ORF15 transcripts, but not protein, were detected in retinas from Rd9/Y male mice that exhibited retinal pathology, including pigment loss and slowly progressing decrease in outer nuclear layer thickness. The levels of rhodopsin and transducin in rod outer segments were also decreased, and M-cone opsin appeared mislocalized within cone photoreceptors. In addition, electroretinogram (ERG) a-and b-wave amplitudes of both Rd9/Y male and Rd9/Rd9 female mice showed moderate gradual reduction that continued to 24 months of age. The presence of multiple retinal features that correlate with findings in individuals with XLRP identifies Rd9 as a valuable model for use in gaining insight into ORF15-associated disease progression and pathogenesis, as well as accelerating the development and testing of therapeutic strategies for this common form of retinal dystrophy.	[Thompson, Debra A.; Khan, Naheed W.; Othman, Mohammad I.; Jia, Lin; Grahek, Garrett; Heckenlively, John R.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Thompson, Debra A.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA; [Wu, Zhijian; Hiriyanna, Suja; Nellissery, Jacob; Li, Tiansen; Colosi, Peter; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Massachusetts System; University of Massachusetts Worcester	Thompson, DA (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	swaroopa@nei.nih.gov; jrheck@umich.edu	wu, zhi/GXH-3041-2022	Thompson, Debra/0000-0003-3485-0794; Chang, Bo/0000-0001-8259-7290; Swaroop, Anand/0000-0002-1975-1141; NELLISSERY, JACOB/0000-0002-1209-664X	National Institutes of Health [RO1-EY007758, RO1-EY007961, RO1-EY019943, P30-EY07003, P60-DK-20572, UL1RR024986]; Foundation Fighting Blindness; Research to Prevent Blindness; intramural program of the National Eye Institute; Senior Scientific Investigator Awards; Clinician-Scientist Award from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000443, ZIAEY000490, R01EY007961, R01EY019943, P30EY007003, ZIAEY000473, R01EY007758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); intramural program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Senior Scientific Investigator Awards; Clinician-Scientist Award from Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from National Institutes of Health (RO1-EY007758, RO1-EY007961, RO1-EY019943, P30-EY07003, P60-DK-20572, UL1RR024986), The Foundation Fighting Blindness, Research to Prevent Blindness, and the intramural program of the National Eye Institute. DAT, JRH, and AS are recipients of Senior Scientific Investigator Awards, and JRH received the Clinician-Scientist Award from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian M, 2006, AM J OPHTHALMOL, V142, P515, DOI 10.1016/j.ajo.2006.03.061; Aguirre GD, 2002, EXP EYE RES, V75, P431, DOI 10.1006/exer.2002.2037; Aleman TS, 2007, INVEST OPHTH VIS SCI, V48, P4759, DOI 10.1167/iovs.07-0453; Aleman TS, 2001, VISION RES, V41, P2779, DOI 10.1016/S0042-6989(01)00157-2; Andreasson S, 1997, AM J OPHTHALMOL, V124, P95; Ayyagari R, 2002, GENOMICS, V80, P166, DOI 10.1006/geno.2002.6815; Beltran WA, 2006, INVEST OPHTH VIS SCI, V47, P1669, DOI 10.1167/iovs.05-0845; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; Beltran WA, 2009, INVEST OPHTH VIS SCI, V50, P3985, DOI 10.1167/iovs.08-3364; Ben-Arie-Weintrob Yael, 2005, Ophthalmic Genet, V26, P91; Boylan JP, 2000, HUM MOL GENET, V9, P2085, DOI 10.1093/hmg/9.14.2085; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; Brunner S, 2010, INVEST OPHTH VIS SCI, V51, P1106, DOI 10.1167/iovs.08-2742; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Fahim AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023021; Fishman GA, 1998, OPHTHALMOLOGY, V105, P2286, DOI 10.1016/S0161-6420(98)91231-3; FISHMAN GA, 1988, ARCH OPHTHALMOL-CHIC, V106, P369; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; He S, 2008, VISION RES, V48, P366, DOI 10.1016/j.visres.2007.08.005; Hemati N, 2005, MOL VIS, V11, P1151; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; HOOD DC, 1992, VISUAL NEUROSCI, V8, P107, DOI 10.1017/S0952523800009275; Iannaccone A, 2004, AM J OPHTHALMOL, V137, P785, DOI 10.1016/S0002-9394(03)01459-4; Jacobson SG, 1997, INVEST OPHTH VIS SCI, V38, P1983; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; LaVail MM, 1997, HISTOLOGICAL METHOD; Lorenz Birgit, 2003, Ophthalmic Genet, V24, P89, DOI 10.1076/opge.24.2.89.14001; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P442, DOI 10.1167/iovs.07-0291; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Neidhardt J, 2008, MOL VIS, V14, P1081; NUSINOWITZ S, 2002, SYSTEMATIC EVALUATIO, P320; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Sandberg MA, 2007, INVEST OPHTH VIS SCI, V48, P1298, DOI 10.1167/iovs.06-0971; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Shu XH, 2007, HUM MUTAT, V28, P322, DOI 10.1002/humu.20461; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WALI N, 1991, DOC OPHTHALMOL, V76, P367, DOI 10.1007/BF00142675; Weleber RG, 1997, ARCH OPHTHALMOL-CHIC, V115, P1429, DOI 10.1001/archopht.1997.01100160599013; Yan D, 1998, J BIOL CHEM, V273, P19656, DOI 10.1074/jbc.273.31.19656; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	61	48	52	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35865	10.1371/journal.pone.0035865	http://dx.doi.org/10.1371/journal.pone.0035865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563472	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700021
J	Hroudova, M; Vojta, P; Strnad, H; Krejcik, Z; Ridl, J; Paces, J; Vlcek, C; Paces, V				Hroudova, Miluse; Vojta, Petr; Strnad, Hynek; Krejcik, Zdenek; Ridl, Jakub; Paces, Jan; Vlcek, Cestmir; Paces, Vaclav			Diversity, Phylogeny and Expression Patterns of Pou and Six Homeodomain Transcription Factors in Hydrozoan Jellyfish Craspedacusta sowerbyi	PLOS ONE			English	Article							LIM HOMEOBOX GENE; SENSORY ORGAN DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; RETINAL GANGLION; EYE DEVELOPMENT; SINE-OCULIS; C-ELEGANS; DEVELOPMENTAL EXPRESSION; CAENORHABDITIS-ELEGANS; SEA-ANEMONE	Formation of all metazoan bodies is controlled by a group of selector genes including homeobox genes, highly conserved across the entire animal kingdom. The homeobox genes from Pou and Six classes are key members of the regulation cascades determining development of sensory organs, nervous system, gonads and muscles. Besides using common bilaterian models, more attention has recently been targeted at the identification and characterization of these genes within the basal metazoan phyla. Cnidaria as a diploblastic sister group to bilateria with simple and yet specialized organs are suitable models for studies on the sensory organ origin and the associated role of homeobox genes. In this work, Pou and Six homeobox genes, together with a broad range of other sensory-specific transcription factors, were identified in the transcriptome of hydrozoan jellyfish Craspedacusta sowerbyi. Phylogenetic analyses of Pou and Six proteins revealed cnidarian-specific sequence motifs and contributed to the classification of individual factors. The majority of the Craspedacusta sowerbyi Pou and Six homeobox genes are predominantly expressed in statocysts, manubrium and nerve ring, the tissues with sensory and nervous activities. The described diversity and expression patterns of Pou and Six factors in hydrozoan jellyfish highlight their evolutionarily conserved functions. This study extends the knowledge of the cnidarian genome complexity and shows that the transcriptome of hydrozoan jellyfish is generally rich in homeodomain transcription factors employed in the regulation of sensory and nervous functions.	[Hroudova, Miluse; Vojta, Petr; Strnad, Hynek; Krejcik, Zdenek; Ridl, Jakub; Paces, Jan; Vlcek, Cestmir; Paces, Vaclav] Acad Sci Czech Republ, Inst Mol Genet, Dept Genom & Bioinformat, Prague, Czech Republic; [Hroudova, Miluse; Paces, Vaclav] Prague Inst Chem Technol, Dept Biochem & Microbiol, Fac Food & Biochem Technol, CR-16628 Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Chemistry & Technology, Prague	Hroudova, M (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Dept Genom & Bioinformat, Prague, Czech Republic.	hroudova@img.cas.cz	Krejcik, Zdenek/A-3505-2013; Pačes, Jan/C-8851-2009; Hradilova, Miluse/G-3829-2014	Pačes, Jan/0000-0003-3059-6127; Hradilova, Miluse/0000-0001-6615-0149; Vojta, Petr/0000-0003-0036-1853; Krejcik, Zdenek/0000-0002-8321-2644	Ministry of Education, Youth and Sports of the Czech Republic [1M6837805002, AV0Z50520514, MSM6046137305]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by grants of the Ministry of Education, Youth and Sports of the Czech Republic 1M6837805002, AV0Z50520514 and MSM6046137305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen B, 2001, ENDOCR REV, V22, P2, DOI 10.1210/er.22.1.2; Ann KJ, 2009, GENESIS, V47, P137, DOI 10.1002/dvg.20454; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Arendt D, 2003, INT J DEV BIOL, V47, P563; Ball EE, 2004, NAT REV GENET, V5, P567, DOI 10.1038/nrg1402; Ball EE, 2002, INT J DEV BIOL, V46, P671; Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Bebenek IG, 2004, DEV GENES EVOL, V214, P342, DOI 10.1007/s00427-004-0407-3; Bessarab DA, 2004, DEV DYNAM, V230, P781, DOI 10.1002/dvdy.20093; Bharathan G, 1997, P NATL ACAD SCI USA, V94, P13749, DOI 10.1073/pnas.94.25.13749; Boero F, 2007, INTEGR COMP BIOL, V47, P693, DOI 10.1093/icb/icm041; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; Collin RWJ, 2008, HUM MUTAT, V29, P545, DOI 10.1002/humu.20693; Colosimo ME, 2004, CURR BIOL, V14, P2245, DOI 10.1016/j.cub.2004.12.030; Cupit PM, 2006, GENE, V383, P1, DOI 10.1016/j.gene.2006.05.009; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; DECORDOBA SR, 2001, CURR GENOMICS, V2, P231; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Erwin DH, 2002, DEVELOPMENT, V129, P3021; Ford HL, 1998, P NATL ACAD SCI USA, V95, P12608, DOI 10.1073/pnas.95.21.12608; Fritzsch B, 2007, INT J DEV BIOL, V51, P663, DOI 10.1387/ijdb.072367bf; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Galliot B, 2011, EUR J NEUROSCI, V34, P847, DOI 10.1111/j.1460-9568.2011.07829.x; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; Hobert O, 1998, BIOL BULL, V195, P377, DOI 10.2307/1543153; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Kappen C, 2000, P NATL ACAD SCI USA, V97, P4481, DOI 10.1073/pnas.97.9.4481; Kawakami K, 2000, BIOESSAYS, V22, P616, DOI 10.1002/1521-1878(200007)22:7<616::AID-BIES4>3.3.CO;2-I; Kenyon KL, 2005, DEV DYNAM, V234, P497, DOI 10.1002/dvdy.20442; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Kumar J, 1997, GENE DEV, V11, P2023, DOI 10.1101/gad.11.16.2023; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lanier J, 2007, DEV BIOL, V302, P703, DOI 10.1016/j.ydbio.2006.10.050; Larroux C, 2008, MOL BIOL EVOL; Lee MH, 2002, J NEUROSCI, V22, P5291; Lee SE, 2003, J MOL EVOL, V56, P509, DOI 10.1007/s00239-002-2421-2; Lesh-Laurie GE, 1991, PLACOZOA PORIFERA CN, VII, P185; Mackie GO, 2000, J EXP BIOL, V203, P1797; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Milani R, 1941, D I S, V14, P52; Millane RC, 2011, DEVELOPMENT, V138, P2429, DOI 10.1242/dev.064931; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Mukherjee K, 2007, J MOL EVOL, V65, P137, DOI 10.1007/s00239-006-0023-0; Nakanishi N, 2010, EVOL DEV, V12, P404, DOI 10.1111/j.1525-142X.2010.00427.x; Nakanishi N, 2009, DEV GENES EVOL, V219, P301, DOI 10.1007/s00427-009-0291-y; Nam J, 2005, MOL BIOL EVOL, V22, P2386, DOI 10.1093/molbev/msi229; O'Brien EK, 2002, DEV GENES EVOL, V212, P394, DOI 10.1007/s00427-002-0256-x; Ozaki H, 2001, MOL CELL BIOL, V21, P3343, DOI 10.1128/MCB.21.10.3343-3350.2001; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Phippard D, 1999, J NEUROSCI, V19, P5980, DOI 10.1523/JNEUROSCI.19-14-05980.1999; Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Plachetzki DC, 2005, TRENDS ECOL EVOL, V20, P465, DOI 10.1016/j.tree.2005.07.001; Porter FD, 1997, DEVELOPMENT, V124, P2935; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ramachandra NB, 2002, DEV GENES EVOL, V212, P55, DOI 10.1007/s00427-001-0207-y; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Ryan JF, 2010, EVODEVO, V1, DOI [10.1186/2041-9139-1181-1189, DOI 10.1186/2041-9139-1181-1189]; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; Sampath K, 1996, BIOCHEM BIOPH RES CO, V219, P565, DOI 10.1006/bbrc.1996.0274; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Satterlie RA, 2011, J EXP BIOL, V214, P1215, DOI 10.1242/jeb.043687; Schierwater B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002457; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Seimiya M, 1997, EUR J BIOCHEM, V243, P27, DOI 10.1111/j.1432-1033.1997.0027a.x; Seimiya M, 2000, DEVELOPMENT, V127, P1879; Seo HC, 1999, MECH DEVELOP, V83, P127, DOI 10.1016/S0925-4773(99)00045-3; Shah D, 2000, DNA SEQUENCE, V11, P457, DOI 10.3109/10425170009033997; Spaniol P, 1996, NUCLEIC ACIDS RES, V24, P4874, DOI 10.1093/nar/24.24.4874; Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220; Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018; Sze JY, 2003, P NATL ACAD SCI USA, V100, P9560, DOI 10.1073/pnas.1530752100; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Veenstra GJC, 1997, MOL BIOL REP, V24, P139, DOI 10.1023/A:1006855632268; Wada S, 2003, DEV GENES EVOL, V213, P222, DOI 10.1007/s00427-003-0321-0; Wang LB, 2008, DEVELOPMENT, V135, P3425, DOI 10.1242/dev.012237; Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Zhang JM, 1999, DEV BIOL, V208, P465, DOI 10.1006/dbio.1999.9218; Zhao Yangu, 2002, Current Molecular Medicine (Hilversum), V2, P13, DOI 10.2174/1566524023363077; Zhou H, 1996, J NEUROSCI, V16, P2261, DOI 10.1523/jneurosci.16-07-02261.1996	106	17	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36420	10.1371/journal.pone.0036420	http://dx.doi.org/10.1371/journal.pone.0036420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558464	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200078
J	Cui, ZL; Wang, J; Zhu, CT; Huang, XC; Lu, JM; Wang, Q; Chen, ZN; Wang, JL; Zhang, Y; Gu, DL; Jing, LJ; Chen, J; Zheng, RJ; Qin, LH; Yang, H; Jin, RL; Liu, ZH; Bi, AX; Liu, JM; Hu, ZY				Cui, Zhenling; Wang, Jie; Zhu, Changtai; Huang, Xiaochen; Lu, Junmei; Wang, Qing; Chen, Zhongnan; Wang, Junling; Zhang, Yan; Gu, Delin; Jing, Lingjie; Chen, Jin; Zheng, Ruijuan; Qin, Lianhua; Yang, Hua; Jin, Ruiliang; Liu, Zhonghua; Bi, Aixiao; Liu, Jinming; Hu, Zhongyi			Evaluation of a Novel Biphasic Culture Medium for Recovery of Mycobacteria: A Multi-Center Study	PLOS ONE			English	Article							NITRATE REDUCTASE ASSAY; TUBERCULOSIS; SYSTEM; GROWTH; AVIUM	Background: Mycobacterial culture and identification provide a definitive diagnosis of TB. Culture on Lowenstein-Jensen (L-J) medium is invariably delayed because of the slow growth of M. tuberculosis on L-J slants. Automated liquid culture systems are expensive. A low-cost culturing medium capable of rapidly indicating the presence of mycobacteria is needed. The aim of this study was to develop and evaluate a novel biphasic culture medium for the recovery of mycobacteria from clinical sputum specimens from suspected pulmonary tuberculosis patients. Methods and Findings: The biphasic medium consisted of 7 ml units of L-J slant medium, 3 ml units of liquid culture medium, growth indicator and a mixture of antimicrobial agents. The decontamination sediments of sputum specimens were incubated in the biphasic culture medium at 37 degrees C. Mycobacterial growth was determined based on the appearance of red granule sediments and the examination using acid-fast bacilli (AFB). The clinical sputum specimens were cultured in the biphasic medium, on L-J slants and in the Bactec MGIT 960 culture system. Among smear-positive specimens, the mycobacteria recovery rate of the biphasic medium was higher than that of the L-J slants (P<0.001) and similar to that of MGIT 960 (P>0.05). Among smear-negative specimens, the mycobacterial recovery rate of the biphasic medium was higher than that of L-J slants (P<0.001) and lower than that of MGIT 960 (P<0.05). The median times to detection of mycobacteria were 14 days, 20 days and 30 days for cultures grown in MGIT, in biphasic medium, on L-J slants for smear negative specimens, respectively (P<0.001). Conclusions: The biphasic culture medium developed in this study is low-cost and suitable for mycobacterial recovery. It does not require any expensive detection instrumentation, decreases the time required for detection of M. tuberculosis complex, and increases the detection rate of M. tuberculosis complex.	[Cui, Zhenling; Wang, Jie; Zhu, Changtai; Huang, Xiaochen; Lu, Junmei; Jing, Lingjie; Chen, Jin; Zheng, Ruijuan; Qin, Lianhua; Yang, Hua; Jin, Ruiliang; Liu, Zhonghua; Bi, Aixiao; Hu, Zhongyi] Tongji Univ, Shanghai Key Lab TB, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Liu, Jinming] Tongji Univ, Dept Resp Med, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China; [Zhu, Changtai] Soochow Univ, Changzhou Tumor Hosp, Dept Lab Med, Changzhou, Peoples R China; [Wang, Qing] Anhui Prov Chest Hosp, Hefei, Peoples R China; [Chen, Zhongnan] Hunan Prov Chest Hosp, Changsha, Hunan, Peoples R China; [Wang, Junling] Shandong Prov Chest Hosp, Jinan, Peoples R China; [Zhang, Yan] Hangzhou Red Cross Hosp, Hangzhou, Zhejiang, Peoples R China; [Gu, Delin] Sixth People Hosp Nantong, Nantong, Peoples R China	Tongji University; Tongji University; Soochow University - China; Shandong University	Cui, ZL (corresponding author), Tongji Univ, Shanghai Key Lab TB, Shanghai Pulm Hosp, Sch Med, Shanghai 200092, Peoples R China.	jinmingliu2007@yahoo.com.cn; shhuzy@163.com	Zhu, Changtai/V-1583-2017; zhu, changtai/W-6581-2019	Zhu, Changtai/0000-0002-5250-1937; zhu, changtai/0000-0002-5250-1937	National Key Project for Infectious Disease [2008ZX10003-003-02]	National Key Project for Infectious Disease	This study was supported by grants from the National Key Project for Infectious Disease (No. 2008ZX10003-003-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2008, J CLIN MICROBIOL, V46, P3243, DOI 10.1128/JCM.00083-08; Angeby KAK, 2002, J CLIN MICROBIOL, V40, P553, DOI 10.1128/JCM.40.2.553-555.2002; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Giampaglia CMS, 2005, INT J TUBERC LUNG D, V9, P206; Greco S, 2009, J CLIN MICROBIOL, V47, P569, DOI 10.1128/JCM.02051-08; Hanna BA, 1999, J CLIN MICROBIOL, V37, P748, DOI 10.1128/JCM.37.3.748-752.1999; International Union against Tuberculosis and Lung Disease, 2000, TECHN SPUT EX TUB DI; Jadaun GRS, 2007, J ANTIMICROB CHEMOTH, V60, P152, DOI 10.1093/jac/dkm117; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kumar M, 2005, DIAGN MICR INFEC DIS, V53, P121, DOI 10.1016/j.diagmicrobio.2005.05.011; Liberato Isabella Ramos de Oliveira, 2004, Rev. Soc. Bras. Med. Trop., V37, P46, DOI 10.1590/S0037-86822004000100012; Mirovic V, 2002, CLIN MICROBIOL INFEC, V8, P709, DOI 10.1046/j.1469-0691.2002.00448.x; Pfyffer GE, 2003, MANUAL CLIN MICROBIO, P532; RAVIGLIONE MC, 1992, B WORLD HEALTH ORGAN, V70, P515; TENGERDY RP, 1967, APPL MICROBIOL, V15, P954, DOI 10.1128/AEM.15.4.954-955.1967; Van Deun A, 2007, PRIORITIES TUBERCULO, P11; WHO, 2010, WHOHTMTB2008393; WHO UNAIDS, 2009, WHOHTMTB2009414; World Health Organization, 2010, WHOHTMTB2008394; World Health Organization, 2010, WHOHTMTB20103; World Health Organization (WHO), 2009, WHOHTMTB2009420; World Health Organization (WHO), 1998, LAB SERVICES TUBERCU	25	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36331	10.1371/journal.pone.0036331	http://dx.doi.org/10.1371/journal.pone.0036331			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558436	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000190
J	Liu, YH; Vaghjiani, V; Tee, JY; To, K; Cui, P; Oh, DY; Manuelpillai, U; Toh, BH; Chan, J				Liu, Yu Han; Vaghjiani, Vijesh; Tee, Jing Yang; To, Kelly; Cui, Peng; Oh, Ding Yuan; Manuelpillai, Ursula; Toh, Ban-Hock; Chan, James			Amniotic Epithelial Cells from the Human Placenta Potently Suppress a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MESENCHYMAL STEM-CELLS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; LYMPHOCYTE-T; TRANSPLANTATION; TOLERANCE; DISEASE	Human amniotic epithelial cells (hAEC) have stem cell-like features and immunomodulatory properties. Here we show that hAEC significantly suppressed splenocyte proliferation in vitro and potently attenuated a mouse model of multiple sclerosis (MS). Central nervous system (CNS) CD3(+) T cell and F4/80(+) monocyte/macrophage infiltration and demyelination were significantly reduced with hAEC treatment. Besides the known secretion of prostaglandin E2 (PGE2), we report the novel finding that hAEC utilize transforming growth factor-beta (TGF-beta) for immunosuppression. Neutralization of TGF-beta or PGE2 in splenocyte proliferation assays significantly reduced hAEC-induced suppression. Splenocytes from hAEC-treated mice showed a Th2 cytokine shift with significantly elevated IL-5 production. While transferred CFSE-labeled hAEC could be detected in the lung, none were identified in the CNS or in lymphoid organs. This is the first report documenting the therapeutic effect of hAEC in a MS-like model and suggest that hAEC may have potential for use as therapy for MS.	[Liu, Yu Han; To, Kelly; Cui, Peng; Oh, Ding Yuan; Toh, Ban-Hock; Chan, James] Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Vaghjiani, Vijesh; Tee, Jing Yang; Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia	Monash University; Monash University	Liu, YH (corresponding author), Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.	james.chan@monash.edu	Tee, Jing Yang/F-2821-2013	Tee, Jing Yang/0000-0003-1605-4938; Vaghjiani, Vijesh/0000-0001-8004-3876; Oh, Ding Yuan/0000-0003-0695-8490	Australian National Health & Medical Research Council (NHMRC) [606473]; National Health and Medical Research Council (NHMRC) [436634]; Victorian Government	Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	W, JYT, UM supported by Australian National Health & Medical Research Council (NHMRC) grant #606473, YHL, KT, DYO, BHT and JC by National Health and Medical Research Council (NHMRC) program grant #436634 and Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Chan J, 2008, AUTOIMMUNITY, V41, P405, DOI 10.1080/08916930802011258; Chan J, 2008, J IMMUNOL, V181, P7571, DOI 10.4049/jimmunol.181.11.7571; Chen XT, 2011, AUTOIMMUNITY, V44, P384, DOI 10.3109/08916934.2010.541173; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Engelhardt B, 2006, J NEURAL TRANSM, V113, P477, DOI 10.1007/s00702-005-0409-y; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HICKEY WF, 1991, J NEUROSCI RES, V28, P254, DOI 10.1002/jnr.490280213; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kong XY, 2008, BRAIN RES, V1205, P108, DOI 10.1016/j.brainres.2008.02.040; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Li HC, 2005, INVEST OPHTH VIS SCI, V46, P900, DOI 10.1167/iovs.04-0495; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; McKarns SC, 2000, IMMUNOPHARMACOLOGY, V48, P101, DOI 10.1016/S0162-3109(00)00183-1; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pratama G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026136; Prockop DJ, 2011, MOL THER; RACKE MK, 1991, J IMMUNOL, V146, P3012; RACKE MK, 1992, INT IMMUNOL, V4, P615, DOI 10.1093/intimm/4.5.615; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; SHALABY MR, 1988, CELL IMMUNOL, V112, P343, DOI 10.1016/0008-8749(88)90303-6; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Stinissen P, 1997, CRIT REV IMMUNOL, V17, P33, DOI 10.1615/CritRevImmunol.v17.i1.20; SWANBORG RH, 1995, CLIN IMMUNOL IMMUNOP, V77, P4, DOI 10.1016/0090-1229(95)90130-2; Uccelli A, 2011, LANCET NEUROL, V10, P649, DOI 10.1016/S1474-4422(11)70121-1; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U; Uchida S, 2003, NEUROSCI LETT, V341, P1, DOI 10.1016/S0304-3940(02)01454-4; Von Budingen HC, 2001, J CLIN IMMUNOL, V21, P155; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Workman CJ, 2009, CELL MOL LIFE SCI, V66, P2603, DOI 10.1007/s00018-009-0026-2; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	46	64	71	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35758	10.1371/journal.pone.0035758	http://dx.doi.org/10.1371/journal.pone.0035758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563398	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349100026
J	Buzoianu, SG; Walsh, MC; Rea, MC; O'Sullivan, O; Crispie, F; Cotter, PD; Ross, RP; Gardiner, GE; Lawlor, PG				Buzoianu, Stefan G.; Walsh, Maria C.; Rea, Mary C.; O'Sullivan, Orla; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			The Effect of Feeding Bt MON810 Maize to Pigs for 110 Days on Intestinal Microbiota	PLOS ONE			English	Article							GUT MICROBIOTA; GASTROINTESTINAL-TRACT; ANTIMICROBIAL ACTIVITY; BACTERIAL COMMUNITY; DIVERSITY; HEALTH; DIET; LACTOBACILLI; PERFORMANCE; REVEALS	Objective: To assess the effects of feeding Bt MON810 maize to pigs for 110 days on the intestinal microbiota. Methodology/Principal Findings: Forty male pigs (similar to 40 days old) were blocked by weight and litter ancestry and assigned to one of four treatments; 1) Isogenic maize-based diet for 110 days (Isogenic); 2) Bt maize-based diet (MON810) for 110 days (Bt); 3) Isogenic maize-based diet for 30 days followed by a Bt maize-based diet for 80 days (Isogenic/Bt); 4) Bt maize-based diet for 30 days followed by an isogenic maize-based diet for 80 days (Bt/Isogenic). Enterobacteriaceae, Lactobacillus and total anaerobes were enumerated in the feces using culture-based methods on days 0, 30, 60 and 100 of the study and in ileal and cecal digesta on day 110. No differences were found between treatments for any of these counts at any time point. The relative abundance of cecal bacteria was also determined using high-throughput 16 S rRNA gene sequencing. No differences were observed in any bacterial taxa between treatments, with the exception of the genus Holdemania which was more abundant in the cecum of pigs fed the isogenic/Bt treatment compared to pigs fed the Bt treatment (0.012 vs 0.003%; P <= 0.05). Conclusions/Significance: Feeding pigs a Bt maize-based diet for 110 days did not affect counts of any of the culturable bacteria enumerated in the feces, ileum or cecum. Neither did it influence the composition of the cecal microbiota, with the exception of a minor increase in the genus Holdemania. As the role of Holdemania in the intestine is still under investigation and no health abnormalities were observed, this change is not likely to be of clinical significance. These results indicate that feeding Bt maize to pigs in the context of its influence on the porcine intestinal microbiota is safe.	[Buzoianu, Stefan G.; Walsh, Maria C.; Lawlor, Peadar G.] Teagasc, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; O'Sullivan, Orla; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul] Teagasc, Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Crispie, Fiona; Cotter, Paul D.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Buzoianu, SG (corresponding author), Teagasc, Anim & Grassland Res & Innovat Ctr, Pig Dev Dept, Fermoy, Cork, Ireland.	ggardiner@wit.ie	Ross, Paul/A-7584-2015; walsh, maria/H-3662-2013; Cotter, Paul/B-7781-2008; Stefan, Buzoianu/F-3030-2010; Cotter, Paul/AAX-5449-2021; O'Sullivan, Orla/ABE-5980-2020; STANTON, CATHERINE/A-9549-2015	Ross, Paul/0000-0003-4876-8839; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; O'Sullivan, Orla/0000-0002-4332-1109; STANTON, CATHERINE/0000-0002-6724-7011; Rea, Mary/0000-0003-3782-0232	European Union [211820]; Teagasc Walsh Fellowship programme	European Union(European Commission); Teagasc Walsh Fellowship programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 211820 and the Teagasc Walsh Fellowship programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	22 SAS/STATH&REG;9, 2010, 22 SAS STAT 9 US GUI; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Buddington RK, 2011, J ANIM SCI, V89, P1506, DOI 10.2527/jas.2010-3705; Buzoianu SG, 2012, ANIMAL, V6, P1609, DOI 10.1017/S1751731112000249; Buzoianu SG, 2012, APPL ENV MI IN PRESS; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Canibe N, 2005, J ANIM SCI, V83, P1287; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castillo M, 2007, LIVEST SCI, V109, P149, DOI 10.1016/j.livsci.2007.01.129; Chassard C, 2008, FEMS MICROBIOL ECOL, V66, P496, DOI 10.1111/j.1574-6941.2008.00595.x; CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Dona A, 2009, CRIT REV FOOD SCI, V49, P164, DOI 10.1080/10408390701855993; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x; Franklin MA, 2002, J ANIM SCI, V80, P2904; Gardiner GE, 2004, APPL ENVIRON MICROB, V70, P1895, DOI 10.1128/AEM.70.4.1895-1906.2004; GASKELL GSS, 2005, EUROPEANS BIOTECHNOL; Hartnell G. F., 2007, BEST PRACTICES CONDU; ILSI International Life Sciences Institute Crop Composition Database, ILSI INT LIF SCI I C; JENSEN BB, 1994, APPL ENVIRON MICROB, V60, P1897, DOI 10.1128/AEM.60.6.1897-1904.1994; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Koskella J, 2002, CAN J MICROBIOL, V48, P262, DOI [10.1139/w02-005, 10.1139/W02-005]; KRAUSE DO, 1995, J ANIM SCI, V73, P2347; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Martinez-Poveda A, 2009, FOOD POLICY, V34, P519, DOI 10.1016/j.foodpol.2009.08.001; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; NAITO S, 1995, J APPL BACTERIOL, V79, P230, DOI 10.1111/j.1365-2672.1995.tb00940.x; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Poletto R, 2009, J ANIM SCI, V87, P304, DOI 10.2527/jas.2008-1188; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Rantakokko-Jalava K, 2002, J CLIN MICROBIOL, V40, P4211, DOI 10.1128/JCM.40.11.4211-4217.2002; Rea MC, 2007, J MED MICROBIOL, V56, P940, DOI 10.1099/jmm.0.47085-0; Rollin F, 2011, TRENDS FOOD SCI TECH, V22, P99, DOI 10.1016/j.tifs.2010.09.001; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Saarela M, 2002, INT J FOOD MICROBIOL, V78, P99, DOI 10.1016/S0168-1605(02)00235-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wiedemann S, 2007, APPL ENVIRON MICROB, V73, P8012, DOI 10.1128/AEM.01060-06; Yudina TG, 2007, ANAEROBE, V13, P6, DOI 10.1016/j.anaerobe.2006.09.006; [No title captured]	56	33	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e33668	10.1371/journal.pone.0033668	http://dx.doi.org/10.1371/journal.pone.0033668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574106	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800002
J	McKenzie, JH; McDevitt, JJ; Fabian, MP; Hwang, GM; Milton, DK				McKenzie, Jennifer H.; McDevitt, James J.; Fabian, M. Patricia; Hwang, Grace M.; Milton, Donald K.			Collection of Aerosolized Human Cytokines Using Teflon (R) Filters	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; ELECTROSTATIC PRECIPITATOR; ASSAYS; VALIDATION; BIOMARKERS; ASTHMA	Background: Collection of exhaled breath samples for the analysis of inflammatory biomarkers is an important area of research aimed at improving our ability to diagnose, treat and understand the mechanisms of chronic pulmonary disease. Current collection methods based on condensation of water vapor from exhaled breath yield biomarker levels at or near the detection limits of immunoassays contributing to problems with reproducibility and validity of biomarker measurements. In this study, we compare the collection efficiency of two aerosol-to-liquid sampling devices to a filter-based collection method for recovery of dilute laboratory generated aerosols of human cytokines so as to identify potential alternatives to exhaled breath condensate collection. Methodology/Principal Findings: Two aerosol-to-liquid sampling devices, the SKC (R) Biosampler and Omni 3000 (TM), as well as Teflon (R) filters were used to collect aerosols of human cytokines generated using a HEART nebulizer and single-pass aerosol chamber setup in order to compare the collection efficiencies of these sampling methods. Additionally, methods for the use of Teflon (R) filters to collect and measure cytokines recovered from aerosols were developed and evaluated through use of a high-sensitivity multiplex immunoassay. Our results show successful collection of cytokines from pg/m(3) aerosol concentrations using Teflon (R) filters and measurement of cytokine levels in the sub-picogram/mL concentration range using a multiplex immunoassay with sampling times less than 30 minutes. Significant degradation of cytokines was observed due to storage of cytokines in concentrated filter extract solutions as compared to storage of dry filters. Conclusions: Use of filter collection methods resulted in significantly higher efficiency of collection than the two aerosol-to-liquid samplers evaluated in our study. The results of this study provide the foundation for a potential new technique to evaluate biomarkers of inflammation in exhaled breath samples.	[McKenzie, Jennifer H.] Univ Massachusetts, Biomed Engn & Biotechnol Program, Lowell, MA USA; [McDevitt, James J.; Fabian, M. Patricia] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Hwang, Grace M.] MITRE Corp, Mclean, VA USA; [Milton, Donald K.] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA	University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health; MITRE Corporation; University System of Maryland; University of Maryland College Park	McKenzie, JH (corresponding author), Univ Massachusetts, Biomed Engn & Biotechnol Program, Lowell, MA USA.	dmilton@umd.edu	Hwang, Grace/L-6096-2019; Milton, Donald K/G-3286-2010	Hwang, Grace/0000-0002-3335-8688; Milton, Donald K/0000-0002-0550-7834; Fabian, M. Patricia/0000-0002-1658-3349	National Institute Environmental Health Sciences [NIEHS 2P30ES00002]; MITRE Corporation, Bedford, Massachusetts, United States of America; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	National Institute Environmental Health Sciences; MITRE Corporation, Bedford, Massachusetts, United States of America; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has received financial support from the National Institute Environmental Health Sciences (grant NIEHS 2P30ES00002) and The MITRE Corporation, Bedford, Massachusetts, United States of America. MITRE acknowledges the Air Transportation Center of Excellence in Airliner Cabin Environment Research (ACER, also known as the National Center for Research in Intermodal Transport Environments - RITES). The contribution of MITRE employee (GMH) was reviewed and approved for public release by the MITRE Corporation (file number 11-0311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M, 2008, ANALYST, V133, P702, DOI 10.1039/b718587c; Almstrand AC, 2012, EUR RESPIR J, V39, P59, DOI 10.1183/09031936.00195610; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Aziz N, 1999, CLIN DIAGN LAB IMMUN, V6, P89, DOI 10.1128/CDLI.6.1.89-95.1999; Bayley DL, 2008, EUR RESPIR J, V31, P943, DOI 10.1183/09031936.00081707; Doherty DE, 2008, COPD, V5, P310, DOI 10.1080/15412550802363386; Effros RM, 2002, AM J RESP CRIT CARE, V165, P663, DOI 10.1164/ajrccm.165.5.2101018; Effros RM, 2005, J APPL PHYSIOL, V99, P1286, DOI 10.1152/japplphysiol.00362.2005; Fabian MP, 2007, QUANTIFICATION RESP; Fabian P, 2011, J AEROSOL MED PULM D, V24, P137, DOI 10.1089/jamp.2010.0815; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Han T, 2010, AEROSOL SCI TECH, V44, P339, DOI 10.1080/02786821003649352; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Horvath I, 2009, EUR RESPIR J, V34, P261, DOI 10.1183/09031936.00142508; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Kazani S, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/4/047001; Khaltaev N, 2007, GLOBAL SURVEILLANCE, Vvii, P146; KIETZMANN D, 1993, INTENS CARE MED, V19, P78, DOI 10.1007/BF01708366; Larsson P, 2012, RESP MED, V106, P197, DOI 10.1016/j.rmed.2011.10.008; Loukides S, 2011, CURR MED CHEM, V18, P1432, DOI 10.2174/092986711795328418; Mainelis G, 2002, AEROSOL SCI TECH, V36, P1073, DOI 10.1080/02786820290092212; Mannino David M, 2007, Proc Am Thorac Soc, V4, P502, DOI 10.1513/pats.200701-001FM; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Panicker G, 2007, CYTOKINE, V37, P176, DOI 10.1016/j.cyto.2007.03.006; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Sack U, 2006, CYTOM PART A, V69A, P169, DOI 10.1002/cyto.a.20231; Sapey E, 2008, EUR RESPIR J, V32, P1408, DOI 10.1183/09031936.00088608; THAVASU PW, 1992, J IMMUNOL METHODS, V153, P115, DOI 10.1016/0022-1759(92)90313-I; Urbano FL, 2008, J MANAGE CARE PHARM, V14, P41, DOI 10.18553/jmcp.2008.14.1.41; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Weist S, 2010, PROTEOMICS, V10, P1515, DOI 10.1002/pmic.200900471	32	5	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35814	10.1371/journal.pone.0035814	http://dx.doi.org/10.1371/journal.pone.0035814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574123	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800019
J	Sanchez, MB; Martinez, JL				Sanchez, Maria B.; Martinez, Jose L.			Differential Epigenetic Compatibility of qnr Antibiotic Resistance Determinants with the Chromosome of Escherichia coli	PLOS ONE			English	Article							QUINOLONE RESISTANCE; PLASMID; GENES; MUTATIONS; EVOLUTION; COST; DISSEMINATION; ADAPTATION; SELECTION; DNA	Environmental bacteria harbor a plethora of genes that, upon their horizontal transfer to new hosts, may confer resistance to antibiotics, although the number of such determinants actually acquired by pathogenic bacteria is very low. The founder effect, fitness costs and ecological connectivity all influence the chances of resistance transfer being successful. We examined the importance of these bottlenecks using the family of quinolone resistance determinants Qnr. The results indicate the epigenetic compatibility of a determinant with the host genome to be of great importance in the acquisition and spread of resistance. A plasmid carrying the widely distributed QnrA determinant was stable in Escherichia coli, whereas the SmQnr determinant was unstable despite both proteins having very similar tertiary structures. This indicates that the fitness costs associated with the acquisition of antibiotic resistance may not derive from a non-specific metabolic burden, but from the acquired gene causing specific changes in bacterial metabolic and regulatory networks. The observed stabilization of the plasmid encoding SmQnr by chromosomal mutations, including a mutant lacking the global regulator HNS, reinforces this idea. Since quinolones are synthetic antibiotics, and since the origin of QnrA is the environmental bacterium Shewanella algae, the role of QnrA in this organism is unlikely to be that of conferring resistance. Its evolution toward this may have occurred through mutations or because of an environmental change (exaptation). The present results indicate that the chromosomally encoded Qnr determinants of S. algae can confer quinolone resistance upon their transfer to E. coli without the need of any further mutation. These results suggest that exaptation is important in the evolution of antibiotic resistance.	[Sanchez, Maria B.; Martinez, Jose L.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Sanchez, MB (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Madrid, Spain.	jlmtnez@cnb.csic.es	Martinez, Jose L/A-4725-2013; Sanchez, Maria Blanca/AAD-8294-2020	Martinez, Jose L/0000-0001-8813-7607; Sanchez, Maria Blanca/0000-0002-5209-4518	Spanish Ministry of Science and Innovation [BIO2008-00090, BIO2011-25255]; European the Union [KBBE-227258 (BIOHYPO), HEALTH-F3-2010-241476 (PAR), HEALTH-F3-2011-282004 (EVOTAR)]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European the Union	Work in our laboratory is funded by grants BIO2008-00090 and BIO2011-25255 from the Spanish Ministry of Science and Innovation, KBBE-227258 (BIOHYPO), HEALTH-F3-2010-241476 (PAR), and HEALTH-F3-2011-282004 (EVOTAR) from European the Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Atlas R, 1993, HDB MICROBIOLOGICAL; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; BAQUERO F, 1985, J ANTIMICROB CHEMOTH, V15, P151; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Blaby IK, 2009, MICROBIOL-SGM, V155, P2676, DOI 10.1099/mic.0.029777-0; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Cattoir V, 2006, J ANTIMICROB CHEMOTH, V58, P1054, DOI 10.1093/jac/dkl361; Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Davies JE, 1997, CIBA F SYMP, V207, P15; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Field CM, 2011, PLASMID IN PRESS; Foucault ML, 2010, P NATL ACAD SCI USA, V107, P16964, DOI 10.1073/pnas.1006855107; GomezGomez JM, 1996, MOL MICROBIOL, V19, P909, DOI 10.1046/j.1365-2958.1996.443955.x; GomezGomez JM, 1997, FEMS MICROBIOL LETT, V154, P271, DOI 10.1111/j.1574-6968.1997.tb12655.x; Gould SJ, 1999, P NATL ACAD SCI USA, V96, P11904, DOI 10.1073/pnas.96.21.11904; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Hernandez A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00022; Hodgman TC, 1998, MOL MICROBIOL, V29, P545, DOI 10.1046/j.1365-2958.1998.00948.x; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kim HB, 2011, ANTIMICROB AGENTS CH, V55, P414, DOI 10.1128/AAC.00991-10; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Marshall CG, 1998, ANTIMICROB AGENTS CH, V42, P2215, DOI 10.1128/AAC.42.9.2215; Martinez JL, 2011, CURR OPIN PHARM; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Mojica FJM, 1997, J BACTERIOL, V179, P3528, DOI 10.1128/jb.179.11.3528-3533.1997; Poirel Laurent, 2005, Antimicrob Agents Chemother, V49, P3523, DOI 10.1128/AAC.49.8.3523-3525.2005; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Sambrook J, 2001, MOL CLONING HARBOR A; Sanchez MB, 2010, ANTIMICROB AGENTS CH, V54, P580, DOI 10.1128/AAC.00496-09; Sanchez MB, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-148; Shimizu K, 2008, ANTIMICROB AGENTS CH, V52, P3823, DOI 10.1128/AAC.00026-08; Skippington E, 2011, FEMS MICROBIOL REV, V35, P707, DOI 10.1111/j.1574-6976.2010.00261.x; Sorensen AH, 2003, ANTIMICROB AGENTS CH, V47, P798, DOI 10.1128/AAC.47.2.798-799.2003; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; SUMMERS DK, 1991, TRENDS BIOTECHNOL, V9, P273, DOI 10.1016/0167-7799(91)90089-Z; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P3050, DOI 10.1128/AAC.49.7.3050-3052.2005; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Vetting MW, 2011, J BIOL CHEM, V286, P25265, DOI 10.1074/jbc.M111.226936; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07	61	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35149	10.1371/journal.pone.0035149	http://dx.doi.org/10.1371/journal.pone.0035149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574114	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800010
J	Frost, NA; Lu, HE; Blanpied, TA				Frost, Nicholas A.; Lu, Hsiangmin E.; Blanpied, Thomas A.			Optimization of Cell Morphology Measurement via Single-Molecule Tracking PALM	PLOS ONE			English	Article							PHOTOACTIVATION LOCALIZATION MICROSCOPY; SERIAL ELECTRON-MICROSCOPY; DENDRITIC SPINES; BIOPHYSICAL CHARACTERISTICS; FLUORESCENT PROTEIN; RAT HIPPOCAMPUS; LIVING CELLS; HIGH-DENSITY; LIVE CELLS; DYNAMICS	In neurons, the shape of dendritic spines relates to synapse function, which is rapidly altered during experience-dependent neural plasticity. The small size of spines makes detailed measurement of their morphology in living cells best suited to super-resolution imaging techniques. The distribution of molecular positions mapped via live-cell Photoactivated Localization Microscopy (PALM) is a powerful approach, but molecular motion complicates this analysis and can degrade overall resolution of the morphological reconstruction. Nevertheless, the motion is of additional interest because tracking single molecules provides diffusion coefficients, bound fraction, and other key functional parameters. We used Monte Carlo simulations to examine features of single-molecule tracking of practical utility for the simultaneous determination of cell morphology. We find that the accuracy of determining both distance and angle of motion depend heavily on the precision with which molecules are localized. Strikingly, diffusion within a bounded region resulted in an inward bias of localizations away from the edges, inaccurately reflecting the region structure. This inward bias additionally resulted in a counterintuitive reduction of measured diffusion coefficient for fast-moving molecules; this effect was accentuated by the long camera exposures typically used in single-molecule tracking. Thus, accurate determination of cell morphology from rapidly moving molecules requires the use of short integration times within each image to minimize artifacts caused by motion during image acquisition. Sequential imaging of neuronal processes using excitation pulses of either 2 ms or 10 ms within imaging frames confirmed this: processes appeared erroneously thinner when imaged using the longer excitation pulse. Using this pulsed excitation approach, we show that PALM can be used to image spine and spine neck morphology in living neurons. These results clarify a number of issues involved in interpretation of single-molecule data in living cells and provide a method to minimize artifacts in single-molecule experiments.	[Frost, Nicholas A.; Lu, Hsiangmin E.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Frost, Nicholas A.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; [Lu, Hsiangmin E.; Blanpied, Thomas A.] Univ Maryland, Sch Med, Program Mol Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Frost, NA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	tblanpied@som.umaryland.edu		Frost, Nicholas/0000-0002-2270-643X; Blanpied, Thomas/0000-0003-4957-557X	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) [NRSA F32-MH086185, NIMH R01-MH080046, R01-MH096376]; Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080046, R01MH096376] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dana Foundation; Katherine D. and Theodore J. Carski Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was from the National Institutes of Health (NIH)/National Institute of Mental Health (NIMH) (http://www.nimh.nih.gov) NRSA F32-MH086185 to NAF, NIMH R01-MH080046, and R01-MH096376 to TAB; and from the Dana Foundation (www.dana.org) and the Katherine D. and Theodore J. Carski Foundation to TAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E, 1874, PROC BRISTOL NAT SOC, VI, P200; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Frost NA, 2010, CURR OPIN NEUROBIOL, V20, P578, DOI 10.1016/j.conb.2010.06.009; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Giannone G, 2010, BIOPHYS J, V99, P1303, DOI 10.1016/j.bpj.2010.06.005; Gould TJ, 2009, NAT PROTOC, V4, P291, DOI 10.1038/nprot.2008.246; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Helmholtz H., 1876, MONTHLY MICROSC J, V16, P15, DOI DOI 10.1111/J.1365-2818.1876.TB05606.X; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Newpher TM, 2009, TRENDS CELL BIOL; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Ober RJ, 2004, BIOPHYS J, V86, P1185, DOI 10.1016/S0006-3495(04)74193-4; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pertsinidis A, 2010, NATURE, V466, P647, DOI 10.1038/nature09163; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ram S, 2008, BIOPHYS J, V95, P6025, DOI 10.1529/biophysj.108.140392; Renner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025731; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; SAXTON MJ, 1995, BIOPHYS J, V69, P389, DOI 10.1016/S0006-3495(95)79911-8; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Urban NT, 2011, BIOPHYS J, V101, P1277, DOI 10.1016/j.bpj.2011.07.027; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	43	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36751	10.1371/journal.pone.0036751	http://dx.doi.org/10.1371/journal.pone.0036751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570741	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400057
J	Morales, L; Del Olmo, N; Valladolid-Acebes, I; Fole, A; Cano, V; Merino, B; Stucchi, P; Ruggieri, D; Lopez, L; Alguacil, LF; Ruiz-Gayo, M				Morales, Lidia; Del Olmo, Nuria; Valladolid-Acebes, Ismael; Fole, Alberto; Cano, Victoria; Merino, Beatriz; Stucchi, Paula; Ruggieri, Daniela; Lopez, Laura; Fernando Alguacil, Luis; Ruiz-Gayo, Mariano			Shift of Circadian Feeding Pattern by High-Fat Diets Is Coincident with Reward Deficits in Obese Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MILD TRAUMATIC LESION; RIGHT PARIETAL CORTEX; NUCLEUS-ACCUMBENS; FOOD PREFERENCES; DOPAMINE; LEPTIN; RATS; MORPHINE; RHYTHMS	Recent studies provide evidence that high-fat diets (HF) trigger both i) a deficit of reward responses linked to a decrease of mesolimbic dopaminergic activity, and ii) a disorganization of circadian feeding behavior that switch from a structured meal-based schedule to a continuous snacking, even during periods normally devoted to rest. This feeding pattern has been shown to be a cause of HF-induced overweight and obesity. Our hypothesis deals with the eventual link between the rewarding properties of food and the circadian distribution of meals. We have investigated the effect of circadian feeding pattern on reward circuits by means of the conditioned-place preference (CPP) paradigm and we have characterized the rewarding properties of natural (food) and artificial (cocaine) reinforcers both in free-feeding ad libitum HF mice and in HF animals submitted to a re-organized feeding schedule based on the standard feeding behavior displayed by mice feeding normal chow ("forced synchronization"). We demonstrate that i) ad libitum HF diet attenuates cocaine and food reward in the CPP protocol, and ii) forced synchronization of feeding prevents this reward deficit. Our study provides further evidence that the rewarding impact of food with low palatability is diminished in mice exposed to a high-fat diet and strongly suggest that the decreased sensitivity to chow as a positive reinforcer triggers a disorganized feeding pattern which might account for metabolic disorders leading to obesity.	[Morales, Lidia; Del Olmo, Nuria; Valladolid-Acebes, Ismael; Fole, Alberto; Cano, Victoria; Merino, Beatriz; Ruggieri, Daniela; Lopez, Laura; Fernando Alguacil, Luis; Ruiz-Gayo, Mariano] Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid, Spain; [Stucchi, Paula] Univ Complutense, Inst Pluridisciplinar, E-28040 Madrid, Spain; [Fernando Alguacil, Luis] Hosp Gen Ciudad Real, Unidad Traslac, Ciudad Real, Spain	San Pablo CEU University; Complutense University of Madrid	Morales, L (corresponding author), Univ CEU San Pablo, Fac Farm, Dept Ciencias Farmaceut & Alimentac, Madrid, Spain.	ruigayo@ceu.es	Ruiz-Gayo, Mariano/H-3720-2015; PALACIOS, BEATRIZ MERINO/F-5517-2017; del Olmo, Nuria/K-8789-2014; Alguacil, Luis Fernando/J-6466-2016; Del Olmo, Nuria/ABG-2171-2020; Cano, Victoria/GRO-4093-2022	Ruiz-Gayo, Mariano/0000-0002-2805-5076; del Olmo, Nuria/0000-0001-5611-4152; Alguacil, Luis Fernando/0000-0002-2542-5983; Del Olmo, Nuria/0000-0001-5611-4152; Valladolid-Acebes, Ismael/0000-0002-7699-9207	Ministerio de Ciencia e Innovacion [SAF 2009-09714, SAF2008-02902]; Fondo de Investigaciones Sanitarias [ISCIII CP08/00188]; Fundacion Universitaria San Pablo-CEU	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Universitaria San Pablo-CEU	This work was supported by Ministerio de Ciencia e Innovacion (SAF 2009-09714; SAF2008-02902), Fondo de Investigaciones Sanitarias (ISCIII CP08/00188), and Fundacion Universitaria San Pablo-CEU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; BARDO MT, 1995, NEUROSCI BIOBEHAV R, V19, P39, DOI 10.1016/0149-7634(94)00021-R; Berthoud HR, 2004, APPETITE, V43, P315, DOI 10.1016/j.appet.2004.04.009; Bray MS, 2010, INT J OBESITY, V34, P1589, DOI 10.1038/ijo.2010.63; Cadoni C, 1999, NEUROSCIENCE, V90, P447, DOI 10.1016/S0306-4522(98)00466-7; Cota D, 2006, NEURON, V51, P678, DOI 10.1016/j.neuron.2006.09.009; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; DREWNOWSKI A, 1992, APPETITE, V18, P207, DOI 10.1016/0195-6663(92)90198-F; DREWNOWSKI A, 1992, INT J OBESITY, V16, P639; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gambarana C, 2003, NEUROSCIENCE, V121, P179, DOI 10.1016/S0306-4522(03)00383-X; Guzman-Ruiz R, 2009, OBESITY FACTS, V2, P149; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kosobud Ann E K, 2007, ScientificWorldJournal, V7, P203; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McClung Colleen A, 2007, ScientificWorldJournal, V7, P194; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1998, APPETITE, V30, P255, DOI 10.1006/appe.1997.0134; Morales L, 2007, ADDICT BIOL, V12, P482, DOI 10.1111/j.1369-1600.2007.00071.x; Morgan D, 2011, CURR PHARM DESIGN, V17, P1168, DOI 10.2174/138161211795656747; Perreau-Lenz S, 2007, 8 EMBO, V8, pS20; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Somoza B, 2007, ENDOCRINOLOGY, V148, P924, DOI 10.1210/en.2006-0914; Stucchi P, 2012, ENDOCRINOLOGY, V153, P690, DOI 10.1210/en.2011-1023; Stucchi P, 2011, BIOCHIMIE, V93, P1779, DOI 10.1016/j.biochi.2011.06.020; Warren M, 2005, J ADDICT DIS, V24, P95, DOI 10.1300/J069v24n03_08; Zheng H, 2007, J NEUROSCI, V27, P11075, DOI 10.1523/JNEUROSCI.3542-07.2007	39	41	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36139	10.1371/journal.pone.0036139	http://dx.doi.org/10.1371/journal.pone.0036139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570696	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400012
J	Ng, AKL; Chan, WH; Choi, ST; Lam, MKH; Lau, KF; Chan, PKS; Au, SWN; Fodor, E; Shaw, PC				Ng, Andy Ka-Leung; Chan, Wai-Hon; Choi, Sze-Ting; Lam, Mandy Ka-Han; Lau, Kwok-Fai; Chan, Paul Kay-Sheung; Au, Shannon Wing-Ngor; Fodor, Ervin; Shaw, Pang-Chui			Influenza Polymerase Activity Correlates with the Strength of Interaction between Nucleoprotein and PB2 through the Host-Specific Residue K/E627	PLOS ONE			English	Article							SINGLE AMINO-ACID; VIRUS POLYMERASE; A-VIRUS; RNA-BINDING; CAPPED RNAS; HUMAN-CELLS; PA SUBUNIT; REPLICATION; RIBONUCLEOPROTEIN; PROTEINS	The ribonucleoprotein (RNP) complex is the essential transcription-replication machinery of the influenza virus. It is composed of the trimeric polymerase (PA, PB1 and PB2), nucleoprotein (NP) and RNA. Elucidating the molecular mechanisms of RNP assembly is central to our understanding of the control of viral transcription and replication and the dependence of these processes on the host cell. In this report, we show, by RNP reconstitution assays and co-immunoprecipitation, that the interaction between NP and polymerase is crucial for the function of the RNP. The functional association of NP and polymerase involves the C-terminal '627' domain of PB2 and it requires NP arginine-150 and either lysine-627 or arginine-630 of PB2. Using surface plasmon resonance, we demonstrate that the interaction between NP and PB2 takes place without the involvement of RNA. At 33, 37 and 41 degrees C in mammalian cells, more positive charges at aa. 627 and 630 of PB2 lead to stronger NP-polymerase interaction, which directly correlates with the higher RNP activity. In conclusion, our study provides new information on the NP-PB2 interaction and shows that the strength of NP-polymerase interaction and the resulting RNP activity are promoted by the positive charges at aa. 627 and 630 of PB2.	[Ng, Andy Ka-Leung; Chan, Wai-Hon; Choi, Sze-Ting; Lam, Mandy Ka-Han; Lau, Kwok-Fai; Au, Shannon Wing-Ngor; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Chan, Paul Kay-Sheung] Chinese Univ Hong Kong, Dept Microbiol, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; University of Oxford	Ng, AKL (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608; Lau, Kwok-Fai/0000-0002-0193-1152; Fodor, Ervin/0000-0003-3249-196X	Research Grants Council General Research Fund grant [CUHK473111]; University Grants Council One-Off Special Equipment Grant from Hong Kong SAR [SEG CUHK08]; MRC [G0700848] Funding Source: UKRI; Medical Research Council [G0700848] Funding Source: researchfish	Research Grants Council General Research Fund grant; University Grants Council One-Off Special Equipment Grant from Hong Kong SAR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Research Grants Council General Research Fund grant (CUHK473111) and a University Grants Council One-Off Special Equipment Grant (SEG CUHK08) from Hong Kong SAR. Some equipment used in this study was obtained through a Special Equipment Grant (SEG CUHK08) of the University Grants Council of Hong Kong SAR. EF was supported by a grant from the MRC (G0700848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Area E, 2004, P NATL ACAD SCI USA, V101, P308, DOI 10.1073/pnas.0307127101; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Chan WH, J VIROL, V84, P7337; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HUANG TS, 1990, J VIROL, V64, P5669, DOI 10.1128/JVI.64.11.5669-5673.1990; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; Mase M, 2006, J GEN VIROL, V87, P3655, DOI 10.1099/vir.0.81843-0; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Medcalf L, 1999, J VIROL, V73, P7349, DOI 10.1128/JVI.73.9.7349-7356.1999; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; WHO, 2012, CUM NUMB CONF HUM CA; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	44	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36415	10.1371/journal.pone.0036415	http://dx.doi.org/10.1371/journal.pone.0036415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570712	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343400028
J	Danilenko, N; Merkulava, E; Siniauskaya, M; Olejnik, O; Levaya-Smaliak, A; Kushniarevich, A; Shymkevich, A; Davydenko, O				Danilenko, Nina; Merkulava, Elena; Siniauskaya, Marina; Olejnik, Olga; Levaya-Smaliak, Anastasia; Kushniarevich, Alena; Shymkevich, Andrey; Davydenko, Oleg			Spectrum of Genetic Changes in Patients with Non-Syndromic Hearing Impairment and Extremely High Carrier Frequency of 35delG GJB2 Mutation in Belarus	PLOS ONE			English	Article							12S RIBOSOMAL-RNA; GJB2 MUTATIONS; HIGH PREVALENCE; DEAFNESS; EXPRESSION	The genetic nature of sensorineural hearing loss (SNHL) has so far been studied for many ethnic groups in various parts of the world. The single-nucleotide guanine deletion (35delG) of the GJB2 gene coding for connexin 26 was shown to be the main genetic cause of autosomal recessive deafness among Europeans. Here we present the results of the first study of GJB2 and three mitochondrial mutations among two groups of Belarusian inhabitants: native people with normal hearing (757 persons) and 391 young patients with non-syndromic SNHL. We have found an extremely high carrier frequency of 35delG GJB2 mutation in Belarus 25.7%. This point deletion has also been detected in 53% of the patients with SNHL. The 312del14 GJB2 was the second most common mutation in the Belarus patient cohort. Mitochondrial A1555G mt-RNR1 substitution was found in two SNHL patients (0.55%) but none were found in the population cohort. No individuals carried the A7445G mutation of mitochondrial mt-TS1. G7444A as well as T961G substitutions were detected in mitochondrial mt-RNR1 at a rate of about 1% both in the patient and population cohorts. A possible reason for Belarusians having the highest mutation carrier frequency in Europe 35delG is discussed.	[Danilenko, Nina; Siniauskaya, Marina; Olejnik, Olga; Shymkevich, Andrey; Davydenko, Oleg] Natl Acad Sci, Inst Cytol & Genet, Minsk, BELARUS; [Merkulava, Elena; Levaya-Smaliak, Anastasia] Belarusian State Med Univ, Minsk, BELARUS; [Kushniarevich, Alena] Estonian Bioctr, Tartu, Estonia	National Academy of Sciences of Belarus (NASB); Institute of Genetics & Cytology of the National Academy of Sciences of Belarus; Belarusian State Medical University; Estonian Biocentre	Danilenko, N (corresponding author), Natl Acad Sci, Inst Cytol & Genet, Minsk, BELARUS.	n.danilenko@tut.by			Belarus government program Health of mother and child - well-being of family [03.03.10]	Belarus government program Health of mother and child - well-being of family	The study was supported by Belarus government program Health of mother and child - well-being of family and state (2010-2012) assignment No. 03.03.10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Antoniadi T, 1999, CLIN GENET, V55, P381; Bitner-Glindzicz M, 2002, BRIT MED BULL, V63, P73, DOI 10.1093/bmb/63.1.73; Cryns K, 2004, J MED GENET, V41, P147, DOI 10.1136/jmg.2003.013896; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Denoyelle F, 1997, HUM MOL GENET, V6, P2173, DOI 10.1093/hmg/6.12.2173; Dzhemileva LU, 2010, J HUM GENET, V55, P749, DOI 10.1038/jhg.2010.101; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Fischel-Ghodsian N, 1999, HUM MUTAT, V13, P261, DOI 10.1002/(SICI)1098-1004(1999)13:4<261::AID-HUMU1>3.0.CO;2-W; FischelGhodsian N, 1997, AM J OTOLARYNG, V18, P173, DOI 10.1016/S0196-0709(97)90078-8; Gasparini P, 2000, EUR J HUM GENET, V8, P19, DOI 10.1038/sj.ejhg.5200406; Green GE, 1999, JAMA-J AM MED ASSOC, V281, P2211, DOI 10.1001/jama.281.23.2211; Guastalla P, 2009, RADIOLOGY, V251, P280, DOI 10.1148/radiol.2511080912; Hilgert N, 2009, CURR MOL MED, V9, P546, DOI 10.2174/156652409788488775; Kokotas H, 2008, AM J MED GENET A, V146A, P2879, DOI 10.1002/ajmg.a.32546; Kokotas H, 2011, DIS MARKERS, V30, P283, DOI [10.1155/2011/350987, 10.3233/DMA-2011-0786]; Kokotas H, 2010, J HUM GENET, V55, P265, DOI 10.1038/jhg.2010.23; Li R, 2004, J MED GENET, V41, P615, DOI 10.1136/jmg.2004.020230; Lucotte G, 2005, GENET TEST, V9, P20, DOI 10.1089/gte.2005.9.20; Man YKS, 2007, J MEMBRANE BIOL, V218, P29, DOI 10.1007/s00232-007-9025-0; Mathew C.G., 1985, METHOD MOL BIOL, V2, P31, DOI DOI 10.1385/0-89603-064-4:31; Meyer CG, 2002, NAT MED, V8, P1332, DOI 10.1038/nm1202-1332; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Rabionet R, 2000, HUM MUTAT, V16, P190, DOI 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.3.CO;2-9; Rothrock CR, 2003, HUM GENET, V113, P18, DOI 10.1007/s00439-003-0944-2; Rydzanicz M, 2010, BIOCHEM BIOPH RES CO, V395, P116, DOI 10.1016/j.bbrc.2010.03.149; Schon Eric A, 2002, Methods Mol Biol, V197, P55, DOI 10.1385/1-59259-284-8:055; Shanske AL, 2001, ARCH PEDIAT ADOL MED, V155, P1210; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Toth T, 2007, INT J MOL MED, V20, P315; Van Laer L, 2001, J MED GENET, V38, P515, DOI 10.1136/jmg.38.8.515; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VanCamp G, 1997, AM J HUM GENET, V60, P758; Wilch E, 2010, CLIN GENET, V78, P267, DOI 10.1111/j.1399-0004.2010.01387.x; Wilcox SA, 2000, HUM GENET, V106, P399, DOI 10.1007/s004390000273; Yang Ai-Fen, 2008, Yichuan, V30, P728, DOI 10.3724/SP.J.1005.2008.00728	40	18	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36354	10.1371/journal.pone.0036354	http://dx.doi.org/10.1371/journal.pone.0036354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567152	gold, Green Published			2022-12-27	WOS:000305341500071
J	Liu, HY; Li, Y; Li, YW; Liu, BX; Wu, H; Wang, J; Wang, YL; Wang, M; Tang, SC; Zhou, QH; Chen, J				Liu, Hongyu; Li, Ying; Li, Yongwen; Liu, Baoxin; Wu, Heng; Wang, Jing; Wang, Yuli; Wang, Min; Tang, Shou-Ching; Zhou, Qinghua; Chen, Jun			Cloning and Functional Analysis of FLJ20420: A Novel Transcription Factor for the BAG-1 Promoter	PLOS ONE			English	Article							GENE-EXPRESSION PATTERNS; INDUCED APOPTOSIS; CANCER-CELLS; PROTEIN; HSP70/HSC70; ISOFORMS; MODELS; BCL-2; P53	BAG-1 is an anti-apoptotic protein that interacts with a variety of cellular molecules to inhibit apoptosis. The mechanisms by which BAG-1 interacts with other proteins to inhibit apoptosis have been extensively explored. However, it is currently unknown how BAG-1 expression is regulated at the molecular level, especially in cancer cells. Here we reported to clone a novel down-regulated BAG-1 expression gene named FLJ20420 using hBAG-1 promoter as a probe to screen Human Hela 59 cDNA library by Southernwestern blot. The FLJ20420 gene encodes a similar to 26-kDa protein that is localized in both the cytoplasm and nucleus. We proved that FLJ20420 protein can specially bind hBAG-1 promoter region by EMSA in vivo and ChIP assay in vivo. Northern blot analysis revealed a low level of FLJ20420 transcriptional expression in normal human tissues (i.e., brain, placenta, lung, liver, kidney, pancreas and cervix), except for heart and skeletal muscles, which showed higher levels. Furthermore, enhanced FLJ20420 expression was observed in tumor cell lines (i.e., MDA468, BT-20, MCF-7, C33A, HeLa and Caski). Knockdown of endogenous FLJ20420 expression significantly increased BAG-1 expression in A549 and L9981 cells, and also significantly enhanced their sensitivity to cisplatin-induced apoptosis. A microarray assay of the FLJ20420 siRNA -transfectants showed altered expression of 505 known genes, including 272 upregulated and 233 downregulated genes. Finally, our gene array studies in lung cancer tissue samples revealed a significant increase in FLJ20420 expression in primary lung cancer relative to the paired normal lung tissue controls (p = 0.0006). The increased expression of FLJ20420 corresponded to a significant decrease in BAG-1 protein expression in the primary lung cancers, relative to the paired normal lung tissue controls (p = 0.0001). Taken together, our experiments suggest that FLJ20420 functions as a down-regulator of BAG-1 expression. Its abnormal expression may be involved in the oncogenesis of human malignancies such as lung cancer.	[Liu, Hongyu; Li, Ying; Li, Yongwen; Wu, Heng; Wang, Jing; Wang, Yuli; Wang, Min; Zhou, Qinghua; Chen, Jun] Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Liu, Baoxin] Henan Tumor Hosp, Dept Thorac Surg, Zhengzhou, Henan, Peoples R China; [Tang, Shou-Ching] Univ Minnesota, Fac Med, Div Hematol Oncol, Minneapolis, MN USA; [Tang, Shou-Ching] Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China	Tianjin Medical University; Zhengzhou University; University of Minnesota System; University of Minnesota Twin Cities; Tianjin Medical University	Liu, HY (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China.	sctang2000@yahoo.com; zhouqh1016@yahoo.com.cn; huntercj2004@yahoo.com	, leeywen/ABA-5704-2020	, leeywen/0000-0001-6102-2949	National Natural Science Foundation of China [30500221, 30500496]; Science and Technology Support Key Program of Tianjin [09ZCZDSF04000, 09ZCZDSF04100, 09ZCZDSF03800]; Ministry of Education for New Century Excellent Talents [NCET-10-0956]; Sylvester Comprehensive Cancer Center at the University of Miami	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Key Program of Tianjin; Ministry of Education for New Century Excellent Talents; Sylvester Comprehensive Cancer Center at the University of Miami	This research was supported by grants from the National Natural Science Foundation of China (30500221 and 30500496), Science and Technology Support Key Program of Tianjin (09ZCZDSF04000, 09ZCZDSF04100 and 09ZCZDSF03800) and the project of Ministry of Education for New Century Excellent Talents (NCET-10-0956). The original cloning of FLJ20420 was carried out in the laboratory of Dr. Shou-Ching Tang in Miami, FL, with grant support from the Sylvester Comprehensive Cancer Center at the University of Miami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1998, LEUKEMIA LYMPHOMA, V30, P483, DOI 10.3109/10428199809057561; Bini L, 2003, BIOCHEM J, V369, P301, DOI 10.1042/BJ20020503; Brochier C, 2008, PHYSIOL GENOMICS, V33, P170, DOI 10.1152/physiolgenomics.00125.2007; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; Chen J, 2005, GENESIS, V43, P196, DOI 10.1002/gene.20171; Coldwell MJ, 2001, ONCOGENE, V20, P4095, DOI 10.1038/sj.onc.1204547; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Dreger M, 2005, J PROTEOME RES, V4, P238, DOI 10.1021/pr049870w; Edmondson RD, 2002, MOL CELL PROTEOMICS, V1, P421, DOI 10.1074/mcp.M100036-MCP200; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Li RCX, 2000, AM J PHYSIOL-HEART C, V279, pH1679, DOI 10.1152/ajpheart.2000.279.4.H1679; Liu HY, 2009, ACTA PHARMACOL SIN, V30, P235, DOI 10.1038/aps.2008.21; Lu XQ, 2007, BLOOD, V110, P4268, DOI 10.1182/blood-2007-04-087775; Ma W, 2008, BIOCHEM BIOPH RES CO, V371, P425, DOI 10.1016/j.bbrc.2008.04.083; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pickering BM, 2004, MOL CELL BIOL, V24, P5595, DOI 10.1128/MCB.24.12.5595-5605.2004; Quentmeier H, 2003, LEUKEMIA RES, V27, P539, DOI 10.1016/S0145-2126(02)00269-2; Rorke S, 2001, INT J CANCER, V95, P317, DOI 10.1002/1097-0215(20010920)95:5<317::AID-IJC1055>3.0.CO;2-J; Schauble S, 2007, J BIOL CHEM, V282, P14952, DOI 10.1074/jbc.M609221200; Sekiya M, 1997, BIOCHEM BIOPH RES CO, V239, P401, DOI 10.1006/bbrc.1997.7478; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tang SC, 2004, BREAST CANCER RES TR, V84, P203, DOI 10.1023/B:BREA.0000019951.32001.93; Tang SC, 1999, J CLIN ONCOL, V17, P1710, DOI 10.1200/JCO.1999.17.6.1710; Tang SC, 2002, IUBMB LIFE, V53, P99, DOI 10.1080/15216540211473; Uriguen L, 2008, GENES BRAIN BEHAV, V7, P649, DOI 10.1111/j.1601-183X.2008.00402.x; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yang XL, 1999, ONCOGENE, V18, P4546, DOI 10.1038/sj.onc.1202843; Yang XL, 1999, CLIN CANCER RES, V5, P1816; Yang XL, 1999, EXP CELL RES, V247, P200, DOI 10.1006/excr.1998.4349; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Zhang F, 2010, ACTA PHARMACOL SIN, V31, P111, DOI 10.1038/aps.2009.178	35	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34832	10.1371/journal.pone.0034832	http://dx.doi.org/10.1371/journal.pone.0034832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567091	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500009
J	Galvez-Peralta, M; He, L; Jorge-Nebert, LF; Wang, B; Miller, ML; Eppert, BL; Afton, S; Nebert, DW				Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Afton, Scott; Nebert, Daniel W.			ZIP8 Zinc Transporter: Indispensable Role for Both Multiple-Organ Organogenesis and Hematopoiesis In Utero	PLOS ONE			English	Article							DYNAMIC TRANSCRIPTOMIC PROFILES; ZEBRAFISH GILLS; IMMUNE-SYSTEM; MOUSE; GENE; MUTATIONS; FAMILY; MEMBER; IDENTIFICATION; ASSOCIATION	Previously this laboratory characterized Slc39a8-encoded ZIP8 as a Zn2+/(HCO3-)(2) symporter; yet, the overall physiological importance of ZIP8 at the whole-organism level remains unclear. Herein we describe the phenotype of the hypomorphic Slc39a8(neo/neo) mouse which has retained the neomycin-resistance gene in intron 3, hence causing significantly decreased ZIP8 mRNA and protein levels in embryo, fetus, placenta, yolk sac, and several tissues of neonates. The Slc39a8(neo) allele is associated with diminished zinc and iron uptake in mouse fetal fibroblast and liver-derived cultures; consequently, Slc39a8(neo/neo) newborns exhibit diminished zinc and iron levels in several tissues. Slc39a8(neo/neo) homozygotes from gestational day(GD)-11.5 onward are pale, growth-stunted, and die between GD18.5 and 48 h postnatally. Defects include: severely hypoplastic spleen; hypoplasia of liver, kidney, lung, and lower limbs. Histologically, Slc39a8(neo/neo) neonates show decreased numbers of hematopoietic islands in yolk sac and liver. Low hemoglobin, hematocrit, red cell count, serum iron, and total iron-binding capacity confirmed severe anemia. Flow cytometry of fetal liver cells revealed the erythroid series strikingly affected in the hypomorph. Zinc-dependent 5-aminolevulinic acid dehydratase, required for heme synthesis, was not different between Slc39a8(+/+) and Slc39a8(neo/neo) offspring. To demonstrate further that the mouse phenotype is due to ZIP8 deficiency, we bred Slc39a8(+/neo) with BAC-transgenic BTZIP8-3 line (carrying three extra copies of the Slc39a8 allele); this cross generated viable Slc39a8(neo/neo)_BTZIP8-3(+/+) pups showing none of the above-mentioned congenital defects-proving Slc39a8(neo/neo) causes the described phenotype. Our study demonstrates that ZIP8-mediated zinc transport plays an unappreciated critical role during in utero and neonatal growth, organ morphogenesis, and hematopoiesis.	[Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Nebert, Daniel W.] Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Galvez-Peralta, Marina; He, Lei; Jorge-Nebert, Lucia F.; Wang, Bin; Miller, Marian L.; Eppert, Bryan L.; Nebert, Daniel W.] Univ Cincinnati, Med Ctr, CEG, Cincinnati, OH 45267 USA; [Afton, Scott] Univ Cincinnati, Dept Chem, Sch Arts & Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Galvez-Peralta, M (corresponding author), Univ Cincinnati, Med Ctr, Dept Environm Hlth, Cincinnati, OH 45267 USA.	dan.nebert@uc.edu			NIH [R01 ES010416, T32 ES016646, P30 ES06096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016646, R01ES010416, P30ES006096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH Grants R01 ES010416 (D.W.N.), T32 ES016646 (M. G.-P.), and P30 ES06096 (D.W.N., M. L. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; BINGHAM PM, 1985, CELL, V40, P819, DOI 10.1016/0092-8674(85)90341-1; Cao YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020634; Carrera N, 2012, BIOL PSYCHIAT, V71, P169, DOI 10.1016/j.biopsych.2011.09.032; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dalton TP, 2000, PHARMACOGENETICS, V10, P141, DOI 10.1097/00008571-200003000-00006; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Dworkin I, 2005, GENETICS, V169, P2115, DOI 10.1534/genetics.104.035766; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Food Nutrition Board, 2001, ZINC DIET REF INT VI, V1, P442; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Gibson JB, 1999, BIOCHEM GENET, V37, P301, DOI 10.1023/A:1018707226595; Giunta C, 2008, AM J HUM GENET, V82, P1290, DOI 10.1016/j.ajhg.2008.05.001; Goldsborough AS, 1996, NATURE, V381, P807, DOI 10.1038/381807a0; HARRISON SM, 1995, DEVELOPMENT, V121, P2479; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; He Lei, 2009, Human Genomics, V3, P195; Hirano T, 2000, ADV IMMUNOL, V97, P149; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Kambe T, 2008, GENESIS, V46, P214, DOI 10.1002/dvg.20382; Kawamura T, 1997, HEPATOLOGY, V26, P1567; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; Li Y, 2009, EXP CELL RES, V315, P2463, DOI 10.1016/j.yexcr.2009.05.016; Liu Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/j.bbrc.2007.11.067; MANSUKHANI A, 1988, MOL GEN GENET, V211, P121, DOI 10.1007/BF00338402; Mocchegiani E, 2010, P NUTR SOC, V69, P290, DOI 10.1017/S0029665110001862; Moore-Scott BA, 2007, DEV DYNAM, V236, P1997, DOI 10.1002/dvdy.21204; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; NEBERT DW, 1991, MOL ENDOCRINOL, V5, P1203, DOI 10.1210/mend-5-9-1203; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Permyakov EA, 2009, J INORG BIOCHEM, V103, P77, DOI 10.1016/j.jinorgbio.2008.09.006; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Robin C, 2004, METH MOLEC MED, V105, P257; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Strolin Benedetti M, 2005, Expert Opin Drug Metab Toxicol, V1, P447; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Wang B, 2007, AM J PHYSIOL-CELL PH, V292, pC1523, DOI 10.1152/ajpcell.00409.2006; Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P289, DOI 10.1016/j.bbrc.2011.05.134; Wang FD, 2004, J BIOL CHEM, V279, P51433, DOI 10.1074/jbc.M408361200; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Zheng DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-553; Zheng D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-548; Zhu Hao, 2007, Syst Synth Biol, V1, P171, DOI 10.1007/s11693-008-9015-2	49	75	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36055	10.1371/journal.pone.0036055	http://dx.doi.org/10.1371/journal.pone.0036055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563477	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700026
J	Haag, LM; Fischer, A; Otto, B; Plickert, R; Kuhl, AA; Gobel, UB; Bereswill, S; Heimesaat, MM				Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Kuehl, Anja A.; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.			Intestinal Microbiota Shifts towards Elevated Commensal Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GERM-FREE-MICE; INFANT MICE; MURINE COLITIS; CROHNS-DISEASE; MUCOSAL FLORA; INFECTION; PATHOGENESIS; ENTERITIS; BACTERIA	Background: The zoonotic pathogen Campylobacter jejuni is a leading cause of bacterial foodborne enterocolitis in humans worldwide. The understanding of immunopathology underlying human campylobacteriosis is hampered by the fact that mice display strong colonization resistance against the pathogen due to their host specific gut microbiota composition. Methodology/Principal Findings: Since the microbiota composition changes significantly during intestinal inflammation we dissected factors contributing to colonization resistance against C. jejuni in murine ileitis, colitis and in infant mice. In contrast to healthy animals C. jejuni could stably colonize mice suffering from intestinal inflammation. Strikingly, in mice with Toxoplasma gondii-induced acute ileitis, C. jejuni disseminated to mesenteric lymphnodes, spleen, liver, kidney, and blood. In infant mice C. jejuni infection induced enterocolitis. Mice suffering from intestinal inflammation and C. jejuni susceptible infant mice displayed characteristical microbiota shifts dominated by increased numbers of commensal Escherichia coli. To further dissect the pivotal role of those distinct microbiota shifts in abrogating colonization resistance, we investigated C. jejuni infection in healthy adult mice in which the microbiota was artificially modified by feeding live commensal E. coli. Strikingly, in animals harboring supra-physiological intestinal E. coli loads, colonization resistance was significantly diminished and C. jejuni infection induced enterocolitis mimicking key features of human campylobacteriosis. Conclusion/Significance: Murine colonization resistance against C. jejuni is abrogated by changes in the microbiota composition towards elevated E. coli loads during intestinal inflammation as well as in infant mice. Intestinal inflammation and microbiota shifts thus represent potential risk factors for C. jejuni infection. Corresponding interplays between C. jejuni and microbiota might occur in human campylobacteriosis. Murine models introduced here mimick key features of human campylobacteriosis and allow for further analysis of immunological and molecular mechanisms of C. jejuni - host interactions.	[Haag, Lea-Maxie; Fischer, Andre; Otto, Bettina; Plickert, Rita; Goebel, Ulf B.; Bereswill, Stefan; Heimesaat, Markus M.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.] Charite, Res Ctr ImmunoSci RCIS, Dept Internal Med Rheumatol & Clin Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Haag, LM (corresponding author), Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Haag, Lea-Maxie/0000-0002-3754-5317; Heimesaat, Markus/0000-0001-6399-651X; Kuhl, Anja/0000-0003-2293-5387	15 German Research Foundation (DFG) [GO363/12-1, CampyGerm, SFB633, TP A7, TP Z1, TP B6, Immuco]; German Federal Ministery of Education and Research (BMBF) [TP1.1, TP 8.2]	15 German Research Foundation (DFG); German Federal Ministery of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the 15 German Research Foundation (DFG) to UBG (GO363/12-1, CampyGerm; SFB633, TP A7), SB (SFB633, TP A7), AK (SFB633, TP Z1), MMH (SFB633, TP B6), LMH and BO (SFB633, Immuco), and from the German Federal Ministery of Education and Research (BMBF) to SB ("Lab in a hanky'' projects TP1.1 and TP 8.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIMIKU AG, 1987, J MED MICROBIOL, V23, P339, DOI 10.1099/00222615-23-4-339; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Allos BM, 1997, J INFECT DIS, V176, pS125, DOI 10.1086/513783; Bereswill S, 2011, EUR J MICROBIOL IMMU, V1, P237, DOI 10.1556/EuJMI.1.2011.3.8; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; DIKER KS, 1992, ACTA MICROBIOL HUNG, V39, P133; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Erridge C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009125; FIELD LH, 1986, INFECT IMMUN, V54, P126, DOI 10.1128/IAI.54.1.126-132.1986; FIELD LH, 1981, INFECT IMMUN, V33, P884, DOI 10.1128/IAI.33.3.884-892.1981; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Guerry P, 2008, TRENDS MICROBIOL, V16, P428, DOI 10.1016/j.tim.2008.07.002; Haag LM, 2012, EUR J MICROBIOL IMMU, V2, P2, DOI 10.1556/EuJMI.2.2012.1.2; HANNINEN ML, 1989, J MED MICROBIOL, V30, P199, DOI 10.1099/00222615-30-3-199; HANNINEN ML, 1990, EPIDEMIOL INFECT, V104, P397, DOI 10.1017/S0950268800047415; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heimesaat MM, 2010, GUT, V59, P1079, DOI 10.1136/gut.2009.197434; Helms M, 2006, CLIN INFECT DIS, V42, P498, DOI 10.1086/499813; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kalischuk LD, 2010, AM J PHYSIOL-GASTR L, V298, pG1, DOI 10.1152/ajpgi.00193.2009; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Kist M, 2001, Contrib Microbiol, V8, P150; Lane JA, 2010, INT J FOOD MICROBIOL, V142, P1, DOI 10.1016/j.ijfoodmicro.2010.05.027; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mahendran V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025417; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Man SM, 2010, INFLAMM BOWEL DIS, V16, P1008, DOI 10.1002/ibd.21157; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Siegmund B, 2001, AM J PHYSIOL-REG I, V281, pR1264, DOI 10.1152/ajpregu.2001.281.4.R1264; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; WALKER RI, 1986, MICROBIOL REV, V50, P81, DOI 10.1128/MMBR.50.1.81-94.1986; Wohlgemuth S, 2011, GUT MICROBES, V2, P159, DOI 10.4161/gmic.2.3.16104; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; YRIOS JW, 1986, INFECT IMMUN, V53, P378, DOI 10.1128/IAI.53.2.378-383.1986; YRIOS JW, 1986, INFECT IMMUN, V53, P384, DOI 10.1128/IAI.53.2.384-392.1986; YRIOS JW, 1986, INFECT IMMUN, V54, P339, DOI 10.1128/IAI.54.2.339-346.1986	50	130	130	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35988	10.1371/journal.pone.0035988	http://dx.doi.org/10.1371/journal.pone.0035988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563475	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700024
J	Valenzuela, NT; Perera, E; Naranjo, T				Valenzuela, Nohelia T.; Perera, Esther; Naranjo, Tomas			Dynamics of Rye Chromosome 1R Regions with High or Low Crossover Frequency in Homology Search and Synapsis Development	PLOS ONE			English	Article							PHYSICAL DISTRIBUTION; CHIASMA FORMATION; TELOMERIC HETEROCHROMATIN; ALLOHEXAPLOID WHEAT; BOUQUET FORMATION; RECOMBINATION; GENOME; ORGANIZATION; MEIOSIS; BEHAVIOR	In many organisms, homologous pairing and synapsis depend on the meiotic recombination machinery that repairs double-strand DNA breaks (DSBs) produced at the onset of meiosis. The culmination of recombination via crossover gives rise to chiasmata, which locate distally in many plant species such as rye, Secale cereale. Although, synapsis initiates close to the chromosome ends, a direct effect of regions with high crossover frequency on partner identification and synapsis initiation has not been demonstrated. Here, we analyze the dynamics of distal and proximal regions of a rye chromosome introgressed into wheat to define their role on meiotic homology search and synapsis. We have used lines with a pair of two-armed chromosome 1R of rye, or a pair of telocentrics of its long arm (1RL), which were homozygous for the standard 1RL structure, homozygous for an inversion of 1RL that changes chiasma location from distal to proximal, or heterozygous for the inversion. Physical mapping of recombination produced in the ditelocentric heterozygote (1RL/1RL(inv)) showed that 70% of crossovers in the arm were confined to a terminal segment representing 10% of the 1RL length. The dynamics of the arms 1RL and 1RL(inv) during zygotene demonstrates that crossover-rich regions are more active in recognizing the homologous partner and developing synapsis than crossover-poor regions. When the crossover-rich regions are positioned in the vicinity of chromosome ends, their association is facilitated by telomere clustering; when they are positioned centrally in one of the two-armed chromosomes and distally in the homolog, their association is probably derived from chromosome elongation. On the other hand, chromosome movements that disassemble the bouquet may facilitate chromosome pairing correction by dissolution of improper chromosome associations. Taken together, these data support that repair of DSBs via crossover is essential in both the search of the homologous partner and consolidation of homologous synapsis.	[Valenzuela, Nohelia T.; Naranjo, Tomas] Univ Complutense, Fac Biol, Dept Genet, E-28040 Madrid, Spain; [Perera, Esther] Univ Complutense, Fac Biol, Dept Biol Vegetal, E-28040 Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Valenzuela, NT (corresponding author), Univ Complutense, Fac Biol, Dept Genet, E-28040 Madrid, Spain.	toranjo@bio.ucm.es	Naranjo, Tomas/R-3238-2018	Naranjo, Tomas/0000-0003-4057-0473; Valenzuela-Martinez, Nohelia T./0000-0002-7091-6992	Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain [BFU2007-66544]; CONICYT from the Chile Government	Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain(Spanish Government); CONICYT from the Chile Government	This work has been supported by grants: BFU2007-66544 from Direccion General de Investigacion, Ministerio de Educacion y Ciencia of Spain, and CONICYT for PhD study from the Chile Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2003, GENOME RES, V13, P753, DOI 10.1101/gr.808603; Anderson LK, 2004, GENETICS, V166, P1923, DOI 10.1534/genetics.166.4.1923; Bass HW, 2000, J CELL SCI, V113, P1033; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Corredor E, 2007, CHROMOSOME RES, V15, P231, DOI 10.1007/s10577-006-1117-7; Cowan CR, 2001, PLANT PHYSIOL, V125, P532, DOI 10.1104/pp.125.2.532; Cuadrado A, 1998, CHROMOSOMA, V107, P587, DOI 10.1007/s004120050345; CURTIS CA, 1991, GENOME, V34, P553, DOI 10.1139/g91-085; DEJONG JH, 1991, GENOME, V34, P109, DOI 10.1139/g91-018; Driscoll CJ, 1971, AGR ABSTR; ENDO TR, 1991, JPN J GENET, V66, P291, DOI 10.1266/jjg.66.291; Francki MG, 2001, GENOME, V44, P266, DOI 10.1139/gen-44-2-266; GILLIES CB, 1975, CR TRAV LAB CARLSB, V40, P135; GILLIES CB, 1985, CHROMOSOMA, V92, P165, DOI 10.1007/BF00348690; Gonzalez-Garcia M, 2011, GENOME, V54, P555, DOI [10.1139/G11-003, 10.1139/g11-003]; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; HOBOLTH P, 1981, CARLSBERG RES COMMUN, V46, P129, DOI 10.1007/BF02910465; HOLM PB, 1988, CARLSBERG RES COMMUN, V53, P191, DOI 10.1007/BF02907179; HOLM PB, 1986, CARLSBERG RES COMMUN, V51, P239, DOI 10.1007/BF02906837; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Jones LE, 2002, THEOR APPL GENET, V104, P1204, DOI 10.1007/s00122-002-0876-6; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kunzel G, 2000, GENETICS, V154, P397; Lacadena JR, 1981, GENETICA; Lukaszewski AJ, 1992, THEOR APPL GENET, V83, P1048, DOI 10.1007/BF00232971; Lukaszewski AJ, 2008, CHROMOSOMA, V117, P569, DOI 10.1007/s00412-008-0174-4; Lukaszewski AJ, 2012, CHROMOSOMA, V121, P201, DOI 10.1007/s00412-011-0354-5; LUKASZEWSKI AJ, 1993, THEOR APPL GENET, V86, P121, DOI 10.1007/BF00223816; LUKASZEWSKI AJ, 1995, THEOR APPL GENET, V90, P714, DOI 10.1007/BF00222138; Luo MC, 1996, GENETICS, V144, P1195; Maestra B, 2002, CHROMOSOME RES, V10, P655, DOI 10.1023/A:1021564327226; Martinez M, 2001, THEOR APPL GENET, V102, P751, DOI 10.1007/s001220051706; Mezard C, 2007, TRENDS GENET, V23, P91, DOI 10.1016/j.tig.2006.12.007; Naranjo T, 2008, CYTOGENET GENOME RES, V120, P320, DOI 10.1159/000121081; Naranjo T, 2010, CYTOGENET GENOME RES, V129, P133, DOI 10.1159/000314029; NARANJO T, 1980, CHROMOSOMA, V81, P249, DOI 10.1007/BF00285951; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pawlowski WP, 2005, TRENDS CELL BIOL, V15, P674, DOI 10.1016/j.tcb.2005.10.005; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Qi LL, 2002, CHROMOSOME RES, V10, P645, DOI 10.1023/A:1021512309480; RICHARDS EJ, 1988, CELL, V53, P127, DOI 10.1016/0092-8674(88)90494-1; SCHERTHAN H, 2001, NAT REV MOL CELL BIO, V6, P975; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95	49	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36385	10.1371/journal.pone.0036385	http://dx.doi.org/10.1371/journal.pone.0036385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558456	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200074
J	Tang, J; Huang, ZM; Chen, YY; Zhang, ZH; Liu, GL; Zhang, J				Tang, Jing; Huang, Zhi-Min; Chen, Ying-Yi; Zhang, Zhao-Hui; Liu, Gao-Lin; Zhang, Jian			A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation	PLOS ONE			English	Article							NASCENT RNA; RECOGNITION; AUTOANTIGEN; BINDING; CELLS	Background: Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying other anti-HBV agents with specific, but distinctive mechanisms of action are needed. The human La (hLa) protein, which forms a stabilizing complex with HBV RNA ribonucleoprotein to promote HBV replication, is a promising target of molecular therapy. Aims: This study aimed to discover novel inhibitors of hLa that could inhibit HBV replication and expression. Methods: A multistage molecular docking approach was used to screen a Specs database and an in-house library against hLa binding sites. Sequential in vitro evaluations were performed to detect potential compounds with high scores in HepG2.2.15 cells. Results: Of the 26 potential compounds with high scores chosen for experimental verification, 12 had HBV DNA inhibition ratios of less than 50% with P<0.05. Six had significant inhibition of HBV e antigen (HBeAg) levels, and 13 had significant inhibition of HBV surface antigen (HBsAg) levels by in vitro assays. Compounds HBSC-11, HBSC-15 and HBSC-34 (HBSC is system prefix for active compounds screened by the library) were selected for evaluation. HBSC-11 was found to have an obvious inhibitory effect on hLa transcription and expression. Conclusions: Our findings suggest that anti-HBV activity of HBSC-11 may be mediated by a reduction in hLa levels. In addition, our data suggest the potential clinical use of hLa inhibitors, such as HBSC-11, for treating HBV infection.	[Tang, Jing; Liu, Gao-Lin] Shanghai Jiao Tong Univ, Dept Pharm, Peoples Hosp 1, Shanghai 200030, Peoples R China; [Huang, Zhi-Min; Chen, Ying-Yi; Zhang, Jian] Shanghai Jiao Tong Univ, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis, Chinese Minist Educ,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zhao-Hui] Shanghai Jiao Tong Univ, Dept Urol, Ruijin Hosp, Luwan Branch, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Tang, J (corresponding author), Shanghai Jiao Tong Univ, Dept Pharm, Peoples Hosp 1, Shanghai 200030, Peoples R China.	gaolinliu2009@gmail.com; jzhang.dr@gmail.com	Zhang, Jian/GXA-1303-2022; huang, zhimin/H-7878-2013; huang, zhimin o/R-4712-2018; zhang, zh/GWV-4677-2022	Zhang, Jian/0000-0002-6558-791X; huang, zhimin o/0000-0001-9230-6039; tang, jing/0000-0003-3100-1842	Natural Science Foundation of China [30873105, 21002062, 81100289]; Natural Science Foundation of Shanghai Province [08ZR1411900]; Research Foundation of First People's Hospital; Shanghai JiaoTong University [10B08]; Shanghai PuJiang Program [10PJ406800]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Province; Research Foundation of First People's Hospital; Shanghai JiaoTong University; Shanghai PuJiang Program(Shanghai Pujiang Program)	This study was supported by grants from the Natural Science Foundation of China (30873105, 21002062 and 81100289), the Natural Science Foundation of Shanghai Province (08ZR1411900), the Research Foundation of First People's Hospital Affiliated with Shanghai JiaoTong University (10B08), in part by grants from Shanghai PuJiang Program (10PJ406800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CS, 2009, J MED CHEM, V52, P2716, DOI 10.1021/jm8011905; Donello JE, 1996, J VIROL, V70, P4345, DOI 10.1128/JVI.70.7.4345-4351.1996; Ehlers I, 2004, J BIOL CHEM, V279, P43437, DOI 10.1074/jbc.M402227200; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Heise T, 2001, J VIROL, V75, P6874, DOI 10.1128/JVI.75.15.6874-6883.2001; Heise T, 1999, J VIROL, V73, P5767, DOI 10.1128/JVI.73.7.5767-5776.1999; Heise TD, 2000, CHRONIC HEPATITIS NE, P23; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Horke S, 2002, J BIOL CHEM, V277, P34949, DOI 10.1074/jbc.M201911200; Kim ND, 2011, BIOORG MED CHEM LETT, V21, P3329, DOI 10.1016/j.bmcl.2011.04.010; Kotik-Kogan O, 2008, STRUCTURE, V16, P852, DOI 10.1016/j.str.2008.02.021; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Maraia RJ, 2001, MOL CELL BIOL, V21, P367, DOI 10.1128/MCB.21.2.367-379.2001; Melagraki G, 2011, CURR MED CHEM, V18, P2612, DOI 10.2174/092986711795933759; Ni Q, 2004, WORLD J GASTROENTERO, V10, P2050, DOI 10.3748/wjg.v10.i14.2050; Schaffler K, 2010, RNA, V16, P1488, DOI 10.1261/rna.2146910; Schrodinger LLC, 2009, GLID VERS 5 5; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Spangberg K, 2001, J GEN VIROL, V82, P113, DOI 10.1099/0022-1317-82-1-113; Stein Lance L., 2009, Infectious Disorders - Drug Targets, V9, P105; Talele TT, 2010, BIOORGAN MED CHEM, V18, P4630, DOI 10.1016/j.bmc.2010.05.030; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Zhang Hui, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P735	24	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36363	10.1371/journal.pone.0036363	http://dx.doi.org/10.1371/journal.pone.0036363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558448	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000197
J	Xi, D; Gandhi, N; Lai, MZ; Kublaoui, BM				Xi, Dong; Gandhi, Nilay; Lai, Meizan; Kublaoui, Bassil M.			Ablation of Sim1 Neurons Causes Obesity through Hyperphagia and Reduced Energy Expenditure	PLOS ONE			English	Article							THYROTROPIN-RELEASING-HORMONE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; AGOUTI-RELATED PROTEIN; BROWN ADIPOSE-TISSUE; INDUCED THERMOGENESIS; SYNTHESIZING NEURONS; NEUROPEPTIDE-Y; DEFICIENT MICE; PATHWAYS; LESIONS	Single-minded 1 (Sim1) is a transcription factor necessary for development of the paraventricular nucleus of the hypothalamus (PVH). This nucleus is a critical regulator of appetite, energy expenditure and body weight. Previously we showed that Sim1(+/-) mice and conditional postnatal Sim1(-/-) mice exhibit hyperphagia, obesity, increased linear growth and susceptibility to diet-induced obesity, but no decrease in energy expenditure. Bilateral ablation of the PVH causes obesity due to hyperphagia and reduced energy expenditure. It remains unknown whether Sim1 neurons regulate energy expenditure. In this study, Sim1cre mice were bred to homozygous inducible diphtheria toxin receptor (iDTR) mice to generate mice expressing the simian DTR in Sim1 cells. In these mice, Sim1 neuron ablation was performed by intracerebroventricular (ICV) injection of diphtheria toxin. Compared to controls, mice with Sim1 neuron ablation became obese (with increased fat mass) on a chow diet due to increased food intake and reduced energy expenditure. In post-injection mice, we observed a strong inverse correlation between the degree of obesity and hypothalamic Sim1 expression. The reduction in baseline energy expenditure observed in these mice was accompanied by a reduction in activity. This reduction in activity did not fully account for the reduced energy expenditure as these mice exhibited decreased resting energy expenditure, decreased body temperature, decreased brown adipose tissue temperature, and decreased UCP1 expression suggesting an impairment of thermogenesis. In injected mice, hypothalamic gene expression of Sim1, oxytocin (OXT) and thyrotropin releasing hormone (TRH) was reduced by about 50%. These results demonstrate that Sim1 neurons in adult mice regulate both food intake and energy expenditure. Based on the body of work in the field, feeding regulation by Sim1 neurons likely occurs in both the PVH and medial amygdala, in contrast to energy expenditure regulation by Sim1 neurons, which likely is localized to the PVH.	[Xi, Dong; Gandhi, Nilay; Lai, Meizan; Kublaoui, Bassil M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol & Diabet,Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Xi, D (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Endocrinol & Diabet,Dept Pediat, Philadelphia, PA 19104 USA.	kublaouib@email.chop.edu			National Institutes of Health [R03 DK091500-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK091500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the National Institutes of Health (R03 DK091500-01 as well as institutional funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER RA, 1995, J COMP NEUROL, V358, P518, DOI 10.1002/cne.903580405; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Brown LM, 2010, BRAIN RES, V1350, P77, DOI 10.1016/j.brainres.2010.04.056; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Camerino C, 2009, OBESITY, V17, P980, DOI 10.1038/oby.2009.12; Cano G, 2003, J COMP NEUROL, V460, P303, DOI 10.1002/cne.10643; CHI ML, 1983, J NEURAL TRANSM, V58, P213, DOI 10.1007/BF01252807; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; DELUCA B, 1989, PHYSIOL BEHAV, V46, P685, DOI 10.1016/0031-9384(89)90352-1; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; EGAWA M, 1991, AM J PHYSIOL, V260, pR328, DOI 10.1152/ajpregu.1991.260.2.R328; Elmquist JK, 1997, ENDOCRINOLOGY, V138, P839, DOI 10.1210/en.138.2.839; Elmquist JK, 2001, INT J OBESITY, V25, pS78, DOI 10.1038/sj.ijo.0801918; Fekete C, 2000, J NEUROSCI, V20, P1550; Foster MT, 2009, OBESITY SILVER SPRIN, V18, P682; Grill HJ, 2010, FRONT NEUROENDOCRIN, V31, P61, DOI 10.1016/j.yfrne.2009.10.005; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Kasahara Y, 2007, BIOSCI BIOTECH BIOCH, V71, P3122, DOI 10.1271/bbb.70498; King BM, 1996, PHYSIOL BEHAV, V60, P1569, DOI 10.1016/S0031-9384(96)00318-6; King BM, 2003, AM J PHYSIOL-REG I, V284, pR965, DOI 10.1152/ajpregu.00249.2002; KIRCHGESSNER AL, 1988, PHYSIOL BEHAV, V42, P517, DOI 10.1016/0031-9384(88)90153-9; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Lee EB, 2011, J NEUROSCI, V31, P14361, DOI 10.1523/JNEUROSCI.3171-11.2011; Legradi G, 1999, ENDOCRINOLOGY, V140, P3643, DOI 10.1210/en.140.8.3643; LEIBOWITZ SF, 1981, PHYSIOL BEHAV, V27, P1031, DOI 10.1016/0031-9384(81)90366-8; Li XS, 2010, OBESITY, V18, P456, DOI 10.1038/oby.2009.312; LUITEN PGM, 1985, BRAIN RES, V329, P374, DOI 10.1016/0006-8993(85)90554-2; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Michaud JL, 2000, MECH DEVELOP, V90, P253, DOI 10.1016/S0925-4773(99)00328-7; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rezende EL, 2009, PHYSIOL BIOCHEM ZOOL, V82, P662, DOI 10.1086/605917; Rollins BL, 2000, AM J PHYSIOL-REG I, V279, pR1348, DOI 10.1152/ajpregu.2000.279.4.R1348; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Rosa CB, 2011, ANAT REC, V294, P1226, DOI 10.1002/ar.21419; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; SAWCHENKO PE, 1982, J COMP NEUROL, V205, P260, DOI 10.1002/cne.902050306; Shi HF, 2009, FRONT NEUROENDOCRIN, V30, P396, DOI 10.1016/j.yfrne.2009.03.004; Shintani M, 2005, BRAIN RES, V1039, P22, DOI 10.1016/j.brainres.2005.01.040; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; Takayanagi Y, 2008, NEUROREPORT, V19, P951, DOI 10.1097/WNR.0b013e3283021ca9; TERHORST GJ, 1987, BRAIN RES BULL, V18, P191, DOI 10.1016/0361-9230(87)90190-0; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wittmann G, 2009, J COMP NEUROL, V515, P313, DOI 10.1002/cne.22017; Wu Q, 2008, P NATL ACAD SCI USA, V105, P2687, DOI 10.1073/pnas.0712062105; Xu C, 2007, MOL ENDOCRINOL, V21, P1234, DOI 10.1210/me.2007-0034; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yu SH, 2000, J CLIN INVEST, V105, P615, DOI 10.1172/JCI8437	58	66	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36453	10.1371/journal.pone.0036453	http://dx.doi.org/10.1371/journal.pone.0036453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558467	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000206
J	Kang, JA; Lee, K; Lee, KM; Cho, S; Seo, J; Hur, EM; Park, CS; Baik, JH; Choi, SY				Kang, Ji-Ah; Lee, Keimin; Lee, Kwang Min; Cho, Sukhee; Seo, Jinsoo; Hur, Eun-Mi; Park, Chul-Seung; Baik, Ja-Hyun; Choi, Se-Young			Desipramine Inhibits Histamine H1 Receptor-Induced Ca2+ Signaling in Rat Hypothalamic Cells	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; REGULATES FOOD-INTAKE; NEURONAL HISTAMINE; WEIGHT-GAIN; PHARMACOLOGICAL-TREATMENT; OVERWEIGHT PATIENT; DIABETES-MELLITUS; FEEDING-BEHAVIOR; H-1 RECEPTOR; AMP-KINASE	The hypothalamus in the brain is the main center for appetite control and integrates signals from adipose tissue and the gastrointestinal tract. Antidepressants are known to modulate the activities of hypothalamic neurons and affect food intake, but the cellular and molecular mechanisms by which antidepressants modulate hypothalamic function remain unclear. Here we have investigated how hypothalamic neurons respond to treatment with antidepressants, including desipramine and sibutramine. In primary cultured rat hypothalamic cells, desipramine markedly suppressed the elevation of intracellular Ca2+ evoked by histamine H1 receptor activation. Desipramine also inhibited the histamine-induced Ca2+ increase and the expression of corticotrophin-releasing hormone in hypothalamic GT1-1 cells. The effect of desipramine was not affected by pretreatment with prazosin or propranolol, excluding catecholamine reuptake activity of desipramine as an underlying mechanism. Sibutramine which is also an antidepressant but decreases food intake, had little effect on the histamine-induced Ca2+ increase or AMP-activated protein kinase activity. Our results reveal that desipramine and sibutramine have different effects on histamine H1 receptor signaling in hypothalamic cells and suggest that distinct regulation of hypothalamic histamine signaling might underlie the differential regulation of food intake between antidepressants.	[Kang, Ji-Ah; Lee, Keimin; Cho, Sukhee; Seo, Jinsoo; Choi, Se-Young] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Physiol, Seoul, South Korea; [Lee, Kwang Min; Park, Chul-Seung] Gwangju Inst Sci & Technol, Sch Life Sci, Kwangju, South Korea; [Hur, Eun-Mi] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA; [Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); Gwangju Institute of Science & Technology (GIST); Johns Hopkins University; Korea University	Kang, JA (corresponding author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Physiol, Seoul, South Korea.	sychoi@snu.ac.kr	Hur, Eun Mi/AAU-4906-2021; Seo, Jinsoo/AAD-4950-2019	Seo, Jinsoo/0000-0001-6432-6964; Park, Chul-Seung/0000-0003-0209-1412; Choi, Se-Young/0000-0001-7534-5167	National Research Foundation of Korea from Korean Ministry of Education, Science and Technology [R01-2007-000-20850, 2011-0028233]	National Research Foundation of Korea from Korean Ministry of Education, Science and Technology	This work was supported by National Research Foundation of Korea (R01-2007-000-20850 and 2011-0028233) from Korean Ministry of Education, Science and Technology (http://www.nrf.re.kr/html/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTELMAN SM, 1977, LIFE SCI, V21, P1747, DOI 10.1016/0024-3205(77)90154-0; Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2; Bray GA, 2007, GASTROENTEROLOGY, V132, P2239, DOI 10.1053/j.gastro.2007.03.053; Chai BX, 2009, PEPTIDES, V30, P1098, DOI 10.1016/j.peptides.2009.03.006; Choi SY, 2001, J NEUROCHEM, V79, P303; Davoodi N, 2008, BEHAV PHARMACOL, V19, P121, DOI 10.1097/FBP.0b013e3282f62c66; DELAESCALERA GM, 1992, ENDOCRINOLOGY, V131, P1397; Galanter CA, 2002, J CHILD ADOL PSYCHOP, V12, P137, DOI 10.1089/104454602760219171; Gobshtis N, 2007, EUR J PHARMACOL, V554, P155, DOI 10.1016/j.ejphar.2006.10.028; Gotoh K, 2005, FASEB J, V19, P1131, DOI 10.1096/fj.04-2384fje; Gotoh K, 2007, J NEUROCHEM, V103, P1102, DOI 10.1111/j.1471-4159.2007.04802.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Heinrichs SC, 1999, NEUROPEPTIDES, V33, P350, DOI 10.1054/npep.1999.0047; Jorgensen EA, 2007, NEUROENDOCRINOLOGY, V86, P210, DOI 10.1159/000108341; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Masaki T, 2003, ENDOCRINOLOGY, V144, P2741, DOI 10.1210/en.2003-0031; Masaki T, 2006, TRENDS PHARMACOL SCI, V27, P279, DOI 10.1016/j.tips.2006.03.008; McIntyre RS, 2001, CAN J PSYCHIAT, V46, P273, DOI 10.1177/070674370104600308; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; NELSON JC, 1984, ARCH GEN PSYCHIAT, V41, P55; NORIS G, 1995, ENDOCRINOLOGY, V136, P2967, DOI 10.1210/en.136.7.2967; OOKUMA K, 1993, BRAIN RES, V628, P235, DOI 10.1016/0006-8993(93)90960-U; OOKUMA K, 1990, PSYCHOPHARMACOLOGY, V101, P481, DOI 10.1007/BF02244225; POTTER WZ, 1991, NEW ENGL J MED, V325, P633; Richelson E, 2000, LIFE SCI, V68, P29, DOI 10.1016/S0024-3205(00)00911-5; SAKATA T, 1988, BRAIN RES, V441, P403, DOI 10.1016/0006-8993(88)91423-0; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Vitalis EA, 2000, P NATL ACAD SCI USA, V97, P1861, DOI 10.1073/pnas.040545197; Yamamoto R, 2011, J BIOL CHEM, V286, P21458, DOI 10.1074/jbc.M110.192260; YAMASHITA N, 1992, BRAIN RES, V594, P215, DOI 10.1016/0006-8993(92)91128-2; Yoshimoto R, 2008, EUR J PHARMACOL, V579, P229, DOI 10.1016/j.ejphar.2007.11.001; Yoshimoto R, 2006, P NATL ACAD SCI USA, V103, P13866, DOI 10.1073/pnas.0506104103; Yoshizawa M, 2009, BIOL PSYCHIAT, V65, P329, DOI 10.1016/j.biopsych.2008.08.012	35	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36185	10.1371/journal.pone.0036185	http://dx.doi.org/10.1371/journal.pone.0036185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563449	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100074
J	Kim, HJ; Lim, SJ; Kwag, HL; Kim, HJ				Kim, Hyoung Jin; Lim, Su Jeung; Kwag, Hye-Lim; Kim, Hong-Jin			The Choice of Resin-Bound Ligand Affects the Structure and Immunogenicity of Column-Purified Human Papillomavirus Type 16 Virus-Like Particles	PLOS ONE			English	Article							MAJOR NEUTRALIZING EPITOPE; HELPER T-CELL; L1 PROTEIN; MONOCLONAL-ANTIBODIES; PURIFICATION; HPV16; BINDING; SPECIFICITY; REACTIVITY; RESPONSES	Cell growth conditions and purification methods are important in determining biopharmaceutical activity. However, in studies aimed at manufacturing virus-like particles (VLPs) for the purpose of creating a prophylactic vaccine and antigen for human papillomavirus (HPV), the effects of the presence of a resin-bound ligand during purification have never been investigated. In this study, we compared the structural integrity and immunogenicity of two kinds of VLPs derived from HPV type 16 (HPV16 VLPs): one VLP was purified by heparin chromatography (hHPV16 VLP) and the other by cation-exchange chromatography (cHPV16 VLP). The reactivity of anti-HPV16 neutralizing monoclonal antibodies (H16.V5 and H16.E70) towards hHPV16 VLP were significantly higher than the observed cHPV16 VLP reactivities, implying that hHPV16 VLP possesses a greater number of neutralizing epitopes and has a greater potential to elicit anti-HPV16 neutralizing antibodies. After the application of heparin chromatography, HPV16 VLP has a higher affinity for H16.V5 and H16.E70. This result indicates that heparin chromatography is valuable in selecting functional HPV16 VLPs. In regard to VLP immunogenicity, the anti-HPV16 L1 IgG and neutralizing antibody levels elicited by immunizations of mice with hHPV16 VLPs were higher than those elicited by cHPV16 VLP with and without adjuvant. Therefore, the ability of hHPV16 VLP to elicit humoral immune responses was superior to that of cHPV16 VLP. We conclude that the specific chromatographic technique employed for the purification of HPV16 VLPs is an important factor in determining the structural characteristics and immunogenicity of column-purified VLPs.	[Kim, Hyoung Jin; Lim, Su Jeung; Kwag, Hye-Lim; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	hongjink@cau.ac.kr			Ministry of Health & Welfare of the Republic of Korea [A085139]	Ministry of Health & Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a Grant (A085139) of the Research & Development Project in Health 363 and Medical Technology of the Ministry of Health & Welfare of the Republic of Korea. http://www.hpeb.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires KA, 2006, APPL ENVIRON MICROB, V72, P745, DOI 10.1128/AEM.72.1.745-752.2006; Bishop B, 2007, J BIOL CHEM, V282, P31803, DOI 10.1074/jbc.M706380200; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buonamassa DT, 2002, VIROLOGY, V293, P335, DOI 10.1006/viro.2001.1289; Carter JJ, 2003, J VIROL, V77, P11625, DOI 10.1128/JVI.77.21.11625-11632.2003; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 2001, VIROLOGY, V291, P324, DOI 10.1006/viro.2001.1220; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Cook JC, 1999, PROTEIN EXPRES PURIF, V17, P477, DOI 10.1006/prep.1999.1155; Culp TD, 2007, VIROLOGY, V361, P435, DOI 10.1016/j.virol.2006.12.002; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; De Witte L, 2007, IMMUNOBIOLOGY, V212, P679, DOI 10.1016/j.imbio.2007.09.006; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Ishikawa-Sekigami T, 2006, BLOOD, V107, P341, DOI 10.1182/blood-2005-05-1896; Kim HJ, 2010, J BIOTECHNOL, V150, P31, DOI 10.1016/j.jbiotec.2010.07.032; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Kim SN, 2007, J VIROL METHODS, V139, P24, DOI 10.1016/j.jviromet.2006.09.004; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mach H, 2006, J PHARM SCI-US, V95, P2195, DOI 10.1002/jps.20696; Madrid-Marina V, 2009, ARCH MED RES, V40, P471, DOI 10.1016/j.arcmed.2009.08.005; Mirano-Bascos D, 2010, J VIROL, V84, P3303, DOI 10.1128/JVI.02242-09; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Moyer AL, 2010, 26 INT PAP C; Opalka D, 2010, CLIN VACCINE IMMUNOL, V17, P818, DOI 10.1128/CVI.00348-09; Park JY, 2002, J MICROBIOL, V40, P313; Park MA, 2008, PROTEIN EXPRES PURIF, V59, P175, DOI 10.1016/j.pep.2008.01.021; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Ros C, 2006, J VIROL, V80, P12017, DOI 10.1128/JVI.01435-06; Ryding J, 2007, J GEN VIROL, V88, P792, DOI 10.1099/vir.0.82449-0; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Schwarz TF, 2009, ADV THER, V26, P983, DOI 10.1007/s12325-009-0079-5; Selinka HC, 2003, J VIROL, V77, P12961, DOI 10.1128/JVI.77.24.12961-12967.2003; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; Sun JH, 2008, CLIN VACCINE IMMUNOL, V15, P303, DOI 10.1128/CVI.00448-07; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Vicente T, 2011, J INVERTEBR PATHOL, V107, pS42, DOI 10.1016/j.jip.2011.05.004; White WI, 1999, J VIROL, V73, P4882, DOI 10.1128/JVI.73.6.4882-4889.1999; Woo MK, 2007, J MICROBIOL BIOTECHN, V17, P1738; Zhang YZ, 2006, HUM IMMUNOL, V67, P215, DOI 10.1016/j.humimm.2006.02.014; Zhao QJ, 2005, J VIROL METHODS, V127, P133, DOI 10.1016/j.jviromet.2005.03.015	49	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35893	10.1371/journal.pone.0035893	http://dx.doi.org/10.1371/journal.pone.0035893			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563414	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100040
J	Koren, J; Miyata, Y; Kiray, J; O'Leary, JC; Nguyen, L; Guo, JP; Blair, LJ; Li, XK; Jinwal, UK; Cheng, JQ; Gestwicki, JE; Dickey, CA				Koren, John, III; Miyata, Yoshinari; Kiray, Janine; O'Leary, John C., III; Nguyen, Lana; Guo, Jianping; Blair, Laura J.; Li, Xiokai; Jinwal, Umesh K.; Cheng, Jin Q.; Gestwicki, Jason E.; Dickey, Chad A.			Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; PHASE-I; MKT 077; HSP70; CHEMOTHERAPY; BINDING; MKT-077; MOT-2; DYE; AKT	MKT-077, a rhodacyanine dye, was shown to produce cancer specific cell death. However, complications prevented the use of this compound beyond clinical trials. Here we describe YM-1, a derivative of MKT-077. We found that YM-1 was more cytotoxic and localized differently than MKT-077. YM-1 demonstrated this cytotoxicity across multiple cancer cell lines. This toxicity was limited to cancer cell lines; immortalized cell models were unaffected. Brief applications of YM-1 were found to be non-toxic. Brief treatment with YM-1 restored tamoxifen sensitivity to a refractory tamoxifen-resistant MCF7 cell model. This effect is potentially due to altered estrogen receptor alpha phosphorylation, an outcome precipitated by selective reductions in Akt levels (Akt/PKB). Thus, modifications to the rhodocyanine scaffold could potentially be made to improve efficacy and pharmacokinetic properties. Moreover, the impact on tamoxifen sensitivity could be a new utility for this compound family.	[Koren, John, III; Kiray, Janine; O'Leary, John C., III; Nguyen, Lana; Blair, Laura J.; Dickey, Chad A.] Univ S Florida, Coll Med, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA; [Miyata, Yoshinari; Li, Xiokai; Gestwicki, Jason E.] Univ Michigan, Dept Pathol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Miyata, Yoshinari; Li, Xiokai; Gestwicki, Jason E.] Univ Michigan, Dept Biol Chem, Inst Life Sci, Ann Arbor, MI 48109 USA; [Guo, Jianping; Cheng, Jin Q.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Jinwal, Umesh K.] Univ S Florida, Coll Pharm, Tampa, FL USA	State University System of Florida; University of South Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Koren, J (corresponding author), Univ S Florida, Coll Med, Dept Mol Med, USF Hlth Byrd Alzheimers Inst, Tampa, FL 33620 USA.	cdickey@health.usf.edu	Li, Xiaokai/D-2680-2014; Li, Xiaokai/A-7162-2012	Koren, John/0000-0002-6017-1763; Blair, Laura/0000-0002-4981-5564	Alzheimer's Association; CurePSP (Progressive supranuclear palsy); National Institutes of Health/National Institute on Aging (NIH/NIA) [R00AG031291]; NINDS (National Institute of Neurological Disorders and Stroke) [R01NS073899]; NIH [R01NS059690]; James & Esther King Grant [1KG02-33967]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899, R01NS059690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); CurePSP (Progressive supranuclear palsy); National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James & Esther King Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Dickey was supported by the Alzheimer's Association, CurePSP (Progressive supranuclear palsy), National Institutes of Health/National Institute on Aging (NIH/NIA) R00AG031291 and NINDS (National Institute of Neurological Disorders and Stroke) R01NS073899. Dr. Gestwicki was supported by the NIH R01NS059690. Dr. Cheng was supported by James & Esther King Grant 1KG02-33967. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia E, 2007, CURR MED CHEM, V14, P3035, DOI 10.2174/092986707782794023; Britten CD, 2000, CLIN CANCER RES, V6, P42; Brognard J, 2001, CANCER RES, V61, P3986; Campbell RA, 2001, J BIOL CHEM; Clark AS, 2002, MOL CANCER THER, V1, P707; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Gabrielli D, 2004, PHOTOCHEM PHOTOBIOL, V79, P227, DOI 10.1562/BE-03-27.1; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Guo JP, 2010, J BIOL CHEM, V285, P3676, DOI 10.1074/jbc.M109.078212; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Jinwal UK, 2009, J NEUROSCI, V29, P12079, DOI 10.1523/JNEUROSCI.3345-09.2009; Kawakami M, 1998, J MED CHEM, V41, P130, DOI 10.1021/jm970590k; Koren J, 2010, J BIOL CHEM; Koya K, 1996, CANCER RES, V56, P538; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Nahta R, 2012, CURR MED CHEM; Oliveira Andre M, 2005, Am J Clin Pathol, V124 Suppl, pS16; Propper DJ, 1999, ANN ONCOL, V10, P923, DOI 10.1023/A:1008336904585; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Rousaki A, 2011, J MOL BIOL; Sun M, 2001, CANCER RES, V61, P5985; Uray IP, 2011, RECENT RESULTS CANC, V188, P147, DOI 10.1007/978-3-642-10858-7_13; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2000, CANCER RES, V60, P6818	27	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35566	10.1371/journal.pone.0035566	http://dx.doi.org/10.1371/journal.pone.0035566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563386	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100015
J	Gonzalo-Gomez, A; Turiegano, E; Leon, Y; Molina, I; Torroja, L; Canal, I				Gonzalo-Gomez, Alicia; Turiegano, Enrique; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Canal, Inmaculada			Ih Current Is Necessary to Maintain Normal Dopamine Fluctuations and Sleep Consolidation in Drosophila	PLOS ONE			English	Article							CIRCADIAN MODULATION; LOCOMOTOR-ACTIVITY; HCN CHANNELS; CLOCK GENES; NEURONS; RHYTHMS; RAT; EXPRESSION; AROUSAL; ETHANOL	HCN channels are becoming pharmacological targets mainly in cardiac diseases. But apart from their well-known role in heart pacemaking, these channels are widely expressed in the nervous system where they contribute to the neuron firing pattern. Consequently, abolishing Ih current might have detrimental consequences in a big repertoire of behavioral traits. Several studies in mammals have identified the Ih current as an important determinant of the firing activity of dopaminergic neurons, and recent evidences link alterations in this current to various dopamine-related disorders. We used the model organism Drosophila melanogaster to investigate how lack of Ih current affects dopamine levels and the behavioral consequences in the sleep: activity pattern. Unlike mammals, in Drosophila there is only one gene encoding HCN channels. We generated a deficiency of the DmIh core gene region and measured, by HPLC, levels of dopamine. Our data demonstrate daily variations of dopamine in wild-type fly heads. Lack of Ih current dramatically alters dopamine pattern, but different mechanisms seem to operate during light and dark conditions. Behaviorally, DmIh mutant flies display alterations in the rest: activity pattern, and altered circadian rhythms. Our data strongly suggest that Ih current is necessary to prevent dopamine overproduction at dark, while light input allows cycling of dopamine in an Ih current dependent manner. Moreover, lack of Ih current results in behavioral defects that are consistent with altered dopamine levels.	[Gonzalo-Gomez, Alicia; Turiegano, Enrique; Leon, Yolanda; Molina, Isabel; Torroja, Laura; Canal, Inmaculada] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Gonzalo-Gomez, A (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	inmaculada.canal@uam.es	Torroja, Laura/L-2449-2013; Torroja, Laura/AAU-7896-2021; Leon, Yolanda/ABG-6797-2020; Molina, Isabel/L-2432-2013; Turiegano, Enrique/M-8679-2013	Torroja, Laura/0000-0001-6939-6259; Torroja, Laura/0000-0001-6939-6259; Molina, Isabel/0000-0003-1687-2447; Turiegano, Enrique/0000-0003-4620-7894; Leon Alvarez, Yolanda/0000-0002-4536-8373	Ministerio de Ciencia e Innovacion [BFU2008-04683]; Comunidad Autonoma de Madrid grant [P-SEM-0255-2006, BFU2010-10981-E]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid grant	This work was supported by Ministerio de Ciencia e Innovacion grant BFU2008-04683 to LT, Comunidad Autonoma de Madrid grant P-SEM-0255-2006 to IC, and BFU2010-10981-E to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Andretic R, 2000, P NATL ACAD SCI USA, V97, P1873, DOI 10.1073/pnas.97.4.1873; Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Arencibia-Albite F, 2007, NEUROSCIENCE, V149, P303, DOI 10.1016/j.neuroscience.2007.08.009; Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Baruscotti M, 2010, PFLUG ARCH EUR J PHY, V460, P405, DOI 10.1007/s00424-010-0810-8; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; CAHILL GM, 1991, J NEUROSCI, V11, P2959; Cangiano L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001327; Castaneda TR, 2004, J PINEAL RES, V36, P177, DOI 10.1046/j.1600-079X.2003.00114.x; Cathala L, 1999, EUR J NEUROSCI, V11, P398, DOI 10.1046/j.1460-9568.1999.00452.x; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cervetto L, 2007, BRIT J PHARMACOL, V150, P383, DOI 10.1038/sj.bjp.0706998; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chan CS, 2011, NAT NEUROSCI, V14, P85, DOI 10.1038/nn.2692; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; Chu HY, 2010, ACTA PHARMACOL SIN, V31, P1036, DOI 10.1038/aps.2010.105; Chung WK, 2009, NEUROBIOL DIS, V33, P499, DOI 10.1016/j.nbd.2008.12.004; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dubruille R, 2008, MOL NEUROBIOL, V38, P129, DOI 10.1007/s12035-008-8035-y; Dzirasa K, 2006, J NEUROSCI, V26, P10577, DOI 10.1523/JNEUROSCI.1767-06.2006; Fernandez MP, 2008, PLOS BIOL, V6, P518, DOI 10.1371/journal.pbio.0060069; Fujii S, 2007, CURR BIOL, V17, P244, DOI 10.1016/j.cub.2006.11.049; George MS, 2009, NAT NEUROSCI, V12, P577, DOI 10.1038/nn.2307; Gisselmann GN, 2005, INSECT BIOCHEM MOLEC, V35, P505, DOI 10.1016/j.ibmb.2005.02.001; Gravotta L, 2011, J MOL NEUROSCI, V45, P162, DOI 10.1007/s12031-011-9520-8; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Hood S, 2010, J NEUROSCI, V30, P14046, DOI 10.1523/JNEUROSCI.2128-10.2010; Keegan KP, 2007, PLOS COMPUT BIOL, V3, P2087, DOI 10.1371/journal.pcbi.0030208; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee KH, 1996, NEURON, V17, P309, DOI 10.1016/S0896-6273(00)80162-2; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Lu B, 2008, GENES BRAIN BEHAV, V7, P730, DOI 10.1111/j.1601-183X.2008.00411.x; Lyons LC, 2009, LEARN MEMORY, V16, P19, DOI 10.1101/lm.1146009; Magee JC, 2001, J NEUROPHYSIOL, V86, P528, DOI 10.1152/jn.2001.86.1.528; Marx Thomas, 1999, Invertebrate Neuroscience, V4, P55, DOI 10.1007/s101580050007; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Okamoto T, 2006, J NEUROPHYSIOL, V95, P619, DOI 10.1152/jn.00682.2005; Parashar V, 2008, RADIAT RES, V169, P707, DOI 10.1667/RR1225.1; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakai T, 2001, P NATL ACAD SCI USA, V98, P9221, DOI 10.1073/pnas.151443298; Seutin V, 2001, NEUROREPORT, V12, P255, DOI 10.1097/00001756-200102120-00015; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shi WM, 1999, CIRC RES, V85, pE1; Sicaeros Beatriz, 2007, J Vis Exp, P200, DOI 10.3791/200; Sleipness EP, 2008, SYNAPSE, V62, P877, DOI 10.1002/syn.20552; Sorribes A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002075; Stieber J, 2006, MOL PHARMACOL, V69, P1328, DOI 10.1124/mol.105.020701; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; Thollon C, 2010, ADV PHARMACOL, V59, P53, DOI 10.1016/S1054-3589(10)59003-3; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Van Swinderen B, 2011, P ROY SOC B-BIOL SCI, V278, P906, DOI 10.1098/rspb.2010.2564; Vandecasteele M, 2008, P NATL ACAD SCI USA, V105, P4904, DOI 10.1073/pnas.0703121105; Vermeulen CJ, 2006, MECH AGEING DEV, V127, P610, DOI 10.1016/j.mad.2006.02.004; Zhang YQ, 2005, MOL CELL PROTEOMICS, V4, P278, DOI 10.1074/mcp.M400174-MCP200; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhou XJ, 2005, J BIOL RHYTHM, V20, P237, DOI 10.1177/0748730405274451; Zolles G, 2006, NEURON, V52, P1027, DOI 10.1016/j.neuron.2006.12.005	73	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36477	10.1371/journal.pone.0036477	http://dx.doi.org/10.1371/journal.pone.0036477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574167	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800063
J	Martinez-Martinez, E; Galvan-Hernandez, CI; Toscano-Marquez, B; Gutierrez-Ospina, G				Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel			Modulatory Role of Sensory Innervation on Hair Follicle Stem Cell Progeny during Wound Healing of the Rat Skin	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; NEUROPEPTIDE SUBSTANCE-P; KERATINOCYTE PROLIFERATION; CAPSAICIN TREATMENT; BULGE AREA; CALCITONIN; EXPRESSION; RECEPTOR; NEURONS; GROWTH	Background: The bulge region of the hair follicle contains resident epithelial stem cells (SCs) that are activated and mobilized during hair growth and after epidermal wounding. However, little is known about the signals that modulate these processes. Clinical and experimental observations show that a reduced supply of sensory innervation is associated with delayed wound healing. Since axon terminals of sensory neurons are among the components of the bulge SC niche, we investigated whether these neurons are involved in the activation and mobilization of the hair stem cells during wound healing. Methodology/Principal Findings: We used neonatal capsaicin treatment to reduce sensory terminals in the rat skin and performed morphometric analyses using design-based stereological methods. Epithelial proliferation was analyzed by quantifying the number of bromodeoxyuridine-labeled (BrdU(+)) nuclei in the epidermis and hair follicles. After wounding, the epidermis of capsaicin-treated rats presented fewer BrdU(+) nuclei than in control rats. To assess SC progeny migration, we employed a double labeling protocol with iododeoxyuridine and chlorodeoxyuridine (IdU(+)/CldU(+)). The proportion of double-labeled cells was similar in the hair follicles of both groups at 32 h postwounding. IdU(+)/CldU(+) cell proportion increased in the epidermis of control rats and decreased in treated rats at 61 h postwounding. The epidermal volume immunostained for keratin 6 was greater in treated rats at 61 h. Confocal microscopy analysis revealed that substance P (SP) and calcitonin gene-related peptide (CGRP) receptor immunoreactivity were both present in CD34(+) and BrdU-retaining cells of the hair follicles. Conclusions/Significance: Our results suggest that capsaicin denervation impairs SC progeny egress from the hair follicles, a circumstance associated with a greater epidermal activation. Altogether, these phenomena would explain the longer times for healing in denervated skin. Thus, sensory innervation may play a functional role in the modulation of hair SC physiology during wound healing.	[Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Coyoacan, DF, Mexico; [Martinez-Martinez, Eduardo; Galvan-Hernandez, Claudio I.; Toscano-Marquez, Brenda; Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Grp Multidisciplinario Invest Celulas Troncales I, Coyoacan, DF, Mexico; [Gutierrez-Ospina, Gabriel] Colonia Copilco Univ, Fac Psicol, Coyoacan, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Martinez-Martinez, E (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Celular & Fisiol, Coyoacan, DF, Mexico.	emartin@biomedicas.unam.mx; gabo@biomedicas.unam.mx	Martínez, Eduardo Martínez/A-2558-2009	Martínez, Eduardo Martínez/0000-0002-9020-559X; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [38615N, 45872M, 53194]; Direccion General de Asuntos del Personal Academico [IN215208]; UNAM (DGAPA); grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM); Direccion General de Estudios de Posgrado-UNAM; IMPULSA-02	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico; UNAM (DGAPA)(Universidad Nacional Autonoma de Mexico); grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM); Direccion General de Estudios de Posgrado-UNAM(Universidad Nacional Autonoma de Mexico); IMPULSA-02	This work was supported by grants 38615N, 45872M, and 53194 from Consejo Nacional de Ciencia y Tecnologia (CONACYT), grant IN215208 from Direccion General de Asuntos del Personal Academico, UNAM (DGAPA), and grant IMPULSA-02 from Coordinacion de la Investigacion Cientifica, UNAM (CIC-UNAM) to GGO. EMM and BTM were fellows of CONACYT. EMM also received support from Direccion General de Estudios de Posgrado-UNAM and IMPULSA-02. CIGH was a fellow of the Fundacion Lorena Alejandra Gallardo I. A. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki R, 2010, J CELL BIOCHEM, V110, P80, DOI 10.1002/jcb.22512; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Barker AR, 2006, ANN PLAS SURG, V57, P339, DOI 10.1097/01.sap.0000221465.69826.b7; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Boerzsei R, 2008, NEUROSCIENCE, V152, P82, DOI 10.1016/j.neuroscience.2007.12.005; Bowers MC, 2005, HYPERTENSION, V46, P51, DOI 10.1161/01.HYP.0000168926.44648.ed; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; BUCK SH, 1983, J NEUROSCI, V3, P2064; Bulut K, 2008, INT J COLORECTAL DIS, V23, P535, DOI 10.1007/s00384-008-0447-7; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; CARR RW, 1993, NEUROREPORT, V4, P467, DOI 10.1097/00001756-199305000-00001; Carrillo P, 1998, NEUROTOXICOL TERATOL, V20, P75, DOI 10.1016/S0892-0362(97)00077-9; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Delgado AV, 2005, EXP BIOL MED, V230, P271; Dong J, 2010, PEPTIDES, V31, P1860, DOI 10.1016/j.peptides.2010.07.007; Engin C, 1998, PLAST RECONSTR SURG, V101, P1887, DOI 10.1097/00006534-199806000-00017; Erin N, 2006, BREAST CANCER RES TR, V99, P351, DOI 10.1007/s10549-006-9219-7; Felderbauer P, 2007, INT J COLORECTAL DIS, V22, P1475, DOI 10.1007/s00384-007-0321-z; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; FUJITA S, 1984, EXP EYE RES, V38, P165, DOI 10.1016/0014-4835(84)90100-3; Fukai T, 2005, WOUND REPAIR REGEN, V13, P175, DOI 10.1111/j.1067-1927.2005.130208.x; Hagner S, 2002, PEPTIDES, V23, P109, DOI 10.1016/S0196-9781(01)00586-1; Harsum S, 2001, DEV BIOL, V238, P27, DOI 10.1006/dbio.2001.0395; Heath J, 2009, J INVEST DERMATOL, V129, P2358, DOI 10.1038/jid.2009.102; Hou QZ, 2011, PAIN, V152, P2036, DOI 10.1016/j.pain.2011.04.033; Huebner AK, 2008, ARCH BIOCHEM BIOPHYS, V473, P210, DOI 10.1016/j.abb.2008.02.013; Ikawa A, 2002, HISTOL HISTOPATHOL, V17, P419, DOI 10.14670/HH-17.419; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jing C, 2010, WOUND REPAIR REGEN, V18, P319, DOI 10.1111/j.1524-475X.2010.00589.x; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kruger L, 1996, PROG BRAIN RES, V113, P255, DOI 10.1016/S0079-6123(08)61093-6; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; MAGGI CA, 1987, N-S ARCH PHARMACOL, V336, P538; Martinez-Martinez E, 2011, ANAT REC, V294, P173, DOI 10.1002/ar.21237; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mowa CN, 2004, J HISTOCHEM CYTOCHEM, V52, P1249, DOI 10.1369/jhc.4R6383.2004; Muller FB, 2003, BRIT J DERMATOL, V148, P30, DOI 10.1046/j.1365-2133.2003.05016.x; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pecze L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003419; Peters EMJ, 2001, J INVEST DERMATOL, V116, P236, DOI 10.1046/j.1523-1747.2001.01232.x; Rook JM, 2009, BIOCHEM PHARMACOL, V77, P1747, DOI 10.1016/j.bcp.2009.03.003; Roosterman D, 2006, PHYSIOL REV, V86, P1309, DOI 10.1152/physrev.00026.2005; Seike M, 2002, J DERMATOL SCI, V28, P135, DOI 10.1016/S0923-1811(01)00155-4; Smith PG, 2002, CELL TISSUE RES, V307, P281, DOI 10.1007/s00441-001-0477-8; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Toda M, 2008, BIOMED PHARMACOTHER, V62, P352, DOI 10.1016/j.biopha.2008.02.003; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wang CB, 2004, J BIOL CHEM, V279, P37423, DOI 10.1074/jbc.M407205200; Westerman R A, 1993, Clin Exp Neurol, V30, P39; Yong EXZ, 2008, J PEDIATR SURG, V43, P1533, DOI 10.1016/j.jpedsurg.2007.11.037; Yu XJ, 2009, CELL BIOL INT, V33, P1144, DOI 10.1016/j.cellbi.2009.07.003	58	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36421	10.1371/journal.pone.0036421	http://dx.doi.org/10.1371/journal.pone.0036421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574159	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800055
J	Westerman, BA; Blom, M; Tanger, E; van der Valk, M; Song, JY; van Santen, M; Gadiot, J; Cornelissen-Steijger, P; Zevenhoven, J; Prosser, HM; Uren, A; Aronica, E; van Lohuizen, M				Westerman, Bart A.; Blom, Marleen; Tanger, Ellen; van der Valk, Martin; Song, Ji-Ying; van Santen, Marije; Gadiot, Jules; Cornelissen-Steijger, Paulien; Zevenhoven, John; Prosser, Haydn M.; Uren, Anthony; Aronica, Eleonora; van Lohuizen, Maarten			GFAP-Cre-Mediated Transgenic Activation of Bmi1 Results in Pituitary Tumors	PLOS ONE			English	Article							CELL SELF-RENEWAL; NEURAL STEM-CELLS; CEREBELLAR DEVELOPMENT; RETINOBLASTOMA GENE; SUBVENTRICULAR ZONE; H2A UBIQUITINATION; TARGET GENE; EXPRESSION; PROLIFERATION; PATHWAY	Bmi1 is a member of the polycomb repressive complex 1 and plays different roles during embryonic development, depending on the developmental context. Bmi1 over expression is observed in many types of cancer, including tumors of astroglial and neural origin. Although genetic depletion of Bmi1 has been described to result in tumor inhibitory effects partly through INK4A/Arf mediated senescence and apoptosis and also through INK4A/Arf independent effects, it has not been proven that Bmi1 can be causally involved in the formation of these tumors. To see whether this is the case, we developed two conditional Bmi1 transgenic models that were crossed with GFAP-Cre mice to activate transgenic expression in neural and glial lineages. We show here that these mice generate intermediate and anterior lobe pituitary tumors that are positive for ACTH and beta-endorphin. Combined transgenic expression of Bmi1 together with conditional loss of Rb resulted in pituitary tumors but was insufficient to induce medulloblastoma therefore indicating that the oncogenic function of Bmi1 depends on regulation of p16(INK4A)/Rb rather than on regulation of p19(ARF)/p53. Human pituitary adenomas show Bmi1 overexpression in over 50% of the cases, which indicates that Bmi1 could be causally involved in formation of these tumors similarly as in our mouse model.	[Westerman, Bart A.; Blom, Marleen; Tanger, Ellen; Gadiot, Jules; Cornelissen-Steijger, Paulien; Zevenhoven, John; Uren, Anthony; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Westerman, Bart A.] Acad Med Ctr, Dept Oncogen, Amsterdam, Netherlands; [van der Valk, Martin; Song, Ji-Ying] Netherlands Canc Inst, Dept Animal Pathol, NL-1066 CX Amsterdam, Netherlands; [van Santen, Marije] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Prosser, Haydn M.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Uren, Anthony] MRC Clin Sci Ctr, Canc Genom Grp, London, England; [Aronica, Eleonora] Acad Med Ctr, Dept Neuro Pathol, Amsterdam, Netherlands; [van Lohuizen, Maarten] Acad Med Ctr, Ctr Biomed Genet, Amsterdam, Netherlands	Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Wellcome Trust Sanger Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Westerman, BA (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl	Westerman, Bart/ACM-8337-2022; Uren, Anthony G/A-5784-2009	Westerman, Bart/0000-0002-9898-9616; Uren, Anthony G/0000-0002-6019-7111; Aronica, Eleonora/0000-0002-3542-3770	Dutch Cancer Society; Medical Research Council [MC_UP_A652_1001, 1116184] Funding Source: researchfish; MRC [MC_UP_A652_1001] Funding Source: UKRI	Dutch Cancer Society(KWF Kankerbestrijding); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft JD, 2008, THEORY PRACTICE HIST, P131; Bea S, 2001, CANCER RES, V61, P2409; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dutton A, 2007, BLOOD, V109, P2597, DOI 10.1182/blood-2006-05-020545; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Farrell WE, 2000, FRONT NEUROENDOCRIN, V21, P174, DOI 10.1006/frne.1999.0195; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Foijer F, 2007, CANCER RES, V67, P9244, DOI 10.1158/0008-5472.CAN-07-1650; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; GRAY F, 2004, MANUAL BASIC NEUROPA; Guidi CJ, 2006, CANCER RES, V66, P8076, DOI 10.1158/0008-5472.CAN-06-1451; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; Hayry V, 2008, ACTA NEUROPATHOL, V116, P97, DOI 10.1007/s00401-008-0376-0; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Hinton DR, 1998, CANCER LETT, V126, P209, DOI 10.1016/S0304-3835(98)00013-5; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Johnson MD, 2007, J HISTOCHEM CYTOCHEM, V55, P1265, DOI 10.1369/jhc.7A7311.2007; Kovacs K, 2001, J NEURO-ONCOL, V54, P121, DOI 10.1023/A:1012945129981; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liu JH, 2008, J SURG ONCOL, V97, P267, DOI 10.1002/jso.20934; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; Marino S, 2000, GENE DEV, V14, P994; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398, DOI 10.1093/jnen/64.5.398; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Sanchez-Beato M, 2006, MODERN PATHOL, V19, P684, DOI 10.1038/modpathol.3800577; Shakhova O, 2006, CANCER RES, V66, P5190, DOI 10.1158/0008-5472.CAN-05-3545; Simpson DJ, 2000, CANCER RES, V60, P1211; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Subkhankulova T, 2010, MOL CELL NEUROSCI, V45, P151, DOI 10.1016/j.mcn.2010.06.006; Tirabosco R, 2008, PATHOL RES PRACT, V204, P625, DOI 10.1016/j.prp.2008.02.007; Tunici P, 2009, METHODS MOL BIOL, V568, P195, DOI 10.1007/978-1-59745-280-9_12; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, CANCER CELL, V15, P514, DOI 10.1016/j.ccr.2009.04.001; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yadirgi G, 2011, STEM CELLS; Yang GF, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-133; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yoshino A, 2007, J NEURO-ONCOL, V83, P153, DOI 10.1007/s11060-006-9316-9	60	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35943	10.1371/journal.pone.0035943	http://dx.doi.org/10.1371/journal.pone.0035943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574128	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800024
J	Barker, M; Solinski, HJ; Hashimoto, H; Tagoe, T; Pilati, N; Hamann, M				Barker, Matthew; Solinski, Hans Juergen; Hashimoto, Haruka; Tagoe, Thomas; Pilati, Nadia; Hamann, Martine			Acoustic Overexposure Increases the Expression of VGLUT-2 Mediated Projections from the Lateral Vestibular Nucleus to the Dorsal Cochlear Nucleus	PLOS ONE			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; SUPERIOR OLIVARY COMPLEX; INTENSE SOUND EXPOSURE; AUDITORY-NERVE FIBERS; INDUCED HEARING-LOSS; BRAIN-STEM; GUINEA-PIG; INFERIOR COLLICULUS; DISCHARGE PATTERNS; SYNAPTIC ENDINGS	The dorsal cochlear nucleus (DCN) is a first relay of the central auditory system as well as a site for integration of multimodal information. Vesicular glutamate transporters VGLUT-1 and VGLUT-2 selectively package glutamate into synaptic vesicles and are found to have different patterns of organization in the DCN. Whereas auditory nerve fibers predominantly co-label with VGLUT-1, somatosensory inputs predominantly co-label with VGLUT-2. Here, we used retrograde and anterograde transport of fluorescent conjugated dextran amine (DA) to demonstrate that the lateral vestibular nucleus (LVN) exhibits ipsilateral projections to both fusiform and deep layers of the rat DCN. Stimulating the LVN induced glutamatergic synaptic currents in fusiform cells and granule cell interneurones. We combined the dextran amine neuronal tracing method with immunohistochemistry and showed that labeled projections from the LVN are co-labeled with VGLUT-2 by contrast to VGLUT-1. Wistar rats were exposed to a loud single tone (15 kHz, 110 dB SPL) for 6 hours. Five days after acoustic overexposure, the level of expression of VGLUT-1 in the DCN was decreased whereas the level of expression of VGLUT-2 in the DCN was increased including terminals originating from the LVN. VGLUT-2 mediated projections from the LVN to the DCN are likely to play a role in the head position in response to sound. Amplification of VGLUT-2 expression after acoustic overexposure could be a compensatory mechanism from vestibular inputs in response to hearing loss and to a decrease of VGLUT-1 expression from auditory nerve fibers.	[Barker, Matthew; Solinski, Hans Juergen; Hashimoto, Haruka; Tagoe, Thomas; Pilati, Nadia; Hamann, Martine] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Barker, M (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	mh86@le.ac.uk	Hamann, Martine/P-8054-2014	Hamann, Martine/0000-0002-9142-6773; Tagoe, Thomas/0000-0002-3352-2142	Wellcome Trust [072033]; Royal Society [RG061307]; Medisearch (University of Leicester) [RM 36G0010]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Medisearch (University of Leicester)	This work has been supported by: Wellcome Trust (Ref 072033) to MH, http://www.wellcome.ac.uk; Royal Society (Ref RG061307) to MH, http://royalsociety.org; and Medisearch (University of Leicester) RM 36G0010 to MH, http://www2.le.ac.uk/colleges/medbiopsych. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1983, NEUROSCI LETT, V37, P205, DOI 10.1016/0304-3940(83)90431-7; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Babalian AL, 2005, EXP BRAIN RES, V167, P451, DOI 10.1007/s00221-005-0178-8; Babalian AL, 2003, EXP BRAIN RES, V153, P452, DOI 10.1007/s00221-003-1619-x; Baguley DM, 2006, SKULL BASE-INTERD AP, V16, P49, DOI 10.1055/s-2005-926216; Balakrishnan V, 2008, J NEUROPHYSIOL, V99, P208, DOI 10.1152/jn.00971.2007; Barker M, 2009, J NEUROSCI METH, V177, P273, DOI 10.1016/j.jneumeth.2008.10.021; BATZRIIZRAELI R, 1990, BRAIN BEHAV EVOLUT, V36, P237, DOI 10.1159/000115310; Billups B, 2005, NEUROSCI LETT, V382, P66, DOI 10.1016/j.neulet.2005.02.071; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; BROWN MC, 1990, HEARING RES, V49, P105, DOI 10.1016/0378-5955(90)90098-A; BROWNER RH, 1975, BRAIN BEHAV EVOLUT, V11, P322, DOI 10.1159/000123643; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Bukowska D, 2003, ARCH ITAL BIOL, V141, P39; Bukowska D, 2002, CELLS TISSUES ORGANS, V170, P61, DOI 10.1159/000047921; BURIAN M, 1988, NEUROSCI LETT, V84, P13, DOI 10.1016/0304-3940(88)90329-1; CHAN YS, 1979, EXP BRAIN RES, V35, P591; D'Sa C, 2007, EUR J NEUROSCI, V26, P666, DOI 10.1111/j.1460-9568.2007.05695.x; Daniels RW, 2011, NEUROBIOL DIS, V41, P415, DOI 10.1016/j.nbd.2010.10.009; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis KA, 1996, J NEUROPHYSIOL, V76, P3012, DOI 10.1152/jn.1996.76.5.3012; Ding J, 1999, J NEUROPHYSIOL, V82, P3434, DOI 10.1152/jn.1999.82.6.3434; Doucet JR, 1997, J COMP NEUROL, V385, P245; FEKETE DM, 1984, J COMP NEUROL, V229, P432, DOI 10.1002/cne.902290311; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Freeman Sharon, 1999, Journal of Basic and Clinical Physiology and Pharmacology, V10, P173; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Fyk-Kolodziej B, 2011, NEUROSCIENCE, V178, P218, DOI 10.1016/j.neuroscience.2010.12.059; Goel A, 2006, NAT NEUROSCI, V9, P1001, DOI 10.1038/nn1725; HACKNEY CM, 1990, ANAT EMBRYOL, V182, P123; Herraiz C, 2007, PROG BRAIN RES, V166, P389, DOI 10.1016/S0079-6123(07)66037-3; Herzog E, 2004, NEUROSCIENCE, V123, P983, DOI 10.1016/j.neuroscience.2003.10.039; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hurley PA, 2007, EUR J NEUROSCI, V26, P1813, DOI 10.1111/j.1460-9568.2007.05811.x; Ito T, 2011, J COMP NEUROL, V519, P316, DOI 10.1002/cne.22521; ITOH K, 1987, BRAIN RES, V400, P145, DOI 10.1016/0006-8993(87)90662-7; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; Jacomme AV, 2003, EXP BRAIN RES, V153, P467, DOI 10.1007/s00221-003-1606-2; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2000, HEARING RES, V140, P165, DOI 10.1016/S0378-5955(99)00197-5; Kaltenbach JA, 2007, HEARING RES, V226, P232, DOI 10.1016/j.heares.2006.07.001; Kameda K, 2010, J NEUROSURG, V112, P152, DOI 10.3171/2009.3.JNS081053; Kaneko T, 2002, NEUROSCI RES, V42, P243, DOI 10.1016/S0168-0102(02)00009-3; Kanold PO, 2001, J NEUROSCI, V21, P7848, DOI 10.1523/JNEUROSCI.21-19-07848.2001; Kanold PO, 1999, J NEUROSCI, V19, P2195; Kim JJ, 2004, J NEUROSCI RES, V77, P829, DOI 10.1002/jnr.20211; Kim JN, 1997, HEARING RES, V103, P169, DOI 10.1016/S0378-5955(96)00173-6; Koehler SD, 2011, EUR J NEUROSCI, V33, P409, DOI 10.1111/j.1460-9568.2010.07547.x; Kong WJ, 2010, BRAIN RES, V1331, P28, DOI 10.1016/j.brainres.2010.02.058; Lai SK, 2006, EUR J NEUROSCI, V23, P2431, DOI 10.1111/j.1460-9568.2006.04762.x; Lawner BE, 1997, INT J DEV NEUROSCI, V15, P601, DOI 10.1016/S0736-5748(96)00115-3; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; MARLINSKY VV, 1992, EXP BRAIN RES, V90, P583; May BJ, 2000, HEARING RES, V148, P74, DOI 10.1016/S0378-5955(00)00142-8; Morest DK, 1998, MICROSC RES TECHNIQ, V41, P205; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; MUGNAINI E, 1980, J COMP NEUROL, V191, P581, DOI 10.1002/cne.901910406; Muly SM, 2002, EXP NEUROL, V177, P202, DOI 10.1006/exnr.2002.7963; Murashita H, 2006, HEARING RES, V214, P1, DOI 10.1016/j.heares.2005.12.008; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; Oh SH, 2007, ACTA OTO-LARYNGOL, V127, P341, DOI 10.1080/00016480701275246; ORLOVSKY GN, 1972, BRAIN RES, V46, P85, DOI 10.1016/0006-8993(72)90007-8; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Piche M, 2007, NEUROSCIENCE, V145, P1144, DOI 10.1016/j.neuroscience.2006.12.050; PIERSON M, 1992, EPILEPSY RES, V13, P35, DOI 10.1016/0920-1211(92)90005-E; Pilati N, 2008, J HISTOCHEM CYTOCHEM, V56, P539, DOI 10.1369/jhc.2008.950246; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Rybalko N, 2011, PHYSIOL BEHAV, V102, P453, DOI 10.1016/j.physbeh.2010.12.010; Ryugo DK, 2003, EXP BRAIN RES, V153, P477, DOI 10.1007/s00221-003-1605-3; Sanes DH, 2011, HEAR RES; Santos MS, 2009, NEUROSCIENCE, V158, P189, DOI 10.1016/j.neuroscience.2008.03.029; Schofield BR, 2005, HEARING RES, V206, P3, DOI 10.1016/j.heares.2005.03.005; Shore SE, 2008, EUR J NEUROSCI, V27, P155, DOI 10.1111/j.1460-9568.2007.05983.x; Shore SE, 2005, EUR J NEUROSCI, V21, P3334, DOI 10.1111/j.1460-9568.2005.04142.x; Shore SE, 2000, J COMP NEUROL, V419, P271, DOI 10.1002/(SICI)1096-9861(20000410)419:3<271::AID-CNE1>3.0.CO;2-M; Shore SE, 2006, HEARING RES, V216, P90, DOI 10.1016/j.heares.2006.01.006; SNYDER RL, 1988, J COMP NEUROL, V278, P209, DOI 10.1002/cne.902780205; Street SE, 2007, J NEUROPHYSIOL, V97, P4162, DOI 10.1152/jn.00469.2006; Sumner CJ, 2005, J NEUROPHYSIOL, V94, P4234, DOI 10.1152/jn.00401.2005; Sutherland DP, 1998, BEHAV BRAIN RES, V97, P1, DOI 10.1016/S0166-4328(98)00008-4; Tascioglu AB, 2005, NEUROANATOMY, V4, P24; THOMPSON AM, 1995, J COMP NEUROL, V351, P104, DOI 10.1002/cne.903510110; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; WEINBERG RJ, 1989, J COMP NEUROL, V282, P142, DOI 10.1002/cne.902820111; WEINBERG RJ, 1987, NEUROSCIENCE, V20, P209, DOI 10.1016/0306-4522(87)90013-3; Wright DD, 1996, J COMP NEUROL, V365, P159, DOI 10.1002/(SICI)1096-9861(19960129)365:1<159::AID-CNE12>3.0.CO;2-L; YOUNG ED, 1995, J NEUROPHYSIOL, V73, P743, DOI 10.1152/jn.1995.73.2.743; Zeng C, 2011, NEUROSCIENCE, V176, P142, DOI 10.1016/j.neuroscience.2010.12.010; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhang FX, 2011, NEUROSCIENCE, V173, P179, DOI 10.1016/j.neuroscience.2010.11.013; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208; Zhou JX, 2004, J NEUROSCI RES, V78, P901, DOI 10.1002/jnr.20343	95	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35955	10.1371/journal.pone.0035955	http://dx.doi.org/10.1371/journal.pone.0035955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570693	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400009
J	Waldhaus, J; Cimerman, J; Gohlke, H; Ehrich, M; Muller, M; Lowenheim, H				Waldhaus, Joerg; Cimerman, Jelka; Gohlke, Henning; Ehrich, Mathias; Mueller, Marcus; Loewenheim, Hubert			Stemness of the Organ of Corti Relates to the Epigenetic Status of Sox2 Enhancers	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; COCHLEAR SUPPORTING CELLS; HAIR-CELLS; SELF-RENEWAL; GENE-EXPRESSION; DIFFERENTIATION; GENERATION; NOTCH; SPECIFICATION; PLURIPOTENCY	In the adult mammalian auditory epithelium, the organ of Corti, loss of sensory hair cells results in permanent hearing loss. The underlying cause for the lack of regenerative response is the depletion of otic progenitors in the cell pool of the sensory epithelium. Here, we show that an increase in the sequence-specific methylation of the otic Sox2 enhancers NOP1 and NOP2 is correlated with a reduced self-renewal potential in vivo and in vitro; additionally, the degree of methylation of NOP1 and NOP2 is correlated with the dedifferentiation potential of postmitotic supporting cells into otic stem cells. Thus, the stemness the organ of Corti is related to the epigenetic status of the otic Sox2 enhancers. These observations validate the continued exploration of treatment strategies for dedifferentiating or reprogramming of differentiated supporting cells into progenitors to regenerate the damaged organ of Corti.	[Waldhaus, Joerg; Cimerman, Jelka; Mueller, Marcus; Loewenheim, Hubert] Univ Tubingen, Med Ctr, Hearing Res Ctr Tubingen, Dept Otorhinolaryngol Head & Neck Surg, Tubingen, Germany; [Gohlke, Henning] SEQUENOM GmbH, Hamburg, Germany; [Ehrich, Mathias] SEQUENOM Inc, San Diego, CA USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Sequenom	Waldhaus, J (corresponding author), Stanford Univ, Dept Otolaryngol, Sch Med, Stanford, CA 94305 USA.	hubert.loewenheim@uni-tuebingen.de	Löwenheim, Hubert/GPS-7207-2022	Löwenheim, Hubert/0000-0001-8200-8804; Ehrich, Mathias/0000-0001-8415-0310	Federal Ministry of Education and Research (BMBF) [BioProfile 0313612A]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported in part by a grant from the Federal Ministry of Education and Research (BMBF) - project BioProfile 0313612A. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Batts SA, 2009, HEARING RES, V249, P15, DOI 10.1016/j.heares.2008.12.008; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chai RJ, 2011, JARO-J ASSOC RES OTO, V12, P455, DOI 10.1007/s10162-011-0267-2; Chaudhary J, 1999, MOL ENDOCRINOL, V13, P774, DOI 10.1210/me.13.5.774; Chen P, 2002, DEVELOPMENT, V129, P2495; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; Diensthuber M, 2009, JARO-J ASSOC RES OTO, V10, P173, DOI 10.1007/s10162-009-0161-3; Do JT, 2009, TRENDS PHARMACOL SCI, V30, P296, DOI 10.1016/j.tips.2009.03.003; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; Iwafuchi-Doi M, 2011, DEV BIOL, V352, P354, DOI 10.1016/j.ydbio.2010.12.027; Jeon SJ, 2011, J NEUROSCI, V31, P8351, DOI 10.1523/JNEUROSCI.6366-10.2011; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li HW, 2003, NAT MED, V9, P1293, DOI 10.1038/nm925; Malgrange B, 2002, MECH DEVELOP, V112, P79, DOI 10.1016/S0925-4773(01)00642-6; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2004, MOL CELL BIOL, V24, P4207, DOI 10.1128/MCB.24.10.4207-4220.2004; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Oshima Kazuo, 2009, V493, P141, DOI 10.1007/978-1-59745-523-7_9; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sahly I, 1997, ANAT EMBRYOL, V196, P159, DOI 10.1007/s004290050088; Savary E, 2007, STEM CELLS, V25, P332, DOI 10.1634/stemcells.2006-0303; Schilham MW, 1998, SEMIN IMMUNOL, V10, P127, DOI 10.1006/smim.1998.0114; Senn P, 2007, JARO-J ASSOC RES OTO, V8, P194, DOI 10.1007/s10162-007-0079-6; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Sinkkonen ST, 2011, SCI REP-UK, V1, DOI 10.1038/srep00026; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Warchol ME, 2011, HEARING RES, V273, P72, DOI 10.1016/j.heares.2010.05.004; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Yuzyuk T, 2009, DEV CELL, V16, P699, DOI 10.1016/j.devcel.2009.03.008; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	52	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36066	10.1371/journal.pone.0036066	http://dx.doi.org/10.1371/journal.pone.0036066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570694	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400010
J	Zhu, CT; Ling, Y; Dong, CL; Zhou, XF; Wang, F				Zhu, Changtai; Ling, Yang; Dong, Chunlei; Zhou, Xifa; Wang, Feng			The Relationship between Oral Squamous Cell Carcinoma and Human Papillomavirus: A Meta-Analysis of a Chinese Population (1994-2011)	PLOS ONE			English	Article							HEAD; NECK; INFECTION; CANCER; RISK; HPV; PREVENTION; OROPHARYNX; PROGNOSIS; SURVIVAL	Background: Previous studies indicated that oral squamous cell carcinomas (OSCC) might be related to human papilloma virus (HPV) infection. However, up to now, there still lacks a large sample study to analyze the relationship between OSCC in a Chinese population and oral HPV infection. In the present study, we used a meta-analysis to evaluate the relationship of OSCC with HPV infection in a Chinese population. Methods: The reports on HPV and OSCC in a Chinese population published between January, 1994, and September, 2011 were retrieved via CNKI/WANFANG/OVID/MEDLINE databases. According to the inclusion criteria, we selected 18 eligible case-control studies. After testing the heterogeneity of the studies by the Cochran Q test, the meta-analyses for HPV and HPV16 were performed using the fixed effects model. Results: The overall positive rates of HPV and HPV16 in OSCC were 58.0% (354/610; 95% confidence interval [CI], 54.1-61.9) and 47.47% (169/356; 95% CI: 42.3-52.7), respectively; which were significantly higher than those in normal controls 10.44% (26/249; 95% CI: 7.2-14.7) and 7.1% (13/182; 95% CI: 4.2-11.8). Quantitative meta-analysis revealed that, compared with normal controls, the combined odds ratios of OSCC with HPV or HPV16 infection were 12.7 (95% CI: 8.0-20.0) and 9.0 (95% CI: 5.1-15.6), respectively. Both Begg's test and funnel plots revealed that no publication bias was found in this present study (P>0.05). Conclusions: High incidences of HPV infection (mainly involving HPV16) were found in the samples of Chinese OSCC. For the Chinese population, HPV infection elevates the risk of OSCC tumorigenesis. Prophylactic HPV-vaccination may reduce the burden of HPV-related OSCC in China.	[Zhu, Changtai; Dong, Chunlei] Soochow Univ, Changzhou Tumor Hosp, Dept Lab Med, Changzhou, Peoples R China; [Ling, Yang] Soochow Univ, Changzhou Tumor Hosp, Dept Oncol, Changzhou, Peoples R China; [Zhou, Xifa; Wang, Feng] Soochow Univ, Changzhou Tumor Hosp, Dept Radiat Oncol, Changzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Ling, Y (corresponding author), Soochow Univ, Changzhou Tumor Hosp, Dept Oncol, Changzhou, Peoples R China.	lingyang11566@163.com	Zhu, Changtai/V-1583-2017; zhu, changtai/W-6581-2019	Zhu, Changtai/0000-0002-5250-1937; zhu, changtai/0000-0002-5250-1937				Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P118; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen RW, 2005, REV MED VIROL, V15, P351, DOI 10.1002/rmv.471; Cleveland JL, 2011, J AM DENT ASSOC, V142, P915, DOI 10.14219/jada.archive.2011.0298; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Elad S, 2010, TRANSPLANTATION, V90, P1243, DOI 10.1097/TP.0b013e3181f9caaa; Gillison ML, 2006, J CLIN ONCOL, V24, P5623, DOI 10.1200/JCO.2006.07.1829; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hsieh CH, 2011, HEAD NECK-J SCI SPEC, V33, P1758, DOI 10.1002/hed.21665; Jung WW, 2004, J MICROBIOL, V42, P255; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Karagas M.R., 2010, BRIT MED J, V341, pc2986; Li W, 2003, INT J CANCER, V106, P553, DOI 10.1002/ijc.11261; Licitra L, 2006, J CLIN ONCOL, V24, P5630, DOI 10.1200/JCO.2005.04.6136; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCullough MJ, 2008, AUST DENT J, V53, P302, DOI 10.1111/j.1834-7819.2008.00070.x; Miller CS, 2001, ORAL SURG ORAL MED O, V91, P622, DOI 10.1067/moe.2001.115392; Munoz N, 1996, Bull Pan Am Health Organ, V30, P362; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Ringstrom E, 2002, CLIN CANCER RES, V8, P3187; Ritchie JM, 2003, INT J CANCER, V104, P336, DOI 10.1002/ijc.10960; Rivero Elena Riet Correa, 2006, Braz. oral res., V20, P21, DOI 10.1590/S1806-83242006000100005; Rodriguez T, 2004, ORAL ONCOL, V40, P207, DOI 10.1016/j.oraloncology.2003.08.014; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Settle K, 2009, CANCER PREV RES, V2, P776, DOI 10.1158/1940-6207.CAPR-09-0149; Silling S, 2012, J CLIN VIROL, V53, P325, DOI 10.1016/j.jcv.2011.12.029; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024083; SYRJANEN K, 1983, INT J ORAL MAXILLOF, V12, P418, DOI 10.1016/S0300-9785(83)80033-7; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Termine N, 2008, ANN ONCOL, V19, P1681, DOI 10.1093/annonc/mdn372; Thorland EC, 2003, ONCOGENE, V22, P1225, DOI 10.1038/sj.onc.1206170; Tsimplaki E, 2012, J ONCOL, V2012, DOI 10.1155/2012/893275; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P157, DOI 10.1111/j.1600-0714.2007.00605.x; Weinberger PM, 2006, J CLIN ONCOL, V24, P736, DOI 10.1200/JCO.2004.00.3335; Wollina U, 2002, HAUTARZT, V53, P795, DOI 10.1007/s00105-002-0413-1; Yamakawa-Kakuta Y, 2009, INT J ONCOL, V35, P983, DOI 10.3892/ijo_00000412; Zygogianni AG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-2	45	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36294	10.1371/journal.pone.0036294	http://dx.doi.org/10.1371/journal.pone.0036294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570701	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400017
J	Bendtsen, KM; Juul, J; Trusina, A				Bendtsen, Kristian Moss; Juul, Jeppe; Trusina, Ala			Fragile DNA Repair Mechanism Reduces Ageing in Multicellular Model	PLOS ONE			English	Article							STEM-CELLS; CELLULAR SENESCENCE; DAMAGE; INSTABILITY; EXPRESSION; CANCER; BRAIN; VITRO; AGE	DNA damages, as well as mutations, increase with age. It is believed that these result from increased genotoxic stress and decreased capacity for DNA repair. The two causes are not independent, DNA damage can, for example, through mutations, compromise the capacity for DNA repair, which in turn increases the amount of unrepaired DNA damage. Despite this vicious circle, we ask, can cells maintain a high DNA repair capacity for some time or is repair capacity bound to continuously decline with age? We here present a simple mathematical model for ageing in multicellular systems where cells subjected to DNA damage can undergo full repair, go apoptotic, or accumulate mutations thus reducing DNA repair capacity. Our model predicts that at the tissue level repair rate does not continuously decline with age, but instead has a characteristic extended period of high and non-declining DNA repair capacity, followed by a rapid decline. Furthermore, the time of high functionality increases, and consequently slows down the ageing process, if the DNA repair mechanism itself is vulnerable to DNA damages. Although counterintuitive at first glance, a fragile repair mechanism allows for a faster removal of compromised cells, thus freeing the space for healthy peers. This finding might be a first step toward understanding why a mutation in single DNA repair protein (e.g. Wrn or Blm) is not buffered by other repair proteins and therefore, leads to severe ageing disorders.	[Bendtsen, Kristian Moss; Juul, Jeppe; Trusina, Ala] Univ Copenhagen, Niels Bohr Inst, CMOL, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Bendtsen, KM (corresponding author), Univ Copenhagen, Niels Bohr Inst, CMOL, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	kmoss@nbi.dk	Trusina, Ala/L-6069-2013; Trusina, Ala/N-5030-2019; trusina, ala/H-7312-2012	Trusina, Ala/0000-0003-1945-454X; Trusina, Ala/0000-0003-1945-454X; 	Danish Research Council, Nordea-fonden, Steno Fellowship	Danish Research Council, Nordea-fonden, Steno Fellowship	This work was supported by the Danish Research Council, Nordea-fonden, Steno Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araia F, 2011, STEMBOOK; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Busuttil RA, 2004, ANN NY ACAD SCI, V1019, P245, DOI 10.1196/annals.1297.041; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Charville GW, 2011, PHILOS T R SOC B, V366, P85, DOI 10.1098/rstb.2010.0279; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Flindt R, 2006, AMAZING NUMBERS BIOL; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com; KELLER G, 1990, J EXP MED, V171, P1407, DOI 10.1084/jem.171.5.1407; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Richardson LL, 2000, BIOL REPROD, V62, P789, DOI 10.1095/biolreprod62.3.789; Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sieburg HB, 2011, P NATL ACAD SCI USA, V108, P4370, DOI 10.1073/pnas.1011414108; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013; Wilson TM, 1996, MUTAT RES-DNA REPAIR, V362, P237, DOI 10.1016/0921-8777(95)00053-4; Wodarz D, 2007, J THEOR BIOL, V245, P449, DOI 10.1016/j.jtbi.2006.10.013	23	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36018	10.1371/journal.pone.0036018	http://dx.doi.org/10.1371/journal.pone.0036018			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567122	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500040
J	Jaramillo, E; Dugan, JE; Hubbard, DM; Melnick, D; Manzano, M; Duarte, C; Campos, C; Sanchez, R				Jaramillo, Eduardo; Dugan, Jenifer E.; Hubbard, David M.; Melnick, Daniel; Manzano, Mario; Duarte, Cristian; Campos, Cesar; Sanchez, Roland			Ecological Implications of Extreme Events: Footprints of the 2010 Earthquake along the Chilean Coast	PLOS ONE			English	Article							MAULE EARTHQUAKE; BEACH ECOSYSTEMS; SEISMIC GAP; TSUNAMI; LESSONS; SLIP	Deciphering ecological effects of major catastrophic events such as earthquakes, tsunamis, volcanic eruptions, storms and fires, requires rapid interdisciplinary efforts often hampered by a lack of pre-event data. Using results of intertidal surveys conducted shortly before and immediately after Chile's 2010 M-w 8.8 earthquake along the entire rupture zone (ca. 34-38 degrees S), we provide the first quantification of earthquake and tsunami effects on sandy beach ecosystems. Our study incorporated anthropogenic coastal development as a key design factor. Ecological responses of beach ecosystems were strongly affected by the magnitude of land-level change. Subsidence along the northern rupture segment combined with tsunami-associated disturbance and drowned beaches. In contrast, along the co-seismically uplifted southern rupture, beaches widened and flattened increasing habitat availability. Post-event changes in abundance and distribution of mobile intertidal invertebrates were not uniform, varying with land-level change, tsunami height and coastal development. On beaches where subsidence occurred, intertidal zones and their associated species disappeared. On some beaches, uplift of rocky subtidal substrate eliminated low intertidal sand beach habitat for ecologically important species. On others, unexpected interactions of uplift with man-made coastal armouring included restoration of upper and mid-intertidal habitat seaward of armouring followed by rapid colonization of mobile crustaceans typical of these zones formerly excluded by constraints imposed by the armouring structures. Responses of coastal ecosystems to major earthquakes appear to vary strongly with land-level change, the mobility of the biota and shore type. Our results show that interactions of extreme events with human-altered shorelines can produce surprising ecological outcomes, and suggest these complex responses to landscape alteration can leave lasting footprints in coastal ecosystems.	[Jaramillo, Eduardo; Manzano, Mario; Campos, Cesar; Sanchez, Roland] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Dugan, Jenifer E.; Hubbard, David M.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Melnick, Daniel] Univ Potsdam, Inst Geowissensch, Potsdam, Germany; [Duarte, Cristian] Univ Austral Chile, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Austral de Chile; University of California System; University of California Santa Barbara; University of Potsdam; Universidad Austral de Chile	Jaramillo, E (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	ejaramillo@uach.cl	Duarte, Cristian/I-4013-2016; Melnick, Daniel/G-8484-2011	Melnick, Daniel/0000-0001-8397-7391; Duarte, Cristian/0000-0002-7033-3551; Sanchez Munoz, Roland/0000-0003-1866-0237	CONICYT (National Commision for Science, Chile); Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; National Science Foundation [OCE-0620276]; German Science Foundation [ME 3157/2-1]	CONICYT (National Commision for Science, Chile); Direccion de Investigacion y Desarrollo, Universidad Austral de Chile; National Science Foundation(National Science Foundation (NSF)); German Science Foundation(German Research Foundation (DFG))	This work was supported by grants from CONICYT (National Commision for Science, Chile; www.conicyt.cl) and Direccion de Investigacion y Desarrollo, Universidad Austral de Chile (http://investigacion.uach.cl/direccion/index.php) to EJ. Support was provided by Santa Barbara Coastal Long Term Ecological Research program (National Science Foundation Award # OCE-0620276) (www.nsf.gov) for JED's participation. DM was supported by grant ME 3157/2-1, German Science Foundation (www.dfg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATWATER BF, 1992, SCIENCE, V258, P1614, DOI 10.1126/science.258.5088.1614; ATWATER BF, 1987, SCIENCE, V236, P942, DOI 10.1126/science.236.4804.942; Brown AC, 2001, ENCY OCEAN SCI, V5, P2496; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; Castilla JC, 2010, MAR ECOL PROG SER, V418, P17, DOI 10.3354/meps08830; Charlier RH, 2005, J COASTAL RES, V21, P79, DOI 10.2112/03561.1; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Corti P, 2002, STUD NEOTROP FAUNA E, V37, P9, DOI 10.1076/snfe.37.1.9.2118; Darwin C, 1851, GEOLOGICAL OBSERVATI; Dugan JE, 2008, MAR ECOL-EVOL PERSP, V29, P160, DOI 10.1111/j.1439-0485.2008.00231.x; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Dugan JE, 2010, ESTUAR COAST, V33, P67, DOI 10.1007/s12237-009-9239-8; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; EMANUEL KA, 1987, NATURE, V326, P483, DOI 10.1038/326483a0; EMERY KO, 1961, LIMNOL OCEANOGR, V6, P90, DOI 10.4319/lo.1961.6.1.0090; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Feagin RA, 2005, FRONT ECOL ENVIRON, V3, P359, DOI 10.2307/3868584; Foster DR, 1998, ECOSYSTEMS, V1, P497, DOI 10.1007/s100219900046; Franklin J.F., 2000, CONSERVATION BIOL PR, V1, P9, DOI DOI 10.1111/J.1526-4629.2000.TB00155.X; Franklin JF, 2000, SCIENCE, V288, P1183, DOI 10.1126/science.288.5469.1183; Fritz HM, 2011, PURE APPL GEOPHYS, V168, P1989, DOI 10.1007/s00024-011-0283-5; HALL MJ, 1991, J COASTAL RES, V7, P771; International Federation of Red Cross and Red Crescent Societies, 2009, WORLD DIS REP 2009 F; Jaramillo E, 2001, ECOL STU AN, V144, P219; Lagos NA, 2008, WETLANDS, V28, P938, DOI 10.1672/07-119.1; Liew SC, 2010, GEOMORPHOLOGY, V114, P520, DOI 10.1016/j.geomorph.2009.08.010; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Lindenmayer DB, 2009, SCIENCE, V324, P463, DOI 10.1126/science.324_463b; Lomnitz C, 2004, SEISMOL RES LETT, V75, P368, DOI 10.1785/gssrl.75.3.368; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; McLachlan A, 1995, OCEANOGR MAR BIOL, V33, P305; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; Nelson A.R., 1992, QUATERN INT, V15, P61, DOI [10.1016/1040-6182(92)90036-2, DOI 10.1016/1040-6182(92)90036-2]; Nordstrom K.F, 2000, BEACHES DUNES DEV CO; PLAFKER G, 1970, GEOL SOC AM BULL, V81, P1001, DOI 10.1130/0016-7606(1970)81[1001:MOTCEO]2.0.CO;2; Reinhardt EG, 2010, MAR GEOL, V269, P18, DOI 10.1016/j.margeo.2009.12.003; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; The Ramsar Convention on Wetlands, CARL ANW SANCT RAMS; Tong XP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045805; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Turner MG, 2003, FRONT ECOL ENVIRON, V1, P351, DOI 10.2307/3868187; Turner MG, 2010, ECOLOGY, V91, P2833, DOI 10.1890/10-0097.1; Vargas G, 2011, ANDEAN GEOL, V38, P219, DOI 10.5027/andgeoV38n1-a12; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wiegel R.L, 2002, SHORE BEACH, V70, P17; Wong PP, 2009, POL J ENVIRON STUD, V18, P5	50	94	97	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35348	10.1371/journal.pone.0035348	http://dx.doi.org/10.1371/journal.pone.0035348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567101	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500019
J	Abdelli, S; Bonny, C				Abdelli, Saida; Bonny, Christophe			JNK3 Maintains Expression of the Insulin Receptor Substrate 2 (IRS2) in Insulin-Secreting Cells: Functional Consequences for Insulin Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-B; PANCREATIC BETA-CELLS; PHYSIOLOGICAL FUNCTIONS; TUMOR SUPPRESSION; MICE LACKING; TRANSCRIPTION; APOPTOSIS; AKT; RESISTANCE; GROWTH	We have recently shown that silencing of the brain/islet specific c-Jun N-terminal Kinase3 (JNK3) isoform enhances both basal and cytokine-induced beta-cell apoptosis, whereas silencing of JNK1 or JNK2 has opposite effects. While it is known that JNK1 or JNK2 may promote apoptosis by inhibiting the activity of the pro-survival Akt pathway, the effect of JNK3 on Akt has not been documented. This study aims to determine the involvement of individual JNKs and specifically JNK3 in the regulation of the Akt signaling pathway in insulin-secreting cells. JNK3 silencing strongly decreases Insulin Receptor Substrate 2 (IRS2) protein expression, and blocks Akt2 but not Akt1 activation by insulin, while the silencing of JNK1 or JNK2 activates both Akt1 and Akt2. Concomitantly, the silencing of JNK1 or JNK2, but not of JNK3, potently phosphorylates the glycogen synthase kinase3 (GSK3 beta). JNK3 silencing also decreases the activity of the transcription factor Forkhead BoxO3A (FoxO3A) that is known to control IRS2 expression, in addition to increasing c-Jun levels that are known to inhibit insulin gene expression. In conclusion, we propose that JNK1/2 on one hand and JNK3 on the other hand, have opposite effects on insulin-signaling in insulin-secreting cells; JNK3 protects beta-cells from apoptosis and dysfunction mainly through maintenance of a normal IRS2 to Akt2 signaling pathway. It seems that JNK3 mediates its effects mainly at the transcriptional level, while JNK1 or JNK2 appear to mediate their pro-apoptotic effect in the cytoplasm.	[Abdelli, Saida; Bonny, Christophe] CHU Vaudois, Serv Med Genet, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Abdelli, S (corresponding author), CHU Vaudois, Serv Med Genet, Lausanne, Switzerland.	christophe.bonny@chuv.ch	Bonny, Christophe/AAV-7214-2021		Swiss National Foundation [FNS 320000-118193]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by a grant from the Swiss National Foundation (FNS 320000-118193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2007, DIABETOLOGIA, V50, P1660, DOI 10.1007/s00125-007-0704-2; Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Abdelli S, 2009, DIABETOLOGIA, V52, P1871, DOI 10.1007/s00125-009-1431-7; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Cantley J, 2007, DIABETOLOGIA, V50, P1248, DOI 10.1007/s00125-007-0637-9; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen WS, 2001, GENE DEV, V15, P2203, DOI 10.1101/gad.913901; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Glauser DA, 2007, J ENDOCRINOL, V193, P195, DOI 10.1677/JOE-06-0191; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holst LS, 1998, BIOCHEM BIOPH RES CO, V250, P181, DOI 10.1006/bbrc.1998.9166; Jaeschke A, 2005, P NATL ACAD SCI USA, V102, P6931, DOI 10.1073/pnas.0502143102; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kim JY, 2010, J KOREAN MED SCI, V25, P1626, DOI 10.3346/jkms.2010.25.11.1626; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Liu Y, 2010, DIABETOLOGIA, V53, P2600, DOI 10.1007/s00125-010-1882-x; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandrup-Poulsen T, 2001, DIABETES, V50, pS58, DOI 10.2337/diabetes.50.2007.S58; MANDRUPPOULSEN T, 1986, DIABETOLOGIA, V29, P63, DOI 10.1007/BF02427283; MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; ROBINSON GLWG, 1995, MOL CELL BIOL, V15, P1398; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Tanabe K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018146; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Tsunekawa S, 2011, DIABETES, V60, P2883, DOI 10.2337/db11-0340; White MF, 1998, CURR TOP MICROBIOL, V228, P179; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	61	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35997	10.1371/journal.pone.0035997	http://dx.doi.org/10.1371/journal.pone.0035997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563476	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700025
J	Bokulich, NA; Joseph, CML; Allen, G; Benson, AK; Mills, DA				Bokulich, Nicholas A.; Joseph, C. M. Lucy; Allen, Greg; Benson, Andrew K.; Mills, David A.			Next-Generation Sequencing Reveals Significant Bacterial Diversity of Botrytized Wine	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; MICROBIAL COMMUNITIES; ACID BACTERIA; YEAST; 16S; FERMENTATION; EVOLUTION; HEALTHY; GRAPE	While wine fermentation has long been known to involve complex microbial communities, the composition and role of bacteria other than a select set of lactic acid bacteria (LAB) has often been assumed either negligible or detrimental. This study served as a pilot study for using barcoded amplicon next-generation sequencing to profile bacterial community structure in wines and grape musts, comparing the taxonomic depth achieved by sequencing two different domains of prokaryotic 16S rDNA (V4 and V5). This study was designed to serve two goals: 1) to empirically determine the most taxonomically informative 16S rDNA target region for barcoded amplicon sequencing of wine, comparing V4 and V5 domains of bacterial 16S rDNA to terminal restriction fragment length polymorphism (TRFLP) of LAB communities; and 2) to explore the bacterial communities of wine fermentation to better understand the biodiversity of wine at a depth previously unattainable using other techniques. Analysis of amplicons from the V4 and V5 provided similar views of the bacterial communities of botrytized wine fermentations, revealing a broad diversity of low-abundance taxa not traditionally associated with wine, as well as atypical LAB communities initially detected by TRFLP. The V4 domain was determined as the more suitable read for wine ecology studies, as it provided greater taxonomic depth for profiling LAB communities. In addition, targeted enrichment was used to isolate two species of Alphaproteobacteria from a finished fermentation. Significant differences in diversity between inoculated and uninoculated samples suggest that Saccharomyces inoculation exerts selective pressure on bacterial diversity in these fermentations, most notably suppressing abundance of acetic acid bacteria. These results determine the bacterial diversity of botrytized wines to be far higher than previously realized, providing further insight into the fermentation dynamics of these wines, and demonstrate the utility of next-generation sequencing for wine ecology studies.	[Bokulich, Nicholas A.; Joseph, C. M. Lucy; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Allen, Greg] Dolce Winery, Oakville, CA USA; [Benson, Andrew K.] Univ Nebraska, Dept Food Sci, Lincoln, NE USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Nebraska System; University of Nebraska Lincoln	Bokulich, NA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David/GXF-1821-2022; Mills, David Andrew/G-2282-2011	Mills, David Andrew/0000-0003-1913-9865; Benson, Andrew/0000-0001-6330-0252; Bokulich, Nicholas/0000-0002-1784-8935	Oregon Wine Board; California Competitive Grants Program for Research in Viticulture and Enology; Wine Spectator scholarship; Wine Spectator; University of California Davis, Department of Viticulture and Enology	Oregon Wine Board; California Competitive Grants Program for Research in Viticulture and Enology; Wine Spectator scholarship; Wine Spectator; University of California Davis, Department of Viticulture and Enology	This work was supported in part by funding from the Oregon Wine Board and the California Competitive Grants Program for Research in Viticulture and Enology. NAB was supported by a Wine Spectator scholarship during the completion of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NAB was supported by a scholarship from a commercial source (Wine Spectator). This scholarship was awarded by a third-party source (University of California Davis, Department of Viticulture and Enology). GA is employed by the Dolce Winery, Oakville. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Allen GR, 2004, THESIS U CALIFORNIA; Andorra I, 2008, FOOD MICROBIOL, V25, P849, DOI 10.1016/j.fm.2008.05.005; Andorra I, 2010, FOOD RES INT, V43, P773, DOI 10.1016/j.foodres.2009.11.014; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bokulich NA, 2012, AM J ENOL VITICULT, V63, P185, DOI 10.5344/ajev.2011.11077; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cocolin L, 2001, AM J ENOL VITICULT, V52, P49; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; JOYEUX A, 1984, APPL ENVIRON MICROB, V48, P153, DOI 10.1128/AEM.48.1.153-156.1984; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Leveau JHJ, 2011, ACTA HORTIC, V905, P31; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martinez I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015046; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Mills DA, 2007, MOL METHODS MICROBIA; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P6705, DOI 10.1128/AEM.01279-07; Nisiotou AA, 2007, APPL ENVIRON MICROB, V73, P2765, DOI 10.1128/AEM.01864-06; Nisiotou AA, 2011, INT J FOOD MICROBIOL, V145, P432, DOI 10.1016/j.ijfoodmicro.2011.01.017; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Renouf V, 2006, J APPL MICROBIOL, V100, P1208, DOI 10.1111/j.1365-2672.2006.02959.x; Renouf V, 2007, APPL MICROBIOL BIOT, V75, P149, DOI 10.1007/s00253-006-0798-3; Ribereau-Gayon P, 1985, AM J ENOL VITICULT, V36, P1985; Sato T, 1998, APPL ENV MICROBIOL, V64; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Soergel DAW, 2012, ISME, V7, DOI [10.1038/ismej.2011.1208, DOI 10.1038/ISMEJ.2011.1208]; Wang Q, 2007, APPL ENV MICROBIOL, V73; Werner JJ, 2011, ISME, DOI [10.1038/ismej.2011.1186, DOI 10.1038/ISMEJ.2011.1186]	39	151	160	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36357	10.1371/journal.pone.0036357	http://dx.doi.org/10.1371/journal.pone.0036357			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563494	Green Published, gold			2022-12-27	WOS:000305340700043
J	Hsu, TW; Wu, CWW; Cheng, YF; Chen, HL; Lu, CH; Cho, KH; Lin, WC; Lin, CP				Hsu, Tun-Wei; Wu, Changwei W.; Cheng, Yu-Fan; Chen, Hsiu-Ling; Lu, Cheng-Hsien; Cho, Kuan-Hung; Lin, Wei-Che; Lin, Ching-Po			Impaired Small-World Network Efficiency and Dynamic Functional Distribution in Patients with Cirrhosis	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SUBCLINICAL HEPATIC-ENCEPHALOPATHY; GRAPH-THEORETICAL ANALYSIS; RESTING-STATE; GLUCOSE-METABOLISM; CORTICAL THICKNESS; BRAIN; CONNECTIVITY; CORTEX; FREQUENCY	Hepatic encephalopathy (HE) is a complex neuropsychiatric syndrome and a major complication of liver cirrhosis. Dysmetabolism of the brain, related to elevated ammonia levels, interferes with intercortical connectivity and cognitive function. For evaluation of network efficiency, a 'small-world' network model can quantify the effectiveness of information transfer within brain networks. This study aimed to use small-world topology to investigate abnormalities of neuronal connectivity among widely distributed brain regions in patients with liver cirrhosis using resting-state functional magnetic resonance imaging (rs-fMRI). Seventeen cirrhotic patients without HE, 9 with minimal HE, 9 with overt HE, and 35 healthy controls were compared. The interregional correlation matrix was obtained by averaging the rs-fMRI time series over all voxels in each of the 90 regions using the automated anatomical labeling model. Cost and correlation threshold values were then applied to construct the functional brain network. The absolute and relative network efficiencies were calculated; quantifying distinct aspects of the local and global topological network organization. Correlations between network topology parameters, ammonia levels, and the severity of HE were determined using linear regression and ANOVA. The local and global topological efficiencies of the functional connectivity network were significantly disrupted in HE patients; showing abnormal small-world properties. Alterations in regional characteristics, including nodal efficiency and nodal strength, occurred predominantly in the association, primary, and limbic/paralimbic regions. The degree of network organization disruption depended on the severity of HE. Ammonia levels were also significantly associated with the alterations in local network properties. Results indicated that alterations in the rs-fMRI network topology of the brain were associated with HE grade; and that focal or diffuse lesions disturbed the functional network to further alter the global topology and efficiency of the whole brain network. These findings provide insights into the functional changes in the human brain in HE.	[Hsu, Tun-Wei; Chen, Hsiu-Ling; Lin, Wei-Che; Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Hsu, Tun-Wei] Taipei Vet Gen Hosp, Dept Diagnost Radiol, Taipei, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Inst Biomed Engn, Tao Yuan, Taiwan; [Cheng, Yu-Fan; Chen, Hsiu-Ling; Lin, Wei-Che] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Neurol, Kaohsiung, Taiwan; [Cho, Kuan-Hung; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Brain Connect Lab, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Central University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Hsu, TW (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	u64lin@yahoo.com.tw; cplin@ym.edu.tw		Hsu, Tun-Wei/0000-0002-4614-6449; Wu, Changwei W./0000-0001-8968-9366	National Science Council [NSC 97-2314-B-182A-104-MY3, NSC 100-2628-E-010-002-MY3]; National Health Research Institute [NHRI-EX100-9813EC]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Science Council (NSC 97-2314-B-182A-104-MY3 to Dr. W. Lin, NSC 100-2628-E-010-002-MY3 to Dr. C. Lin) and National Health Research Institute (NHRI-EX100-9813EC to Dr. C. Lin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; ALMDAL T, 1989, SCAND J GASTROENTERO, V24, P299, DOI 10.3109/00365528909093050; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Cordoba J, 1996, SEMIN LIVER DIS, V16, P271, DOI 10.1055/s-2007-1007240; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; de Haan W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-101; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fernandez R, 2007, NEUROLOGY, V68, P2066, DOI 10.1212/01.wnl.0000264873.62313.81; Gerber T, 2000, DRUGS, V60, P1353, DOI 10.2165/00003495-200060060-00008; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2009, BRAIN, V132, P3366, DOI 10.1093/brain/awp089; Hertz L, 2007, METAB BRAIN DIS, V22, P199, DOI 10.1007/s11011-007-9068-z; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kale RA, 2006, HEPATOLOGY, V43, P698, DOI 10.1002/hep.21114; Kato A, 2000, HEPATOL RES, V17, P237, DOI 10.1016/S1386-6346(99)00080-7; KAWATOKO T, 1992, Fukuoka Acta Medica, V83, P33; LAI JCK, 1986, J NEUROCHEM, V47, P1376, DOI 10.1111/j.1471-4159.1986.tb00768.x; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; Lockwood AH, 2002, METAB BRAIN DIS, V17, P29, DOI 10.1023/A:1014000313824; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Norenberg MD, 2005, METAB BRAIN DIS, V20, P303, DOI 10.1007/s11011-005-7911-7; OCARROLL RE, 1991, LANCET, V337, P1250, DOI 10.1016/0140-6736(91)92920-W; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Schiff S, 2006, CLIN NEUROPHYSIOL, V117, P1728, DOI 10.1016/j.clinph.2006.04.020; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Toga AW, 2003, NAT REV NEUROSCI, V4, P37, DOI 10.1038/nrn1009; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; TRZEPACZ PT, 1994, J NEUROPSYCH CLIN N, V6, P170; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2010, NEUROIMAGE, V51, P1106, DOI 10.1016/j.neuroimage.2010.03.011; van Dellen E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008081; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wu K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019608; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zafiris O, 2004, NEUROIMAGE, V22, P541, DOI 10.1016/j.neuroimage.2004.01.038; Zhao QB, 2008, PHYSICA A, V387, P5952, DOI 10.1016/j.physa.2008.07.002; Zwingmann C, 2003, HEPATOLOGY, V37, P420, DOI 10.1053/jhep.2003.50052	59	38	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35266	10.1371/journal.pone.0035266	http://dx.doi.org/10.1371/journal.pone.0035266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563460	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700009
J	Lardizabal, MN; Nocito, AL; Daniele, SM; Ornella, LA; Palatnik, JF; Veggi, LM				Lardizabal, Maria N.; Nocito, Ana L.; Daniele, Stella M.; Ornella, Leonardo A.; Palatnik, Javier F.; Veggi, Luis M.			Reference Genes for Real-Time PCR Quantification of MicroRNAs and Messenger RNAs in Rat Models of Hepatotoxicity	PLOS ONE			English	Article							RT-PCR; HOUSEKEEPING GENES; RELATIVE QUANTIFICATION; QUANTITATIVE PCR; LIVER-DISEASES; EXPRESSION; NORMALIZATION; TARGET; INJURY; GUIDELINES	Hepatotoxicity is associated with major changes in liver gene expression induced by xenobiotic exposure. Understanding the underlying mechanisms is critical for its clinical diagnosis and treatment. MicroRNAs are key regulators of gene expression that control mRNA stability and translation, during normal development and pathology. The canonical technique to measure gene transcript levels is Real-Time qPCR, which has been successfully modified to determine the levels of microRNAs as well. However, in order to obtain accurate data in a multi-step method like RT-qPCR, the normalization with endogenous, stably expressed reference genes is mandatory. Since the expression stability of candidate reference genes varies greatly depending on experimental factors, the aim of our study was to identify a combination of genes for optimal normalization of microRNA and mRNA qPCR expression data in experimental models of acute hepatotoxicity. Rats were treated with four traditional hepatotoxins: acetaminophen, carbon tetrachloride, D-galactosamine and thioacetamide, and the liver expression levels of two groups of candidate reference genes, one for microRNA and the other for mRNA normalization, were determined by RT-qPCR in compliance with the MIQE guidelines. In the present study, we report that traditional reference genes such as U6 spliceosomal RNA, Beta Actin and Glyceraldehyde-3P-dehydrogenase altered their expression in response to classic hepatotoxins and therefore cannot be used as reference genes in hepatotoxicity studies. Stability rankings of candidate reference genes, considering only those that did not alter their expression, were determined using geNorm, NormFinder and BestKeeper software packages. The potential candidates whose measurements were stable were further tested in different combinations to find the optimal set of reference genes that accurately determine mRNA and miRNA levels. Finally, the combination of MicroRNA-16/5S Ribosomal RNA and Beta 2 Microglobulin/18S Ribosomal RNA were validated as optimal reference genes for microRNA and mRNA quantification, respectively, in rat models of acute hepatotoxicity.	[Lardizabal, Maria N.; Veggi, Luis M.] CONICET UNR, IFISE, Rosario, Santa Fe, Argentina; [Nocito, Ana L.] Univ Nacl Rosario, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina; [Daniele, Stella M.; Veggi, Luis M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Palatnik, Javier F.] CONICET UNR, IBR, Rosario, Santa Fe, Argentina; [Ornella, Leonardo A.] CONICET UNR UPCAM, CIFASIS, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Lardizabal, MN (corresponding author), CONICET UNR, IFISE, Rosario, Santa Fe, Argentina.	veggi@ifise-conicet.gov.ar	Ornella, Leonardo/ABA-6551-2021	Palatnik, Javier/0000-0001-7996-5224	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional de Rosario	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Rosario	This work was supported financially by Research Grants from Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.gov.ar/), Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar) and from Universidad Nacional de Rosario (http://www.unr.edu.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; ARMENDARIZBORUNDA J, 1990, FASEB J, V4, P215, DOI 10.1096/fasebj.4.2.2298342; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Fox BC, 2010, TOXICOL IN VITRO, V24, P1962, DOI 10.1016/j.tiv.2010.08.007; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gant TW, 2005, MUTAT RES-FUND MOL M, V575, P4, DOI 10.1016/j.mrfmmm.2005.02.007; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Heinloth AN, 2004, TOXICOL SCI, V80, P193, DOI 10.1093/toxsci/kfh145; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Kheirelseid EAH, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-12; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Li JN, 2010, J VIROL METHODS, V169, P316, DOI 10.1016/j.jviromet.2010.07.036; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; Mehendale HM, 2005, TOXICOL PATHOL, V33, P41, DOI 10.1080/01926230590881808; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Miyamoto M, 2008, TOXICOL SCI, V106, P538, DOI 10.1093/toxsci/kfn188; Nishimura M, 2006, BIOCHEM BIOPH RES CO, V346, P1033, DOI 10.1016/j.bbrc.2006.06.012; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihur V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-62; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smits Katrien, 2009, BMC Res Notes, V2, P246, DOI 10.1186/1756-0500-2-246; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GP, 2010, MOL BIOTECHNOL, V46, P49, DOI 10.1007/s12033-010-9274-5; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Xing Wei, 2009, J Biomol Tech, V20, P109; Yoshitsugu H, 2006, DRUG METAB PHARMACOK, V21, P465, DOI 10.2133/dmpk.21.465; Zimmerman H., 1999, HEPATOTOXICITY, V2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	55	78	83	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36323	10.1371/journal.pone.0036323	http://dx.doi.org/10.1371/journal.pone.0036323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563491	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700040
J	Hughes, GL; Pike, AD; Xue, P; Rasgon, JL				Hughes, Grant L.; Pike, Andrew D.; Xue, Ping; Rasgon, Jason L.			Invasion of Wolbachia into Anopheles and Other Insect Germlines in an Ex vivo Organ Culture System	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; AEDES-AEGYPTI; MOSQUITO; GAMBIAE; VITELLOGENIN; STRAIN; ENDOSYMBIONTS; PIPIENTIS; INFECTION	The common bacterial endosymbiont Wolbachia manipulates its host's reproduction to promote its own maternal transmission, and can interfere with pathogen development in many insects making it an attractive agent for the control of arthropod-borne disease. However, many important species, including Anopheles mosquitoes, are uninfected. Wolbachia can be artificially transferred between insects in the laboratory but this can be a laborious and sometimes fruitless process. We used a simple ex vivo culturing technique to assess the suitability of Wolbachia-host germline associations. Wolbachia infects the dissected germline tissue of multiple insect species when the host tissue and bacteria are cultured together. Ovary and testis infection occurs in a density-dependent manner. Wolbachia strains are more capable of invading the germline of their native or closely related rather than divergent hosts. The ability of Wolbachia to associate with the germline of novel hosts is crucial for the development of stably-transinfected insect lines. Rapid assessment of the suitability of a strain-host combination prior to transinfection may dictate use of a particular Wolbachia strain. Furthermore, the cultured germline tissues of two major Anopheline vectors of Plasmodium parasites are susceptible to Wolbachia infection. This finding further enhances the prospect of using Wolbachia for the biological control of malaria.	[Hughes, Grant L.; Rasgon, Jason L.] Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Hughes, Grant L.; Rasgon, Jason L.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Pike, Andrew D.; Xue, Ping] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hughes, GL (corresponding author), Penn State Univ, Dept Entomol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA.	jlr54@psu.edu		Rasgon, Jason/0000-0002-4050-8429; Hughes, Grant/0000-0002-7567-7185; Pike, Andrew/0000-0003-3155-9969	United States National Institutes of Health [R21AI070178]; Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship; Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070178] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship; Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by United States National Institutes of Health grant R21AI070178 to JLR. GLH was supported by the Johns Hopkins School of Public Health (JHSPH) Jane Welsh Russell Scholarship and a Johns Hopkins Malaria Research Institute (JHMRI) postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; DEITSCH KW, 1995, INSECT BIOCHEM MOLEC, V25, P449, DOI 10.1016/0965-1748(94)00082-A; FALLON AM, 1974, J INSECT PHYSIOL, V20, P1815, DOI 10.1016/0022-1910(74)90211-X; Fenollar F, 2003, ANTIMICROB AGENTS CH, V47, P1665, DOI 10.1128/AAC.47.5.1665-1671.2003; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; GUBLER DJ, 1968, AM J EPIDEMIOL, V87, P502, DOI 10.1093/oxfordjournals.aje.a120840; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; KAMBHAMPATI S, 1993, EVOLUTION, V47, P673, DOI [10.2307/2410079, 10.1111/j.1558-5646.1993.tb02121.x]; KITAMURA SIRO, 1964, KOBE J MED SCI, V10, P85; KOLLER CN, 1989, INSECT BIOCHEM, V19, P693; MARHOUL Z, 1972, T ROY SOC TROP MED H, V66, P183, DOI 10.1016/0035-9203(72)90068-5; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Provost-Javier KN, 2010, INSECT MOL BIOL, V19, P423, DOI 10.1111/j.1365-2583.2010.00999.x; Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P7718, DOI 10.1128/AEM.01578-06; Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Walker T, 2011, MEM I OSWALDO CRUZ, V106, P212, DOI 10.1590/S0074-02762011000900026; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969	34	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36277	10.1371/journal.pone.0036277	http://dx.doi.org/10.1371/journal.pone.0036277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558418	Green Submitted, gold, Green Published			2022-12-27	WOS:000305340200059
J	Liu, N; He, S; Tolbert, E; Gong, RJ; Bayliss, G; Zhuang, SG				Liu, Na; He, Song; Tolbert, Evelyn; Gong, Rujun; Bayliss, George; Zhuang, Shougang			Suramin Alleviates Glomerular Injury and Inflammation in the Remnant Kidney	PLOS ONE			English	Article							NF-KAPPA-B; ATTENUATES RENAL INJURY; GROWTH-FACTOR; INTERSTITIAL FIBROSIS; CHEMOATTRACTANT PROTEIN-1; FIBROBLAST ACTIVATION; CHEMOKINE RECEPTORS; RAT-KIDNEY; EXPRESSION; INHIBITION	Background: Recently, we demonstrated that suramin, a compound that inhibits the interaction of multiple cytokines/growth factors with their receptors, inhibits activation and proliferation of renal interstitial fibroblasts, and attenuates the development of renal interstitial fibrosis in the murine model of unilateral ureteral obstruction (UUO). However, it remains unclear whether suramin can alleviate glomerular and vascular lesions, which are not typical pathological changes in the UUO model. So we tested the efficacy of suramin in the remnant kidney after 5/6 nephrectomy, a model characterized by the slow development of glomerulosclerosis, vascular sclerosis, tubulointerstitial fibrosis and renal inflammation, mimicking human disease. Methods/Findings: 5/6 of normal renal mass was surgically ablated in male rats. On the second week after surgery, rats were randomly divided into suramin treatment and non-treatment groups. Suramin was given at 10 mg/kg once per week for two weeks. In the remnant kidney of mice receiving suramin, glomerulosclerosis and vascular sclerosis as well as inflammation were ameliorated. Suramin also attenuated tubular expression of two chemokines, monocyte chemoattractant protein-1 and regulated upon expression normal T cell expressed and secreted (RANTES). After renal mass ablation, several intracellular molecules associated with renal fibrosis, including NF-kappaB p65, Smad-3, signal transducer and activator of transcription-3 and extracellular regulated kinase 1/2, are phosphorylated; suramin treatment inhibited their phosphorylation. Futhermore, suramin abolished renal ablation-induced phosphorylation of epidermal growth factor receptor and platelet derived growth factor receptor, two receptors that mediate renal fibrosis. Conclusions and Significance: These findings suggest that suramin attenuates glomerular and vascular injury and reduces inflammatory responses by suppression of multiple growth factor receptor-mediated profibrotic signaling pathways. Therefore, suramin may be a useful drug in preventing the fibrosis and sclerosis that characterizes progression of chronic kidney disease.	[Liu, Na; He, Song; Zhuang, Shougang] Tongji Univ, Dept Nephrol, Shanghai E Hosp, Sch Med, Shanghai 200092, Peoples R China; [Liu, Na; Tolbert, Evelyn; Gong, Rujun; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Alpert Med Sch, Providence, RI 02903 USA; [He, Song] Shekou Peoples Hosp, Dept Lab Med, Shenzhen, Guangdong, Peoples R China	Tongji University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Liu, N (corresponding author), Tongji Univ, Dept Nephrol, Shanghai E Hosp, Sch Med, Shanghai 200092, Peoples R China.	szhuang@lifespan.org			National Institutes of Health [DK-071997, DK-085065]; Brown Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071997, R01DK085065] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brown Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK-071997, and DK-085065) and the Brown Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdiu A, 1999, CANCER LETT, V146, P189, DOI 10.1016/S0304-3835(99)00260-8; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; BEHRENS MT, 1989, AM J PHYSIOL, V257, pF1059, DOI 10.1152/ajprenal.1989.257.6.F1059; Sanz AB, 2010, J AM SOC NEPHROL, V21, P1254, DOI 10.1681/ASN.2010020218; Berthier CC, 2009, DIABETES, V58, P469, DOI 10.2337/db08-1328; Bidani AK, 2000, KIDNEY INT, V57, P1651, DOI 10.1046/j.1523-1755.2000.00009.x; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Braunstein J, 2003, J BIOL CHEM, V278, P34133, DOI 10.1074/jbc.M304531200; Chen SL, 2003, AM J PHYSIOL-ENDOC M, V284, pE1089, DOI 10.1152/ajpendo.00540.2002; Chen Y, 2011, MOL VIS, V17, P3072; Cho Min Hyun, 2010, Korean J Pediatr, V53, P735, DOI 10.3345/kjp.2010.53.7.735; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; Daha MR, 2000, NEPHROL DIAL TRANSPL, V15, P41, DOI 10.1093/ndt/15.suppl_6.41; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Fujihara CK, 1998, KIDNEY INT, V54, P1510, DOI 10.1046/j.1523-1755.1998.00138.x; Fujiuchi S, 1997, ONCOLOGY, V54, P134; Gong RJ, 2004, J AM SOC NEPHROL, V15, P2868, DOI 10.1097/01.ASN.0000141962.44300.3A; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; HARRIS KPG, 1993, CLIN SCI, V85, P27, DOI 10.1042/cs0850027; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Kakuta Y, 2011, TRANSPL INT, V24, P514, DOI 10.1111/j.1432-2277.2011.01224.x; KLOEN P, 1994, EUR J CANCER, V30A, P678, DOI 10.1016/0959-8049(94)90544-4; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lange-Sperandio B, 2007, AM J PATHOL, V171, P861, DOI 10.2353/ajpath.2007.061199; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Liu N, 2011, CURR CLIN PHARMACOL, V6, P137, DOI 10.2174/157488411796151174; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Ludewig D, 2000, CELL TISSUE RES, V299, P97, DOI 10.1007/s004419900118; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Pang MY, 2009, AM J PHYSIOL-RENAL, V297, pF996, DOI 10.1152/ajprenal.00282.2009; Pawluczyk IZA, 1997, J AM SOC NEPHROL, V8, P1525; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shimizu H, 2003, J AM SOC NEPHROL, V14, P1496, DOI 10.1097/01.ASN.0000069223.98703.8E; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Terzi F, 2000, J CLIN INVEST, V106, P225, DOI 10.1172/JCI8315; Timoshanko JR, 2005, J AM SOC NEPHROL, V16, P2646, DOI 10.1681/ASN.2004121107; VANGOOR H, 1992, LAB INVEST, V66, P564; Wada Takashi, 2006, Nihon Rinsho, V64 Suppl 2, P288; Waldherr R, 1988, Contrib Nephrol, V60, P64; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	53	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36194	10.1371/journal.pone.0036194	http://dx.doi.org/10.1371/journal.pone.0036194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558380	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000152
J	Perez-Martinez, J; Perez-Martinez, FC; Carrion, B; Masia, J; Ortega, A; Simarro, E; Nam-Cha, SH; Cena, V				Perez-Martinez, Juan; Perez-Martinez, Francisco C.; Carrion, Blanca; Masia, Jesus; Ortega, Agustin; Simarro, Esther; Nam-Cha, Syong H.; Cena, Valentin			Aliskiren Prevents the Toxic Effects of Peritoneal Dialysis Fluids during Chronic Dialysis in Rats	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; HIGH GLUCOSE; ULTRAFILTRATION CAPACITY; MESENCHYMAL TRANSITION; MESOTHELIAL CELLS; OXIDATIVE STRESS; SOLUTE TRANSPORT; P38 MAPK; MEMBRANE; DEATH	The benefits of long-term peritoneal dialysis (PD) in patients with end-stage renal failure are short-lived due to structural and functional changes in the peritoneal membrane. In this report, we provide evidence for the in vitro and in vivo participation of the renin-angiotensin-aldosterone system (RAAS) in the signaling pathway leading to peritoneal fibrosis during PD. Exposure to high-glucose PD fluids (PDFs) increases damage and fibrosis markers in both isolated rat peritoneal mesothelial cells and in the peritoneum of rats after chronic dialysis. In both cases, the addition of the RAAS inhibitor aliskiren markedly improved damage and fibrosis markers, and prevented functional modifications in the peritoneal transport, as measured by the peritoneal equilibrium test. These data suggest that inhibition of the RAAS may be a novel way to improve the efficacy of PD by preventing inflammation and fibrosis following peritoneal exposure to high-glucose PDFs.	[Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Dept Ciencias Med, CSIC, Albacete, Spain; [Perez-Martinez, Juan; Masia, Jesus; Ortega, Agustin] Complejo Hosp Univ, Dept Nephrol, Albacete, Spain; [Cena, Valentin] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Perez-Martinez, Francisco C.; Carrion, Blanca] NanoDrugs SL, Dept Res & Dev, Albacete, Spain; [Simarro, Esther] Complejo Hosp Univ, Dept Clin Chem, Albacete, Spain; [Nam-Cha, Syong H.] Complejo Hosp Univ, Dept Pathol, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; CIBERNED; Instituto de Salud Carlos III	Perez-Martinez, J (corresponding author), Complejo Hosp Univ, Dept Nephrol, Albacete, Spain.	valentin.cena@gmail.com	Cena, Valentin/L-1751-2017	Cena, Valentin/0000-0001-8928-3681	Fondo de Investigaciones Sanitarias [PI081434]; Ministerio de Ciencia e Innovacion [BFU2011-30161-C02-01, PI10/01420]; Consejeria de Educacion [PII1I09-0163-4002, POII10-0274-3182]; Consejeria de Salud y Bienestar Social [PI-2009/32]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejeria de Educacion; Consejeria de Salud y Bienestar Social	This work has been supported, in part, by grants PI081434 from Fondo de Investigaciones Sanitarias, BFU2011-30161-C02-01 from Ministerio de Ciencia e Innovacion and PII1I09-0163-4002 and POII10-0274-3182 from Consejeria de Educacion, JCCM to V.C.; and PI10/01420 from the Fondo de Investigaciones Sanitarias, Ministerio de Ciencia e Innovacion; and PI-2009/32 from Consejeria de Salud y Bienestar Social, JCCM, to J.P.-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aroeira LS, 2007, J AM SOC NEPHROL, V18, P2004, DOI 10.1681/ASN.2006111292; Bailie GR, 2005, PHARMACOTHERAPY, V25, P491, DOI 10.1592/phco.25.4.491.61034; Bozkurt D, 2008, PERITON DIALYSIS INT, V28, pS38; Carrion B, 2011, PERITON DIALYSIS INT, V31, P325, DOI 10.3747/pdi.2010.00164; Chaudhary K, 2010, CLIN J AM SOC NEPHRO, V5, P723, DOI 10.2215/CJN.05720809; Chung SH, 2005, NEPHROL DIAL TRANSPL, V20, P1207, DOI 10.1093/ndt/gfh772; Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285; Davies SJ, 2004, KIDNEY INT, V66, P2437, DOI 10.1111/j.1523-1755.2004.66021.x; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Fusshoeller A, 2008, PEDIATR NEPHROL, V23, P19, DOI 10.1007/s00467-007-0541-z; Gotloib L, 2009, CONTRIB NEPHROL, V163, P35, DOI 10.1159/000223778; Ha H, 2000, PERITON DIALYSIS INT, V20, pS10; HEIMBURGER O, 1990, KIDNEY INT, V38, P495, DOI 10.1038/ki.1990.231; Holmes C, 2006, KIDNEY INT, V70, pS104, DOI 10.1038/sj.ki.5001924; Jensen C, 2008, NAT REV DRUG DISCOV, V7, P399, DOI 10.1038/nrd2550; Jiang N, 2008, BLOOD PURIFICAT, V26, P423, DOI 10.1159/000153248; Jordan J, 2000, BRIT J PHARMACOL, V130, P1496, DOI 10.1038/sj.bjp.0703451; Ke CY, 2010, EUR J CLIN INVEST, V40, P301, DOI 10.1111/j.1365-2362.2010.02264.x; Krediet RT, 1999, KIDNEY INT, V55, P341, DOI 10.1046/j.1523-1755.1999.00264.x; Lameire N, 2010, NAT REV NEPHROL, V6, P75, DOI 10.1038/nrneph.2009.210; Lavrentyev EN, 2009, AM J PHYSIOL-HEART C, V296, pH106, DOI 10.1152/ajpheart.00239.2008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margetts PJ, 2005, J AM SOC NEPHROL, V16, P425, DOI 10.1681/ASN.2004060436; Mortier S, 2003, BLOOD PURIFICAT, V21, P14, DOI 10.1159/000067867; Muller DN, 2006, CLIN J AM SOC NEPHRO, V1, P221, DOI 10.2215/CJN.01201005; Nagy JA, 1996, KIDNEY INT S, V56, pS2; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nessim SJ, 2010, KIDNEY INT, V78, P23, DOI 10.1038/ki.2010.90; Noh H, 2005, PERITON DIALYSIS INT, V25, P38; Posadas I, 2007, BRIT J PHARMACOL, V150, P577, DOI 10.1038/sj.bjp.0706993; Simoncini S, 2005, INT IMMUNOL, V17, P489, DOI 10.1093/intimm/dxh229; Singh R, 2003, J AM SOC NEPHROL, V14, P873, DOI 10.1097/01.ASN.0000060804.40201.6E; Singh VP, 2008, AM J PHYSIOL-HEART C, V294, pH1675, DOI 10.1152/ajpheart.91493.2007; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Weber KT, 1999, INT J BIOCHEM CELL B, V31, P395, DOI 10.1016/S1357-2725(98)00125-3; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; Xu ZG, 2003, KIDNEY INT, V63, P958, DOI 10.1046/j.1523-1755.2003.00836.x; Yung S, 2000, KIDNEY INT, V58, P1953, DOI 10.1111/j.1523-1755.2000.00367.x	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36268	10.1371/journal.pone.0036268	http://dx.doi.org/10.1371/journal.pone.0036268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558414	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000175
J	Starr, C; Nekaris, KAI; Leung, L				Starr, Carly; Nekaris, K. A. I.; Leung, Luke			Hiding from the Moonlight: Luminosity and Temperature Affect Activity of Asian Nocturnal Primates in a Highly Seasonal Forest	PLOS ONE			English	Article							LORIS NYCTICEBUS-COUCANG; CATHEMERAL ACTIVITY; DAILY TORPOR; SOCIAL-ORGANIZATION; MICROCEBUS-MURINUS; ACTIVITY PATTERNS; SLOW; LEMUR; BEHAVIOR; METABOLISM	The effect of moonlight and temperature on activity of slow lorises was previously little known and this knowledge might be useful for understanding many aspects of their behavioural ecology, and developing strategies to monitor and protect populations. In this study we aimed to determine if the activity of the pygmy loris (Nycticebus pygmaeus) is affected by ambient temperature and/or moonlight in a mixed deciduous forest. We radio-collared five females and five males in the Seima Protection Forest, Cambodia, in February to May, 2008 and January to March, 2009 and recorded their behaviour at 5 minutes intervals, totalling 2736 observations. We classified each observation as either inactive (sleeping or alert) or active behaviour (travel, feeding, grooming, or others). Moon luminosity (bright/dark) and ambient temperature were recorded for each observation. The response variable, activity, was binary (active or inactive), and a logit link function was used. Ambient temperature alone did not significantly affect mean activity. Although mean activity was significantly affected by moonlight, the interaction between moonlight and temperature was also significant: on bright nights, studied animals were increasingly more active with higher temperature; and on dark nights they were consistently active regardless of temperature. The most plausible explanation is that on bright cold nights the combined risk of being seen and attacked by predators and heat loss outweigh the benefit of active behaviours.	[Starr, Carly; Leung, Luke] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Nekaris, K. A. I.] Oxford Brookes Univ, Nocturnal Primate Res Grp, Sch Social Sci & Law, Oxford OX3 0BP, England	University of Queensland; Oxford Brookes University	Starr, C (corresponding author), Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia.	c.starr@uq.edu.au		Leung, Luke/0000-0002-8829-4925	Wildlife Conservation Society; World Wide Fund for Nature; Fauna Cambodia programme; Flora International - Cambodia programme	Wildlife Conservation Society; World Wide Fund for Nature; Fauna Cambodia programme; Flora International - Cambodia programme	We are grateful to Mr Men Soriyun and staff from Cambodian Forestry Administration's Department of Wildlife and Biodiversity Forestry Administration, the Ministry of Environment for permission to work in the site. Staff from the Wildlife Conservation Society, World Wide Fund for Nature, and Fauna and Flora International - Cambodia programmes provided logistical assistance and support for this study. This would not have been possible without the help of many local people and field assistants; in particular, we wish to thank Hao, Sam At, Eam Sam Un, Som Piseth, Melissa Jenson, and Richard Moore. Allan Lisle assisted with the analysis.	Allman J., 1977, PROGR PSYCHOBIOLOGY, V7, P1; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; Bearder SK, 2007, DEV PRIMATOL-PROG PR, P206, DOI 10.1007/978-0-387-34810-0_9; BEARDER SK, 1974, J HUM EVOL, V3, P37, DOI 10.1016/0047-2484(74)90105-5; Bearder SK, 2006, FOLIA PRIMATOL, V77, P50, DOI 10.1159/000089695; Bearder SK, 2002, EAT OR BE EATEN, P21, DOI 10.1017/CBO9780511610233.003; Bearder SK, 1967, THESIS U WITWATERSRA; Bernede L., 2009, THESIS OXFORD BROOKE; BOWERS MA, 1990, ECOLOGY, V71, P2334, DOI 10.2307/1938644; Brandon-Jones D, 2004, INT J PRIMATOL, V25, P97, DOI 10.1023/B:IJOP.0000014647.18720.32; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Curtis DJ, 1999, AM J PRIMATOL, V47, P279, DOI 10.1002/(SICI)1098-2345(1999)47:4<279::AID-AJP2>3.0.CO;2-U; Dausmann K. H., 2008, HYPOMETABOLISM ANIMA, P327; Dausmann KH, 2005, J COMP PHYSIOL B, V175, P147, DOI 10.1007/s00360-004-0470-0; Donati G, 2006, FOLIA PRIMATOL, V77, P104, DOI 10.1159/000089698; Donati G, 2001, AM J PRIMATOL, V53, P69, DOI 10.1002/1098-2345(200102)53:2<69::AID-AJP2>3.0.CO;2-R; Donati G, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P119; Donati Giuseppe, 2006, Journal of Anthropological Sciences, V84, P7; Eberle M, 2008, AM J PRIMATOL, V70, P410, DOI 10.1002/ajp.20496; Evans, 2003, STUDY RESIN TAPPING; Evans TD, 2000, MAMMALIA, V64, P55, DOI 10.1515/mamm.2000.64.1.55; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fernandez-Duque E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012572; Fichtel C, 2007, AM J PRIMATOL, V69, P611, DOI 10.1002/ajp.20363; Fietz J, 1999, OECOLOGIA, V121, P157, DOI 10.1007/s004420050917; Fitch-Snyder H., 2001, MANAGEMENT LORISES C; Fooden J, 1996, INT J PRIMATOL, V17, P845, DOI 10.1007/BF02735268; Gursky S, 2006, AM J PHYS ANTHROPOL, V129, P601, DOI 10.1002/ajpa.20364; Gursky S, 2003, INT J PRIMATOL, V24, P351, DOI 10.1023/A:1023053301059; Hagey LR, 2007, DEV PRIMATOL-PROG PR, P253, DOI 10.1007/978-0-387-34810-0_12; Ishida Hidemi, 1992, P139; Javier E. L., 1997, RICE PRODUCTION CAMB, P39; JulienLaferriere D, 1997, J MAMMAL, V78, P251, DOI 10.2307/1382659; Kappeler PM, 2003, BEHAV ECOL SOCIOBIOL, V54, P359, DOI 10.1007/s00265-003-0652-x; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Kays RW, 2001, J ZOOL, V253, P491, DOI 10.1017/S0952836901000450; Kramer KM, 2001, J MAMMAL, V82, P535, DOI 10.1644/1545-1542(2001)082<0535:EOLIOA>2.0.CO;2; LOCKARD RB, 1974, J MAMMAL, V55, P189, DOI 10.2307/1379266; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Martin P., 1993, MEASURING BEHAV, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McArdle JE, 1981, RECENT ADV PRIMATOL, P123; MULLER EF, 1985, FOLIA PRIMATOL, V44, P216, DOI 10.1159/000156215; MULLER EF, 1979, COMP BIOCHEM PHYS A, V64, P109, DOI 10.1016/0300-9629(79)90438-9; Mutschler T, 1999, NEW DIRECTIONS IN LEMUR STUDIES, P221; Nash L.T., 1986, P357; Nash LT, 2007, DEV PRIMATOL-PROG PR, P173, DOI 10.1007/978-0-387-34810-0_8; Nekaris KAI, 2007, FOLIA PRIMATOL, V78, P211, DOI 10.1159/000102316; Nekaris KAI, 2010, DEV PRIMATOL-PROG PR, P155, DOI 10.1007/978-1-4419-6661-2_8; Nekaris KAI, 2007, DEV PRIMATOL-PROG PR, P222, DOI 10.1007/978-0-387-34810-0_10; Nekaris KAI, 2001, FOLIA PRIMATOL, V72, P228, DOI 10.1159/000049942; Newman C, 2005, OIKOS, V108, P623, DOI 10.1111/j.0030-1299.2005.13399.x; Nguyen KV, 2000, BIOCLIMATIC DIAGRAMS; NISBETT RA, 1993, INT J PRIMATOL, V14, P765, DOI 10.1007/BF02192190; Nowack J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010797; OFARRELL MJ, 1974, J MAMMAL, V55, P809, DOI 10.2307/1379409; Ortmann S, 1997, NATURWISSENSCHAFTEN, V84, P28, DOI 10.1007/s001140050344; Osman-Hill WC., 1953, PRIMATES COMP ANATOM; Overdorff DJ, 1995, CREATURES DARK NOCTU; Pullen SL, 2000, AM J PRIMATOL, V51, P79, DOI 10.1002/(SICI)1098-2345(200005)51:1<79::AID-AJP6>3.0.CO;2-B; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Radespiel U, 2003, AM J PRIMATOL, V59, P139, DOI 10.1002/ajp.10071; Rahlfs M, 2010, ETHOLOGY, V116, P429, DOI 10.1111/j.1439-0310.2010.01756.x; Ramussen DT, 1986, LIFE HIST BEHAV SLOW; Ratajszczak R, 1998, FOLIA PRIMATOL, V69, P171, DOI 10.1159/000052710; Regal P.J., 1978, P183; Schmid J, 2000, OECOLOGIA, V123, P175, DOI 10.1007/s004420051003; Schmid J, 2000, J COMP PHYSIOL B, V170, P59, DOI 10.1007/s003600050008; Schulke O, 2007, ACTA ETHOL, V10, P13, DOI 10.1007/s10211-006-0023-5; Starr C, 2011, ORYX, V45, P135, DOI 10.1017/S0030605310001316; Streicher U., 2004, THESIS LUDWIG MAXIMI; Streicher U, 2008, NYCTICEBUS PYGMAEUS; Streicher U., 2004, CONSERVATION PRIMATE; Tan Y, 2005, P NATL ACAD SCI USA, V102, P14712, DOI 10.1073/pnas.0507042102; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; Walston J., 2001, WILDLIFE SURVEY SO M; Wang GD, 2010, GENOME BIOL EVOL, V2, P277, DOI 10.1093/gbe/evq020; Wiens F, 2003, J ZOOL, V261, P35, DOI 10.1017/S0952836903003947; Wiens F, 1999, FOLIA PRIMATOL, V70, P362, DOI 10.1159/000021719; WIENS F, 2002, THESIS BAYREUTH U BA; Wiens F, 2006, J MAMMAL, V87, P790, DOI 10.1644/06-MAMM-A-007R1.1	82	31	31	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36396	10.1371/journal.pone.0036396	http://dx.doi.org/10.1371/journal.pone.0036396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558461	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000205
J	Qin, Y; Schneider, TM; Brenner, MP				Qin, Yu; Schneider, Tobias M.; Brenner, Michael P.			Sequencing by Hybridization of Long Targets	PLOS ONE			English	Article							ACID SEQUENCE; DNA; SEARCH	Sequencing by Hybridization (SBH) reconstructs an n-long target DNA sequence from its biochemically determined l-long subsequences. In the standard approach, the length of a uniformly random sequence that can be unambiguously reconstructed is limited to n=O(2(l)) due to repetitive subsequences causing reconstruction degeneracies. We present a modified sequencing method that overcomes this limitation without the need for different types of biochemical assays and is robust to error.	[Qin, Yu] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Qin, Y (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	brenner@seas.harvard.edu	Schneider, Tobias/C-5797-2015	Schneider, Tobias/0000-0002-8617-8998	National Science Foundation, through the Harvard Materials Research and Engineering Center [DMR-0820484]; Division of Mathematical Sciences [DMS-0907985]	National Science Foundation, through the Harvard Materials Research and Engineering Center(National Science Foundation (NSF)); Division of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by the National Science Foundation, through the Harvard Materials Research and Engineering Center DMR-0820484) and the Division of Mathematical Sciences (DMS-0907985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate AR, 2010, P NATL ACAD SCI USA, V107, P19163, DOI 10.1073/pnas.1006888107; Abate AR, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431281; Arratia R, 1996, J COMPUT BIOL, V3, P425, DOI 10.1089/cmb.1996.3.425; BAINS W, 1988, J THEOR BIOL, V135, P303, DOI 10.1016/S0022-5193(88)80246-7; Blazewicz J, 2005, ANN OPER RES, V138, P67, DOI 10.1007/s10479-005-2445-2; Blazewicz J, 2003, THEOR COMPUT SCI, V290, P1459, DOI 10.1016/S0304-3975(02)00063-4; Blazewicz J, 2000, EUR J OPER RES, V125, P257, DOI 10.1016/S0377-2217(99)00456-7; Blum C, 2008, COMPUT OPER RES, V35, P3620, DOI 10.1016/j.cor.2007.03.007; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1989, GENOMICS, V4, P114; Dyer M, 1994, J Comput Biol, V1, P105, DOI 10.1089/cmb.1994.1.105; Endo TA, 2004, BIOINFORMATICS, V20, P2181, DOI 10.1093/bioinformatics/bth202; Frieze AM, 1999, J COMPUT BIOL, V6, P361, DOI 10.1089/106652799318328; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V7, P63, DOI 10.1080/07391102.1989.10507752	16	2	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35819	10.1371/journal.pone.0035819	http://dx.doi.org/10.1371/journal.pone.0035819			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574124	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800020
J	Ramakrishnan, C; Rademacher, A; Soichot, J; Costa, G; Waters, AP; Janse, CJ; Ramesar, J; Franke-Fayard, BM; Levashina, EA				Ramakrishnan, Chandra; Rademacher, Annika; Soichot, Julien; Costa, Giulia; Waters, Andrew P.; Janse, Chris J.; Ramesar, Jai; Franke-Fayard, Blandine M.; Levashina, Elena A.			Salivary Gland-Specific P. berghei Reporter Lines Enable Rapid Evaluation of Tissue-Specific Sporozoite Loads in Mosquitoes	PLOS ONE			English	Article							COMPLEMENT-LIKE PROTEIN; PLASMODIUM-BERGHEI; ANOPHELES-GAMBIAE; MALARIA PARASITES; BLOOD STAGES; LIFE-CYCLE; EXPRESSING GFP; INVASION; STAGE; PHAGOCYTOSIS	Malaria is a life-threatening human infectious disease transmitted by mosquitoes. Levels of the salivary gland sporozoites (sgs), the only mosquito stage infectious to a mammalian host, represent an important cumulative index of Plasmodium development within a mosquito. However, current techniques of sgs quantification are laborious and imprecise. Here, transgenic P. berghei reporter lines that produce the green fluorescent protein fused to luciferase (GFP-LUC) specifically in sgs were generated, verified and characterised. Fluorescence microscopy confirmed the sgs stage specificity of expression of the reporter gene. The luciferase activity of the reporter lines was then exploited to establish a simple and fast biochemical assay to evaluate sgs loads in whole mosquitoes. Using this assay we successfully identified differences in sgs loads in mosquitoes silenced for genes that display opposing effects on P. berghei ookinete/oocyst development. It offers a new powerful tool to study infectivity of P. berghei to the mosquito, including analysis of vector-parasite interactions and evaluation of transmission-blocking vaccines.	[Ramakrishnan, Chandra; Rademacher, Annika; Soichot, Julien; Costa, Giulia; Levashina, Elena A.] Univ Strasbourg, Inst Biol Mol & Cellulaire, CNRS UPR9022, INSERM U963, Strasbourg, France; [Waters, Andrew P.] Univ Glasgow, Glasgow Biomed Res Ctr, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Waters, Andrew P.] Univ Glasgow, Div Infect & Immun, Fac Biomed Life Sci, Glasgow, Lanark, Scotland; [Janse, Chris J.; Ramesar, Jai; Franke-Fayard, Blandine M.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol,Leiden Malaria Res Grp, Leiden, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Glasgow; University of Glasgow; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ramakrishnan, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Cell & Mol Biol, London, England.	e.levashina@ibmc-cnrs.unistra.fr	Waters, Andy P/C-9377-2009	Waters, Andy P/0000-0001-8900-2982; Levashina, Elena/0000-0003-4605-906X; , Blandine/0000-0001-6041-4182; Janse, Chris J/0000-0002-6410-6205	EC FP6th BioMalPar Network of Excellence; EC FP7th EviMalar Network of Excellence; Centre National de la Recherche Scientifique [UPR9022]; Inserm [U963]	EC FP6th BioMalPar Network of Excellence; EC FP7th EviMalar Network of Excellence; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by EC FP6th BioMalPar (http://www.biomalpar.org/) and EC FP7th EviMalar (http://www.evimalar.org/) Networks of Excellence, and by funding from the Centre National de la Recherche Scientifique (UPR9022) and Inserm (U963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLINGSLEY PF, 1991, T ROY SOC TROP MED H, V85, P450, DOI 10.1016/0035-9203(91)90215-K; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2004, CURR OPIN IMMUNOL, V16, P16, DOI 10.1016/j.coi.2003.11.010; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2008, INT J PARASITOL, V38, P1651, DOI 10.1016/j.ijpara.2008.05.012; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Franke-Fayard B, 2006, NAT PROTOC, V1, P476, DOI 10.1038/nprot.2006.69; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Hernandez-Martinez S, 2002, J MED ENTOMOL, V39, P61, DOI 10.1603/0022-2585-39.1.61; Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Jacobs-Lorena VY, 2010, MOL BIOCHEM PARASIT, V171, P40, DOI 10.1016/j.molbiopara.2009.12.009; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; Kooij TWA, 2005, MOL BIOCHEM PARASIT, V144, P16, DOI 10.1016/j.molbiopara.2005.07.003; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Ploemen IHJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007881; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Sambrook J., 2002, MOL CLONING LAB MANU; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Thompson J, 2001, MOL BIOCHEM PARASIT, V118, P147, DOI 10.1016/S0166-6851(01)00377-2; van Dijk MR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000853; Vernick KD, 1996, AM J TROP MED HYG, V54, P430, DOI 10.4269/ajtmh.1996.54.430; Vernick KD, 1995, EXP PARASITOL, V81, P436, DOI 10.1006/expr.1995.1136; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36376	10.1371/journal.pone.0036376	http://dx.doi.org/10.1371/journal.pone.0036376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574152	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000305349800048
J	Cui, YH; Ge, ZQ; Rizak, JD; Zhai, C; Zhou, Z; Gong, SJ; Che, Y				Cui, Yonghua; Ge, Zhiqiang; Rizak, Joshua Dominic; Zhai, Chao; Zhou, Zhu; Gong, Songjie; Che, Yi			Deficits in Water Maze Performance and Oxidative Stress in the Hippocampus and Striatum Induced by Extremely Low Frequency Magnetic Field Exposure	PLOS ONE			English	Article							50 HZ; ELECTROMAGNETIC-FIELDS; 1 MT; MEMORY; RATS; MORTALITY; BRAIN; TASK	The exposures to extremely low frequency magnetic field (ELF-MF) in our environment have dramatically increased. Epidemiological studies suggest that there is a possible association between ELF-MF exposure and increased risks of cardiovascular disease, cancers and neurodegenerative disorders. Animal studies show that ELF-MF exposure may interfere with the activity of brain cells, generate behavioral and cognitive disturbances, and produce deficits in attention, perception and spatial learning. Although, many research efforts have been focused on the interaction between ELF-MF exposure and the central nervous system, the mechanism of interaction is still unknown. In this study, we examined the effects of ELF-MF exposure on learning in mice using two water maze tasks and on some parameters indicative of oxidative stress in the hippocampus and striatum. We found that ELF-MF exposure (1 mT, 50 Hz) induced serious oxidative stress in the hippocampus and striatum and impaired hippocampal-dependent spatial learning and striatum-dependent habit learning. This study provides evidence for the association between the impairment of learning and the oxidative stress in hippocampus and striatum induced by ELF-MF exposure.	[Cui, Yonghua; Ge, Zhiqiang; Zhai, Chao; Zhou, Zhu; Gong, Songjie; Che, Yi] Soochow Univ, Coll Med, Suzhou, Peoples R China; [Rizak, Joshua Dominic] Chinese Acad Sci, Lab Primate Neurosci Res, Key Lab Anim Models, Kunming Inst Zool, Kunming, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Kunming Institute of Zoology	Cui, YH (corresponding author), Soochow Univ, Coll Med, Suzhou, Peoples R China.	cheyiwenshan@sina.com			National Basic Research Program of China, Chinese National Science Foundation [31172089]	National Basic Research Program of China, Chinese National Science Foundation	This work was supported by National Basic Research Program of China, Chinese National Science Foundation (31172089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2008, BRAIN RES, V1221, P30, DOI 10.1016/j.brainres.2008.05.007; Amara S, 2009, GEN PHYSIOL BIOPHYS, V28, P260, DOI 10.4149/gpb_2009_03_260; Buttiglione M, 2007, J CELL PHYSIOL, V213, P759, DOI 10.1002/jcp.21146; Che Y, 2007, BRAIN RES BULL, V74, P178, DOI 10.1016/j.brainresbull.2007.06.009; Davanipour Z, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-13; Davanipour Zoreh, 2009, Pathophysiology, V16, P149, DOI 10.1016/j.pathophys.2009.01.005; Hakansson N, 2003, AM J EPIDEMIOL, V158, P534, DOI 10.1093/aje/kwg197; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Helbert A. L., 1998, FASEB J, V12, P395; Jelenkovic A, 2006, BRAIN RES BULL, V68, P355, DOI 10.1016/j.brainresbull.2005.09.011; Keck ME, 2001, NEUROPSYCHOPHARMACOL, V24, P337, DOI 10.1016/S0893-133X(00)00191-3; Lacy-Hulbert A, 1998, FASEB J, V12, P395, DOI 10.1096/fasebj.12.6.395; Lai H, 2004, ENVIRON HEALTH PERSP, V112, P687, DOI 10.1289/ehp.6355; Lee H. J., 2011, BIOELECTROMAGNETICS; LISSI E, 1992, FREE RADICAL RES COM, V17, P299, DOI 10.3109/10715769209079523; Ljubuncic P, 2000, GUT, V47, P710, DOI 10.1136/gut.47.5.710; LOOMIS DP, 1990, BRIT J IND MED, V47, P633; Lopuch S, 2009, BEHAV PROCESS, V81, P133, DOI 10.1016/j.beproc.2008.12.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maaroufi K, 2009, NEUROBIOL LEARN MEM, V92, P345, DOI 10.1016/j.nlm.2009.04.002; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mostafa RM, 2002, PHYSIOL BEHAV, V765, P89; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; Prasad K, 2009, EXP NEUROL, V215, P358, DOI 10.1016/j.expneurol.2008.11.003; Prato FS, 1996, BIOELECTROMAGNETICS, V17, P123, DOI 10.1002/(SICI)1521-186X(1996)17:2<123::AID-BEM6>3.0.CO;2-5; Ravera S, 2011, ELECTROMAGN BIOL MED, V30, P67, DOI 10.3109/15368378.2011.566770; Reyes-Guerrero G, 2006, BRAIN RES, V1095, P131, DOI 10.1016/j.brainres.2006.04.020; ROY S, 1995, FEBS LETT, V376, P164, DOI 10.1016/0014-5793(95)01266-X; Sienkiewicz ZJ, 2001, BIOELECTROMAGNETICS, V22, P19, DOI 10.1002/1521-186X(200101)22:1<19::AID-BEM3>3.0.CO;2-0; Sun H, 2010, BIOELECTROMAGNETICS, V311, P50; Trimmel M, 1998, TOXICOL LETT, V96-7, P377, DOI 10.1016/S0378-4274(98)00096-4	33	36	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e32196	10.1371/journal.pone.0032196	http://dx.doi.org/10.1371/journal.pone.0032196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570685	Green Submitted, gold, Green Published			2022-12-27	WOS:000305343400001
J	Hegemann, A; Matson, KD; Versteegh, MA; Tieleman, BI				Hegemann, Arne; Matson, Kevin D.; Versteegh, Maaike A.; Tieleman, B. Irene			Wild Skylarks Seasonally Modulate Energy Budgets but Maintain Energetically Costly Inflammatory Immune Responses throughout the Annual Cycle	PLOS ONE			English	Article							ACUTE-PHASE RESPONSE; BASAL METABOLIC-RATE; TRADE-OFFS; LIFE-HISTORY; ECOLOGICAL IMMUNOLOGY; PARENTAL EFFORT; WIND-TUNNEL; STRESS; ADJUSTMENTS; BIRDS	A central hypothesis of ecological immunology is that immune defences are traded off against competing physiological and behavioural processes. During energetically demanding periods, birds are predicted to switch from expensive inflammatory responses to less costly immune responses. Acute phase responses (APRs) are a particularly costly form of immune defence, and, hence, seasonal modulations in APRs are expected. Yet, hypotheses about APR modulation remain untested in free-living organisms throughout a complete annual cycle. We studied seasonal modulations in the APRs and in the energy budgets of skylarks Alauda arvensis, a partial migrant bird from temperate zones that experiences substantial ecological changes during its annual cycle. We characterized throughout the annual cycle changes in their energy budgets by measuring basal metabolic rate (BMR) and body mass. We quantified APRs by measuring the effects of a lipopolysaccharide injection on metabolic rate, body mass, body temperature, and concentrations of glucose and ketone. Body mass and BMR were lowest during breeding, highest during winter and intermediate during spring migration, moult and autumn migration. Despite this variation in energy budgets, the magnitude of the APR, as measured by all variables, was similar in all annual cycle stages. Thus, while we find evidence that some annual cycle stages are relatively more energetically constrained, we find no support for the hypothesis that during these annual cycle stages birds compromise an immune defence that is itself energetically costly. We suggest that the ability to mount an APR may be so essential to survival in every annual cycle stage that skylarks do not trade off this costly form of defence with other annual cycle demands.	[Hegemann, Arne; Matson, Kevin D.; Versteegh, Maaike A.; Tieleman, B. Irene] Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	University of Groningen	Hegemann, A (corresponding author), Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands.	a.hegemann@rug.nl	Matson, Kevin/G-3855-2010; Hegemann, Arne/I-3092-2019; Matson, Kevin D./R-1986-2019	Matson, Kevin/0000-0002-4373-5926; Hegemann, Arne/0000-0002-3309-9866	BirdLife Netherlands; Schure-Beijerinck-Popping Fonds; Rosalind Franklin Fellowship; Netherlands Organization for Scientific Research [Veni 863.04.023, Veni 863.08.026]; NWO [036.001.690]	BirdLife Netherlands; Schure-Beijerinck-Popping Fonds; Rosalind Franklin Fellowship; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from BirdLife Netherlands (BIT), Schure-Beijerinck-Popping Fonds (AH), a Rosalind Franklin Fellowship (BIT) and the Netherlands Organization for Scientific Research (Veni 863.04.023 to BIT, Veni 863.08.026 to KDM). Open access publishing costs were paid by the NWO (036.001.690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardia DR, 2005, ECOLOGY, V86, P2040, DOI 10.1890/04-1619; BARACOS VE, 1987, CAN J PHYSIOL PHARM, V65, P1248, DOI 10.1139/y87-199; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; CHEREL Y, 1988, AM J PHYSIOL, V254, pR170, DOI 10.1152/ajpregu.1988.254.2.R170; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; Deerenberg C, 1998, J COMP PHYSIOL B, V168, P507, DOI 10.1007/s003600050171; Deerenberg C., 2003, AVIAN SCI, V2, P217; Donald P., 2004, SKYLARK; DRENT RH, 1980, ARDEA, V68, P225; Gessaman J.A., 1987, National Wildlife Federation Scientific and Technical Series, P289; Glutz von Blotzheim, 1985, HDB VOGEL MITTELEURO; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hasselquist D, 2007, J ORNITHOL, V148, pS571, DOI 10.1007/s10336-007-0201-x; Hasselquist D, 2007, J EXP BIOL, V210, P1123, DOI 10.1242/jeb.02712; Hegemann A, 2012, RING MIGRAT IN PRESS, V27; Hegemann A, 2012, OECOLOGIA IN PRESS; Hegemann A, 2010, ARDEA, V98, P135, DOI 10.5253/078.098.0202; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; King JR., 1974, AVIAN ENERGETICS, P4; KLASING K. C., 1998, COMP AVIAN NUTR; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Koutsos EA, 2001, COMP BIOCHEM PHYS C, V128, P255, DOI 10.1016/S1532-0456(00)00199-X; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; MCNAB BK, 1988, OECOLOGIA, V77, P343, DOI 10.1007/BF00378040; Mendes L, 2006, J ORNITHOL, V147, P274, DOI 10.1007/s10336-006-0070-8; Merino S, 2006, J ANIM ECOL, V75, P1147, DOI 10.1111/j.1365-2656.2006.01135.x; Mueller P, 2001, P NATL ACAD SCI USA, V98, P12550, DOI 10.1073/pnas.221456698; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Nudds RL, 2001, FUNCT ECOL, V15, P458, DOI 10.1046/j.0269-8463.2001.00546.x; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, J EXP BIOL, V209, P3062, DOI 10.1242/jeb.02371; Owen-Ashley NT, 2006, HORM BEHAV, V49, P15, DOI 10.1016/j.yhbeh.2005.04.009; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Pap PL, 2010, NATURWISSENSCHAFTEN, V97, P891, DOI 10.1007/s00114-010-0706-7; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; R Core Team, 2020, R LANG ENV STAT COMP; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Tieleman BI, 2008, BEHAV ECOL, V19, P949, DOI 10.1093/beheco/arn051; Tieleman BI, 2004, ECOLOGY, V85, P1399, DOI 10.1890/03-0170; Tieleman BI, 2003, ECOLOGY, V84, P1800, DOI 10.1890/0012-9658(2003)084[1800:PVOLAA]2.0.CO;2; Tieleman BI, 2002, PHYSIOL BIOCHEM ZOOL, V75, P305, DOI 10.1086/341998; VAN DOBBEN W. H., 1939, Ardea, V28, P61; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Warnes G.R., Various R Programming Tools for Plotting Data 2020	66	54	61	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36358	10.1371/journal.pone.0036358	http://dx.doi.org/10.1371/journal.pone.0036358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570706	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400022
J	Matesanz, F; Gonzalez-Perez, A; Lucas, M; Sanna, S; Gayan, J; Urcelay, E; Zara, I; Pitzalis, M; Cavanillas, ML; Arroyo, R; Zoledziewska, M; Marrosu, M; Fernandez, O; Leyva, L; Alcina, A; Fedetz, M; Moreno-Rey, C; Velasco, J; Real, LM; Ruiz-Pena, JL; Cucca, F; Ruiz, A; Izquierdo, G				Matesanz, Fuencisla; Gonzalez-Perez, Antonio; Lucas, Miguel; Sanna, Serena; Gayan, Javier; Urcelay, Elena; Zara, Ilenia; Pitzalis, Maristella; Cavanillas, Maria L.; Arroyo, Rafael; Zoledziewska, Magdalena; Marrosu, Marisa; Fernandez, Oscar; Leyva, Laura; Alcina, Antonio; Fedetz, Maria; Moreno-Rey, Concha; Velasco, Juan; Real, Luis M.; Luis Ruiz-Pena, Juan; Cucca, Francesco; Ruiz, Agustin; Izquierdo, Guillermo			Genome-Wide Association Study of Multiple Sclerosis Confirms a Novel Locus at 5p13.1	PLOS ONE			English	Article							GENE-EXPRESSION; SUSCEPTIBILITY LOCI; DIAGNOSTIC-CRITERIA; METAANALYSIS; POPULATION; RISK; PATHOGENESIS; GUIDELINES; NUMBER; SNPS	Multiple Sclerosis (MS) is the most common progressive and disabling neurological condition affecting young adults in the world today. From a genetic point of view, MS is a complex disorder resulting from the combination of genetic and non-genetic factors. We aimed to identify previously unidentified loci conducting a new GWAS of Multiple Sclerosis (MS) in a sample of 296 MS cases and 801 controls from the Spanish population. Meta-analysis of our data in combination with previous GWAS was done. A total of 17 GWAS-significant SNPs, corresponding to three different loci were identified: HLA, IL2RA, and 5p13.1. All three have been previously reported as GWAS-significant. We confirmed our observation in 5p13.1 for rs9292777 using two additional independent Spanish samples to make a total of 4912 MS cases and 7498 controls (ORpooled = 0.84; 95%CI: 0.80-0.89; p = 1.36x10-9). This SNP differs from the one reported within this locus in a recent GWAS. Although it is unclear whether both signals are tapping the same genetic association, it seems clear that this locus plays an important role in the pathogenesis of MS.	[Matesanz, Fuencisla; Luis Ruiz-Pena, Juan; Izquierdo, Guillermo] Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain; [Gonzalez-Perez, Antonio; Gayan, Javier; Moreno-Rey, Concha; Velasco, Juan; Real, Luis M.; Ruiz, Agustin] Neocodex, Dept Struct Genom, Seville, Spain; [Lucas, Miguel] Hosp Virgen Macarena, Serv Biol Mol, Seville, Spain; [Sanna, Serena; Cucca, Francesco] CNR, Ist Ric Genet & Biomed, Monserrato, Italy; [Urcelay, Elena; Cavanillas, Maria L.] IdISSC, Dept Immunol, Madrid, Spain; [Zara, Ilenia] AGCT, Ctr Adv Studies Res & Dev Sardinia CRS4, Pula, Italy; [Pitzalis, Maristella; Zoledziewska, Magdalena; Cucca, Francesco] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy; [Arroyo, Rafael] IdISSC, Dept Neurol, Multiple Sclerosis Unit, Madrid, Spain; [Marrosu, Marisa] Univ Cagliari, Dipartimento Sci Neurol & Cardiovasc, Ctr Sclerosi Multipla, Cagliari, Italy; [Fernandez, Oscar; Leyva, Laura] Hosp Reg Univ Carlos Haya, Serv Neurol, Inst Neurociencias Clin, Malaga, Spain; [Alcina, Antonio; Fedetz, Maria] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain	Hospital Universitario Virgen Macarena; Hospital Universitario Virgen Macarena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Sassari; University of Cagliari; Hospital Carlos Haya; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Matesanz, F (corresponding author), Hosp Virgen Macarena, Unidad Esclerosis Multiple, Seville, Spain.	aruiz@neocodex.es	sanna, serena/H-3009-2019; González-Pérez, Antonio/AAY-4179-2021; Real, Luis M/K-9646-2014; peña, juan luis ruiz/Z-6168-2019; Gonzalez-Perez, Antonio/A-5247-2010; Leyva, Laura/B-5574-2019; Ruiz, Agustin/G-5677-2012; Real, Luis Miguel/H-5379-2011; Leyva, Laura/R-2187-2019; Alcina, Antonio/T-1893-2017; Matesanz, Fuencisla/F-3715-2016	sanna, serena/0000-0002-3768-1749; González-Pérez, Antonio/0000-0001-9771-5982; Real, Luis M/0000-0003-4932-7429; peña, juan luis ruiz/0000-0003-3956-1131; Gonzalez-Perez, Antonio/0000-0001-9771-5982; Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625; Alcina, Antonio/0000-0001-7294-0948; Matesanz, Fuencisla/0000-0002-9429-1819; Zoledziewska, Magdalena/0000-0002-3033-6133; Urcelay, Elena/0000-0001-8470-8396; Ruiz Laza, Agustin/0000-0003-2633-2495; CUCCA, Francesco/0000-0002-7414-1995; Marrosu, Maria Giovanna/0000-0003-2334-2081; Pitzalis, Maristella/0000-0003-4975-6987	Neuroinvest; Carlos III; Fonde de Investigaciones Sanitarias (FIS); Agencia IDEA, Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia [830882]; Corporacion Tecnologica de Andalucia [07/124]; Ministerio de Educacion y Ciencia [PCT-A41502790-2007, PCT-010000-2007-18]; Programa de Ayudas Torres Quevedo del Ministerio de Ciencia e Innovacion [PTQ2002-0206, PTQ2003-0549, PTQ2003-0546, PTQ2003-0782, PTQ2003-0783, PTQ2004-0838, PTQ04-1-0006, PTQ04-3-0718, PTQ06-1-0002]; Fondos Europeos de Desarrollo Regional [P09-CTS-5218 FEDER]; Ministerio de Ciencia e Innovacion [SAF2009-11491]; Fondo de Investigacion Sanitaria [PI081636]; FIS [PI10/1985]; National Institutes of Health (NIH); GlaxoSmithKline; Wellcome Trust [076113, 085475]; Fondazione Italiana Sclerosi Multipla (FISM) [2008/R/7]; Italian Ministry of Scientific Research (MIUR) [2007KXNKNP]; US National Institutes of Health from National Institute of Aging (NIA) [NO1-AG-1-2109]; GSK	Neuroinvest; Carlos III(Instituto de Salud Carlos III); Fonde de Investigaciones Sanitarias (FIS); Agencia IDEA, Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia(Junta de Andalucia); Corporacion Tecnologica de Andalucia; Ministerio de Educacion y Ciencia(Spanish Government); Programa de Ayudas Torres Quevedo del Ministerio de Ciencia e Innovacion; Fondos Europeos de Desarrollo Regional; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Wellcome Trust(Wellcome Trust); Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); US National Institutes of Health from National Institute of Aging (NIA); GSK(GlaxoSmithKline)	The Macarena MS project was supported by Neuroinvest, Carlos III, and Fonde de Investigaciones Sanitarias (FIS) grants. The project to collect and genotype the Spanish controls was supported in part by: Agencia IDEA, Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia (830882); Corporacion Tecnologica de Andalucia (07/124); Ministerio de Educacion y Ciencia (PCT-A41502790-2007 and PCT-010000-2007-18); Programa de Ayudas Torres Quevedo del Ministerio de Ciencia e Innovacion (PTQ2002-0206, PTQ2003-0549, PTQ2003-0546, PTQ2003-0782, PTQ2003-0783, PTQ2004-0838, PTQ04-1-0006, PTQ04-3-0718, PTQ06-1-0002). CIBER de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM) is an ISCIII project. The validation project was supported by Fondos Europeos de Desarrollo Regional (P09-CTS-5218 FEDER), Ministerio de Ciencia e Innovacion (SAF2009-11491) to Dr. Alcina, and Fondo de Investigacion Sanitaria (PI081636) to Dr. Matesanz, and FIS PI10/1985. Funding support for the IMSGC GWAS of Multiple Sclerosis and the Genetic Multiple Sclerosis Associations (GeneMSA) projects were provided by National Institutes of Health (NIH) and GlaxoSmithKline, respectively, and the genotyping of samples was provided by the National Institute of Neurological Disorders and Stroke (NINDS). Some of the datasets used for the analyses described in this manuscript were obtained from the NINDS Database found at http://www.ncbi.nlm.nih.gov/sites/entrez?db=gap through dbGaP accession numbers phs000139.v1.p1 and phs000171.v1.p1. This study also makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. This Sardinian GWAS study was supported by the Fondazione Italiana Sclerosi Multipla (FISM) Cod. 2008/R/7 to Dr. Cucca, by the Italian Ministry of Scientific Research (MIUR grant 2007KXNKNP) and by US National Institutes of Health contract NO1-AG-1-2109 from National Institute of Aging (NIA) to the SardiNIA ('ProgeNIA') team. Sardinian GWAS authors are grateful to all cases and controls, and to the wide network of collaborators, clinicians and nurses of clinical and hospitals in the island. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; As a declaration of competing financial interest, several authors in this study (Dr. Gonzalez-Perez, Dr. Gayan, Dr. Moreno-Rey, Dr. Velasco, Dr. Real, and Dr. Ruiz) are employees and/or shareholders in Neocodex. The authors have also used publicly available data from a study that received funding from GSK. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavanillas ML, 2010, GENES IMMUN; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; JERSILD C, 1973, LANCET, V2, P1221; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Li Y, 2010, GENET EPIDEMIOL; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zuvich RL, 2009, SEMIN IMMUNOL, V21, P328, DOI 10.1016/j.smim.2009.08.003	32	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36140	10.1371/journal.pone.0036140	http://dx.doi.org/10.1371/journal.pone.0036140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570697	gold, Green Published			2022-12-27	WOS:000305343400013
J	Ono, M; Qiang, WN; Serna, VA; Yin, P; Coon, JS; Navarro, A; Monsivais, D; Kakinuma, T; Dyson, M; Druschitz, S; Unno, K; Kurita, T; Bulun, SE				Ono, Masanori; Qiang, Wenan; Serna, Vanida Ann; Yin, Ping; Coon, John S.; Navarro, Antonia; Monsivais, Diana; Kakinuma, Toshiyuki; Dyson, Matthew; Druschitz, Stacy; Unno, Kenji; Kurita, Takeshi; Bulun, Serdar E.			Role of Stem Cells in Human Uterine Leiomyoma Growth	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; STEM/PROGENITOR CELLS; AROMATASE EXPRESSION; SIDE POPULATION; PROGESTERONE; FIBROIDS; MOUSE; GENE; IDENTIFICATION; ACTIVATION	Background: Uterine leiomyoma is the most common benign tumor in reproductive-age women. Each leiomyoma is thought to be a benign monoclonal tumor arising from a single transformed myometrial smooth muscle cell; however, it is not known what leiomyoma cell type is responsible for tumor growth. Thus, we tested the hypothesis that a distinct stem/reservoir cell-enriched population, designated as the leiomyoma-derived side population (LMSP), is responsible for cell proliferation and tumor growth. Principal Findings: LMSP comprised approximately 1% of all leiomyoma and 2% of all myometrium-derived cells. All LMSP and leiomyoma-derived main population (LMMP) but none of the side or main population cells isolated from adjacent myometrium carried a mediator complex subunit 12 mutation, a genetic marker of neoplastic transformation. Messenger RNA levels for estrogen receptor-alpha, progesterone receptor and smooth muscle cell markers were barely detectable and significantly lower in the LMSP compared with the LMMP. LMSP alone did not attach or survive in monolayer culture in the presence or absence of estradiol and progestin, whereas LMMP readily grew under these conditions. LMSP did attach and survive when directly mixed with unsorted myometrial cells in monolayer culture. After resorting and reculturing, LMSP gained full potential of proliferation. Intriguingly, xenografts comprised of LMSP and unsorted myometrial smooth muscle cells grew into relatively large tumors (3.67 +/- 1.07 mm(3)), whereas xenografts comprised of LMMP and unsorted myometrial smooth muscle cells produced smaller tumors (0.54 +/- 0.20 mm(3), p<0.05, n = 10 paired patient samples). LMSP xenografts displayed significantly higher proliferative activity compared with LMMP xenografts (p<0.05). Conclusions: Our data suggest that LMSP, which have stem/reservoir cell characteristics, are necessary for in vivo growth of leiomyoma xenograft tumors. Lower estrogen and progesterone receptor levels in LMSP suggests an indirect paracrine effect of steroid hormones on stem cells via the mature neighboring cells.	[Ono, Masanori; Qiang, Wenan; Serna, Vanida Ann; Yin, Ping; Coon, John S.; Navarro, Antonia; Monsivais, Diana; Kakinuma, Toshiyuki; Dyson, Matthew; Druschitz, Stacy; Unno, Kenji; Kurita, Takeshi; Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Ono, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Div Reprod Biol Res, Chicago, IL 60611 USA.	s-bulun@northwestern.edu	Qiang, Wenan/AAA-7633-2021; Kurita, Takeshi/A-2236-2013; Ono, Masanori/F-7443-2019	Kurita, Takeshi/0000-0003-4281-5884; Qiang, Wenan/0000-0001-5068-7128; Dyson, Matthew/0000-0003-3596-5753; Ono, Masanori/0000-0001-9249-6813; Kakinuma, Toshiyuki/0000-0001-7853-4860	Northwestern University Flow Cytometry Facility; Cancer Center Support Grant [NCI CA060553]; National Institutes of Health [NIH/NICHD 5P01HD057877, 1R01HD064402, NIH/NCI 1R01CA154358]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064402, P01HD057877] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA154358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	Northwestern University Flow Cytometry Facility; Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). This study was supported by National Institutes of Health Grant NIH/NICHD 5P01HD057877, 1R01HD064402, NIH/NCI 1R01CA154358. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Canevari RA, 2005, AM J OBSTET GYNECOL, V193, P1395, DOI 10.1016/j.ajog.2005.02.097; Cervello I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021221; Chang HL, 2010, REPROD SCI, V17, P158, DOI 10.1177/1933719109348924; Fernandez-Valdivia R, 2011, MOL CELL ENDOCRINOL; Gargett CE, 2008, MOL CELL ENDOCRINOL, V288, P22, DOI 10.1016/j.mce.2008.02.026; Greathouse KL, 2008, REPROD SCI, V15, P765, DOI 10.1177/1933719108322440; HASHIMOTO K, 1995, GYNECOL OBSTET INVES, V40, P204, DOI 10.1159/000292336; Hodge JC, 2009, GENE CHROMOSOME CANC, V48, P865, DOI 10.1002/gcc.20692; Ishikawa H, 2008, J CLIN ENDOCR METAB, V93, P981, DOI 10.1210/jc.2007-2507; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Khazaei M, 2009, FERTIL STERIL, V91, P2172, DOI 10.1016/j.fertnstert.2008.02.090; Kurita T, 2005, DIFFERENTIATION, V73, P313, DOI 10.1111/j.1432-0436.2005.00033.x; Kurita T, 2010, DIFFERENTIATION, V80, P99, DOI 10.1016/j.diff.2010.06.007; Lydon JP, 2010, NATURE, V465, P695, DOI 10.1038/465695a; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; McDonnel AC, 2005, CANCER LETT, V221, P49, DOI 10.1016/j.canlet.2004.09.011; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Ono M, 2010, HUM REPROD, V25, P2059, DOI 10.1093/humrep/deq163; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Othman EER, 2008, BEST PRACT RES CL OB, V22, P589, DOI 10.1016/j.bpobgyn.2008.01.014; Parker WH, 2007, FERTIL STERIL, V87, P725, DOI 10.1016/j.fertnstert.2007.01.093; Quesenberry PJ, 2002, BLOOD, V100, P4266, DOI 10.1182/blood-2002-04-1246; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schwab KE, 2008, HUM REPROD, V23, P934, DOI 10.1093/humrep/den051; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Szotek PP, 2007, STEM CELLS, V25, P1317, DOI 10.1634/stemcells.2006-0204; Usadi RS, 2008, J CLIN ENDOCR METAB, V93, P4058, DOI 10.1210/jc.2008-0460; Velagaleti GVN, 2010, CANCER GENET CYTOGEN, V202, P11, DOI 10.1016/j.cancergencyto.2010.06.002; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Wallach EE, 2004, OBSTET GYNECOL, V104, P393, DOI 10.1097/01.AOG.0000136079.62513.39; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Yin P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029021; Young HE, 2004, CURR TOP MICROBIOL, V280, P71; Zhang P, 2006, HUM PATHOL, V37, P1350, DOI 10.1016/j.humpath.2006.05.005	43	101	104	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36935	10.1371/journal.pone.0036935	http://dx.doi.org/10.1371/journal.pone.0036935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570742	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400058
J	Cheng, F; Wu, J; Fang, L; Sun, SL; Liu, B; Lin, K; Bonnema, G; Wang, XW				Cheng, Feng; Wu, Jian; Fang, Lu; Sun, Silong; Liu, Bo; Lin, Ke; Bonnema, Guusje; Wang, Xiaowu			Biased Gene Fractionation and Dominant Gene Expression among the Subgenomes of Brassica rapa	PLOS ONE			English	Article							SHORT READ ALIGNMENT; ARABIDOPSIS-THALIANA; DNA METHYLATION; GENOME SEQUENCE; DUPLICATION; EVOLUTION; POLYPLOIDS; PLANTS	Polyploidization, both ancient and recent, is frequent among plants. A "two-step theory'' was proposed to explain the meso-triplication of the Brassica "A'' genome: Brassica rapa. By accurately partitioning of this genome, we observed that genes in the less fractioned subgenome (LF) were dominantly expressed over the genes in more fractioned subgenomes (MFs: MF1 and MF2), while the genes in MF1 were slightly dominantly expressed over the genes in MF2. The results indicated that the dominantly expressed genes tended to be resistant against gene fractionation. By re-sequencing two B. rapa accessions: a vegetable turnip (VT117) and a Rapid Cycling line (L144), we found that genes in LF had less non-synonymous or frameshift mutations than genes in MFs; however mutation rates were not significantly different between MF1 and MF2. The differences in gene expression patterns and on-going gene death among the three subgenomes suggest that "two-step'' genome triplication and differential subgenome methylation played important roles in the genome evolution of B. rapa.	[Cheng, Feng; Wu, Jian; Fang, Lu; Sun, Silong; Liu, Bo; Wang, Xiaowu] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Lin, Ke; Bonnema, Guusje] Lab Plant Breeding, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Cheng, F (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China.	wangxw@mail.caas.net.cn	Cheng, Feng/P-3233-2015; Wang, Xiaowu/L-2579-2019; 刘博, 博/AAR-9824-2020	Cheng, Feng/0000-0003-2982-9675; Sun, Silong/0000-0002-4541-9126; Bonnema, Guusje/0000-0002-2298-6849	Chinese Ministry of Science and Technology; National Basic Research Program of China [2012CB113901, 2012CB113906]; National High Technology R&D Program of China [2012AA100201]; China International Science and Technology Cooperation [2010DFA31730]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); National High Technology R&D Program of China(National High Technology Research and Development Program of China); China International Science and Technology Cooperation	This work was funded by the Chinese Ministry of Science and Technology, the National Basic Research Program of China (2012CB113901, 2012CB113906), the National High Technology R&D Program of China (2012AA100201), and China International Science and Technology Cooperation (2010DFA31730) to Dr. Wang. The work was done in the Key Laboratory of Biology and Genetic Improvement of Horticultural Crops, Ministry of Agriculture, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Parkin IAP, 2005, GENETICS, V171, P765, DOI 10.1534/genetics.105.042093; Phillips T, 2008, NATURE ED, V1; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schranz ME, 2006, TRENDS PLANT SCI, V11, P535, DOI 10.1016/j.tplants.2006.09.002; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Spillane C, 2007, NATURE, V448, P349, DOI 10.1038/nature05984; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-239; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502	30	180	186	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36442	10.1371/journal.pone.0036442	http://dx.doi.org/10.1371/journal.pone.0036442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567157	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500076
J	Nakayama, S; Harcourt, JL; Johnstone, RA; Manica, A				Nakayama, Shinnosuke; Harcourt, Jennifer L.; Johnstone, Rufus A.; Manica, Andrea			Initiative, Personality and Leadership in Pairs of Foraging Fish	PLOS ONE			English	Article							STICKLEBACKS GASTEROSTEUS-ACULEATUS; ROACH RUTILUS-RUTILUS; DECISION-MAKING; COLLECTIVE BEHAVIOR; SOCIAL-CONTEXT; BOLDNESS; SHOALS; MOVEMENTS; EVOLUTION; DYNAMICS	Studies of coordinated movement have found that, in many animal species, bolder individuals are more likely to initiate movement and shyer individuals to follow. Here, we show that in pairs of foraging stickleback fish, leadership is not merely a passive consequence of temperamental differences. Instead, the act of initiating a joint foraging trip out of cover itself brings about a change in the role that an individual plays throughout the subsequent trip, and success in recruiting a partner affects an individual's tendency to initiate the next trip. On each joint trip, whichever fish took the initiative in leading out of cover gains greater influence over its partner's behaviour, which persists even after several changes in position (i.e. termination attempts and re-joining). During any given trip, the initiator is less responsive to its partner's movements than during trips initiated by the partner. An individual's personality had an important effect on its response to failure to recruit a partner: while bold fish were unaffected by failures to initiate a joint trip, shy individuals were less likely to attempt another initiation after a failure. This difference provides a positive feedback mechanism that can partially stabilise social roles within the pair, but it is not strong enough to prevent occasional swaps, with individuals dynamically adjusting their responses to one another as they exchange roles.	[Nakayama, Shinnosuke; Harcourt, Jennifer L.; Johnstone, Rufus A.; Manica, Andrea] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Nakayama, S (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	sn407@cam.ac.uk; raj1003@cam.ac.uk; am315@cam.ac.uk	Manica, Andrea/B-5497-2008; Manica, Andrea/N-9013-2019	Manica, Andrea/0000-0003-1895-450X; Manica, Andrea/0000-0003-1895-450X	Association for the Study of Animal Behaviour; NERC; Japan Society of the Promotion of Science	Association for the Study of Animal Behaviour; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Japan Society of the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded by a grant from the Association for the Study of Animal Behaviour to AM, a NERC studentship to JLH, and a fellowship from Japan Society of the Promotion of Science to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Borg B, 2004, BEHAVIOUR, V141, P1521, DOI 10.1163/1568539042948213; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; Harcourt JL, 2009, CURR BIOL, V19, P248, DOI 10.1016/j.cub.2008.12.051; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Jacobs A, 2008, BEHAV PROCESS, V79, P111, DOI 10.1016/j.beproc.2008.05.004; Johnstone RA, 2011, P NATL ACAD SCI USA, V108, P8373, DOI 10.1073/pnas.1102191108; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; King AJ, 2011, ANIM BEHAV, V82, P1337, DOI 10.1016/j.anbehav.2011.09.017; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Kurvers RHJM, 2010, P ROY SOC B-BIOL SCI, V277, P601, DOI 10.1098/rspb.2009.1474; Kurvers RHJM, 2009, ANIM BEHAV, V78, P447, DOI 10.1016/j.anbehav.2009.06.002; Leblond C, 2006, BEHAVIOUR, V143, P1263, DOI 10.1163/156853906778691603; Leca JB, 2003, ANIM BEHAV, V66, P1045, DOI 10.1006/anbe.2003.2276; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Magnhagen C, 2009, P ROY SOC B-BIOL SCI, V276, P3369, DOI 10.1098/rspb.2009.0851; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nakayama S, 2011, J ANIM ECOL, V80, P1299, DOI 10.1111/j.1365-2656.2011.01859.x; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Petit O, 2010, BEHAV PROCESS, V84, P635, DOI 10.1016/j.beproc.2010.04.009; Pike TW, 2008, P ROY SOC B-BIOL SCI, V275, P2515, DOI 10.1098/rspb.2008.0744; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2010, BEHAV PROCESS, V84, P668, DOI 10.1016/j.beproc.2010.03.001; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Sueur C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000917; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; van Oers K, 2005, BEHAV ECOL, V16, P716, DOI 10.1093/beheco/ari045; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2011, P NATL ACAD SCI USA, V108, P2312, DOI 10.1073/pnas.1007102108; Webster MM, 2007, BEHAVIOUR, V144, P351, DOI 10.1163/156853907780425721; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x	43	50	53	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36606	10.1371/journal.pone.0036606	http://dx.doi.org/10.1371/journal.pone.0036606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567168	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500088
J	Silver, HJ; Niswender, KD; Keil, CD; Jiang, L; Feng, QP; Chiu, S; Krauss, RM; Wilke, RA				Silver, Heidi J.; Niswender, Kevin D.; Keil, Charles D.; Jiang, Lan; Feng, Qiping; Chiu, Sally; Krauss, Ronald M.; Wilke, Russell A.			CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake	PLOS ONE			English	Article							BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; CB1 RECEPTOR; LOW-CARBOHYDRATE; ENDOTHELIAL LIPASE; METABOLIC SYNDROME; GENETIC-VARIATION; CONTROLLED-TRIALS; FASTING LIPIDS	Background: Success in further reducing the burden of cardiovascular disease (CVD) is threatened by the increasing prevalence of obesity-related atherogenic dyslipidemia. HDL-cholesterol (HDL-C) level is inversely correlated with CVD risk; each 1 mg/dl decrease in HDL-C is associated with a 6% reduction in risk. We previously showed that a common CNR1 haplotype, H3 (frequency 20%), is protective against the reduction in HDL-C that typically accompanies weight gain. In the present study, we extend that observation by reporting the effect of CNR1 haplotype on HDL-C response to modification of dietary fat intake in weight maintenance and weight loss. Methods: Six haplotype tagging SNPs that cover the CNR1 gene locus were genotyped in 590 adults of varying body mass index (cohort 1 is 411 males with BMI 18.5-30.0 kg/m(2); cohort 2 is 71 females with BMI18.5-30.0 kg/m(2); and cohort 3 is 108 females with BMI 30-39.9 kg/m(2)). Dietary intakes were modified so that fat intake in the "high fat'' condition was 15-20% greater than in the "low fat'' condition, and lipid profiles were compared between carriers versus noncarriers for each of the five commonly observed CNR1 haplotypes (H1-H5). Results: In normal to overweight subjects on eucaloric diets, the H3 haplotype was significantly associated with short-term high fat diet induced changes in HDL-C level in females (carriers 5.9 mg/dl. noncarriers, p = 0.007). The H3 haplotype was also significantly associated with HDL-C level after 16 weeks on high fat calorie restricted diet in obese females (carriers 6.8 mg/dl. noncarriers, p = 0.009). Conclusion: Variability within the CNR1 gene locus contributes to gender-related differences in the HDL-cholesterol response to change in dietary fat intake. Functional characterization of this relationship in vitro may offer insights that potentially yield therapeutic guidance targeting dietary macronutrient composition, a direction much needed in the current epidemic of obesity.	[Silver, Heidi J.; Keil, Charles D.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA; [Niswender, Kevin D.] Tennessee Valley Healthcare Syst, Nashville, TN USA; [Niswender, Kevin D.] Vanderbilt Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Nashville, TN 37212 USA; [Jiang, Lan] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37212 USA; [Feng, Qiping; Wilke, Russell A.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Chiu, Sally; Krauss, Ronald M.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Silver, HJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37212 USA.	heidi.j.silver@vanderbilt.edu	Biguzzi, Felipe A/E-4724-2015; Feng, Qiping/F-7941-2013		Dr. Robert C. and Veronica Atkins Foundation; Vanderbilt CTSA from National Center for Research Resources, National Institutes of Health [1 UL1 RR024975]; Tennessee Valley Healthcare System, NIH [DK064857, DK069927]; Vanderbilt Diabetes Research and Training Center [DK020593]; NIH [U01HL069757, R01DK080007]; Department of Atherosclerosis Research; Children's Hospital Oakland Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, KL2RR024977, TL1RR024978] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, K08DK064857, R01DK069927, R01DK080007, P30DK020593] Funding Source: NIH RePORTER	Dr. Robert C. and Veronica Atkins Foundation; Vanderbilt CTSA from National Center for Research Resources, National Institutes of Health; Tennessee Valley Healthcare System, NIH; Vanderbilt Diabetes Research and Training Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Atherosclerosis Research; Children's Hospital Oakland Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by The Dr. Robert C. and Veronica Atkins Foundation (HJS), the Vanderbilt CTSA grant 1 UL1 RR024975 from the National Center for Research Resources, National Institutes of Health (HJS), the Tennessee Valley Healthcare System, NIH grants DK064857 and DK069927, and the Vanderbilt Diabetes Research and Training Center grant DK020593 (KDN), NIH Grant U01HL069757 (RMK), the Department of Atherosclerosis Research, the Children's Hospital Oakland Research Institute (RMK), and NIH Grant R01DK080007 (RAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashen MD, 2005, NEW ENGL J MED, V353, P1252, DOI 10.1056/NEJMcp044370; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Baye TM, 2008, PHARMACOGENOMICS, V9, P1647, DOI 10.2217/14622416.9.11.1647; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bray GA, 2011, AM J CLIN NUTR, V93, P481, DOI 10.3945/ajcn.110.011114; Brown CD, 2000, OBES RES, V8, P605, DOI 10.1038/oby.2000.79; Denke MA, 2000, JAMA-J AM MED ASSOC, V284, P2740, DOI 10.1001/jama.284.21.2740; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dreon DM, 1997, ARTERIOSCL THROM VAS, V17, P707, DOI 10.1161/01.ATV.17.4.707; Dreon DM, 1998, AM J CLIN NUTR, V67, P828, DOI 10.1093/ajcn/67.5.828; Dreon DM, 1997, J AM COLL NUTR, V16, P313, DOI 10.1080/07315724.1997.10718692; Feng QP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015779; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gary-Bobo M, 2006, MOL PHARMACOL, V69, P471, DOI 10.1124/mol.105.015040; Gary-Bobo M, 2007, HEPATOLOGY, V46, P122, DOI 10.1002/hep.21641; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Jansen S, 1998, J NUTR, V128, P1144, DOI 10.1093/jn/128.7.1144; Jourdan T, 2010, DIABETES, V59, P926, DOI 10.2337/db09-1482; Kanders B, 1994, OBESITY PATHOPHYSIOL, P167; Kim JK, 2006, J WOMENS HEALTH, V15, P734, DOI 10.1089/jwh.2006.15.734; Knoblauch H, 2004, HUM MOL GENET, V13, P993, DOI 10.1093/hmg/ddh119; Krauss RM, 1997, WORLD REV NUTR DIET, V80, P22; KRAUSS RM, 1995, AM J CLIN NUTR, V62, p478S, DOI 10.1093/ajcn/62.2.478S; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Moshfegb A, 1999, FASEB J, V13, pA603; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ordovas JM, 2006, J AM DIET ASSOC, V106, P1074, DOI 10.1016/j.jada.2006.04.016; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ruby MA, 2008, P NATL ACAD SCI USA, V105, P14561, DOI 10.1073/pnas.0807232105; Ruilopea LM, 2008, J HYPERTENS, V26, P357, DOI 10.1097/HJH.0b013e3282f2d625; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; Serdula MK, 1999, JAMA-J AM MED ASSOC, V282, P1353, DOI 10.1001/jama.282.14.1353; Sharman MJ, 2004, J NUTR, V134, P880, DOI 10.1093/jn/134.4.880; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Stafford JM, 2008, DIABETES, V57, P1482, DOI 10.2337/db07-1702; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turner SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019586; Tyler K, 2000, EUR J PHARMACOL, V409, P207, DOI 10.1016/S0014-2999(00)00843-8; Volek JS, 2004, J AM COLL NUTR, V23, P177, DOI 10.1080/07315724.2004.10719359; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weggemans RM, 1999, EUR J CLIN INVEST, V29, P827; Wilke RA, 2011, PHARMACOGENOMICS J, V11, P162, DOI 10.1038/tpj.2010.86; Wilke Russell A, 2010, Prev Cardiol, V13, P63, DOI 10.1111/j.1751-7141.2009.00055.x; Willett WC, 1998, AM J CLIN NUTR, V68, P1149, DOI 10.1093/ajcn/68.6.1149; Yasuda T, 2010, CIRC J, V74, P2263, DOI 10.1253/circj.CJ-10-0934	60	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36166	10.1371/journal.pone.0036166	http://dx.doi.org/10.1371/journal.pone.0036166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567136	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500055
J	Felcher, KJ; Coombs, JJ; Massa, AN; Hansey, CN; Hamilton, JP; Veilleux, RE; Buell, CR; Douches, DS				Felcher, Kimberly J.; Coombs, Joseph J.; Massa, Alicia N.; Hansey, Candice N.; Hamilton, John P.; Veilleux, Richard E.; Buell, C. Robin; Douches, David S.			Integration of Two Diploid Potato Linkage Maps with the Potato Genome Sequence	PLOS ONE			English	Article							SOLANUM-CHACOENSE; GENETIC-RECOMBINATION; RFLP MAPS; MAIZE; RICE; PHUREJA; TOMATO; HYBRID; MUTANT	To facilitate genome-guided breeding in potato, we developed an 8303 Single Nucleotide Polymorphism (SNP) marker array using potato genome and transcriptome resources. To validate the Infinium 8303 Potato Array, we developed linkage maps from two diploid populations (DRH and D84) and compared these maps with the assembled potato genome sequence. Both populations used the doubled monoploid reference genotype DM1-3 516 R44 as the female parent but had different heterozygous diploid male parents (RH89-039-16 and 84SD22). Over 4,400 markers were mapped (1,960 in DRH and 2,454 in D84, 787 in common) resulting in map sizes of 965 (DRH) and 792 (D84) cM, covering 87% (DRH) and 88% (D84) of genome sequence length. Of the mapped markers, 33.5% were in candidate genes selected for the array, 4.5% were markers from existing genetic maps, and 61% were selected based on distribution across the genome. Markers with distorted segregation ratios occurred in blocks in both linkage maps, accounting for 4% (DRH) and 9% (D84) of mapped markers. Markers with distorted segregation ratios were unique to each population with blocks on chromosomes 9 and 12 in DRH and 3, 4, 6 and 8 in D84. Chromosome assignment of markers based on linkage mapping differed from sequence alignment with the Potato Genome Sequencing Consortium (PGSC) pseudomolecules for 1% of the mapped markers with some disconcordant markers attributable to paralogs. In total, 126 (DRH) and 226 (D84) mapped markers were not anchored to the pseudomolecules and provide new scaffold anchoring data to improve the potato genome assembly. The high degree of concordance between the linkage maps and the pseudomolecules demonstrates both the quality of the potato genome sequence and the functionality of the Infinium 8303 Potato Array. The broad genome coverage of the Infinium 8303 Potato Array compared to other marker sets will enable numerous downstream applications.	[Felcher, Kimberly J.; Coombs, Joseph J.; Douches, David S.] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; [Massa, Alicia N.; Hansey, Candice N.; Hamilton, John P.; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Veilleux, Richard E.] Virginia Tech, Dept Hort, Blacksburg, VA USA	Michigan State University; Michigan State University; Virginia Polytechnic Institute & State University	Felcher, KJ (corresponding author), Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA.	douchesd@msu.edu	Hamilton, John P/G-1379-2016	Hamilton, John P/0000-0002-8682-5526; Buell, C Robin/0000-0002-6727-4677	U.S. National Science Foundation [DBI-0834044]; USDA NIFA AFRI [2009-85606-05673]	U.S. National Science Foundation(National Science Foundation (NSF)); USDA NIFA AFRI(United States Department of Agriculture (USDA))	This work was supported by funds from the U.S. National Science Foundation Plant Genome Research Program (DBI-0834044) to CRB and funds from USDA NIFA AFRI Plant Breeding, Genetics and Genome grant 2009-85606-05673 to DSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anithakumari AM, 2010, MOL BREEDING, V26, P65, DOI 10.1007/s11032-009-9377-5; [Anonymous], 2006, JOINMAP4; BIRHMAN RK, 1994, J HERED, V85, P241, DOI 10.1093/oxfordjournals.jhered.a111445; BONIERBALE MW, 1988, GENETICS, V120, P1095; Caromel B, 2003, THEOR APPL GENET, V106, P1517, DOI 10.1007/s00122-003-1211-6; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; DOUCHES DS, 1988, HEREDITY, V60, P183, DOI 10.1038/hdy.1988.30; GEBHARDT C, 1991, THEOR APPL GENET, V83, P49, DOI 10.1007/BF00229225; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hamilton JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-302; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; JACOBS JME, 1995, THEOR APPL GENET, V91, P289, DOI 10.1007/BF00220891; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Milbourne D, 1998, MOL GEN GENET, V259, P233, DOI 10.1007/s004380050809; Paz MM, 1999, PLANT BREEDING, V118, P53, DOI 10.1046/j.1439-0523.1999.118001053.x; Potato Genome Sequencing Consortium, 2011, NATURE, V475, P186; Rezvoy C, 2007, BIOINFORMATICS, V23, P2188, DOI 10.1093/bioinformatics/btm315; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen YJ, 2004, PLANT PHYSIOL, V135, P1198, DOI 10.1104/pp.103.038463; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; van Zandvoort P, 1997, MOL GEN GENET, V255, P428; Veilleux RE, 1998, J AM SOC HORTIC SCI, V123, P854, DOI 10.21273/JASHS.123.5.854; Zhu YL, 2003, GENETICS, V163, P1123	26	147	152	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36347	10.1371/journal.pone.0036347	http://dx.doi.org/10.1371/journal.pone.0036347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558443	Green Published, gold			2022-12-27	WOS:000305336000193
J	Abderrahmani, R; Francois, A; Buard, V; Tarlet, G; Blirando, K; Hneino, M; Vaurijoux, A; Benderitter, M; Sabourin, JC; Milliat, F				Abderrahmani, Rym; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Blirando, Karl; Hneino, Mohammad; Vaurijoux, Aurelie; Benderitter, Marc; Sabourin, Jean-Christophe; Milliat, Fabien			PAI-1-Dependent Endothelial Cell Death Determines Severity of Radiation-Induced Intestinal Injury	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; INDUCED GASTROINTESTINAL SYNDROME; INDUCED PULMONARY-FIBROSIS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; IN-VIVO; IONIZING-RADIATION; INDUCED APOPTOSIS; TUMOR-GROWTH; AKT PATHWAY	Normal tissue toxicity still remains a dose-limiting factor in clinical radiation therapy. Recently, plasminogen activator inhibitor type 1 (SERPINE1/PAI-1) was reported as an essential mediator of late radiation-induced intestinal injury. However, it is not clear whether PAI-1 plays a role in acute radiation-induced intestinal damage and we hypothesized that PAI-1 may play a role in the endothelium radiosensitivity. In vivo, in a model of radiation enteropathy in PAI-1 -/- mice, apoptosis of radiosensitive compartments, epithelial and microvascular endothelium was quantified. In vitro, the role of PAI-1 in the radiation-induced endothelial cells (ECs) death was investigated. The level of apoptotic ECs is lower in PAI-1 -/- compared with Wt mice after irradiation. This is associated with a conserved microvascular density and consequently with a better mucosal integrity in PAI-1 -/- mice. In vitro, irradiation rapidly stimulates PAI-1 expression in ECs and radiation sensitivity is increased in ECs that stably overexpress PAI-1, whereas PAI-1 knockdown increases EC survival after irradiation. Moreover, ECs prepared from PAI-1 -/- mice are more resistant to radiation-induced cell death than Wt ECs and this is associated with activation of the Akt pathway. This study demonstrates that PAI-1 plays a key role in radiation-induced EC death in the intestine and suggests that this contributes strongly to the progression of radiation-induced intestinal injury.	[Abderrahmani, Rym; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Blirando, Karl; Hneino, Mohammad; Benderitter, Marc; Milliat, Fabien] Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France; [Vaurijoux, Aurelie] Inst Radiol Protect & Nucl Safety, Lab Biol Dosimetry, Fontenay Aux Roses, France; [Sabourin, Jean-Christophe] Rouen Univ Hosp, Dept Pathol, Rouen, France	CHU de Rouen	Abderrahmani, R (corresponding author), Inst Radiol Protect & Nucl Safety, Lab Radiopathol & Expt Therapeut, Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		Milliat, Fabien/0000-0001-8249-9498; TARLET, Georges/0000-0002-4756-5127; Vaurijoux, Aurelie/0000-0002-6418-4182	Electricite de France (EDF)	Electricite de France (EDF)(Electricite de France (EDF))	This work was supported by Electricite de France (EDF) and is included in the IRSN program ROSIRIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani R, 2009, INT J RADIAT ONCOL, V74, P942, DOI 10.1016/j.ijrobp.2009.01.077; Andreyev J, 2005, GUT, V54, P1051, DOI 10.1136/gut.2004.062596; Artman T, 2010, INT J RADIAT ONCOL, V76, P574, DOI 10.1016/j.ijrobp.2009.08.035; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Balsara RD, 2006, J BIOL CHEM, V281, P22527, DOI 10.1074/jbc.M512819200; Balsara RD, 2008, THROMB HAEMOSTASIS, V100, P1029, DOI 10.1160/TH08-07-0427; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Bonnaud S, 2010, CANCER RES, V70, P9905, DOI 10.1158/0008-5472.CAN-10-2043; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Chen YB, 2006, ARTERIOSCL THROM VAS, V26, P1777, DOI 10.1161/01.ATV.0000227514.50065.2a; Chen YB, 2004, J CELL BIOCHEM, V92, P178, DOI 10.1002/jcb.20058; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Collins-Underwood JR, 2008, FREE RADICAL BIO MED, V45, P929, DOI 10.1016/j.freeradbiomed.2008.06.024; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Eitzman DT, 2000, BLOOD, V96, P4212; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Gudkov AV, 2008, INT J RADIAT ONCOL, V70, P800, DOI 10.1016/j.ijrobp.2007.07.2396; Hageman J, 2005, CLIN CANCER RES, V11, P5956, DOI 10.1158/1078-0432.CCR-05-0427; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Jin YP, 2004, HUM IMMUNOL, V65, P291, DOI 10.1016/j.humimm.2004.01.002; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Lademann UA, 2008, THROMB HAEMOSTASIS, V100, P1041, DOI 10.1160/TH08-04-0266; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Oikawa T, 1997, KIDNEY INT, V51, P164, DOI 10.1038/ki.1997.20; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Schneider DJ, 2008, THROMB HAEMOSTASIS, V100, P1037, DOI 10.1160/TH08-04-0234; Schuller BW, 2007, INT J RADIAT ONCOL, V68, P205, DOI 10.1016/j.ijrobp.2006.12.069; Schuller BW, 2006, P NATL ACAD SCI USA, V103, P3787, DOI 10.1073/pnas.0600133103; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Soff GA, 1995, J CLIN INVEST, V96, P2593, DOI 10.1172/JCI118323; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; Vozenin-Brotons MC, 2004, RADIAT RES, V161, P299, DOI 10.1667/RR3128; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Zhao WL, 1999, RADIAT RES, V152, P160, DOI 10.2307/3580089; Zhao WL, 2001, CANCER RES, V61, P5537; Zheng H, 2000, GASTROENTEROLOGY, V119, P1286, DOI 10.1053/gast.2000.19282	52	40	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35740	10.1371/journal.pone.0035740	http://dx.doi.org/10.1371/journal.pone.0035740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563394	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100022
J	Glisic, S; Jailwala, P				Glisic, Sanja; Jailwala, Parthav			Interaction between Treg Apoptosis Pathways, Treg Function and HLA Risk Evolves during Type 1 Diabetes Pathogenesis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; MHC CLASS-II; INDUCED CELL-DEATH; HUMAN T-CELLS; POLYMERASE CHAIN-REACTION; NF-KAPPA-B; OXIDATIVE STRESS; HUMAN NEUTROPHILS; HIGH-RESOLUTION; MESSENGER-RNA	We have previously reported increased apoptosis of regulatory T cells (Tregs) in recent-onset Type 1 Diabetes subjects (RO T1D) in the honeymoon phase and in multiple autoantibody-positive (Ab+) subjects, some of which are developing T1D. We have also reported that increased Treg apoptosis was associated with High HLA risk and that it subsided with cessation of honeymoon period. In this report, we present results generated using genetics, genomics, functional cell-based assays and flow cytometry to assess cellular changes at the T-cell level during T1D pathogenesis. We measured ex vivo Treg apoptosis and Treg function, surface markers expression, expression of HLA class II genes, the influence of HLA risk on Treg apoptosis and function, and evaluated contribution of genes reported to be involved in the apoptosis process. This integrated comprehensive approach uncovered important information that can serve as a basis for future studies aimed to modulate Treg cell responsiveness to apoptotic signals in autoimmunity. For example, T1D will progress in those subjects where increased Treg apoptosis is accompanied with decreased Treg function. Furthermore, Tregs from High HLA risk healthy controls had increased Treg apoptosis levels and overexpressed FADD but not Fas/FasL. Tregs from RO T1D subjects in the honeymoon phase were primarily dying through withdrawal of growth hormones with contribution of oxidative stress, mitochondrial apoptotic pathways, and employment of TNF-receptor family members. Ab+ subjects, however, expressed high inflammation level, which probably contributed to Treg apoptosis, although other apoptotic pathways were also activated: withdrawal of growth hormones, oxidative stress, mitochondrial apoptosis and Fas/FasL apoptotic pathways. The value of these results lie in potentially different preventive treatment subjects would receive depending on disease progression stage when treated.	[Glisic, Sanja] Med Coll Wisconsin, Childrens Hosp Wisconsin, Human & Mol Genet Ctr, Dept Pediat,Max McGee Natl Res Ctr Juvenile Diabe, Milwaukee, WI 53226 USA; [Jailwala, Parthav] NCI Frederick, SAIC Frederick, Adv Biomed Comp Ctr, Bethesda, MD USA	Children's Hospital of Wisconsin; Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Glisic, S (corresponding author), Med Coll Wisconsin, Childrens Hosp Wisconsin, Human & Mol Genet Ctr, Dept Pediat,Max McGee Natl Res Ctr Juvenile Diabe, Milwaukee, WI 53226 USA.	sglisic@mcw.edu			Research Affairs Committee [9304653]; Max McGee National Research Center for Juvenile Diabetes; Human Molecular Genetics Center at Medical College of Wisconsin; Children's Research Institute of Wisconsin	Research Affairs Committee; Max McGee National Research Center for Juvenile Diabetes; Human Molecular Genetics Center at Medical College of Wisconsin; Children's Research Institute of Wisconsin	This study was supported by Research Affairs Committee #9304653 and through Max McGee National Research Center for Juvenile Diabetes, Human Molecular Genetics Center at Medical College of Wisconsin and Children's Research Institute of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; BAISCH JM, 1990, NEW ENGL J MED, V322, P1836, DOI 10.1056/NEJM199006283222602; BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BENOIST C, 1990, ANNU REV IMMUNOL, V8, P681, DOI 10.1146/annurev.immunol.8.1.681; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Cowburn AS, 2011, AM J RESP CELL MOL, V44, P879, DOI 10.1165/rcmb.2010-0101OC; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Dabelea D, 2007, JAMA-J AM MED ASSOC, V297, P2716; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Donner H, 2002, EUR J IMMUNOGENET, V29, P321, DOI 10.1046/j.1365-2370.2002.00321.x; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; ERLICH HA, 1991, DIABETES, V40, P478, DOI 10.2337/diabetes.40.4.478; Fang HY, 2011, ONCOL REP, V26, P359, DOI 10.3892/or.2011.1292; Ferstl B, 2004, GENES IMMUN, V5, P405, DOI 10.1038/sj.gene.6364108; Fritzsching B, 2005, J IMMUNOL, V175, P32, DOI 10.4049/jimmunol.175.1.32; Glisic S, 2009, GENES IMMUN, V10, P334, DOI 10.1038/gene.2009.14; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gorus F K, 1996, Verh K Acad Geneeskd Belg, V58, P539; Greenbaum CJ, 2002, J AUTOIMMUN, V18, P67, DOI 10.1006/jaut.2001.0562; HEWITT CRA, 1989, J IMMUNOL, V143, P762; Himer L, 2010, FASEB J, V24, P2631, DOI 10.1096/fj.10-155192; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ishola DA, 2006, KIDNEY INT, V70, P724, DOI 10.1038/sj.ki.5001629; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; KANSAS GS, 1991, J IMMUNOL, V147, P4094; Kato-Kogoe N, 2010, LAB INVEST, V90, P1747, DOI 10.1038/labinvest.2010.128; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; Kwok WW, 1996, J EXP MED, V183, P1253, DOI 10.1084/jem.183.3.1253; LASALLE JM, 1991, J IMMUNOL, V147, P774; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lie BA, 1999, AM J HUM GENET, V64, P793, DOI 10.1086/302283; MASCLE F, 1990, NOUV REV FR HEMATOL, V32, P333; Mauro C, 2006, J BIOL CHEM, V281, P2631, DOI 10.1074/jbc.M502181200; MOONEY NA, 1990, J IMMUNOL, V145, P2070; MorzyckaWroblewska E, 1997, IMMUNOGENETICS, V45, P163, DOI 10.1007/s002510050185; Nejentsev S, 2000, DIABETES, V49, P2217, DOI 10.2337/diabetes.49.12.2217; Nepom GT, 1998, DIABETES, V47, P1177, DOI 10.2337/diabetes.47.8.1177; NERUP J, 1974, LANCET, V2, P864; Noble JA, 1996, AM J HUM GENET, V59, P1134; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Pociot F, 2002, GENES IMMUN, V3, P235, DOI 10.1038/sj.gene.6363875; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Redondo MJ, 2001, RECENT PROG HORM RES, V56, P69, DOI 10.1210/rp.56.1.69; Reinisch W, 2003, CLIN EXP IMMUNOL, V133, P476, DOI 10.1046/j.1365-2249.2003.02245.x; Rhoads DM, 2006, PLANT PHYSIOL, V141, P357, DOI 10.1104/pp.106.079129; Robertson LA, 2006, CAN J PHYSIOL PHARM, V84, P39, DOI 10.1139/Y05-142; ROTTER JI, 1984, CLIN GENET, V26, P529; Russell JW, 2002, FASEB J, V16, P1738, DOI 10.1096/fj.01-1027com; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; She JX, 1996, IMMUNOL TODAY, V17, P323, DOI 10.1016/0167-5699(96)10014-1; Shen HM, 2004, MOL CELL BIOL, V24, P5914, DOI 10.1128/MCB.24.13.5914-5922.2004; SHOOKSTER L, 1987, HUM IMMUNOL, V20, P59, DOI 10.1016/0198-8859(87)90006-1; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Sood SK, 2011, WORLD J SURG, V35, P1984, DOI 10.1007/s00268-011-1185-5; Stehlik C, 2003, J BIOL CHEM, V278, P31941, DOI 10.1074/jbc.M300009200; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Thibeault A, 1999, CELL IMMUNOL, V192, P79, DOI 10.1006/cimm.1998.1428; THORSBY E, 1993, DIABETOLOGIA, V36, P371, DOI 10.1007/BF00402270; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1990, CURR TOP MICROBIOL, V164, P17; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Valdes AM, 2005, TISSUE ANTIGENS, V65, P115, DOI 10.1111/j.1399-0039.2005.00348.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vincent R, 1996, J IMMUNOL, V156, P603; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; WYSSCORAY T, 1992, CELL IMMUNOL, V139, P268, DOI 10.1016/0008-8749(92)90119-A; Xiang JL, 1996, P NATL ACAD SCI USA, V93, P14559, DOI 10.1073/pnas.93.25.14559; Yamamoto T, 2002, J NEURAL TRANSM, V109, P1, DOI 10.1007/s702-002-8232-1; Yun TJ, 1998, J IMMUNOL, V161, P6113; Yun TJ, 2001, J IMMUNOL, V166, P1482, DOI 10.4049/jimmunol.166.3.1482; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	76	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36040	10.1371/journal.pone.0036040	http://dx.doi.org/10.1371/journal.pone.0036040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563437	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100063
J	Kroetz, SM; Srinivasan, J; Yaghoobian, J; Sternberg, PW; Hong, RL				Kroetz, Silvina M.; Srinivasan, Jagan; Yaghoobian, Jonathan; Sternberg, Paul W.; Hong, Ray L.			The cGMP Signaling Pathway Affects Feeding Behavior in the Necromenic Nematode Pristionchus pacificus	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; C-ELEGANS; BODY-SIZE; CAENORHABDITIS-ELEGANS; BEETLE; FOOD	Background: The genetic tractability and the species-specific association with beetles make the nematode Pristionchus pacificus an exciting emerging model organism for comparative studies in development and behavior. P. pacificus differs from Caenorhabditis elegans (a bacterial feeder) by its buccal teeth and the lack of pharyngeal grinders, but almost nothing is known about which genes coordinate P. pacificus feeding behaviors, such as pharyngeal pumping rate, locomotion, and fat storage. Methodology/Principal Findings: We analyzed P. pacificus pharyngeal pumping rate and locomotion behavior on and off food, as well as on different species of bacteria (Escherichia coli, Bacillus subtilis, and Caulobacter crescentus). We found that the cGMP-dependent protein kinase G (PKG) Ppa-EGL-4 in P. pacificus plays an important role in regulating the pumping rate, mouth form dimorphism, the duration of forward locomotion, and the amount of fat stored in intestine. In addition, Ppa-EGL-4 interacts with Ppa-OBI-1, a recently identified protein involved in chemosensation, to influence feeding and locomotion behavior. We also found that C. crescentus NA1000 increased pharyngeal pumping as well as fat storage in P. pacificus. Conclusions: The PKG EGL-4 has conserved functions in regulating feeding behavior in both C. elegans and P. pacificus nematodes. The Ppa-EGL-4 also has been co-opted during evolution to regulate P. pacificus mouth form dimorphism that indirectly affect pharyngeal pumping rate. Specifically, the lack of Ppa-EGL-4 function increases pharyngeal pumping, time spent in forward locomotion, and fat storage, in part as a result of higher food intake. Ppa-OBI-1 functions upstream or parallel to Ppa-EGL-4. The beetle-associated omnivorous P. pacificus respond differently to changes in food state and food quality compared to the exclusively bacteriovorous C. elegans.	[Kroetz, Silvina M.; Yaghoobian, Jonathan; Hong, Ray L.] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Srinivasan, Jagan; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California State University System; California State University Northridge; California Institute of Technology	Kroetz, SM (corresponding author), Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA.	ray.hong@csun.edu	Srinivasan, Jagan/B-6215-2015	Sternberg, Paul/0000-0002-7699-0173; Srinivasan, Jagan/0000-0001-5449-7938	Minority Access to Research Careers (MARC); Caltech; National Institutes of Health [SC2GM089602]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM105579, SC2GM089602] Funding Source: NIH RePORTER	Minority Access to Research Careers (MARC); Caltech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Minority Access to Research Careers (MARC) and Caltech's MURF (Minority Undergraduate Research Fellowship) to SMK, HHMI to JS and PWS, and National Institutes of Health grant SC2GM089602 awarded to RLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVERY L, 1993, GENETICS, V134, P454; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-69; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fitzpatrick MJ, 2004, INTEGR COMP BIOL, V44, P28, DOI 10.1093/icb/44.1.28; Foster Woodruff, 1946, J BACTERIOL, P51; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Herrmann M, 2006, ZOOLOGY, V109, P96, DOI 10.1016/j.zool.2006.03.001; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; Hirschmann H., 1951, Zoologische Jahrbuecher (Systematik), V80, P132; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hong RL, 2008, EVOL DEV, V10, P273, DOI 10.1111/j.1525-142X.2008.00236.x; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Li G, 2006, BIOPHYS J, V91, P2726, DOI 10.1529/biophysj.106.080697; Nakano Y, 2004, GENES CELLS, V9, P773, DOI 10.1111/j.1365-2443.2004.00771.x; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Poindexter, 1981, MICROBIOLOGICAL REV, V45, P123; Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rae R, 2010, ENVIRON MICROBIOL, V12, P3007, DOI 10.1111/j.1462-2920.2010.02278.x; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; RAIZEN DM, 1995, GENETICS, V141, P1365; Rivard L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-22; SARGENT MG, 1975, J BACTERIOL, V123, P7, DOI 10.1128/JB.123.1.7-19.1975; Schulte RD, 2011, BIOL LETT; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; TRENT C, 1983, GENETICS, V104, P619; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	40	22	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34464	10.1371/journal.pone.0034464	http://dx.doi.org/10.1371/journal.pone.0034464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563372	Green Published, gold, Green Accepted			2022-12-27	WOS:000305349100002
J	Sheridan, MA; Sarsour, K; Jutte, D; D'Esposito, M; Boyce, WT				Sheridan, Margaret A.; Sarsour, Khaled; Jutte, Douglas; D'Esposito, Mark; Boyce, W. Thomas			The Impact of Social Disparity on Prefrontal Function in Childhood	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; LIFE-COURSE; SELECTIVE ATTENTION; COGNITIVE CONTROL; WORKING-MEMORY; RISK EXPOSURE; BRAIN; HEALTH; STRESS; PREDICTION	The prefrontal cortex (PFC) develops from birth through late adolescence. This extended developmental trajectory provides many opportunities for experience to shape the structure and function of the PFC. To date, a few studies have reported links between parental socioeconomic status (SES) and prefrontal function in childhood, raising the possibility that aspects of environment associated with SES impact prefrontal function. Considering that behavioral measures of prefrontal function are associated with learning across multiple domains, this is an important area of investigation. In this study, we used fMRI to replicate previous findings, demonstrating an association between parental SES and PFC function during childhood. In addition, we present two hypothetical mechanisms by which SES could come to affect PFC function of this association: language environment and stress reactivity. We measured language use in the home environment and change in salivary cortisol before and after fMRI scanning. Complexity of family language, but not the child's own language use, was associated with both parental SES and PFC activation. Change in salivary cortisol was also associated with both SES and PFC activation. These observed associations emphasize the importance of both enrichment and adversity-reduction interventions in creating good developmental environments for all children.	[Sheridan, Margaret A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Sheridan, Margaret A.] Childrens Hosp, Boston, MA 02115 USA; [Sarsour, Khaled] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Jutte, Douglas] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [D'Esposito, Mark] Helen Wills Neurosci Inst, Berkeley, CA USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Boyce, W. Thomas] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Boyce, W. Thomas] Univ British Columbia, Coll Interdisciplinary Studies, Vancouver, BC V5Z 1M9, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Eli Lilly; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of British Columbia; University of British Columbia	Sheridan, MA (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	margaret.sheridan@childrens.harvard.edu		Sheridan, Margaret/0000-0002-8909-7501	National Institute of Mental Health [5R21MH70950]; Robert Wood Johnson Health and Society Scholars program (Harvard site); NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH092555, R21MH070950] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Robert Wood Johnson Health and Society Scholars program (Harvard site); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (5R21MH70950) and by the Robert Wood Johnson Health and Society Scholars program (Harvard site). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Ardila A, 2005, DEV NEUROPSYCHOL, V28, P539, DOI 10.1207/s15326942dn2801_5; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Balodis IM, 2010, PSYCHONEUROENDOCRINO, V35, P1363, DOI 10.1016/j.psyneuen.2010.03.011; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Boettiger CA, 2005, J NEUROSCI, V25, P2723, DOI 10.1523/JNEUROSCI.3697-04.2005; Botvin GJ, 2007, INT REV PSYCHIATR, V19, P607, DOI 10.1080/09540260701797753; Cao J, 2001, LECT NOTES STAT, V159, P169; Cohen S, 2004, PSYCHOSOM MED, V66, P553, DOI 10.1097/01.psy.0000126200.05189.d3; D'Angiulli A, 2008, NEUROPSYCHOLOGY, V22, P293, DOI 10.1037/0894-4105.22.3.293; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Eiland L, 2010, HIPPOCAMPUS; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Evans GW, 2009, P NATL ACAD SCI USA, V106, P6545, DOI 10.1073/pnas.0811910106; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Farah MJ, 2006, BRAIN RES, V1110, P166, DOI 10.1016/j.brainres.2006.06.072; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Fujiwara T, 2009, INT J EPIDEMIOL, V38, P1310, DOI 10.1093/ije/dyp226; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gianaros PJ, 2010, PSYCHOSOM MED, V72, P450, DOI 10.1097/PSY.0b013e3181e1a23c; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldwater DS, 2009, NEUROSCIENCE, V164, P798, DOI 10.1016/j.neuroscience.2009.08.053; Gonzalez V, 2005, NABE REV RES PRACT, V3, P67; Gottlieb G, 2004, PREV SCI, V5, P245, DOI 10.1023/B:PREV.0000045358.12782.6b; Gunnar MR, 2007, PROG BRAIN RES, V167, P137, DOI 10.1016/S0079-6123(07)67010-1; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hart B., 1995, MEANINGFUL DIFFERENC; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hertzman C, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P21; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Kishiyama MM, 2009, J COGNITIVE NEUROSCI, V21, P1106, DOI 10.1162/jocn.2009.21101; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Melchior M, 2007, AM J EPIDEMIOL, V166, P966, DOI 10.1093/aje/kwm155; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller G, 2007, PSYCHOSOM MED, V69, P402, DOI 10.1097/PSY.0b013e318068fcf9; Miyake A, 2001, J EXP PSYCHOL GEN, V130, P621, DOI 10.1037/0096-3445.130.4.621; Noble KG, 2005, DEVELOPMENTAL SCI, V8, P74, DOI 10.1111/j.1467-7687.2005.00394.x; Noble KG, 2007, DEVELOPMENTAL SCI, V10, P464, DOI 10.1111/j.1467-7687.2007.00600.x; Noble KG, 2006, DEVELOPMENTAL SCI, V9, P642; Nuru-Jeter AM, 2010, COMPR CHILD ADOLES N, V33, P59, DOI 10.3109/01460861003663953; Pollitt RA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-7; Raizada RDS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.003.2010; Rossi AF, 2009, EXP BRAIN RES, V192, P489, DOI 10.1007/s00221-008-1642-z; Sarsour K, 2011, J INT NEUROPSYCH SOC, V17, P120, DOI 10.1017/S1355617710001335; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Stevens C, 2009, DEVELOPMENTAL SCI, V12, P634, DOI 10.1111/j.1467-7687.2009.00807.x; STEVENSON HW, 1986, CHILD DEV, V57, P646, DOI 10.2307/1130343; WALKER D, 1994, CHILD DEV, V65, P606, DOI 10.2307/1131404; Zelazo PD, 2006, PSYCHOL REP, V98, P858, DOI 10.2466/PR0.98.3.858-860	62	138	140	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35744	10.1371/journal.pone.0035744	http://dx.doi.org/10.1371/journal.pone.0035744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563395	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100023
J	Tseng, HH; Chuah, QY; Yang, PM; Chen, CT; Chao, JC; Lin, MD; Chiu, SJ				Tseng, Ho-Hsing; Chuah, Qiu-Yu; Yang, Pei-Ming; Chen, Chiung-Tong; Chao, Jung-Chi; Lin, Ming-Der; Chiu, Shu-Jun			Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3 ',4 ',5 '-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells	PLOS ONE			English	Article							TUMOR-TRANSFORMING GENE; SPINDLE ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; MITOTIC CATASTROPHE; PROTEIN-KINASE; BREAST-CANCER; SIGNAL-TRANSDUCTION; RECENT PROGRESS; POOR-PROGNOSIS; EXPRESSION	BPR0L075 [6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole] is a novel anti-microtubule drug with anti-tumor and anti-angiogenic activities in vitro and in vivo. Securin is required for genome stability, and is expressed abundantly in most cancer cells, promoting cell proliferation and tumorigenesis. In this study, we found that BPR0L075 efficiently induced cell death of HCT116 human colorectal cancer cells that have higher expression levels of securin. The cytotoxicity of BPR0L075 was attenuated in isogenic securin-null HCT116 cells. BPR0L075 induced DNA damage response, G(2)/M arrest, and activation of the spindle assembly checkpoint in HCT116 cells. Interestingly, BPR0L075 induced phosphorylation of securin. BPR0L075 withdrawal resulted in degradation of securin, mitotic exit, and mitotic catastrophe, which were attenuated in securin-null cells. Inhibition of cdc2 decreased securin phosphorylation, G(2)/M arrest and cell death induced by BPR0L075. Moreover, BPR0L075 caused cell death through a caspase-independent mechanism and activation of JNK and p38 MAPK pathways. These findings provided evidence for the first time that BPR0L075 treatment is beneficial for the treatment of human colorectal tumors with higher levels of securin. Thus, we suggest that the expression levels of securin may be a predictive factor for application in anti-cancer therapy with BPR0L075 in human cancer cells.	[Tseng, Ho-Hsing; Chuah, Qiu-Yu; Chao, Jung-Chi; Chiu, Shu-Jun] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Yang, Pei-Ming] Natl Taiwan Univ, Coll Med, Dept Pharmacol, Taipei 10764, Taiwan; [Chen, Chiung-Tong] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Taiwan; [Lin, Ming-Der] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; National Taiwan University; National Health Research Institutes - Taiwan; Tzu Chi University	Tseng, HH (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	chiusj@mail.tcu.edu.tw	Chen, Chiung-Tong/D-2075-2010; Lin, Ming-Der/AAL-5302-2020; Yang, Pei-Ming/G-3763-2014	Yang, Pei-Ming/0000-0002-4004-2518; Lin, Ming-Der/0000-0003-3411-5685	National Science Council, Taiwan [NSC 99-2314-B-320-004-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	National Science Council, Taiwan (NSC 99-2314-B-320-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Chen CP, 2010, ANTICANCER RES, V30, P2813; Chen WS, 2010, INT J RADIAT ONCOL, V77, P566, DOI 10.1016/j.ijrobp.2009.12.013; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Chiu SJ, 2008, TOXICOL LETT, V179, P63, DOI 10.1016/j.toxlet.2008.04.004; Chiu SJ, 2006, TOXICOL LETT, V167, P122, DOI 10.1016/j.toxlet.2006.08.018; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deacon K, 2003, MOL BIOL CELL, V14, P2071, DOI 10.1091/mbc.e02-10-0653; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Fujii T, 2006, HEPATOLOGY, V43, P1267, DOI 10.1002/hep.21181; Genkai N, 2006, ONCOL REP, V15, P1569; Gil-Bernabe AM, 2006, MOL CELL BIOL, V26, P4017, DOI 10.1128/MCB.01904-05; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hsu TS, 2008, CANCER CHEMOTH PHARM, V62, P799, DOI 10.1007/s00280-007-0667-5; Jiang RH, 2010, J CELL BIOCHEM, V111, P274, DOI 10.1002/jcb.22697; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Keyes BE, 2008, GENETICS, V178, P589, DOI 10.1534/genetics.107.083642; Kim DS, 2007, CARCINOGENESIS, V28, P749, DOI 10.1093/carcin/bgl202; Kiselyov A, 2007, ANTI-CANCER AGENT ME, V7, P189, DOI 10.2174/187152007780058650; Kroemer G, 2011, FRONTIERS ONCOLOGY, V1; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Liu YN, 2008, MOL CELL BIOL, V28, P7096, DOI 10.1128/MCB.00449-08; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Moreno-Mateos MA, 2011, MOL BIOL CELL, V22, P4302, DOI 10.1091/mbc.E10-10-0838; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; Ogbagabriel S, 2005, MODERN PATHOL, V18, P985, DOI 10.1038/modpathol.3800382; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Pei L, 2000, J BIOL CHEM, V275, P31191, DOI 10.1074/jbc.M002451200; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Shi Q, 1998, CURR PHARM DESIGN, V4, P219; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; Tfelt-Hansen J, 2006, CLIN MED RES, V4, P130, DOI 10.3121/cmr.4.2.130; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Vogel C, 2004, ONCOGENE, V23, P6845, DOI 10.1038/sj.onc.1207860; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; Xu R, 2009, ANTICANCER RES, V29, P261; Yu SH, 2011, CANCER LETT, V300, P96, DOI 10.1016/j.canlet.2010.09.015; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	53	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36006	10.1371/journal.pone.0036006	http://dx.doi.org/10.1371/journal.pone.0036006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563433	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100059
J	Giustina, A; Mazziotti, G; Torri, V; Spinello, M; Floriani, I; Melmed, S				Giustina, Andrea; Mazziotti, Gherardo; Torri, Valter; Spinello, Maurizio; Floriani, Irene; Melmed, Shlomo			Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly	PLOS ONE			English	Article							SOMATOSTATIN ANALOG THERAPY; SECRETING PITUITARY-ADENOMAS; PRIMARY MEDICAL THERAPY; LONG-ACTING OCTREOTIDE; GROWTH-HORMONE; LANREOTIDE-SR; SMS 201-995; CONSENSUS STATEMENT; TERM TREATMENT; LAR	Background: The long-acting somatostatin analogue octreotide is used either as an adjuvant or primary therapy to lower growth hormone (GH) levels in patients with acromegaly and may also induce pituitary tumor shrinkage. Objective: We performed a meta-analysis to accurately assess the effect of octreotide on pituitary tumor shrinkage. Data Sources: A computerized Medline and Embase search was undertaken to identify potentially eligible studies. Study Eligibility Criteria: Eligibility criteria included treatment with octreotide, availability of numerical metrics on tumor shrinkage and clear definition of a clinically relevant reduction in tumor size. Primary endpoints included the proportion of patients with tumor shrinkage and mean percentage reduction in tumor volume. Data Extraction and Analysis: The electronic search identified 2202 articles. Of these, 41 studies fulfilling the eligibility criteria were selected for data extraction and analysis. In total, 1685 patients were included, ranging from 6 to 189 patients per trial. For the analysis of the effect of octreotide on pituitary tumor shrinkage a random effect model was used to account for differences in both effect size and sampling error. Results: Octreotide was shown to induce tumor shrinkage in 53.0% [95% CI: 45.0%-61.0%] of treated patients. In patients treated with the LAR formulation of octreotide, this increased to 66.0%, [95% CI: 57.0%-74.0%]. In the nine studies in which tumor shrinkage was quantified, the overall weighted mean percentage reduction in tumor size was 37.4% [95% CI: 22.4%-52.4%], rising to 50.6% [95% CI: 42.7%-58.4%] with octreotide LAR. Limitations: Most trials examined were open-label and had no control group. Conclusions: Octreotide LAR induces clinically relevant tumor shrinkage in more than half of patients with acromegaly.	[Giustina, Andrea; Mazziotti, Gherardo] Univ Brescia, Montichiari Hosp, Dept Med & Surg Sci, Chair Endocrinol, Brescia, Italy; [Mazziotti, Gherardo] Azienda Osped Carlo Poma, Dept Med, Endocrine Unit, Mantua, Italy; [Torri, Valter; Floriani, Irene] Ist Ric Farmacol Mario Negri, Milan, Italy; [Spinello, Maurizio] Novartis Farma, Origgio, Varese, Italy; [Melmed, Shlomo] Cedars Sinai Med Ctr, Pituitary Ctr, Los Angeles, CA USA	University of Brescia; Hospital Carlo Poma; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Novartis; Cedars Sinai Medical Center	Giustina, A (corresponding author), Univ Brescia, Montichiari Hosp, Dept Med & Surg Sci, Chair Endocrinol, Brescia, Italy.	a.giustina@libero.it	Mazziotti, Gherardo/AAC-1983-2019; Torri, Valter/H-7550-2015; Giustina, Andrea/AAN-5938-2020	Mazziotti, Gherardo/0000-0001-5458-701X; Torri, Valter/0000-0001-9541-9354; Spinello, Maurizio/0000-0002-1056-2248	Ipsen; Novartis; Pfizer	Ipsen(Ipsen); Novartis(Novartis); Pfizer(Pfizer)	AG is a consultant for Ipsen and Novartis and lecturer for Pfizer and Italfarmaco. GM is a consultant for Novartis and received lecture fees from Ipsen. VT is consultant for Novartis. IF is consultant for Novartis. MS is Novartis Farma employee. SM is a consultant for Novartis and Chiasma, and receives research grants from Novartis, Pfizer and Ipsen. The authors declare that the article is actually concerned with the Novartis product Octreotide. The authors declare that the following authors are consultant for Novartis: AG (also consultant for Ipsen and lecturer for Pfizer and Italfarmaco), GM (also lecturer for Ipsen), VT, IF and SM (consultant also Chiasma, and receives research grants from Pfizer and Ipsen. The authors declare that the above mentioned relationships did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abe T, 2001, EUR J ENDOCRINOL, V145, P137, DOI 10.1530/eje.0.1450137; Amato G, 2002, CLIN ENDOCRINOL, V56, P65, DOI 10.1046/j.0300-0664.2001.01438.x; AROSIO M, 1995, EUR J ENDOCRINOL, V133, P430, DOI 10.1530/eje.0.1330430; Astruc B, 2005, J CLIN PHARMACOL, V45, P836, DOI 10.1177/0091270005277936; Auriemmal RS, 2008, J ENDOCRINOL INVEST, V31, P956, DOI 10.1007/BF03345632; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Bevan JS, 2005, J CLIN ENDOCR METAB, V90, P1856, DOI 10.1210/jc.2004-1093; Bevan JS, 2002, J CLIN ENDOCR METAB, V87, P4554, DOI 10.1210/jc.2001-012012; Cheung NW, 1997, AUST NZ J MED, V27, P12, DOI 10.1111/j.1445-5994.1997.tb00907.x; CHIODINI PG, 1987, J CLIN ENDOCR METAB, V64, P447, DOI 10.1210/jcem-64-3-447; Colao A, 1999, J ENDOCRINOL INVEST, V22, P176, DOI 10.1007/BF03343538; Colao A, 2007, J ENDOCRINOL INVEST, V30, P903, DOI 10.1007/BF03349235; Colao A, 1996, J CLIN ENDOCR METAB, V81, P2356, DOI 10.1210/jc.81.6.2356; Colao A, 2006, CLIN ENDOCRINOL, V64, P342, DOI 10.1111/j.1365-2265.2006.02467.x; Colao A, 1997, J CLIN ENDOCR METAB, V82, P3308, DOI 10.1210/jc.82.10.3308; Colao A, 2001, J CLIN ENDOCR METAB, V86, P2779, DOI 10.1210/jc.86.6.2779; Colao A, 2008, J CLIN ENDOCR METAB, V93, P3436, DOI 10.1210/jc.2008-0424; Colao A, 2009, CLIN ENDOCRINOL, V70, P757, DOI 10.1111/j.1365-2265.2008.03441.x; Coy DH, 1996, METABOLISM, V45, P21, DOI 10.1016/S0026-0495(96)90073-6; Cozzi R, 2003, J CLIN ENDOCR METAB, V88, P3090, DOI 10.1210/jc.2003-030110; Cozzi R, 2006, J CLIN ENDOCR METAB, V91, P1397, DOI 10.1210/jc.2005-2347; EZZAT S, 1992, ANN INTERN MED, V117, P711, DOI 10.7326/0003-4819-117-9-711; Flogstad AK, 1997, J CLIN ENDOCR METAB, V82, P23, DOI 10.1210/jc.82.1.23; Freda PU, 2005, J CLIN ENDOCR METAB, V90, P4465, DOI 10.1210/jc.2005-0260; Giustina A, 2000, J CLIN ENDOCR METAB, V85, P526, DOI 10.1210/jc.85.2.526; Giustina A, 2011, PITUITARY, V14, P125, DOI 10.1007/s11102-010-0269-9; Giustina A, 2010, J CLIN ENDOCR METAB, V95, P3141, DOI 10.1210/jc.2009-2670; Giustina A, 1996, PHARMACOL RES, V34, P247, DOI 10.1006/phrs.1996.0095; Giustina A, 2009, EUR J ENDOCRINOL, V161, P331, DOI 10.1530/EJE-09-0372; Gola M, 2006, J ENDOCRINOL INVEST, V29, P86, DOI 10.1007/BF03349183; HORIKAWA R, 1988, ENDOCRINOL JAPON, V35, P741; Jallad RS, 2007, CLIN ENDOCRINOL, V67, P310, DOI 10.1111/j.1365-2265.2007.02885.x; Jallad RS, 2005, CLIN ENDOCRINOL, V63, P168, DOI 10.1111/j.1365-2265.2005.02317.x; Jane JA, 2011, J CLIN ENDOCR METAB, V96, P2732, DOI 10.1210/jc.2011-0554; Jenkins PJ, 2004, HORM RES, V62, P227, DOI 10.1159/000081418; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; Kristof RA, 1999, ACTA NEUROCHIR, V141, P399, DOI 10.1007/s007010050316; LAMBERTS SWJ, 1987, J CLIN ENDOCR METAB, V65, P703, DOI 10.1210/jcem-65-4-703; Lancranjan I, 1996, METABOLISM, V45, P67, DOI 10.1016/S0026-0495(96)90087-6; LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P519, DOI 10.1097/00004728-199207000-00004; Lundin P, 1997, AM J NEURORADIOL, V18, P765; Luque-Ramirez M, 2010, HORM METAB RES, V42, P38, DOI 10.1055/s-0029-1239506; Maison P, 2007, J CLIN ENDOCR METAB, V92, P1743, DOI 10.1210/jc.2006-2547; Mazziotti G, 2010, PITUITARY, V13, P60, DOI 10.1007/s11102-009-0169-z; Mazziotti G, 2009, J CLIN ENDOCR METAB, V94, P1500, DOI 10.1210/jc.2008-2332; Melmed S, 2005, J CLIN ENDOCR METAB, V90, P4405, DOI 10.1210/jc.2004-2466; Melmed S, 2005, EUR J ENDOCRINOL, V153, P737, DOI 10.1530/eje.1.02036; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Mercado M, 2007, CLIN ENDOCRINOL, V66, P859, DOI 10.1111/j.1365-2265.2007.02825.x; Murray RD, 2008, J CLIN ENDOCR METAB, V93, P2957, DOI 10.1210/jc.2008-0027; Naidich MJ, 1999, ENDOCRIN METAB CLIN, V28, P45, DOI 10.1016/S0889-8529(05)70057-8; Newman CB, 1998, J CLIN ENDOCR METAB, V83, P3034, DOI 10.1210/jc.83.9.3034; Oshino S, 2006, ENDOCR J, V53, P125, DOI 10.1507/endocrj.53.125; Petersenn S, 2010, J CLIN ENDOCR METAB, V95, P2781, DOI 10.1210/jc.2009-2272; PLEWE G, 1984, LANCET, V2, P782; Plockinger U, 2005, ACTA NEUROCHIR, V147, P485, DOI 10.1007/s00701-005-0511-9; PLOCKINGER U, 1994, J CLIN ENDOCR METAB, V79, P1416, DOI 10.1210/jc.79.5.1416; Resmini E, 2007, J CLIN ENDOCR METAB, V92, P1592, DOI 10.1210/jc.2006-2084; SASSOLAS G, 1990, J CLIN ENDOCR METAB, V71, P391, DOI 10.1210/jcem-71-2-391; Shimon I, 1998, ANN INTERN MED, V129, P472, DOI 10.7326/0003-4819-129-6-199809150-00009; STEVENAERT A, 1993, ACTA ENDOCRINOL-COP, V129, P18; STEVENAERT A, 1992, METABOLISM, V41, P51, DOI 10.1016/0026-0495(92)90031-5; Taboada GF, 2008, EUR J ENDOCRINOL, V158, P295, DOI 10.1530/EJE-07-0562; Tamura M, 1998, ENDOCR J, V45, P269, DOI 10.1507/endocrj.45.269; VANCE M L, 1991, Archives of Internal Medicine, V151, P1573, DOI 10.1001/archinte.151.8.1573; WANG C, 1989, J CLIN ENDOCR METAB, V69, P670, DOI 10.1210/jcem-69-3-670; Yin Jian, 2005, Chinese Medical Sciences Journal, V20, P23	69	129	136	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36411	10.1371/journal.pone.0036411	http://dx.doi.org/10.1371/journal.pone.0036411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574156	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800052
J	Hirose, S; Watanabe, T; Jimura, K; Katsura, M; Kunimatsu, A; Abe, O; Ohtomo, K; Miyashita, Y; Konishi, S				Hirose, Satoshi; Watanabe, Takamitsu; Jimura, Koji; Katsura, Masaki; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni; Miyashita, Yasushi; Konishi, Seiki			Local Signal Time-Series during Rest Used for Areal Boundary Mapping in Individual Human Brains	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; ORIENTATION COLUMNS; CINGULATE CORTEX; VISUAL-CORTEX; NETWORKS; FLUCTUATIONS; ARCHITECTURE; PARCELLATION; FREQUENCY; LOBE	It is widely thought that resting state functional connectivity likely reflects functional interaction among brain areas and that different functional areas interact with different sets of brain areas. A method for mapping areal boundaries has been formulated based on the large-scale spatial characteristics of regional interaction revealed by resting state functional connectivity. In the present study, we present a novel analysis for areal boundary mapping that requires only the signal timecourses within a region of interest, without reference to the information from outside the region. The areal boundaries were generated by the novel analysis and were compared with those generated by the previously-established standard analysis. The boundaries were robust and reproducible across the two analyses, in two regions of interest tested. These results suggest that the information for areal boundaries is readily available inside the region of interest.	[Hirose, Satoshi; Watanabe, Takamitsu; Jimura, Koji; Miyashita, Yasushi; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; [Katsura, Masaki; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Hirose, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.	sahirose@m.u-tokyo.ac.jp; konishi@m.u-tokyo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; Watanabe, Takamitsu/H-7234-2018; Miyashita, Yasushi/B-7171-2019	Kunimatsu, Akira/0000-0002-7141-2585; Watanabe, Takamitsu/0000-0002-8104-6873; Miyashita, Yasushi/0000-0003-3496-8637; Abe, Osamu/0000-0002-1180-2629	JSPS Fellowship [20-6285]; Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" from Ministry of Education, Culture, Sports, Science and Technology, Japan [12601-A03]; Takeda Science Foundation;  [19002010];  [22300134]	JSPS Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" from Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	SH is supported by JSPS Fellowship (20-6285) for Young Scientists. This work was supported by a Grant-in-Aid for Specially Promoted Research (19002010) to YM, a Grant-in-Aid for Scientific Research B (22300134) to SK, the Global COE Program "Integrative Life Science Based on the study of Biosignaling Mechanisms" (12601-A03) to YM from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behrens TEJ, 2006, NEUROIMAGE, V30, P220, DOI 10.1016/j.neuroimage.2005.09.036; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Carr VA, 2010, NEURON, V65, P298, DOI 10.1016/j.neuron.2009.12.022; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Cohen AL, 2008, NEUROIMAGE, V41, P45, DOI 10.1016/j.neuroimage.2008.01.066; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hirose S, 2009, NEUROIMAGE, V47, P442, DOI 10.1016/j.neuroimage.2009.04.094; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jimura K, 2004, NEUROIMAGE, V22, P1578, DOI 10.1016/j.neuroimage.2004.04.012; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Moon CH, 2007, J NEUROSCI, V27, P6892, DOI 10.1523/JNEUROSCI.0445-07.2007; Nelson SM, 2010, NEURON, V67, P156, DOI 10.1016/j.neuron.2010.05.025; Nir Y, 2006, NEUROIMAGE, V30, P1313, DOI 10.1016/j.neuroimage.2005.11.018; Salvador R, 2005, PHILOS T R SOC B, V360, P937, DOI 10.1098/rstb.2005.1645; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Talairach J., 1988, COPLANAR STEREOTAXIC; Tian LX, 2012, NEUROIMAGE, V60, P539, DOI 10.1016/j.neuroimage.2011.11.098; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zeineh MM, 2001, ANAT RECORD, V265, P111, DOI 10.1002/ar.1061; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	51	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36496	10.1371/journal.pone.0036496	http://dx.doi.org/10.1371/journal.pone.0036496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574171	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800067
J	Velho, TAF; Lu, K; Ribeiro, S; Pinaud, R; Vicario, D; Mello, CV				Velho, Tarciso A. F.; Lu, Kai; Ribeiro, Sidarta; Pinaud, Raphael; Vicario, David; Mello, Claudio V.			Noradrenergic Control of Gene Expression and Long-Term Neuronal Adaptation Evoked by Learned Vocalizations in Songbirds	PLOS ONE			English	Article							LOCUS-COERULEUS NEURONS; IMMEDIATE-EARLY GENE; ZEBRA FINCH BRAIN; AUDITORY RESPONSES; PROTEIN-SYNTHESIS; LASTING MEMORIES; PERFORANT PATH; DENTATE GYRUS; AWAKE RATS; LATE-PHASE	Norepinephrine (NE) is thought to play important roles in the consolidation and retrieval of long-term memories, but its role in the processing and memorization of complex acoustic signals used for vocal communication has yet to be determined. We have used a combination of gene expression analysis, electrophysiological recordings and pharmacological manipulations in zebra finches to examine the role of noradrenergic transmission in the brain's response to birdsong, a learned vocal behavior that shares important features with human speech. We show that noradrenergic transmission is required for both the expression of activity-dependent genes and the long-term maintenance of stimulus-specific electrophysiological adaptation that are induced in central auditory neurons by stimulation with birdsong. Specifically, we show that the caudomedial nidopallium (NCM), an area directly involved in the auditory processing and memorization of birdsong, receives strong noradrenergic innervation. Song-responsive neurons in this area express alpha-adrenergic receptors and are in close proximity to noradrenergic terminals. We further show that local alpha-adrenergic antagonism interferes with song-induced gene expression, without affecting spontaneous or evoked electrophysiological activity, thus dissociating the molecular and electrophysiological responses to song. Moreover, alpha-adrenergic antagonism disrupts the maintenance but not the acquisition of the adapted physiological state. We suggest that the noradrenergic system regulates long-term changes in song-responsive neurons by modulating the gene expression response that is associated with the electrophysiological activation triggered by song. We also suggest that this mechanism may be an important contributor to long-term auditory memories of learned vocalizations.	[Velho, Tarciso A. F.; Pinaud, Raphael; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Velho, Tarciso A. F.; Pinaud, Raphael; Mello, Claudio V.] Oregon Hlth & Sci Univ, Inst Neurol Sci, Portland, OR 97201 USA; [Lu, Kai; Vicario, David] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA; [Ribeiro, Sidarta] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Oregon Health & Science University; Oregon Health & Science University; Rutgers State University New Brunswick; Universidade Federal do Rio Grande do Norte	Velho, TAF (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	melloc@ohsu.edu	Ribeiro, Sidarta/C-5794-2016	Ribeiro, Sidarta/0000-0001-9325-9545; Mello, Claudio/0000-0002-9826-8421	NINDS (National Institute of Neurological Disorders and Stroke) [DC03823, DC008854]; NIGMS (National Institute of General Medical Sciences) [GM092842]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008854] Funding Source: NIH RePORTER	NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from NINDS (National Institute of Neurological Disorders and Stroke; DC03823) and NIGMS (National Institute of General Medical Sciences; GM092842) to CVM, and a grant from NINDS (DC008854) to DV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; ASTONJONES G, 1981, J NEUROSCI, V1, P887; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; Bramham CR, 1997, NEUROREPORT, V8, P719, DOI 10.1097/00001756-199702100-00028; Brenowitz EA, 1997, J NEUROBIOL, V33, P495, DOI 10.1002/(SICI)1097-4695(19971105)33:5<495::AID-NEU1>3.3.CO;2-D; Cardin JA, 2004, J NEUROSCI, V24, P7745, DOI 10.1523/JNEUROSCI.1951-04.2004; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Cirelli C, 2000, J NEUROSCI, V20, P9187; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; FOOTE SL, 1980, P NATL ACAD SCI-BIOL, V77, P3033, DOI 10.1073/pnas.77.5.3033; GEORGE JM, 1992, MOL BRAIN RES, V12, P323, DOI 10.1016/0169-328X(92)90134-W; Gibbs ME, 2002, PROG NEUROBIOL, V67, P345, DOI 10.1016/S0301-0082(02)00023-0; Gobes SMH, 2007, CURR BIOL, V17, P789, DOI 10.1016/j.cub.2007.03.059; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Huang YY, 1996, NEURON, V16, P611, DOI 10.1016/S0896-6273(00)80080-X; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jeong JK, 2005, J COMP NEUROL, V489, P23, DOI 10.1002/cne.20605; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Lindquist JM, 2000, J BIOL CHEM, V275, P22670, DOI 10.1074/jbc.M909093199; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Mandairon N, 2008, EUR J NEUROSCI, V27, P1210, DOI 10.1111/j.1460-9568.2008.06101.x; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2000, TRENDS PHARMACOL SCI, V21, P208, DOI 10.1016/S0165-6147(00)01473-5; Mello C V, 1997, Methods Mol Biol, V85, P205; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; Mello CV, 2004, ANN NY ACAD SCI, V1016, P263, DOI 10.1196/annals.1298.021; Mello CV, 1998, J COMP NEUROL, V400, P207; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MOORE RY, 1979, ANNU REV NEUROSCI, V2, P113, DOI 10.1146/annurev.ne.02.030179.000553; Murchison CF, 2004, CELL, V117, P131, DOI 10.1016/S0092-8674(04)00259-4; Pawlisch BA, 2011, NEUROSCI LETT, V496, P20, DOI 10.1016/j.neulet.2011.03.078; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pinaud R, 2008, J NEUROPHYSIOL; Poirier C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020131; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Scheiderer CL, 2004, J NEUROPHYSIOL, V91, P1071, DOI 10.1152/jn.00420.2003; Sizemore M, 2008, J NEUROPHYSIOL, V100, P8, DOI 10.1152/jn.01212.2007; Solis MM, 2006, J NEUROPHYSIOL, V95, P2265, DOI 10.1152/jn.00836.2005; STANTON PK, 1985, J NEUROSCI, V5, P2169; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Velho TAF, 2008, J NEUROSCI, V28, P11871, DOI 10.1523/JNEUROSCI.2307-08.2008; Velho TAF, 2008, TRANSCRIPTIONAL REGULATION BY NEURONAL ACTIVITY, P3, DOI 10.1007/978-0-387-73609-9_1; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Wang YA, 2010, P NATL ACAD SCI USA, V107, P12676, DOI 10.1073/pnas.1006645107	55	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36276	10.1371/journal.pone.0036276	http://dx.doi.org/10.1371/journal.pone.0036276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574146	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800042
J	Nilsson, E; Larsen, G; Manikkam, M; Guerrero-Bosagna, C; Savenkova, MI; Skinner, MK				Nilsson, Eric; Larsen, Ginger; Manikkam, Mohan; Guerrero-Bosagna, Carlos; Savenkova, Marina I.; Skinner, Michael K.			Environmentally Induced Epigenetic Transgenerational Inheritance of Ovarian Disease	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; FOLLICLE DEVELOPMENT; BISPHENOL-A; PRENATAL TESTOSTERONE; DEVELOPMENTAL ORIGINS; PRIMORDIAL FOLLICLES; NEONATAL EXPOSURE; GENE-EXPRESSION; JET FUELS; PREVALENCE	The actions of environmental toxicants and relevant mixtures in promoting the epigenetic transgenerational inheritance of ovarian disease was investigated with the use of a fungicide, a pesticide mixture, a plastic mixture, dioxin and a hydrocarbon mixture. After transient exposure of an F0 gestating female rat during embryonic gonadal sex determination, the F1 and F3 generation progeny adult onset ovarian disease was assessed. Transgenerational disease phenotypes observed included an increase in cysts resembling human polycystic ovarian disease (PCO) and a decrease in the ovarian primordial follicle pool size resembling primary ovarian insufficiency (POI). The F3 generation granulosa cells were isolated and found to have a transgenerational effect on the transcriptome and epigenome (differential DNA methylation). Epigenetic biomarkers for environmental exposure and associated gene networks were identified. Epigenetic transgenerational inheritance of ovarian disease states was induced by all the different classes of environmental compounds, suggesting a role of environmental epigenetics in ovarian disease etiology.	[Nilsson, Eric; Larsen, Ginger; Manikkam, Mohan; Guerrero-Bosagna, Carlos; Savenkova, Marina I.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Nilsson, E (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Nilsson, Eric/AAR-5021-2020; Guerrero-Bosagna, Carlos/W-7319-2019; Savenkova, Marina/AAN-9927-2021	Guerrero-Bosagna, Carlos/0000-0003-1935-5875; 	Department of Defense; National Institutes of Health; National Institute of Environmental Health Sciences	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research was supported by Department of Defense and National Institutes of Health. National Institute of Environmental Health Sciences support to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2009, AM J PRIMATOL, V71, P776, DOI 10.1002/ajp.20679; Acosta JI, 2010, ENDOCRINOLOGY, V151, P3795, DOI 10.1210/en.2010-0055; Anway MD, 2008, PROSTATE, V68, P517, DOI 10.1002/pros.20724; Anway MD, 2008, REPROD BIOMED ONLINE, V16, P23, DOI 10.1016/S1472-6483(10)60553-6; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Anzalone CR, 2001, BIOL REPROD, V64, P1056, DOI 10.1095/biolreprod64.4.1056; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Binelli M, 2010, REPROD FERT DEVELOP, V22, P1, DOI 10.1071/RD09218; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Brouwers MM, 2006, HUM REPROD, V21, P666, DOI 10.1093/humrep/dei398; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Chen Zi-Jiang, 2010, Front Med China, V4, P280, DOI 10.1007/s11684-010-0098-2; Choong MK, 2011, CLIN GASTROENTE 0429; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Cordts EB, 2011, ARCH GYNECOL OBSTET, V283, P635, DOI 10.1007/s00404-010-1815-4; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; Dasgupta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012401; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Dixit H, 2010, REPROD BIOMED ONLINE, V20, P724, DOI 10.1016/j.rbmo.2010.02.018; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fernandez M, 2010, ENVIRON HEALTH PERSP, V118, P1217, DOI 10.1289/ehp.0901257; Franks S, 2006, INT J ANDROL, V29, P278, DOI 10.1111/j.1365-2605.2005.00623.x; Glintborg D, 2010, GYNECOL ENDOCRINOL, V26, P281, DOI 10.3109/09513590903247873; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hakre S, 2011, CURR OPIN HIV AIDS, V6, P19, DOI 10.1097/COH.0b013e3283412384; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hickey TE, 2006, J CLIN ENDOCR METAB, V91, P2789, DOI 10.1210/jc.2006-0069; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/s0074-7696(08)61524-7; Hylkema Machteld N, 2009, Proc Am Thorac Soc, V6, P660, DOI 10.1513/pats.200907-065DP; Jablonska O, 2010, INT J ANDROL, V33, P405, DOI 10.1111/j.1365-2605.2009.01031.x; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones GL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-149; Jordan CD, 2010, J HISTOCHEM CYTOCHEM, V58, P903, DOI 10.1369/jhc.2010.956615; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kaminsky Z, 2011, MOL PSYCHIATR; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; Kuriakose JS, 2010, CLIN EXP ALLERGY, V40, P1602, DOI 10.1111/j.1365-2222.2010.03599.x; Li ZX, 2008, MED HYPOTHESES, V70, P638, DOI 10.1016/j.mehy.2006.09.076; Lohff JC, 2006, MENOPAUSE, V13, P482, DOI 10.1097/01.gme.0000191883.59799.2e; Macklon NS, 1999, HORM RES, V52, P161, DOI 10.1159/000023456; Maclaran K, 2011, J FAM PLAN REPROD H, V37, P35, DOI 10.1136/jfprhc.2010.0015; Manikkam M, 2006, ENDOCRINOLOGY, V147, P1997, DOI 10.1210/en.2005-1338; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; Mattie DR, 2011, TOXICOL APPL PHARM, V254, P127, DOI 10.1016/j.taap.2010.04.022; McGuire MM, 2011, FERTIL STERIL, V95, P1595, DOI 10.1016/j.fertnstert.2010.12.052; Menke MN, 2007, CURR OPIN OBSTET GYN, V19, P355, DOI 10.1097/GCO.0b013e328220e877; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Moran C, 2010, GYNECOL OBSTET INVES, V69, P274, DOI 10.1159/000277640; Mukherjee S, 2010, INDIAN J MED RES, V131, P743; Nan HM, 2005, WORLD J GASTROENTERO, V11, P3834; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Persani L, 2011, J ENDOCRINOL INVEST, V34, P244, DOI [10.1007/BF03347073, 10.3275/7502]; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; Peters CA, 1999, J BIOL CHEM, V274, P37499, DOI 10.1074/jbc.274.52.37499; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; Pogribny IP, 2006, MUTAT RES-FUND MOL M, V593, P80, DOI 10.1016/j.mrfmmm.2005.06.028; Pyun JA, 2011, FERTIL STERIL, V95, P397, DOI 10.1016/j.fertnstert.2010.08.038; Reddy P, 2010, TRENDS ENDOCRIN MET, V21, P96, DOI 10.1016/j.tem.2009.10.001; Ritchie GD, 2003, J TOXICOL ENV HEAL B, V6, P357, DOI 10.1080/10937400306473; Rodriguez HA, 2010, REPROD TOXICOL, V30, P550, DOI 10.1016/j.reprotox.2010.07.008; Roghair RD, 2005, AM J PHYSIOL-REG I, V288, pR46, DOI 10.1152/ajpregu.00165.2004; Roos N, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6309; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Schindler R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012979; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2011, EPIGENETICS-US, V6, P838, DOI 10.4161/epi.6.7.16537; Skinner MK, 2011, BIRTH DEFECTS RES C, V93, P51, DOI 10.1002/bdrc.20199; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Smith P, 2009, BIOL REPROD, V80, P726, DOI 10.1095/biolreprod.108.072801; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Thornburg KL, 2010, ADV GENET, V71, P57, DOI [10.1016/B978-0-12-380864-6.00003-1, 10.1016/S0065-2660(10)71003-8]; van Houten EL, 2012, ENDOCRINOLOGY; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; Wang BB, 2011, HUM REPROD, V26, P950, DOI 10.1093/humrep/der001; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Wong SS, 2008, TOXICOLOGY, V254, P106, DOI 10.1016/j.tox.2008.09.018; Woods KS, 2002, FERTIL STERIL, V77, P1125, DOI 10.1016/S0015-0282(02)03119-9; Yanes LL, 2011, GENDER MED, V8, P103, DOI 10.1016/j.genm.2010.11.013; Zhao ZY, 2011, ACTA OBSTET GYN SCAN, V90, P678, DOI 10.1111/j.1600-0412.2011.01118.x	106	163	165	4	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36129	10.1371/journal.pone.0036129	http://dx.doi.org/10.1371/journal.pone.0036129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570695	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400011
J	Yokoyama, U; Ishiwata, R; Jin, MH; Kato, Y; Suzuki, O; Jin, HL; Ichikawa, Y; Kumagaya, S; Katayama, Y; Fujita, T; Okumura, S; Sato, M; Sugimoto, Y; Aoki, H; Suzuki, S; Masuda, M; Minamisawa, S; Ishikawa, Y				Yokoyama, Utako; Ishiwata, Ryo; Jin, Mei-Hua; Kato, Yuko; Suzuki, Orie; Jin, Huiling; Ichikawa, Yasuhiro; Kumagaya, Syun; Katayama, Yuzo; Fujita, Takayuki; Okumura, Satoshi; Sato, Motohiko; Sugimoto, Yukihiko; Aoki, Hiroki; Suzuki, Shinichi; Masuda, Munetaka; Minamisawa, Susumu; Ishikawa, Yoshihiro			Inhibition of EP4 Signaling Attenuates Aortic Aneurysm Formation	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHESIS; DUCTUS-ARTERIOSUS; RECEPTOR; MICE; EXPRESSION; ACTIVATION; CYCLOOXYGENASE; INFLAMMATION; MACROPHAGES; RISK	Background: Aortic aneurysm is a common but life-threatening disease among the elderly, for which no effective medical therapy is currently available. Activation of prostaglandin E-2 (PGE(2)) is known to increase the expression of matrix metalloproteinase (MMP) and the release of inflammatory cytokines, and may thus exacerbate abdominal aortic aneurism (AAA) formation. We hypothesized that selective blocking of PGE(2), in particular, EP4 prostanoid receptor signaling, would attenuate the development of AAA. Methods and Findings: Immunohistochemical analysis of human AAA tissues demonstrated that EP4 expression was greater in AAA areas than that in non-diseased areas. Interestingly, EP4 expression was proportional to the degree of elastic fiber degradation. In cultured human aortic smooth muscle cells (ASMCs), PGE(2) stimulation increased EP4 protein expression (1.4 +/- 0.08-fold), and EP4 stimulation with ONO-AE1-329 increased MMP-2 activity and interleukin-6 (IL-6) production (1.4 +/- 0.03- and 1.7 +/- 0.14-fold, respectively, P<0.05). Accordingly, we examined the effect of EP4 inhibition in an ApoE(-/-) mouse model of AAA infused with angiotensin II. Oral administration of ONO-AE3-208 (0.01-0.5 mg/kg/day), an EP4 antagonist, for 4 weeks significantly decreased the formation of AAA (45-87% reduction, P<0.05). Similarly, EP4(+/-)/ApoE(-/-) mice exhibited significantly less AAA formation than EP4(+/+)/ApoE(-/-) mice (76% reduction, P<0.01). AAA formation induced by periaortic CaCl2 application was also reduced in EP4(+/-) mice compared with wild-type mice (73% reduction, P<0.001). Furthermore, in human AAA tissue organ cultures containing SMCs and macrophages, doses of the EP4 antagonist at 10-100 nM decreased MMP-2 activation and IL-6 production (0.6 +/- 0.06- and 0.7 +/- 0.06-fold, respectively, P<0.05) without increasing MMP-9 activity or MCP-1 secretion. Thus, either pharmacological or genetic EP4 inhibition attenuated AAA formation in multiple mouse and human models by lowering MMP activity and cytokine release. Conclusion: An EP4 antagonist that prevents the activation of MMP and thereby inhibits the degradation of aortic elastic fiber may serve as a new strategy for medical treatment of AAA.	[Yokoyama, Utako; Ishiwata, Ryo; Jin, Mei-Hua; Kato, Yuko; Suzuki, Orie; Jin, Huiling; Ichikawa, Yasuhiro; Kumagaya, Syun; Fujita, Takayuki; Okumura, Satoshi; Sato, Motohiko; Ishikawa, Yoshihiro] Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan; [Katayama, Yuzo; Suzuki, Shinichi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan; [Sugimoto, Yukihiko] Kumamoto Univ, Dept Pharmaceut Biochem, Kumamoto, Japan; [Aoki, Hiroki] Kurume Univ, Cardiovasc Res Inst, Kurume, Fukuoka 830, Japan; [Ishiwata, Ryo; Kumagaya, Syun; Minamisawa, Susumu] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Life Sci & Med Biosci, Tokyo, Japan	Yokohama City University; Yokohama City University; Kumamoto University; Kurume University; Waseda University	Yokoyama, U (corresponding author), Yokohama City Univ, Cardiovasc Res Inst, Yokohama, Kanagawa 232, Japan.	utako@yokohama-cu.ac.jp; yishikaw@med.yokohama-cu.ac.jp	Yokoyama, Utako/AAD-1404-2022; Sugimoto, Yukihiko/AAV-6470-2021	Yokoyama, Utako/0000-0003-1803-0155; Sugimoto, Yukihiko/0000-0001-6973-932X; Ishiwata, Ryo/0000-0001-8006-5485; Minamisawa, Susumu/0000-0003-4728-2116	Ministry of Education, Culture, Sports, Science and Technology of Japan; Adaptable and Seamless Technology transfer Program through target-driven R D [AS231Z00231G]; Yokohama Foundation for Advanced Medical Science; Takeda Science Foundation; Japan Heart Foundation Research Grant; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Kitsuen Research Foundation;  [1123116514];  [22136009]; Grants-in-Aid for Scientific Research [23136516, 24659100, 21590936, 23791233] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology transfer Program through target-driven R D; Yokohama Foundation for Advanced Medical Science; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation Research Grant; Sumitomo Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kanae Foundation for the Promotion of Medical Science; Kitsuen Research Foundation; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (UY, SS, MM, SM, YI), Adaptable and Seamless Technology transfer Program through target-driven R & D (UY, AS231Z00231G), Grant-in-Aid for Scientific Research on Innovative Areas (UY, 1123116514; YI, 22136009), the Yokohama Foundation for Advanced Medical Science (UY, SM), the Takeda Science Foundation (UY, SM, YI), the Japan Heart Foundation Research Grant (UY), the Sumitomo Foundation (UY), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (UY), the Kanae Foundation for the Promotion of Medical Science (UY) and Kitsuen Research Foundation (YI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annambhotla S, 2008, WORLD J SURG, V32, P976, DOI 10.1007/s00268-007-9456-x; Bayston T, 2003, J VASC SURG, V38, P354, DOI 10.1016/S0741-5214(03)00339-2; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1925, DOI 10.1161/01.ATV.0000177814.41505.41; COLLIN J, 1988, LANCET, V2, P613; CORCORAN ML, 1992, J BIOL CHEM, V267, P515; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; Guo DC, 2006, ANN NY ACAD SCI, V1085, P339, DOI 10.1196/annals.1383.013; Hishikari K, 2009, CARDIOVASC RES, V81, P123, DOI 10.1093/cvr/cvn254; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; King VL, 2006, ARTERIOSCL THROM VAS, V26, P1137, DOI 10.1161/01.ATV.0000216119.79008.ac; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGettigan P, 2006, JAMA-J AM MED ASSOC, V296, P1633, DOI 10.1001/jama.296.13.jrv60011; Nataraj C, 2001, J CLIN INVEST, V108, P1229, DOI 10.1172/JCI13640; Pavlovic S, 2006, J BIOL CHEM, V281, P3321, DOI 10.1074/jbc.M506846200; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; SCOTT RAP, 1991, BRIT J SURG, V78, P1122, DOI 10.1002/bjs.1800780929; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Steenport M, 2009, J IMMUNOL, V183, P8119, DOI 10.4049/jimmunol.0901925; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang EHC, 2011, ARTERIOSCL THROM VAS, V31, P261, DOI 10.1161/ATVBAHA.110.216580; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Treska V, 2002, CYTOKINES CELL MOL T, V7, P91, DOI 10.1080/13684730310001652; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	33	58	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36724	10.1371/journal.pone.0036724	http://dx.doi.org/10.1371/journal.pone.0036724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570740	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400056
J	Hill, EJ; Jimenez-Gonzalez, C; Tarczyluk, M; Nagel, DA; Coleman, MD; Parri, HR				Hill, Eric J.; Jimenez-Gonzalez, Cristina; Tarczyluk, Marta; Nagel, David A.; Coleman, Michael D.; Parri, H. Rheinallt			NT2 Derived Neuronal and Astrocytic Network Signalling	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; IN-SITU; SYNAPTIC-TRANSMISSION; CALCIUM OSCILLATIONS; NTERA-2 CELLS; GLIAL-CELLS; GLUTAMATE; LINE; TERATOCARCINOMA; COMMUNICATION	A major focus of stem cell research is the generation of neurons that may then be implanted to treat neurodegenerative diseases. However, a picture is emerging where astrocytes are partners to neurons in sustaining and modulating brain function. We therefore investigated the functional properties of NT2 derived astrocytes and neurons using electrophysiological and calcium imaging approaches. NT2 neurons (NT2Ns) expressed sodium dependent action potentials, as well as responses to depolarisation and the neurotransmitter glutamate. NT2Ns exhibited spontaneous and coordinated calcium elevations in clusters and in extended processes, indicating local and long distance signalling. Tetrodotoxin sensitive network activity could also be evoked by electrical stimulation. Similarly, NT2 astrocytes (NT2As) exhibited morphology and functional properties consistent with this glial cell type. NT2As responded to neuronal activity and to exogenously applied neurotransmitters with calcium elevations, and in contrast to neurons, also exhibited spontaneous rhythmic calcium oscillations. NT2As also generated propagating calcium waves that were gap junction and purinergic signalling dependent. Our results show that NT2 derived astrocytes exhibit appropriate functionality and that NT2N networks interact with NT2A networks in co-culture. These findings underline the utility of such cultures to investigate human brain cell type signalling under controlled conditions. Furthermore, since stem cell derived neuron function and survival is of great importance therapeutically, our findings suggest that the presence of complementary astrocytes may be valuable in supporting stem cell derived neuronal networks. Indeed, this also supports the intriguing possibility of selective therapeutic replacement of astrocytes in diseases where these cells are either lost or lose functionality.	[Hill, Eric J.; Tarczyluk, Marta] Aston Univ, ARCHA, Birmingham B4 7ET, W Midlands, England; [Jimenez-Gonzalez, Cristina; Nagel, David A.; Coleman, Michael D.; Parri, H. Rheinallt] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Aston University; Aston University	Hill, EJ (corresponding author), Aston Univ, ARCHA, Birmingham B4 7ET, W Midlands, England.	Parrihr@aston.ac.uk	Tarczyluk-Wells, Marta/H-9079-2019; Parri, Rheinallt/D-1748-2013; Coleman, Michael Damian/AAD-5503-2019	Tarczyluk-Wells, Marta/0000-0001-6381-8000; Parri, Rheinallt/0000-0002-1412-2688; Coleman, MIchael D/0000-0002-5510-6852; Hill, Eric/0000-0002-9419-1500	Biotechnology and Biological Sciences Research Council [BB/H008527/1]; Wellcome Trust [78068]; Humane Research Trust; Alzheimer's Research Trust [PPG2007B/6, PPG2009B-3]; BBSRC [BB/H008527/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Humane Research Trust; Alzheimer's Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the Biotechnology and Biological Sciences Research Council (BB/H008527/1)(www.bbsrc.ac.uk), Wellcome Trust (78068)(www.wellcome.ac.uk), Humane Research Trust(www.humaneresearch.org.uk), Alzheimer's Research Trust (PPG2007B/6 and PPG2009B-3)(www.alzheimersresearchuk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bani-Yaghoub M, 1999, NEUROREPORT, V10, P3843, DOI 10.1097/00001756-199912160-00022; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Braet K, 2001, EUR J NEUROSCI, V13, P79, DOI 10.1046/j.1460-9568.2001.01372.x; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Chapman H, 2007, BRAIN RES, V1129, P15, DOI 10.1016/j.brainres.2006.10.060; Coyle DE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016174; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Ferrari A, 2000, FEBS LETT, V486, P121, DOI 10.1016/S0014-5793(00)02251-1; FINKBEINER S, 1992, NEURON, V8, P1101, DOI 10.1016/0896-6273(92)90131-V; de Arriba SG, 2006, NEUROCHEM INT, V49, P466, DOI 10.1016/j.neuint.2006.03.005; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Gortz P, 2004, BRAIN RES, V1018, P18, DOI 10.1016/j.brainres.2004.05.076; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Guan XJ, 1997, J CELL BIOL, V139, P1785, DOI 10.1083/jcb.139.7.1785; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Hartley RS, 1999, J COMP NEUROL, V407, P1, DOI 10.1002/(SICI)1096-9861(19990428)407:1<1::AID-CNE1>3.0.CO;2-Z; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; LEE VMY, 1986, J NEUROSCI, V6, P514; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Neelands TR, 2000, J NEUROPHYSIOL, V84, P2933, DOI 10.1152/jn.2000.84.6.2933; Neelands TR, 1999, J NEUROSCI, V19, P7057, DOI 10.1523/JNEUROSCI.19-16-07057.1999; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman MB, 2002, DEV BRAIN RES, V139, P73, DOI 10.1016/S0165-3806(02)00513-8; Parri HR, 2010, EUR J NEUROSCI, V32, P29, DOI 10.1111/j.1460-9568.2010.07281.x; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Podrygajlo G, 2010, NEUROSCI LETT, V468, P207, DOI 10.1016/j.neulet.2009.10.092; Podrygajlo G, 2009, CELL TISSUE RES, V336, P439, DOI 10.1007/s00441-009-0783-0; Porter JT, 1996, J NEUROSCI, V16, P5073; Robertson SJ, 1998, J PHYSIOL-LONDON, V508, P691, DOI 10.1111/j.1469-7793.1998.691bp.x; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Sandhu JK, 2002, J NEUROSCI RES, V68, P604, DOI 10.1002/jnr.10236; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Stewart R, 2003, STEM CELLS, V21, P248, DOI 10.1634/stemcells.21-3-248; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Woehrling EK, 2007, TOXICOL IN VITRO, V21, P1241, DOI 10.1016/j.tiv.2007.04.011; Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2; Woehrling EK, 2010, NEUROTOX RES, V17, P103, DOI 10.1007/s12640-009-9084-3; YOUNKIN DP, 1993, P NATL ACAD SCI USA, V90, P2174, DOI 10.1073/pnas.90.6.2174	47	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36098	10.1371/journal.pone.0036098	http://dx.doi.org/10.1371/journal.pone.0036098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567128	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500046
J	Smith, MA; Bertrand, C; Crosby, K; Eveleigh, ES; Fernandez-Triana, J; Fisher, BL; Gibbs, J; Hajibabaei, M; Hallwachs, W; Hind, K; Hrcek, J; Huang, DW; Janda, M; Janzen, DH; Li, YW; Miller, SE; Packer, L; Quicke, D; Ratnasingham, S; Rodriguez, J; Rougerie, R; Shaw, MR; Sheffield, C; Stahlhut, JK; Steinke, D; Whitfield, J; Wood, M; Zhou, X				Smith, M. Alex; Bertrand, Claudia; Crosby, Kate; Eveleigh, Eldon S.; Fernandez-Triana, Jose; Fisher, Brian L.; Gibbs, Jason; Hajibabaei, Mehrdad; Hallwachs, Winnie; Hind, Katharine; Hrcek, Jan; Huang, Da-Wei; Janda, Milan; Janzen, Daniel H.; Li, Yanwei; Miller, Scott E.; Packer, Laurence; Quicke, Donald; Ratnasingham, Sujeevan; Rodriguez, Josephine; Rougerie, Rodolphe; Shaw, Mark R.; Sheffield, Cory; Stahlhut, Julie K.; Steinke, Dirk; Whitfield, James; Wood, Monty; Zhou, Xin			Wolbachia and DNA Barcoding Insects: Patterns, Potential, and Problems	PLOS ONE			English	Article							PARASITOID FLIES DIPTERA; MITOCHONDRIAL-DNA; HYBRID INTROGRESSION; BACTERIAL SYMBIONTS; SELECTIVE SWEEPS; DIVERSITY; GENUS; IDENTIFICATIONS; COMMUNITIES; DISCORDANCE	Wolbachia is a genus of bacterial endosymbionts that impacts the breeding systems of their hosts. Wolbachia can confuse the patterns of mitochondrial variation, including DNA barcodes, because it influences the pathways through which mitochondria are inherited. We examined the extent to which these endosymbionts are detected in routine DNA barcoding, assessed their impact upon the insect sequence divergence and identification accuracy, and considered the variation present in Wolbachia COI. Using both standard PCR assays (Wolbachia surface coding protein - wsp), and bacterial COI fragments we found evidence of Wolbachia in insect total genomic extracts created for DNA barcoding library construction. When >2 million insect COI trace files were examined on the Barcode of Life Datasystem (BOLD) Wolbachia COI was present in 0.16% of the cases. It is possible to generate Wolbachia COI using standard insect primers; however, that amplicon was never confused with the COI of the host. Wolbachia alleles recovered were predominantly Supergroup A and were broadly distributed geographically and phylogenetically. We conclude that the presence of the Wolbachia DNA in total genomic extracts made from insects is unlikely to compromise the accuracy of the DNA barcode library; in fact, the ability to query this DNA library (the database and the extracts) for endosymbionts is one of the ancillary benefits of such a large scale endeavor - for which we provide several examples. It is our conclusion that regular assays for Wolbachia presence and type can, and should, be adopted by large scale insect barcoding initiatives. While COI is one of the five multi-locus sequence typing (MLST) genes used for categorizing Wolbachia, there is limited overlap with the eukaryotic DNA barcode region.	[Smith, M. Alex; Bertrand, Claudia; Fernandez-Triana, Jose; Hajibabaei, Mehrdad; Ratnasingham, Sujeevan; Stahlhut, Julie K.; Steinke, Dirk] Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada; [Crosby, Kate] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Eveleigh, Eldon S.] Atlantic Forestry Ctr, Nat Resources Canada, Canadian Forest Serv, Fredericton, NB, Canada; [Fisher, Brian L.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Gibbs, Jason] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Hallwachs, Winnie; Janzen, Daniel H.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Hind, Katharine] Univ New Brunswick, Fredericton, NB, Canada; [Hrcek, Jan] Univ S Bohemia, Ctr Biol, Czech Acad Sci, Ceske Budejovice, Czech Republic; [Hrcek, Jan] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Huang, Da-Wei; Li, Yanwei] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Janda, Milan; Miller, Scott E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Packer, Laurence; Sheffield, Cory] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada; [Quicke, Donald] Imperial Coll London, Div Biol, Ascot, Berks, England; [Quicke, Donald] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Rodriguez, Josephine] Univ Calif Santa Barbara, NCEAS, Santa Barbara, CA 93106 USA; [Rougerie, Rodolphe] Univ Rouen, Lab ECODIV, Mont St Aignan, France; [Shaw, Mark R.] Natl Museums Scotland, Edinburgh, Midlothian, Scotland; [Whitfield, James] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Wood, Monty] Agr & Agri Food Canada, Diptera Unit, Canadian Natl Collect Insects Arachnids & Nematod, Ottawa, ON, Canada; [Zhou, Xin] Beijing Genom Inst BGI BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	University of Guelph; Dalhousie University; Natural Resources Canada; Canadian Forest Service; California Academy of Sciences; Cornell University; University of Pennsylvania; University of New Brunswick; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Chinese Academy of Sciences; Institute of Zoology, CAS; Harvard University; York University - Canada; Imperial College London; Natural History Museum London; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Universite de Rouen Normandie; University of Illinois System; University of Illinois Urbana-Champaign; Agriculture & Agri Food Canada; Beijing Genomics Institute (BGI)	Smith, MA (corresponding author), Univ Guelph, Dept Integrat Biol & Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada.	salex@uoguelph.ca	Zhou, Xin/D-4025-2009; Rougerie, Rodolphe/D-2930-2009; Hrček, Jan/D-7335-2015; Ratnasingham, Sujeevan/G-9103-2014; Sheffield, Cory/I-4812-2019; Gibbs, Jason/H-6963-2012; Janda, Milan/H-7216-2014; Smith, M Alex/B-4468-2013; li, yan/GTI-4638-2022; Steinke, Dirk/D-4700-2009; Quicke, Donald LJ/I-5948-2012; Fisher, Brian L./S-9374-2019; Zhou, Xin/AAI-9326-2021	Zhou, Xin/0000-0002-1407-7952; Rougerie, Rodolphe/0000-0003-0937-2815; Hrček, Jan/0000-0003-0711-6447; Sheffield, Cory/0000-0003-0603-7333; Gibbs, Jason/0000-0002-4945-5423; Janda, Milan/0000-0003-3038-0107; Smith, M Alex/0000-0002-8650-2575; Zhou, Xin/0000-0002-1407-7952; Crosby, Kate/0000-0003-1860-8367; Steinke, Dirk/0000-0002-8992-575X; packer, laurence/0000-0002-1711-8203; Fernandez-Triana, Jose/0000-0003-0425-0309; Quicke, Donald/0000-0003-4471-6775; Miller, Scott/0000-0002-4138-1378; Stahlhut, Julie/0000-0001-6813-5727; Fisher, Brian/0000-0002-4653-3270	Natural Sciences and Engineering Research Council of Canada (NSERC); Centre national de la recherche scientifique (CNRS) (French Guiana); Natural Resources Canada; Canadian Forest Service; Alfred P. Sloan Foundation; National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395, DEB 1020510]; USDA [AG sub UGA RC293-359]; NSF [DEB-0841885, DEB 0515699]; Czech Science Foundation [P505/10/0673]; Marie Currie Fellowship [PIOFGA2009-25448]; National Natural Science Foundation of China (NSFC) [31090253]; National Center for Ecological Analysis and Synthesis, US NSF [EF-0553768]; Wege Foundation of Grand Rapids, Michigan; International Conservation Fund of Canada (Nova Scotia); Genome Canada; Government of Canada through Genome Canada; Ontario Genomics Institute [2008-0GI-ICI-03]; Division Of Environmental Biology [0842395] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre national de la recherche scientifique (CNRS) (French Guiana); Natural Resources Canada(Natural Resources CanadaCanadian Forest Service); Canadian Forest Service(Natural Resources CanadaCanadian Forest Service); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); NSF(National Science Foundation (NSF)); Czech Science Foundation(Grant Agency of the Czech Republic); Marie Currie Fellowship; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Center for Ecological Analysis and Synthesis, US NSF(National Science Foundation (NSF)); Wege Foundation of Grand Rapids, Michigan; International Conservation Fund of Canada (Nova Scotia); Genome Canada(Genome Canada); Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	MAS was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant and the Nouragues research grant by the Centre national de la recherche scientifique (CNRS) (French Guiana). ESE was supported by Natural Resources Canada, Canadian Forest Service. MH was supported by an NSERC Discovery Grant. DS was supported by the Alfred P. Sloan Foundation. BLF was supported by National Science Foundation Grants DEB-0072713, DEB-0344731, and DEB-0842395. JBW was supported by NSF grant DEB 1020510 and USDA Grant AG sub UGA RC293-359. SEM, JH and MJ were supported by NSF grant DEB-0841885 and Czech Science Foundation grant P505/10/0673. MJ was supported by a Marie Currie Fellowship (PIOFGA2009-25448). HDW was supported by the National Natural Science Foundation of China (NSFC grant no. 31090253). JR was supported by the National Center for Ecological Analysis and Synthesis, US NSF Grant #EF-0553768. DHJ was supported by NSF DEB 0515699, the Wege Foundation of Grand Rapids, Michigan, the International Conservation Fund of Canada (Nova Scotia), and private donors to the Guanacaste Dry Forest Conservation Fund. JG was supported through funding to the Canadian Barcode of Life Network from Genome Canada, NSERC, and other sponsors listed at www.BOLNET.ca. Laboratory analyses on sequences generated since 2009 were funded by the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-0GI-ICI-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Ballard JWO, 2000, MOL BIOL EVOL, V17, P1126, DOI 10.1093/oxfordjournals.molbev.a026394; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Chen LL, 2010, INSECT SCI, V17, P101, DOI 10.1111/j.1744-7917.2009.01291.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Engelstadter J, 2010, ANNU REV ECOL SYST, V40, P127; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez Triana J, 2011, PLOS ONE, V6; Fernandez Triana J, PLOS ONE IN PRESS; Ferrari J, 2011, PHILOS T R SOC B, V366, P1389, DOI 10.1098/rstb.2010.0226; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Grasso DA, 2000, ETHOL ECOL EVOL, V12, P309; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Jiggins FM, 2003, GENETICS, V164, P5; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Li YW, 2010, MOL ECOL RESOUR, V10, P31, DOI 10.1111/j.1755-0998.2009.02671.x; Linares MC, 2009, MOL PHYLOGENET EVOL, V50, P485, DOI 10.1016/j.ympev.2008.11.008; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Nice CC, 2009, BIOL CONSERV, V142, P3137, DOI 10.1016/j.biocon.2009.08.020; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raychoudhury R, 2010, HEREDITY, V104, P318, DOI 10.1038/hdy.2009.160; Raychoudhury R, 2009, EVOLUTION, V63, P165, DOI 10.1111/j.1558-5646.2008.00533.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Schmidt BC, 2009, ZOOL J LINN SOC-LOND, V156, P507, DOI 10.1111/j.1096-3642.2008.00496.x; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014424; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Smith MA, 2009, MOL ECOL RESOUR, V9, P208, DOI 10.1111/j.1755-0998.2009.02646.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Sun XJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-86; Swartz ER, 2008, S AFR J SCI, V104, P293; Virgilio M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-206; Weinert LA, 2007, BIOL LETTERS, V3, P678, DOI 10.1098/rsbl.2007.0373; Wenseleers T, 1998, P ROY SOC B-BIOL SCI, V265, P1447, DOI 10.1098/rspb.1998.0456; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062	47	102	107	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36514	10.1371/journal.pone.0036514	http://dx.doi.org/10.1371/journal.pone.0036514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567162	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500082
J	McCoy, ES; Taylor-Blake, B; Zylka, MJ				McCoy, Eric S.; Taylor-Blake, Bonnie; Zylka, Mark J.			CGRP alpha-Expressing Sensory Neurons Respond to Stimuli that Evoke Sensations of Pain and Itch	PLOS ONE			English	Article							GENE-RELATED-PEPTIDE; CENTRAL-NERVOUS-SYSTEM; PROSTATIC ACID-PHOSPHATASE; PRIMARY AFFERENT NEURONS; ROOT GANGLION NEURONS; DORSAL-HORN NEURONS; RAT SPINAL-CORD; NOCICEPTIVE NEURONS; BETA-CGRP; DIFFERENTIAL EXPRESSION	Calcitonin gene-related peptide (CGRP alpha, encoded by Calca) is a classic marker of nociceptive dorsal root ganglia (DRG) neurons. Despite years of research, it is unclear what stimuli these neurons detect in vitro or in vivo. To facilitate functional studies of these neurons, we genetically targeted an axonal tracer (farnesylated enhanced green fluorescent protein; GFP) and a LoxP-stopped cell ablation construct (human diphtheria toxin receptor; DTR) to the Calca locus. In culture, 10-50% (depending on ligand) of all CGRP alpha-GFP-positive (+) neurons responded to capsaicin, mustard oil, menthol, acidic pH, ATP, and pruritogens (histamine and chloroquine), suggesting a role for peptidergic neurons in detecting noxious stimuli and itch. In contrast, few (2.2 +/- 1.3%) CGRP alpha-GFP(+) neurons responded to the TRPM8-selective cooling agent icilin. In adult mice, CGRP alpha-GFP(+) cell bodies were located in the DRG, spinal cord (motor neurons and dorsal horn neurons), brain and thyroid-reproducibly marking all cell types known to express Calca. Half of all CGRP alpha-GFP(+) DRG neurons expressed TRPV1, similar to 25% expressed neurofilament-200, <10% contained nonpeptidergic markers (IB4 and Prostatic acid phosphatase) and almost none (<1%) expressed TRPM8. CGRP alpha-GFP(+) neurons innervated the dorsal spinal cord and innervated cutaneous and visceral tissues. This included nerve endings in the epidermis and on guard hairs. Our study provides direct evidence that CGRP alpha(+) DRG neurons respond to agonists that evoke pain and itch and constitute a sensory circuit that is largely distinct from nonpeptidergic circuits and TRPM8(+)/cool temperature circuits. In future studies, it should be possible to conditionally ablate CGRP alpha-expressing neurons to evaluate sensory and non-sensory functions for these neurons.	[McCoy, Eric S.; Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	McCoy, ES (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, UNC Neurosci Ctr, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022		Searle Scholars Program; Klingenstein Foundation; Rita Allen Foundation; NINDS [R01NS060725, R01NS067688, P30NS045892]; NICHD; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067688, P30NS045892, R01NS060725] Funding Source: NIH RePORTER	Searle Scholars Program; Klingenstein Foundation(Klingenstein Philanthropies); Rita Allen Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from The Searle Scholars Program, The Klingenstein Foundation, The Rita Allen Foundation and NINDS (R01NS060725, R01NS067688). Confocal imaging was performed at the UNC Confocal and Multiphoton Imaging Core. The BAC Core and Imaging Core are funded by grants from NINDS (P30NS045892) and NICHD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2004, GENESIS, V38, P122, DOI 10.1002/gene.20010; Baillie LD, 2011, J NEUROSCI METH, V198, P274, DOI 10.1016/j.jneumeth.2011.04.015; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Benemei Silvia, 2009, Handb Exp Pharmacol, P75, DOI 10.1007/978-3-540-79090-7_3; BIELLA G, 1991, BRAIN RES, V559, P352, DOI 10.1016/0006-8993(91)90024-P; BROWN AG, 1967, J PHYSIOL-LONDON, V193, P707, DOI 10.1113/jphysiol.1967.sp008390; Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; CONRATH M, 1989, J CHEM NEUROANAT, V2, P335; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; ISHIDAYAMAMOTO A, 1989, BRAIN RES, V491, P93, DOI 10.1016/0006-8993(89)90090-5; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; KAWAI Y, 1985, NEUROSCIENCE, V15, P747, DOI 10.1016/0306-4522(85)90076-4; KRESSE A, 1995, BRAIN RES BULL, V36, P261, DOI 10.1016/0361-9230(94)00201-B; KRUGER L, 1988, BRAIN RES, V463, P223, DOI 10.1016/0006-8993(88)90395-2; KRUGER L, 1989, J COMP NEUROL, V280, P291, DOI 10.1002/cne.902800210; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Lawson SN, 2002, J PHYSIOL-LONDON, V540, P989, DOI 10.1113/jphysiol.2001.013086; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; MCCARTHY PW, 1990, NEUROSCIENCE, V34, P623, DOI 10.1016/0306-4522(90)90169-5; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mishra SK, 2010, MOL CELL NEUROSCI, V43, P157, DOI 10.1016/j.mcn.2009.10.006; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; MULDERRY PK, 1988, NEUROSCIENCE, V25, P195; NAVARRO X, 1995, J NEUROSCI RES, V41, P111, DOI 10.1002/jnr.490410113; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; NOGUCHI K, 1990, MOL BRAIN RES, V7, P299, DOI 10.1016/0169-328X(90)90080-W; OHTANI R, 1989, CELL TISSUE RES, V258, P35; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; ROBINE S, 1985, P NATL ACAD SCI USA, V82, P8488, DOI 10.1073/pnas.82.24.8488; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Salmon AM, 1999, NEUROREPORT, V10, P849, DOI 10.1097/00001756-199903170-00033; Salmon AM, 2001, NAT NEUROSCI, V4, P357, DOI 10.1038/86001; SARIA A, 1986, NEUROSCI LETT, V63, P310, DOI 10.1016/0304-3940(86)90376-9; Schutz B, 2004, J COMP NEUROL, V476, P32, DOI 10.1002/cne.20211; SILVERMAN JD, 1989, J COMP NEUROL, V280, P303, DOI 10.1002/cne.902800211; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Taylor-Blake B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008674; Tie-Jun SS, 2001, NEUROREPORT, V12, P739, DOI 10.1097/00001756-200103260-00025; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Woodbury CJ, 2001, J COMP NEUROL, V436, P304; Wrigley PJ, 2009, BRIT J PHARMACOL, V157, P371, DOI 10.1111/j.1476-5381.2009.00167.x; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhang LP, 2001, PAIN, V89, P265, DOI 10.1016/S0304-3959(00)00378-X; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	66	78	79	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36355	10.1371/journal.pone.0036355	http://dx.doi.org/10.1371/journal.pone.0036355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563493	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700042
J	Lea, WA; Simeonov, A				Lea, Wendy A.; Simeonov, Anton			Differential Scanning Fluorometry Signatures as Indicators of Enzyme Inhibitor Mode of Action: Case Study of Glutathione S-Transferase	PLOS ONE			English	Article							PROMOTE PROTEIN STABILITY; ELECTROPHILE BINDING-SITE; THERMAL SHIFT ASSAYS; PI CLASS GLUTATHIONE; SCHISTOSOMA-JAPONICUM; ETHACRYNIC-ACID; CONFORMATIONAL STABILITY; 3-DIMENSIONAL STRUCTURE; SCREENING METHODS; DRUG DISCOVERY	Differential scanning fluorometry (DSF), also referred to as fluorescence thermal shift, is emerging as a convenient method to evaluate the stabilizing effect of small molecules on proteins of interest. However, its use in the mechanism of action studies has received far less attention. Herein, the ability of DSF to report on inhibitor mode of action was evaluated using glutathione S-transferase (GST) as a model enzyme that utilizes two distinct substrates and is known to be subject to a range of inhibition modes. Detailed investigation of the propensity of small molecule inhibitors to protect GST from thermal denaturation revealed that compounds with different inhibition modes displayed distinct thermal shift signatures when tested in the presence or absence of the enzyme's native co-substrate glutathione (GSH). Glutathione-competitive inhibitors produced dose-dependent thermal shift trendlines that converged at high compound concentrations. Inhibitors acting via the formation of glutathione conjugates induced a very pronounced stabilizing effect toward the protein only when GSH was present. Lastly, compounds known to act as noncompetitive inhibitors exhibited parallel concentration-dependent trends. Similar effects were observed with human GST isozymes A1-1 and M1-1. The results illustrate the potential of DSF as a tool to differentiate diverse classes of inhibitors based on simple analysis of co-substrate dependency of protein stabilization.	[Lea, Wendy A.; Simeonov, Anton] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI)	Lea, WA (corresponding author), NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA.	asimeono@mail.nih.gov			Molecular Libraries of Initiative of the NIH Roadmap for Medical Research; Intramural Research Program of the NHGRI, NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	Molecular Libraries of Initiative of the NIH Roadmap for Medical Research; Intramural Research Program of the NHGRI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding by the Molecular Libraries of Initiative of the NIH Roadmap for Medical Research, and the Intramural Research Program of the NHGRI, NIH, is hereby gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andujar-Sanchez M, 2005, BIOCHEMISTRY-US, V44, P1174, DOI 10.1021/bi0483110; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; ASKELOF P, 1975, BIOCHEM J, V147, P513, DOI 10.1042/bj1470513; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; Bergsdorf C, 2010, EXPERT OPIN DRUG DIS, V5, P1095, DOI 10.1517/17460441.2010.524641; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; CAMERON AD, 1995, STRUCTURE, V3, P717, DOI 10.1016/S0969-2126(01)00206-4; Cardoso RMF, 2003, PROTEINS, V51, P137, DOI 10.1002/prot.10345; Carver TE, 2005, J BIOL CHEM, V280, P11704, DOI 10.1074/jbc.M413278200; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Eaton DL, 1999, TOXICOL SCI, V49, P156, DOI 10.1093/toxsci/49.2.156; Erhardt J, 1996, FEBS LETT, V391, P313, DOI 10.1016/0014-5793(96)00768-5; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Filippakopoulos P, NATURE, V468, P1067; Kaplan W, 1997, PROTEIN SCI, V6, P399; Khan MA, 2010, CHINESE J CANCER RES, V22, P87, DOI 10.1007/s11670-010-0087-7; Kursula I, 2005, PROTEIN PEPTIDE LETT, V12, P709, DOI 10.2174/0929866054696154; Laborde E, CELL DEATH DIFFER, V17, P1373; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lyon RP, 2003, BIOCHEMISTRY-US, V42, P10418, DOI 10.1021/bi0346188; Mahajan S, 2005, CELL MOL LIFE SCI, V62, P1221, DOI 10.1007/s00018-005-4524-6; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Mathew N, 2006, EXPERT OPIN THER PAT, V16, P431, DOI 10.1517/13543776.16.4.431; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; MCTIGUE MA, 1995, J MOL BIOL, V246, P21, DOI 10.1006/jmbi.1994.0061; Merlos M, 1990, EXPERIENTIA, V47, P616; MEYER DJ, 1993, XENOBIOTICA, V23, P823, DOI 10.3109/00498259309059411; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Niesen FH, PLOS ONE, V5; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nieslanik BS, 2000, J BIOL CHEM, V275, P17447, DOI 10.1074/jbc.M002083200; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 1997, BIOCHEMISTRY-US, V36, P576, DOI 10.1021/bi962316i; Ortiz-Salmeron E, 2001, BBA-PROTEIN STRUCT M, V1548, P106, DOI 10.1016/S0167-4838(01)00224-2; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Poklar N, 1997, BIOCHEMISTRY-US, V36, P14345, DOI 10.1021/bi971719v; Quesada-Soriano I, 2006, BBA-PROTEINS PROTEOM, V1764, P979, DOI 10.1016/j.bbapap.2006.03.002; REINEMER P, 1992, J MOL BIOL, V227, P214, DOI 10.1016/0022-2836(92)90692-D; Ricci G, 2005, J BIOL CHEM, V280, P26397, DOI 10.1074/jbc.M503295200; Rufer AC, 2005, ACTA CRYSTALLOGR F, V61, P263, DOI 10.1107/S1744309105004823; Todd Matthew J, 2005, Drug Discov Today Technol, V2, P267, DOI 10.1016/j.ddtec.2005.08.015; van Zanden JJ, 2003, CHEM-BIOL INTERACT, V145, P139, DOI 10.1016/S0009-2797(02)00250-8; VANBLADEREN PJ, 1991, PHARMACOL THERAPEUT, V51, P35, DOI 10.1016/0163-7258(91)90040-S; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Xu XC, 1997, INFECT IMMUN, V65, P3867, DOI 10.1128/IAI.65.9.3867-3874.1997; Yasgar A, 2010, ASSAY DRUG DEV TECHN, V8, P200, DOI 10.1089/adt.2009.0248; Yassin Z, 2004, BBA-PROTEINS PROTEOM, V1698, P227, DOI 10.1016/j.bbapap.2003.12.004; Zubriene A, 2009, INT J MOL SCI, V10, P2662, DOI 10.3390/ijms10062662	52	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36219	10.1371/journal.pone.0036219	http://dx.doi.org/10.1371/journal.pone.0036219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558390	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200051
J	Grant, AV; Araujo, MI; Ponte, EV; Oliveira, RR; Gao, P; Cruz, AA; Barnes, KC; Beaty, TH				Grant, Audrey V.; Araujo, Maria Ilma; Ponte, Eduardo Vieira; Oliveira, Ricardo Riccio; Gao, Peisong; Cruz, Alvaro A.; Barnes, Kathleen C.; Beaty, Terri H.			Functional Polymorphisms in IL13 Are Protective against High Schistosoma mansoni Infection Intensity in a Brazilian Population	PLOS ONE			English	Article							IMMUNOGLOBULIN-E; PROMOTER POLYMORPHISM; CHROMOSOME 5Q31-Q33; ASSOCIATION; ASTHMA; LOCUS; IL-13; HAPLOTYPE; ATOPY; IGE	Background: IL-13 is a signature cytokine of the helper T cell type 2 (TH2) pathway which underlies host defense to helminthic infection and activates production of IgE in both parasitized populations and in urban settings after allergen exposure. Methodology/Principal Findings: Two functional polymorphisms in IL13, rs1800925 (or c.1-1111C>T) and rs20541 (or R130Q) were previously found to be associated with Schistosoma hematobium infection intensity. They have not been thoroughly explored in S. mansoni-endemic populations, however, and were selected along with 5 tagging SNPs for genotyping in 812 individuals in 318 nuclear families from a schistosomiasis-endemic area of Conde, Bahia, in Brazil. Regression models using GEE to account for family membership and family-based quantitative transmission disequilibrium tests (QTDT) were used to evaluate associations with total serum IgE (tIgE) levels and S. mansoni fecal egg counts adjusted for non-genetic covariates. We identified a protective effect for the T allele at rs20541 (P = 0.005) against high S. mansoni egg counts, corroborated by QTDT (P = 0.014). Our findings also suggested evidence for protective effects for the T allele at rs1800925 and A allele at rs2066960 after GEE analysis only (P = 0.050, 0.0002). Conclusions/Significance: The two functional variants in IL13 are protective against high S. mansoni egg counts. These markers showed no evidence of association with tIgE levels, unlike tIgE levels previously studied in non-parasitized or atopic study populations.	[Grant, Audrey V.; Barnes, Kathleen C.; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Grant, Audrey V.; Gao, Peisong; Barnes, Kathleen C.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD USA; [Araujo, Maria Ilma; Oliveira, Ricardo Riccio; Cruz, Alvaro A.] Hosp Univ Prof Edgard Santos, Serv Imunol, Salvador, BA, Brazil; [Ponte, Eduardo Vieira; Cruz, Alvaro A.] Univ Fed Bahia, Sch Med, Programa Controle Asma & Rinite Alerg Bahia, Salvador, BA, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Universidade Federal da Bahia	Grant, AV (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	audrey.grant@inserm.fr	Oliveira, Ricardo/E-7707-2017; Cruz, Alvaro A/I-1676-2012	Oliveira, Ricardo/0000-0001-9586-2313; Cruz, Alvaro A/0000-0002-7403-3871	Glaxo-Smith-Kline [WE445]; National Institutes of Health [AI050024]; Mary Beryl Patch Turnbull Scholar Program; Glaxo-Smith-Kline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112088] Funding Source: NIH RePORTER	Glaxo-Smith-Kline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Beryl Patch Turnbull Scholar Program; Glaxo-Smith-Kline(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by Glaxo-Smith-Kline under the project WE445 entitled "Immunogenetics of Schistosomiasis and Asthma," and National Institutes of Health grant #AI050024. KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study benefited from financial support from Glaxo-Smith-Kline. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Arima K, 2002, J ALLERGY CLIN IMMUN, V109, P980, DOI 10.1067/mai.2002.124656; AZEVEDO ES, 1980, ANN HUM GENET, V44, P55, DOI 10.1111/j.1469-1809.1980.tb00945.x; Bethony JM, 2008, ACTA TROP, V108, P166, DOI 10.1016/j.actatropica.2007.11.008; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gatlin MR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000375; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; GERRARD JW, 1978, AM J HUM GENET, V30, P46; Grant AV, 2011, GENES IMMUN, V12, P46, DOI 10.1038/gene.2010.50; Grant AV, 2008, J INFECT DIS, V198, P1227, DOI 10.1086/591946; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hummelshoj T, 2003, EUR J IMMUNOGENET, V30, P355, DOI 10.1046/j.1365-2370.2003.00416.x; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; KATZ N, 1970, J PARASITOL, V56, P1032, DOI 10.2307/3277532; Katz N., 1978, Revista do Instituto de Medicina Tropical de Sao Paulo, V20, P273; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; Maier LM, 2006, J ALLERGY CLIN IMMUN, V117, P1306, DOI 10.1016/j.jaci.2005.12.1354; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; Masters M, 1985, EPIDEMIOLOGY REV, V7, P49; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MullerMyhsok B, 1997, AM J HUM GENET, V61, P452, DOI 10.1016/S0002-9297(07)64073-7; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Quinnell RJ, 2003, INT J PARASITOL, V33, P1219, DOI 10.1016/S0020-7519(03)00175-9; Tarazona-Santos E, 2005, GENES IMMUN, V6, P53, DOI 10.1038/sj.gene.6364149; Vercelli D, 2002, CURR OPIN ALLERGY CL, V2, P389, DOI 10.1097/00130832-200210000-00004; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	36	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35863	10.1371/journal.pone.0035863	http://dx.doi.org/10.1371/journal.pone.0035863			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574126	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800022
J	Hicks, CC; McClanahan, TR				Hicks, Christina C.; McClanahan, Timothy R.			Assessing Gear Modifications Needed to Optimize Yields in a Heavily Exploited, Multi-Species, Seagrass and Coral Reef Fishery	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; SOUTHERN ARABIAN GULF; LIFE-HISTORY; POPULATION BIOLOGY; ARTISANAL FISHERY; MARINE RESERVES; FISHING GEAR; LENGTH; BEDS; SUSTAINABILITY	Effective management is necessary if small-scale fisheries, such as those found in mixed habitats including seagrass and coral reefs, are to continue providing food for many of the poorest communities of the world. Gear-based management, although under represented and under studied, has the potential to be adaptive, address multiple objectives, and be crafted to the socio-economic setting. Management effectiveness in seagrass and coral reef fisheries has generally been evaluated at the scale of the fish community. However, community level indicators can mask species-specific declines that provide significant portions of the fisheries yields and income. Using a unique dataset, containing ten years of species level length frequency catch data from a multi-gear, multi-species seagrass and coral reef fishery in Kenya, we evaluate species specific fishery statuses, compare gear use to gear regulations and estimate the potential needs for further gear restrictions. Despite the high diversity of the fishery, fifteen species represented over 90% of the catch, and only three species represented 60% of the catch. The three most abundant species in the catch, Lethrinus lentjan (Lacepede), Siganus sutor (Valenciennes) and Leptoscarus vaigiensis (Quoy & Gaimard) all showed evidence of growth overfishing. Lethrinus lentjan, with an exploitation rate of 0.82, also shows evidence of recruitment overfishing. Current legal but weakly enforced gear restrictions are capable of protecting a significant portion of the catch up to maturity but optimization of yield will require that the current mesh size be increased from 6.3 to 8.8 and 9.2 cm to increase yields of L. lentjan and S. sutor, respectively. Given the difficulties of enforcing mesh size, we recommend that the economic benefits of these larger mesh sizes be communicated and enforced through co-management. This abstract is also available in Kiswahili (Abstract S1).	[Hicks, Christina C.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Hicks, Christina C.] Coral Reef Conservat Project, Mombasa, Kenya; [McClanahan, Timothy R.] Wildlife Conservat Soc, Marine Programs, New York, NY USA	James Cook University; Wildlife Conservation Society	Hicks, CC (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.	Christina.c.hicks@gmail.com	McClanahan, Tim/K-4998-2019; Hicks, Christina/M-6182-2015; Hicks, christina/B-1421-2013	Hicks, Christina/0000-0002-7399-4603; McClanahan, Timothy/0000-0001-5821-3584	Eppley Foundation; McBean Foundation; Tiffany Foundation; Pew Fellows Program in Marine Conservation	Eppley Foundation; McBean Foundation; Tiffany Foundation; Pew Fellows Program in Marine Conservation	This study was funded through grants from the Eppley, McBean, Tiffany Foundations and the Pew Fellows Program in Marine Conservation. Research clearance was provided by Kenya's Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; [Anonymous], 1986, SMITHS SEA FISHES; [Anonymous], 2001, QUANTITATIVE FISHERI; Armsworth PR, 2002, ECOLOGY, V83, P1092, DOI 10.1890/0012-9658(2002)083[1092:RLPRAL]2.0.CO;2; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Beverton R.J.H., 1956, J CONS INT EXPLOR ME, V14, P67; Cinner JE, 2009, MAR POLICY, V33, P489, DOI 10.1016/j.marpol.2008.11.001; Cinner JE, 2009, J APPL ECOL, V46, P724, DOI 10.1111/j.1365-2664.2009.01648.x; Currey LM, 2009, COMP BIOL KEY INTERR; Davies TE, 2009, FISHERIES MANAG ECOL, V16, P279, DOI 10.1111/j.1365-2400.2009.00665.x; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; EHRHARDT NM, 1992, T AM FISH SOC, V121, P115, DOI 10.1577/1548-8659(1992)121<0115:AOTLMM>2.3.CO;2; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; Froese R., 2012, FISHBASE; Gell FR, 2002, MAR FRESHWATER RES, V53, P115, DOI 10.1071/MF01125; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grandcourt E, 2007, J APPL ICHTHYOL, V23, P53, DOI 10.1111/j.1439-0426.2006.00796.x; Grandcourt EM, 2004, FISH RES, V69, P331, DOI 10.1016/j.fishres.2004.06.008; Grandcourt EM, 2002, MAR FRESHWATER RES, V53, P123, DOI 10.1071/MF01123; Grol MGG, 2011, OECOLOGIA, V165, P79, DOI 10.1007/s00442-010-1833-8; Gulland J.A., 1971, FISH RESOURCES OCEAN; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hilborn R, 2004, B MAR SCI, V74, P493; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Jennings S, 2004, MAR ECOL PROG SER, V274, P279; Jennings S., 2001, MARINE FISHERIES ECO; Jennings S, 2007, ICES J MAR SCI, V64, P1525, DOI 10.1093/icesjms/fsm104; Johnson JE, 2010, REV FISH SCI, V18, P106, DOI 10.1080/10641260903434557; Kaunda-Arara Boaz, 2003, Western Indian Ocean Journal of Marine Science, V2, P105; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Legendre P., 2012, NUMERICAL ECOLOGY; Lieske E, 1994, COLLINGS POCKET GUID; MACLENNAN DN, 1992, FISH RES, V13, P201, DOI 10.1016/0165-7836(92)90076-6; Mahon R, 1997, CAN J FISH AQUAT SCI, V54, P2207, DOI 10.1139/cjfas-54-9-2207; Mangi SC, 2006, MAR POLLUT BULL, V52, P1646, DOI 10.1016/j.marpolbul.2006.06.006; McClanahan TR, 2008, AQUAT CONSERV, V18, P493, DOI 10.1002/aqc.874; McClanahan TR, 2011, J EXP MAR BIOL ECOL, V408, P3, DOI 10.1016/j.jembe.2011.07.021; McClanahan TR, 2011, FISHERIES MANAG ECOL, V18, P50, DOI 10.1111/j.1365-2400.2010.00768.x; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2011, P NATL ACAD SCI USA, V108, P17230, DOI 10.1073/pnas.1106861108; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Munro JL, 2003, PROCEEDINGS OF THE FIFTY-FOURTH ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P28; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D., 1983, FAO FISH TECH PAP, P1; Peterman RM, 2004, ICES J MAR SCI, V61, P1331, DOI 10.1016/j.icesjms.2004.08.017; Quinn GP, 2003, EXPT DESIGN DATA ANA; ROBERTS CM, 1993, AMBIO, V22, P363; Rochet MJ, 2000, OIKOS, V91, P255, DOI 10.1034/j.1600-0706.2000.910206.x; Russ GR, 1998, CORAL REEFS, V17, P399, DOI 10.1007/s003380050146; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sparre P., 1998, INTRO TROPICAL FIS 1; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x	63	83	91	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36022	10.1371/journal.pone.0036022	http://dx.doi.org/10.1371/journal.pone.0036022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574133	Green Published, Green Accepted, gold			2022-12-27	WOS:000305349800029
J	Nawaz, HM; Kylsten, P; Hamada, N; Yamamoto, D; Smith, CIE; Lindvall, JM				Nawaz, Hossain M.; Kylsten, Per; Hamada, Noriko; Yamamoto, Daisuke; Smith, C. I. Edvard; Lindvall, Jessica M.			Differential Evolutionary Wiring of the Tyrosine Kinase Btk	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TEC-FAMILY; B-CELLS; BONE-MARROW; XID MICE; DROSOPHILA; SRC64; ACTIN; EXPRESSION; LOCALIZATION	Background: A central question within biology is how intracellular signaling pathways are maintained throughout evolution. Btk29A is considered to be the fly-homolog of the mammalian Bruton's tyrosine kinase (Btk), which is a non-receptor tyrosine-kinase of the Tec-family. In mammalian cells, there is a single transcript splice-form and the corresponding Btk-protein plays an important role for B-lymphocyte development with alterations within the human BTK gene causing the immunodeficiency disease X-linked agammaglobulinemia in man and a related disorder in mice. In contrast, the Drosophila Btk29A locus encodes two splice-variants, where the type 2-form is the more related to the mammalian Btk gene product displaying more than 80% homology. In Drosophila, Btk29A displays a dynamic pattern of expression through the embryonic to adult stages. Complete loss-of-function of both splice-forms is lethal, whereas selective absence of the type 2-form reduces the adult lifespan of the fly and causes developmental abnormalities in male genitalia. Methodology/Principal Findings: Out of 7004-7979 transcripts expressed in the four sample groups, 5587 (70-79%) were found in all four tissues and strains. Here, we investigated the role of Btk29A type 2 on a transcriptomic level in larval CNS and adult heads. We used samples either selectively defective in Btk29A type 2 (Btk29A(ficP)) or revertant flies with restored Btk29A type 2-function (Btk29A((fic Exc1-16))). The whole transcriptomic profile for the different sample groups revealed Gene Ontology patterns reflecting lifespan abnormalities in adult head neuronal tissue, but not in larvae. Conclusions: In the Btk29A type 2-deficient strains there was no significant overlap between transcriptomic alterations in adult heads and larvae neuronal tissue, respectively. Moreover, there was no significant overlap of the transcriptomic changes between flies and mammals, suggesting that the evolutionary conservation is confined to components of the proximal signaling, whereas the corresponding, downstream transcriptional regulation has been differentially wired.	[Nawaz, Hossain M.; Smith, C. I. Edvard] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Clin Res Ctr, Stockholm, Sweden; [Kylsten, Per] Europaskolan, Strangnas, Sweden; [Hamada, Noriko; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan; [Lindvall, Jessica M.] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Lindvall, Jessica M.] BioinformaticServ, Saltsjobaden, Sweden	Karolinska Institutet; Karolinska University Hospital; Tohoku University; Karolinska Institutet; Karolinska University Hospital	Lindvall, JM (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Lab Med,Clin Res Ctr, Stockholm, Sweden.	jessica.lindvall@ki.se	Lindvall, Jessica M/A-1762-2013	SMITH, C. I. Edvard/0000-0003-1907-3392; Lindvall, Jessica/0000-0002-5042-8481; , Daisuke/0000-0002-4623-0106	Swedish Cancer Society; Torsten and Ragnar Soderberg Foundation	Swedish Cancer Society(Swedish Cancer Society); Torsten and Ragnar Soderberg Foundation	This work was supported by the Swedish Cancer Society and the Torsten and Ragnar Soderberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; Baba K, 1999, MOL CELL BIOL, V19, P4405; Bina S, 2010, EMBO REP, V11, P201, DOI 10.1038/embor.2010.1; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; CAMPANA D, 1990, J IMMUNOL, V145, P1675; Chandrasekaran V, 2005, DEVELOPMENT, V132, P3515, DOI 10.1242/dev.01926; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHOU TB, 1992, GENETICS, V131, P643; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Guarnieri DJ, 1998, MOL CELL, V1, P831, DOI 10.1016/S1097-2765(00)80082-9; Hamada N, 2005, FEBS LETT, V579, P4131, DOI 10.1016/j.febslet.2005.06.042; Hicks JK, 2007, EUKARYOT CELL, V6, P413, DOI 10.1128/EC.00213-06; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Islam TC, 2000, J GENE MED, V2, P204; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lindvall JM, 2006, BIOCHEM BIOPH RES CO, V346, P461, DOI 10.1016/j.bbrc.2006.05.146; Lindvall JM, 2004, EUR J IMMUNOL, V34, P1981, DOI 10.1002/eji.200324051; Liu CH, 2011, J IMMUNOL, V187, P230, DOI 10.4049/jimmunol.1100157; Lu N, 2004, EMBO J, V23, P1089, DOI 10.1038/sj.emboj.7600127; Monroe JG, 2007, ADV IMMUNOL, V95, P1, DOI 10.1016/S0065-2776(07)95001-4; Mukhopadhyay S, 2001, J CELL BIOCHEM, V81, P659, DOI 10.1002/jcb.1088; Noordzij JG, 2002, PEDIATR RES, V51, P159, DOI 10.1203/00006450-200202000-00007; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Ortutay C, 2008, ADV GENET, V64, P51, DOI 10.1016/S0065-2660(08)00803-1; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Roulier EM, 1998, MOL CELL, V1, P819, DOI 10.1016/S1097-2765(00)80081-7; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Tateno M, 2000, SCIENCE, V287, P324, DOI 10.1126/science.287.5451.324; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Thomas JH, 2004, DEVELOPMENT, V131, P863, DOI 10.1242/dev.00989; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Uckun FM, 1998, BIOCHEM PHARMACOL, V56, P683, DOI 10.1016/S0006-2952(98)00122-1; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yeh BJ, 2007, NATURE, V447, P596, DOI 10.1038/nature05851	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35640	10.1371/journal.pone.0035640	http://dx.doi.org/10.1371/journal.pone.0035640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574122	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800018
J	Ventoso, I; Kochetov, A; Montaner, D; Dopazo, J; Santoyo, J				Ventoso, Ivan; Kochetov, Alex; Montaner, David; Dopazo, Joaquin; Santoyo, Javier			Extensive Translatome Remodeling during ER Stress Response in Mammalian Cells	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; UNFOLDED PROTEIN RESPONSE; INDUCED GENE-EXPRESSION; RIBOSOME ENTRY SITES; GENOME-WIDE ANALYSIS; SECONDARY STRUCTURE; 5'-UNTRANSLATED REGION; EUKARYOTIC RIBOSOMES; INTERNAL INITIATION; IN-VIVO	In this work we have described the translatome of two mammalian cell lines, NIH3T3 and Jurkat, by scoring the relative polysome association of similar to 10,000 mRNA under normal and ER stress conditions. We have found that translation efficiencies of mRNA correlated poorly with transcript abundance, although a general tendency was observed so that the highest translation efficiencies were found in abundant mRNA. Despite the differences found between mouse (NIH3T3) and human (Jurkat) cells, both cell types share a common translatome composed by similar to 800-900 mRNA that encode proteins involved in basic cellular functions. Upon stress, an extensive remodeling in translatomes was observed so that translation of similar to 50% of mRNA was inhibited in both cell types, this effect being more dramatic for those mRNA that accounted for most of the cell translation. Interestingly, we found two subsets comprising 1000-1500 mRNA whose translation resisted or was induced by stress. Translation arrest resistant class includes many mRNA encoding aminoacyl tRNA synthetases, ATPases and enzymes involved in DNA replication and stress response such as BiP. This class of mRNA is characterized by high translation rates in both control and stress conditions. Translation inducible class includes mRNA whose translation was relieved after stress, showing a high enrichment in early response transcription factors of bZIP and zinc finger C2H2 classes. Unlike yeast, a general coordination between changes in translation and transcription upon stress (potentiation) was not observed in mammalian cells. Among the different features of mRNA analyzed, we found a relevant association of translation efficiency with the presence of upstream ATG in the 5'UTR and with the length of coding sequence of mRNA, and a looser association with other parameters such as the length and the G+C content of 5'UTR. A model for translatome remodeling during the acute phase of stress response in mammalian cells is proposed.	[Ventoso, Ivan] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Ventoso, Ivan] Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid, Spain; [Montaner, David; Dopazo, Joaquin; Santoyo, Javier] CIPF, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin; Santoyo, Javier] ISCIII, CIBERER, Valencia, Spain; [Dopazo, Joaquin] CIPF, Funct Genom Node INB, Valencia, Spain; [Kochetov, Alex] Inst Cytol & Genet, Novosibirsk, Russia	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Prince Felipe Research Center; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Ventoso, I (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain.	iventoso@cbm.uam.es	Ventoso, Iván/N-4018-2014; Kochetov, Alex/R-9689-2016; Santoyo-Lopez, Javier/C-9714-2012; Dopazo, Joaquin/A-9270-2014; Montaner, David/A-9362-2014	Ventoso, Iván/0000-0001-7887-3520; Kochetov, Alex/0000-0003-3151-5181; Santoyo-Lopez, Javier/0000-0003-1988-5059; Dopazo, Joaquin/0000-0003-3318-120X; Montaner, David/0000-0002-2484-3278	Fundacion Mutua Madrilena [BFU2010-17411]; Ministerio de Ciencia e Innovacion [BIO2008-04212]; Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER) [PROMETEO/2010/001]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion [RD06/0020/1019]; Russian Academy of Sciences; Russian Ministry of Science Education; SD RAS Complex Integration Program; RFBR [12-04-00686]; Russian Ministry of Science Education [02.740.11.0705]; RAS (Molecular and Cellular Biology); SD RAS Partner Integration Program;  [BFBR811-04-00471]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion; Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Science Education(Ministry of Education and Science, Russian Federation); SD RAS Complex Integration Program; RFBR(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Science Education(Ministry of Education and Science, Russian Federation); RAS (Molecular and Cellular Biology); SD RAS Partner Integration Program; 	This work was supported by grants of the Fundacion Mutua Madrilena (FMM2008), BFU2010-17411 and BIO2008-04212 from the Ministerio de Ciencia e Innovacion and PROMETEO/2010/001 from the Generalitat Valenciana-Fondo Europeo Desarrollo Regional (GVA-FEDER). The Centro de Investigacion Biomedica en Red (CIBER) de Enfermedades Raras is an initiative of the Instituto de Salud carlos III (ISCIII). This work was also partly supported by a grant (RD06/0020/1019) from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovacion. AK was supported by BFBR811-04-00471, the Programme of Russian Academy of Sciences, Russian Ministry of Science & Education and SD RAS Complex Integration Program. AK is grateful to RFBR (12-04-00686), Russian Ministry of Science & Education (02.740.11.0705), Program of RAS (Molecular and Cellular Biology) and SD RAS Partner Integration Program for support. Institutional support from the Fundacion Ramon Areces is also acknowledged. Completion of this project took about 1 year and the estimated cost was 5,000 (sic) excluding salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Baranick BT, 2008, P NATL ACAD SCI USA, V105, P4733, DOI 10.1073/pnas.0710650105; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Do AND, 2009, PHYSIOL GENOMICS, V38, P328, DOI 10.1152/physiolgenomics.90396.2008; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fountoulakis M, 2004, J CHROMATOGR A, V1038, P247, DOI 10.1016/j.chroma.2004.03.032; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gulow K, 2002, J CELL SCI, V115, P2443; Gundacker N, 2006, ELECTROPHORESIS, V27, P2712, DOI 10.1002/elps.200500964; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halbeisen RE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000105; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jackson RJ, 2005, BIOCHEM SOC T, V33, P1231, DOI 10.1042/BST0331231; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kimball SR, 2010, J BIOL CHEM, V285, P29027, DOI 10.1074/jbc.R110.137208; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lasko P, 2003, DEV CELL, V5, P671, DOI 10.1016/S1534-5807(03)00333-2; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM; Parsyan A, 2009, P NATL ACAD SCI USA, V106, P22217, DOI 10.1073/pnas.0909773106; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Robbins-Pianka A, 2010, BIOINFORMATICS, V26, P2651, DOI 10.1093/bioinformatics/btq509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sehgal A, 2000, ONCOGENE, V19, P2836, DOI 10.1038/sj.onc.1203601; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spence J, 2006, MOL CANCER RES, V4, P47, DOI 10.1158/1541-7786.MCR-04-0187; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Sudhakar A, 2000, BIOCHEMISTRY-US, V39, P12929, DOI 10.1021/bi0008682; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Traxler E, 2004, PROTEOMICS, V4, P1314, DOI 10.1002/pmic.200300774; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Watatani Y, 2008, J BIOL CHEM, V283, P2543, DOI 10.1074/jbc.M707781200; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071; Wu L, 2007, MOL CELL PROTEOMICS, V6, P1343, DOI 10.1074/mcp.M700017-MCP200; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	83	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35915	10.1371/journal.pone.0035915	http://dx.doi.org/10.1371/journal.pone.0035915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574127	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800023
J	Franck, E; Bonneau, C; Jean, L; Henry, JP; Lacoume, Y; Salvetti, A; Boyer, O; Adriouch, S				Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Henry, Jean-Paul; Lacoume, Yann; Salvetti, Anna; Boyer, Olivier; Adriouch, Sahil			Immunological Tolerance to Muscle Autoantigens Involves Peripheral Deletion of Autoreactive CD8(+) T Cells	PLOS ONE			English	Article							IDIOPATHIC INFLAMMATORY MYOPATHIES; CLASS-I; DENDRITIC CELLS; SELF-ANTIGENS; CROSS-PRESENTATION; EXPRESSION; INDUCTION; CTLA-4; PD-1; AUTOIMMUNITY	Muscle potentially represents the most abundant source of autoantigens of the body and can be targeted by a variety of severe autoimmune diseases. Yet, the mechanisms of immunological tolerance toward muscle autoantigens remain mostly unknown. We investigated this issue in transgenic SM-Ova mice that express an ovalbumin (Ova) neo-autoantigen specifically in skeletal muscle. We previously reported that antigen specific CD4(+) T cell are immunologically ignorant to endogenous Ova in this model but can be stimulated upon immunization. In contrast, Ova-specific CD8(+) T cells were suspected to be either unresponsive to Ova challenge or functionally defective. We now extend our investigations on the mechanisms governing CD8(+) tolerance in SM-Ova mice. We show herein that Ova-specific CD8(+) T cells are not detected upon challenge with strongly immunogenic Ova vaccines even after depletion of regulatory T cells. Ova-specific CD8(+) T cells from OT-I mice adoptively transferred to SM-Ova mice started to proliferate in vivo, acquired CD69 and PD-1 but subsequently down-regulated Bcl-2 and disappeared from the periphery, suggesting a mechanism of peripheral deletion. Peripheral deletion of endogenous Ova-specific cells was formally demonstrated in chimeric SM-Ova mice engrafted with bone marrow cells containing T cell precursors from OT-I TCR-transgenic mice. Thus, the present findings demonstrate that immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8(+) T cells.	[Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Boyer, Olivier; Adriouch, Sahil] INSERM, U905, Rouen, France; [Franck, Emilie; Bonneau, Carole; Jean, Laetitia; Henry, Jean-Paul; Lacoume, Yann; Boyer, Olivier; Adriouch, Sahil] Univ Rouen, IRIB, Normandy, France; [Henry, Jean-Paul] INSERM, U1096, Rouen, France; [Salvetti, Anna] Ecole Normale Super Lyon ENS, INSERM, U758, Lyon, France; [Boyer, Olivier] Rouen Univ Hosp, Dept Immunol, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen	Franck, E (corresponding author), INSERM, U905, Rouen, France.	olivier.boyer@chu-rouen.fr; sahil.adriouch@univ-rouen.fr	Boyer, Olivier/N-6552-2013; Salvetti, Anna/I-6204-2016; ADRIOUCH, Sahil/G-8999-2012; Salvetti, Anna/F-9560-2013	Boyer, Olivier/0000-0002-7591-307X; ADRIOUCH, Sahil/0000-0002-0265-7773; Salvetti, Anna/0000-0003-2007-8350	"Association Francaise contre les Myopathies" (AFM); "Institut National de la Sante Et de la Recherche Medicale" (INSERM); Region Haute-Normandie	"Association Francaise contre les Myopathies" (AFM)(Association Francaise contre les Myopathies); "Institut National de la Sante Et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Haute-Normandie(Region Normandie)	This study was funded by the "Association Francaise contre les Myopathies" (AFM). E. F. was the recipient of a joint Ph.D. fellowship from "Institut National de la Sante Et de la Recherche Medicale" (INSERM) and "Region Haute-Normandie". No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriouch S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00199; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BENDER A, 1995, J EXP MED, V181, P1863, DOI 10.1084/jem.181.5.1863; Benveniste O, 2001, J IMMUNOL, V167, P3521, DOI 10.4049/jimmunol.167.6.3521; Berzins SP, 1998, J EXP MED, V187, P1839, DOI 10.1084/jem.187.11.1839; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Calbo S, 2008, J IMMUNOL, V181, P408, DOI 10.4049/jimmunol.181.1.408; Cox S, 2010, INT J RHEUM DIS, V13, P117, DOI 10.1111/j.1756-185X.2010.01472.x; Dalakas MC, 2010, CURR OPIN PHARMACOL, V10, P346, DOI 10.1016/j.coph.2010.03.001; Dalakas MC, 2010, NAT REV RHEUMATOL, V6, P129, DOI 10.1038/nrrheum.2010.2; EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freitas AA, 1996, EUR J IMMUNOL, V26, P2640, DOI 10.1002/eji.1830261115; GOEBELS N, 1992, J IMMUNOL, V149, P661; Haverkamp JM, 2011, PROSTATE, V71, P1139, DOI 10.1002/pros.21327; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 2001, J IMMUNOL, V166, P1439, DOI 10.4049/jimmunol.166.3.1439; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Leitao C, 2009, J IMMUNOL, V182, P5232, DOI 10.4049/jimmunol.0804071; Lutz MB, 2009, EUR J IMMUNOL, V39, P2325, DOI 10.1002/eji.200939548; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; MCDOUALL RM, 1989, J NEUROL SCI, V89, P213, DOI 10.1016/0022-510X(89)90023-3; Miller JFAP, 1998, IMMUNOL REV, V165, P267, DOI 10.1111/j.1600-065X.1998.tb01244.x; Murata K, 1999, AM J PATHOL, V155, P453, DOI 10.1016/S0002-9440(10)65141-3; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Rowe HM, 2006, MOL THER, V13, P310, DOI 10.1016/j.ymthe.2005.08.025; Shibaki A, 2004, J INVEST DERMATOL, V123, P109, DOI 10.1111/j.0022-202X.2004.22701.x; van der Pas J, 2004, J NEUROL NEUROSUR PS, V75, P136; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wang LX, 2005, BLOOD, V105, P4226, DOI 10.1182/blood-2004-03-0848; Wiendl H, 2003, FASEB J, V17, P1892, DOI 10.1096/fj.03-0039fje; Williams MB, 1997, J IMMUNOL, V159, P1746	37	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36444	10.1371/journal.pone.0036444	http://dx.doi.org/10.1371/journal.pone.0036444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570714	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400030
J	Khanna, RC; Pallerla, SR; Eeda, SS; Gudapati, BK; Cassard, SD; Rani, PK; Shantha, GPS; Chakrabarti, S; Schein, OD				Khanna, Rohit C.; Pallerla, Srinivasa Reddy; Eeda, Shiva Shankar; Gudapati, Bala Krishna; Cassard, Sandra D.; Rani, Padmaja Kumari; Shantha, Ghanshyam Palamaner Subash; Chakrabarti, Subhabrata; Schein, Oliver D.			Population Based Outcomes of Cataract Surgery in Three Tribal Areas of Andhra Pradesh, India: Risk Factors for Poor Outcomes	PLOS ONE			English	Article							EYE SURVEY; VISUAL OUTCOMES; OLDER ADULTS; BLINDNESS; DISTRICT; PREVALENCE; ACUITY; NEPAL	Purpose: To report visual outcomes and risk factors for poor outcomes of cataract surgery in three Integrated Tribal Development Agency (ITDA) areas of Andhra Pradesh, India. Methods and Results: Using validated Rapid Assessment of Avoidable Blindness (RAAB) methodology, a population based cross-sectional study, was conducted in three ITDA areas. A two-stage sampling procedure was used to select 7281 participants aged 50 years and above. Vision assessment using a tumbling E chart and standard ocular examinations were completed. Visual outcomes and risk factors for poor outcomes were assessed among subjects undergoing cataract surgery (1548 eyes of 1124 subjects). Mean age at surgery was 67+/-68 years; Among the operated eyes, presenting visual acuity (PVA) and best corrected visual acuity (BCVA) worse than 6/18 was seen in 492 (31.8%; 95% CI, 29.5-34.2%) and 298 eyes (19.3%; 95% CI, 17.3-21.3%), respectively. Similarly, PVA and BCVA worse than 6/60 was seen in 219 (14.1%; 95% CI, 12.4-16%) and 147 eyes (9.5%; 95% CI, 8.1-11.1%), respectively. When either eye was taken into consideration, the PVA and BCVA worse than 6/18 was seen in 323 (20.1%; 95% CI, 18.9-23%) and 144 subjects (9.3%; 95% CI, 7.9-10.9%), respectively. PVA and BCVA worse than 6/60 was seen in 74 (4.8%; 95% CI, 3.8-6%) and 49 subjects (3.2%; 95% CI, 2.4-4.2%), respectively. Posterior capsular opacification was seen in 51 of 1316 pseudophakic eyes (3.9%; 95% CI, 2.9-5.1%). In multivariable analysis among pseudophakic subjects with PVA worse than 6/18, increasing age (p = 0.002) and undergoing free surgery (p = 0.05) were independent risk factors. Undergoing surgery before 2005 (p = 0.05) and being illiterate (p = 0.05) were independent risk factors for BCVA worse than 6/18. Conclusions: There are changing trends with improved outcomes in cataract surgery among these tribal populations of India. However, post-operative refractive error correction remains an issue, especially for those undergoing free surgeries.	[Khanna, Rohit C.; Rani, Padmaja Kumari; Chakrabarti, Subhabrata] LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Hyderabad, Andhra Pradesh, India; [Khanna, Rohit C.; Rani, Padmaja Kumari] LV Prasad Eye Inst, Int Ctr Adv Rural Eyecare, Community Eye Hlth, Allen Foster Res Ctr, Hyderabad, Andhra Pradesh, India; [Pallerla, Srinivasa Reddy; Eeda, Shiva Shankar; Gudapati, Bala Krishna] Andhra Pradesh Right Sight Soc, Hyderabad, Andhra Pradesh, India; [Cassard, Sandra D.; Schein, Oliver D.] Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; [Shantha, Ghanshyam Palamaner Subash; Schein, Oliver D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Khanna, RC (corresponding author), LV Prasad Eye Inst, Brien Holden Eye Res Ctr, Banjara Hills, Hyderabad, Andhra Pradesh, India.	rohit@lvpei.org	pallerla, srinivasa r/F-4575-2014; Chakrabarti, Subhabrata/F-2468-2015	pallerla, srinivasa r/0000-0001-9126-1676; Chakrabarti, Subhabrata/0000-0003-3717-4963	Department for International Development (DFID) UK	Department for International Development (DFID) UK	Funding for conducting the study was received from Department for International Development (DFID) UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angra SK, 1997, INDIAN J MED RES, V106, P312; Baranano AE, 2008, OPHTHALMOLOGY, V115, P815, DOI 10.1016/j.ophtha.2007.05.052; Dandona L, 2003, CLIN EXP OPHTHALMOL, V31, P23, DOI 10.1046/j.1442-9071.2003.00595.x; Dandona L, 1999, AM J OPHTHALMOL, V127, P650, DOI 10.1016/S0002-9394(99)00044-6; Dua AS, 2005, NATL PROGRAMME CONTR, P299; GLYNN RJ, 1992, ARCH OPHTHALMOL-CHIC, V110, P381, DOI 10.1001/archopht.1992.01080150079033; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Jose R, 1995, Indian J Ophthalmol, V43, P35; Kandel RP, 2010, OPHTHAL EPIDEMIOL, V17, P276, DOI 10.3109/09286586.2010.508355; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lau J, 2002, BRIT J OPHTHALMOL, V86, P12, DOI 10.1136/bjo.86.1.12; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Murthy GVS, 2009, OPHTHAL EPIDEMIOL, V16, P400, DOI 10.3109/09286580903315809; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P686, DOI 10.1016/S0161-6420(00)00578-9; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Park K., 2007, TXB PREVENTIVE SOCIA; Sapkota YD, 2010, OPHTHAL EPIDEMIOL, V17, P82, DOI 10.3109/09286581003624947; StataCorp, 2009, STAT STAT SOFTW REL; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P313, DOI 10.1076/opep.9.5.313.10339; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Vijaya L, 2010, INDIAN J OPHTHALMOL, V58, P223, DOI 10.4103/0301-4738.62648; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	24	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35701	10.1371/journal.pone.0035701	http://dx.doi.org/10.1371/journal.pone.0035701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567108	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500026
J	Nzeduru, CV; Ronca, S; Wilkinson, MJ				Nzeduru, Chinyere V.; Ronca, Sandra; Wilkinson, Mike J.			DNA Barcoding Simplifies Environmental Risk Assessment of Genetically Modified Crops in Biodiverse Regions	PLOS ONE			English	Article							COWPEA VIGNA-UNGUICULATA; TRANSGENIC CROPS; NONTARGET; NIGERIA; WALP.; FOOD	Transgenes encoding for insecticidal crystal (Cry) proteins from the soil-dwelling bacterium Bacillus Thuringiensis have been widely introduced into Genetically Modified (GM) crops to confer protection against insect pests. Concern that these transgenes may also harm beneficial or otherwise valued insects (so-called Non Target Organisms, NTOs) represents a major element of the Environmental Risk Assessments (ERAs) used by all countries prior to commercial release. Compiling a comprehensive list of potentially susceptible NTOs is therefore a necessary part of an ERA for any Cry toxin-containing GM crop. In partly-characterised and biodiverse countries, NTO identification is slowed by the need for taxonomic expertise and time to enable morphological identifications. This limitation represents a potentially serious barrier to timely adoption of GM technology in some developing countries. We consider Bt Cry1A cowpea (Vigna unguiculata) in Nigeria as an exemplar to demonstrate how COI barcoding can provide a simple and cost-effective means of addressing this problem. Over a period of eight weeks, we collected 163 insects from cowpea flowers across the agroecological and geographic range of the crop in Nigeria. These individuals included 32 Operational Taxonomic Units (OTUs) spanning four Orders and that could mostly be assigned to genus or species level. They included 12 Lepidopterans and two Coleopterans (both potentially sensitive to different groups of Cry proteins). Thus, barcode-assisted diagnoses were highly harmonised across groups (typically to genus or species level) and so were insensitive to expertise or knowledge gaps. Decisively, the entire study was completed within four months at a cost of less than 10,000 US$. The broader implications of the findings for food security and the capacity for safe adoption of GM technology are briefly explored.	[Nzeduru, Chinyere V.] Fed Minist Environm, Dept Forestry, Biosafety Unit, Abuja, Nigeria; [Ronca, Sandra; Wilkinson, Mike J.] Aberystwyth Univ, Insitute Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales	Aberystwyth University	Nzeduru, CV (corresponding author), Fed Minist Environm, Dept Forestry, Biosafety Unit, Abuja, Nigeria.	Mike.Wilkinson@Adelaide.edu.au		Wilkinson, Michael/0000-0002-9881-6993	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The work was part of an M.Sc. dissertation. The scholarship to attend the course and consumables pent during its execution was funded by the Bill & Melinda Gates Foundation. The foundation requested to see the manuscript prior to submission via [Grantee.Comms@gatesfoundation.org] but did not change the manuscript in any way. They were not involved in its design or writing. Thus, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesoye A, 2008, AFR J BIOTECHNOL, V7, P3200; Agbonlahor M. U., 2009, Journal of Human Ecology, V25, P25; Aliyu B, 2007, EUPHYTICA, V155, P295, DOI 10.1007/s10681-006-9331-0; Anderson K, 2010, NEW BIOTECHNOL, V27, P558, DOI 10.1016/j.nbt.2010.05.012; Asiwe JAN, 2009, AFR J BIOTECHNOL, V8, P226; Ayanwale BA, 2002, ISSUES AFRICAN RURAL, V21; Bull SE, 2011, PLANT CELL REP, V30, P779, DOI 10.1007/s00299-010-0986-6; Delmer DP, 2005, P NATL ACAD SCI USA, V102, P15739, DOI 10.1073/pnas.0505895102; Dias FMS, 2010, NEOTROP ENTOMOL, V39, P1044, DOI 10.1590/S1519-566X2010000600030; Ellard S, 2009, PRACTICE GUIDELINES; Ferry N, 2006, TRANSGENIC RES, V15, P501, DOI 10.1007/s11248-006-0021-4; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heinrichs E. A, 1994, BIOL MANAGEMENT RICE; Hordzi W. H. K., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P4880; Ivo NL, 2008, PLANT CELL REP, V27, P1475, DOI 10.1007/s00299-008-0573-2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knecht S, 2010, BASIC APPL ECOL, V11, P346, DOI 10.1016/j.baae.2010.02.010; Langyintuo A. S., 2006, AgBioForum, V9, P111; Larsen TB, 2011, IUCN 2011 IUCN RED L; Machuka J, 1999, ENTOMOL EXP APPL, V93, P179, DOI 10.1023/A:1003801120192; Mahalakshmi V., 2007, Plant Genetic Resources Characterization and Utilization, V5, P113, DOI 10.1017/S1479262107837166; Manyong V., 2005, FARMERSPERCEPTIONS B; Nieto A, 2010, IUCN 2011 IUCN RED L; Odey J, 2010, CBD 4 NATL REPORT AB; Olaniyan S.A., 2007, ESTUD BIOL, V29; Olumukoro JO, 2007, AFR ZOOL, V42, P1; Popelka JC, 2004, PLANT SCI, V167, P195, DOI 10.1016/j.plantsci.2004.03.027; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Raybould A, 2005, BIOL SCI SER, P169; Raybould A, 2010, FOOD SECUR, V2, P247, DOI 10.1007/s12571-010-0066-3; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2009, J APPL ENTOMOL, V133, P571, DOI 10.1111/j.1439-0418.2009.01423.x; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Roy DB, 2003, PHILOS T ROY SOC B, V358, P1879, DOI 10.1098/rstb.2003.1404; Sanchis V, 2011, AGRON SUSTAIN DEV, V31, P217, DOI 10.1051/agro/2010027; SANGER F, 1977, NATURE, V265, P687, DOI 10.1038/265687a0; Singh BB, 2003, FIELD CROP RES, V84, P169, DOI 10.1016/S0378-4290(03)00148-5; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Then C, 2010, ENVIRON SCI POLLUT R, V17, P791, DOI 10.1007/s11356-009-0208-3; Thomson JA, 2008, PHILOS T R SOC B, V363, P905, DOI 10.1098/rstb.2007.2191; VAILLANCOURT RE, 1992, AM J BOT, V79, P1194, DOI 10.2307/2445219; van Swaay C, 2010, IUCN 2011 IUCN RED L; Virgilio M, 2009, MOL PHYLOGENET EVOL, V51, P531, DOI 10.1016/j.ympev.2009.01.003; World Conservation Monitoring Centre, 1996, IUCN 2011 IUCN RED L; Yu HL, 2011, J INTEGR PLANT BIOL, V53, P520, DOI 10.1111/j.1744-7909.2011.01047.x	46	1	2	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35929	10.1371/journal.pone.0035929	http://dx.doi.org/10.1371/journal.pone.0035929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567120	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500038
J	Martino, L; Masini, M; Novelli, M; Beffy, P; Bugliani, M; Marselli, L; Masiello, P; Marchetti, P; De Tata, V				Martino, Luisa; Masini, Matilde; Novelli, Michela; Beffy, Pascale; Bugliani, Marco; Marselli, Lorella; Masiello, Pellegrino; Marchetti, Piero; De Tata, Vincenzo			Palmitate Activates Autophagy in INS-1E beta-Cells and in Isolated Rat and Human Pancreatic Islets	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FREE FATTY-ACIDS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; LIPID-METABOLISM; MAMMALIAN-CELLS; SELF-DIGESTION; DEATH; APOPTOSIS; DISEASE	We have investigated the in vitro effects of increased levels of glucose and free fatty acids on autophagy activation in pancreatic beta cells. INS-1E cells and isolated rat and human pancreatic islets were incubated for various times (from 2 to 24 h) at different concentrations of glucose and/or palmitic acid. Then, cell survival was evaluated and autophagy activation was explored by using various biochemical and morphological techniques. In INS-1E cells as well as in rat and human islets, 0.5 and 1.0 mM palmitate markedly increased autophagic vacuole formation, whereas high glucose was ineffective alone and caused little additional change when combined with palmitate. Furthermore, LC3-II immunofluorescence co-localized with that of cathepsin D, a lysosomal marker, showing that the autophagic flux was not hampered in PA-treated cells. These effects were maintained up to 18-24 h incubation and were associated with a significant decline of cell survival correlated with both palmitate concentration and incubation time. Ultrastructural analysis showed that autophagy activation, as evidenced by the occurrence of many autophagic vacuoles in the cytoplasm of beta cells, was associated with a diffuse and remarkable swelling of the endoplasmic reticulum. Our results indicate that among the metabolic alterations typically associated with type 2 diabetes, high free fatty acids levels could play a role in the activation of autophagy in beta cells, through a mechanism that might involve the induction of endoplasmic reticulum stress.	[Martino, Luisa; Masini, Matilde; Novelli, Michela; Masiello, Pellegrino; De Tata, Vincenzo] Univ Pisa, Dept Expt Pathol, Pisa, Italy; [Beffy, Pascale] Univ Pisa, Inst Clin Physiol, CNR, Pisa, Italy; [Bugliani, Marco; Marselli, Lorella; Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa; University of Pisa	Martino, L (corresponding author), Univ Pisa, Dept Expt Pathol, Pisa, Italy.	vincenzo.detata@med.unipi.it	Marchetti, Piero/J-7439-2013; Bugliani, Marco/I-3168-2019	Marchetti, Piero/0000-0003-4907-0635; Bugliani, Marco/0000-0002-1744-1561; Marselli, Lorella/0000-0002-6698-2962	Innovative Medicines Initiative Joint Undertaking [155005]; European Union; EFPIA companies	Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA companies	The work leading to this publication has been supported in part by the Innovative Medicines Initiative Joint Undertaking under grant agreement no 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002182; Bergamini Ettore, 2006, Molecular Aspects of Medicine, V27, P403, DOI 10.1016/j.mam.2006.08.001; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Choi SE, 2009, ENDOCRINOLOGY, V150, P126, DOI 10.1210/en.2008-0483; Cnop M, 2010, DIABETES OBES METAB, V12, P76, DOI 10.1111/j.1463-1326.2010.01279.x; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Czaja MJ, 2011, GASTROENTEROLOGY, V140, P1895, DOI 10.1053/j.gastro.2011.04.038; Czaja MJ, 2009, AUTOPHAGY, V5, P866, DOI 10.4161/auto.9040; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gump JM, 2011, TRENDS CELL BIOL, V21, P387, DOI 10.1016/j.tcb.2011.03.007; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hwang SL, 2012, BIOCHEM BIOPH RES CO, V418, P402, DOI 10.1016/j.bbrc.2012.01.038; Ito S, 2007, INT J ONCOL, V31, P261; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kadowaki Motoni, 2006, Molecular Aspects of Medicine, V27, P426, DOI 10.1016/j.mam.2006.08.010; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kaushik S, 2010, DIABETES OBES METAB, V12, P4, DOI 10.1111/j.1463-1326.2010.01263.x; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kovsan J, 2010, AM J PHYSIOL-ENDOC M, V298, pE1, DOI 10.1152/ajpendo.00562.2009; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Ladriere L, 2010, J CLIN ENDOCR METAB, V95, P1442, DOI 10.1210/jc.2009-2322; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marchetti P, 2008, REGUL PEPTIDES, V146, P4, DOI 10.1016/j.regpep.2007.08.017; Marsh BJ, 2007, MOL ENDOCRINOL, V21, P2255, DOI 10.1210/me.2007-0077; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Misler S, 2010, ISLETS, V2, P210, DOI 10.4161/isl.2.4.12156; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Novelli M, 2001, MOL CELL ENDOCRINOL, V175, P57, DOI 10.1016/S0303-7207(01)00400-2; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Poitout V, 1996, DIABETES METAB, V22, P7; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	71	98	99	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36188	10.1371/journal.pone.0036188	http://dx.doi.org/10.1371/journal.pone.0036188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563482	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700031
J	Nicklasson, M; Sjoling, A; von Mentzer, A; Qadri, F; Svennerholm, AM				Nicklasson, Matilda; Sjoling, Asa; von Mentzer, Astrid; Qadri, Firdausi; Svennerholm, Ann-Mari			Expression of Colonization Factor CS5 of Enterotoxigenic Escherichia coli (ETEC) Is Enhanced In Vivo and by the Bile Component Na Glycocholate Hydrate	PLOS ONE			English	Article							GM1-ENZYME-LINKED IMMUNOSORBENT-ASSAY; VIBRIO-CHOLERAE; VIRULENCE FACTORS; DIARRHEA; TOXIN; IDENTIFICATION; BANGLADESH; SECRETION; ANTIGENS; ADHESIN	Enterotoxigenic Escherichia coli (ETEC) is an important cause of acute watery diarrhoea in developing countries. Colonization factors (CFs) on the bacterial surface mediate adhesion to the small intestinal epithelium. Two of the most common CFs worldwide are coli surface antigens 5 and 6 (CS5, CS6). In this study we investigated the expression of CS5 and CS6 in vivo, and the effects of bile and sodium bicarbonate, present in the human gut, on the expression of CS5. Five CS5+ CS6 ETEC isolates from adult Bangladeshi patients with acute diarrhoea were studied. The level of transcription from the CS5 operon was approximately 100-fold higher than from the CS6 operon in ETEC bacteria recovered directly from diarrhoeal stool without sub-culturing (in vivo). The glyco-conjugated primary bile salt sodium glycocholate hydrate (NaGCH) induced phenotypic expression of CS5 in a dose-dependent manner and caused a 100-fold up-regulation of CS5 mRNA levels; this is the first description of NaGCH as an enteropathogenic virulence inducer. The relative transcription levels from the CS5 and CS6 operons in the presence of bile or NaGCH in vitro were similar to those in vivo. Another bile salt, sodium deoxycholate (NaDC), previously reported to induce enteropathogenic virulence, also induced expression of CS5, whereas sodium bicarbonate did not.	[Nicklasson, Matilda; Sjoling, Asa; von Mentzer, Astrid; Svennerholm, Ann-Mari] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh	University of Gothenburg; International Centre for Diarrhoeal Disease Research (ICDDR)	Nicklasson, M (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	matilda.nicklasson@microbio.gu.se	von Mentzer, Astrid/I-5449-2018; Qadri, Firdausi/AAF-4583-2019; Al, Mamun M./AAF-5850-2019	von Mentzer, Astrid/0000-0002-2167-1394; Sjoling, Asa/0000-0003-1529-1720	Swedish Agency for Research and Economic Cooperation (Sida-SAREC); Swedish International Development Agency [INT-ICDDR, B-HN-01-AV]; Swedish Research Council [16X-09084]; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation	Swedish Agency for Research and Economic Cooperation (Sida-SAREC); Swedish International Development Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission); International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Marianne and Marcus Wallenberg Foundation; Magnus Bergvall Foundation	This study was supported by the Swedish Agency for Research and Economic Cooperation (Sida-SAREC) and the Swedish International Development Agency (grants INT-ICDDR, B-HN-01-AV): www.sida.se; the Swedish Research Council (grant 16X-09084): www.vr.se; the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b): www.icddrb.org; the Marianne and Marcus Wallenberg Foundation: www.wallenberg.com; and the Magnus Bergvall Foundation: www.magnbergvallsstiftelse.nu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Abuaita BH, 2009, INFECT IMMUN, V77, P4111, DOI 10.1128/IAI.00409-09; Barrett K, 2010, GASTROINTESTINAL PHY; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bolin I, 2006, J CLIN MICROBIOL, V44, P3872, DOI 10.1128/JCM.00790-06; DEHAAN LAM, 1991, FEMS MICROBIOL LETT, V83, P341, DOI 10.1016/0378-1097(91)90499-Z; Duthy TG, 2002, J BACTERIOL, V184, P1065, DOI 10.1128/jb.184.4.1065-1077.2002; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Favre D, 2006, VACCINE, V24, P4354, DOI 10.1016/j.vaccine.2006.02.052; Gaastra W, 1996, TRENDS MICROBIOL, V4, P444, DOI 10.1016/0966-842X(96)10068-8; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; GREWAL HMS, 1994, J CLIN MICROBIOL, V32, P1295, DOI 10.1128/JCM.32.5.1295-1301.1994; Grewal HMS, 1997, INFECT IMMUN, V65, P507, DOI 10.1128/IAI.65.2.507-513.1997; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Lothigius A, 2007, J APPL MICROBIOL; Lunelli M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002163; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nicklasson M, 2008, MICROB PATHOGENESIS, V44, P246, DOI 10.1016/j.micpath.2007.06.009; Pichel M, 2000, INFECT IMMUN, V68, P3280, DOI 10.1128/IAI.68.6.3280-3285.2000; Qadri F, 2000, J CLIN MICROBIOL, V38, P27; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Qadri F, 2007, INFECT IMMUN, V75, P3961, DOI 10.1128/IAI.00459-07; Qadri F, 2007, INFECT IMMUN, V75, P2269, DOI 10.1128/IAI.01856-06; Rivera-Amill V, 2001, J INFECT DIS, V183, P1607, DOI 10.1086/320704; Sanchez J, 2005, CURR OPIN IMMUNOL, V17, P388, DOI 10.1016/j.coi.2005.06.007; Shaheen HI, 2004, J CLIN MICROBIOL, V42, P5588, DOI 10.1128/JCM.42.12.5588-5595.2004; Sjoling A, 2007, J CLIN MICROBIOL; Sjoling A, 2006, MICROBES INFECT, V8, P2797, DOI 10.1016/j.micinf.2006.08.011; Stensrud KF, 2008, J BIOL CHEM, V283, P18646, DOI 10.1074/jbc.M802799200; Svennerholm AM, 2004, BEST PRACT RES CL GA, V18, P421, DOI 10.1016/j.bpg.2003.11.004; SVENNERHOLM AM, 1986, J CLIN MICROBIOL, V24, P585, DOI 10.1128/JCM.24.4.585-590.1986; SVENNERHOLM AM, 1983, J CLIN MICROBIOL, V17, P596, DOI 10.1128/JCM.17.4.596-600.1983; Torres AG, 2007, CELL MICROBIOL, V9, P1039, DOI 10.1111/j.1462-5822.2006.00850.x; von Sonnenburg F, 2000, LANCET, V356, P133, DOI 10.1016/S0140-6736(00)02451-X; WHO, 1987, PROGR CONTR DIARRH D, P9; Willson FE, 1933, J AM PHARM ASSOC, P788; Wolf MK, 1997, FEMS MICROBIOL LETT, V148, P35, DOI 10.1016/S0378-1097(97)00009-8; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; World health organization, 1999, WEEKLY EPIDEMIOL REC, V13, P98	42	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e35827	10.1371/journal.pone.0035827	http://dx.doi.org/10.1371/journal.pone.0035827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22563407	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200023
J	Jeong, HW; Kim, JH; Kim, JY; Ha, SJ; Kong, YY				Jeong, Hyun-Woo; Kim, Ji-Hoon; Kim, Joo-Yeon; Ha, Sang-Jun; Kong, Young-Yun			Mind Bomb-1 in Dendritic Cells Is Specifically Required for Notch-mediated T Helper Type 2 Differentiation	PLOS ONE			English	Article							IFN-GAMMA; UP-REGULATION; IN-VIVO; ACTIVATION; RESPONSES; EXPRESSION; LIGANDS; GENE; HOMOLOG; LIGASE	In dendritic cell (DC)-CD4(+) T cell interaction, Notch signaling has been implicated in the CD4(+) T cell activation, proliferation, and subset differentiation. However, there has been a lot of debate on the exact role of Notch signaling. Here, we observed that expression of Mind bomb-1 (Mib1), a critical regulator of Notch ligands for the activation of Notch signaling, increases gradually as precursor cells differentiate into DCs in mice. To clarify the role of Mib1 in DC-CD4(+) T cell interactions, we generated Mib1-null bone marrow-derived DCs. These cells readily expressed Notch ligands but failed to initiate Notch activation in the adjacent cells. Nevertheless, Mib1-null DCs were able to prime the activation and proliferation of CD4(+) T cells, suggesting that Notch activation in CD4(+) T cells is not required for these processes. Intriguingly, stimulation of CD4(+) T cells with Mib1-null DCs resulted in dramatically diminished Th2 cell populations, while preserving Th1 cell populations, both in vitro and in vivo. Our results demonstrate that Mib1 in DCs is critical for the activation of Notch signaling in CD4(+) T cells, and Notch signaling reinforces Th2 differentiation, but is not required for the activation or proliferation of the CD4(+) T cells.	[Jeong, Hyun-Woo; Kim, Ji-Hoon; Kim, Joo-Yeon; Kong, Young-Yun] Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea; [Ha, Sang-Jun] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Seoul National University (SNU); Yonsei University	Jeong, HW (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul, South Korea.	ykong@snu.ac.kr		Jeong, Hyun-Woo/0000-0002-6976-6739; Ha, Sang-Jun/0000-0002-1192-6031	National Research Foundation of Korea [2011-0000309]; Korea Science and Engineering Foundation (KOSEF); Korea government (MOST) [2011-0019269]; Korean Government (MEST) [NRF-M1AXA002-2010-0029780, NRF-2011-355-C00079]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MOST)(Ministry of Science & Technology (MOST), Republic of KoreaKorean Government); Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the Basic Science Research Program through the National Research Foundation of Korea (2011-0000309); the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST) (2011-0019269); and the National Research Foundation of Korea Grant funded by the Korean Government (MEST) (NRF-M1AXA002-2010-0029780 and NRF-2011-355-C00079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Amsen D, 2009, NAT REV IMMUNOL, V9, P116, DOI 10.1038/nri2488; De Renzis S, 2006, DEV CELL, V10, P257, DOI 10.1016/j.devcel.2006.01.011; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Ito T, 2009, J CLIN INVEST, V119, P33, DOI 10.1172/JCI35647; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Kim YW, 2008, BLOOD, V112, P4628, DOI 10.1182/blood-2008-03-148999; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Koo BK, 2009, GASTROENTEROLOGY, V137, P145, DOI 10.1053/j.gastro.2009.03.046; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kostianovsky AM, 2007, J IMMUNOL, V178, P6158, DOI 10.4049/jimmunol.178.10.6158; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; MAGGI E, 1992, J IMMUNOL, V148, P2142; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Ostroukhova M, 2006, J CLIN INVEST, V116, P996, DOI 10.1172/JCI26490; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; SCOTT P, 1991, J IMMUNOL, V147, P3149; Song R, 2008, J EXP MED, V205, P2525, DOI 10.1084/jem.20081344; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Sun J, 2008, J IMMUNOL, V180, P1655, DOI 10.4049/jimmunol.180.3.1655; Tacchini-Cottier F, 2004, EUR J IMMUNOL, V34, P1588, DOI 10.1002/eji.200324337; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Yoon KJ, 2008, NEURON, V58, P519, DOI 10.1016/j.neuron.2008.03.018; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36359	10.1371/journal.pone.0036359	http://dx.doi.org/10.1371/journal.pone.0036359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558446	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000196
J	Martincova, E; Voleman, L; Najdrova, V; De Napoli, M; Eshar, S; Gualdron, M; Hopp, CS; Sanin, DE; Tembo, DL; Van Tyne, D; Walker, D; Marcincikova, M; Tachezy, J; Dolezal, P				Martincova, Eva; Voleman, Lubos; Najdrova, Vladimira; De Napoli, Maximiliano; Eshar, Shiri; Gualdron, Melisa; Hopp, Christine S.; Sanin, David E.; Tembo, Dumizulu L.; Van Tyne, Daria; Walker, Dawn; Marcincikova, Michaela; Tachezy, Jan; Dolezal, Pavel			Live Imaging of Mitosomes and Hydrogenosomes by HaloTag Technology	PLOS ONE			English	Article							PROTOZOAN GIARDIA-LAMBLIA; TRICHOMONAS-VAGINALIS; FLUORESCENT PROTEINS; FUSION PROTEINS; LIVING CELLS; INTESTINALIS; COMPLEX; TRANSFORMATION; CYTOSKELETON; MATURATION	Hydrogenosomes and mitosomes represent remarkable mitochondrial adaptations in the anaerobic parasitic protists such as Trichomonas vaginalis and Giardia intestinalis, respectively. In order to provide a tool to study these organelles in the live cells, the HaloTag was fused to G. intestinalis IscU and T. vaginalis frataxin and expressed in the mitosomes and hydrogenosomes, respectively. The incubation of the parasites with the fluorescent Halo-ligand resulted in highly specific organellar labeling, allowing live imaging of the organelles. With the array of available ligands the HaloTag technology offers a new tool to study the dynamics of mitochondria-related compartments as well as other cellular components in these intriguing unicellular eukaryotes.	[Martincova, Eva; Voleman, Lubos; Najdrova, Vladimira; Marcincikova, Michaela; Tachezy, Jan; Dolezal, Pavel] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [De Napoli, Maximiliano] CONICET UNSAM, IIB INTECH, Lab Parasitol Mol, Chascomus, Buenos Aires, Argentina; [Eshar, Shiri] Hebrew Univ Jerusalem, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IMRIC,Hadassah Med Sch, Jerusalem, Israel; [Gualdron, Melisa] Christian De Duve Inst Cellular Pathol, Brussels, Belgium; [Hopp, Christine S.] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England; [Sanin, David E.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Tembo, Dumizulu L.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Van Tyne, Daria] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Walker, Dawn] Integrated Biomed Sci Ctr Microbial Interface Bio, Dept Internal Med, Columbus, OH USA	Charles University Prague; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hebrew University of Jerusalem; University of London; London School of Hygiene & Tropical Medicine; University of York - UK; University of Malawi; Harvard University; Harvard T.H. Chan School of Public Health	Martincova, E (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	paveldolezal@yahoo.com	Gualdrón-López, Melisa/A-4438-2016; Najdrová, Vladimíra/R-4414-2017; Voleman, Luboš/M-8076-2017; Pyrihová, Eva/V-2088-2017; Tachezy, Jan/R-4945-2017; Sanin, David E/CAA-0391-2022; Sanin, David E/CAA-0373-2022; Dolezal, Pavel/V-1907-2017; Van Tyne, Daria/K-1251-2019	Gualdrón-López, Melisa/0000-0002-8202-6751; Najdrová, Vladimíra/0000-0002-1971-3882; Voleman, Luboš/0000-0003-0589-240X; Pyrihová, Eva/0000-0001-5611-1234; Tachezy, Jan/0000-0001-6976-8446; Sanin, David E/0000-0003-0188-7267; Sanin, David E/0000-0003-0188-7267; Dolezal, Pavel/0000-0003-1285-9026; Van Tyne, Daria/0000-0001-7284-0103; Hopp, Christine/0000-0002-0528-9531	Czech Science Agency [P305/10/0651, LC07032]; Ministry of Education of the Czech Republic MSM [0021620858]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; Wellcome Trust	Czech Science Agency; Ministry of Education of the Czech Republic MSM(Ministry of Education, Youth & Sports - Czech Republic); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wellcome Trust(Wellcome TrustEuropean Commission)	Funding was provided by grants from the Czech Science Agency P305/10/0651 and LC07032 and from the Ministry of Education of the Czech Republic MSM 0021620858 and from the funders of the Biology of Parasitism course in Woods Hole (Burroughs Wellcome Fund, Howard Hughes Medical Institute and Wellcome Trust). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Carpenter ML, 2009, EUKARYOT CELL, V8, P916, DOI 10.1128/EC.00041-09; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Dagley MJ, 2009, MOL BIOL EVOL, V26, P1941, DOI 10.1093/molbev/msp117; Davis-Hayman SR, 2002, MOL BIOCHEM PARASIT, V122, P1, DOI 10.1016/S0166-6851(02)00063-4; Dawson SC, 2010, METHOD CELL BIOL, V97, P307, DOI 10.1016/S0091-679X(10)97017-9; Delgadillo MG, 1997, P NATL ACAD SCI USA, V94, P4716, DOI 10.1073/pnas.94.9.4716; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2007, EUKARYOT CELL, V6, P1431, DOI 10.1128/EC.00027-07; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Elias EV, 2008, J BIOL CHEM, V283, P35996, DOI 10.1074/jbc.M806545200; Elmendorf HG, 2003, INT J PARASITOL, V33, P3, DOI 10.1016/S0020-7519(02)00228-X; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Gourguechon S, 2011, EUKARYOT CELL, V10, P142, DOI 10.1128/EC.00190-10; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hehl AB, 2004, MOL MICROBIOL, V53, P19, DOI 10.1111/j.1365-2958.2004.04115.x; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Konrad C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000835; Lauwaet T, 2007, MOL BIOCHEM PARASIT, V152, P80, DOI 10.1016/j.molbiopara.2006.12.001; Lloyd D, 2000, MICROBIOL-UK, V146, P3109, DOI 10.1099/00221287-146-12-3109; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Mukherjee M, 2006, EUKARYOT CELL, V5, P2062, DOI 10.1128/EC.00205-06; Paredez AR, 2011, P NATL ACAD SCI USA, V108, P6151, DOI 10.1073/pnas.1018593108; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Prucca CG, 2008, NATURE, V456, P750, DOI 10.1038/nature07585; Rada P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024428; Regoes A, 2005, BIOTECHNIQUES, V39, P809, DOI 10.2144/000112054; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shiflett AM, 2010, ANNU REV MICROBIOL, V64, P409, DOI 10.1146/annurev.micro.62.081307.162826; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Smith A, RES MICROBIOL, V162, P646; Smutna T, 2009, EUKARYOT CELL, V8, P47, DOI 10.1128/EC.00276-08; Stefanic S, 2009, J CELL SCI, V122, P2846, DOI 10.1242/jcs.049411; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Urh Marjeta, 2008, V421, P191; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wombacher R, 2011, J BIOPHOTONICS, V4, P391, DOI 10.1002/jbio.201100018; YU DC, 1995, MOL CELL BIOL, V15, P4867; Yu DC, 1996, MOL BIOCHEM PARASIT, V83, P81, DOI 10.1016/S0166-6851(96)02752-1	49	14	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36314	10.1371/journal.pone.0036314	http://dx.doi.org/10.1371/journal.pone.0036314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558433	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000188
J	Ekstrom, MP; Jogreus, C; Strom, KE				Ekstrom, Magnus P.; Jogreus, Claes; Strom, Kerstin E.			Comorbidity and Sex-Related Differences in Mortality in Oxygen-Dependent Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							PREDICT MORTALITY; CO-MORBIDITY; GENDER; SURVIVAL; THERAPY; DETERMINANTS; EMPHYSEMA; SEVERITY; OUTCOMES; MODELS	Background: It is not known why survival differs between men and women in oxygen-dependent chronic obstructive pulmonary disease (COPD). The present study evaluates differences in comorbidity between men and women, and tests the hypothesis that comorbidity contributes to sex-related differences in mortality in oxygen-dependent COPD. Methods: National prospective study of patients aged 50 years or older, starting long-term oxygen therapy (LTOT) for COPD in Sweden between 1992 and 2008. Comorbidities were obtained from the Swedish Hospital Discharge Register. Sex-related differences in comorbidity were estimated using logistic regression, adjusting for age, smoking status and year of inclusion. The effect of comorbidity on overall mortality and the interaction between comorbidity and sex were evaluated using Cox regression, adjusting for age, sex, Pa-O2 breathing air, FEV1, smoking history and year of inclusion. Results: In total, 8,712 patients (55% women) were included and 6,729 patients died during the study period. No patient was lost to follow-up. Compared with women, men had significantly more arrhythmia, cancer, ischemic heart disease and renal failure, and less hypertension, mental disorders, osteoporosis and rheumatoid arthritis (P<0.05 for all odds ratios). Comorbidity was an independent predictor of mortality, and the effect was similar for the sexes. Women had lower mortality, which remained unchanged even after adjusting for comorbidity; hazard ratio 0.73 (95% confidence interval, 0.68-0.77; P<0.001). Conclusions: Comorbidity is different in men and women, but does not explain the sex-related difference in mortality in oxygen-dependent COPD.	[Ekstrom, Magnus P.; Strom, Kerstin E.] Lund Univ, Dept Resp Med & Allergol, Inst Clin Sci, Lund, Sweden; [Jogreus, Claes] Blekinge Inst Technol, Dept Math & Sci, Sch Engn, Karlskrona, Sweden	Lund University; Blekinge Institute Technology	Ekstrom, MP (corresponding author), Lund Univ, Dept Resp Med & Allergol, Inst Clin Sci, Lund, Sweden.	pmekstrom@gmail.com		Ekstrom, Magnus/0000-0002-7227-5113	Swedish Heart and Lung Foundation; Swedish National Board of Health and Welfare; Research Council of Blekinge	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish National Board of Health and Welfare; Research Council of Blekinge	The study was supported by grants from the Swedish Heart and Lung Foundation (URL: http://www.hjart-lungfonden.se), the Swedish National Board of Health and Welfare (URL: http://www.socialstyrelsen.se), and the Research Council of Blekinge (http://www.ltblekinge.se/omlandstinget/blekingekompetenscentrum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro P, 2010, RESP MED, V104, P253, DOI 10.1016/j.rmed.2009.09.019; Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 1992, MAN INT STAT CLASS D; BERGLUND E, 1963, ACTA MED SCAND, V173, P185; Celli B, 2011, AM J RESP CRIT CARE, V183, P317, DOI 10.1164/rccm.201004-0665OC; Chailleux E, 1996, CHEST, V109, P741, DOI 10.1378/chest.109.3.741; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COX DR, 1972, J R STAT SOC B, V34, P187; Crockett AJ, 2001, INTERN MED J, V31, P448, DOI 10.1046/j.1445-5994.2001.00103.x; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; de Torres JP, 2009, EUR RESPIR J, V33, P528, DOI 10.1183/09031936.00096108; de Torres JP, 2005, CHEST, V128, P2012, DOI 10.1378/chest.128.4.2012; de Torres JP, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-72; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Ekstrom M, 2010, CHEST, V137, P31, DOI 10.1378/chest.09-0636; Ekstrom MP, 2011, AM J RESP CRIT CARE, V183, P1032, DOI 10.1164/rccm.201010-1704OC; FLENLEY DC, 1981, LANCET, V1, P681; Franklin KA, 2007, RESP MED, V101, P1506, DOI 10.1016/j.rmed.2007.01.009; Hanania NA, 2011, AM J RESP CRIT CARE, V183, P604, DOI 10.1164/rccm.201003-0472OC; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Incalzi RA, 1997, EUR RESPIR J, V10, P2794, DOI 10.1183/09031936.97.10122794; Lash TL, 2011, LUNG, V189, P27, DOI 10.1007/s00408-010-9274-z; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Machado MCL, 2006, AM J RESP CRIT CARE, V174, P524, DOI 10.1164/rccm.200507-1057OC; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Marti S, 2006, EUR RESPIR J, V27, P689, DOI 10.1183/09031936.06.00076405; MIYAMOTO K, 1995, AM J RESP CRIT CARE, V152, P972, DOI 10.1164/ajrccm.152.3.7663812; Rothman K.J., 2008, MODERN EPIDEMIOLOGY, P128; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; STROM K, 1988, EUR RESPIR J, V1, P952; Swedish National Board of Health and Welfare, 2008, QUAL CONT SWED HOSP; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Health Organization (WHO), 1978, MAN INT CLASS DIS IN; XU X, 1994, EUR RESPIR J, V7, P1056	38	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35806	10.1371/journal.pone.0035806	http://dx.doi.org/10.1371/journal.pone.0035806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563405	gold, Green Published			2022-12-27	WOS:000305349100032
J	Luksha, L; Stenvinkel, P; Hammarqvist, F; Carrero, JJ; Davidge, ST; Kublickiene, K				Luksha, Leanid; Stenvinkel, Peter; Hammarqvist, Folke; Carrero, Juan Jesus; Davidge, Sandra T.; Kublickiene, Karolina			Mechanisms of Endothelial Dysfunction in Resistance Arteries from Patients with End-Stage Renal Disease	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CHRONIC KIDNEY-DISEASE; EXPERIMENTAL DIABETIC-NEPHROPATHY; HYPERPOLARIZING FACTOR; ASYMMETRIC DIMETHYLARGININE; DEPENDENT VASODILATION; CARDIOVASCULAR-DISEASE; SUPEROXIDE-PRODUCTION; MESENTERIC-ARTERIES; HYPERTENSIVE-RATS	The study focuses on the mechanisms of endothelial dysfunction in the uremic milieu. Subcutaneous resistance arteries from 35 end-stage renal disease (ESRD) patients and 28 matched controls were studied ex-vivo. Basal and receptor-dependent effects of endothelium-derived factors, expression of endothelial NO synthase (eNOS), prerequisites for myoendothelial gap junctions (MEGJ), and associations between endothelium-dependent responses and plasma levels of endothelial dysfunction markers were assessed. The contribution of endothelium-derived hyperpolarizing factor (EDHF) to endothelium-dependent relaxation was impaired in uremic arteries after stimulation with bradykinin, but not acetylcholine, reflecting the agonist-specific differences. Diminished vasodilator influences of the endothelium on basal tone and enhanced plasma levels of asymmetrical dimethyl L-arginine (ADMA) suggest impairment in NO-mediated regulation of uremic arteries. eNOS expression and contribution of MEGJs to EDHF type responses were unaltered. Plasma levels of ADMA were negatively associated with endothelium-dependent responses in uremic arteries. Preserved responses of smooth muscle to pinacidil and NO-donor indicate alterations within the endothelium and tolerance of vasodilator mechanisms to the uremic retention products at the level of smooth muscle. We conclude that both EDHF and NO pathways that control resistance artery tone are impaired in the uremic milieu. For the first time, we validate the alterations in EDHF type responses linked to kinin receptors in ESRD patients. The association between plasma ADMA concentrations and endothelial function in uremic resistance vasculature may have diagnostic and future therapeutic implications.	[Luksha, Leanid; Kublickiene, Karolina] Karolinska Inst, Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Stenvinkel, Peter; Carrero, Juan Jesus] Karolinska Inst, Karolinska Univ Hosp, Div Renal Med, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Karolinska Univ Hosp, Div Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; University of Alberta	Luksha, L (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	karolina.kublickiene@ki.se		Kublickiene, Karolina/0000-0002-4841-6836; Carrero, Juan Jesus/0000-0003-4763-2024; Davidge, Sandra/0000-0002-5559-4905; Stenvinkel, Peter/0000-0002-8785-4820	Swedish Society of Medicine; Swedish Heart and Lung Foundation; Center for Gender Medicine at Karolinska Institutet; Loo and Hans Ostermans Foundation; Swedish Kidney Association; Karolinska Institute Research Funds; AFA insurance; Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden; Canadian Institute for Health Research	Swedish Society of Medicine; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Center for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Loo and Hans Ostermans Foundation; Swedish Kidney Association; Karolinska Institute Research Funds(Karolinska Institutet); AFA insurance; Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Financial support was provided by grants from the Swedish Society of Medicine, Swedish Heart and Lung Foundation, Center for Gender Medicine at Karolinska Institutet, Loo and Hans Ostermans Foundation, the Swedish Kidney Association and the Karolinska Institute Research Funds. L. Luksha is supported by PostDoc research grants from AFA insurance and Department of Clinical Science, Intervention & Technology (CLINTEC) at Karolinska Institutet, Sweden. S. Davidge is supported by Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Albrecht EWJA, 2003, NITRIC OXIDE-BIOL CH, V8, P53, DOI 10.1016/S1089-8603(02)00132-5; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Benchetrit S, 2003, EUR J CLIN INVEST, V33, P26, DOI 10.1046/j.1365-2362.2003.01102.x; Billecke SS, 2009, NEPHROL DIAL TRANSPL, V24, P489, DOI 10.1093/ndt/gfn500; Bonomini M, 2005, KIDNEY INT, V67, P1899, DOI 10.1111/j.1523-1755.2005.00288.x; Chhabra N, 2009, INTERNET J MED UPDAT, V4, P33; Deka DK, 1998, EUR J PHARMACOL, V348, P11, DOI 10.1016/S0014-2999(98)00066-1; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Gomez-Fernandez P, 2005, NEFROLOGIA, V25, P155; Gschwend S, 2009, LIFE SCI, V85, P431, DOI 10.1016/j.lfs.2009.07.006; Kalliovalkama J, 1999, AM J PHYSIOL-HEART C, V277, pH1622, DOI 10.1152/ajpheart.1999.277.4.H1622; Kao MPC, 2010, J HUM HYPERTENS, V24, P1, DOI 10.1038/jhh.2009.70; Kim SW, 2000, J KOREAN MED SCI, V15, P425, DOI 10.3346/jkms.2000.15.4.425; Kimura K, 1999, SCAND J CLIN LAB INV, V59, P199, DOI 10.1080/00365519950185724; Kohler R, 2005, KIDNEY INT, V67, P2280, DOI 10.1111/j.1523-1755.2005.00331.x; KUHBERGER E, 1993, J CARDIOVASC PHARM, V21, P947; Le Brocq M, 2008, ANTIOXID REDOX SIGN, V10, P1631, DOI 10.1089/ars.2007.2013; Linden E, 2008, CLIN J AM SOC NEPHRO, V3, P691, DOI 10.2215/CJN.04291007; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Luksha L, 2010, BIOL REPROD, V83, P728, DOI 10.1095/biolreprod.110.084426; Luksha L, 2009, ATHEROSCLEROSIS, V202, P330, DOI 10.1016/j.atherosclerosis.2008.06.008; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Malyszko JS, 2006, J NEPHROL, V19, P150; Mittermayer F, 2005, J AM SOC NEPHROL, V16, P1832, DOI 10.1681/ASN.2004121109; Morris STW, 2001, KIDNEY INT, V60, P1077, DOI 10.1046/j.1523-1755.2001.0600031077.x; Pascoal IF, 1998, J CLIN INVEST, V101, P464, DOI 10.1172/JCI557; Passauer J, 2005, KIDNEY INT, V67, P1907, DOI 10.1111/j.1523-1755.2005.00289.x; Passauer J, 2005, J AM SOC NEPHROL, V16, P959, DOI 10.1681/ASN.2004070582; Passauer J, 2000, J AM SOC NEPHROL, V11, P1726, DOI 10.1681/ASN.V1191726; Prasad A, 2000, J AM COLL CARDIOL, V36, P1467, DOI 10.1016/S0735-1097(00)00892-5; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; Satoh M, 2005, AM J PHYSIOL-RENAL, V288, pF1144, DOI 10.1152/ajprenal.00221.2004; Satoh M, 2008, NEPHROL DIAL TRANSPL, V23, P3806, DOI 10.1093/ndt/gfn357; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Sokoya EM, 2007, MICROVASC RES, V74, P39, DOI 10.1016/j.mvr.2007.03.003; Stenvinkel P, 2003, J AM SOC NEPHROL, V14, P1927, DOI 10.1097/01.ASN.0000069165.79509.42; Stojnic N, 2007, J PHARMACOL SCI, V104, P122, DOI 10.1254/jphs.FP0061434; Veresh Z, 2008, HYPERTENSION, V52, P960, DOI 10.1161/HYPERTENSIONAHA.108.116731; Vettoretti S, 2006, J HYPERTENS, V24, P2215, DOI 10.1097/01.hjh.0000249699.04113.36; Wadham C, 2009, EXPERT OPIN DRUG MET, V5, P303, DOI [10.1517/17425250902785172 , 10.1517/17425250902785172]; Wirth KJ, 1996, N-S ARCH PHARMACOL, V354, P38; Yilmaz MI, 2008, NEPHROL DIAL TRANSPL, V23, P959, DOI 10.1093/ndt/gfm727; Yilmaz MI, 2005, TRANSPLANTATION, V80, P1660, DOI 10.1097/01.tp.0000183750.22675.be	45	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36056	10.1371/journal.pone.0036056	http://dx.doi.org/10.1371/journal.pone.0036056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563439	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100065
J	Nilsson, S; Moller, C; Jirstrom, K; Lee, A; Busch, S; Lamb, R; Landberg, G				Nilsson, Sofie; Moller, Christina; Jirstrom, Karin; Lee, Alexander; Busch, Susann; Lamb, Rebecca; Landberg, Goran			Downregulation of miR-92a Is Associated with Aggressive Breast Cancer Features and Increased Tumour Macrophage Infiltration	PLOS ONE			English	Article							EXPRESSION; MICRORNAS; DEREGULATION; PLASMA	Background: MicroRNAs are small non-coding RNAs involved in the regulation of gene expression on a posttranscriptional level. These regulatory RNAs have been implicated in numerous cellular processes and are further deregulated in different cancer types, including breast cancer. MiR-92a is part of the miR-17 similar to 92 cluster, which was first reported to be linked to tumourigenesis. However, little is known about the expression of miR-92a in breast cancer and potential associations to tumour properties. The expression of miR-92a was therefore characterized in 144 invasive breast cancer samples using in situ hybridization and related to clinico-pathological data as well as to selected key properties of the tumour stroma, including the presence of macrophages (CD68) and cancer activated fibroblasts (alpha-SMA). Methodology/Principal Findings: To measure miR-92a levels, an in situ hybridisation protocol was developed and validated using cell lines and miR-92a inhibitors. The expression in the tumour samples was objectively evaluated using digital image analysis program subtracting background activities. We found that the miR-92a expression varied between tumours and was inversely correlated to tumour grade (r = -0.276, p = 0.003) and recurrence-free survival (p = 0.008) and provided independent prognostic information in multivariate Cox analysis (HR: 0.375, CI: 0.145-0.972, p = 0.043). MiR-92a was moreover inversely correlated to the number of infiltrating macrophages in the tumour stroma (r = -0.357, p<0.001), and downregulation of miR-92a promoted cell migration (p<0.01). Conclusions/Significance: This study demonstrates that downregulation of miR-92a in breast cancer is linked to key epithelial and stromal properties as well as clinical outcome.	[Nilsson, Sofie; Moller, Christina; Landberg, Goran] Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden; [Jirstrom, Karin] Lund Univ, Dept Clin Sci, Skane Univ Hosp, Lund, Sweden; [Nilsson, Sofie; Lee, Alexander; Busch, Susann; Lamb, Rebecca; Landberg, Goran] Univ Manchester, Breakthrough Breast Canc Res Unit, Paterson Inst Canc Res,Manchester Acad Hlth Sci C, Sch Canc & Enabling Sci,Christie NHS Fdn Trust, Manchester, Lancs, England	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester	Nilsson, S (corresponding author), Lund Univ, Ctr Mol Pathol, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden.	goran.landberg@med.lu.se			Swedish Cancer Society; Breakthrough Breast Cancer	Swedish Cancer Society(Swedish Cancer Society); Breakthrough Breast Cancer	The study was supported by the Swedish Cancer Society, http://www.cancerfonden.se, and Breakthrough Breast Cancer, http://www.breakthrough.org.uk/. The funders provided financial support for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bonauer A, 2009, CELL CYCLE, V8, P3866, DOI 10.4161/cc.8.23.9994; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Fu SW, 2011, J CANCER, V2, P116, DOI 10.7150/jca.2.116; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Mollerstrom E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-296; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	21	67	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36051	10.1371/journal.pone.0036051	http://dx.doi.org/10.1371/journal.pone.0036051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563438	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100064
J	Niwa, F; Bannai, H; Arizono, M; Fukatsu, K; Triller, A; Mikoshiba, K				Niwa, Fumihiro; Bannai, Hiroko; Arizono, Misa; Fukatsu, Kazumi; Triller, Antoine; Mikoshiba, Katsuhiko			Gephyrin-Independent GABA(A)R Mobility and Clustering during Plasticity	PLOS ONE			English	Article							INHIBITORY SYNAPSES; GABAERGIC SYNAPSES; STATUS EPILEPTICUS; LATERAL DIFFUSION; SYNAPTIC PLASTICITY; RECEPTOR SUBTYPES; GAMMA-2 SUBUNIT; DIRECT BINDING; TRAFFICKING; DYNAMICS	The activity-dependent modulation of GABA-A receptor (GABA(A)R) clustering at synapses controls inhibitory synaptic transmission. Several lines of evidence suggest that gephyrin, an inhibitory synaptic scaffold protein, is a critical factor in the regulation of GABA(A)R clustering during inhibitory synaptic plasticity induced by neuronal excitation. In this study, we tested this hypothesis by studying relative gephyrin dynamics and GABA(A)R declustering during excitatory activity. Surprisingly, we found that gephyrin dispersal is not essential for GABA(A)R declustering during excitatory activity. In cultured hippocampal neurons, quantitative immunocytochemistry showed that the dispersal of synaptic GABA(A)Rs accompanied with neuronal excitation evoked by 4-aminopyridine (4AP) or N-methyl-D-aspartic acid (NMDA) precedes that of gephyrin. Single-particle tracking of quantum dot labeled-GABA(A)Rs revealed that excitation-induced enhancement of GABA(A)R lateral mobility also occurred before the shrinkage of gephyrin clusters. Physical inhibition of GABA(A)R lateral diffusion on the cell surface and inhibition of a Ca2+ dependent phosphatase, calcineurin, completely eliminated the 4AP-induced decrease in gephyrin cluster size, but not the NMDA-induced decrease in cluster size, suggesting the existence of two different mechanisms of gephyrin declustering during activity-dependent plasticity, a GABA(A)R-dependent regulatory mechanism and a GABA(A)R-independent one. Our results also indicate that GABA(A)R mobility and clustering after sustained excitatory activity is independent of gephyrin.	[Niwa, Fumihiro; Bannai, Hiroko; Arizono, Misa; Fukatsu, Kazumi; Mikoshiba, Katsuhiko] RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama, Japan; [Niwa, Fumihiro] Univ Tokyo, Inst Med Sci, Grad Sch Frontier Sci, Lab Funct Genom,Dept Med Genome Sci,Minato Ku, Tokyo, Japan; [Arizono, Misa] Univ Tokyo, Inst Med Sci, Div Neuronal Network, Tokyo, Japan; [Triller, Antoine] Ecole Normale Super, Inst Natl Sante & Rech Med, U1024, Ctr Natl Rech Sci,UMR8197,Inst Biol, F-75231 Paris, France	RIKEN; University of Tokyo; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Niwa, F (corresponding author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Saitama, Japan.	hbannai@brain.riken.jp	Bannai, Hiroko/I-7130-2014; Niwa, Fumihiro/GNP-0007-2022; Mikoshiba, Katsuhiko/N-7943-2015; Niwa, Fumihiro/U-4422-2019	Bannai, Hiroko/0000-0002-0951-488X; Niwa, Fumihiro/0000-0002-0206-1902; Niwa, Fumihiro/0000-0002-0206-1902; Arizono, Misa/0000-0002-7726-6531; TRILLER, Antoine/0000-0002-7530-1233	Kato Memorial Bioscience Foundation; Toray Science Foundation; RIKEN;  [20220007];  [20700300]	Kato Memorial Bioscience Foundation; Toray Science Foundation(Toray Industries, Inc.); RIKEN; ; 	This work is supported by Grant-in-Aid for Scientific Research (20220007 to KM, 20700300 to HB), grants from the Kato Memorial Bioscience Foundation, and Toray Science Foundation (to HB). FN and MA were supported by the Junior Research Associate program of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; BENKE D, 1991, J BIOL CHEM, V266, P4478; BONNEAU S, 2004, P IEEE INT S BIOL IM; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Das A, 2005, J NEUROSCI RES, V81, P551, DOI 10.1002/jnr.20581; Dobie FA, 2011, J NEUROSCI, V31, P10481, DOI 10.1523/JNEUROSCI.6023-10.2011; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gerrow K, 2010, CURR OPIN NEUROBIOL, V20, P631, DOI 10.1016/j.conb.2010.06.010; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; GOSLIN K, 1998, CULTURING NERVE CELL; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kawasaki BT, 1997, J NEUROSCI RES, V49, P381, DOI 10.1002/(SICI)1097-4547(19970801)49:3<381::AID-JNR13>3.0.CO;2-2; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Levi S, 2002, J NEUROSCI, V22, P4274, DOI 10.1523/JNEUROSCI.22-11-04274.2002; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; Marsden KC, 2007, J NEUROSCI, V27, P14326, DOI 10.1523/JNEUROSCI.4433-07.2007; Marsden KC, 2010, P NATL ACAD SCI USA, V107, P20559, DOI 10.1073/pnas.1010346107; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Muir J, 2010, P NATL ACAD SCI USA, V107, P16679, DOI 10.1073/pnas.1000589107; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Naylor DE, 2005, J NEUROSCI, V25, P7724, DOI 10.1523/JNEUROSCI.4944-04.2005; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Panzanelli P., 2011, J PHYSL; Racine V, 2007, J MICROSC-OXFORD, V225, P214, DOI 10.1111/j.1365-2818.2007.01723.x; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1; Sekimoto K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031905; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Studer R, 2006, EUR J NEUROSCI, V24, P1307, DOI 10.1111/j.1460-9568.2006.05006.x; Terunuma M, 2008, J NEUROSCI, V28, P376, DOI 10.1523/JNEUROSCI.4346-07.2008; Tretter V, 2011, J BIOL CHEM; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tyagarajan SK, 2011, P NATL ACAD SCI USA, V108, P379, DOI 10.1073/pnas.1011824108; Tyagarajan SK, 2010, J PHYSIOL-LONDON, V588, P101, DOI 10.1113/jphysiol.2009.178517; Wang J, 2003, J NEUROSCI, V23, P826	49	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36148	10.1371/journal.pone.0036148	http://dx.doi.org/10.1371/journal.pone.0036148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563445	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100070
J	Voytek, B; Soltani, M; Pickard, N; Kishiyama, MM; Knight, RT				Voytek, Bradley; Soltani, Maryam; Pickard, Natasha; Kishiyama, Mark M.; Knight, Robert T.			Prefrontal Cortex Lesions Impair Object-Spatial Integration	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; WORKING-MEMORY; HUMAN BRAIN; INFORMATION; LOCATION; NEURONS; HUMANS	How and where object and spatial information are perceptually integrated in the brain is a central question in visual cognition. Single-unit physiology, scalp EEG, and fMRI research suggests that the prefrontal cortex (PFC) is a critical locus for object-spatial integration. To test the causal participation of the PFC in an object-spatial integration network, we studied ten patients with unilateral PFC damage performing a lateralized object-spatial integration task. Consistent with single-unit and neuroimaging studies, we found that PFC lesions result in a significant behavioral impairment in object-spatial integration. Furthermore, by manipulating inter-hemispheric transfer of object-spatial information, we found that masking of visual transfer impairs performance in the contralesional visual field in the PFC patients. Our results provide the first evidence that the PFC plays a key, causal role in an object-spatial integration network. Patient performance is also discussed within the context of compensation by the non-lesioned PFC.	[Voytek, Bradley; Soltani, Maryam; Pickard, Natasha; Kishiyama, Mark M.; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Soltani, Maryam; Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Voytek, Bradley] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Soltani, Maryam] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Diego	Voytek, B (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	bradley.voytek@gmail.com	Voytek, Bradley/K-3305-2016	Voytek, Bradley/0000-0003-1640-2525	American Psychological Association [5-T32-MH18882]; National Institute of Neurological Disorders and Stroke [NS21135-22S1, NS21135, PO40813]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021135, R56NS021135] Funding Source: NIH RePORTER	American Psychological Association; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.V. is funded by the American Psychological Association Diversity Program in Neuroscience (5-T32-MH18882) and B.V. and R.T.K. by the National Institute of Neurological Disorders and Stroke (NS21135-22S1, NS21135, and PO40813). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carmichael ST, 2001, NEUROBIOL DIS, V8, P910, DOI 10.1006/nbdi.2001.0425; Cichy RM, 2011, NEUROIMAGE, V54, P2297, DOI 10.1016/j.neuroimage.2010.09.044; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Green DM, 1966, SIGNAL DETECTION THE; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Hasegawa I, 1998, SCIENCE, V281, P814, DOI 10.1126/science.281.5378.814; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Lytton W W, 1999, Prog Brain Res, V121, P203; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; RUGG MD, 1984, NEUROPSYCHOLOGIA, V22, P215, DOI 10.1016/0028-3932(84)90064-2; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Simon-Thomas ER, 2003, COGNITIVE BRAIN RES, V16, P457, DOI 10.1016/S0926-6410(03)00060-0; SMITH EE, 1995, J COGNITIVE NEUROSCI, V7, P337, DOI 10.1162/jocn.1995.7.3.337; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; von Monakow C, 1969, MOOD STATES MIND; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Voytek B, 2010, P NATL ACAD SCI USA, V107, P18167, DOI 10.1073/pnas.1007277107; Wang YP, 2000, NEUROSCI LETT, V293, P17, DOI 10.1016/S0304-3940(00)01480-4; WILSON FA, 1993, SCIENCE, V25, P1955; Wundt W., 1902, OUTLINES PSYCHOL; Yago Elena, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P609, DOI 10.3758/CABN.4.4.609	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34937	10.1371/journal.pone.0034937	http://dx.doi.org/10.1371/journal.pone.0034937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563375	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100005
J	Eros, T; Gustafsson, P; Greenberg, LA; Bergman, E				Eros, Tibor; Gustafsson, Par; Greenberg, Larry A.; Bergman, Eva			Forest-Stream Linkages: Effects of Terrestrial Invertebrate Input and Light on Diet and Growth of Brown Trout (Salmo trutta) in a Boreal Forest Stream	PLOS ONE			English	Article							DWELLING ATLANTIC SALMON; RIPARIAN BUFFER WIDTH; FOOD WEBS; HABITAT USE; EXPERIMENTAL MANIPULATION; ARTHROPOD INPUTS; HEADWATER STREAM; RAINBOW-TROUT; BROOK TROUT; PREY	Subsidies of energy and material from the riparian zone have large impacts on recipient stream habitats. Human-induced changes, such as deforestation, may profoundly affect these pathways. However, the strength of individual factors on stream ecosystems is poorly understood since the factors involved often interact in complex ways. We isolated two of these factors, manipulating the flux of terrestrial input and the intensity of light in a 262 factorial design, where we followed the growth and diet of two size-classes of brown trout (Salmo trutta) and the development of periphyton, grazer macroinvertebrates, terrestrial invertebrate inputs, and drift in twelve 20 m long enclosed stream reaches in a five-month-long experiment in a boreal coniferous forest stream. We found that light intensity, which was artificially increased 2.5 times above ambient levels, had an effect on grazer density, but no detectable effect on chlorophyll a biomass. We also found a seasonal effect on the amount of drift and that the reduction of terrestrial prey input, accomplished by covering enclosures with transparent plastic, had a negative impact on the amount of terrestrial invertebrates in the drift. Further, trout growth was strongly seasonal and followed the same pattern as drift biomass, and the reduction of terrestrial prey input had a negative effect on trout growth. Diet analysis was consistent with growth differences, showing that trout in open enclosures consumed relatively more terrestrial prey in summer than trout living in covered enclosures. We also predicted ontogenetic differences in the diet and growth of old and young trout, where we expected old fish to be more affected by the terrestrial prey reduction, but we found little evidence of ontogenetic differences. Overall, our results showed that reduced terrestrial prey inputs, as would be expected from forest harvesting, shaped differences in the growth and diet of the top predator, brown trout.	[Eros, Tibor; Gustafsson, Par; Greenberg, Larry A.; Bergman, Eva] Karlstad Univ, Dept Biol, Karlstad, Sweden; [Eros, Tibor] Hungarian Acad Sci, Balaton Limnol Inst, Ctr Ecol Res, Tihany, Hungary; [Gustafsson, Par] Cty Board Varmland, Karlstad, Sweden	Karlstad University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute	Eros, T (corresponding author), Karlstad Univ, Dept Biol, Karlstad, Sweden.	eva.bergman.1868@kau.se	Bergman, Eva/R-8464-2016; Bergman, Eva/AAR-8368-2021; Eros, Tibor/I-1671-2019	Bergman, Eva/0000-0003-2220-1615; Bergman, Eva/0000-0003-2220-1615; 	Trygger's Foundation; Karlstad University	Trygger's Foundation; Karlstad University	This work was funded by the Trygger's Foundation and Karlstad University. TE is a Bolyai Janos Research Fellow at the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan J.D., 2009, STREAM ECOLOGY STRUC, V2nd; Allan JD, 2003, CAN J FISH AQUAT SCI, V60, P309, DOI 10.1139/F03-019; ALLEN KR, 1951, NZ MARINE DEP FISHER, V10, P1; Anderson M.J., 2004, CAP FORTRAN COMPUTER; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Andersson J., 2009, GIS BASED LANDSCAPE; BACHMAN RA, 1984, T AM FISH SOC, V113, P1, DOI 10.1577/1548-8659(1984)113&lt;1:FBOFWA&gt;2.0.CO;2; Baxter CV, 2007, OECOLOGIA, V153, P461, DOI 10.1007/s00442-007-0743-x; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Bergkvist A, 2002, SMALL FOREST STREAMS; Bremset G, 1999, ANIM BEHAV, V58, P1047, DOI 10.1006/anbe.1999.1218; Bridcut EE, 2000, HYDROBIOLOGIA, V427, P83, DOI 10.1023/A:1003927331472; Bridcut EE, 1995, CAN J FISH AQUAT SCI, V52, P2543, DOI 10.1139/f95-845; BRIDCUT EE, 1993, J FISH BIOL, V43, P889, DOI 10.1006/jfbi.1993.1192; Carlson SM, 2007, J FISH BIOL, V71, P1430, DOI 10.1111/j.1095-8649.2007.01615.x; Cloe WW, 1996, FRESHWATER BIOL, V36, P105; COOPER EL, 1953, COPEIA, P107; COOPER SD, 1990, ECOLOGY, V71, P1503, DOI 10.2307/1938287; Crisp DT, EUROPE SPECIAL REFER; Cummins K.W., 1971, INT ASS THEORETICAL, V18, P1, DOI [DOI 10.1080/05384680.1971.11903918, 10. 1080/05384680. 1971. 11903918]; Dineen G, 2007, BIOL ENVIRON, V107B, P167, DOI 10.3318/BIOE.2007.107.3.167; Dineen G, 2007, J FISH BIOL, V71, P17, DOI 10.1111/j.1095-8649.2007.01441.x; DUNBRACK RL, 1983, ENVIRON BIOL FISH, V8, P203, DOI 10.1007/BF00001086; Elliott JM, 1994, QUANTITATIVE ECOLOGY, Vviii; Fausch KD, 2002, TRENDS ECOL EVOL, V17, P429, DOI 10.1016/S0169-5347(02)02572-7; FEMINELLA JW, 1989, FRESHWATER BIOL, V22, P445, DOI 10.1111/j.1365-2427.1989.tb01117.x; Gille E, 2002, RIPARIAN ZONE SMALL; Greenberg L, 2005, ARCH HYDROBIOL, V164, P39, DOI 10.1127/0003-9136/2005/0164-0039; GREENBERG LA, 1994, FRESHWATER BIOL, V32, P1, DOI 10.1111/j.1365-2427.1994.tb00860.x; GREGORY SV, 1991, BIOSCIENCE, V41, P540, DOI 10.2307/1311607; Heggenes J, 2002, J FISH BIOL, V60, P72, DOI 10.1006/jfbi.2001.1811; Heggenes J, 1999, ECOL FRESHW FISH, V8, P1, DOI 10.1111/j.1600-0633.1999.tb00048.x; Heggenes J., 1989, NORDIC J FRESHWATER, V64, P74; HILL WR, 1995, ECOLOGY, V76, P1297, DOI 10.2307/1940936; Hill WR, 2002, FRESHWATER BIOL, V47, P1245, DOI 10.1046/j.1365-2427.2002.00837.x; Hill WR, 2001, ECOLOGY, V82, P2306, DOI 10.1890/0012-9658(2001)082[2306:SERTFL]2.0.CO;2; Hynes H. B. N., 1970, ECOLOGY RUNNING WATE; Kawaguchi Y, 2001, FRESHWATER BIOL, V46, P303, DOI 10.1046/j.1365-2427.2001.00667.x; Kiffney PM, 2004, J N AM BENTHOL SOC, V23, P542, DOI 10.1899/0887-3593(2004)023&lt;0542:ELAACM&gt;2.0.CO;2; Kiffney PM, 2003, J APPL ECOL, V40, P1060, DOI 10.1111/j.1365-2664.2003.00855.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Letcher BH, 2003, J FISH BIOL, V62, P97, DOI 10.1046/j.1095-8649.2003.00009.x; MakiPetays A, 1997, CAN J FISH AQUAT SCI, V54, P520, DOI 10.1139/cjfas-54-3-520; Mallory MA, 2005, J ANIM ECOL, V74, P1020, DOI 10.1111/j.1365-2656.2005.01000.x; Marczak LB, 2008, OECOLOGIA, V156, P249, DOI 10.1007/s00442-008-0989-y; MASON CF, 1982, FRESHWATER BIOL, V12, P305, DOI 10.1111/j.1365-2427.1982.tb00624.x; Meissner K, 2006, J ANIM ECOL, V75, P421, DOI 10.1111/j.1365-2656.2006.01063.x; Montori A, 2006, INT REV HYDROBIOL, V91, P438, DOI 10.1002/iroh.200510899; Murdock JN, 2007, J PHYCOL, V43, P449, DOI 10.1111/j.1529-8817.2007.00357.x; Naiman RJ, 1997, ANNU REV ECOL SYST, V28, P621, DOI 10.1146/annurev.ecolsys.28.1.621; Nakano S, 1999, ECOL RES, V14, P351, DOI 10.1046/j.1440-1703.1999.00315.x; Nakano S, 1999, ECOLOGY, V80, P2435; Nakano S., 1994, Ecology of Freshwater Fish, V3, P153, DOI 10.1111/j.1600-0633.1994.tb00017.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nilsson A., 1996, AQUATIC INSECTS NO E; Northcote TG, FISHES FORESTRY; Persson A, 2002, OIKOS, V97, P271, DOI 10.1034/j.1600-0706.2002.970213.x; Ricker WE, 1979, GROWTH RATES MODELS; ROSEMOND AD, 1993, OECOLOGIA, V94, P585, DOI 10.1007/BF00566976; Rosemond AD, 2000, CAN J FISH AQUAT SCI, V57, P66, DOI 10.1139/cjfas-57-1-66; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Sempeski P, 1996, CAN J ZOOL, V74, P1597, DOI 10.1139/z96-176; Steingrimsson SO, 2002, ENVIRON BIOL FISH, V63, P417, DOI 10.1023/A:1014976612970; Teixeira A, 2006, B FR PECHE PISCIC, P1, DOI 10.1051/kmae:2006004; TWOMEY H, 1990, Aquaculture and Fisheries Management, V21, P137, DOI 10.1111/j.1365-2109.1990.tb00390.x; Webster JJ, 2005, J FRESHWATER ECOL, V20, P101, DOI 10.1080/02705060.2005.9664942; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wipfli MS, 1997, CAN J FISH AQUAT SCI, V54, P1259, DOI 10.1139/cjfas-54-6-1259; Zadorina V. M., 1988, VOP IKHTIOL, V2, P259; Zimmerman JKH, 2006, J N AM BENTHOL SOC, V25, P453, DOI 10.1899/0887-3593(2006)25[453:EOSEOD]2.0.CO;2	71	29	30	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36462	10.1371/journal.pone.0036462	http://dx.doi.org/10.1371/journal.pone.0036462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574164	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800060
J	Ku, YX; Hong, B; Zhou, WJ; Bodner, M; Zhou, YD				Ku, Yixuan; Hong, Bo; Zhou, Wenjing; Bodner, Mark; Zhou, Yong-Di			Sequential Neural Processes in Abacus Mental Addition: An EEG and fMRI Case Study	PLOS ONE			English	Article							WORKING-MEMORY RESOURCES; DIGIT MEMORY; TEMPORAL GYRUS; BRAIN; EXPERTS; ACTIVATION; AREAS; COMPONENTS; CHILDREN; MIDDLE	Abacus experts are able to mentally calculate multi-digit numbers rapidly. Some behavioral and neuroimaging studies have suggested a visuospatial and visuomotor strategy during abacus mental calculation. However, no study up to now has attempted to dissociate temporally the visuospatial neural process from the visuomotor neural process during abacus mental calculation. In the present study, an abacus expert performed the mental addition tasks (8-digit and 4-digit addends presented in visual or auditory modes) swiftly and accurately. The 100% correct rates in this expert's task performance were significantly higher than those of ordinary subjects performing 1-digit and 2-digit addition tasks. ERPs, EEG source localizations, and fMRI results taken together suggested visuospatial and visuomotor processes were sequentially arranged during the abacus mental addition with visual addends and could be dissociated from each other temporally. The visuospatial transformation of the numbers, in which the superior parietal lobule was most likely involved, might occur first (around 380 ms) after the onset of the stimuli. The visuomotor processing, in which the superior/middle frontal gyri were most likely involved, might occur later (around 440 ms). Meanwhile, fMRI results suggested that neural networks involved in the abacus mental addition with auditory stimuli were similar to those in the visual abacus mental addition. The most prominently activated brain areas in both conditions included the bilateral superior parietal lobules (BA 7) and bilateral middle frontal gyri (BA 6). These results suggest a supra-modal brain network in abacus mental addition, which may develop from normal mental calculation networks.	[Ku, Yixuan] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE, Shanghai 200062, Peoples R China; [Ku, Yixuan; Hong, Bo; Zhou, Wenjing] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Bodner, Mark] MIND Res Inst, Santa Ana, CA USA; [Zhou, Yong-Di] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD USA	East China Normal University; Tsinghua University; Johns Hopkins University	Ku, YX (corresponding author), E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE, Shanghai 200062, Peoples R China.	yixuanku@gmail.com; yzhou12@jhmi.edu	Zhou, Yongdi/GOH-3291-2022; Ku, Yixuan/D-4063-2018	Ku, Yixuan/0000-0003-2804-5123	National Natural Science Foundation of China [31100742]; China Postdoctoral Science Foundation [20100480615, 201104246]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31100742) and China Postdoctoral Science Foundation (20100480615 and 201104246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen FY, 2006, NEUROSCI LETT, V403, P46, DOI 10.1016/j.neulet.2006.04.041; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; De Rammelaere S, 1999, PSYCHOL RES-PSYCH FO, V62, P72, DOI 10.1007/s004260050041; De Rammelaere S, 2001, MEM COGNITION, V29, P267, DOI 10.3758/BF03194920; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 2005, MONKEY BRAIN HUMAN B, P133; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Frank MC, 2012, J EXP PSYCHOL GEN, V141, P134, DOI 10.1037/a0024427; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Furst AJ, 2000, MEM COGNITION, V28, P774, DOI 10.3758/BF03198412; Godinho F, 2006, J NEUROSCI, V26, P11454, DOI 10.1523/JNEUROSCI.2260-06.2006; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; HATANO G, 1983, COGNITION, V15, P95, DOI 10.1016/0010-0277(83)90035-5; HATANO G, 1977, COGNITION, V5, P47, DOI 10.1016/0010-0277(77)90016-6; HATTA T, 1989, APPL COGNITIVE PSYCH, V3, P23, DOI 10.1002/acp.2350030104; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Iguchi Y, 2000, CLIN NEUROPHYSIOL, V111, P204, DOI 10.1016/S1388-2457(99)00244-8; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Ku YX, 2010, NEUROSCI LETT, V472, P5, DOI 10.1016/j.neulet.2010.01.040; Langan J, 2011, BEHAV BRAIN RES, V225, P160, DOI 10.1016/j.bbr.2011.07.014; Lemaire P, 1996, EUR J COGN PSYCHOL, V8, P73, DOI 10.1080/095414496383211; LOGIE RH, 1994, MEM COGNITION, V22, P395, DOI 10.3758/BF03200866; Menninger K., 1992, NUMBER WORDS NUMBER; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Onitsuka T, 2004, AM J PSYCHIAT, V161, P1603, DOI 10.1176/appi.ajp.161.9.1603; Oshio R, 2010, NEUROIMAGE, V49, P1108, DOI 10.1016/j.neuroimage.2009.07.034; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PAULI P, 1994, COGNITIVE BRAIN RES, V2, P21, DOI 10.1016/0926-6410(94)90017-5; Pinel P, 2010, J COGNITIVE NEUROSCI, V22, P48, DOI 10.1162/jocn.2009.21184; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rueckert L, 1996, NEUROIMAGE, V3, P97, DOI 10.1006/nimg.1996.0011; Sakai K, 1998, J NEUROSCI, V18, P1827; Seitz K, 2000, EUR J COGN PSYCHOL, V12, P552, DOI 10.1080/095414400750050231; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; STIGLER JW, 1984, COGNITIVE PSYCHOL, V16, P145, DOI 10.1016/0010-0285(84)90006-9; Tanaka S, 2002, NEUROREPORT, V13, P2187, DOI 10.1097/00001756-200212030-00005; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	49	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36410	10.1371/journal.pone.0036410	http://dx.doi.org/10.1371/journal.pone.0036410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574155	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800051
J	Mallet, S; Weiss, S; Jacques, N; Leh-Louis, V; Sacerdot, C; Casaregola, S				Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Leh-Louis, Veronique; Sacerdot, Christine; Casaregola, Serge			Insights into the Life Cycle of Yeasts from the CTG Clade Revealed by the Analysis of the Millerozyma (Pichia) farinosa Species Complex	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; NATURAL HYBRIDS; SACCHAROMYCES-KUDRIAVZEVII; GEN. NOV; DEBARYOMYCES; RECOMBINATION; DNA; SORBITOPHILA; POLYMORPHISM; INHERITANCE	Among ascomycetous yeasts, the CTG clade is so-called because its constituent species translate CTG as serine instead of leucine. Though the biology of certain pathogenic species such as Candida albicans has been much studied, little is known about the life cycles of non-pathogen species of the CTG clade. Taking advantage of the recently obtained sequence of the biotechnological Millerozyma (Pichiasorbitophila) farinosa strain CBS 7064, we used MLST to better define phylogenic relationships between most of the Millerozyma farinosa strains available in public collections. This led to the constitution of four phylogenetic clades diverging from 8% to 15% at the DNA level and possibly constituting a species complex (M. farinosa) and to the proposal of two new species: Millerozyma miso sp. nov. CBS 2004(T) (=CLIB 1230(T)) and Candida pseudofarinosa sp. nov.NCYC 386(T) (=CLIB 1231(T)). Further analysis showed that M. farinosa isolates exist as haploid and inter-clade hybrids. Despite the sequence divergence between the clades, secondary contacts after reproductive isolation were evidenced, as revealed by both introgression and mitochondria transfer between clades. We also showed that the inter-clade hybrids do sporulate to generate mainly viable vegetative diploid spores that are not the result of meiosis, and very rarely aneuploid spores possibly through the loss of heterozygosity during sporulation. Taken together, these results show that in this part of the CTG clade, non-Mendelian genetic exchanges occur at high rates through hybridization between divergent strainsfrom distinct clades and subsequent massive loss of heterozygosity. This combination of mechanisms could constitute an alternative sexuality leading to an unsuspected biodiversity.	[Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Casaregola, Serge] CIRM Levures, INRA, Micalis Inst, UMR1319, Thiverval Grignon, France; [Mallet, Sandrine; Weiss, Stephanie; Jacques, Noemie; Casaregola, Serge] AgroParisTech, Micalis Inst, UMR1319, Thiverval Grignon, France; [Leh-Louis, Veronique] Univ Strasbourg, CNRS, UMR7156, Strasbourg, France; [Sacerdot, Christine] Univ Paris 06, UFR 927, UMR 3525, CNRS,Unite Genet Mol Levures,Inst Pasteur, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Mallet, S (corresponding author), CIRM Levures, INRA, Micalis Inst, UMR1319, Thiverval Grignon, France.	serge.casaregola@grignon.inra.fr		Sacerdot, Christine/0000-0002-7402-3411	AIP Bioresources INRA grant; European Community [FP7-228310]	AIP Bioresources INRA grant; European Community(European Commission)	This work was supported by an AIP Bioresources INRA grant. This work has received funding from the European Community's Seventh Framework Programme (FP7, 2007-2013), Research Infrastructures action, under grant agreement No. FP7-228310 (EMbaRC project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2007, J CLIN MICROBIOL, V45, P3456, DOI 10.1128/JCM.00788-07; ANAISSIE E, 1989, REV INFECT DIS, V11, P369; Bennett RJ, 2005, ANNU REV MICROBIOL, V59, P233, DOI 10.1146/annurev.micro.59.030804.121310; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Corredor M, 2003, ANTON LEEUW INT J G, V83, P215, DOI 10.1023/A:1023322301634; Daniel HM, 2001, INT J SYST EVOL MICR, V51, P1593, DOI 10.1099/00207713-51-4-1593; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forche A, 2005, EUKARYOT CELL, V4, P156, DOI 10.1128/EC.4.1.156-165.2005; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Fritsch ES, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-99; Fundyga RE, 2004, INFECT GENET EVOL, V4, P37, DOI 10.1016/j.meegid.2003.11.002; Gangl H, 2009, NEW BIOTECHNOL, V25, P244, DOI 10.1016/j.nbt.2008.10.001; GarciaMartos P, 1996, MYCOPATHOLOGIA, V136, P67, DOI 10.1007/BF00437497; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Groth G, 1999, INT J SYST BACTERIOL, V49, P1933; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; HERSKOWITZ I, 1988, MICROBIOL REV, V52, P536, DOI 10.1128/MMBR.52.4.536-553.1988; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jacques N, 2010, EUKARYOT CELL, V9, P449, DOI 10.1128/EC.00263-09; Jacques N, 2009, INT J SYST EVOL MICR, V59, P1242, DOI 10.1099/ijs.0.004325-0; James SA, 2005, FEMS YEAST RES, V5, P747, DOI 10.1016/j.femsyr.2005.02.004; Jung PP, 2010, CURR GENET, V56, P507, DOI 10.1007/s00294-010-0318-y; Jung PP, 2009, FEMS YEAST RES, V9, P903, DOI 10.1111/j.1567-1364.2009.00540.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Kurtzman C. P., 1998, P273, DOI 10.1016/B978-044481312-1/50046-0; Kurtzman CP, 2008, FEMS YEAST RES, V8, P939, DOI 10.1111/j.1567-1364.2008.00419.x; Kurtzman CP, 2007, FEMS YEAST RES, V7, P141, DOI 10.1111/j.1567-1364.2006.00157.x; Kurtzman CP, 2010, MYCOSCIENCE, V51, P2, DOI 10.1007/s10267-009-0011-5; KURTZMAN CP, 1975, MYCOPATHOLOGIA, V55, P29, DOI 10.1007/BF00467088; LAGES F, 1995, YEAST, V11, P111, DOI 10.1002/yea.320110203; Lee F-L, 1992, B JPN FED CULTURE CO, V8, P71; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Louis VL, 2012, G3-GENES GENOM GENET, V2, P299, DOI 10.1534/g3.111.000745; Maresova L, 2003, FOLIA MICROBIOL, V48, P211, DOI 10.1007/BF02930958; Marinoni G, 2004, FEMS YEAST RES, V4, P587, DOI 10.1016/j.femsyr.2003.12.005; MARTINI AV, 1985, INT J SYST BACTERIOL, V35, P508; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; PAULA CR, 1990, MYCOPATHOLOGIA, V112, P119, DOI 10.1007/BF00436507; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Porman AM, 2011, P NATL ACAD SCI USA, V108, P21158, DOI 10.1073/pnas.1112076109; Prillinger H, 1999, ANTON LEEUW INT J G, V75, P267, DOI 10.1023/A:1001889917533; Rainieri S, 2008, FEMS YEAST RES, V8, P586, DOI 10.1111/j.1567-1364.2008.00363.x; Reedy JL, 2009, CURR BIOL, V19, P891, DOI 10.1016/j.cub.2009.04.058; Rodrigues F, 2003, APPL ENVIRON MICROB, V69, P649, DOI 10.1128/AEM.69.1.649-653.2003; RODRIGUESDEMIRANDA L, 1980, A VAN LEEUW J MICROB, V46, P157, DOI 10.1007/BF00444070; ROEDER GS, 1990, TRENDS GENET, V6, P385, DOI 10.1016/0168-9525(90)90297-J; Sacerdot C, 2008, FEMS YEAST RES, V8, P846, DOI 10.1111/j.1567-1364.2008.00409.x; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Solieri L, 2010, TRENDS MICROBIOL, V18, P521, DOI 10.1016/j.tim.2010.08.001; Suzuki C, 2003, YEAST, V20, P905, DOI 10.1002/yea.1017; Szekvolgyi L, 2010, FEBS J, V277, P571, DOI 10.1111/j.1742-4658.2009.07502.x; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsui CKM, 2008, FEMS YEAST RES, V8, P651, DOI 10.1111/j.1567-1364.2007.00342.x; VANDERWALT JP, 1977, A VAN LEEUW J MICROB, V43, P205, DOI 10.1007/BF00395675	60	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35842	10.1371/journal.pone.0035842	http://dx.doi.org/10.1371/journal.pone.0035842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574125	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800021
J	Wang, LH; Liu, LP; Shi, Y; Cao, HW; Chaturvedi, R; Calcutt, MW; Hu, TH; Ren, XB; Wilson, KT; Polk, DB; Yan, F				Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Chaturvedi, Rupesh; Calcutt, M. Wade; Hu, Tianhui; Ren, Xiubao; Wilson, Keith T.; Polk, D. Brent; Yan, Fang			Berberine Induces Caspase-Independent Cell Death in Colon Tumor Cells through Activation of Apoptosis-Inducing Factor	PLOS ONE			English	Article							SIGNALING PATHWAYS; CANCER; MITOCHONDRIAL; PROTEASES; MUTATION; NECROSIS; STRESS; TRIAL; STAGE; LINES	Berberine, an isoquinoline alkaloid derived from plants, is a traditional medicine for treating bacterial diarrhea and intestinal parasite infections. Although berberine has recently been shown to suppress growth of several tumor cell lines, information regarding the effect of berberine on colon tumor growth is limited. Here, we investigated the mechanisms underlying the effects of berberine on regulating the fate of colon tumor cells, specifically the mouse immorto-Min colonic epithelial (IMCE) cells carrying the Apc(min) mutation, and of normal colon epithelial cells, namely young adult mouse colonic epithelium (YAMC) cells. Berberine decreased colon tumor colony formation in agar, and induced cell death and LDH release in a time- and concentration-dependent manner in IMCE cells. In contrast, YAMC cells were not sensitive to berberine-induced cell death. Berberine did not stimulate caspase activation, and PARP cleavage and berberine-induced cell death were not affected by a caspase inhibitor in IMCE cells. Rather, berberine stimulated a caspase-independent cell death mediator, apoptosis-inducing factor (AIF) release from mitochondria and nuclear translocation in a ROS production-dependent manner. Amelioration of berberine-stimulated ROS production or suppression of AIF expression blocked berberine-induced cell death and LDH release in IMCE cells. Furthermore, two targets of ROS production in cells, cathepsin B release from lysosomes and PARP activation were induced by berberine. Blockage of either of these pathways decreased berberine-induced AIF activation and cell death in IMCE cells. Thus, berberine-stimulated ROS production leads to cathepsin B release and PARP activation-dependent AIF activation, resulting in caspase-independent cell death in colon tumor cells. Notably, normal colon epithelial cells are less susceptible to berberine-induced cell death, which suggests the specific inhibitory effects of berberine on colon tumor cell growth.	[Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Yan, Fang] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Wang, Lihong; Liu, Liping; Shi, Yan; Cao, Hanwei; Yan, Fang] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN USA; [Wang, Lihong; Hu, Tianhui] Xiamen Univ, Coll Med, Canc Res Ctr, Xiamen, Peoples R China; [Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Calcutt, M. Wade] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Ren, Xiubao; Yan, Fang] Tianjin Med Univ, Canc Inst & Hosp, Dept Biotherapy, Tianjin, Peoples R China; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Polk, D. Brent] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Polk, D. Brent] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Vanderbilt University; Vanderbilt University; Xiamen University; Vanderbilt University; Vanderbilt University; Tianjin Medical University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Southern California; Children's Hospital Los Angeles	Wang, LH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	fang.yan@vanderbilt.edu	Shi, Y/G-3964-2010; Hu, T/G-3381-2010; liu, li/HGC-0900-2022	Wilson, Keith/0000-0003-4421-1830	NIH [R01DK081134, R01DK56008, R01AT004821, R01DK053620, P30DK058404]; Department of Veterans Affairs; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK081134, R01DK056008, R01DK053620] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001453] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants R01DK081134 (F.Y.), R01DK56008 (D. B. P.), R01AT004821 and R01DK053620 (K. T. W.), P30DK058404 (Vanderbilt University Digestive Disease Research Center) and Department of Veterans Affairs (K. T. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2006, CLIN LUNG CANCER, V7, P417, DOI 10.3816/CLC.2006.n.027; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Burgeiro A, 2011, ANTI-CANCER DRUG, V22, P507, DOI 10.1097/CAD.0b013e32834438f6; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hyun MS, 2010, J CELL BIOCHEM, V109, P329, DOI 10.1002/jcb.22384; Imanshahidi M, 2008, PHYTOTHER RES, V22, P999, DOI 10.1002/ptr.2399; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Li X, 2007, NEUROSCIENCE, V144, P56, DOI 10.1016/j.neuroscience.2006.08.065; Liu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021416; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rugo H, 2007, BREAST CANCER RES TR, V105, P17, DOI 10.1007/s10549-006-9430-6; Sun YY, 2009, ANTI-CANCER DRUG, V20, P757, DOI 10.1097/CAD.0b013e328330d95b; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Turk V, 2004, CANCER CELL, V5, P409, DOI 10.1016/S1535-6108(04)00117-5; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zha WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009069; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	33	81	86	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36418	10.1371/journal.pone.0036418	http://dx.doi.org/10.1371/journal.pone.0036418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574158	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800054
J	Abdelwahab, MG; Fenton, KE; Preul, MC; Rho, JM; Lynch, A; Stafford, P; Scheck, AC				Abdelwahab, Mohammed G.; Fenton, Kathryn E.; Preul, Mark C.; Rho, Jong M.; Lynch, Andrew; Stafford, Phillip; Scheck, Adrienne C.			The Ketogenic Diet Is an Effective Adjuvant to Radiation Therapy for the Treatment of Malignant Glioma	PLOS ONE			English	Article							KETONE-BODIES; GLIOBLASTOMA CELLS; CANCER-CELLS; BRAIN CANCER; 2-DEOXY-D-GLUCOSE; METABOLISM; GLUCOSE; GROWTH; AKT; RESTRICTION	Introduction: The ketogenic diet (KD) is a high-fat, low-carbohydrate diet that alters metabolism by increasing the level of ketone bodies in the blood. KetoCal (R) (KC) is a nutritionally complete, commercially available 4:1 (fat: carbohydrate+protein) ketogenic formula that is an effective non-pharmacologic treatment for the management of refractory pediatric epilepsy. Diet-induced ketosis causes changes to brain homeostasis that have potential for the treatment of other neurological diseases such as malignant gliomas. Methods: We used an intracranial bioluminescent mouse model of malignant glioma. Following implantation animals were maintained on standard diet (SD) or KC. The mice received 2x4 Gy of whole brain radiation and tumor growth was followed by in vivo imaging. Results: Animals fed KC had elevated levels of beta-hydroxybutyrate (p = 0.0173) and an increased median survival of approximately 5 days relative to animals maintained on SD. KC plus radiation treatment were more than additive, and in 9 of 11 irradiated animals maintained on KC the bioluminescent signal from the tumor cells diminished below the level of detection (p<0.0001). Animals were switched to SD 101 days after implantation and no signs of tumor recurrence were seen for over 200 days. Conclusions: KC significantly enhances the anti-tumor effect of radiation. This suggests that cellular metabolic alterations induced through KC may be useful as an adjuvant to the current standard of care for the treatment of human malignant gliomas.	[Abdelwahab, Mohammed G.; Fenton, Kathryn E.; Preul, Mark C.; Rho, Jong M.; Scheck, Adrienne C.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Lynch, Andrew] Danone Res, Ctr Specialised Nutr, Nutricia Adv Med Nutr, Liverpool, Merseyside, England; [Stafford, Phillip] Arizona State Univ, AZ Biodesign, Ctr Innovat Med, Sch Life Sci, Tempe, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Danone Nutricia; Arizona State University; Arizona State University-Tempe	Abdelwahab, MG (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA.	adrienne.scheck@thebni.edu	Scheck, Adrienne/AAH-5040-2020	Scheck, Adrienne/0000-0003-3497-1895	Nutricia Advanced Medical Nutrition through Nutricia North America; Arizona Disease Research Commission [1010]	Nutricia Advanced Medical Nutrition through Nutricia North America(Danone Nutricia); Arizona Disease Research Commission	This work was supported in part by a grant from Nutricia Advanced Medical Nutrition through Nutricia North America, the company that distributes KetoCal (R) in the USA. The funders had no role in data collection and analysis, decision to publish or preparation of the manuscript, but did input to the study design. Web sites: Nutricia - http://nutrition.nutricia.com/ Students Supporting Brain Tumor Research - www.ssbtr.org Arizona Disease Research Commission - http://azdhs.gov/biomedical/ (contract 1010 to ACS) No additional external funding was received for this study.	Abdelwahab MG, 2011, JOVE-J VIS EXP, DOI 10.3791/3403; Baranano Kristin W, 2008, Curr Treat Options Neurol, V10, P410, DOI 10.1007/s11940-008-0043-8; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Eloqayli H, 2011, NEUROCHEM RES, V36, P1566, DOI 10.1007/s11064-011-0485-3; Gupta S, 2009, J CANCER RES THER, V5, P16, DOI 10.4103/0973-1482.55135; Jouanneau E, 2006, CANCER IMMUNOL IMMUN, V55, P254, DOI 10.1007/s00262-005-0040-7; Li HF, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-43; Liang BC, 2011, INT J MOL MED, V27, P159, DOI 10.3892/ijmm.2010.579; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Maurer GD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-315; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; Mulrooney TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018085; NEBELING LC, 1995, J AM DIET ASSOC, V95, P693, DOI 10.1016/S0002-8223(95)00189-1; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Newcomb EW, 2006, CLIN CANCER RES, V12, P4730, DOI 10.1158/1078-0432.CCR-06-0593; Nicholas MK, 2011, SEMIN ONCOL, V38, P243, DOI 10.1053/j.seminoncol.2011.01.009; Niyazi M, 2011, RADIOTHER ONCOL, V98, P1, DOI 10.1016/j.radonc.2010.11.006; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Roesler R, 2010, EXPERT REV ANTICANC, V10, P1735, DOI [10.1586/era.10.167, 10.1586/ERA.10.167]; Ruggiero A, 2006, J NEURO-ONCOL, V77, P89, DOI 10.1007/s11060-005-9011-2; Samala R, 2011, NEUROCHEM INT, V58, P5, DOI 10.1016/j.neuint.2010.10.011; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Seyfried TN, 2010, LANCET ONCOL, V11, P811, DOI 10.1016/S1470-2045(10)70166-2; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Stafford P, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-74; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamada M, 1999, CANCER CHEMOTH PHARM, V44, P59, DOI 10.1007/s002800050945; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	38	170	180	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36197	10.1371/journal.pone.0036197	http://dx.doi.org/10.1371/journal.pone.0036197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563484	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700033
J	Richier, S; Macey, AI; Pratt, NJ; Honey, DJ; Moore, CM; Bibby, TS				Richier, Sophie; Macey, Anna I.; Pratt, Nicola J.; Honey, David J.; Moore, C. Mark; Bibby, Thomas S.			Abundances of Iron-Binding Photosynthetic and Nitrogen-Fixing Proteins of Trichodesmium Both in Culture and In Situ from the North Atlantic	PLOS ONE			English	Article							TRIMERIC PHOTOSYSTEM-I; N-2 FIXATION; PHOSPHORUS LIMITATION; MOLECULAR ASSESSMENT; STRUCTURAL BASIS; HIGH LIGHT; CYANOBACTERIUM; GROWTH; SPP.; PACIFIC	Marine cyanobacteria of the genus Trichodesmium occur throughout the oligotrophic tropical and subtropical oceans, where they can dominate the diazotrophic community in regions with high inputs of the trace metal iron (Fe). Iron is necessary for the functionality of enzymes involved in the processes of both photosynthesis and nitrogen fixation. We combined laboratory and field-based quantifications of the absolute concentrations of key enzymes involved in both photosynthesis and nitrogen fixation to determine how Trichodesmium allocates resources to these processes. We determined that protein level responses of Trichodesmium to iron-starvation involve down-regulation of the nitrogen fixation apparatus. In contrast, the photosynthetic apparatus is largely maintained, although re-arrangements do occur, including accumulation of the iron-stress-induced chlorophyll-binding protein IsiA. Data from natural populations of Trichodesmium spp. collected in the North Atlantic demonstrated a protein profile similar to iron-starved Trichodesmium in culture, suggestive of acclimation towards a minimal iron requirement even within an oceanic region receiving a high iron-flux. Estimates of cellular metabolic iron requirements are consistent with the availability of this trace metal playing a major role in restricting the biomass and activity of Trichodesmium throughout much of the subtropical ocean.	[Richier, Sophie; Macey, Anna I.; Pratt, Nicola J.; Honey, David J.; Moore, C. Mark; Bibby, Thomas S.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Richier, S (corresponding author), Univ Southampton, Natl Oceanog Ctr, European Way, Southampton, Hants, England.	s.richier@noc.soton.ac.uk	Bibby, Thomas/C-9159-2014	Bibby, Thomas/0000-0003-1743-473X; Moore, Mark/0000-0002-9541-6046	United Kingdom Natural Environment Research Council (NERC) [NE/F019254/1]; UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans [2025]; National Oceanography Centre, Southampton; AMT programme [206]; NERC [NE/F019254/1] Funding Source: UKRI; Natural Environment Research Council [NE/F019254/1] Funding Source: researchfish	United Kingdom Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans; National Oceanography Centre, Southampton; AMT programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The study was supported by the United Kingdom Natural Environment Research Council (NERC) through grant number NE/F019254/1 (TSB and CMM). This study was also supported by the UK Natural Environment Research Council through the UK Marine Research Institutes strategic research programme Oceans 2025 awarded to Plymouth Marine Laboratory and The National Oceanography Centre, Southampton. This contribution is number 206 of the AMT programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GL, 1984, BIOCHEMISTRY-US, V23, P2118, DOI 10.1021/bi00305a002; Baker AR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018518; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Bergquist BA, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002505; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Bibby TS, 2008, DEEP-SEA RES PT II, V55, P1310, DOI 10.1016/j.dsr2.2008.01.014; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Bibby TS, 2009, PLOS ONE, DOI [10.1371/journal.pone.0004601, DOI 10.1371/JOURNAL.-PONE.0004601]; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Chappell PD, 2010, ENVIRON MICROBIOL, V12, P13, DOI 10.1111/j.1462-2920.2009.02026.x; Chappell PD, 2012, ISME J, V6, P1728, DOI 10.1038/ismej.2012.13; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Compaore J, 2010, ENVIRON MICROBIOL, V12, P54, DOI 10.1111/j.1462-2920.2009.02034.x; Dominic B, 1998, MICROBIOL-UK, V144, P3359, DOI 10.1099/00221287-144-12-3359; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; Eady R. R., 1979, A treatise on dinitrogen fixation. Inorganic and physical chemistry and biochemistry, P399; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Fu FX, 2003, BIOTECHNOL LETT, V25, P645, DOI 10.1023/A:1023068232375; GALLON JR, 1992, NEW PHYTOL, V122, P571; Gao Y, 2001, GEOPHYS RES LETT, V28, P29, DOI 10.1029/2000GL011926; Havaux M, 2005, FEBS LETT, V579, P2289, DOI 10.1016/j.febslet.2005.03.021; Hewson I, 2009, ISME J, V3, P1286, DOI 10.1038/ismej.2009.75; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hynes AM, 2009, LIMNOL OCEANOGR, V54, P1438, DOI 10.4319/lo.2009.54.5.1438; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Johnson JL, 2000, BBA-PROTEIN STRUCT M, V1543, P24, DOI 10.1016/S0167-4838(00)00195-3; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Kustka A, 2003, J PHYCOL, V39, P12, DOI 10.1046/j.1529-8817.2003.01156.x; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Michel KP, 2004, PHYSIOL PLANTARUM, V120, P36, DOI 10.1111/j.0031-9317.2004.0229.x; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Monteiro FM, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003902; Monteiro FM, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003731; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; MOREL FMM, 1991, LIMNOL OCEANOGR, V36, P1742, DOI 10.4319/lo.1991.36.8.1742; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; PAERL HW, 1994, APPL ENVIRON MICROB, V60, P1044, DOI 10.1128/AEM.60.3.1044-1047.1994; PAERL HW, 1987, LIMNOL OCEANOGR, V32, P525, DOI 10.4319/lo.1987.32.3.0525; PAERL HW, 1989, J PHYCOL, V25, P773, DOI 10.1111/j.0022-3646.1989.00773.x; PRUFERTBEBOUT L, 1993, APPL ENVIRON MICROB, V59, P1367, DOI 10.1128/AEM.59.5.1367-1375.1993; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rubin M, 2011, NAT GEOSCI, V4, P529, DOI 10.1038/NGEO1181; RUETER JG, 1990, J PHYCOL, V26, P30, DOI 10.1111/j.0022-3646.1990.00030.x; RUETER JG, 1988, J PHYCOL, V24, P249; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Sheridan CC, 2002, J PLANKTON RES, V24, P913, DOI 10.1093/plankt/24.9.913; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Singh AK, 2007, PHOTOSYNTH RES, V93, P17, DOI 10.1007/s11120-007-9151-7; Sohm JA, 2006, MAR ECOL PROG SER, V317, P21, DOI 10.3354/meps317021; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Sohm JA, 2008, LIMNOL OCEANOGR, V53, P2495, DOI 10.4319/lo.2008.53.6.2495; STEWART WDP, 1973, ANNU REV MICROBIOL, V27, P283, DOI 10.1146/annurev.mi.27.100173.001435; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Webb EA, 2001, APPL ENVIRON MICROB, V67, P5444, DOI 10.1128/AEM.67.12.5444-5452.2001; Webb EA, 2007, LIMNOL OCEANOGR, V52, P2221, DOI 10.4319/lo.2007.52.5.2221; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Westberry TK, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002673; Whittaker S, 2011, ENV MICROBIOL REP, V3, P54, DOI 10.1111/j.1758-2229.2010.00187.x; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 2011, TRENDS MICROBIOL, V19, P162, DOI 10.1016/j.tim.2010.12.004; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	89	32	33	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35571	10.1371/journal.pone.0035571	http://dx.doi.org/10.1371/journal.pone.0035571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563465	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305340700014
J	Schultsz, C; Jansen, E; Keijzers, W; Rothkamp, A; Duim, B; Wagenaar, JA; van der Ende, A				Schultsz, Constance; Jansen, Ewout; Keijzers, Wendy; Rothkamp, Anja; Duim, Birgitta; Wagenaar, Jaap A.; van der Ende, Arie			Differences in the Population Structure of Invasive Streptococcus suis Strains Isolated from Pigs and from Humans in the Netherlands	PLOS ONE			English	Article							MURAMIDASE-RELEASED PROTEIN; EXTRACELLULAR PROTEIN; DISEASED PIGS; SEROTYPE 14; CPS LOCUS; VIRULENCE; IDENTIFICATION; MENINGITIS; PHAGOCYTOSIS; DETERMINANT	Streptococcus suis serotype 2 is the main cause of zoonotic S. suis infection despite the fact that other serotypes are frequently isolated from diseased pigs. Studies comparing concurrent invasive human and pig isolates from a single geographical location are lacking. We compared the population structures of invasive S. suis strains isolated between 1986 and 2008 from human patients (N = 24) and from pigs with invasive disease (N = 124) in the Netherlands by serotyping and multi locus sequence typing (MLST). Fifty-six percent of pig isolates were of serotype 9 belonging to 15 clonal complexes (CCs) or singleton sequence types (ST). In contrast, all human isolates were of serotype 2 and belonged to two non-overlapping clonal complexes CC1 (58%) and CC20 (42%). The proportion of serotype 2 isolates among S. suis strains isolated from humans was significantly higher than among strains isolated from pigs (24/24 vs. 29/124; P<0.0001). This difference remained significant when only strains within CC1 and CC20 were considered (24/24 vs. 27/37, P = 0.004). The Simpson diversity index of the S. suis population isolated from humans (0.598) was smaller than of the population isolated from pigs (0.765, P = 0.05) indicating that the S. suis population isolated from infected pigs was more diverse than the S. suis population isolated from human patients. S. suis serotype 2 strains of CC20 were all negative in a PCR for detection of genes encoding extracellular protein factor (EF) variants. These data indicate that the polysaccharide capsule is an important correlate of human S. suis infection, irrespective of the ST and EF encoding gene type of S. suis strains.	[Schultsz, Constance] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Schultsz, Constance] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Schultsz, Constance; Jansen, Ewout; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Keijzers, Wendy; van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Ctr Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands; [Rothkamp, Anja] GD Anim Hlth Serv, Deventer, Netherlands; [Duim, Birgitta; Wagenaar, Jaap A.] Univ Utrecht, Fac Vet Med, Dept Immunol & Infect Dis, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	Schultsz, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	schultsz@gmail.com		van der Ende, Arie/0000-0003-1298-3086	European Commission Seventh Framework Programme under ANTIGONE [278976]	European Commission Seventh Framework Programme under ANTIGONE	The work published in this article has received partial funding from the European Commission Seventh Framework Programme under ANTIGONE with project number 278976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AG, 2001, INFECT IMMUN, V69, P2732, DOI 10.1128/IAI.69.4.2732-2735.2001; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Baums CG, 2006, INFECT IMMUN, V74, P6154, DOI 10.1128/IAI.00359-06; Beineke A, 2008, VET MICROBIOL, V128, P423, DOI 10.1016/j.vetmic.2007.10.028; Charland N, 1996, FEMS IMMUNOL MED MIC, V14, P195, DOI 10.1111/j.1574-695X.1996.tb00287.x; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2009, VET MICROBIOL, V139, P310, DOI 10.1016/j.vetmic.2009.06.024; Halaby T, 2000, EUR J CLIN MICROBIOL, V19, P943, DOI 10.1007/PL00011230; Haleis A, 2009, EMERG INFECT DIS, V15, P350, DOI 10.3201/eid1502.080842; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Li P, 2010, MICROB PATHOGENESIS, V49, P305, DOI 10.1016/j.micpath.2010.07.001; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Nghia HDT, 2008, EMERG INFECT DIS, V14, P155, DOI 10.3201/eid1401.070534; Hoa NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017943; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; Smith HE, 2000, MICROB PATHOGENESIS, V29, P127, DOI 10.1006/mpat.2000.0372; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Smith HE, 1999, INFECT IMMUN, V67, P1750; Takamatsu D, 2008, EMERG INFECT DIS, V14, P181, DOI 10.3201/eid1401.070568; van de Beek D, 2008, J INFECTION, V57, P158, DOI 10.1016/j.jinf.2008.04.009; van der Peet-Schwering CMC, 2008, 119 AN SCI GROUP, P119; VECHT U, 1991, INFECT IMMUN, V59, P3156, DOI 10.1128/IAI.59.9.3156-3162.1991; Vimr E, 2002, TRENDS MICROBIOL, V10, P254, DOI 10.1016/S0966-842X(02)02361-2; Wei ZG, 2009, VET MICROBIOL, V137, P196, DOI 10.1016/j.vetmic.2008.12.015; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2000, VET MICROBIOL, V74, P237, DOI 10.1016/S0378-1135(00)00188-7; Wisselink HJ, 2002, J CLIN MICROBIOL, V40, P2922, DOI 10.1128/JCM.40.8.2922-2929.2002	35	76	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e33854	10.1371/journal.pone.0033854	http://dx.doi.org/10.1371/journal.pone.0033854			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563452	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700001
J	Skorobogata, O; Rocheleau, CE				Skorobogata, Olga; Rocheleau, Christian E.			RAB-7 Antagonizes LET-23 EGFR Signaling during Vulva Development in Caenorhabditis elegans	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; C-ELEGANS; FACTOR RECEPTOR; ENDOCYTIC TRAFFICKING; CELL LINEAGES; PROTEIN; RAS; REGULATOR; NEMATODE; LOCALIZATION	The Rab7 GTPase regulates late endosome trafficking of the Epidermal Growth Factor Receptor (EGFR) to the lysosome for degradation. However, less is known about how Rab7 activity, functioning late in the endocytic pathway, affects EGFR signaling. Here we used Caenorhabditis elegans vulva cell fate induction, a paradigm for genetic analysis of EGFR/Receptor Tyrosine Kinase (RTK) signaling, to assess the genetic requirements for rab-7. Using a rab-7 deletion mutant, we demonstrate that rab-7 antagonizes LET-23 EGFR signaling to a similar extent, but in a distinct manner, as previously described negative regulators such as sli-1 c-Cbl. Epistasis analysis places rab-7 upstream of or in parallel to lin-3 EGF and let-23 EGFR. However, expression of gfp::rab-7 in the Vulva Presursor Cells (VPCs) is sufficient to rescue the rab-7(2) VPC induction phenotypes indicating that RAB-7 functions in the signal receiving cell. We show that components of the Endosomal Sorting Complex Required for Transport (ESCRT)-0, and -I, complexes, hgrs-1 Hrs, and vps-28, also antagonize signaling, suggesting that LET-23 EGFR likely transits through Multivesicular Bodies (MVBs) en route to the lysosome. Consistent with RAB-7 regulating LET-23 EGFR trafficking, rab-7 mutants have increased number of LET-23:: GFP-positive endosomes. Our data imply that Rab7, by mediating EGFR trafficking and degradation, plays an important role in downregulation of EGFR signaling. Failure to downregulate EGFR signaling contributes to oncogenesis, and thus Rab7 could possess tumor suppressor activity in humans.	[Skorobogata, Olga] McGill Univ, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Skorobogata, O (corresponding author), McGill Univ, Dept Med, Div Endocrinol & Metab, Montreal, PQ, Canada.	christian.rocheleau@mcgill.ca		Rocheleau, Christian/0000-0001-6738-5636	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant [RGPIN 341579-07]; Canada Research Chair in Signaling and Development; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship; FRSQ Master's training award; National Institutes of Health (NIH) - National Center for Research Resources (NCRR)	Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Signaling and Development; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship(Canadian Institutes of Health Research (CIHR)); FRSQ Master's training award; National Institutes of Health (NIH) - National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (RGPIN 341579-07) to CER. CER. was supported by a Canada Research Chair in Signaling and Development and is supported by the Fonds de la recherche en sante du Quebec (FRSQ). OS is supported by a Canadian Institutes for Health Research (CIHR) Frederick Banting and Charles Best Canada graduate scholarship and a FRSQ Master's training award. The Research Institute at the McGill University Health Centre is supported in part by the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Laetitia Chotard, Adam Saffer, and Meera Sundaram, for critical reading of the manuscript, Marc-Andre Sylvain for technical assistance, Aparna Bhat and Elaine Xie for help scoring LET-23::GFP foci, and Richard Roy, Stuart Kim, Barth Grant, Takao Inoue and Hiroyuki Arai for sharing reagents. C. E. R. thanks H. Robert Horvitz and lab members (M. I. T.) for their generosity and support. The rab-7(ok511) deletion mutant was generated by the C. elegans Reverse Genetics Core Facility at the University of British Columbia, which is part of the International C. elegans Gene Knockout Consortium. Most of the nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) - National Center for Research Resources (NCRR).	AROIAN RV, 1991, GENETICS, V128, P251; AROIAN RV, 1994, EMBO J, V13, P360, DOI 10.1002/j.1460-2075.1994.tb06269.x; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Berset TA, 2005, GENE DEV, V19, P1328, DOI 10.1101/gad.333505; BRENNER S, 1974, GENETICS, V77, P71; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burdine RD, 1998, DEVELOPMENT, V125, P1083; Ceresa BP, 2006, HISTOL HISTOPATHOL, V21, P987, DOI 10.14670/HH-21.987; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Duerr Janet S, 2006, WormBook, P1; Edgley ML, 2001, MOL GENET GENOMICS, V266, P385, DOI 10.1007/s004380100523; Eisenmann DM, 1997, GENETICS, V146, P553; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; FERGUSON EL, 1985, GENETICS, V110, P17; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Gu MY, 2008, J CELL BIOL, V183, P881, DOI 10.1083/jcb.200806088; Gupta BP, 2006, GENETICS, V174, P1315, DOI 10.1534/genetics.106.063990; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hwang BJ, 2004, DEVELOPMENT, V131, P143, DOI 10.1242/dev.00924; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; JONGEWARD GD, 1995, GENETICS, V139, P1553; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kobuna H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001055; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Martinu L, 2002, J BIOL CHEM, V277, P50996, DOI 10.1074/jbc.M204869200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MERESSE S, 1995, J CELL SCI, V108, P3349; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Myers TR, 2005, DEV CELL, V8, P117, DOI 10.1016/j.devcel.2004.11.015; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rocheleau CE, 2005, P NATL ACAD SCI USA, V102, P11757, DOI 10.1073/pnas.0500937102; Rocheleau CE, 2008, GENETICS, V178, P1431, DOI 10.1534/genetics.107.084608; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; SCHIMMOLLER F, 1993, J CELL SCI, V106, P823; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schubbert S, 2007, CURR OPIN GENET DEV, V17, P15, DOI 10.1016/j.gde.2006.12.004; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shim J, 2000, MOL BIOL CELL, V11, P2743, DOI 10.1091/mbc.11.8.2743; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sternberg Paul W, 2005, WormBook, P1, DOI 10.1895/wormbook.1.6.1; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061	73	16	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36489	10.1371/journal.pone.0036489	http://dx.doi.org/10.1371/journal.pone.0036489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558469	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200082
J	Neoh, KB; Yeap, BK; Tsunoda, K; Yoshimura, T; Lee, CY				Neoh, Kok-Boon; Yeap, Beng-Keok; Tsunoda, Kunio; Yoshimura, Tsuyoshi; Lee, Chow-Yang			Do Termites Avoid Carcasses? Behavioral Responses Depend on the Nature of the Carcasses	PLOS ONE			English	Article							FORMOSAN SUBTERRANEAN TERMITE; DEVELOPMENTAL PATHWAYS; DEFENSIVE BEHAVIOR; CASTE COMPOSITIONS; OLEIC-ACID; HONEY-BEE; ISOPTERA; COLONIES; NITROGEN; ANT	Background: Undertaking behavior is a significant adaptation to social life in enclosed nests. Workers are known to remove dead colony members from the nest. Such behavior prevents the spread of pathogens that may be detrimental to a colony. To date, little is known about the ethological aspects of how termites deal with carcasses. Methodology and Principal Findings: In this study, we tested the responses to carcasses of four species from different subterranean termite taxa: Coptotermes formosanus Shiraki and Reticulitermes speratus (Kolbe) (lower termites) and Microcerotermes crassus Snyder and Globitermes sulphureus Haviland (higher termites). We also used different types of carcasses (freshly killed, 1-, 3-, and 7-day-old, and oven-killed carcasses) and mutilated nestmates to investigate whether the termites exhibited any behavioral responses that were specific to carcasses in certain conditions. Some behavioral responses were performed specifically on certain types of carcasses or mutilated termites. C. formosanus and R. speratus exhibited the following behaviors: (1) the frequency and time spent in antennating, grooming, and carcass removal of freshly killed, 1-day-old, and oven-killed carcasses were high, but these behaviors decreased as the carcasses aged; (2) the termites repeatedly crawled under the aging carcass piles; and (3) only newly dead termites were consumed as a food source. In contrast, M. crassus and G. sulphureus workers performed relatively few behavioral acts. Our results cast a new light on the previous notion that termites are necrophobic in nature. Conclusion: We conclude that the behavioral response towards carcasses depends largely on the nature of the carcasses and termite species, and the response is more complex than was previously thought. Such behavioral responses likely are associated with the threat posed to the colony by the carcasses and the feeding habits and nesting ecology of a given species.	[Neoh, Kok-Boon; Yeap, Beng-Keok; Lee, Chow-Yang] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Urban Entomol Lab, George Town, Malaysia; [Tsunoda, Kunio; Yoshimura, Tsuyoshi; Lee, Chow-Yang] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan	Universiti Sains Malaysia; Kyoto University	Neoh, KB (corresponding author), Kyoto Univ, Ctr SE Asian Studies, Yoshida Sakyo Ku, Kyoto, Japan.	chowyang@usm.my	Lee, Chow-Yang/C-7129-2009; Neoh, Kok-Boon/A-4070-2011	Lee, Chow-Yang/0000-0001-8279-4104; Neoh, Kok-Boon/0000-0002-8462-6662	Japan Society for the Promotion of Science; Bayer Environmental Science (Singapore); Universiti Sains Malaysia; Kyoto University, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bayer Environmental Science (Singapore); Universiti Sains Malaysia(Universiti Sains Malaysia); Kyoto University, Japan	This research was a part of the experiment conducted with funding aid from the Japan Society for the Promotion of Science - Exchange Program for East Asian Young Researchers (2010) [Fostering Program of Leading Young Scientists toward the Establishment of Humanosphere Science in East Asia at the Research Institute for Sustainable Humanosphere of Kyoto University] which K-BN and B-KY participated in the program. The other portion of the work carried out in Universiti Sains Malaysia was funded by Bayer Environmental Science (Singapore). K-BN was funded by a postdoctoral fellowship from Universiti Sains Malaysia, and C-YL by a visiting professorship, Kyoto University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1996, JPN J APPL ENTOMOL Z, V40, P265, DOI 10.1303/jjaez.40.265; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Bordereau C, 1997, INSECT SOC, V44, P289, DOI 10.1007/s000400050049; Campora Cory E., 2007, Proceedings of the Hawaiian Entomological Society, V39, P127; Choe DH, 2009, P NATL ACAD SCI USA, V106, P8251, DOI 10.1073/pnas.0901270106; Chouvenc T, 2012, INSECT SOC, V59, P119, DOI 10.1007/s00040-011-0197-3; Chouvenc T, 2005, 16 ANN M EUR CHEM RE, pE1; COWLING EB, 1966, CAN J BOTANY, V44, P1539, DOI 10.1139/b66-167; Crosland MWJ, 2004, ETHOL ECOL EVOL, V16, P117; Crosland MWJ, 1997, ANIM BEHAV, V54, P999, DOI 10.1006/anbe.1997.0509; Dawes-Gromadzki T, 2003, J TROP ECOL, V19, P449, DOI 10.1017/S0266467403003481; EISNER T, 1976, BEHAV ECOL SOCIOBIOL, V1, P83, DOI 10.1007/BF00299954; Fei HX, 2005, J AGR URBAN ENTOMOL, V22, P159; GORDON DM, 1983, J CHEM ECOL, V9, P105, DOI 10.1007/BF00987774; HASKINS C P, 1974, Psyche (Cambridge), V81, P258, DOI 10.1155/1974/80395; Howse P, 1965, INSECTES SOC, V12, P335; Hu XP, 2006, NAT C URB ENT, P40; HUNGATE R. E., 1941, ANN ENT SOC AMERICA, V34, P467; Kitade O, 2010, SOCIOBIOLOGY, V55, P379; Korb J, 2003, NATURWISSENSCHAFTEN, V90, P212, DOI 10.1007/s00114-002-0401-4; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; LINDSTROM M, 1990, NATURWISSENSCHAFTEN, V77, P134, DOI 10.1007/BF01134477; Lopez-Riquelme GO, 2006, PHYSIOL ENTOMOL, V31, P353, DOI 10.1111/j.1365-3032.2006.00526.x; Masterman R, 2001, J COMP PHYSIOL A, V187, P441, DOI 10.1007/s003590100216; Moore B. P., 1969, BIOL TERMITES, P233; POTRIKUS CJ, 1981, P NATL ACAD SCI-BIOL, V78, P4601, DOI 10.1073/pnas.78.7.4601; Renucci M, 2011, INSECT SOC, V58, P9, DOI 10.1007/s00040-010-0109-y; Roisin Y, 1999, INSECT SOC, V46, P273, DOI 10.1007/s000400050146; ROLLO CD, 1994, NATURWISSENSCHAFTEN, V81, P409, DOI 10.1007/BF01132695; Roonwal M. L., 1970, P315; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Saran RK, 2007, J ECON ENTOMOL, V100, P495, DOI 10.1603/0022-0493(2007)100[495:TUATEO]2.0.CO;2; Sobotnik J, 2008, J INSECT BEHAV, V21, P521, DOI 10.1007/s10905-008-9147-y; Sobotnik J, 2008, J CHEM ECOL, V34, P478, DOI 10.1007/s10886-008-9450-2; Song DL, 2006, SOCIOBIOLOGY, V47, P27; Stewart AD, 2006, SOCIOBIOLOGY, V48, P727; Su NY, 1999, SOCIOBIOLOGY, V33, P185; Su NY, 2005, J ECON ENTOMOL, V98, P2143, DOI 10.1603/0022-0493-98.6.2143; SU NY, 1982, J ECON ENTOMOL, V75, P188, DOI 10.1093/jee/75.2.188; Tayasu I, 2002, SOIL BIOL BIOCHEM, V34, P297, DOI 10.1016/S0038-0717(01)00181-X; Thorne B.L., 1982, Psyche (Cambridge), V89, P133, DOI 10.1155/1982/86584; Torales GJ, 2004, SOCIOBIOLOGY, V43, P523; Trumbo ST, 1997, ETHOLOGY, V103, P966; Ulyshen MD, 2012, NATURWISSENSCHAFTEN, V99, P89, DOI 10.1007/s00114-011-0871-3; VISSCHER PK, 1983, ANIM BEHAV, V31, P1070, DOI 10.1016/S0003-3472(83)80014-1; WILSON EDWARD O., 1958, PSYCHE, V65, P108, DOI 10.1155/1958/69391; Wong N, 2010, SOCIOBIOLOGY, V55, P353; Woodrow RJ, 2008, SOCIOBIOLOGY, V52, P107; Yao M, 2009, EVOL BIOL, V36, P267, DOI 10.1007/s11692-009-9069-4; Yeoh BH, 2007, SOCIOBIOLOGY, V50, P457	51	33	36	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36375	10.1371/journal.pone.0036375	http://dx.doi.org/10.1371/journal.pone.0036375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558452	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000199
J	Nomura, K; Inoue, K; Akimoto, K				Nomura, Kyoko; Inoue, Kazuo; Akimoto, Kimihiko			A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; HBA(1C); RISK; A1C; PROGRESSION; HEMOGLOBIN; VALUES	Backgrounds: We compared the usefulness of fasting plasma glucose (FPG), or hemoglobin A1c (HbA1c), or both in predicting type 2 diabetes. Methods: This retrospective cohort study investigated 9,322 Japanese adults (4,786 men and 4,536 women), aged 19-69 yrs, free of diabetes at baseline. Usefulness was assessed by predictive values (PV), sensitivity, specificity, and the area under the receiver operating characteristic curve (AUROC) maximised under the best cut-off point. Results: During the average 6 years of follow-up, 221 men (4.6%) and 92 women (2%) developed diabetes. The best cut-off points for FPG (i.e., 5.67 mmol/l for men and 5.5 mmol/l for women) gave excellent AUROC, and the highest positive PV (13% for men and 9% for women) in predicting diabetes. In high risk subjects with FPG 6.1-6.9 mmol/l, 119 men (26.8%) and 39 women (28.3%) developed diabetes. Under the best cut-off points of FPG 6.39 mmol/l and A1c 5.8, AUROC and positive PV for FPG slightly decreased indicating FPG became less useful and were statistically indistinguishable from those for HbA1c in men. In fact, HbA1c was the most useful in women: HbA1c of 6.0% gave the highest positive likelihood ratio of 2.74 and larger AUROC than did FPG. Although AUROC for HbA1c was acceptable and indistinguishable from that for the combined use, HbA1c had higher specificity and positive LR than did the combined use. Conclusions: This study demonstrated that FPG was the most useful to predict diabetes in the general population. However, in subjects with FPG 6.1-6.9 mmol/l, FPG became less useful and diagnostic performance of FPG was indistinguishable from that of HbA1c in men whereas HbA1c was the most useful in women. Thus, a two-step screening, measurement of HbA1c in association with FPG, may be useful in predicting diabetes.	[Nomura, Kyoko] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Inoue, Kazuo] Teikyo Univ, Sch Med, Dept Community Med, Tokyo 173, Japan; [Akimoto, Kimihiko] Med Checkup Ctr, Tokyo, Japan	Teikyo University; Teikyo University	Nomura, K (corresponding author), Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan.	kyoko@med.teikyo-u.ac.jp	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 1999, Diabetologia, V42, P647; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Ko GTC, 1998, DIABETES CARE, V21, P1221, DOI 10.2337/diacare.21.8.1221; Ko GTC, 2000, DIABETES CARE, V23, P1770, DOI 10.2337/diacare.23.12.1770; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016/j.amjmed.2010.11.025; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; PANZER RJ, 1999, DIAGNOSTIC STRATEGIE, P18; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Tominaga M, 2005, ANN CLIN BIOCHEM, V42, P41, DOI 10.1258/0004563053026835; Wang WY, 2002, DIABETES CARE, V25, P1365, DOI 10.2337/diacare.25.8.1365; Zhou J, 2009, DIABETES CARE, V32, P1188, DOI 10.2337/dc09-0076	23	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36309	10.1371/journal.pone.0036309	http://dx.doi.org/10.1371/journal.pone.0036309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558430	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000185
J	Lioudyno, MI; Broccio, M; Sokolov, Y; Rasool, S; Wu, J; Alkire, MT; Liu, V; Kozak, JA; Dennison, PR; Glabe, CG; Losche, M; Hall, JE				Lioudyno, Maria I.; Broccio, Matteo; Sokolov, Yuri; Rasool, Suhail; Wu, Jessica; Alkire, Michael T.; Liu, Virginia; Kozak, J. Ashot; Dennison, Philip R.; Glabe, Charles G.; Loesche, Mathias; Hall, James E.			Effect of Synthetic A beta Peptide Oligomers and Fluorinated Solvents on Kv1.3 Channel Properties and Membrane Conductance	PLOS ONE			English	Article							ALPHA-7 NICOTINIC ACETYLCHOLINE; SOLUBLE AMYLOID OLIGOMERS; GATED POTASSIUM CHANNELS; ALZHEIMERS-DISEASE; K+ CHANNELS; FIBRILLAR OLIGOMERS; CORTICAL-NEURONS; PRIMARY CULTURES; LIPID-BILAYERS; PROTEIN 1-40	The impact of synthetic amyloid beta (1-42) (A beta(1-42)) oligomers on biophysical properties of voltage-gated potassium channels Kv 1.3 and lipid bilayer membranes (BLMs) was quantified for protocols using hexafluoroisopropanol (HFIP) or sodium hydroxide (NaOH) as solvents prior to initiating the oligomer formation. Regardless of the solvent used A beta(1-42) samples contained oligomers that reacted with the conformation-specific antibodies A11 and OC and had similar size distributions as determined by dynamic light scattering. Patch-clamp recordings of the potassium currents showed that synthetic A beta(1-42) oligomers accelerate the activation and inactivation kinetics of Kv 1.3 current with no significant effect on current amplitude. In contrast to oligomeric samples, freshly prepared, presumably monomeric, A beta(1-42) solutions had no effect on Kv 1.3 channel properties. A beta(1-42) oligomers had no effect on the steady-state current (at -80 mV) recorded from Kv 1.3-expressing cells but increased the conductance of artificial BLMs in a dose-dependent fashion. Formation of amyloid channels, however, was not observed due to conditions of the experiments. To exclude the effects of HFIP (used to dissolve lyophilized A beta(1-42) peptide), and trifluoroacetic acid (TFA) (used during A beta(1-42) synthesis), we determined concentrations of these fluorinated compounds in the stock A beta(1-42) solutions by F-19 NMR. After extensive evaporation, the concentration of HFIP in the 100 x stock A beta(1-42) solutions was,similar to 1.7 mu M. The concentration of residual TFA in the 70 x stock A beta(1-42) solutions was similar to 20 mu M. Even at the stock concentrations neither HFIP nor TFA alone had any effect on potassium currents or BLMs. The A beta(1-42) oligomers prepared with HFIP as solvent, however, were more potent in the electrophysiological tests, suggesting that fluorinated compounds, such as HFIP or structurally-related inhalational anesthetics, may affect A beta(1-42) aggregation and potentially enhance ability of oligomers to modulate voltage-gated ion channels and biological membrane properties.	[Lioudyno, Maria I.; Sokolov, Yuri; Liu, Virginia; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Broccio, Matteo; Loesche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Rasool, Suhail; Wu, Jessica; Glabe, Charles G.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Alkire, Michael T.; Liu, Virginia] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Irvine, CA USA; [Kozak, J. Ashot] Wright State Univ, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA; [Dennison, Philip R.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA; [Loesche, Mathias] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Loesche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA	University of California System; University of California Irvine; Carnegie Mellon University; University of California System; University of California Irvine; University of California System; University of California Irvine; University System of Ohio; Wright State University Dayton; University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; Carnegie Mellon University	Lioudyno, MI (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	jhall@uci.edu	Lösche, Mathias/J-2986-2013; Hall, James E/K-6306-2012	Lösche, Mathias/0000-0001-6666-916X; 	National Institutes of Health [1P01 AG032131]; Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG032131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (1P01 AG032131) and the Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; Bittner EA, 2011, CAN J ANESTH, V58, P216, DOI 10.1007/s12630-010-9418-x; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; BURDICK D, 1992, J BIOL CHEM, V267, P546; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Carnini A, 2007, CURR ALZHEIMER RES, V4, P233; Chen C, 2005, BIOCHEM BIOPH RES CO, V338, P1913, DOI 10.1016/j.bbrc.2005.10.169; Cherubini A, 2010, NEUROSCI LETT, V469, P214, DOI 10.1016/j.neulet.2009.11.077; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Chung S, 2001, NEUROSCI LETT, V300, P67, DOI 10.1016/S0304-3940(01)01516-6; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Decker H, 2010, J NEUROCHEM, V115, P1520, DOI 10.1111/j.1471-4159.2010.07058.x; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; Esteban JA, 2004, TRENDS NEUROSCI, V27, P1, DOI 10.1016/j.tins.2003.10.008; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fodale V, 2010, ANAESTHESIA, V65, P388, DOI 10.1111/j.1365-2044.2010.06244.x; Fordyce CB, 2005, J NEUROSCI, V25, P7139, DOI 10.1523/JNEUROSCI.1251-05.2005; Good TA, 1996, BIOPHYS J, V70, P296, DOI 10.1016/S0006-3495(96)79570-X; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Han J, 2001, BIOCHEM BIOPH RES CO, V285, P1136, DOI 10.1006/bbrc.2001.5291; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Holmes TC, 1996, J NEUROSCI, V16, P1581; Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3; Jeon YJ, 2008, NEUROREPORT, V19, P1661, DOI 10.1097/WNR.0b013e3283140f10; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Juhasz G, 2010, J ALZHEIMERS DIS, V19, P1055, DOI [10.3233/JAD-2010-1301, 10.3233/JAD-2009-1301]; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kawahara M, 2000, BRAIN RES BULL, V53, P389, DOI 10.1016/S0361-9230(00)00370-1; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Kokubo H, 2005, BRAIN RES, V1031, P222, DOI 10.1016/j.brainres.2004.10.041; KUES WA, 1992, EUR J NEUROSCI, V4, P1296, DOI 10.1111/j.1460-9568.1992.tb00155.x; Kupper J, 2002, PFLUG ARCH EUR J PHY, V443, P541, DOI 10.1007/s00424-001-0734-4; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Levitt M, 1997, ANNU REV BIOCHEM, V66, P549, DOI 10.1146/annurev.biochem.66.1.549; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Liebau S, 2006, J NEUROCHEM, V99, P426, DOI 10.1111/j.1471-4159.2006.03967.x; Lopez-Toledano MA, 2010, J ALZHEIMERS DIS, V20, P395, DOI 10.3233/JAD-2010-1388; MacManus A, 2000, J BIOL CHEM, V275, P4713, DOI 10.1074/jbc.275.7.4713; Mamikonyan G, 2007, J BIOL CHEM, V282, P22376, DOI 10.1074/jbc.M700088200; Mandal PK, 2009, BIOCHEM BIOPH RES CO, V379, P716, DOI 10.1016/j.bbrc.2008.12.092; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; OhnoShosaku T, 1996, NEUROSCI LETT, V207, P195, DOI 10.1016/0304-3940(96)12518-0; Pannaccione A, 2005, J NEUROCHEM, V94, P572, DOI 10.1111/j.1471-4159.2005.03075.x; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Ramsden M, 2002, BRAIN RES, V956, P254, DOI 10.1016/S0006-8993(02)03547-3; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Rodriguez JJ, 2008, PLOS ONE, V3, P1; Rodriguez JJ, 2009, NEUROREPORT, V20, P907, DOI 10.1097/WNR.0b013e32832be77d; Sarsoza F, 2009, ACTA NEUROPATHOL, V118, P505, DOI 10.1007/s00401-009-0530-3; Seidler NW, 2009, PROTEIN PEPTIDE LETT, V16, P182, DOI 10.2174/092986609787316324; Sokolov Yuri, 2006, J Gen Physiol, V128, P637, DOI 10.1085/jgp.200609533; Somodi S, 2004, AM J PHYSIOL-CELL PH, V287, pC1067, DOI 10.1152/ajpcell.00438.2003; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Stefani M, 2010, FEBS J, V277, P4602, DOI 10.1111/j.1742-4658.2010.07889.x; Taniuchi N, 2007, NEUROREPORT, V18, P1801, DOI 10.1097/WNR.0b013e3282f1c9e9; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Wang HY, 2009, J NEUROSCI, V29, P10961, DOI 10.1523/JNEUROSCI.6088-08.2009; Wang HY, 2000, J NEUROCHEM, V75, P1155, DOI 10.1046/j.1471-4159.2000.0751155.x; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Xie ZC, 2006, EXP GERONTOL, V41, P346, DOI 10.1016/j.exger.2006.01.014; Ye CP, 2003, NEUROBIOL DIS, V13, P177, DOI 10.1016/S0969-9961(03)00068-8; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Ziabreva I, 2006, J PSYCHOSOM RES, V61, P311, DOI 10.1016/j.jpsychores.2006.07.017	82	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35090	10.1371/journal.pone.0035090	http://dx.doi.org/10.1371/journal.pone.0035090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563377	Green Published, gold			2022-12-27	WOS:000305349100006
J	Zhou, WB; He, ZY; Xue, JL; Wang, MH; Zha, XM; Ling, LJ; Chen, L; Wang, S; Liu, X				Zhou, Wenbin; He, Zhongyuan; Xue, Jialei; Wang, Minghai; Zha, Xiaoming; Ling, Lijun; Chen, Lin; Wang, Shui; Liu, Xiaoan			Molecular Subtype Classification Is a Determinant of Non-Sentinel Lymph Node Metastasis in Breast Cancer Patients with Positive Sentinel Lymph Nodes	PLOS ONE			English	Article							GUIDELINE RECOMMENDATIONS; AXILLARY DISSECTION; ONLINE CALCULATOR; BIOPSY; INVOLVEMENT; PREDICTION; MORBIDITY; MODELS	Background: Previous studies suggested that the molecular subtypes were strongly associated with sentinel lymph node (SLN) status. The purpose of this study was to determine whether molecular subtype classification was associated with non-sentinel lymph nodes (NSLN) metastasis in patients with a positive SLN. Methodology and Principal Findings: Between January 2001 and March 2011, a total of 130 patients with a positive SLN were recruited. All these patients underwent a complete axillary lymph node dissection. The univariate and multivariate analyses of NSLN metastasis were performed. In univariate and multivariate analyses, large tumor size, macrometastasis and high tumor grade were all significant risk factors of NSLN metastasis in patients with a positive SLN. In univariate analysis, luminal B subgroup showed higher rate of NSLN metastasis than other subgroup (P = 0.027). When other variables were adjusted in multivariate analysis, the molecular subtype classification was a determinant of NSLN metastasis. Relative to triple negative subgroup, both luminal A (P = 0.047) and luminal B (P = 0.010) subgroups showed a higher risk of NSLN metastasis. Otherwise, HER2 over-expression subgroup did not have a higher risk than triple negative subgroup (P = 0.183). The area under the curve (AUC) value was 0.8095 for the Cambridge model. When molecular subtype classification was added to the Cambridge model, the AUC value was 0.8475. Conclusions: Except for other factors, molecular subtype classification was a determinant of NSLN metastasis in patients with a positive SLN. The predictive accuracy of mathematical models including molecular subtype should be determined in the future.	[Zhou, Wenbin; He, Zhongyuan; Xue, Jialei; Wang, Minghai; Zha, Xiaoming; Ling, Lijun; Chen, Lin; Wang, Shui; Liu, Xiaoan] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Peoples R China	Nanjing Medical University	Zhou, WB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Peoples R China.	ws0801@hotmail.com; liuxiaoan@126.com			National Natural Science Foundation of China [81172502]; Science and Education for Health Foundation of Jiangsu Province [RC2007054]; First Affiliated Hospital of NJMU [IRT-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Education for Health Foundation of Jiangsu Province; First Affiliated Hospital of NJMU	This work was supported in part by the National Natural Science Foundation of China (81172502), the Science and Education for Health Foundation of Jiangsu Province (RC2007054), and the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU (IRT-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdessalam SF, 2001, AM J SURG, V182, P316, DOI 10.1016/S0002-9610(01)00719-X; Cady B, 1997, J SURG ONCOL, V66, P7, DOI 10.1002/(SICI)1096-9098(199709)66:1<7::AID-JSO3>3.0.CO;2-8; Chen K, 2011, CANC SCI; Cserni G, 2004, JPN J CLIN ONCOL, V34, P519, DOI 10.1093/jjco/hyh090; Degnim AC, 2005, AM J SURG, V190, P543, DOI 10.1016/j.amjsurg.2005.06.008; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Hack TF, 1999, J CLIN ONCOL, V17, P143, DOI 10.1200/JCO.1999.17.1.143; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Keshtgar MRS, 2002, LANCET ONCOL, V3, P105, DOI 10.1016/S1470-2045(02)00652-6; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Moghaddam Y, 2010, BRIT J SURG, V97, P1646, DOI 10.1002/bjs.7181; Morton DL, 2005, ANN SURG, V242, P302, DOI 10.1097/01.sla.0000181092.50141.fa; Nos C, 2003, BRIT J SURG, V90, P1354, DOI 10.1002/bjs.4325; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rahusen FD, 2001, ARCH SURG-CHICAGO, V136, P1059, DOI 10.1001/archsurg.136.9.1059; Reyal F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020297; Reynolds C, 1999, J CLIN ONCOL, V17, P1720, DOI 10.1200/JCO.1999.17.6.1720; Schrenk P, 2005, BRIT J SURG, V92, P707, DOI 10.1002/bjs.4937; Scow JS, 2009, CANCER-AM CANCER SOC, V115, P4064, DOI 10.1002/cncr.24469; Turner RR, 1997, ANN SURG, V226, P271, DOI 10.1097/00000658-199709000-00006; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Weaver DL, 2000, CANCER, V88, P1099, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.3.CO;2-Z; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yin WJ, 2009, BREAST CANCER RES TR, V115, P325, DOI 10.1007/s10549-008-0096-0; Zhou WB, 2011, CAN J SURG, V54, P300, DOI 10.1503/cjs.006010	30	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35881	10.1371/journal.pone.0035881	http://dx.doi.org/10.1371/journal.pone.0035881			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563412	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100038
J	Liu, N; Zhang, YJ; Chang, SJ; Kan, HM; Lin, LJ				Liu, Nan; Zhang, Yingjun; Chang, Shujuan; Kan, Haiming; Lin, Lijun			Impact of Grazing on Soil Carbon and Microbial Biomass in Typical Steppe and Desert Steppe of Inner Mongolia	PLOS ONE			English	Article							DEGRADED SANDY GRASSLAND; ORGANIC-CARBON; MIXED-GRASS; TERM MANAGEMENT; ALPINE MEADOW; STOCKING RATE; NITROGEN; PLANT; SEQUESTRATION; INTENSITY	The potential of grazing lands to sequester carbon must be understood to develop effective soil conservation measures and sustain livestock production. Our objective was to evaluate the effects of grazing on soil organic carbon (SOC), total nitrogen (TN), microbial biomass carbon (MBC) in Typical steppe and Desert steppe ecosystems, which are both important grassland resources for animal grazing and ecological conservation in China, and to derive region-specific soil C changes associated with different stocking rates (ungrazed, UG; lightly grazed, LG; moderately grazed, MG; heavily grazed, HG). This study substantiated that significant higher SOC, TN and MBC appeared with the treatment of LG in typical steppe. From 2004 to 2010, grazing treatments increased soil carbon storage in desert steppe, which was partly due to the grazing history. The higher MBC concentration and MBC/SOC suggest a great potential for carbon sequestration in the desert steppe ecosystem. The greater MBC in desert steppe than typical steppe was mainly the result of higher precipitation and temperature, instead of soil substrate. The change of MBC and the strong positive relationships between MBC and SOC indicated that MBC in the soil was a sensitive index to indicate the dynamics of soil organic carbon in both steppes in Inner Mongolia of China.	[Liu, Nan; Zhang, Yingjun; Chang, Shujuan; Kan, Haiming; Lin, Lijun] China Agr Univ, Coll Anim Sci & Technol, Inst Grassland Sci, Beijing 100094, Peoples R China	China Agricultural University	Liu, N (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Inst Grassland Sci, Beijing 100094, Peoples R China.	zhangyj@cau.edu.cn	Zhang, Yingjun/A-2400-2015	Zhang, Yingjun/0000-0001-5776-4392	earmarked fund for Modern Agro-industry Technology Research System [CARS-35]; 973 project [2007CB106805];  [200903060]	earmarked fund for Modern Agro-industry Technology Research System; 973 project(National Basic Research Program of China); 	Research was funded by the earmarked fund for Modern Agro-industry Technology Research System (CARS-35) and the 973 project (Grant 2007CB106805) and the project (200903060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril A, 2001, APPL SOIL ECOL, V16, P243, DOI 10.1016/S0929-1393(00)00122-0; Ananyeva ND, 1999, BIOL FERT SOILS, V29, P291, DOI 10.1007/s003740050555; Anderson JD, 2008, APPL SOIL ECOL, V40, P387, DOI 10.1016/j.apsoil.2008.06.008; ANDERSON TH, 1989, SOIL BIOL BIOCHEM, V21, P471, DOI 10.1016/0038-0717(89)90117-X; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Bagchi S, 2010, ECOL LETT, V13, P959, DOI 10.1111/j.1461-0248.2010.01486.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bird SB, 2002, ENVIRON POLLUT, V116, P445, DOI 10.1016/S0269-7491(01)00222-6; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Derner JD, 2007, J SOIL WATER CONSERV, V62, P77; Derner JD, 2006, PLANT SOIL, V280, P77, DOI 10.1007/s11104-005-2554-3; DORMAAR JF, 1990, J RANGE MANAGE, V43, P456, DOI 10.2307/3899012; Du Preez C. C., 1993, African Journal of Range and Forage Science, V10, P108, DOI 10.1080/10220119.1993.9638333; FRANK AB, 1995, J RANGE MANAGE, V48, P470, DOI 10.2307/4002255; Frazao LA, 2010, AGR ECOSYST ENVIRON, V135, P161, DOI 10.1016/j.agee.2009.09.003; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gao YH, 2007, POL J ECOL, V55, P469; Gao YH, 2009, J FOOD AGRIC ENVIRON, V7, P749; Hamilton EW, 2001, ECOLOGY, V82, P2397, DOI 10.1890/0012-9658(2001)082[2397:CPSSMA]2.0.CO;2; Guodong HD, 2008, AGR ECOSYST ENVIRON, V125, P21, DOI 10.1016/j.agee.2007.11.009; Harris WN, 2007, ACTA OECOL, V32, P207, DOI 10.1016/j.actao.2007.05.001; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; Heady HF., 2019, RANGELAND ECOLOGY MA, V1st; Holt JA, 1997, APPL SOIL ECOL, V5, P143, DOI 10.1016/S0929-1393(96)00145-X; HU J.Y, 2009, STUDY EEOLOGICAL CHA; Ingram LJ, 2008, SOIL SCI SOC AM J, V72, P939, DOI 10.2136/sssaj2007.0038; INSAM H, 1988, MICROBIAL ECOL, V15, P177, DOI 10.1007/BF02011711; Kelly RH, 1996, ECOLOGY, V77, P2516, DOI 10.2307/2265750; KIEFT TL, 1994, BIOL FERT SOILS, V18, P155, DOI 10.1007/BF00336463; Li CL, 2008, AGR ECOSYST ENVIRON, V128, P109, DOI 10.1016/j.agee.2008.05.008; Lin Y, 2010, AGR ECOSYST ENVIRON, V138, P282, DOI 10.1016/j.agee.2010.05.013; Liu WX, 2010, GEODERMA, V158, P259, DOI 10.1016/j.geoderma.2010.05.004; Lu FM, 2011, BIOL FERT SOILS, V47, P187, DOI 10.1007/s00374-010-0522-4; Murray S., 2000, PILOT ANAL GLOBAL EC; NAETH MA, 1991, J RANGE MANAGE, V44, P7, DOI 10.2307/4002629; Nardoto GB, 2003, PESQUI AGROPECU BRAS, V38, P955, DOI 10.1590/S0100-204X2003000800008; Nielsen MN, 2002, MICROORGANISMS INDIC; Northup BK, 1999, APPL SOIL ECOL, V13, P259, DOI 10.1016/S0929-1393(99)00039-6; Pineiro G, 2010, RANGELAND ECOL MANAG, V63, P109, DOI 10.2111/08-255.1; Reeder JD, 2004, ENVIRON MANAGE, V33, P485, DOI 10.1007/s00267-003-9106-5; Reeder JD, 2002, ENVIRON POLLUT, V116, P457, DOI 10.1016/S0269-7491(01)00223-8; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; Schuman GE, 1999, ECOL APPL, V9, P65, DOI 10.1890/1051-0761(1999)009[0065:IOGMOT]2.0.CO;2; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; SHARIFF AR, 1994, J RANGE MANAGE, V47, P444, DOI 10.2307/4002994; Shrestha G, 2008, AGR ECOSYST ENVIRON, V125, P173, DOI 10.1016/j.agee.2007.12.007; Smith JL, 1990, SOIL BIOCH, V6, P357; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Su YZ, 2003, NEW ZEAL J AGR RES, V46, P321, DOI 10.1080/00288233.2003.9513560; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang Changting, 2008, Chinese Journal of Applied and Environmental Biology, V14, P225; Wang QiLan, 2008, Acta Prataculturae Sinica, V17, P39; Wang ZW, 2011, RANGELAND ECOL MANAG, V64, P249, DOI 10.2111/REM-D-09-00033.1; XIAO XM, 1995, J ARID ENVIRON, V31, P283, DOI 10.1016/S0140-1963(05)80033-3; Yang Hao, 2009, Chinese Journal of Plant Ecology, V33, P499, DOI 10.3773/j.issn.1005-264x.2009.03.009; Yang Y, 2010, THESIS INNER MONGOLI; Yu M, 2004, J ENVIRON QUAL, V33, P1675, DOI 10.2134/jeq2004.1675	60	75	81	19	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36434	10.1371/journal.pone.0036434	http://dx.doi.org/10.1371/journal.pone.0036434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574161	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800057
J	Salem, M; Vallejo, RL; Leeds, TD; Palti, Y; Liu, SX; Sabbagh, A; Rexroad, CE; Yao, JB				Salem, Mohamed; Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Liu, Sixin; Sabbagh, Annas; Rexroad, Caird E., III; Yao, Jianbo			RNA-Seq Identifies SNP Markers for Growth Traits in Rainbow Trout	PLOS ONE			English	Article							SINGLE GENETIC LINE; SALMON SALMO-SALAR; FEED-EFFICIENCY; MITOCHONDRIAL-FUNCTION; ONCORHYNCHUS-MYKISS; ABNORMAL GROWTH; ASSOCIATION; GENOME; MUSCLE; EXPRESSION	Fast growth is an important and highly desired trait, which affects the profitability of food animal production, with feed costs accounting for the largest proportion of production costs. Traditional phenotype-based selection is typically used to select for growth traits; however, genetic improvement is slow over generations. Single nucleotide polymorphisms (SNPs) explain 90% of the genetic differences between individuals; therefore, they are most suitable for genetic evaluation and strategies that employ molecular genetics for selective breeding. SNPs found within or near a coding sequence are of particular interest because they are more likely to alter the biological function of a protein. We aimed to use SNPs to identify markers and genes associated with genetic variation in growth. RNA-Seq whole-transcriptome analysis of pooled cDNA samples from a population of rainbow trout selected for improved growth versus unselected genetic cohorts (10 fish from 1 full-sib family each) identified SNP markers associated with growth-rate. The allelic imbalances (the ratio between the allele frequencies of the fast growing sample and that of the slow growing sample) were considered at scores >5.0 as an amplification and <0.2 as loss of heterozygosity. A subset of SNPs (n = 54) were validated and evaluated for association with growth traits in 778 individuals of a three-generation parent/offspring panel representing 40 families. Twenty-two SNP markers and one mitochondrial haplotype were significantly associated with growth traits. Polymorphism of 48 of the markers was confirmed in other commercially important aquaculture stocks. Many markers were clustered into genes of metabolic energy production pathways and are suitable candidates for genetic selection. The study demonstrates that RNA-Seq at low sequence coverage of divergent populations is a fast and effective means of identifying SNPs, with allelic imbalances between phenotypes. This technique is suitable for marker development in non-model species lacking complete and well-annotated genome reference sequences.	[Salem, Mohamed; Sabbagh, Annas; Yao, Jianbo] W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA; [Vallejo, Roger L.; Leeds, Timothy D.; Palti, Yniv; Liu, Sixin; Rexroad, Caird E., III] Natl Ctr Cool & Cold Water Aquaculture, Kearneysville, WV USA	West Virginia University	Salem, M (corresponding author), W Virginia Univ, Lab Anim Biotechnol & Genom, Div Anim & Nutr Sci, Morgantown, WV 26506 USA.	mosalem@mail.wvu.edu	Salem, Mohamed/AGB-2739-2022; Vallejo, Roger/AAE-7591-2020	Salem, Mohamed/0000-0003-2142-6716; Vallejo, Roger/0000-0002-5399-3531; Leeds, Timothy/0000-0002-9872-1134	United States Department of Agriculture Cooperative State Research, Education, and Extension Service; States Department of Agriculture Cooperative Agreement [58-1930-5-537]; National Research Initiative Competitive Grant [2007-35205-17914]; Agriculture and Food Research Initiative Competitive Grant	United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); States Department of Agriculture Cooperative Agreement; National Research Initiative Competitive Grant; Agriculture and Food Research Initiative Competitive Grant	This project was supported by the United States Department of Agriculture Cooperative State Research, Education, and Extension Service; United States Department of Agriculture Cooperative Agreement No. 58-1930-5-537; National Research Initiative Competitive Grant No. 2007-35205-17914 and Agriculture and Food Research Initiative Competitive Grant no. It is published with the approval of the Director of the West Virginia Agriculture and Forestry Experiment Station as scientific paper No. 3130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg P, 2006, P 8 WORLD C GEN APPL, P27; Bernard C, 2009, MEAT SCI, V82, P205, DOI 10.1016/j.meatsci.2009.01.012; Blangero J, 2009, HUM BIOL, V81, P849, DOI 10.3378/027.081.0626; BOLDMAN KG, 1995, MANUAL USE IN PRESS; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Brookes A.J, 2007, SINGLE NUCLEOTIDE PO; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Castro-Gago M, 2010, ACTA PAEDIATR, V99, P796, DOI 10.1111/j.1651-2227.2010.01738.x; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dekkers J. C. M., 2004, J ANIM SCI, V82, pE313; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Eya JC, 2011, AQUACULTURE, V321, P71, DOI 10.1016/j.aquaculture.2011.08.037; Eya JC, 2010, N AM J AQUACULT, V72, P225, DOI 10.1577/A09-058.1; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Haller JF, 2011, BBA-MOL BASIS DIS, V1812, P1393, DOI 10.1016/j.bbadis.2011.07.007; Havill LM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S91; Iqbal M, 2004, POULTRY SCI, V83, P474, DOI 10.1093/ps/83.3.474; Johnson NA, 2007, AQUACULTURE, V266, P53, DOI 10.1016/j.aquaculture.2007.02.054; MacMillan JR, 2003, AQUACULTURE, V226, P91, DOI 10.1016/S0044-8486(03)00470-8; Miller Neil A, 2008, J Comput Sci Syst Biol, V1, P132; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Nathanailides C, 1996, J FISH BIOL, V48, P549, DOI 10.1006/jfbi.1996.0054; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Palti Y, 2012, MAR BIOTECHNOL, V14, P343, DOI 10.1007/s10126-011-9418-z; Palti Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-180; Paulson TG, 1999, GENOME RES, V9, P482; PELLETIER D, 1993, J EXP ZOOL, V265, P477, DOI 10.1002/jez.1402650503; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Ryynanen HJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-192; Salem M, 2006, PHYSIOL GENOMICS, V28, P33, DOI 10.1152/physiolgenomics.00114.2006; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Salem M, 2010, J PROTEOMICS, V73, P778, DOI 10.1016/j.jprot.2009.10.014; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; SAS, 2007, HELP DOC; SAS Institute Inc, 2007, SAS 9 1 3 HELP DOC; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Sillanpaa MJ, 2011, HEREDITY, V106, P511, DOI 10.1038/hdy.2010.91; Silverstein JT, 2006, N AM J AQUACULT, V68, P168, DOI 10.1577/A05-010.1; Silverstein JT, 2004, AQUAC RES, V35, P40, DOI 10.1111/j.1365-2109.2004.00979.x; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Vallejo RL, 2010, J ANIM SCI, V88, P3814, DOI 10.2527/jas.2010-2951; VANDERWALT LD, 1993, COMP BIOCHEM PHYS B, V104, P765, DOI 10.1016/0305-0491(93)90210-V; Villanueva B, 2004, J ANIM SCI, V82, P1305; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wang SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-450; Wolf K., 1985, Journal of Applied Ichthyology, V1, P131, DOI 10.1111/j.1439-0426.1985.tb00422.x; Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x; Zador E, 2007, CELL CALCIUM, V41, P379, DOI 10.1016/j.ceca.2006.08.001; Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174	63	114	123	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36264	10.1371/journal.pone.0036264	http://dx.doi.org/10.1371/journal.pone.0036264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574143	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800039
J	Sperling, LE; Klaczinski, J; Schutz, C; Rudolph, L; Layer, PG				Sperling, Laura E.; Klaczinski, Janine; Schuetz, Corina; Rudolph, Lydia; Layer, Paul G.			Mouse Acetylcholinesterase Enhances Neurite Outgrowth of Rat R28 Cells Through Interaction With Laminin-1	PLOS ONE			English	Article							AMYLOID-BETA-PEPTIDE; PERIPHERAL ANIONIC SITE; C-TERMINAL PEPTIDE; NEURONS IN-VITRO; READTHROUGH ACETYLCHOLINESTERASE; TRANSMEMBRANE PROTEIN; HIPPOCAMPAL-NEURONS; ALZHEIMERS FIBRILS; PROMOTING SITE; BINDING SITES	The enzyme acetylcholinesterase (AChE) terminates synaptic transmission at cholinergic synapses by hydrolyzing the neurotransmitter acetylcholine, but can also exert 'non-classical', morpho-regulatory effects on developing neurons such as stimulation of neurite outgrowth. Here, we investigated the role of AChE binding to laminin-1 on the regulation of neurite outgrowth by using cell culture, immunocytochemistry, and molecular biological approaches. To explore the role of AChE, we examined fiber growth of cells overexpressing different forms of AChE, and/or during their growth on laminin-1. A significant increase of neuritic growth as compared with controls was observed for neurons over-expressing AChE. Accordingly, addition of globular AChE to the medium increased total length of neurites. Co-transfection with PRIMA, a membrane anchor of AChE, led to an increase in fiber length similar to AChE overexpressing cells. Transfection with an AChE mutant that leads to the retention of AChE within cells had no stimulatory effect on neurite length. Noticeably, the longest neurites were produced by neurons overexpressing AChE and growing on laminin-1, suggesting that the AChE/laminin interaction is involved in regulating neurite outgrowth. Our findings demonstrate that binding of AChE to laminin-1 alters AChE activity and leads to increased neurite growth in culture. A possible mechanism of the AChE effect on neurite outgrowth is proposed due to the interaction of AChE with laminin-1.	[Sperling, Laura E.; Klaczinski, Janine; Schuetz, Corina; Rudolph, Lydia; Layer, Paul G.] Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany	Technical University of Darmstadt	Sperling, LE (corresponding author), Tech Univ Darmstadt, Fachbereich Biol, Darmstadt, Germany.	sperling@bio.tu-darmstadt.de	Sperling, Laura Elena/H-1649-2011	Sperling, Laura Elena/0000-0001-9171-7696	EU [QLK4-CT-2002-02264]	EU(European Commission)	This work was supported by the EU contract SENS-PESTI, QLK4-CT-2002-02264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 1998, J NEUROSCI, V18, P3213; Anderson AA, 2008, J CELL PHYSIOL, V215, P82, DOI 10.1002/jcp.21288; AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Bataille S, 1998, EUR J NEUROSCI, V10, P560, DOI 10.1046/j.1460-9568.1998.00065.x; Beeri R, 1997, J NEUROCHEM, V69, P2441; Bigbee JW, 2000, BRAIN RES, V861, P354, DOI 10.1016/S0006-8993(00)02046-1; Birikh KR, 2003, P NATL ACAD SCI USA, V100, P283, DOI 10.1073/pnas.0135647100; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SS, 1983, P NATL ACAD SCI-BIOL, V80, P5927, DOI 10.1073/pnas.80.19.5927; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; Bytyqi AH, 2004, EUR J NEUROSCI, V20, P2953, DOI 10.1111/j.1460-9568.2004.03753.x; CHANGEUX JP, 1966, MOL PHARMACOL, V2, P369; Chen VP, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00036; Day T, 2002, NEUROSCIENCE, V111, P649, DOI 10.1016/S0306-4522(02)00031-3; De Ferrari GV, 2001, BIOCHEMISTRY-US, V40, P10447, DOI 10.1021/bi0101392; De Jaco A, 2006, J BIOL CHEM, V281, P9667, DOI 10.1074/jbc.M510262200; De Jaco A, 2002, J NEUROSCI RES, V70, P756, DOI 10.1002/jnr.10436; DECURTIS I, 1991, J CELL BIOL, V113, P405, DOI 10.1083/jcb.113.2.405; DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x; Deutsch VR, 2002, EXP HEMATOL, V30, P1153, DOI 10.1016/S0301-472X(02)00900-1; Dori A, 2006, J MOL NEUROSCI, V28, P247, DOI 10.1385/JMN:28:3:247; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Giordano C, 2007, BIOCHEM BIOPH RES CO, V356, P398, DOI 10.1016/j.bbrc.2007.02.146; Greenberg DS, 2010, NEURODEGENER DIS, V7, P60, DOI 10.1159/000285507; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; Grisaru D, 2001, MOL MED, V7, P93, DOI 10.1007/BF03401943; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Hanin G, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00028; HUCHO F, 1991, TRENDS PHARMACOL SCI, V12, P422; Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200; Ido H, 2008, J BIOL CHEM, V283, P28149, DOI 10.1074/jbc.M803553200; Inestrosa NC, 1996, MOL PSYCHIATR, V1, P359; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Johnson G, 1999, BIOCHEM BIOPH RES CO, V258, P758, DOI 10.1006/bbrc.1999.0705; Johnson G, 2004, BIOCHEM BIOPH RES CO, V319, P448, DOI 10.1016/j.bbrc.2004.05.018; Johnson G, 2004, J CELL BIOCHEM, V91, P999, DOI 10.1002/jcb.10785; Johnson G, 2003, NEUROSCI LETT, V337, P37, DOI 10.1016/S0304-3940(02)01298-3; Johnson G, 2000, APPL BIOCHEM BIOTECH, V83, P131, DOI 10.1385/ABAB:83:1-3:131; Johnson G, 2008, FEBS J, V275, P5129, DOI 10.1111/j.1742-4658.2008.06644.x; Johnson G, 2008, BIOCHEM J, V411, P507, DOI 10.1042/BJ20071404; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Karpel R, 1996, J NEUROCHEM, V66, P114; KLEINMAN HK, 1990, ANN NY ACAD SCI, V580, P302, DOI 10.1111/j.1749-6632.1990.tb17939.x; Koenigsberger C, 1997, J NEUROCHEM, V69, P1389; LAYER PG, 1987, P NATL ACAD SCI USA, V84, P284, DOI 10.1073/pnas.84.1.284; LAYER PG, 1993, CELL TISSUE RES, V273, P219, DOI 10.1007/BF00312823; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LevLehman E, 1997, BLOOD, V89, P3644, DOI 10.1182/blood.V89.10.3644.3644_3644_3653; Liang D, 2009, J BIOL CHEM, V284, P5195, DOI 10.1074/jbc.M806260200; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Olivera S, 2003, MOL CELL NEUROSCI, V23, P96, DOI 10.1016/S1044-7431(03)00021-6; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Paraoanu LE, 2004, FEBS LETT, V576, P161, DOI 10.1016/j.febslet.2004.08.078; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Plantman S, 2008, MOL CELL NEUROSCI, V39, P50, DOI 10.1016/j.mcn.2008.05.015; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.neuro.14.1.531; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Seigel GM, 2004, CURR EYE RES, V28, P257, DOI 10.1076/ceyr.28.4.257.27831; Sharma KV, 1998, J NEUROSCI RES, V53, P454, DOI 10.1002/(SICI)1097-4547(19980815)53:4<454::AID-JNR7>3.3.CO;2-E; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Vogel-Hopker A, 2011, PROTEIN PEPT LETT; Woolf NJ, 1997, CONSCIOUS COGN, V6, P574, DOI 10.1006/ccog.1997.0319	67	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36683	10.1371/journal.pone.0036683	http://dx.doi.org/10.1371/journal.pone.0036683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570738	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400054
J	Andersen, SB; Ferrari, M; Evans, HC; Elliot, SL; Boomsma, JJ; Hughes, DP				Andersen, Sandra B.; Ferrari, Matthew; Evans, Harry C.; Elliot, Simon L.; Boomsma, Jacobus J.; Hughes, David P.			Disease Dynamics in a Specialized Parasite of Ant Societies	PLOS ONE			English	Article							TROPICAL FOREST ECOSYSTEMS; ANISOPLIAE VAR. ACRIDUM; LIFE; FUNGI; FORMICIDAE; EVOLUTION; CADAVERS; GROWTH	Coevolution between ant colonies and their rare specialized parasites are intriguing, because lethal infections of workers may correspond to tolerable chronic diseases of colonies, but the parasite adaptations that allow stable coexistence with ants are virtually unknown. We explore the trade-offs experienced by Ophiocordyceps parasites manipulating ants into dying in nearby graveyards. We used field data from Brazil and Thailand to parameterize and fit a model for the growth rate of graveyards. We show that parasite pressure is much lower than the abundance of ant cadavers suggests and that hyperparasites often castrate Ophiocordyceps. However, once fruiting bodies become sexually mature they appear robust. Such parasite life-history traits are consistent with iteroparity-a reproductive strategy rarely considered in fungi. We discuss how tropical habitats with high biodiversity of hyperparasites and high spore mortality has likely been crucial for the evolution and maintenance of iteroparity in parasites with low dispersal potential.	[Andersen, Sandra B.; Boomsma, Jacobus J.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark; [Ferrari, Matthew] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Evans, Harry C.] CAB Int, E UK, Egham, Surrey, England; [Evans, Harry C.; Elliot, Simon L.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil; [Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Andersen, SB (corresponding author), Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark.	SBAndersen@bio.ku.dk; DPHughes@psu.edu	Boomsma, Jacobus J/M-2785-2014; Elliot, Simon Luke/A-5557-2013	Boomsma, Jacobus J/0000-0002-3598-1609; Elliot, Simon Luke/0000-0002-7469-2949; Andersen, Sandra Breum/0000-0002-7030-040X	Ph.D. Scholarship from Science Faculty of the University of Copenhagen; Danish National Research Foundation; Brazilian science foundation (CNPq); Outgoing International Marie Curie Fellowship	Ph.D. Scholarship from Science Faculty of the University of Copenhagen; Danish National Research Foundation(Danmarks Grundforskningsfond); Brazilian science foundation (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Outgoing International Marie Curie Fellowship	SBA was funded by a Ph.D. Scholarship from the Science Faculty of the University of Copenhagen, and JJB and SBA were supported by the Danish National Research Foundation. HCE and SLE were funded by the Brazilian science foundation (CNPq). DPH was funded by an Outgoing International Marie Curie Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Arthurs S, 2001, J INVERTEBR PATHOL, V78, P59, DOI 10.1006/jipa.2001.5050; Arthurs SP, 2001, ENTOMOL EXP APPL, V100, P69, DOI 10.1023/A:1019265214318; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BOOMSMA JJ, 2005, INSECT EVOLUTIONARY; CARNEY WP, 1969, AM MIDL NAT, V82, P605, DOI 10.2307/2423801; CHARNOV EL, 1973, AM NAT, V107, P791, DOI 10.1086/282877; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Evans HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017024; EVANS HC, 1982, ECOL ENTOMOL, V7, P47, DOI 10.1111/j.1365-2311.1982.tb00643.x; EVANS HC, 1974, J APPL ECOL, V11, P37, DOI 10.2307/2402003; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Hamilton W.D., 1987, P81; Harper J. L, 1977, POPULATION BIOL PLAN; Hatzipapas P, 2002, MYCOL RES, V106, P1349, DOI 10.1017/S0953756202006792; HOLLDOBLER B, ANTS; Hoover K, 2011, SCIENCE, V333, P1401, DOI 10.1126/science.1209199; Hughes DP, 2008, TRENDS ECOL EVOL, V23, P672, DOI 10.1016/j.tree.2008.07.011; Isaka M, 2005, ACCOUNTS CHEM RES, V38, P813, DOI 10.1021/ar040247r; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; Keller S, 2003, BIOCONTROL, V48, P307, DOI 10.1023/A:1023646207455; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Leger RJS, 2008, J INVERTEBR PATHOL, V98, P271, DOI 10.1016/j.jip.2008.01.007; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LESTON D, 1973, PANS (PEST ARTIC NEWS SUMM), V19, P311; Liu HP, 2003, J INVERTEBR PATHOL, V82, P139, DOI 10.1016/S0022-2011(03)00018-1; MACKAY WP, 1985, OECOLOGIA, V66, P484, DOI 10.1007/BF00379338; Majer Jonathan D., 1993, P115; Marikovsky P. I., 1962, Insectes Sociaux Paris, V9, P173, DOI 10.1007/BF02224263; Metcalfe NB, 2003, EXP GERONTOL, V38, P935, DOI 10.1016/S0531-5565(03)00159-1; MIRENDA JT, 1981, ANIM BEHAV, V29, P410, DOI 10.1016/S0003-3472(81)80100-5; Moore D, 2008, BR MYCOL SY, V28, P79; Naug D, 2002, J THEOR BIOL, V215, P427, DOI 10.1006/jtbi.2001.2524; Pontoppidan MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004835; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; Poulin R, EVOLUTIONARY ECOLOGY; Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0; Sanjuan T, 2001, REV BIOL TROP, V49, P945; Schmid-Hempel P, EVOLUTIONARY PARASIT; Schmid-Hempel P, PARASITES SOCIAL INS; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; Soanes DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012725; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Wilson K, 2003, J ANIM ECOL, V72, P133, DOI 10.1046/j.1365-2656.2003.00680.x; Yanoviak SP, 2008, AM NAT, V171, P536, DOI 10.1086/528968	47	31	31	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36352	10.1371/journal.pone.0036352	http://dx.doi.org/10.1371/journal.pone.0036352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567151	Green Published, gold			2022-12-27	WOS:000305341500070
J	Buffart, LM; Thong, MSY; Schep, G; Chinapaw, MJM; Brug, J; van de Poll-Franse, LV				Buffart, Laurien M.; Thong, Melissa S. Y.; Schep, Goof; Chinapaw, Mai J. M.; Brug, Johannes; van de Poll-Franse, Lonneke V.			Self-Reported Physical Activity: Its Correlates and Relationship with Health-Related Quality of Life in a Large Cohort of Colorectal Cancer Survivors	PLOS ONE			English	Article							EXERCISE BEHAVIOR; RANDOMIZED-TRIAL; HOSPITAL ANXIETY; COLON-CANCER; FATIGUE; VALIDATION; DEPRESSION; IMPACT; QUESTIONNAIRE; COMPENDIUM	Background: Physical activity (PA) is suggested to be an important non-pharmacologic means to improve health-related outcomes among cancer survivors. We aimed to describe the PA level, its correlates, and association with health-related quality of life (HRQoL) in colorectal cancer (CRC) survivors. Methods: CRC survivors identified from the Eindhoven Cancer Registry treated between 1998 and 2007 were included. Survivors completed validated questionnaires on PA, distress, fatigue, and HRQoL. Moderate-to-vigorous physical activity (MVPA) levels were calculated by summing the time spent on walking, bicycling, gardening and sports (>= 3 MET). Multiple linear regression analyses were conducted to study which socio-demographic and clinical factors were associated with MVPA. Furthermore, we examined associations between MVPA and physical and mental HRQoL, and whether these associations were mediated by fatigue and distress. Results: Cross-sectional data of 1371 survivors (response: 82%) were analysed. Participants were 69.5 (SD 9.7) years old, 56% were male, and survival duration was 3.9 (SD 2.5) years. Participants self-reported on average 95.5 (SD 80.3) min on MVPA per day. Younger age, male sex, being employed, non-smoking, lower BMI, colon cancer (vs. rectal cancer), chemotherapy treatment and having no co-morbidities were associated with higher MVPA (p<0.05). MVPA was positively associated with physical HRQoL (regression coefficient of total association (c) = 0.030; se = 0.004) after adjusting for socio-demographic and clinical factors. Fatigue mediated this association between MVPA and physical HRQoL (44% mediated). The association between MVPA and mental HRQoL was not statistically significant after adjusting for socio-demographic and cancer-related factors (c = 0.005; se = 0.004). Conclusion: In CRC survivors, clinical factors including the absence of co-morbidity, tumour site and chemotherapy treatment were associated with higher MVPA, in addition to several socio-demographic factors. Higher MVPA was associated with higher physical HRQoL but not with mental HRQoL. Fatigue and distress mediated the association between MVPA and HRQoL.	[Buffart, Laurien M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Buffart, Laurien M.; Chinapaw, Mai J. M.; Brug, Johannes] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Thong, Melissa S. Y.; van de Poll-Franse, Lonneke V.] Tilburg Univ, Ctr Res Psychol Somat Dis CoRPS, NL-5000 LE Tilburg, Netherlands; [Thong, Melissa S. Y.; van de Poll-Franse, Lonneke V.] Comprehens Canc Ctr S, Eindhoven, Netherlands; [Schep, Goof] Maxima Med Ctr Veldhoven, Dept Sports Med, Veldhoven, Netherlands; [Chinapaw, Mai J. M.] Vrije Univ Amsterdam Med Ctr, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Tilburg University; Maxima Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Buffart, LM (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands.	l.buffart@vumc.nl	van de Poll, Lonneke/AAA-9509-2021; Buffart, Laurien/ABA-8889-2020; Brug, Johannes/A-8242-2018; Thong, Melissa/AAC-8052-2021; Paw, Mai Chin A/N-1665-2019	Buffart, Laurien/0000-0002-8095-436X; Brug, Johannes/0000-0002-1904-7349; Paw, Mai Chin A/0000-0001-6259-2441	Comprehensive Cancer Centre South, Eindhoven, the Netherlands; EMGO Institute for Health and Care Research; Cancer Research Award from Dutch Cancer Society [UVT-2009-4349]	Comprehensive Cancer Centre South, Eindhoven, the Netherlands; EMGO Institute for Health and Care Research; Cancer Research Award from Dutch Cancer Society	The data collection of this study was funded by the Comprehensive Cancer Centre South, Eindhoven, the Netherlands. The contribution of Laurien M. Buffart was supported by a fellowship granted by the EMGO Institute for Health and Care Research. Dr. Lonneke van de Poll-Franse is supported by a Cancer Research Award from the Dutch Cancer Society (#UVT-2009-4349). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blanchard CM, 2003, PREV MED, V37, P389, DOI 10.1016/S0091-7435(03)00150-6; Centraal Bureau voor de Statistiek, 2011, GEZ LEEFST ZORGG T M; Courneya K S, 1997, J Altern Complement Med, V3, P215, DOI 10.1089/acm.1997.3.215; Courneya KS, 2009, BREAST CANCER RES TR, V114, P179, DOI 10.1007/s10549-008-9987-3; Courneya KS, 2005, ANN BEHAV MED, V29, P147, DOI 10.1207/s15324796abm2902_9; Courneya KS, 2003, EUR J CANCER CARE, V12, P347, DOI 10.1046/j.1365-2354.2003.00437.x; Courneya KS, 2003, MED SCI SPORT EXER, V35, P1846, DOI 10.1249/01.MSS.0000093622.41587.B6; Courneya KS, 1999, ANN BEHAV MED, V21, P171, DOI 10.1007/BF02908298; Courneya KS, 2001, PSYCHO-ONCOL, V10, P444, DOI 10.1002/pon.524; COURNEYA KS, 1999, PSYCHOL HEALTH MED, V4, P181, DOI DOI 10.1080/135485099106315; Craft LL, 2012, CANCER EPIDEM BIOMAR, V21, P3, DOI 10.1158/1055-9965.EPI-11-0634; Cramp F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006145.pub2; Curt G A, 2000, Oncologist, V5, P353, DOI 10.1634/theoncologist.5-5-353; Cust AE, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-33; Demark-Wahnefried W, 2008, AM FAM PHYSICIAN, V77, P1573; Denlinger CS, 2009, J NATL COMPR CANC NE, V7, P883, DOI 10.6004/jnccn.2009.0058; Dimeo FC, 2001, CANCER, V92, P1689, DOI 10.1002/1097-0142(20010915)92:6+<1689::AID-CNCR1498>3.0.CO;2-H; Duijn C, 2002, MAANDSTATISTIEK BEVO, V50, P32; Duijts SFA, 2011, PSYCHO-ONCOLOGY, V20, P115, DOI 10.1002/pon.1728; Grimmett C, 2011, QUAL LIFE RES, V20, P1237, DOI 10.1007/s11136-011-9855-1; Hawkes AL, 2008, SUPPORT CARE CANCER, V16, P1097, DOI 10.1007/s00520-008-0421-5; Hawkes AL, 2011, EUR J CANCER, V47, P267, DOI 10.1016/j.ejca.2010.10.002; Haydon AMM, 2006, GUT, V55, P62, DOI 10.1136/gut.2005.068189; Husson O, 2013, PSYCHO-ONCOLOGY, V22, P490, DOI 10.1002/pon.3042; IKCnet Dutch Cancer Registration, 2012, SURV; Irwin ML, 2008, CANCER J, V14, P435, DOI 10.1097/PPO.0b013e31818daeee; Janssen-Heijnen MLG., 2005, RESULTS 50 YEARS CAN; Jones LW, 2004, ANN BEHAV MED, V28, P105, DOI 10.1207/s15324796abm2802_5; Lynch BM, 2008, J CLIN ONCOL, V26, P4480, DOI 10.1200/JCO.2007.15.7917; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3527, DOI 10.1200/JCO.2006.06.0855; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P3535, DOI 10.1200/JCO.2006.06.0863; Meyerhardt JA, 2009, ARCH INTERN MED, V169, P2102, DOI 10.1001/archinternmed.2009.412; Michielsen HJ, 2004, EUR J PSYCHOL ASSESS, V20, P39, DOI 10.1027/1015-5759.20.1.39; Michielsen HJ, 2003, J PSYCHOSOM RES, V54, P345, DOI 10.1016/S0022-3999(02)00392-6; Montazeri A, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-102; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Sapp AL, 2003, CANCER-AM CANCER SOC, V98, P1749, DOI 10.1002/cncr.11717; Schwartz AL, 1999, QUAL LIFE RES, V8, P529, DOI 10.1023/A:1008978611274; SNAITH P, 1988, BRIT MED J, V297, P1544, DOI 10.1136/bmj.297.6662.1544; Speck RM, 2010, J CANCER SURVIV, V4, P87, DOI 10.1007/s11764-009-0110-5; Speed-Andrews AE, 2012, EUR J CANCER CARE, V21, P187, DOI 10.1111/j.1365-2354.2011.01290.x; Speed-Andrews AE, 2009, CURR SPORT MED REP, V8, P176, DOI 10.1249/JSR.0b013e3181ae98f3; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Thong MSY, 2011, EUR J CANCER, V47, P1798, DOI 10.1016/j.ejca.2011.02.006; Thong MSY, 2011, INT J RADIAT ONCOL, V81, pE49, DOI 10.1016/j.ijrobp.2010.12.030; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Union Internationale Contre le Cancer (UICC), 2002, CLASS MAL TUM; van de Poll-Franse LV, 2011, EUR J CANCER, V47, P2188, DOI 10.1016/j.ejca.2011.04.034; Velthuis MJ, 2010, CLIN ONCOL-UK, V22, P208, DOI 10.1016/j.clon.2009.12.005; Vodermaier A, 2009, JNCI-J NATL CANCER I, V101, P1464, DOI 10.1093/jnci/djp336; Voskuil DW, 2010, ANN ONCOL, V21, P2094, DOI 10.1093/annonc/mdq151; Wolin KY, 2011, RECENT RESULTS CANC, V186, P73, DOI 10.1007/978-3-642-04231-7_4; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	63	71	73	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36164	10.1371/journal.pone.0036164	http://dx.doi.org/10.1371/journal.pone.0036164			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567135	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500054
J	Flores-Mateo, G; Violan-Fors, C; Carrillo-Santisteve, P; Peiro, S; Argimon, JM				Flores-Mateo, Gemma; Violan-Fors, Concepcion; Carrillo-Santisteve, Paloma; Peiro, Salvador; Argimon, Josep-Maria			Effectiveness of Organizational Interventions to Reduce Emergency Department Utilization: A Systematic Review	PLOS ONE			English	Review							PRIMARY-HEALTH-CARE; NURSE TELEPHONE CONSULTATION; SAME-DAY APPOINTMENTS; WALK-IN CENTERS; MANAGED CARE; GENERAL-PRACTITIONER; PATIENT KNOWLEDGE; CONTROLLED-TRIAL; AMBULATORY-CARE; IMPACT	Background: Emergency department (ED) utilization has dramatically increased in developed countries over the last twenty years. Because it has been associated with adverse outcomes, increased costs, and an overload on the hospital organization, several policies have tried to curb this growing trend. The aim of this study is to systematically review the effectiveness of organizational interventions designed to reduce ED utilization. Methodology/Principal Findings: We conducted electronic searches using free text and Medical Subject Headings on PubMed and The Cochrane Library to identify studies of ED visits, re-visits and mortality. We performed complementary searches of grey literature, manual searches and direct contacts with experts. We included studies that investigated the effectiveness of interventions designed to reduce ED visits and the following study designs: time series, cross-sectional, repeated cross-sectional, longitudinal, quasi-experimental studies, and randomized trial. We excluded studies on specific conditions, children and with no relevant outcomes (ED visits, re-visits or adverse events). From 2,348 potentially useful references, 48 satisfied the inclusion criteria. We classified the interventions in mutually exclusive categories: 1) Interventions addressing the supply and accessibility of services: 25 studies examined efforts to increase primary care physicians, centers, or hours of service; 2) Interventions addressing the demand for services: 6 studies examined educational interventions and 17 examined barrier interventions (gatekeeping or cost). Conclusions/Significance: The evidence suggests that interventions aimed at increasing primary care accessibility and ED cost-sharing are effective in reducing ED use. However, the rest of the interventions aimed at decreasing ED utilization showed contradictory results. Changes in health care policies require rigorous evaluation before being implemented since these can have a high impact on individual health and use of health care resources. Systematic review registration: http://www.crd.york.ac.uk/PROSPERO. Identifier: CRD420111253	[Flores-Mateo, Gemma; Violan-Fors, Concepcion; Carrillo-Santisteve, Paloma] Inst Univ Invest Atencio Primaria Jordi Gol, Barcelona, Spain; [Flores-Mateo, Gemma] Univ Rovira & Virgili, Tarragona, Spain; [Violan-Fors, Concepcion] Univ Autonoma Barcelona, Bellaterra, Spain; [Violan-Fors, Concepcion] Inst Catala Salut, Catalunya, Spain; [Peiro, Salvador] Ctr Super Invest Salud Publ, Valencia, Spain; [Argimon, Josep-Maria] Serv Catala Salut, Div Avaluacio, Barcelona, Spain	Universitat Rovira i Virgili; Autonomous University of Barcelona	Flores-Mateo, G (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol, Barcelona, Spain.	gflores@idiapjgol.org	Violan, Concepcion/I-4493-2019; Peiro, Salvador/H-5778-2017; Violán, Concepcion/HHC-2893-2022	Violan, Concepcion/0000-0003-3309-5360; Peiro, Salvador/0000-0002-3902-569X; Violán, Concepcion/0000-0003-3309-5360; Flores-Mateo, Gemma/0000-0001-6901-7327				Alberola Benavent V, 1994, Aten Primaria, V14, P825; Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Bertakis KD, 1999, MED CARE, V37, P78, DOI 10.1097/00005650-199901000-00011; Bird SR, 2007, AUST HEALTH REV, V31, P451, DOI 10.1071/AH070451; Bolibar I, 1996, MED CLIN-BARCELONA, V107, P289; Brekke KR, 2007, J HEALTH ECON, V26, P149, DOI 10.1016/j.jhealeco.2006.04.004; Bunn F, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004180.PUB2, 10.1002/14651858.CD004180.pub2]; Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x; Centers for Disease Control and Prevention, 2012, HLTH DAT INT; Chalder M, 2003, BRIT MED J, V326, P532, DOI 10.1136/bmj.326.7388.532; DARNELL JC, 1985, MED CARE, V23, P20, DOI 10.1097/00005650-198501000-00003; de la Fuente DO, 2007, REV ESP SALUD PUBLIC, V81, P191, DOI [10.1590/S1135-57272007000200009, 10.1590/s1135-57272007000200009]; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Derlet RW, 1997, ANN EMERG MED, V30, P292, DOI 10.1016/S0196-0644(97)70164-1; DeSalvo A, 2000, Clin Perform Qual Health Care, V8, P35, DOI 10.1108/14664100010333017; Falik M, 2001, MED CARE, V39, P551, DOI 10.1097/00005650-200106000-00004; Federico SG, 2007, PEDIATRICS, V120, pe1009, DOI 10.1542/peds.2006-3094; Ferris TG, 2001, NEW ENGL J MED, V345, P1312, DOI 10.1056/NEJMsa010097; Gill J M, 1996, Fam Med, V28, P178; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Grudzen CR, 2007, JAMA-J AM MED ASSOC, V297, P1126, DOI 10.1001/jama.297.10.1126; Hartung DM, 2008, MED CARE, V46, P565, DOI 10.1097/MLR.0b013e3181734a77; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Hsu J, 2004, MED CARE, V42, P290, DOI 10.1097/01.mlr.0000114917.50457.52; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; Hsu RT, 2003, BRIT MED J, V326, P530, DOI 10.1136/bmj.326.7388.530; Hurley R E, 1989, Health Care Manage Rev, V14, P63; Ionescu-Ittu R, 2007, CAN MED ASSOC J, V177, P1362, DOI 10.1503/cmaj.061615; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; Lattimer V, 2000, BMJ-BRIT MED J, V320, P1053, DOI 10.1136/bmj.320.7241.1053; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lowe RA, 2005, MED CARE, V43, P792, DOI 10.1097/01.mlr.0000170413.60054.54; Lowe RA, 2010, MED CARE, V48, P619, DOI 10.1097/MLR.0b013e3181dbddb1; MARTIN DP, 1989, AM J PUBLIC HEALTH, V79, P1628, DOI 10.2105/AJPH.79.12.1628; McKinstry B, 2002, BRIT J GEN PRACT, V52, P306; Michelen W, 2006, J HEALTH CARE POOR U, V17, P59, DOI 10.1353/hpu.2006.0010; Murphy AW, 1997, FAM PRACT, V14, P407, DOI 10.1093/fampra/14.5.407; Mustard CA, 1998, CAN MED ASSOC J, V158, P49; Newton MF, 2008, JAMA-J AM MED ASSOC, V300, P1914, DOI 10.1001/jama.300.16.1914; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; OGRADY KF, 1985, NEW ENGL J MED, V313, P484, DOI 10.1056/NEJM198508223130806; Pasarín M Isabel, 2006, Gac Sanit, V20, P91, DOI 10.1157/13087318; Pearson DA, 2007, ANN EMERG MED, V50, P646, DOI 10.1016/j.annemergmed.2007.07.015; PEIRO S, 1999, EC SALUD, V33, P3; Philips H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-222; Ragin DF, 2005, ACAD EMERG MED, V12, P1158, DOI 10.1197/j.aem.2005.06.030; Rector TS, 1999, AM J MANAG CARE, V5, P1505; Reed M, 2005, MED CARE, V43, P810, DOI 10.1097/01.mlr.0000170416.68260.78; Remler DK, 2009, ANNU REV PUBL HEALTH, V30, P293, DOI 10.1146/annurev.publhealth.29.020907.090804; Retchin SM, 2009, AM J MANAG CARE, V15, P245; Richards DA, 2002, BRIT MED J, V325, P1214, DOI 10.1136/bmj.325.7374.1214; Roberts E, 1998, HEALTH POLICY, V44, P191, DOI 10.1016/S0168-8510(98)00021-9; Rust G, 2009, J RURAL HEALTH, V25, P8, DOI 10.1111/j.1748-0361.2009.00193.x; Salisbury C, 2007, EMERG MED J, V24, P265, DOI 10.1136/emj.2006.042507; Schillinger D, 2000, J GEN INTERN MED, V15, P329, DOI 10.1046/j.1525-1497.2000.07010.x; Scott JC, 2004, J AM GERIATR SOC, V52, P1463, DOI 10.1111/j.1532-5415.2004.52408.x; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; SJONELL G, 1986, FAM PRACT, V3, P148, DOI 10.1093/fampra/3.3.148; Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194; Sprivulis PC, 2006, MED J AUSTRALIA, V184, P208, DOI 10.5694/j.1326-5377.2006.tb00203.x; Stein AT, 2002, FAM PRACT, V19, P207, DOI 10.1093/fampra/19.2.207; Valdres Carroquino P, 1993, Aten Primaria, V11, P178; van Uden CJT, 2005, J GEN INTERN MED, V20, P612, DOI 10.1111/j.1525-1497.2005.0091.x; Vedsted P, 2001, SCAND J PRIM HEALTH, V19, P95; Viner KM, 2000, ANN EMERG MED, V35, P272, DOI 10.1016/S0196-0644(00)70079-5; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; Walters JAE, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001288.pub3; Waters TM, 2011, HEALTH SERV RES, V46, P155, DOI 10.1111/j.1475-6773.2010.01191.x; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; Wilson Amy R, 2008, Benefits Q, V24, P46; Wong MD, 2001, AM J PUBLIC HEALTH, V91, P1889, DOI 10.2105/AJPH.91.11.1889; Young GP, 1997, ACAD EMERG MED, V4, P1129, DOI 10.1111/j.1553-2712.1997.tb03695.x	74	69	69	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35903	10.1371/journal.pone.0035903	http://dx.doi.org/10.1371/journal.pone.0035903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567118	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500036
J	Morris, DS; Tynan, MA				Morris, Daniel S.; Tynan, Michael A.			Fiscal and Policy Implications of Selling Pipe Tobacco for Roll-Your-Own Cigarettes in the United States	PLOS ONE			English	Article								Background: The Federal excise tax was increased for tobacco products on April 1, 2009. While excise tax rates prior to the increase were the same for roll-your-own (RYO) and pipe tobacco, the tax on pipe tobacco was $21.95 per pound less than the tax on RYO tobacco after the increase. Subsequently, tobacco manufacturers began labeling loose tobacco as pipe tobacco and marketing these products to RYO consumers at a lower price. Retailers refer to these products as "dual purpose'' or "dual use'' pipe tobacco. Methods: Data on tobacco tax collections comes from the Alcohol and Tobacco Tax and Trade Bureau. Joinpoint software was used to identify changes in sales trends. Estimates were generated for the amount of pipe tobacco sold for RYO use and for Federal and state tax revenue lost through August 2011. Results: Approximately 45 million pounds of pipe tobacco has been sold for RYO use from April 2009 to August 2011, lowering state and Federal revenue by over $1.3 billion. Conclusions: Marketing pipe tobacco as "dual purpose'' and selling it for RYO use provides an opportunity to avoid paying higher cigarette prices. This blunts the public health impact excise tax increases would otherwise have on reducing tobacco use through higher prices. Selling pipe tobacco for RYO use decreases state and Federal revenue and also avoids regulations on flavored tobacco, banned descriptors, prohibitions on shipping, and reporting requirements.	[Morris, Daniel S.] Oregon Hlth Author, Tobacco Prevent & Educ Program, Portland, OR USA; [Tynan, Michael A.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Morris, DS (corresponding author), Oregon Hlth Author, Tobacco Prevent & Educ Program, Portland, OR USA.	daniel.s.morris@state.or.us						Alcohol and Tobacco Tax and Trade Bureau, 2011, TTBGOV TOB STAT; Alcohol and Tobacco Tax and Trade Bureau, 2010, FREQ ASK QUEST REG T; Alcohol and Tobacco Tax and Trade Bureau, 2011, TTBGOV TAX FEE RAT; Alcohol and Tobacco Tax and Trade Bureau, PIP TOB; Alcohol and Tobacco Tax and Trade Bureau, 2010, TTB RUL 2010 4 CIG M; [Anonymous], JOINP REGR PROGR VER; Apuzzo Matt, ASS PRESS; Chaloupka FJ, 2011, TOB CONTROL, V20, P235, DOI 10.1136/tc.2010.039982; DeCicca P, 2010, EXCISE TAX AVOIDANCE; Dougher C, 2011, S FLORIDA SUN SENTIN; Farrelly MC, 2003, STATE CIGARETTE EXCI; Hunstinger D, 2011, INDIANAPOLIS STAR; *I MED, 2007, END TOB PROBL BLUEPR; Kesmodel D, 2010, WALL STREET J; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Morris DS, 2010, TOB CONTROL, V19, P421, DOI 10.1136/tc.2009.034280; Orzechowski W, 2011, TAX BURDEN TOBACCO, V45; Powell M., 2011, SEATTLE TIMES; Shelley D, 2007, AM J PUBLIC HEALTH, V97, P1483, DOI 10.2105/AJPH.2005.079921; Stehr M, 2005, J HEALTH ECON, V24, P277, DOI 10.1016/j.jhealeco.2004.08.005; US Department of Health and Human Services, 2000, RED TOB US REP SURG; Wisconsin Department of Revenue, 2011, REV ISS NOT ROLL YOU; World Health Organization, 2008, MPOWER POL PACK REV; Young D, 2006, TOB CONTROL, V15, P76, DOI 10.1136/tc.2005.013268	24	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36487	10.1371/journal.pone.0036487	http://dx.doi.org/10.1371/journal.pone.0036487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567159	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500078
J	Pence, BD; Lowder, TW; Keylock, KT; Potter, VJV; Cook, MD; McAuley, E; Woods, JA				Pence, Brandt D.; Lowder, Thomas W.; Keylock, K. Todd; Potter, Victoria J. Vieira; Cook, Marc D.; McAuley, Edward; Woods, Jeffrey A.			Relationship between Systemic Inflammation and Delayed-Type Hypersensitivity Response to Candida Antigen in Older Adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMMUNE FUNCTION; ANTIBODY-RESPONSE; CELL DIVERSITY; EXERCISE; DISEASE; VACCINATION; MECHANISMS; DECREASES; HUMANS	Research has shown that aging is associated with increased systemic inflammation as well as a reduction in the strength of immune responses. However, little evidence exists linking the decrease in cell-mediated immunity in older adults with other health parameters. We sought to examine the relationship between cell-mediated immunity as measured in vivo by the delayed-type hypersensitivity (DTH) response to candida antigen and demographic and physiological variables in older (6580 y.o.) adults. Candida antigen response was not related to gender or obesity, or to a number of other physiological variables including fitness and body composition. However, positive responders had significantly lower serum C-reactive protein levels (CRP, p<0.05) vs. non-responders. Furthermore, subjects with CRP<4.75 mg.L-1 had greater odds of developing a positive response compared to those with CRP>4.75 mg.L-1. Therefore, positive responses to candida antigen in older adults appears to be related to lower levels of systemic inflammation.	[Pence, Brandt D.; Lowder, Thomas W.; Keylock, K. Todd; Cook, Marc D.; McAuley, Edward; Woods, Jeffrey A.] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Pence, Brandt D.; Potter, Victoria J. Vieira; Cook, Marc D.; Woods, Jeffrey A.] Univ Illinois, Integrat Immunol & Behav Program, Urbana, IL USA; [Potter, Victoria J. Vieira; Woods, Jeffrey A.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [McAuley, Edward] Univ Illinois, Dept Psychol, Urbana, IL USA; [Woods, Jeffrey A.] Univ Illinois, Dept Pathol, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Pence, BD (corresponding author), Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA.	woods1@illinois.edu	Lowder, Thomas/GZM-3182-2022	Pence, Brandt/0000-0002-4059-9092; Lowder, Thomas/0000-0001-9301-4599	National Institutes of Health [R01 AG18861]; NATIONAL INSTITUTE ON AGING [R01AG018861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (nih.gov, grant number R01 AG18861) to JAW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; CHRISTOU NV, 1995, ANN SURG, V222, P534; Christou NV, 1995, ANN SURG, V222, P546; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; El Yousfi M, 2005, MECH AGEING DEV, V126, P874, DOI 10.1016/j.mad.2005.03.008; FIETTA A, 1994, GERONTOLOGY, V40, P237; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Gibson KL, 2009, AGING CELL, V8, P18, DOI 10.1111/j.1474-9726.2008.00443.x; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Grant RW, 2008, BRAIN BEHAV IMMUN, V22, P923, DOI 10.1016/j.bbi.2008.01.006; Iannitti T, 2011, HUM BIOL, V83, P531, DOI 10.3378/027.083.0407; Keylock KT, 2008, AM J PHYSIOL-REG I, V294, pR179, DOI 10.1152/ajpregu.00177.2007; Keylock KT, 2007, J APPL PHYSIOL, V102, P1090, DOI 10.1152/japplphysiol.00790.2006; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pence BD, 2011, AM J LIFESTYLE MED, V5, P238, DOI 10.1177/1559827610392317; Phan HM, 2008, AM J GERIATR CARDIOL, V17, P101; Rafi A, 2005, ANN ALLERG ASTHMA IM, V94, P445, DOI 10.1016/S1081-1206(10)61114-3; Simpson RJ, 2011, EXERC SPORT SCI REV, V39, P23, DOI 10.1097/JES.0b013e318201f39d; Smith TP, 2004, J APPL PHYSIOL, V97, P491, DOI 10.1152/japplphysiol.01404.2003; Vieira VJ, 2009, BRAIN BEHAV IMMUN, V23, P485, DOI 10.1016/j.bbi.2009.01.011; WAKSMAN BH, 1979, CELL IMMUNOL, V42, P155, DOI 10.1016/0008-8749(79)90229-6; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Windgassen EB, 2011, POSTGRAD MED, V123, P114, DOI 10.3810/pgm.2011.01.2252; Wolters B, 2003, VACCINE, V21, P3623, DOI 10.1016/S0264-410X(03)00399-2; Woods JA, 1999, MECH AGEING DEV, V109, P1, DOI 10.1016/S0047-6374(99)00014-7; Woods JA, 2003, BRAIN BEHAV IMMUN, V17, P384, DOI 10.1016/S0889-1591(03)00030-8; Woods JA, 2009, J AM GERIATR SOC, V57, P2183, DOI 10.1111/j.1532-5415.2009.02563.x; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36403	10.1371/journal.pone.0036403	http://dx.doi.org/10.1371/journal.pone.0036403			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567155	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500074
J	Potgieter, KR; Davies-Mostert, HT				Potgieter, Katherine R.; Davies-Mostert, Harriet T.			A Simple Visual Estimation of Food Consumption in Carnivores	PLOS ONE			English	Article							AFRICAN WILD DOGS; LYCAON-PICTUS	Belly-size ratings or belly scores are frequently used in carnivore research as a method of rating whether and how much an animal has eaten. This method provides only a rough ordinal measure of fullness and does not quantify the amount of food an animal has consumed. Here we present a method for estimating the amount of meat consumed by individual African wild dogs Lycaon pictus. We fed 0.5 kg pieces of meat to wild dogs being temporarily held in enclosures and measured the corresponding change in belly size using lateral side photographs taken perpendicular to the animal. The ratio of belly depth to body length was positively related to the mass of meat consumed and provided a useful estimate of the consumption. Similar relationships could be calculated to determine amounts consumed by other carnivores, thus providing a useful tool in the study of feeding behaviour.	[Potgieter, Katherine R.; Davies-Mostert, Harriet T.] Endangered Wildlife Trust, Modderfontein, South Africa		Potgieter, KR (corresponding author), Endangered Wildlife Trust, Modderfontein, South Africa.	kathpotgieter@gmail.com		Davies-Mostert, Harriet/0000-0001-7824-4863; Potgieter Forssman, Katherine/0000-0003-1704-984X				Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 2002, AFRICAN WILD DOG BEH; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; Fanshawe John H., 1997, P11; FRAME LH, 1979, Z TIERPSYCHOL, V50, P225; Knobel DL, 2002, J WILDLIFE DIS, V38, P352, DOI 10.7589/0090-3558-38.2.352; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; MALCOLM JR, 1979, THESIS HARVARD U; McNutt J. W., 2008, IUCN 2010 IUCN RED L; MILLS M. G. L., 2004, WILD CANIDS STATUS S, P174; Spong G, 2004, BEHAV ECOL SOCIOBIOL, V55, P325, DOI 10.1007/s00265-003-0723-z; Woodroffe R, 1997, STATUS SURVEY CONSER	13	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34543	10.1371/journal.pone.0034543	http://dx.doi.org/10.1371/journal.pone.0034543			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567086	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500004
J	Sendagire, I; Van der Loeff, MS; Kambugu, A; Konde-Lule, J; Cobelens, F				Sendagire, Ibrahim; Van der Loeff, Maarten Schim; Kambugu, Andrew; Konde-Lule, Joseph; Cobelens, Frank			Urban Movement and Alcohol Intake Strongly Predict Defaulting from Tuberculosis Treatment: An Operational Study	PLOS ONE			English	Article							TREATMENT ADHERENCE; CONTROL PROGRAM; RISK-FACTORS; HIV; ETHIOPIA; DISTRICT; FAILURE; KAMPALA; COHORT; ADULTS	Background: High levels of defaulting from treatment challenge tuberculosis control in many African cities. We assessed defaulting from tuberculosis treatment in an African urban setting. Methods: An observational study among adult patients with smear-positive pulmonary tuberculosis receiving treatment at urban primary care clinics in Kampala, Uganda. Defaulting was defined as having missed two consecutive monthly clinic visits while not being reported to have died or continued treatment elsewhere. Defaulting patients were actively followedup and interviewed. We assessed proportions of patients abandoning treatment with and without the information obtained through active follow-up and we examined associated factors through multivariable logistic regression. Results: Between April 2007 and April 2008, 270 adults aged >= 15 years were included; 54 patients (20%) were recorded as treatment defaulters. On active follow-up vital status was established of 28/54 (52%) patients. Of these, 19 (68%) had completely stopped treatment, one (4%) had died and eight (29%) had continued treatment elsewhere. Extrapolating this to all defaulters meant that 14% rather than 20% of all patients had truly abandoned treatment. Daily consumption of alcohol, recorded at the start of treatment, predicted defaulting (adjusted odds ratio [ORadj] 4.4, 95% CI 1.8-13.5), as did change of residence during treatment (ORadj 8.7, 95% CI 1.8-41.5); 32% of patients abandoning treatment had changed residence. Conclusions: A high proportion of tuberculosis patients in primary care clinics in Kampala abandon treatment. Assessing change of residence during scheduled clinic appointments may serve as an early warning signal that the patient may default and needs adherence counseling.	[Sendagire, Ibrahim] Kampala Capital City Author, Directorate Hlth, Kampala, Uganda; [Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Van der Loeff, Maarten Schim] Publ Hlth Serv Amsterdam, Dept Res, Amsterdam, Netherlands; [Kambugu, Andrew] Makerere Univ, Coll Hlth Sci, Sch Med, Infect Dis Inst, Kampala, Uganda; [Konde-Lule, Joseph] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam; Makerere University; Makerere University	Sendagire, I (corresponding author), Kampala Capital City Author, Directorate Hlth, Kampala, Uganda.	f.cobelens@aighd.org		Cobelens, Frank/0000-0002-4367-1133	Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP)	Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP)	This study was funded by the Netherlands African Partnership for Clinical Trials and Capacity Building Program (NACCAP: http://www.nwo.nl/nwohome.nsf/pages/NWOP_5VWBMM_eng). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai XQ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-112; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Dodor Ea, 2008, Ghana Med J, V42, P144; Edginton ME, 2002, INT J TUBERC LUNG D, V6, P1075; Edington ME, 2008, INT J TUBERC LUNG D, V12, P786; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Hill RC, 2005, INT J TUBERC LUNG D, V9, P1349; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Matsubayashi T, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S9; Meissner PE, 2002, INT J TUBERC LUNG D, V6, P903; Ministry of Health, 2010, HLTH SECT STRAT INV; Obiri-Danso K, 2009, INTERNET J PULMONARY, V11, P1; Okwera A, 2006, INT J TUBERC LUNG D, V10, P39; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Shargie EB, 2007, PLOS MED, V4, P280, DOI 10.1371/journal.pmed.0040037; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Vijay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010043; Vree M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-134; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2010, GLOB TUB CONTR; World Health Organization, 2009, GLOB TUB CONTR EP ST	24	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35908	10.1371/journal.pone.0035908	http://dx.doi.org/10.1371/journal.pone.0035908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567119	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500037
J	Yang, K; Mooney, C; Spahlinger, G; Schuetze, S; Arias-Pulido, H; Verschraegen, C; Gimotty, P; Buckanovich, RJ				Yang, Kun; Mooney, Colin; Spahlinger, Greg; Schuetze, Scott; Arias-Pulido, Hugo; Verschraegen, Claire; Gimotty, Phyllis; Buckanovich, Ronald J.			DR6 as a Diagnostic and Predictive Biomarker in Adult Sarcoma	PLOS ONE			English	Article							RECEPTOR SUPERFAMILY; DEATH; EXPRESSION; IDENTIFICATION; CLASSIFICATION; MEMBER; ALPHA	Background: The Death Receptor 6 (DR6) protein is elevated in the serum of ovarian cancer patients. We tested DR6 serum protein levels as a diagnostic/predictive biomarker in several epithelial tumors and sarcomas. Methods: DR6 gene expression profiles were screened in publically available arrays of solid tumors. A quantitative immunofluorescent western blot analysis was developed to test the serum of healthy controls and patients with sarcoma, uterine carcinosarcoma, bladder, liver, and pancreatic carcinomas. Change in DR6 serum levels was used to assay the ability of DR6 to predict the response to therapy of sarcoma patients. Results: DR6 mRNA is highly expressed in all tumor types assayed. Western blot analysis of serum DR6 protein demonstrated high reproducibility (r = 0.97). Compared to healthy donor controls, DR6 serum levels were not elevated in patients with uterine carcinosarcoma, bladder, liver, or pancreatic cancers. Serum DR6 protein levels from adult sarcoma patients were significantly elevated (p < 0.001). This was most evident for patients with synovial sarcoma. Change in serum DR6 levels during therapy correlated with clinical benefit from therapy (sensitivity 75%, and positive predictive value 87%). Conclusion: DR6 may be a clinically useful diagnostic and predictive serum biomarker for some adult sarcoma subtypes. Impact: Diagnosis of sarcoma can be difficult and can lead to improper management of these cancers. DR6 serum protein may be a tool to aid in the diagnosis of some sarcomatous tumors to improve treatment planning. For patients with advanced disease, rising DR6 levels predict non-response to therapy and may expedite therapeutic decision making and reduce reliance on radiologic imaging.	[Yang, Kun; Mooney, Colin; Spahlinger, Greg; Schuetze, Scott; Buckanovich, Ronald J.] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA; [Arias-Pulido, Hugo; Verschraegen, Claire] Univ New Mexico, Div Hematol Oncol, Dept Internal Med, Albuquerque, NM 87131 USA; [Gimotty, Phyllis] Univ Penn, Dept Biostat, Philadelphia, PA 19104 USA; [Buckanovich, Ronald J.] Univ Michigan, Dept Obstet & Gynecol, Div Gynecol Oncol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of New Mexico; University of Pennsylvania; University of Michigan System; University of Michigan	Yang, K (corresponding author), Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA.	ronaldbu@med.umich.edu	Gimotty, Phyllis/GWZ-4136-2022; Verschraegen, Claire/AAE-7620-2020; Arias-Pulido, Hugo/AEN-1741-2022	Gimotty, Phyllis/0000-0002-3850-9799; Verschraegen, Claire/0000-0001-6544-3089; Arias-Pulido, Hugo/0000-0003-4941-1110	Damon Runyon Cancer Research Foundation; National Institutes of Health DP2 Award [00440377]	Damon Runyon Cancer Research Foundation; National Institutes of Health DP2 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was generously supported by the Damon Runyon Cancer Research Foundation and the National Institutes of Health DP2 Award grant #00440377. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benschop R, 2009, ADV EXP MED BIOL, V647, P186, DOI 10.1007/978-0-387-89520-8_13; Buckanovich RJ, 2007, J CLIN ONCOL, V25, P852, DOI 10.1200/JCO.2006.08.8583; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; Fletcher CDM, 2002, PATHOLOGY GENETICS T; Gronchi A, 2010, ANN SURG, V251, P506, DOI 10.1097/SLA.0b013e3181cf87fa; Herbst RS, 2010, CLIN CANCER RES, V16, P5883, DOI 10.1158/1078-0432.CCR-10-0631; Hsu HC, 2006, CURR DIRECT AUTOIMMU, V9, P37; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kasof GM, 2001, ONCOGENE, V20, P7965, DOI 10.1038/sj.onc.1204985; LOPRINZI CL, 1986, J CLIN ONCOL, V4, P46, DOI 10.1200/JCO.1986.4.1.46; Nash PT, 2005, MED J AUSTRALIA, V183, P205, DOI 10.5694/j.1326-5377.2005.tb06998.x; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; Su AI, 2001, CANCER RES, V61, P7388; Ta HM, 2010, P NATL ACAD SCI USA, V107, P20281, DOI 10.1073/pnas.1011686107; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; TANABE KK, 1994, CANCER-AM CANCER SOC, V73, P1652, DOI 10.1002/1097-0142(19940315)73:6<1652::AID-CNCR2820730617>3.0.CO;2-X; Tetu B, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1503; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484	22	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36525	10.1371/journal.pone.0036525	http://dx.doi.org/10.1371/journal.pone.0036525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567163	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500083
J	Sapari, NS; Loh, M; Vaithilingam, A; Soong, R				Sapari, Nur Sabrina; Loh, Marie; Vaithilingam, Aparna; Soong, Richie			Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis	PLOS ONE			English	Article							TUMOR-RELATED GENES; CPG ISLAND HYPERMETHYLATION; HELICOBACTER-PYLORI; EPIGENETIC ALTERATIONS; PROMOTER METHYLATION; ABERRANT METHYLATION; BIOMARKERS; ASSOCIATION; PROGRESSION; SUPPRESSOR	Background: Accumulating evidence indicates aberrant DNA methylation is involved in gastric tumourigenesis, suggesting it may be a useful clinical biomarker for the disease. The aim of this study was to consolidate and summarize published data on the potential of methylation in gastric cancer (GC) risk prediction, prognostication and prediction of treatment response. Methods: Relevant studies were identified from PubMed using a systematic search approach. Results were summarized by meta-analysis. Mantel-Haenszel odds ratios were computed for each methylation event assuming the random-effects model. Results: A review of 589 retrieved publications identified 415 relevant articles, including 143 case-control studies on gene methylation of 142 individual genes in GC clinical samples. A total of 77 genes were significantly differentially methylated between tumour and normal gastric tissue from GC subjects, of which data on 62 was derived from single studies. Methylation of 15, 4 and 7 genes in normal gastric tissue, plasma and serum respectively was significantly different in frequency between GC and non-cancer subjects. A prognostic significance was reported for 18 genes and predictive significance was reported for p16 methylation, although many inconsistent findings were also observed. No bias due to assay, use of fixed tissue or CpG sites analysed was detected, however a slight bias towards publication of positive findings was observed. Conclusions: DNA methylation is a promising biomarker for GC risk prediction and prognostication. Further focused validation of candidate methylation markers in independent cohorts is required to develop its clinical potential.	[Sapari, Nur Sabrina; Loh, Marie; Vaithilingam, Aparna; Soong, Richie] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Loh, Marie] Univ Western Australia, Sch Surg, Crawley, Australia; [Soong, Richie] Natl Univ Singapore, Dept Pathol, Singapore 117548, Singapore	National University of Singapore; University of Western Australia; National University of Singapore	Sapari, NS (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	csirs@nus.edu.sg		Soong, Richie/0000-0002-0152-1225; Loh, Marie/0000-0003-3626-8466	National Medical Research Council [NMRC/TCR/001/2007]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the National Medical Research Council (NMRC/TCR/001/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Castellvi-Bel Sergi, 2006, Gastroenterology, V131, P1647, DOI 10.1053/j.gastro.2006.09.038; Chan AOO, 2003, AM J PATHOL, V163, P370, DOI 10.1016/S0002-9440(10)63663-2; Choi IS, 2005, CELL RES, V15, P247, DOI 10.1038/sj.cr.7290293; Corvalan AH, 2010, RECENT PAT DNA GENE; Enomoto S, 2010, WORLD J GASTRO ENDOS, V2, P381, DOI 10.4253/wjge.v2.i12.381; Estecio MRH, 2011, FEBS LETT, V585, P2078, DOI 10.1016/j.febslet.2010.12.001; Fan XY, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-92; Fang JY, 1996, CHINESE MED J-PEKING, V109, P787; Garcia M, 2007, GLOBAL CANC FACTS FI; Hou P, 2005, BIOCHEM GENET, V43, P1, DOI 10.1007/s10528-005-1062-8; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kato K, 2008, INT J CANCER, V122, P603, DOI 10.1002/ijc.23143; Kim TY, 2004, ALIMENT PHARM THER, V20, P131, DOI 10.1111/j.1365-2036.2004.01984.x; Kiyohara Chikako, 2007, Int J Med Sci, V4, P59; Koga Y, 2006, J GASTROENTEROL, V41, P133, DOI 10.1007/s00535-005-1732-7; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Levenson VV, 2004, PHARMACOGENOMICS, V5, P699, DOI 10.1517/14622416.5.6.699; Mitsuno M, 2007, J GASTROENTEROL, V42, P866, DOI 10.1007/s00535-007-2113-1; Miyakura Y, 2001, GASTROENTEROLOGY, V121, P1300, DOI 10.1053/gast.2001.29616; Miyamoto K, 2005, JPN J CLIN ONCOL, V35, P293, DOI 10.1093/jjco/hyi088; Mulero-Navarro S, 2008, CRIT REV ONCOL HEMAT, V68, P1, DOI 10.1016/j.critrevonc.2008.03.001; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Nakajima Takeshi, 2008, Environmental Health and Preventive Medicine, V13, P8, DOI 10.1007/s12199-007-0005-x; Napieralski R, 2007, CLIN CANCER RES, V13, P5095, DOI 10.1158/1078-0432.CCR-07-0241; Nardone G, 2004, ALIMENT PHARM THER, V20, P261, DOI 10.1111/j.1365-2036.2004.02075.x; Nardone G, 2007, DIGEST DIS, V25, P225, DOI 10.1159/000103890; Nardone Gerardo, 2008, Expert Rev Gastroenterol Hepatol, V2, P243, DOI 10.1586/17474124.2.2.243; Nobili S, 2011, WORLD J GASTROENTERO, V17, P290, DOI 10.3748/wjg.v17.i3.290; Ottini L, 2006, ANN ONCOL, V17, pVII97, DOI 10.1093/annonc/mdl960; Oue N, 2003, CANCER SCI, V94, P901, DOI 10.1111/j.1349-7006.2003.tb01373.x; Oue N, 2006, CANCER-AM CANCER SOC, V106, P1250, DOI 10.1002/cncr.21754; Paluszczak J, 2006, J APPL GENET, V47, P365, DOI 10.1007/BF03194647; Park SY, 2010, VIRCHOWS ARCH, V457, P415, DOI 10.1007/s00428-010-0962-0; Rashid A, 2004, GASTROENTEROLOGY, V127, P1578, DOI 10.1053/j.gastro.2004.09.007; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Shivapurkar N, 2010, CURR MOL MED, V10, P123, DOI 10.2174/156652410790963303; Suzuki T, 2007, ONCOL REP, V18, P329; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Tamura G, 2002, HISTOL HISTOPATHOL, V17, P323, DOI 10.14670/HH-17.323; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192; Toyota M, 1999, CANCER RES, V59, P5438; Ushijima T, 2006, J GASTROENTEROL, V41, P401, DOI 10.1007/s00535-006-1846-6; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Vogiatzi P, 2007, J CELL PHYSIOL, V211, P287, DOI 10.1002/jcp.20982; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widschwendter M, 2002, CLIN CANCER RES, V8, P17; Yamamoto E, 2011, DIGESTION, V83, P241, DOI 10.1159/000320453; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yasui W, 2006, SCAND J SURG, V95, P225, DOI 10.1177/145749690609500403; Yasui Wataru, 2005, Gastric Cancer, V8, P86, DOI 10.1007/s10120-005-0320-0; Ye T, 2010, MINI-REV MED CHEM, V10, P1034, DOI 10.2174/1389557511009011034; Yoshida K, 2006, ANTICANCER RES, V26, P49	57	73	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36275	10.1371/journal.pone.0036275	http://dx.doi.org/10.1371/journal.pone.0036275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558417	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000178
J	Kadirkamanathan, V; Anderson, SR; Billings, SA; Zhang, XL; Holmes, GR; Reyes-Aldasoro, CC; Elks, PM; Renshaw, SA				Kadirkamanathan, Visakan; Anderson, Sean R.; Billings, Stephen A.; Zhang, Xiliang; Holmes, Geoffrey R.; Reyes-Aldasoro, Constantino C.; Elks, Philip M.; Renshaw, Stephen A.			The Neutrophil's Eye-View: Inference and Visualisation of the Chemoattractant Field Driving Cell Chemotaxis In Vivo	PLOS ONE			English	Article							ZEBRAFISH; MODEL; INFLAMMATION; RESOLUTION; GRADIENTS; UNDERSTAND; MIGRATION; MOTILITY; SYSTEM; GUIDE	As we begin to understand the signals that drive chemotaxis in vivo, it is becoming clear that there is a complex interplay of chemotactic factors, which changes over time as the inflammatory response evolves. New animal models such as transgenic lines of zebrafish, which are near transparent and where the neutrophils express a green fluorescent protein, have the potential to greatly increase our understanding of the chemotactic process under conditions of wounding and infection from video microscopy data. Measurement of the chemoattractants over space (and their evolution over time) is a key objective for understanding the signals driving neutrophil chemotaxis. However, it is not possible to measure and visualise the most important contributors to in vivo chemotaxis, and in fact the understanding of the main contributors at any particular time is incomplete. The key insight that we make in this investigation is that the neutrophils themselves are sensing the underlying field that is driving their action and we can use the observations of neutrophil movement to infer the hidden net chemoattractant field by use of a novel computational framework. We apply the methodology to multiple in vivo neutrophil recruitment data sets to demonstrate this new technique and find that the method provides consistent estimates of the chemoattractant field across the majority of experiments. The framework that we derive represents an important new methodology for cell biologists investigating the signalling processes driving cell chemotaxis, which we label the neutrophils eye-view of the chemoattractant field.	[Kadirkamanathan, Visakan; Anderson, Sean R.; Billings, Stephen A.; Zhang, Xiliang; Holmes, Geoffrey R.] Univ Sheffield, Dept Automat Control & Syst Engn, Complex Syst & Signal Proc Grp, Sheffield, S Yorkshire, England; [Reyes-Aldasoro, Constantino C.] Univ Sussex, Sch Engn & Design, Brighton, E Sussex, England; [Elks, Philip M.; Renshaw, Stephen A.] Univ Sheffield, MRC Ctr Dev & Biomed Genet, Sheffield, S Yorkshire, England; [Renshaw, Stephen A.] Univ Sheffield, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England	University of Sheffield; University of Sussex; University of Sheffield; University of Sheffield	Kadirkamanathan, V (corresponding author), Univ Sheffield, Dept Automat Control & Syst Engn, Complex Syst & Signal Proc Grp, Sheffield, S Yorkshire, England.	visakan@sheffield.ac.uk	Renshaw, Steve/E-6192-2010; Reyes-Aldasoro, Constantino/S-5093-2019	Renshaw, Steve/0000-0003-1790-1641; Reyes-Aldasoro, Constantino/0000-0002-9466-2018; Holmes, Geoffrey/0000-0002-8861-9638; Kadirkamanathan, Visakan/0000-0002-4243-2501; Anderson, Sean/0000-0002-7452-5681; Elks, Philip/0000-0003-1683-0749	Engineering and Physical Sciences Research Council, UK [EP/H00453X/1]; European Research Council [NSYS 226037]; Medical Research Council, UK [G0700091, G0701932]; Wellcome Trust [WT082909MA]; EPSRC [EP/G042209/1, EP/H00453X/1] Funding Source: UKRI; MRC [G0701932] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H00453X/1, EP/G042209/1] Funding Source: researchfish; Medical Research Council [G0701932] Funding Source: researchfish	Engineering and Physical Sciences Research Council, UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Engineering and Physical Sciences Research Council, UK Grant No: EP/H00453X/1 (http://www.epsrc.ac.uk). European Research Council, Advanced Investigator Award: NSYS 226037 (http://erc.europa.eu/). Medical Research Council, UK, Centre Grant for Stephen A. Renshaw: G0700091, Senior Clinical Fellowship to Stephen A. Renshaw: G0701932 (http://www.mrc.ac.uk). Wellcome Trust, Project Grant supporting Philip M. Elks: WT082909MA (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billings SA, 2007, NEURAL NETWORKS, V20, P1081, DOI 10.1016/j.neunet.2007.09.017; Bosgraaf L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005253; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Coca D, 2002, AUTOMATICA, V38, P1851, DOI 10.1016/S0005-1098(02)00099-7; Dewar M, 2009, IEEE T SIGNAL PROCES, V57, P83, DOI 10.1109/TSP.2008.2005091; Dewar MA, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-21; Elks PM, 2011, METHODS MOL BIOL, V769, P261, DOI 10.1007/978-1-61779-207-6_18; Elks PM, 2011, BLOOD, V118, P712, DOI 10.1182/blood-2010-12-324186; FIORETTI S, 1989, INT J SYST SCI, V20, P33, DOI 10.1080/00207728908910103; Freestone DR, 2011, NEUROIMAGE, V56, P1043, DOI 10.1016/j.neuroimage.2011.02.027; Hillen T, 2009, J MATH BIOL, V58, P183, DOI 10.1007/s00285-008-0201-3; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Kailath T, 2000, PR H INF SY, pXIX; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Liu GPP, 1999, IEEE T SYST MAN CY C, V29, P34, DOI 10.1109/5326.740668; Martin JS, 2009, BIOCHEM SOC T, V37, P830, DOI 10.1042/BST0370830; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Mathias JR, 2009, METHODS MOL BIOL, V571, P151, DOI 10.1007/978-1-60761-198-1_10; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Olariu V, 2009, BIOINFORMATICS, V25, P2824, DOI 10.1093/bioinformatics/btp456; Otsu N, 1975, AUTOMATICA, V11, P285; Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008; PETERKA V, 1981, AUTOMATICA, V17, P41, DOI 10.1016/0005-1098(81)90083-2; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; Renshaw SA, 2007, EXP LUNG RES, V33, P549, DOI 10.1080/01902140701756778; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Scerri K, 2009, IEEE T SIGNAL PROCES, V57, P482, DOI 10.1109/TSP.2008.2008550; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Wikle CK, 2011, J TIME SER ANAL, V32, P339, DOI 10.1111/j.1467-9892.2011.00729.x; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805; Young P, 1999, J APPL STAT, V26, P103, DOI 10.1080/02664769922692; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	42	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35182	10.1371/journal.pone.0035182	http://dx.doi.org/10.1371/journal.pone.0035182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563379	Green Accepted, gold, Green Published			2022-12-27	WOS:000305349100008
J	Somalinga, BR; Day, CE; Wei, SG; Roth, MG; Thomas, PJ				Somalinga, Balajee R.; Day, Cameron E.; Wei, Shuguang; Roth, Michael G.; Thomas, Philip J.			TDP-43 Identified from a Genome Wide RNAi Screen for SOD1 Regulators	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; MOTOR-NEURONS; IN-VITRO; PROTEIN; MUTATIONS; DEGENERATION; GLUTAMATE; COMPLEMENTATION	Amyotrophic Lateral Sclerosis (ALS) is a late-onset, progressive neurodegenerative disease affecting motor neurons in the brain stem and spinal cord leading to loss of voluntary muscular function and ultimately, death due to respiratory failure. A subset of ALS cases are familial and associated with mutations in superoxide dismutase 1 (SOD1) that destabilize the protein and predispose it to aggregation. In spite of the fact that sporadic and familial forms of ALS share many common pathophysiological features, the mechanistic relationship between SOD1-associated and sporadic forms of the disease if any, is not well understood. To better understand any molecular connections, a cell-based protein folding assay was employed to screen a whole genome RNAi library for genes that regulate levels of soluble SOD1. Statistically significant hits that modulate SOD1 levels, when analyzed by pathway analysis revealed a highly ranked network containing TAR DNA binging protein (TDP-43), a major component of aggregates characteristic of sporadic ALS. Biochemical experiments confirmed the action of TDP-43 on SOD1. These results highlight an unexpected relationship between TDP-43 and SOD1 which may have implications in disease pathogenesis.	[Somalinga, Balajee R.; Day, Cameron E.; Thomas, Philip J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wei, Shuguang; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Somalinga, BR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	balajee.somalinga@utsouthwestern.edu; philip.thomas@utsouthwestern.edu	Thomas, Philip J/F-7115-2012	Somalinga, Balajee/0000-0002-6930-2790; Roth, Michael/0000-0002-9056-332X	ALS Association; Reata Pharmaceuticals; University of Texas; NATIONAL CANCER INSTITUTE [P30CA142543, P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049835] Funding Source: NIH RePORTER	ALS Association; Reata Pharmaceuticals; University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research work was funded through grants from the ALS Association and a Sponsored Research Agreement from Reata Pharmaceuticals. Chris Wigley at Reata Pharmaceuticals gave comments and suggestions during the preparation of the manuscript.; Philip J. Thomas is a founder and Scientific Advisory Board Member of Reata Pharmaceuticals. He holds shares of Reata common stock. Reata has a sponsored research agreement with the University of Texas that supports work in Phillip J. Thomas' laboratory. Reata has licensed the beta galactosidase assay from the University of Texas Board of Reagent (Patent holders) for small molecule discovery. The license does not restrict the use of or distribution of the assay for research purposes. Patents: U.S. Patent Number: 7,635,569 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C., Stidham, Rhesa D. Issued: 12/22/09 U. S. Patent Number: 7,455,978 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C.; Stidham, Rhesa D. Issued: 11/25/08 U.S. Patent Number: 6,727,070 Patent Title: Protein/Solubility Folding Assessed by Structural Complementation. Inventors: Thomas, Philip J.; Hunt, John F.; Wigley, William C.; Stidham, Rhesa D. Issued: 04/27/04 This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; Beal MF, 2000, BRAIN, V123, P1291, DOI 10.1093/brain/123.7.1291; Beal MF, 1998, BBA-BIOENERGETICS, V1366, P211, DOI 10.1124/jpet.112.192138; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Broom WJ, 2008, AMYOTROPH LATERAL SC, V9, P229, DOI 10.1080/17482960802103107; Broom WJ, 2006, J BIOMOL SCREEN, V11, P729, DOI 10.1177/1087057106290937; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Chung NJ, 2008, J BIOMOL SCREEN, V13, P149, DOI 10.1177/1087057107312035; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; COURATIER P, 1993, LANCET, V341, P265, DOI 10.1016/0140-6736(93)92615-Z; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Craig E, 2002, EMBO J, V21, P31, DOI 10.1093/emboj/21.1.31; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kambuj PA, 2003, THESIS U TEXAS ARLIN; Kruman II, 1999, EXP NEUROL, V160, P28, DOI 10.1006/exnr.1999.7190; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Lindberg MJ, 2002, P NATL ACAD SCI USA, V99, P16607, DOI 10.1073/pnas.262527099; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Somalinga BR, 2011, J BIOMOL SCREEN, V16, P974, DOI 10.1177/1087057111418505; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35818	10.1371/journal.pone.0035818	http://dx.doi.org/10.1371/journal.pone.0035818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563406	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100033
J	Gao, C; Jiang, TY; Dou, PP; Ma, CQ; Li, LX; Kong, J; Xu, P				Gao, Chao; Jiang, Tianyi; Dou, Peipei; Ma, Cuiqing; Li, Lixiang; Kong, Jian; Xu, Ping			NAD-Independent L-Lactate Dehydrogenase Is Required for L-Lactate Utilization in Pseudomonas stutzeri SDM	PLOS ONE			English	Article							BOUND L-LACTATE; CORYNEBACTERIUM-GLUTAMICUM; ESCHERICHIA-COLI; (S)-MANDELATE DEHYDROGENASE; NEISSERIA-GONORRHOEAE; SOLUBLE MUTANT; MEMBRANE; PURIFICATION; EXPRESSION; SEQUENCE	Background: Various Pseudomonas strains can use L-lactate as their sole carbon source for growth. However, the L-lactate-utilizing enzymes in Pseudomonas have never been identified and further studied. Methodology/Principal Findings: An NAD-independent L-lactate dehydrogenase (L-iLDH) was purified from the membrane fraction of Pseudomonas stutzeri SDM. The enzyme catalyzes the oxidation of L-lactate to pyruvate by using FMN as cofactor. After cloning its encoding gene (lldD), L-iLDH was successfully expressed, purified from a recombinant Escherichia coli strain, and characterized. An lldD mutant of P. stutzeri SDM was constructed by gene knockout technology. This mutant was unable to grow on L-lactate, but retained the ability to grow on pyruvate. Conclusions/Significance: It is proposed that L-iLDH plays an indispensable function in Pseudomonas L-lactate utilization by catalyzing the conversion of L-lactate into pyruvate.	[Gao, Chao; Jiang, Tianyi; Dou, Peipei; Ma, Cuiqing; Li, Lixiang; Kong, Jian; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Gao, Chao; Dou, Peipei; Xu, Ping] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Gao, Chao; Dou, Peipei; Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, C (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Ma, Cuiqing/0000-0002-7468-1027; Gao, Chao/0000-0002-5205-0670	National Natural Science Foundation of China [31000014, 31070062]; Ministry of Science and Technology of China; National Basic Research Program of China [2007CB707803]; Research Fund for the Doctoral Program of Higher Education of China [20090131110036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Basic Research Program of China(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The work was supported by the National Natural Science Foundation of China (31000014 and 31070062), and by the grants from the Ministry of Science and Technology of China, National Basic Research Program of China (2007CB707803), and the Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20090131110036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATNAGAR RK, 1989, J GEN MICROBIOL, V135, P353; BLACK MT, 1989, BIOCHEM J, V258, P255, DOI 10.1042/bj2580255; BROWN PR, 1987, J GEN MICROBIOL, V133, P1521; Chapman SK, 1996, BIOCHEM SOC T, V24, P73, DOI 10.1042/bst0240073; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Eppink MHM, 1997, J BACTERIOL, V179, P6680, DOI 10.1128/jb.179.21.6680-6687.1997; FU KS, 1989, INFECT IMMUN, V57, P2173, DOI 10.1128/IAI.57.7.2173-2178.1989; FUTAI M, 1977, J BIOL CHEM, V252, P5820; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Goffin P, 2004, J BACTERIOL, V186, P6661, DOI 10.1128/JB.186.19.6661-6666.2004; Hao JR, 2007, BIOTECHNOL LETT, V29, P105, DOI 10.1007/s10529-006-9204-6; Jasso-Chavez R, 2001, ARCH BIOCHEM BIOPHYS, V390, P295, DOI 10.1006/abbi.2001.2353; Jiang TY, 2012, J BACTERIOL, V194, P894, DOI 10.1128/JB.06478-11; Jimenez JI, 2008, P NATL ACAD SCI USA, V105, P11329, DOI 10.1073/pnas.0802273105; Kato O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-321; KEMP MB, 1972, BIOCHEM J, V130, P307, DOI 10.1042/bj1300307; Kose M, 2004, TURKISH J PEDIATR, V46, P177; Lalucat J, 2006, MICROBIOL MOL BIOL R, V70, P510, DOI 10.1128/MMBR.00047-05; LE KHD, 1991, J BIOL CHEM, V266, P20877; Ma CQ, 2007, APPL MICROBIOL BIOT, V77, P91, DOI 10.1007/s00253-007-1132-4; MAEDAYORITA K, 1995, BIOCHIMIE, V77, P631, DOI 10.1016/0300-9084(96)88178-8; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MITRA B, 1993, BIOCHEMISTRY-US, V32, P12959, DOI 10.1021/bi00211a003; NAGEL M, 1990, ARCH MICROBIOL, V154, P605; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Neuner A, 2011, BIOTECHNOL J, V6, P318, DOI 10.1002/biot.201000307; OBRIEN RW, 1977, AUST J BIOL SCI, V30, P553, DOI 10.1071/BI9770553; Parsons NJ, 1996, MICROB PATHOGENESIS, V21, P193, DOI 10.1006/mpat.1996.0054; Rejman J, 2007, HUM GENE THER, V18, P642, DOI 10.1089/hum.2006.192; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Sharkey MA, 2011, ARCH MICROBIOL, V193, P731, DOI 10.1007/s00203-011-0711-z; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smith H, 2001, INFECT IMMUN, V69, P6565, DOI 10.1128/IAI.69.11.6565-6572.2001; Stansen C, 2005, APPL ENVIRON MICROB, V71, P5920, DOI 10.1128/AEM.71.10.5920-5928.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sukumar N, 2001, BIOCHEMISTRY-US, V40, P9870, DOI 10.1021/bi010938k; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TSOU AY, 1990, BIOCHEMISTRY-US, V29, P9856, DOI 10.1021/bi00494a015; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; VOLOKITA M, 1987, J BIOL CHEM, V262, P15825; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M; Yates E, 2000, INT J MED MICROBIOL, V290, P627	46	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36519	10.1371/journal.pone.0036519	http://dx.doi.org/10.1371/journal.pone.0036519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574176	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800073
J	Niemiec, MS; Weise, CF; Wittung-Stafshede, P				Niemiec, Moritz S.; Weise, Christoph F.; Wittung-Stafshede, Pernilla			In Vitro Thermodynamic Dissection of Human Copper Transfer from Chaperone to Target Protein	PLOS ONE			English	Article							WILSON-DISEASE PROTEIN; TRANSPORTING ATPASES; MENKES PROTEIN; CU(I) BINDING; ATOX1; COPZ; METALLOCHAPERONES; TRAFFICKING; DOMAIN-4; DYNAMICS	Transient protein-protein and protein-ligand interactions are fundamental components of biological activity. To understand biological activity, not only the structures of the involved proteins are important but also the energetics of the individual steps of a reaction. Here we use in vitro biophysical methods to deduce thermodynamic parameters of copper (Cu) transfer from the human copper chaperone Atox1 to the fourth metal-binding domain of the Wilson disease protein (WD4). Atox1 and WD4 have the same fold (ferredoxin-like fold) and Cu-binding site (two surface exposed cysteine residues) and thus it is not clear what drives metal transfer from one protein to the other. Cu transfer is a two-step reaction involving a metal-dependent ternary complex in which the metal is coordinated by cysteines from both proteins (i.e., Atox1-Cu-WD4). We employ size exclusion chromatography to estimate individual equilibrium constants for the two steps. This information together with calorimetric titration data are used to reveal enthalpic and entropic contributions of each step in the transfer process. Upon combining the equilibrium constants for both steps, a metal exchange factor (from Atox1 to WD4) of 10 is calculated, governed by a negative net enthalpy change of similar to 10 kJ/mol. Thus, small variations in interaction energies, not always obvious upon comparing protein structures alone, may fuel vectorial metal transfer.	[Niemiec, Moritz S.; Weise, Christoph F.; Wittung-Stafshede, Pernilla] Umea Univ, Dept Chem, Chem Biol Ctr, Umea, Sweden	Umea University	Niemiec, MS (corresponding author), Umea Univ, Dept Chem, Chem Biol Ctr, Umea, Sweden.	pernilla.wittung@chem.umu.se	wittung-stafshede, pernilla/AAV-4392-2021	wittung-stafshede, pernilla/0000-0003-1058-1964	Swedish Natural Research Council; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Umea University	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Umea University	The Swedish Natural Research Council, the Knut and Alice Wallenberg Foundation, Goran Gustafsson Foundation, and Umea University provided financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achila D, 2006, P NATL ACAD SCI USA, V103, P5729, DOI 10.1073/pnas.0504472103; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Badarau A, J AM CHEM SOC, V133, P2983; Banci L, 2005, FEBS J, V272, P865, DOI 10.1111/j.1742-4658.2004.04526.x; Banci L, 2008, BIOCHEMISTRY-US, V47, P7423, DOI 10.1021/bi8004736; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Banci L, 2009, BIOCHEM J, V422, P37, DOI 10.1042/BJ20090422; Banci L, 2009, J BIOL CHEM, V284, P9354, DOI 10.1074/jbc.M805981200; Festa R. A., CURR BIOL, V21, pR877; Hamza I, 2003, P NATL ACAD SCI USA, V100, P1215, DOI 10.1073/pnas.0336230100; Hansson H, 2001, FEBS LETT, V489, P67, DOI 10.1016/S0014-5793(00)02438-8; Harris ED, 2003, CRIT REV CL LAB SCI, V40, P547, DOI 10.1080/10408360390250649; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Hussain F, 2008, P NATL ACAD SCI USA, V105, P11158, DOI 10.1073/pnas.0802928105; Hussain F, 2009, J AM CHEM SOC, V131, P16371, DOI 10.1021/ja9058266; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Luke K, 2005, BIOPHYS J, V89, P3332, DOI 10.1529/biophysj.105.067223; Lutsenko S, 2007, ARCH BIOCHEM BIOPHYS, V463, P134, DOI 10.1016/j.abb.2007.04.013; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Multhaup G, 2001, BIOCHEM BIOPH RES CO, V288, P172, DOI 10.1006/bbrc.2001.5757; O'Halloran TV, 2000, J BIOL CHEM, V275, P25057, DOI 10.1074/jbc.R000006200; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; PRESTA A, 1995, EUR J BIOCHEM, V227, P226, DOI 10.1111/j.1432-1033.1995.tb20380.x; Privalov PL, 1999, J MOL BIOL, V294, P997, DOI 10.1006/jmbi.1999.3285; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Robinson NJ, ANN REV BIOCH, V79, P537; Rodriguez-Granillo A, J PHYS CHEM B, V114, P3698; Rodriguez-Granillo A, 2008, J PHYS CHEM B, V112, P4583, DOI 10.1021/jp711787x; Rodriguez-Granillo A, 2009, BIOCHEMISTRY-US, V48, P5849, DOI 10.1021/bi900235g; Stillman M J, 1994, Met Based Drugs, V1, P375, DOI 10.1155/MBD.1994.375; Strausak D, 2003, J BIOL CHEM, V278, P20821, DOI 10.1074/jbc.M212437200; Wernimont AK, 2004, J BIOL CHEM, V279, P12269, DOI 10.1074/jbc.M311213200; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; Wittung-Stafshede P, 2004, INORG CHEM, V43, P7926, DOI 10.1021/ic049398g; Yatsunyk LA, 2007, J BIOL CHEM, V282, P8622, DOI 10.1074/jbc.M609533200	36	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36102	10.1371/journal.pone.0036102	http://dx.doi.org/10.1371/journal.pone.0036102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574136	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800032
J	Peng, L; Oberst, MD; Huang, JQ; Brohawn, P; Morehouse, C; Lekstrom, K; Baeuerle, PA; Wu, H; Yao, YH; Coats, SR; Dall'Acqua, W; Damschroder, M; Hammond, SA				Peng, Li; Oberst, Michael D.; Huang, Jiaqi; Brohawn, Philip; Morehouse, Chris; Lekstrom, Kristen; Baeuerle, Patrick A.; Wu, Herren; Yao, Yihong; Coats, Steven R.; Dall'Acqua, William; Damschroder, Melissa; Hammond, Scott A.			The CEA/CD3-Bispecific Antibody MEDI-565 (MT111) Binds a Nonlinear Epitope in the Full-Length but Not a Short Splice Variant of CEA	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; CARCINOEMBRYONIC ANTIGEN CEA; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; TUMOR-GROWTH; THERAPEUTIC WINDOW; POTENT CONTROL; BITE ANTIBODY; CELL LYSIS; CONSTRUCTS	MEDI-565 (also known as MT111) is a bispecific T-cell engager (BiTE (R)) antibody in development for the treatment of patients with cancers expressing carcinoembryonic antigen (CEA). MEDI-565 binds CEA on cancer cells and CD3 on T cells to induce T-cell mediated killing of cancer cells. To understand the molecular basis of human CEA recognition by MEDI-565 and how polymorphisms and spliced forms of CEA may affect MEDI-565 activity, we mapped the epitope of MEDI-565 on CEA using mutagenesis and homology modeling approaches. We found that MEDI-565 recognized a conformational epitope in the A2 domain comprised of amino acids 326-349 and 388-410, with critical residues F-326, T-328, N-333, V-388, G(389), P-390, E-392, I-408, and N-410. Two non-synonymous single-nucleotide polymorphisms (SNPs) (rs10407503, rs7249230) were identified in the epitope region, but they are found at low homozygosity rates. Searching the National Center for Biotechnology Information GenBank (R) database, we further identified a single, previously uncharacterized mRNA splice variant of CEA that lacks a portion of the N-terminal domain, the A1 and B1 domains, and a large portion of the A2 domain. Real-time quantitative polymerase chain reaction analysis of multiple cancers showed widespread expression of full-length CEA in these tumors, with less frequent but concordant expression of the CEA splice variant. Because the epitope was largely absent from the CEA splice variant, MEDI-565 did not bind or mediate T-cell killing of cells solely expressing this form of CEA. In addition, the splice variant did not interfere with MEDI-565 binding or activity when co-expressed with full-length CEA. Thus MEDI-565 may broadly target CEA-positive tumors without regard for expression of the short splice variant of CEA. Together our data suggest that MEDI-565 activity will neither be impacted by SNPs nor by a splice variant of CEA.	[Peng, Li; Lekstrom, Kristen; Wu, Herren; Coats, Steven R.; Dall'Acqua, William; Damschroder, Melissa] MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Oberst, Michael D.; Hammond, Scott A.] MedImmune LLC, Preclin Oncol, Gaithersburg, MD USA; [Huang, Jiaqi; Brohawn, Philip; Morehouse, Chris; Yao, Yihong] MedImmune LLC, Translat Sci, Gaithersburg, MD USA; [Baeuerle, Patrick A.] Amgen Res Munich GmbH, Munich, Germany	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune; Amgen; Amgen Research Munich GmbH	Peng, L (corresponding author), MedImmune LLC, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD USA.	damschroderm@medimmune.com; hammonds@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532				Amann M, 2009, CANCER IMMUNOL IMMUN, V58, P95, DOI 10.1007/s00262-008-0529-y; Amann M, 2008, CANCER RES, V68, P143, DOI 10.1158/0008-5472.CAN-07-2182; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; Behr TM, 2002, CANCER-AM CANCER SOC, V94, P1373, DOI 10.1002/cncr.10308; Bjerner J, 2002, TUMOR BIOL, V23, P249, DOI 10.1159/000067255; BOXER GM, 1994, BRIT J CANCER, V69, P307, DOI 10.1038/bjc.1994.56; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; Brischwein K, 2007, J IMMUNOTHER, V30, P798, DOI 10.1097/CJI.0b013e318156750c; CHESTER KA, 1994, INT J CANCER, V57, P67, DOI 10.1002/ijc.2910570113; Dreier T, 2003, J IMMUNOL, V170, P4397, DOI 10.4049/jimmunol.170.8.4397; Duffy MJ, 2001, CLIN CHEM, V47, P624; Francis RJ, 2002, BRIT J CANCER, V87, P600, DOI 10.1038/sj.bjc.6600517; Fuhrmann S, 2010, AACR M; GOLDENBERG DM, 1993, J NUCL MED, V34, P61; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; HAMMARSTROM S, 1989, CANCER RES, V49, P4852; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hampton R, 2002, ONCOGENE, V21, P7817, DOI 10.1038/sj.onc.1205906; HARWOOD PJ, 1986, BRIT J CANCER, V54, P75, DOI 10.1038/bjc.1986.154; HASS GM, 1991, CANCER RES, V51, P1876; HEFTA SA, 1988, P NATL ACAD SCI USA, V85, P4648, DOI 10.1073/pnas.85.13.4648; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Hong H, 2008, BIOMARK INSIGHTS, V3, P435; Huang Emina H, 2002, Expert Rev Vaccines, V1, P49, DOI 10.1586/14760584.1.1.49; Kaplan BE, 1998, J PEPT RES, V52, P249; Kim HJ, 2009, ACTA ONCOL, V48, P385, DOI 10.1080/02841860802446761; Kischel R, 2009, AACR M; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Lutterbuese R, 2009, J IMMUNOTHER, V32, P341, DOI 10.1097/CJI.0b013e31819b7c70; Mack M, 1997, J IMMUNOL, V158, P3965; MACK M, 1995, P NATL ACAD SCI USA, V92, P7021, DOI 10.1073/pnas.92.15.7021; Moffat FL, 1996, J CLIN ONCOL, V14, P2295, DOI 10.1200/JCO.1996.14.8.2295; MURAKAMI M, 1995, HYBRIDOMA, V14, P19, DOI 10.1089/hyb.1995.14.19; Nagorsen D, 2011, EXP CELL RES, V317, P1255, DOI 10.1016/j.yexcr.2011.03.010; NAP M, 1992, CANCER RES, V52, P2329; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V144, P634, DOI 10.1016/S0006-291X(87)80013-X; OIKAWA S, 1987, BIOCHEM BIOPH RES CO, V142, P511, DOI 10.1016/0006-291X(87)90304-4; Osada T, 2010, BRIT J CANCER, V102, P124, DOI 10.1038/sj.bjc.6605364; Rother M, 2007, J CLIN ONCOL, V25, P1293, DOI 10.1200/JCO.2006.10.0974; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; SCHWARZ K, 1988, MOL IMMUNOL, V25, P889, DOI 10.1016/0161-5890(88)90126-5; Solassol I, 2001, TUMOR BIOL, V22, P184, DOI 10.1159/000050614; Tan KM, 2002, EMBO J, V21, P2076, DOI 10.1093/emboj/21.9.2076; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Wimberger P, 2003, INT J CANCER, V105, P241, DOI 10.1002/ijc.11056; Witthauer J, 2009, BREAST CANCER RES TR, V117, P471, DOI 10.1007/s10549-008-0185-0; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Yamamoto M, 2004, HEPATO-GASTROENTEROL, V51, P147; ZHOU H, 1993, J CELL BIOL, V122, P951, DOI 10.1083/jcb.122.4.951	56	24	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36412	10.1371/journal.pone.0036412	http://dx.doi.org/10.1371/journal.pone.0036412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574157	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800053
J	Han, RJ; Kitlinska, JB; Munday, WR; Gallicano, GI; Zukowska, Z				Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Gallicano, G. Ian; Zukowska, Zofia			Stress Hormone Epinephrine Enhances Adipogenesis in Murine Embryonic Stem Cells by Up-Regulating the Neuropeptide Y System	PLOS ONE			English	Article							MECHANISMS LINKING OBESITY; WHITE ADIPOSE-TISSUE; IN-VIVO; INSULIN-RESISTANCE; SELF-RENEWAL; FAT; DIFFERENTIATION; ADIPOCYTES; COTRANSMISSION; THERMOGENESIS	Prenatal stress, psychologically and metabolically, increases the risk of obesity and diabetes in the progeny. However, the mechanisms of the pathogenesis remain unknown. In adult mice, stress activates NPY and its Y2R in a glucocorticoid-dependent manner in the abdominal fat. This increased adipogenesis and angiogenesis, leading to abdominal obesity and metabolic syndrome which were inhibited by intra-fat Y2R inactivation. To determine whether stress elevates NPY system and accelerates adipogenic potential of embryo, here we "stressed" murine embryonic stem cells (mESCs) in vitro with epinephrine (EPI) during their adipogenic differentiation. EPI was added during the commitment stage together with insulin, and followed by dexamethasone in the standard adipogenic differentiation medium. Undifferentiated embryonic bodies (EBs) showed no detectable expression of NPY. EPI markedly up-regulated the expression NPY and the Y1R at the commitment stage, followed by increased Y2R mRNA at the late of the commitment stage and the differentiation stage. EPI significantly increased EB cells proliferation and expression of the preadipocyte marker Pref-1 at the commitment stage. EPI also accelerated and amplified adipogenic differentiation detected by increasing the adipocyte markers FABP4 and PPAR gamma mRNAs and Oil-red O-staining at the end of the differentiation stage. EPI-induced adipogenesis was completely prevented by antagonists of the NPY receptors (Y1R+Y2R+Y5R), indicating that it was mediated by the NPY system in mESC's. Taken together, these data suggest that stress may play an important role in programing ESCs for accelerated adipogenesis by altering the stress induced hormonal regulation of the NPY system.	[Han, Ruijun; Zukowska, Zofia] Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, Minneapolis, MN 55455 USA; [Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Zukowska, Zofia] Georgetown Univ, Med Ctr, Dept Physiol, Washington, DC 20007 USA; [Han, Ruijun; Kitlinska, Joanna B.; Munday, William R.; Zukowska, Zofia] Georgetown Univ, Med Ctr, Dept Biophys, Washington, DC 20007 USA; [Gallicano, G. Ian] Georgetown Univ, Med Ctr, Dept Biochem, Washington, DC 20007 USA; [Gallicano, G. Ian] Georgetown Univ, Med Ctr, Dept Cellular & Mol Biol, Washington, DC 20007 USA	University of Minnesota System; University of Minnesota Twin Cities; Georgetown University; Georgetown University; Georgetown University; Georgetown University	Han, RJ (corresponding author), Univ Minnesota, Dept Integrat Biol & Physiol, Stress Physiol Ctr, Minneapolis, MN 55455 USA.	rhan@umn.edu	Han, Ruijun/K-6614-2012		United States National Institutes of Health [R01HL067357, R37HL055310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116476, R37HL055310, R01HL067357] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States National Institutes of Health grants R01HL067357 and R37HL055310 to Z.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005341; Abe K, 2010, EXP BIOL MED, V235, P1179, DOI 10.1258/ebm.2010.009136; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BALBI D, 1994, MOL BRAIN RES, V23, P310, DOI 10.1016/0169-328X(94)90240-2; Bartness TJ, 2005, P NUTR SOC, V64, P53, DOI 10.1079/PNS2004409; Bedoui S, 2002, J NEUROIMMUNOL, V132, P25, DOI 10.1016/S0165-5728(02)00278-3; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536; Couture JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004743; Dani C, 1997, J CELL SCI, V110, P1279; Dodt C, 2003, ACTA PHYSIOL SCAND, V177, P351, DOI 10.1046/j.1365-201X.2003.01077.x; Feng GS, 2007, CELL RES, V17, P37, DOI 10.1038/sj.cr.7310140; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Hales CN, 2003, DIABETOLOGIA, V46, P1013, DOI 10.1007/s00125-003-1131-7; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kos K, 2007, AM J PHYSIOL-ENDOC M, V293, pE1335, DOI 10.1152/ajpendo.00333.2007; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Kuo LE, 2008, ANN NY ACAD SCI, V1148, P232, DOI 10.1196/annals.1410.035; Li LJ, 2003, ARTERIOSCL THROM VAS, V23, P1204, DOI 10.1161/01.ATV.0000071349.30914.25; Lu M, 2008, J ENDOCRINOL, V196, P159, DOI 10.1677/JOE-07-0452; Lundberg JM, 1996, PHARMACOL REV, V48, P113; LUNDBERG JM, 1989, NEUROSCIENCE, V28, P475, DOI 10.1016/0306-4522(89)90193-0; MCMAHON TJ, 1992, PHYS REV B, V45, P4512, DOI 10.1103/PhysRevB.45.4512; Mobley S, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/701212; Monteiro MC, 2011, STEM CELLS, V29, P1837, DOI 10.1002/stem.737; Morganstein DL, 2010, CELL RES, V20, P434, DOI 10.1038/cr.2010.11; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Pons J, 2008, CAN J PHYSIOL PHARM, V86, P438, DOI [10.1139/Y08-054, 10.1139/y08-054]; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Sousa DM, 2009, CURR DRUG TARGETS, V10, P9, DOI 10.2174/138945009787122888; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spencer SJ, 2011, STRESS, V14, P233, DOI 10.3109/10253890.2010.534831; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Szabo E, 2009, STEM CELLS, V27, P2092, DOI 10.1002/stem.137; Tai TC, 2007, J NEUROCHEM, V101, P1108, DOI 10.1111/j.1471-4159.2007.04484.x; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Turtzo LC, 2002, HORM METAB RES, V34, P607, DOI 10.1055/s-2002-38245; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Vazao H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017771; WAHLESTEDT C, 1990, AM J PHYSIOL, V258, pR736, DOI 10.1152/ajpregu.1990.258.3.R736; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Zhou JX, 2010, STEM CELLS, V28, P1741, DOI 10.1002/stem.504; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006	56	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36609	10.1371/journal.pone.0036609	http://dx.doi.org/10.1371/journal.pone.0036609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570731	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400047
J	Bannach, O; Birkmann, E; Reinartz, E; Jaeger, KE; Langeveld, JPM; Rohwer, RG; Gregori, L; Terry, LA; Willbold, D; Riesner, D				Bannach, Oliver; Birkmann, Eva; Reinartz, Elke; Jaeger, Karl-Erich; Langeveld, Jan P. M.; Rohwer, Robert G.; Gregori, Luisa; Terry, Linda A.; Willbold, Dieter; Riesner, Detlev			Detection of Prion Protein Particles in Blood Plasma of Scrapie Infected Sheep	PLOS ONE			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; CREUTZFELDT-JAKOB-DISEASE; INFECTIVITY; REMOVAL; AMPLIFICATION; COMPONENTS; LEVEL; PRPSC	Prion diseases are transmissible neurodegenerative diseases affecting humans and animals. The agent of the disease is the prion consisting mainly, if not solely, of a misfolded and aggregated isoform of the host-encoded prion protein (PrP). Transmission of prions can occur naturally but also accidentally, e.g. by blood transfusion, which has raised serious concerns about blood product safety and emphasized the need for a reliable diagnostic test. In this report we present a method based on surface-FIDA (fluorescence intensity distribution analysis), that exploits the high state of molecular aggregation of PrP as an unequivocal diagnostic marker of the disease, and show that it can detect infection in blood. To prepare PrP aggregates from blood plasma we introduced a detergent and lipase treatment to separate PrP from blood lipophilic components. Prion protein aggregates were subsequently precipitated by phosphotungstic acid, immobilized on a glass surface by covalently bound capture antibodies, and finally labeled with fluorescent antibody probes. Individual PrP aggregates were visualized by laser scanning microscopy where signal intensity was proportional to aggregate size. After signal processing to remove the background from low fluorescence particles, fluorescence intensities of all remaining PrP particles were summed. We detected PrP aggregates in plasma samples from six out of ten scrapie-positive sheep with no false positives from uninfected sheep. Applying simultaneous intensity and size discrimination, ten out of ten samples from scrapie sheep could be differentiated from uninfected sheep. The implications for ante mortem diagnosis of prion diseases are discussed.	[Bannach, Oliver; Birkmann, Eva; Reinartz, Elke; Willbold, Dieter; Riesner, Detlev] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Birkmann, Eva; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst ICS 6, Julich, Germany; [Jaeger, Karl-Erich] Univ Dusseldorf, Res Ctr Julich, Inst Mol Enzyme Technol, Julich, Germany; [Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands; [Rohwer, Robert G.; Gregori, Luisa] VA Med Ctr, Med Res Serv 151, Mol Neurovirol Lab, VA Maryland Hlth Care Syst, Baltimore, MD USA; [Terry, Linda A.] Anim Hlth & Vet Labs Agcy, Addlestone, Surrey, England; [Gregori, Luisa] Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Wageningen University & Research; Veterinary Laboratories Agency; University System of Maryland; University of Maryland Baltimore	Bannach, O (corresponding author), Ctr Biol Evaluat & Res, Food & Drug Adm, Rockville, MD USA.	bannacho@hhu.de	Bannach, Oliver/A-4794-2015; Birkmann, Eva/H-6019-2013; Willbold, Dieter/A-6280-2013; jaeger, karl/ABB-1955-2020	Bannach, Oliver/0000-0002-7438-3791; Birkmann, Eva/0000-0002-2069-0630; Willbold, Dieter/0000-0002-0065-7366; 	UK Food Standards Agency [M03063]; VA Merit Review funding; NIH [N01-NS-0-2327]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [N01NS002327] Funding Source: NIH RePORTER	UK Food Standards Agency; VA Merit Review funding(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the UK Food Standards Agency (project M03063). RGR and LG were supported by VA Merit Review funding and NIH Contract: N01-NS-0-2327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Beekes M, 1996, TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES: PRION DISEASES, P143; Birkmann E, 2006, BIOL CHEM, V387, P95, DOI 10.1515/BC.2006.013; Birkmann E, 2007, VET MICROBIOL, V123, P294, DOI 10.1016/j.vetmic.2007.04.001; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Flan B, 2007, TRANSFUS CLIN BIOL, V14, P51, DOI 10.1016/j.tracli.2007.04.008; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Ironside JW, 2010, HAEMOPHILIA, V16, P175, DOI 10.1111/j.1365-2516.2010.02317.x; Janissen R, 2009, COLLOID SURFACE B, V71, P200, DOI 10.1016/j.colsurfb.2009.02.011; Knight R, 2010, TRANSFUS APHER SCI, V43, P387, DOI 10.1016/j.transci.2010.09.003; Korth C, 1997, NATURE, V390, P74, DOI 10.1038/36337; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Orru CD, 2012, PRION, V6; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Post K, 1998, BIOL CHEM, V379, P1307, DOI 10.1515/bchm.1998.379.11.1307; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Rohwer RG, 2004, CHIS TSE M; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Safar JG, 2006, P NATL ACAD SCI USA, V103, P11312, DOI 10.1073/pnas.0604021103; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT REV MICROBIOL, V2, P809, DOI 10.1038/nrmicro1003; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stucki M, 2008, BIOLOGICALS, V36, P239, DOI 10.1016/j.biologicals.2008.01.004; Tateishi J, 2001, BIOLOGICALS, V29, P17, DOI 10.1006/biol.2001.0269; Tateishi Jun, 1993, Membrane, V18, P357; Terry LA, 2009, J VIROL, V83, P12552, DOI 10.1128/JVI.00311-09; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Trieschmann L, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-26; Van Holten RW, 2003, VOX SANG, V85, P20, DOI 10.1046/j.1423-0410.2003.00312.x; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; World Health Organisation, 2006, WHO TABL TISS INF DI; Yunoki M, 2008, BIOLOGICALS, V36, P27, DOI 10.1016/j.biologicals.2007.04.005; Yunoki M, 2010, BIOLOGICALS, V38, P311, DOI 10.1016/j.biologicals.2009.10.018	49	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36620	10.1371/journal.pone.0036620	http://dx.doi.org/10.1371/journal.pone.0036620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567169	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500089
J	Fradin, D; Le Fur, S; Mille, C; Naoui, N; Groves, C; Zelenika, D; McCarthy, MI; Lathrop, M; Bougneres, P				Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Groves, Chris; Zelenika, Diana; McCarthy, Mark I.; Lathrop, Mark; Bougneres, Pierre			Association of the CpG Methylation Pattern of the Proximal Insulin Gene Promoter with Type 1 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; HUMAN THYMUS; EXPRESSION; LOCUS; LINKAGE; RISK	The insulin (INS) region is the second most important locus associated with Type 1 Diabetes (T1D). The study of the DNA methylation pattern of the 7 CpGs proximal to the TSS in the INS gene promoter revealed that T1D patients have a lower level of methylation of CpG -19, -135 and -234 (p = 2.10(-16)) and a higher methylation of CpG -180 than controls, while methylation was comparable for CpG -69, -102, -206. The magnitude of the hypomethylation relative to a control population was 8-15% of the corresponding levels in controls and was correlated in CpGs -19 and -135 (r = 0.77) and CpG 135 and -234 (r = 0.65). 70/485 (14%) of T1D patients had a simultaneous decrease in methylation of CpG -19, -135, -234 versus none in 317 controls. CpG methylation did not correlate with glycated hemoglobin or with T1D duration. The methylation of CpG -69, -102, -180, -206, but not CpG -19, -135, -234 was strongly influenced by the cis-genotype at rs689, a SNP known to show a strong association with T1D. We hypothesize that part of this genetic association could in fact be mediated at the statistical and functional level by the underlying changes in neighboring CpG methylation. Our observation of a CpG-specific, locus-specific methylation pattern, although it can provide an epigenetic biomarker of a multifactorial disease, does not indicate whether the reported epigenetic pattern preexists or follows the establishment of T1D. To explore the effect of chronic hyperglycemia on CpG methylation, we studied non obese patients with type 2 diabetes (T2D) who were found to have decreased CpG-19 methylation versus age-matched controls, similar to T1D (p = 2.10(-6)) but increased CpG-234 methylation (p = 5.10(-8)), the opposite of T1D. The causality and natural history of the different epigenetic changes associated with T1D or T2D remain to be determined.	[Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Univ Paris 11, INSERM, U986, Bicetre Hosp, Paris, France; [Fradin, Delphine; Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Univ Paris 11, Dept Pediat Endocrinol, Bicetre Hosp, Paris, France; [Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] Hop St Vincent de Paul, F-75674 Paris, France; [Le Fur, Sophie; Mille, Clemence; Naoui, Nadia; Bougneres, Pierre] ISIS DIAB Cohort, Le Kremlin Bicetre, France; [Zelenika, Diana; Lathrop, Mark] Ctr Natl Genotypage, Evry, France; [Groves, Chris; McCarthy, Mark I.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Oxford	Fradin, D (corresponding author), Univ Paris 11, INSERM, U986, Bicetre Hosp, Paris, France.	pierre.bougneres@inserm.fr	Fradin, Delphine/K-7181-2015; McCarthy, Mark/M-3763-2015	Fradin, Delphine/0000-0001-6231-2649; McCarthy, Mark/0000-0002-4393-0510	Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete; Programme Hospitalier de Recherche Clinique	Centre National de Genotypage (Evry); Association pour la Recherche sur le Diabete(Fondation ARC pour la Recherche sur le Cancer); Programme Hospitalier de Recherche Clinique	The authors acknowledge the support of "Alliance Diabete de Type 1 NovoNordisk-INSERM,'' Centre National de Genotypage (Evry), Association pour la Recherche sur le Diabete, and Programme Hospitalier de Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2011, P NATL ACAD SCI USA, V108, P19018, DOI 10.1073/pnas.1111008108; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bell CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014040; Bennett ST, 1996, ANNU REV GENET, V30, P343, DOI 10.1146/annurev.genet.30.1.343; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Concannon P, 2005, DIABETES, V54, P2995, DOI 10.2337/diabetes.54.10.2995; COX NJ, 1989, DIABETES, V38, P653, DOI 10.2337/diabetes.38.5.653; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kuroda A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006953; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; MEABURN EL, 2010, EPIGENETICS, V5; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002216; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Rakyan VK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002300; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Yang BT, 2010, DIABETOLOGIA; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	26	67	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36278	10.1371/journal.pone.0036278	http://dx.doi.org/10.1371/journal.pone.0036278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567146	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500065
J	Wang, JJ; Li, YQ; Han, ZJ; Zhu, YL; Xie, ZJ; Wang, J; Liu, YP; Li, XC				Wang, Jianjun; Li, Yanqing; Han, Zhaojun; Zhu, Youli; Xie, Zhijuan; Wang, Jian; Liu, Yaping; Li, Xianchun			Molecular Characterization of a Ryanodine Receptor Gene in the Rice Leaffolder, Cnaphalocrocis medinalis (Guenee)	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; NEGATIVE SPLICE VARIANT; ANTHRANILIC DIAMIDES; CDNA CLONING; IDENTIFICATION; REVEALS; BINDING; DOMAIN; LOOP; FLUBENDIAMIDE	Ryanodine receptors (RyRs) are the targets of two novel classes of synthetic insecticidal chemicals, phthalic acid diamides and anthranilic diamides. Isolation of full-length RyR cDNAs is a critical step towards the structural and functional characterization of insect RyRs and an understanding of the molecular mechanisms underlying the species selective toxicity of diamide insecticides. However, there has been little research on the insect RyR genes due to the high molecular weight of the RyR proteins. In this study, we isolated a full-length RyR cDNA (named as CmRyR) from Cnaphalocrocis medinalis, an important rice pest throughout Southeast Asia. The composite CmRyR gene contains an ORF of 15264 bp encoding a protein of 5087 amino acid residues, which shares 79% overall identity with its Drosophila melanogaster homologue. All hallmarks of the RyR proteins are conserved in the CmRyR protein, suggesting that CmRyR is a structural and functional analogue of known RyRs. A multiple sequence alignment illustrates that the insect RyRs share high levels of amino acid sequence identity at the the COOH-terminal region. However, the amino acid residues analogous to the CmRyR residues N-4922, N-4924, N-4935, L-4950, L-4981, N-5013 and T-5064 are unique to lepidopteran RyRs compared with non-lepidopteran insect RyRs. This finding suggests that these residues may be involved in the differences in channel properties between lepidopteran and non-lepidopteran insect RyRs and in the species selective toxicity of diamide insecticides. Furthermore, two alternative splicing sites were identified in the CmRyR gene, one of which was located in the central part of the predicted second SPRY domain. Diagnostic PCR showed that the inclusion frequencies of two mutually exclusive exons (a/b) and one optional exon (c) differed between developmental stages or adult anatomical regions. Our results imply that alternative splicing may be a major means of generating functional diversity in C. medinalis RyR channel.	[Wang, Jianjun; Li, Yanqing; Zhu, Youli; Xie, Zhijuan; Wang, Jian; Liu, Yaping] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China; [Li, Xianchun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Li, Xianchun] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Han, Zhaojun] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Peoples R China	Yangzhou University; University of Arizona; University of Arizona; Nanjing Agricultural University	Wang, JJ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Peoples R China.	wangjj@yzu.edu.cn			National Natural Science Foundation of China [31171841]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant 31171841 to JJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cui YF, 2009, INT J BIOCHEM CELL B, V41, P677, DOI 10.1016/j.biocel.2008.08.004; Dabertrand F, 2006, CELL CALCIUM, V40, P11, DOI 10.1016/j.ceca.2006.03.008; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; FUTATSUGI A, 1995, BIOCHEM J, V305, P373, DOI 10.1042/bj3050373; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Gutteridge S., 2003, U.S. Patent, Patent No. [7,205,147, 7205147]; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; HALL LM, 1995, ACS SYM SER, V591, P162; INUI M, 1987, J BIOL CHEM, V262, P15637; Jiang DW, 2003, J BIOL CHEM, V278, P4763, DOI 10.1074/jbc.M210410200; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kimura T, 2009, CELL CALCIUM, V45, P264, DOI 10.1016/j.ceca.2008.11.005; Lahm G.P., 2007, PESTICIDE CHEM CROP, P111, DOI [10.1002/9783527611249.ch11, DOI 10.1002/9783527611249.CH11]; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; Leeb T, 1998, FEBS LETT, V423, P367, DOI 10.1016/S0014-5793(98)00124-0; Marziah G, 1996, FEBS LETT, V394, P76, DOI 10.1016/0014-5793(96)00944-1; Masaki T, 2006, MOL PHARMACOL, V69, P1733, DOI 10.1124/mol.105.020339; MIGNERY GA, 1993, METH NEUROSCI, V18, P247; Miyatake R, 1996, FEBS LETT, V395, P123, DOI 10.1016/0014-5793(96)01022-8; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Puente E, 2000, INSECT BIOCHEM MOLEC, V30, P335, DOI 10.1016/S0965-1748(00)00009-6; Ross D, 2002, CELL CALCIUM, V32, P307, DOI 10.1016/S0143-4160(02)00198-7; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Wang XL, 2012, PESTIC BIOCHEM PHYS, V102, P204, DOI 10.1016/j.pestbp.2012.01.009; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; ZORZATO F, 1994, BIOCHEM BIOPH RES CO, V203, P1725, DOI 10.1006/bbrc.1994.2385; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	48	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36623	10.1371/journal.pone.0036623	http://dx.doi.org/10.1371/journal.pone.0036623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567170	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500090
J	Edvardson, S; Cinnamon, Y; Ta-Shma, A; Shaag, A; Yim, YI; Zenvirt, S; Jalas, C; Lesage, S; Brice, A; Taraboulos, A; Kaestner, KH; Greene, LE; Elpeleg, O				Edvardson, Simon; Cinnamon, Yuval; Ta-Shma, Asaf; Shaag, Avraham; Yim, Yang-In; Zenvirt, Shamir; Jalas, Chaim; Lesage, Suzanne; Brice, Alexis; Taraboulos, Albert; Kaestner, Klaus H.; Greene, Lois E.; Elpeleg, Orly			A Deleterious Mutation in DNAJC6 Encoding the Neuronal-Specific Clathrin-Uncoating Co-Chaperone Auxilin, Is Associated with Juvenile Parkinsonism	PLOS ONE			English	Article							COATED VESICLES; ENDOCYTOSIS; DISEASE; RECEPTORS; PROTEIN; VPS35; GENE	Parkinson disease is caused by neuronal loss in the substantia nigra which manifests by abnormality of movement, muscle tone, and postural stability. Several genes have been implicated in the pathogenesis of Parkinson disease, but the underlying molecular basis is still unknown for similar to 70% of the patients. Using homozygosity mapping and whole exome sequencing we identified a deleterious mutation in DNAJC6 in two patients with juvenile Parkinsonism. The mutation was associated with abnormal transcripts and marked reduced DNAJC6 mRNA level. DNAJC6 encodes the HSP40 Auxilin, a protein which is selectively expressed in neurons and confers specificity to the ATPase activity of its partner Hcs70 in clathrin uncoating. In Auxilin null mice it was previously shown that the abnormally increased retention of assembled clathrin on vesicles and in empty cages leads to impaired synaptic vesicle recycling and perturbed clathrin mediated endocytosis. Endocytosis function, studied by transferring uptake, was normal in fibroblasts from our patients, likely because of the presence of another J-domain containing partner which co-chaperones Hsc70-mediated uncoating activity in non-neuronal cells. The present report underscores the importance of the endocytic/lysosomal pathway in the pathogenesis of Parkinson disease and other forms of Parkinsonism.	[Edvardson, Simon; Cinnamon, Yuval; Ta-Shma, Asaf; Shaag, Avraham; Zenvirt, Shamir; Elpeleg, Orly] Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel; [Yim, Yang-In; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Jalas, Chaim] Ctr Rare Jewish Genet Disorders, Brooklyn, NY USA; [Lesage, Suzanne; Brice, Alexis] Univ Paris 06, Hosp Pitie Salpetriere, CNRS UMR 7225, CRICM,INSERM,UMR S975, Paris, France; [Taraboulos, Albert] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, IL-91010 Jerusalem, Israel; [Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hebrew University of Jerusalem; University of Pennsylvania	Edvardson, S (corresponding author), Hebrew Univ Jerusalem, Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel.	Elpeleg@hadassah.org.il	Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	brice, alexis/0000-0002-0941-3990; Jalas, Chaim/0000-0002-3788-0924; Edvardson, Simon/0000-0003-2878-1278	Hadassah Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER	Hadassah Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Internal funds of Hadassah Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Gasser T, 2011, MOVEMENT DISORD, V26, P1042, DOI 10.1002/mds.23637; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hirst J, 2008, TRAFFIC, V9, P1354, DOI 10.1111/j.1600-0854.2008.00764.x; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Ohtsuka K, 2000, CELL STRESS CHAPERON, V5, P98, DOI 10.1379/1466-1268(2000)005<0098:MHDHCO>2.0.CO;2; Paspalas CD, 2006, EUR J NEUROSCI, V24, P1395, DOI 10.1111/j.1460-9568.2006.05023.x; Plagnol V, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002142; Potashkin JA, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/658083; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Sakaguchi-Nakashima A, 2007, CURR BIOL, V17, P592, DOI 10.1016/j.cub.2007.01.074; Scheele U, 2001, J BIOL CHEM, V276, P36131, DOI 10.1074/jbc.M106511200; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859; Yim YI, 2010, P NATL ACAD SCI USA, V107, P4412, DOI 10.1073/pnas.1000738107; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	27	192	195	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36458	10.1371/journal.pone.0036458	http://dx.doi.org/10.1371/journal.pone.0036458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563501	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700050
J	Meyers, SC; Liston, A; Meinke, R				Meyers, Stephen C.; Liston, Aaron; Meinke, Robert			An Evaluation of Putative Sympatric Speciation within Limnanthes (Limnanthaceae)	PLOS ONE			English	Article							EVOLUTIONARY BIOLOGY; CHLOROPLAST; POPULATION; CALIFORNIA; GENOME; PALMS	Limnanthes floccosa ssp. floccosa and L. floccosa ssp. grandiflora are two of five subspecies within Limnanthes floccosa endemic to vernal pools in southern Oregon and northern California. Three seasons of monitoring natural populations have quantified that L. floccosa ssp. grandiflora is always found growing sympatrically with L. floccosa ssp. floccosa and that their flowering times overlap considerably. Despite their subspecific rank within the same species crossing experiments have confirmed that their F1 hybrids are sterile. An analysis of twelve microsatellite markers, with unique alleles in each taxon, also shows exceedingly low levels of gene flow between populations of the two subspecies. Due to the lack of previous phylogenetic resolution among L. floccosa subspecies, we used Illumina next generation sequencing to identify single nucleotide polymorphisms from genomic DNA libraries of L. floccosa ssp. floccosa and L. floccosa ssp. grandiflora. These data were used to identify single nucleotide polymorphisms in the chloroplast, mitochondrial, and nuclear genomes. From these variable loci, a total of 2772 bp was obtained using Sanger sequencing of ten individuals representing all subspecies of L. floccosa and an outgroup. The resulting phylogenetic reconstruction was fully resolved. Our results indicate that although L. floccosa ssp. floccosa and L. floccosa ssp. grandiflora are closely related, they are not sister taxa and therefore likely did not diverge as a result of a sympatric speciation event.	[Meyers, Stephen C.; Liston, Aaron; Meinke, Robert] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University	Meyers, SC (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	meyersst@science.oregonstate.edu			Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology	Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology	This work was funded, in part, by the Leslie and Vera Gottlieb Research Fund in Plant Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; ARROYO MTK, 1973, EVOLUTION, V27, P679, DOI 10.1111/j.1558-5646.1973.tb00715.x; ARROYO MTK, 1973, BRITTONIA, V25, P177, DOI 10.2307/2805936; Babik W, 2009, MOL ECOL, V18, P3629, DOI 10.1111/j.1365-294X.2009.04306.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Coyne J.A., 2004, SPECIATION; Darwin C, 1859, ORIGIN SPECIES MEANS; Dobzhansky T., 1937; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; King JL, 1996, HYDROBIOLOGIA, V328, P85, DOI 10.1007/BF00018707; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kishore VK, 2004, THEOR APPL GENET, V108, P450, DOI 10.1007/s00122-003-1447-1; Marshall JL, 2002, TRENDS ECOL EVOL, V17, P558, DOI 10.1016/S0169-5347(02)02636-8; Mayr E, 1942, SYSTEMATICS ORIGIN S; Meyers SC, 2010, ACTA HORTIC, V859, P309, DOI 10.17660/ActaHortic.2010.859.36; Meyers SC, 2008, SURVEY SEED BULKING; Meyers SC, 2010, SYST BOT, V35, P552, DOI 10.1600/036364410792495854; ORNDUFF R, 1993, JEPSON MANUAL HIGHER, P736; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Peck ME, 1961, MANUAL HIGHER PLANTS, P506; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schliewen UK, 2006, NATURE, V444, pE12, DOI 10.1038/nature05419; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stuessy TF, 2006, NATURE, V443, DOI 10.1038/nature05216; TOY SJ, 1966, ECON BOT, V20, P71, DOI 10.1007/BF02861928; Whittall JB, 2010, MOL ECOL, V19, P100, DOI 10.1111/j.1365-294X.2009.04474.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	35	5	5	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36480	10.1371/journal.pone.0036480	http://dx.doi.org/10.1371/journal.pone.0036480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563502	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700051
J	Wasti, SP; Simkhada, P; Randall, J; Freeman, JV; van Teijlingen, E				Wasti, Sharada P.; Simkhada, Padam; Randall, Julian; Freeman, Jennifer V.; van Teijlingen, Edwin			Factors Influencing Adherence to Antiretroviral Treatment in Nepal: A Mixed-Methods Study	PLOS ONE			English	Article							SELF-REPORTED ADHERENCE; MEDICATION ADHERENCE; THERAPY ADHERENCE; DRUG-RESISTANCE; CLINICAL-TRIALS; SOCIAL SUPPORT; ART ADHERENCE; HIV; BARRIERS; FACILITATORS	Background: Antiretroviral therapy (ART) is a lifesaver for individual patients treated for Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). Maintaining optimal adherence to antiretroviral drugs is essential for HIV infection management. This study aimed to understand the factors influencing adherence amongst ART-prescribed patients and care providers in Nepal. Methods: A cross-sectional mixed-methods study surveying 330 ART-prescribed patients and 34 in-depth interviews with three different types of stakeholders: patients, care providers, and key people at policy level. Adherence was assessed through survey self-reporting and during the interviews. A multivariate logistic regression model was used to identify factors associated with adherence, supplemented with a thematic analysis of the interview transcripts. Results: A total of 282 (85.5%) respondents reported complete adherence, i.e. no missed doses in the four-weeks prior to interview. Major factors influencing adherence were: non-disclosure of HIV status (OR = 17.99, p = 0.014); alcohol use (OR = 12.89, p =<0.001), being female (OR = 6.91, p = 0.001), being illiterate (OR = 4.58, p = 0.015), side-effects (OR = 6.04, p = 0.025), ART started <= 24 months (OR = 3.18, p = 0.009), travel time to hospital >1 hour (OR = 2.84, p = 0.035). Similarly, lack of knowledge and negative perception towards ART medications also significantly affected non-adherence. Transport costs (for repeat prescription), followed by pills running out, not wanting others to notice, side-effects, and being busy were the most common reasons for non-adherence. The interviews also revealed religious or ritual obstacles, stigma and discrimination, ART-associated costs, transport problems, lack of support, and side-effects as contributing to non-adherence. Conclusion: Improving adherence requires a supportive environment; accessible treatment; clear instructions about regimens; and regimens tailored to individual patients' lifestyles. Healthcare workers should address some of the practical and cultural issues around ART medicine whilst policy-makers should develop appropriate social policy to promote adherence among ART-prescribed patients.	[Wasti, Sharada P.; Simkhada, Padam; Freeman, Jennifer V.] Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England; [Randall, Julian] Univ Aberdeen, Sch Business, Aberdeen, Scotland; [van Teijlingen, Edwin] Bournemouth Univ, Bournemouth, Dorset, England	University of Sheffield; University of Aberdeen; Bournemouth University	Wasti, SP (corresponding author), Univ Sheffield, Sch Hlth & Related Res ScHARR, Sheffield, S Yorkshire, England.	s.wasti@sheffield.ac.uk	Wasti, Sharada/AAO-7742-2021; van Teijlingen, Edwin R/A-3727-2010	van Teijlingen, Edwin R/0000-0001-5523-8583; Simkhada, Padam/0000-0002-5706-6479; Wasti, Dr. Sharada Prasad/0000-0001-8833-7801				Adam BD, 2003, AIDS CARE, V15, P263, DOI 10.1080/0954012031000068407; Adeneye A K, 2006, World Health Popul, V8, P46; Alakija Kazeem Salami, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P191, DOI 10.1177/1545109710368722; Alker AP, 2004, 15 INT C AIDS BANGK; Amico KR, 2009, AIDS BEHAV, V13, P66, DOI 10.1007/s10461-007-9311-y; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bazeley, 2007, QUALITATIVE DATA ANA; Bonolo PD, 2005, AIDS, V19, pS5; Bowling A., 2014, RES METHODS HLTH INV; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Catz SL, 2000, HEALTH PSYCHOL, V19, P124, DOI 10.1037/0278-6133.19.2.124; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Fletcher CV, 2005, JAIDS-J ACQ IMM DEF, V40, P301, DOI 10.1097/01.qai.0000180078.53321.6a; Fumaz CR, 2008, AIDS CARE, V20, P796, DOI 10.1080/09540120701694022; Furber AS, 2004, BMJ-BRIT MED J, V329, P1281, DOI 10.1136/bmj.329.7477.1281; Hansel A, 2001, J ACQ IMMUN DEF SYND, V26, P191, DOI 10.1097/00126334-200102010-00016; Hardon A., 2006, ACCESS ADHERENCE CHA; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Johnson VR, 2010, PATIENT EDUC COUNS, V79, P14, DOI 10.1016/j.pec.2009.07.002; Keenan KF, 2005, J FAM PLAN REPROD H, V31, P40, DOI 10.1783/0000000052972825; Kleeberger CA, 2001, J ACQ IMMUN DEF SYND, V26, P82, DOI 10.1097/00126334-200101010-00012; Konkle-Parker DJ, 2008, J ASSOC NURSE AIDS C, V19, P98, DOI 10.1016/j.jana.2007.09.005; Kumarasamy N, 2005, AIDS PATIENT CARE ST, V19, P526, DOI 10.1089/apc.2005.19.526; Lewis MP, 2006, AIDS CARE, V18, P140, DOI 10.1080/09540120500161835; Li L, 2010, NURS HEALTH SCI, V12, P212, DOI 10.1111/j.1442-2018.2010.00521.x; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Mbonu NC, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/145891; Mehta S, 1997, AIDS, V11, P1665, DOI 10.1097/00002030-199714000-00002; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mimiaga MJ, 2010, AIDS CARE, V22, P1305, DOI 10.1080/09540121003758515; Murphy DA, 2005, ARCH PEDIAT ADOL MED, V159, P764, DOI 10.1001/archpedi.159.8.764; Murphy DA, 2003, AIDS CARE, V15, P217, DOI 10.1080/0954012031000068362; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Ncama BP, 2008, INT J NURS STUD, V45, P1757, DOI 10.1016/j.ijnurstu.2008.06.006; NCASC, 2009, FACTSH 4 ANT ART SER; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Rabkin J G, 1998, GMHC Treat Issues, V12, P8; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Remien RH, 2003, AIDS BEHAV, V7, P61, DOI 10.1023/A:1022513507669; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Royal SW, 2009, AIDS CARE, V21, P448, DOI 10.1080/09540120802270250; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Sarna A, 2008, INDIAN J MED RES, V127, P28; Schein E.H., 1985, CLASSICS ORG THEORY, V3, P490; Shah B, 2007, CLIN INFECT DIS, V44, P1235, DOI 10.1086/513429; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Smith-Estelle A, 2003, REPROD HEALTH MATTER, V11, P142, DOI 10.1016/S0968-8080(03)02292-4; Sorensen S, 2002, 14 INT AIDS C BARC I; Stevens W, 2004, BMJ-BRIT MED J, V328, P280, DOI 10.1136/bmj.328.7434.280; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Swartz L, 2002, BMJ-BRIT MED J, V325, P914, DOI 10.1136/bmj.325.7370.914; Thomas D., 2004, INCREASING ACCESS ES; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; van der Wal MHL, 2006, EUR HEART J, V27, P434, DOI 10.1093/eurheartj/ehi603; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; Wagner G, 2004, JAIDS-J ACQ IMM DEF, V35, P203, DOI 10.1097/00126334-200402010-00016; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; Wanyama J, 2007, AIDS, V21, P1486, DOI 10.1097/QAD.0b013e32823ecf7f; Wasti SP, 2012, TROP MED INT HEALTH, V17, P71, DOI 10.1111/j.1365-3156.2011.02888.x; Wasti SP., 2011, HLTH SCI J, V5, P37; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; *WHO, 2003, ADH LONG TERM EV ACT; WHO, INN CAR CHRON COND B; Willard S., 2008, Journal of the International Association of Physicians in AIDS Care, V7, pS17, DOI 10.1177/1545109708315404; World Bank, 2001, UND ACC DEM UT HLTH	75	104	105	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35547	10.1371/journal.pone.0035547	http://dx.doi.org/10.1371/journal.pone.0035547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UN	22563464	Green Published, Green Accepted, gold			2022-12-27	WOS:000305340700013
J	Dura, B; Kovacs, GTA; Giovangrandi, L				Dura, Burak; Kovacs, Gregory T. A.; Giovangrandi, Laurent			Spatiotemporally Controlled Cardiac Conduction Block Using High-Frequency Electrical Stimulation	PLOS ONE			English	Article							ULTRARAPID SUBTHRESHOLD STIMULATION; ALTERNATING-CURRENT; VENTRICULAR REFRACTORINESS; REENTRANT TACHYCARDIA; HL-1 CARDIOMYOCYTES; CURRENTS; CELL; TERMINATION; MODEL; EXCITATION	Background: Methods for the electrical inhibition of cardiac excitation have long been sought to control excitability and conduction, but to date remain largely impractical. High-amplitude alternating current (AC) stimulation has been known to extend cardiac action potentials (APs), and has been recently exploited to terminate reentrant arrhythmias by producing reversible conduction blocks. Yet, low-amplitude currents at similar frequencies have been shown to entrain cardiac tissues by generation of repetitive APs, leading in some cases to ventricular fibrillation and hemodynamic collapse in vivo. Therefore, an inhibition method that does not lead to entrainment - irrespective of the stimulation amplitude (bound to fluctuate in an in vivo setting) - is highly desirable. Methodology/Principal Findings: We investigated the effects of broader amplitude and frequency ranges on the inhibitory effects of extracellular AC stimulation on HL-1 cardiomyocytes cultured on microelectrode arrays, using both sinusoidal and square waveforms. Our results indicate that, at sufficiently high frequencies, cardiac tissue exhibits a binary response to stimulus amplitude with either prolonged APs or no effect, thereby effectively avoiding the risks of entrainment by repetitive firing observed at lower frequencies. We further demonstrate the ability to precisely define reversible local conduction blocks in beating cultures without influencing the propagation activity in non-blocked areas. The conduction blocks were spatiotemporally controlled by electrode geometry and stimuli duration, respectively, and sustainable for long durations (300 s). Conclusion/Significance: Inhibition of cardiac excitation induced by high-frequency AC stimulation exhibits a binary response to amplitude above a threshold frequency, enabling the generation of reversible conduction blocks without the risks of entrainment. This inhibition method could yield novel approaches for arrhythmia modeling in vitro, as well as safer and more efficacious tools for in vivo cardiac mapping and radio-frequency ablation guidance applications.	[Dura, Burak; Kovacs, Gregory T. A.; Giovangrandi, Laurent] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University	Dura, B (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	giovan@stanford.edu			Medtronic, Inc.; Medtronic	Medtronic, Inc.(Medtronic); Medtronic(Medtronic)	The authors have read the journal's policy and have the following conflicts: Stanford University has filed U.S. provisional patent applications related to this work. In addition, this research effort has been funded by Medtronic, Inc. Dr. Giovangrandi benefited from a travel grant from Medtronic. GTAK owns Medtronic stocks. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANTONI H, 1970, PFLUG ARCH EUR J PHY, V314, P274, DOI 10.1007/BF00592287; Antoni H., 1970, PFLUGERS ARCH, V814, P274; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Basser PJ, 2000, ANNU REV BIOMED ENG, V2, P377, DOI 10.1146/annurev.bioeng.2.1.377; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bromm B, 1971, PFLUGERS ARCH, V329, P155; CHORRO FJ, 1994, EUR HEART J, V15, P1681, DOI 10.1093/oxfordjournals.eurheartj.a060452; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dura B, 2012, IEEE T BIO-MED ENG, V59, P1381, DOI 10.1109/TBME.2012.2188136; FISHER JD, 1983, AM J CARDIOL, V51, P1334, DOI 10.1016/0002-9149(83)90308-9; FROMER M, 1992, J AM COLL CARDIOL, V20, P879, DOI 10.1016/0735-1097(92)90188-S; Gilchrist KH, 2001, BIOSENS BIOELECTRON, V16, P557, DOI 10.1016/S0956-5663(01)00169-5; Gonzalez H, 2003, BIOSYSTEMS, V71, P71, DOI 10.1016/S0303-2647(03)00111-4; Gray RA, 1996, PACE 2, V19, P666; Katz B, 1939, J PHYSIOL-LONDON, V96, P202, DOI 10.1113/jphysiol.1939.sp003771; Malkin RA, 2003, MED BIOL ENG COMPUT, V41, P640, DOI 10.1007/BF02349971; Malkin RA, 2001, J CARDIOVASC ELECTR, V12, P1154, DOI 10.1046/j.1540-8167.2001.01154.x; Meunier JM, 1999, J CARDIOVASC ELECTR, V10, P1619, DOI 10.1111/j.1540-8167.1999.tb00226.x; Meunier JM, 2001, J CARDIOVASC ELECTR, V12, P1176, DOI 10.1046/j.1540-8167.2001.01176.x; Nygren A, 1998, CIRC RES, V82, P63; PAYA R, 1991, J ELECTROCARDIOL, V24, P63, DOI 10.1016/0022-0736(91)90082-W; Prevost J, 1899, CR HEBD ACAD SCI, V128, P668; PRYSTOWSKY EN, 1983, CIRCULATION, V68, P707, DOI 10.1161/01.CIR.68.4.707; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Schoen I, 2008, J NEUROPHYSIOL, V100, P346, DOI 10.1152/jn.90287.2008; SHENASA M, 1988, CIRCULATION, V78, P1135, DOI 10.1161/01.CIR.78.5.1135; Swedlow CD, 1987, CIRCULATION, V76, P1101; Tandri H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002445; Thomas SP, 2000, CIRC RES, V87, P467; Vigmond EJ, 2001, J CARDIOVASC ELECTR, V12, P1145, DOI 10.1046/j.1540-8167.2001.01145.x; VINET A, 1994, ANN BIOMED ENG, V22, P568, DOI 10.1007/BF02368285; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Whittington RH, 2006, THESIS STANFORD U ST; Willems S, 2001, J AM COLL CARDIOL, V37, P1645, DOI 10.1016/S0735-1097(01)01206-2; WINDLE JR, 1986, AM J CARDIOL, V57, P381, DOI 10.1016/0002-9149(86)90757-5; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	36	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36217	10.1371/journal.pone.0036217	http://dx.doi.org/10.1371/journal.pone.0036217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558389	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200050
J	Schachtele, SJ; Hu, SX; Lokensgard, JR				Schachtele, Scott J.; Hu, Shuxian; Lokensgard, James R.			Modulation of Experimental Herpes Encephalitis-Associated Neurotoxicity through Sulforaphane Treatment	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; SIMPLEX-VIRUS; REACTIVE OXYGEN; MICROGLIAL CELLS; GENE-EXPRESSION; ASTROCYTES; PROTECTS; BRAIN	Reactive oxygen species (ROS) produced by brain-infiltrating macrophages and neutrophils, as well as resident microglia, are pivotal to pathogen clearance during viral brain infection. However, unchecked free radical generation is also responsible for damage to and cytotoxicity of critical host tissue bystander to primary infection. These unwanted effects of excessive ROS are combated by local cellular production of antioxidant enzymes, including heme oxygenase-1 (HO-1) and glutathione peroxidase 1 (Gpx1). In this study, we showed that experimental murine herpes encephalitis triggered robust ROS production, as well as an opposing upregulation of the antioxidants HO-1 and Gpx1. This antioxidant response was insufficient to prevent tissue damage, neurotoxicity, and mortality associated with viral brain infection. Previous studies corroborate our data supporting astrocytes as the major antioxidant producer in brain cell cultures exposed to HSV-1 stimulated microglia. We hypothesized that stimulating opposing antioxidative responses in astrocytes, as well as neurons, would mitigate the effects of ROS-mediated neurotoxicity both in vitro and during viral brain infection in vivo. Here, we demonstrate that the addition of sulforaphane, a potent stimulator of antioxidant responses, enhanced HO-1 and Gpx1 expression in astrocytes through the activation of nuclear factor-E2-related factor 2 (Nrf2). Additionally, sulforaphane treatment was found to be effective in reducing neurotoxicity associated with HSV-stimulated microglial ROS production. Finally, intraperitoneal injections of sulforaphane into mice during active HSV infection reduced neuroinflammation via a decrease in brain-infiltrating leukocytes, macrophage- and neutrophil-produced ROS, and MHCII-positive, activated microglia. These data support a key role for astrocyte-produced antioxidants in modulating oxidative stress and neuronal damage in response to viral infection.	[Schachtele, Scott J.; Hu, Shuxian; Lokensgard, James R.] Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Schachtele, SJ (corresponding author), Univ Minnesota, Dept Med, Ctr Infect Dis & Microbiol Translat Res, Box 736 UMHC, Minneapolis, MN 55455 USA.	loken006@umn.edu			National Institute of Mental Health [R01MH-066703]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066703] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grant R01MH-066703 from the National Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2006, GENE THER, V13, P1645, DOI 10.1038/sj.gt.3302821; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; ARMIEN A, 2009, BRAIN PATHOL; Bergstrom P, 2011, NEUROPHARMACOLOGY, V60, P343, DOI 10.1016/j.neuropharm.2010.09.023; Block ML, 2007, BIOCHEM SOC T, V35, P1127, DOI 10.1042/BST0351127; Calkins MJ, 2010, TOXICOL SCI, V115, P557, DOI 10.1093/toxsci/kfq072; Chang G, 2010, BIOL PHARM BULL, V33, P1477, DOI 10.1248/bpb.33.1477; Chen G, 2011, J NEUROSCI RES, V89, P515, DOI 10.1002/jnr.22577; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Duffy S, 1998, J NEUROCHEM, V71, P69; FORD AL, 1995, J IMMUNOL, V154, P4309; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; Gonenc S, 2000, NEUROSCI LETT, V289, P107, DOI 10.1016/S0304-3940(00)01272-6; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hamo L, 2007, GLIA, V55, P1169, DOI 10.1002/glia.20538; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Hu S, 2010, J NEUROINFLAMM, V8, P123; Innamorato NG, 2008, J IMMUNOL, V181, P680, DOI 10.4049/jimmunol.181.1.680; Jazwa A, 2011, ANTIOXID REDOX SIGN, V14, P2347, DOI 10.1089/ars.2010.3731; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Kavouras JH, 2007, J NEUROVIROL, V13, P416, DOI 10.1080/13550280701460573; Kelsey NA, 2010, MOLECULES, V15, P7792, DOI 10.3390/molecules15117792; Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louboutin JP, 2009, NEUROBIOL DIS, V34, P462, DOI 10.1016/j.nbd.2009.03.003; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Marques CP, 2008, J NEUROVIROL, V14, P229, DOI 10.1080/13550280802093927; Marques CP, 2006, VIRUS RES, V121, P1, DOI 10.1016/j.virusres.2006.03.009; Martin LD, 1997, ENVIRON HEALTH PERSP, V105, P1301, DOI 10.2307/3433551; Milatovic D, 2002, J NEUROVIROL, V8, P295, DOI 10.1080/13550280290100743; Nimura T, 1996, MOL BRAIN RES, V37, P201, DOI 10.1016/0169-328X(95)00315-J; Reddy PV, 2011, NEUROCHEM INT; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Sacktor N, 2004, J NEUROIMMUNOL, V157, P176, DOI 10.1016/j.jneuroim.2004.08.037; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Schachtele SJ, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-35; Siebert A, 2009, J NEUROSCI RES, V87, P1659, DOI 10.1002/jnr.21975; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Teng ZP, 2004, NEUROBIOL DIS, V17, P179, DOI 10.1016/j.nbd.2004.07.009; Turchan-Cholewo J, 2009, ANTIOXID REDOX SIGN, V11, P193, DOI [10.1089/ars.2008.2097, 10.1089/ARS.2008.2097]; Vargas MR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001094; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wang X, 2012, J NEUROTRAUMA; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	47	43	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36216	10.1371/journal.pone.0036216	http://dx.doi.org/10.1371/journal.pone.0036216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558388	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000159
J	Powell, JE; Henders, AK; McRae, AF; Caracella, A; Smith, S; Wright, MJ; Whitfield, JB; Dermitzakis, ET; Martin, NG; Visscher, PM; Montgomery, GW				Powell, Joseph E.; Henders, Anjali K.; McRae, Allan F.; Caracella, Anthony; Smith, Sara; Wright, Margaret J.; Whitfield, John B.; Dermitzakis, Emmanouil T.; Martin, Nicholas G.; Visscher, Peter M.; Montgomery, Grant W.			The Brisbane Systems Genetics Study: Genetical Genomics Meets Complex Trait Genetics	PLOS ONE			English	Article							WIDE ASSOCIATION; MISSING HERITABILITY; HUMAN-POPULATIONS; BIPOLAR DISORDER; EXPRESSION; DISEASE; VARIANTS; LINKAGE; COMMON; LOCI	There is growing evidence that genetic risk factors for common disease are caused by hereditary changes of gene regulation acting in complex pathways. Clearly understanding the molecular genetic relationships between genetic control of gene expression and its effect on complex diseases is essential. Here we describe the Brisbane Systems Genetics Study (BSGS), a family-based study that will be used to elucidate the genetic factors affecting gene expression and the role of gene regulation in mediating endophenotypes and complex diseases. BSGS comprises of a total of 962 individuals from 314 families, for which we have high-density genotype, gene expression and phenotypic data. Families consist of combinations of both monozygotic and dizygotic twin pairs, their siblings, and, for 72 families, both parents. A significant advantage of the inclusion of parents is improved power to disentangle environmental, additive genetic and non-additive genetic effects of gene expression and measured phenotypes. Furthermore, it allows for the estimation of parent-of-origin effects, something that has not previously been systematically investigated in human genetical genomics studies. Measured phenotypes available within the BSGS include blood phenotypes and biochemical traits measured from components of the tissue sample in which transcription levels are determined, providing an ideal test case for systems genetics approaches. We report results from an expression quantitative trait loci (eQTL) analysis using 862 individuals from BSGS to test for associations between expression levels of 17,926 probes and 528,509 SNP genotypes. At a study wide significance level approximately 15,000 associations were observed between expression levels and SNP genotypes. These associations corresponded to a total of 2,081 expression quantitative trait loci (eQTL) involving 1,503 probes. The majority of identified eQTL (87%) were located within cis-regions.	[Powell, Joseph E.; McRae, Allan F.; Visscher, Peter M.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Powell, Joseph E.; Henders, Anjali K.; McRae, Allan F.; Caracella, Anthony; Smith, Sara; Wright, Margaret J.; Whitfield, John B.; Martin, Nicholas G.; Visscher, Peter M.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Geneva; University of Queensland	Powell, JE (corresponding author), Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia.	joseph.powell@uq.edu.au	Powell, Joseph/G-3027-2014; Wright, Margaret Jane/A-4560-2016; Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020; Dermitzakis, Emmanouil/B-7687-2013; Wright, Margaret J/H-3308-2014; McRae, Allan F/J-2644-2014; Martin, Nicholas/R-9235-2019; Henders, Anjali/E-3126-2017	Powell, Joseph/0000-0001-9031-6356; Wright, Margaret Jane/0000-0001-7133-4970; Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760; McRae, Allan F/0000-0001-5286-5485; Martin, Nicholas/0000-0003-4069-8020; Henders, Anjali/0000-0003-3672-1451; Whitfield, John/0000-0002-1103-0876; Powell, Joseph/0000-0002-5070-4124	Australian National Health and Medical Research Council (NHMRC) [241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498]; Australian Research Council [A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921]; NHMRC [389892, 496667, 613601]; NHMRC Fellowship Scheme; Louis-Jeantet Foundation	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Fellowship Scheme(National Health and Medical Research Council (NHMRC) of Australia); Louis-Jeantet Foundation	We acknowledge funding by Australian National Health and Medical Research Council (NHMRC) grants 241944, 339462, 389927, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 552485, 552498 and Australian Research Council grants A7960034, A79906588, A79801419, DP0770096, DP0212016, DP0343921 for building and maintaining the adolescent twin family resource through which samples were collected. This research was supported by NHMRC grants 389892, 496667 and 613601. Dr. Montgomery and Dr. Visscher are supported by the NHMRC Fellowship Scheme. Dr. Dermitzakis acknowledges funds from the Louis-Jeantet Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Aitken JF, 1996, MELANOMA RES, V6, P155, DOI 10.1097/00008390-199604000-00011; Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beekman M, 2003, EUR J HUM GENET, V11, P845, DOI 10.1038/sj.ejhg.5201053; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Benyamin B, 2009, AM J HUM GENET, V84, P60, DOI 10.1016/j.ajhg.2008.11.011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Ferreira MAR, 2009, AM J HUM GENET, V85, P745, DOI 10.1016/j.ajhg.2009.10.005; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hottenga JJ, 2007, HYPERTENSION, V49, P832, DOI 10.1161/01.HYP.0000260092.93964.ed; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Iwamoto K, 2004, J HUM GENET, V49, P227, DOI 10.1007/s10038-004-0136-5; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kato T, 2005, MOL PSYCHIATR, V10, P1045, DOI 10.1038/sj.mp.4001719; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kutalik Z, 2011, HUM MOL GENET, V20, P3710, DOI 10.1093/hmg/ddr272; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lynch M., 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McGregor B, 1999, GENET EPIDEMIOL, V16, P40, DOI 10.1002/(SICI)1098-2272(1999)16:1<40::AID-GEPI4>3.3.CO;2-T; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Middelberg RP, 2006, CLIN CHIM ACTA, V374, P87, DOI 10.1016/j.cca.2006.05.033; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naukkarinen J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000976; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; O'Connor DT, 2008, CIRCULATION, V118, P247, DOI 10.1161/CIRCULATIONAHA.107.709105; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/twin.6.5.354; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tan HY, 2008, MOL PSYCHIATR, V13, P233, DOI 10.1038/sj.mp.4002145; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Wright MJ, 2004, AUST J PSYCHOL, V56, P65, DOI 10.1080/00049530410001734865; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhu G, 2007, EUR J HUM GENET, V15, P94, DOI 10.1038/sj.ejhg.5201729	62	64	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35430	10.1371/journal.pone.0035430	http://dx.doi.org/10.1371/journal.pone.0035430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563384	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100013
J	Hysek, CM; Simmler, LD; Nicola, VG; Vischer, N; Donzelli, M; Krahenbuhl, S; Grouzmann, E; Huwyler, J; Hoener, MC; Liechti, ME				Hysek, Cedric M.; Simmler, Linda D.; Nicola, Valentina G.; Vischer, Nerina; Donzelli, Massimiliano; Kraehenbuehl, Stephan; Grouzmann, Eric; Huwyler, Joerg; Hoener, Marius C.; Liechti, Matthias E.			Duloxetine Inhibits Effects of MDMA ("Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study	PLOS ONE			English	Article							HUMAN MONOAMINE TRANSPORTERS; INDUCED SEROTONIN RELEASE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; NOREPINEPHRINE TRANSPORTERS; DOPAMINE RELEASE; RAT-BRAIN; PHARMACOKINETICS; AFFINITY; COCAINE; NEUROTOXICITY	This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4-methylenedioxy-methamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects. The clinical study used a double-blind, randomized, placebo-controlled, four-session, crossover design. In vitro, duloxetine blocked the release of both 5-HT and NE by MDMA or by its metabolite 3,4-methylenedioxyamphetamine from transmitter-loaded human cells expressing the 5-HT or NE transporter. In humans, duloxetine inhibited the effects of MDMA including elevations in circulating NE, increases in blood pressure and heart rate, and the subjective drug effects. Duloxetine inhibited the pharmacodynamic response to MDMA despite an increase in duloxetine-associated elevations in plasma MDMA levels. The findings confirm the important role of MDMA-induced 5-HT and NE release in the psychotropic effects of MDMA. Duloxetine may be useful in the treatment of psychostimulant dependence.	[Hysek, Cedric M.; Simmler, Linda D.; Nicola, Valentina G.; Vischer, Nerina; Donzelli, Massimiliano; Kraehenbuehl, Stephan; Liechti, Matthias E.] Univ Hosp, Dept Biomed, Div Clin Pharmacol & Toxicol, Psychopharmacol Res Grp, Basel, Switzerland; [Hysek, Cedric M.; Simmler, Linda D.; Nicola, Valentina G.; Vischer, Nerina; Donzelli, Massimiliano; Kraehenbuehl, Stephan; Liechti, Matthias E.] Univ Hosp, Dept Internal Med, Basel, Switzerland; [Huwyler, Joerg] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Grouzmann, Eric] Univ Hosp, Div Clin Pharmacol, Lausanne, Switzerland; [Grouzmann, Eric] Univ Hosp, Div Toxicol, Lausanne, Switzerland; [Hoener, Marius C.] F Hoffmann La Roche Ltd, Div Pharmaceut, Neurosci Res, Basel, Switzerland	University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Roche Holding	Hysek, CM (corresponding author), Univ Hosp, Dept Biomed, Div Clin Pharmacol & Toxicol, Psychopharmacol Res Grp, Basel, Switzerland.	mliechti@uhbs.ch	Hoener, Marius C/I-6464-2012; Simmler, Linda D/R-4128-2016; Huwyler, Joerg/C-6573-2013; Krähenbühl, Stephan/Z-4744-2019	Hoener, Marius C/0000-0001-6510-6250; Simmler, Linda D/0000-0003-3512-4057; Huwyler, Joerg/0000-0003-1748-5676; Vischer, Nerina/0000-0002-1030-6359	Swiss National Science Foundation [32320_126231]; University of Basel [DPH2037]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was supported by the Swiss National Science Foundation (grant no. 32320_126231) and the University of Basel (grant no. DPH2037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTAGLIA G, 1988, EUR J PHARMACOL, V149, P159, DOI 10.1016/0014-2999(88)90056-8; Baumann MH, 2008, PHARMACOL BIOCHEM BE, V90, P208, DOI 10.1016/j.pbb.2008.02.018; Bedi G, 2010, BIOL PSYCHIAT, V68, P1134, DOI 10.1016/j.biopsych.2010.08.003; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Cami J, 2000, J CLIN PSYCHOPHARM, V20, P455, DOI 10.1097/00004714-200008000-00010; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Debus G., 1978, EIGENSCHAFTSWORTERLI; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Dittrich A, 1998, PHARMACOPSYCHIATRY, V31, P80, DOI 10.1055/s-2007-979351; Farre M, 2007, J PHARMACOL EXP THER, V323, P954, DOI 10.1124/jpet.107.129056; Field JR, 2010, J BIOL CHEM, V285, P11270, DOI 10.1074/jbc.M109.093658; Gould GG, 2007, BIOL PSYCHIAT, V61, P210, DOI 10.1016/j.biopsych.2006.02.029; Gudelsky GA, 1996, J NEUROCHEM, V66, P243; GUDELSKY GA, 1994, EUR J PHARMACOL, V264, P325, DOI 10.1016/0014-2999(94)90669-6; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; HERMLE L, 1993, NEUROPSYCHOPHARMACOL, V8, P171, DOI 10.1038/npp.1993.19; Hondebrink L, 2011, NEUROPHARMACOLOGY, V61, P202, DOI 10.1016/j.neuropharm.2011.03.028; Hysek CM, 2011, CLIN PHARMACOL THER, V90, P246, DOI 10.1038/clpt.2011.78; Hysek CM, 2012, J PHARMACOL EXP THER, V340, P286, DOI 10.1124/jpet.111.188425; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Knadler MP, 2011, CLIN PHARMACOKINET, V50, P281, DOI 10.2165/11539240-000000000-00000; Kolbrich EA, 2008, J CLIN PSYCHOPHARM, V28, P432, DOI 10.1097/JCP.0b013e31817ef470; Liechti ME, 2000, EUR NEUROPSYCHOPHARM, V10, P289, DOI 10.1016/S0924-977X(00)00086-9; Liechti ME, 2000, NEUROPSYCHOPHARMACOL, V22, P513, DOI 10.1016/S0893-133X(99)00148-7; Matthies HJG, 2010, J NEUROSCI, V30, P7863, DOI 10.1523/JNEUROSCI.4574-09.2010; Pifl C, 2005, J PHARMACOL EXP THER, V314, P346, DOI 10.1124/jpet.105.084426; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Rothman RB, 2000, SYNAPSE, V35, P222, DOI 10.1002/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K; Rothman RB, 2010, SYNAPSE, V64, P862, DOI 10.1002/syn.20804; RUDNICK G, 1992, P NATL ACAD SCI USA, V89, P1817, DOI 10.1073/pnas.89.5.1817; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Segura M, 2005, CLIN PHARMACOKINET, V44, P649, DOI 10.2165/00003088-200544060-00006; Simmler LD, 2011, J CLIN ENDOCR METAB, V96, P2844, DOI 10.1210/jc.2011-1143; Sofuoglu M, 2009, AM J DRUG ALCOHOL AB, V35, P412, DOI 10.3109/00952990903383961; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; Tancer M, 2007, PSYCHOPHARMACOLOGY, V189, P565, DOI 10.1007/s00213-006-0576-z; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Thompson BJ, 2011, P NATL ACAD SCI USA, V108, P3785, DOI 10.1073/pnas.1011920108; Torok M, 1998, DRUG METAB DISPOS, V26, P1144; VANDYKE C, 1978, SCIENCE, V200, P211, DOI 10.1126/science.24895; Verrico CD, 2008, J PSYCHOPHARMACOL, V22, P187, DOI 10.1177/0269881107083639; Verrico CD, 2007, PSYCHOPHARMACOLOGY, V189, P489, DOI 10.1007/s00213-005-0174-5; WALL SC, 1995, MOL PHARMACOL, V47, P544; Wittchen H.-U., 1997, SKID 1 STRUKTURIERTE; Wong D T, 1998, Expert Opin Investig Drugs, V7, P1691, DOI 10.1517/13543784.7.10.1691; Zerssen, 1976, BESCHWERDEN LISTE MU; Zhao RK, 2009, CLIN THER, V31, P1022, DOI 10.1016/j.clinthera.2009.05.005	50	121	122	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36476	10.1371/journal.pone.0036476	http://dx.doi.org/10.1371/journal.pone.0036476			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574166	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800062
J	Saikolappan, S; Estrella, J; Sasindran, SJ; Khan, A; Armitige, LY; Jagannath, C; Dhandayuthapani, S				Saikolappan, Sankaralingam; Estrella, Jaymie; Sasindran, Smitha J.; Khan, Arshad; Armitige, Lisa Y.; Jagannath, Chinnaswamy; Dhandayuthapani, Subramanian			The fbpA/sapM Double Knock Out Strain of Mycobacterium tuberculosis Is Highly Attenuated and Immunogenic in Macrophages	PLOS ONE			English	Article							PROGRESSIVE PULMONARY TUBERCULOSIS; BALB/C MOUSE MODEL; PHAGOSOME MATURATION; PROTECTIVE IMMUNITY; VACCINE EFFICACY; DENDRITIC CELLS; ANTIGEN 85B; PANTOTHENATE AUXOTROPH; MURINE MACROPHAGES; TUBERCLE-BACILLI	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death due to bacterial infections in mankind, and BCG, an attenuated strain of Mycobacterium bovis, is an approved vaccine. BCG sequesters in immature phagosomes of antigen presenting cells (APCs), which do not fuse with lysosomes, leading to decreased antigen processing and reduced Th1 responses. However, an Mtb derived Delta fbpA attenuated mutant underwent limited phagosome maturation, enhanced immunogenicity and was as effective as BCG in protecting mice against TB. To facilitate phagosome maturation of Delta fbpA, we disrupted an additional gene sapM, which encodes for an acid phosphatase. Compared to the wild type Mtb, the Delta fbpA Delta sapM (double knock out; DKO) strain was attenuated for growth in mouse macrophages and PMA activated human THP1 macrophages. Attenuation correlated with increased oxidants in macrophages in response to DKO infection and enhanced labeling of lysosomal markers (CD63 and rab7) on DKO phagosomes. An in vitro Antigen 85B peptide presentation assay was used to determine antigen presentation to T cells by APCs infected with DKO or other mycobacterial strains. This revealed that DKO infected APCs showed the strongest ability to present Ag85B to T cells (>2500 pgs/mL in 4 hrs) as compared to APCs infected with wild type Mtb or Delta fbpA or Delta sapM strain (<1000 pgs/mL in 4 hrs), indicating that DKO strain has enhanced immunogenicity than other strains. The ability of DKO to undergo lysosomal fusion and vacuolar acidification correlated with antigen presentation since bafilomycin, that inhibits acidification in APCs, reduced antigen presentation. Finally, the DKO vaccine elicited a better Th1 response in mice after subcutaneous vaccination than either Delta fbpA or Delta sapM. Since Delta fbpA has been used in mice as a candidate vaccine and the DKO (Delta fbpA Delta sapM) mutant is more immunogenic than Delta fbpA, we propose the DKO is a potential anti-tuberculosis vaccine.	[Saikolappan, Sankaralingam; Sasindran, Smitha J.; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX USA; [Saikolappan, Sankaralingam; Sasindran, Smitha J.; Dhandayuthapani, Subramanian] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, Edinburg, TX USA; [Estrella, Jaymie; Khan, Arshad; Armitige, Lisa Y.; Jagannath, Chinnaswamy] Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health Science Center Houston	Saikolappan, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Reg Acad Hlth Ctr, Edinburg, TX USA.	Jagannath@uth.tmc.edu; dhandayutha@uthscsa.edu	Khan, Arshad/E-6855-2015	Khan, Arshad/0000-0003-3655-2854	National Institutes of Health/National Institute of Allergy and Infectious Diseases grants [AI78420, AI49534]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049534, R01AI078420] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI78420 (CJ & SD) and AI49534 (CJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2007, CLIN EXP IMMUNOL, V147, P330, DOI 10.1111/j.1365-2249.2006.03284.x; Aguilar LD, 2006, VACCINE, V24, P2333, DOI 10.1016/j.vaccine.2005.11.051; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2001, TRENDS IMMUNOL, V22, P160, DOI 10.1016/S1471-4906(01)01865-8; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Armitige LY, 2000, INFECT IMMUN, V68, P767, DOI 10.1128/IAI.68.2.767-778.2000; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Asensio JAG, 2008, EXPERT OPIN BIOL TH, V8, P201, DOI 10.1517/14712598.8.2.201 ; AUSUBEL F, 1989, CURRENT PRTOCOLS MOL; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Brosch R, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P19; Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Copenhaver RH, 2004, INFECT IMMUN, V72, P7084, DOI 10.1128/IAI.72.12.7084-7095.2004; Daniel DS, 2006, J IMMUNOL, V177, P4688, DOI 10.4049/jimmunol.177.7.4688; Dhandayuthapani S, 2007, FRONT BIOSCI-LANDMRK, V12, P4676, DOI 10.2741/2417; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Festjens N, 2011, EMBO MOL MED, V3, P222, DOI 10.1002/emmm.201000125; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Henao-Tamayo M, 2007, VACCINE, V25, P7153, DOI 10.1016/j.vaccine.2007.07.042; Hess J, 1998, P NATL ACAD SCI USA, V95, P5299, DOI 10.1073/pnas.95.9.5299; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Infante E, 2005, CLIN EXP IMMUNOL, V141, P21, DOI 10.1111/j.1365-2249.2005.02832.x; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Katti MK, 2008, CELL MICROBIOL, V10, P1286, DOI 10.1111/j.1462-5822.2008.01126.x; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Larsen MH, 2009, VACCINE, V27, P4709, DOI 10.1016/j.vaccine.2009.05.050; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; Orme IA, 2005, MICROBES INFECT, V7, P905, DOI 10.1016/j.micinf.2005.03.008; PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550; Pando RH, 2010, INFECT IMMUN, V78, P3168, DOI 10.1128/IAI.00023-10; Parida SK, 2010, CURR OPIN IMMUNOL, V22, P374, DOI 10.1016/j.coi.2010.04.006; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pavelka MS, 2003, INFECT IMMUN, V71, P4190, DOI 10.1128/IAI.71.7.4190-4192.2003; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Ramachandra L, 2005, INFECT IMMUN, V73, P1097, DOI 10.1128/IAI.73.2.1097-1105.2005; Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421; Roche CM, 2011, J VACCINE VACC UNPUB; Roy E, 2006, IMMUNOL LETT, V103, P196, DOI 10.1016/j.imlet.2005.10.011; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Russell DG, 1998, TRENDS MICROBIOL, V6, P212, DOI 10.1016/S0966-842X(98)01286-4; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2005, MICROBES INFECT, V7, P955, DOI 10.1016/j.micinf.2005.04.001; Sambandamurthy VK, 2005, INFECT IMMUN, V73, P1196, DOI 10.1128/IAI.73.2.1196-1203.2005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Singh CR, 2006, J IMMUNOL, V177, P3250, DOI 10.4049/jimmunol.177.5.3250; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; VANSOOLINGEN D, 1995, EUR RESPIR J, V8, pS649; Venketaraman V, 2003, TUBERCULOSIS, V83, P311, DOI 10.1016/S1472-9792(03)00050-7; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001	67	34	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36198	10.1371/journal.pone.0036198	http://dx.doi.org/10.1371/journal.pone.0036198			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574140	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800036
J	Domingo, C; Escadafal, C; Rumer, L; Mendez, JA; Garcia, P; Sall, AA; Teichmann, A; Donoso-Mantke, O; Niedrig, M				Domingo, Cristina; Escadafal, Camille; Rumer, Leonid; Mendez, Jairo A.; Garcia, Paquita; Sall, Amadou A.; Teichmann, Anette; Donoso-Mantke, Oliver; Niedrig, Matthias			First International External Quality Assessment Study on Molecular and Serological Methods for Yellow Fever Diagnosis	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRUS-INFECTION; DENGUE VIRUS; FLAVIVIRUSES; ASSAY; IDENTIFICATION; ACCURACY	Objective: We describe an external quality assurance (EQA) study designed to assess the efficiency and accurateness of molecular and serological methods used by expert laboratories performing YF diagnosis. Study Design: For molecular diagnosis evaluation, a panel was prepared of 14 human plasma samples containing specific RNA of different YFV strains (YFV-17D, YFV South American strain [Brazil], YFV IvoryC1999 strain), and specificity samples containing other flaviviruses and negative controls. For the serological panel, 13 human plasma samples with anti-YFV-specific antibodies against different strains of YFV (YFV-17D strain, YFV IvoryC1999 strain, and YFV Brazilian strain), as well as specificity and negative controls, were included. Results: Thirty-six laboratories from Europe, the Americas, Middle East, and Africa participated in these EQA activities. Only 16% of the analyses reported met all evaluation criteria with optimal performance. Serial dilutions of YFV-17D showed that in general the methodologies reported provided a suitable sensitivity. Failures were mainly due to the inability to detect wild-type strains or the presence of false positives. Performance in the serological diagnosis varied, mainly depending on the methodology used. Anti-YFV IgM detection was not performed in 16% of the reports using IIF or ELISA techniques, although it is preferable for the diagnosis of YFV acute infections. A good sensitivity profile was achieved in general; however, in the detection of IgM antibodies a lack of sensitivity of anti-YFV antibodies against the vaccine strain 17D was observed, and of the anti-YFV IgG antibodies against a West African strain. Neutralization assays showed a very good performance; however, the unexpected presence of false positives underlined the need of improving the running protocols. Conclusion: This EQA provides information on each laboratory's efficacy of RT-PCR and serological YFV diagnosis techniques. The results indicate the need for improving serological and molecular diagnosis techniques and provide a follow-up of the diagnostic profiles.	[Domingo, Cristina; Escadafal, Camille; Rumer, Leonid; Teichmann, Anette; Donoso-Mantke, Oliver; Niedrig, Matthias] Robert Koch Inst, Ctr Biol Secur, Berlin, Germany; [Mendez, Jairo A.] Inst Nacl Salud, Lab Virol, Bogota, Colombia; [Garcia, Paquita] Inst Nacl Salud, Lab Enfermedades Metaxen, Lima, Peru; [Sall, Amadou A.] Inst Pasteur, Dakar, Senegal	Robert Koch Institute; Instituto Nacional de Salud (Colombia); Instituto Nacional de Salud - Peru; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Domingo, C (corresponding author), Robert Koch Inst, Ctr Biol Secur, Berlin, Germany.	Domingo-CarrascoC@rki.de	Domingo, Cristina/AAW-2819-2021	Domingo, Cristina/0000-0003-0957-3377	European Centre for Disease Prevention and Control (ECDC) [ECDC/2008/011]	European Centre for Disease Prevention and Control (ECDC)	This study was performed by the European Network for the Diagnostics of 'Imported' Viral Diseases-Collaborative Laboratory Response Network (ENIVD-CLRN) funded by the European Centre for Disease Prevention and Control (ECDC), contract no. ECDC/2008/011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WKLY EPIDEMIOL REC, V83, P105; ANSARI MZ, 1993, J CLIN LAB ANAL, V7, P230, DOI 10.1002/jcla.1860070408; Bae HG, 2005, J CLIN VIROL, V33, P274, DOI 10.1016/j.jcv.2004.12.001; Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0; Brown T M, 1994, Clin Diagn Virol, V2, P41, DOI 10.1016/0928-0197(94)90034-5; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Doblas A, 2006, J CLIN VIROL, V36, P156, DOI 10.1016/j.jcv.2006.02.005; Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10; Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833; Domingo C, 2009, DIAGN MICR INFEC DIS, V65, P42, DOI 10.1016/j.diagmicrobio.2009.05.004; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; Heraud JM, 1999, EMERG INFECT DIS, V5, P429, DOI 10.3201/eid0503.990314; Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2; Lemmer A, 2004, J CLIN VIROL, V30, P291, DOI 10.1016/j.jcv.2003.11.002; Mantel N, 2008, J VIROL METHODS, V151, P40, DOI 10.1016/j.jviromet.2008.03.026; Mantke OD, 2004, J CLIN VIROL, V29, P105, DOI 10.1016/S1386-6532(03)00110-0; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206; Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x; Niedrig M, 2007, EUROSURVEILLANCE, V12; Niedrig M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-72; Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104; Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Takacs Maria, 1994, Acta Microbiologica et Immunologica Hungarica, V41, P83; Talarmin A, 1998, J CLIN MICROBIOL, V36, P1189, DOI 10.1128/JCM.36.5.1189-1192.1998; Van der Stuyft P, 1999, LANCET, V353, P1558, DOI 10.1016/S0140-6736(99)03291-2; WHO, 2003, WHO REC STAND SURV S, P40; WHO, 1998, WHO REP GLOB SURV EP; WHO Media Centre, 2009, YELL FEV FACT SHEET; 2006, WKLY EPIDEMIOL REC, V81, P317	34	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36291	10.1371/journal.pone.0036291	http://dx.doi.org/10.1371/journal.pone.0036291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570700	Green Published, gold			2022-12-27	WOS:000305343400016
J	Kohn, KW; Zeeberg, BR; Reinhold, WC; Sunshine, M; Luna, A; Pommier, Y				Kohn, Kurt W.; Zeeberg, Barry R.; Reinhold, William C.; Sunshine, Margot; Luna, Augustin; Pommier, Yves			Gene Expression Profiles of the NCI-60 Human Tumor Cell Lines Define Molecular Interaction Networks Governing Cell Migration Processes	PLOS ONE			English	Article							R-RAS; MESENCHYMAL TRANSITION; INTERACTION MAPS; E-CADHERIN; KAPPA-B; CANCER; AXL; ACTIVATION; RECEPTOR; INTEGRIN	Although there is extensive information on gene expression and molecular interactions in various cell types, integrating those data in a functionally coherent manner remains challenging. This study explores the premise that genes whose expression at the mRNA level is correlated over diverse cell lines are likely to function together in a network of molecular interactions. We previously derived expression-correlated gene clusters from the database of the NCI-60 human tumor cell lines and associated each cluster with function categories of the Gene Ontology (GO) database. From a cluster rich in genes associated with GO categories related to cell migration, we extracted 15 genes that were highly cross-correlated; prominent among them were RRAS, AXL, ADAM9, FN14, and integrin-beta1. We then used those 15 genes as bait to identify other correlated genes in the NCI-60 database. A survey of current literature disclosed, not only that many of the expression-correlated genes engaged in molecular interactions related to migration, invasion, and metastasis, but that highly cross-correlated subsets of those genes engaged in specific cell migration processes. We assembled this information in molecular interaction maps (MIMs) that depict networks governing 3 cell migration processes: degradation of extracellular matrix, production of transient focal complexes at the leading edge of the cell, and retraction of the rear part of the cell. Also depicted are interactions controlling the release and effects of calcium ions, which may regulate migration in a spaciotemporal manner in the cell. The MIMs and associated text comprise a detailed and integrated summary of what is currently known or surmised about the role of the expression cross-correlated genes in molecular networks governing those processes.	[Kohn, Kurt W.; Zeeberg, Barry R.; Reinhold, William C.; Sunshine, Margot; Luna, Augustin; Pommier, Yves] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kohn, KW (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	kohnk@mail.nih.gov	zeeberg, barry/AAO-1246-2020; Reinhold, William/J-6704-2017	Reinhold, William/0000-0001-5513-9323	National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC006150, ZIABC006192] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagorda A, 2006, THROMB HAEMOSTASIS, V95, P12, DOI 10.1160/TH05-07-0483; Barker HE, 2011, CANCER RES, V71, P1561, DOI 10.1158/0008-5472.CAN-10-2868; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Cavet ME, 2010, HYPERTENSION, V56, P105, DOI 10.1161/HYPERTENSIONAHA.109.144642; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chorianopoulos E, 2010, BASIC RES CARDIOL, V105, P301, DOI 10.1007/s00395-009-0046-y; Conklin MW, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-14; Coon BG, 2010, J BIOL CHEM, V285, P33073, DOI 10.1074/jbc.M110.124123; Dang M, 2011, J BIOL CHEM, V286, P17704, DOI 10.1074/jbc.M110.187823; Devbhandari RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024901; Dolznig H, 2011, AM J PATHOL, V179, P487, DOI 10.1016/j.ajpath.2011.03.015; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Faye C, 2009, J BIOL CHEM, V284, P22041, DOI 10.1074/jbc.M109.002964; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Giannone G, 2004, J BIOL CHEM, V279, P28715, DOI 10.1074/jbc.M404054200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; GO-project, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI DOI 10.1093/NAR/GKJ021; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Haile WB, 2010, NEUROSCIENCE; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; John AS, 2010, J ONCOL, V2010, DOI 10.1155/2010/645376; Johnstone DB, 2011, MOL CELL BIOL, V31, P2162, DOI 10.1128/MCB.05234-11; Kim J, 2006, BIOCHEM BIOPH RES CO, V344, P1284, DOI 10.1016/j.bbrc.2006.04.016; Kohn KW, 2006, MOL BIOL CELL, V17, P1, DOI 10.1091/mbc.E05-09-0824; Kohn KW, 1999, MOL BIOL CELL, V10, P2703, DOI 10.1091/mbc.10.8.2703; Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Luna A, 2011, BIOINFORMATICS, V27, P2165, DOI 10.1093/bioinformatics/btr336; Mahimkar RM, 2005, BIOCHEM J, V385, P461, DOI 10.1042/BJ20041133; Mazzocca A, 2005, CANCER RES, V65, P4728, DOI 10.1158/0008-5472.CAN-04-4449; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Page RE, 2007, CELL ONCOL, V29, P289; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; Reinhold WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025991; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Shang X, 2011, J BIOL CHEM, V286, P24068, DOI 10.1074/jbc.M111.226951; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sotgia F, 2012, ANNU REV PATHOL-MECH, V7, P423, DOI 10.1146/annurev-pathol-011811-120856; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Vicente-Manzanares M, 2011, METHODS MOL BIOL, V769, P1, DOI 10.1007/978-1-61779-207-6_1; Vuoriluoto K, 2010, ONCOGENE; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wei C, 2011, CURR OPIN CELL BIOL, V24, P1; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Weinstein John N, 2004, Breast Dis, V19, P11; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wozniak MA, 2005, MOL BIOL CELL, V16, P84, DOI 10.1091/mbc.E04-04-0277; Xu MZ, 2010, ONCOGENE; Yan Q, 2011, BIOCHEMISTRY-US, V50, P566, DOI 10.1021/bi101639y; Yan Q, 2010, BIOCHEMISTRY-US, V49, P3685, DOI 10.1021/bi902067f; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zeeberg BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030317; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zevian S, 2011, J BIOL CHEM, V286, P7496, DOI 10.1074/jbc.M110.173583; Zigrino P, 2007, J BIOL CHEM, V282, P30785, DOI 10.1074/jbc.M701658200	91	22	22	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35716	10.1371/journal.pone.0035716	http://dx.doi.org/10.1371/journal.pone.0035716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570691	gold, Green Submitted, Green Published			2022-12-27	WOS:000305343400007
J	Bisias, D; Lo, AW; Watkins, JF				Bisias, Dimitrios; Lo, Andrew W.; Watkins, James F.			Estimating the NIH Efficient Frontier	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH; PORTFOLIO	Background: The National Institutes of Health (NIH) is among the world's largest investors in biomedical research, with a mandate to: "...lengthen life, and reduce the burdens of illness and disability." Its funding decisions have been criticized as insufficiently focused on disease burden. We hypothesize that modern portfolio theory can create a closer link between basic research and outcome, and offer insight into basic-science related improvements in public health. We propose portfolio theory as a systematic framework for making biomedical funding allocation decisions-one that is directly tied to the risk/reward trade-off of burden-of-disease outcomes. Methods and Findings: Using data from 1965 to 2007, we provide estimates of the NIH "efficient frontier", the set of funding allocations across 7 groups of disease-oriented NIH institutes that yield the greatest expected return on investment for a given level of risk, where return on investment is measured by subsequent impact on U.S. years of life lost (YLL). The results suggest that NIH may be actively managing its research risk, given that the volatility of its current allocation is 17% less than that of an equal-allocation portfolio with similar expected returns. The estimated efficient frontier suggests that further improvements in expected return (89% to 119% vs. current) or reduction in risk (22% to 35% vs. current) are available holding risk or expected return, respectively, constant, and that 28% to 89% greater decrease in average years-of-life-lost per unit risk may be achievable. However, these results also reflect the imprecision of YLL as a measure of disease burden, the noisy statistical link between basic research and YLL, and other known limitations of portfolio theory itself. Conclusions: Our analysis is intended to serve as a proof-of-concept and starting point for applying quantitative methods to allocating biomedical research funding that are objective, systematic, transparent, repeatable, and expressly designed to reduce the burden of disease. By approaching funding decisions in a more analytical fashion, it may be possible to improve their ultimate outcomes while reducing unintended consequences.	[Bisias, Dimitrios; Lo, Andrew W.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; [Lo, Andrew W.] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Lo, Andrew W.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Lo, Andrew W.] AlphaSimplex Grp LLC, Cambridge, MA USA; [Watkins, James F.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Watkins, James F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bisias, D (corresponding author), MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA.	alo@mit.edu		Watkins, James/0000-0003-0440-5905	Citigroup; Bank of America	Citigroup; Bank of America	The authors have read the journal's policy and have the following conflicts: the Massachusetts Institute of Technology Laboratory for Financial Engineering receives research grants from Citigroup and Bank of America and while the funds weren't specifically designated for this study, a portion of those funds were contributed to a general pool that was directed to support a variety of faculty and student research projects, of which this study was one. AWL has the following declarations: (1) chairman, chief investment strategist, AlphaSimplex Group LLC (an asset management firm); (2) consultant, United States Treasury (Office of Financial Research); (3) member, Financial Advisory Roundtable, Federal Reserve Bank of New York; (4) member, Economic Advisory Committee, FINRA; (5) member, Academic Advisory and Research Committee, Moody's; (6) member, Board of Trustees, Beth Israel Deaconess Medical Center; (7) research associate, National Bureau of Economic Research; (8) Research grant from the National Science Foundation on systemic risk; (9) Patent pending on cryptographic methods for computing systemic risk; (10) Patent awarded (U.S. Patent No. 7,599,876 October 6, 2009) "Electronic Market-Maker''; (11) Patent awarded (U.S. Patent No. 7,562,042 July 14, 2009) "Data Processor for Implementing Forecasting Algorithms". There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	ANDERSON C, 1993, SCIENCE, V260, P483, DOI 10.1126/science.8475380; Bade A, 2009, MATH METHOD OPER RES, V70, P337, DOI 10.1007/s00186-008-0271-4; Black N, 2009, J HEALTH SERV RES PO, V14, P120, DOI 10.1258/jhsrp.2008.008165; Bridges J F P, 2002, Eur J Health Econ, V3, P47, DOI 10.1007/s10198-001-0090-5; Chandra S, 2003, J REGIONAL SCI, V43, P95, DOI 10.1111/1467-9787.00291; COMROE JH, 1976, SCIENCE, V192, P105, DOI 10.1126/science.769161; Dorsey ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007015; Freeman R, 2009, 931 CTR EC PERF; Grant J, 2000, BMJ-BRIT MED J, V320, P1107, DOI 10.1136/bmj.320.7242.1107; Hanney S, 2003, BENCH BEDSIDE TRACIN; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Istook Jr. Ernest, 1997, J NIH RES, V9, P26; Johnston SC, 2006, ANN NEUROL, V60, p9A, DOI 10.1002/ana.20921; Lane J, 2011, SCIENCE, V331, P678, DOI 10.1126/science.1201865; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; MCFARLAN FW, 1981, HARVARD BUS REV, V59, P142; MOSTELLER F, 1981, SCIENCE, V211, P881, DOI 10.1126/science.6781066; O'Brien BJ, 2000, MED CARE, V38, P460, DOI 10.1097/00005650-200005000-00003; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Rangel SJ, 2002, ANN SURG, V236, P277, DOI 10.1097/00000658-200209000-00004; Sendi P, 2004, VALUE HEALTH, V7, P595, DOI 10.1111/j.1524-4733.2004.75010.x; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411	24	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34569	10.1371/journal.pone.0034569	http://dx.doi.org/10.1371/journal.pone.0034569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567087	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500005
J	Gibbs, KE; Currie, DJ				Gibbs, Katherine E.; Currie, David J.			Protecting Endangered Species: Do the Main Legislative Tools Work?	PLOS ONE			English	Article							CRITICAL HABITAT; ACT; RECOVERY; CONSERVATION; EVOLUTION	It is critical to assess the effectiveness of the tools used to protect endangered species. The main tools enabled under the U. S. Endangered Species Act (ESA) to promote species recovery are funding, recovery plan development and critical habitat designation. Earlier studies sometimes found that statistically significant effects of these tools could be detected, but they have not answered the question of whether the effects were large enough to be biologically meaningful. Here, we ask: how much does the recovery status of ESA-listed species improve with the application of these tools? We used species' staus reports to Congress from 1988 to 2006 to quantify two measures of recovery for 1179 species. We related these to the amount of federal funding, years with a recovery plan, years with critical habitat designation, the amount of peer-reviewed scientific information, and time listed. We found that change in recovery status of listed species was, at best, only very weakly related to any of these tools. Recovery was positively related to the number of years listed, years with a recovery plan, and funding, however, these tools combined explain <13% of the variation in recovery status among species. Earlier studies that reported significant effects of these tools did not focus on effect sizes; however, they are in fact similarly small. One must conclude either that these tools are not very effective in promoting species' recovery, or (as we suspect) that species recovery data are so poor that it is impossible to tell whether the tools are effective or not. It is critically important to assess the effectiveness of tools used to promote species recovery; it is therefore also critically important to obtain population status data that are adequate to that task.	[Gibbs, Katherine E.; Currie, David J.] Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Gibbs, KE (corresponding author), Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada.	katiemgibbs@gmail.com		Currie, David J./0000-0002-4906-2363	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by grants from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2001, CONSERV BIOL, V15, P1274, DOI 10.1046/j.1523-1739.2001.00430.x; Bean MJ, 2009, ENDANGERED SPECIES A, P369; Boersma PD, 2001, BIOSCIENCE, V51, P643; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Gosnell H, 2001, NAT RESOUR J, V41, P561; Greenwald DN, 2006, ENDANGERED SPECIES A, P51; Hagen AN, 2006, CONSERV BIOL, V20, P399, DOI 10.1111/j.1523-1739.2006.00320.x; Hoekstra JM, 2002, ECOL APPL, V12, P701, DOI 10.1890/1051-0761(2002)012[0701:ACRFCH]2.0.CO;2; Kerkvliet J, 2007, ECOL ECON, V63, P499, DOI 10.1016/j.ecolecon.2006.12.007; Male TD, 2005, ECOL LETT, V8, P986, DOI 10.1111/j.1461-0248.2005.00806.x; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Miller JK, 2002, BIOSCIENCE, V52, P163, DOI 10.1641/0006-3568(2002)052[0163:TESADA]2.0.CO;2; Mittlbock M, 1999, COMPUT METH PROG BIO, V58, P17, DOI 10.1016/S0169-2607(98)00061-3; *NATURESERVE, 2009, NATURESERVE EXPL ONL; Pullin AS, 2009, BIOL CONSERV, V142, P931, DOI 10.1016/j.biocon.2009.01.010; Rachlinski JJ, 1997, CORNELL LAW REV, V82, P356; SALZMAN J, 1990, HARVARD ENVIRON LAW, V14, P311; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Scott JM, 2005, FRONT ECOL ENVIRON, V3, P383, DOI 10.1890/1540-9295(2005)003[0383:ROISUT]2.0.CO;2; Solomon BD, 1998, ENVIRON MANAGE, V22, P9, DOI 10.1007/s002679900080; Suckling Kieran F., 2006, P75; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; TEAR TH, 1995, CONSERV BIOL, V9, P182, DOI 10.1046/j.1523-1739.1995.09010182.x; Thompson Jr. BH, 2006, ENDANGERED SPECIES A, P101; U. S. Department of the Interior, 2003, END SPEC ACT BROK; U. S. Fish and Wildlife Service, 2008, REP C REC THREAT END; U.S. Fish and Wildlife Service, 1990, FED STAT END THREAT; U. S. Fish and Wildlife Service, 2007, CRIT HAB WHAT IS IT; U. S. Fish and Wildlife Service, 1990, REP C REC THREAT END; *US FISH WILDL SER, 2006, THREAT END SPEC SYST; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	31	32	33	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35730	10.1371/journal.pone.0035730	http://dx.doi.org/10.1371/journal.pone.0035730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959US	22567111	gold, Green Published			2022-12-27	WOS:000305341500029
J	Glavan, G; See, RE; Zivin, M				Glavan, Gordana; See, Ronald Eugene; Zivin, Marko			Differential Patterns of Synaptotagmin7 mRNA Expression in Rats with Kainate- and Pilocarpine-Induced Seizures	PLOS ONE			English	Article							STRIATAL DOPAMINE; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NMDA RECEPTORS; EPILEPSY; STIMULATION; GLUTAMATE; NEURONS; BRAIN; VII	Previous studies in rat models of neurodegenerative disorders have shown disregulation of striatal synaptotagmin7 mRNA. Here we explored the expression of synaptotagmin7 mRNA in the brains of rats with seizures triggered by the glutamatergic agonist kainate (10 mg/kg) or by the muscarinic agonist pilocarpine (30 mg/kg) in LiCl (3 mEq/kg) pre-treated (24 h) rats, in a time-course experiment (30 min - 1 day). After kainate-induced seizures, synaptotagmin7 mRNA levels were transiently and uniformly increased throughout the dorsal and ventral striatum (accumbens) at 8 and 12 h, but not at 24 h, followed at 24 h by somewhat variable upregulation within different parts of the cerebral cortex, amigdala and thalamic nuclei, the hippocampus and the lateral septum. By contrast, after LiCl/pilocarpine-induced seizures, there was a more prolonged increase of striatal Synaptotagmin7 mRNA levels (at 8, 12 and 24 h), but only in the ventromedial striatum, while in some other of the aforementioned brain regions there was a decline to below the basal levels. After systemic post-treatment with muscarinic antagonist scopolamine in a dose of 2 mg/kg the seizures were either extinguished or attenuated. In scopolamine post-treated animals with extinguished seizures the striatal synaptotagmin7 mRNA levels (at 12 h after the onset of seizures) were not different from the levels in control animals without seizures, while in rats with attenuated seizures, the upregulation closely resembled kainate seizures-like pattern of striatal upregulation. In the dose of 1 mg/kg, scopolamine did not significantly affect the progression of pilocarpine-induced seizures or pilocarpine seizures-like pattern of striatal upregulation of synaptotagmin7 mRNA. In control experiments, equivalent doses of scopolamine per se did not affect the expression of synaptotagmin7 mRNA. We conclude that here described differential time course and pattern of synaptotagmin7 mRNA expression imply regional differences of pathophysiological brain activation and plasticity in these two models of seizures.	[Glavan, Gordana; Zivin, Marko] Univ Ljubljana, Fac Med, Inst Pathophysiol, Brain Res Lab, Ljubljana, Slovenia; [See, Ronald Eugene] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	University of Ljubljana; Medical University of South Carolina	Glavan, G (corresponding author), Univ Ljubljana, Fac Med, Inst Pathophysiol, Brain Res Lab, Ljubljana, Slovenia.	zivin@mf.uni-lj.si			Ministry of Higher Education, Science and Technology [P3-0171]	Ministry of Higher Education, Science and Technology	This study was supported by a grant from the Ministry of Higher Education, Science and Technology, grant no P3-0171. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam AM, 1996, NEUROPHARMACOLOGY, V35, P159, DOI 10.1016/0028-3908(95)00154-9; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BONHAUS DW, 1986, J NEUROSCI, V6, P3024; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CAVALHEIRO EA, 1986, BRAIN RES, V377, P173, DOI 10.1016/0006-8993(86)91204-7; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; Danzer SC, 2010, HIPPOCAMPUS, V20, P113, DOI 10.1002/hipo.20589; DeLapp NW, 1996, LIFE SCI, V59, P565, DOI 10.1016/0024-3205(96)00337-2; Fukuda M, 2006, MOL MECH EXOCYTOSIS, P42; Glavan G, 2005, NEUROSCIENCE, V135, P545, DOI 10.1016/j.neuroscience.2005.05.050; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Keefe KA, 1996, J COMP NEUROL, V367, P165, DOI 10.1002/(SICI)1096-9861(19960401)367:2<165::AID-CNE1>3.0.CO;2-3; Konradi C, 1996, J NEUROSCI, V16, P4231; KUSSKE JA, 1979, EXP NEUROL, V65, P616, DOI 10.1016/0014-4886(79)90048-7; Lee B, 2009, J NEUROCHEM, V108, P1251, DOI 10.1111/j.1471-4159.2008.05864.x; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; LEVEY AI, 1991, J NEUROSCI, V11, P3218; Lukasiuk K, 2006, PROG BRAIN RES, V158, P223, DOI 10.1016/S0079-6123(06)58011-2; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Morris TA, 2000, MOL BRAIN RES, V79, P138, DOI 10.1016/S0169-328X(00)00112-1; Pal R, 2007, NEUROSCI LETT, V424, P194, DOI 10.1016/j.neulet.2007.07.033; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Slaght SJ, 2002, EPILEPTIC DISORD, V4, pS9; Smolders I, 1997, J NEUROCHEM, V68, P1942; Smolders I, 1996, J NEUROCHEM, V66, P2373; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 2002, EMBO J, V21, P270, DOI 10.1093/emboj/21.3.270; Sugita S, 2001, NEURON, V30, P459, DOI 10.1016/S0896-6273(01)00290-2; Tarazi FI, 1998, SYNAPSE, V30, P227, DOI 10.1002/(SICI)1098-2396(199810)30:2<227::AID-SYN13>3.3.CO;2-F; Tayebati SK, 2004, EXP GERONTOL, V39, P217, DOI 10.1016/j.exger.2003.10.016; TURSKI L, 1986, BRAIN RES, V370, P294, DOI 10.1016/0006-8993(86)90484-1; Wang JQ, 1996, NEUROSCIENCE, V75, P43, DOI 10.1016/0306-4522(96)00277-1; Wirtshafter D, 2004, EUR J PHARMACOL, V488, P85, DOI 10.1016/j.ejphar.2004.02.025; Zagulska-Szymczak S, 2001, NEUROCHEM INT, V38, P485, DOI 10.1016/S0197-0186(00)00101-7; Zivin M, 1996, BRIT J PHARMACOL, V119, P1187, DOI 10.1111/j.1476-5381.1996.tb16021.x	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36114	10.1371/journal.pone.0036114	http://dx.doi.org/10.1371/journal.pone.0036114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567130	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500048
J	Kefford, BJ; Hickey, GL; Gasith, A; Ben-David, E; Dunlop, JE; Palmer, CG; Allan, K; Choy, SC; Piscart, C				Kefford, Ben J.; Hickey, Graeme L.; Gasith, Avital; Ben-David, Elad; Dunlop, Jason E.; Palmer, Carolyn G.; Allan, Kaylene; Choy, Satish C.; Piscart, Christophe			Global Scale Variation in the Salinity Sensitivity of Riverine Macroinvertebrates: Eastern Australia, France, Israel and South Africa	PLOS ONE			English	Article							RISK-ASSESSMENT; TOLERANCE; DISTRIBUTIONS; WATER; VICTORIA; SALINIZATION; COMMUNITIES; HATCHLINGS; STREAMS; EGGS	Salinity is a key abiotic property of inland waters; it has a major influence on biotic communities and is affected by many natural and anthropogenic processes. Salinity of inland waters tends to increase with aridity, and biota of inland waters may have evolved greater salt tolerance in more arid regions. Here we compare the sensitivity of stream macroinvertebrate species to salinity from a relatively wet region in France (Lorraine and Brittany) to that in three relatively arid regions eastern Australia (Victoria, Queensland and Tasmania), South Africa (south-east of the Eastern Cape Province) and Israel using the identical experimental method in all locations. The species whose salinity tolerance was tested, were somewhat more salt tolerant in eastern Australia and South Africa than France, with those in Israel being intermediate. However, by far the greatest source of variation in species sensitivity was between taxonomic groups (Order and Class) and not between the regions. We used a Bayesian statistical model to estimate the species sensitivity distributions (SSDs) for salinity in eastern Australia and France adjusting for the assemblages of species in these regions. The assemblage in France was slightly more salinity sensitive than that in eastern Australia. We therefore suggest that regional salinity sensitivity is therefore likely to depend most on the taxonomic composition of respective macroinvertebrate assemblages. On this basis it would be possible to screen rivers globally for risk from salinisation.	[Kefford, Ben J.] Univ Technol Sydney, Sch Environm, Ctr Environm Sustainabil, Broadway, NSW, Australia; [Hickey, Graeme L.] Univ Manchester, NIBHI, Manchester, Lancs, England; [Gasith, Avital; Ben-David, Elad] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Dunlop, Jason E.; Choy, Satish C.] Dept Environm & Resource Management, Brisbane, Qld, Australia; [Palmer, Carolyn G.] Rhodes Univ, Inst Water Res, ZA-6140 Grahamstown, South Africa; [Allan, Kaylene] Univ Tasmania, Dept Zool, Sandy Bay, Tas, Australia; [Piscart, Christophe] Univ Lyon 1, UMR CNRS Ecol Hydrosyst Nat & Anthropises 5023, F-69622 Villeurbanne, France	University of Technology Sydney; University of Manchester; Tel Aviv University; Rhodes University; University of Tasmania; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kefford, BJ (corresponding author), Univ Technol Sydney, Sch Environm, Ctr Environm Sustainabil, Broadway, NSW, Australia.	ben.kefford@rmit.edu.au	Piscart, christophe/AAD-8973-2019	Piscart, christophe/0000-0002-4054-4542; Palmer, Carolyn/0000-0001-7349-1304; Kefford, Ben/0000-0001-6789-4254				Allan K, BIOL EFFECTS SECONDA; Barnett S, 2003, 200326 DWLBC, P37; Bayly IAE, 1973, INLAND WATERS THEIR; Dunlop JE, 2008, ENVIRON POLLUT, V151, P621, DOI 10.1016/j.envpol.2007.03.020; Forbes VE, 2002, HUM ECOL RISK ASSESS, V8, P473, DOI 10.1080/10807030290879781; Gelman A, 1996, BAYESIAN ANAL, V1, P1; Grist EPM, 2006, ENVIRON SCI TECHNOL, V40, P395, DOI 10.1021/es050871e; Hassell KL, 2006, J EXP BIOL, V209, P4024, DOI 10.1242/jeb.02457; Hayashi TI, 2011, ENVIRON SCI POLLUT R, V18, P365, DOI 10.1007/s11356-010-0380-5; Hayashi TI, 2010, HUM ECOL RISK ASSESS, V16, P251, DOI 10.1080/10807031003670279; Hickey GL, 2008, ENVIRON TOXICOL CHEM, V27, P2403, DOI 10.1897/08-079.1; Horrigan N, 2007, MAR FRESHWATER RES, V58, P178, DOI 10.1071/MF05241; Illies J., 1978, LIMNOFAUNA EUROPAEA; Kaushal SS, 2005, P NATL ACAD SCI USA, V102, P13517, DOI 10.1073/pnas.0506414102; Kay WR, 2001, J N AM BENTHOL SOC, V20, P182, DOI 10.2307/1468314; Kefford B, 2007, SALT NUTR SEDIMENT I, P9; Kefford BJ, 2007, MAR FRESHWATER RES, V58, P1019, DOI 10.1071/MF06046; Kefford BJ, 2007, AQUAT ECOL, V41, P335, DOI 10.1007/s10452-006-9066-y; Kefford BJ, 2006, CAN J FISH AQUAT SCI, V63, P1865, DOI 10.1139/F06-080; Kefford BJ, 2011, ENVIRON POLLUT, V159, P302, DOI 10.1016/j.envpol.2010.08.025; Kefford BJ, 2010, ENVIRON TOXICOL CHEM, V29, P2123, DOI 10.1002/etc.256; Kefford BJ, 2006, ENVIRON POLLUT, V141, P409, DOI 10.1016/j.envpol.2005.08.064; Kefford BJ, 2005, HUM ECOL RISK ASSESS, V11, P1025, DOI 10.1080/10807030500257770; Kefford BJ, 2005, MAR FRESHWATER RES, V56, P163, DOI 10.1071/MF04098; Kefford BJ, 2005, ENVIRON POLLUT, V134, P377, DOI 10.1016/j.envpol.2004.09.018; Kefford BJ, 2004, HYDROBIOLOGIA, V517, P179, DOI 10.1023/B:HYDR.0000027346.06304.bc; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; Kefford BJ, 2003, MAR FRESHWATER RES, V54, P755, DOI 10.1071/MF02081; McNeil VH, 2007, HYDROL EARTH SYST SC, V11, P1295, DOI 10.5194/hess-11-1295-2007; NIELSEN DL, 2000, ECOLOGICAL EFFECTS D; PECK AJ, 1978, AUST J SOIL RES, V16, P157, DOI 10.1071/SR9780157; Pinder AM, 2005, HYDROBIOLOGIA, V543, P1, DOI 10.1007/s10750-004-5712-3; Piscart C, 2005, HYDROBIOLOGIA, V551, P227, DOI 10.1007/s10750-005-4463-0; Posthuma L., 2001, SPECIES SENSITIVITY; R Development Core Team, 2010, R LANG ENV STAT COMP; Schulz Claus-Juergen, 1998, Limnologica, V28, P367; Statzner B, 2010, FRESHWATER BIOL, V55, P80, DOI 10.1111/j.1365-2427.2009.02369.x; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; WILLIAMS WD, 1991, HYDROBIOLOGIA, V210, P151, DOI 10.1007/BF00014329; WILLIAMS WD, 1987, AMBIO, V16, P180; Wood W.E., 1924, J ROYAL SOC W AUSTR, V10, P35	41	70	70	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35224	10.1371/journal.pone.0035224	http://dx.doi.org/10.1371/journal.pone.0035224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567097	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500015
J	Ritter, DI; Dong, ZQ; Guo, S; Chuang, JH				Ritter, Deborah I.; Dong, Zhiqiang; Guo, Su; Chuang, Jeffrey H.			Transcriptional Enhancers in Protein-Coding Exons of Vertebrate Developmental Genes	PLOS ONE			English	Article							PREDICTIVE CHROMATIN SIGNATURES; REGULATORY ELEMENTS; CONSERVED ELEMENTS; BINDING-SITES; IN-VIVO; C-MYC; SEQUENCE; ZEBRAFISH; IDENTIFICATION; EXPRESSION	Many conserved noncoding sequences function as transcriptional enhancers that regulate gene expression. Here, we report that protein-coding DNA also frequently contains enhancers functioning at the transcriptional level. We tested the enhancer activity of 31 protein-coding exons, which we chose based on strong sequence conservation between zebrafish and human, and occurrence in developmental genes, using a Tol2 transposable GFP reporter assay in zebrafish. For each exon we measured GFP expression in hundreds of embryos in 10 anatomies via a novel system that implements the voice-recognition capabilities of a cellular phone. We find that 24/31 (77%) exons drive GFP expression compared to a minimal promoter control, and 14/24 are anatomy-specific (expression in four anatomies or less). GFP expression driven by these coding enhancers frequently overlaps the anatomies where the host gene is expressed (60%), suggesting self-regulation. Highly conserved coding sequences and highly conserved noncoding sequences do not significantly differ in enhancer activity (coding: 24/31 vs. noncoding: 105/147) or tissue-specificity (coding: 14/24 vs. noncoding: 50/105). Furthermore, coding and noncoding enhancers display similar levels of the enhancer-related histone modification H3K4me1 (coding: 9/24 vs noncoding: 34/81). Meanwhile, coding enhancers are over three times as likely to contain an H3K4me1 mark as other exons of the host gene. Our work suggests that developmental transcriptional enhancers do not discriminate between coding and noncoding DNA and reveals widespread dual functions in protein-coding DNA.	[Ritter, Deborah I.; Chuang, Jeffrey H.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Dong, Zhiqiang; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Biol Sci, San Francisco, CA 94143 USA; [Dong, Zhiqiang; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA	Boston College; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ritter, DI (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.	Su.Guo@ucsf.edu; chuangj@bc.edu		Chuang, Jeffrey/0000-0002-3298-2358	National Institutes of Health [NS042626]; National Science Foundation [EF0850155]; Emerging Frontiers [0850155] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health NS042626 (SG) and National Science Foundation EF0850155 (JHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday AW, 2011, DEV BIOL; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Barthel KKB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002184; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Birnbaum RY, 2012, GENOME RES IN PRESS, DOI [10.1101//gr.133546.111, DOI 10.1101//GR.133546.111]; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cao F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003474; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen HP, 2008, GENOMICS, V92, P292, DOI 10.1016/j.ygeno.2008.07.009; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Delporte FM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-53; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Eagleson GW, 2008, BRAIN RES BULL, V75, P281, DOI 10.1016/j.brainresbull.2007.11.014; Euskirchen GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002008; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Fox AK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-186; Friedli M, SYSTEMATIC ENHANCER, DOI [10.1371/journal.pone.0015741, DOI 10.1371/JOURNAL.PONE.0015741]; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Grogan SP, 2008, ARTHRITIS RHEUM-US, V58, P2754, DOI 10.1002/art.23730; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho PA, 2011, J CLIN ONCOL, V29, P704, DOI 10.1200/JCO.2010.31.9327; Hon GC, 2009, HUM MOL GENET, V18, pR195, DOI 10.1093/hmg/ddp409; Hufton AL, 2009, GENOME RES, V19, P2036, DOI 10.1101/gr.093237.109; Itzkovitz S, 2007, GENOME RES, V17, P405, DOI 10.1101/gr.5987307; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kikuta Hiroshi, 2009, V546, P69, DOI 10.1007/978-1-60327-977-2_5; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KIMURA M, 1979, SCI AM, V241, P98, DOI 10.1038/scientificamerican1179-98; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kural D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r133; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee D, 2011, GENOME RES, V21, P2167, DOI 10.1101/gr.121905.111; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Loots GG, 2008, ADV GENET, V61, P269, DOI 10.1016/S0065-2660(07)00010-7; Macquarrie KL, 2011, TRENDS GENET; Maile T, 2004, SCIENCE, V304, P1010, DOI 10.1126/science.1095001; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; McGrath MF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-254; Muller F, 1999, DEVELOPMENT, V126, P2103; Navratilova P, 2009, DEV BIOL, V327, P526, DOI 10.1016/j.ydbio.2008.10.044; Navratilova P, 2010, MOL GENET GENOMICS, V283, P171, DOI 10.1007/s00438-009-0503-1; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Oulion S, 2010, MOL BIOL EVOL, V27, P2829, DOI 10.1093/molbev/msq172; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pennacchio LA, 2007, GENOME RES, V17, P201, DOI 10.1101/gr.5972507; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2018, R LANG ENV STAT COMP; REINHARD E, 1994, DEVELOPMENT, V120, P1767; Ritter DI, 2010, MOL BIOL EVOL, V27, P2322, DOI 10.1093/molbev/msq128; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubinstein ND, 2011, MOL BIOL EVOL, V28, P3297, DOI 10.1093/molbev/msr162; Sanges R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r56; Schattner P, 2006, NUCLEIC ACIDS RES, V34, P1700, DOI 10.1093/nar/gkl095; Shin JT, 2005, NUCLEIC ACIDS RES, V33, P5437, DOI 10.1093/nar/gki853; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sprague J, 2006, NUCLEIC ACIDS RES, V34, pD581, DOI 10.1093/nar/gkj086; Suzuki R, 2011, DNA RES, V18, P177, DOI 10.1093/dnares/dsr010; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Urasaki A, 2008, P NATL ACAD SCI USA, V105, P19827, DOI 10.1073/pnas.0810380105; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Winkler C, 2003, DEV GENES EVOL, V213, P541, DOI 10.1007/s00427-003-0360-6; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	90	31	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35202	10.1371/journal.pone.0035202	http://dx.doi.org/10.1371/journal.pone.0035202			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567096	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500014
J	Holiga, S; Moller, HE; Sieger, T; Schroeter, ML; Jech, R; Mueller, K				Holiga, Stefan; Moeller, Harald E.; Sieger, Tomas; Schroeter, Matthias L.; Jech, Robert; Mueller, Karsten			Accounting for Movement Increases Sensitivity in Detecting Brain Activity in Parkinson's Disease	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; FMRI TIME-SERIES; FUNCTIONAL MRI; BASAL GANGLIA; CORTICAL ACTIVATION; INFERENCE; DIAGNOSIS; LEVODOPA; AMPLITUDE; FEATURES	Parkinson's disease (PD) is manifested by motor impairment, which may impede the ability to accurately perform motor tasks during functional magnetic resonance imaging (fMRI). Both temporal and amplitude deviations of movement performance affect the blood oxygenation level-dependent (BOLD) response. We present a general approach for assessing PD patients' movement control employing simultaneously recorded fMRI time series and behavioral data of the patients' kinematics using MR-compatible gloves. Twelve male patients with advanced PD were examined with fMRI at 1.5T during epoch-based visually paced finger tapping. MR-compatible gloves were utilized online to quantify motor outcome in two conditions with or without dopaminergic medication. Modeling of individual-level brain activity included (i) a predictor consisting of a condition-specific, constant-amplitude boxcar function convolved with the canonical hemodynamic response function (HRF) as commonly used in fMRI statistics (standard model), or (ii) a custom-made predictor computed from glove time series convolved with the HRF (kinematic model). Factorial statistics yielded a parametric map for each modeling technique, showing the medication effect on the group level. Patients showed bilateral response to levodopa in putamen and globus pallidus during the motor experiment. Interestingly, kinematic modeling produced significantly higher activation in terms of both the extent and amplitude of activity. Our results appear to account for movement performance in fMRI motor experiments with PD and increase sensitivity in detecting brain response to levodopa. We strongly advocate quantitatively controlling for motor performance to reach more reliable and robust analyses in fMRI with PD patients.	[Holiga, Stefan; Moeller, Harald E.; Schroeter, Matthias L.; Mueller, Karsten] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Sieger, Tomas; Jech, Robert] Charles Univ Prague, Dept Neurol, Prague, Czech Republic; [Sieger, Tomas; Jech, Robert] Charles Univ Prague, Ctr Clin Neurosci, Prague, Czech Republic; [Sieger, Tomas] Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic; [Schroeter, Matthias L.] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Schroeter, Matthias L.] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, Leipzig, Germany; [Schroeter, Matthias L.] FTLD Consortium, Leipzig, Germany	Max Planck Society; Charles University Prague; Charles University Prague; Czech Technical University Prague; Leipzig University; Leipzig University	Holiga, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	holiga@cbs.mpg.de	Jech, Robert/HHY-7342-2022; Möller, Harald/AAB-4679-2019; Moller, Harald E/A-1565-2008; Sieger, Tomas/AAD-9342-2019	Jech, Robert/0000-0002-9732-8947; Möller, Harald/0000-0002-5659-1925; Moller, Harald E/0000-0002-5659-1925; Sieger, Tomas/0000-0003-4960-1934	Czech Science Foundation [309/09/1145]; Czech Ministry of Education [MSM 0021620849]; Czech Technical University in Prague [SGS10/279/OHK3/3T/13]; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom);  [PRVOUK-P26/LF1/4]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Technical University in Prague; International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom); 	This work was supported by the Czech Science Foundation: grant project 309/09/1145, by the Czech Ministry of Education: research project MSM 0021620849, by the research project PRVOUK-P26/LF1/4 and by the Czech Technical University in Prague: grant project SGS10/279/OHK3/3T/13. Stefan Holiga is supported by a stipend from the International Max Planck Research School on Neuroscience of Communication: Function, Structure, and Plasticity (IMPRS NeuroCom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Andrade A, 1999, NEUROIMAGE, V10, P483, DOI 10.1006/nimg.1999.0479; Antonini A, 2009, LANCET NEUROL, V8, P929, DOI 10.1016/S1474-4422(09)70225-X; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Brett M., 2002, NEUROIMAGE, V16, P1140, DOI DOI 10.1016/S1053-8119(02)90013-3; Brooks DJ, 2001, J NEURAL TRANSM, V108, P1283, DOI 10.1007/s007020100005; Buhmann C, 2003, BRAIN, V126, P451, DOI 10.1093/brain/awg033; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Casellato C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-49; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Dagher A, 2007, MOL IMAGING BIOL, V9, P234, DOI 10.1007/s11307-007-0089-0; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009; Evans A.C., 1993, NUCL SCI S MED IM C, P1813, DOI DOI 10.1109/NSSMIC.1993.373602; Feigin A, 2001, NEUROLOGY, V57, P2083, DOI 10.1212/WNL.57.11.2083; Foki T, 2010, EXP NEUROL, V225, P416, DOI 10.1016/j.expneurol.2010.07.019; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Haslinger B, 2001, BRAIN, V124, P558, DOI 10.1093/brain/124.3.558; Helmich RC, 2011, HUM BRAIN MAPP; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holden A, 2006, PARKINSONISM RELAT D, V12, P73, DOI 10.1016/j.parkreldis.2005.11.001; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kraft E, 2009, PARKINSONISM RELAT D, V15, P558, DOI 10.1016/j.parkreldis.2009.02.005; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Little MA, 2010, INT CONF ACOUST SPEE, P4162, DOI 10.1109/ICASSP.2010.5495722; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Luo WL, 2003, NEUROIMAGE, V19, P1014, DOI 10.1016/S1053-8119(03)00149-6; Lutz K, 2005, NEUROSCI LETT, V373, P61, DOI 10.1016/j.neulet.2004.09.058; MacIntosh BJ, 2004, NEUROIMAGE, V22, P1619, DOI 10.1016/j.neuroimage.2004.03.035; MacIntosh B, 2007, HUM BRAIN MAPP, V28, P835, DOI 10.1002/hbm.20308; Mohamed MA, 2004, AM J ROENTGENOL, V183, P759, DOI 10.2214/ajr.183.3.1830759; Moonen C., 1999, FUNCTIONAL MRI; Moraschi M, 2010, MAGN RESON IMAGING, V28, P1152, DOI 10.1016/j.mri.2010.03.025; Ng B, 2010, HUM BRAIN MAPP, V31, P88, DOI 10.1002/hbm.20847; Parkinson's Disease Foundation (U.S.), 1986, REC DEV PARK DIS; Penny W, 2003, NEUROIMAGE, V19, P727, DOI 10.1016/S1053-8119(03)00071-5; Peters S, 2003, NEUROREPORT, V14, P809, DOI 10.1097/00001756-200305060-00006; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Roweis S, 1999, NEURAL COMPUT, V11, P305, DOI 10.1162/089976699300016674; Sabatini U, 2000, BRAIN, V123, P394, DOI 10.1093/brain/123.2.394; Sadato N, 1997, J CEREBR BLOOD F MET, V17, P670; Schaechter JD, 2006, NEUROIMAGE, V31, P1549, DOI 10.1016/j.neuroimage.2006.02.029; Scholz VH, 2000, BRAIN RES, V879, P204, DOI 10.1016/S0006-8993(00)02749-9; Sen S, 2010, NEUROSCIENCE, V166, P712, DOI 10.1016/j.neuroscience.2009.12.036; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Thickbroom GW, 1998, EXP BRAIN RES, V121, P59, DOI 10.1007/s002210050437; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Duinen H, 2008, HUM BRAIN MAPP, V29, P281, DOI 10.1002/hbm.20388; van Nuenen BFL, 2009, MOVEMENT DISORD, V24, pS703, DOI 10.1002/mds.22635; Van Rootselaar AF, 2007, HUM BRAIN MAPP, V28, P1117, DOI 10.1002/hbm.20336; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yu H, 2007, NEUROIMAGE, V35, P222, DOI 10.1016/j.neuroimage.2006.11.047	62	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36271	10.1371/journal.pone.0036271	http://dx.doi.org/10.1371/journal.pone.0036271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563486	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700035
J	Meerpohl, JJ; Herrle, F; Antes, G; von Elm, E				Meerpohl, Joerg J.; Herrle, Florian; Antes, Gerd; von Elm, Erik			Scientific Value of Systematic Reviews: Survey of Editors of Core Clinical Journals	PLOS ONE			English	Review							METAANALYSIS; TRIALS	Background: Synthesizing research evidence using systematic and rigorous methods has become a key feature of evidence-based medicine and knowledge translation. Systematic reviews (SRs) may or may not include a meta-analysis depending on the suitability of available data. They are often being criticised as 'secondary research' and denied the status of original research. Scientific journals play an important role in the publication process. How they appraise a given type of research influences the status of that research in the scientific community. We investigated the attitudes of editors of core clinical journals towards SRs and their value for publication. Methods: We identified the 118 journals labelled as "core clinical journals'' by the National Library of Medicine, USA in April 2009. The journals' editors were surveyed by email in 2009 and asked whether they considered SRs as original research projects; whether they published SRs; and for which section of the journal they would consider a SR manuscript. Results: The editors of 65 journals (55%) responded. Most respondents considered SRs to be original research (71%) and almost all journals (93%) published SRs. Several editors regarded the use of Cochrane methodology or a meta-analysis as quality criteria; for some respondents these criteria were premises for the consideration of SRs as original research. Journals placed SRs in various sections such as "Review'' or "Feature article''. Characterization of non-responding journals showed that about two thirds do publish systematic reviews. Discussion: Currently, the editors of most core clinical journals consider SRs original research. Our findings are limited by a non-responder rate of 45%. Individual comments suggest that this is a grey area and attitudes differ widely. A debate about the definition of 'original research' in the context of SRs is warranted.	[Meerpohl, Joerg J.; Herrle, Florian; Antes, Gerd; von Elm, Erik] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany; [Meerpohl, Joerg J.] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, Freiburg, Germany; [Herrle, Florian] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, D-6800 Mannheim, Germany; Univ Lausanne Hosp, IUMSP, Cochrane Switzerland, Lausanne, Switzerland	University of Freiburg; University of Freiburg; Ruprecht Karls University Heidelberg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Meerpohl, JJ (corresponding author), Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany.	meerpohl@cochrane.de	Meerpohl, Joerg J/J-4224-2013	Meerpohl, Joerg J/0000-0002-1333-5403; von Elm, Erik/0000-0002-7412-0406	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We would like to thank Stefan Reinders and Rebecca Weida for their assistance. The open access publication of this work was supported by the Deutsche Forschungsgemeinschaft.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Chalmers I, 2002, EVAL HEALTH PROF, V25, P12, DOI 10.1177/0163278702025001003; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; FEINSTEIN AR, 1995, J CLIN EPIDEMIOL, V48, P71, DOI 10.1016/0895-4356(94)00110-C; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Institute of Medicine (U.S.), 2011, CLIN PRACT GUID WE C; Institute of Medicine (US), 2011, FIND WHAT WORKS HLTH; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lind J, 1753, TOGETHER CRITICAL CH; Medical Research Council, 2011, FUND OPP; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Petticrew M, 2001, BMJ-BRIT MED J, V322, P98, DOI 10.1136/bmj.322.7278.98; Sutton AJ, 2008, STAT MED, V27, P625, DOI 10.1002/sim.2934; VanLare JM, 2010, NEW ENGL J MED, V362, P970, DOI 10.1056/NEJMp1000096	21	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35732	10.1371/journal.pone.0035732	http://dx.doi.org/10.1371/journal.pone.0035732			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563469	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700018
J	Molinas, A; Sicard, G; Jakob, I				Molinas, Adrien; Sicard, Gilles; Jakob, Ingrid			Functional Evidence of Multidrug Resistance Transporters (MDR) in Rodent Olfactory Epithelium	PLOS ONE			English	Article							PRODUCT P-GLYCOPROTEIN; BLOOD-BRAIN-BARRIER; RECEPTOR NEURONS; CYCLIC-NUCLEOTIDES; TUMOR-CELLS; EXPRESSION; LOCALIZATION; PROTEIN; GENE; TISSUES	Background: P-glycoprotein (Pgp) and multidrug resistance-associated protein (MRP1) are membrane transporter proteins which function as efflux pumps at cell membranes and are considered to exert a protective function against the entry of xenobiotics. While evidence for Pgp and MRP transporter activity is reported for olfactory tissue, their possible interaction and participation in the olfactory response has not been investigated. Principal Findings: Functional activity of putative MDR transporters was assessed by means of the fluorometric calcein acetoxymethyl ester (calcein-AM) accumulation assay on acute rat and mouse olfactory tissue slices. Calcein-AM uptake was measured as fluorescence intensity changes in the presence of Pgp or MRP specific inhibitors. Epifluorescence microscopy measured time course analysis in the olfactory epithelium revealed significant inhibitor-dependent calcein uptake in the presence of each of the selected inhibitors. Furthermore, intracellular calcein accumulation in olfactory receptor neurons was also significantly increased in the presence of either one of the Pgp or MRP inhibitors. The presence of Pgp or MRP1 encoding genes in the olfactory mucosa of rat and mouse was confirmed by RT-PCR with appropriate pairs of species-specific primers. Both transporters were expressed in both newborn and adult olfactory mucosa of both species. To assess a possible involvement of MDR transporters in the olfactory response, we examined the electrophysiological response to odorants in the presence of the selected MDR inhibitors by recording electroolfactograms (EOG). In both animal species, MRPs inhibitors induced a marked reduction of the EOG magnitude, while Pgp inhibitors had only a minor or no measurable effect. Conclusions: The findings suggest that both Pgp and MRP transporters are functional in the olfactory mucosa and in olfactory receptor neurons. Pgp and MRPs may be cellular constituents of olfactory receptor neurons and represent potential mechanisms for modulation of the olfactory response.	[Molinas, Adrien; Sicard, Gilles; Jakob, Ingrid] Univ Bourgogne, Equipe Neurophysiol Peripherie Syst Chimiosensori, Ctr Sci Gout & Alimentat, INRA,CNRS UMR 6265, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Molinas, A (corresponding author), Univ Bourgogne, Equipe Neurophysiol Peripherie Syst Chimiosensori, Ctr Sci Gout & Alimentat, INRA,CNRS UMR 6265, Dijon, France.	ingrid.jakob@u-bourgogne.fr			Fondation Edmond Roudnitska (Paris, France)	Fondation Edmond Roudnitska (Paris, France)	AM was supported by a PhD fellowship from the Fondation Edmond Roudnitska (Paris, France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bakos E, 2007, PFLUG ARCH EUR J PHY, V453, P621, DOI 10.1007/s00424-006-0160-8; BROXTERMAN HJ, 1990, BRIT J CANCER, V62, P85, DOI 10.1038/bjc.1990.234; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Chen S, 2000, J NEUROPHYSIOL, V84, P575, DOI 10.1152/jn.2000.84.1.575; Chen Y, 2000, J CELL BIOL, V148, P863, DOI 10.1083/jcb.148.5.863; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Costa VM, 2009, CHEM RES TOXICOL, V22, P129, DOI 10.1021/tx8002577; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; Dogan AL, 2004, LEUKEMIA RES, V28, P619, DOI 10.1016/j.leukres.2003.10.015; Falcao AS, 2007, NEUROSCIENCE, V144, P878, DOI 10.1016/j.neuroscience.2006.10.026; FELLER N, 1995, BRIT J CANCER, V72, P543, DOI 10.1038/bjc.1995.371; FELLER N, 1995, FEBS LETT, V368, P385, DOI 10.1016/0014-5793(95)00677-2; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Flens MJ, 1996, AM J PATHOL, V148, P1237; FOXWELL BMJ, 1989, MOL PHARMACOL, V36, P543; Gautam SH, 2007, NEUROSCIENCE, V144, P702, DOI 10.1016/j.neuroscience.2006.10.012; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Genter MB, 2010, DRUG METAB DISPOS, V38, P1644, DOI 10.1124/dmd.110.034611; Gollapudi S, 1997, CANCER CHEMOTH PHARM, V40, P150, DOI 10.1007/s002800050640; Graff CL, 2005, PHARM RES-DORDR, V22, P86, DOI 10.1007/s11095-004-9013-3; Hall RA, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001672; Hegg CC, 2003, J NEUROSCI, V23, P8291; Heydel JM, 2010, DRUG METAB REV, V42, P74, DOI 10.3109/03602530903208363; Hirrlinger J, 2002, J NEUROCHEM, V82, P716, DOI 10.1046/j.1471-4159.2002.01082.x; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; Jakob I, 1998, AM J PHYSIOL-CELL PH, V274, pC182, DOI 10.1152/ajpcell.1998.274.1.C182; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kandimalla KK, 2005, PHARM RES-DORDR, V22, P1121, DOI 10.1007/s11095-005-5420-3; Karssen AM, 2004, ANN NY ACAD SCI, V1032, P308, DOI 10.1196/annals.1314.048; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Kudo H, 2010, NEUROSCI LETT, V468, P98, DOI 10.1016/j.neulet.2009.10.073; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; McAleer MA, 1999, J BIOL CHEM, V274, P23541, DOI 10.1074/jbc.274.33.23541; Motulsky H, 2010, INTUITIVE BIOSTATIST, P237; NEF P, 1989, J BIOL CHEM, V264, P6780, DOI 10.1016/S0021-9258(18)83497-4; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Reid G, 2003, MOL PHARMACOL, V63, P1094, DOI 10.1124/mol.63.5.1094; Reisert J, 2011, J GEN PHYSIOL, V138, P303, DOI 10.1085/jgp.201110645; Rosati A, 2003, DEV GROWTH DIFFER, V45, P377; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; Schiengold M, 2001, MECH AGEING DEV, V122, P255, DOI 10.1016/S0047-6374(00)00223-2; Steinke A, 2008, HISTOCHEM CELL BIOL, V130, P339, DOI 10.1007/s00418-008-0441-8; STROTMANN J, 1991, CELL TISSUE RES, V266, P247, DOI 10.1007/BF00318180; Thiebaud N, 2011, NEUROSCI LETT, V505, P180, DOI 10.1016/j.neulet.2011.10.018; Thiebaud N, 2010, DRUG METAB DISPOS, V38, P1865, DOI 10.1124/dmd.110.035014; THIEBAUT F, 1989, J HISTOCHEM CYTOCHEM, V37, P159, DOI 10.1177/37.2.2463300; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; ThorntonManning JR, 1997, MUTAT RES-FUND MOL M, V380, P43, DOI 10.1016/S0027-5107(97)00126-7; Tsai CE, 2002, BIOL NEONATE, V81, P58, DOI 10.1159/000047185; Volk H, 2005, J HISTOCHEM CYTOCHEM, V53, P517, DOI 10.1369/jhc.4A6451.2005; Volk HA, 2004, NEUROSCIENCE, V123, P751, DOI 10.1016/j.neuroscience.2003.10.012; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Wioland MA, 2000, J HISTOCHEM CYTOCHEM, V48, P1215, DOI 10.1177/002215540004800905; Xie M, 2011, MOL PHARMACOL, V80, P281, DOI 10.1124/mol.111.071134	64	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36167	10.1371/journal.pone.0036167	http://dx.doi.org/10.1371/journal.pone.0036167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563480	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700029
J	Panaampon, J; Ngaosuwankul, N; Suptawiwat, O; Noisumdaeng, P; Sangsiriwut, K; Siridechadilok, B; Lerdsamran, H; Auewarakul, P; Pooruk, P; Puthavathana, P				Panaampon, Jutatip; Ngaosuwankul, Nathamon; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Sangsiriwut, Kantima; Siridechadilok, Bunpote; Lerdsamran, Hatairat; Auewarakul, Prasert; Pooruk, Phisanu; Puthavathana, Pilaipan			A Novel Pathogenic Mechanism of Highly Pathogenic Avian Influenza H5N1 Viruses Involves Hemagglutinin Mediated Resistance to Serum Innate Inhibitors	PLOS ONE			English	Article							N-LINKED GLYCOSYLATION; A-VIRUS; PROVED VIREMIA; INFECTION; VIRULENCE; SYSTEM; NEUTRALIZATION; COLLECTIN; PROTEINS	In this study, the effect of innate serum inhibitors on influenza virus infection was addressed. Seasonal influenza A(H1N1) and A(H3N2), 2009 pandemic A(H1N1) (H1N1pdm) and highly pathogenic avian influenza (HPAI) A(H5N1) viruses were tested with guinea pig sera negative for antibodies against all of these viruses as evaluated by hemagglutination-inhibition and microneutralization assays. In the presence of serum inhibitors, the infection by each virus was inhibited differently as measured by the amount of viral nucleoprotein produced in Madin-Darby canine kidney cells. The serum inhibitors inhibited seasonal influenza A(H3N2) virus the most, while the effect was less in seasonal influenza A(H1N1) and H1N1pdm viruses. The suppression by serum inhibitors could be reduced by heat inactivation or treatment with receptor destroying enzyme. In contrast, all H5N1 strains tested were resistant to serum inhibitors. To determine which structure (hemagglutinin (HA) and/or neuraminidase (NA)) on the virus particles that provided the resistance, reverse genetics (rg) was applied to construct chimeric recombinant viruses from A/Puerto Rico/8/1934(H1N1) (PR8) plasmid vectors. rgPR8-H5 HA and rgPR8-H5 HANA were resistant to serum inhibitors while rgPR8-H5 NA and PR8 A(H1N1) parental viruses were sensitive, suggesting that HA of HPAI H5N1 viruses bestowed viral resistance to serum inhibition. These results suggested that the ability to resist serum inhibition might enable the viremic H5N1 viruses to disseminate to distal end organs. The present study also analyzed for correlation between susceptibility to serum inhibitors and number of glycosylation sites present on the globular heads of HA and NA. H3N2 viruses, the subtype with highest susceptibility to serum inhibitors, harbored the highest number of glycosylation sites on the HA globular head. However, this positive correlation cannot be drawn for the other influenza subtypes.	[Panaampon, Jutatip; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Lerdsamran, Hatairat; Auewarakul, Prasert; Pooruk, Phisanu; Puthavathana, Pilaipan] Mahidol Univ, Dept Microbiol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Panaampon, Jutatip; Ngaosuwankul, Nathamon; Suptawiwat, Ornpreya; Noisumdaeng, Pirom; Lerdsamran, Hatairat; Auewarakul, Prasert; Puthavathana, Pilaipan] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Ngaosuwankul, Nathamon] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Sangsiriwut, Kantima] Mahidol Univ, Dept Prevent Med, Fac Med Siriraj Hosp, Bangkok 10700, Thailand; [Siridechadilok, Bunpote] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Panaampon, J (corresponding author), Mahidol Univ, Dept Microbiol, Fac Med Siriraj Hosp, Bangkok 10700, Thailand.	siput@mahidol.ac.th		Auewarakul, Prasert/0000-0002-4745-4291; Kosoltanapiwat, Nathamon/0000-0001-7465-0696	Thailand Research Fund for Senior Research Scholar; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University	Thailand Research Fund for Senior Research Scholar; Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Faculty of Medicine Siriraj Hospital, Mahidol University; Mahidol University	This study was supported by the Thailand Research Fund for Senior Research Scholar, Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, scholarship for graduate students, Faculty of Medicine Siriraj Hospital, Mahidol University, and Mahidol University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ANDERS EM, 1994, J GEN VIROL, V75, P615, DOI 10.1099/0022-1317-75-3-615; ANDERS EM, 1990, P NATL ACAD SCI USA, V87, P4485, DOI 10.1073/pnas.87.12.4485; Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; Cherry Joshua L, 2009, PLoS Curr, V1, pRRN1001; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; COHEN A, 1961, VIROLOGY, V13, P58, DOI 10.1016/0042-6822(61)90032-0; Cwach KT, 2012, INFLUENZA OTHER RESP, V6, P127, DOI 10.1111/j.1750-2659.2011.00283.x; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; Hawkes RA, 1979, DIAGNOSTIC PROCEDURE, P32; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horvath A, 2001, ANTIVIR RES, V52, P43, DOI 10.1016/S0166-3542(01)00158-9; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Job ER, 2010, J IMMUNOL, V185, P4284, DOI 10.4049/jimmunol.1001613; Kase T, 1999, IMMUNOLOGY, V97, P385; KHAKPOUR M, 1969, BRIT MED J, V4, P208, DOI 10.1136/bmj.4.5677.208; Krizanova O, 1969, Curr Top Microbiol Immunol, V47, P125; Krug RM, 2006, SCIENCE, V311, P1562, DOI 10.1126/science.1125998; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; NAFICY K, 1963, NEW ENGL J MED, V269, P964, DOI 10.1056/NEJM196310312691807; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piwpankaew Y, 2010, APMIS, V118, P895, DOI 10.1111/j.1600-0463.2010.02676.x; PRITCHETT TJ, 1989, J BIOL CHEM, V264, P9850; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Reading PC, 2007, ADV EXP MED BIOL, V598, P279; Reading PC, 1997, J VIROL, V71, P8204, DOI 10.1128/JVI.71.11.8204-8212.1997; Reading PC, 1995, BIOCHEM BIOPH RES CO, V217, P1128, DOI 10.1006/bbrc.1995.2886; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tate MD, 2011, J IMMUNOL, V187, P1884, DOI 10.4049/jimmunol.1100295; Tate MD, 2011, VIROLOGY, V413, P84, DOI 10.1016/j.virol.2011.01.036; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tsuruoka H, 1997, Nihon Rinsho, V55, P2714; Vigerust DJ, 2007, J VIROL, V81, P8593, DOI 10.1128/JVI.00769-07; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; World Health Organization, 2002, WHO MAN AN INFL DIAG	41	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36318	10.1371/journal.pone.0036318	http://dx.doi.org/10.1371/journal.pone.0036318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563489	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700038
J	Chen, YC; Su, YC; Lee, CC; Huang, YS; Hwang, SJ				Chen, Yi-Chun; Su, Yu-Chieh; Lee, Ching-Chih; Huang, Yung-Sung; Hwang, Shang-Jyh			Chronic Kidney Disease Itself Is a Causal Risk Factor for Stroke beyond Traditional Cardiovascular Risk Factors: A Nationwide Cohort Study in Taiwan	PLOS ONE			English	Article							GENERAL JAPANESE POPULATION; GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; ISCHEMIC-STROKE; RENAL-INSUFFICIENCY; NORTHERN-MANHATTAN; PROPENSITY SCORE; YOUNG-ADULTS; CANCER; CKD	Background: Cardiovascular disease (CVD) is a leading cause of mortality and morbidity in patients with chronic kidney disease (CKD). In Taiwan, CVD is dominated by strokes but there is no robust evidence for a causal relationship between CKD and stroke. This study aimed to explore such causal association. Methods: We conducted a nationwide retrospective cohort study based on the Taiwan National Health Insurance Research Database from 2004 to 2007. Each patient identified was individually tracked for a full three years from the index admission to identify those in whom any type of stroke developed. The study cohort consisted of patients hospitalized with a principal diagnosis of CKD and no traditional cardiovascular risk factors at baseline (n = 1393) and an age-matched control cohort of patients hospitalized for appendectomies (n = 1393, a surrogate for the general population). Cox proportional hazard regression and propensity score model were used to compare the three-year stroke-free survival rate of the two cohorts after adjustment for possible confounding factors. Results: There were 256 stroke patients, 156 (11.2%) in the study cohort and 100 (7.2%) in the control cohort. After adjusting for covariates, patients with primary CKD had a 1.94-fold greater risk for stroke (95% CI, 1.45-2.60; p<0.001) based on Cox regression and a 1.68-fold greater risk for stroke (95% CI, 1.25-2.25; p = 0.001) based on propensity score. This was still the case for two cohorts younger than 75 years old and without traditional cardiovascular risk factors. Conclusions: This study of Taiwanese patients indicates that CKD itself is a causal risk factor for stroke beyond the traditional cardiovascular risk factors. Primary CKD patients have higher risk for stroke than the general population and all CKD patients, irrespective of the presence or severity of traditional cardiovascular risk factors, should be made aware of the stroke risk and monitored for stroke prevention.	[Chen, Yi-Chun] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Chen, Yi-Chun; Su, Yu-Chieh; Lee, Ching-Chih; Huang, Yung-Sung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Shang-Jyh] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, YC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan.	df254246@tzuchi.com.tw; solomons1117@yahoo.com.tw	Su, Yu-Chieh/M-7867-2013; Chen, Yi-Chun/GYJ-2065-2022	Su, Yu-Chieh/0000-0002-1771-9017				Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chiu HF, 2011, AM J GASTROENTEROL, V106, P894, DOI 10.1038/ajg.2010.475; Cho AH, 2009, NEUROLOGY, V73, P1645, DOI 10.1212/WNL.0b013e3181c1defa; Collins AJ, 2011, AM J KIDNEY DIS, V57, pA8, DOI 10.1053/j.ajkd.2010.10.007; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS27, DOI 10.1053/j.ajkd.2008.07.055; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Daly C, 2007, NEPHROL DIAL TRANSPL, V22, P19, DOI 10.1093/ndt/gfm445; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Foley RN, 2005, J AM SOC NEPHROL, V16, P489, DOI 10.1681/ASN.2004030203; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Kobayashi S, 2004, AM J KIDNEY DIS, V44, P35, DOI 10.1053/j.ajkd.2004.03.026; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lee CC, 2011, STROKE, V42, P48, DOI 10.1161/STROKEAHA.110.597070; Lee M, 2011, BMJ-BRIT MED J, V341, pc4249; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao DP, 1997, STROKE, V28, P1908, DOI 10.1161/01.STR.28.10.1908; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; Lin HC, 2007, J AFFECT DISORDERS, V100, P49, DOI 10.1016/j.jad.2006.09.016; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Nakayama M, 2007, NEPHROL DIAL TRANSPL, V22, P1910, DOI 10.1093/ndt/gfm051; Nickolas TL, 2008, STROKE, V39, P2876, DOI 10.1161/STROKEAHA.107.513713; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sheu JJ, 2010, STROKE, V41, P2033, DOI 10.1161/STROKEAHA.110.588558; Sheu JJ, 2010, STROKE, V41, P961, DOI 10.1161/STROKEAHA.109.577742; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Winkelmayer WC, 2005, AM J KIDNEY DIS, V46, P225, DOI 10.1053/j.ajkd.2005.04.029; Wu CY, 2010, J CLIN ONCOL, V28, P2952, DOI 10.1200/JCO.2009.26.0695; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882	43	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36332	10.1371/journal.pone.0036332	http://dx.doi.org/10.1371/journal.pone.0036332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558437	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200066
J	Ashek, A; Menzies, RI; Mullins, LJ; Bellamy, COC; Harmar, AJ; Kenyon, CJ; Flatman, PW; Mullins, JJ; Bailey, MA				Ashek, Ali; Menzies, Robert I.; Mullins, Linda J.; Bellamy, Christopher O. C.; Harmar, Anthony J.; Kenyon, Christopher J.; Flatman, Peter W.; Mullins, John J.; Bailey, Matthew A.			Activation of Thiazide-Sensitive Co-Transport by Angiotensin II in the cyp1a1-Ren2 Hypertensive Rat	PLOS ONE			English	Article							NA+-CL-COTRANSPORTER; CYP1A1REN-2 TRANSGENIC RATS; TUBULAR SODIUM-REABSORPTION; BLOOD-PRESSURE; DISTAL TUBULE; RENAL HEMODYNAMICS; CONVERTING-ENZYME; COLLECTING DUCT; DIETARY SALT; ALDOSTERONE	Transgenic rats with inducible expression of the mouse Ren2 gene were used to elucidate mechanisms leading to the development of hypertension and renal injury. Ren2 transgene activation was induced by administration of a naturally occurring aryl hydrocarbon, indole-3-carbinol (100 mg/kg/day by gastric gavage). Blood pressure and renal parameters were recorded in both conscious and anesthetized (butabarbital sodium; 120 mg/kg IP) rats at selected time-points during the development of hypertension. Hypertension was evident by the second day of treatment, being preceded by reduced renal sodium excretion due to activation of the thiazide-sensitive sodium-chloride co-transporter. Renal injury was evident after the first day of transgene induction, being initially limited to the pre-glomerular vasculature. Mircoalbuminuria and tubuloinsterstitial injury developed once hypertension was established. Chronic treatment with either hydrochlorothiazide or an AT1 receptor antagonist normalized sodium reabsorption, significantly blunted hypertension and prevented renal injury. Urinary aldosterone excretion was increased similar to 20 fold, but chronic mineralocorticoid receptor antagonism with spironolactone neither restored natriuretic capacity nor prevented hypertension. Spironolactone nevertheless ameliorated vascular damage and prevented albuminuria. This study finds activation of sodium-chloride co-transport to be a key mechanism in angiotensin II-dependent hypertension. Furthermore, renal vascular injury in this setting reflects both barotrauma and pressure-independent pathways associated with direct detrimental effects of angiotensin II and aldosterone.	[Ashek, Ali; Menzies, Robert I.; Mullins, Linda J.; Harmar, Anthony J.; Kenyon, Christopher J.; Mullins, John J.; Bailey, Matthew A.] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Flatman, Peter W.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Bellamy, Christopher O. C.] Edinburgh New Royal Infirm, Dept Pathol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Ashek, A (corresponding author), Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	matthew.bailey@ed.ac.uk	Bailey, Matthew A./AAH-3395-2020	Bailey, Matthew A./0000-0003-4244-5668; Harmar, Anthony/0000-0002-3838-9264; Mullins, Linda/0000-0002-6743-8707	British Heart Foundation; Wellcome Trust; European Commission; University of Edinburgh; British Heart Foundation Centre of Research Excellence (CoRE)	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); University of Edinburgh; British Heart Foundation Centre of Research Excellence (CoRE)	This work was supported by the British Heart Foundation (www.BHF.org.uk); the Wellcome Trust www.wellcome.ac.uk); and the European Commission FP7: Euratrans (www.euratrans.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Gillian Brooker for expert technical assistance. Ali Ashek received a University of Edinburgh PhD Studentship; Robert Menzies holds a 4-year PhD studentship from the British Heart Foundation Centre of Research Excellence (CoRE) Award to The University of Edinburgh.	Al-Dujaili EAS, 2009, STEROIDS, V74, P456, DOI 10.1016/j.steroids.2008.12.012; ANDO K, 1990, AM J PHYSIOL, V259, pR1012, DOI 10.1152/ajpregu.1990.259.5.R1012; Ballew JR, 2001, J HYPERTENS, V19, P1601, DOI 10.1097/00004872-200109000-00012; Beutler KT, 2003, HYPERTENSION, V41, P1143, DOI 10.1161/01.HYP.0000066129.12106.E2; Bidani AK, 2004, HYPERTENSION, V44, P595, DOI 10.1161/01.HYP.0000145180.38707.84; Bidani AK, 2009, HYPERTENSION, V54, P393, DOI 10.1161/HYPERTENSIONAHA.109.133777; Brem AS, 2010, AM J PHYSIOL-RENAL, V298, pF1178, DOI 10.1152/ajprenal.00532.2009; Cherney DZI, 2010, DIABETES CARE, V33, P361, DOI 10.2337/dc09-1303; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Crowley SD, 2011, AM J PHYSIOL-RENAL, V301, pF1124, DOI 10.1152/ajprenal.00305.2011; Csiky B, 1997, AM J PHYSIOL-HEART C, V273, pH1275, DOI 10.1152/ajpheart.1997.273.3.H1275; DEGASPARO M, 1987, J PHARMACOL EXP THER, V240, P650; Ellison DH, 2009, HYPERTENSION, V54, P196, DOI 10.1161/HYPERTENSIONAHA.109.129171; Erbanova M, 2009, J HYPERTENS, V27, P575, DOI 10.1097/HJH.0b013e32831cbd5a; Fink GD, 1997, CLIN EXP PHARMACOL P, V24, P91, DOI 10.1111/j.1440-1681.1997.tb01789.x; Granger CB, 2003, LANCET, V362, P772, DOI 10.1016/S0140-6736(03)14284-5; HALL JE, 1986, AM J PHYSIOL, V250, pR960, DOI 10.1152/ajpregu.1986.250.6.R960; Hannemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017992; HARRIS PJ, 1977, PFLUG ARCH EUR J PHY, V367, P295, DOI 10.1007/BF00581370; Hiranyachattada S, 1996, BRIT J PHARMACOL, V119, P617, DOI 10.1111/j.1476-5381.1996.tb15717.x; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Honetschlagerova Z, 2011, J PHYSIOL-LONDON, V589, P207, DOI 10.1113/jphysiol.2010.199505; Hu LF, 1998, J HYPERTENS, V16, P1285, DOI 10.1097/00004872-199816090-00010; Huskova Z, 2010, J HYPERTENS, V28, P495, DOI 10.1097/HJH.0b013e3283345d69; KANAGY NL, 1990, AM J PHYSIOL, V259, pR102, DOI 10.1152/ajpregu.1990.259.1.R102; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Lee DH, 2009, AM J PHYSIOL-RENAL, V296, pF810, DOI 10.1152/ajprenal.90606.2008; Leviel F, 2011, J CLIN INVEST, V121, P1668, DOI 10.1172/JCI57722; Liu XJ, 2009, J BIOL CHEM, V284, P15564, DOI 10.1074/jbc.M806584200; Maitland K, 2006, CIRCULATION, V114, P905, DOI 10.1161/CIRCULATIONAHA.106.622316; McDonough AA, 2010, AM J PHYSIOL-REG I, V298, pR851, DOI 10.1152/ajpregu.00002.2010; Mitchell KD, 2005, AM J PHYSIOL-RENAL, V289, pF1210, DOI 10.1152/ajprenal.00461.2004; Mori T, 2004, HYPERTENSION, V43, P752, DOI 10.1161/01.HYP.0000120971.49659.6a; Nishikawa T, 2005, J STEROID BIOCHEM, V96, P309, DOI 10.1016/j.jsbmb.2005.03.005; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF1584, DOI 10.1152/ajprenal.00124.2007; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Pallone TL, 2003, AM J PHYSIOL-RENAL, V284, pF253, DOI 10.1152/ajprenal.00304.2002; Patterson ME, 2005, AM J PHYSIOL-RENAL, V289, pF754, DOI 10.1152/ajprenal.00419.2004; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Polichnowski AJ, 2009, HYPERTENSION, V54, P1269, DOI 10.1161/HYPERTENSIONAHA.109.139287; Prieto MC, 2011, AM J PHYSIOL-RENAL, V300, pF581, DOI 10.1152/ajprenal.00433.2010; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; RAUCH AL, 1988, J HYPERTENS, V6, P537, DOI 10.1097/00004872-198807000-00004; Rocha R, 2000, ENDOCRINOLOGY, V141, P3871, DOI 10.1210/en.141.10.3871; Sandberg MB, 2006, AM J PHYSIOL-RENAL, V291, pF503, DOI 10.1152/ajprenal.00482.2005; Schluter T, 2010, J HYPERTENS, V28, P2267, DOI 10.1097/HJH.0b013e32833d77b4; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Silva GB, 2008, HYPERTENSION, V52, P1091, DOI 10.1161/HYPERTENSIONAHA.108.120212; Talati G, 2010, BIOCHEM BIOPH RES CO, V393, P844, DOI 10.1016/j.bbrc.2010.02.096; Thomsen K, 1997, NEPHRON, V77, P125, DOI 10.1159/000190264; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; van der Lubbe N, 2011, KIDNEY INT, V79, P66, DOI 10.1038/ki.2010.290; Velazquez H, 1996, AM J PHYSIOL-RENAL, V270, pF211, DOI 10.1152/ajprenal.1996.270.1.F211; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Young JH, 2002, J AM SOC NEPHROL, V13, P2776, DOI 10.1097/01.ASN.0000031805.09178.37; Zhao D, 2009, HYPERTENSION, V54, P120, DOI 10.1161/HYPERTENSIONAHA.109.133785	58	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36311	10.1371/journal.pone.0036311	http://dx.doi.org/10.1371/journal.pone.0036311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558431	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000186
J	Malinovschi, A; Janson, C; Hogman, M; Rolla, G; Toren, K; Norback, D; Olin, AC				Malinovschi, Andrei; Janson, Christer; Hogman, Marieann; Rolla, Giovanni; Toren, Kjell; Norback, Dan; Olin, Anna-Carin			Bronchial Responsiveness Is Related to Increased Exhaled NO (FENO) in Non-Smokers and Decreased FENO in Smokers	PLOS ONE			English	Article							NITRIC-OXIDE MEASUREMENTS; RESPIRATORY HEALTH SURVEY; AIRWAY RESPONSIVENESS; METHACHOLINE RESPONSIVENESS; BREATH CONDENSATE; MURINE MODEL; GUINEA-PIGS; ASTHMA; ATOPY; HYPERRESPONSIVENESS	Rationale: Both atopy and smoking are known to be associated with increased bronchial responsiveness. Fraction of nitric (NO) in the exhaled air (FENO), a marker of airways inflammation, is decreased by smoking and increased by atopy. NO has also a physiological bronchodilating and bronchoprotective role. Objectives: To investigate how the relation between FENO and bronchial responsiveness is modulated by atopy and smoking habits. Methods: Exhaled NO measurements and methacholine challenge were performed in 468 subjects from the random sample of three European Community Respiratory Health Survey II centers: Turin (Italy), Gothenburg and Uppsala (both Sweden). Atopy status was defined by using specific IgE measurements while smoking status was questionnaire-assessed. Main Results: Increased bronchial responsiveness was associated with increased FENO levels in non-smokers (p = 0.02) and decreased FENO levels in current smokers (p = 0.03). The negative association between bronchial responsiveness and FENO was seen only in the group smoking less <10 cigarettes/day (p = 0.008). Increased bronchial responsiveness was associated with increased FENO in atopic subjects (p = 0.04) while no significant association was found in non-atopic participants. The reported interaction between FENO and smoking and atopy, respectively were maintained after adjusting for possible confounders (p-values<0.05). Conclusions: The present study highlights the interactions of the relationship between FENO and bronchial responsiveness with smoking and atopy, suggesting different mechanisms behind atopy- and smoking-related increases of bronchial responsiveness.	[Malinovschi, Andrei] Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden; [Janson, Christer; Hogman, Marieann; Norback, Dan] Uppsala Univ, Asthma & Allergy Res Ctr, Uppsala, Sweden; [Janson, Christer; Hogman, Marieann] Uppsala Univ, Dept Med Sci Resp Med & Allergol, Uppsala, Sweden; [Hogman, Marieann] Uppsala Univ, Ctr Res & Dev, Cty Council Gavleborg, Uppsala, Sweden; [Rolla, Giovanni] Univ Turin, Dept Allergy & Clin Immunol, Turin, Italy; [Rolla, Giovanni] Mauriziano Hosp, Turin, Italy; [Toren, Kjell; Olin, Anna-Carin] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Norback, Dan] Uppsala Univ, Dept Med Sci Occupat & Environm Med, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Sahlgrenska University Hospital; Uppsala University	Malinovschi, A (corresponding author), Uppsala Univ, Dept Med Sci Clin Physiol, Uppsala, Sweden.	Andrei.Malinovschi@medsci.uu.se	Olin, Anna-Carin/ABH-2627-2021; Rolla, Giovanni/C-9901-2009	Rolla, Giovanni/0000-0001-5997-7172; Norback, Dan/0000-0002-5174-6668	Swedish Heart Lung Foundation; Swedish Medical Research Council; Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR)	Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by: Swedish Heart Lung Foundation; Swedish Medical Research Council; Swedish Association against Asthma and Allergy; Bror Hjerpstedts Foundation; Agnes and Mac Rudbergs Foundation; Italian Ministry of Education, University and Research (MUIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; ASSREUY J, 1993, BRIT J PHARMACOL, V108, P833, DOI 10.1111/j.1476-5381.1993.tb12886.x; Balint B, 2001, THORAX, V56, P456, DOI 10.1136/thorax.56.6.456; Borrill Z, 2006, RESP MED, V100, P1392, DOI 10.1016/j.rmed.2005.11.018; BRUSSELLE G, 1995, AM J RESP CELL MOL, V12, P254, DOI 10.1165/ajrcmb.12.3.7873190; BRYANT DH, 1976, CLIN ALLERGY, V6, P373, DOI 10.1111/j.1365-2222.1976.tb01919.x; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Chinn S, 1997, EUR RESPIR J, V10, P2495, DOI 10.1183/09031936.97.10112495; Corradi M, 2001, AM J RESP CRIT CARE, V163, P854, DOI 10.1164/ajrccm.163.4.2001108; Deykin A, 2002, AM J RESP CRIT CARE, V165, P1597, DOI 10.1164/rccm.2201081; DJUKANOVIC R, 1992, EUR RESPIR J, V5, P538; Emms JC, 1997, BRIT J PHARMACOL, V122, P779, DOI 10.1038/sj.bjp.0701440; Franklin PJ, 2004, CHEST, V126, P1540, DOI 10.1378/chest.126.5.1540; Franklin PJ, 2003, THORAX, V58, P1048, DOI 10.1136/thorax.58.12.1048; GERRARD JW, 1980, AM REV RESPIR DIS, V122, P577; Hessel EM, 1998, J IMMUNOL, V160, P2998; Horvath I, 1999, CLIN EXP ALLERGY, V29, P1276; Hoyt JC, 2003, EXP LUNG RES, V29, P17, DOI 10.1080/01902140303759; Janson C, 1997, EUR RESPIR J, V10, P1795, DOI 10.1183/09031936.97.10081795; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jatakanon A, 1998, THORAX, V53, P91, DOI 10.1136/thx.53.2.91; Jones KL, 1998, AM J PHYSIOL-LUNG C, V275, pL1120, DOI 10.1152/ajplung.1998.275.6.L1120; KHARITONOV SA, 1994, LANCET, V343, P133, DOI 10.1016/S0140-6736(94)90931-8; Laan M, 1999, THORAX, V54, P911, DOI 10.1136/thx.54.10.911; Laberge S, 1997, AM J RESP CELL MOL, V17, P193, DOI 10.1165/ajrcmb.17.2.2750; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Ludviksdottir D, 1999, RESP MED, V93, P552, DOI 10.1016/S0954-6111(99)90154-3; Malinovschi A, 2006, EUR RESPIR J, V28, P339, DOI 10.1183/09031936.06.00113705; Malinovschi A, 2009, ALLERGY, V64, P55, DOI 10.1111/j.1398-9995.2008.01835.x; Malinovschi A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-92; Olin AC, 2006, CHEST, V130, P1319, DOI 10.1378/chest.130.5.1319; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ricciardolo FLM, 1996, LANCET, V348, P374, DOI 10.1016/S0140-6736(96)04450-9; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Riess A, 1996, AM J RESP CRIT CARE, V154, P1444, DOI 10.1164/ajrccm.154.5.8912762; Rytila P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-69; Salome CM, 1999, AM J RESP CRIT CARE, V159, P911, DOI 10.1164/ajrccm.159.3.9802108; Schwartz J, 2002, CHEST, V122, P812, DOI 10.1378/chest.122.3.812; Silvestri M, 1999, EUR RESPIR J, V13, P321, DOI 10.1034/j.1399-3003.1999.13b17.x; Smith AD, 2004, AM J RESP CRIT CARE, V169, P473, DOI 10.1164/rccm.200310-1376OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Sunyer J, 1997, THORAX, V52, P235, DOI 10.1136/thx.52.3.235; Suresh V, 2007, AM J RESP CELL MOL, V37, P97, DOI 10.1165/rcmb.2006-0419OC; Taylor DR, 2006, THORAX, V61, P817, DOI 10.1136/thx.2005.056093; Taylor DA, 1998, THORAX, V53, P483, DOI 10.1136/thx.53.6.483; Verbanck S, 2004, AM J RESP CRIT CARE, V170, P414, DOI 10.1164/rccm.200401-037OC; Wang H, 2002, EARLY HUM DEV, V67, P79, DOI 10.1016/S0378-3782(01)00257-2; Wang Y, 2005, CLIN EXP ALLERGY, V35, P1104, DOI 10.1111/j.1365-2222.2005.02301.x; Warke TJ, 2002, THORAX, V57, P383, DOI 10.1136/thorax.57.5.383; Yoshihara S, 1998, AM J RESP CRIT CARE, V157, P547, DOI 10.1164/ajrccm.157.2.9704074	51	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35725	10.1371/journal.pone.0035725	http://dx.doi.org/10.1371/journal.pone.0035725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563393	Green Published, gold			2022-12-27	WOS:000305349100021
J	Zheng, Y; Lilo, S; Mena, P; Bliska, JB				Zheng, Ying; Lilo, Sarit; Mena, Patricio; Bliska, James B.			YopJ-Induced Caspase-1 Activation in Yersinia-Infected Macrophages: Independent of Apoptosis, Linked to Necrosis, Dispensable for Innate Host Defense	PLOS ONE			English	Article							INDUCED CELL-DEATH; NF-KAPPA-B; BACTERIA-FACED MACROPHAGES; CHROMATIN PROTEIN HMGB1; III SECRETION SYSTEM; NLRP3 INFLAMMASOME; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINE; LEGIONELLA-PNEUMOPHILA; NALP3 INFLAMMASOME	Yersinia outer protein J (YopJ) is a type III secretion system (T3SS) effector of pathogenic Yersinia (Yersinia pestis, Yersinia enterocolitica and Yersinia pseudotuberculosis) that is secreted into host cells. YopJ inhibits survival response pathways in macrophages, causing cell death. Allelic variation of YopJ is responsible for differential cytotoxicity in Yersinia strains. YopJ isoforms in Y. enterocolitica O:8 (YopP) and Y. pestis KIM (YopJ(KIM)) strains have high cytotoxic activity. In addition, YopJ(KIM)-induced macrophage death is associated with caspase-1 activation and interleukin-1 beta (IL-1 beta secretion. Here, the mechanism of YopJ(KIM)-induced cell death, caspase-1 activation, and IL-1 beta secretion in primary murine macrophages was examined. Caspase-3/7 activity was low and the caspase-3 substrate poly (ADP-ribose) polymerase (PARP) was not cleaved in Y. pestis KIM5-infected macrophages. In addition, cytotoxicity and IL-1 beta secretion were not reduced in the presence of a caspase-8 inhibitor, or in B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 homologous antagonist/killer (Bak) knockout macrophages, showing that YopJ(KIM)-mediated cell death and caspase-1 activation occur independent of mitochondrial-directed apoptosis. KIM5-infected macrophages released high mobility group protein B1 (HMGB1), a marker of necrosis, and microscopic analysis revealed that necrotic cells contained active caspase-1, indicating that caspase-1 activation is associated with necrosis. Inhibitor studies showed that receptor interacting protein 1 (RIP1) kinase and reactive oxygen species (ROS) were not required for cytotoxicity or IL-beta release in KIM5-infected macrophages. IL-1 beta secretion was reduced in the presence of cathepsin B inhibitors, suggesting that activation of caspase-1 requires cathepsin B activity. Ectopically-expressed YopP caused higher cytotoxicity and secretion of IL-1 beta in Y. pseudotuberculosis-infected macrophages than YopJ(KIM). Wild-type and congenic caspase 1 knockout C57BL/6 mice were equally susceptible to lethal infection with Y. pseudotuberculosis ectopically expressing YopP. These data suggest that YopJ-induced caspase-1 activation in Yersinia-infected macrophages is a downstream consequence of necrotic cell death and is dispensable for innate host resistance to a strain with enhanced cytotoxicity.	[Zheng, Ying] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zheng, Y (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	jbliska@ms.cc.sunysb.edu			Public Health Service [R56-AI043389, P01-AI055621]; Northeast Biodefense Center [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, R56AI043389, P01AI055621] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R56-AI043389, P01-AI055621 and the Northeast Biodefense Center U54-AI057158-Lipkin awarded to JBB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bergsbaken T, 2007, PLOS PATHOG, V3, P1570, DOI 10.1371/journal.ppat.0030161; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bortner CD, 2002, CELL DEATH DIFFER, V9, P1307, DOI 10.1038/sj.cdd.4401126; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Brodsky IE, 2010, CELL HOST MICROBE, V7, P376, DOI 10.1016/j.chom.2010.04.009; Brodsky IE, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000067; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Das R, 2007, GENES IMMUN, V8, P308, DOI 10.1038/sj.gene.6364389; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dockrell DH, 2001, J INFECTION, V42, P227, DOI 10.1053/jinf.2001.0836; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Fairbairn IP, 2004, BIOCHEM SOC T, V32, P496, DOI 10.1042/BST0320496; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Grobner S, 2007, APOPTOSIS, V12, P1813, DOI 10.1007/s10495-007-0100-x; Grobner S, 2007, INFECT IMMUN, V75, P512, DOI 10.1128/IAI.00756-06; Grobner S, 2006, APOPTOSIS, V11, P1959, DOI 10.1007/s10495-006-0189-3; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; JONAS D, 1994, INFECT IMMUN, V62, P1304, DOI 10.1128/IAI.62.4.1304-1312.1994; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Li HF, 2009, J IMMUNOL, V183, P1528, DOI 10.4049/jimmunol.0901080; Lilo S, 2008, INFECT IMMUN; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mittal R, 2010, J BIOL CHEM, V285, P19927, DOI 10.1074/jbc.M110.126581; Monack DM, 1997, P NATL ACAD SCI USA, V94, P10385, DOI 10.1073/pnas.94.19.10385; Mukherjee S, 2007, TRENDS BIOCHEM SCI, V32, P210, DOI 10.1016/j.tibs.2007.03.007; Navarre WW, 2000, CELL MICROBIOL, V2, P265, DOI 10.1046/j.1462-5822.2000.00056.x; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Porcelli SA, 2008, NAT IMMUNOL, V9, P1101, DOI 10.1038/ni1008-1101; Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003; Ruckdeschel K, 2002, J IMMUNOL, V168, P4601, DOI 10.4049/jimmunol.168.9.4601; Ruckdeschel K, 2004, J IMMUNOL, V173, P3320, DOI 10.4049/jimmunol.173.5.3320; Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x; Spinner JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009279; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305; Zauberman A, 2006, INFECT IMMUN, V74, P3239, DOI 10.1128/IAI.00097-06; Zauberman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005938; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhang Y, 2003, INFECT IMMUN, V71, P1513, DOI 10.1128/IAI.71.3.1513-1519.2003; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006; Zheng Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002026; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	85	31	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36019	10.1371/journal.pone.0036019	http://dx.doi.org/10.1371/journal.pone.0036019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563435	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100061
J	Ezoe, S; Morooka, T; Noda, T; Sabin, ML; Koike, S				Ezoe, Satoshi; Morooka, Takeo; Noda, Tatsuya; Sabin, Miriam Lewis; Koike, Soichi			Population Size Estimation of Men Who Have Sex with Men through the Network Scale-Up Method in Japan	PLOS ONE			English	Article							INTERNET; PEOPLE	Background: Men who have sex with men (MSM) are one of the groups most at risk for HIV infection in Japan. However, size estimates of MSM populations have not been conducted with sufficient frequency and rigor because of the difficulty, high cost and stigma associated with reaching such populations. This study examined an innovative and simple method for estimating the size of the MSM population in Japan. We combined an internet survey with the network scale-up method, a social network method for estimating the size of hard-to-reach populations, for the first time in Japan. Methods and Findings: An internet survey was conducted among 1,500 internet users who registered with a nationwide internet-research agency. The survey participants were asked how many members of particular groups with known population sizes (firepersons, police officers, and military personnel) they knew as acquaintances. The participants were also asked to identify the number of their acquaintances whom they understood to be MSM. Using these survey results with the network scale-up method, the personal network size and MSM population size were estimated. The personal network size was estimated to be 363.5 regardless of the sex of the acquaintances and 174.0 for only male acquaintances. The estimated MSM prevalence among the total male population in Japan was 0.0402% without adjustment, and 2.87% after adjusting for the transmission error of MSM. Conclusions: The estimated personal network size and MSM prevalence seen in this study were comparable to those from previous survey results based on the direct-estimation method. Estimating population sizes through combining an internet survey with the network scale-up method appeared to be an effective method from the perspectives of rapidity, simplicity, and low cost as compared with more-conventional methods.	[Ezoe, Satoshi; Sabin, Miriam Lewis] Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland; [Ezoe, Satoshi] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Tokyo, Japan; [Morooka, Takeo] Int Univ Hlth & Welf, Grad Sch, Dept Hlth Serv Management, Tokyo, Japan; [Noda, Tatsuya] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Hamamatsu, Shizuoka 4313192, Japan; [Koike, Soichi] Tokyo Univ Hosp, Dept Planning Informat & Management, Tokyo 113, Japan	UNAIDS; Juntendo University; International University of Health & Welfare; Hamamatsu University School of Medicine; University of Tokyo	Ezoe, S (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland.	ezoes@unaids.org		Noda, Tatsuya/0000-0002-3652-7547; Sabin, Miriam/0000-0002-7758-8338	Health and Labour Sciences Research Grants; Ministry of Health Labour and Welfare, Japan	Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health and Labour Sciences Research Grants (Research on HIV/AIDS), the Ministry of Health Labour and Welfare (http://www.mhlw.go.jp/english/), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; Eysenbach G, 2002, J MED INTERNET RES, V4, DOI 10.2196/jmir.4.2.e13; Fire and Disaster Management Agency, 2007, WHIT PAP FIR SERV; Hidaka Y, 2005, REACH ONLINE 2005 ST; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Kadushin C, 2006, J DRUG ISSUES, V36, P417, DOI 10.1177/002204260603600209; Kihara M, 1999, NATL SURVEY HIV STD; Killworth PD, 1998, EVALUATION REV, V22, P289, DOI 10.1177/0193841X9802200205; Killworth PD, 1998, SOC NETWORKS, V20, P23, DOI 10.1016/S0378-8733(96)00305-X; Mahy M, 2010, NETWORK SCALE UP PRO; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; McCormick TH, 2010, J AM STAT ASSOC, V105, P59, DOI 10.1198/jasa.2009.ap08518; Ministry of Defense, 2008, DEF JAP ANN WHIT PAP; Ministry of Internal Affairs and Communication, 2009, STAT TEL SERV US; Munakata T, 1993, Nihon Rinsho, V51 Suppl, P479; National Police Agency, 2008, WHIT PAP POL; Salganik MJ, 2011, SOC NETWORKS, V33, P70, DOI 10.1016/j.socnet.2010.10.006; Tsuji R, 2003, SOCIOL THEOR METHOD, V18, P15; UNAIDS, 2010, GETTING ZERO 2011 20; UNAIDS, 2010, REP UNAIDS HIV UNPUB; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS/WHO, 2010, WORK GROUP GLOB HIV; Yasunaga H, 2004, NIPPON KOSHU EISEI Z, V53, P40; Zheng T, 2006, J AM STAT ASSOC, V101, P409, DOI 10.1198/016214505000001168	25	47	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2012	7	1							e31184	10.1371/journal.pone.0031184	http://dx.doi.org/10.1371/journal.pone.0031184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	964KO	22563366	Green Published, gold			2022-12-27	WOS:000305693600001
J	Dowd, EC; Barch, DM				Dowd, Erin C.; Barch, Deanna M.			Pavlovian Reward Prediction and Receipt in Schizophrenia: Relationship to Anhedonia	PLOS ONE			English	Article							BASAL GANGLIA; SIGNIFICANT ACTIVATION; NEURAL RESPONSE; WORKING-MEMORY; EXPECTED VALUE; REPRESENTATIONS; DOPAMINE; SYMPTOMS; SALIENCE; CORTEX	Reward processing abnormalities have been implicated in the pathophysiology of negative symptoms such as anhedonia and avolition in schizophrenia. However, studies examining neural responses to reward anticipation and receipt have largely relied on instrumental tasks, which may confound reward processing abnormalities with deficits in response selection and execution. 25 chronic, medicated outpatients with schizophrenia and 20 healthy controls underwent functional magnetic resonance imaging using a Pavlovian reward prediction paradigm with no response requirements. Subjects passively viewed cues that predicted subsequent receipt of monetary reward or non-reward, and blood-oxygen-level-dependent signal was measured at the time of cue presentation and receipt. At the group level, neural responses to both reward anticipation and receipt were largely similar between groups. At the time of cue presentation, striatal anticipatory responses did not differ between patients and controls. Right anterior insula demonstrated greater activation for nonreward than reward cues in controls, and for reward than nonreward cues in patients. At the time of receipt, robust responses to receipt of reward vs. nonreward were seen in striatum, midbrain, and frontal cortex in both groups. Furthermore, both groups demonstrated responses to unexpected versus expected outcomes in cortical areas including bilateral dorsolateral prefrontal cortex. Individual difference analyses in patients revealed an association between physical anhedonia and activity in ventral striatum and ventromedial prefrontal cortex during anticipation of reward, in which greater anhedonia severity was associated with reduced activation to money versus no-money cues. In ventromedial prefrontal cortex, this relationship held among both controls and patients, suggesting a relationship between anticipatory activity and anhedonia irrespective of diagnosis. These findings suggest that in the absence of response requirements, brain responses to reward receipt are largely intact in medicated individuals with chronic schizophrenia, while reward anticipation responses in left ventral striatum are reduced in those patients with greater anhedonia severity.	[Dowd, Erin C.] Washington Univ, Neurosci Program, Div Biol & Biomed Sci, St Louis, MO 63130 USA; [Barch, Deanna M.] Washington Univ, Dept Psychol Psychiat & Radiol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Dowd, EC (corresponding author), Washington Univ, Neurosci Program, Div Biol & Biomed Sci, St Louis, MO 63130 USA.	dowde@wusm.wustl.edu	Barch, Deanna M/G-8638-2013		National Institute of Mental Health [MH071616]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616, R01MH066031] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by National Institute of Mental Health grant MH071616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Andreasen N.C., 1983, SCALE ASSESSMENT POS; ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Andreasen NC, 1983, SCALE ASSESSMENT NEG; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Barch DM, 2010, SCHIZOPHRENIA BULL, V36, P919, DOI 10.1093/schbul/sbq068; Barch DM, 2002, J ABNORM PSYCHOL, V111, P478, DOI 10.1037//0021-843X.111.3.478; Beck SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009251; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Chapman L. J., 1978, REVISED PHYS A UNPUB; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Dowd EC, 2010, BIOL PSYCHIAT, V67, P902, DOI 10.1016/j.biopsych.2009.10.020; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; ERLENMEYERKIMLING L, 1993, SCHIZOPHRENIA BULL, V19, P141, DOI 10.1093/schbul/19.1.141; First MB, 2001, STRUCTURED CLIN INTE; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1994, HUM BRAIN MAPP, V2, P1; Gardner DM, 2010, AM J PSYCHIAT, V167, P686, DOI 10.1176/appi.ajp.2009.09060802; Gold JM, 2008, SCHIZOPHRENIA BULL, V34, P835, DOI 10.1093/schbul/sbn068; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Guillin O, 2007, INT REV NEUROBIOL, V78, P1, DOI 10.1016/S0074-7742(06)78001-1; Harvey PO, 2010, J PSYCHIATR RES, V44, P707, DOI 10.1016/j.jpsychires.2009.12.008; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; Horan WP, 2011, SCHIZOPHR RES, V132, P140, DOI 10.1016/j.schres.2011.06.030; Horan WP, 2006, SCHIZOPHRENIA BULL, V32, P259, DOI 10.1093/schbul/sbj009; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Juckel G, 2006, NEUROIMAGE, V29, P409, DOI 10.1016/j.neuroimage.2005.07.051; Juckel G, 2006, PSYCHOPHARMACOLOGY, V187, P222, DOI 10.1007/s00213-006-0405-4; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koch K, 2010, NEUROIMAGE, V50, P223, DOI 10.1016/j.neuroimage.2009.12.031; Kring AM, 2008, SCHIZOPHRENIA BULL, V34, P819, DOI 10.1093/schbul/sbn071; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Morris RW, 2012, MOL PSYCHIATR, V17, P235, DOI [10.1038/mp.2012.1, 10.1038/mp.2011.75]; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schultz W, 2001, NEUROSCIENTIST, V7, P293, DOI 10.1177/107385840100700406; Simon JJ, 2010, SCHIZOPHR RES, V118, P154, DOI 10.1016/j.schres.2009.11.007; Snyder A.Z., 1996, QUANTIFICATION BRAIN; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Walter H, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/neuro.08.062.2009; Walter H, 2009, PSYCHOPHARMACOLOGY, V206, P121, DOI 10.1007/s00213-009-1586-4; Waltz JA, 2010, NEUROPSYCHOPHARMACOL, V35, P2427, DOI 10.1038/npp.2010.126; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576; Ziauddeen H, 2010, CURR OPIN PSYCHIATR, V23, P91, DOI 10.1097/YCO.0b013e328336661b	67	105	106	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35622	10.1371/journal.pone.0035622	http://dx.doi.org/10.1371/journal.pone.0035622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WV	22574121	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800017
J	Feng, L; Gao, L; Lu, HW; Muller, R				Feng, Lin; Gao, Li; Lu, Hongwang; Mueller, Rolf			Noseleaf Dynamics during Pulse Emission in Horseshoe Bats	PLOS ONE			English	Article								Horseshoe bats emit their biosonar pulses nasally and diffract the outgoing ultrasonic waves by conspicuous structures that surrounded the nostrils. Here, we report quantitative experimental data on the motion of a prominent component of these structures, the anterior leaf, using synchronized laser Doppler vibrometry and acoustic recordings in the greater horseshoe bat (Rhinolophus ferrumequinum). The vibrometry data has demonstrated non-random motion patterns in the anterior leaf. In these patterns, the outer rim of the walls of the anterior leaf twitches forward and inwards to decrease the aperture of the noseleaf and increase the curvature of its surfaces. Noseleaf displacements were correlated with the emitted ultrasonic pulses. After their onset, the inward displacements increased monotonically towards their maximum value which was always reached within the duration of the biosonar pulse, typically towards its end. In other words, the anterior leaf's surfaces were moving inwards during most of the pulse. Non-random motions were not present in all recorded pulse trains, but could apparently be switched on or off. Such switches happened between sequences of consecutive pulses but were never observed between individual pulses within a sequence. The amplitudes of the emitted biosonar pulse and accompanying noseleaf movement were not correlated in the analyzed data set. The measured velocities of the noseleaf surface were too small to induce Doppler shifts of a magnitude with a likely significance. However, the displacement amplitudes were significant in comparison with the overall size of the anterior leaf and the sound wavelengths. These results indicate the possibility that horseshoe bats use dynamic sensing principles on the emission side of their biosonar system. Given the already available evidence that such mechanisms exist for biosonar reception, it may be hypothesized that time-variant mechanisms play a pervasive role in the biosonar sensing of horseshoe bats.	[Feng, Lin; Gao, Li; Lu, Hongwang; Mueller, Rolf] Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China; [Mueller, Rolf] Virginia Tech, Dept Mech Engn, Danville, VA USA	Shandong University; Virginia Polytechnic Institute & State University	Feng, L (corresponding author), Shandong Univ, Sch Phys, SDU VT Int Lab, Jinan, Shandong, Peoples R China.	rolf.mueller@vt.edu			National Natural Science Foundation of China [11074149]; China Postdoctoral Science Foundation; Shandong Taishan Fund; Foundation for Young Scientists in Shandong Province [BS2011DX021]; Independent Innovation Foundation of Shandong University [2010HW005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong Taishan Fund; Foundation for Young Scientists in Shandong Province; Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (grant no: 11074149, http://www.nsfc.gov.cn), the China Postdoctoral Science Foundation, the Shandong Taishan Fund, the Foundation for Young Scientists in Shandong Province (grant no. BS2011DX021) and the Independent Innovation Foundation of Shandong University (grant no. 2010HW005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csorba C, 2003, HORSESHOE BATS WORLD; Gao L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.214301; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Koopman K. F., 1994, CHIROPTERA SYSTEMATI; Kuc R, 2010, J ACOUST SOC AM, V128, P3190, DOI 10.1121/1.3488304; Metzner W, 2010, HBK BEHAV NEUROSCI, V19, P403, DOI 10.1016/B978-0-12-374593-4.00037-1; Muller R, 2010, J ACOUST SOC AM, V128, P1414, DOI 10.1121/1.3365246; Muller R, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108701; OBRIST MK, 1993, J EXP BIOL, V180, P119; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; SCHULLER G, 1979, J COMP PHYSIOL, V132, P47, DOI 10.1007/BF00617731; Zhang ZW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038701; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701; Zhuang Q, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051902	14	34	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34685	10.1371/journal.pone.0034685	http://dx.doi.org/10.1371/journal.pone.0034685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574110	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800006
J	Jiang, HW; Wu, PZ; Zhang, S; Song, C; Chen, YP; Li, MR; Jia, YX; Fang, XH; Chen, F; Wu, GJ				Jiang, Huawu; Wu, Pingzhi; Zhang, Sheng; Song, Chi; Chen, Yaping; Li, Meiru; Jia, Yongxia; Fang, Xiaohua; Chen, Fan; Wu, Guojiang			Global Analysis of Gene Expression Profiles in Developing Physic Nut (Jatropha curcas L.) Seeds	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; PENTOSE-PHOSPHATE PATHWAYS; BRASSICA-NAPUS; SEQUENCE TAGS; TRANSCRIPTOME ANALYSIS; REVEALS DIFFERENCES; DEVELOPING EMBRYOS; PLASTID ENVELOPE; METABOLIC FLUXES; OIL ACCUMULATION	Background: Physic nut (Jatropha curcas L.) is an oilseed plant species with high potential utility as a biofuel. Furthermore, following recent sequencing of its genome and the availability of expressed sequence tag (EST) libraries, it is a valuable model plant for studying carbon assimilation in endosperms of oilseed plants. There have been several transcriptomic analyses of developing physic nut seeds using ESTs, but they have provided limited information on the accumulation of stored resources in the seeds. Methodology/Principal Findings: We applied next-generation Illumina sequencing technology to analyze global gene expression profiles of developing physic nut seeds 14, 19, 25, 29, 35, 41, and 45 days after pollination (DAP). The acquired profiles reveal the key genes, and their expression timeframes, involved in major metabolic processes including: carbon flow, starch metabolism, and synthesis of storage lipids and proteins in the developing seeds. The main period of storage reserves synthesis in the seeds appears to be 29-41 DAP, and the fatty acid composition of the developing seeds is consistent with relative expression levels of different isoforms of acyl-ACP thioesterase and fatty acid desaturase genes. Several transcription factor genes whose expression coincides with storage reserve deposition correspond to those known to regulate the process in Arabidopsis. Conclusions/Significance: The results will facilitate searches for genes that influence de novo lipid synthesis, accumulation and their regulatory networks in developing physic nut seeds, and other oil seeds. Thus, they will be helpful in attempts to modify these plants for efficient biofuel production.	[Jiang, Huawu; Wu, Pingzhi; Zhang, Sheng; Chen, Yaping; Li, Meiru; Jia, Yongxia; Wu, Guojiang] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Zhang, Sheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Song, Chi] BGI Shenzhen, Shenzhen, Peoples R China; [Fang, Xiaohua; Chen, Fan] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Jiang, HW (corresponding author), Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	fchen@genetics.ac.cn; wugj@scbg.ac.cn		Chen, Fan/0000-0003-4482-3116; ZHANG, SHENG/0000-0003-0843-0622	National Basic Research Program of China (973 Program) [2010CB126603]; NSFC-Guangdong Joint Fund of Natural Sciences [U0733005]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); NSFC-Guangdong Joint Fund of Natural Sciences(National Natural Science Foundation of China (NSFC))	The research work was supported by grants from the National Basic Research Program of China (973 Program) (2010CB126603) (http://www.973.gov.cn/) and the NSFC-Guangdong Joint Fund of Natural Sciences (U0733005) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten WMJ, 2007, BIOFUEL BIOPROD BIOR, V1, P283, DOI 10.1002/bbb.39; Alonso AP, 2007, PLANT J, V52, P296, DOI 10.1111/j.1365-313X.2007.03235.x; Andriotis VME, 2010, PLANT J, V64, P128, DOI 10.1111/j.1365-313X.2010.04313.x; ARONDEL V, 1992, SCIENCE, V258, P1353, DOI 10.1126/science.1455229; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bensmihen S, 2005, J EXP BOT, V56, P597, DOI 10.1093/jxb/eri050; Bocock PN, 2008, PLANTA, V227, P565, DOI 10.1007/s00425-007-0639-3; Buttner M, 2007, FEBS LETT, V581, P2318, DOI 10.1016/j.febslet.2007.03.016; Carles C, 2002, PLANT J, V30, P373, DOI 10.1046/j.1365-313X.2002.01295.x; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen GQ, 2007, LIPIDS, V42, P263, DOI 10.1007/s11745-007-3022-z; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; daSilva PMFR, 1997, PLANTA, V203, P480, DOI 10.1007/s004250050217; Debnath M, 2008, CURR PHARM BIOTECHNO, V9, P288, DOI 10.2174/138920108785161541; DENNIS DT, 1982, ANNU REV PLANT PHYS, V33, P27, DOI 10.1146/annurev.pp.33.060182.000331; Eicks M, 2002, PLANT PHYSIOL, V128, P512, DOI 10.1104/pp.010576; Emes MJ, 2003, J EXP BOT, V54, P569, DOI 10.1093/jxb/erg089; FALES FW, 1951, J BIOL CHEM, V193, P113; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fischer K, 2002, TRENDS PLANT SCI, V7, P345, DOI 10.1016/S1360-1385(02)02291-4; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Gubitz GM, 1999, BIORESOURCE TECHNOL, V67, P73, DOI 10.1016/S0960-8524(99)00069-3; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; KANG F, 1994, PLANT J, V6, P795, DOI 10.1046/j.1365-313X.1994.6060795.x; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; King AJ, 2009, J EXP BOT, V60, P2897, DOI 10.1093/jxb/erp025; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; KNUTZON DS, 1992, PLANT PHYSIOL, V100, P1751, DOI 10.1104/pp.100.4.1751; Krishnakumar J, 2008, THERM SCI, V12, P159, DOI 10.2298/TSCI0802159K; KUNST L, 1992, PLANT PHYSIOL BIOCH, V30, P425; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Li FP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-168; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Li-Beisson Y., 2010, ACYL LIPID METABOLIS; Lu CF, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-42; Luerssen K, 1998, PLANT J, V15, P755, DOI 10.1046/j.1365-313X.1998.00259.x; Makkar HPS, 1998, PLANT FOOD HUM NUTR, V52, P31, DOI 10.1023/A:1008054010079; Makkar HPS, 1998, FOOD CHEM, V62, P207, DOI 10.1016/S0308-8146(97)00183-0; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Monke G, 2004, PLANTA, V219, P158, DOI 10.1007/s00425-004-1206-9; Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Niu Y, 2009, MOL PLANT, V2, P1107, DOI 10.1093/mp/ssp042; NORTON G, 1975, PLANTA, V123, P163, DOI 10.1007/BF00383865; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; PARCY F, 1994, PLANT CELL, V6, P1567, DOI 10.1105/tpc.6.11.1567; Parcy F, 1997, PLANT CELL, V9, P1265, DOI 10.1105/tpc.9.8.1265; Penfield S, 2006, PLANT CELL, V18, P1887, DOI 10.1105/tpc.106.041277; Periappuram C, 2000, PLANT PHYSIOL, V122, P1193, DOI 10.1104/pp.122.4.1193; Prabhakar V, 2010, PLANT CELL, V22, P2594, DOI 10.1105/tpc.109.073171; Rawsthorne S, 2002, PROG LIPID RES, V41, P182, DOI 10.1016/S0163-7827(01)00023-6; Reich M, 2004, BIOINFORMATICS, V20, P1797, DOI 10.1093/bioinformatics/bth138; Reiser J, 2004, PLANT PHYSIOL, V136, P3524, DOI 10.1104/pp.104.049502; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Sarin R, 2007, FUEL, V86, P1365, DOI 10.1016/j.fuel.2006.11.040; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; SCHUNEMANN D, 1993, PLANT PHYSIOL, V103, P131, DOI 10.1104/pp.103.1.131; Sherson SM, 2003, J EXP BOT, V54, P525, DOI 10.1093/jxb/erg055; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; SIMCOX PD, 1977, PLANT PHYSIOL, V59, P1128, DOI 10.1104/pp.59.6.1128; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Sriram G, 2004, PLANT PHYSIOL, V136, P3043, DOI 10.1104/pp.104.050625; Troncoso-Ponce MA, 2011, PLANT J, V68, P1014, DOI 10.1111/j.1365-313X.2011.04751.x; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Vigeolas H, 2004, PLANT PHYSIOL, V136, P2676, DOI 10.1104/pp.104.046854; Voelker TA, 1997, PLANT PHYSIOL, V114, P669, DOI 10.1104/pp.114.2.669; Wakao S, 2008, PLANT PHYSIOL, V146, P277, DOI 10.1104/pp.107.108423; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weber APM, 2011, ANNU REV PLANT BIOL, V62, P53, DOI 10.1146/annurev-arplant-042110-103903; Weber APM, 2005, ANNU REV PLANT BIOL, V56, P133, DOI 10.1146/annurev.arplant.56.032604.144228; White JA, 2000, PLANT PHYSIOL, V124, P1582, DOI 10.1104/pp.124.4.1582; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Wu PZ, 2009, TREE PHYSIOL, V29, P1299, DOI 10.1093/treephys/tpp054; Xu RH, 2011, BIOMASS BIOENERG, V35, P1683, DOI 10.1016/j.biombioe.2011.01.001; Yang Y, 2011, PLANT PHYSIOL, V156, P873, DOI 10.1104/pp.111.175950	84	62	71	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36522	10.1371/journal.pone.0036522	http://dx.doi.org/10.1371/journal.pone.0036522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574177	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800074
J	Beucher, A; Gjernes, E; Collin, C; Courtney, M; Meunier, A; Collombat, P; Gradwohl, G				Beucher, Anthony; Gjernes, Elisabet; Collin, Caitlin; Courtney, Monica; Meunier, Aline; Collombat, Patrick; Gradwohl, Gerard			The Homeodomain-Containing Transcription Factors Arx and Pax4 Control Enteroendocrine Subtype Specification in Mice	PLOS ONE			English	Article							CELL FATE SPECIFICATION; PANCREATIC-ISLET CELLS; BETA-CELLS; ENDOCRINE PANCREAS; GASTROINTESTINAL-TRACT; GLUCOSE-HOMEOSTASIS; ABNORMAL GENITALIA; GENE-EXPRESSION; GUT HORMONES; ALPHA-CELL	Intestinal hormones are key regulators of digestion and energy homeostasis secreted by rare enteroendocrine cells. These cells produce over ten different hormones including GLP-1 and GIP peptides known to promote insulin secretion. To date, the molecular mechanisms controlling the specification of the various enteroendocrine subtypes from multipotent Neurog3(+) endocrine progenitor cells, as well as their number, remain largely unknown. In contrast, in the embryonic pancreas, the opposite activities of Arx and Pax4 homeodomain transcription factors promote islet progenitor cells towards the different endocrine cell fates. In this study, we thus investigated the role of Arx and Pax4 in enteroendocrine subtype specification. The small intestine and colon of Arx-and Pax4-deficient mice were analyzed using histological, molecular, and lineage tracing approaches. We show that Arx is expressed in endocrine progenitors (Neurog3(+)) and in early differentiating (ChromograninA(-)) GLP-1-, GIP-, CCK-, Sct-Gastrin- and Ghrelin-producing cells. We noted a dramatic reduction or a complete loss of all these enteroendocrine cell types in Arx mutants. Serotonin- and Somatostatin-secreting cells do not express Arx and, accordingly, the differentiation of Serotonin cells was not affected in Arx mutants. However, the number of Somatostatin-expressing D-cells is increased as Arx-deficient progenitor cells are redirected to the D-cell lineage. In Pax4-deficient mice, the differentiation of Serotonin and Somatostatin cells is impaired, as well as of GIP and Gastrin cells. In contrast, the number of GLP-1 producing L-cells is increased concomitantly with an upregulation of Arx. Thus, while Arx and Pax4 are necessary for the development of Land D-cells respectively, they conversely restrict D- and L-cells fates suggesting antagonistic functions in D/L cell allocation. In conclusion, these finding demonstrate that, downstream of Neurog3, the specification of a subset of enteroendocrine subtypes relies on both Arx and Pax4, while others depend only on Arx or Pax4.	[Beucher, Anthony; Collin, Caitlin; Meunier, Aline; Gradwohl, Gerard] Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, Illkirch Graffenstaden, France; [Gjernes, Elisabet; Courtney, Monica; Collombat, Patrick] INSERM UMR 636, Diabet Genet Team, Nice, France; [Gjernes, Elisabet; Courtney, Monica; Collombat, Patrick] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Beucher, A (corresponding author), Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, Illkirch Graffenstaden, France.	gradwohl@igbmc.fr	Collin, Caitlin/H-9315-2012; collombat, patrick/P-3741-2019; Gradwohl, Gérard/AFM-9024-2022; collombat, patrick/F-4495-2015; Gradwohl, Gérard/H-8543-2014	collombat, patrick/0000-0001-8232-1438; Gradwohl, Gérard/0000-0002-6730-2615; collombat, patrick/0000-0001-8232-1438; Gradwohl, Gérard/0000-0002-6730-2615; Beucher, Anthony/0000-0003-4489-1848; Meunier, Aline/0000-0003-3594-168X	Institut National de la Sante et de la Recherche Medicale (INSERM); Agence Nationale de la Recherche (ANR); Juvenile Diabetes Research foundation (JDRF); European Research Council (ERC); Fondation pour la Recherche Medicale (FRM); Association Francaise des Diabetiques (AFD); Fondation Schlumberger pour l'Education et la Recherche; Mr. and Mrs. Olivier Dorato	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Juvenile Diabetes Research foundation (JDRF)(Juvenile Diabetes Research Foundation); European Research Council (ERC)(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association Francaise des Diabetiques (AFD); Fondation Schlumberger pour l'Education et la Recherche; Mr. and Mrs. Olivier Dorato	The authors are supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Agence Nationale de la Recherche (ANR), the Juvenile Diabetes Research foundation (JDRF), the European Research Council (ERC), the Fondation pour la Recherche Medicale (FRM), the Association Francaise des Diabetiques (AFD), Mr. and Mrs. Olivier Dorato and the Fondation Schlumberger pour l'Education et la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen C, 2009, AM J PHYSIOL-GASTR L, V297, pG1126, DOI 10.1152/ajpgi.90586.2008; Collombat P, 2005, DEVELOPMENT, V132, P2969, DOI 10.1242/dev.01870; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Desai S, 2008, DEV BIOL, V313, P58, DOI 10.1016/j.ydbio.2007.09.047; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Gauthier BR, 2002, MOL ENDOCRINOL, V16, P170, DOI 10.1210/me.16.1.170; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Heller RS, 2005, DEV BIOL, V286, P217, DOI 10.1016/j.ydbio.2005.06.041; Hill JT, 2010, MOL ENDOCRINOL, V24, P381, DOI 10.1210/me.2009-0360; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Larsson LI, 1998, MECH DEVELOP, V79, P153, DOI 10.1016/S0925-4773(98)00182-8; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; LEONARD J, 1992, P NATL ACAD SCI USA, V89, P6247, DOI 10.1073/pnas.89.14.6247; Mellitzer G, 2010, J CLIN INVEST, V120, P1708, DOI 10.1172/JCI40794; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nanba Yukiko, 2007, No To Hattatsu, V39, P379; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; RINDI G, 1990, AM J PATHOL, V136, P1349; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Ye DZ, 2009, GASTROENTEROLOGY, V137, P2052, DOI 10.1053/j.gastro.2009.08.059	34	60	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36449	10.1371/journal.pone.0036449	http://dx.doi.org/10.1371/journal.pone.0036449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570716	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400032
J	Henderson, M; Clark, C; Stansfeld, S; Hotopf, M				Henderson, Max; Clark, Charlotte; Stansfeld, Stephen; Hotopf, Matthew			A Lifecourse Approach to Long-Term Sickness Absence-A Cohort Study	PLOS ONE			English	Article							PSYCHOSOCIAL WORK CHARACTERISTICS; LOW-BACK-PAIN; PSYCHOLOGICAL DISTRESS; DISABILITY PENSION; RISK-FACTORS; FOLLOW-UP; HEALTH; LEAVE; PREDICTORS; CHILDHOOD	Background: Most research on long-term sickness absence has focussed on exposure to occupational psychosocial risk factors such as low decision latitude. These provide an incomplete explanation as they do not account for other relevant factors. Such occupational risk factors may be confounded by social or temperamental risk factors earlier in life. Methods: We analysed data from the 1958 British Birth Cohort. Long-term sickness absence was defined as receipt of Incapacity Benefit/Severe Disablement Allowance at age 42. In those in employment aged 33 we examined the effects of psychological distress, musculoskeletal symptoms, and low decision latitude. These were then adjusted for IQ, educational attainment, and the presence of early life somatic and neurotic symptoms. Results: Low decision latitude predicted subsequent long-term absence, and this association remained, albeit reduced, following adjustment for psychological distress and musculoskeletal symptoms at age 33. Low decision latitude was no longer associated with long-term absence when IQ and educational attainment were included. Adjusting for early life somatic and neurotic symptoms had little impact. Discussion: A greater understanding of the ways in which occupational risk factors interact with individual vulnerabilities across the life-course is required. Self reported low decision latitude might reflect the impact of education and cognitive ability on how threat, and the ability to manage threat, is perceived, rather than being an independent risk factor for long-term sick leave. This has implications for policy aimed at reducing long-term sick leave.	[Henderson, Max; Hotopf, Matthew] Kings Coll London, Dept Psychol Med, Inst Psychiat, London WC2R 2LS, England; [Clark, Charlotte; Stansfeld, Stephen] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Psychiat, Wolfson Inst Prevent Med, London, England	University of London; King's College London; University of London; Queen Mary University London	Henderson, M (corresponding author), Kings Coll London, Dept Psychol Med, Inst Psychiat, London WC2R 2LS, England.	max.j.henderson@kcl.ac.uk	Hotopf, Matthew/E-4971-2010	Hotopf, Matthew/0000-0002-3980-4466; Clark, Charlotte/0000-0003-3031-4986	Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); Guys and St Thomas' Charity; South London and Maudsley Trustees; Engineering and Physical Sciences Research Council Fellowship; NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust; Institute of Psychiatry, King's College London; MRC [G1001799, G106/1252] Funding Source: UKRI; Medical Research Council [G106/1252, G1001799] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Guys and St Thomas' Charity; South London and Maudsley Trustees; Engineering and Physical Sciences Research Council Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust; Institute of Psychiatry, King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Henderson received support from a Medical Research Council Research Training Fellowship in Health Services and Health of the Public Research. He is now supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) Nucleus jointly funded by the Guys and St Thomas' Charity and the South London and Maudsley Trustees. Dr. Clark received support from an Engineering and Physical Sciences Research Council Fellowship. Professor Hotopf is supported by the NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley National Health Service (NHS) Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlind I, 1996, SCAND J SOC MED, V24, P27, DOI 10.1177/140349489602400105; Alexanderson K, 2004, SCAND J PUBLIC HEALT, V32, P12, DOI 10.1080/14034950410021808; [Anonymous], COMMUNICATION; BARSKY AJ, 1988, NEW ENGL J MED, V318, P414, DOI 10.1056/NEJM198802183180705; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Boot CRL, 2005, INT ARCH OCC ENV HEA, V78, P633, DOI 10.1007/s00420-005-0004-4; Bultmann U, 2005, J OCCUP ENVIRON MED, V47, P941; Cattrell A, 2011, OCCUP MED-OXFORD, V61, P148, DOI 10.1093/occmed/kqr008; CBI, 2010, PATH RECOVERY ABSENC; Cheung SY, 1997, J CHILD PSYCHOL PSYC, V38, P575, DOI 10.1111/j.1469-7610.1997.tb01544.x; Coggon D, 2005, OCCUP ENVIRON MED, V62, P281, DOI 10.1136/oem.2004.017335; Culpin M, 1930, NERVOUS TEMPERAMENT; de Lange AH, 2002, SCAND J WORK ENV HEA, V28, P94, DOI 10.5271/sjweh.653; Department for Work and Pensions, 2004, PATHW WORK HELP PEOP; Department for Work and Pensions, 2010, COAL OUR PROGR GOVT; Department for Work and Pensions, 2007, WORK BETT NEXT STEPS; Douglas James W.B, 1964, HOME SCH; Duijts SFA, 2007, J CLIN EPIDEMIOL, V60, P1105, DOI 10.1016/j.jclinepi.2007.04.008; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fleten N, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-46; Fritz JM, 2001, PAIN, V94, P7, DOI 10.1016/S0304-3959(01)00333-5; Gheldof ELM, 2005, PAIN, V113, P71, DOI 10.1016/j.pain.2004.09.040; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Hagen EM, 2005, SPINE, V30, P2717, DOI 10.1097/01.brs.0000190394.05359.c7; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Harvey S.B., 2009, PSYCHIATRY, V8, P174, DOI [10.1016/j.mppsy.2009.03.011, DOI 10.1016/J.MPPSY.2009.03.011, DOI 10.1016/j.mppsy.2009.03.011]; Head J, 2006, J EPIDEMIOL COMMUN H, V60, P55, DOI 10.1136/jech.2005.038752; Health and Safety Executive, 2005, TACKL STRESS MAN STA; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Henderson M, 2012, BMJ OPEN, V2; Henderson M, 2009, BRIT J PSYCHIAT, V194, P220, DOI 10.1192/bjp.bp.107.044271; Iennaco JD, 2010, AM J EPIDEMIOL, V171, P303, DOI 10.1093/aje/kwp359; Ijzelenberg W, 2005, SPINE, V30, P1550, DOI 10.1097/01.brs.0000167533.83154.28; IJzelenberg W, 2004, SCAND J WORK ENV HEA, V30, P56, DOI 10.5271/sjweh.765; Jobcentre Plus, 2007, GUID DIS PEOPL THOSE; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Knudsen AK, 2010, J PSYCHOSOM RES, V69, P59, DOI 10.1016/j.jpsychores.2010.03.007; LINDSTROM I, 1994, SPINE, V19, P888, DOI 10.1097/00007632-199404150-00004; Lucire Y, 2001, CONSTRUCTING RSI BEL; Matthews S, 1998, SOC SCI MED, V46, P1417, DOI 10.1016/S0277-9536(97)10141-1; Matthews S, 2001, PSYCHOL MED, V31, P725, DOI 10.1017/S0033291701003683; OECD, 2003, TRANSF DIS AB POL PR; OECD, 2006, SICKN DIS WORK ORGAN; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Rehkopf DH, 2010, SCAND J WORK ENV HEA, V36, P449, DOI 10.5271/sjweh.3081; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Rubin DB, 2004, MULTIPLE IMPUTATION; Rutter M L, 1970, J R Coll Physicians Lond, V4, P211; Schnyder U, 2003, AM J PSYCHIAT, V160, P2025, DOI 10.1176/appi.ajp.160.11.2025; Severeijns R, 2004, HEALTH PSYCHOL, V23, P49, DOI 10.1037/0278-6133.23.1.49; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Stansfeld S, 2002, BRIT J PSYCHIAT, V181, P96; Stansfeld SA, 1997, J PSYCHOSOM RES, V43, P73, DOI 10.1016/S0022-3999(97)00001-9; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Taimela S, 2008, OCCUP ENVIRON MED, V65, P236, DOI 10.1136/oem.2007.032706; Theorell T, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e9; Upmark M, 2001, SCAND J PUBLIC HEALT, V29, P96, DOI 10.1177/14034948010290020601; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Virtanen M, 2008, AM J PSYCHIAT, V165, P1482, DOI 10.1176/appi.ajp.2008.07121929; Voss M, 2001, OCCUP ENVIRON MED, V58, P178, DOI 10.1136/oem.58.3.178; Waddell G., 2006, WORK GOOD YOUR HLTH; Waddell G, 2002, BACK PAIN INCAPACITY; Waddell Gordon, 2007, J Insur Med, V39, P109	67	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36645	10.1371/journal.pone.0036645	http://dx.doi.org/10.1371/journal.pone.0036645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VF	22570734	gold, Green Published			2022-12-27	WOS:000305343400050
J	Ayub, MJ; Nyambega, B; Simonetti, L; Duffy, T; Longhi, SA; Gomez, KA; Hoebeke, J; Levin, MJ; Smulski, CR				Juri Ayub, Maximiliano; Nyambega, Benson; Simonetti, Leandro; Duffy, Tomas; Longhi, Silvia A.; Gomez, Karina A.; Hoebeke, Johan; Levin, Mariano J.; Smulski, Cristian R.			Selective Blockade of Trypanosomatid Protein Synthesis by a Recombinant Antibody Anti-Trypanosoma cruzi P2 beta Protein	PLOS ONE			English	Article							RIBOSOMAL-P PROTEINS; MONOCLONAL-ANTIBODY; BLOOD-STREAM; AUTOANTIBODIES; INTRABODIES; INHIBITION; EXPRESSION; ALIGNMENT; COMPLEX; BINDING	The ribosomal P proteins are located on the stalk of the ribosomal large subunit and play a critical role during the elongation step of protein synthesis. The single chain recombinant antibody C5 (scFv C5) directed against the C-terminal region of the Trypanosoma cruzi P2 beta protein (TcP2 beta) recognizes the conserved C-terminal end of all T. cruzi ribosomal P proteins. Although this region is highly conserved among different species, surface plasmon resonance analysis showed that the scFv C5 possesses very low affinity for the corresponding mammalian epitope, despite having only one single amino-acid change. Crystallographic analysis, in silico modelization and NMR assays support the analysis, increasing our understanding on the structural basis of epitope specificity. In vitro protein synthesis experiments showed that scFv C5 was able to specifically block translation by T. cruzi and Crithidia fasciculata ribosomes, but virtually had no effect on Rattus norvegicus ribosomes. Therefore, we used the scFv C5 coding sequence to make inducible intrabodies in Trypanosoma brucei. Transgenic parasites showed a strong decrease in their growth rate after induction. These results strengthen the importance of the P protein C terminal regions for ribosomal translation activity and suggest that trypanosomatid ribosomal P proteins could be a possible target for selective therapeutic agents that could be derived from structural analysis of the scFv C5 antibody paratope.	[Juri Ayub, Maximiliano; Nyambega, Benson; Simonetti, Leandro; Duffy, Tomas; Longhi, Silvia A.; Gomez, Karina A.; Levin, Mariano J.; Smulski, Cristian R.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina; [Juri Ayub, Maximiliano] Univ Nacl San Luis, Consejo Nacl Invest Cient & Tecn, Inst Multidisciplinario Invest Biol San Luis, San Luis, Argentina; [Nyambega, Benson] Maseno Univ, Dept Med Biochem, Kisumu, Kenya; [Nyambega, Benson] Heidelberg Univ, Zentrum Mol Biol, D-6900 Heidelberg, Germany; [Hoebeke, Johan; Smulski, Cristian R.] IBMC, Immunol & Chim Therapeut UPR 9021, Strasbourg, France	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis; Maseno University; Ruprecht Karls University Heidelberg	Ayub, MJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Lab Biol Mol Enfermedad Chagas, Buenos Aires, DF, Argentina.	CristianRoberto.Smulski@unil.ch	Duffy, Tomas/S-6045-2017; Nyambega, Benson/GOH-3417-2022	Nyambega, Benson/0000-0002-0947-0354; Gomez, Karina Andrea/0000-0001-8115-667X; Simonetti, Leandro/0000-0003-1283-9770; Smulski, Cristian/0000-0003-4186-8116; Juri Ayub, Maximiliano/0000-0002-5787-0993	World Health Organization/Special Program for Research and Training in Tropical Diseases; Universidad de Buenos Aires; Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia; National Agency of Scientific and Technological Promotion [FONCYT BID 1201/OC-AR 01-14389]; ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine); CONICET	World Health Organization/Special Program for Research and Training in Tropical Diseases(World Health Organization); Universidad de Buenos Aires(University of Buenos Aires); Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia; National Agency of Scientific and Technological Promotion(ANPCyT); ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research has been initially supported by grants from the World Health Organization/Special Program for Research and Training in Tropical Diseases, Universidad de Buenos Aires, Ministerio de Salud y Accion Social-Beca Ramon Carrillo-Arturo Onativia, and the National Agency of Scientific and Technological Promotion (FONCYT BID 1201/OC-AR 01-14389). Support of ECOS-SECyT project "Anticorps anti-proteines ribosomales P de T. cruzi comme inhibiteur specifique de la traduction" (France-Argentine, 2005-2008) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sylviane Muller and Prof. Sylvie Fournel (UPR 9021 Strasbourg, France) for helpful collaboration in the publication of this article as well as Dr. I. D. Algranati for his advice about in vitro translation experiments and helpful discussions about the manuscript. We sincerely thank Prof. Dr. Christine Clayton (ZMBH, Heidelberg, Germany) for facilitating the expressions in T. brucei. M.J.A., S. A. L. and K. A. G. are members of scientific career of CONICET. L. S. and T. D. have fellowships from CONICET.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayub MJ, 2008, EXP PARASITOL, V118, P442, DOI 10.1016/j.exppara.2007.09.002; Ayub MJ, 2005, GENE, V357, P129, DOI 10.1016/j.gene.2005.06.006; BaileySerres J, 1997, PLANT PHYSIOL, V114, P1293, DOI 10.1104/pp.114.4.1293; Ballesta JPG, 1999, FEMS MICROBIOL REV, V23, P537, DOI 10.1111/j.1574-6976.1999.tb00412.x; Bargis-Surgey P, 1999, EUR J BIOCHEM, V262, P606, DOI 10.1046/j.1432-1327.1999.00434.x; Berezov A, 2003, IMMUNOL RES, V27, P303, DOI 10.1385/IR:27:2-3:303; Bergami PL, 2003, BIOCHEM BIOPH RES CO, V301, P819, DOI 10.1016/S0006-291X(02)03074-4; Bergami PL, 2001, FASEB J, V15, P2602, DOI 10.1096/fj.01-0132com; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Boldicke T, 2005, J IMMUNOL METHODS, V300, P146, DOI 10.1016/j.jim.2005.03.007; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Gonzalo P, 2003, BIOL CELL, V95, P179, DOI 10.1016/S0248-4900(03)00034-0; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAVERGNE JP, 1987, FEBS LETT, V216, P83, DOI 10.1016/0014-5793(87)80761-5; LEVIN MJ, 1993, PARASITOL TODAY, V9, P381, DOI 10.1016/0169-4758(93)90088-W; LEVIN MJ, 1989, AM J TROP MED HYG, V41, P530, DOI 10.4269/ajtmh.1989.41.530; Mahler E, 2001, EUR J IMMUNOL, V31, P2210, DOI 10.1002/1521-4141(200107)31:7&lt;2210::AID-IMMU2210&gt;3.0.CO;2-J; Manful T, 2009, MOL BIOCHEM PARASIT, V166, P186, DOI 10.1016/j.molbiopara.2009.03.003; MESRI EA, 1990, J CLIN MICROBIOL, V28, P1219, DOI 10.1128/JCM.28.6.1219-1224.1990; MULLER S, 1985, BIOCHIM BIOPHYS ACTA, V827, P235, DOI 10.1016/0167-4838(85)90208-0; Paganetti P, 2005, J CELL BIOL, V168, P863, DOI 10.1083/jcb.200410047; Pizarro JC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001375; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; Smulski C, 2006, FASEB J, V20, P1396, DOI 10.1096/fj.05-5699com; Smulski CR, 2011, J MOL RECOGNIT, V24, P359, DOI 10.1002/jmr.1089; Soares MR, 2004, FEBS LETT, V560, P134, DOI 10.1016/S0014-5793(04)00088-2; STACEY DW, 1988, ARCH BIOCHEM BIOPHYS, V267, P398; Stocks MR, 2004, DRUG DISCOV TODAY, V9, P960, DOI 10.1016/S1359-6446(04)03269-6; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wolfgang WJ, 2005, P NATL ACAD SCI USA, V102, P11563, DOI 10.1073/pnas.0505321102; Zampieri S, 2003, CELL MOL LIFE SCI, V60, P588, DOI 10.1007/s000180300050	40	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36233	10.1371/journal.pone.0036233	http://dx.doi.org/10.1371/journal.pone.0036233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570698	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400014
J	Lakhani, B; Vette, AH; Mansfield, A; Miyasike-daSilva, V; McIlroy, WE				Lakhani, Bimal; Vette, Albert H.; Mansfield, Avril; Miyasike-daSilva, Veronica; McIlroy, William E.			Electrophysiological Correlates of Changes in Reaction Time Based on Stimulus Intensity	PLOS ONE			English	Article							SOMATOSENSORY EVOKED-POTENTIALS; CHOICE-REACTION TIME; SACCADIC REACTION-TIME; MEDIAN NERVE; PARKINSONS-DISEASE; LATENCY; MOVEMENTS; STIMULATION; TASK; AGE	Background: Although reaction time is commonly used as an indicator of central nervous system integrity, little is currently understood about the mechanisms that determine processing time. In the current study, we are interested in determining the differences in electrophysiological events associated with significant changes in reaction time that could be elicited by changes in stimulus intensity. The primary objective is to assess the effect of increasing stimulus intensity on the latency and amplitude of afferent inputs to the somatosensory cortex, and their relation to reaction time. Methods: Median nerve stimulation was applied to the non-dominant hand of 12 healthy young adults at two different stimulus intensities (HIGH & LOW). Participants were asked to either press a button as fast as possible with their dominant hand or remain quiet following the stimulus. Electroencephalography was used to measure somatosensory evoked potentials (SEPs) and event related potentials (ERPs). Electromyography from the flexor digitorum superficialis of the button-pressing hand was used to assess reaction time. Response time was the time of button press. Results: Reaction time and response time were significantly shorter following the HIGH intensity stimulus compared to the LOW intensity stimulus. There were no differences in SEP (N20 & P24) peak latencies and peak-to-peak amplitude for the two stimulus intensities. ERPs, locked to response time, demonstrated a significantly larger pre-movement negativity to positivity following the HIGH intensity stimulus over the Cz electrode. Discussion: This work demonstrates that rapid reaction times are not attributable to the latency of afferent processing from the stimulated site to the somatosensory cortex, and those latency reductions occur further along the sensorimotor transformation pathway. Evidence from ERPs indicates that frontal planning areas such as the supplementary motor area may play a role in transforming the elevated sensory volley from the somatosensory cortex into a more rapid motor response.	[Lakhani, Bimal; McIlroy, William E.] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada; [Lakhani, Bimal; Vette, Albert H.; Mansfield, Avril; McIlroy, William E.] Toronto Rehab, Mobil Res Team, Toronto, ON, Canada; [Vette, Albert H.; Miyasike-daSilva, Veronica; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada	University of Toronto; University of Waterloo	Lakhani, B (corresponding author), Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON, Canada.	wmcilroy@uwaterloo.ca	Mansfield, Avril/B-8589-2013	Mansfield, Avril/0000-0002-0396-5815; Lakhani, Bimal/0000-0002-6833-6454; McIlroy, William/0000-0003-2319-1746	Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research; Toronto Rehabilitation Institute; Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Toronto Rehabilitation Institute(University of Toronto); Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario	The authors acknowledge the support of the Natural Sciences and Engineering Research Council of Canada, the Heart and Stroke Foundation of Canada, the Canadian Institutes of Health Research. The authors also acknowledge the support of Toronto Rehabilitation Institute who receives funding under the Provincial Rehabilitation Research Program from the Ministry of Health and Long-Term Care in Ontario. The views expressed do not necessarily reflect those of the Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam JJ, 1999, ERGONOMICS, V42, P327, DOI 10.1080/001401399185685; Bell AH, 2006, EXP BRAIN RES, V174, P53, DOI 10.1007/s00221-006-0420-z; Brebner JT, 1980, REACTION TIMES; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; DEECKE L, 1969, EXP BRAIN RES, V7, P158; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; Gage WH, 2007, EXP BRAIN RES, V181, P627, DOI 10.1007/s00221-007-0959-3; Galton F., 1899, J ANTHR I, V19, P27, DOI 10.2307/2842529; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; GRISOLIA JS, 1980, ELECTROEN CLIN NEURO, V50, P375, DOI 10.1016/0013-4694(80)90005-X; Hada Y, 2006, CLIN EEG NEUROSCI, V37, P25, DOI 10.1177/155005940603700106; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jaskowski P, 2004, PERCEPT PSYCHOPHYS, V66, P535, DOI 10.3758/BF03194899; KAKIGI R, 1994, NEUROSCI RES, V20, P165, DOI 10.1016/0168-0102(94)90034-5; Kida T, 2003, INT J PSYCHOPHYSIOL, V48, P275, DOI 10.1016/S0167-8760(03)00021-7; KOHFELD DL, 1971, J EXP PSYCHOL, V88, P251, DOI 10.1037/h0030891; KRAMER AF, 1988, BIOL PSYCHOL, V26, P231, DOI 10.1016/0301-0511(88)90022-1; KRITCHEVSKY M, 1978, ARCH NEUROL-CHICAGO, V35, P706, DOI 10.1001/archneur.1978.00500350010003; Kutukcu Y, 1999, BRAIN RES, V815, P367, DOI 10.1016/S0006-8993(98)01060-9; Lakhani B, 2011, BRAIN RES, V1416, P35, DOI 10.1016/j.brainres.2011.08.013; LeDoux J, 1996, PROG BRAIN RES, V107, P437; Legon W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-112; Luchies CW, 2002, J GERONTOL A-BIOL, V57, pM246, DOI 10.1093/gerona/57.4.M246; Maki BE, 1997, PHYS THER, V77, P488, DOI 10.1093/ptj/77.5.488; NOBLE CE, 1964, PERCEPT MOTOR SKILL, V19, P935, DOI 10.2466/pms.1964.19.3.935; Pins D, 1996, PERCEPT PSYCHOPHYS, V58, P390, DOI 10.3758/BF03206815; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Carreiro LRR, 2011, NEUROSCI LETT, V487, P345, DOI 10.1016/j.neulet.2010.10.053; Schubert M, 1998, NEUROSCI RES, V30, P125, DOI 10.1016/S0168-0102(97)00115-6; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Sibley KM, 2010, NEUROSCI LETT, V485, P217, DOI 10.1016/j.neulet.2010.09.015; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Thobois S, 2007, NEUROIMAGE, V37, P243, DOI 10.1016/j.neuroimage.2007.04.049; VaezMousavi SM, 2009, PHYSIOL BEHAV, V98, P326, DOI 10.1016/j.physbeh.2009.06.007; WELFORD AT, 1976, INT J AGING HUM DEV, V7, P189, DOI 10.2190/9477-XQE6-Q52U-758J; WIEDERHOLT WC, 1970, J NEUROL NEUROSUR PS, V33, P438, DOI 10.1136/jnnp.33.4.438	38	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36407	10.1371/journal.pone.0036407	http://dx.doi.org/10.1371/journal.pone.0036407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570711	Green Published, gold			2022-12-27	WOS:000305343400027
J	Olszewski, J; Haehnel, M; Taguchi, M; Liao, JC				Olszewski, Julia; Haehnel, Melanie; Taguchi, Masashige; Liao, James C.			Zebrafish Larvae Exhibit Rheotaxis and Can Escape a Continuous Suction Source Using Their Lateral Line	PLOS ONE			English	Article							FISHES; RHEOTROPISM; SOMATOTOPY; FLOW	Zebrafish larvae show a robust behavior called rheotaxis, whereby they use their lateral line system to orient upstream in the presence of a steady current. At 5 days post fertilization, rheotactic larvae can detect and initiate a swimming burst away from a continuous point-source of suction. Burst distance and velocity increase when fish initiate bursts closer to the suction source where flow velocity is higher. We suggest that either the magnitude of the burst reflects the initial flow stimulus, or fish may continually sense flow during the burst to determine where to stop. By removing specific neuromasts of the posterior lateral line along the body, we show how the location and number of flow sensors play a role in detecting a continuous suction source. We show that the burst response critically depends on the presence of neuromasts on the tail. Flow information relayed by neuromasts appears to be involved in the selection of appropriate behavioral responses. We hypothesize that caudally located neuromasts may be preferentially connected to fast swimming spinal motor networks while rostrally located neuromasts are connected to slow swimming motor networks at an early age.	[Olszewski, Julia] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Haehnel, Melanie; Taguchi, Masashige; Liao, James C.] Univ Florida, Dept Biol, Whitney Lab Marine Biosci, St Augustine, FL USA	Brown University; State University System of Florida; University of Florida	Olszewski, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	jliao@whitney.ufl.edu	Haehnel-Taguchi, Melanie/AAR-5589-2021	Haehnel-Taguchi, Melanie/0000-0003-0508-8171	National Institutes of Health NIH [RO1 DC010809]; National Science Foundation NSF REU [DBI 648969]; Deutsche Forschungsgemeinschaft [HA 6481/1-1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010809] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health NIH RO1 DC010809 to JCL, National Science Foundation NSF REU DBI 648969 to the Whitney Lab for Marine Bioscience and a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (HA 6481/1-1) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; ARNOLD GP, 1978, J EXP BIOL, V75, P147; ARNOLD GP, 1974, BIOL REV, V49, P515, DOI 10.1111/j.1469-185X.1974.tb01173.x; Baker CF, 1999, J COMP PHYSIOL A, V184, P519, DOI 10.1007/s003590050351; Chagnaud BP, 2008, J NEUROSCI, V28, P4479, DOI 10.1523/JNEUROSCI.4959-07.2008; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; EATON RC, 1986, T AM FISH SOC, V115, P128, DOI 10.1577/1548-8659(1986)115<128:ROTTER>2.0.CO;2; Engeszer RE, 2007, ZEBRAFISH, V4, P21, DOI 10.1089/zeb.2006.9997; FERO K, 2010, ZEBRAFISH MODELS NEU; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Lyon EP, 1904, AM J PHYSIOL, V12, P149, DOI 10.1152/ajplegacy.1904.12.2.149; MATHEWSON RF, 1972, COMP BIOCHEM PHYSIOL, V42, P79, DOI 10.1016/0300-9629(72)90369-6; McClure MM, 2006, J FISH BIOL, V69, P553, DOI 10.1111/j.1095-8649.2006.01125.x; McHenry MJ, 2009, BIOL LETTERS, V5, P477, DOI 10.1098/rsbl.2009.0048; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; MONTGOMERY J, 1995, REV FISH BIOL FISHER, V5, P399, DOI 10.1007/BF01103813; Montgomery JC, 1997, NATURE, V389, P960, DOI 10.1038/40135; Nicolson T, 1998, NEURON, V20, P271, DOI 10.1016/S0896-6273(00)80455-9; Pujol-Marti J, 2010, DEV DYNAM, V239, P1919, DOI 10.1002/dvdy.22320; Reichardt W, 1987, J COMP PHYSIOL A, V161, P533; Simmons A, 2004, J COMP PHYSIOL A, V190, P747, DOI 10.1007/s00359-004-0534-3	22	67	67	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36661	10.1371/journal.pone.0036661	http://dx.doi.org/10.1371/journal.pone.0036661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570735	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400051
J	Ruiz-Estevez, M; Lopez-Leon, MD; Cabrero, J; Camacho, JPM				Ruiz-Estevez, Mercedes; Dolores Lopez-Leon, Ma; Cabrero, Josefa; Camacho, Juan Pedro M.			B-Chromosome Ribosomal DNA Is Functional in the Grasshopper Eyprepocnemis plorans	PLOS ONE			English	Article							NUCLEOLAR ORGANIZER REGIONS; NOR ACTIVITY; RNA GENES; TRANSCRIPTION; EVOLUTION; PROTEINS; HETEROCHROMATIN; DISTORTION; SEQUENCES; MEIOSIS	B-chromosomes are frequently argued to be genetically inert elements, but activity for some particular genes has been reported, especially for ribosomal RNA (rRNA) genes whose expression can easily be detected at the cytological level by the visualization of their phenotypic expression, i.e., the nucleolus. The B-24 chromosome in the grasshopper Eyprepocnemis plorans frequently shows a nucleolus attached to it during meiotic prophase I. Here we show the presence of rRNA transcripts that unequivocally came from the B-24 chromosome. To detect these transcripts, we designed primers specifically anchoring at the ITS-2 region, so that the reverse primer was complementary to the B chromosome DNA sequence including a differential adenine insertion being absent in the ITS2 of A chromosomes. PCR analysis carried out on genomic DNA showed amplification in B-carrying males but not in B-lacking ones. PCR analyses performed on complementary DNA showed amplification in about half of B-carrying males. Joint cytological and molecular analysis performed on 34 B-carrying males showed a close correspondence between the presence of B-specific transcripts and of nucleoli attached to the B chromosome. In addition, the molecular analysis revealed activity of the B chromosome rDNA in 10 out of the 13 B-carrying females analysed. Our results suggest that the nucleoli attached to B chromosomes are actively formed by expression of the rDNA carried by them, and not by recruitment of nucleolar materials formed in A chromosome nucleolar organizing regions. Therefore, B-chromosome rDNA in E. plorans is functional since it is actively transcribed to form the nucleolus attached to the B chromosome. This demonstrates that some heterochromatic B chromosomes can harbour functional genes.	[Ruiz-Estevez, Mercedes; Dolores Lopez-Leon, Ma; Cabrero, Josefa; Camacho, Juan Pedro M.] Univ Granada, Dept Genet, Granada, Spain	University of Granada	Ruiz-Estevez, M (corresponding author), Univ Granada, Dept Genet, Granada, Spain.	jpmcamac@ugr.es	Cabrero, Josefa/L-8899-2014; López-León, María Dolores/L-9026-2014; Camacho, Juan Pedro M/L-6869-2014	Cabrero, Josefa/0000-0002-5848-6985; López-León, María Dolores/0000-0003-2337-7313; Camacho, Juan Pedro M/0000-0002-2507-9814	Spanish Ministerio de Ciencia e Innovacion [CGL2009-11917]; FEDER funds; fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); FEDER funds(European Commission); fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion	This study was supported by a grant from the Spanish Ministerio de Ciencia e Innovacion (CGL2009-11917), and was partially performed by FEDER funds. M. Ruiz-Estevez was supported by a fellowship (FPU) from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; BIDAU CJ, 1986, CAN J GENET CYTOL, V28, P138, DOI 10.1139/g86-018; BROCKHOUSE C, 1989, GENOME, V32, P516, DOI 10.1139/g89-477; BUSCH H, 1979, CANCER RES, V39, P857; Busch H, 1997, J TUMOR MARKER ONCOL, V12, P5; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 1999, HEREDITY, V83, P435, DOI 10.1038/sj.hdy.6885960; CABRERO J, 1987, GENOME, V29, P116, DOI 10.1139/g87-020; Camacho JPM, 2004, CYTOGENET GENOME RES, V106, P325, DOI 10.1159/000079307; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Carchilan M, 2007, PLANT CELL, V19, P1738, DOI 10.1105/tpc.106.046946; Carchilan M, 2009, CHROMOSOMA, V118, P607, DOI 10.1007/s00412-009-0222-8; CARLSON WR, 1986, CRIT REV PLANT SCI, V3, P201, DOI 10.1080/07352688609382210; Carmo-Fonseca M, 2000, NAT CELL BIOL, V2, pE107, DOI 10.1038/35014078; Caspersson T., 1950, CELL GROWTH CELL FUN; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; DONALD TM, 1995, HEREDITY, V74, P556, DOI 10.1038/hdy.1995.77; Donald TM, 1997, GENOME, V40, P674, DOI 10.1139/g97-089; FOX DP, 1974, CHROMOSOMA, V45, P43; GREEN DM, 1988, CHROMOSOMA, V97, P55, DOI 10.1007/BF00331795; GREEN DM, 1990, GENOME, V33, P818, DOI 10.1139/g90-123; Han FP, 2007, PLANT CELL, V19, P524, DOI 10.1105/tpc.106.049577; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; ISHAK B, 1991, CHROMOSOMA, V100, P278, DOI 10.1007/BF00344162; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Lopez-Leon MD, 1999, CHROMOSOME RES, V7, P83, DOI 10.1023/A:1009270310092; LOPEZLEON MD, 1995, GENOME, V38, P68, DOI 10.1139/g95-008; LOPEZLEON MD, 1991, CHROMOSOMA, V100, P134, DOI 10.1007/BF00418247; LOPEZLEON MD, 1995, HEREDITY, V74, P296, DOI 10.1038/hdy.1995.43; Manrique-Poyato MI, 2006, CHROMOSOME RES, V14, P693, DOI 10.1007/s10577-006-1081-2; Manrique-Poyato MI, 2010, THESIS U GRANADA; Marschner S, 2007, GENOME, V50, P638, DOI 10.1139/G07-048; Mosgoeller W, 2004, MOL BIOL INTELL UNIT, P10; Nakamoto K, 2001, AM J PATHOL, V159, P1363, DOI 10.1016/S0002-9440(10)62523-0; OKABE Y, 1991, ANTICANCER RES, V11, P2031; Perfectti F, 2004, CYTOGENET GENOME RES, V106, P338, DOI 10.1159/000079309; Pikaard CS, 2000, TRENDS GENET, V16, P495, DOI 10.1016/S0168-9525(00)02113-2; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; ROUSSEL P, 1992, EXP CELL RES, V203, P259, DOI 10.1016/0014-4827(92)90063-E; ROUSSEL P, 1994, EXP CELL RES, V214, P465, DOI 10.1006/excr.1994.1283; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; RUFAS JS, 1982, ARCH BIOL, V93, P267; Sabrina B, 2009, CARYOLOGIA, V62, P95, DOI 10.1080/00087114.2004.10589674; Stitou S, 2004, CYTOGENET GENOME RES, V106, P344, DOI 10.1159/000079310; Teruel M, 2009, THESIS U GRANADA; Teruel M, 2007, CHROMOSOME RES, V15, P755, DOI 10.1007/s10577-007-1159-5; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOMA, V118, P291, DOI 10.1007/s00412-008-0197-x; THIELE J, 1993, VIRCHOWS ARCH A, V423, P409, DOI 10.1007/BF01606529; van Vugt JJFA, 2005, CHROMOSOMA, V114, P410, DOI 10.1007/s00412-005-0026-4; Yoshida K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002203; Zurita S, 1998, EVOLUTION, V52, P274, DOI 10.1111/j.1558-5646.1998.tb05163.x	55	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36600	10.1371/journal.pone.0036600	http://dx.doi.org/10.1371/journal.pone.0036600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570730	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400046
J	Song, JK; Park, MH; Choi, DY; Yoo, HS; Han, SB; Yoon, DY; Hong, JT				Song, Ju Kyoung; Park, Mi Hee; Choi, Dong-Young; Yoo, Hwan Soo; Han, Sang Bae; Yoon, Do Young; Hong, Jin Tae			Deficiency of C-C Chemokine Receptor 5 Suppresses Tumor Development via Inactivation of NF-kappa B and Upregulation of IL-1Ra in Melanoma Model	PLOS ONE			English	Article							HUMAN BREAST-CANCER; CELL GROWTH; IN-VIVO; INTERLEUKIN-1; ANTAGONIST; EXPRESSION; ADENOCARCINOMA; INHIBITION; LYMPHOMA; PROMOTES	To evaluate the relevance of C-C chemokine receptor type 5 (CCR5) expression and tumor development, we compared melanoma growth in CCR5 knockout (CCR5(-/-)) mice and wild type (CCR5(+/+)) mice. CCR5(-/-) mice showed reduced tumor volume, tumor weight, and increased survival rate when compared to CCR5(+/+) mice. We investigated the activation of NF-kappa B since it is an implicated transcription factor in the regulation of genes involving cell growth, apoptosis, and tumor growth. Significant inhibition of DNA binding activity of NF-kappa B, and translocation of p50 and p65 into the nucleus through the inhibition of phosphorylation of I kappa B was found in the melanoma tissues of CCR5(-/-) mice compared to melanoma tissues of CCR5(+/+) mice. NF-kappa B target apoptotic protein expression, such as cleaved caspase-3, cleaved PARP, and Bax, was elevated, whereas the survival protein expression levels, such as Bcl-2, C-IAP1, was decreased in the melanoma tissues of CCR5(-/-) mice. Interestingly, we found that the level of IL-1Ra, a tumor growth suppressive cytokine, was significantly elevated in tumor tissue and spleen of CCR5(-/-) mice compared to the level in CCR5(+/+) mice. Moreover, infiltration of CD8(+) cytotoxic T cell and CD57(+) natural killer cells was significantly increased in melanoma tumor and spleen tissue of CCR5(-/-) mice compared to that of CCR5(+/+) mice. Therefore, these results showed that CCR5 deficiency caused apoptotic cell death of melanoma through inhibition of NF-kappa B and upregulation of IL-1Ra.	[Song, Ju Kyoung; Park, Mi Hee; Choi, Dong-Young; Yoo, Hwan Soo; Han, Sang Bae; Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Cheongju, Chungbuk, South Korea; [Yoon, Do Young] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea	Chungbuk National University; Konkuk University	Song, JK (corresponding author), Chungbuk Natl Univ, Coll Pharm & Med Res Ctr, Cheongju, Chungbuk, South Korea.	jinthong@chungbuk.ac.kr			Korea Research Foundation [MRC 9440, R13-2010-002948]	Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Korea Research Foundation Grant (MRC 9440, R13-2010-002948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 1997, ADV IMMUNOL, V65, P1, DOI 10.1016/S0065-2776(08)60740-3; Aldinucci D, 2008, INT J CANCER, V122, P769, DOI 10.1002/ijc.23119; Arend WP, 2000, ANN RHEUM DIS, V59, P60, DOI 10.1136/ard.59.suppl_1.i60; Bar D, 2004, FASEB J, V18, P161, DOI 10.1096/fj.03-0483fje; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Borczuk AC, 2008, ONCOGENE, V27, P557, DOI 10.1038/sj.onc.1210662; Chan KK, 2010, J PATHOL, V221, P164, DOI 10.1002/path.2699; Cheng J, 2012, J SURG RES, V174, P166, DOI 10.1016/j.jss.2010.12.014; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; Dabaghmanesh N, 2009, CANCER SCI, V100, P737, DOI 10.1111/j.1349-7006.2009.01083.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; DINARELLO CA, 1991, BLOOD, V77, P1627; DINARELLO CA, 1991, IMMUNOL TODAY, V12, P404, DOI 10.1016/0167-5699(91)90142-G; Elkabets M, 2009, J IMMUNOL, V182, P4874, DOI 10.4049/jimmunol.0803916; Erreni M, 2009, METHOD ENZYMOL, V460, P105, DOI 10.1016/S0076-6879(09)05205-7; Fukuda M, 2010, INT J ONCOL, V36, P1355, DOI 10.3892/ijo_00000620; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Gerondakis S, 1996, P NATL ACAD SCI USA, V93, P3405, DOI 10.1073/pnas.93.8.3405; Gilmore TD, 2001, ONCOGENE, V20, P7098, DOI 10.1038/sj.onc.1204898; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kazmierski W, 2003, BIOORGAN MED CHEM, V11, P2663, DOI 10.1016/S0968-0896(03)00161-5; Kokura S, 2005, CANCER LETT, V218, P171, DOI 10.1016/j.canlet.2004.07.026; Konishi N, 2005, ONCOLOGY-BASEL, V68, P138, DOI 10.1159/000086768; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; La E, 1999, MOL CARCINOGEN, V24, P276, DOI 10.1002/(SICI)1098-2744(199904)24:4<276::AID-MC5>3.0.CO;2-#; La EH, 2001, MOL CARCINOGEN, V30, P218, DOI 10.1002/mc.1031; Lavi G, 2007, J CONTROL RELEASE, V123, P123, DOI 10.1016/j.jconrel.2007.07.015; Lentsch AB, 1997, J CLIN INVEST, V100, P2443, DOI 10.1172/JCI119786; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ng-Cashin J, 2003, J IMMUNOL, V170, P4201, DOI 10.4049/jimmunol.170.8.4201; Oh JH, 2011, ONCOGENE, V30, P3345, DOI 10.1038/onc.2011.52; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pantschenko AG, 2003, INT J ONCOL, V23, P269; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Ricote M, 2004, CANCER-AM CANCER SOC, V100, P1388, DOI 10.1002/cncr.20142; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Seidl H, 2007, HUM PATHOL, V38, P768, DOI 10.1016/j.humpath.2006.11.013; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Sutton A, 2007, MOL CANCER RES, V5, P21, DOI 10.1158/1541-7786.MCR-06-0103; Tan MCB, 2009, J IMMUNOL, V182, P1746, DOI 10.4049/jimmunol.182.3.1746; Triozzi PL, 2010, ANTICANCER RES, V30, P345; Valdivia-Silva JE, 2009, CANCER LETT, V283, P176, DOI 10.1016/j.canlet.2009.03.040; VIDALVANACLOCHA F, 1994, CANCER RES, V54, P2667; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; Weinreich DM, 2003, CANCER RES, V63, P5957; Wu XS, 2009, CURR PHARM DESIGN, V15, P742, DOI 10.2174/138161209787582165; Zhang XP, 2010, BIOORG MED CHEM LETT, V20, P4627, DOI 10.1016/j.bmcl.2010.06.003	54	134	137	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e33747	10.1371/journal.pone.0033747	http://dx.doi.org/10.1371/journal.pone.0033747			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567084	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500002
J	Peterson, AJ; Jensen, PA; Shimell, M; Stefancsik, R; Wijayatonge, R; Herder, R; Raftery, LA; O'Connor, MB				Peterson, Aidan J.; Jensen, Philip A.; Shimell, MaryJane; Stefancsik, Ray; Wijayatonge, Ranjula; Herder, Rachel; Raftery, Laurel A.; O'Connor, Michael B.			R-Smad Competition Controls Activin Receptor Output in Drosophila	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BMP; SIGNALS; PHOSPHORYLATION; PROTEIN; EMBRYO; PROLIFERATION; ACTIVATION; MECHANISMS; COMPLEXES	Animals use TGF-beta superfamily signal transduction pathways during development and tissue maintenance. The superfamily has traditionally been divided into TGF-beta/Activin and BMP branches based on relationships between ligands, receptors, and R-Smads. Several previous reports have shown that, in cell culture systems, "BMP-specific" Smads can be phosphorylated in response to TGF-beta/Activin pathway activation. Using Drosophila cell culture as well as in vivo assays, we find that Baboon, the Drosophila TGF-beta/Activin-specific Type I receptor, can phosphorylate Mad, the BMP-specific R-Smad, in addition to its normal substrate, dSmad2. The Baboon-Mad activation appears direct because it occurs in the absence of canonical BMP Type I receptors. Wing phenotypes generated by Baboon gain-of-function require Mad, and are partially suppressed by over-expression of dSmad2. In the larval wing disc, activated Baboon cell-autonomously causes C-terminal Mad phosphorylation, but only when endogenous dSmad2 protein is depleted. The Baboon-Mad relationship is thus controlled by dSmad2 levels. Elevated P-Mad is seen in several tissues of dSmad2 protein-null mutant larvae, and these levels are normalized in dSmad2; baboon double mutants, indicating that the cross-talk reaction and Smad competition occur with endogenous levels of signaling components in vivo. In addition, we find that high levels of Activin signaling cause substantial turnover in dSmad2 protein, providing a potential cross-pathway signal-switching mechanism. We propose that the dual activity of TGF-beta/Activin receptors is an ancient feature, and we discuss several ways this activity can modulate TGF-beta signaling output.	[Peterson, Aidan J.; Jensen, Philip A.; Shimell, MaryJane; Herder, Rachel; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Stefancsik, Ray; Wijayatonge, Ranjula; Raftery, Laurel A.] Harvard Univ, Sch Med, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA USA; [Raftery, Laurel A.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Peterson, AJ (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	Raftery, Laurel/H-1406-2012; O'Connor, Michael B/C-9977-2014	Raftery, Laurel/0000-0003-4797-4163; O'Connor, Michael B/0000-0002-3067-5506; Stefancsik, Ray/0000-0001-8314-2140	National Institutes of Health [R01 GM95746, R01 GM060501, T32 HD007430-11A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095746, R01GM060501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants to MBO (R01 GM95746) and LAR (R01 GM060501). PAJ was supported in part by a National Institutes of Health Institutional Training Grant (T32 HD007430-11A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Daly AC, 2008, MOL CELL BIOL, V28, P6889, DOI 10.1128/MCB.01192-08; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Haerry TE, 2010, MECH DEVELOP, V127, P358, DOI 10.1016/j.mod.2010.04.001; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Jensen PA, 2009, MECH DEVELOP, V126, P950, DOI 10.1016/j.mod.2009.09.003; Jornvall H, 2001, J BIOL CHEM, V276, P5140, DOI 10.1074/jbc.M005200200; Liu IM, 2009, EMBO J, V28, P88, DOI 10.1038/emboj.2008.266; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	30	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36548	10.1371/journal.pone.0036548	http://dx.doi.org/10.1371/journal.pone.0036548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563507	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340700056
J	Tan, CW; Chan, YF; Sim, KM; Tan, EL; Poh, CL				Tan, Chee Wah; Chan, Yoke Fun; Sim, Kooi Mow; Tan, Eng Lee; Poh, Chit Laa			Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1	PLOS ONE			English	Article							SIMPLEX-VIRUS INFECTION; LACTOFERRICIN INHIBIT; ADENOVIRAL INFECTION; HEPARAN-SULFATE; BINDING; ENTRY; INTERFERENCE; EPIDEMIC; TARGETS; HIV-1	Enterovirus 71 (EV-71) is the main causative agent of hand, foot and mouth disease (HFMD). In recent years, EV-71 infections were reported to cause high fatalities and severe neurological complications in Asia. Currently, no effective antiviral or vaccine is available to treat or prevent EV-71 infection. In this study, we have discovered a synthetic peptide which could be developed as a potential antiviral for inhibition of EV-71. Ninety five synthetic peptides (15-mers) overlapping the entire EV-71 capsid protein, VP1, were chemically synthesized and tested for antiviral properties against EV-71 in human Rhabdomyosarcoma (RD) cells. One peptide, SP40, was found to significantly reduce cytopathic effects of all representative EV-71 strains from genotypes A, B and C tested, with IC50 values ranging from 6-9.3 mu M in RD cells. The in vitro inhibitory effect of SP40 exhibited a dose dependent concentration corresponding to a decrease in infectious viral particles, total viral RNA and the levels of VP1 protein. The antiviral activity of SP40 peptide was not restricted to a specific cell line as inhibition of EV-71 was observed in RD, HeLa, HT-29 and Vero cells. Besides inhibition of EV-71, it also had antiviral activities against CV-A16 and poliovirus type 1 in cell culture. Mechanism of action studies suggested that the SP40 peptide was not virucidal but was able to block viral attachment to the RD cells. Substitutions of arginine and lysine residues with alanine in the SP40 peptide at positions R3A, R4A, K5A and R13A were found to significantly decrease antiviral activities, implying the importance of positively charged amino acids for the antiviral activities. The data demonstrated the potential and feasibility of SP40 as a broad spectrum antiviral agent against EV-71.	[Tan, Chee Wah; Chan, Yoke Fun] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Sim, Kooi Mow] Univ Tunku Abdul Rahman, Fac Sci, Dept Chem Sci, Kampar, Malaysia; [Tan, Eng Lee] Singapore Polytech, Ctr Biomed & Life Sci, Singapore, Singapore; [Poh, Chit Laa] Sunway Univ, Sch Hlth & Nat Sci, Petaling Jaya, Malaysia	Universiti Malaya; Universiti Tunku Abdul Rahman (UTAR); Singapore Polytechnic; Sunway University	Tan, CW (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	chitlaa.poh@gmail.com	Tan, Chee Wah/K-7450-2012; abubakar, sazaly/B-3957-2010; Chan, Yoke Fun/B-5351-2010	abubakar, sazaly/0000-0002-9267-1420; Chan, Yoke Fun/0000-0001-7089-0510; Poh, Chit-Laa/0000-0001-8475-6291; Tan, Chee Wah/0000-0001-9837-1413	UTAR (Universiti Tunku Abdul Rahman) Research Fund [6200/P04]; University of Malaya Research Grant [RG245/10HTM]; Sunway University Research Grant [INT-SHNS-0111-01]; High Impact Research Grant [UM.C/625/1/HIR/014]	UTAR (Universiti Tunku Abdul Rahman) Research Fund; University of Malaya Research Grant; Sunway University Research Grant; High Impact Research Grant	This work was supported by grants from UTAR (Universiti Tunku Abdul Rahman) Research Fund (6200/P04), University of Malaya Research Grant (RG245/10HTM), Sunway University Research Grant (INT-SHNS-0111-01) awarded to CLP and High Impact Research Grant (UM.C/625/1/HIR/014) awarded to YFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08; Andersen JH, 2003, ANTIVIR RES, V58, P209, DOI 10.1016/S0166-3542(02)00214-0; Andersen JH, 2001, ANTIVIR RES, V51, P141, DOI 10.1016/S0166-3542(01)00146-2; Bastian A, 2001, REGUL PEPTIDES, V101, P157, DOI 10.1016/S0167-0115(01)00282-8; Belaid A, 2002, J MED VIROL, V66, P229, DOI 10.1002/jmv.2134; Brown BA, 1995, VIRUS RES, V39, P195, DOI 10.1016/0168-1702(95)00087-9; Chan YF, 2011, NEUROL ASIA, V16, P1; Chang Luan-Yin, 2008, Pediatrics and Neonatology, V49, P103, DOI 10.1016/S1875-9572(08)60023-6; Chen P, 2012, J BIOL CHEM, V287, P6406, DOI 10.1074/jbc.M111.301622; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Gropp R, 1999, HUM GENE THER, V10, P957, DOI 10.1089/10430349950018355; HEINZ BA, 1995, J VIROL, V69, P4189, DOI 10.1128/JVI.69.7.4189-4197.1995; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49; Huther A, 2007, AIDS REV, V9, P208; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kilby JM, 1998, NAT MED, V4, P1302, DOI 10.1038/3293; Kim DH, 2008, BMB REP, V41, P640, DOI 10.5483/BMBRep.2008.41.9.640; Li C, 2007, CURR MED CHEM, V14, P847, DOI 10.2174/092986707780363032; Li ZH, 2008, J INFECT DIS, V197, P854, DOI 10.1086/527326; Lin TY, 2002, J INFECT DIS, V186, P1161, DOI 10.1086/343809; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu R, 2010, ANTIVIR RES, V86, P172, DOI 10.1016/j.antiviral.2010.02.316; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; MANN DM, 1994, J BIOL CHEM, V269, P23661; Marchetti M, 2004, VIROLOGY, V318, P405, DOI 10.1016/j.virol.2003.09.029; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Patick AK, 1997, 10 INT C ANT RES ANT; Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109; Reed L.J., 1983, AM J HYG, V27, P493; Rotbart HA, 1998, ANTIVIR RES, V38, P1, DOI 10.1016/S0166-3542(97)00068-5; Shih SR, 2004, ANTIMICROB AGENTS CH, V48, P3523, DOI 10.1128/AAC.48.9.3523-3529.2004; Shimazaki K, 1998, J DAIRY SCI, V81, P2841, DOI 10.3168/jds.S0022-0302(98)75843-6; Shindarov LM, 1979, J HYG EPID MICROB IM, V23, P12; Sim ACN, 2005, VIROLOGY, V341, P72, DOI 10.1016/j.virol.2005.06.047; Stanway G, 2005, VIRUS TAXONOMY, P757; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tiwari V, 2011, J BIOL CHEM, V286, P25406, DOI 10.1074/jbc.M110.201103; van der Strate BWA, 2001, ANTIVIR RES, V52, P225, DOI 10.1016/S0166-3542(01)00195-4; Weng TY, 2005, ANTIVIR RES, V67, P31, DOI 10.1016/j.antiviral.2005.03.005; Wu KX, 2010, DRUG DISCOV TODAY, V15, P1041, DOI 10.1016/j.drudis.2010.10.008; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723	46	29	36	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34589	10.1371/journal.pone.0034589	http://dx.doi.org/10.1371/journal.pone.0034589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563456	Green Published, Green Accepted, gold			2022-12-27	WOS:000305340700005
J	Knappskog, S; Gansmo, LB; Romundstad, P; Bjornslett, M; Trovik, J; Sommerfelt-Pettersen, J; Lokkevik, E; Tollenaar, RAEM; Seynaeve, C; Devilee, P; Salvesen, HB; Dorum, A; Hveem, K; Vatten, L; Lonning, PE				Knappskog, Stian; Gansmo, Liv B.; Romundstad, Pal; Bjornslett, Merete; Trovik, Jone; Sommerfelt-Pettersen, Jan; Lokkevik, Erik; Tollenaar, Rob A. E. M.; Seynaeve, Caroline; Devilee, Peter; Salvesen, Helga B.; Dorum, Anne; Hveem, Kristian; Vatten, Lars; Lonning, Per E.		Norwegian Breast Canc Grp	MDM2 Promoter SNP344T > A (rs1196333) Status Does Not Affect Cancer Risk	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; ACCELERATES TUMOR-FORMATION; ADVANCED BREAST-CANCER; P53 PROTEIN; SNP309; GENE; POLYMORPHISM; AMPLIFICATION; EXPRESSION; MUTATIONS	The MDM2 proto-oncogene plays a key role in central cellular processes like growth control and apoptosis, and the gene locus is frequently amplified in sarcomas. Two polymorphisms located in the MDM2 promoter P2 have been shown to affect cancer risk. One of these polymorphisms (SNP309T>G; rs2279744) facilitates Sp1 transcription factor binding to the promoter and is associated with increased cancer risk. In contrast, SNP285G>C (rs117039649), located 24 bp upstream of rs2279744, and in complete linkage disequilibrium with the SNP309G allele, reduces Sp1 recruitment and lowers cancer risk. Thus, fine tuning of MDM2 expression has proven to be of significant importance with respect to tumorigenesis. We assessed the potential functional effects of a third MDM2 promoter P2 polymorphism (SNP344T>A; rs1196333) located on the SNP309T allele. While in silico analyses indicated SNP344A to modulate TFAP2A, SPIB and AP1 transcription factor binding, we found no effect of SNP344 status on MDM2 expression levels. Assessing the frequency of SNP344A in healthy Caucasians (n = 2,954) and patients suffering from ovarian (n = 1,927), breast (n = 1,271), endometrial (n = 895) or prostatic cancer (n = 641), we detected no significant difference in the distribution of this polymorphism between any of these cancer forms and healthy controls (6.1% in healthy controls, and 4.9%, 5.0%, 5.4% and 7.2% in the cancer groups, respectively). In conclusion, our findings provide no evidence indicating that SNP344A may affect MDM2 transcription or cancer risk.	[Knappskog, Stian; Gansmo, Liv B.; Lonning, Per E.] Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway; [Knappskog, Stian; Gansmo, Liv B.; Lonning, Per E.] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Romundstad, Pal; Hveem, Kristian; Vatten, Lars] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Bjornslett, Merete] Oslo Univ Hosp Radiumhosp, Dept Med Genet, Oslo, Norway; [Bjornslett, Merete; Dorum, Anne] Univ Oslo, Norwegian Radium Hosp, Fac Div, Oslo, Norway; [Trovik, Jone; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; [Trovik, Jone; Salvesen, Helga B.] Univ Bergen, Inst Clin Med, Bergen, Norway; [Sommerfelt-Pettersen, Jan] Royal Norwegian Navy, Bergen, Norway; [Lokkevik, Erik] Oslo Univ Hosp, Dept Oncol, Div Surg & Canc Med, Oslo, Norway; [Tollenaar, Rob A. E. M.] Leiden Univ Med Ctr, Dept Surg, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel den Hoed Canc Ctr Rotterdam, Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands; [Devilee, Peter] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Devilee, Peter] Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands; [Dorum, Anne] Oslo Univ Hosp Radiumhosp, Dept Gynecol Oncol, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); University of Oslo	Knappskog, S (corresponding author), Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway.	stian.knappskog@med.uib.no	Hveem, Kristian/AFV-4683-2022; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; DEVILEE, PETER/ABR-2140-2022; Devilee, Peter/GXV-8005-2022; salvesen, Helga B/C-1187-2017	salvesen, Helga B/0000-0002-4438-8831; Gansmo, Liv B./0000-0002-2914-9103; Dorum, Anne/0000-0002-6274-2398; Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655; Sommerfelt-Pettersen, Jan/0000-0002-3008-5928; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Cancer Society; Norwegian Health Region West	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health Region West	The study was supported by grants from the Norwegian Cancer Society and the Norwegian Health Region West. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Chrisanthar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019249; Chrisanthar R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003062; Economopoulos KP, 2010, BREAST CANCER RES TR, V120, P211, DOI 10.1007/s10549-009-0467-1; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Geisler S, 2001, CANCER RES, V61, P2505; Hu ZB, 2007, CANCER EPIDEM BIOMAR, V16, P2717, DOI 10.1158/1055-9965.EPI-07-0634; Knappskog S, 2012, EUR J CANCER, V48, P1988, DOI 10.1016/j.ejca.2011.10.024; Knappskog S, 2011, ONCOTARGET, V2, P251; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Landers JE, 1997, CANCER RES, V57, P3562; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; SHEIKH MS, 1993, CANCER RES, V53, P3226; Trotta R, 2003, CANCER CELL, V3, P145, DOI 10.1016/S1535-6108(03)00020-5; XIAO ZX, 1995, NATURE, V375, P694, DOI 10.1038/375694a0	20	11	12	0	297	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36263	10.1371/journal.pone.0036263	http://dx.doi.org/10.1371/journal.pone.0036263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558411	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200058
J	Phua, DYL; Rifkin-Graboi, A; Saw, SM; Meaney, MJ; Qiu, AQ				Phua, Desiree Yee-Ling; Rifkin-Graboi, Anne; Saw, Seang-Mei; Meaney, Michael J.; Qiu, Anqi			Executive Functions of Six-Year-Old Boys with Normal Birth Weight and Gestational Age	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE FUNCTION; POSTNATAL-GROWTH; NORMAL RANGE; INFANTS BORN; CHILDREN; PRETERM; TERM; PERFORMANCE; OUTCOMES	Impaired fetal development, reflected by low birth weight or prematurity, predicts an increased risk for psychopathology, especially attention deficit hyperactivity disorder (ADHD). Such effects cut across the normal range of birth weight and gestation. Despite the strength of existing epidemiological data, cognitive pathways that link fetal development to mental health are largely unknown. In this study we examined the relation of birth weight (>2500 g) and gestational age (37-41 weeks) within the normal range with specific executive functions in 195 Singaporean six-year-old boys of Chinese ethnicity. Birth weight adjusted for gestational age was used as indicator of fetal growth while gestational age was indicative of fetal maturity. Linear regression revealed that increased fetal growth within the normal range is associated with an improved ability to learn rules during the intra/extra-dimensional shift task and to retain visual information for short period of time during the delayed matching to sample task. Moreover, faster and consistent reaction times during the stop-signal task were observed among boys born at term, but with higher gestational age. Hence, even among boys born at term with normal birth weight, variations in fetal growth and maturity showed distinct effects on specific executive functions.	[Phua, Desiree Yee-Ling; Rifkin-Graboi, Anne; Meaney, Michael J.; Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Saw, Seang-Mei] Singapore Eye Res Inst, Singapore, Singapore; [Saw, Seang-Mei] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Qiu, Anqi] Natl Univ Singapore, Dept Bioengn, Singapore 117548, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; Singapore National Eye Center; National University of Singapore; McGill University; National University of Singapore; National University of Singapore	Phua, DYL (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.	bieqa@nus.edu.sg	Meaney, Michael/N-5931-2019; Phua, Desiree Y/I-1791-2019; Rifkin-Graboi, Anne/AAH-3658-2022; Rifkin-Graboi, Anne/AFM-0959-2022; Qiu, Anqi/H-2267-2011	Phua, Desiree Y/0000-0001-6055-656X; Qiu, Anqi/0000-0002-0215-6338; Rifkin-Graboi, Anne/0000-0002-7641-4678	Agency of Science, Technology and Research (A*STAR) [SICS-09/1/1/001]	Agency of Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR))	This study was supported by the Agency of Science, Technology and Research (A*STAR; ref: SICS-09/1/1/001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Boulet SL, 2011, MATERN CHILD HLTH J, V15, P836, DOI 10.1007/s10995-009-0538-2; Breslau N, 1996, J ABNORM CHILD PSYCH, V24, P385, DOI 10.1007/BF01441637; Breslau N, 2004, PEDIATRICS, V114, P1035, DOI 10.1542/peds.2004-0069; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chyi LJ, 2008, J PEDIATR-US, V153, P25, DOI 10.1016/j.jpeds.2008.01.027; Corbett BA, 2009, PSYCHIAT RES, V166, P210, DOI 10.1016/j.psychres.2008.02.005; Dannemiller JL, 2004, INFANT BEHAV DEV, V27, P204, DOI 10.1016/j.infbeh.2003.09.003; De Blasio MJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE75, DOI 10.1152/ajpendo.00689.2006; Deary IJ, 2001, INTELLIGENCE, V29, P389, DOI 10.1016/S0160-2896(01)00062-9; Diamond A, 2006, TRENDS COGN SCI, V10, P212, DOI 10.1016/j.tics.2006.03.003; Dirani M, 2010, INVEST OPHTH VIS SCI, V51, P1348, DOI 10.1167/iovs.09-3587; Fray PJ, 1996, INT J GERIATR PSYCH, V11, P329; Heinonen K, 2008, PEDIATRICS, V121, pE1325, DOI 10.1542/peds.2007-1172; HUGHES C, 1994, NEUROPSYCHOLOGIA, V32, P477, DOI 10.1016/0028-3932(94)90092-2; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Kalff AC, 2005, J INT NEUROPSYCH SOC, V11, P173; Kinney HC, 2006, SEMIN PERINATOL, V30, P81, DOI 10.1053/j.semperi.2006.02.006; Kirkhart MW, 2001, J GEN PSYCHOL, V128, P447, DOI 10.1080/00221300109598921; LAGERSTROM M, 1994, INT J PSYCHOPHYSIOL, V17, P175, DOI 10.1016/0167-8760(94)90033-7; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Livesey D, 2006, HUM MOVEMENT SCI, V25, P50, DOI 10.1016/j.humov.2005.10.008; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; Luciana M, 2002, DEV NEUROPSYCHOL, V22, P595, DOI 10.1207/S15326942DN2203_3; Lundgren EM, 2008, BEST PRACT RES CL EN, V22, P477, DOI 10.1016/j.beem.2008.01.014; Marit M, 2009, J PEDIAT, V155, p[848, e841]; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; Moe V, 2001, INFANT MENT HEALTH J, V22, P334, DOI 10.1002/imhj.1005; Molfese VJ, 2010, CONTEMP EDUC PSYCHOL, V35, P116, DOI 10.1016/j.cedpsych.2010.03.004; Morse SB, 2009, PEDIATRICS, V123, pE622, DOI 10.1542/peds.2008-1405; Mullis PE, 2008, BEST PRACT RES CL EN, V22, P173, DOI 10.1016/j.beem.2007.07.010; Power C, 2006, J PEDIATR-US, V148, P54, DOI 10.1016/j.jpeds.2005.07.028; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; RICKARDS AL, 1993, J DEV BEHAV PEDIATR, V14, P363; Roth S, 1999, EARLY HUM DEV, V55, P39, DOI 10.1016/S0378-3782(99)00002-X; Shenkin SD, 2001, ARCH DIS CHILD, V85, P189, DOI 10.1136/adc.85.3.189; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Silva A, 2006, ANN EPIDEMIOL, V16, P469, DOI 10.1016/j.annepidem.2005.06.056; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; van Batenburg-Eddes T, 2008, EARLY HUM DEV, V84, P659, DOI 10.1016/j.earlhumdev.2008.04.007; van der Sluis S, 2007, INTELLIGENCE, V35, P427, DOI 10.1016/j.intell.2006.09.001; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	46	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36502	10.1371/journal.pone.0036502	http://dx.doi.org/10.1371/journal.pone.0036502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UL	22558470	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200083
J	Wang, XH; Wen, XH; Xia, Y; Hu, M; Zhao, F; Ding, K				Wang, Xiaohui; Wen, Xianghua; Xia, Yu; Hu, Ma; Zhao, Fang; Ding, Kun			Ammonia Oxidizing Bacteria Community Dynamics in a Pilot-Scale Wastewater Treatment Plant	PLOS ONE			English	Article							RESTRICTION FRAGMENT LENGTH; AEROBIC BIOFILM REACTORS; ACTIVATED-SLUDGE; MICROBIAL COMMUNITIES; DIVERSITY; QUANTIFICATION; GROWTH	Background: Chemoautotrophic ammonia oxidizing bacteria (AOB) have the metabolic ability to oxidize ammonia to nitrite aerobically. This metabolic feature has been widely used, in combination with denitrification, to remove nitrogen from wastewater in wastewater treatment plants (WWTPs). However, the relative influence of specific deterministic environmental factors to AOB community dynamics in WWTP is uncertain. The ecological principles underlying AOB community dynamics and nitrification stability and how they are related are also poorly understood. Methodology/Principal Findings: The community dynamics of ammonia oxidizing bacteria (AOB) in a pilot-scale WWTP were monitored over a one-year period by Terminal Restriction Fragment Length Polymorphism (T-RFLP). During the study period, the effluent ammonia concentrations were almost below 2 mg/L, except for the first 60 days, indicting stable nitrification. T-RFLP results showed that, during the test period with stable nitrification, the AOB community structures were not stable, and the average change rate (every 15 days) of AOB community structures was 10%+/- 8%. The correlations between T-RFLP profiles and 10 operational and environmental parameters were tested by Canonical Correlation Analysis (CCA) and Mantel test. The results indicated that the dynamics of AOB community correlated most strongly with Dissolved Oxygen (DO), effluent ammonia, effluent Biochemical Oxygen Demand (BOD) and temperature. Conclusions/Significance: This study suggests that nitrification stability is not necessarily accompanied by a stable AOB community, and provides insight into parameters controlling the AOB community dynamics within bioreactors with stable nitrification.	[Wang, Xiaohui; Wen, Xianghua; Xia, Yu; Hu, Ma; Zhao, Fang; Ding, Kun] Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing 100084, Peoples R China	Tsinghua University	Wang, XH (corresponding author), Tsinghua Univ, Environm Simulat & Pollut Control State Key Joint, Sch Environm, Beijing 100084, Peoples R China.	xhwen@tsinghua.edu.cn	wen, xianghua/A-7551-2015		NSFC [51078207]; Specialized Research Fund for the Doctoral Program of Higher Education [20090002770003]; Tsinghua University [20101081834]	NSFC(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Tsinghua University	This study was supported by the NSFC (51078207), Specialized Research Fund for the Doctoral Program of Higher Education (20090002770003), and the Research funding of Tsinghua University (20101081834). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsubasi AT, 2009, ENVIRON SCI TECHNOL, V43, P2950, DOI 10.1021/es8026488; Briones A, 2003, CURR OPIN BIOTECH, V14, P270, DOI 10.1016/S0958-1669(03)00065-X; Dytczak MA, 2008, WATER RES, V42, P2320, DOI 10.1016/j.watres.2007.12.018; Gentile ME, 2007, APPL ENVIRON MICROB, V73, P680, DOI 10.1128/AEM.01519-06; Gilbride KA, 2006, J MICROBIOL METH, V66, P1, DOI 10.1016/j.mimet.2006.02.016; Hallin S, 2005, J APPL MICROBIOL, V99, P629, DOI 10.1111/j.1365-2672.2005.02608.x; Kaplan CW, 2003, J MICROBIOL METH, V54, P121, DOI 10.1016/S0167-7012(03)00003-4; Lim J, 2008, BIOTECHNOL BIOENG, V99, P1374, DOI 10.1002/bit.21715; Limpiyakorn T, 2005, FEMS MICROBIOL ECOL, V54, P205, DOI 10.1016/j.femsec.2005.03.017; Limpiyakorn T, 2007, FEMS MICROBIOL ECOL, V60, P501, DOI 10.1111/j.1574-6941.2007.00307.x; Lydmark P, 2007, ENVIRON MICROBIOL, V9, P2220, DOI 10.1111/j.1462-2920.2007.01336.x; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Miura Y, 2007, WATER RES, V41, P627, DOI 10.1016/j.watres.2006.11.005; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; Park HD, 2004, WATER RES, V38, P3275, DOI 10.1016/j.watres.2004.04.047; Park HD, 2009, J MICROBIOL BIOTECHN, V19, P346, DOI 10.4014/jmb.0806.399; Park JJ, 2008, WATER SCI TECHNOL, V57, P1889, DOI 10.2166/wst.2008.622; Park JJ, 2008, KOREAN J CHEM ENG, V25, P1448, DOI 10.1007/s11814-008-0238-4; Pholchan MK, 2010, WATER RES, V44, P1341, DOI 10.1016/j.watres.2009.11.005; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Rowan AK, 2003, WATER SCI TECHNOL, V48, P17, DOI 10.2166/wst.2003.0149; Satoh H, 2006, BIOTECHNOL BIOENG, V94, P762, DOI 10.1002/bit.20894; Siripong S, 2007, WATER RES, V41, P1110, DOI 10.1016/j.watres.2006.11.050; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Wang XH, 2010, J ENVIRON SCI-CHINA, V22, P627, DOI 10.1016/S1001-0742(09)60155-8; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Wittebolle L, 2009, J APPL MICROBIOL, V107, P385, DOI 10.1111/j.1365-2672.2009.04222.x; Wittebolle L, 2008, APPL ENVIRON MICROB, V74, P286, DOI 10.1128/AEM.01006-07; Xia S, 2008, ECOL ENG, V32, P256, DOI 10.1016/j.ecoleng.2007.11.013; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Zhang B, 2010, BIORESOURCE TECHNOL, V101, P3054, DOI 10.1016/j.biortech.2009.12.048	34	26	30	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36272	10.1371/journal.pone.0036272	http://dx.doi.org/10.1371/journal.pone.0036272			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558415	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000176
J	Marquez-Ruiz, J; Cheron, G				Marquez-Ruiz, Javier; Cheron, Guy			Sensory Stimulation-Dependent Plasticity in the Cerebellar Cortex of Alert Mice	PLOS ONE			English	Article							LONG-TERM DEPRESSION; PARALLEL FIBER SYNAPSES; PURKINJE-CELL DENDRITES; SYNAPTIC PLASTICITY; GRANULE CELL; GLUTAMATE SENSITIVITY; SPATIAL-ORGANIZATION; TACTILE STIMULATION; IN-VIVO; RAT	In vitro studies have supported the occurrence of cerebellar long-term depression (LTD), an interaction between the parallel fibers and Purkinje cells (PCs) that requires the combined activation of the parallel and climbing fibers. To demonstrate the existence of LTD in alert animals, we investigated the plasticity of local field potentials (LFPs) evoked by electrical stimulation of the whisker pad. The recorded LFP showed two major negative waves corresponding to trigeminal (broken into the N2 and N3 components) and cortical responses. PC unitary extracellular recording showed that N2 and N3 occurred concurrently with PC evoked simple spikes, followed by an evoked complex spike. Polarity inversion of the N3 component at the PC level and N3 amplitude reduction after electrical stimulation of the parallel fiber volley applied on the surface of the cerebellum 2 ms earlier strongly suggest that N3 was related to the parallel fiber-PC synapse activity. LFP measurements elicited by single whisker pad stimulus were performed before and after trains of electrical stimuli given at a frequency of 8 Hz for 10 min. We demonstrated that during this later situation, the stimulation of the PC by parallel and climbing fibers was reinforced. After 8-Hz stimulation, we observed long-term modifications (lasting at least 30 min) characterized by a specific decrease of the N3 amplitude accompanied by an increase of the N2 and N3 latency peaks. These plastic modifications indicated the existence of cerebellar LTD in alert animals involving both timing and synaptic modulations. These results corroborate the idea that LTD may underlie basic physiological functions related to calcium-dependent synaptic plasticity in the cerebellum.	[Marquez-Ruiz, Javier] Univ Pablo de Olavide, Div Neurociencias, Seville, Spain; [Cheron, Guy] Univ Mons, Lab Electrophysiol, B-7000 Mons, Belgium; [Cheron, Guy] Univ Libre Brussels, Lab Neurophysiol & Movement Biomech CP601, Brussels, Belgium	Universidad Pablo de Olavide; University of Mons; Universite Libre de Bruxelles	Marquez-Ruiz, J (corresponding author), Univ Pablo de Olavide, Div Neurociencias, Seville, Spain.	gcheron@ulb.ac.be	Márquez-Ruiz, Javier/P-3998-2014	Márquez-Ruiz, Javier/0000-0002-8036-8707	Belgian Federal Science Policy Office; European Space Agency [AO-2004,118]; Belgian National Fund for Scientific Research (FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Ministerio de Educacion of the Spanish Government	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); European Space Agency(European Space AgencyEuropean Commission); Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles; Universite de Mons (Belgium); Ministerio de Educacion of the Spanish Government(Spanish Government)	This work was funded by the Belgian Federal Science Policy Office, the European Space Agency, (AO-2004,118), the Belgian National Fund for Scientific Research (FNRS), and the research funds of the Universite Libre de Bruxelles and the Universite de Mons (Belgium). This work was also supported by the Ministerio de Educacion y Ciencia Programa Nacional de Movilidad de Recursos Humanos del Plan nacional de I-D+I 2008-2011 of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1980, J PHYSIOL-LONDON, V309, P357, DOI 10.1113/jphysiol.1980.sp013513; Bidoret C, 2009, P NATL ACAD SCI USA, V106, P14126, DOI 10.1073/pnas.0904284106; Bosman LWJ, 2010, J PHYSIOL-LONDON, V588, P3757, DOI 10.1113/jphysiol.2010.195180; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chen G, 2009, J NEUROPHYSIOL, V101, P234, DOI 10.1152/jn.90829.2008; Cheron G, 2004, J NEUROSCI, V24, P434, DOI 10.1523/JNEUROSCI.3197-03.2004; Cheron G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007991; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1988, BRAIN RES, V458, P397, DOI 10.1016/0006-8993(88)90486-6; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; Daniel H, 1998, TRENDS NEUROSCI, V21, P401, DOI 10.1016/S0166-2236(98)01304-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; EBNER TJ, 1983, J NEUROPHYSIOL, V50, P205, DOI 10.1152/jn.1983.50.1.205; ECCLES JC, 1967, EXP BRAIN RES, V3, P58; ECCLES JC, 1966, EXP BRAIN RES, V1, P1; Eccles JC, 1967, CEREBELLUM NEURONAL; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; EKEROT CF, 1989, NEUROSCI RES, V6, P264, DOI 10.1016/0168-0102(89)90065-5; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; Holtzman T, 2006, J PHYSIOL-LONDON, V574, P491, DOI 10.1113/jphysiol.2006.108282; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; Llinas R, 1997, LEARN MEMORY, V3, P445, DOI 10.1101/lm.3.6.445; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Llinas RR, 1982, CEREBELLUM NEW VISTA, P189; Lu H, 2009, J COMP NEUROL, V514, P583, DOI 10.1002/cne.22041; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Megevand P, 2009, J NEUROSCI, V29, P5326, DOI 10.1523/JNEUROSCI.5965-08.2009; Mittmann W, 2007, J NEUROSCI, V27, P5559, DOI 10.1523/JNEUROSCI.5117-06.2007; Morissette J, 1996, EXP BRAIN RES, V109, P240; OJAKANGAS CL, 1992, J NEUROPHYSIOL, V68, P2222, DOI 10.1152/jn.1992.68.6.2222; Piochon Claire, 2010, J Neurosci, V30, P15330, DOI 10.1523/JNEUROSCI.4344-10.2010; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Roggeri L, 2008, J NEUROSCI, V28, P6354, DOI 10.1523/JNEUROSCI.5709-07.2008; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Servais L, 2007, P NATL ACAD SCI USA, V104, P9858, DOI 10.1073/pnas.0607037104; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang X, 2009, NEUROSCIENCE, V162, P713, DOI 10.1016/j.neuroscience.2009.01.071; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	56	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36184	10.1371/journal.pone.0036184	http://dx.doi.org/10.1371/journal.pone.0036184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563448	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100073
J	Luzon-Toro, B; Torroglosa, A; Nunez-Torres, R; Enguix-Riego, MV; Fernandez, RM; de Agustin, JC; Antinolo, G; Borrego, S				Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Carlos de Agustin, Juan; Antinolo, Guillermo; Borrego, Salud			Comprehensive Analysis of NRG1 Common and Rare Variants in Hirschsprung Patients	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ENTERIC NERVOUS-SYSTEM; NEU DIFFERENTIATION FACTORS; TRANSCRIPTION FACTOR SOX10; SUSCEPTIBILITY LOCUS; CYTOPLASMIC TAIL; MOUSE MODEL; DISEASE; RET; GENE	Hirschsprung disease (HSCR, OMIM 142623) is a developmental disorder characterized by the absence of ganglion cells along variable lengths of the distal gastrointestinal tract, which results in tonic contraction of the aganglionic gut segment and functional intestinal obstruction. The RET proto-oncogene is the major gene for HSCR with differential contributions of its rare and common, coding and noncoding mutations to the multifactorial nature of this pathology. Many other genes have been described to be associated with the pathology, as NRG1 gene (8p12), encoding neuregulin 1, which is implicated in the development of the enteric nervous system (ENS), and seems to contribute by both common and rare variants. Here we present the results of a comprehensive analysis of the NRG1 gene in the context of the disease in a series of 207 Spanish HSCR patients, by both mutational screening of its coding sequence and evaluation of 3 common tag SNPs as low penetrance susceptibility factors, finding some potentially damaging variants which we have functionally characterized. All of them were found to be associated with a significant reduction of the normal NRG1 protein levels. The fact that those mutations analyzed alter NRG1 protein would suggest that they would be related with HSCR disease not only in Chinese but also in a Caucasian population, which reinforces the implication of NRG1 gene in this pathology.	[Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Antinolo, Guillermo; Borrego, Salud] Univ Seville, CSIC, Univ Hosp Virgen Rocio, Dept Genet Reprod & Fetal Med,Inst Biomed Seville, Seville, Spain; [Luzon-Toro, Berta; Torroglosa, Ana; Nunez-Torres, Rocio; Valle Enguix-Riego, Maria; Maria Fernandez, Raquel; Antinolo, Guillermo; Borrego, Salud] Ctr Biomed Network Res Rare Dis CIBERER, Seville, Spain; [Carlos de Agustin, Juan] Univ Hosp Virgen Rocio, Dept Pediat Surg, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Virgen del Rocio University Hospital	Luzon-Toro, B (corresponding author), Univ Seville, CSIC, Univ Hosp Virgen Rocio, Dept Genet Reprod & Fetal Med,Inst Biomed Seville, Seville, Spain.	salud.borrego.sspa@juntadeandalucia.es	IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; LUZON, BERTA/D-4884-2014; De Agustin, Juan/AAT-1824-2021; IBIS, MALFORMACIONES/H-7372-2016; Torroglosa, Ana/AAU-9812-2020; IBIS, GENETICA/P-3384-2015	De Agustin, Juan/0000-0002-2413-2871; Antinolo Gil, Guillermo/0000-0002-2113-074X; Torroglosa, Ana/0000-0003-1911-7906	Instituto de Salud Carlos III, Spain [PI1001290]; Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia [CTS-2590, CTS-7447]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia)	This study was funded by the Instituto de Salud Carlos III, Spain (PI1001290) and Consejeria de Innovacion Ciencia y Empresa de la Junta de Andalucia (CTS-2590 and CTS-7447). The CIBER de Enfermedades Raras is an initiative of the ISCIII, Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brooks AS, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.038125; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chakravarti A, 2002, HIRSCHSPRUNG DIS MET; Crone SA, 2003, NEURON, V37, P29, DOI 10.1016/S0896-6273(02)01128-5; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fernandez RM, 2009, ANN HUM GENET, V73, P19, DOI 10.1111/j.1469-1809.2008.00479.x; Fernandez RM, 2005, J MED GENET, V42, P322, DOI 10.1136/jmg.2004.023960; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2008, EUR J HUM GENET, V16, P833, DOI 10.1038/ejhg.2008.18; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Liu XF, 1998, J BIOL CHEM, V273, P34335, DOI 10.1074/jbc.273.51.34335; Liu XF, 1998, P NATL ACAD SCI USA, V95, P13024, DOI 10.1073/pnas.95.22.13024; LU HS, 1995, J BIOL CHEM, V270, P4784, DOI 10.1074/jbc.270.9.4784; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; MEYER D, 1994, P NATL ACAD SCI USA, V91, P1064, DOI 10.1073/pnas.91.3.1064; Nunez-Torres R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-138; ORRURTREGER A, 1993, P NATL ACAD SCI USA, V90, P1867, DOI 10.1073/pnas.90.5.1867; Ota K, 1998, MOL CELL, V2, P495, DOI 10.1016/S1097-2765(00)80149-5; Paratore C, 2002, HUM MOL GENET, V11, P3075, DOI 10.1093/hmg/11.24.3075; Paratore C, 2001, DEVELOPMENT, V128, P3949; Phusantisampan T, 2012, J HUM GENET, V57, P286, DOI 10.1038/jhg.2012.18; PRIGENT SA, 1992, ONCOGENE, V7, P1273; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Ruiz-Ferrer M, 2008, J PEDIATR SURG, V43, P1308, DOI 10.1016/j.jpedsurg.2008.02.076; Ruiz-Ferrer M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023475; Ruiz-Ferrer M, 2011, J MOL MED, V89, P471, DOI 10.1007/s00109-010-0714-2; Schroering A, 1998, J BIOL CHEM, V273, P30643, DOI 10.1074/jbc.273.46.30643; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Tang CSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016181; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909	41	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36524	10.1371/journal.pone.0036524	http://dx.doi.org/10.1371/journal.pone.0036524			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574178	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800075
J	Macedo, E; Zanetta, DMT; Abdulkader, RCRM				Macedo, Etienne; Zanetta, Dirce M. T.; Abdulkader, Regina C. R. M.			Long-Term Follow-Up of Patients after Acute Kidney Injury: Patterns of Renal Functional Recovery	PLOS ONE			English	Article							ACUTE TUBULAR-NECROSIS; BASE-LINE CREATININE; REPLACEMENT THERAPY; FAILURE; EPIDEMIOLOGY; SURVIVORS; DIALYSIS; OUTCOMES; DECLINE; RISK	Background and Objectives: Patients who survive acute kidney injury (AKI), especially those with partial renal recovery, present a higher long-term mortality risk. However, there is no consensus on the best time to assess renal function after an episode of acute kidney injury or agreement on the definition of renal recovery. In addition, only limited data regarding predictors of recovery are available. Design, Setting, Participants, & Measurements: From 1984 to 2009, 84 adult survivors of acute kidney injury were followed by the same nephrologist (RCRMA) for a median time of 4.1 years. Patients were seen at least once each year after discharge until end stage renal disease (ESRD) or death. In each consultation serum creatinine was measured and glomerular filtration rate estimated. Renal recovery was defined as a glomerular filtration rate value >= 60 mL/min/1.73 m2. A multiple logistic regression was performed to evaluate factors independently associated with renal recovery. Results: The median length of follow-up was 50 months (30-90 months). All patients had stabilized their glomerular filtration rates by 18 months and 83% of them stabilized earlier: up to 12 months. Renal recovery occurred in 16 patients (19%) at discharge and in 54 (64%) by 18 months. Six patients died and four patients progressed to ESRD during the follow up period. Age (OR 1.09, p < 0.0001) and serum creatinine at hospital discharge (OR 2.48, p = 0.007) were independent factors associated with non renal recovery. The acute kidney injury severity, evaluated by peak serum creatinine and need for dialysis, was not associated with non renal recovery. Conclusions: Renal recovery must be evaluated no earlier than one year after an acute kidney injury episode. Nephrology referral should be considered mainly for older patients and those with elevated serum creatinine at hospital discharge.	[Macedo, Etienne; Abdulkader, Regina C. R. M.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Macedo, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.	kader@usp.br	Macedo, Etienne/D-4659-2012; Zanetta, Dirce M T/G-4950-2013	Macedo, Etienne/0000-0002-3669-6519; Zanetta, Dirce Maria/0000-0002-7273-5087				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Andrikos Emilios, 2009, Blood Purif, V28, P239, DOI 10.1159/000231986; Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Bagshaw SM, 2006, CURR OPIN CRIT CARE, V12, P544; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Bellomo R, 2005, CRIT CARE CLIN, V21, P223, DOI 10.1016/j.ccc.2004.12.001; Bhandari S, 1996, QJM-MON J ASSOC PHYS, V89, P415; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; COSENTINO F, 1994, NEPHROL DIAL TRANSPL, V9, P179; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; James MT, 2010, KIDNEY INT, V78, P803, DOI 10.1038/ki.2010.258; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pickering JW, 2010, CLIN J AM SOC NEPHRO, V5, P1165, DOI 10.2215/CJN.08531109; Ponte B, 2008, NEPHROL DIAL TRANSPL, V23, P3859, DOI 10.1093/ndt/gfn398; Schiffl H, 2006, NEPHROL DIAL TRANSPL, V21, P1248, DOI 10.1093/ndt/gfk069; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Sesso R, 2008, NEPHROLOGY, V13, P99, DOI 10.1111/j.1440-1797.2008.00919.x; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Tolwani A, 2008, INT J ARTIF ORGANS, V31, P190, DOI 10.1177/039139880803100212; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; van Kuijk JP, 2010, CLIN J AM SOC NEPHRO, V5, P1198, DOI 10.2215/CJN.00020110; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322	32	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36388	10.1371/journal.pone.0036388	http://dx.doi.org/10.1371/journal.pone.0036388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574153	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800049
J	Maudoux, A; Lefebvre, P; Cabay, JE; Demertzi, A; Vanhaudenhuyse, A; Laureys, S; Soddu, A				Maudoux, Audrey; Lefebvre, Philippe; Cabay, Jean-Evrard; Demertzi, Athena; Vanhaudenhuyse, Audrey; Laureys, Steven; Soddu, Andrea			Auditory Resting-State Network Connectivity in Tinnitus: A Functional MRI Study	PLOS ONE			English	Article							RESONANCE-IMAGING FMRI; DEFAULT NETWORK; CORTEX; ACTIVATION; MECHANISMS; MODE; PAIN	The underlying functional neuroanatomy of tinnitus remains poorly understood. Few studies have focused on functional cerebral connectivity changes in tinnitus patients. The aim of this study was to test if functional MRI "resting-state'' connectivity patterns in auditory network differ between tinnitus patients and normal controls. Thirteen chronic tinnitus subjects and fifteen age-matched healthy controls were studied on a 3 tesla MRI. Connectivity was investigated using independent component analysis and an automated component selection approach taking into account the spatial and temporal properties of each component. Connectivity in extra-auditory regions such as brainstem, basal ganglia/NAc, cerebellum, parahippocampal, right prefrontal, parietal, and sensorimotor areas was found to be increased in tinnitus subjects. The right primary auditory cortex, left prefrontal, left fusiform gyrus, and bilateral occipital regions showed a decreased connectivity in tinnitus. These results show that there is a modification of cortical and subcortical functional connectivity in tinnitus encompassing attentional, mnemonic, and emotional networks. Our data corroborate the hypothesized implication of non-auditory regions in tinnitus physiopathology and suggest that various regions of the brain seem involved in the persistent awareness of the phenomenon as well as in the development of the associated distress leading to disabling chronic tinnitus.	[Maudoux, Audrey; Demertzi, Athena; Vanhaudenhuyse, Audrey; Laureys, Steven; Soddu, Andrea] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Maudoux, Audrey; Lefebvre, Philippe] Univ Liege, OtoRhinoLaryngol Head & Neck Surg Dept, Liege, Belgium; [Cabay, Jean-Evrard] Univ Liege, CHU Sart Tilman Hosp, Dept Radiol, Liege, Belgium; [Laureys, Steven] Univ Liege, CHU Sart Tilman Hosp, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Maudoux, A (corresponding author), Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium.	amaudoux@doct.ulg.ac.be; Andrea.Soddu@ulg.ac.be	Vanhaudenhuyse, Audrey/AAP-2455-2020; Soddu, Andrea/K-7087-2014; Demertzi, Athena/I-1251-2019; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021	Soddu, Andrea/0000-0001-6833-745X; Demertzi, Athena/0000-0001-8021-3759; Laureys, Steven/0000-0002-3096-3807	Belgian National Funds for Scientific Research (FNRS) [FNRS 9.4501.12]; European Commission; James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action [ARC-06/11-340]; Public Utility Foundation "Universite Europeenne du Travail''; Fondazione Europea di Ricerca Biomedica; University and University Hospital of Liege	Belgian National Funds for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Commission(European CommissionEuropean Commission Joint Research Centre); James McDonnell Foundation; Mind Science Foundation; French Speaking Community Concerted Research Action; Public Utility Foundation "Universite Europeenne du Travail''; Fondazione Europea di Ricerca Biomedica; University and University Hospital of Liege	This research was funded by the Belgian National Funds for Scientific Research (FNRS), the Tinnitus Prize 2011 (FNRS 9.4501.12), the European Commission, the James McDonnell Foundation, the Mind Science Foundation, the French Speaking Community Concerted Research Action (ARC-06/11-340), the Public Utility Foundation "Universite Europeenne du Travail,'' "Fondazione Europea di Ricerca Biomedica,'' and the University and University Hospital of Liege. AM is a Research Fellow; AV and AS are Post-Doctoral Fellows, and SL is a Senior Research Associate at the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjamian P, 2009, HEARING RES, V253, P15, DOI 10.1016/j.heares.2009.04.001; Barrs DM, 1984, J LARYNGOL OTOL S, V98, P287; BEARD AW, 1965, J PSYCHOSOM RES, V9, P29, DOI 10.1016/0022-3999(65)90008-5; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; De Martino F, 2007, NEUROIMAGE, V34, P177, DOI 10.1016/j.neuroimage.2006.08.041; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Demertzi A, 2011, PROG BRAIN RES, V193, P309, DOI 10.1016/B978-0-444-53839-0.00020-X; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engelien A, 2000, ANN NY ACAD SCI, V911, P477; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hallam RS., 1996, MANUAL TINNITUS QUES; House J W, 1981, Ciba Found Symp, V85, P204; Hunter MD, 2006, P NATL ACAD SCI USA, V103, P189, DOI 10.1073/pnas.0506268103; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Kleinjung T, 2008, OTOLARYNG HEAD NECK, V138, P497, DOI 10.1016/j.otohns.2007.12.022; Knight R.T., 1995, ADV NEUROL, V66, P34; KNIGHT RT, 1995, ADV NEUROL, V66, P21; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Larson PS, 2012, NEUROSURGERY, V70, P398, DOI 10.1227/NEU.0b013e3182320ab5; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lockwood AH, 2001, NEUROLOGY, V56, P472, DOI 10.1212/WNL.56.4.472; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Moller, 2011, TXB TINNITUS; MURPHY JP, 1951, YALE J BIOL MED, V23, P493; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Osaki Y, 2005, NEUROREPORT, V16, P1625, DOI 10.1097/01.wnr.0000183899.85277.08; Petacchi A, 2005, HUM BRAIN MAPP, V25, P118, DOI 10.1002/hbm.20137; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Schlee W, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-80; Schlee W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003720; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2011, EXP BRAIN RES, V210, P217, DOI 10.1007/s00221-011-2617-z; WATTS J W, 1946, J Int Coll Surg, V9, P679; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; WHO, 1991, HEARING NETWORK NEWS, V1; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	57	144	153	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36222	10.1371/journal.pone.0036222	http://dx.doi.org/10.1371/journal.pone.0036222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574141	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800037
J	Penwell, WF; Arivett, BA; Actis, LA				Penwell, William F.; Arivett, Brock A.; Actis, Luis A.			The Acinetobacter baumannii entA Gene Located Outside the Acinetobactin Cluster Is Critical for Siderophore Production, Iron Acquisition and Virulence	PLOS ONE			English	Article							2,3-DIHYDROXYBENZOIC ACID; VIBRIO-ANGUILLARUM; BRUCELLA-ABORTUS; GENOME SEQUENCE; PLASMID PJM1; PATHOGEN; BIOSYNTHESIS; SYSTEM; VIBRIO-ANGUILLARUM-775; IDENTIFICATION	Acinetobacter baumannii causes severe infections in compromised patients, who present an iron-limited environment that controls bacterial growth. This pathogen has responded to this restriction by expressing high-affinity iron acquisition systems including that mediated by the siderophore acinetobactin. Gene cloning, functional assays and biochemical tests showed that the A. baumannii genome contains a single functional copy of an entA ortholog. This gene, which is essential for the biosynthesis of the acinetobactin precursor 2,3-dihydroxybenzoic acid (DHBA), locates outside of the acinetobactin gene cluster, which otherwise harbors all genes needed for acinetobactin biosynthesis, export and transport. In silico analyses and genetic complementation tests showed that entA locates next to an entB ortholog, which codes for a putative protein that contains the isochorismatase lyase domain, which is needed for DHBA biosynthesis from isochorismic acid, but lacks the aryl carrier protein domain, which is needed for tethering activated DHBA and completion of siderophore biosynthesis. Thus, basF, which locates within the acinetobactin gene cluster, is the only fully functional entB ortholog present in ATCC 19606(T). The differences in amino acid length and sequences between these two EntB orthologs and the differences in the genetic context within which the entA and entB genes are found in different A. baumannii isolates indicate that they were acquired from different sources by horizontal transfer. Interestingly, the AYE strain proved to be a natural entA mutant capable of acquiring iron via an uncharacterized siderophore-mediated system, an observation that underlines the ability of different A. baumannii isolates to acquire iron using different systems. Finally, experimental infections using in vivo and ex vivo models demonstrate the role of DHBA and acinetobactin intermediates in the virulence of the ATCC 19606(T) cells, although to a lesser extent when compared to the responses obtained with bacteria producing and using fully matured acinetobactin to acquire iron.	[Penwell, William F.; Arivett, Brock A.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA	University System of Ohio; Miami University	Penwell, WF (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@muohio.edu	Arivett, Brock/T-2569-2018	Arivett, Brock/0000-0002-1291-3814	US Public Health [AI070174]; NSF [0420479]; Miami University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070174] Funding Source: NIH RePORTER	US Public Health(United States Department of Health & Human ServicesUnited States Public Health Service); NSF(National Science Foundation (NSF)); Miami University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	US Public Health AI070174 and NSF 0420479 grants and Miami University funds supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Alice AF, 2005, J BACTERIOL, V187, P2209, DOI 10.1128/JB.187.6.2209-2214.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSTEY NM, 1992, CLIN INFECT DIS, V14, P83, DOI 10.1093/clinids/14.1.83; Antunes LCS, 2011, RES MICROBIOL, V162, P279, DOI 10.1016/j.resmic.2010.10.010; Arnow LE, 1937, J BIOL CHEM, V118, P531; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bellaire BH, 2003, INFECT IMMUN, V71, P2927, DOI 10.1128/IAI.71.5.2927-2932.2003; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Crichton RR., 2009, IRON METABOLISM MOL; Crosa JH., 2004, IRON TRANSPORT BACTE; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; Di Lorenzo M, 2011, BIOMETALS, V24, P629, DOI 10.1007/s10534-011-9416-7; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Dorsey CW, 2003, J CLIN MICROBIOL, V41, P4188, DOI 10.1128/JCM.41.9.4188-4193.2003; Dorsey CW, 2003, MICROBIOL-SGM, V149, P1227, DOI 10.1099/mic.0.26204-0; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Earhart C.F., 1996, ESCHERICHIA COLI SAL, V2nd ed., P1075; ECHENIQUE JR, 1992, J BACTERIOL, V174, P7670, DOI 10.1128/JB.174.23.7670-7679.1992; Eijkelkamp BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-126; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; Mihara K, 2004, MICROBIOL-SGM, V150, P2587, DOI 10.1099/mic.0.27141-0; Naka H, 2008, ENVIRON MICROBIOL, V10, P265, DOI 10.1111/j.1462-2920.2007.01450.x; Naka H, 2012, BIOMETALS, V25, P125, DOI 10.1007/s10534-011-9488-4; Parent MA, 2002, MICROB PATHOGENESIS, V32, P239, DOI 10.1006/mpat.2002.0500; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Sambrook J., 2001, MOL CLONING LAB MANU; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; STAAB JF, 1990, J BACTERIOL, V172, P6403, DOI 10.1128/jb.172.11.6403-6410.1990; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; WALSH CT, 1990, CHEM REV, V90, P1105, DOI 10.1021/cr00105a003; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou Z, 2007, P NATL ACAD SCI USA, V104, P11621, DOI 10.1073/pnas.0705122104; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	52	52	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36493	10.1371/journal.pone.0036493	http://dx.doi.org/10.1371/journal.pone.0036493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570720	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400036
J	Connell, C; Tong, HI; Wang, Z; Allmann, E; Lu, YA				Connell, Christina; Tong, Hsin-I; Wang, Zi; Allmann, Erin; Lu, Yuanan			New Approaches for Enhanced Detection of Enteroviruses from Hawaiian Environmental Waters	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; TIME RT-PCR; REVERSE-TRANSCRIPTASE PCR; WATERBORNE ENTERIC VIRUSES; CELL-CULTURE; INFECTIOUS ENTEROVIRUSES; SURFACE WATERS; ASSAY; IDENTIFICATION; AMPLIFICATION	Health risks associated with sewage-contaminated recreational waters are of important public health concern. Reliable water monitoring systems are therefore crucial. Current recreational water quality criteria rely predominantly on the enumeration of bacterial indicators, while potentially dangerous viral pathogens often remain undetected. Human enteric viruses have been proposed as alternative indicators; however, their detection is often hindered by low viral concentrations present in the environment. Reported here are novel and effective laboratory protocols for viral concentration and highly sensitive and optimized RT-PCR for the efficient detection of enteroviruses, an important enteric virus subset, in Hawaiian environmental waters. Eighteen published enterovirus primer pairs were comparatively evaluated for detection sensitivity. The primer set exhibiting the lowest detection limit under optimized conditions, EQ-1/EQ-2, was validated in a field survey of 22 recreational bodies of water located around the island of Oahu, Hawaii. Eleven sites tested positive for enterovirus, indicating fecal contamination at these locations. As an additional means of viral concentration, shellfish were collected from 9 sample sites and subjected to dissection, RNA extraction, and subsequent RT-PCR. Shellfish tissue from 6 of 9 sites tested positive for enterovirus. The techniques implemented here are valuable resources to aid accurate reflection of microbial contamination in Hawaii's environmental waters.	[Connell, Christina] Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA; Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Connell, C (corresponding author), Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA.	yuanan@hawaii.edu			Centers for Oceans and Human Health (COHH); National Institutes of Environmental Health Sciences [P50ES012740]; National Science Foundation [OCE04-32479, OCE09-11000]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P50ES012740] Funding Source: NIH RePORTER	Centers for Oceans and Human Health (COHH); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the Centers for Oceans and Human Health (COHH) program, the National Institutes of Environmental Health Sciences (P50ES012740) and the National Science Foundation (OCE04-32479 and OCE09-11000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBASZADEGAN M, 1993, APPL ENVIRON MICROB, V59, P1318, DOI 10.1128/AEM.59.5.1318-1324.1993; Asahina AY, 2009, J VIROL METHODS, V158, P46, DOI 10.1016/j.jviromet.2009.01.013; Bej AK, 2001, APPL ENVIRON MICROB, V57, P1013; Bessaud M, 2008, J VIROL METHODS, V149, P277, DOI 10.1016/j.jviromet.2008.01.027; Boehm AB, 2003, ENVIRON SCI TECHNOL, V37, P673, DOI 10.1021/es025934x; Bosch A., 1998, CURR OPIN BIOTECH, V19, P295; Byappanahalli M, 2004, WATER SCI TECHNOL, V50, P27, DOI 10.2166/wst.2004.0009; Choi S, 2005, APPL ENVIRON MICROB, V71, P7426, DOI 10.1128/AEM.71.11.7426-7433.2005; Chung HM, 1996, APPL ENVIRON MICROB, V62, P3772, DOI 10.1128/AEM.62.10.3772-3778.1996; Dierssen U, 2008, J CLIN VIROL, V42, P58, DOI 10.1016/j.jcv.2007.11.016; Donaldson KA, 2002, WATER RES, V36, P2505, DOI 10.1016/S0043-1354(01)00479-1; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Formiga-Cruz M, 2003, APPL ENVIRON MICROB, V69, P1556, DOI 10.1128/AEM.69.3.1556-1563.2003; Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; FUJIOKA RS, 1980, APPL ENVIRON MICROB, V39, P1105, DOI 10.1128/AEM.39.6.1105-1110.1980; Gersberg RM, 2006, APPL ENVIRON MICROB, V72, P7438, DOI 10.1128/AEM.01024-06; Gregory JB, 2006, APPL ENVIRON MICROB, V72, P3960, DOI 10.1128/AEM.02291-05; Griffin DW, 2003, CLIN MICROBIOL REV, V16, P129, DOI 10.1128/CMR.16.1.129-143.2003; Hot D, 2003, WATER RES, V37, P4703, DOI 10.1016/S0043-1354(03)00439-1; Hymas WC, 2008, CLIN CHEM, V54, P406, DOI 10.1373/clinchem.2007.095414; Ijzerman MM, 1997, J VIROL METHODS, V63, P145, DOI 10.1016/S0166-0934(96)02123-4; Iturriza-Gomara M, 2006, J MED VIROL, V78, P243, DOI 10.1002/jmv.20533; Jothikumar N, 2010, J VIROL METHODS, V169, P8, DOI 10.1016/j.jviromet.2010.06.005; Karamoko Y, 2005, J VIROL METHODS, V126, P135, DOI 10.1016/j.jviromet.2005.02.003; Lee C, 2004, APPL ENVIRON MICROB, V70, P6695, DOI 10.1128/AEM.70.11.6695-6705.2004; LEES DN, 1994, APPL ENVIRON MICROB, V60, P2999, DOI 10.1128/AEM.60.8.2999-3005.1994; Oberste MS, 2004, J GEN VIROL, V85, P2577, DOI 10.1099/vir.0.79925-0; PIRAINO FF, 1982, PUBLIC HEALTH REP, V97, P346; PUIG M, 1994, APPL ENVIRON MICROB, V60, P2963, DOI 10.1128/AEM.60.8.2963-2970.1994; Rajtar B, 2008, ANN AGR ENV MED, V15, P199; Reynolds KA, 1998, CAN J MICROBIOL, V44, P598, DOI 10.1139/cjm-44-6-598; Reynolds KA, 1996, APPL ENVIRON MICROB, V62, P1424, DOI 10.1128/AEM.62.4.1424-1427.1996; Schvoerer E, 2001, RES MICROBIOL, V152, P179, DOI 10.1016/S0923-2508(01)01190-1; Schwab KJ, 1996, APPL ENVIRON MICROB, V62, P2086, DOI 10.1128/AEM.62.6.2086-2094.1996; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tong H, 2011, THESIS U HAWAII MANO; Tong HI, 2011, WATER RES, V45, P5837, DOI 10.1016/j.watres.2011.08.030; Tong HI, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-57; Zhang CM, 2010, J ENVIRON SCI-CHINA, V22, P1261, DOI 10.1016/S1001-0742(09)60248-5; Zoll GJ, 1991, J CLIN VIROL, V30, P160	40	89	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e32442	10.1371/journal.pone.0032442	http://dx.doi.org/10.1371/journal.pone.0032442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567083	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500001
J	Asad, S; Nikamo, P; Gyllenberg, A; Bennet, H; Hansson, O; Wierup, N; Carlsson, A; Forsander, G; Ivarsson, SA; Larsson, H; Lernmark, A; Lindblad, B; Ludvigsson, J; Marcus, C; Ronningen, KS; Nerup, J; Pociot, F; Luthman, H; Fex, M; Kockum, I				Asad, Samina; Nikamo, Pernilla; Gyllenberg, Alexandra; Bennet, Hedvig; Hansson, Ola; Wierup, Nils; Carlsson, Annelie; Forsander, Gun; Ivarsson, Sten-Anders; Larsson, Helena; Lernmark, Ake; Lindblad, Bengt; Ludvigsson, Johnny; Marcus, Claude; Ronningen, Kjersti S.; Nerup, Jan; Pociot, Flemming; Luthman, Holger; Fex, Malin; Kockum, Ingrid		Diabet Incidence Sweden Study Grp	HTR1A a Novel Type 1 Diabetes Susceptibility Gene on Chromosome 5p13-q13	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ASSOCIATION ANALYSIS; RECEPTORS; LINKAGE; RISK; SEROTONIN; MULTIPLEX; FAMILIES; PEPTIDE; REGIONS	Background: We have previously performed a genome-wide linkage study in Scandinavian Type 1 diabetes (T1D) families. In the Swedish families, we detected suggestive linkage (LOD <= 2.2) to the chromosome 5p13-q13 region. The aim of our study was to investigate the linked region in search for possible T1D susceptibility genes. Methodology/Principal Findings: Microsatellites were genotyped in the Scandinavian families to fine-map the previously linked region. Further, SNPs were genotyped in Swedish and Danish families as well as Swedish sporadic cases. In the Swedish families we detected genome-wide significant linkage to the 5-hydroxytryptamine receptor 1A (HTR1A) gene (LOD 3.98, p<9.8x10(-6)). Markers tagging two separate genes; the ring finger protein 180 (RNF180) and HTR1A showed association to T1D in the Swedish and Danish families (p<0.002, p<0.001 respectively). The association was not confirmed in sporadic cases. Conditional analysis indicates that the primary association was to HTR1A. Quantitative PCR show that transcripts of both HTR1A and RNF180 are present in human islets of Langerhans. Moreover, immunohistochemical analysis confirmed the presence of the 5-HTR1A protein in isolated human islets of Langerhans as well as in sections of human pancreas. Conclusions: We have identified and confirmed the association of both HTR1A and RFN180, two genes in high linkage disequilibrium (LD) to T1D in two separate family materials. As both HTR1A and RFN180 were expressed at the mRNA level and HTR1A as protein in human islets of Langerhans, we suggest that HTR1A may affect T1D susceptibility by modulating the initial autoimmune attack or either islet regeneration, insulin release, or both.	[Asad, Samina; Gyllenberg, Alexandra; Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Nikamo, Pernilla] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Bennet, Hedvig; Ivarsson, Sten-Anders; Larsson, Helena; Lernmark, Ake; Pociot, Flemming; Luthman, Holger; Fex, Malin] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Celiac Unit, Malmo, Sweden; [Bennet, Hedvig; Hansson, Ola; Wierup, Nils; Luthman, Holger; Fex, Malin] Lund Univ, Ctr Diabet, Lund, Sweden; [Carlsson, Annelie] Univ Lund Hosp, Dept Pediat, S-22185 Lund, Sweden; [Forsander, Gun; Lindblad, Bengt] Queen Silvia Childrens Hosp, Dept Pediat, Gothenburg, Sweden; [Ludvigsson, Johnny] Linkoping Univ Hosp, Div Pediat, Dept Clin & Expt Med, Diabet Res Ctr, S-58185 Linkoping, Sweden; [Marcus, Claude] Karolinska Inst, Div Pediat, Dept Clin Sci Intervent & Technol, Natl Childhood Obes Ctr, Stockholm, Sweden; [Ronningen, Kjersti S.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Pediat Res, N-0027 Oslo, Norway; [Nerup, Jan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Pociot, Flemming] Univ Hosp Glostrup, Glostrup Res Inst, Glostrup, Denmark	Karolinska Institutet; Karolinska Institutet; Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; Queen Silvia Children's Hospital; Linkoping University; Karolinska Institutet; University of Oslo; National Hospital Norway; Steno Diabetes Center; University of Copenhagen	Asad, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	ingrid.kockum@ki.se	Ludvigsson, Johnny/AAI-2051-2020; Lernmark, Åke/F-8140-2015; Kockum, Ingrid/O-8781-2018; Hansson, Ola/F-1793-2011; Marcus, Claude/ABE-1177-2020	Ludvigsson, Johnny/0000-0003-1695-5234; Lernmark, Åke/0000-0003-1735-0499; Kockum, Ingrid/0000-0002-0867-4726; Hansson, Ola/0000-0002-7394-7639; Marcus, Claude/0000-0003-0890-2650; Pociot, Flemming/0000-0003-3274-5448; Fex, Malin/0000-0003-0675-7576; Elding Larsson, Helena/0000-0003-3306-1742	Swedish Research Council; Svenska Diabetes Fonden; Barndiabetes Fonden; Magnus Bergvalls Stiftelse; Novo Nordisk Foundation; Krapperup foundation; Ake Wiberg foundation; Swedish Society for Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Svenska Diabetes Fonden; Barndiabetes Fonden; Magnus Bergvalls Stiftelse; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Krapperup foundation; Ake Wiberg foundation; Swedish Society for Medicine	The study has been funded by Swedish Research Council, Svenska Diabetes Fonden, Barndiabetes Fonden, Magnus Bergvalls Stiftelse, the Novo Nordisk Foundation, the Krapperup foundation, the Ake Wiberg foundation and the Swedish Society for Medicine (to MF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUNE TM, 1993, J IMMUNOL, V151, P1175; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlsson AKI, 2011, INT J OBESITY, P1; Coulie B, 1998, AM J PHYSIOL-ENDOC M, V274, pE317, DOI 10.1152/ajpendo.1998.274.2.E317; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; Hedstrom AK, 2009, NEUROLOGY, V73, P696, DOI 10.1212/WNL.0b013e3181b59c40; Holm P, 2004, DIABETES, V53, P1584, DOI 10.2337/diabetes.53.6.1584; Holm P, 2001, AM J HUM GENET, V69, P1301; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Jensen RA, 2007, J DIABETES COMPLICAT, V21, P205, DOI 10.1016/j.jdiacomp.2006.01.004; Kirchgessner AL, 1996, J COMP NEUROL, V364, P439, DOI 10.1002/(SICI)1096-9861(19960115)364:3<439::AID-CNE5>3.0.CO;2-5; Kling A, 2008, ANN RHEUM DIS, V67, P1111, DOI 10.1136/ard.2007.074948; Lesurtel M, 2008, CELL MOL LIFE SCI, V65, P940, DOI 10.1007/s00018-007-7377-3; Li MA, 2006, AM J HUM GENET S, VS79, P416; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Mohanan VV, 2006, LIFE SCI, V78, P1603, DOI 10.1016/j.lfs.2005.07.027; Namjou B, 2005, ARTHRITIS RHEUM-US, V52, P3646, DOI 10.1002/art.21413; Namjou B, 2002, ARTHRITIS RHEUM, V46, P2937, DOI 10.1002/art.10588; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; SUNDLER F, 1980, INVEST CELL PATHOL, V3, P87; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Zawalich WS, 2004, ENDOCRINE, V23, P11, DOI 10.1385/ENDO:23:1:11	35	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35439	10.1371/journal.pone.0035439	http://dx.doi.org/10.1371/journal.pone.0035439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563461	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700010
J	Vitaliano, GD; Vitaliano, F; Rios, JD; Renshaw, PF; Teicher, MH				Vitaliano, Gordana D.; Vitaliano, Franco; Rios, Jose D.; Renshaw, Perry F.; Teicher, Martin H.			New Clathrin-Based Nanoplatforms for Magnetic Resonance Imaging	PLOS ONE			English	Article							MRI CONTRAST AGENTS; CENTRAL-NERVOUS-SYSTEM; DRUG-DELIVERY; IN-VITRO; GD-DTPA; VIRAL NANOPARTICLES; RELAXIVITY; ALBUMIN; ENDOCYTOSIS; STRATEGIES	Background: Magnetic Resonance Imaging (MRI) has high spatial resolution, but low sensitivity for visualization of molecular targets in the central nervous system (CNS). Our goal was to develop a new MRI method with the potential for non-invasive molecular brain imaging. We herein introduce new bio-nanotechnology approaches for designing CNS contrast media based on the ubiquitous clathrin cell protein. Methodology/Principal Findings: The first approach utilizes three-legged clathrin triskelia modified to carry 81 gadolinium chelates. The second approach uses clathrin cages self-assembled from triskelia and designed to carry 432 gadolinium chelates. Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents. Relaxivity was evaluated at 0.47 T. A series of studies were conducted to ascertain whether fluorescent-tagged clathrin nanoplatforms could cross the blood brain barriers (BBB) unaided following intranasal, intravenous, and intraperitoneal routes of administration. Clathrin nanoparticles can be constituted as triskelia (18.5 nm in size), and as cages assembled from them (55 nm). The mean chelate: clathrin heavy chain molar ratio was 27.04+/-4.8: 1 for triskelia, and 4.2+/-1.04: 1 for cages. Triskelia had ionic relaxivity of 16 mM(-1) s(-1), and molecular relaxivity of 1,166 mM(-1) s(-1), while cages had ionic relaxivity of 81 mM(-1) s(-1) and molecular relaxivity of 31,512 mM(-1) s(-1). Thus, cages exhibited 20 times higher ionic relaxivity and 8,000-fold greater molecular relaxivity than gadopentetate dimeglumine. Clathrin nanoplatforms modified with fluorescent tags were able to cross or bypass the BBB without enhancements following intravenous, intraperitoneal and intranasal administration in rats. Conclusions/Significance: Use of clathrin triskelia and cages as carriers of CNS contrast media represents a new approach. This new biocompatible protein-based nanotechnology demonstrated suitable physicochemical properties to warrant further in vivo imaging and drug delivery studies. Significantly, both nanotransporters crossed and/or bypassed the BBB without enhancers. Thus, clathrin nanoplatforms could be an appealing alternative to existing CNS bio-nanotechnologies.	[Vitaliano, Gordana D.; Rios, Jose D.; Teicher, Martin H.] Harvard Univ, McLean Hosp, Sch Med, Lab Dev Psychopharmacol,Brain Imaging Ctr,Dept Ps, Belmont, MA USA; [Vitaliano, Franco] VXM, Boston, MA USA; [Renshaw, Perry F.] Univ Utah, Sch Med, Inst Brain, Salt Lake City, UT USA	Harvard University; McLean Hospital; Utah System of Higher Education; University of Utah	Vitaliano, GD (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Lab Dev Psychopharmacol,Brain Imaging Ctr,Dept Ps, Belmont, MA USA.	gvitaliano@mclean.harvard.edu	Teicher, Martin H/P-3906-2017; Renshaw, Perry/O-1384-2018	Teicher, Martin H/0000-0002-6036-0177; 	National Institute on Drug Abuse [1R03DA025804]; Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA025804, K05DA031247] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Brain and Behavior Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported, in part, by research grants from the National Institute on Drug Abuse www.nida.nih.gov (1R03DA025804) and the Brain and Behavior Research Foundation www.bbrfoundation.org to GV, who was a NARSAD Sidney R. Baer, Jr. Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Aime S, 2009, ACCOUNTS CHEM RES, V42, P822, DOI 10.1021/ar800192p; Allen M, 2005, MAGN RESON MED, V54, P807, DOI 10.1002/mrm.20614; Ananta JS, 2010, NAT NANOTECHNOL, V5, P815, DOI [10.1038/nnano.2010.203, 10.1038/NNANO.2010.203]; Anderson EA, 2006, NANO LETT, V6, P1160, DOI 10.1021/nl060378g; Artemov D, 2004, CURR PHARM BIOTECHNO, V5, P485, DOI 10.2174/1389201043376553; Baba T, 2001, TRAFFIC, V2, P501, DOI 10.1034/j.1600-0854.2001.20707.x; Basilion JP, 2005, CURR TOP DEV BIOL, V70, P1, DOI 10.1016/S0070-2153(05)70001-6; Bhaskar S, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-3; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Bryant LH, 1999, JMRI-J MAGN RESON IM, V9, P348, DOI 10.1002/(SICI)1522-2586(199902)9:2<348::AID-JMRI30>3.0.CO;2-J; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Caravan P, 2009, ACCOUNTS CHEM RES, V42, P851, DOI 10.1021/ar800220p; Cheng ZL, 2008, LANGMUIR, V24, P8169, DOI 10.1021/la801027q; Cheng ZL, 2010, ANGEW CHEM INT EDIT, V49, P346, DOI 10.1002/anie.200905133; Cooper MS, 2006, NAT PROTOC, V1, P314, DOI 10.1038/nprot.2006.49; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Datta A, 2008, J AM CHEM SOC, V130, P2546, DOI 10.1021/ja0765363; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Fatouros PP, 2006, RADIOLOGY, V240, P756, DOI 10.1148/radiol.2403051341; Ferguson ML, 2006, BIOCHEMISTRY-US, V45, P5916, DOI 10.1021/bi052568w; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Fries PH, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456987; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Gasco MR, 2009, PROG BRAIN RES, V180, P181, DOI 10.1016/S0079-6123(08)80010-6; Giesel FL, 2006, INVEST RADIOL, V41, P222, DOI 10.1097/01.rli.0000192421.81037.d5; Gouin S, 2001, BIOCONJUGATE CHEM, V12, P372, DOI 10.1021/bc000109w; GRAGERA RR, 1993, CELL MOL BIOL, V39, P819; Granseth B, 2007, J PHYSIOL-LONDON, V585, P681, DOI 10.1113/jphysiol.2007.139022; Hooker JM, 2007, NANO LETT, V7, P2207, DOI 10.1021/nl070512c; Jaszberenyi Z, 2007, J BIOL INORG CHEM, V12, P406, DOI 10.1007/s00775-006-0197-3; Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441; Kateb B, 2011, NEUROIMAGE, V54, pS106, DOI 10.1016/j.neuroimage.2010.01.105; Kircher MF, 2003, CANCER RES, V63, P8122; KIRCHHAUSEN T, 1986, J ULTRA MOL STRUCT R, V94, P199, DOI 10.1016/0889-1605(86)90067-4; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kobayashi H, 2005, ADV DRUG DELIVER REV, V57, P2271, DOI 10.1016/j.addr.2005.09.016; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; Kotova S, 2010, FEBS LETT, V584, P44, DOI 10.1016/j.febslet.2009.11.039; Kozlowska D, 2009, ADV DRUG DELIVER REV, V61, P1402, DOI 10.1016/j.addr.2009.09.003; Liepold L, 2007, MAGN RESON MED, V58, P871, DOI 10.1002/mrm.21307; MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602; Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014; McAteer MA, 2009, PROG BRAIN RES, V180, P73, DOI 10.1016/S0079-6123(08)80004-0; Mirzadeh S, 1990, BIOCONJUGATE CHEM, V1, P59, DOI 10.1021/bc00001a007; Morawski AM, 2004, MAGN RESON MED, V51, P480, DOI 10.1002/mrm.20010; Mulder WJM, 2009, ACCOUNTS CHEM RES, V42, P904, DOI 10.1021/ar800223c; Nagaraja TN, 2006, J NEUROSCI METH, V157, P238, DOI 10.1016/j.jneumeth.2006.05.013; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Nicolle GM, 2002, CHEM-EUR J, V8, P1040, DOI 10.1002/1521-3765(20020301)8:5<1040::AID-CHEM1040>3.0.CO;2-D; Noebauer-Huhmann IM, 2010, INVEST RADIOL, V45, P554, DOI 10.1097/RLI.0b013e3181ebd4e3; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; PAAJANEN H, 1990, MAGNET RESON MED, V13, P38, DOI 10.1002/mrm.1910130106; Park JW, 2008, BIOCHEM BIOPH RES CO, V366, P769, DOI 10.1016/j.bbrc.2007.12.045; Partha R, 2009, INT J NANOMED, V4, P261; Pearse BMF, 2000, CURR OPIN STRUC BIOL, V10, P220, DOI 10.1016/S0959-440X(00)00071-3; Pierre VC, 2006, INORG CHEM, V45, P8355, DOI 10.1021/ic061262q; PIPPIN CG, 1992, BIOCONJUGATE CHEM, V3, P342, DOI 10.1021/bc00016a014; Port M, 2005, INVEST RADIOL, V40, P565, DOI 10.1097/01.rli.0000175388.98721.9b; Provenzale JM, 2009, AM J NEURORADIOL, V30, P1293, DOI 10.3174/ajnr.A1590; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; SCHUHMANNGIAMPIERI G, 1991, INVEST RADIOL, V26, P969, DOI 10.1097/00004424-199111000-00008; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; Traub LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000192; Villaraza AJL, 2010, CHEM REV, V110, P2921, DOI 10.1021/cr900232t; Vitaliano F, 2008, US Patent, Patent No. 7393924; Yang Z, 2010, J R SOC INTERFACE, V7, pS411, DOI 10.1098/rsif.2010.0158.focus; YOSHIMURA T, 1991, BIOCHEMISTRY-US, V30, P4528, DOI 10.1021/bi00232a023; ZARRILLI R, 1985, ARCH BIOCHEM BIOPHYS, V241, P22, DOI 10.1016/0003-9861(85)90356-X; Zhu YX, 2001, METHOD ENZYMOL, V329, P379	72	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35821	10.1371/journal.pone.0035821	http://dx.doi.org/10.1371/journal.pone.0035821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563470	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700019
J	Ahlehoff, O; Skov, L; Gislason, G; Lindhardsen, J; Kristensen, SL; Iversen, L; Lasthein, S; Gniadecki, R; Dam, TN; Torp-Pedersen, C; Hansen, PR				Ahlehoff, Ole; Skov, Lone; Gislason, Gunnar; Lindhardsen, Jesper; Kristensen, Soren Lund; Iversen, Lars; Lasthein, Stine; Gniadecki, Robert; Dam, Tomas Norman; Torp-Pedersen, Christian; Hansen, Peter Riis			Pharmacological Undertreatment of Coronary Risk Factors in Patients with Psoriasis: Observational Study of the Danish Nationwide Registries	PLOS ONE			English	Article							CONSENSUS; QUALITY; DISEASE; CARE	Background: Patients with psoriasis have increased prevalence of coronary risk factors and limited recent results have suggested that these risk factors are undertreated in patients with psoriasis. This may contribute to the increased risk of cardiovascular diseases observed in patients with psoriasis. Objective: To examine the pharmacological treatment of coronary risk factors in patients with severe psoriasis treated with biologic agents in a real-world setting. Methods and Findings: Medical history of patients with severe psoriasis treated with biologic agents in the time period 2007-09 was retrieved from a Danish nationwide registry (DERMBIO). Individual-level linkage of nationwide administrative registries of hospitalizations, concomitant medications, and socioeconomic status was performed to gain insights into the use of pharmacological treatment. A total of 693 patients (mean age 46.1+/-12.7 years, 65.7% male) with severe psoriasis treated with biologic agents were identified. Hypertension, hypercholesterolemia, and diabetes mellitus were identified in 16.6%, 9.2%, and 6.7% of cases, respectively. Patients with severe psoriasis were significantly less likely to receive cardiovascular pharmacotherapy compared to age, sex, and coronary risk factor matched controls. In psoriatic patients with hypertension 27.7% received no antihypertensive pharmacotherapy. Patients with dyslipidemia received cholesterol-lowering medications in 55.8% of cases and patients with diabetes mellitus received angiotensin converting enzyme inhibitors/angiotensin II receptor blockers and cholesterol-lowering medications in 42.1% and 23.7% of cases, respectively. Similar results were found for the subset of patients with >1 coronary risk factor and for high risk patients with established atherosclerotic disease. Conclusion: This nationwide study of patients with severe psoriasis demonstrated substantial undertreatment of coronary risk factors. Increased focus on identifying cardiovascular risk factors and initiation of preventive cardiovascular pharmacotherapy in patients with psoriasis is warranted.	[Ahlehoff, Ole; Gislason, Gunnar; Lindhardsen, Jesper; Kristensen, Soren Lund; Torp-Pedersen, Christian; Hansen, Peter Riis] Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark; [Ahlehoff, Ole] Copenhagen Univ Hosp Roskilde, Dept Internal Med, Roskilde, Denmark; [Skov, Lone] Copenhagen Univ Hosp Gentofte, Dept Dermatol, Hellerup, Denmark; [Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark; [Lasthein, Stine] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense, Denmark; [Gniadecki, Robert] Copenhagen Univ Hosp Bispebjerg, Dept Dermatol, Copenhagen, Denmark; [Dam, Tomas Norman] Copenhagen Univ Hosp Roskilde, Dept Dermatol, Roskilde, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Ahlehoff, O (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Hellerup, Denmark.	olahha01@geh.regionh.dk	Gniadecki, Robert/A-5696-2010; Kristensen, Søren Lund/J-5267-2019; Gislason, Gunnar/B-7561-2009; Skov, Lone/W-3575-2018; Hansen, Peter Riis/AAR-7659-2020	Gniadecki, Robert/0000-0002-2310-8300; Kristensen, Søren Lund/0000-0002-9759-7397; Gislason, Gunnar/0000-0002-0548-402X; Skov, Lone/0000-0002-4784-9680; Iversen, Lars/0000-0003-1816-4508; Hansen, Peter Riis/0000-0002-9056-535X	Axel Muusfeldts Foundation; DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis); Danish Psoriasis Association; Abbott; Janssen-Cilag; Merck-Serono; MSD; Pfizer	Axel Muusfeldts Foundation; DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis); Danish Psoriasis Association; Abbott(Abbott Laboratories); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck-Serono(Merck & Company); MSD; Pfizer(Pfizer)	The study was financially supported by unrestricted grants from the Axel Muusfeldts Foundation, DERMBIO, (Dermatologisk Database for Biologisk Behandling af Psoriasis) and the Danish Psoriasis Association. DERMBIO database maintenance expenditure is covered by unrestricted equal grants from the manufacturers of biologics (Abbott, Janssen-Cilag, Merck-Serono [2007-2009], MSD, Pfizer). The database is administered by an independent steering committee of specialists in dermatology representing the dermatological departments and private practices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P237, DOI 10.1111/j.1365-2796.2011.02368.x; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2011, EUR HEART J     0825; [Anonymous], 2010, 18 UDV NEDS DDS DCS; Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99; Balci DD, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2008.02936.x; Basavaraj KH, 2010, INT J DERMATOL, V49, P1351, DOI 10.1111/j.1365-4632.2010.04570.x; De Simone C, 2011, EUR J DERMATOL, V21, P510, DOI 10.1684/ejd.2011.1324; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Friedewald VE, 2008, AM J CARDIOL, V102, P1631, DOI 10.1016/j.amjcard.2008.10.004; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gisondi P, 2010, AM J CARDIOL, V106, P1754, DOI 10.1016/j.amjcard.2010.08.016; Gniadecki R, 2011, BRIT J DERMATOL, V164, P1091, DOI 10.1111/j.1365-2133.2011.10213.x; Kimball AB, 2011, J AM ACAD DERMA 1021; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Kones Richard, 2011, Ther Adv Cardiovasc Dis, V5, P61, DOI 10.1177/1753944710391350; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; MacLean CH, 2000, JAMA-J AM MED ASSOC, V284, P984, DOI 10.1001/jama.284.8.984; Malik S, 2007, DIABETES RES CLIN PR, V77, P126, DOI 10.1016/j.diabres.2006.10.016; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Menter A, 2010, J EUR ACAD DERMATOL, V24, P1371, DOI 10.1111/j.1468-3083.2010.03656.x; Parsi KK, 2011, J AM ACAD DERMA 1112; Peters MJ, ANN RHEUM DIS, V69, P325; Wakkee M, 2007, ATHEROSCLEROSIS, V190, P1, DOI 10.1016/j.atherosclerosis.2006.07.011; Wenger NS, 2003, ANN INTERN MED, V139, P740, DOI 10.7326/0003-4819-139-9-200311040-00008; Zafrir B, 2006, EUR J INTERN MED, V17, P495, DOI 10.1016/j.ejim.2006.03.005	26	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36342	10.1371/journal.pone.0036342	http://dx.doi.org/10.1371/journal.pone.0036342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558442	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200069
J	Chen, CC; Tsai, SH; Lu, CC; Hu, ST; Wu, TS; Huang, TT; Said-Sadier, N; Ojcius, DM; Lai, HC				Chen, Chang-Chieh; Tsai, Sheng-Hui; Lu, Chia-Chen; Hu, Shiau-Ting; Wu, Ting-Shu; Huang, Tsung-Teng; Said-Sadier, Najwane; Ojcius, David M.; Lai, Hsin-Chih			Activation of an NLRP3 Inflammasome Restricts Mycobacterium kansasii Infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS INFECTION; INTERFERON-GAMMA; CLINICAL-MANIFESTATIONS; FRANCISELLA-TULARENSIS; CHLAMYDIAL INFECTION; PROTECTIVE IMMUNITY; RECEPTOR ANTAGONIST; NALP3 INFLAMMASOME	Mycobacterium kansasii has emerged as an important nontuberculous mycobacterium pathogen, whose incidence and prevalence have been increasing in the last decade. M. kansasii can cause pulmonary tuberculosis clinically and radiographically indistinguishable from that caused by Mycobacterium tuberculosis infection. Unlike the widely-studied M. tuberculosis, little is known about the innate immune response against M. kansasii infection. Although inflammasome activation plays an important role in host defense against bacterial infection, its role against atypical mycobacteria remains poorly understood. In this report, the role of inflammasome activity in THP-1 macrophages against M. kansasii infection was studied. Results indicated that viable, but not heat-killed, M. kansasii induced caspase-1-dependent IL-1 beta secretion in macrophages. The underlying mechanism was found to be through activation of an inflammasome containing the NLR (Nod-like receptor) family member NLRP3 and the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). Further, potassium efflux, lysosomal acidification, ROS production and cathepsin B release played a role in M. kansasii-induced inflammasome activation. Finally, the secreted IL-1 beta derived from caspase-1 activation was shown to restrict intracellular M. kansasii. These findings demonstrate a biological role for the NLRP3 inflammasome in host defense against M. kansasii.	[Chen, Chang-Chieh] Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan; [Tsai, Sheng-Hui; Hu, Shiau-Ting] Natl Yang Ming Univ, Sch Life Sci, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Lu, Chia-Chen] Fu Jen Catholic Univ, Dept Resp Therapy, Taipei, Taiwan; [Hu, Shiau-Ting] Natl Yang Ming Univ, Sch Med, Dept Microbiol & Immunol, Taipei 112, Taiwan; [Wu, Ting-Shu] Chang Gung Mem Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Wu, Ting-Shu] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Ojcius, David M.; Lai, Hsin-Chih] Chang Gung Univ, Ctr Mol & Clin Immunol, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Huang, Tsung-Teng] Chang Gung Univ, Lab Nanomat, Tao Yuan, Taiwan; [Huang, Tsung-Teng; Lai, Hsin-Chih] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Tao Yuan, Taiwan; [Said-Sadier, Najwane; Ojcius, David M.] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Said-Sadier, Najwane; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	Industrial Technology Research Institute - Taiwan; National Yang Ming Chiao Tung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; University of California System; University of California Merced; University of California System; University of California Merced	Chen, CC (corresponding author), Ind Technol Res Inst, Green Energy & Environm Res Labs, Hsinchu, Taiwan.	hclai@mail.cgu.edu.tw	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council, Taiwan, ROC [NSC 99-2321-B-002-022]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This work was supported by grant NSC 99-2321-B-002-022 from the National Science Council, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2011, J IMMUNOL, V187, P4744, DOI 10.4049/jimmunol.1101457; Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Abdul-Sater AA, 2010, MICROBES INFECT, V12, P652, DOI 10.1016/j.micinf.2010.04.008; Abdul-Sater AA, 2009, J BIOL CHEM, V284, P26789, DOI 10.1074/jbc.M109.026823; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Arend SM, 2005, J INFECT DIS, V191, P1301, DOI 10.1086/428950; Arend SM, 2004, CLIN MICROBIOL INFEC, V10, P738, DOI 10.1111/j.1469-0691.2004.00898.x; Atianand MK, 2011, J BIOL CHEM, V286, P39033, DOI 10.1074/jbc.M111.244079; Awomoyi AA, 2005, J ENDOTOXIN RES, V11, P281, DOI 10.1179/096805105X58706; Bartralot R, 2000, J CUTAN PATHOL, V27, P124, DOI 10.1034/j.1600-0560.2000.027003124.x; Bellamy R., 1998, Tubercle and Lung Disease, V79, P83, DOI 10.1054/tuld.1998.0009; Bittner MJ, 1996, CLIN INFECT DIS, V22, P1109, DOI 10.1093/clinids/22.6.1109; Bloch KC, 1998, ANN INTERN MED, V129, P698, DOI 10.7326/0003-4819-129-9-199811010-00004; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; BUCKNER CB, 1991, AM J ROENTGENOL, V156, P255, DOI 10.2214/ajr.156.2.1898796; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Caruso AM, 1999, J IMMUNOL, V162, P5407; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CHENSUE SW, 1992, AM J PATHOL, V140, P269; Choi HH, 2010, FEBS LETT, V584, P2445, DOI 10.1016/j.febslet.2010.04.050; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; de Veerdonk FLV, 2011, TRENDS IMMUNOL, V32, P110, DOI 10.1016/j.it.2011.01.003; Delbridge LM, 2007, CURR OPIN IMMUNOL, V19, P10, DOI 10.1016/j.coi.2006.11.005; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dorhoi A, 2012, EUR J IMMUNOL, V42, P374, DOI 10.1002/eji.201141548; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Evans AJ, 1996, THORAX, V51, P1243, DOI 10.1136/thx.51.12.1243; Evans SA, 1996, THORAX, V51, P1248, DOI 10.1136/thx.51.12.1248; Fantuzzi G, 1999, J CLIN IMMUNOL, V19, P1, DOI 10.1023/A:1020506300324; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; Florido M, 2002, IMMUNOLOGY, V106, P590, DOI 10.1046/j.1365-2567.2002.01459.x; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Gadkowski LB, 2008, CLIN MICROBIOL REV, V21, P305, DOI 10.1128/CMR.00060-07; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Gavrilin MA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00011; Gomez LM, 2006, TISSUE ANTIGENS, V67, P290, DOI 10.1111/j.1399-0039.2006.00566.x; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; HAVELL EA, 1992, J IMMUNOL, V148, P1486; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; KASAHARA K, 1988, AM J PATHOL, V130, P629; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Koh WJ, 2006, INT J TUBERC LUNG D, V10, P1001; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kurenuma T, 2009, INFECT IMMUN, V77, P3992, DOI 10.1128/IAI.00015-09; Lee HM, 2012, IMMUNOL CELL BIOL, V90, P601, DOI 10.1038/icb.2011.72; LILLO M, 1990, REV INFECT DIS, V12, P760; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Master SS, 2008, CELL HOST MICROBE, V3, P224, DOI 10.1016/j.chom.2008.03.003; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; McIntire CR, 2009, APOPTOSIS, V14, P522, DOI 10.1007/s10495-009-0312-3; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mishra BB, 2010, CELL MICROBIOL, V12, P1046, DOI 10.1111/j.1462-5822.2010.01450.x; MULLER I, 1987, INFECT IMMUN, V55, P2037; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Novo E, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-5; Paull DE, 2003, TRANSPLANTATION, V76, P270, DOI 10.1097/01.TP.0000072018.06230.A1; Pintado V, 2001, INFECTION, V29, P48, DOI 10.1007/s15010-001-0061-x; Pollock JM, 1997, J INFECT DIS, V175, P1251, DOI 10.1086/593686; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Said-Sadier N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010008; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Satoskar AR, 1998, EUR J IMMUNOL, V28, P2066, DOI 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X; Saunders BM, 2002, CELL IMMUNOL, V216, P65, DOI 10.1016/S0008-8749(02)00510-5; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; SHAFER RW, 1992, CLIN INFECT DIS, V15, P161, DOI 10.1093/clinids/15.1.161; SHERER R, 1986, ANN INTERN MED, V105, P710, DOI 10.7326/0003-4819-105-5-710; Shitrit D, 2007, EUR J CLIN MICROBIOL, V26, P679, DOI 10.1007/s10096-007-0331-3; Silva RA, 2001, IMMUNOLOGY, V103, P368, DOI 10.1046/j.1365-2567.2001.01237.x; SINGER II, 1995, J EXP MED, V182, P1447, DOI 10.1084/jem.182.5.1447; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stanley SA, 2007, J IMMUNOL, V178, P3143, DOI 10.4049/jimmunol.178.5.3143; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Taillard C, 2003, J CLIN MICROBIOL, V41, P1240, DOI 10.1128/JCM.41.3.1240-1244.2003; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; TSUKAMURA M, 1988, AM REV RESPIR DIS, V137, P1280, DOI 10.1164/ajrccm/137.6.1280; VALAINIS GT, 1991, J ACQ IMMUN DEF SYND, V4, P516; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wallace RJ, 1998, AM J RESP CRIT CARE, V158, P1235, DOI 10.1164/ajrccm.158.4.9712098; Walter K, 2010, IMMUNOBIOLOGY, V215, P804, DOI 10.1016/j.imbio.2010.05.015; Wieland CW, 2006, MICROBES INFECT, V8, P2409, DOI 10.1016/j.micinf.2006.05.002; Wieland CW, 2006, AM J RESP CELL MOL, V34, P167, DOI 10.1165/rcmb.2005-0198OC; Wilkinson RJ, 1999, J EXP MED, V189, P1863, DOI 10.1084/jem.189.12.1863; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; WITZIG RS, 1995, CLIN INFECT DIS, V21, P77, DOI 10.1093/clinids/21.1.77; WOLINSKY E, 1979, AM REV RESPIR DIS, V119, P107; Wu TS, 2009, J ANTIMICROB CHEMOTH, V64, P511, DOI 10.1093/jac/dkp238; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Yazdi AS, 2010, J INNATE IMMUN, V2, P228, DOI 10.1159/000283688; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	115	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36292	10.1371/journal.pone.0036292	http://dx.doi.org/10.1371/journal.pone.0036292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558425	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200064
J	Lussiana, C; Clemente, SVL; Ghelardi, A; Lonardi, M; Tarquino, IAP; Floridia, M				Lussiana, Cristina; Loa Clemente, Sofia Vanda; Ghelardi, Angelo; Lonardi, Magda; Pulido Tarquino, Ivan Alejandro; Floridia, Marco			Effectiveness of a Prevention of Mother-to-Child HIV Transmission Programme in an Urban Hospital in Angola	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; WOMEN; PREGNANCY; OUTCOMES; INFECTION	Background: Antiretroviral therapy is effective in reducing rates of mother-to child transmission of HIV to low levels in resource-limited contexts but the applicability and efficacy of these programs in the field are scarcely known. In order to explore such issues, we performed a descriptive study on retrospective data from hospital records of HIV-infected pregnant women who accessed in 2007-2010 the Luanda Municipal Hospital service for prevention of mother-to-child transmission (PMTCT). The main outcome measure was infant survival and HIV transmission. Our aim was to evaluate PMTCT programme in a local hospital setting in Africa. Results: Data for 104 pregnancies and 107 infants were analysed. Sixty-eight women (65.4%) had a first visit before or during pregnancy and received combination antiretroviral treatment (ART) in pregnancy. The remaining 36 women (34.6%) presented after delivery and received no ART during pregnancy. Across a median cohort follow-up time of 73 weeks, mortality among women with and without ART in pregnancy was 4.4% and 16.7%, respectively (death hazard ratio: 0.30, 95% CI 0.07-1.20, p = 0.089). The estimated rates of HIV transmission or death in the infants over a median follow up time of 74 weeks were 8.5% with maternal ART during pregnancy and 38.9% without maternal ART during pregnancy. Following adjustment for use of oral zidovudine in the newborn and exposure to maternal milk, no ART in pregnancy remained associated with a 5-fold higher infant risk of HIV transmission or death (adjusted odds ratio: 5.13, 95% CI: 1.31-20.15, p = 0.019). Conclusions: Among the women and infants adhering to the PMTCT programme, HIV transmission and mortality were low. However, many women presented too late for PMTCT, and about 20% of infants did not complete follow up. This suggests the need of targeted interventions that maintain the access of mothers and infants to prevention and care services for HIV.	[Lussiana, Cristina; Pulido Tarquino, Ivan Alejandro] Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola; [Loa Clemente, Sofia Vanda] Hosp Divina Providencia, Clin Direct, Luanda, Angola; [Ghelardi, Angelo] Hosp Divina Providencia, Project Direct, Luanda, Angola; [Lonardi, Magda] Hosp Divina Providencia, Dept Pediat, Luanda, Angola; [Floridia, Marco] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Lussiana, C (corresponding author), Hosp Divina Providencia, Infect Dis Lab, Luanda, Angola.	cristinaelle@hotmail.it	Floridia, Marco/Q-6571-2017; Pulido Tarquino, Ivan Alejandro/GPS-7553-2022	Floridia, Marco/0000-0003-3971-0141; Pulido Tarquino, Ivan Alejandro/0000-0002-1448-8268				Ahoua L, 2010, J TROP PEDIATRICS, V56, P43, DOI 10.1093/tropej/fmp054; Azcoaga-Lorenzo A, 2011, AIDS CARE, V23, P274, DOI 10.1080/09540121.2010.507750; Balogun M, 2010, PAN AFR MED J, V5; Chinkonde JR, 2009, REPROD HEALTH MATTER, V17, P143, DOI 10.1016/S0968-8080(09)33440-0; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dryden-Peterson S, 2011, J ACQUIR IMMUNE 0722; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Kouanda S, 2010, AIDS CARE, V22, P843, DOI 10.1080/09540120903499204; Koura K G, 2011, Med Trop (Mars), V71, P63; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Marazzi MC, 2010, AIDS, V24, P2819, DOI 10.1097/QAD.0b013e32833ff58c; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mirkuzie AH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-267; Mockenhaupt FP, 2000, T ROY SOC TROP MED H, V94, P477, DOI 10.1016/S0035-9203(00)90057-9; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2018, RECOMMENDATIONS USE; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Tchendjou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010411; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2021, ANT DRUGS TREAT PREG; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891	21	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36381	10.1371/journal.pone.0036381	http://dx.doi.org/10.1371/journal.pone.0036381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558455	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200073
J	Du, J; Nordfors, C; Nasman, A; Sobkowiak, M; Romanitan, M; Dalianis, T; Ramqvist, T				Du, Juan; Nordfors, Cecilia; Nasman, Anders; Sobkowiak, Michal; Romanitan, Mircea; Dalianis, Tina; Ramqvist, Torbjorn			Human Papillomavirus (HPV) 16 E6 Variants in Tonsillar Cancer in Comparison to Those in Cervical Cancer in Stockholm, Sweden	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTRAEPITHELIAL NEOPLASIA; TYPE-16; ASSOCIATION; HUMAN-PAPILLOMAVIRUS-16; WOMEN; POPULATIONS; PREVALENCE; EPIDEMIC; PROTEINS	Background: Human papillomavirus (HPV), especially HPV16, is associated with the development of both cervical and tonsillar cancer and intratype variants in the amino acid sequence of the HPV16 E6 oncoprotein have been demonstrated to be associated with viral persistence and cancer lesions. For this reason the presence of HPV16 E6 variants in tonsillar squamous cell carcinoma (TSCC) in cervical cancer (CC), as well as in cervical samples (CS), were explored. Methods: HPV16 E6 was sequenced in 108 TSCC and 52 CC samples from patients diagnosed 2000-2008 in the County of Stockholm, and in 51 CS from young women attending a youth health center in Stockholm. Results: The rare E6 variant R10G was relatively frequent (19%) in TSCC, absent in CC and infrequent (4%) in CS, while the well-known L83V variant was common in TSCC (40%), CC (31%), and CS (29%). The difference for R10G was significant between TSCC and CC (p=0.0003), as well as between TSCC and CS (p=0.009). The HPV16 European phylogenetic lineage and its derivatives dominated in all samples (>90%). Conclusion: The relatively high frequency of the R10G variant in TSCC, as compared to what has been found in CC both in the present study as well as in several other studies in different countries, may indicate a difference between TSCC and CC with regard to tumor induction and development. Alternatively, there could be differences with regard to the oral and cervical prevalence of this variant that need to be explored further.	[Du, Juan; Nordfors, Cecilia; Nasman, Anders; Sobkowiak, Michal; Romanitan, Mircea; Dalianis, Tina; Ramqvist, Torbjorn] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Du, J (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	juan.du@ki.se		Sobkowiak, Michal/0000-0003-2932-1994; Nasman, Anders/0000-0003-4602-4297; Dalianis, Tina/0000-0001-7022-2424; Du, Juan/0000-0001-7649-9571	Swedish Institute for Infectious Disease Control; Swedish Cancer Foundation [100258]; Swedish Research Council [K2011-56X-15282-07-6]; Stockholm Cancer Society [101081]; Stockholm City Council [2010067]; Karolinska Institute	Swedish Institute for Infectious Disease Control; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm Cancer Society; Stockholm City Council; Karolinska Institute(Karolinska Institutet)	Financial support was provided by the Swedish Institute for Infectious Disease Control, the Swedish Cancer Foundation (100258), the Swedish Research Council (K2011-56X-15282-07-6), the Stockholm Cancer Society (101081), the Stockholm City Council (2010067) and the Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attner P, 2011, INT J CANC IN PRESS; Attner P, 2010, INT J CANCER, V126, P2879, DOI 10.1002/ijc.24994; Bernard HU, 2006, INT J CANCER, V118, P1071, DOI 10.1002/ijc.21655; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Boscolo-Rizzo P, 2009, J CANCER RES CLIN, V135, P559, DOI 10.1007/s00432-008-0490-3; Cai HB, 2010, EJSO-EUR J SURG ONC, V36, P160, DOI 10.1016/j.ejso.2009.07.186; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cleveland JL, 2011, J AM DENT ASSOC, V142, P915, DOI 10.14219/jada.archive.2011.0298; Du J, 2011, ACTA ONCOL, V50, P1215, DOI 10.3109/0284186X.2011.584556; ELLIS JRM, 1995, NAT MED, V1, P464, DOI 10.1038/nm0595-464; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hammarstedt L, 2007, ACTA OTO-LARYNGOL, V127, P988, DOI 10.1080/00016480601110170; HO L, 1991, J CLIN MICROBIOL, V29, P1765, DOI 10.1128/JCM.29.9.1765-1772.1991; Hu X, 2001, BRIT J CANCER, V84, P791, DOI 10.1054/bjoc.2000.1619; Hu XR, 1999, INT J CANCER, V83, P34, DOI 10.1002/(SICI)1097-0215(19990924)83:1<34::AID-IJC7>3.0.CO;2-Q; Huertas-Salgado A, 2011, VIROLOGY, V410, P201, DOI 10.1016/j.virol.2010.10.039; Lichtig H, 2006, VIROLOGY, V350, P216, DOI 10.1016/j.virol.2006.01.038; Matsumoto K, 2003, INT J CANCER, V106, P919, DOI 10.1002/ijc.11332; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Nindl I, 1999, INT J CANCER, V82, P203, DOI 10.1002/(SICI)1097-0215(19990719)82:2<203::AID-IJC9>3.0.CO;2-9; Pillai MR, 2009, INT J CANCER, V125, P91, DOI 10.1002/ijc.24322; Ramqvist T, 2011, ANTICANCER RES, V31, P1515; Ramqvist T, 2011, SCAND J INFECT DIS, V43, P115, DOI 10.3109/00365548.2010.526957; Richard C, 2010, ONCOGENE, V29, P3435, DOI 10.1038/onc.2010.93; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Swan DC, 2005, GYNECOL ONCOL, V96, P695, DOI 10.1016/j.ygyno.2004.11.045; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Terai M, 2002, CLONING SEQUENCING N; Wise-Draper TM, 2008, FRONT BIOSCI-LANDMRK, V13, P1003, DOI 10.2741/2739; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Zehbe I, 2003, HUM IMMUNOL, V64, P538, DOI 10.1016/S0198-8859(03)00033-8; Zehbe I, 2001, INT J CANCER, V94, P711, DOI 10.1002/ijc.1520; Zehbe I, 1998, CANCER RES, V58, P829; Zehbe I, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-77; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	39	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36239	10.1371/journal.pone.0036239	http://dx.doi.org/10.1371/journal.pone.0036239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558401	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000168
J	Guo, TT; Kong, J; Zhang, L; Zhang, CC; Hu, SM				Guo, Tingting; Kong, Jian; Zhang, Li; Zhang, Chenchen; Hu, Shumin			Fine Tuning of the Lactate and Diacetyl Production through Promoter Engineering in Lactococcus lactis	PLOS ONE			English	Article							ALPHA-ACETOLACTATE SYNTHASE; ELECTRON-TRANSPORT CHAIN; COMPLETE GENOME SEQUENCE; ACID BACTERIA; NADH OXIDASE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RESPIRATION CAPACITY; IN-VIVO	Lactococcus lactis is a well-studied bacterium widely used in dairy fermentation and capable of producing metabolites with organoleptic and nutritional characteristics. For fine tuning of the distribution of glycolytic flux at the pyruvate branch from lactate to diacetyl and balancing the production of the two metabolites under aerobic conditions, a constitutive promoter library was constructed by randomizing the promoter sequence of the H2O-forming NADH oxidase gene in L. lactis. The library consisted of 30 promoters covering a wide range of activities from 7,000 to 380,000 relative fluorescence units using a green fluorescent protein as reporter. Eleven typical promoters of the library were selected for the constitutive expression of the H2O-forming NADH oxidase gene in L. lactis, and the NADH oxidase activity increased from 9.43 to 58.17-fold of the wild-type strain in small steps of activity change under aerobic conditions. Meanwhile, the lactate yield decreased from 21.15 +/- 0.08 mM to 9.94 +/- 0.07 mM, and the corresponding diacetyl production increased from 1.07 +/- 0.03 mM to 4.16 +/- 0.06 mM with the intracellular NADH/NAD(+) ratios varying from 0.711 +/- 0.005 to 0.383 +/- 0.003. The results indicated that the reduced pyruvate to lactate flux was rerouted to the diacetyl with an almost linear flux variation via altered NADH/NAD(+) ratios. Therefore, we provided a novel strategy to precisely control the pyruvate distribution for fine tuning of the lactate and diacetyl production through promoter engineering in L. lactis. Interestingly, the increased H2O-forming NADH oxidase activity led to 76.95% lower H2O2 concentration in the recombinant strain than that of the wild-type strain after 24 h of aerated cultivation. The viable cells were significantly elevated by four orders of magnitude within 28 days of storage at 4 degrees C, suggesting that the increased enzyme activity could eliminate H2O2 accumulation and prolong cell survival.	[Guo, Tingting; Kong, Jian; Zhang, Li; Zhang, Chenchen; Hu, Shumin] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Guo, TT (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	kongjian@sdu.edu.cn			National Natural Science Foundation of China (NSFC) [31070091]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20100131110035]; Hi-tech Research and Development Program of China [2011AA100902]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was financially supported by a grant from the National Natural Science Foundation of China (NSFC, grant no. 31070091, http://www.nsfc.gov.cn/Portal0/default106.htm); a grant from the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP, grant no. 20100131110035, http://www.cutech.edu.cn/cn/index.htm); and Hi-tech Research and Development Program of China (grant no. 2011AA100902, http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Andersen HW, 2001, EUR J BIOCHEM, V268, P6379, DOI 10.1046/j.0014-2956.2001.02599.x; BASSIT N, 1993, APPL ENVIRON MICROB, V59, P1893, DOI 10.1128/AEM.59.6.1893-1897.1993; Benson KH, 1996, APPL MICROBIOL BIOT, V45, P107, DOI 10.1007/s002530050656; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bruno-Barcena JM, 2004, APPL ENVIRON MICROB, V70, P4702, DOI 10.1128/AEM.70.8.4702-4710.2004; de Felipe FL, 1998, J BACTERIOL, V180, P3804; de Felipe FL, 2001, INT DAIRY J, V11, P37, DOI 10.1016/S0958-6946(01)00031-0; de Vos WM, 2004, TRENDS BIOTECHNOL, V22, P72, DOI 10.1016/j.tibtech.2003.11.011; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gaudu P, 2002, ANTON LEEUW INT J G, V82, P263, DOI 10.1023/A:1020635600343; Hammer K, 2006, TRENDS BIOTECHNOL, V24, P53, DOI 10.1016/j.tibtech.2005.12.003; Heux S, 2006, METAB ENG, V8, P303, DOI 10.1016/j.ymben.2005.12.003; Hoefnagel MHN, 2002, MICROBIOL-SGM, V148, P1003, DOI 10.1099/00221287-148-4-1003; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hols P, 1999, NAT BIOTECHNOL, V17, P588, DOI 10.1038/9902; Hugenholtz J, 2000, APPL ENVIRON MICROB, V66, P4112, DOI 10.1128/AEM.66.9.4112-4114.2000; Hugenholtz J, 2008, INT DAIRY J, V18, P466, DOI 10.1016/j.idairyj.2007.11.015; Jensen NBS, 2001, APPL ENVIRON MICROB, V67, P2677, DOI 10.1128/AEM.67.6.2677-2682.2001; Jensen PR, 1998, APPL ENVIRON MICROB, V64, P82; Jeppsson M, 2003, YEAST, V20, P1263, DOI 10.1002/yea.1043; Jiang RR, 2004, TETRAHEDRON-ASYMMETR, V15, P2939, DOI 10.1016/j.tetasy.2004.07.057; Kleerebezem M, 2003, CURR OPIN BIOTECH, V14, P232, DOI 10.1016/S0958-1669(03)00033-8; Kleerebezem M, 2002, J BIOTECHNOL, V98, P199, DOI 10.1016/S0168-1656(02)00132-3; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Koebmann BJ, 2002, ANTON LEEUW INT J G, V82, P237, DOI 10.1023/A:1020643918089; Le Loir Y, 1998, J BACTERIOL, V180, P1895, DOI 10.1128/JB.180.7.1895-1903.1998; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Liu SQ, 2003, INT J FOOD MICROBIOL, V83, P115, DOI 10.1016/S0168-1605(02)00366-5; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Marty-Teysset C, 2000, APPL ENVIRON MICROB, V66, P262, DOI 10.1128/AEM.66.1.262-267.2000; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mijakovic I, 2005, CURR OPIN BIOTECH, V16, P329, DOI 10.1016/j.copbio.2005.04.003; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Odamaki T, 2011, J DAIRY SCI, V94, P1112, DOI 10.3168/jds.2010-3286; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Pedersen MB, 2008, J BACTERIOL, V190, P4903, DOI 10.1128/JB.00447-08; PLATTEEUW C, 1995, APPL ENVIRON MICROB, V61, P3967, DOI 10.1128/AEM.61.11.3967-3971.1995; Pudlik AM, 2011, J BACTERIOL, V193, P4049, DOI [10.1128/JB.05012-11, 10.1128/JB.01171-10]; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Sambrook J, 1989, MOL CLONING, V2; San KY, 2002, METAB ENG, V4, P182, DOI 10.1006/mben.2001.0220; Solem C, 2002, APPL ENVIRON MICROB, V68, P2397, DOI 10.1128/AEM.68.5.2397-2403.2002; Stephanopoulos G, 1999, METAB ENG, V1, P1, DOI 10.1006/mben.1998.0101; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P3069, DOI 10.1128/AEM.69.6.3069-3076.2003; Tachon S, 2010, APPL ENVIRON MICROB, V76, P1311, DOI 10.1128/AEM.02120-09; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; Vogel RF, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S6; Vos W. M. de, 1994, Genetics and biotechnology of lactic acid bacteria., P52; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wisselink HW, 2004, APPL ENVIRON MICROB, V70, P4286, DOI 10.1128/AEM.70.7.4286-4292.2004	55	41	45	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36296	10.1371/journal.pone.0036296	http://dx.doi.org/10.1371/journal.pone.0036296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558426	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000181
J	Leclercq, V; Seitz, AR				Leclercq, Virginie; Seitz, Aaron R.			Fast-TIPL Occurs for Salient Images without a Memorization Requirement in Men but Not in Women	PLOS ONE			English	Article							ACETYLCHOLINE; PLASTICITY; SPECIFICITY; DOPAMINE	Recent research of task-irrelevant perceptual learning (TIPL) demonstrates that stimuli that are consistently presented at relevant point in times (e.g. with task-targets or rewards) are learned, even in the absence of attention to these stimuli. However, different research paradigms have observed different results for how salient stimuli are learned; with some studies showing no learning, some studies showing positive learning and others showing negative learning effects. In this paper we focused on how the level of processing of stimuli impacts fast-TIPL. We conducted three different experiments in which the level of processing of the information paired with a target was manipulated. Our results indicated that fast-TIPL occurs when participants have to memorize the information presented with the target, but also when they just have to process this information for a secondary task without an explicit memorization of those stimuli. However, fast-TIPL does not occur when participants have to ignore the target-paired information. This observation is consistent with recent models of TIPL that suggest that attentional signals can either enhance or suppress learning depending on whether those stimuli are distracting or not to the subjects' objectives. Our results also revealed a robust gender effect in fast-TIPL, where male subjects consistently show fast-TIPL, whereas the observation of fast-TIPL is inconsistent in female subjects.	[Leclercq, Virginie; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Leclercq, V (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	virginie.leclercq@ucr.edu						Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Choi H, 2009, VISION RES, V49, P2586, DOI 10.1016/j.visres.2009.07.004; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; DeSchepper B, 1996, J EXP PSYCHOL LEARN, V22, P27, DOI 10.1037/0278-7393.22.1.27; Dewald AD, 2011, ACTA PSYCHO IN PRESS; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kimchi R, 2009, ACTA PSYCHOL, V130, P64, DOI 10.1016/j.actpsy.2008.10.002; Leclercq V, 2012, ATTEN PERCE IN PRESS; Leclercq V, 2012, VISION RES, V61, P70, DOI 10.1016/j.visres.2011.07.017; Lin JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000337; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Roelfsema PR, 2010, TRENDS COGN SCI, V14, P64, DOI 10.1016/j.tics.2009.11.005; Rokem A, 2010, CURR BIOL, V20, P1723, DOI 10.1016/j.cub.2010.08.027; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Swallow KM, 2011, ATTEN PERCEPT PSYCHO, V73, P389, DOI 10.3758/s13414-010-0045-y; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Tully K, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-15; Urban NBL, 2010, BIOL PSYCHIAT, V68, P689, DOI 10.1016/j.biopsych.2010.06.005; Watanabe T, 2002, NAT NEUROSCI, V5, P1003, DOI 10.1038/nn915; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36228	10.1371/journal.pone.0036228	http://dx.doi.org/10.1371/journal.pone.0036228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558395	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336000162
J	Moran, NA; Hansen, AK; Powell, JE; Sabree, ZL				Moran, Nancy A.; Hansen, Allison K.; Powell, J. Elijah; Sabree, Zakee L.			Distinctive Gut Microbiota of Honey Bees Assessed Using Deep Sampling from Individual Worker Bees	PLOS ONE			English	Article							RIBOSOMAL-RNA SEQUENCES; BACTERIAL COMMUNITY; DIVERSITY; ASSEMBLAGES; GENOMES; HINDGUT	Surveys of 16S rDNA sequences from the honey bee, Apis mellifera, have revealed the presence of eight distinctive bacterial phylotypes in intestinal tracts of adult worker bees. Because previous studies have been limited to relatively few sequences from samples pooled from multiple hosts, the extent of variation in this microbiota among individuals within and between colonies and locations has been unclear. We surveyed the gut microbiota of 40 individual workers from two sites, Arizona and Maryland USA, sampling four colonies per site. Universal primers were used to amplify regions of 16S ribosomal RNA genes, and amplicons were sequenced using 454 pyrotag methods, enabling analysis of about 330,000 bacterial reads. Over 99% of these sequences belonged to clusters for which the first blastn hits in GenBank were members of the known bee phylotypes. Four phylotypes, one within Gammaproteobacteria (corresponding to "Candidatus Gilliamella apicola'') one within Betaproteobacteria ("Candidatus Snodgrassella alvi''), and two within Lactobacillus, were present in every bee, though their frequencies varied. The same typical bacterial phylotypes were present in all colonies and at both sites. Community profiles differed significantly among colonies and between sites, mostly due to the presence in some Arizona colonies of two species of Enterobacteriaceae not retrieved previously from bees. Analysis of Sanger sequences of rRNA of the Snodgrassella and Gilliamella phylotypes revealed that single bees contain numerous distinct strains of each phylotype. Strains showed some differentiation between localities, especially for the Snodgrassella phylotype.	[Moran, Nancy A.; Hansen, Allison K.; Powell, J. Elijah; Sabree, Zakee L.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Moran, NA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	nancy.moran@yale.edu	Moran, Nancy A/G-1591-2010	Powell, Jenkyn/0000-0002-2758-6174; Hansen, Allison/0000-0002-3066-5527	National Science Foundation [1046153]; Yale University; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	National Science Foundation(National Science Foundation (NSF)); Yale University; Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	Financial support was provided by the National Science Foundation Dimensions of Biodiversity award 1046153 to Nancy Moran. Some funding came from Yale University. Sample processing and sequencing was conducted by the U.S. Department of Energy Joint Genome Institute, which is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andert J, 2010, FEMS MICROBIOL ECOL, V74, P439, DOI 10.1111/j.1574-6941.2010.00950.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chazdon RL, 1998, MAN BIOSPH, V20, P285; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Drummond AJ, 2011, GENEIOUS V5 4 WEBSIT; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Hansen AK, 2009, NORTHWEST SCI, V83, P348, DOI 10.3955/046.083.0406; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martinson VG, 2012, APPL ENV MICROBIOL, P78; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mather P. M., 1976, COMPUTATIONAL METHOD; McCune B., 2011, PC ORD MULTIVARIATE; Mielke P.W., 1984, HDB STAT, V4, P813, DOI DOI 10.1016/S0169-7161(84)04036-0; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; MOORE AJ, 1987, ANIM BEHAV, V35, P1159, DOI 10.1016/S0003-3472(87)80172-0; Nalepa CA, 2001, INSECT SOC, V48, P194, DOI 10.1007/PL00001767; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SPSS Inc, 2007, SPSS WIND STAND VERS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269	43	237	253	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36393	10.1371/journal.pone.0036393	http://dx.doi.org/10.1371/journal.pone.0036393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558460	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000204
J	Ye, M; Luo, SM; Xie, JF; Li, YF; Xu, T; Liu, Y; Song, YY; Zhu-Salzman, K; Zeng, RS				Ye, Mao; Luo, Shi Ming; Xie, Jie Fen; Li, Yan Fang; Xu, Tao; Liu, Yang; Song, Yuan Yuan; Zhu-Salzman, Keyan; Zeng, Ren Sen			Silencing COI1 in Rice Increases Susceptibility to Chewing Insects and Impairs Inducible Defense	PLOS ONE			English	Article							NILAPARVATA-LUGENS EGGS; METHYL JASMONATE; NICOTIANA-ATTENUATA; PLANT DEFENSE; ARABIDOPSIS-THALIANA; SIGNALING PATHWAYS; GENE-EXPRESSION; PHYTOTOXIN CORONATINE; PROTEASE INHIBITORS; MICROARRAY ANALYSIS	The jasmonic acid (JA) pathway plays a key role in plant defense responses against herbivorous insects. CORONATINE INSENSITIVE1 (COI1) is an F-box protein essential for all jasmonate responses. However, the precise defense function of COI1 in monocotyledonous plants, especially in rice (Oryza sativa L.) is largely unknown. We silenced OsCOI1 in rice plants via RNA interference (RNAi) to determine the role of OsCOI1 in rice defense against rice leaf folder (LF) Cnaphalocrocis medinalis, a chewing insect, and brown planthopper (BPH) Nilaparvata lugens, a phloem-feeding insect. In wild-type rice plants (WT), the transcripts of OsCOI1 were strongly and continuously up-regulated by LF infestation and methyl jasmonate (MeJA) treatment, but not by BPH infestation. The abundance of trypsin protease inhibitor (TrypPI), and the enzymatic activities of polyphenol oxidase (PPO) and peroxidase (POD) were enhanced in response to both LF and BPH infestation, but the activity of lipoxygenase (LOX) was only induced by LF. The RNAi lines with repressed expression of OsCOI1 showed reduced resistance against LF, but no change against BPH. Silencing OsCOI1 did not alter LF-induced LOX activity and JA content, but it led to a reduction in the TrypPI content, POD and PPO activity by 62.3%, 48.5% and 27.2%, respectively. In addition, MeJA-induced TrypPI and POD activity were reduced by 57.2% and 48.2% in OsCOI1 RNAi plants. These results suggest that OsCOI1 is an indispensable signaling component, controlling JA-regulated defense against chewing insect (LF) in rice plants, and COI1 is also required for induction of TrypPI, POD and PPO in rice defense response to LF infestation.	[Ye, Mao; Song, Yuan Yuan; Zeng, Ren Sen] S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Ye, Mao; Luo, Shi Ming; Xie, Jie Fen; Xu, Tao; Song, Yuan Yuan; Zeng, Ren Sen] S China Agr Univ, Key Lab Trop Agroenvironm, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Li, Yan Fang] Guangdong Acad Agr Sci China, Inst Plant Protect, Guangzhou, Guangdong, Peoples R China; [Liu, Yang] S China Agr Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Ministry of Agriculture & Rural Affairs; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University; Guangdong Academy of Agricultural Sciences; South China Agricultural University; Texas A&M University System; Texas A&M University College Station	Ye, M (corresponding author), S China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Minist Agr, Guangzhou, Guangdong, Peoples R China.	rszeng@scau.edu.cn	Zeng, Ren-sen/AAI-2067-2020; li, yan/GTI-4638-2022	Zeng, Rensen/0000-0002-6435-3054; Song, Yuanyuan/0000-0002-5295-803X	National 973 Project of China [2011CB100400]; National Natural Science Foundation of China [31070388, 31028018, 30870390]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Science and Technology Plan Project [2008A030101008, 2008B021500001]; Ph.D. Programs Foundation of the Ministry of Education of China [20104404110004]	National 973 Project of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Guangdong Science and Technology Plan Project; Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China)	This research was financially supported by the National 973 Project of China (2011CB100400), National Natural Science Foundation of China (31070388, 31028018, 30870390), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2010), Guangdong Science and Technology Plan Project (2008A030101008, 2008B021500001) and Ph.D. Programs Foundation of the Ministry of Education of China (20104404110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2010, J EXP BOT, V61, P4373, DOI 10.1093/jxb/erq240; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BENDER CL, 1989, J BACTERIOL, V171, P807, DOI 10.1128/jb.171.2.807-812.1989; Berger S, 1996, PLANT PHYSIOL, V111, P525, DOI 10.1104/pp.111.2.525; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Devoto A, 2005, PLANT MOL BIOL, V58, P497, DOI 10.1007/s11103-005-7306-5; Devoto A, 2002, PLANT J, V32, P457, DOI 10.1046/j.1365-313X.2002.01432.x; Du B, 2009, P NATL ACAD SCI USA, V106, P22163, DOI 10.1073/pnas.0912139106; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; FARMER EE, 1992, PLANT PHYSIOL, V98, P995, DOI 10.1104/pp.98.3.995; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fidantsef AL, 1999, PHYSIOL MOL PLANT P, V54, P97, DOI 10.1006/pmpp.1998.0192; Gosset V, 2009, J EXP BOT, V60, P1231, DOI 10.1093/jxb/erp015; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Heidel AJ, 2004, PLANT CELL ENVIRON, V27, P1362, DOI 10.1111/j.1365-3040.2004.01228.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hu TZ, 2006, PROG BIOCHEM BIOPHYS, V33, P388; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kiefer E, 2000, PLANT MOL BIOL REP, V18, P33, DOI 10.1007/BF02825291; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; KRAUS TE, 1994, PLANT CELL PHYSIOL, V35, P45; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; Lou YG, 2005, J CHEM ECOL, V31, P1985, DOI 10.1007/s10886-005-6072-9; Lou YG, 2006, J CHEM ECOL, V32, P2375, DOI 10.1007/s10886-006-9151-7; MACRI F, 1994, BBA-LIPID LIPID MET, V1215, P109, DOI 10.1016/0005-2760(94)90098-1; Mei Chuansheng, 2007, Methods Mol Biol, V354, P161; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; MITCHELL RE, 1982, PHYSIOL PLANT PATHOL, V20, P83, DOI 10.1016/0048-4059(82)90026-1; Moran PJ, 2002, ARCH INSECT BIOCHEM, V51, P182, DOI 10.1002/arch.10064; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Mosblech A, 2011, PLANT J, V65, P949, DOI 10.1111/j.1365-313X.2011.04480.x; Paschold A, 2008, PLANT CELL PHYSIOL, V49, P1165, DOI 10.1093/pcp/pcn091; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Pechan T, 2000, PLANT CELL, V12, P1031, DOI 10.1105/tpc.12.7.1031; Rani PU, 2010, ACTA PHYSIOL PLANT, V32, P695, DOI 10.1007/s11738-009-0449-2; Rayapuram C, 2007, PLANT J, V52, P700, DOI 10.1111/j.1365-313X.2007.03267.x; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1003, DOI 10.1093/pcp/pcn077; Song YuanYuan, 2010, Acta Agriculturae Universitatis Jiangxiensis, V32, P1056; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Stenzel I, 2003, PLANT MOL BIOL, V51, P895, DOI 10.1023/A:1023049319723; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; VanDoorn A, 2011, NEW PHYTOL, V190, P640, DOI 10.1111/j.1469-8137.2010.03622.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang Qi-Xiang, 2008, Acta Entomologica Sinica, V51, P1265; Wang Z, 2008, PLANT CELL REP, V27, P125, DOI 10.1007/s00299-007-0410-z; Wang ZL, 2005, MOL PLANT MICROBE IN, V18, P1285, DOI 10.1094/MPMI-18-1285; Ward KA, 1999, PLANT GROWTH REGUL, V27, P49, DOI 10.1023/A:1006188418523; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Xu T, 2003, CHINESE SCI BULL, V48, P1982, DOI 10.1360/03wc0072; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; ZAUBERMAN G, 1991, SCI HORTIC-AMSTERDAM, V47, P89, DOI 10.1016/0304-4238(91)90030-3; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zhou GX, 2009, PLANT J, V60, P638, DOI 10.1111/j.1365-313X.2009.03988.x; Zhu-Salzman K, 2004, PLANT PHYSIOL, V134, P420, DOI 10.1104/pp.103.028324	72	74	83	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36214	10.1371/journal.pone.0036214	http://dx.doi.org/10.1371/journal.pone.0036214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558386	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000157
J	Barca, L; Pezzulo, G				Barca, Laura; Pezzulo, Giovanni			Unfolding Visual Lexical Decision in Time	PLOS ONE			English	Article							WORD; CONTEXT; TRANSPARENT; RECOGNITION; PERCEPTION; ACCOUNT; MEMORY; MODEL	Visual lexical decision is a classical paradigm in psycholinguistics, and numerous studies have assessed the so-called "lexicality effect'' (i.e., better performance with lexical than non-lexical stimuli). Far less is known about the dynamics of choice, because many studies measured overall reaction times, which are not informative about underlying processes. To unfold visual lexical decision in (over) time, we measured participants' hand movements toward one of two item alternatives by recording the streaming x,y coordinates of the computer mouse. Participants categorized four kinds of stimuli as "lexical'' or "non-lexical:'' high and low frequency words, pseudowords, and letter strings. Spatial attraction toward the opposite category was present for low frequency words and pseudowords. Increasing the ambiguity of the stimuli led to greater movement complexity and trajectory attraction to competitors, whereas no such effect was present for high frequency words and letter strings. Results fit well with dynamic models of perceptual decision-making, which describe the process as a competition between alternatives guided by the continuous accumulation of evidence. More broadly, our results point to a key role of statistical decision theory in studying linguistic processing in terms of dynamic and non-modular mechanisms.	[Barca, Laura; Pezzulo, Giovanni] Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy; [Pezzulo, Giovanni] Natl Res Council ILC CNR, Ist Linguist Computaz Antonio Zampolli, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Linguistica Computazionale "A. Zampolli" (ILC-CNR)	Barca, L (corresponding author), Natl Res Council ISTC CNR, Inst Cognit Sci & Technol, Rome, Italy.	laurabarcapst@gmail.com	Pezzulo, Giovanni/AAY-3586-2020; Pezzulo, Giovanni/F-6854-2014; Barca, Laura/J-8274-2018	Pezzulo, Giovanni/0000-0001-6813-8282; Pezzulo, Giovanni/0000-0001-6813-8282; Barca, Laura/0000-0002-8553-7717	European Community [224919, 270108]	European Community(European Commission)	This research was supported by funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements 224919 (WoRHD, supporting L.B.), and 270108 (Goal-Leaders, supporting G.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barca L, 2011, ESCOP C SAN SEB; Barca L, 2007, READ WRIT, V20, P495, DOI 10.1007/s11145-006-9040-z; Barca L, 2011, BRAIN LANG, V118, P53, DOI 10.1016/j.bandl.2010.09.003; Barca L, 2010, READ WRIT, V23, P569, DOI 10.1007/s11145-009-9192-8; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Blais C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006448; Brysbaert M., 2007, LANGUAGE AS FIXED EF; Burani C, 2006, PSYCHON B REV, V13, P346, DOI 10.3758/BF03193855; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cornelissen PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005359; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Egner T, 2010, J NEUROSCI, V30, P16601, DOI 10.1523/JNEUROSCI.2770-10.2010; Ellis AW, 2009, PHILOS T R SOC B, V364, P3675, DOI 10.1098/rstb.2009.0187; Freeman JB, 2011, PSYCHON B REV, V18, P705, DOI 10.3758/s13423-011-0097-6; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Freeman JB, 2010, J EXP SOC PSYCHOL, V46, P179, DOI 10.1016/j.jesp.2009.10.002; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gaskell MG, 2002, COGNITIVE PSYCHOL, V45, P220; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Kinoshita S, 2004, MEM COGNITION, V32, P1255, DOI 10.3758/BF03206316; Magnuson JS, 2003, J EXP PSYCHOL GEN, V132, P202, DOI 10.1037/0096-3445.132.2.202; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Pagliuca G, 2008, LANG COGNITIVE PROC, V23, P422, DOI 10.1080/01690960701626036; Paulesu E, 2000, NAT NEUROSCI, V3, P9196; Pezzulo G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00005; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Rao RPN, 1999, NAT NEUROSCI, V2, P1; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Resulaj A, 2009, NATURE, V461, P263, DOI 10.1038/nature08275; Revill KP, 2008, P NATL ACAD SCI USA, V105, P13111, DOI 10.1073/pnas.0807054105; Shiffrin RM, 1997, PSYCHON B REV, V4, P145, DOI 10.3758/BF03209391; Song YY, 2010, J NEUROSCI, V30, P9869, DOI 10.1523/JNEUROSCI.0140-10.2010; SPIVEY J, 2007, CONTINUITY MIND; Spivey MJ, 2005, P NATL ACAD SCI USA, V102, P10393, DOI 10.1073/pnas.0503903102; Tsetsos K, 2011, FRONT NEUROSCI, P5; Twomey T, 2011, NEUROIMAGE, V55, P1242, DOI 10.1016/j.neuroimage.2011.01.001; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129	43	49	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35932	10.1371/journal.pone.0035932	http://dx.doi.org/10.1371/journal.pone.0035932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563419	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100045
J	Cat, AND; Escoubet, B; Agrapart, V; Griol-Charhbili, V; Schoeb, T; Feng, WG; Jaimes, E; Warnock, DG; Jaisser, F				Cat, Aurelie Nguyen Dinh; Escoubet, Brigitte; Agrapart, Vincent; Griol-Charhbili, Violaine; Schoeb, Trenton; Feng, Wenguang; Jaimes, Edgar; Warnock, David G.; Jaisser, Frederic			Cardiomyopathy and Response to Enzyme Replacement Therapy in a Male Mouse Model for Fabry Disease	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE; MINERALOCORTICOID RECEPTOR; CARDIAC MANIFESTATIONS; NATURAL-HISTORY; DEFICIENT MICE; OUTCOME SURVEY; HEART; EXPRESSION; PREVALENCE; REGISTRY	Fabry disease is an X-linked disorder of glycosphingolipid metabolism that results in progressive accumulation of neutral glycosphingolipids, (predominately globotriaosylceramide; GL-3) in lysosomes, as well as other cellular compartments and the extracellular space. Our aim was to characterize the cardiac phenotype of male knock-out mice that are deficient in alpha-galactosidase A activity, as a model for Fabry disease and test the efficacy of Enzyme Replacement Therapy with agalsidase-beta. Male mice (3-4 months of age) were characterized with awake blood pressure and heart rate measurements, cardiac echocardiography and electrocardiography measurements under light anesthesia, histological studies and molecular studies with real-time polymerase chain reaction. The Fabry knock-out mouse has bradycardia and lower blood pressure than control wild type (CB7BL/6J) mice. In Fabry knock-out mice, the cardiomyopathy associated mild hypertrophy at echography with normal systolic LV function and mild diastolic dysfunction. Premature atrial contractions were more frequent in without conduction defect. Heart weight normalized to tibial length was increased in Fabry knockout mice. Ascending aorta dilatation was observed. Molecular studies were consistent with early stages of cardiac remodeling. A single dose of agalsidase-beta (3 mg/kg) did not affect the LV hypertrophy, function or heart rate, but did improve the mRNA signals of early cardiac remodeling. In conclusion, the alpha-galactosidase A deficient mice at 3 to 4 months of age have cardiac and vascular alterations similar to that described in early clinical stage of Fabry disease in children and adolescents. Enzyme replacement therapy affects cardiac molecular remodeling after a single dose.	[Cat, Aurelie Nguyen Dinh; Escoubet, Brigitte; Agrapart, Vincent; Griol-Charhbili, Violaine; Jaisser, Frederic] Inserm, U872, Team 1, Paris, France; [Cat, Aurelie Nguyen Dinh; Agrapart, Vincent; Griol-Charhbili, Violaine; Jaisser, Frederic] Univ Paris 06, Paris, France; [Escoubet, Brigitte] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Escoubet, Brigitte] Univ Paris 07, Bichat Federat Res Inst 02, Ctr Explorat Fonct Imagerie, Paris, France; [Schoeb, Trenton; Feng, Wenguang; Jaimes, Edgar; Warnock, David G.] Univ Alabama Birmingham, Birmingham, AL USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Alabama System; University of Alabama Birmingham	Cat, AND (corresponding author), Inserm, U872, Team 1, Paris, France.	frederic.jaisser@crc.jussieu.fr	CAT, Aurelie NGUYEN DINH/H-8182-2013; Jaisser, Frederic/P-4287-2017	Jaisser, Frederic/0000-0001-9051-1901	Institut National de la Sante et de la Recherche Medicale; GENZYME Investigator Sponsored Research Program; Centre de Recherche Industrielle et Technique; INSERM/Conseil Regional Ile de France; Lefoulon-Delalande postdoctoral fellowship; Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America; Genzyme Corporation, Cambridge, Massachusetts, United States of America; GENZYME Corporation through the GENZYME Investigator Sponsored Research Program	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); GENZYME Investigator Sponsored Research Program; Centre de Recherche Industrielle et Technique; INSERM/Conseil Regional Ile de France; Lefoulon-Delalande postdoctoral fellowship; Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America; Genzyme Corporation, Cambridge, Massachusetts, United States of America; GENZYME Corporation through the GENZYME Investigator Sponsored Research Program	This work was supported by grants to FJ from Institut National de la Sante et de la Recherche Medicale, the GENZYME Investigator Sponsored Research Program and the Centre de Recherche Industrielle et Technique. ANDC held a PhD grant from INSERM/Conseil Regional Ile de France; VG-C held a Lefoulon-Delalande postdoctoral fellowship. DGW received support from the Division of Nephrology and Department of Medicine at the University of Alabama at Birmingham, Birmingham Alabama, United States of America, and Genzyme Corporation, Cambridge, Massachusetts, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of the work was financed by GENZYME Corporation through the GENZYME Investigator Sponsored Research Program. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2014, METABOLIC MOL BASES; Barbey F, 2010, EUR HEART J, V31, P347, DOI 10.1093/eurheartj/ehp426; Bichara M, 2006, GLYCOBIOLOGY, V16, P36, DOI 10.1093/glycob/cwj035; Bierer G, 2005, RESPIRATION, V72, P504, DOI 10.1159/000087675; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Chimenti C, 2008, AM J PATHOL, V172, P1482, DOI 10.2353/ajpath.2008.070576; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Fervenza FC, 2008, KIDNEY INT, V73, P1193, DOI 10.1038/sj.ki.5002677; FERVENZA FC, 2008, BIOLOGICS, V2, P1; Guo X, 2002, AM J PHYSIOL-HEART C, V283, pH1829, DOI 10.1152/ajpheart.00224.2002; Hopkin RJ, 2008, PEDIATR RES, V64, P550, DOI 10.1203/PDR.0b013e318183f132; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Kampmann C, 2008, ACTA PAEDIATR, V97, P463, DOI 10.1111/j.1651-2227.2008.00700.x; Kaneski CR, 2006, NEUROLOGY, V67, P2045, DOI 10.1212/01.wnl.0000247278.88077.09; Kouris NT, 2005, INT J CARDIOL, V99, P327, DOI 10.1016/j.ijcard.2003.10.065; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Lobo T, 2008, INTERN MED J, V38, P407, DOI 10.1111/j.1445-5994.2008.01669.x; Mallon AM, 2008, NUCLEIC ACIDS RES, V36, pD715, DOI 10.1093/nar/gkm728; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Mehta A, 2009, J MED GENET, V46, P548, DOI 10.1136/jmg.2008.065904; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Olivotto I, 2003, J AM COLL CARDIOL, V41, P315, DOI 10.1016/S0735-1097(02)02713-4; Ouvrard-Pascaud A, 2005, CIRCULATION, V111, P3025, DOI 10.1161/CIRCULATIONAHA.104.503706; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Ries M, 2005, PEDIATRICS, V115, pE344, DOI 10.1542/peds.2004-1678; Rozenfeld PA, 2011, CAN J CARDIOL, V27, P339, DOI 10.1016/j.cjca.2010.12.035; Sadick Norman, 2007, Heart Lung Circ, V16, P200, DOI 10.1016/j.hlc.2007.03.007; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Shah JS, 2005, AM J CARDIOL, V96, P842, DOI 10.1016/j.amjcard.2005.05.033; Shah JS, 2005, ACTA PAEDIATR, V94, P11, DOI 10.1080/08035320510028058; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shu L, 2009, J AM SOC NEPHROL; Shu LM, 2005, J AM SOC NEPHROL, V16, P2636, DOI 10.1681/ASN.2005040383; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Takenaka T, 2008, J CARDIOL, V51, P50, DOI 10.1016/j.jjcc.2007.12.001; Toro R, 2009, INT J CARDIOL, V132, P38, DOI 10.1016/j.ijcard.2008.04.075; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wanner C, 2010, CLIN J AM SOC NEPHRO, V5, P2220, DOI 10.2215/CJN.04340510; Warnock DG, 2011, RENAL OUTCOMES AGALS; Weidemann F, 2011, ANNU REV MED, V62, P59, DOI 10.1146/annurev-med-090910-085119; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278	48	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e33743	10.1371/journal.pone.0033743	http://dx.doi.org/10.1371/journal.pone.0033743			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574107	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349800003
J	Ito, S; Ishii, A; Kakusho, N; Taniyama, C; Yamazaki, S; Fukatsu, R; Sakaue-Sawano, A; Miyawaki, A; Masai, H				Ito, Sayuri; Ishii, Ai; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Fukatsu, Rino; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Masai, Hisao			Mechanism of Cancer Cell Death Induced by Depletion of an Essential Replication Regulator	PLOS ONE			English	Article							IN-VITRO PHOSPHORYLATION; DNA-REPLICATION; CDC7 KINASE; S-PHASE; NUCLEAR-LOCALIZATION; DEPENDENT ACTIVATION; MITOTIC CATASTROPHE; INDUCED APOPTOSIS; MAMMALIAN-CELLS; FISSION YEAST	Background: Depletion of replication factors often causes cell death in cancer cells. Depletion of Cdc7, a kinase essential for initiation of DNA replication, induces cancer cell death regardless of its p53 status, but the precise pathways of cell death induction have not been characterized. Methodology/Principal Findings: We have used the recently-developed cell cycle indicator, Fucci, to precisely characterize the cell death process induced by Cdc7 depletion. We have also generated and utilized similar fluorescent cell cycle indicators using fusion with other cell cycle regulators to analyze modes of cell death in live cells in both p53-positive and -negative backgrounds. We show that distinct cell-cycle responses are induced in p53-positive and -negative cells by Cdc7 depletion. p53-negative cells predominantly arrest temporally in G2-phase, accumulating CyclinB1 and other mitotic regulators. Prolonged arrest at G2-phase and abrupt entry into aberrant M-phase in the presence of accumulated CyclinB1 are followed by cell death at the post-mitotic state. Abrogation of cytoplasmic CyclinB1 accumulation partially decreases cell death. The ATR-MK2 pathway is responsible for sequestration of CyclinB1 with 14-3-3s protein. In contrast, p53-positive cancer cells do not accumulate CyclinB1, but appear to die mostly through entry into aberrant S-phase after Cdc7 depletion. The combination of Cdc7 inhibition with known anti-cancer agents significantly stimulates cell death effects in cancer cells in a genotype-dependent manner, providing a strategic basis for future combination therapies. Conclusions: Our results show that the use of Fucci, and similar fluorescent cell cycle indicators, offers a convenient assay system with which to identify cell cycle events associated with cancer cell death. They also indicate genotype-specific cell death modes induced by deficient initiation of DNA replication in cancer cells and its potential exploitation for development of efficient cancer therapies.	[Ito, Sayuri; Ishii, Ai; Kakusho, Naoko; Taniyama, Chika; Yamazaki, Satoshi; Fukatsu, Rino; Masai, Hisao] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama, Japan	Tokyo Metropolitan Institute of Medical Science; RIKEN	Ito, S (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Genome Dynam Project, Setagaya Ku, Tokyo, Japan.	masai-hs@igakuken.or.jp	Miyawaki, Atsushi/K-3569-2014	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Basic Scientific Research (A) and a Grant-in-Aid for Scientific Research on Priority Area "Chromosome Cycle'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alvarez-Fernandez M, 2010, EMBO REP, V11, P452, DOI 10.1038/embor.2010.46; Arai R, 2002, J CELL SCI, V115, P887; BARINAGA M, 1994, SCIENCE, V265, P1175, DOI 10.1126/science.8066458; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Im JS, 2008, J BIOL CHEM, V283, P25171, DOI 10.1074/jbc.M802851200; Ito S, 2008, DRUG NEWS PERSPECT, V21, P481, DOI 10.1358/dnp.2008.21.9.1290818; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kan QM, 2008, J BIOL CHEM, V283, P17864, DOI 10.1074/jbc.M802055200; Kim JM, 2008, ONCOGENE, V27, P3475, DOI 10.1038/sj.onc.1210994; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lau E, 2009, MOL BIOL CELL, V20, P3953, DOI 10.1091/mbc.E09-01-0022; Marumoto T, 2002, GENES CELLS, V7, P1173, DOI 10.1046/j.1365-2443.2002.00592.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matsumoto S, 2010, CELL CYCLE, V9, P4627, DOI 10.4161/cc.9.23.13937; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Montagnoli A, 2008, NAT CHEM BIOL, V4, P357, DOI 10.1038/nchembio.90; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Porter LA, 2000, BLOOD, V95, P2645; Rodriguez-Acebes S, 2010, AM J PATHOL, V177, P2034, DOI 10.2353/ajpath.2010.100421; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sawa Masaaki, 2009, Drug Des Devel Ther, V2, P255; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Takahashi TS, 2008, GENE DEV, V22, P1894, DOI 10.1101/gad.1683308; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tudzarova S, 2010, EMBO J, V29, P3381, DOI 10.1038/emboj.2010.201; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36372	10.1371/journal.pone.0036372	http://dx.doi.org/10.1371/journal.pone.0036372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574151	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800047
J	Lin, YF; Jamison, S; Lin, WS				Lin, Yifeng; Jamison, Stephanie; Lin, Wensheng			Interferon-gamma Activates Nuclear Factor-kappa B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS LESIONS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-CYCLE EXIT; IFN-GAMMA; STAT1-INDEPENDENT PATHWAYS; INDUCED MEDULLOBLASTOMA; TRANSCRIPTION FACTORS; MEDICAL PROGRESS	Our previous studies have demonstrated that the effects of the immune cytokine interferon-gamma (IFN-gamma) in immune-mediated demyelinating diseases are mediated, at least in part, by the unfolded protein response (UPR) in oligodendrocytes. Data indicate that some biological effects of IFN-gamma are elicited through activation of the transcription factor nuclear factor-kappa B (NF-kappa B). Interestingly, it has been shown that activation of the pancreatic endoplasmic reticulum kinase (PERK) branch of the UPR triggers NF-kappa B activation. In this study, we showed that IFN-gamma-induced NF-kappa B activation was associated with activation of PERK signaling in the oligodendroglial cell line Oli-neu. We further demonstrated that blockage of PERK signaling diminished IFN-gamma-induced NF-kappa B activation in Oli-neu cells. Importantly, we showed that NF-kappa B activation in oligodendrocytes correlated with activation of PERK signaling in transgenic mice that ectopically express IFN-gamma in the central nervous system (CNS), and that enhancing IFN-gamma-induced activation of PERK signaling further increased NF-kappa B activation in oligodendrocytes. Additionally, we showed that suppression of the NF-kappa B pathway rendered Oli-neu cells susceptible to the cytotoxicity of IFN-gamma, reactive oxygen species, and reactive nitrogen species. Our results indicate that the UPR is involved in IFN-gamma-induced NF-kappa B activation in oligodendrocytes and suggest that NF-kappa B activation by IFN-gamma represents one mechanism by which IFN-gamma exerts its effects on oligodendrocytes in immune-mediated demyelinating diseases.	[Lin, Yifeng; Jamison, Stephanie; Lin, Wensheng] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Lin, Wensheng] Univ S Alabama, Coll Med, Dept Comparat Med, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama	Lin, YF (corresponding author), Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA.	wlin@usouthal.edu	Lin, Wensheng/J-2661-2019	Lin, Wensheng/0000-0003-4931-7642	National Multiple Sclerosis Society [TA 3026-A-1]; National Institutes of Health [S10RR027535]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027535] Funding Source: NIH RePORTER	National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from the National Multiple Sclerosis Society to WL (TA 3026-A-1). This work utilized the Nikon A1 confocal microscope funded by S10RR027535 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanov R, 2007, J NEUROSCI, V27, P2013, DOI 10.1523/JNEUROSCI.4689-06.2007; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Baud O, 2004, EUR J NEUROSCI, V20, P1713, DOI 10.1111/j.1460-9568.2004.03616.x; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bonetti B, 1999, AM J PATHOL, V155, P1433, DOI 10.1016/S0002-9440(10)65456-9; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Buntinx M, 2002, CRIT REV IMMUNOL, V22, P391; Chew LJ, 2005, GLIA, V52, P127, DOI 10.1002/glia.20232; Deb A, 2001, J IMMUNOL, V166, P6170, DOI 10.4049/jimmunol.166.10.6170; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Hamanoue M, 2004, NEUROCHEM RES, V29, P1571, DOI 10.1023/B:NERE.0000029571.39497.56; Hilliard B, 1999, J IMMUNOL, V163, P2937; Horwitz MS, 1997, NAT MED, V3, P1037, DOI 10.1038/nm0997-1037; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kondo A, 2010, BLOOD, V116, P1124, DOI 10.1182/blood-2009-12-255125; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Lees JR, 2007, J CLIN INVEST, V117, P297, DOI 10.1172/JCI31254; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2007, J CLIN INVEST, V117, P448, DOI 10.1172/JCI29571; Lin WS, 2011, J NEUROSCI RES, V89, P1586, DOI 10.1002/jnr.22693; Lin WS, 2010, J NEUROSCI RES, V88, P2569, DOI 10.1002/jnr.22425; Lin WS, 2006, BRAIN, V129, P1306, DOI 10.1093/brain/awl044; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lin WS, 2004, J NEUROSCI, V24, P10074, DOI 10.1523/JNEUROSCI.2604-04.2004; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Mhaille AN, 2008, J NEUROPATH EXP NEUR, V67, P200, DOI 10.1097/NEN.0b013e318165b239; Nicholas RS, 2001, EUR J NEUROSCI, V13, P959, DOI 10.1046/j.0953-816x.2001.01470.x; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Raasch J, 2011, BRAIN, V134, P1184, DOI 10.1093/brain/awq359; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Tanner DC, 2011, J NEUROSCI, V31, P6235, DOI 10.1523/JNEUROSCI.5905-10.2011; Thapa RJ, 2011, MOL CELL BIOL, V31, P2934, DOI 10.1128/MCB.05445-11; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Vollgraf U, 1999, J NEUROCHEM, V73, P2501, DOI 10.1046/j.1471-4159.1999.0732501.x; Yan J, 2008, CNS NEUROL DISORD-DR, V7, P536, DOI 10.2174/187152708787122941; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	46	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36408	10.1371/journal.pone.0036408	http://dx.doi.org/10.1371/journal.pone.0036408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574154	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349800050
J	Reznichenko, A; Snieder, H; van den Born, J; de Borst, MH; Damman, J; van Dijk, MCRF; van Goor, H; Hepkema, BG; Hillebrands, JL; Leuvenink, HGD; Niesing, J; Bakker, SJL; Seelen, M; Navis, G				Reznichenko, Anna; Snieder, Harold; van den Born, Jacob; de Borst, Martin H.; Damman, Jeffrey; van Dijk, Marcory C. R. F.; van Goor, Harry; Hepkema, Bouke G.; Hillebrands, Jan-Luuk; Leuvenink, Henri G. D.; Niesing, Jan; Bakker, Stephan J. L.; Seelen, Marc; Navis, Gerjan		REGaTTA REnal GeneTics TrAnsplanta	CUBN as a Novel Locus for End-Stage Renal Disease: Insights from Renal Transplantation	PLOS ONE			English	Article							ASSOCIATION; TOOL; SET	Chronic kidney disease (CKD) is a complex disorder. As genome-wide association studies identified cubilin gene CUBN as a locus for albuminuria, and urinary protein loss is a risk factor for progressive CKD, we tested the hypothesis that common genetic variants in CUBN are associated with end-stage renal disease (ESRD) and proteinuria. First, a total of 1142 patients with ESRD, admitted for renal transplantation, and 1186 donors were genotyped for SNPs rs7918972 and rs1801239 (case-control study). The rs7918972 minor allele frequency (MAF) was higher in ESRD patients comparing to kidney donors, implicating an increased risk for ESRD (OR 1.39, p = 0.0004) in native kidneys. Second, after transplantation recipients were followed for 5.8 [3.8-9.2] years (longitudinal study) documenting ESRD in transplanted kidneys - graft failure (GF). During post-transplant follow-up 92 (9.6%) cases of death-censored GF occurred. Donor rs7918972 MAF, representing genotype of the transplanted kidney, was 16.3% in GF vs 10.7% in cases with functioning graft. Consistently, a multivariate Cox regression analysis showed that donor rs7918972 is a predictor of GF, although statistical significance was not reached (HR 1.53, p = 0.055). There was no association of recipient rs7918972 with GF. Rs1801239 was not associated with ESRD or GF. In line with an association with the outcome, donor rs7918972 was associated with elevated proteinuria levels cross-sectionally at 1 year after transplantation. Thus, we identified CUBN rs7918972 as a novel risk variant for renal function loss in two independent settings: ESRD in native kidneys and GF in transplanted kidneys.	[Reznichenko, Anna; van den Born, Jacob; de Borst, Martin H.; Bakker, Stephan J. L.; Seelen, Marc; Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Damman, Jeffrey; Leuvenink, Henri G. D.; Niesing, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [van Dijk, Marcory C. R. F.; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Hepkema, Bouke G.] Univ Groningen, Univ Med Ctr Groningen, Dept Transplant Immunol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Reznichenko, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands.	a.reznichenko@umcg.nl	Bakker, Stephan J. L./J-4023-2015; van+Goor, Harry/AAS-7712-2020	Bakker, Stephan J. L./0000-0003-3356-6791; Leuvenink, Henri/0000-0001-5036-2999; Hillebrands, Jan-Luuk/0000-0003-3135-3274; De Borst, Martin/0000-0002-4127-8733; van Goor, Harry/0000-0002-6670-1577	GENECURE grant [EU_FP-6037697]	GENECURE grant	Funding was provided by GENECURE grant EU_FP-6037697. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Boger CA, 2011, KIDNEY BLOOD PRESS R, V34, P225, DOI 10.1159/000326901; Boger CA, 2011, J AM SOC NEPHROL, V22, P555, DOI 10.1681/ASN.2010060598; Broekroelofs J, 1998, J AM SOC NEPHROL, V9, P2075; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Grasbeck R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-17; Hollenberg Norman K, 2003, Curr Hypertens Rep, V5, P356; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kottgen A, 2010, AM J KIDNEY DIS, V56, P743, DOI 10.1053/j.ajkd.2010.05.018; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; Ovunc B, 2011, J AM SOC NEPHROL, V22, P1815, DOI 10.1681/ASN.2011040337; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382	15	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36512	10.1371/journal.pone.0036512	http://dx.doi.org/10.1371/journal.pone.0036512			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574174	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800071
J	Yiu, KH; Atsma, DE; Delgado, V; Ng, ACT; Witkowski, TG; Ewe, SH; Auger, D; Holman, ER; van Mil, AM; Breuning, MH; Tse, HF; Bax, JJ; Schalij, MJ; Marsan, NA				Yiu, Kai Hang; Atsma, Douwe E.; Delgado, Victoria; Ng, Arnold C. T.; Witkowski, Tomasz G.; Ewe, See Hooi; Auger, Dominique; Holman, Eduard R.; van Mil, Anneke M.; Breuning, Martijn H.; Tse, Hung Fat; Bax, Jeroen J.; Schalij, Martin J.; Marsan, Nina Ajmone			Myocardial Structural Alteration and Systolic Dysfunction in Preclinical Hypertrophic Cardiomyopathy Mutation Carriers	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; STANDARDS COMMITTEE; RISK STRATIFICATION; MAGNETIC-RESONANCE; DIASTOLIC FUNCTION; TASK-FORCE; ABNORMALITIES; TISSUE; ECHOCARDIOGRAPHY; DIAGNOSIS	Background: To evaluate the presence of myocardial structural alterations and subtle myocardial dysfunction during familial screening in asymptomatic mutation carriers without hypertrophic cardiomyopathy (HCM) phenotype. Methods and Findings: Sixteen HCM families with pathogenic mutation were studied and 46 patients with phenotype expression (Mut+/Phen+) and 47 patients without phenotype expression (Mut+/Phen-) were observed. Twenty-five control subjects, matched with the Mut+/Phen- group, were recruited for comparison. Echocardiography was performed to evaluate conventional parameters, myocardial structural alteration by calibrated integrated backscatter (cIBS) and global and segmental longitudinal strain by speckle tracking analysis. All 3 groups had similar left ventricular dimensions and ejection fraction. Basal anteroseptal cIBS was the highest in Mut+/Phen+ patients (-14.0+/-4.6 dB, p<0.01) and was higher in Mut+/Phen- patients as compared to controls (-17.0+/-2.3 vs. -22.6+/-2.9 dB, p<0.01) suggesting significant myocardial structural alterations. Global and basal anteroseptal longitudinal strains (-8.4+/-4.0%, p<0.01) were the most impaired in Mut+/Phen+ patients as compared to the other 2 groups. Although global longitudinal strain was similar between Mut+/Phen- group and controls, basal anteroseptal strain was lower in Mut+/Phen- patients (-14.1+/-3.8%, p<0.01) as compared to controls (-19.9+/-2.9%, p<0.01), suggesting a subclinical segmental systolic dysfunction. A combination of >-19.0 dB basal anteroseptal cIBS or >-18.0% basal anteroseptal longitudinal strain had a sensitivity of 98% and a specificity of 72% in differentiating Mut+/Phen- group from controls. Conclusion: The use of cIBS and segmental longitudinal strain can differentiate HCM Mut+/Phen- patients from controls with important clinical implications for the family screening and follow-up of these patients.	[Yiu, Kai Hang; Atsma, Douwe E.; Delgado, Victoria; Ng, Arnold C. T.; Witkowski, Tomasz G.; Ewe, See Hooi; Auger, Dominique; Holman, Eduard R.; Bax, Jeroen J.; Schalij, Martin J.; Marsan, Nina Ajmone] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Yiu, Kai Hang; Tse, Hung Fat] Univ Hong Kong, Queen Mary Hosp, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Yiu, Kai Hang; Marsan, Nina Ajmone] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [van Mil, Anneke M.; Breuning, Martijn H.] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Hong Kong; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Yiu, KH (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	n.ajmone@lumc.nl	ajmone marsan, nina/AAJ-8108-2021; Tse, Hung-Fat/C-4426-2009; Delgado, Victoria/AAL-4731-2021; Yiu, Kai Hang/AAI-2879-2021; Auger, Dominique/AAG-3819-2020; /D-1427-2011	ajmone marsan, nina/0000-0001-7208-5769; Tse, Hung-Fat/0000-0002-9578-7808; Delgado, Victoria/0000-0002-9841-2737; /0000-0003-2145-3108; Ng, Arnold/0000-0002-1925-9958; Witkowski, Tomasz/0000-0002-9383-4578	Hong Kong Heart Foundation; Biotronik; Medtronic; Boston Scientific Corporation; Lantheus Medical Imaging; St Jude Medical; GE Healthcare; Edwards Lifesciences	Hong Kong Heart Foundation; Biotronik; Medtronic(Medtronic); Boston Scientific Corporation(Boston Scientific); Lantheus Medical Imaging; St Jude Medical(St. Jude Medical); GE Healthcare(General ElectricGE Healthcare); Edwards Lifesciences	Kai Hang Yiu is financially supported by a research grant from the Hong Kong Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to disclose the following conflicts of interest: The Department of Cardiology of Leiden University Medical Centre received research grants from Biotronik, Medtronic, Boston Scientific Corporation, Lantheus Medical Imaging, St Jude Medical, GE Healthcare, and Edwards Lifesciences. Dr Victoria Delgado received consultant fees from St Jude Medical. The remaining authors have no financial or other conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Bertini M, 2010, CIRC-CARDIOVASC IMAG, V3, P86, DOI 10.1161/CIRCIMAGING.109.882324; Christiaans I, 2011, EUR HEART J, V32, P1161, DOI 10.1093/eurheartj/ehr092; Christiaans I, 2010, EUR HEART J, V31, P842, DOI 10.1093/eurheartj/ehp539; Delgado V, 2008, J AM COLL CARDIOL, V51, P1944, DOI 10.1016/j.jacc.2008.02.040; Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036; Gersh BJ, 2011, CIRCULATION, V124, pE783, DOI 10.1161/CIR.0b013e318223e2bd; Ghio S, 2009, EUR J HEART FAIL, V11, P952, DOI 10.1093/eurjhf/hfp122; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; MADARAS EI, 1988, J ACOUST SOC AM, V83, P762, DOI 10.1121/1.396119; Marian AJ, 2000, LANCET, V355, P58, DOI 10.1016/S0140-6736(99)06187-5; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2009, J AM COLL CARDIOL, V54, P220, DOI 10.1016/j.jacc.2009.05.006; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Michels M, 2009, EUR HEART J, V30, P2593, DOI 10.1093/eurheartj/ehp306; Michels M, 2009, JACC-CARDIOVASC IMAG, V2, P58, DOI 10.1016/j.jcmg.2008.08.003; Mizuno R, 2001, CARDIOLOGY, V96, P16, DOI 10.1159/000047381; MOTTLEY JG, 1988, J ACOUST SOC AM, V83, P755, DOI 10.1121/1.396118; Nagueh SF, 2003, CIRCULATION, V108, P395, DOI 10.1161/01.CIR.0000084500.72232.8D; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; Nagueh SF, 1999, CIRCULATION, V99, P254, DOI 10.1161/01.CIR.99.2.254; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Russel IK, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-3; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047	31	30	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36115	10.1371/journal.pone.0036115	http://dx.doi.org/10.1371/journal.pone.0036115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574137	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800033
J	de Silva, S; Planelles, V; Wu, L				de Silva, Suresh; Planelles, Vicente; Wu, Li			Differential Effects of Vpr on Single-cycle and Spreading HIV-1 Infections in CD4(+) T-cells and Dendritic Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL PROTEIN-R; MACROPHAGE INFECTION; NONDIVIDING CELLS; MUTATIONAL ANALYSIS; MYELOID CELLS; IN-VIVO; TRANSMISSION; REPLICATION; ACTIVATION	The Vpr protein of human immunodeficiency virus type 1 (HIV-1) contributes to viral replication in non-dividing cells, specifically those of the myeloid lineage. However, the effects of Vpr in enhancing HIV-1 infection in dendritic cells have not been extensively investigated. Here, we evaluated the role of Vpr during infection of highly permissive peripheral blood mononuclear cells (PBMCs) and CD4(+) T-cells and compared it to that of monocyte-derived dendritic cells (MDDCs), which are less susceptible to HIV-1 infection. Infections of dividing PBMCs and non-dividing MDDCs were carried out with single-cycle and replication-competent HIV-1 encoding intact Vpr or Vpr-defective mutants. In contrast to previous findings, we observed that single-cycle HIV-1 infection of both PBMCs and MDDCs was significantly enhanced in the presence of Vpr when the viral stocks were carefully characterized and titrated. HIV-1 DNA quantification revealed that Vpr only enhanced the reverse transcription and nuclear import processes in single-cycle HIV-1 infected MDDCs, but not in CD4(+) T-cells. However, a significant enhancement in HIV-1 gag mRNA expression was observed in both CD4(+) T-cells and MDDCs in the presence of Vpr. Furthermore, Vpr complementation into HIV-1 virions did not affect single-cycle viral infection of MDDCs, suggesting that newly synthesized Vpr plays a significant role to facilitate single-cycle HIV-1 infection. Over the course of a spreading infection, Vpr significantly enhanced replication-competent HIV-1 infection in MDDCs, while it modestly promoted viral infection in activated PBMCs. Quantification of viral DNA in replication-competent HIV-1 infected PBMCs and MDDCs revealed similar levels of reverse transcription products, but increased nuclear import in the presence of Vpr independent of the cell types. Taken together, our results suggest that Vpr has differential effects on single-cycle and spreading HIV-1 infections, which are dependent on the permissiveness of the target cell.	[de Silva, Suresh; Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Planelles, Vicente] Univ Utah, Dept Pathol, Div Microbiol & Immunol, Salt Lake City, UT USA	University System of Ohio; Ohio State University; Utah System of Higher Education; University of Utah	de Silva, S (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA.	wu.840@osu.edu	Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487	NIH [AI068493, AI078762, AI098524]; Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI098524, R21AI078762, R21AI102822, R01AI068493] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Preparedness for Infectious Diseases of The Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant (AI068493) to L. W. from the NIH and by the program of Public Health Preparedness for Infectious Diseases of The Ohio State University. L. W. and S. D. were supported in part by grants AI078762 and AI098524 to L. W. from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 1996, J MOL BIOL, V261, P599, DOI 10.1006/jmbi.1996.0485; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Ao Z, 2004, J VIROL, V78, P3170, DOI 10.1128/JVI.78.6.3170-3177.2004; Arokium H, 2009, J VIROL, V83, P11283, DOI 10.1128/JVI.00756-09; Ayinde D, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-35; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; BALLIET JW, 1994, VIROLOGY, V200, P623, DOI 10.1006/viro.1994.1225; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DEDERA D, 1989, J VIROL, V63, P3205, DOI 10.1128/JVI.63.7.3205-3208.1989; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Gummuluru S, 1999, J VIROL, V73, P5422, DOI 10.1128/JVI.73.7.5422-5430.1999; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janas Alicia M, 2009, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2605s43; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; Majumder B, 2009, CURR HIV RES, V7, P169, DOI 10.2174/157016209787581445; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; PAXTON W, 1993, J VIROL, V67, P7229, DOI 10.1128/JVI.67.12.7229-7237.1993; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; PLANELLES V, 1995, J VIROL, V69, P5883, DOI 10.1128/JVI.69.9.5883-5889.1995; Planelles V, 2011, VIRUSES-BASEL, V3, P1624, DOI 10.3390/v3091624; Planelles V, 2009, CURR TOP MICROBIOL, V339, P177, DOI 10.1007/978-3-642-02175-6_9; Rey F, 1998, J GEN VIROL, V79, P1083, DOI 10.1099/0022-1317-79-5-1083; Riviere L, 2010, J VIROL, V84, P729, DOI 10.1128/JVI.01952-09; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; SCHWARTZ S, 1991, VIROLOGY, V183, P677, DOI 10.1016/0042-6822(91)90996-O; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; St Gelais C, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-55; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yamashita M, 2005, PLOS PATHOG, V1, P170, DOI 10.1371/journal.ppat.0010018; Yamashita M, 2009, J VIROL, V83, P9835, DOI 10.1128/JVI.01084-09; Zhu YH, 2001, J VIROL, V75, P3791, DOI 10.1128/JVI.75.8.3791-3801.2001	53	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35385	10.1371/journal.pone.0035385	http://dx.doi.org/10.1371/journal.pone.0035385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570689	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400005
J	Bessoltane, N; Toffano-Nioche, C; Solignac, M; Mougel, F				Bessoltane, Nadia; Toffano-Nioche, Claire; Solignac, Michel; Mougel, Florence			Fine Scale Analysis of Crossover and Non-Crossover and Detection of Recombination Sequence Motifs in the Honeybee (Apis mellifera)	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; GENE CONVERSION; CROSSING-OVER; LINKAGE MAP; HOT-SPOTS; GENOME; HOTSPOTS; RATES; HETEROGENEITY; ORGANIZATION	Background: Meiotic exchanges are non-uniformly distributed across the genome of most studied organisms. This uneven distribution suggests that recombination is initiated by specific signals and/or regulations. Some of these signals were recently identified in humans and mice. However, it is unclear whether or not sequence signals are also involved in chromosomal recombination of insects. Methodology: We analyzed recombination frequencies in the honeybee, in which genome sequencing provided a large amount of SNPs spread over the entire set of chromosomes. As the genome sequences were obtained from a pool of haploid males, which were the progeny of a single queen, an oocyte method (study of recombination on haploid males that develop from unfertilized eggs and hence are the direct reflect of female gametes haplotypes) was developed to detect recombined pairs of SNP sites. Sequences were further compared between recombinant and non-recombinant fragments to detect recombination-specific motifs. Conclusions: Recombination events between adjacent SNP sites were detected at an average distance of 92 bp and revealed the existence of high rates of recombination events. This study also shows the presence of conversion without crossover (i.e. non-crossover) events, the number of which largely outnumbers that of crossover events. Furthermore the comparison of sequences that have undergone recombination with sequences that have not, led to the discovery of sequence motifs (CGCA, GCCGC, CCGCA), which may correspond to recombination signals.	[Bessoltane, Nadia; Solignac, Michel; Mougel, Florence] CNRS, Lab Evolut Genomes Speciat, Gif Sur Yvette, France; [Bessoltane, Nadia; Toffano-Nioche, Claire; Solignac, Michel; Mougel, Florence] Univ Paris 11, Orsay, France; [Bessoltane, Nadia; Toffano-Nioche, Claire] Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR8621, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bessoltane, N (corresponding author), CNRS, Lab Evolut Genomes Speciat, Gif Sur Yvette, France.	mougel@legs.cnrs-gif.fr						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Anderson LK, 1999, GENETICS, V151, P1569; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; CHAKRAVARTI A, 1986, P NATL ACAD SCI USA, V83, P1045, DOI 10.1073/pnas.83.4.1045; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Cirulli ET, 2007, J MOL EVOL, V64, P129, DOI 10.1007/s00239-006-0142-7; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DARLINGTON C. D., 1932, CYTOLOGIA, V3, P169; Defrance M, 2008, NAT PROTOC, V3, P1589, DOI 10.1038/nprot.2008.98; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hellenthal G, 2006, CURR OPIN GENET DEV, V16, P565, DOI 10.1016/j.gde.2006.10.001; HILLIKER AJ, 1994, GENETICS, V137, P1019; HUNT GJ, 1995, GENETICS, V139, P1371; Janky R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-37; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; Lien S, 2000, AM J HUM GENET, V66, P557, DOI 10.1086/302754; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mather K, 1936, J GENET, V33, P207, DOI 10.1007/BF02982533; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Morgenstern B, 2004, NUCLEIC ACIDS RES, V32, pW33, DOI 10.1093/nar/gkh373; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; Qi J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-475; R Development Core Team, R LANG ENV STAT COMP; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Smit A.F.A., REPEATMASKER; Solignac M, 2004, GENETICS, V167, P253, DOI 10.1534/genetics.167.1.253; Solignac M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r66; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Steiner WW, 2009, GENETICS, V182, P459, DOI 10.1534/genetics.109.101253; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; Szekvolgyi L, 2010, FEBS J, V277, P571, DOI 10.1111/j.1742-4658.2009.07502.x; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; von Salome J, 2007, IMMUNOGENETICS, V59, P261, DOI 10.1007/s00251-007-0196-8; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yin JM, 2009, BIOINFORMATICS, V25, pI231, DOI 10.1093/bioinformatics/btp229; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	61	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36229	10.1371/journal.pone.0036229	http://dx.doi.org/10.1371/journal.pone.0036229			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567142	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500061
J	Sun, YY; Yu, WZ; Huang, LZ; Hou, J; Gong, PH; Zheng, Y; Zhao, MW; Zhou, P; Li, XX				Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Gong, Peihua; Zheng, Yi; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin			Is Asthma Related to Choroidal Neovascularization?	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; VISUAL IMPAIRMENT; MOUSE MODEL; COMPLEMENT; C3; PROGRESSION; PREVALENCE; COMPSTATIN; INHIBITOR	Background: Age-related degeneration(AMD) and asthma are both diseases that are related to the activation of the complement system. The association between AMD and asthma has been debated in previous studies. The authors investigated the relationship between AMD and asthma systemically. Principal Findings: The epidemiological study showed that asthma was related to choroidal neovascularization(CNV) subtype(OR = 1.721, P = 0.023). However, the meta-analysis showed there was no association between AMD and asthma. In an animal model, we found more fluoresce in leakage of CNV lesions by FA analysis and more angiogenesis by histological analysis in rats with asthma. Western blot demonstrated an elevated level of C3 alpha-chain, C3 alpha'-chain and VEGF. After compstatin was intravitreally injected, CNV leakage decreased according to FA analysis, with the level of C3 and VEGF protein decreasing at the same time. Significance: This study first investigated the relationship between AMD and asthma systematically, and it was found that asthma could be a risk factor for the development of AMD. The study may provide a better understanding of the disease, which may advance the potential for screening asthma patients in clinical practice.	[Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin] Peking Univ Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Sun, Yaoyao; Yu, Wenzhen; Huang, Lvzhen; Hou, Jing; Zhao, Mingwei; Zhou, Peng; Li, Xiaoxin] Minist Educ, Key Lab Vis Loss & Restorat, Beijing, Peoples R China; [Gong, Peihua] Peking Univ Peoples Hosp, Dept Respirat, Beijing, Peoples R China; [Zheng, Yi] Peking Univ, Dept Immunol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Zhou, Peng] Fudan Univ, Dept Ophthalmol Eye & ENT, Hosp Affiliated, Shanghai 200433, Peoples R China	Peking University; Peking University; Peking University; Fudan University	Sun, YY (corresponding author), Peking Univ Peoples Hosp, Dept Ophthalmol, Beijing, Peoples R China.	dr_lixiaoxin@126.com			National Basic Research Program of China (973 Program) [2011CB510200]; National Natural Science Foundation of China [81070740]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Basic Research Program of China (973 Program 2011CB510200, http://www.973.gov. cn/AreaAppl.aspx) and the National Natural Science Foundation of China (Grant No. 81070740, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdugo M, 2008, INVEST OPHTH VIS SCI, V49, P1633, DOI 10.1167/iovs.07-0767; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen SD, 2008, NEUROSCI LETT, V440, P87, DOI 10.1016/j.neulet.2008.03.092; Fattah MA, 2010, INDIAN J PEDIATR, V77, P771, DOI 10.1007/s12098-010-0117-y; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Ida H, 2003, INVEST OPHTH VIS SCI, V44, P5430, DOI 10.1167/iovs.03-0609; Inoue H, 2008, J HUM GENET, V53, P728, DOI 10.1007/s10038-008-0304-0; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Kim Cinoo, 2010, Korean J Ophthalmol, V24, P163, DOI 10.3341/kjo.2010.24.3.163; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P840, DOI 10.1001/archopht.126.6.840; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; Lopez de Victoria A, 2011, CHEM BIOL DRUG DES, V77, P431, DOI 10.1111/j.1747-0285.2011.01111.x; Lyzogubov VV, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204701; Mizutani N, 2009, J IMMUNOL, V183, P4039, DOI 10.4049/jimmunol.0901468; Montezuma Sandra R, 2007, Semin Ophthalmol, V22, P229, DOI 10.1080/08820530701745140; Moorthy S, 2011, AM J OPHTHALMOL, V151, P375, DOI 10.1016/j.ajo.2010.09.001; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Rakic J-M, 2006, Bull Soc Belge Ophtalmol, P9; Rohrer B, 2009, INVEST OPHTH VIS SCI, V50, P3056, DOI 10.1167/iovs.08-2222; Sahu A, 2003, MOL IMMUNOL, V39, P557, DOI 10.1016/S0161-5890(02)00212-2; Scholl HPN, 2007, MOL VIS, V13, P196; Seddon JM, 2004, INT OPHTHALMOL CLIN, V44; Seddon JM, 2009, INVEST OPHTHALMOL, V50, P2050; Shalev V, 2011, OPHTHAL EPIDEMIOL, V18, P83, DOI 10.3109/09286586.2011.560746; Sheets KG, 2010, MOL VIS, V16, P320; VINDING T, 1990, ACTA OPHTHALMOL, V68, P162; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wang JJ, 2007, OPHTHALMOLOGY, V114, P92, DOI 10.1016/j.ophtha.2006.07.017; Werner-Klein M, 2008, PULM PHARMACOL THER, V21, P648, DOI 10.1016/j.pupt.2008.03.002; Wysong A, 2009, ARCH OPHTHALMOL-CHIC, V127, P320, DOI 10.1001/archophthalmol.2008.613; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yu KD, 2011, BREAST CANCER RES TR, V126, P365, DOI 10.1007/s10549-010-0937-5; Zhou P, 2011, FASEB J, V25, P3489, DOI 10.1096/fj.11-189258	37	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35415	10.1371/journal.pone.0035415	http://dx.doi.org/10.1371/journal.pone.0035415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567103	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500021
J	Thiaville, MM; Stoeck, A; Chen, L; Wu, RC; Magnani, L; Oidtman, J; Shih, IM; Lupien, M; Wang, TL				Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Magnani, Luca; Oidtman, Jessica; Shih, Ie-Ming; Lupien, Mathieu; Wang, Tian-Li			Identification of PBX1 Target Genes in Cancer Cells by Global Mapping of PBX1 Binding Sites	PLOS ONE			English	Article							HOMEODOMAIN PROTEINS; OVARIAN-CANCER; HOX; EXPRESSION; MOTIF; DNA; PROLIFERATION; TRANSCRIPTION; HEXAPEPTIDE; CARCINOMAS	PBX1 is a TALE homeodomain transcription factor involved in organogenesis and tumorigenesis. Although it has been shown that ovarian, breast, and melanoma cancer cells depend on PBX1 for cell growth and survival, the molecular mechanism of how PBX1 promotes tumorigenesis remains unclear. Here, we applied an integrated approach by overlapping PBX1 ChIP-chip targets with the PBX1-regulated transcriptome in ovarian cancer cells to identify genes whose transcription was directly regulated by PBX1. We further determined if PBX1 target genes identified in ovarian cancer cells were co-overexpressed with PBX1 in carcinoma tissues. By analyzing TCGA gene expression microarray datasets from ovarian serous carcinomas, we found co-upregulation of PBX1 and a significant number of its direct target genes. Among the PBX1 target genes, a homeodomain protein MEOX1 whose DNA binding motif was enriched in PBX1-immunoprecipicated DNA sequences was selected for functional analysis. We demonstrated that MEOX1 protein interacts with PBX1 protein and inhibition of MEOX1 yields a similar growth inhibitory phenotype as PBX1 suppression. Furthermore, ectopically expressed MEOX1 functionally rescued the PBX1-withdrawn effect, suggesting MEOX1 mediates the cellular growth signal of PBX1. These results demonstrate that MEOX1 is a critical target gene and cofactor of PBX1 in ovarian cancers.	[Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Oidtman, Jessica; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Thiaville, Michelle M.; Stoeck, Alexander; Chen, Li; Wu, Ren-Chin; Oidtman, Jessica; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA; [Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Chen, Li] Virginia Polytech Inst & State Univ, Dept Elect & Comp Engn, Arlington, VA USA; [Magnani, Luca; Lupien, Mathieu] Dartmouth Med Sch, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Virginia Polytechnic Institute & State University; Dartmouth College; Norris Cotton Cancer Center	Thiaville, MM (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA.	tlw@jhmi.edu	sdsd, shihieih/ABE-6190-2020; Magnani, Luca/N-1094-2015; Chen, Li/P-5945-2014	Magnani, Luca/0000-0002-7534-0785; Lupien, Mathieu/0000-0003-0929-9478; Wu, Ren-Chin/0000-0003-1439-0874	American Cancer Society [RSG-08-174-01-GMC]; NIH/NCI [R01CA148826, R01CA103937, R01CA129080, U24CA160036]; NATIONAL CANCER INSTITUTE [U24CA160036, R01CA129080, R01CA148826, R01CA103937] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by American Cancer Society grant RSG-08-174-01-GMC and NIH/NCI grants: R01CA148826, R01CA103937, R01CA129080, and U24CA160036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspland SE, 2001, ONCOGENE, V20, P5708, DOI 10.1038/sj.onc.1204592; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Brendolan A, 2005, DEVELOPMENT, V132, P3113, DOI 10.1242/dev.01884; Delval S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025247; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Fernandez LC, 2008, CANCER LETT, V266, P144, DOI 10.1016/j.canlet.2008.02.042; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Guazzi S, 1998, J BIOL CHEM, V273, P11092, DOI 10.1074/jbc.273.18.11092; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811; LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303; Ma JL, 2011, FERTIL STERIL, V95, P2615, DOI 10.1016/j.fertnstert.2011.04.074; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Morgan R, 2007, CANCER RES, V67, P5806, DOI 10.1158/0008-5472.CAN-06-4231; Morgan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-89; Park JT, 2008, CANCER RES, V68, P8852, DOI 10.1158/0008-5472.CAN-08-0517; PHELAN ML, 1995, MOL CELL BIOL, V15, P3989; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rodrigo I, 2004, MOL CELL BIOL, V24, P2757, DOI 10.1128/MCB.24.7.2757-2766.2004; Schnabel CA, 2003, DEV BIOL, V254, P262, DOI 10.1016/S0012-1606(02)00038-6; Selleri L, 2001, DEVELOPMENT, V128, P3543; Su AI, 2001, CANCER RES, V61, P7388; Xiao Y, 2011, ONCOGENE, V30, P287, DOI 10.1038/onc.2010.405; Yeasmin S, 2010, GYNECOL ONCOL, V117, P409, DOI 10.1016/j.ygyno.2010.03.004	28	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36054	10.1371/journal.pone.0036054	http://dx.doi.org/10.1371/journal.pone.0036054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567123	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500041
J	Furmaga, H; Carreno, FR; Frazer, A				Furmaga, Havan; Carreno, Flavia Regina; Frazer, Alan			Vagal Nerve Stimulation Rapidly Activates Brain-Derived Neurotrophic Factor Receptor TrkB in Rat Brain	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; HIPPOCAMPAL-NEURONS; GROWTH-FACTOR; SIGNAL-TRANSDUCTION; TYROSINE KINASE; FACTOR BDNF; SEROTONIN TRANSPORTER; ANTIDEPRESSANT ACTION; TRUNCATED RECEPTORS; GENE-EXPRESSION	Background: Vagal nerve stimulation (VNS) has been approved for treatment-resistant depression. Many antidepressants increase expression of brain-derived neurotrophic factor (BDNF) in brain or activate, via phosphorylation, its receptor, TrkB. There have been no studies yet of whether VNS would also cause phosphorylation of TrkB. Methods: Western blot analysis was used to evaluate the phosphorylation status of TrkB in the hippocampus of rats administered VNS either acutely or chronically. Acute effects of VNS were compared with those caused by fluoxetine or desipramine (DMI) whereas its chronic effects were compared with those of sertraline or DMI. Results: All treatments, given either acutely or chronically, significantly elevated phosphorylation of tyrosines 705 and 816 on TrkB in the hippocampus. However, only VNS increased the phosphorylation of tyrosine 515, with both acute and chronic administration causing this effect. Pretreatment with K252a, a nonspecific tyrosine kinase inhibitor, blocked the phosphorylation caused by acute VNS at all three tyrosines. Downstream effectors of Y515, namely Akt and ERK, were also phosphorylated after acute treatment with VNS, whereas DMI did not cause this effect. Conclusion: VNS rapidly activates TrkB phosphorylation and this effect persists over time. VNS-induced phosphorylation of tyrosine 515 is distinct from the effect of standard antidepressant drugs.	[Furmaga, Havan; Carreno, Flavia Regina; Frazer, Alan] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Frazer, Alan] S Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Furmaga, H (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	frazer@uthscsa.edu		frazer, alan/0000-0003-1525-9974	National Institute of Mental Health grant [R01 MH082933]; Cyberonics, Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082933] Funding Source: NIH RePORTER	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cyberonics, Inc.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health grant R01 MH082933 (Alan Frazer). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs. Furmaga and Carreno have no competing interests to declare. Previously, Dr. Frazer received financial compensation as a consultant for Cyberonics, Inc. and had also obtained grant support from them for a preclinical study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Benmansour S, 2002, J NEUROSCI, V22, P6766; Benmansour S, 1999, J NEUROSCI, V19, P10494; Benmansour S, 2008, EUR J PHARMACOL, V587, P90, DOI 10.1016/j.ejphar.2008.03.048; Berghuis P, 2005, P NATL ACAD SCI USA, V102, P19115, DOI 10.1073/pnas.0509494102; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Biggio F, 2009, INT J NEUROPSYCHOPH, V12, P1209, DOI 10.1017/S1461145709000200; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Bondi CO, 2007, NEUROPSYCHOPHARMACOL; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen MJ, 2007, CELL SIGNAL, V19, P114, DOI 10.1016/j.cellsig.2006.05.028; Cunningham JT, 2008, NEUROPSYCHOPHARMACOL, V33, P1884, DOI 10.1038/sj.npp.1301570; Dorr AE, 2006, J PHARMACOL EXP THER, V318, P890, DOI 10.1124/jpet.106.104166; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; Dwivedi Y, 2003, ARCH GEN PSYCHIAT, V60, P804, DOI 10.1001/archpsyc.60.8.804; Eide FF, 1996, J NEUROSCI, V16, P3123; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Frazer A, 2000, J CLIN PSYCHIAT, V61, P25; Furmaga H, 2011, BIOL PSYCHI IN PRESS; George MS, 2005, BIOL PSYCHIAT, V58, P364, DOI 10.1016/j.biopsych.2005.07.028; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karege F, 2005, BIOL PSYCHIAT, V57, P1068, DOI 10.1016/j.biopsych.2005.01.008; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; KNUSEL B, 1992, J NEUROCHEM, V59, P1987; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Krahl SE, 2004, J PSYCHIATR RES, V38, P237, DOI 10.1016/j.jpsychires.2003.11.005; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lewis MA, 2006, MOL PHARMACOL, V69, P1396, DOI 10.1124/mol.105.020255; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MACKINTOSH C, 1994, TRENDS BIOCHEM SCI, V19, P444, DOI 10.1016/0968-0004(94)90127-9; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458; Nahas Z, 2005, J CLIN PSYCHIAT, V66, P1097, DOI 10.4088/JCP.v66n0902; NIBUYA M, 1995, J NEUROSCI, V15, P7539; NYE SH, 1992, MOL BIOL CELL, V3, P677, DOI 10.1091/mbc.3.6.677; Pereira DB, 2006, J NEUROSCI RES, V83, P832, DOI 10.1002/jnr.20784; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; RANTAMAKI T, 2007, NEUROPSYCHOPHARMACOL; Rantamaki T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020567; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rush AJ, 2005, BIOL PSYCHIAT, V58, P355, DOI 10.1016/j.biopsych.2005.05.024; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Saarelainen T, 2003, J NEUROSCI, V23, P349; Salio C, 2005, EUR J NEUROSCI, V22, P1951, DOI 10.1111/j.1460-9568.2005.04392.x; Schlaepfer TE, 2008, PSYCHOL MED, V38, P651, DOI 10.1017/S0033291707001924; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; TAPLEY P, 1992, ONCOGENE, V7, P371; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Xu HY, 2003, NEUROPSYCHOPHARMACOL, V28, P53, DOI 10.1038/sj.npp.1300009; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Yuen EC, 1999, EXP NEUROL, V159, P297, DOI 10.1006/exnr.1999.7148	66	61	62	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34844	10.1371/journal.pone.0034844	http://dx.doi.org/10.1371/journal.pone.0034844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563458	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700007
J	Richard, M; Erny, A; Care, B; Traversier, A; Barthelemy, M; Hay, A; Lin, YP; Ferraris, O; Lina, B				Richard, Mathilde; Erny, Alexandra; Care, Bertrand; Traversier, Aurelien; Barthelemy, Mendy; Hay, Alan; Lin, Yi Pu; Ferraris, Olivier; Lina, Bruno			Rescue of a H3N2 Influenza Virus Containing a Deficient Neuraminidase Protein by a Hemagglutinin with a Low Receptor-Binding Affinity	PLOS ONE			English	Article							A VIRUS; POSTREASSORTMENT CHANGES; ACTIVE-SITE; AMINO-ACID; 4-GUANIDINO-NEU5AC2EN; REPLICATION; SPECIFICITY; SENSITIVITY; INHIBITORS; MUTATIONS	Influenza viruses possess at their surface two glycoproteins, the hemagglutinin and the neuraminidase, of which the antagonistic functions have to be well balanced for the virus to grow efficiently. Ferraris et al. isolated in 2003-2004 viruses lacking both a NA gene and protein (H3NA-viruses) (Ferraris O., 2006, Vaccine, 24(44-46): 6656-9). In this study we showed that the hemagglutinins of two of the H3NA-viruses have reduced affinity for SA alpha 2.6Gal receptors, between 49 and 128 times lower than that of the A/Moscow/10/99 (H3N2) virus and no detectable affinity for SA alpha 2.3Gal receptors. We also showed that the low hemagglutinin affinity of the H3NA-viruses compensates for the lack of NA activity and allows the restoration of the growth of an A/Moscow/10/99 virus deficient in neuraminidase. These observations increase our understanding of H3NA-viruses in relation to the balance between the functional activities of the neuraminidase and hemagglutinin.	[Richard, Mathilde; Erny, Alexandra; Traversier, Aurelien; Barthelemy, Mendy; Ferraris, Olivier; Lina, Bruno] Univ Lyon, Fac Med RTH Laennec, EMR UCBL 4610, Lab Virol & Pathol Humaine VirPath, Lyon, France; [Care, Bertrand; Hay, Alan; Lin, Yi Pu] Univ Lyon, CNRS, INRIA, INSA Lyon,LIRIS,UMR5205, F-69621 Lyon, France; Natl Inst Med Res, London NW7 1AA, England	Centre National de la Recherche Scientifique (CNRS); Inria; Institut National des Sciences Appliquees de Lyon - INSA Lyon; MRC National Institute for Medical Research	Richard, M (corresponding author), Univ Lyon, Fac Med RTH Laennec, EMR UCBL 4610, Lab Virol & Pathol Humaine VirPath, Lyon, France.	richard.mathilde@gmail.com	lina, bruno/N-3663-2019; Richard, Mathilde/F-5461-2017; LINA, bruno/M-4572-2014	lina, bruno/0000-0002-8959-2123; Richard, Mathilde/0000-0003-0240-9312; Traversier, Aurelien/0000-0003-1874-3075; Barthelemy, Mendy/0000-0001-6939-7796	Centre National de Recherche Scientifique; Groupement d'Etudes Immunologiques; Ministere de la Recherche; Roche; Sanofi-Pasteur; Novartis; GSK; Biocryst; Merck	Centre National de Recherche Scientifique; Groupement d'Etudes Immunologiques; Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Roche(Roche Holding); Sanofi-Pasteur; Novartis(Novartis); GSK(GlaxoSmithKline); Biocryst; Merck(Merck & Company)	This work was supported by the Centre National de Recherche Scientifique, the Groupement d'Etudes Immunologiques. Dr. Richard received a grant from the Ministere de la Recherche. These funding sources had no role in study design, data collection, analysis and interpretation of the results, decision to publish, and preparation of the manuscript.; Dr. Lina has received travel grants from Roche, research grants from Roche, Sanofi-Pasteur and consulting fees from Roche, Novartis, GSK, Biocryst, Merck, Sanofi-Pasteur. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	AKAIKE H, 1978, ANN I STAT MATH, V30, P9, DOI 10.1007/BF02480194; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Baz M, 2007, ANTIVIR RES, V74, P159, DOI 10.1016/j.antiviral.2006.10.012; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Ferraris O, 2006, VACCINE, V24, P6656, DOI 10.1016/j.vaccine.2006.05.050; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Ilyushina NA, 2005, ARCH VIROL, V150, P1327, DOI 10.1007/s00705-005-0490-4; Kaverin NV, 1998, VIROLOGY, V244, P315, DOI 10.1006/viro.1998.9119; Kaverin NV, 2000, VIRUS RES, V66, P123, DOI 10.1016/S0168-1702(99)00131-8; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Linderman JJ, 1993, RECEPTORS MODELS BIN; Luo C, 1999, J GEN VIROL, V80, P2969, DOI 10.1099/0022-1317-80-11-2969; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Mochalova L, 2010, GLYCOCONJUGATE J, V27, P321, DOI 10.1007/s10719-010-9280-7; Moules V, 2010, VIROLOGY, V404, P215, DOI 10.1016/j.virol.2010.04.030; OHUCHI M, 1995, VIROLOGY, V212, P77, DOI 10.1006/viro.1995.1455; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richard M, 2011, ANTIMICROB AGENTS CH; SAUTER NK, 1992, P NATL ACAD SCI USA, V89, P324, DOI 10.1073/pnas.89.1.324; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	24	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e33880	10.1371/journal.pone.0033880	http://dx.doi.org/10.1371/journal.pone.0033880			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563453	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340700002
J	Xu, F; Yan, SX; Li, F; Cai, MQ; Chai, WH; Wu, MM; Fu, CW; Zhao, ZH; Kan, HD; Kang, KF; Xu, JH				Xu, Feng; Yan, Shuxian; Li, Fei; Cai, Minqiang; Chai, Weihan; Wu, Minmin; Fu, Chaowei; Zhao, Zhuohui; Kan, Haidong; Kang, Kefei; Xu, Jinhua			Prevalence of Childhood Atopic Dermatitis: An Urban and Rural Community-Based Study in Shanghai, China	PLOS ONE			English	Article							DIAGNOSTIC-CRITERIA; ALLERGIC RHINITIS; RISK-FACTORS; ECZEMA; ASTHMA; SYMPTOMS; CHILDREN	Background: Atopic dermatitis (AD) is a common inflammatory and chronically relapsing disorder with increasing prevalence. However, little is known about its prevalence in Shanghai, the top metropolitan of China. This study will estimate and compare the prevalence of AD in urban and rural areas in representative samples of 3 to 6-year-old children in Shanghai. Methodology/Principal Findings: A descriptive cross-sectional study was performed. Pre-school children were obtained by cluster sampling from 8 communities in different districts in Shanghai. The main instrument was the core questionnaire module for AD used in the U. K. Working Party's study. All the data were statistically analyzed by EpiData 3.1 and SPSS16.0. A total of 10436 children completed the study satisfactorily, with a response rate of 95.8%. The prevalence of AD in 3 to 6-year-old children was 8.3% (Male: 8.5%, Female: 8.2%). The prevalence in urban areas of Shanghai was gradiently and significantly higher than that in rural areas. The highest prevalence was in the core urban area (10.2% in Xuhui Tianping) vs. the lowest far from the urban areas (4.6% in Chongming Baozhen). Conclusions/Significance: The prevalence of AD was 8.3% (95%CI: 7.6%-9.1%) in children aged 3 to 6 in Shanghai. The prevalence of AD decreased from the center to the rural areas in Shanghai.	[Xu, Feng; Yan, Shuxian; Li, Fei; Kang, Kefei; Xu, Jinhua] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Cai, Minqiang] Xinjing Community Hlth Serv Ctr, Shanghai, Peoples R China; [Chai, Weihan] Jiading Dist Tradit Chinese Med Hosp, Dept Dermatol, Shanghai, Peoples R China; [Wu, Minmin; Fu, Chaowei; Zhao, Zhuohui; Kan, Haidong] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ,Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Xu, F (corresponding author), Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	xjhhuashan@yahoo.com.cn	Kan, Haidong/AGU-0328-2022; Fu, Chaowei/H-7811-2013	Fu, Chaowei/0000-0003-0966-8552; zhao, zhuohui/0000-0001-8596-0278	Chinese Medical Fund of Shanghai Municipal Health Bureau [2010QL034A]; National Natural Science Foundation of China (NSFC) [30800894]	Chinese Medical Fund of Shanghai Municipal Health Bureau; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Chinese Medical Fund of Shanghai Municipal Health Bureau (2010QL034A), National Natural Science Foundation of China (NSFC no. 30800894) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braback L, 2004, CLIN EXP ALLERGY, V34, P38, DOI 10.1111/j.1365-2222.2004.01841.x; Dotterud LK, 2004, J EUR ACAD DERMATOL, V18, P131, DOI 10.1111/j.1468-3083.2004.00794.x; Gu H, 2001, BRIT J DERMATOL, V145, P428, DOI 10.1046/j.1365-2133.2001.04379.x; [顾恒 Gu Heng], 2004, [中华皮肤科杂志, Chinese Journa of Dermatology], V37, P29; Guiote-Dominguez MV, 2008, ACTAS DERMO-SIFILOGR, V99, P628, DOI 10.1016/S0001-7310(08)74759-8; Hatakka K, 2009, ACTA PAEDIATR, V98, P817, DOI 10.1111/j.1651-2227.2008.01198.x; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Peters AS, 2010, J ALLERGY CLIN IMMUN, V126, P590, DOI 10.1016/j.jaci.2010.06.020; Saeki H, 2005, BRIT J DERMATOL, V152, P110, DOI 10.1111/J.1365-2133.2004.06271.X; Schram ME, 2010, BRIT J DERMATOL, V162, P964, DOI 10.1111/j.1365-2133.2010.09689.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Van De Ven MOM, 2006, EUR J PUBLIC HEALTH, V16, P549, DOI 10.1093/eurpub/ckl022; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x	14	67	90	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36174	10.1371/journal.pone.0036174	http://dx.doi.org/10.1371/journal.pone.0036174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563481	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700030
J	Feekings, J; Bartolino, V; Madsen, N; Catchpole, T				Feekings, Jordan; Bartolino, Valerio; Madsen, Niels; Catchpole, Tom			Fishery Discards: Factors Affecting Their Variability within a Demersal Trawl Fishery	PLOS ONE			English	Article							NEPHROPS-NORVEGICUS FISHERY; NORTH-SEA; SELECTIVE DEVICES; KATTEGAT; MANAGEMENT; BYCATCH; RATES	Discards represent one of the most important issues within current commercial fishing. It occurs for a range of reasons and is influenced by an even more complex array of factors. We address this issue by examining the data collected within the Danish discard observer program and describe the factors that influence discarding within the Danish Kattegat demersal fleet over the period 1997 to 2008. Generalised additive models were used to assess how discards of the 3 main target species, Norway lobster, cod and plaice, and their subcomponents (under and over minimum landings size) are influenced by important factors and their potential relevance to management. Our results show that discards are influenced by a range of different factors that are different for each species and portion of discards. We argue that knowledge about the factors influential to discarding and their use in relation to potential mitigation measures are essential for future fisheries management strategies.	[Feekings, Jordan; Madsen, Niels] Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Hirtshals, Denmark; [Bartolino, Valerio] Swedish Univ Agr Sci, Dept Aquat Resources, Lysekil, Sweden; [Bartolino, Valerio] Univ Gothenburg, Dept Earth Sci, Gothenburg, Sweden; [Catchpole, Tom] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England	Technical University of Denmark; Swedish University of Agricultural Sciences; University of Gothenburg; Centre for Environment Fisheries & Aquaculture Science	Feekings, J (corresponding author), Tech Univ Denmark DTU Aqua, Natl Inst Aquat Resources, Hirtshals, Denmark.	jpfe@aqua.dtu.dk	Feekings, Jordan/AAJ-1245-2021	Feekings, Jordan/0000-0001-9103-7332; Madsen, Niels/0000-0002-4409-1122; Bartolino, Valerio/0000-0002-4506-4329	European Union; Danish Ministry of Food, Agriculture, and Fisheries	European Union(European Commission); Danish Ministry of Food, Agriculture, and Fisheries	This study was conducted as part of the BADMINTON project (Bycatch And Discards: Management INdicators, Trends and location), which was carried out with the financial support of the European Union and Danish Ministry of Food, Agriculture, and Fisheries (http://83.212.243.10/badminton.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2009, ICES J MAR SCI, V66, P763, DOI 10.1093/icesjms/fsp033; Alverson DL, 1996, REV FISH BIOL FISHER, V6, P443, DOI 10.1007/BF00164325; [Anonymous], 2007, POLICY REDUCE UNWANT; Borges L, 2006, ICES J MAR SCI, V63, P1086, DOI 10.1016/j.icesjms.2006.03.017; Catchpole TL, 2011, FISH RES, V107, P94, DOI 10.1016/j.fishres.2010.10.012; Catchpole TL, 2005, MAR POLICY, V29, P421, DOI 10.1016/j.marpol.2004.07.001; Catchpole TL, 2005, FISH RES, V72, P45, DOI 10.1016/j.fishres.2004.10.012; Catchpole TL, 2010, J ENVIRON MANAGE, V91, P717, DOI 10.1016/j.jenvman.2009.09.035; Diamond B, 2011, REV FISH SCI, V19, P231, DOI 10.1080/10641262.2011.585432; Frandsen RP, 2010, ICES J MAR SCI, V67, P1721, DOI 10.1093/icesjms/fsq050; Frandsen RP, 2009, FISH RES, V97, P243, DOI 10.1016/j.fishres.2009.02.010; Frandsen RP, 2010, FISH RES, V101, P156, DOI 10.1016/j.fishres.2009.09.017; Groenewold S, 2000, ICES J MAR SCI, V57, P1395, DOI 10.1006/jmsc.2000.0914; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Herrmann B, 2006, FISH RES, V80, P148, DOI 10.1016/j.fishres.2006.04.018; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; ICES, 2004, 2004ACFM13 ICES CM; Johnsen JP, 2011, MAR POLICY, V35, P130, DOI 10.1016/j.marpol.2010.08.011; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Madsen N, 2010, ICES J MAR SCI, V67, P2042, DOI 10.1093/icesjms/fsq153; Madsen N, 2010, FISH RES, V103, P25, DOI 10.1016/j.fishres.2010.01.008; Mark Freeberg J.G.Pope, 1994, GLOBAL ASSESSMENT FI; Murawski S. A., 1996, Journal of Northwest Atlantic Fishery Science, V19, P31; Pascoe S., 1997, FAO FISH TECH PAP, V370, p137p; Poos JJ, 2010, ICES J MAR SCI, V67, P323, DOI 10.1093/icesjms/fsp241; Reeves SA, 1990, 990G53 ICES CM; Rochet MJ, 2005, CAN J FISH AQUAT SCI, V62, P224, DOI 10.1139/F04-185; Rochet MJ, 2002, ICES J MAR SCI, V59, P538, DOI 10.1006/jmsc.2002.1182; STECF, 2011, EV FISH EFF REG REG; Stratoudakis Y, 2001, AQUAT LIVING RESOUR, V14, P283, DOI 10.1016/S0990-7440(01)01135-4; Stratoudakis Y, 1999, ICES J MAR SCI, V56, P592, DOI 10.1006/jmsc.1999.0500; Stratoudakis Y, 1998, CAN J FISH AQUAT SCI, V55, P1632, DOI 10.1139/cjfas-55-7-1632; Ulleweit J, 2010, J APPL ICHTHYOL, V26, P54, DOI 10.1111/j.1439-0426.2010.01449.x; Valentinsson D, 2008, FISH RES, V90, P109, DOI 10.1016/j.fishres.2007.10.011; VANBEEK FA, 1990, NETH J SEA RES, V26, P151, DOI 10.1016/0077-7579(90)90064-N; Vitale F, 2008, FISH RES, V90, P36, DOI 10.1016/j.fishres.2007.09.023; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Welch DJ, 2008, FISH RES, V90, P247, DOI 10.1016/j.fishres.2007.10.023; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; WOODS SN, 2006, GEN ADDITIVE MODELS; Zeller D, 2005, FISH FISH, V6, P156, DOI 10.1111/j.1467-2979.2005.00177.x; Zuur Alain F., 2009, P1; 2009, REFORM COMMON FISHER	45	78	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36409	10.1371/journal.pone.0036409	http://dx.doi.org/10.1371/journal.pone.0036409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558463	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305340200077
J	Monasta, L; Ronfani, L; Marchetti, F; Montico, M; Brumatti, LV; Bavcar, A; Grasso, D; Barbiero, C; Tamburlini, G				Monasta, Lorenzo; Ronfani, Luca; Marchetti, Federico; Montico, Marcella; Brumatti, Liza Vecchi; Bavcar, Alessandro; Grasso, Domenico; Barbiero, Chiara; Tamburlini, Giorgio			Burden of Disease Caused by Otitis Media: Systematic Review and Global Estimates	PLOS ONE			English	Review							SENSORINEURAL HEARING-LOSS; RISK-FACTORS; CONTROLLED TRIAL; CHILDREN; PREVALENCE; HEALTH; SCHOOL; EPIDEMIOLOGY; ANTIBIOTICS; IMPAIRMENT	Background: Otitis media (OM) is a leading cause of health care visits and drugs prescription. Its complications and sequelae are important causes of preventable hearing loss, particularly in developing countries. Within the Global Burden of Diseases, Injuries, and Risk Factors Study, for the year 2005 we estimated the incidence of acute OM, chronic suppurative OM, and related hearing loss and mortality for all ages and the 21 WHO regional areas. Methods: We identified risk factors, complications and sequelae of OM. We carried out an extensive literature review (Medline, Embase, Lilacs and Wholis) which lead to the selection of 114 papers comprising relevant data. Data were available from 15 of the 21 WHO regions. To estimate incidence and prevalence for all countries we adopted a two stage approach based on risk factors formulas and regression modelling. Results: Acute OM incidence rate is 10.85% i.e. 709million cases each year with 51% of these occurring in under-fives. Chronic suppurative OM incidence rate is 4.76% i.e. 31million cases, with 22.6% of cases occurring annually in under-fives. OM-related hearing impairment has a prevalence of 30.82 per ten-thousand. Each year 21thousand people die due to complications of OM. Conclusions: Our study is the first attempt to systematically review the available information and provide global estimates for OM and related conditions. The overall burden deriving from AOM, CSOM and their sequelae is considerable, particularly in the first five years of life and in the poorest countries. The findings call for incorporating OM-focused action within preventive and case management strategies, with emphasis on the more affected.	[Monasta, Lorenzo; Ronfani, Luca; Montico, Marcella; Barbiero, Chiara] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy; [Marchetti, Federico] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat, Trieste, Italy; [Brumatti, Liza Vecchi; Tamburlini, Giorgio] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Res Direct, Trieste, Italy; [Bavcar, Alessandro] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Unit Hlth Serv Res & Int Hlth, Trieste, Italy; [Grasso, Domenico] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Dept Paediat Surg, Ear Nose & Throat Unit, Trieste, Italy	IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; IRCCS Burlo Garofolo; IRCCS Burlo Garofolo	Monasta, L (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Epidemiol & Biostat Unit, Trieste, Italy.	monasta@burlo.trieste.it	Monasta, Lorenzo/B-1388-2012; Montico, Marcella/B-5290-2013; Ronfani, Luca/B-6668-2013; Vecchi Brumatti, Liza/J-4968-2016; barbiero, chiara/B-5340-2013	Monasta, Lorenzo/0000-0001-7774-548X; Montico, Marcella/0000-0003-0377-8232; Ronfani, Luca/0000-0001-5710-3914; Vecchi Brumatti, Liza/0000-0001-8149-1873; Barbiero, Chiara/0000-0003-2589-3717; Marchetti, Federico/0000-0002-1257-7312	University of Edinburgh; Institute for Maternal and Child Health - Istituto Di Ricovero e Cura a Carattere Scientifico "Burlo Garofolo" [31/09]	University of Edinburgh; Institute for Maternal and Child Health - Istituto Di Ricovero e Cura a Carattere Scientifico "Burlo Garofolo"	For this work, financial support was received by the University of Edinburgh and by the Institute for Maternal and Child Health - Istituto Di Ricovero e Cura a Carattere Scientifico "Burlo Garofolo" (n.31/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin J, 2007, CLIN EVID, V2007; Al Khabori M, 2004, INT J AUDIOL, V43, P486, DOI 10.1080/14992020400050062; Alberta Clinical Practice Guidelines Working Group, 2000, DIAGN TREATM AC OT M; [Anonymous], 2008, WORLD HLTH STAT 2008; Arlinger S, 2009, SCAND J PSYCHOL, V50, P371, DOI 10.1111/j.1467-9450.2009.00753.x; Bansal R, 1998, Indian J Otolaryngol Head Neck Surg, V50, P147, DOI 10.1007/BF02991678; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; BERMAN S, 1995, PEDIATRICS, V96, P126; Bluestone CD, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/00034894021110S304; Boonacker CWB, 2011, PHARMACOECONOMICS, V29, P199, DOI 10.2165/11584930-000000000-00000; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Casselbrant M.L, 2003, EVIDENCE BASED OTITI, V2nd, P147; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; CUSIMANO F, 1989, J LARYNGOL OTOL, V103, P158, DOI 10.1017/S0022215100108333; Damoiseaux RA, 2011, CLIN EVID, V2011; de Azevedo Alexandre Fernandes, 2007, Braz J Otorhinolaryngol, V73, P671; ELANGO S, 1991, INT J PEDIATR OTORHI, V22, P75, DOI 10.1016/0165-5876(91)90098-V; Gunasekera H, 2009, J PAEDIATR CHILD H, V45, P425, DOI 10.1111/j.1440-1754.2009.01532.x; Harvard University Institute for Health Metrics and Evaluation at the University of Washington Johns Hopkins University University of Queensland World Health Organization, 2009, GBD STUD OP IN PRESS; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Hoberman A, 2011, NEW ENGL J MED, V364, P105, DOI 10.1056/NEJMoa0912254; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jacob A, 1997, INT J PEDIATR OTORHI, V39, P133, DOI 10.1016/S0165-5876(96)01479-6; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Lasisi AO, 2007, INT J PEDIATR OTORHI, V71, P1549, DOI 10.1016/j.ijporl.2007.06.005; Lasisi AO, 2007, ANN TROP PAEDIATR, V27, P291, DOI 10.1179/146532807X245689; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Liu Cheng, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P661; Mandel EM, 2008, INT J PEDIATR OTORHI, V72, P491, DOI 10.1016/j.ijporl.2007.12.008; Marchetti F, 2005, ARCH PEDIAT ADOL MED, V159, P679, DOI 10.1001/archpedi.159.7.679; Mathers C., GLOBAL BURDEN HEARIN; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Medline plus enciclopedia, 2011, HEAR LOSS; Mustafa T, 2006, SD T P FAKULTESI DER, V13, P1; NICE Short Clinical Guidelines Technical Team, 2008, RESP TRACT INF ANT P; OECD, 2008, OECD HLTH DAT 2008; OECD, 2008, OECD FIG 2008; Osma U, 2000, J LARYNGOL OTOL, V114, P97, DOI 10.1258/0022215001905012; Papp Z, 2003, OTOL NEUROTOL, V24, P141, DOI 10.1097/00129492-200303000-00003; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; PRESCOTT CAJ, 1991, S AFR MED J, V79, P90; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Roberts J, 2004, J DEV BEHAV PEDIATR, V25, P110, DOI 10.1097/00004703-200404000-00007; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; SADE J, 1976, J LARYNGOL OTOL, V90, P743, DOI 10.1017/S0022215100082645; SIGN, 2003, DIAGN MAN CHILDH OT; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; Taipale A, 2011, ACTA PAEDIAT; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; TEELE DW, 1990, J INFECT DIS, V162, P685, DOI 10.1093/infdis/162.3.685; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; UNICEF, 2006, STAT WORLDS CHILDR 2; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2022, GLOB BURD DIS 2004 U; WHO, 2001, WHO INT CLASS FUNCT; WHO-PDH, 1991, REP INF WORK GROUP P; Williams CJ, 2009, MED J AUSTRALIA, V191, pS69; World Health Organization, 2004, CHRON SUPP OT MED CS; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	64	498	522	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36226	10.1371/journal.pone.0036226	http://dx.doi.org/10.1371/journal.pone.0036226			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558393	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200052
J	Chen, M; Zou, M; Yang, L; He, SP				Chen, Ming; Zou, Ming; Yang, Lei; He, Shunping			Basal Jawed Vertebrate Phylogenomics Using Transcriptomic Data from Solexa Sequencing	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CARTILAGINOUS FISHES; DIVERGENCE TIMES; MONTE-CARLO; PROTEIN; ALIGNMENTS; ORIGIN; TREE; ORTHOSELECT; EUKARYOTES	The traditionally accepted relationships among basal jawed vertebrates have been challenged by some molecular phylogenetic analyses based on mitochondrial sequences. Those studies split extant gnathostomes into two monophyletic groups: tetrapods and piscine branch, including Chondrichthyes, Actinopterygii and sarcopterygian fishes. Lungfish and bichir are found in a basal position on the piscine branch. Based on transcriptomes of an armored bichir (Polypterus delhezi) and an African lungfish (Protopterus sp.) we generated, expressed sequences and whole genome sequences available from public databases, we obtained 111 genes to reconstruct the phylogenetic tree of basal jawed vertebrates and estimated their times of divergence. Our phylogenomic study supports the traditional relationship. We found that gnathostomes are divided into Chondrichthyes and the Osteichthyes, both with 100% support values (posterior probabilities and bootstrap values). Chimaeras were found to have a basal position among cartilaginous fishes with a 100% support value. Osteichthyes were divided into Actinopterygii and Sarcopterygii with 100% support value. Lungfish and tetrapods form a monophyletic group with 100% posterior probability. Bichir and two teleost species form a monophyletic group with 100% support value. The previous tree, based on mitochondrial data, was significantly rejected by an approximately unbiased test (AU test, p=0). The time of divergence between lungfish and tetrapods was estimated to be 391.8 Ma and the divergence of bichir from pufferfish and medaka was estimated to be 330.6 Ma. These estimates closely match the fossil record. In conclusion, our phylogenomic study successfully resolved the relationship of basal jawed vertebrates based on transtriptomes, EST and whole genome sequences.	[Chen, Ming; Zou, Ming; He, Shunping] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China; [Chen, Ming; Zou, Ming] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Yang, Lei] St Louis Univ, Lab Integrated Biodivers Conservat & Genom, Dept Biol, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Chen, M (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Inst Hydrobiol, Wuhan, Peoples R China.	clad@ihb.ac.cn			National Natural Science Foundation of China (NSFC) [30530120]; National Science Foundation USA (NSF) [EF-0431326]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Science Foundation USA (NSF)(National Science Foundation (NSF))	Funding support was provided by grants 30530120 from National Natural Science Foundation of China (NSFC) and EF-0431326 (to R. L. Mayden) from National Science Foundation USA (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ADACHI J, 1993, J MOL EVOL, V36, P270, DOI 10.1007/BF00160483; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archibald JD, 1996, SCIENCE, V272, P1150, DOI 10.1126/science.272.5265.1150; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Bernardos S, 2006, ACTA BOT GALLICA, V153, P153, DOI 10.1080/12538078.2006.10515534; Birney E, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P56; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cranston K, 2005, HEREDITY, V94, P461, DOI 10.1038/sj.hdy.6800644; Dimmick WW, 2001, COPEIA, P536, DOI 10.1643/0045-8511(2001)001[0536:SIAFPA]2.0.CO;2; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hallstrom BM, 2009, MOL BIOL EVOL, V26, P463, DOI 10.1093/molbev/msn271; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Inoue JG, 2003, MOL PHYLOGENET EVOL, V26, P110, DOI 10.1016/S1055-7903(02)00331-7; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Janvier P., 1996, EARLY VERTEBRATES; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kullberg M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000775; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Martin A, 2001, GENETICA, V111, P349, DOI 10.1023/A:1013747532647; MEYER A, 1990, J MOL EVOL, V31, P359, DOI 10.1007/BF02106050; Miller M.A., 2010, P GAT COMP ENV WORKS; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Noack K, 1996, GENETICS, V144, P1165; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Rasmussen AS, 1999, P NATL ACAD SCI USA, V96, P2177, DOI 10.1073/pnas.96.5.2177; Rasmussen AS, 1999, J MOL EVOL, V48, P118, DOI 10.1007/PL00006439; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Romer AS., 1986, VERTEBRATE BODY; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; Sansom IJ, 2005, BIOL LETT-UK, V1, P446, DOI 10.1098/rsbl.2005.0349; Schreiber F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-219; Schreiber F, 2009, NUCLEIC ACIDS RES, V37, pW185, DOI 10.1093/nar/gkp434; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; THOMAS WK, 1989, J MOL EVOL, V29, P233, DOI 10.1007/BF02100207; Venkatesh B, 2001, P NATL ACAD SCI USA, V98, P11382, DOI 10.1073/pnas.201415598; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; Zardoya R, 1996, GENETICS, V142, P1249; Zardoya R, 2001, VERTEBRATE PHYLOGENY; Zhu M, 2004, NATURE, V432, P94, DOI 10.1038/nature02843	59	29	29	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36256	10.1371/journal.pone.0036256	http://dx.doi.org/10.1371/journal.pone.0036256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558409	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000173
J	Harms, LR; Turner, KM; Eyles, DW; Young, JW; McGrath, JJ; Burne, THJ				Harms, Lauren R.; Turner, Karly M.; Eyles, Darryl W.; Young, Jared W.; McGrath, John J.; Burne, Thomas H. J.			Attentional Processing in C57BL/6J Mice Exposed to Developmental Vitamin D Deficiency	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; REACTION-TIME-TASK; LATENT INHIBITION; ADULT-RAT; SCHIZOPHRENIA; ALTERS; HYPERLOCOMOTION; RISK; NEUROANATOMY; METAANALYSIS	Epidemiological evidence suggests that Developmental Vitamin D (DVD) deficiency is associated with an increased risk of schizophrenia. DVD deficiency in mice is associated with altered behaviour, however there has been no detailed investigation of cognitive behaviours in DVD-deficient mice. The aim of this study was to determine the effect of DVD deficiency on a range of cognitive tasks assessing attentional processing in C57BL/6J mice. DVD deficiency was established by feeding female C57BL/6J mice a vitamin D-deficient diet from four weeks of age. After six weeks on the diet, vitamin D-deficient and control females were mated with vitamin D-normal males and upon birth of the pups, all dams were returned to a diet containing vitamin D. The adult offspring were tested on a range of cognitive behavioural tests, including the five-choice serial reaction task (5C-SRT) and five-choice continuous performance test (5C-CPT), as well as latent inhibition using a fear conditioning paradigm. DVD deficiency was not associated with altered attentional performance on the 5C-SRT. In the 5C-CPT DVD-deficient male mice exhibited an impairment in inhibiting repetitive responses by making more perseverative responses, with no changes in premature or false alarm responding. DVD deficiency did not affect the acquisition or retention of cued fear conditioning, nor did it affect the expression of latent inhibition using a fear conditioning paradigm. DVD-deficient mice exhibited no major impairments in any of the cognitive domains tested. However, impairments in perseverative responding in DVD-deficient mice may indicate that these animals have specific alterations in systems governing compulsive or reward-seeking behaviour.	[Harms, Lauren R.; Turner, Karly M.; Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Eyles, Darryl W.; McGrath, John J.; Burne, Thomas H. J.] Pk Ctr Mental Hlth, Queensland Ctr Mental Hlth Res, Richlands, Qld, Australia; [Young, Jared W.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [McGrath, John J.] Univ Queensland, Discipline Psychiat, St Lucia, Qld, Australia	University of Queensland; Queensland Centre for Mental Health Research; University of California System; University of California San Diego; University of Queensland	Harms, LR (corresponding author), Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia.	t.burne@uq.edu.au	Harms, Lauren R/J-8698-2012; Turner, Karly/F-4607-2012; Young, Jared W/G-9601-2012; Burne, Thomas H/C-5656-2009; McGrath, John Joseph/G-5493-2010; Eyles, Darryl W/X-3386-2018	Turner, Karly/0000-0003-3714-5118; Burne, Thomas H/0000-0003-3502-9789; McGrath, John Joseph/0000-0002-4792-6068; Eyles, Darryl W/0000-0002-5023-7095; Harms, Lauren/0000-0003-2268-8654	National Health and Medical Research Council of Australia [511066]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant no. 511066 from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00158; Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Becker A, 2005, BEHAV BRAIN RES, V161, P306, DOI 10.1016/j.bbr.2005.02.015; Burne THJ, 2004, BEHAV BRAIN RES, V154, P549, DOI 10.1016/j.bbr.2004.03.023; Burne THJ, 2006, BEHAV BRAIN RES, V174, P119, DOI 10.1016/j.bbr.2006.07.015; de Abreu DAF, 2010, BEHAV BRAIN RES, V208, P603, DOI 10.1016/j.bbr.2010.01.005; de Bruin NMWJ, 2006, PHYSIOL BEHAV, V89, P692, DOI 10.1016/j.physbeh.2006.08.009; Eagle DM, 2010, NEUROSCI BIOBEHAV R, V34, P50, DOI 10.1016/j.neubiorev.2009.07.003; Eyles D, 2003, NEUROSCIENCE, V118, P641, DOI 10.1016/S0306-4522(03)00040-X; Eyles D.W., 2009, PSYCHNEURO S1, V34, pS247, DOI [10.1016/B978-0-12-381978-9.10032-0, DOI 10.1016/J.PSYNEUEN.2009.04.015]; Eyles DW, 2010, ACTA PAEDIATR, V99, P645, DOI 10.1111/j.1651-2227.2010.01797.x; FELDON J, 1991, BIOL PSYCHIAT, V29, P635, DOI 10.1016/0006-3223(91)90133-7; Feron F, 2005, BRAIN RES BULL, V65, P141, DOI 10.1016/j.brainresbull.2004.12.007; Fineberg NA, 2011, BRIT J PHARMACOL, V164, P1044, DOI 10.1111/j.1476-5381.2011.01422.x; Green MF, 1996, AM J PSYCHIAT, V153, P321; Green MF, 2006, J CLIN PSYCHIAT, V67, P3, DOI 10.4088/JCP.1006e12; Harms LR, 2008, BEHAV BRAIN RES, V187, P343, DOI 10.1016/j.bbr.2007.09.032; Harms LR, 2012, BEHAV BRAIN RES, V230, P125, DOI 10.1016/j.bbr.2012.02.007; Harms LR, 2011, BEST PRACT RES CL EN, V25, P657, DOI 10.1016/j.beem.2011.05.009; Harvey PD, 1998, AM J PSYCHIAT, V155, P1080, DOI 10.1176/ajp.155.8.1080; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Humby T, 1999, EUR J NEUROSCI, V11, P2813, DOI 10.1046/j.1460-9568.1999.00701.x; Keefe RSE, 2007, ARCH GEN PSYCHIAT, V64, P633, DOI 10.1001/archpsyc.64.6.633; Kesby JP, 2006, BIOL PSYCHIAT, V60, P591, DOI 10.1016/j.biopsych.2006.02.033; Kesby James P, 2012, Psychopharmacology (Berl), V220, P455, DOI 10.1007/s00213-011-2492-0; Kesby JP, 2010, PSYCHOPHARMACOLOGY, V208, P159, DOI 10.1007/s00213-009-1717-y; LUBOW RE, 1995, PSYCHOL BULL, V117, P87, DOI 10.1037/0033-2909.117.1.87; McGrath J, 1999, SCHIZOPHR RES, V40, P173, DOI 10.1016/S0920-9964(99)00052-3; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Mongeau R, 2007, BEHAV BRAIN RES, V183, P147, DOI 10.1016/j.bbr.2007.06.002; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; O'Loan J, 2007, PSYCHONEUROENDOCRINO, V32, P227, DOI 10.1016/j.psyneuen.2006.12.006; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; ROBBINS TW, 1979, NEUROPHARMACOLOGY, V18, P931, DOI 10.1016/0028-3908(79)90157-6; SCARONE S, 1992, PSYCHIAT RES-NEUROIM, V45, P115, DOI 10.1016/0925-4927(92)90005-O; Stanfield AC, 2008, EUR PSYCHIAT, V23, P289, DOI 10.1016/j.eurpsy.2007.05.006; Vidal CN, 2008, PSYCHIAT RES-NEUROIM, V163, P106, DOI 10.1016/j.pscychresns.2007.11.002; Winstanley CA, 2003, PSYCHOPHARMACOLOGY, V167, P304, DOI 10.1007/s00213-003-1398-x; Young JW, 2011, BEHAV BRAIN RES, V222, P183, DOI 10.1016/j.bbr.2011.03.054	43	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35896	10.1371/journal.pone.0035896	http://dx.doi.org/10.1371/journal.pone.0035896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563415	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100041
J	Robertson, B; Huerta-Ocampo, I; Ericsson, J; Stephenson-Jones, M; Perez-Fernandez, J; Bolam, JP; Diaz-Heijtz, R; Grillner, S				Robertson, Brita; Huerta-Ocampo, Icnelia; Ericsson, Jesper; Stephenson-Jones, Marcus; Perez-Fernandez, Juan; Bolam, J. Paul; Diaz-Heijtz, Rochellys; Grillner, Sten			The Dopamine D2 Receptor Gene in Lamprey, Its Expression in the Striatum and Cellular Effects of D2 Receptor Activation	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; IN-SITU HYBRIDIZATION; BASAL GANGLIA; TYROSINE-HYDROXYLASE; MESSENGER-RNA; LAMPETRA-FLUVIATILIS; NUCLEUS-ACCUMBENS; SLICE PREPARATION; CALCIUM-CHANNELS; RAT-BRAIN	All basal ganglia subnuclei have recently been identified in lampreys, the phylogenetically oldest group of vertebrates. Furthermore, the interconnectivity of these nuclei is similar to mammals and tyrosine hydroxylase-positive (dopaminergic) fibers have been detected within the input layer, the striatum. Striatal processing is critically dependent on the interplay with the dopamine system, and we explore here whether D2 receptors are expressed in the lamprey striatum and their potential role. We have identified a cDNA encoding the dopamine D2 receptor from the lamprey brain and the deduced protein sequence showed close phylogenetic relationship with other vertebrate D2 receptors, and an almost 100% identity within the transmembrane domains containing the amino acids essential for dopamine binding. There was a strong and distinct expression of D2 receptor mRNA in a subpopulation of striatal neurons, and in the same region tyrosine hydroxylase-immunoreactive synaptic terminals were identified at the ultrastructural level. The synaptic incidence of tyrosine hydroxylase-immunoreactive boutons was highest in a region ventrolateral to the compact layer of striatal neurons, a region where most striatal dendrites arborise. Application of a D2 receptor agonist modulates striatal neurons by causing a reduced spike discharge and a diminished post-inhibitory rebound. We conclude that the D2 receptor gene had already evolved in the earliest group of vertebrates, cyclostomes, when they diverged from the main vertebrate line of evolution (560 mya), and that it is expressed in striatum where it exerts similar cellular effects to that in other vertebrates. These results together with our previous published data (Stephenson-Jones et al. 2011, 2012) further emphasize the high degree of conservation of the basal ganglia, also with regard to the indirect loop, and its role as a basic mechanism for action selection in all vertebrates.	[Robertson, Brita; Ericsson, Jesper; Stephenson-Jones, Marcus; Diaz-Heijtz, Rochellys; Grillner, Sten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Huerta-Ocampo, Icnelia; Bolam, J. Paul] Univ Oxford, Dept Pharmacol, MRC Anat Neuropharmacol Unit, Oxford OX1 3QT, England; [Perez-Fernandez, Juan] Univ Vigo, Fac Biol, Dept Funct Biol & Hlth Sci, Neurolam Grp, Vigo 36310, Spain	Karolinska Institutet; University of Oxford; Universidade de Vigo	Robertson, B (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	sten.grillner@ki.se	Perez Fernandez, Juan/A-8561-2019; Pérez-Fernández, Juan/AAR-7467-2021	Perez Fernandez, Juan/0000-0001-7109-951X; Pérez-Fernández, Juan/0000-0001-7109-951X; Bolam, J Paul/0000-0002-5008-8405; Stephenson-Jones, Marcus/0000-0003-4718-4452	EU [001917, 21610]; Swedish research council [VR-M-3026, VR-NT 621-2007-6049]; Karolinska Institutet; FP7 [201716]; Stockholm Brain Institute; Spanish MICINN-FEDER [BFU2009-13369]; MRC [MC_U138164490] Funding Source: UKRI; Medical Research Council [MC_U138164490] Funding Source: researchfish	EU(European Commission); Swedish research council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); FP7; Stockholm Brain Institute; Spanish MICINN-FEDER(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by EU FP5 `Neurobotics' 001917 (to Dr. Grillner), EU FP7 'Lampetra' 21610 (to Dr. Grillner), Swedish research council, VR-M-3026, VR-NT 621-2007-6049 (to Dr. Grillner), Karolinska Institutet's Research funds (to Dr. Robertson), FP7 Select-and-Act 201716 (to Dr. Grillner and Dr. Bolam) and Karolinska Institutet Doctoral funds (to Dr. Ericsson), Stockholm Brain Institute (to Dr. Grillner and Dr. Diaz-Heijtz), Spanish MICINN-FEDER BFU2009-13369 (to Dr. Perez-Fernandez). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Barral J, 2010, CELL MOL NEUROBIOL, V30, P743, DOI 10.1007/s10571-010-9499-7; Boehmler W, 2004, DEV DYNAM, V230, P481, DOI 10.1002/dvdy.20075; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; BOUYER JJ, 1984, J COMP NEUROL, V227, P92, DOI 10.1002/cne.902270110; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Ericsson J, 2007, J NEUROSCI METH, V165, P251, DOI 10.1016/j.jneumeth.2007.05.034; Ericsson J, 2011, J PHYSIOL-LONDON, V589, P2979, DOI 10.1113/jphysiol.2011.209643; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FREUND TF, 1984, NEUROSCIENCE, V13, P1189, DOI 10.1016/0306-4522(84)90294-X; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Grillner S, 1997, SCIENCE, V278, P1087, DOI 10.1126/science.278.5340.1087; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HernandezLopez S, 1997, J NEUROSCI, V17, P3334; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Le Crom Stephane, 2003, Journal of Structural and Functional Genomics, V3, P161, DOI 10.1023/A:1022686622752; LeMoine C, 1996, NEUROSCIENCE, V73, P131, DOI 10.1016/0306-4522(96)00029-2; Lipscombe D, 2002, CIRC RES, V90, P933, DOI 10.1161/01.RES.0000019740.52306.92; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Megias M, 2007, SOC NEUROSCIENCE, P35129; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; Moss J, 2008, J NEUROSCI, V28, P11221, DOI 10.1523/JNEUROSCI.2780-08.2008; NEVE KA, 2003, STRUCTURAL ANAL MAMM, P17; O'Connell LA, 2011, J COMP NEUROL, V519, P75, DOI 10.1002/cne.22506; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pasqualini C, 2009, ENDOCRINOLOGY, V150, P1377, DOI 10.1210/en.2008-0578; Pierre J, 1997, J COMP NEUROL, V380, P119; Pierre-Simons J, 2002, J COMP NEUROL, V447, P163, DOI 10.1002/cne.10225; Pombal MA, 1997, J COMP NEUROL, V386, P71; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reiner A, 1998, BRAIN RES REV, V28, P235, DOI 10.1016/S0165-0173(98)00016-2; Schnell SA, 1999, J COMP NEUROL, V407, P543, DOI 10.1002/(SICI)1096-9861(19990517)407:4<543::AID-CNE6>3.0.CO;2-O; Stephenson-Jones M, 2012, J COMP NEUROL; Stephenson-Jones M, 2011, CURR BIOL, V21, P1081, DOI 10.1016/j.cub.2011.05.001; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Thompson RH, 2008, EUR J NEUROSCI, V27, P1452, DOI 10.1111/j.1460-9568.2008.06125.x; Vacher C, 2003, J COMP NEUROL, V458, P32, DOI 10.1002/cne.10545; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; Vernier P, 1997, AMPHIOXUS D1 BETA RE; Wang D, 2011, J NEUROPHYSIOL, V105, P1212, DOI 10.1152/jn.00324.2009; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; West AR, 2002, J NEUROSCI, V22, P294, DOI 10.1523/JNEUROSCI.22-01-00294.2002; Xhaard H, 2006, J MED CHEM, V49, P1706, DOI 10.1021/jm0511031	58	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35642	10.1371/journal.pone.0035642	http://dx.doi.org/10.1371/journal.pone.0035642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563388	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100017
J	Faber, TE; Schuurhof, A; Vonk, A; Koppelman, GH; Hennus, MP; Kimpen, JLL; Janssen, R; Bont, LJ				Faber, Tina E.; Schuurhof, Annemieke; Vonk, Annelies; Koppelman, Gerard H.; Hennus, Marije P.; Kimpen, Jan L. L.; Janssen, Riny; Bont, Louis J.			IL1RL1 Gene Variants and Nasopharyngeal IL1RL-a Levels Are Associated with Severe RSV Bronchiolitis: A Multicenter Cohort Study	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PULMONARY BACTERIAL COINFECTION; INTERLEUKIN-1 RECEPTOR; SOLUBLE ST2; TH2 CELLS; ASTHMA; INFECTION; INFANTS; T1/ST2; ANTIBIOTICS	Background: Targets for intervention are required for respiratory syncytial virus (RSV) bronchiolitis, a common disease during infancy for which no effective treatment exists. Clinical and genetic studies indicate that IL1RL1 plays an important role in the development and exacerbations of asthma. Human IL1RL1 encodes three isoforms, including soluble IL1RL1-a, that can influence IL33 signalling by modifying inflammatory responses to epithelial damage. We hypothesized that IL1RL1 gene variants and soluble IL1RL1-a are associated with severe RSV bronchiolitis. Methodology/Principal Findings: We studied the association between RSV and 3 selected IL1RL1 single-nucleotide polymorphisms rs1921622, rs11685480 or rs1420101 in 81 ventilated and 384 non-ventilated children under 1 year of age hospitalized with primary RSV bronchiolitis in comparison to 930 healthy controls. Severe RSV infection was defined by need for mechanical ventilation. Furthermore, we examined soluble IL1RL1-a concentration in nasopharyngeal aspirates from children hospitalized with primary RSV bronchiolitis. An association between SNP rs1921622 and disease severity was found at the allele and genotype level (p = 0.011 and p = 0.040, respectively). In hospitalized non-ventilated patients, RSV bronchiolitis was not associated with IL1RL1 genotypes. Median concentrations of soluble IL1RL1-a in nasopharyngeal aspirates were >20-fold higher in ventilated infants when compared to non-ventilated infants with RSV (median [and quartiles] 9,357 [936-15,528] pg/ml vs. 405 [112-1,193] pg/ml respectively; p<0.001). Conclusions: We found a genetic link between rs1921622 IL1RL1 polymorphism and disease severity in RSV bronchiolitis. The potential biological role of IL1RL1 in the pathogenesis of severe RSV bronchiolitis was further supported by high local concentrations of IL1RL1 in children with most severe disease. We speculate that IL1RL1a modifies epithelial damage mediated inflammatory responses during RSV bronchiolitis and thus may serve as a novel target for intervention to control disease severity.	[Faber, Tina E.; Vonk, Annelies] Med Ctr Leeuwarden, Dept Pediat, Leeuwarden, Netherlands; [Schuurhof, Annemieke; Janssen, Riny] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Beatrix Childrens Hosp, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol,GRIAC Res, Groningen, Netherlands; [Hennus, Marije P.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Intens Care, Utrecht, Netherlands; [Kimpen, Jan L. L.; Bont, Louis J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands	Medical Center Leeuwarden; Netherlands National Institute for Public Health & the Environment; University of Groningen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Faber, TE (corresponding author), Med Ctr Leeuwarden, Dept Pediat, Leeuwarden, Netherlands.	tina.faber@gmail.com	Koppelman, Gerard/AAG-9187-2020; Hennus, Marije/D-1643-2014	Hennus, Marije/0000-0003-1508-0456; Koppelman, Gerard/0000-0001-8567-3252	Netherlands Asthma Foundation [3.2.09.081JU]	Netherlands Asthma Foundation	GK from the University Medical Center Groningen, GRIAC Research Institute, was supported by the Netherlands Asthma Foundation, grant 3.2.09.081JU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2009, TISSUE ANTIGENS, V73, P206, DOI 10.1111/j.1399-0039.2008.01185.x; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Dale M, 1999, GENOMICS, V57, P177, DOI 10.1006/geno.1999.5767; Duttweiler L, 2004, ARCH DIS CHILD, V89, P1155, DOI 10.1136/adc.2004.049551; Eggers KM, 2010, AM HEART J, V159, P788, DOI 10.1016/j.ahj.2010.02.022; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hacker S, 2009, J CLIN LAB ANAL, V23, P372, DOI 10.1002/jcla.20348; Hayakawa H, 2007, J BIOL CHEM, V282, P26369, DOI 10.1074/jbc.M704916200; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Kabir ARML, 2009, ACTA PAEDIATR, V98, P1593, DOI 10.1111/j.1651-2227.2009.01389.x; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P474, DOI 10.1006/bbrc.1997.6810; Lecart S, 2002, EUR J IMMUNOL, V32, P2979, DOI 10.1002/1521-4141(2002010)32:10<2979::AID-IMMU2979>3.0.CO;2-5; Lenney W, 2009, EUR RESPIR J, V34, P531, DOI 10.1183/09031936.00166508; Levin D, 2010, PEDIATR CRIT CARE ME, V11, P390, DOI 10.1097/PCC.0b013e3181b809c5; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Mangan NE, 2007, EUR J IMMUNOL, V37, P1302, DOI 10.1002/eji.200636520; Martinez-Rumayor A, 2008, AM J CLIN PATHOL, V130, P578, DOI 10.1309/WMG2BFRC97MKKQKP; McGuirk P, 2002, J EXP MED, V195, P221, DOI 10.1084/jem.20011288; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakki A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-50; Perez-Yarza EG, 2007, PEDIATR INFECT DIS J, V26, P733, DOI 10.1097/INF.0b013e3180618c42; Ralston S, 2011, ARCH PEDIAT ADOL MED, V165, P951, DOI 10.1001/archpediatrics.2011.155; Reijmerink NE, 2010, ALLERGY, V65, P199, DOI 10.1111/j.1398-9995.2009.02111.x; Reijmerink NE, 2008, J ALLERGY CLIN IMMUN, V122, P651, DOI 10.1016/j.jaci.2008.06.030; Resch B, 2007, ACTA PAEDIATR, V96, P495, DOI 10.1111/j.1651-2227.2007.00226.x; Savenije OEM, 2011, J ALLERGY CLIN IMMUN, V127, P750, DOI 10.1016/j.jaci.2010.12.014; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schuurhof A, 2012, EUR RESP J IN PRESS; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Spurling GKP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005189.pub3; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Szerafin T, 2009, THORAC CARDIOV SURG, V57, P25, DOI 10.1055/s-2008-1039044; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Thorburn K, 2007, INTENS CARE MED, V33, P565, DOI 10.1007/s00134-006-0486-x; Thorburn K, 2011, PEDIATR CRIT CARE ME, V12, P119, DOI 10.1097/PCC.0b013e3181fe292f; Walzl G, 2001, J EXP MED, V193, P785, DOI 10.1084/jem.193.7.785; Wu H, 2010, J ALLERGY CLIN IMMUN, V125, P321, DOI 10.1016/j.jaci.2009.09.007; Xu D, 1998, J EXP MED, V187, P787, DOI 10.1084/jem.187.5.787	41	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34364	10.1371/journal.pone.0034364	http://dx.doi.org/10.1371/journal.pone.0034364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574108	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800004
J	Solemdal, K; Sandvik, L; Willumsen, T; Mowe, M; Hummel, T				Solemdal, Kirsten; Sandvik, Leiv; Willumsen, Tiril; Mowe, Morten; Hummel, Thomas			The Impact of Oral Health on Taste Ability in Acutely Hospitalized Elderly	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SJOGRENS-SYNDROME; SMELL; SALIVA; SENSITIVITY; DISEASE; CARIES; SEX; AGE; MALNUTRITION	Objective: To investigate to what extent various oral health variables are associated with taste ability in acutely hospitalized elderly. Background: Impaired taste may contribute to weight loss in elderly. Many frail elderly have poor oral health characterized by caries, poor oral hygiene, and dry mouth. However, the possible influence of such factors on taste ability in acutely hospitalized elderly has not been investigated. Materials and Methods: The study was cross-sectional. A total of 174 (55 men) acutely hospitalized elderly, coming from their own homes and with adequate cognitive function, were included. Dental status, decayed teeth, oral bacteria, oral hygiene, dry mouth and tongue changes were recorded. Growth of oral bacteria was assessed with CRT (R) Bacteria Kit. Taste ability was evaluated with 16 taste strips impregnated with sweet, sour, salty and bitter taste solutions in 4 concentrations each. Correct identification was given score 1, and maximum total taste score was 16. Results: Mean age was 84 yrs. (range 70-103 yrs.). Total taste score was significantly and markedly reduced in patients with decayed teeth, poor oral hygiene, high growth of oral bacteria and dry mouth. Sweet and salty taste were particularly impaired in patients with dry mouth. Sour taste was impaired in patients with high growth of oral bacteria. Conclusion: This study shows that taste ability was reduced in acutely hospitalized elderly with caries activity, high growth of oral bacteria, poor oral hygiene, and dry mouth. Our findings indicate that good oral health is important for adequate gustatory function. Maintaining proper oral hygiene in hospitalized elderly should therefore get high priority among hospital staff.	[Solemdal, Kirsten; Sandvik, Leiv; Willumsen, Tiril] Univ Oslo, Fac Dent, Oslo, Norway; [Mowe, Morten] Univ Oslo, Dept Med, Oslo Univ Hosp, Oslo, Norway; [Mowe, Morten] Univ Oslo, Fac Med, Oslo, Norway; [Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany	University of Oslo; University of Oslo; University of Oslo; Technische Universitat Dresden	Solemdal, K (corresponding author), Univ Oslo, Fac Dent, Oslo, Norway.	kirsso@odont.uio.no	Willumsen, Tiril/N-4133-2018		The Norwegian Society for Elderly	The Norwegian Society for Elderly	The authors thank The Norwegian Society for Elderly for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohmer T, 2000, AGE AGEING, V29, P47, DOI 10.1093/ageing/29.1.47; Chapman-Novakofski K, 1999, J AM DIET ASSOC, V99, P1536, DOI 10.1016/S0002-8223(99)00377-6; Doty RL, 2008, DRUG SAFETY, V31, P199, DOI 10.2165/00002018-200831030-00002; Duffy VB, 1999, CHEM SENSES, V24, P671, DOI 10.1093/chemse/24.6.671; FIKENTSCHER R, 1977, CLIN OTOLARYNGOL, V2, P183, DOI 10.1111/j.1365-2273.1977.tb01356.x; Finkelstein JA, 1999, PHYSIOL BEHAV, V66, P173, DOI 10.1016/S0031-9384(98)00261-3; Genton L, 2011, INT J VITAM NUTR RES, V81, P143, DOI 10.1024/0300-9831/a000058; Gimmestad AL, 2006, NOR TANNLAEGEFOREN T, V5, P268; HENRICSSON V, 1990, SCAND J DENT RES, V98, P520; Henriksen B M, 1999, Spec Care Dentist, V19, P154, DOI 10.1111/j.1754-4505.1999.tb01378.x; Henriksen Birgitte M, 2005, Oral Health Prev Dent, V3, P203; Henriksen Birgitte Moesgaard, 2004, Spec Care Dentist, V24, P254; Henriksen BM, KRITERIEBESKRIVELSE; HYDE RJ, 1981, NEUROBIOL AGING, V2, P315, DOI 10.1016/0197-4580(81)90041-5; Kamel UF, 2009, RHEUMATOLOGY, V48, P1512, DOI 10.1093/rheumatology/kep249; Konsberg R, 1985, SV SJUKHUSTANDL TIDN, V10, P3; Kostka E, 2008, LARYNGO RHINO OTOL, V87, P546, DOI 10.1055/s-2007-995614; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; LANGAN MJ, 1976, J GERONTOL, V31, P413, DOI 10.1093/geronj/31.4.413; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Lundgren T, 2007, ORAL DIS, V13, P177, DOI 10.1111/j.1601-0825.2006.01261.x; Matsuo R, 2000, CRIT REV ORAL BIOL M, V11, P216, DOI 10.1177/10454411000110020501; MATTES RD, 1994, J AM DIET ASSOC, V94, P50, DOI 10.1016/0002-8223(94)92041-9; MCWHIRTER JP, 1994, BRIT MED J, V308, P945, DOI 10.1136/bmj.308.6934.945; Mese H, 2007, J ORAL REHABIL, V34, P711, DOI 10.1111/j.1365-2842.2007.01794.x; Mowe M, 2002, J Nutr Health Aging, V6, P81; MOWE M, 1994, AM J CLIN NUTR, V59, P317, DOI 10.1093/ajcn/59.2.317; Mueller C, 2003, RHINOLOGY, V41, P2; Mulder I, 1999, J GERONTOL A-BIOL, V54, pB324; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Nederfors T, 1997, COMMUNITY DENT ORAL, V25, P211, DOI 10.1111/j.1600-0528.1997.tb00928.x; Norderyd O, 2012, GERODONTOLOGY, V29, P4, DOI 10.1111/j.1741-2358.2010.00380.x; Ohno Tomohisa, 2003, Journal of Medical and Dental Sciences, V50, P101; Pajukoski H, 1999, ORAL SURG ORAL MED O, V88, P437, DOI 10.1016/S1079-2104(99)70058-2; Planas M, 2004, CLIN NUTR, V23, P1016, DOI 10.1016/j.clnu.2004.01.003; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; Quirynen M, 2004, J CLIN PERIODONTOL, V31, P506, DOI 10.1111/j.0303-6979.2004.00507.x; Samson H, 2009, EUR J ORAL SCI, V117, P575, DOI 10.1111/j.1600-0722.2009.00673.x; Sanchez-Garcia S, 2008, GERODONTOLOGY, V25, P26, DOI 10.1111/j.1741-2358.2007.00184.x; Saotome Yasuhiko, 2006, Gerodontology, V23, P219, DOI 10.1111/j.1741-2358.2006.00127.x; Sasano T, 2010, BIOL PHARM BULL, V33, P1791, DOI 10.1248/bpb.33.1791; Schiffman SS, 2000, EUR J CLIN NUTR, V54, pS54, DOI 10.1038/sj.ejcn.1601026; Schiffman SS, 1997, JAMA-J AM MED ASSOC, V278, P1357, DOI 10.1001/jama.278.16.1357; Ship J A, 1992, Clin Geriatr Med, V8, P483; Solemdal K, 2011, GERODONTOLOGY; SPIELMAN AI, 1990, J DENT RES, V69, P838, DOI 10.1177/00220345900690030101; THUMFART W, 1980, Z GERONTOL, V13, P158; Vilstrup L, 2007, GERODONTOLOGY, V24, P3, DOI 10.1111/j.1741-2358.2007.00141.x; Wayler A H, 1990, Spec Care Dentist, V10, P107, DOI 10.1111/j.1754-4505.1990.tb00771.x; WEIFFENBACH JM, 1982, J GERONTOL, V37, P372, DOI 10.1093/geronj/37.3.372; WEIFFENBACH JM, 1995, PHYSIOL BEHAV, V57, P89, DOI 10.1016/0031-9384(94)00211-M; WHO, 1997, BAS METH; Winkler S, 1999, J AM DENT ASSOC, V130, P1759, DOI 10.14219/jada.archive.1999.0133; Woschnagg H, 2002, LANCET, V359, P891, DOI 10.1016/S0140-6736(02)07933-3	54	52	53	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36557	10.1371/journal.pone.0036557	http://dx.doi.org/10.1371/journal.pone.0036557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570725	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400041
J	Doubeni, CA; Jambaulikar, GD; Fouayzi, H; Robinson, SB; Gunter, MJ; Field, TS; Roblin, DW; Fletcher, RH				Doubeni, Chyke A.; Jambaulikar, Guruprasad D.; Fouayzi, Hassan; Robinson, Scott B.; Gunter, Margaret J.; Field, Terry S.; Roblin, Douglas W.; Fletcher, Robert H.			Neighborhood Socioeconomic Status and Use of Colonoscopy in an Insured Population - A Retrospective Cohort Study	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; CANCER SCREENING-TESTS; COLORECTAL-CANCER; UNITED-STATES; GEOGRAPHIC-VARIATION; MEDICARE ENROLLEES; LEVEL POVERTY; HEALTH-CARE; TASK-FORCE	Background: Low-socioeconomic status (SES) is associated with a higher colorectal cancer (CRC) incidence and mortality. Screening with colonoscopy, the most commonly used test in the US, has been shown to reduce the risk of death from CRC. This study examined if, among insured persons receiving care in integrated healthcare delivery systems, differences exist in colonoscopy use according to neighborhood SES. Methods: We assembled a retrospective cohort of 100,566 men and women, 50-74 years old, who had been enrolled in one of three US health plans for >= 1 year on January 1, 2000. Subjects were followed until the date of first colonoscopy, date of disenrollment from the health plan, or December 31, 2007, whichever occurred first. We obtained data on colonoscopy use from administrative records. We defined screening colonoscopy as an examination that was not preceded by gastrointestinal conditions in the prior 6-month period. Neighborhood SES was measured using the percentage of households in each subject's census-tract with an income below 1999 federal poverty levels based on 2000 US census data. Analyses, adjusted for demographics and comorbidity index, were performed using Weibull regression models. Results: The average age of the cohort was 60 years and 52.7% were female. During 449,738 person-years of follow-up, fewer subjects in the lowest SES quartile (Q1) compared to the highest quartile (Q4) had any colonoscopy (26.7% vs. 37.1%) or a screening colonoscopy (7.6% vs. 13.3%). In regression analyses, compared to Q4, subjects in Q1 were 16% (adjusted HR = 0.84, 95% CI: 0.80-0.88) less likely to undergo any colonoscopy and 30%(adjusted HR = 0.70, CI: 0.65-0.75) less likely to undergo a screening colonoscopy. Conclusion: People in lower-SES neighborhoods are less likely to undergo a colonoscopy, even among insured subjects receiving care in integrated healthcare systems. Removing health insurance barriers alone is unlikely to eliminate disparities in colonoscopy use.	[Doubeni, Chyke A.; Jambaulikar, Guruprasad D.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA 01655 USA; [Doubeni, Chyke A.; Fouayzi, Hassan; Field, Terry S.] Univ Massachusetts, Sch Med, Dept Med, Meyers Primary Care Inst Reliant Med Grp Fallon C, Worcester, MA USA; [Robinson, Scott B.] Premier Inc, Charlotte, NC USA; [Gunter, Margaret J.] LCF Res, Albuquerque, NM USA; [Roblin, Douglas W.] Kaiser Permanente Georgia, Ctr Hlth Res SE, Atlanta, GA USA; [Fletcher, Robert H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Kaiser Permanente; Harvard University; Harvard Medical School	Doubeni, CA (corresponding author), Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA 01655 USA.	chyke.doubeni@umassmed.edu	Doubeni, Chyke A/W-6749-2019; Fouayzi, Hassan/AHD-0143-2022	Doubeni, Chyke A/0000-0001-7495-0285; Gunter, Marc/0000-0001-5472-6761	Health Maintenance Organization Cancer Research Network; National Institutes of Health/National Cancer Institute [U19CA79689, 5K01CA127118, U54CA163262]; NATIONAL CANCER INSTITUTE [U01CA151736, U54CA163262, U19CA079689, K01CA127118] Funding Source: NIH RePORTER	Health Maintenance Organization Cancer Research Network; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Health Maintenance Organization Cancer Research Network through funding from the National Institutes of Health/National Cancer Institute (U19CA79689: Cancer Research Network Across Health Care Systems). Dr. Doubeni and Dr. Jambaulikar were also supported by the National Institutes of Health/National Cancer Institute (5K01CA127118, U54CA163262). The views expressed herein are solely those of the authors and do not necessarily reflect those of the participating health plans or the Health Maintenance Organization Cancer Research Network or its affiliated entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bajracharya SM, 2006, INT Q COMMUNITY HEAL, V26, P23, DOI 10.2190/13R7-5177-G833-8V85; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Christie J, 2008, J NATL MED ASSOC, V100, P278, DOI 10.1016/S0027-9684(15)31240-2; Denberg TD, 2005, J GEN INTERN MED, V20, P989, DOI 10.1111/j.1525-1497.2005.00164.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Division of Cancer Prevention and Control National Center for Chronic Disease Prevention and Health Promotion, 2011, COL CANC CONTR PROGR; Dorn SD, 2012, CLIN GASTROENTEROL H, V10, P278, DOI 10.1016/j.cgh.2011.11.020; Doubeni CA, 2012, CANCER-AM CANCER SOC, V118, P3636, DOI 10.1002/cncr.26677; Doubeni CA, 2012, AM J PUBLIC HEALTH, V102, P680, DOI 10.2105/AJPH.2011.300158; Doubeni CA, 2010, ANN FAM MED, V8, P299, DOI 10.1370/afm.1112; Doubeni CA, 2009, CANCER EPIDEM BIOMAR, V18, P2170, DOI 10.1158/1055-9965.EPI-09-0104; Frederiksen BL, 2010, BRIT J CANCER, V103, P1496, DOI 10.1038/sj.bjc.6605962; Green AR, 2008, J GEN INTERN MED, V23, P834, DOI 10.1007/s11606-008-0572-6; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; Klabunde CN, 2011, CANCER EPIDEM BIOMAR, V20, P1611, DOI 10.1158/1055-9965.EPI-11-0220; Ko CW, 2002, ARCH INTERN MED, V162, P2581, DOI 10.1001/archinte.162.22.2581; Koh HK, 2010, NEW ENGL J MED, V363, P1296, DOI 10.1056/NEJMp1008560; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637; Lebwohl B, 2011, J CLIN GASTROENTEROL, V45, pE47, DOI 10.1097/MCG.0b013e3181f595c3; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2011, EPIDEMIOL REV, V33, P101, DOI 10.1093/epirev/mxr007; Lian M, 2011, AM J EPIDEMIOL, V174, P828, DOI 10.1093/aje/kwr162; Lian M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-358; Macintyre S, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-32; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Myers RE, 2008, MED CARE, V46, pS123, DOI 10.1097/MLR.0b013e31817fdf46; Parikh-Patel A, 2006, CANCER-AM CANCER SOC, V107, P1189, DOI 10.1002/cncr.22016; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Rex DK, 2008, CLIN GASTROENTEROL H, V6, P506, DOI 10.1016/j.cgh.2008.02.025; Richardson Lisa C., 2011, Morbidity and Mortality Weekly Report, V60, P884; Rutten LJF, 2004, PREV MED, V38, P258, DOI 10.1016/j.ypmed.2003.10.011; Siegel RL, 2008, J NATL MED ASSOC, V100, P1441, DOI 10.1016/S0027-9684(15)31544-3; Singh GK, 2003, NCI CANC SURVEILLANC, V4; Stock C, 2011, ENDOSCOPY, V43, P771, DOI 10.1055/s-0030-1256504; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Wharam JF, 2008, ANN INTERN MED, V148, P647, DOI 10.7326/0003-4819-148-9-200805060-00004; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	44	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36392	10.1371/journal.pone.0036392	http://dx.doi.org/10.1371/journal.pone.0036392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567154	Green Published, gold			2022-12-27	WOS:000305341500073
J	Letouze, E; Sow, A; Petel, F; Rosati, R; Figueiredo, BC; Burnichon, N; Gimenez-Roqueplo, AP; Lalli, E; de Reynies, A				Letouze, Eric; Sow, Aliou; Petel, Fabien; Rosati, Roberto; Figueiredo, Bonald C.; Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule; Lalli, Enzo; de Reynies, Aurelien			Identity by Descent Mapping of Founder Mutations in Cancer Using High-Resolution Tumor SNP Data	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; LOSS-OF-HETEROZYGOSITY; ADRENOCORTICAL TUMORS; BREAST-CANCER; ARRAYS; BRCA1; INDIVIDUALS; POPULATIONS; EXPRESSION; FREQUENCY	Dense genotype data can be used to detect chromosome fragments inherited from a common ancestor in apparently unrelated individuals. A disease-causing mutation inherited from a common founder may thus be detected by searching for a common haplotype signature in a sample population of patients. We present here FounderTracker, a computational method for the genome-wide detection of founder mutations in cancer using dense tumor SNP profiles. Our method is based on two assumptions. First, the wild-type allele frequently undergoes loss of heterozygosity (LOH) in the tumors of germline mutation carriers. Second, the overlap between the ancestral chromosome fragments inherited from a common founder will define a minimal haplotype conserved in each patient carrying the founder mutation. Our approach thus relies on the detection of haplotypes with significant identity by descent (IBD) sharing within recurrent regions of LOH to highlight genomic loci likely to harbor a founder mutation. We validated this approach by analyzing two real cancer data sets in which we successfully identified founder mutations of well-characterized tumor suppressor genes. We then used simulated data to evaluate the ability of our method to detect IBD tracts as a function of their size and frequency. We show that FounderTracker can detect haplotypes of low prevalence with high power and specificity, significantly outperforming existing methods. FounderTracker is thus a powerful tool for discovering unknown founder mutations that may explain part of the "missing" heritability in cancer. This method is freely available and can be used online at the FounderTracker website.	[Letouze, Eric; Sow, Aliou; Petel, Fabien; de Reynies, Aurelien] Ligue Natl Contre Canc, Programme Cartes Identite Tumeurs, Paris, France; [Rosati, Roberto; Figueiredo, Bonald C.] Inst Pesquisa Pele Pequeno Principe, Curitiba, Parana, Brazil; [Rosati, Roberto; Figueiredo, Bonald C.] Fac Pequeno Principe, Curitiba, Parana, Brazil; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] INSERM, UMR970, Paris Cardiovasc Res Ctr, Paris, France; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] Hop Europe Georges Pompidou, Assistance Publique Hopitaux Paris, Serv Genet, Paris, France; [Burnichon, Nelly; Gimenez-Roqueplo, Anne-Paule] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Lalli, Enzo] Univ Nice, Valbonne, France; [Lalli, Enzo] CNRS, UMR 6097, Inst Pharmacol Mol & Cellulaire, Valbonne, France	Hospital Pequeno Principe; Hospital Pequeno Principe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Letouze, E (corresponding author), Ligue Natl Contre Canc, Programme Cartes Identite Tumeurs, Paris, France.	LetouzeE@ligue-cancer.net	Burnichon, Nelly/AAF-6003-2020; Letouzé, Eric/AAP-9924-2020; GIMENEZ-ROQUEPLO, Anne-Paule/T-6752-2018; de Reyniès, Aurélien/Q-8640-2017; Rosati, Roberto/AAF-3708-2020; de Figueiredo, Bonald Cavalcante/AAD-6672-2021; Lalli, Enzo/F-7052-2013	Letouzé, Eric/0000-0002-6369-2839; GIMENEZ-ROQUEPLO, Anne-Paule/0000-0002-4816-670X; de Reyniès, Aurélien/0000-0002-1328-5290; Rosati, Roberto/0000-0002-0475-3654; de Figueiredo, Bonald Cavalcante/0000-0002-1051-2056; Lalli, Enzo/0000-0002-0584-5681	Institut National du Cancer and CNRS (LIA NEOGENEX); CNPq; CAPES; Programme Hospitalier de Recherche Clinique grant COMETE 3 [AOM 06 179]	Institut National du Cancer and CNRS (LIA NEOGENEX); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programme Hospitalier de Recherche Clinique grant COMETE 3	This work is part of the CIT program from the French Ligue Nationale Contre le Cancer (http://cit.ligue-cancer.net/index.php/en). This work was supported by grants from Institut National du Cancer and CNRS (LIA NEOGENEX) to Enzo Lalli; CNPq and CAPES grants to Bonald C. Figueiredo. This work was supported by the Programme Hospitalier de Recherche Clinique grant COMETE 3 (AOM 06 179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Beroukhim R, 2006, PLOS COMPUT BIOL, V2, P323, DOI 10.1371/journal.pcbi.0020041; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Burnichon N, 2011, HUMAN MOL GENETICS; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chapman NH, 2003, THEOR POPUL BIOL, V64, P141, DOI 10.1016/S0040-5809(03)00071-6; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; Dworkin AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001136; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Figueiredo BC, 2006, J MED GENET, V43, P91, DOI 10.1136/jmg.2004.030551; Freeman EA, 2008, J STAT SOFTW, V23, P1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gimenez-Roqueplo AP, 2008, CLIN EXP PHARMACOL P, V35, P376, DOI 10.1111/j.1440-1681.2008.04881.x; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Kenny EE, 2009, P NATL ACAD SCI USA, V106, P13886, DOI 10.1073/pnas.0907336106; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; LaFramboise T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001086; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Letouze E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r76; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Osorio A, 2002, INT J CANCER, V99, P305, DOI 10.1002/ijc.10337; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pianovski MAD, 2006, PEDIATR BLOOD CANCER, V47, P56, DOI 10.1002/pbc.20624; Pinto Emilia M., 2004, Arq Bras Endocrinol Metab, V48, P647, DOI 10.1590/S0004-27302004000500009; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Probst CM, 2000, HUM BIOL, V72, P597; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosati R, 2008, CANCER GENET CYTOGEN, V186, P19, DOI 10.1016/j.cancergencyto.2008.05.010; Staaf J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-409; Staaf J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r136; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; TONIN P, 1995, AM J HUM GENET, V57, P189; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35897	10.1371/journal.pone.0035897	http://dx.doi.org/10.1371/journal.pone.0035897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567117	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500035
J	Molina-Ortiz, P; Villarejo, A; MacPherson, M; Santos, V; Montes, A; Souchelnytskyi, S; Portillo, F; Cano, A				Molina-Ortiz, Patricia; Villarejo, Ana; MacPherson, Matthew; Santos, Vanesa; Montes, Amalia; Souchelnytskyi, Serhiy; Portillo, Francisco; Cano, Amparo			Characterization of the SNAG and SLUG Domains of Snail2 in the Repression of E-Cadherin and EMT Induction: Modulation by Serine 4 Phosphorylation	PLOS ONE			English	Article							NEURAL CREST DEVELOPMENT; EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; GENE-EXPRESSION; PROTEIN; REGULATOR; CANCER; CELLS; MEMBERS; TWIST	Snail1 and Snail2, two highly related members of the Snail superfamily, are direct transcriptional repressors of E-cadherin and EMT inducers. Previous comparative gene profiling analyses have revealed important differences in the gene expression pattern regulated by Snail1 and Snail2, indicating functional differences between both factors. The molecular mechanism of Snail1- mediated repression has been elucidated to some extent, but very little is presently known on the repression mediated by Snail2. In the present work, we report on the characterization of Snail2 repression of E-cadherin and its regulation by phosphorylation. Both the N-terminal SNAG and the central SLUG domains of Snail2 are required for efficient repression of the E-cadherin promoter. The co-repressor NCoR interacts with Snail2 through the SNAG domain, while CtBP1 is recruited through the SLUG domain. Interestingly, the SNAG domain is absolutely required for EMT induction while the SLUG domain plays a negative modulation of Snail2 mediated EMT. Additionally, we identify here novel in vivo phosphorylation sites at serine 4 and serine 88 of Snail2 and demonstrate the functional implication of serine 4 in the regulation of Snail2-mediated repressor activity of E-cadherin and in Snail2 induction of EMT.	[Molina-Ortiz, Patricia; Villarejo, Ana; MacPherson, Matthew; Santos, Vanesa; Montes, Amalia; Portillo, Francisco; Cano, Amparo] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Inst Invest Biomed Alberto Sols CSIC UAM,IdiPAZ, Madrid, Spain; [Souchelnytskyi, Serhiy] Karolinska Inst, Karolinska Biom Ctr, Dept Oncol Pathol, Stockholm, Sweden	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Karolinska Institutet	Molina-Ortiz, P (corresponding author), Univ Liege, GIGA Res Ctr, Lab Funct Genet, Liege, Belgium.	acano@iib.uam.es	Souchelnytskyi, Serhiy/J-9446-2014; Souchelnytskyi, Serhiy/G-6491-2011	Portillo Perez, Francisco/0000-0003-4922-346X; Souchelnytskyi, Serhiy/0000-0001-8243-9276	EU-FP6 (RTN-Epiplast Carcinoma) [MRTN-CT-2004-005428]; Spanish Ministry of Science Innovation [SAF2007-06351, SAF2010-21143, CDS2007-00017]; Fundacion Mutua Madrilena [FMM2009]; EU Marie Curie program; FPI fellowship from Spanish Ministry of Science Innovation; FPU fellowship from Spanish Ministry of Education	EU-FP6 (RTN-Epiplast Carcinoma); Spanish Ministry of Science Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); EU Marie Curie program(European Commission); FPI fellowship from Spanish Ministry of Science Innovation; FPU fellowship from Spanish Ministry of Education(German Research Foundation (DFG))	This work was supported by the EU-FP6 (RTN-Epiplast Carcinoma, MRTN-CT-2004-005428), the Spanish Ministry of Science & Innovation (SAF2007-06351, SAF2010-21143, Consolider Ingenio CDS2007-00017) and Fundacion Mutua Madrilena (FMM2009) to AC. During the realization of this work MMcP was supported by the EU Marie Curie program and PMO was supported by a FPI fellowship from the Spanish Ministry of Science & Innovation. AV is supported by a FPU fellowship from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Aybar MJ, 2003, DEVELOPMENT, V130, P483, DOI 10.1242/dev.00238; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Bailey CK, 2007, BIOCHEM BIOPH RES CO, V353, P661, DOI 10.1016/j.bbrc.2006.12.097; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dominguez D, 2003, MOL CELL BIOL, V23, P5078, DOI 10.1128/MCB.23.14.5078-5089.2003; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hajra KM, 2002, CANCER RES, V62, P1613; Hemavathy K, 2000, MOL CELL BIOL, V20, P5087, DOI 10.1128/MCB.20.14.5087-5095.2000; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Hou ZY, 2008, MOL CELL BIOL, V28, P3198, DOI 10.1128/MCB.01435-07; Jiang RL, 1998, DEV BIOL, V198, P277, DOI 10.1016/S0012-1606(98)80005-5; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Lin YW, 2010, EMBO J, V29, P1803, DOI 10.1038/emboj.2010.63; Manzanares M, 2001, TRENDS GENET, V17, P178, DOI 10.1016/S0168-9525(01)02232-6; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mingot JM, 2009, J CELL SCI, V122, P1452, DOI 10.1242/jcs.041749; Mittal MK, 2008, BIOCHEM BIOPH RES CO, V372, P30, DOI 10.1016/j.bbrc.2008.04.187; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Moreno-Bueno G, 2009, NAT PROTOC, V4, P1591, DOI 10.1038/nprot.2009.152; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nakayama H, 1998, DEV BIOL, V199, P150, DOI 10.1006/dbio.1998.8914; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2008, ONCOGENE, V27, P4690, DOI 10.1038/onc.2008.118; Peinado H, 2005, EMBO J, V24, P3446, DOI 10.1038/sj.emboj.7600781; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; MacPherson MR, 2010, MOL BIOL CELL, V21, P244, DOI 10.1091/mbc.E09-06-0504; Sefton M, 1998, DEVELOPMENT, V125, P3111; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Vernon AE, 2006, DEVELOPMENT, V133, P3359, DOI 10.1242/dev.02504; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhang K, 2012, EMBO J, V31, P29, DOI 10.1038/emboj.2011.357; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	54	39	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36132	10.1371/journal.pone.0036132	http://dx.doi.org/10.1371/journal.pone.0036132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567133	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500051
J	Desrues, L; Lefebvre, T; Lecointre, C; Schouft, MT; Leprince, J; Compere, V; Morin, F; Proust, F; Gandolfo, P; Tonon, MC; Castel, H				Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene			Down-Regulation of GABA(A) Receptor via Promiscuity with the Vasoactive Peptide Urotensin II Receptor. Potential Involvement in Astrocyte Plasticity	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; BETA-ADRENERGIC-RECEPTOR; SUBUNIT MESSENGER-RNAS; A RECEPTOR; ION CHANNELS; ENDOGENOUS LIGAND; ORPHAN RECEPTOR; RAT-BRAIN; CELL; MODULATION	GABA(A) receptor (GABA(A)R) expression level is inversely correlated with the proliferation rate of astrocytes after stroke or during malignancy of astrocytoma, leading to the hypothesis that GABA(A)R expression/activation may work as a cell proliferation repressor. A number of vasoactive peptides exhibit the potential to modulate astrocyte proliferation, and the question whether these mechanisms may imply alteration in GABA(A)R-mediated functions and/or plasma membrane densities is open. The peptide urotensin II (UII) activates a G protein-coupled receptor named UT, and mediates potent vasoconstriction or vasodilation in mammalian vasculature. We have previously demonstrated that UII activates a PLC/PIPs/Ca2+ transduction pathway, via both G(q) and G(i/o) proteins and stimulates astrocyte proliferation in culture. It was also shown that UT/G(q)/IP3 coupling is regulated by the GABA(A)R in rat cultured astrocytes. Here we report that UT and GABA(A)R are co-expressed in cerebellar glial cells from rat brain slices, in human native astrocytes and in glioma cell line, and that UII inhibited the GABAergic activity in rat cultured astrocytes. In CHO cell line co-expressing human UT and combinations of GABA(A)R subunits, UII markedly depressed the GABA current (beta(3)gamma(2)>alpha(2)beta(3)gamma(2)>alpha(2)beta(1)gamma(2)). This effect, characterized by a fast short-term inhibition followed by drastic and irreversible run-down, is not relayed by G proteins. The run-down partially involves Ca2+ and phosphorylation processes, requires dynamin, and results from GABA(A)R internalization. Thus, activation of the vasoactive G protein-coupled receptor UT triggers functional inhibition and endocytosis of GABA(A)R in CHO and human astrocytes, via its receptor C-terminus. This UII-induced disappearance of the repressor activity of GABA(A)R, may play a key role in the initiation of astrocyte proliferation.	[Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene] Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France; [Desrues, Laurence; Lefebvre, Thomas; Lecointre, Celine; Schouft, Marie-Therese; Leprince, Jerome; Compere, Vincent; Morin, Fabrice; Proust, Francois; Gandolfo, Pierrick; Tonon, Marie-Christine; Castel, Helene] Univ Rouen, Normandy Univ PRES, Inst Res & Biomed Innovat IRIB, Mont St Aignan, France; [Compere, Vincent] Rouen Univ Hosp, Dept Anesthesiol & Crit Care, Rouen, France; [Proust, Francois] Rouen Univ Hosp, Dept Neurosurg, Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; CHU de Rouen; CHU de Rouen	Desrues, L (corresponding author), Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France.	helene.castel@univ-rouen.fr	castel, helene/B-8675-2009; Leprince, Jerome/N-9083-2017	castel, helene/0000-0002-8972-5555; Morin, Fabrice/0000-0001-6785-1967; Leprince, Jerome/0000-0002-7814-9927	Inserm; University of Rouen; Conseil regional de Haute-Normandie	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rouen; Conseil regional de Haute-Normandie(Region Normandie)	This work was supported by Inserm, University of Rouen and the Conseil regional de Haute-Normandie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Barnes EM, 2001, INT REV NEUROBIOL, V48, P1, DOI 10.1016/S0074-7742(01)48012-3; Behm DJ, 2008, BRIT J PHARMACOL, V155, P374, DOI 10.1038/bjp.2008.266; Bianchi MT, 2001, J NEUROSCI, V21, P1127; BLAIR LAC, 1988, SCIENCE, V242, P577, DOI 10.1126/science.2845583; Boileau AJ, 2002, NEUROPHARMACOLOGY, V43, P695, DOI 10.1016/S0028-3908(02)00036-9; BOVOLIN P, 1992, P NATL ACAD SCI USA, V89, P9344, DOI 10.1073/pnas.89.19.9344; Brandon NJ, 2002, PHARMACOL THERAPEUT, V94, P113, DOI 10.1016/S0163-7258(02)00175-4; BUREAU M, 1995, J NEUROCHEM, V65, P2006; Cao WH, 2000, J BIOL CHEM, V275, P38131, DOI 10.1074/jbc.C000592200; Castel H, 2006, J NEUROCHEM, V99, P582, DOI 10.1111/j.1471-4159.2006.04130.x; Chatenet D, 2004, PEPTIDES, V25, P1819, DOI 10.1016/j.peptides.2004.04.019; Clark SD, 2001, BRAIN RES, V923, P120, DOI 10.1016/S0006-8993(01)03208-5; Clozel M, 2004, J PHARMACOL EXP THER, V311, P204, DOI 10.1124/jpet.104.068320; Coulouarn Y, 1999, FEBS LETT, V457, P28, DOI 10.1016/S0014-5793(99)01003-0; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; D'Hulst C, 2009, DRUG DISCOV TODAY, V14, P866, DOI 10.1016/j.drudis.2009.06.009; Desrues L, 2008, PEPTIDES, V29, P727, DOI 10.1016/j.peptides.2008.01.024; Diallo M, 2008, PEPTIDES, V29, P813, DOI 10.1016/j.peptides.2007.10.023; DominguezPerrot C, 1996, J PHYSIOL-LONDON, V497, P145, DOI 10.1113/jphysiol.1996.sp021756; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; EDDLESTON ALWF, 1993, GASTROENTEROL JPN, V28, P57; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; FRASER DD, 1995, J NEUROSCI, V15, P2720; Fritschy JM, 2006, CEREBELLUM, V5, P275, DOI 10.1080/14734220600962805; Gandolfo P, 1997, EUR J PHARMACOL, V322, P275, DOI 10.1016/S0014-2999(97)00012-5; Gartlon J, 2001, PSYCHOPHARMACOLOGY, V155, P426, DOI 10.1007/s002130100715; Gong H, 2004, J APPL PHYSIOL, V97, P2228, DOI 10.1152/japplphysiol.00540.2004; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Guidolin D, 2010, REGUL PEPTIDES, V162, P26, DOI 10.1016/j.regpep.2010.02.009; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Jakubik J, 2002, J PHARMACOL EXP THER, V301, P1033, DOI 10.1124/jpet.301.3.1033; Jarry M, 2010, BIOCHEM J, V428, P113, DOI 10.1042/BJ20090867; Jegou S, 2006, J COMP NEUROL, V495, P21, DOI 10.1002/cne.20845; Johns DG, 2004, N-S ARCH PHARMACOL, V370, P238, DOI 10.1007/s00210-004-0980-z; Kawabata Keita, 1996, Kaku Igaku, V33, P391; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Labarrere P, 2003, J ENZYM INHIB MED CH, V18, P77, DOI 10.1080/1475636031000093507; Labrakakis C, 1998, EUR J NEUROSCI, V10, P231, DOI 10.1046/j.1460-9568.1998.00036.x; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Lefebvre T, 2009, J NEUROCHEM, V110, P976, DOI 10.1111/j.1471-4159.2009.06197.x; LI HL, 1993, HIPPOCAMPUS, V3, P527, DOI 10.1002/hipo.450030412; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lin YZ, 2003, HYPERTENS RES, V26, P839, DOI 10.1291/hypres.26.839; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; LUHMANN HJ, 1995, EPILEPSY RES, V22, P43, DOI 10.1016/0920-1211(95)00032-6; McKhann GM, 1997, J NEUROSCI, V17, P6850; Mori M, 1999, BIOCHEM BIOPH RES CO, V265, P123, DOI 10.1006/bbrc.1999.1640; Moriwaki H, 1998, J NUCL MED, V39, P1348; Moss SJ, 1996, INT REV NEUROBIOL, V39, P1, DOI 10.1016/S0074-7742(08)60662-5; Muller V, 2002, NUCL MED COMMUN, V23, P1191, DOI 10.1097/01.mnm.0000046211.83338.0c; NILSSON M, 1993, NEUROSCIENCE, V54, P605, DOI 10.1016/0306-4522(93)90232-5; Nothacker HP, 1999, NAT CELL BIOL, V1, P383, DOI 10.1038/14081; Nutt DJ, 2010, J PSYCHOPHARMACOL, V24, P1601, DOI 10.1177/0269881109106927; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Ohyama M, 1999, ANN NUCL MED, V13, P309, DOI 10.1007/BF03164869; Ono T, 2008, NEUROSCI LETT, V440, P275, DOI 10.1016/j.neulet.2008.05.096; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Prasad SVN, 2005, NAT CELL BIOL, V7, P785, DOI 10.1038/ncb1278; PRITCHETT DB, 1988, SCIENCE, V242, P1306, DOI 10.1126/science.2848320; Proulx CD, 2005, BIOCHEM J, V385, P115, DOI 10.1042/BJ20040807; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; PUIA G, 1991, MOL PHARMACOL, V39, P691; Qi JG, 2004, HEART VESSELS, V19, P81, DOI 10.1007/s00380-003-0739-3; Rissman RA, 2003, NEUROSCIENCE, V120, P695, DOI 10.1016/S0306-4522(03)00030-7; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Schwartz-Bloom RD, 2001, J NEUROCHEM, V77, P353, DOI 10.1046/j.1471-4159.2001.00274.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shi LB, 2006, ATHEROSCLEROSIS, V188, P260, DOI 10.1016/j.atherosclerosis.2005.10.044; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sotelo C, 2004, PROG NEUROBIOL, V72, P295, DOI 10.1016/j.pneurobio.2004.03.004; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Taft JR, 2005, INT J NEUROSCI, V115, P1333, DOI 10.1080/00207450590934570; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Tateishi N, 2006, BRAIN RES, V1089, P79, DOI 10.1016/j.brainres.2006.02.139; Tretter V, 1997, J NEUROSCI, V17, P2728; VERHEUL HB, 1993, EUR J NEUROSCI, V5, P955, DOI 10.1111/j.1460-9568.1993.tb00946.x; VONBLANKENFELD G, 1991, EUR J NEUROSCI, V3, P310; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Watanabe T, 2001, CIRCULATION, V104, P16, DOI 10.1161/hc2601.092848; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151, DOI 10.1152/jn.1994.71.6.2151; ZERN MA, 1993, GASTROENTEROL JPN, V28, P76; Ziltener P, 2002, J RECEPT SIGNAL TR R, V22, P155, DOI 10.1081/RRS-120014593	92	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36319	10.1371/journal.pone.0036319	http://dx.doi.org/10.1371/journal.pone.0036319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563490	Green Published, gold			2022-12-27	WOS:000305340700039
J	Fujiwara, M				Fujiwara, Masami			Demographic Diversity and Sustainable Fisheries	PLOS ONE			English	Article							HISTORY; RECRUITMENT; RESILIENCE; STABILITY; PATTERNS; MODELS	Fish species are diverse. For example, some exhibit early maturation while others delay maturation, some adopt semelparous reproductive strategies while others are iteroparous, and some are long-lived and others short-lived. The diversity is likely to have profound effects on fish population dynamics, which in turn has implications for fisheries management. In this study, a simple density-dependent stage-structured population model was used to investigate the effect of life history traits on sustainable yield, population resilience, and the coefficient of variation (CV) of the adult abundance. The study showed that semelparous fish can produce very high sustainable yields, near or above 50% of the carrying capacity, whereas long-lived iteroparous fish can produce very low sustainable yields, which are often much less than 10% of the carrying capacity. The difference is not because of different levels of sustainable fishing mortality rate, but because of difference in the sensitivity of the equilibrium abundance to fishing mortality. On the other hand, the resilience of fish stocks increases from delayed maturation to early maturation strategies but remains almost unchanged from semelparous to long-lived iteroparous. The CV of the adult abundance increases with increased fishing mortality, not because more individuals are recruited into the adult stage (as previous speculated), but because the mean abundance is more sensitive to fishing mortality than its standard deviation. The magnitudes of these effects vary depending on the life history strategies of the fish species involved. It is evident that any past high yield of long-lived iteroparous fish is a transient yield level, and future commercial fisheries should focus more on fish that are short-lived (including semelparous species) with high compensatory capacity.	Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012	Fujiwara, Masami/0000-0002-9255-6043	United States National Oceanic and Atmospheric Administration (DOC) [NFFR7500-10-18114]	United States National Oceanic and Atmospheric Administration (DOC)	This work was funded in part by the United States National Oceanic and Atmospheric Administration (DOC Contract-NFFR7500-10-18114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADAMS PB, 1980, FISH B-NOAA, V78, P1; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], QUANTITATIVE FISHERI; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; BEDDINGTON JR, 1976, J ANIM ECOL, V45, P791, DOI 10.2307/3581; Beverton R.J.H., 1957, FISH INVEST SER, P19; Brooks EN, 2010, ICES J MAR SCI, V67, P165, DOI 10.1093/icesjms/fsp225; Cadrin SX, 2008, FISH RES, V94, P367, DOI 10.1016/j.fishres.2008.06.004; Caswell, 2000, MATRIX POPULATION MO; COSTANTINO RF, 1995, NATURE, V375, P227, DOI 10.1038/375227a0; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; DEANGELIS DL, 1980, ECOLOGY, V61, P764, DOI 10.2307/1936746; Fromentin JM, 2001, FISH RES, V53, P133, DOI 10.1016/S0165-7836(00)00299-X; Fujiwara M, 2011, SCI REP-UK, V1, DOI 10.1038/srep00107; Goodwin NB, 2006, CAN J FISH AQUAT SCI, V63, P494, DOI 10.1139/f05-234; Haddon M., 2011, MODELLING QUANTITATI; Hannesson R, 1994, 04299337 FAO DN; HARRISON GW, 1979, AM NAT, V113, P659, DOI 10.1086/283424; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Jennings S., 2001, MARINE FISHERIES ECO; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; Myers RA, 1996, FISH B-NOAA, V94, P707; Pinsky ML, 2011, P NATL ACAD SCI USA, V108, P8317, DOI 10.1073/pnas.1015313108; Quinn T.J., 1999, BIOL RES MANAG SER; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rose KA, 2003, ANNU REV ECOL EVOL S, V34, P127, DOI 10.1146/annurev.ecolsys.34.011802.132423; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shuter BJ, 2005, CAN J FISH AQUAT SCI, V62, P725, DOI 10.1139/F05-067; Stearns S., 1992, EVOLUTION LIFE HIST; USDOC, 2007, 94265 USDOC; Verhulst P.-F., 1838, CORRESP MATH PHYS, V10, P113; Wiedenmann J, 2009, BIOL CONSERV, V142, P2990, DOI 10.1016/j.biocon.2009.07.031; Williams EH, 2003, CAN J FISH AQUAT SCI, V60, P1037, DOI 10.1139/F03-099; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; WINEMILLER KO, 1993, AM NAT, V142, P585, DOI 10.1086/285559; Worden L, 2010, THEOR POPUL BIOL, V78, P239, DOI 10.1016/j.tpb.2010.07.004	38	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34556	10.1371/journal.pone.0034556	http://dx.doi.org/10.1371/journal.pone.0034556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563455	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700004
J	Fukui, T; Gomi, H				Fukui, Takao; Gomi, Hiroaki			Action Evaluation Is Modulated Dominantly by Internal Sensorimotor Information and Partly by Noncausal External Cue	PLOS ONE			English	Article							MOTOR CONTROL; VISUAL MASKING; MASKED STIMULI; AWARENESS; MOVEMENTS; TARGET; PREDICTION; RESPONSES; HAND; PERCEPTION	Previous studies demonstrated that human motor actions are not always monitored by perceptual awareness and that implicit motor control plays a key role in performing actions. In addition, appropriate evaluation of our own motor behavior is vital for human life. Here we combined a reaching task with a visual backward masking paradigm to induce an implicit motor response that is congruent or incongruent with the visual perception. We used this to investigate (i) how we evaluate such implicit motor response that could be inconsistent with perceptual awareness and (ii) the possible contributions of reaching error, external visual cues, and internal sensorimotor information to this evaluation. Participants were instructed, after each trial, to rate their own reaching performance on a 5-point scale (i. e., smooth - clumsy). They also needed to identify a color presented at a fixation point that could be changed just after the reaching start. The color was linked to the prime-mask congruency (i. e., congruent-green, incongruent-blue) in the practice phase, and then inconsistent pairs (congruent-blue or incongruent-green) were introduced in the test phase. We found early trajectory deviations induced by the invisible prime stimulus, and such implicit motor responses are significantly correlated with the action evaluation score. The results suggest the "conscious'' action evaluation is properly monitoring online sensory outcomes derived by implicit motor control. Furthermore, statistical path analyses showed that internal sensorimotor information from the motor behavior modulated by the invisible prime was the predominant cue for the action evaluation, while the color-cue association learned in the practice phase in some cases biases the action evaluation in the test phase.	[Fukui, Takao; Gomi, Hiroaki] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Fukui, Takao; Gomi, Hiroaki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Fukui, T (corresponding author), Univ Lyon 1, CNRS, UMR5292, INSERM,U1028,CNRL,Equipe ImpAct, Bron, France.	gomi.hiroaki@lab.ntt.co.jp	Gomi, Hiroaki/AEL-2645-2022; Gomi, Hiroaki/C-5269-2013	Gomi, Hiroaki/0000-0003-3541-2251	Nippon Telegraph and Telephone; CREST of Japan Science and Technology Agency; Nippon Telegraph and Telephone Co	Nippon Telegraph and Telephone; CREST of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Nippon Telegraph and Telephone Co	The authors received annual research funding from Nippon Telegraph and Telephone, who, through the employment of Takao Fukui and Hiroaki Gomi, were involved in conceiving, designing and performing the experiments, and analyzing the data. This study was also supported by the CREST of Japan Science and Technology Agency (http://www.jst.go.jp). CREST had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Takao Fukui and Hiroaki Gomi are employed by Nippon Telegraph and Telephone Co who were one of the funders of this study. There are no patents, products in development or marketed products related to this research/study to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Berti A, 2005, SCIENCE, V309, P488, DOI 10.1126/science.1110625; Berti A, 2006, CURR DIR PSYCHOL SCI, V15, P245, DOI 10.1111/j.1467-8721.2006.00445.x; Blakemore SJ, 2003, CURR OPIN NEUROBIOL, V13, P219, DOI 10.1016/S0959-4388(03)00043-6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B., 2006, VISUAL MASKING; Brenner E, 1997, J MOTOR BEHAV, V29, P297, DOI 10.1080/00222899709600017; Carey DP, 2001, NEUROPSYCHOLOGIA, V39, P885, DOI 10.1016/S0028-3932(01)00036-7; Christoff K, 2011, TRENDS COGN SCI, V15, P104, DOI 10.1016/j.tics.2011.01.001; Cressman EK, 2007, CONSCIOUS COGN, V16, P265, DOI 10.1016/j.concog.2006.06.003; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Desmurget M, 2009, TRENDS COGN SCI, V13, P411, DOI 10.1016/j.tics.2009.08.001; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Farell B, 1999, VISION RES PRACTICAL, P129; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Fourneret Pierre, 2002, Cogn Neuropsychiatry, V7, P139, DOI 10.1080/13546800143000212; Fukui T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005782; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gomi H, 2006, J NEUROSCI, V26, P5301, DOI 10.1523/JNEUROSCI.0340-06.2006; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 1999, EXP BRAIN RES, V127, P102, DOI 10.1007/s002210050778; Haggard P, 2009, SCIENCE, V324, P731, DOI 10.1126/science.1173827; Jeannerod M., 2006, DOES CONSCIOUSNESS C; Jeannerod M, 2006, MOTOR COGNITION WHAT, DOI 10.1093/acprof:oso/9780198569657.001.0001/acprof-9780198569657; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; Johnson H, 2005, NEUROPSYCHOLOGIA, V43, P227, DOI 10.1016/j.neuropsychologia.2004.11.009; Kadota K, 2010, J NEUROSCI, V30, P205, DOI 10.1523/JNEUROSCI.2599-09.2010; KAHNEMAN D, 1968, PSYCHOL BULL, V70, P404, DOI 10.1037/h0026731; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Myers R., 1990, CLASSICAL MODERN REG; NEUMANN O, 1994, ATTENTION PERFORM, V15, P123; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; PRABLANC C, 1992, J NEUROPHYSIOL, V67, P455, DOI 10.1152/jn.1992.67.2.455; Sato A, 2009, COGNITION, V110, P74, DOI 10.1016/j.cognition.2008.10.011; Schmidt F, 2010, ATTEN PERCEPT PSYCHO, V72, P1480, DOI 10.3758/APP.72.6.1480; Schmidt T, 2002, PSYCHOL SCI, V13, P112, DOI 10.1111/1467-9280.00421; Schmidt T, 2008, PERCEPT PSYCHOPHYS, V70, P443, DOI 10.3758/PP.70.3.443; Schmidt T, 2006, BEHAV NEUROSCI, V120, P1005, DOI 10.1037/0735-7044.120.5.1005; Schmidt T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00169; Schmidt T, 2009, ATTEN PERCEPT PSYCHO, V71, P594, DOI 10.3758/APP.71.3.594; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Slachevsky A, 2001, J COGNITIVE NEUROSCI, V13, P332, DOI 10.1162/08989290151137386; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Synofzik M, 2006, J NEUROPHYSIOL, V96, P1592, DOI 10.1152/jn.00104.2006; Taylor JL, 1996, EXP BRAIN RES, V110, P62; TAYLOR JL, 1990, J NEUROPHYSIOL, V63, P439, DOI 10.1152/jn.1990.63.3.439; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Veerman MM, 2008, EXP BRAIN RES, V187, P219, DOI 10.1007/s00221-008-1296-x; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0	58	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e34985	10.1371/journal.pone.0034985	http://dx.doi.org/10.1371/journal.pone.0034985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UN	22563459	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700008
J	Raza, H; John, A				Raza, Haider; John, Annie			Implications of Altered Glutathione Metabolism in Aspirin-Induced Oxidative Stress and Mitochondrial Dysfunction in HepG2 Cells	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYTOCHROME-C; REACTIVE OXYGEN; NITRIC-OXIDE; ELECTRON-TRANSPORT; INDUCED APOPTOSIS; N-ACETYLCYSTEINE; REDOX METABOLISM; PROTEIN-KINASE; CANCER	We have previously reported that acetylsalicylic acid (aspirin, ASA) induces cell cycle arrest, oxidative stress and mitochondrial dysfunction in HepG2 cells. In the present study, we have further elucidated that altered glutathione (GSH)-redox metabolism in HepG2 cells play a critical role in ASA-induced cytotoxicity. Using selected doses and time point for ASA toxicity, we have demonstrated that when GSH synthesis is inhibited in HepG2 cells by buthionine sulfoximine (BSO), prior to ASA treatment, cytotoxicity of the drug is augmented. On the other hand, when GSH-depleted cells were treated with N-acetyl cysteine (NAC), cytotoxicity/apoptosis caused by ASA was attenuated with a significant recovery in oxidative stress, GSH homeostasis, DNA fragmentation and some of the mitochondrial functions. NAC treatment, however, had no significant effects on the drug-induced inhibition of mitochondrial aconitase activity and ATP synthesis in GSH-depleted cells. Our results have confirmed that aspirin increases apoptosis by increased reactive oxygen species production, loss of mitochondrial membrane potential and inhibition of mitochondrial respiratory functions. These effects were further amplified when GSH-depleted cells were treated with ASA. We have also shown that some of the effects of aspirin might be associated with reduced GSH homeostasis, as treatment of cells with NAC attenuated the effects of BSO and aspirin. Our results strongly suggest that GSH dependent redox homeostasis in HepG2 cells is critical in preserving mitochondrial functions and preventing oxidative stress associated complications caused by aspirin treatment.	[Raza, Haider; John, Annie] United Arab Emirates UAE Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), United Arab Emirates UAE Univ, Fac Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Terry Fox Cancer Research Funds; Faculty of Medicine and Health Sciences Research Committee fund from UAE University	Terry Fox Cancer Research Funds; Faculty of Medicine and Health Sciences Research Committee fund from UAE University	The work was supported by Terry Fox Cancer Research Funds and Faculty of Medicine and Health Sciences Research Committee fund from UAE University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Baron JA, 2003, PROG EXP TUMOR RES, V37, P1; Bellosillo B, 1998, BLOOD, V92, P1406, DOI 10.1182/blood.V92.4.1406.416k17_1406_1414; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; Chen G, 2011, ANTIOXID REDOX SIGN, V15, P2911, DOI 10.1089/ars.2011.4170; Dikshit P, 2006, J BIOL CHEM, V281, P29228, DOI 10.1074/jbc.M602629200; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; Franco R, 2008, J BIOL CHEM, V283, P36071, DOI 10.1074/jbc.M807061200; Fulda S, 2011, ANTIOXID REDOX SIGN, V15, P2937, DOI 10.1089/ars.2011.4078; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goel A, 2003, CLIN CANCER RES, V9, P383; Grosser N, 2003, ARTERIOSCL THROM VAS, V23, P1345, DOI 10.1161/01.ATV.0000083296.57581.AE; Hammond CL, 2004, TOXICOL APPL PHARM, V195, P12, DOI 10.1016/j.taap.2003.10.008; Husain SS, 2002, AM J GASTROENTEROL, V97, P542; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Kim KM, 2005, J BIOL CHEM, V280, P41047, DOI 10.1074/jbc.M503713200; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Lesnefsky EJ, 2004, J BIOL CHEM, V279, P47961, DOI 10.1074/jbc.M409720200; Low ICC, 2011, ANTIOXID REDOX SIGN, V15, P2975, DOI 10.1089/ars.2010.3851; Lu Y, 2007, FREE RADICAL BIO MED, V43, P1061, DOI 10.1016/j.freeradbiomed.2007.06.021; Luyendyk JP, 2010, COMPREHENSIVE TOXICOLOGY, VOL 9: HEPATIC TOXICOLOGY, 2ND EDITION, P295; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Manov I, 2004, BASIC CLIN PHARMACOL, V94, P213, DOI 10.1111/j.1742-7843.2004.pto940504.x; Meyer LE, 2006, J BIOL CHEM, V281, P37361, DOI 10.1074/jbc.M604123200; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Pique M, 2000, FEBS LETT, V480, P193, DOI 10.1016/S0014-5793(00)01922-0; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Raza H, 2005, TOXICOL APPL PHARM, V207, P212, DOI 10.1016/j.taap.2005.01.004; Raza H, 2002, BIOCHEM J, V366, P45, DOI 10.1042/BJ20020533; Raza H, 2008, TOXICOL APPL PHARM, V226, P161, DOI 10.1016/j.taap.2007.09.002; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Schwenger P, 1997, P NATL ACAD SCI USA, V94, P2869, DOI 10.1073/pnas.94.7.2869; Spear JF, 2007, AM J PHYSIOL-HEART C, V292, pH2459, DOI 10.1152/ajpheart.00459.2006; Sun J, 2010, ARCH BIOCHEM BIOPHYS, V494, P130, DOI 10.1016/j.abb.2009.11.019; Sun Y, 2011, J PHARMACOL EXP THER, V338, P775, DOI 10.1124/jpet.111.183533; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Voehringer DW, 1998, P NATL ACAD SCI USA, V95, P2956, DOI 10.1073/pnas.95.6.2956; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wu YJ, 2005, J PHARMACOL EXP THER, V312, P424, DOI 10.1124/jpet.104.075119; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200; Zimmermann KC, 2000, NEOPLASIA, V2, P505, DOI 10.1038/sj.neo.7900120; Zweier JL, 2011, ANTIOXID REDOX SIGN, V14, P1769, DOI 10.1089/ars.2011.3904	54	45	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36325	10.1371/journal.pone.0036325	http://dx.doi.org/10.1371/journal.pone.0036325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558435	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200065
J	Sandau, US; Alderman, Z; Corfas, G; Ojeda, SR; Raber, J				Sandau, Ursula S.; Alderman, Zefora; Corfas, Gabriel; Ojeda, Sergio R.; Raber, Jacob			Astrocyte-Specific Disruption of SynCAM1 Signaling Results in ADHD-Like Behavioral Manifestations	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CELL-ADHESION MOLECULE; FEMALE SEXUAL DEVELOPMENT; IMMUNOGLOBULIN SUPERFAMILY; 3'-UNTRANSLATED REGION; NEUROENDOCRINE BRAIN; PREPULSE INHIBITION; CALCIUM-CHANNELS; CLOCK GENE	SynCAM1 is an adhesion molecule involved in synaptic differentiation and organization. SynCAM1 is also expressed in astroglial cells where it mediates astrocyte-to astrocyte and glial-neuronal adhesive communication. In astrocytes, SynCAM1 is functionally linked to erbB4 receptors, which are involved in the control of both neuronal/glial development and mature neuronal and glial function. Here we report that mice carrying a dominant-negative form of SynCAM1 specifically targeted to astrocytes (termed GFAP-DNSynCAM1 mice) exhibit disrupted diurnal locomotor activity with enhanced and more frequent episodes of activity than control littermates during the day (when the animals are normally sleeping) accompanied by shorter periods of rest. GFAP-DNSynCAM1 mice also display high levels of basal activity in the dark period (the rodent's awake/active time) that are attenuated by the psychostimulant D, L-amphetamine, and reduced anxiety levels in response to both avoidable and unavoidable provoking stimuli. These results indicate that disruption of SynCAM1-dependent astroglial function results in behavioral abnormalities similar to those described in animals model of attention-deficit hyperactive disorder (ADHD), and suggest a hitherto unappreciated contribution of glial cells to the pathophysiology of this disorder.	[Sandau, Ursula S.; Alderman, Zefora; Ojeda, Sergio R.; Raber, Jacob] Oregon Hlth & Sci Univ, Div Neurosci, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Beaverton, OR USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Dept Neurol, Beaverton, OR USA; [Corfas, Gabriel] Harvard Univ, Childrens Hosp, Sch Med, FM Kirby Neurobiol Program, Boston, MA 02115 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Harvard University; Boston Children's Hospital; Harvard Medical School	Sandau, US (corresponding author), Legacy Emanuel Hosp, Ctr Hlth, Portland, OR 97227 USA.	ojedas@ohsu.edu; raberj@ohsu.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473	National Institutes of Health [MH-77647, MH-65438, HD25123, RR000163]; NINDS [National Institute of Neurological Disorders and Stroke] [R01 NS35884]; NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award; Development Disability Research Center Grant NIH [P30-HD 18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077647, R01MH065438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035884] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS [National Institute of Neurological Disorders and Stroke](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award; Development Disability Research Center Grant NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health MH-77647 (JR), MH-65438, HD25123, and RR000163 for the operation of the Oregon National Primate Research Center (SRO), NINDS [National Institute of Neurological Disorders and Stroke] R01 NS35884, a NARSAD [National Alliance for Research on Schizophrenia and Depression] Independent Investigator Award, and a Development Disability Research Center Grant NIH P30-HD 18655 (Dr. Corfas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arime Y, 2011, BIOL PHARM BULL, V34, P1373, DOI 10.1248/bpb.34.1373; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; Brunner D, 1999, BEHAV NEUROSCI, V113, P587; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Drolet G, 2002, NEUROPSYCHOPHARMACOL, V27, P400, DOI 10.1016/S0893-133X(02)00303-2; Dziedzic B, 2003, J NEUROSCI, V23, P915; Fan Xueliang, 2012, Curr Top Behav Neurosci, V9, P273, DOI 10.1007/7854_2011_121; Fan XL, 2010, NEUROBIOL DIS, V37, P228, DOI 10.1016/j.nbd.2009.10.009; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Fujita E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.23; Fukami T, 2002, GENE, V295, P7, DOI 10.1016/S0378-1119(02)00835-1; Furuse T, 2010, EUR J NEUROSCI, V31, P1281, DOI 10.1111/j.1460-9568.2010.07164.x; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Giaume C, 2009, NEUROSCIENTIST, V15, P351, DOI 10.1177/1073858409336092; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hess EJ, 1996, J NEUROSCI, V16, P3104, DOI 10.1523/jneurosci.16-09-03104.1996; Hoover KB, 2000, CURR OPIN CELL BIOL, V12, P229, DOI 10.1016/S0955-0674(99)00080-0; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kissling C, 2008, AM J MED GENET B, V147B, P333, DOI 10.1002/ajmg.b.30602; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Lomniczi A, 2006, J NEUROSCI, V26, P51, DOI 10.1523/JNEUROSCI.2939-05.2006; Marpegan L, 2011, J NEUROSCI, V31, P8342, DOI 10.1523/JNEUROSCI.6537-10.2011; Maximov A, 2002, J NEUROSCI, V22, P6939; Maximov A, 1999, J BIOL CHEM, V274, P24453, DOI 10.1074/jbc.274.35.24453; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Plappert CF, 2004, BEHAV BRAIN RES, V152, P403, DOI 10.1016/j.bbr.2003.10.025; Prevot V, 2003, J NEUROSCI, V23, P230; Raber J, 1997, J NEUROCHEM, V68, P176; Ralph RJ, 2001, J PHARMACOL EXP THER, V298, P148; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Rougon G, 2003, ANNU REV NEUROSCI, V26, P207, DOI 10.1146/annurev.neuro.26.041002.131014; Sandau US, 2011, ENDOCRINOLOGY, V152, P2364, DOI 10.1210/en.2010-1435; Sandau US, 2011, ENDOCRINOLOGY, V152, P2353, DOI 10.1210/en.2010-1434; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Stagi M, 2010, P NATL ACAD SCI USA, V107, P7568, DOI 10.1073/pnas.0911798107; Studer FE, 2006, NEUROSCIENCE, V142, P125, DOI 10.1016/j.neuroscience.2006.06.016; Thapar A, 2005, HUM MOL GENET, V14, pR275, DOI 10.1093/hmg/ddi263; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Xu XH, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-48; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995	56	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36424	10.1371/journal.pone.0036424	http://dx.doi.org/10.1371/journal.pone.0036424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558465	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340200079
J	Mah, CL; Blake, DB				Mah, Christopher L.; Blake, Daniel B.			Global Diversity and Phylogeny of the Asteroidea (Echinodermata)	PLOS ONE			English	Review							SEA STARS ASTEROIDEA; HIGH-DISPERSAL STARFISH; OF-THORNS STARFISH; PHOTOPERIODIC REGULATION; FEEDING-BEHAVIOR; ASTERIAS-AMURENSIS; LARV-AE; BATHYMETRIC DISTRIBUTION; SEASTARS ECHINODERMATA; MOLECULAR SYSTEMATICS	Members of the Asteroidea (phylum Echinodermata), popularly known as starfish or sea stars, are ecologically important and diverse members of marine ecosystems in all of the world's oceans. We present a comprehensive overview of diversity and phylogeny as they have figured into the evolution of the Asteroidea from Paleozoic to the living fauna. Living post-Paleozoic asteroids, the Neoasteroidea, are morphologically separate from those in the Paleozoic. Early Paleozoic asteroid faunas were diverse and displayed morphology that foreshadowed later living taxa. Preservation presents significant difficulties, but fossil occurrence and current accounts suggests a diverse Paleozoic fauna, which underwent extinction around the Permian-Triassic interval was followed by re-diversification of at least one surviving lineage. Ongoing phylogenetic classification debates include the status of the Paxillosida and the Concentricycloidea. Fossil and molecular evidence has been and continues to be part of the ongoing evolution of asteroid phylogenetic research. The modern lineages of asteroids include the Valvatacea, the Forcipulatacea, the Spinlosida, and the Velatida. We present an overview of diversity in these taxa, as well as brief notes on broader significance, ecology, and functional morphology of each. Although much asteroid taxonomy is stable, many new taxa remain to be discovered with many new species currently awaiting description. The Goniasteridae is currently one of the most diverse families within the Asteroidea. New data from molecular phylogenetics and the advent of global biodiversity databases, such as the World Asteroidea Database (http://www.marinespecies.org/Asteroidea/) present important new springboards for understanding the global biodiversity and evolution of asteroids.	[Mah, Christopher L.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Mah, Christopher L.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Blake, Daniel B.] Univ Illinois, Dept Geol, Urbana, IL USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Louisiana State University System; Louisiana State University; University of Illinois System; University of Illinois Urbana-Champaign	Mah, CL (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	mahch@si.edu		Mah, Christopher/0000-0002-0178-8237	National Science Foundation [1036358]; Division Of Environmental Biology [1036358] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This publication has been supported by National Science Foundation 1036358 Assembling the Echinoderm Tree of Life grant to Louisiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTON MS, 1966, J FISH RES BOARD CAN, V23, P1673, DOI 10.1139/f66-158; ANDERSON JM, 1960, BIOL BULL, V119, P371, DOI 10.2307/1539257; [Anonymous], 2005, J SYST PALAEONTOL, V3, P29; Ayers KL, 2005, MAR BIOL, V147, P1045, DOI 10.1007/s00227-005-1632-7; BAKER AN, 1986, NATURE, V321, P862, DOI 10.1038/321862a0; BARKER MF, 1977, J EXP MAR BIOL ECOL, V30, P95, DOI 10.1016/0022-0981(77)90030-2; BARKER MF, 1979, J EXP MAR BIOL ECOL, V41, P195, DOI 10.1016/0022-0981(79)90133-3; BARTELS C, 1998, CAMB PALEOBIOL SER, V3, pR9; BEDDINGFIELD SD, 1993, MAR BIOL, V115, P669, DOI 10.1007/BF00349375; Benavides-Serrato Milena, 2007, Memoirs of Museum Victoria, V64, P71; BIRKELAND C, 1974, ECOL MONOGR, V44, P211, DOI 10.2307/1942312; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; Blake D.B., 1988, P309; Blake D.B., 1989, Echinoderm Studies, V3, P179; Blake D.B., 1984, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P74; Blake DB, 2008, J PALEONTOL, V82, P645, DOI 10.1666/07-013.1; Blake DB, 2007, ACTA PALAEONTOL POL, V52, P519; Blake DB, 2006, PALAEONTOL Z, V80, P284, DOI 10.1007/BF02988442; Blake Daniel B., 2002, Palaeontologische Zeitschrift, V76, P357; Blake Daniel B., 2003, Palaeontologische Zeitschrift, V77, P23; Blake DB, 2009, PALAEONTOL Z, V83, P293, DOI 10.1007/s12542-009-0020-x; BLAKE DB, 1979, J PALEONTOL, V53, P1145; BLAKE DB, 1983, B MAR SCI, V33, P703; BLAKE DB, 1994, LETHAIA, V27, P235, DOI 10.1111/j.1502-3931.1994.tb01415.x; BLAKE DB, 1984, ECLOGAE GEOL HELV, V77, P631; BLAKE DB, 1987, J NAT HIST, V21, P481, DOI 10.1080/00222938700771141; Blake DB, 2000, RIV ITAL PALEONTOL S, V106, P141, DOI 10.13130/2039-4942/5395; Blake DB, 1996, PALAEONTOLOGY, V39, P179; BLAKE DB, 1972, SCIENCE, V176, P306, DOI 10.1126/science.176.4032.306; BLAKE DB, 1990, B MAR SCI, V46, P701; Boolootian R.A, 1966, PHYSL ECHINODERMATA; Bos AR, 2008, MAR BIOL, V156, P55, DOI 10.1007/s00227-008-1064-2; Bos AR, 2011, MAR BIOL, V158, P639, DOI 10.1007/s00227-010-1588-0; Bowden DA, 2011, DEEP-SEA RES PT II, V58, P119, DOI 10.1016/j.dsr2.2010.09.006; Breton G., 1986, Bulletin Trimestriel de la Societe Geologique de Normandie et des Amis du Museum du Havre, V72, P91; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Byrne M, 2005, DEV GENES EVOL, V215, P608, DOI 10.1007/s00427-005-0018-7; Byrne M, 2003, BIOL BULL-US, V205, P285, DOI 10.2307/1543292; BYRNE M, 1995, BIOL BULL, V188, P293, DOI 10.2307/1542306; Byrne M, 2007, B MAR SCI, V81, P209; Byrne M, 2006, INTEGR COMP BIOL, V46, P243, DOI 10.1093/icb/icj033; Cerra A, 2004, EVOL DEV, V6, P105, DOI 10.1111/j.1525-142X.2004.04015.x; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; CHIA FS, 1994, MICROSCOPIC ANATOMY, V14, P169; Chia Fu Shiang, 1991, P301; Clark A.M., 1984, Bulletin of the British Museum (Natural History) Zoology, V47, P19; Clark A.M., 1989, Echinoderm Studies, V3, P225; Clark A.M., 1992, P1; Clark A.M., 1962, BANZ ANTARCTIC RES B, V9, P68; Clark A. M., 1993, ECHINODERM STUDIES, P187, DOI DOI 10.1201/9781003072553-4; Clark A. M., 1977, STARFISHES RELATED E; Clark Ailsa M., 1996, V5, P183; Clark AM, 2001, ECHINOD ST, V6, P229; Clark AM, 1971, BR MUS NAT HIST PUBL, V690, p[ix, 1]; Clark AM, 1962, ANN MAG NAT HIST, V13, P243; CLARK H E S, 1982, National Museum of New Zealand Records, V2, P35; Clark H. L., 1921, Department of Marine Biology Carnegie Institution Washington, V10, P1; Clark HES, 2001, NIWA BIODIVERSITY ME, V117, P1; Clark HL, 1920, B MUS COMP ZOOL HARV, V51, P25; Coteur G, 2003, ARCH ENVIRON CON TOX, V45, P190, DOI 10.1007/s00244-003-0199-x; Cuenot L, 1966, TRAITE ZOOLOGIE ANAT, P3; Danis B, 2003, MAR ECOL PROG SER, V253, P155, DOI 10.3354/meps253155; DAYTON PK, 1974, ECOL MONOGR, V44, P105, DOI 10.2307/1942321; Dean J, 1999, ZOOL J LINN SOC-LOND, V126, P225, DOI 10.1006/zjls.1998.0159; DEARBORN JH, 1991, MAR ECOL PROG SER, V77, P65, DOI 10.3354/meps077065; Dearborn JH, 1977, ADAPTATIONS ANTARCTI, P293; Djakonov AM, 1968, TABL ANAL FAUNE URSS; Doderlein L., 1936, Siboga Expeditie Leiden, V46c, P295; Doderlein L., 1917, SIBOGA EXPED A, V46, P1, DOI 10.5962/bhl.title.11319; Doderlein L., 1935, SIBOGA EXPED, V46, P71, DOI 10.5962/bhl.title.11319; Doderlein LH, 1920, SIBOGA EXPED, V46b, P193; Doderlein LH, 1924, SIBOGA EXPED, V46, P4969; Downey M. E., 1970, Smithson. Contr. Zool., VNo. 64, P1; Downey ME, 1986, SMITHSON CONTRIB ZOO, V435, P1, DOI [10.5479/si.00810282.435, DOI 10.5479/SI.00810282.435]; Duxbury A. C., 2010, INTRO WORLDS OCEANS, V10th; Eernisse DJ, 2010, ZOOTAXA, P22, DOI 10.11646/zootaxa.2329.1.2; EMSON RH, 1994, MAR BIOL, V118, P433, DOI 10.1007/BF00350300; ERICSSON J, 1973, Ophelia, V12, P53; Fell H. B., 1963, Report of the Smithsonian Institution, V1962, P457; FELL HB, 1962, SCIENCE, V136, P633, DOI 10.1126/science.136.3516.633; FELL HB, 1963, PHILOS T ROY SOC B, V246, P381, DOI 10.1098/rstb.1963.0010; Fell HB, 1962, U KANS PALEONTOL CON, V6, P1; Fisher W. K., 1928, Bulletin United States National Museum, V76, P1; Fisher W. K., 1930, Bulletin United States National Museum, V76, P1; Fisher WK, 1911, B US NAT MUS, V76, pxiii+420; FLAMMANG P, 1995, BELG J ZOOL, V125, P125; Flammang P, 1998, J EXP BIOL, V201, P2383; FLAMMANG P, 1994, BIOL BULL, V187, P35, DOI 10.2307/1542163; Flammang Patrick, 1996, Echinoderm Studies, V5, P1; Flowers JM, 2001, MAR BIOL, V139, P475, DOI 10.1007/s002270100595; Foltz DW, 2008, MAR BIOL, V154, P593, DOI 10.1007/s00227-008-0952-9; Foltz DW, 2007, MOL PHYLOGENET EVOL, V43, P627, DOI 10.1016/j.ympev.2006.10.012; Fontanella FM, 2001, ECHINODERM RES, P91; Fujita Toshihiko, 2002, Species Diversity, V7, P317; Fujita Toshihiko, 1994, Bulletin of the National Science Museum Series A (Zoology), V20, P183; Gale Andrew Scott, 2011, Special Papers in Palaeontology, V85, P1; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Galkin S.V., 1984, Tsitologiya, V119, P164; Gasparini JL, 2005, BIODIVERS CONSERV, V14, P2883, DOI 10.1007/s10531-004-0222-1; Gaymer CF, 2001, J MAR BIOL ASSOC UK, V81, P827, DOI 10.1017/S0025315401004660; Gemmill JF, 1915, P ZOOL SOC LOND, V1915, P1; Georgiades ET, 2006, CHEMOSPHERE, V65, P1869, DOI 10.1016/j.chemosphere.2006.03.071; Gerard K, 2008, CR BIOL, V331, P137, DOI 10.1016/j.crvi.2007.11.005; Gollub M, 2003, COMP BIOCHEM PHYS B, V134, P89, DOI 10.1016/S1096-4959(02)00190-2; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Grace R.V., 1974, Tane, V20, P162; Grainger E. H., 1966, Bulletin Fisheries Research Board of Canada, VNo. 152, P1; Green E, 2003, MARINE ORNAMENTAL SPECIES: COLLECTION, CULTURE & CONSERVATION, P31; Guensburg Thomas, 2003, American Paleontologist, V11, P3; Guensburg TE, 2009, J PALEONTOL, V83, P350, DOI 10.1666/08-090.1; HALPERN JA, 1970, B MAR SCI, V20, P193; HEALY JM, 1988, ZOOL SCR, V17, P297, DOI 10.1111/j.1463-6409.1988.tb00105.x; Herringshaw LG, 2007, ZOOL J LINN SOC-LOND, V150, P743, DOI 10.1111/j.1096-3642.2007.00299.x; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Hotchkiss F.H.C., 1976, Bulletin Br Mus nat Hist (Zool), V30, P263; Howell KL, 2004, MAR BIOL, V144, P977, DOI 10.1007/s00227-003-1248-8; Howell KL, 2002, DEEP-SEA RES PT I, V49, P1901, DOI 10.1016/S0967-0637(02)00090-0; Hrincevich AW, 2000, AM ZOOL, V40, P365, DOI 10.1668/0003-1569(2000)040[0365:PAOMLI]2.0.CO;2; Hyman L. H., 1955, INVERTEBRATES; Jackson AC, 2009, MAR ECOL PROG SER, V376, P153, DOI 10.3354/meps07807; Jagt John W.M., 2000, Scripta Geologica, V121, P377; JANGOUX M, 1984, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V6, P279; Jangoux M., 1982, ECHINODERM NUTR, P117, DOI DOI 10.1201/9781003078920-6; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; JANIES DA, 1994, ECHINODERMS THROUGH TIME, P319; JANIES DA, 1994, REPRODUCTION AND DEVELOPMENT OF MARINE INVERTEBRATES, P246; Janies Daniel, 1999, P311; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; Janosik AM, 2011, POLAR BIOL, V34, P575, DOI 10.1007/s00300-010-0916-7; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; Joly-Turquin G, 2009, ARCH ENVIRON CON TOX, V56, P209, DOI 10.1007/s00244-008-9176-8; JONES DS, 1988, J PALEONTOL, V62, P126; KESLING R V, 1971, Contributions from the Museum of Paleontology University of Michigan, V23, P181; KESLING R V, 1970, Contributions from the Museum of Paleontology University of Michigan, V23, P73; Kesling R. V., 1967, Contributions from the Museum of Paleontology University of Michigan, V21, P73; KESLING R V, 1969, Contributions from the Museum of Paleontology University of Michigan, V22, P249; Kesling R. V., 1964, Contributions from the Museum of Paleontology University of Michigan, V19, P115; KESLING R V, 1969, Contributions from the Museum of Paleontology University of Michigan, V22, P361; KESLING ROBERT V., 1966, J PALEONTOL, V40, P1157; KESLING RV, 1962, J PALEONTOL, V36, P933; Kitajima A, 2005, DEV BIOL, V280, P48, DOI 10.1016/j.ydbio.2004.12.033; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Kochzius M, 2009, MAR ECOL PROG SER, V396, P211, DOI 10.3354/meps08281; Koseoglu M, 2001, CRYOBIOLOGY, V43, P248, DOI 10.1006/cryo.2001.2348; LAFAY B, 1995, SYST BIOL, V44, P190, DOI 10.2307/2413706; Lawrence J. M., 1987, FUNCTIONAL BIOL ECHI, DOI 10.1002/iroh.19890740316; Lawrence JM, 2001, CAN J ZOOL, V79, P1251, DOI 10.1139/cjz-79-7-1251; LECLAIR EE, 1993, PALAIOS, V8, P233, DOI 10.2307/3515146; Lehmann W. M., 1957, Abhandlungen der Hessischen Landesamtes fuer Bodenforschung, V21, P1; Lemaitre R, 2009, ANTIZ V 1 07 DATABAS; MacBride EW, 1923, NATURE, V111, P47, DOI 10.1038/111047a0; MacBride EW, 1921, NATURE, V106, P501; MacBridge EW, 1923, NATURE, V111, P323, DOI 10.1038/111323a0; Madsen F. J., 1961, Galathea Report, V4, P177; MADSEN F J, 1987, Steenstrupia, V13, P201; Madsen F. J., 1961, Galathea Report, V4, P33; MADSEN FJ, 1966, NATURE, V209, P1367, DOI 10.1038/2091367a0; Mah C, 2005, ZOOSYSTEMA, V27, P137; Mah C, 2011, WORLD ASTEROIDEA DAT; Mah C, 2012, WORLD ASTEROIDEA DAT; Mah C, 2010, WORLD ASTEROIDEA DAT; Mah C. L., 1998, P273; Mah C, 2007, INVERTEBR SYST, V21, P311, DOI 10.1071/IS06049; Mah C, 2007, ZOOL J LINN SOC-LOND, V150, P177, DOI 10.1111/j.1096-3642.2007.00291.x; Mah C, 2011, ZOOL J LINN SOC-LOND, V162, P646, DOI 10.1111/j.1096-3642.2010.00688.x; Mah C, 2011, ZOOL J LINN SOC-LOND, V161, P769, DOI 10.1111/j.1096-3642.2010.00659.x; Mah C, 2010, ZOOL J LINN SOC-LOND, V160, P266, DOI 10.1111/j.1096-3642.2010.00638.x; Mah CL, 2006, ZOOSYSTEMA, V28, P917; Mah CL, 2006, INVERTEBR BIOL, V125, P136, DOI 10.1111/j.1744-7410.2006.00048.x; Mah CL, 2011, ZOOTAXA, P1; Mah Christopher L., 1999, Zoosystema, V21, P535; Mah CL, 2003, B MAR SCI, V73, P685; Mah CL, 2000, AM ZOOL, V40, P375, DOI 10.1668/0003-1569(2000)040[0375:PPOTFA]2.0.CO;2; Mah CL, 2009, WORLD ASTEROIDEA DAT; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; Matsubara M, 2004, ZOOL SCI, V21, P785, DOI 10.2108/zsj.21.785; MAUZEY KP, 1968, ECOLOGY, V49, P603, DOI 10.2307/1935526; MCCLARY DJ, 1989, MAR BIOL, V103, P531, DOI 10.1007/BF00399585; MCCLARY DJ, 1990, J EXP MAR BIOL ECOL, V142, P183, DOI 10.1016/0022-0981(90)90090-Y; McClintock JB, 2011, J GEOL, V119, P457, DOI 10.1086/660890; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; MCCLINTOCK JB, 1988, MAR BIOL, V99, P235, DOI 10.1007/BF00391986; MCCLINTOCK JB, 1985, OECOLOGIA, V66, P291, DOI 10.1007/BF00379867; MCEDWARD LR, 1995, BIOL J LINN SOC, V54, P299, DOI 10.1111/j.1095-8312.1995.tb01040.x; McEdward LR, 2001, CAN J ZOOL, V79, P1125, DOI 10.1139/cjz-79-7-1125; MCEDWARD LR, 1992, BIOL BULL, V182, P177, DOI 10.2307/1542111; MCKNIGHT DG, 1975, J ROY SOC NEW ZEAL, V5, P13, DOI 10.1080/03036758.1975.10419376; Melarange R, 2003, J EXP BIOL, V206, P893, DOI 10.1242/jeb.00197; MENGE BA, 1972, ECOLOGY, V53, P635, DOI 10.2307/1934777; MENGE BA, 1974, ECOLOGY, V55, P84, DOI 10.2307/1934620; MENGE BA, 1975, MAR BIOL, V31, P87, DOI 10.1007/BF00390651; Menge BA, 1999, ECOL MONOGR, V69, P297, DOI 10.1890/0012-9615(1999)069[0297:TDABUR]2.0.CO;2; MENGE JL, 1974, ECOL MONOGR, V44, P189, DOI 10.2307/1942311; Micael J, 2009, OCEANOGR MAR BIOL, V47, P191; Mooi R, 2001, CAN J ZOOL, V79, P1209, DOI 10.1139/cjz-79-7-1209; Mortensen T, 1922, NATURE, V110, P806, DOI 10.1038/110806a0; Mortensen TH, 1923, NATURE, V111, P322, DOI 10.1038/111322b0; Muller A.H., 1963, LEHRBUCH PALAOZOOLOG; NANCE JM, 1979, J EXP MAR BIOL ECOL, V40, P259, DOI 10.1016/0022-0981(79)90055-8; Naughton KM, 2009, INVERTEBR SYST, V23, P348, DOI 10.1071/IS08021; NERAUDEAU D, 1993, GEOBIOS-LYON, V26, P105, DOI 10.1016/S0016-6995(93)80011-F; O'Loughlin P. Mark, 2004, Memoirs of Museum Victoria, V61, P1; OCLAIR CE, 1985, MAR BIOL, V84, P331, DOI 10.1007/BF00392503; Ortiz M, 2003, ARCH HYDROBIOL, V157, P213, DOI 10.1127/0003-9136/2003/0157-0213; Otim O, 2005, GENE EXPR PATTERNS, V5, P381, DOI 10.1016/j.modgep.2004.09.009; PAINE RT, 1969, ECOLOGY, V50, P950, DOI 10.2307/1936888; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1974, OECOLOGIA, V15, P93, DOI 10.1007/BF00345739; PAINE RT, 1971, ECOLOGY, V52, P1096, DOI 10.2307/1933819; Pawson D. L., 1976, Thalassia Jugosl, V12, P287; PEARSE JS, 1986, INT J INVER REP DEV, V9, P71, DOI 10.1080/01688170.1986.10510181; PEARSE JS, 1986, INT J INVER REP DEV, V9, P289, DOI 10.1080/01688170.1986.10510205; PEARSE JS, 1986, AM ZOOL, V26, P417; PEARSE JS, 1982, MAR BIOL, V67, P121, DOI 10.1007/BF00401277; Pearse JS, 2002, INVERTEBR REPROD DEV, V41, P73, DOI 10.1080/07924259.2002.9652737; PEARSE VB, 1994, ECHINODERMS THROUGH TIME, P121; Perrier E., 1894, EXPEDITIONS SCI TRAV, V3, P1; Perrier E., 1884, NOUVELLES ARCH MUSEU, V6, P127; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; PHILIP GM, 1965, NATURE, V208, P766, DOI 10.1038/208766a0; Pillay D, 2010, MAR ECOL PROG SER, V398, P173, DOI 10.3354/meps08286; Rodenhouse Inria Zintheo, 1946, UNIV WASHINGTON PUBL BIOL, V12, P21; Ross DJ, 2006, ESTUAR COAST SHELF S, V67, P695, DOI 10.1016/j.ecss.2005.11.038; Ross DJ, 2002, MAR ECOL PROG SER, V241, P99, DOI 10.3354/meps241099; Ross DJ, 2004, MAR BIOL, V144, P747, DOI 10.1007/s00227-003-1223-4; Ross DJ, 2003, J EXP MAR BIOL ECOL, V288, P257, DOI 10.1016/S0022-0981(03)00022-4; Rowe F.W.E., 1994, P149; ROWE F W E, 1989, Proceedings of the Linnean Society of New South Wales, V111, P293; ROWE FWE, 1988, PROC R SOC SER B-BIO, V233, P431, DOI 10.1098/rspb.1988.0032; Rowe FWE, 1982, MICRONESICA, V18, P89; Santos R, 2005, J MORPHOL, V263, P259, DOI 10.1002/jmor.10187; Scheibling RE, 2008, B MAR SCI, V82, P221; SCHMID P H, 1981, Marine Ecology, V2, P207, DOI 10.1111/j.1439-0485.1981.tb00095.x; Schondorf F., 1910, Jahrbuecher des Vereins fuer Naturkunde Wiesbaden, V63; SCHUCHERT C, 1914, FOSSILIUM CATALOGUS, V1; Schuchert C., 1915, B US NAT MUS, V88; SHICK JM, 1981, MAR ECOL PROG SER, V5, P165, DOI 10.3354/meps005165; Sladen WP, 1889, REPORT SCI RESULTS V, V30; Sloan N.A., 1980, Oceanography and Marine Biology an Annual Review, V18, P57; SLOAN NA, 1983, OPHELIA, V22, P125, DOI 10.1080/00785326.1983.10426591; Smith A.B., 1988, P17; SMITH A B, 1990, Memoirs of the Queensland Museum, V28, P715; SMITH AB, 1985, GEOL MAG, V122, P351, DOI 10.1017/S0016756800031794; Spencer W.K., 1966, TREATISE INVERTEBRAT, V3, pU4; SPENCER WK, 1951, PHILOS T ROY SOC B, V235, P87, DOI 10.1098/rstb.1951.0001; Spencer WK, 1914, BRIT PALAEOZOIC AST; Stickle WB, 2001, INVERTEBR BIOL, V120, P88, DOI 10.1111/j.1744-7410.2001.tb00029.x; Stohr S., 2007, WORLD OPHIUROIDEA DA; Szathmary PL, 2009, MAR ECOL PROG SER, V374, P43, DOI 10.3354/meps07682; Twitchett RJ, 2005, CR PALEVOL, V4, P531, DOI 10.1016/j.crpv.2005.02.006; Ubaghs G., 1953, TRAITE PALEONTOLOGIE, V3, P774; Valentincic T., 1983, Echinoderm Studies, V1, P111; VANVELDHUIZEN HD, 1981, OECOLOGIA, V48, P214, DOI 10.1007/BF00347967; VENTURA CRR, 1995, B MAR SCI, V56, P268; Viguier C., 1878, Compte Rendu, Vlxxxvi, P681; Villier L, 1999, CR ACAD SCI II A, V328, P353, DOI 10.1016/S1251-8050(99)80129-3; Villier L, 2004, GEOBIOS-LYON, V37, P807, DOI 10.1016/j.geobios.2003.05.010; Villier L, 2009, J PALEONTOL, V83, P389, DOI 10.1666/08-030.1; Villier Loic, 2004, Palaeontologische Zeitschrift, V78, P281; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; Wabnitz Colette, 2003, P1; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Wares JP, 2001, BIOL BULL-US, V201, P95, DOI 10.2307/1543530; Waters JM, 2004, MOL PHYLOGENET EVOL, V30, P872, DOI 10.1016/j.ympev.2003.08.019; Waters JM, 2003, J BIOGEOGR, V30, P1787, DOI 10.1046/j.0305-0270.2003.00978.x; Waters JM, 2003, MAR BIOL, V142, P185, DOI 10.1007/s00227-002-0915-5; Williams ST, 1997, MOL ECOL, V6, P559, DOI 10.1046/j.1365-294X.1997.00221.x; Williams ST, 2000, MAR BIOL, V136, P137, DOI 10.1007/s002270050016; Williams ST, 1998, EVOLUTION, V52, P87, DOI 10.1111/j.1558-5646.1998.tb05141.x; Wong MC, 2005, J EXP MAR BIOL ECOL, V327, P1, DOI 10.1016/j.jembe.2005.05.018; YAMAGUCHI M, 1975, Biotropica, V7, P12, DOI 10.2307/2989795; Yamaoka M, 1987, KASEKI TOMO PUBLICAT, V31, P5; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x; Zhao YL, 2010, J PALEONTOL, V84, P668, DOI 10.1666/09-159.1; Zulliger Deborah E., 2010, Zootaxa, V2504, P1	275	94	106	9	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e35644	10.1371/journal.pone.0035644	http://dx.doi.org/10.1371/journal.pone.0035644			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22563389	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336000043
J	Brookshire, G; Casasanto, D				Brookshire, Geoffrey; Casasanto, Daniel			Motivation and Motor Control: Hemispheric Specialization for Approach Motivation Reverses with Handedness	PLOS ONE			English	Article							FRONTAL EEG ASYMMETRY; BEHAVIORAL ACTIVATION; INHIBITION SYSTEMS; BRAIN ACTIVITY; ALPHA; STIMULI; VALENCE; FMRI; BAD	Background: According to decades of research on affective motivation in the human brain, approach motivational states are supported primarily by the left hemisphere and avoidance states by the right hemisphere. The underlying cause of this specialization, however, has remained unknown. Here we conducted a first test of the Sword and Shield Hypothesis (SSH), according to which the hemispheric laterality of affective motivation depends on the laterality of motor control for the dominant hand (i.e., the "sword hand,'' used preferentially to perform approach actions) and the nondominant hand (i.e., the "shield hand,'' used preferentially to perform avoidance actions). Methodology/Principal Findings: To determine whether the laterality of approach motivation varies with handedness, we measured alpha-band power (an inverse index of neural activity) in right- and left-handers during resting-state electroencephalography and analyzed hemispheric alpha-power asymmetries as a function of the participants' trait approach motivational tendencies. Stronger approach motivation was associated with more left-hemisphere activity in right-handers, but with more right-hemisphere activity in left-handers. Conclusions: The hemispheric correlates of approach motivation reversed between right- and left-handers, consistent with the way they typically use their dominant and nondominant hands to perform approach and avoidance actions. In both right- and left-handers, approach motivation was lateralized to the same hemisphere that controls the dominant hand. This covariation between neural systems for action and emotion provides initial support for the SSH.	[Brookshire, Geoffrey; Casasanto, Daniel] New Sch Social Res, Dept Psychol, New York, NY 10011 USA; [Brookshire, Geoffrey; Casasanto, Daniel] Max Planck Inst Psycholinguist, Neurobiol Language Dept, Nijmegen, Netherlands; [Casasanto, Daniel] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	The New School; Max Planck Society; Radboud University Nijmegen	Brookshire, G (corresponding author), New Sch Social Res, Dept Psychol, New York, NY 10011 USA.	casasanto@alum.mit.edu		Brookshire, Geoffrey/0000-0002-3830-2587	Max Planck Gesellschaft; University of California at Berkeley; James S. McDonnell Foundation [220020236]	Max Planck Gesellschaft(Max Planck Society); University of California at Berkeley; James S. McDonnell Foundation	Research was supported by the Max Planck Gesellschaft (http://www.mpg.de), a Haas Fellowship from the University of California at Berkeley (http://berkeley.edu) to G.B., and a James S. McDonnell Foundation Scholar Award (#220020236; http://www.jsmf.org) to D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2008, PSYCHOPHYSIOLOGY, V45, P11, DOI 10.1111/j.1469-8986.2007.00609.x; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Berkman ET, 2010, J COGNITIVE NEUROSCI, V22, P1970, DOI 10.1162/jocn.2009.21317; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Casasanto D, 2012, COGNITIVE SCI, V36, P359, DOI 10.1111/j.1551-6709.2011.01199.x; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Coan JA, 2003, PSYCHOPHYSIOLOGY, V40, P106, DOI 10.1111/1469-8986.00011; COREN S, 1992, AM J PUBLIC HEALTH, V82, P1176, DOI 10.2105/AJPH.82.8.1176-b; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P39, DOI 10.1111/j.1467-9280.1992.tb00254.x; Everhart DE, 1996, PERCEPT MOTOR SKILL, V82, P264, DOI 10.2466/pms.1996.82.1.264; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harris LJ, 2010, LATERALITY, V15, P15, DOI 10.1080/13576500701650430; HELLIGE JB, 1994, J EXP PSYCHOL GEN, V123, P235, DOI 10.1037/0096-3445.123.3.235; Janicak PG, 2010, BRAIN STIMUL, V3, P187, DOI 10.1016/j.brs.2010.07.003; Kinsbourne M., 1978, ASYMMETRICAL FUNCTIO, P3; Laufs H, 2003, NEUROIMAGE, V19, P1463, DOI 10.1016/S1053-8119(03)00286-6; Markman AB, 2005, PSYCHOL SCI, V16, P6, DOI 10.1111/j.0956-7976.2005.00772.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Reuter-Lorenz P, 1983, NEUROPSYCHOLOGIA, V22, P687; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Scheeringa R, 2009, NEUROIMAGE, V44, P1224, DOI 10.1016/j.neuroimage.2008.08.041; Shackman AJ, 2009, PSYCHOL SCI, V20, P1500, DOI 10.1111/j.1467-9280.2009.02476.x; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	32	43	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36036	10.1371/journal.pone.0036036	http://dx.doi.org/10.1371/journal.pone.0036036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563436	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100062
J	Caffrey, BE; Williams, TA; Jiang, XW; Toft, C; Hokamp, K; Fares, MA				Caffrey, Brian E.; Williams, Tom A.; Jiang, Xiaowei; Toft, Christina; Hokamp, Karsten; Fares, Mario A.			Proteome-Wide Analysis of Functional Divergence in Bacteria: Exploring a Host of Ecological Adaptations	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; GENOME SEQUENCE; STATISTICAL-METHODS; LIKELIHOOD METHOD; COG DATABASE; EVOLUTION; BUCHNERA; APHIDS; SUBSTITUTION; DIVERSITY	Functional divergence is the process by which new genes and functions originate through the modification of existing ones. Both genetic and environmental factors influence the evolution of new functions, including gene duplication or changes in the ecological requirements of an organism. Novel functions emerge at the expense of ancestral ones and are generally accompanied by changes in the selective forces at constrained protein regions. We present software capable of analyzing whole proteomes, identifying putative amino acid replacements leading to functional change in each protein and performing statistical tests on all tabulated data. We apply this method to 750 complete bacterial proteomes to identify high-level patterns of functional divergence and link these patterns to ecological adaptations. Proteome-wide analyses of functional divergence in bacteria with different ecologies reveal a separation between proteins involved in information processing (Ribosome biogenesis etc.) and those which are dependent on the environment (energy metabolism, defense etc.). We show that the evolution of pathogenic and symbiotic bacteria is constrained by their association with the host, and also identify unusual events of functional divergence even in well-studied bacteria such as Escherichia coli. We present a description of the roles of phylogeny and ecology in functional divergence at the level of entire proteomes in bacteria.	[Caffrey, Brian E.; Williams, Tom A.; Jiang, Xiaowei; Hokamp, Karsten; Fares, Mario A.] Univ Dublin, Dept Genet, Trinity Coll, Dublin, Ireland; [Toft, Christina] Uppsala Univ, Evolutionary Biol Ctr, Dept Mol Evolut, Uppsala, Sweden; [Fares, Mario A.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Integrat Syst Biol Grp, E-46071 Valencia, Spain	Trinity College Dublin; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Caffrey, BE (corresponding author), Univ Dublin, Dept Genet, Trinity Coll, Dublin, Ireland.	faresm@tcd.ie	Toft, Christina/I-1693-2015; Fares, Mario/L-7100-2016; Jiang, Xiaowei/D-1079-2010	Toft, Christina/0000-0003-1714-6703; Fares, Mario/0000-0002-4345-3013; Jiang, Xiaowei/0000-0002-6030-1249; Williams, Tom/0000-0003-1072-0223; Hokamp, Karsten/0000-0001-7464-2370	Spanish Ministerio de Ciencia e Inovacion [BFU2009-12022]; Science Foundation Ireland [10/RFP/GEN2685]	Spanish Ministerio de Ciencia e Inovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was supported by a grant from the Spanish Ministerio de Ciencia e Inovacion (BFU2009-12022) and a grant of the Research Frontiers Program (10/RFP/GEN2685) from Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Anderson BE, 1997, CLIN MICROBIOL REV, V10, P203, DOI 10.1128/CMR.10.2.203; Azuma Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-111; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berglund AC, 2005, J MOL EVOL, V60, P499, DOI 10.1007/s00239-004-0223-4; BRENNER DJ, 1991, J CLIN MICROBIOL, V29, P1299, DOI 10.1128/JCM.29.7.1299-1302.1991; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Degnan PH, 2005, GENOME RES, V15, P1023, DOI 10.1101/gr.3771305; Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fares MA, 2002, J MOL EVOL, V55, P509, DOI 10.1007/s00239-002-2346-9; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Gillespie J. H., 2004, POPULATION GENETICS; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, J COMPUT BIOL, V8, P221, DOI 10.1089/10665270152530827; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kampinga HH, 2004, INT J HYPERTHER, V20, P131, DOI 10.1080/02656730310001627713; Kimura M., 1983, NEUTRAL THEORY MOL E; Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001; Lake JA, 1999, SCIENCE, V283, P2027, DOI 10.1126/science.283.5410.2027; LASZLO A, 1992, CELL PROLIFERAT, V25, P59, DOI 10.1111/j.1365-2184.1992.tb01482.x; Lepock J, 1997, ADV MOL CEL, P223; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Makarova KS, 1999, GENOME RES, V9, P608; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nielsen R, 1998, GENETICS, V148, P929; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ohno S., 1970, P1; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Pikuta EV, 2007, CRIT REV MICROBIOL, V33, P183, DOI 10.1080/10408410701451948; Pinto G, 2008, P ROY SOC B-BIOL SCI, V275, P2749, DOI 10.1098/rspb.2008.0686; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Sandstrom J, 2000, J INSECT PHYSIOL, V46, P33, DOI 10.1016/S0022-1910(99)00098-0; SCHERER DC, 1993, INFECT IMMUN, V61, P4962, DOI 10.1128/IAI.61.12.4962-4971.1993; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Suzuki Y, 2004, J MOL EVOL, V59, P11, DOI 10.1007/s00239-004-2599-6; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Toft C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000344; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Williams TA, 2009, TRENDS GENET; Williams TA, 2010, TRENDS GENET, V26, P47, DOI 10.1016/j.tig.2009.11.009; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2004, MOL BIOL EVOL, V21, P1332, DOI 10.1093/molbev/msh117; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	84	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35659	10.1371/journal.pone.0035659	http://dx.doi.org/10.1371/journal.pone.0035659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563391	Green Published, gold			2022-12-27	WOS:000305349100019
J	Kuhl, HS; N'Guessan, A; Riedel, J; Metzger, S; Deschner, T				Kuehl, Hjalmar S.; N'Guessan, Antoine; Riedel, Julia; Metzger, Sonja; Deschner, Tobias			The Effect of Climate Fluctuation on Chimpanzee Birth Sex Ratio	PLOS ONE			English	Article							TAI-NATIONAL-PARK; EL-NINO; IMPACTS; ECOLOGY; PHENOLOGY; RAINFALL; DENSITY; AFRICA; LINK	Climate and weather conditions, such as the North Atlantic Oscillation, precipitation and temperature influence the birth sex ratio (BSR) of various higher latitude species, including deer, elephant seals or northern human populations. Although, tropical regions show only little variation in temperature, climate and weather conditions can fluctuate with consequences for phenology and food resource availability. Here, we evaluate, whether the BSR of chimpanzees, inhabiting African tropical forests, is affected by climate fluctuations as well. Additionally, we evaluate, if variation in consumption of a key food resource with high nutritional value, Coula edulis nuts, is linked to both climate fluctuations and variation in BSR. We use long-term data from two study groups located in Tai National Park, Cote d'Ivoire to assess the influence of local weather conditions and the global climate driver El Nino Southern Oscillation (ENSO) on offspring sex. Cote d'Ivoire has experienced considerable climate variation over the last decades, with increasing temperature and declining precipitation. For both groups we find very similar time windows around the month of conception, in which offspring sex is well predicted by ENSO, with more males following low ENSO values, corresponding to periods of high rainfall. Furthermore, we find that the time spent cracking and feeding on Coula nuts is strongly influenced by climate conditions. Although, some of our analysis suggest that a higher proportion of males is born after periods with higher nut consumption frequency, we cannot conclude decisively at this point that nut consumption may influence shifts in BSR. All results combined suggest that also chimpanzees may experience climate related shifts in offspring sex ratios as response to climate fluctuation.	[Kuehl, Hjalmar S.; Riedel, Julia; Deschner, Tobias] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [N'Guessan, Antoine] Univ Cocody, Abidjan, Cote Ivoire; [N'Guessan, Antoine] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Metzger, Sonja] Robert Koch Inst, Berlin, Germany	Max Planck Society; Robert Koch Institute	Kuhl, HS (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	kuehl@eva.mpg.de			Max Planck Society; Ivorian authorities; Ministry of the Environment and Forests; Ministry of Research; Tai National Park; Swiss Research Center in Abidjan	Max Planck Society(Max Planck SocietyFoundation CELLEX); Ivorian authorities; Ministry of the Environment and Forests; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Tai National Park; Swiss Research Center in Abidjan	This work was funded by the Max Planck Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ivorian authorities for long-term support, especially the Ministry of the Environment and Forests as well as the Ministry of Research, the directorship of the Tai National Park, and the Swiss Research Center in Abidjan. We thank Christophe Boesch for making all data available for this study and all the numerous field assistants and students who collected the demographic and behavioral data in the Tai Chimpanzee Project over the last three decades. We thank Roger Mundry for statistical advice on data analysis, Fabian Leendertz for very helpful discussions about the manuscript, and Klaus Wolters for providing the MEI dataset.	Anderson DP, 2005, BIOTROPICA, V37, P631, DOI 10.1111/j.1744-7429.2005.00080.x; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Boesch C, 2000, CHIMPANZEES TAI FORE; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Dahlhoff EP, 2007, J BIOSCIENCES, V32, P477, DOI 10.1007/s12038-007-0047-7; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Fisher RA, 1930, GENETICAL THEORY NAT; Goldenberg SB, 1996, J CLIMATE, V9, P1169, DOI 10.1175/1520-0442(1996)009<1169:PMFTAO>2.0.CO;2; Gomendio M, 2006, SCIENCE, V314, P1445, DOI 10.1126/science.1133064; Gone M, 2007, THESIS U COCODY ABID; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Henzi P, 2003, EVOL ANTHROPOL, V12, P217, DOI 10.1002/evan.10121; Herbinger I, 2001, INT J PRIMATOL, V22, P143, DOI 10.1023/A:1005663212997; Kruuk LEB, 1999, NATURE, V399, P459, DOI 10.1038/20917; Lee DE, 2009, J MAMMAL, V90, P1, DOI 10.1644/08-MAMM-A-130.1; Love OP, 2005, AM NAT, V166, P751, DOI 10.1086/497440; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Post E, 1999, P NATL ACAD SCI USA, V96, P4467, DOI 10.1073/pnas.96.8.4467; R Core Team, 2018, R LANG ENV STAT COMP; Reusch TBH, 2007, MOL ECOL, V16, P3973, DOI 10.1111/j.1365-294X.2007.03454.x; Riedel J, 2011, AM J PRIMATOL, V73, P305, DOI 10.1002/ajp.20897; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Rosenfeld CS, 2003, P NATL ACAD SCI USA, V100, P4628, DOI 10.1073/pnas.0330808100; Servat E, 1997, J HYDROL, V191, P1, DOI 10.1016/S0022-1694(96)03068-5; SHINODA M, 1995, INT J CLIMATOL, V15, P639, DOI 10.1002/joc.3370150605; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Silk JB, 2008, P ROY SOC B-BIOL SCI, V275, P1761, DOI 10.1098/rspb.2008.0340; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; [No title captured], DOI 10.1093/ajcn/70.3.504s	37	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35610	10.1371/journal.pone.0035610	http://dx.doi.org/10.1371/journal.pone.0035610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563387	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100016
J	Tezuka, T; Marubashi, W				Tezuka, Takahiro; Marubashi, Wataru			Genes in S and T Subgenomes Are Responsible for Hybrid Lethality in Interspecific Hybrids between Nicotiana tabacum and Nicotiana occidentalis	PLOS ONE			English	Article							Q-CHROMOSOME; SECTION SUAVEOLENTES; DNA MARKERS; CELL-DEATH; TOBACCO; SOLANACEAE; ORIGIN; RESISTANCE; HYBRIDIZATION; CROSSES	Background: Many species of Nicotiana section Suaveolentes produce inviable F-1 hybrids after crossing with Nicotiana tabacum (genome constitution SSTT), a phenomenon that is often called hybrid lethality. Through crosses with monosomic lines of N. tabacum lacking a Q chromosome, we previously determined that hybrid lethality is caused by interaction between gene(s) on the Q chromosome belonging to the S subgenome of N. tabacum and gene(s) in Suaveolentes species. Here, we examined if hybrid seedlings from the cross N. occidentalis (section Suaveolentes) xN. tabacum are inviable despite a lack of the Q chromosome. Methodology/Principal Findings: Hybrid lethality in the cross of N. occidentalis xN. tabacum was characterized by shoots with fading color. This symptom differed from what has been previously observed in lethal crosses between many species in section Suaveolentes and N. tabacum. In crosses of monosomic N. tabacum plants lacking the Q chromosome with N. occidentalis, hybrid lethality was observed in hybrid seedlings either lacking or possessing the Q chromosome. N. occidentalis was then crossed with two progenitors of N. tabacum, N. sylvestris (SS) and N. tomentosiformis (TT), to reveal which subgenome of N. tabacum contains gene(s) responsible for hybrid lethality. Hybrid seedlings from the crosses N. occidentalis xN. tomentosiformis and N. occidentalis xN. sylvestris were inviable. Conclusions/Significance: Although the specific symptoms of hybrid lethality in the cross N. occidentalis xN. tabacum were similar to those appearing in hybrids from the cross N. occidentalis xN. tomentosiformis, genes in both the S and T subgenomes of N. tabacum appear responsible for hybrid lethality in crosses with N. occidentalis.	[Tezuka, Takahiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan; [Marubashi, Wataru] Meiji Univ, Sch Agr, Kawasaki, Kanagawa, Japan	Osaka Metropolitan University; Meiji University	Tezuka, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 591, Japan.	tezuka@plant.osakafu-u.ac.jp	Tezuka, Takahiro/AAH-9589-2021	Tezuka, Takahiro/0000-0002-9203-1140	Japan Society for the Promotion of Science, Japan [20880024]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grant-in-Aid for Young Scientists (Start-up) No. 20880024 from the Japan Society for the Promotion of Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Bai D, 1995, THEOR APPL GENET, V91, P1184, DOI 10.1007/BF00220927; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; BURK LG, 1966, ECON BOT, V20, P76, DOI 10.1007/BF02861929; CAMERON DR, 1959, TOBACCO SCI, V3, P164; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clausen RE, 1944, GENETICS, V29, P447; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; Figueroa-Castro DM, 2009, SEX PLANT REPROD, V22, P187, DOI 10.1007/s00497-009-0103-6; GOODSPEED TH, 1954, GENUS NICOTIANA; GRAY JC, 1974, NATURE, V252, P226, DOI 10.1038/252226a0; Hancock CN, 2003, PHILOS T R SOC B, V358, P1133, DOI 10.1098/rstb.2003.1284; Hannah MA, 2007, NEW PHYTOL, V176, P537, DOI 10.1111/j.1469-8137.2007.02215.x; Ichitani K, 2011, RICE, V4, P29, DOI 10.1007/s12284-011-9062-2; Iizuka T, 2012, EUPHYTICA IN PRESS, DOI [10.1007/s10681-011-0570-3, DOI 10.1007/S10681-011-0570-3]; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; KENTON A, 1993, MOL GEN GENET, V240, P159, DOI 10.1007/BF00277053; Knapp S, 2004, TAXON, V53, P73, DOI 10.2307/4135490; KUBO T, 1982, TOBACCO SCI, V26, P126; Kuboyama T, 2000, SEX PLANT REPROD, V12, P333, DOI 10.1007/s004970000027; KUBOYAMA T, 1994, SEX PLANT REPROD, V7, P250, DOI 10.1007/BF00232744; Kuboyama T, 2009, RICE, V2, P93, DOI 10.1007/s12284-009-9026-y; Ladiges PY, 2011, J BIOGEOGR, V38, P2066, DOI 10.1111/j.1365-2699.2011.02554.x; Lee CB, 2008, SEX PLANT REPROD, V21, P183, DOI 10.1007/s00497-008-0077-9; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Li BC, 2006, CROP SCI, V46, P554, DOI 10.2135/cropsci2005.04-0027; Lim KY, 2000, CHROMOSOMA, V109, P245, DOI 10.1007/s004120000074; Marks CE, 2011, AUST SYST BOT, V24, P61, DOI 10.1071/SB11006; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; MERXMUELLER H, 1975, Mitteilungen der Botanischen Staatssammlung Muenchen, V12, P91; Moyle LC, 2009, TRENDS ECOL EVOL, V24, P591, DOI 10.1016/j.tree.2009.05.010; Murad L, 2004, HEREDITY, V92, P352, DOI 10.1038/sj.hdy.6800431; Murad L, 2002, AM J BOT, V89, P921, DOI 10.3732/ajb.89.6.921; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; NIKOVA VM, 1990, PLANT CELL TISS ORG, V23, P71, DOI 10.1007/BF00116092; NIKOVA VM, 1991, PLANT CELL TISS ORG, V27, P289, DOI 10.1007/BF00157593; Olmo HP, 1935, GENETICS, V20, P0286; Rieseberg LH, 2010, ANN BOT-LONDON, V106, P439, DOI 10.1093/aob/mcq126; SHEEN SJ, 1972, EVOLUTION, V26, P143, DOI 10.1111/j.1558-5646.1972.tb00181.x; Ternovskii MF, 1972, SOV GENET, V8, p[27, 38]; Tezuka T, 2006, THEOR APPL GENET, V112, P1172, DOI 10.1007/s00122-006-0219-0; Tezuka T, 2004, PLANT CELL PHYSIOL, V45, P1863, DOI 10.1093/pcp/pch204; Tezuka T, 2004, BREEDING SCI, V54, P59, DOI 10.1270/jsbbs.54.59; Tezuka T, 2007, PLANTA, V226, P753, DOI 10.1007/s00425-007-0522-2; Tezuka T, 2010, ANN BOT-LONDON, V106, P267, DOI 10.1093/aob/mcq114; Yamada T, 1999, BREEDING SCI, V49, P203, DOI 10.1270/jsbbs.49.203	48	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36204	10.1371/journal.pone.0036204	http://dx.doi.org/10.1371/journal.pone.0036204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563450	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100075
J	Yacoby, I; Tegler, LT; Pochekailov, S; Zhang, SG; King, PW				Yacoby, Iftach; Tegler, Lotta Tollstoy; Pochekailov, Sergii; Zhang, Shuguang; King, Paul W.			Optimized Expression and Purification for High-Activity Preparations of Algal [FeFe]-Hydrogenase	PLOS ONE			English	Article							ESCHERICHIA-COLI; HYDROGENASES; CLASSIFICATION; MATURATION; DIVERSITY; PROTEINS; ENZYMES; SITE	Background: Recombinant expression and purification of metallo-enzymes, including hydrogenases, at high-yields is challenging due to complex, and enzyme specific, post-translational maturation processes. Low fidelities of maturation result in preparations containing a significant fraction of inactive, apo-protein that are not suitable for biophysical or crystallographic studies. Principal Findings: We describe the construction, overexpression and high-yield purification of a fusion protein consisting of the algal [2Fe2S]-ferredoxin PetF (Fd) and [FeFe]-hydrogenase HydA1. The maturation of Fd-HydA1 was optimized through improvements in culture conditions and media components used for expression. We also demonstrated that fusion of Fd to the N-terminus of HydA1, in comparison to the C-terminus, led to increased expression levels that were 4-fold higher. Together, these improvements led to enhanced HydA1 activity and improved yield after purification. The strong binding-affinity of Fd for DEAE allowed for two-step purification by ion exchange and StrepTactin affinity chromatography. In addition, the incorporation of a TEV protease site in the Fd-HydA1 linker allowed for the proteolytic removal of Fd after DEAE step, and purification of HydA1 alone by StrepTactin. In combination, this process resulted in HydA1 purification yields of 5 mg L-1 of culture from E. coli with specific activities of 1000 U (U = 1 mu mol hydrogen evolved mg(-1) min(-1)). Significance: The [FeFe]-hydrogenases are highly efficient enzymes and their catalytic sites provide model structures for synthetic efforts to develop robust hydrogen activation catalysts. In order to characterize their structure-function properties in greater detail, and to use hydrogenases for biotechnological applications, reliable methods for rapid, high-yield expression and purification are required.	[Yacoby, Iftach; Tegler, Lotta Tollstoy; Pochekailov, Sergii; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Yacoby, I (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Tel Aviv, Israel.	iftachy@post.tau.ac.il; shuguang@mit.edu; Paul.King@nrel.gov	Yacoby, Iftach/HDL-7206-2022; King, Paul W./D-9979-2011; Yacoby, Iftach/AAF-4056-2020	King, Paul W./0000-0001-5039-654X; Yacoby, Iftach/0000-0003-0177-0624; Zhang, Shuguang/0000-0002-3856-3752; Tollstoy Tegler, Lotta/0000-0003-0875-9516	MITei; EMBO; Yang Trust Fund; Swedish Chemical Society; Wenner-Gren Foundation; US Department of Energy [DE-AC36-08-GO28308]; National Renewable Energy Laboratory; US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division	MITei; EMBO(European Molecular Biology Organization (EMBO)); Yang Trust Fund; Swedish Chemical Society; Wenner-Gren Foundation; US Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE))	This work was supported by a MITei grant to SZ and IY. IY also gratefully acknowledges support from an EMBO Fellowship and the Yang Trust Fund. LTT gratefully acknowledges fellowship support from the Swedish Chemical Society and the Wenner-Gren Foundation. PWK gratefully acknowledges support from the US Department of Energy under contract DE-AC36-08-GO28308 with the National Renewable Energy Laboratory; and the US Department of Energy Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Brown KA, 2010, J AM CHEM SOC, V132, P9672, DOI 10.1021/ja101031r; Calusinska M, 2010, MICROBIOL-SGM, V156, P1575, DOI 10.1099/mic.0.032771-0; English CM, 2009, DALTON T, P9970, DOI 10.1039/b913426n; Evans DJ, 2003, CHEM SOC REV, V32, P268, DOI 10.1039/b201317g; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ghirardi ML, 2007, ANNU REV PLANT BIOL, V58, P71, DOI 10.1146/annurev.arplant.58.032806.103848; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lambertz C, 2011, J BIOL CHEM, V286, P40614, DOI 10.1074/jbc.M111.283648; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Madden C, 2012, J AM CHEM SOC, V134, P1577, DOI 10.1021/ja207461t; Magnuson A, 2009, ACCOUNTS CHEM RES, V42, P1899, DOI 10.1021/ar900127h; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Melis A, 2007, ADV EXP MED BIOL, V616, P108; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Seibert M, 2008, BIOENERGY, P273; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Yacoby I, 2011, P NATL ACAD SCI USA, V108, P9396, DOI 10.1073/pnas.1103659108; Zhang LP, 2002, PHILOS T R SOC B, V357, P1499, DOI 10.1098/rstb.2002.1152	34	31	32	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35886	10.1371/journal.pone.0035886	http://dx.doi.org/10.1371/journal.pone.0035886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563413	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100039
J	Dudley, DM; Chin, EN; Bimber, BN; Sanabani, SS; Tarosso, LF; Costa, PR; Sauer, MM; Kallas, EG; O'Connor, DH				Dudley, Dawn M.; Chin, Emily N.; Bimber, Benjamin N.; Sanabani, Sabri S.; Tarosso, Leandro F.; Costa, Priscilla R.; Sauer, Mariana M.; Kallas, Esper G.; O'Connor, David H.			Low-Cost Ultra-Wide Genotyping Using Roche/454 Pyrosequencing for Surveillance of HIV Drug Resistance	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE; HIV-1-INFECTED PATIENTS; TREATMENT-NAIVE; SCALING-UP; MUTATIONS; PREVALENCE; VARIANTS; CHILDREN; FAILURE	Background: Great efforts have been made to increase accessibility of HIV antiretroviral therapy (ART) in low and middle-income countries. The threat of wide-scale emergence of drug resistance could severely hamper ART scale-up efforts. Population-based surveillance of transmitted HIV drug resistance ensures the use of appropriate first-line regimens to maximize efficacy of ART programs where drug options are limited. However, traditional HIV genotyping is extremely expensive, providing a cost barrier to wide-scale and frequent HIV drug resistance surveillance. Methods/Results: We have developed a low-cost laboratory-scale next-generation sequencing-based genotyping method to monitor drug resistance. We designed primers specifically to amplify protease and reverse transcriptase from Brazilian HIV subtypes and developed a multiplexing scheme using multiplex identifier tags to minimize cost while providing more robust data than traditional genotyping techniques. Using this approach, we characterized drug resistance from plasma in 81 HIV infected individuals collected in Sao Paulo, Brazil. We describe the complexities of analyzing next-generation sequencing data and present a simplified open-source workflow to analyze drug resistance data. From this data, we identified drug resistance mutations in 20% of treatment naive individuals in our cohort, which is similar to frequencies identified using traditional genotyping in Brazilian patient samples. Conclusion: The developed ultra-wide sequencing approach described here allows multiplexing of at least 48 patient samples per sequencing run, 4 times more than the current genotyping method. This method is also 4-fold more sensitive (5% minimal detection frequency vs. 20%) at a cost 3-5 x less than the traditional Sanger-based genotyping method. Lastly, by using a benchtop next-generation sequencer (Roche/454 GS Junior), this approach can be more easily implemented in low-resource settings. This data provides proof-of-concept that next-generation HIV drug resistance genotyping is a feasible and low-cost alternative to current genotyping methods and may be particularly beneficial for in-country surveillance of transmitted drug resistance.	[Dudley, Dawn M.; Bimber, Benjamin N.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA; [Chin, Emily N.] Univ Wisconsin Madison, Dept Cellular & Mol Biol, Madison, WI USA; [O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Sanabani, Sabri S.] Univ Sao Paulo, Sao Paulo Inst Trop Med, Sao Paulo, Brazil; [Tarosso, Leandro F.; Costa, Priscilla R.; Sauer, Mariana M.; Kallas, Esper G.] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; Universidade de Sao Paulo	Dudley, DM (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.	doconnor@primate.wisc.edu	Tarosso, Leandro F./H-6267-2012; Sanabani, Sabri Saeed/F-5600-2012	Sanabani, Sabri Saeed/0000-0002-8876-8262; Bimber, Benjamin/0000-0001-8092-3080; o'connor, david/0000-0003-2139-470X; Kallas, Esper/0000-0003-2026-6925	National Institutes of Health R01 grant [Al077376]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/15856-9, 2006/50096-0]; CAPES scholarships; FAPESP scholarships	National Institutes of Health R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES scholarships(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP scholarships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Work at UW-Madison was supported by a National Institutes of Health R01 grant Al077376. The study was also supported by grants 2004/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). SS and MMS have been supported by CAPES scholarships; LFT and PRC have been supported by FAPESP scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBENEK K, 1989, J BIOL CHEM, V264, P16948; Bennett DE, 2008, ANTIVIR THER, V13, P25; De Wolf H, 2011, J VIROL METHODS, V175, P129, DOI 10.1016/j.jviromet.2011.04.023; Delobel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021655; Eshleman SH, 2004, J CLIN MICROBIOL, V42, P2711, DOI 10.1128/JCM.42.6.2711-2717.2004; Ferreira FGF, 2010, AIDS RES HUM RETROV, V26, P229, DOI 10.1089/aid.2009.0146; Gonsalez CR, 2007, VIRUS RES, V129, P87, DOI 10.1016/j.virusres.2007.06.021; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Ji HZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009263; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Pedroso C, 2007, JAIDS-J ACQ IMM DEF, V45, P251, DOI 10.1097/QAI.0b013e318050d8b0; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Sungkanuparph S, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-12; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Wainberg MA, 2011, NEW ENGL J MED, V365, P637, DOI 10.1056/NEJMra1004180; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS UNICEF, 2009, UN ACC SCAL HIV INT; World Health Organization, 2010, WHO HIVRESNET HIV DR; World Health Organization, 2010, UN ACC SCAL PRIOR HI	31	69	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36494	10.1371/journal.pone.0036494	http://dx.doi.org/10.1371/journal.pone.0036494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574170	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800066
J	Zheng, WW; Peng, T; He, W; Zhang, HY				Zheng, Weiwei; Peng, Tao; He, Wei; Zhang, Hongyu			High-Throughput Sequencing to Reveal Genes Involved in Reproduction and Development in Bactrocera dorsalis (Diptera: Tephritidae)	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; PROGRAMMED CELL-DEATH; ORIENTAL FRUIT-FLY; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; PHOSPHOINOSITIDE 3-KINASE; SEXUAL ORIENTATION; SIGNALING PATHWAY; BTB DOMAIN; BEHAVIOR	Background: Tephritid fruit flies in the genus Bactrocera are of major economic significance in agriculture causing considerable loss to the fruit and vegetable industry. Currently, there is no ideal control program. Molecular means is an effective method for pest control at present, but genomic or transcriptomic data for members of this genus remains limited. To facilitate molecular research into reproduction and development mechanisms, and finally effective control on these pests, an extensive transcriptome for the oriental fruit fly Bactrocera dorsalis was produced using the Roche 454-FLX platform. Results: We obtained over 350 million bases of cDNA derived from the whole body of B. dorsalis at different developmental stages. In a single run, 747,206 sequencing reads with a mean read length of 382 bp were obtained. These reads were assembled into 28,782 contigs and 169,966 singletons. The mean contig size was 750 bp and many nearly full-length transcripts were assembled. Additionally, we identified a great number of genes that are involved in reproduction and development as well as genes that represent nearly all major conserved metazoan signal transduction pathways, such as insulin signal transduction. Furthermore, transcriptome changes during development were analyzed. A total of 2,977 differentially expressed genes (DEGs) were detected between larvae and pupae libraries, while there were 1,621 DEGs between adults and larvae, and 2,002 between adults and pupae. These DEGs were functionally annotated with KEGG pathway annotation and 9 genes were validated by qRT-PCR. Conclusion: Our data represent the extensive sequence resources available for B. dorsalis and provide for the first time access to the genetic architecture of reproduction and development as well as major signal transduction pathways in the Tephritid fruit fly pests, allowing us to elucidate the molecular mechanisms underlying courtship, ovipositing, development and detailed analyses of the signal transduction pathways.	[Zheng, Weiwei; Peng, Tao; Zhang, Hongyu] Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China; [Zheng, Weiwei; Peng, Tao; Zhang, Hongyu] Huazhong Agr Univ, Inst Urban & Hort Pests, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China; [He, Wei] Shanghai Hanyu Biolab, Shanghai, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Zheng, WW (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Hubei Key Lab Insect Resource Applicat & Sustaina, Coll Plant Sci & Technol, Wuhan, Hunan, Peoples R China.	hongyu.zhang@mail.hzau.edu.cn			Special Fund for Agro-Scientific Research in the Public Interest [200903047]; China Postdoctoral Science Foundation [5220112958]; Fundamental Research Funds for the Central Universities [529020900202225]; Ph.D. Programs Foundation of Ministry of Education of China [4010121026]; earmarked fund for Modern Agro-Industry Technology Research System [CARS-27]	Special Fund for Agro-Scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); earmarked fund for Modern Agro-Industry Technology Research System	This research was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 200903047), the China Postdoctoral Science Foundation (No. 5220112958), the Fundamental Research Funds for the Central Universities (No. 529020900202225), the Ph.D. Programs Foundation of Ministry of Education of China (No. 4010121026), and the earmarked fund for Modern Agro-Industry Technology Research System (No. CARS-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beaver LM, 2004, CURR BIOL, V14, P1492, DOI 10.1016/j.cub.2004.08.022; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Carney GE, 2003, GENETICS, V164, P173; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Gaines P, 2000, GENETICS, V154, P1627; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Huang H, 1999, DEVELOPMENT, V126, P5365; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; Jonsson H, 2005, CELL MOL LIFE SCI, V62, P397, DOI 10.1007/s00018-004-4365-8; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Kuniyoshi H, 2002, GENETICS, V162, P1775; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Lukacsovich T, 2003, ARCH INSECT BIOCHEM, V54, P77, DOI 10.1002/arch.10105; Mesce KA, 2002, FRONT NEUROENDOCRIN, V23, P179, DOI 10.1006/frne.2002.0228; Metcalf RL, 1992, PLANT KAIROMONES INS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Ren Q, 2009, FISH SHELLFISH IMMUN, V26, P787, DOI 10.1016/j.fsi.2009.03.004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Suganya R, 2010, ARCH INSECT BIOCHEM, V75, P45, DOI 10.1002/arch.20383; Toivonen JM, 2001, GENETICS, V159, P241; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Villella A, 1997, GENETICS, V147, P1107; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zheng WW, 2010, MOL CELL ENDOCRINOL, V315, P282, DOI 10.1016/j.mce.2009.10.018; Zhou XF, 2002, DEVELOPMENT, V129, P2259	55	52	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36463	10.1371/journal.pone.0036463	http://dx.doi.org/10.1371/journal.pone.0036463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570719	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400035
J	Chen, H; Li, JY; Li, HY; Hu, YH; Tevebaugh, W; Yamamoto, M; Que, JW; Chen, XX				Chen, Hao; Li, Jianying; Li, Haiyan; Hu, Yuhui; Tevebaugh, Whitney; Yamamoto, Masayuki; Que, Jianwen; Chen, Xiaoxin			Transcript Profiling Identifies Dynamic Gene Expression Patterns and an Important Role for Nrf2/Keap1 Pathway in the Developing Mouse Esophagus	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; PPAR-BETA/DELTA; EPITHELIAL-CELLS; FACTOR NRF2; DIFFERENTIATION; ACTIVATION; FOREGUT; LUNG; MORPHOGENESIS; MODULATION	Background and Aims: Morphological changes during human and mouse esophageal development have been well characterized. However, changes at the molecular level in the course of esophageal morphogenesis remain unclear. This study aims to globally profile critical genes and signaling pathways during the development of mouse esophagus. By using microarray analysis this study also aims to determine how the Nrf2/Keap1 pathway regulates the morphogenesis of the esophageal epithelium. Methods: Gene expression microarrays were used to survey gene expression in the esophagus at three critical phases: specification, metaplasia and maturation. The esophagi were isolated from wild-type, Nrf2(-/-), Keap1(-/-), or Nrf2(-/-) Keap1(-/-) embryos or young adult mice. Array data were statistically analyzed for differentially expressed genes and pathways. Histochemical and immunohistochemical staining were used to verify potential involvement of the Wnt pathway, Ppar beta/delta and the PI3K/Akt pathway in the development of esophageal epithelium. Results: Dynamic gene expression patterns accompanied the morphological changes of the developing esophagus at critical phases. Particularly, the Nrf2/Keap1 pathway had a baseline activity in the metaplasia phase and was further activated in the maturation phase. The Wnt pathway was active early and became inactive later in the metaplasia phase. In addition, Keap1(-/-) mice showed increased expression of Nrf2 downstream targets and genes involved in keratinization. Microarray and immunostaining data also suggested that esophageal hyperkeratosis in the Keap1(-/-) mice was due to activation of Ppar beta/delta and the PI3K/Akt pathway. Conclusions: Morphological changes of the esophageal epithelium are associated with dynamic changes in gene expression. Nrf2/Keap1 pathway activity is required for maturation of mouse esophageal epithelium.	[Chen, Hao; Hu, Yuhui; Tevebaugh, Whitney; Chen, Xiaoxin] N Carolina Cent Univ, Canc Res Program, JLC BBRI, Durham, NC USA; [Li, Jianying] Frontier Bioinformat Solut LLC, Cary, NC USA; [Li, Haiyan] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY USA; [Yamamoto, Masayuki] Tohoku Univ, Dept Med Biochem, Grad Sch Med, Sendai, Miyagi 980, Japan; [Que, Jianwen] Univ Rochester, Dept Biomed Genet, Rochester, NY USA; [Chen, Xiaoxin] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC USA	University of North Carolina; North Carolina Central University; University of Rochester; Tohoku University; University of Rochester; University of North Carolina; University of North Carolina Chapel Hill	Chen, H (corresponding author), N Carolina Cent Univ, Canc Res Program, JLC BBRI, Durham, NC USA.	jianwen_que@urmc.rochester.edu; lchen@nccu.edu	Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436	NCI NIH HHS [U54 CA156735] Funding Source: Medline; NIDDK NIH HHS [K99 DK082650, R00 DK082650] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA156735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK082650, R00DK082650] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chou JW, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-427; Clement G, 2007, EXPERT OPIN THER TAR, V11, P375, DOI 10.1517/14728222.11.3.375; Coleman JD, 2007, FREE RADICAL BIO MED, V42, P1155, DOI 10.1016/j.freeradbiomed.2007.01.003; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DUAN HJ, 1993, CELL MOL BIOL, V39, P309; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Goldman A, 2011, AM J PHYSIOL-GASTR L, V300, pG292, DOI 10.1152/ajpgi.00461.2010; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Harris-Johnson KS, 2009, P NATL ACAD SCI USA, V106, P16287, DOI 10.1073/pnas.0902274106; Herring W, 2010, GASTROENTEROLOGY, V139, pE6, DOI 10.1053/j.gastro.2009.09.074; Higashiyama H, 2007, HISTOCHEM CELL BIOL, V127, P485, DOI 10.1007/s00418-007-0279-5; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Jiang YJ, 2010, J INVEST DERMATOL, V130, P511, DOI 10.1038/jid.2009.245; JOHNS BAE, 1952, J ANAT, V86, P431; Jonker L, 2004, MECH DEVELOP, V121, P1313, DOI 10.1016/j.mod.2004.07.002; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerns M, 2010, MOL BIOL CELL, V21, P4068, DOI 10.1091/mbc.E10-02-0153; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; MENARD D, 1995, MICROSC RES TECHNIQ, V31, P215, DOI 10.1002/jemt.1070310305; Milano F, 2007, GASTROENTEROLOGY, V132, P2412, DOI 10.1053/j.gastro.2007.03.026; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Oshima T, 2011, AM J PHYSIOL-CELL PH, V300, pC1422, DOI 10.1152/ajpcell.00376.2010; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; RAYMOND C, 1991, ANAT REC, V230, P225, DOI 10.1002/ar.1092300210; Rodriguez P, 2010, DEVELOPMENT, V137, P4171, DOI 10.1242/dev.056077; Romanowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009701; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; SPEED T, STAT ANAL GENE EXPRE; Suzuki A, 2003, CANCER RES, V63, P674; Suzuki T, 2011, CANCER RES, V71, P1700, DOI 10.1158/0008-5472.CAN-10-2939; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Taccioli C, 2009, GASTROENTEROLOGY, V136, P953, DOI 10.1053/j.gastro.2008.11.039; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Vermeij WP, 2011, J INVEST DERMATOL, V131, P1435, DOI 10.1038/jid.2010.433; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang DH, 2010, GASTROENTEROLOGY, V138, P1810, DOI 10.1053/j.gastro.2010.01.048; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x; Yu WY, 2005, DEV BIOL, V284, P157, DOI 10.1016/j.ydbio.2005.04.042; Zhu F, 2009, HISTOL HISTOPATHOL, V24, P265, DOI 10.14670/HH-24.265	53	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36504	10.1371/journal.pone.0036504	http://dx.doi.org/10.1371/journal.pone.0036504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567161	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500081
J	Kao, FF; Mahmuda, S; Pinto, R; Triccas, JA; West, NP; Britton, WJ				Kao, Fan F.; Mahmuda, Sultana; Pinto, Rachel; Triccas, James A.; West, Nicholas P.; Britton, Warwick J.			The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice	PLOS ONE			English	Article							BACILLE-CALMETTE-GUERIN; DNA VACCINES; ANTIGEN MPB83; BOVINE TUBERCULOSIS; FUSION PROTEIN; PLASMID DNA; SKIN-TEST; T-CELLS; INFECTION; BCG	The long-term control of tuberculosis (TB) will require the development of more effective anti-TB vaccines, as the only licensed vaccine, Mycobacterium bovis bacille Calmette-Guerin (BCG), has limited protective efficacy against infectious pulmonary TB. Subunit vaccines have an improved safety profile over live, attenuated vaccines, such as BCG, and may be used in immuno-compromised individuals. MPT83 (Rv2873) is a secreted mycobacterial lipoprotein expressed on the surface of Mycobacterium tuberculosis. In this study, we examined whether recombinant MPT83 is recognized during human and murine M. tuberculosis infection. We assessed the immunogenicity and protective efficacy of MPT83 as a protein vaccine, with monophosphyl lipid A (MPLA) in dimethyl-dioctadecyl ammonium bromide (DDA) as adjuvant, or as a DNA vaccine in C57BL/6 mice and mapped the T cell epitopes with peptide scanning. We demonstrated that rMPT83 was recognised by strong proliferative and Interferon (IFN)-gamma-secreting T cell responses in peripheral blood mononuclear cells (PBMC) from patients with active TB, but not from healthy, tuberculin skin test-negative control subjects. MPT83 also stimulated strong IFN-gamma T cell responses during experimental murine M. tuberculosis infection. Immunization with either rMPT83 in MPLA/DDA or DNA-MPT83 stimulated antigen-specific T cell responses, and we identified MPT83(127-135) (PTNAAFDKL) as the dominant H-2(b)-restricted CD8(+) T cell epitope within MPT83. Further, immunization of C57BL/6 mice with rMPT83/MPLA/DDA or DNA-MPT83 stimulated significant levels of protection in the lungs and spleens against aerosol challenge with M. tuberculosis. Interestingly, immunization with rMPT83 in MPLA/DDA primed for stronger IFN-gamma T cell responses to the whole protein following challenge, while DNA-MPT83 primed for stronger CD8(+) T cell responses to MPT83(127-135). Therefore MPT83 is a protective T cell antigen commonly recognized during human M. tuberculosis infection and should be considered for inclusion in future TB subunit vaccines.	[Kao, Fan F.; Mahmuda, Sultana; Triccas, James A.; West, Nicholas P.; Britton, Warwick J.] Centenary Inst, Mycobacterial Res Program, Sydney, NSW, Australia; [Pinto, Rachel; Triccas, James A.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Discipline Infect Dis & Immunol, Cent Clin Sch, Sydney, NSW 2006, Australia; [Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Discipline Med, Cent Clin Sch, Sydney, NSW 2006, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney	Kao, FF (corresponding author), Centenary Inst, Mycobacterial Res Program, Sydney, NSW, Australia.	wbritton@med.usyd.edu.au	West, Nicholas P/C-3119-2008; Triccas, Jamie/AAD-7629-2020	West, Nicholas P/0000-0003-0955-9890; Triccas, James/0000-0003-3730-2339; Britton, Warwick/0000-0001-6721-9646	National Health and Medical Research Council of Australia [512269]; New South Wales Department of Health; Australian Postgraduate Award; AusAid Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Department of Health; Australian Postgraduate Award(Australian Government); AusAid Scholarship	This work was supported by Project Grant 512269 from the National Health and Medical Research Council of Australia and the New South Wales Department of Health through its research infrastructure grant to the Centenary Institute. F. Kao and S. Mahmuda were recipients of an Australian Postgraduate Award and an AusAid Scholarship respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005930; Aagaard C, 2009, IMMUNOL CELL BIOL, V87, P279, DOI 10.1038/icb.2009.14; Cai H, 2005, DNA CELL BIOL, V24, P605, DOI 10.1089/dna.2005.24.605; Cai H, 2005, VACCINE, V23, P3887, DOI 10.1016/j.vaccine.2005.03.025; Chambers MA, 2002, INFECT IMMUN, V70, P2159, DOI 10.1128/IAI.70.4.2159-2165.2002; Chambers MA, 2004, FEMS IMMUNOL MED MIC, V41, P93, DOI 10.1016/j.femsim.2004.01.004; Chambers MA, 2000, CLIN INFECT DIS, V30, pS283, DOI 10.1086/313875; Charlet D, 2005, MOL MICROBIOL, V56, P1302, DOI 10.1111/j.1365-2958.2005.04618.x; Derrick SC, 2004, VACCINE, V23, P780, DOI 10.1016/j.vaccine.2004.07.036; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Feng CG, 2001, INFECT IMMUN, V69, P4174, DOI 10.1128/IAI.69.6.4174-4176.2001; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; GOODGER J, 1994, VET REC, V135, P82, DOI 10.1136/vr.135.4.82; Green LR, 2009, CLIN VACCINE IMMUNOL, V16, P1309, DOI 10.1128/CVI.00028-09; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Harboe M, 1998, INFECT IMMUN, V66, P289, DOI 10.1128/IAI.66.1.289-296.1998; Henriksen- Lacey M, 2011, J CONTROL RELEASE; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Hewinson RG, 1996, SCAND J IMMUNOL, V43, P490, DOI 10.1046/j.1365-3083.1996.d01-78.x; Hoft DF, 2008, J INFECT DIS, V198, P1491, DOI 10.1086/592450; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Langermans JAM, 2005, VACCINE, V23, P2740, DOI 10.1016/j.vaccine.2004.11.051; Lesellier S, 2008, VET IMMUNOL IMMUNOP, V122, P35, DOI 10.1016/j.vetimm.2007.11.005; Malen H, 2008, PROTEOMICS, V8, P1859, DOI 10.1002/pmic.200700528; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Morris S, 2000, VACCINE, V18, P2155, DOI 10.1016/S0264-410X(99)00540-X; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Nambiar JK, 2010, EUR J IMMUNOL, V40, P153, DOI 10.1002/eji.200939665; Reed S, 2005, MICROBES INFECT, V7, P922, DOI 10.1016/j.micinf.2005.03.011; Romero CD, 2011, INFECT IMMUN; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Sander CR, 2009, AM J RESP CRIT CARE, V179, P724, DOI 10.1164/rccm.200809-1486OC; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; Shanahan ER, 2010, VACCINE, V28, P1341, DOI 10.1016/j.vaccine.2009.11.010; Skeiky YAW, 2010, VACCINE, V28, P1084, DOI 10.1016/j.vaccine.2009.10.114; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Vordermeier HM, 2000, VACCINE, V19, P1246, DOI 10.1016/S0264-410X(00)00238-3; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001; Werninghaus K, 2009, J EXP MED, V206, P89, DOI 10.1084/jem.20081445; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; Whelan AO, 2010, J CLIN MICROBIOL, V48, P3176, DOI 10.1128/JCM.00420-10; WHO, 2011, WHO GLOBAL TUBERCULO; WIKER HG, 1991, J GEN MICROBIOL, V137, P875, DOI 10.1099/00221287-137-4-875; Wiker HG, 1998, INFECT IMMUN, V66, P1445, DOI 10.1128/IAI.66.4.1445-1452.1998; Xue T, 2004, INFECT IMMUN, V72, P6324, DOI 10.1128/IAI.72.11.6324-6329.2004	49	25	28	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34991	10.1371/journal.pone.0034991	http://dx.doi.org/10.1371/journal.pone.0034991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567094	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500012
J	Martinez-Alborcia, MJ; Valverde, A; Parrilla, I; Vazquez, JM; Martinez, EA; Roca, J				Martinez-Alborcia, Maria J.; Valverde, Anthony; Parrilla, Inmaculada; Vazquez, Juan M.; Martinez, Emilio A.; Roca, Jordi			Detrimental Effects of Non-Functional Spermatozoa on the Freezability of Functional Spermatozoa from Boar Ejaculate	PLOS ONE			English	Article							SPERM CRYOPRESERVATION; ANIMAL VARIABILITY; LIPID-COMPOSITION; COOLING RATES; SEMEN; PLASMA; MALONDIALDEHYDE; INSEMINATION; INCUBATION; INSIGHTS	In the present study, the impact of non-functional spermatozoa on the cryopreservation success of functional boar spermatozoa was evaluated. Fifteen sperm-rich ejaculate fractions collected from five fertile boars were frozen with different proportions of induced non-functional sperm (0 -native semen sample-, 25, 50 and 75% non-functional spermatozoa). After thawing, the recovery of motile and viable spermatozoa was assessed, and the functional of the spermatozoa was evaluated from plasma membrane fluidity and intracellular reactive oxygen species (ROS) generation upon exposure to capacitation conditions. In addition, the lipid peroxidation of the plasma membrane was assessed by the indirect measurement of malondialdehyde (MDA) generation. The normalized (with respect to a native semen sample) sperm motility (assessed by CASA) and viability (cytometrically assessed after staining with Hoechst 33342, propidium iodide and fluorescein-conjugated peanut agglutinin) decreased (p < 0.01) as the proportion of functional spermatozoa in the semen samples before freezing decreased, irrespective of the semen donor. However, the magnitude of the effect differed (p < 0.01) among boars. Moreover, semen samples with the largest non-functional sperm subpopulation before freezing showed the highest (p < 0.01) levels of MDA after thawing. The thawed viable spermatozoa of semen samples with a high proportion of nonfunctional spermatozoa before freezing were also functionally different from those of samples with a low proportion of nonfunctional spermatozoa. These differences consisted of higher (p < 0.01) levels of intracellular ROS generation (assessed with 5-(and-6) chloromethyl-20,70-dichlorodihydrofluorescein diacetate acetyl ester; CM-H(2)DCFDA) and increased (p < 0.01) membrane fluidity (assessed with Merocyanine 540). These findings indicate that non-functional spermatozoa in the semen samples before freezing negatively influence the freezability of functional spermatozoa.	[Martinez-Alborcia, Maria J.; Parrilla, Inmaculada; Vazquez, Juan M.; Martinez, Emilio A.; Roca, Jordi] Univ Murcia, Dept Med & Anim Surg, Fac Vet Sci, Murcia, Spain; [Valverde, Anthony] Costa Rica Inst Technol, Agron Sch, Cartago, Costa Rica	University of Murcia; Instituto Tecnologico de Costa Rica	Martinez-Alborcia, MJ (corresponding author), Univ Murcia, Dept Med & Anim Surg, Fac Vet Sci, Murcia, Spain.	roca@um.es	Parrilla, Inmaculada/I-1045-2015; Martinez, Emilio A/I-1901-2015; Vazquez, Juan M/C-2053-2008; Valverde, Anthony/GQO-7737-2022; Abarca, Anthony Valverde/AAF-6652-2019; Roca, Jordi/H-9365-2015	Martinez, Emilio A/0000-0003-1260-9721; Abarca, Anthony Valverde/0000-0002-3191-6965; Roca, Jordi/0000-0002-4213-3093; Parrilla, Inmaculada/0000-0002-5121-758X; Martinez-Alborcia, Maria Jose/0000-0001-5533-5463; Vazquez, Juan Maria/0000-0002-8674-6350	Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia), Madrid, Spain [AGL2008-04127]; Grupos de Excelencia de la Region de Murcia (GERM), Murcia, Spain [04543/07]; The IAMZ of Zaragoza (Spain)	Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia), Madrid, Spain; Grupos de Excelencia de la Region de Murcia (GERM), Murcia, Spain; The IAMZ of Zaragoza (Spain)	This experimental study was supported by the Comision Interministerial de Ciencia y Tecnologia (CICYT-Ganaderia, AGL2008-04127), Madrid, Spain and Grupos de Excelencia de la Region de Murcia (GERM,04543/07), Murcia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to AIM Iberica for supplying the boar ejaculates used in this study. The IAMZ of Zaragoza (Spain) is acknowledged for funding scholarships for A. Valverde.	Agarwal Ashok, 2005, Indian Journal of Experimental Biology, V43, P963; Aitken R John, 2003, Adv Exp Med Biol, V518, P85; Aitken RJ, 1998, J CELL SCI, V111, P645; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Bailey JL, 2008, THERIOGENOLOGY, V70, P1251, DOI 10.1016/j.theriogenology.2008.06.014; Bansal Amrit Kaur, 2010, Vet Med Int, V2010, DOI 10.4061/2011/686137; Caballero I, 2009, INT J ANDROL, V32, P505, DOI 10.1111/j.1365-2605.2008.00887.x; Cerolini S, 2001, REPRODUCTION, V121, P395, DOI 10.1530/rep.0.1210395; Chiba L., 2009, ANIMAL NUTR HDB, P285; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Cremades T, 2005, J ANDROL, V26, P610, DOI 10.2164/jandrol.05028; Gerard-Monnier D, 1998, CHEM RES TOXICOL, V11, P1176, DOI 10.1021/tx9701790; Grossfeld R, 2008, THERIOGENOLOGY, V70, P1225, DOI 10.1016/j.theriogenology.2008.07.017; Guthrie HD, 2008, THERIOGENOLOGY, V70, P1209, DOI 10.1016/j.theriogenology.2008.06.017; Guthrie HD, 2006, J ANIM SCI, V84, P2089, DOI 10.2527/jas.2005-766; Guthrie HD, 2005, THERIOGENOLOGY, V63, P396, DOI 10.1016/j.theriogenology.2004.09.020; Harrison RAP, 1996, MOL REPROD DEV, V45, P378, DOI 10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V; Hernandez M, 2007, J ANDROL, V28, P689, DOI 10.2164/jandrol.107.002725; Hernandez M, 2007, THERIOGENOLOGY, V67, P1436, DOI 10.1016/j.theriogenology.2007.02.012; Holt WV, 2005, THERIOGENOLOGY, V63, P370, DOI 10.1016/j.theriogenology.2004.09.018; JANERO DR, 1989, LIPIDS, V24, P125, DOI 10.1007/BF02535249; JOHNSON LA, 1988, ZUCHTHYGIENE, V23, P49; Juarez JD, 2011, REPROD FERT DEVELOP, V23, P681, DOI 10.1071/RD10216; Makker K, 2009, INDIAN J MED RES, V129, P357; Maldjian A, 2005, THERIOGENOLOGY, V63, P411, DOI 10.1016/j.theriogenology.2004.09.021; Maxwell WMC, 1997, MOL REPROD DEV, V46, P408, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;408::AID-MRD21&gt;3.0.CO;2-T; Medrano A, 2002, REPRODUCTION, V123, P315, DOI 10.1530/rep.0.1230315; Medrano A, 2009, ANDROLOGIA, V41, P246, DOI 10.1111/j.1439-0272.2009.00927.x; Morrell JM, 2011, REPROD DOMEST ANIM, V46, P18, DOI 10.1111/j.1439-0531.2011.01866.x; Morrell J M, 2010, Vet Med Int, V2011, DOI 10.4061/2011/894767; Rath D., 2009, SOC REPROD FERTIL S, V66, P51, DOI DOI 10.1530/BIOSCIPROCS.18.0004; Roca J, 2006, J ANIM SCI, V84, P2692, DOI 10.2527/jas.2006-094; Roca J, 2011, REPROD DOMEST ANIM, V46, P79, DOI 10.1111/j.1439-0531.2011.01828.x; Saravia F, 2005, THERIOGENOLOGY, V63, P1320, DOI 10.1016/j.theriogenology.2004.06.012; Sikka Suresh C., 1996, Frontiers in Bioscience (online), V1, pE78; TAMULI MK, 1994, VET REC, V135, P160, DOI 10.1136/vr.135.7.160; Thurston LM, 2002, BIOL REPROD, V66, P545, DOI 10.1095/biolreprod66.3.545; Upreti GC, 1998, ANIM REPROD SCI, V51, P275, DOI 10.1016/S0378-4320(98)00082-7	38	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36550	10.1371/journal.pone.0036550	http://dx.doi.org/10.1371/journal.pone.0036550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567165	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500085
J	Broome, HJ; Hebert, MD				Broome, Hanna J.; Hebert, Michael D.			In Vitro RNase and Nucleic Acid Binding Activities Implicate Coilin in U snRNA Processing	PLOS ONE			English	Article							C-TERMINAL DOMAIN; CAJAL BODIES; BODY; SMN; PHOSPHORYLATION; INTERPHASE; PROTEIN; GENES; TRANSCRIPTION; ASSOCIATION	Coilin is known as the marker protein for Cajal bodies (CBs), subnuclear domains important for the biogenesis of small nuclear ribonucleoproteins (snRNPs) which function in pre-mRNA splicing. CBs associate non-randomly with U1 and U2 gene loci, which produce the small nuclear RNA (snRNA) component of the respective snRNP. Despite recognition as the CB marker protein, coilin is primarily nucleoplasmic, and the function of this fraction is not fully characterized. Here we show that coilin binds double stranded DNA and has RNase activity in vitro. U1 and U2 snRNAs undergo a processing event of the primary transcript prior to incorporation in the snRNP. We find that coilin displays RNase activity within the CU region of the U2 snRNA primary transcript in vitro, and that coilin knockdown results in accumulation of the 3' pre-processed U1 and U2 snRNA. These findings present new characteristics of coilin in vitro, and suggest additional functions of the protein in vivo.	[Broome, Hanna J.; Hebert, Michael D.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center	Broome, HJ (corresponding author), Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA.	mhebert@umc.edu			United States National Institutes of Health [R01GM081448]; Mississippi INBRE [P20RR016476]; National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081448] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mississippi INBRE; National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the United States National Institutes of Health (R01GM081448) and supported in part by the Mississippi INBRE (P20RR016476) funded by the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE LEC, 1991, J EXP MED, V173, P1407, DOI 10.1084/jem.173.6.1407; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bellini M, 1998, MOL BIOL CELL, V9, P2987, DOI 10.1091/mbc.9.10.2987; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; CARMOFONSECA M, 1993, J CELL BIOL, V120, P841, DOI 10.1083/jcb.120.4.841; Carrero ZI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025743; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Cuello P, 1999, EMBO J, V18, P2867, DOI 10.1093/emboj/18.10.2867; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Egloff S, 2008, BIOCHEM SOC T, V36, P590, DOI 10.1042/BST0360590; FREY MR, 1995, P NATL ACAD SCI USA, V92, P5915, DOI 10.1073/pnas.92.13.5915; Frey MR, 1999, CURR BIOL, V9, P126, DOI 10.1016/S0960-9822(99)80066-9; Frey MR, 2001, J CELL BIOL, V154, P499, DOI 10.1083/jcb.200105084; Gilder AS, 2011, MOL BIOL CELL, V22, P1070, DOI 10.1091/mbc.E10-08-0731; Hearst SM, 2009, J CELL SCI, V122, P1872, DOI 10.1242/jcs.044040; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hebert MD, 2001, GENE DEV, V15, P2720, DOI 10.1101/gad.908401; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Hebert MD, 2010, ARCH BIOCHEM BIOPHYS, V496, P69, DOI 10.1016/j.abb.2010.02.012; Jacobs EY, 1999, MOL BIOL CELL, V10, P1653, DOI 10.1091/mbc.10.5.1653; Jacobs EY, 2004, MOL CELL BIOL, V24, P846, DOI 10.1128/MCB.24.2.846-855.2004; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; Lemm I, 2006, MOL BIOL CELL, V17, P3221, DOI 10.1091/mbc.E06-03-0247; Li Y, 2010, TOXICOL SCI, V118, P435, DOI 10.1093/toxsci/kfq282; Licciulli S, 2011, AM J PATHOL, V178, P2397, DOI 10.1016/j.ajpath.2011.01.019; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Mahmoudi S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000521; Mao YS, 2011, TRENDS GENET; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Matera AG, 2009, DEV CELL, V17, P639, DOI 10.1016/j.devcel.2009.10.017; Medlin JE, 2003, EMBO J, V22, P925, DOI 10.1093/emboj/cdg077; Morency E, 2007, J CELL BIOL, V177, P757, DOI 10.1083/jcb.200612107; Morris GE, 2008, BBA-MOL CELL RES, V1783, P2108, DOI 10.1016/j.bbamcr.2008.07.016; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Shanbhag R, 2010, FEBS LETT, V584, P4351, DOI 10.1016/j.febslet.2010.09.034; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Smith KP, 2000, MOL BIOL CELL, V11, P2987, DOI 10.1091/mbc.11.9.2987; Strzelecka M, 2010, NUCLEUS IN PRESS; Sun J, 2005, J CELL SCI, V118, P4995, DOI 10.1242/jcs.02613; Takata H, 2012, J CELL SCI, V125, P166, DOI 10.1242/jcs.090837; Toyota CG, 2010, CHROMOSOMA, V119, P205, DOI 10.1007/s00412-009-0249-x; Tucker KE, 2001, J CELL BIOL, V154, P293, DOI 10.1083/jcb.200104083; Uguen P, 2004, NUCLEIC ACIDS RES, V32, P2987, DOI 10.1093/nar/gkh619; Velma V, 2010, FEBS LETT, V584, P4735, DOI 10.1016/j.febslet.2010.11.004; Walker MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006171; White AE, 2011, J CELL BIOL, V193, P677, DOI 10.1083/jcb.201012077; Whittom AA, 2008, CELL MOL LIFE SCI, V65, P1256, DOI 10.1007/s00018-008-7587-3; Xu HZ, 2005, CHROMOSOMA, V114, P155, DOI 10.1007/s00412-005-0003-y; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Young PJ, 2000, EXP CELL RES, V256, P365, DOI 10.1006/excr.2000.4858	55	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36300	10.1371/journal.pone.0036300	http://dx.doi.org/10.1371/journal.pone.0036300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558428	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000183
J	Pacheco-Tucuch, FS; Ramirez-Sierra, MJ; Gourbiere, S; Dumonteil, E				Santiago Pacheco-Tucuch, Freddy; Jesus Ramirez-Sierra, Maria; Gourbiere, Sebastien; Dumonteil, Eric			Public Street Lights Increase House Infestation by the Chagas Disease Vector Triatoma dimidiata	PLOS ONE			English	Article							YUCATAN PENINSULA; HEMIPTERA REDUVIIDAE; TRYPANOSOMA-CRUZI; COLORED LIGHT; DISPERSAL; DYNAMICS; TRANSMISSION; PERSPECTIVES; HETEROPTERA; INSECTICIDE	Triatoma dimidiata is one of the primary vectors of Chagas disease. We previously documented the spatio-temporal infestation of houses by this species in the Yucatan peninsula, Mexico, and found that non-domiciliated triatomines were specifically attracted to houses. However, the factors mediating this attraction remained unclear. Artificial light has been known for a long time to attract many insect species, and therefore may contribute to the spread of different vector-borne diseases. Also, based on the collection of different species of triatomines with light traps, several authors have suggested that light might attract triatomines to houses, but the role of artificial light in house infestation has never been clearly demonstrated and quantified. Here we performed a spatial analysis of house infestation pattern by T. dimidiata in relation to the distribution of artificial light sources in three different villages from the Yucatan peninsula, Mexico. In all three villages, infested houses were significantly closer to public street light sources than non-infested houses (18.0 +/- 0.6 vs 22.6 +/- 0.4 m), and street lights rather than domestic lights were associated with house infestation. Accordingly, houses closer to a public street lights were 1.64 times more likely to be infested than houses further away (OR, CI95% 1.23-2.18). Behavioral experiments using a dual-choice chamber further confirmed that adult male and females were attracted to white light during their nocturnal activity. Attraction was also dependent on light color and decreased with increasing wavelength. While public lighting is usually associated with increased development, these data clearly show that it also directly contributes to house infestation by non-domiciliated T. dimidiata.	[Santiago Pacheco-Tucuch, Freddy; Jesus Ramirez-Sierra, Maria; Dumonteil, Eric] Univ Autonoma Yucatan, Parasitol Lab, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico; [Gourbiere, Sebastien] Univ Perpignan, UMR CNRS UPVD Ecol & Evolut Interact 5244, F-66025 Perpignan, France; [Gourbiere, Sebastien] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton, E Sussex, England; [Dumonteil, Eric] Tulane Univ, Dept Trop Med, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Universidad Autonoma de Yucatan; Centre National de la Recherche Scientifique (CNRS); Universite Perpignan Via Domitia; University of Sussex; Tulane University	Pacheco-Tucuch, FS (corresponding author), Univ Autonoma Yucatan, Parasitol Lab, Ctr Invest Reg Dr Hideyo Noguchi, Merida, Yucatan, Mexico.	oliver@uady.mx	Gourbière, Sébastien/C-4320-2011	Dumonteil, Eric/0000-0001-9376-0209; Gourbiere, Sebastien/0000-0002-6701-4795	UNDP/WorldBank/ WHO International Development Research Center (IDRC) [A90276]; EU [253483]	UNDP/WorldBank/ WHO International Development Research Center (IDRC); EU(European Commission)	This investigation received financial support from the UNDP/WorldBank/ WHO Special Program for Research and Training in Tropical Diseases (TDR)/International Development Research Center (IDRC), Project #A90276, and by EU-FP7-PEOPLE-Intra-European Fellowship for career development (IEF) grant no. 253483. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbu C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001045; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416; Barghini A, 2010, ENVIRON HEALTH PERSP, V118, P1503, DOI 10.1289/ehp.1002115; BARGUES MD, 2002, T R SOC TROP MED S1, V96, P159, DOI DOI 10.1016/S0035-9203(02)90069-6; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Burkett DA, 2005, FLA ENTOMOL, V88, P383, DOI 10.1653/0015-4040(2005)88[383:LEOCLA]2.0.CO;2; Burkett DA, 1998, J AM MOSQUITO CONTR, V14, P186; CAMPOS F, 1931, REV COL NAC VICENTE, V13, P107; de la Fuente ALC, 2007, ACTA TROP, V101, P115, DOI 10.1016/j.actatropica.2006.12.007; Castro MCM, 2010, MEM I OSWALDO CRUZ, V105, P1061, DOI 10.1590/S0074-02762010000800019; Bargues MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000233; Dorn PL, 2007, INFECT GENET EVOL, V7, P343, DOI 10.1016/j.meegid.2006.10.001; Dorn PL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000393; Dumonteil E, 2004, MEM I OSWALDO CRUZ, V99, P253, DOI 10.1590/S0074-02762004000300002; Dumonteil E, 2002, AM J TROP MED HYG, V67, P176, DOI 10.4269/ajtmh.2002.67.176; Dumonteil E, 2009, J PARASITOL, V95, P469, DOI 10.1645/GE-1712.1; Feliciangeli MD, 2002, TROP MED INT HEALTH, V7, P280, DOI 10.1046/j.1365-3156.2002.00853.x; Gamboa-Leon R, 2011, J PARASITOL, V97, P338, DOI 10.1645/GE-2545.1; Gourbiere S, 2012, HEREDITY, V108, P190, DOI 10.1038/hdy.2011.71; Gourbiere S, 2008, AM J TROP MED HYG, V78, P133, DOI 10.4269/ajtmh.2008.78.133; Guerenstein PG, 2009, ACTA TROP, V110, P148, DOI 10.1016/j.actatropica.2008.09.019; Guzman-Tapia Y, 2007, VECTOR-BORNE ZOONOT, V7, P597, DOI 10.1089/vbz.2007.0133; Herrera-Aguilar M, 2009, INFECT GENET EVOL, V9, P1345, DOI 10.1016/j.meegid.2009.09.009; Kelber A, 2002, NATURE, V419, P922, DOI 10.1038/nature01065; Lazzari CR, 2009, MEM I OSWALDO CRUZ, V104, P65, DOI 10.1590/S0074-02762009000900011; Minoli SA, 2006, ACTA TROP, V97, P324, DOI 10.1016/j.actatropica.2005.12.005; Nakagawa J, 2003, ANN TROP MED PARASIT, V97, P289, DOI 10.1179/000349803235001895; Noireau F, 1999, MEM I OSWALDO CRUZ, V94, P451, DOI 10.1590/S0074-02761999000400004; Nouvellet P, 2011, INFECT GENET EVOL, V11, P1243, DOI 10.1016/j.meegid.2011.04.008; Payet V, 2009, VECTOR-BORNE ZOONOT, V9, P243, DOI 10.1089/vbz.2008.0078; Perry GLW, 2006, PLANT ECOL, V187, P59, DOI 10.1007/s11258-006-9133-4; Dias JC, 2008, REV SOC BRAS MED TRO, V41, P193, DOI 10.1590/S0037-86822008000200012; Polonio R, 2009, VECTOR-BORNE ZOONOT, V9, P19, DOI 10.1089/vbz.2008.0002; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Ramirez-Sierra MJ, 2010, TROP MED INT HEALTH, V15, P77, DOI 10.1111/j.1365-3156.2009.02422.x; Rebollar-Tellez EA, 2009, J VECTOR ECOL, V34, P304, DOI [10.1111/j.1948-7134.2009.00038.x, 10.3376/038.034.0216]; Reisenman CE, 2006, J COMP PHYSIOL A, V192, P39, DOI 10.1007/s00359-005-0045-x; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; Tamay-Segovia P, 2008, AM J TROP MED HYG, V78, P472, DOI 10.4269/ajtmh.2008.78.472; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x; Wastavino GR, 2004, MEM I OSWALDO CRUZ, V99, P433, DOI 10.1590/S0074-02762004000400015; WISNIVESKYCOLLI C, 1993, MEM I OSWALDO CRUZ, V88, P27, DOI 10.1590/S0074-02761993000100006; Zeledon R, 2006, MEM I OSWALDO CRUZ, V101, P75, DOI 10.1590/S0074-02762006000100014	46	66	68	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36207	10.1371/journal.pone.0036207	http://dx.doi.org/10.1371/journal.pone.0036207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558384	gold, Green Published			2022-12-27	WOS:000305336000155
J	Ci, XX; Chu, X; Wei, MM; Yang, XF; Cai, QR; Deng, XM				Ci, Xinxin; Chu, Xiao; Wei, Miaomiao; Yang, Xiaofeng; Cai, Qinren; Deng, Xuming			Different Effects of Farrerol on an OVA-Induced Allergic Asthma and LPS-induced Acute Lung Injury	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; MURINE MODEL; INFLAMMATION; MICE; HYPERRESPONSIVENESS; INFILTRATION; INHIBITION; PROTECTS; THERAPY; AIRWAYS	Background: Farrerol, isolated from rhododendron, has been shown to have the anti-bacterial activity, but no details on the anti-inflammatory activity. We further evaluated the effects of this compound in two experimental models of lung diseases. Methodology/Principal Findings: For the asthma model, female BALB/c mice were challenged with ovalbumin (OVA), and then treated daily with farrerol (20 and 40 mg/kg, ip) as a therapeutic treatment from day 22 to day 26 post immunization. To induce acute lung injury, female BALB/c mice were injected intranasally with LPS and treated with farrerol (20 and 40 mg/kg, i.p.) 1 h prior to LPS stimulation. Inflammation in the two different models was determined using ELISA, histology, real-time PCR and western blot. Farrerol significantly regulated the phenotype challenged by OVA, like cell number, Th1 and Th2 cytokines levels in the BALF, the OVA-specific IgE level in the serum, goblet cell hyperplasia in the airway, airway hyperresponsiveness to inhaled methacholine and mRNA expression of chemokines and their receptors. Furthermore, farrerol markedly attenuated the activation of phosphorylation of Akt and nuclear factor-kappa B (NF-kappa B) subunit p65 both in vivo and in vitro. However, farrerol has no effect on the acute lung injury model. Conclusion/Significance: Our finding demonstrates that the distinct anti-inflammatory effect of farrerol in the treatment of asthma acts by inhibiting the PI3K and NF-kappa B pathway.	[Ci, Xinxin; Chu, Xiao; Wei, Miaomiao; Yang, Xiaofeng; Cai, Qinren; Deng, Xuming] Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China	Jilin University	Ci, XX (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Inst Zoonoses, Changchun 130023, Jilin, Peoples R China.	xumingdeng@jluhp.edu.cn			National Science and Technology Supporting Plan of China [2006BAD31B03- 4]	National Science and Technology Supporting Plan of China	This study was financed by the National Science and Technology Supporting Plan of China (No. 2006BAD31B03- 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Bao Z, 2007, AM J RESP CRIT CARE, V176, P431, DOI 10.1164/rccm.200609-1292OC; Barnes PJ, 2006, LAB INVEST, V86, P867, DOI 10.1038/labinvest.3700456; Broide DH, 2011, J ALLERGY CLIN IMMUN, V127, P689, DOI 10.1016/j.jaci.2011.01.027; Cao YH, 2002, J CHROMATOGR A, V943, P153, DOI 10.1016/S0021-9673(01)01434-0; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Choi JR, 2009, INT IMMUNOPHARMACOL, V9, P918, DOI 10.1016/j.intimp.2009.03.018; Choi SE, 2011, PHYTOTHER RES; Duan W, 2006, CURR DRUG TARGETS, V7, P691, DOI 10.2174/138945006777435353; Edwan JH, 2004, J IMMUNOL, V172, P5016, DOI 10.4049/jimmunol.172.8.5016; Greenberger PA, 2008, J ALLERGY CLIN IMMUN, V121, pS393, DOI 10.1016/j.jaci.2007.07.039; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; IWAMOTO I, 1993, J EXP MED, V177, P573, DOI 10.1084/jem.177.2.573; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; KosKudla B, 1997, ULTRASOUND MED BIOL, V23, P1325, DOI 10.1016/S0301-5629(97)00195-6; Li QY, 2011, ACTA PHARMACOL SIN, V32, P433, DOI 10.1038/aps.2011.1; Manson SC, 2009, RESP MED, V103, P975, DOI 10.1016/j.rmed.2009.01.003; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Pantano C, 2008, AM J RESP CRIT CARE, V177, P959, DOI 10.1164/rccm.200707-1096OC; Park SJ, 2008, RESPIROLOGY, V13, P764, DOI 10.1111/j.1440-1843.2008.01369.x; Qiu JZ, 2011, FEMS MICROBIOL LETT, V315, P129, DOI 10.1111/j.1574-6968.2010.02183.x; Rogerio AP, 2008, EUR J PHARMACOL, V580, P262, DOI 10.1016/j.ejphar.2007.10.034; Rogerio AP, 2009, BRIT J PHARMACOL, V158, P1074, DOI 10.1111/j.1476-5381.2009.00177.x; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Roth M, 2006, CURR DRUG TARGETS, V7, P589, DOI 10.2174/138945006776818638; Shields Conor J, 2002, Curr Opin Crit Care, V8, P158, DOI 10.1097/00075198-200204000-00012; Tian JN, 2005, BIOORGAN MED CHEM, V13, P4124, DOI 10.1016/j.bmc.2005.02.065; Tritar-Cherif Fatma, 2002, Tunis Med, V80, P1; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]; Zhang XM, 2009, INT IMMUNOPHARMACOL, V9, P1525, DOI 10.1016/j.intimp.2009.09.007; Zhou HQ, 2011, INFLAMM RES, V60, P981, DOI 10.1007/s00011-011-0359-9; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	35	60	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34634	10.1371/journal.pone.0034634	http://dx.doi.org/10.1371/journal.pone.0034634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563373	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100003
J	Kim, HS; Ernst, JA; Brown, C; Bostrom, J; Fuh, G; Lee, CWV; Huang, A; Vandlen, RL; Yansura, DG				Kim, Hok Seon; Ernst, James A.; Brown, Cecilia; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.; Huang, Arthur; Vandlen, Richard L.; Yansura, Daniel G.			Translation Levels Control Multi-Spanning Membrane Protein Expression	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOTHELIAL GROWTH-FACTOR; ESCHERICHIA-COLI; COUPLED RECEPTOR; NUCLEOTIDE-SEQUENCE; HUMAN HOMOLOG; GENE; OVEREXPRESSION; ANTIBODIES; PROMOTERS	Attempts to express eukaryotic multi-spanning membrane proteins at high-levels have been generally unsuccessful. In order to investigate the cause of this limitation and gain insight into the rate limiting processes involved, we have analyzed the effect of translation levels on the expression of several human membrane proteins in Escherichia coli (E. coli). These results demonstrate that excessive translation initiation rates of membrane proteins cause a block in protein synthesis and ultimately prevent the high-level accumulation of these proteins. Moderate translation rates allow coupling of peptide synthesis and membrane targeting, resulting in a significant increase in protein expression and accumulation over time. The current study evaluates four membrane proteins, CD20 (4-transmembrane (TM) helixes), the G-protein coupled receptors (GPCRs, 7-TMs) RA1c and EG-VEGFR1, and Patched 1 (12-TMs), and demonstrates the critical role of translation initiation rates in the targeting, insertion and folding of integral membrane proteins in the E. coli membrane.	[Kim, Hok Seon; Brown, Cecilia; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.; Huang, Arthur; Yansura, Daniel G.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ernst, James A.; Bostrom, Jenny; Fuh, Germaine; Lee, Chingwei V.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Ernst, James A.; Vandlen, Richard L.; Yansura, Daniel G.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kim, HS (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	ernst.james@gene.com; yansura.dan@gene.com						Battersby S, 2004, J CLIN ENDOCR METAB, V89, P2463, DOI 10.1210/jc.2003-032012; Berinstein NL, 1998, ANN ONCOL, V9, P995, DOI 10.1023/A:1008416911099; Columbus L, 2009, J AM CHEM SOC, V131, P7320, DOI 10.1021/ja808776j; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Eshaghi S, 2005, PROTEIN SCI, V14, P676, DOI 10.1110/ps.041127005; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hayhurst A, 1999, PROTEIN EXPRES PURIF, V15, P336, DOI 10.1006/prep.1999.1035; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; ISHIDATE K, 1986, J BIOL CHEM, V261, P428; JENSEN PR, 1993, EUR J BIOCHEM, V211, P181, DOI 10.1111/j.1432-1033.1993.tb19885.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KIKUCHI Y, 1981, NUCLEIC ACIDS RES, V9, P5671, DOI 10.1093/nar/9.21.5671; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; MAKINO K, 1986, J MOL BIOL, V190, P37, DOI 10.1016/0022-2836(86)90073-2; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; MCCARTHY JEG, 1990, TRENDS GENET, V6, P78, DOI 10.1016/0168-9525(90)90098-Q; MIOZZARI GF, 1978, J BACTERIOL, V133, P1457, DOI 10.1128/JB.133.3.1457-1466.1978; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Parker R, 2000, BBA-GENE STRUCT EXPR, V1491, P369, DOI 10.1016/S0167-4781(00)00023-3; Polyak MJ, 2002, BLOOD, V99, P3256, DOI 10.1182/blood.V99.9.3256; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; SCHOLTISSEK S, 1987, NUCLEIC ACIDS RES, V15, P3185, DOI 10.1093/nar/15.7.3185; SHAND RF, 1991, BIOCHEMISTRY-US, V30, P3082, DOI 10.1021/bi00226a015; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; van Dalen A, 2000, EMBO REP, V1, P340, DOI 10.1093/embo-reports/kvd067; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wagner S, 2007, MOL CELL PROTEOMICS, V6, P1527, DOI 10.1074/mcp.M600431-MCP200; Wagner S, 2006, TRENDS BIOTECHNOL, V24, P364, DOI 10.1016/j.tibtech.2006.06.008; WALTER P, 1983, J CELL BIOL, V97, P1693, DOI 10.1083/jcb.97.6.1693; Weng JS, 2005, J CELL BIOCHEM, V96, P1034, DOI 10.1002/jcb.20600; Xu LL, 2000, CANCER RES, V60, P6568	39	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35844	10.1371/journal.pone.0035844	http://dx.doi.org/10.1371/journal.pone.0035844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563408	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100034
J	Ryan, SJ; Ehrlich, DE; Jasnow, AM; Daftary, S; Madsen, TE; Rainnie, DG				Ryan, Steven J.; Ehrlich, David E.; Jasnow, Aaron M.; Daftary, Shabrine; Madsen, Teresa E.; Rainnie, Donald G.			Spike-Timing Precision and Neuronal Synchrony Are Enhanced by an Interaction between Synaptic Inhibition and Membrane Oscillations in the Amygdala	PLOS ONE			English	Article							RAT BASOLATERAL AMYGDALA; METABOTROPIC GLUTAMATE RECEPTORS; FEAR-POTENTIATED STARTLE; PARVALBUMIN-IMMUNOREACTIVE INTERNEURONS; DEPENDENT PROTEIN-KINASE; CURRENT I-H; T-TYPE; LATERAL AMYGDALA; CALCIUM-CHANNELS; NEOCORTICAL NEURONS	The basolateral complex of the amygdala (BLA) is a critical component of the neural circuit regulating fear learning. During fear learning and recall, the amygdala and other brain regions, including the hippocampus and prefrontal cortex, exhibit phase-locked oscillations in the high delta/low theta frequency band (similar to 2-6 Hz) that have been shown to contribute to the learning process. Network oscillations are commonly generated by inhibitory synaptic input that coordinates action potentials in groups of neurons. In the rat BLA, principal neurons spontaneously receive synchronized, inhibitory input in the form of compound, rhythmic, inhibitory postsynaptic potentials (IPSPs), likely originating from burst-firing parvalbumin interneurons. Here we investigated the role of compound IPSPs in the rat and rhesus macaque BLA in regulating action potential synchrony and spike-timing precision. Furthermore, because principal neurons exhibit intrinsic oscillatory properties and resonance between 4 and 5 Hz, in the same frequency band observed during fear, we investigated whether compound IPSPs and intrinsic oscillations interact to promote rhythmic activity in the BLA at this frequency. Using whole-cell patch clamp in brain slices, we demonstrate that compound IPSPs, which occur spontaneously and are synchronized across principal neurons in both the rat and primate BLA, significantly improve spike-timing precision in BLA principal neurons for a window of similar to 300 ms following each IPSP. We also show that compound IPSPs coordinate the firing of pairs of BLA principal neurons, and significantly improve spike synchrony for a window of,130 ms. Compound IPSPs enhance a 5 Hz calcium-dependent membrane potential oscillation (MPO) in these neurons, likely contributing to the improvement in spike-timing precision and synchronization of spiking. Activation of the cAMP-PKA signaling cascade enhanced the MPO, and inhibition of this cascade blocked the MPO. We discuss these results in the context of spike-timing dependent plasticity and modulation by neurotransmitters important for fear learning, such as dopamine.	[Ryan, Steven J.; Ehrlich, David E.; Jasnow, Aaron M.; Daftary, Shabrine; Madsen, Teresa E.; Rainnie, Donald G.] Emory Univ, Sch Med, Div Behav Neurosci & Psychiat Disorders, Dept Psychiat & Behav Sci,Yerkes Res Ctr, Atlanta, GA 30322 USA	Emory University	Ryan, SJ (corresponding author), Emory Univ, Sch Med, Div Behav Neurosci & Psychiat Disorders, Dept Psychiat & Behav Sci,Yerkes Res Ctr, Atlanta, GA 30322 USA.	drainni@emory.edu	Rainnie, Donald/L-3853-2016; Madsen, Teresa/J-2645-2013	Rainnie, Donald/0000-0003-0758-0530; Madsen, Teresa/0000-0002-7358-5869; Ryan, Steven/0000-0003-3650-7746; Ehrlich, David/0000-0003-2823-731X	NIH [MH 069852, RR-00165]; Atlanta Clinical and Translational Science Institute (ACTSI); PHS, National Institutes of Health, National Center for Research Resources [UL1 RR025008]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069852] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Atlanta Clinical and Translational Science Institute (ACTSI); PHS, National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH Grant MH 069852 to DGR was the primary source of funding for materials and salaries for those involved in the design and execution of all experiments, as well as data analysis and manuscript preparation. NIH Base grant RR-00165 to the Yerkes National Primate Research center also provides some support to this research in the form of facilities. The authors also received some support from the Atlanta Clinical and Translational Science Institute (ACTSI), in turn supported in part by PHS Grant UL1 RR025008 from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript; the funders' only role in data analysis was ACTSI's consultation on techniques for statistical comparisons of data presented in figures 3 and 4.	Anderson D, 2010, NAT NEUROSCI, V13, P333, DOI 10.1038/nn.2493; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bauer EP, 2007, J NEUROSCI, V27, P9369, DOI 10.1523/JNEUROSCI.2153-07.2007; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; CARLSEN J, 1988, BRAIN RES, V441, P377, DOI 10.1016/0006-8993(88)91418-7; Chhatwal JP, 2009, NEUROPSYCHOPHARMACOL, V34, P509, DOI 10.1038/npp.2008.97; Chung L, 2007, NEUROPEPTIDES, V41, P453, DOI 10.1016/j.npep.2007.08.001; Collins DR, 2001, J NEUROPHYSIOL, V85, P1661, DOI 10.1152/jn.2001.85.4.1661; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Davis M., 2000, AMYGDALA, P213; Fujisawa S, 2011, NEURON, V72, P153, DOI 10.1016/j.neuron.2011.08.018; GEAN PW, 1989, BRAIN RES, V480, P160, DOI 10.1016/0006-8993(89)91578-3; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Hammack SE, 2007, J NEUROPHYSIOL, V98, P638, DOI 10.1152/jn.00382.2007; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hoffman DA, 1998, J NEUROSCI, V18, P3521; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; HUTCHEON B, 1994, J NEUROPHYSIOL, V71, P583, DOI 10.1152/jn.1994.71.2.583; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Ingram SL, 1996, J PHYSIOL-LONDON, V492, P97, DOI 10.1113/jphysiol.1996.sp021292; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Josselyn SA, 2004, NEUROBIOL LEARN MEM, V82, P159, DOI 10.1016/j.nlm.2004.05.008; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Josselyn Sheena A., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P481, DOI 10.2174/156800705774322058; Jutrast MJ, 2010, CURR OPIN NEUROBIOL, V20, P150, DOI 10.1016/j.conb.2010.02.006; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim JA, 2006, J PHARMACOL EXP THER, V318, P230, DOI 10.1124/jpet.106.101402; Lamont EW, 1998, BRAIN RES, V795, P128, DOI 10.1016/S0006-8993(98)00281-9; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lesting J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021714; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026065; Lin CH, 2005, LEARN MEMORY, V12, P130, DOI 10.1101/lm.85304; Lin HC, 2000, J NEUROSCI, V20, P9017; Loretan K, 2004, NEUROPHARMACOLOGY, V47, P631, DOI 10.1016/j.neuropharm.2004.07.015; Madsen TE, 2009, SOC NEUR ANN M CHIC; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mascagni F, 2003, BRAIN RES, V976, P171, DOI 10.1016/S0006-8993(03)02625-8; McDonald AJ, 2005, BRAIN RES, V1035, P32, DOI 10.1016/j.brainres.2004.11.052; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McDonald AJ, 2002, BRAIN RES, V943, P237, DOI 10.1016/S0006-8993(02)02650-1; McDonald AJ, 2001, NEUROSCIENCE, V102, P413, DOI 10.1016/S0306-4522(00)00481-4; MISERENDINO MJD, 1990, NATURE, V345, P716, DOI 10.1038/345716a0; Mitra S, 2008, OBSERVED BRAIN DYNAM; Molineux ML, 2005, J NEUROSCI, V25, P10863, DOI 10.1523/JNEUROSCI.3436-05.2005; Muller JF, 2005, J NEUROSCI, V25, P7366, DOI 10.1523/JNEUROSCI.0899-05.2005; Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832; Muly EC, 2007, J COMP NEUROL, V505, P682, DOI 10.1002/cne.21525; Muly EC, 2009, BRAIN STRUCT FUNCT, V213, P375, DOI 10.1007/s00429-009-0214-8; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 1998, J NEUROPHYSIOL, V79, P217, DOI 10.1152/jn.1998.79.1.217; Pape HC, 2005, HIPPOCAMPUS, V15, P874, DOI 10.1002/hipo.20120; Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5; Pape HC, 1998, J NEUROPHYSIOL, V79, P205, DOI 10.1152/jn.1998.79.1.205; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Paz R, 2008, LEARN MEMORY, V15, P524, DOI 10.1101/lm.932408; Pelletier JG, 2004, BIOL PSYCHIAT, V55, P559, DOI 10.1016/j.biopsych.2003.08.019; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Person AL, 2005, NEURON, V46, P129, DOI 10.1016/j.neuron.2004.12.057; Pike FG, 2000, J PHYSIOL-LONDON, V529, P205, DOI 10.1111/j.1469-7793.2000.00205.x; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Popescu AT, 2011, J NEUROPHYSIOL, V105, P687, DOI 10.1152/jn.00732.2010; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; RAINNIE DG, 1991, J NEUROPHYSIOL, V66, P986, DOI 10.1152/jn.1991.66.3.986; RAINNIE DG, 1994, J NEUROSCI, V14, P7208; Rainnie DG, 1999, J NEUROPHYSIOL, V82, P69, DOI 10.1152/jn.1999.82.1.69; RAINNIE DG, 1993, J NEUROPHYSIOL, V69, P1350, DOI 10.1152/jn.1993.69.4.1350; Rainnie DG, 1999, SOC NEUR ANN M MIAM; Rainnie DG, 2009, POST TRAUMATIC STRES; Rainnie DG, 2006, J COMP NEUROL, V498, P142, DOI 10.1002/cne.21049; Ramadan O, 2009, J BIOL CHEM, V284, P5042, DOI 10.1074/jbc.M809132200; Randall FE, 2011, EUR J NEUROSCI, V33, P914, DOI 10.1111/j.1460-9568.2010.07582.x; Robbe D, 2006, NAT NEUROSCI, V9, P1526, DOI 10.1038/nn1801; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Russier M, 2003, J PHYSIOL-LONDON, V549, P21, DOI 10.1113/jphysiol.2002.037069; Sangha S, 2009, J NEUROSCI, V29, P15713, DOI 10.1523/JNEUROSCI.2620-09.2009; Schaefer AT, 2006, PLOS BIOL, V4, P1010, DOI 10.1371/journal.pbio.0040163; Schafe GE, 1999, LEARN MEMORY, V6, P97; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Sinfield JL, 2006, EUR J NEUROSCI, V24, P3091, DOI 10.1111/j.1460-9568.2006.05202.x; Sohal VS, 2006, J NEUROSCI, V26, P4247, DOI 10.1523/JNEUROSCI.3812-05.2006; SOLTESZ I, 1993, J NEUROPHYSIOL, V70, P97, DOI 10.1152/jn.1993.70.1.97; Szinyei C, 2000, J NEUROSCI, V20, P8909; Szucs A, 2009, NEURON, V61, P439, DOI 10.1016/j.neuron.2008.12.032; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Woodruff AR, 2007, J NEUROPHYSIOL, V98, P2956, DOI 10.1152/jn.00739.2007; Woodruff AR, 2007, J NEUROSCI, V27, P553, DOI 10.1523/JNEUROSCI.3686-06.2007; Young CK, 2011, J NEUROPHYSIOL, V106, P497, DOI 10.1152/jn.00358.2011; Zaccolo M, 2003, TRENDS NEUROSCI, V26, P53, DOI 10.1016/S0166-2236(02)00017-6; Zhang JC, 2009, P NATL ACAD SCI USA, V106, P13028, DOI 10.1073/pnas.0900546106	106	33	33	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35320	10.1371/journal.pone.0035320	http://dx.doi.org/10.1371/journal.pone.0035320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563382	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100011
J	Sun, YP; Dong, ZQ; Khodabakhsh, H; Chatterjee, S; Guo, S				Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su			Zebrafish Chemical Screening Reveals the Impairment of Dopaminergic Neuronal Survival by Cardiac Glycosides	PLOS ONE			English	Article							PARKINSONS-DISEASE; SMALL MOLECULES; ROTENONE MODEL; IDENTIFICATION; GENES; SYSTEM; DRUGS; NA,K-ATPASE; EXPRESSION; MUTATIONS	Parkinson's disease is a neurodegenerative disorder characterized by the prominent degeneration of dopaminergic (DA) neurons among other cell types. Here we report a first chemical screen of over 5,000 compounds in zebrafish, aimed at identifying small molecule modulators of DA neuron development or survival. We find that Neriifolin, a member of the cardiac glycoside family of compounds, impairs survival but not differentiation of both zebrafish and mammalian DA neurons. Cardiac glycosides are inhibitors of Na+/K+ ATPase activity and widely used for treating heart disorders. Our data suggest that Neriifolin impairs DA neuronal survival by targeting the neuronal enriched Na+/K+ ATPase alpha 3 subunit (ATP1A3). Modulation of ionic homeostasis, knockdown of p53, or treatment with antioxidants protects DA neurons from Neriifolin-induced death. These results reveal a previously unknown effect of cardiac glycosides on DA neuronal survival and suggest that it is mediated through ATP1A3 inhibition, oxidative stress, and p53. They also elucidate potential approaches for counteracting the neurotoxicity of this valuable class of medications.	[Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA; [Sun, Yaping; Dong, Zhiqiang; Khodabakhsh, Hadie; Chatterjee, Sandip; Guo, Su] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Biol Sci, San Francisco, CA 94143 USA; [Khodabakhsh, Hadie] George Washington Univ, Sch Med, Washington, DC USA; [Chatterjee, Sandip] Scripps Res Inst, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; George Washington University; Scripps Research Institute	Sun, YP (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Program Human Genet, San Francisco, CA 94143 USA.	su.guo@ucsf.edu			NIH [DA023904]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by NIH DA023904. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; Bournival J, 2009, CELL MOL NEUROBIOL, V29, P1169, DOI 10.1007/s10571-009-9411-5; Bretaud S, 2004, NEUROTOXICOL TERATOL, V26, P857, DOI 10.1016/j.ntt.2004.06.014; CARNEY MWP, 1985, CLIN NEUROPHARMACOL, V8, P193, DOI 10.1097/00002826-198506000-00011; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; CHIUEH CC, 1984, PSYCHOPHARMACOL BULL, V20, P548; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Guo S, 2009, EXPERT OPIN DRUG DIS, V4, P715, DOI 10.1517/17460440902988464; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Heo HJ, 2004, J AGR FOOD CHEM, V52, P7514, DOI 10.1021/jf049243r; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Holzschuh J, 2001, MECH DEVELOP, V101, P237, DOI 10.1016/S0925-4773(01)00287-8; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Lam CS, 2005, EUR J NEUROSCI, V21, P1758, DOI 10.1111/j.1460-9568.2005.03988.x; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Ma PM, 2003, J COMP NEUROL, V460, P13, DOI 10.1002/cne.10544; McCarty, 1998, CATECHOLAMINES BRIDG; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Miyazaki I, 2008, ACTA MED OKAYAMA, V62, P141; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Perier C, 2003, TRENDS NEUROSCI, V26, P345, DOI 10.1016/S0166-2236(03)00144-9; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Rajarao SJR, 2001, GENOME RES, V11, P1211, DOI 10.1101/gr.186001; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Smeets W. J. A. J., 1994, PHYLOGENY DEV CATECH; Song YH, 2001, PSYCHOSOMATICS, V42, P369, DOI 10.1176/appi.psy.42.4.369; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Stern HM, 2005, NAT CHEM BIOL, V1, P366, DOI 10.1038/nchembio749; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Thisse C, 2005, ZFIN DIRECT DATA SUB; Yeh JRJ, 2009, NAT CHEM BIOL, V5, P236, DOI 10.1038/nchembio.147; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	54	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35645	10.1371/journal.pone.0035645	http://dx.doi.org/10.1371/journal.pone.0035645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563390	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100018
J	Cardoso, MA; Scopel, KKG; Muniz, PT; Villamor, E; Ferreira, MU				Cardoso, Marly A.; Scopel, Kezia K. G.; Muniz, Pascoal T.; Villamor, Eduardo; Ferreira, Marcelo U.			Underlying Factors Associated with Anemia in Amazonian Children: A Population-Based, Cross-Sectional Study	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; IRON-DEFICIENCY; PREGNANT-WOMEN; YOUNG-CHILDREN; MALARIA; PREVALENCE; HEALTH; SCHOOLCHILDREN; CONSEQUENCES; NUTRITION	Background: Although iron deficiency is considered to be the main cause of anemia in children worldwide, other contributors to childhood anemia remain little studied in developing countries. We estimated the relative contributions of different factors to anemia in a population-based, cross-sectional survey. Methodology: We obtained venous blood samples from 1111 children aged 6 months to 10 years living in the frontier town of Acrelandia, northwest Brazil, to estimate the prevalence of anemia and iron deficiency by measuring hemoglobin, erythrocyte indices, ferritin, soluble transferrin receptor, and C-reactive protein concentrations. Children were simultaneously screened for vitamin A, vitamin B-12, and folate deficiencies; intestinal parasite infections; glucose-6-phosphate dehydrogenase deficiency; and sickle cell trait carriage. Multiple Poisson regression and adjusted prevalence ratios (aPR) were used to describe associations between anemia and the independent variables. Principal Findings: The prevalence of anemia, iron deficiency, and iron-deficiency anemia were 13.6%, 45.4%, and 10.3%, respectively. Children whose families were in the highest income quartile, compared with the lowest, had a lower risk of anemia (aPR, 0.60; 95% CI, 0.37-0.98). Child age (<24 months, 2.90; 2.01-4.20) and maternal parity (>2 pregnancies, 2.01; 1.40-2.87) were positively associated with anemia. Other associated correlates were iron deficiency (2.1; 1.4-3.0), vitamin B-12 (1.4; 1.0-2.2), and folate (2.0; 1.3-3.1) deficiencies, and C-reactive protein concentrations (>5 mg/L, 1.5; 1.1-2.2). Conclusions: Addressing morbidities and multiple nutritional deficiencies in children and mothers and improving the purchasing power of poorer families are potentially important interventions to reduce the burden of anemia.	[Cardoso, Marly A.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Scopel, Kezia K. G.] Univ Fed Juiz de Fora, Dept Parasitol Immunol & Microbiol, Juiz De Fora, Minas Gerais, Brazil; [Muniz, Pascoal T.] Univ Fed Acre, Dept Hlth Sci, Rio Branco, Acre, Brazil; [Villamor, Eduardo] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci & Epidemiol, Ann Arbor, MI 48109 USA; [Ferreira, Marcelo U.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade Federal do Acre (UFAC); University of Michigan System; University of Michigan; Universidade de Sao Paulo	Cardoso, MA (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	marlyac@usp.br	Ferreira, Marcelo U/G-8289-2011; Cardoso, Marly Augusto/B-8010-2013	Ferreira, Marcelo U/0000-0002-5293-9090; Cardoso, Marly Augusto/0000-0003-0973-3908	Sao Paulo State Research Agency [FAPESP 07/53042-1]; National Research Agency of Brazil [CNPq 470573/2007-4]	Sao Paulo State Research Agency; National Research Agency of Brazil	This work was supported by the Sao Paulo State Research Agency (FAPESP 07/53042-1) and the National Research Agency of Brazil (CNPq 470573/2007-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agho KE, 2008, J HEALTH POPUL NUTR, V26, P200; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2008, WORLDW PREV AN 1993; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; BOWDEN DK, 1985, LANCET, V2, P1025; Brasil, 2008, PESQ NAC DEM SAUD CR; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; CARDOSO MA, 1994, EUR J CLIN NUTR, V48, P326; Castro TG, 2009, PUBLIC HEALTH NUTR, V12, P2335, DOI 10.1017/S1368980009004923; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Cogswell ME, 2009, AM J CLIN NUTR, V89, P1334, DOI 10.3945/ajcn.2008.27151; Cook JD, 2005, BEST PRACT RES CL HA, V18, P319, DOI 10.1016/j.beha.2004.08.022; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; Darrow LA, 2011, EPIDEMIOLOGY, V22, P53, DOI 10.1097/EDE.0b013e3181fce49b; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Ferreira MU, 2007, AM J PUBLIC HEALTH, V97, P237, DOI 10.2105/AJPH.2005.078121; Ferreira RGM, 2002, HUM BIOL, V74, P607, DOI 10.1353/hub.2002.0041; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gomes LF, 2004, ANTIOXID REDOX SIGN, V6, P237, DOI 10.1089/152308604322899305; GYORKOS TW, 1989, AM J EPIDEMIOL, V130, P976, DOI 10.1093/oxfordjournals.aje.a115430; Hamel AR, 2002, BLOOD CELL MOL DIS, V28, P399, DOI 10.1006/bcmd.2002.0524; Instituto Brasileiro de Geografia e Estatistica, 2000, RES AM CENS DEM 2000; Kalaivani K, 2009, INDIAN J MED RES, V130, P627; Katsuragawa Tony H., 2004, Rev. Bras. Hematol. Hemoter., V26, P268, DOI 10.1590/S1516-84842004000400007; Levy A, 2005, EUR J EPIDEMIOL, V20, P277, DOI 10.1007/s10654-004-6515-6; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lopez-Antunano FJ, 1999, SALUD PUBLICA MEXICO, V41, P410, DOI 10.1590/S0036-36341999000500010; Lutter CK, 2008, J NUTR, V138, P2523, DOI 10.3945/jn.108.095406; Maslova E, 2009, FOOD NUTR BULL, V30, P103, DOI 10.1177/156482650903000201; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Monteiro CA, 2010, B WORLD HEALTH ORGAN, V88, P305, DOI 10.2471/BLT.09.069195; Muniz PT, 2007, CAD SAUDE PUBLICA, V23, P1283, DOI 10.1590/S0102-311X2007000600004; Oliveira JM, 2008, NUTR REV, V66, P141, DOI 10.1111/j.1753-4887.2008.00018.x; Pasricha SR, 2011, AM J CLIN NUTR, V94, P1358, DOI 10.3945/ajcn.111.018580; Pasricha SR, 2010, PEDIATRICS, V126, pE140, DOI 10.1542/peds.2009-3108; Semba RD, 2002, EUR J CLIN NUTR, V56, P271, DOI 10.1038/sj.ejcn.1601320; Stoltzfus RJ, 2008, J NUTR, V138, P2542, DOI 10.3945/jn.108.094888; Stoltzfus RJ, 2000, J NUTR, V130, P1724, DOI 10.1093/jn/130.7.1724; Thurlow RA, 2005, AM J CLIN NUTR, V82, P380, DOI 10.1093/ajcn/82.2.380; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Travassos Claudia, 2004, Cad. Saúde Pública, V20, P660, DOI 10.1590/S0102-311X2004000300003; van den Broek NR, 1998, BRIT J HAEMATOL, V103, P817, DOI 10.1046/j.1365-2141.1998.01035.x; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Villamor E, 2008, J NUTR, V138, P1391, DOI 10.1093/jn/138.7.1391; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT; World Health Organization, 2001, IR DEF AN ASS ED PRE; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	50	66	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36341	10.1371/journal.pone.0036341	http://dx.doi.org/10.1371/journal.pone.0036341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574149	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800045
J	Li, SF; Zou, QH; Li, J; Li, J; Wang, DY; Yan, CG; Dong, Q; Zang, YF				Li, Sufang; Zou, Qihong; Li, Jun; Li, Jin; Wang, Deyi; Yan, Chaogan; Dong, Qi; Zang, Yu-Feng			5-HTTLPR Polymorphism Impacts Task-Evoked and Resting-State Activities of the Amygdala in Han Chinese	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSIVE DISORDER; LATE-LIFE DEPRESSION; REGIONAL HOMOGENEITY; FUNCTIONAL POLYMORPHISM; ANTIDEPRESSANT RESPONSE; ALLELIC VARIATION; BIASED ATTENTION; PARKINSONS-DISEASE; NO ASSOCIATION	Background: Prior research has shown that the amygdala of carriers of the short allele (s) of the serotonin transporter (5-HTT) gene (5-HTTLPR) have a larger response to negative emotional stimuli and higher spontaneous activity during the resting state than non-carriers. However, recent studies have suggested that the effects of 5-HTTLPR may be specific to different ethnic groups. Few studies have been conducted to address this issue. Methodology/Principal Findings: Blood oxygenation level dependent (BOLD) functional magnetic resonance imaging (fMRI) was conducted on thirty-eight healthy Han Chinese subjects (l/l group, n = 19; s/s group, n = 19) during the resting state and during an emotional processing task. Compared with the s/s group, the l/l group showed significantly increased regional homogeneity or local synchronization in the right amygdala during the resting state (vertical bar t vertical bar. 2.028, p<0.05, corrected), but no significant difference was found in the bilateral amygdala in response to negative stimuli in the emotional processing task. Conclusions/Significance: 5-HTTLPR can alter the spontaneous activity of the amygdala in Han Chinese. However, the effect of 5-HTTLPR on the amygdala both in task state and resting state in Asian population was no similar with Caucasians. They suggest that the effect of 5-HTTLPR on the amygdala may be modulated by ethnic differences.	[Li, Sufang; Li, Jun; Li, Jin; Wang, Deyi; Yan, Chaogan; Dong, Qi; Zang, Yu-Feng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zou, Qihong] Peking Univ, MRI Res Ctr, Beijing 100871, Peoples R China; [Zou, Qihong] Peking Univ, Beijing City Key Lab Med Phys & Engn, Beijing 100871, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Beijing Normal University; Peking University; Peking University; Hangzhou Normal University	Li, SF (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zangyf@hznu.edu.cn	Li, Sufang/N-5697-2016; ZANG, Yu-Feng/J-1558-2012; Yan, Chao-Gan/D-1713-2015	Li, Sufang/0000-0002-4716-4761; ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Chao-Gan/0000-0003-3413-5977	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); 111 Project from Ministry of Education of China [B07008]; NSFC [81020108022, 30770594]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project from Ministry of Education of China(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT), the 111 Project from the Ministry of Education of China (B07008), and NSFC (81020108022, 30770594). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, MANUAL BECK ANXIETY; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Beitchman JH, 2006, AM J PSYCHIAT, V163, P1103, DOI 10.1176/appi.ajp.163.6.1103; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Canli T, 2005, P NATL ACAD SCI USA, V102, P12224, DOI 10.1073/pnas.0503880102; Canli T, 2006, P NATL ACAD SCI USA, V103, P16033, DOI 10.1073/pnas.0601674103; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Cullen KR, 2011, BRAIN CONNECT, V1, P61, DOI 10.1089/brain.2010.0001; Dannlowski U, 2007, GENES BRAIN BEHAV, V6, P672, DOI 10.1111/j.1601-183X.2006.00297.x; Dorado P, 2007, FUND CLIN PHARMACOL, V21, P451, DOI 10.1111/j.1472-8206.2007.00501.x; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Goldman N, 2010, DEPRESS ANXIETY, V27, P260, DOI 10.1002/da.20660; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hauser J, 2003, EUR PSYCHIAT, V18, P129, DOI 10.1016/S0924-9338(03)00026-9; Heils A, 1996, J NEUROCHEM, V66, P2621; Heinz A, 2005, NAT NEUROSCI, V8, P20, DOI 10.1038/nn1366; Heinz A, 2007, BIOL PSYCHIAT, V61, P1011, DOI 10.1016/j.biopsych.2006.08.019; Hoefgen B, 2005, BIOL PSYCHIAT, V57, P247, DOI 10.1016/j.biopsych.2004.11.027; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; [黄宇霞 Huang Yuxia], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P631; Joo YH, 2007, J KOREAN MED SCI, V22, P138, DOI 10.3346/jkms.2007.22.1.138; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kensinger EA, 2003, EMOTION, V3, P378, DOI 10.1037/1528-3542.3.4.378; Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042; Kim H, 2006, JAMA-J AM MED ASSOC, V296, P1609, DOI 10.1001/jama.296.13.1609; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kiyohara C, 2010, PSYCHIAT GENET, V20, P49, DOI 10.1097/YPG.0b013e328335112b; Kunugi H, 1997, MOL PSYCHIATR, V2, P457, DOI 10.1038/sj.mp.4000334; Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Lee BT, 2008, GENES BRAIN BEHAV, V7, P899, DOI 10.1111/j.1601-183X.2008.00429.x; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Long XY, 2008, J NEUROSCI METH, V171, P349, DOI 10.1016/j.jneumeth.2008.03.021; Lotrich FE, 2004, PSYCHIAT GENET, V14, P121, DOI 10.1097/00041444-200409000-00001; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mankinen K, 2011, BRAIN RES, V1373, P221, DOI 10.1016/j.brainres.2010.12.004; Mrazek DA, 2009, AM J MED GENET B, V150B, P341, DOI 10.1002/ajmg.b.30816; Munafo MR, 2008, BIOL PSYCHIAT, V63, P852, DOI 10.1016/j.biopsych.2007.08.016; Ohara K, 1998, BIOL PSYCHIAT, V44, P550, DOI 10.1016/S0006-3223(98)00112-7; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Pollock BG, 2000, NEUROPSYCHOPHARMACOL, V23, P587, DOI 10.1016/S0893-133X(00)00132-9; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Salvador R, 2010, HUM BRAIN MAPP, V31, P2003, DOI 10.1002/hbm.20993; Shi M, 2008, ACTA NEUROPSYCHIATR, V20, P139, DOI 10.1111/j.1601-5215.2008.00282.x; Shukla DK, 2010, NEUROSCI LETT, V476, P46, DOI 10.1016/j.neulet.2010.03.080; Smeraldi E, 1998, MOL PSYCHIATR, V3, P508, DOI 10.1038/sj.mp.4000425; Smolka MN, 2007, MOL PSYCHIATR, V12, P307, DOI 10.1038/sj.mp.4001946; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Viviani R, 2010, BIOL PSYCHIAT, V67, P317, DOI 10.1016/j.biopsych.2009.08.035; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yang T, 2010, NEUROREPORT, V21, P786, DOI 10.1097/WNR.0b013e32833cadf0; Yao ZJ, 2009, J AFFECT DISORDERS, V115, P430, DOI 10.1016/j.jad.2008.10.013; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1; Yuan YG, 2008, J AFFECT DISORDERS, V111, P145, DOI 10.1016/j.jad.2008.02.016; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang JL, 2009, NEUROSCI LETT, V455, P155, DOI 10.1016/j.neulet.2009.03.037; Zhang KR, 2009, J AFFECT DISORDERS, V114, P224, DOI 10.1016/j.jad.2008.07.012; Zhong Y, 2011, EPILEPSY RES, V97, P83, DOI 10.1016/j.eplepsyres.2011.07.007; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	75	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36513	10.1371/journal.pone.0036513	http://dx.doi.org/10.1371/journal.pone.0036513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574175	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800072
J	Tebbets, B; Stewart, D; Lawry, S; Nett, J; Nantel, A; Andes, D; Klein, BS				Tebbets, Brad; Stewart, Douglas; Lawry, Stephanie; Nett, Jeniel; Nantel, Andre; Andes, David; Klein, Bruce S.			Identification and Characterization of Antifungal Compounds Using a Saccharomyces cerevisiae Reporter Bioassay	PLOS ONE			English	Article							2-COMPONENT HISTIDINE KINASE; ACTIVATED PROTEIN-KINASE; OSMOTIC-STRESS RESPONSE; CANDIDA-ALBICANS; HYPHAL DEVELOPMENT; DNA-DAMAGE; RESISTANCE; GENE; FLUCONAZOLE; FLUDIOXONIL	New antifungal drugs are urgently needed due to the currently limited selection, the emergence of drug resistance, and the toxicity of several commonly used drugs. To identify drug leads, we screened small molecules using a Saccharomyces cerevisiae reporter bioassay in which S. cerevisiae heterologously expresses Hik1, a group III hybrid histidine kinase (HHK) from Magnaporthe grisea. Group III HHKs are integral in fungal cell physiology, and highly conserved throughout this kingdom; they are absent in mammals, making them an attractive drug target. Our screen identified compounds 13 and 33, which showed robust activity against numerous fungal genera including Candida spp., Cryptococcus spp. and molds such as Aspergillus fumigatus and Rhizopus oryzae. Drug-resistant Candida albicans from patients were also highly susceptible to compounds 13 and 33. While the compounds do not act directly on HHKs, microarray analysis showed that compound 13 induced transcripts associated with oxidative stress, and compound 33, transcripts linked with heavy metal stress. Both compounds were highly active against C. albicans biofilm, in vitro and in vivo, and exerted synergy with fluconazole, which was inactive alone. Thus, we identified potent, broad-spectrum antifungal drug leads from a small molecule screen using a high-throughput, S. cerevisiae reporter bioassay.	[Tebbets, Brad; Stewart, Douglas; Lawry, Stephanie; Klein, Bruce S.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Nett, Jeniel; Andes, David] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI USA; [Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Internal Med, Madison, WI USA; [Tebbets, Brad; Klein, Bruce S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI USA; [Lawry, Stephanie] Univ Wisconsin Madison, Sch Med & Publ Hlth, Cellular & Mol Pathol Program, Madison, WI USA; [Tebbets, Brad] Univ Wisconsin Madison, Sch Med & Publ Hlth, Microbiol Doctoral Training Program, Madison, WI USA; [Nantel, Andre] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; National Research Council Canada	Tebbets, B (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA.	bsklein@wisc.edu	Andes, David/ABE-8033-2020	Lawry, Stephanie/0000-0002-1172-7577; Andes, David/0000-0002-7927-9950	National Institutes of Health [AI086025, AI35681]; Canadian Institutes of Health Research [MOP-84341]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086025, R37AI035681, R01AI035681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI086025 and AI35681 (BK) and Canadian Institutes of Health Research grant MOP-84341 (AN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arana DM, 2010, J ANTIMICROB CHEMOTH, V65, P54, DOI 10.1093/jac/dkp407; Avenot H, 2005, CURR GENET, V47, P234, DOI 10.1007/s00294-005-0568-2; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Clemons KV, 2002, MED MYCOL, V40, P259, DOI 10.1080/mmy.40.3.259.262; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Florio AR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-97; Green S. R., 2001, CURRENT PROTOCOLS CE; Gupte M, 2002, APPL MICROBIOL BIOT, V58, P46, DOI 10.1007/s002530100822; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450, DOI 10.1128/JCM.36.5.1450-1452.1998; Hussein B, 2011, EUKARYOT CELL, V10, P384, DOI 10.1128/EC.00278-10; Kanetis L, 2008, PHYTOPATHOLOGY, V98, P205, DOI 10.1094/PHYTO-98-2-0205; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Lamb D, 1999, DRUG RESIST UPDATE, V2, P390, DOI 10.1054/drup.1999.0112; Li DM, 2010, CURR OPIN MICROBIOL, V13, P424, DOI 10.1016/j.mib.2010.04.007; Masson JY, 1996, MOL CELL BIOL, V16, P2091; MCCALLA DR, 1971, CANCER RES, V31, P2184; Motoyama T, 2005, CURR GENET, V47, P298, DOI 10.1007/s00294-005-0572-6; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; MUKHERJEE U, 1990, CANCER BIOCHEM BIOPH, V11, P275; Nantel A., 2007, MED MYCOLOGY CELLULA, P181; Nemecek JC, 2006, SCIENCE, V312, P583, DOI 10.1126/science.1124105; Nett J, 2007, ANTIMICROB AGENTS CH, V51, P510, DOI 10.1128/AAC.01056-06; Nett JE, 2010, INFECT IMMUN, V78, P3650, DOI 10.1128/IAI.00480-10; Ochiai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2209, DOI 10.1271/bbb.66.2209; Ochiai N, 2001, PEST MANAG SCI, V57, P437, DOI 10.1002/ps.302; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553; Sharma M, 2010, FEMS YEAST RES, V10, P570, DOI 10.1111/j.1567-1364.2010.00637.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Uppuluri P, 2008, ANTIMICROB AGENTS CH, V52, P1127, DOI 10.1128/AAC.01397-07; Vylkova S, 2007, EUKARYOT CELL, V6, P1876, DOI 10.1128/EC.00039-07; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999; Yoshimi A, 2004, MOL GENET GENOMICS, V271, P228, DOI 10.1007/s00438-003-0974-4	38	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36021	10.1371/journal.pone.0036021	http://dx.doi.org/10.1371/journal.pone.0036021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574132	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800028
J	Frank, JG; Mendelowitz, D				Frank, Julie G.; Mendelowitz, David			Synaptic and Intrinsic Activation of GABAergic Neurons in the Cardiorespiratory Brainstem Network	PLOS ONE			English	Article							RESPIRATORY RHYTHM GENERATION; CARDIAC VAGAL NEURONS; PRE-BOTZINGER COMPLEX; PREBOTZINGER COMPLEX; PACEMAKER NEURONS; NUCLEUS AMBIGUUS; PARASYMPATHETIC NEURONS; NICOTINIC RECEPTORS; NEURAL-NETWORK; SPINAL-CORD	GABAergic pathways in the brainstem play an essential role in respiratory rhythmogenesis and interactions between the respiratory and cardiovascular neuronal control networks. However, little is known about the identity and function of these GABAergic inhibitory neurons and what determines their activity. In this study we have identified a population of GABAergic neurons in the ventrolateral medulla that receive increased excitatory post-synaptic potentials during inspiration, but also have spontaneous firing in the absence of synaptic input. Using transgenic mice that express GFP under the control of the Gad1 (GAD67) gene promoter, we determined that this population of GABAergic neurons is in close apposition to cardioinhibitory parasympathetic cardiac neurons in the nucleus ambiguus (NA). These neurons fire in synchronization with inspiratory activity. Although they receive excitatory glutamatergic synaptic inputs during inspiration, this excitatory neurotransmission was not altered by blocking nicotinic receptors, and many of these GABAergic neurons continue to fire after synaptic blockade. The spontaneous firing in these GABAergic neurons was not altered by the voltage-gated calcium channel blocker cadmium chloride that blocks both neurotransmission to these neurons and voltage-gated Ca2+ currents, but spontaneous firing was diminished by riluzole, demonstrating a role of persistent sodium channels in the spontaneous firing in these cardiorespiratory GABAergic neurons that possess a pacemaker phenotype. The spontaneously firing GABAergic neurons identified in this study that increase their activity during inspiration would support respiratory rhythm generation if they acted primarily to inhibit post-inspiratory neurons and thereby release inspiration neurons to increase their activity. This population of inspiratory-modulated GABAergic neurons could also play a role in inhibiting neurons that are most active during expiration and provide a framework for respiratory sinus arrhythmia as there is an increase in heart rate during inspiration that occurs via inhibition of premotor parasympathetic cardioinhibitory neurons in the NA during inspiration.	[Frank, Julie G.; Mendelowitz, David] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA	George Washington University	Frank, JG (corresponding author), George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20052 USA.	dmendel@gwu.edu			National Institutes of Health National Heart, Lung, and Blood Institute [HL-49965, HL-72006, HL-59895]; American Heart Association; The National Center for Research Resources [1S10RR025565-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025565] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059895, R29HL049965, R01HL049965, R01HL072006] Funding Source: NIH RePORTER	National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); The National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health National Heart, Lung, and Blood Institute Grants HL-49965, HL-72006, and HL-59895 to Dr. Mendelowitz and American Heart Association predoctoral fellowship to Dr. Frank. Confocal images were generated with a grant from The National Center for Research Resources 1S10RR025565-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALIS UJ, 1994, BIOL CYBERN, V70, P311, DOI 10.1007/BF00200329; Dehkordi O, 2004, RESP PHYSIOL NEUROBI, V141, P21, DOI 10.1016/j.resp.2004.03.006; Dehkordi O, 2007, BRAIN RES, V1185, P95, DOI 10.1016/j.brainres.2007.09.027; Del Negro CA, 2005, J NEUROSCI, V25, P446, DOI 10.1523/JNEUROSCI.2237-04.2005; DUFFIN J, 1991, NEUROREPORT, V2, P623, DOI 10.1097/00001756-199110000-00018; Ellenberger HH, 1999, J COMP NEUROL, V411, P130, DOI 10.1002/(SICI)1096-9861(19990816)411:1<130::AID-CNE10>3.0.CO;2-C; Favero MT, 2011, RESP PHYSL NEUROBIOL; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; Frank JG, 2009, J NEUROPHYSIOL, V101, P1755, DOI 10.1152/jn.91134.2008; Johnson SM, 2001, J NEUROPHYSIOL, V85, P1772, DOI 10.1152/jn.2001.85.4.1772; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Kuwana SI, 2006, EUR J NEUROSCI, V23, P667, DOI 10.1111/j.1460-9568.2006.04591.x; Loewy AD, CENTRAL REGULATION A; Mendelowitz D, 1996, AM J PHYSIOL-HEART C, V271, pH2609, DOI 10.1152/ajpheart.1996.271.6.H2609; MENDELOWITZ D, 1991, NEUROSCI LETT, V132, P217, DOI 10.1016/0304-3940(91)90305-D; Muller KJ, 2009, PHILOS T R SOC B, V364, P2485, DOI 10.1098/rstb.2009.0070; Neff RA, 2003, CIRC RES, V93, P565, DOI 10.1161/01.RES.0000090361.45027.5B; Neff RA, 1998, BRAIN RES, V792, P277, DOI 10.1016/S0006-8993(98)00149-8; Neff RA, 1998, CIRC RES, V83, P1241, DOI 10.1161/01.RES.83.12.1241; OGILVIE MD, 1992, AM J PHYSIOL, V263, pR962, DOI 10.1152/ajpregu.1992.263.4.R962; Pace RW, 2007, J PHYSIOL-LONDON, V580, P485, DOI 10.1113/jphysiol.2006.124602; PATRICK J, 1987, ANN NY ACAD SCI, V505, P194; Richter D W, 1992, Curr Opin Neurobiol, V2, P788, DOI 10.1016/0959-4388(92)90135-8; Rybak IA, 1997, J NEUROPHYSIOL, V77, P1994, DOI 10.1152/jn.1997.77.4.1994; Shao XM, 2001, J NEUROPHYSIOL, V85, P2461, DOI 10.1152/jn.2001.85.6.2461; Shao XSM, 2002, J NEUROPHYSIOL, V88, P1851, DOI 10.1152/jn.2002.88.4.1851; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Stornetta RL, 2004, J COMP NEUROL, V479, P257, DOI 10.1002/cne.20332; Stornetta RL, 1999, J COMP NEUROL, V407, P367; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thoby-Brisson M, 2001, J NEUROPHYSIOL, V86, P104, DOI 10.1152/jn.2001.86.1.104; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; URBANSKI RW, 1988, J AUTONOM NERV SYST, V25, P181, DOI 10.1016/0165-1838(88)90023-9; Wang JJ, 2002, NEUROSCI LETT, V332, P195, DOI 10.1016/S0304-3940(02)00957-6; Wang JJ, 2001, BRAIN RES, V889, P78, DOI 10.1016/S0006-8993(00)03112-7; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691	39	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36459	10.1371/journal.pone.0036459	http://dx.doi.org/10.1371/journal.pone.0036459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570717	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400033
J	Wallin, JJ; Guan, J; Edgar, KA; Zhou, W; Francis, R; Torres, AC; Haverty, PM; Eastham-Anderson, J; Arena, S; Bardelli, A; Griffin, S; Goodall, JE; Grimshaw, KM; Hoeflich, KP; Torrance, C; Belvin, M; Friedman, LS				Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Haverty, Peter M.; Eastham-Anderson, Jeffrey; Arena, Sabrina; Bardelli, Alberto; Griffin, Sue; Goodall, John E.; Grimshaw, Kyla M.; Hoeflich, Klaus P.; Torrance, Christopher; Belvin, Marcia; Friedman, Lori S.			Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; I PHOSPHATIDYLINOSITIDE 3-KINASES; BREAST-CANCER CELLS; PIK3CA MUTATIONS; GENE-EXPRESSION; ONCOGENIC PATHWAYS; INHIBITOR; KINASE; POTENT; LINES	The PTEN/PI3K pathway is commonly mutated in cancer and therefore represents an attractive target for therapeutic intervention. To investigate the primary phenotypes mediated by increased pathway signaling in a clean, patient-relevant context, an activating PIK3CA mutation (H1047R) was knocked-in to an endogenous allele of the MCF10A non-tumorigenic human breast epithelial cell line. Introduction of an endogenously mutated PIK3CA allele resulted in a marked epithelial-mesenchymal transition (EMT) and invasive phenotype, compared to isogenic wild-type cells. The invasive phenotype was linked to enhanced PIP3 production via a S6K-IRS positive feedback mechanism. Moreover, potent and selective inhibitors of PI3K were highly effective in reversing this phenotype, which is optimally revealed in 3-dimensional cell culture. In contrast, inhibition of Akt or mTOR exacerbated the invasive phenotype. Our results suggest that invasion is a core phenotype mediated by increased PTEN/PI3K pathway activity and that therapeutic agents targeting different nodes of the PI3K pathway may have dramatic differences in their ability to reverse or promote cancer metastasis.	[Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Hoeflich, Klaus P.; Belvin, Marcia; Friedman, Lori S.] Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA; [Wallin, Jeffrey J.; Guan, Jane; Edgar, Kyle A.; Zhou, Wei; Francis, Ross; Torres, Anthony C.; Hoeflich, Klaus P.; Belvin, Marcia; Friedman, Lori S.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Haverty, Peter M.] Genentech Inc, Bioinformat, San Francisco, CA 94080 USA; [Eastham-Anderson, Jeffrey] Genentech Inc, Pathol, San Francisco, CA 94080 USA; [Arena, Sabrina; Bardelli, Alberto] Univ Turin, Sch Med, Mol Genet Lab, Inst Canc Res & Treatment, Candiolo, Italy; [Bardelli, Alberto] FIRC Inst Mol Oncol, Milan, Italy; [Griffin, Sue; Goodall, John E.; Grimshaw, Kyla M.; Torrance, Christopher] Horizon Discovery Ltd, Cambridge, England	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin; IFOM - FIRC Institute of Molecular Oncology	Wallin, JJ (corresponding author), Genentech Inc, Dept Canc Signaling, San Francisco, CA 94080 USA.	jwallin@gene.com	Arena, Sabrina/H-4985-2012; BARDELLI, Alberto/J-9721-2018	Arena, Sabrina/0000-0002-1318-2494; Wallin, Jeffrey/0000-0002-5952-3813; BARDELLI, Alberto/0000-0003-1647-5070	Italian Association for Cancer Research (AIRC); Italian Ministry of Health, Regione Piemonte; Italian Ministry of University and Research; CRT Progetto Alfieri; Fondazione Monte dei Paschi di Siena, Siena, Italy; Association for International Cancer Research (AICR-UK); EU [037297]; EU FP7 Marie Curie CAN-GENE	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health, Regione Piemonte; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); CRT Progetto Alfieri; Fondazione Monte dei Paschi di Siena, Siena, Italy; Association for International Cancer Research (AICR-UK); EU(European Commission); EU FP7 Marie Curie CAN-GENE	Alberto Bardelli is supported by grants from Italian Association for Cancer Research (AIRC) (AB), Italian Ministry of Health, Regione Piemonte (AB), Italian Ministry of University and Research, CRT Progetto Alfieri (AB), Fondazione Monte dei Paschi di Siena, Siena, Italy (AS) and Association for International Cancer Research (AICR-UK) (AB), EU FP6 contract 037297 (AB), and EU FP7 Marie Curie CAN-GENE (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus SE, CLIN CANC RES, V16, P790; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Edgar KA, CANC RES, V70, P1164; Finlay M, 2008, MORPHOLINO PYRIMIDIN, VS-151, P85; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gustin JP, 2009, P NATL ACAD SCI USA, V106, P2835, DOI 10.1073/pnas.0813351106; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li SY, 2006, BREAST CANCER RES TR, V96, P91, DOI 10.1007/s10549-005-9048-0; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Raynaud FI, 2009, MOL CANCER THER, V8, P1725, DOI 10.1158/1535-7163.MCT-08-1200; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Thomson S, 2008, CLIN EXP METASTAS, V25, P843, DOI 10.1007/s10585-008-9200-4; Wallin JJ, 2011, MOL CANC THER; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Yao E, 2009, CLIN CANCER RES, V15, P4147, DOI 10.1158/1078-0432.CCR-08-2814; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244; Zhao ZJ, 2005, BIOORG MED CHEM LETT, V15, P905, DOI 10.1016/j.bmcl.2004.12.062	48	41	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36402	10.1371/journal.pone.0036402	http://dx.doi.org/10.1371/journal.pone.0036402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570710	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400026
J	Bhoopathi, P; Gorantla, B; Sailaja, GS; Gondi, CS; Gujrati, M; Klopfenstein, JD; Rao, JS				Bhoopathi, Praveen; Gorantla, Bharathi; Sailaja, G. S.; Gondi, Christopher S.; Gujrati, Meena; Klopfenstein, Jeffrey D.; Rao, Jasti S.			SPARC Overexpression Inhibits Cell Proliferation in Neuroblastoma and Is Partly Mediated by Tumor Suppressor Protein PTEN and AKT	PLOS ONE			English	Article							BREAST-CANCER CELLS; GROWTH-FACTOR; LUNG-CANCER; NULL MICE; C-JUN; MATRICELLULAR PROTEIN; IONIZING-RADIATION; ENHANCED GROWTH; MESANGIAL CELLS; KINASE-B	Secreted protein acidic and rich in cysteine (SPARC) is also known as BM-40 or Osteonectin, a multi-functional protein modulating cell-cell and cell-matrix interactions. In cancer, SPARC is not only linked with a highly aggressive phenotype, but it also acts as a tumor suppressor. In the present study, we sought to characterize the function of SPARC and its role in sensitizing neuroblastoma cells to radio-therapy. SPARC overexpression in neuroblastoma cells inhibited cell proliferation in vitro. Additionally, SPARC overexpression significantly suppressed the activity of AKT and this suppression was accompanied by an increase in the tumor suppressor protein PTEN both in vitro and in vivo. Restoration of neuroblastoma cell radiosensitivity was achieved by overexpression of SPARC in neuroblastoma cells in vitro and in vivo. To confirm the role of the AKT in proliferation inhibited by SPARC overexpression, we transfected neuroblastoma cells with a plasmid vector carrying myr-AKT. Myr-AKT overexpression reversed SPARC-mediated PTEN and increased proliferation of neuroblastoma cells in vitro. PTEN overexpression in parallel with SPARC siRNA resulted in decreased AKT phosphorylation and proliferation in vitro. Taken together, these results establish SPARC as an effector of AKT-PTEN-mediated inhibition of proliferation in neuroblastoma in vitro and in vivo.	[Bhoopathi, Praveen; Gorantla, Bharathi; Sailaja, G. S.; Gondi, Christopher S.; Rao, Jasti S.] Univ Illinois Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Gujrati, Meena] Univ Illinois Coll Med Peoria, Dept Pathol, Peoria, IL USA; [Klopfenstein, Jeffrey D.; Rao, Jasti S.] Univ Illinois Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Bhoopathi, P (corresponding author), Univ Illinois Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu		Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health [CA147792]; NATIONAL CANCER INSTITUTE [R01CA147792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by award number CA147792 (to JSR) from the National Institutes of Health. Contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan NG, 2006, CELL MOL NEUROBIOL, V26, P901, DOI 10.1007/s10571-006-9064-6; Bhoopathi P, 2010, CELL DEATH DIFFER, V17, P1529, DOI 10.1038/cdd.2010.28; Bhoopathi P, 2008, J BIOL CHEM, V283, P1545, DOI 10.1074/jbc.M707931200; Bhoopathi P, 2011, CANCER RES, V71, P4908, DOI 10.1158/0008-5472.CAN-10-3395; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Brognard J, 2001, CANCER RES, V61, P3986; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chetty C, 2007, ONCOGENE, V26, P7675, DOI 10.1038/sj.onc.1210584; Chetty C, 2008, CANCER RES, V68, P4736, DOI 10.1158/0008-5472.CAN-07-6612; Chetty C, 2009, INT J CANCER, V124, P2468, DOI 10.1002/ijc.24209; Chlenski A, 2002, CANCER RES, V62, P7357; Chlenski A, 2010, SEMIN CELL DEV BIOL, V21, P55, DOI 10.1016/j.semcdb.2009.11.018; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dhanesuan N, 2002, BREAST CANCER RES TR, V75, P73, DOI 10.1023/A:1016536725958; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Dong JT, 2001, CLIN CANCER RES, V7, P304; Francki A, 2004, J CELL BIOCHEM, V91, P915, DOI 10.1002/jcb.20008; Francki A, 2003, J CELL BIOCHEM, V88, P802, DOI 10.1002/jcb.10424; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; Ho R, 2002, CANCER RES, V62, P6462; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huang WC, 2009, J FORMOS MED ASSOC, V108, P180, DOI 10.1016/S0929-6646(09)60051-6; Iliakis G, 2003, ONCOGENE, V22, P5834, DOI 10.1038/sj.onc.1206682; Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382; Jorgensen TJ, 2009, CANCER BIOL THER, V8, P665, DOI 10.4161/cbt.8.8.8304; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; Kurschat P, 2000, CLIN EXP DERMATOL, V25, P482, DOI 10.1046/j.1365-2230.2000.00701.x; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li L, 2004, J BIOL CHEM, V279, P4058, DOI 10.1074/jbc.M310415200; Liu HY, 2011, CANCER BIOTHER RADIO, V26, P705, DOI 10.1089/cbr.2011.0987; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; METTOUCHI A, 1994, EMBO J, V13, P5668, DOI 10.1002/j.1460-2075.1994.tb06905.x; Motamed K, 2003, J CELL BIOCHEM, V90, P408, DOI 10.1002/jcb.10645; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; Nie J, 2009, J CELL COMMUN SIGNAL, V3, P247, DOI 10.1007/s12079-009-0064-4; Perry ME, 2004, MOL CANCER RES, V2, P9; Petersen S, 1998, ONCOGENE, V17, P449, DOI 10.1038/sj.onc.1201949; Podhajcer OL, 2008, CANCER METAST REV, V27, P523, DOI 10.1007/s10555-008-9135-x; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; Said N, 2005, AM J PATHOL, V167, P1739, DOI 10.1016/S0002-9440(10)61255-2; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; Tai IT, 2005, J CLIN INVEST, V115, P1492, DOI 10.1172/JCI23002; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Teyssier F, 1999, B CANCER, V86, P345; Thomas SL, 2010, NEURO-ONCOLOGY, V12, P941, DOI 10.1093/neuonc/noq048; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang L, 2007, HEPATOL RES, V37, P389, DOI 10.1111/j.1872-034X.2007.00042.x; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin XY, 2001, CANCER RES, V61, P6487; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; Zhan M, 2004, HISTOL HISTOPATHOL, V19, P915, DOI 10.14670/HH-19.915; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	71	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36093	10.1371/journal.pone.0036093	http://dx.doi.org/10.1371/journal.pone.0036093			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567126	Green Published, gold			2022-12-27	WOS:000305341500044
J	Harris, S; Craze, M; Newton, J; Fisher, M; Shima, DT; Tozer, GM; Kanthou, C				Harris, Sheila; Craze, Madeleine; Newton, Jillian; Fisher, Matthew; Shima, David T.; Tozer, Gillian M.; Kanthou, Chryso			Do Anti-Angiogenic VEGF (VEGFxxxb) Isoforms Exist? A Cautionary Tale	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPLICE VARIANT; MESSENGER-RNA; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; POOR-PROGNOSIS; TUMOR-GROWTH; A ISOFORM; VEGF(165)B; BINDING	Splicing of the human vascular endothelial growth factor-A (VEGF-A) gene has been reported to generate angiogenic (VEGFxxx) and anti-angiogenic (VEGFxxxb) isoforms. Corresponding VEGFxxxb isoforms have also been reported in rat and mouse. We examined VEGFxxxb expression in mouse fibrosarcoma cell lines expressing all or individual VEGF isoforms (VEGF120, 164 or 188), grown in vitro and in vivo, and compared results with those from normal mouse and human tissues. Importantly, genetic construction of VEGF164 and VEGF188 expressing fibrosarcomas, in which exon 7 is fused to the conventional exon 8, precludes VEGFxxxb splicing from occurring. Thus, these two fibrosarcoma cell lines provided endogenous negative controls. Using RT-PCR we show that primers designed to simultaneously amplify VEGFxxx and VEGFxxxb isoforms amplified only VEGFxxx variants in both species. Moreover, only VEGFxxx species were generated when mouse podocytes were treated with TGF beta-1, a reported activator of VEGFxxxb splice selection in human podocytes. A VEGF164/120 heteroduplex species was identified as a PCR artefact, specifically in mouse. VEGFxxxb isoform-specific PCR did amplify putative VEGFxxxb species in mouse and human tissues, but unexpectedly also in VEGF188 and VEGF164 fibrosarcoma cells and tumours, where splicing to produce true VEGFxxxb isoforms cannot occur. Moreover, these products were only consistently generated using reverse primers spanning more than 5 bases across the 8b/7 or 8b/5 splice junctions. Primer annealing to VEGFxxx transcripts and amplification of exon 8b primer 'tails' explained the artefactual generation of VEGFxxxb products, since the same products were generated when the PCR reactions were performed with cDNA from VEGF164/VEGF188 'knock-in' vectors used in the generation of single VEGF isoform-expressing transgenic mice from which the fibrosarcoma lines were developed. Collectively, our results highlight important pitfalls in data interpretation associated with detecting VEGFxxxb isoforms using current methods, and demonstrate that anti-angiogenic isoforms are not commonly expressed in mouse or human tissues.	[Harris, Sheila; Craze, Madeleine; Fisher, Matthew; Tozer, Gillian M.; Kanthou, Chryso] Univ Sheffield, Sch Med, Dept Oncol, Canc Res United Kingdom Tumour Microcirculat Grp, Sheffield, S Yorkshire, England; [Newton, Jillian] Sheffield Hallam Univ, Biomed Ctr, Sheffield S1 1WB, S Yorkshire, England; [Shima, David T.] UCL, Inst Ophthalmol, London, England	University of Sheffield; Sheffield Hallam University; University of London; University College London	Harris, S (corresponding author), Univ Sheffield, Sch Med, Dept Oncol, Canc Res United Kingdom Tumour Microcirculat Grp, Sheffield, S Yorkshire, England.	Sheila.harris@sheffield.ac.uk			Cancer Research United Kingdom [C1276/A9993]	Cancer Research United Kingdom(Cancer Research UK)	This work was supported by Cancer Research United Kingdom (Programme Grant Tumour Microcirculation, grant number C1276/A9993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artac RA, 2009, BIOL REPROD, V81, P978, DOI 10.1095/biolreprod.109.078097; Bates DO, 2002, CANCER RES, V62, P4123; Bevan HS, 2008, NEPHRON PHYSIOL, V110, P57, DOI 10.1159/000177614; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Catena R, MOL CANC, V9, P320; Cui TG, 2004, AM J PHYSIOL-RENAL, V286, pF767, DOI 10.1152/ajprenal.00337.2003; Das K, 2007, UROL ONCOL-SEMIN ORI, V25, P317, DOI 10.1016/j.urolonc.2007.01.015; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Eckhart L, 1999, J BIOL CHEM, V274, P2613, DOI 10.1074/jbc.274.5.2613; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ergorul C, 2008, MOL VIS, V14, P1517; FERRARA N, 1995, BREAST CANCER RES TR, V36, P127, DOI 10.1007/BF00666035; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Kawamura H, 2008, CANCER RES, V68, P4683, DOI 10.1158/0008-5472.CAN-07-6577; Konopatskaya O, 2006, MOL VIS, V12, P626; Kowanetz M, 2006, CLIN CANCER RES, V12, P5018, DOI 10.1158/1078-0432.CCR-06-1520; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Lee YH, 1999, EUR J CANCER, V35, P1089, DOI 10.1016/S0959-8049(99)00073-8; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Magnussen AL, INVEST OPHTHALMOL VI; Miller-Kasprzak E, 2008, BIOMED PHARMACOTHER, V62, P158, DOI 10.1016/j.biopha.2007.07.015; Mundel P, 1997, EXPT CELL RES; Ng YS, 2001, DEV DYNAM, V220, P112, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1093>3.0.CO;2-D; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Perrin RM, 2005, DIABETOLOGIA, V48, P2422, DOI 10.1007/s00125-005-1951-8; Pritchard-Jones RO, 2007, BRIT J CANCER, V97, P223, DOI 10.1038/sj.bjc.6603839; Qiu Y, 2008, FASEB J, V22, P1104, DOI 10.1096/fj.07-9718com; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Rennel ES, 2009, BRIT J CANCER, V101, P1183, DOI 10.1038/sj.bjc.6605249; Rennel ES, 2008, EUR J CANCER, V44, P1883, DOI 10.1016/j.ejca.2008.05.027; Rennel ES, 2009, FUTURE ONCOL, V5, P703, DOI 10.2217/FON.09.33; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Schumacher VA, 2007, J AM SOC NEPHROL, V18, P719, DOI 10.1681/ASN.2006020124; Senger DR, 2010, MOL BIOL CELL, V21, P377, DOI 10.1091/mbc.E09-07-0591; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Suarez SC, 2006, CELL MOL LIFE SCI, V63, P2067, DOI 10.1007/s00018-006-6254-9; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Tomisawa M, 1999, EUR J CANCER, V35, P133, DOI 10.1016/S0959-8049(98)00278-0; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Uthoff SMS, 2002, INT J CANCER, V101, P32, DOI 10.1002/ijc.10552; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Vincenz C, 1997, J BIOL CHEM, V272, P6578, DOI 10.1074/jbc.272.10.6578; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Zhang L, 2002, BIOCHEM BIOPH RES CO, V292, P860, DOI 10.1006/bbrc.2002.6710; Zhao M, 2011, EXP EYE RES, V93, P921, DOI 10.1016/j.exer.2011.10.013	55	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35231	10.1371/journal.pone.0035231	http://dx.doi.org/10.1371/journal.pone.0035231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567098	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500016
J	Hneino, M; Francois, A; Buard, V; Tarlet, G; Abderrahmani, R; Blirando, K; Hoodless, PA; Benderitter, M; Milliat, F				Hneino, Mohammad; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Abderrahmani, Rym; Blirando, Karl; Hoodless, Pamela A.; Benderitter, Marc; Milliat, Fabien			The TGF-beta/Smad Repressor TG-Interacting Factor 1 (TGIF1) Plays a Role in Radiation-Induced Intestinal Injury Independently of a Smad Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; UBIQUITIN-DEPENDENT DEGRADATION; TRANSCRIPTIONAL COREPRESSOR TGIF; ENDOTHELIAL-CELLS; RENAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; IONIZING-RADIATION; DOWN-REGULATION; EXPRESSION; TGF-BETA-1	Despite advances in radiation delivery protocols, exposure of normal tissues during the course of radiation therapy remains a limiting factor of cancer treatment. If the canonical TGF-beta/Smad pathway has been extensively studied and implicated in the development of radiation damage in various organs, the precise modalities of its activation following radiation exposure remain elusive. In the present study, we hypothesized that TGF-beta 1 signaling and target genes expression may depend on radiation-induced modifications in Smad transcriptional co-repressors/inhibitors expressions (TGIF1, SnoN, Ski and Smad7). In endothelial cells (HUVECs) and in a model of experimental radiation enteropathy in mice, radiation exposure increases expression of TGF-beta/Smad pathway and of its target gene PAI-1, together with the overexpression of Smad co-repressor TGIF1. In mice, TGIF1 deficiency is not associated with changes in the expression of radiation-induced TGF-beta pathway-related transcripts following localized small intestinal irradiation. In HUVECs, TGIF1 overexpression or silencing has no influence either on the radiation-induced Smad activation or the Smad3-dependent PAI-1 overexpression. However, TGIF1 genetic deficiency sensitizes mice to radiation-induced intestinal damage after total body or localized small intestinal radiation exposure, demonstrating that TGIF1 plays a role in radiation-induced intestinal injury. In conclusion, the TGF-beta/Smad co-repressor TGIF1 plays a role in radiation-induced normal tissue damage by a Smad-independent mechanism.	[Hneino, Mohammad; Francois, Agnes; Buard, Valerie; Tarlet, Georges; Abderrahmani, Rym; Blirando, Karl; Benderitter, Marc; Milliat, Fabien] Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt, Fontenay Aux Roses, France; [Hoodless, Pamela A.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hoodless, Pamela A.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of British Columbia; British Columbia Cancer Agency	Hneino, M (corresponding author), Inst Radiol Protect & Nucl Safety IRSN, Lab Radiopathol & Expt, Fontenay Aux Roses, France.	fabien.milliat@irsn.fr		TARLET, Georges/0000-0002-4756-5127; Hoodless, Pamela/0000-0003-1371-0725; Milliat, Fabien/0000-0001-8249-9498				Aguilella C, 2003, HUM GENET, V112, P131, DOI 10.1007/s00439-002-0862-8; Andarawewa KL, 2007, INT J RADIAT BIOL, V83, P803, DOI 10.1080/09553000701711063; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586; Anscher MS, 1998, LUNG CANCER-J IASLC, V19, P109, DOI 10.1016/S0169-5002(97)00076-7; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Demange C, 2009, MOL CELL, V36, P1073, DOI 10.1016/j.molcel.2009.12.009; Denham JW, 2002, RADIOTHER ONCOL, V63, P129, DOI 10.1016/S0167-8140(02)00060-9; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ehrhart EJ, 1997, FASEB J, V11, P991, DOI 10.1096/fasebj.11.12.9337152; Flanders KC, 2003, AM J PATHOL, V163, P2247, DOI 10.1016/S0002-9440(10)63582-1; Flanders KC, 2002, AM J PATHOL, V160, P1057, DOI 10.1016/S0002-9440(10)64926-7; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Hamid R, 2008, BBA-GENE REGUL MECH, V1779, P347, DOI 10.1016/j.bbagrm.2008.04.003; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; Haydont V, 2008, AM J PHYSIOL-CELL PH, V294, pC1332, DOI 10.1152/ajpcell.90626.2007; Huang Y, 2006, KIDNEY INT, V69, P1713, DOI 10.1038/sj.ki.5000260; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jobling ME, 2006, RADIAT RES, V166, P839, DOI 10.1667/RR0695.1; Kraft M, 1996, RADIAT RES, V146, P619, DOI 10.2307/3579377; Kruse JJCM, 2009, RADIAT RES, V171, P188, DOI 10.1667/RR1526.1; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Milliat F, 2008, AM J PATHOL, V172, P691, DOI 10.2353/ajpath.2008.070930; Milliat F, 2006, AM J PATHOL, V169, P1484, DOI 10.2353/ajpath.2006.060116; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; Robbins MEC, 2001, RADIAT RES, V155, P481, DOI 10.1667/0033-7587(2001)155[0481:TROTTI]2.0.CO;2; Scharpfenecker M, 2009, RADIOTHER ONCOL, V92, P484, DOI 10.1016/j.radonc.2009.06.013; Scharpfenecker M, 2009, INT J RADIAT ONCOL, V73, P506, DOI 10.1016/j.ijrobp.2008.09.052; Schultze-Mosgau S, 2004, RADIOTHER ONCOL, V70, P249, DOI 10.1016/j.radonc.2004.01.010; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Wang JR, 1998, AM J PATHOL, V153, P1531, DOI 10.1016/S0002-9440(10)65741-0; Wotton D, 1999, J BIOL CHEM, V274, P37105, DOI 10.1074/jbc.274.52.37105; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827	48	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35672	10.1371/journal.pone.0035672	http://dx.doi.org/10.1371/journal.pone.0035672			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567107	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500025
J	Liu, DB; Gong, J; Dai, WK; Kang, XC; Huang, Z; Zhang, HM; Liu, W; Liu, L; Ma, JP; Xia, ZL; Chen, YX; Chen, YW; Wang, DP; Ni, PX; Guo, AY; Xiong, XY				Liu, Dongbo; Gong, Jing; Dai, Wenkui; Kang, Xincong; Huang, Zhuo; Zhang, Hong-Mei; Liu, Wei; Liu, Le; Ma, Junping; Xia, Zhilan; Chen, Yuxin; Chen, Yuewen; Wang, Depeng; Ni, Peixiang; Guo, An-Yuan; Xiong, Xingyao			The Genome of Ganderma lucidum Provide Insights into Triterpense Biosynthesis and Wood Degradation	PLOS ONE			English	Article							GANODERMA-LUCIDUM; VEGETATIVE INCOMPATIBILITY; NATURAL-PRODUCTS; GENE; PROTEIN; DATABASE; LIGNIN; TOOL; BIODEGRADATION; IDENTIFICATION	Background: Ganoderma lucidum (Reishi or Ling Zhi) is one of the most famous Traditional Chinese Medicines and has been widely used in the treatment of various human diseases in Asia countries. It is also a fungus with strong wood degradation ability with potential in bioenergy production. However, genes, pathways and mechanisms of these functions are still unknown. Methodology/Principal Findings: The genome of G. lucidum was sequenced and assembled into a 39.9 megabases (Mb) draft genome, which encoded 12,080 protein-coding genes and similar to 83% of them were similar to public sequences. We performed comprehensive annotation for G. lucidum genes and made comparisons with genes in other fungi genomes. Genes in the biosynthesis of the main G. lucidum active ingredients, ganoderic acids (GAs), were characterized. Among the GAs synthases, we identified a fusion gene, the N and C terminal of which are homologous to two different enzymes. Moreover, the fusion gene was only found in basidiomycetes. As a white rot fungus with wood degradation ability, abundant carbohydrate-active enzymes and ligninolytic enzymes were identified in the G. lucidum genome and were compared with other fungi. Conclusions/Significance: The genome sequence and well annotation of G. lucidum will provide new insights in function analyses including its medicinal mechanism. The characterization of genes in the triterpene biosynthesis and wood degradation will facilitate bio-engineering research in the production of its active ingredients and bioenergy.	[Liu, Dongbo; Xiong, Xingyao] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China; [Liu, Dongbo; Kang, Xincong; Xia, Zhilan; Chen, Yuxin; Chen, Yuewen] State Key Lab Subhlth Intervent Technol, Changsha, Hunan, Peoples R China; [Gong, Jing; Zhang, Hong-Mei; Liu, Wei; Guo, An-Yuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China; [Dai, Wenkui; Liu, Le; Ma, Junping; Ni, Peixiang] Beijing Genome Inst BGI Shenzhen, Shenzhen, Guangdong, Peoples R China; [Huang, Zhuo] Hunan Wanyuan Biotech Co Ltd, Changsha, Hunan, Peoples R China; [Gong, Jing; Zhang, Hong-Mei; Liu, Wei; Wang, Depeng] Next Biosci Co Ltd, Wuhan, Hubei, Peoples R China; [Wang, Depeng] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China	Hunan Agricultural University; Huazhong University of Science & Technology; Beijing Genomics Institute (BGI); South China University of Technology	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Hubei, Peoples R China.	guoay@mail.hust.edu.cn; xiongxy@hunau.net	Guo, An-Yuan/K-3656-2012		National Program on Key Basic Research Project (973 Program) [2012CB723000]; Key Projects in the National Science & Technology Program [2012BAD33B00]; National Natural Science Foundation of China [31171271]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Key Projects in the National Science & Technology Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding of this project was provided by the programs National Program on Key Basic Research Project (973 Program, 2012CB723000 to DBL), Key Projects in the National Science & Technology Program (2012BAD33B00 to DBL), and National Natural Science Foundation of China (31171271 to AYG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Asgher M, 2008, BIODEGRADATION, V19, P771, DOI 10.1007/s10532-008-9185-3; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augustin JM, 2011, PHYTOCHEMISTRY, V72, P435, DOI 10.1016/j.phytochem.2011.01.015; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Borodovsky Mark, 2003, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0405s01; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chu TT, 2011, BR J NUTR, P1; CRICK FHC, 1966, J MOL BIOL, V19, P548, DOI 10.1016/S0022-2836(66)80022-0; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hefner T, 2002, BIOORGAN MED CHEM, V10, P1731, DOI 10.1016/S0968-0896(02)00029-9; JiDing Z, 1989, CHINESE GANODERMA LU; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang XinCong, 2011, Journal of Hunan Agricultural University, V37, P147, DOI 10.3724/SP.J.1238.2011.00147; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LEE SY, 1990, CHEM PHARM BULL, V38, P1359, DOI 10.1248/cpb.38.1359; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lin ZB, 2005, J PHARMACOL SCI, V99, P144, DOI 10.1254/jphs.CRJ05008X; Lin ZB, 2004, ACTA PHARMACOL SIN, V25, P1387; Lin ZB, 2007, MODERN RES GANODERMA; Loubradou G, 2000, RES MICROBIOL, V151, P239, DOI 10.1016/S0923-2508(00)00145-5; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Makela MR, 2006, CURR GENET, V50, P323, DOI 10.1007/s00294-006-0090-1; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; MARZULLO L, 1995, J BIOL CHEM, V270, P3823, DOI 10.1074/jbc.270.8.3823; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Shang CH, 2008, BIOSCI BIOTECH BIOCH, V72, P1333, DOI 10.1271/bbb.80011; Shang CH, 2010, BIOSCI BIOTECH BIOCH, V74, P974, DOI 10.1271/bbb.90833; Shi LA, 2010, APPL MICROBIOL BIOT, V88, P1243, DOI 10.1007/s00253-010-2871-1; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; Sijia Zhao XC, 2011, P 2011 INT M GAN RES; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wang X, 2006, APPL MICROBIOL BIOT, V72, P508, DOI 10.1007/s00253-006-0314-9; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yuen JWM, 2005, NUTR CANCER, V53, P11, DOI 10.1207/s15327914nc5301_2; Zhao MW, 2007, J MICROBIOL BIOTECHN, V17, P1106	63	70	78	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36146	10.1371/journal.pone.0036146	http://dx.doi.org/10.1371/journal.pone.0036146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567134	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341500052
J	Lima, MJ; Docherty, HM; Chen, YX; Vallier, L; Docherty, K				Lima, Maria Joao; Docherty, Hilary M.; Chen, Yuanxiao; Vallier, Ludovic; Docherty, Kevin			Pancreatic Transcription Factors Containing Protein Transduction Domains Drive Mouse Embryonic Stem Cells towards Endocrine Pancreas	PLOS ONE			English	Article							DUODENAL HOMEOBOX-1; BETA-CELLS; DIFFERENTIATION; PDX-1; EXPRESSION; ENDODERM; MAFA	Protein transduction domains (PTDs), such as the HIV1-TAT peptide, have been previously used to promote the uptake of proteins into a range of cell types, including stem cells. Here we generated pancreatic transcription factors containing PTD sequences and administered these to endoderm enriched mouse embryonic stem (ES) cells under conditions that were designed to mimic the pattern of expression of these factors in the developing pancreas. The ES cells were first cultured as embryoid bodies and treated with Activin A and Bone morphogenetic protein 4 (BMP4) to promote formation of definitive endoderm. Cells were subsequently plated as a monolayer and treated with different combinations of the modified recombinant transcription factors Pdx1 and MafA. The results demonstrate that each transcription factor was efficiently taken up by the cells, where they were localized in the nuclei. RT-qPCR was used to measure the expression levels of pancreatic markers. After the addition of Pdx1 alone for a period of five days, followed by the combination of Pdx1 and TAT-MafA in a second phase, up-regulation of insulin 1, insulin 2, Pdx1, Glut2, Pax4 and Nkx6.1 was observed. As assessed by immunocytochemistry, double positive insulin and Pdx1 cells were detected in the differentiated cultures. Although the pattern of pancreatic markers expression in these cultures was comparable to that of a mouse transformed beta-cell line (MIN6) and human islets, the expression levels of insulin observed in the differentiated ES cell cultures were several orders of magnitude lower. This suggests that, although PTD-TFs may prove useful in studying the role of exogenous TFs in the differentiation of ES cells towards islets and other pancreatic lineages, the amount of insulin generated is well below that required for therapeutically useful cells.	[Lima, Maria Joao; Docherty, Hilary M.; Chen, Yuanxiao; Docherty, Kevin] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland; [Vallier, Ludovic] Anne McLaren Lab Regenerat Med, Cambridge, England	University of Aberdeen; University of Cambridge	Lima, MJ (corresponding author), Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen, Scotland.	k.docherty@abdn.ac.uk	vallier, ludovic/C-6368-2011; Lima, Maria Joao/HHR-9895-2022	Lima, Maria Joao/0000-0003-0597-7892; Vallier, Ludovic/0000-0002-3848-2602; Docherty, Kevin/0000-0001-6765-2060	Juvenile Diabetes Research Foundation International (JDRF); Wellcome Trust; Medical Research Council [G0800784B, G0701448, G0800784] Funding Source: researchfish; MRC [G0800784, G0701448] Funding Source: UKRI	Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Juvenile Diabetes Research Foundation International (JDRF) and Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Bernardo AS, 2009, STEM CELLS, V27, P341, DOI 10.1634/stemcells.2008-0310; Chen J, 2006, BIOCHEM BIOPH RES CO, V347, P931, DOI 10.1016/j.bbrc.2006.06.173; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Docherty K, 2011, STEM CELL BIOL REGEN, P177; Docherty K, 2007, SEMIN CELL DEV BIOL, V18, P827, DOI 10.1016/j.semcdb.2007.09.009; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Krosl G, 2005, BIOL BLOOD MARROW TR, V11, P19, DOI 10.1016/j.bbmt.2004.12.054; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lima MJ, MOL CELL ENDOCRINOL; Manceur A, 2007, ANAL BIOCHEM, V364, P51, DOI 10.1016/j.ab.2007.02.015; McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Noguchi H, 2003, DIABETES, V52, P1732, DOI 10.2337/diabetes.52.7.1732; Offield MF, 1996, DEVELOPMENT, V122, P983; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353	29	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36481	10.1371/journal.pone.0036481	http://dx.doi.org/10.1371/journal.pone.0036481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563503	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700052
J	Aaron, SD; Vandemheen, KL; Freitag, A; Pedder, L; Cameron, W; Lavoie, A; Paterson, N; Wilcox, P; Rabin, H; Tullis, E; Morrison, N; Ratjen, F				Aaron, Shawn D.; Vandemheen, Katherine L.; Freitag, Andreas; Pedder, Linda; Cameron, William; Lavoie, Annick; Paterson, Nigel; Wilcox, Pearce; Rabin, Harvey; Tullis, Elizabeth; Morrison, Nancy; Ratjen, Felix			Treatment of Aspergillus fumigatus in Patients with Cystic Fibrosis: A Randomized, Placebo-Controlled Pilot Study	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; IMMUNE-RESPONSES; ADULT PATIENTS; PREVALENCE; COLONIZATION; INFECTION; FREQUENCY	Background: Many patients with cystic fibrosis develop persistent airway infection/colonization with Aspergillus fumigatus, however the impact of A. fumigatus on clinical outcomes remains unclear. The objective of this study was to determine whether treatment directed against Aspergillus fumigatus improves pulmonary function and clinical outcomes in patients with cystic fibrosis (CF). Methods: We performed a double-blind randomized placebo-controlled pilot clinical trial involving 35 patients with CF whose sputum cultures were chronically positive for A. fumigatus. Participants were centrally randomized to receive either oral itraconazole 5 mg/kg/d (N = 18) or placebo (N = 17) for 24 weeks. The primary outcome was the proportion of patients who experienced a respiratory exacerbation requiring intravenous antibiotics over the 24 week treatment period. Secondary outcomes included changes in FEV1 and quality of life. Results: Over the 24 week treatment period, 4 of 18 (22%) patients randomized to itraconazole experienced a respiratory exacerbation requiring intravenous antibiotics, compared to 5 of 16 (31%) placebo treated patients, P = 0.70. FEV1 declined by 4.62% over 24 weeks in the patients randomized to itraconazole, compared to a 0.32% improvement in the placebo group (between group difference = -4.94%, 95% CI: -15.33 to 5.45, P = 0.34). Quality of life did not differ between the 2 treatment groups throughout the study. Therapeutic itraconazole blood levels were not achieved in 43% of patients randomized to itraconazole. Conclusion: We did not identify clinical benefit from itraconazole treatment for CF patients whose sputum was chronically colonized with A. fumigatus. Limitations of this pilot study were its small sample size, and failure to achieve therapeutic levels of itraconazole in many patients.	[Aaron, Shawn D.; Vandemheen, Katherine L.; Cameron, William] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Freitag, Andreas; Pedder, Linda] McMaster Univ, Hamilton, ON, Canada; [Lavoie, Annick] Ctr Hosp Univ Montreal, Montreal, PQ, Canada; [Paterson, Nigel] Univ Western Ontario, London, ON, Canada; [Wilcox, Pearce] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Rabin, Harvey] Univ Calgary, Calgary, AB, Canada; [Tullis, Elizabeth] Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Morrison, Nancy] Capital Hlth Dist, Halifax, NS, Canada; [Ratjen, Felix] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Ottawa; Ottawa Hospital Research Institute; McMaster University; Universite de Montreal; Western University (University of Western Ontario); University of British Columbia; University of Calgary; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Aaron, SD (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada.	saaron@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Ratjen, Felix/0000-0003-4057-6592; Aaron, Shawn/0000-0002-4762-3542	Cystic Fibrosis Canada; Physician Services Foundation of Ontario	Cystic Fibrosis Canada; Physician Services Foundation of Ontario	This study was funded by Cystic Fibrosis Canada and Physician Services Foundation of Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2010, CHEST, V137, P171, DOI 10.1378/chest.09-1103; Bakare N, 2003, MYCOSES, V46, P19, DOI 10.1046/j.1439-0507.2003.00830.x; Bargon J, 1999, RESP MED, V93, P835, DOI 10.1016/S0954-6111(99)90270-6; Burns JL, 1999, J INFECT DIS, V179, P1190, DOI 10.1086/314727; Conway SP, 2004, J ANTIMICROB CHEMOTH, V53, P841, DOI 10.1093/jac/dkh175; Corey M, 2001, CANADIAN CYSTIC FIBR; Cystic Fibrosis Canada, 2009, CAN CYST FIBR PAT DA; de Boer K, 2011, THORAX, V66, P680, DOI 10.1136/thx.2011.161117; ELDAHR JM, 1994, AM J RESP CRIT CARE, V150, P1513, DOI 10.1164/ajrccm.150.6.7952609; Hilliard Tom, 2005, J Cyst Fibros, V4, P215, DOI 10.1016/j.jcf.2005.05.019; Moss RB, 2010, CURR OPIN PULM MED, V16, P598, DOI 10.1097/MCP.0b013e32833e24a6; MURALI PS, 1994, CHEST, V106, P513, DOI 10.1378/chest.106.2.513; Quittner AL, 2000, J PEDIATR PSYCHOL, V25, P403, DOI 10.1093/jpepsy/25.6.403; Shoseyov D, 2006, CHEST, V130, P222, DOI 10.1378/chest.130.1.222; SIMMONDS EJ, 1994, ARCH DIS CHILD, V70, P139, DOI 10.1136/adc.70.2.139; Skov M, 2005, RESP MED, V99, P887, DOI 10.1016/j.rmed.2004.11.018; Stevens DA, 2003, CLIN INFECT DIS, V37, pS225, DOI 10.1086/376525; Wark P, 2000, COCHRANE LIB	18	59	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36077	10.1371/journal.pone.0036077	http://dx.doi.org/10.1371/journal.pone.0036077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22563440	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200039
J	Amyot, J; Semache, M; Ferdaoussi, M; Fontes, G; Poitout, V				Amyot, Julie; Semache, Meriem; Ferdaoussi, Mourad; Fontes, Ghislaine; Poitout, Vincent			Lipopolysaccharides Impair Insulin Gene Expression in Isolated Islets of Langerhans via Toll-Like Receptor-4 and NF-kappa B Signalling	PLOS ONE			English	Article							PANCREATIC-BETA-CELLS; BINDING PROTEIN BETA; DIET-INDUCED OBESITY; HIGH-FAT DIET; GUT MICROBIOTA; TRANSCRIPTION FACTOR; ADIPOSE-TISSUE; PALMITATE INHIBITION; DIABETES-MELLITUS; INNATE IMMUNITY	Background: Type 2 diabetes is characterized by pancreatic beta-cell dysfunction and is associated with low-grade inflammation. Recent observations suggest that the signalling cascade activated by lipopolysaccharides (LPS) binding to Toll-Like Receptor 4 (TLR4) exerts deleterious effects on pancreatic beta-cell function; however, the molecular mechanisms of these effects are incompletely understood. In this study, we tested the hypothesis that LPS alters insulin gene expression via TLR4 and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) in islets. Methodology/Principal Findings: A 24-h exposure of isolated human, rat and mouse islets of Langerhans to LPS dose-dependently reduced insulin gene expression. This was associated in mouse and rat islets with decreased mRNA expression of pancreas-duodenum homebox-1 (PDX-1) and mammalian homologue of avian MafA/l-Maf (MafA). Accordingly, LPS exposure also decreased glucose-induced insulin secretion. LPS repression of insulin, PDX-1 and MafA expression, as well as its inhibition of insulin secretion, were not observed in islets from TLR4-deficient mice. LPS inhibition of beta-cell gene expression in rat islets was prevented by inhibition of the NF-kappa B pathway, but not the p38 mitogen-activated protein kinase (p38 MAPK) pathway. Conclusions/Significance: Our findings demonstrate that LPS inhibit beta-cell gene expression in a TLR4-dependent manner and via NF-kappa B signaling in pancreatic islets, suggesting a novel mechanism by which the gut microbiota might affect pancreatic beta-cell function.	[Amyot, Julie; Semache, Meriem; Ferdaoussi, Mourad; Fontes, Ghislaine; Poitout, Vincent] CRCHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Amyot, Julie; Semache, Meriem; Poitout, Vincent] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Amyot, J (corresponding author), CRCHUM, Montreal Diabet Res Ctr, Montreal, PQ, Canada.	vincent.poitout@umontreal.ca	Ferdaoussi, Mourad/AGN-8892-2022	Ferdaoussi, Mourad/0000-0001-7636-0959; Poitout, Vincent/0000-0002-6555-5053	National Institutes of Health [R01DK58096]; Fonds de la Recherche en Sante du Quebec; Diabete Quebec; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM); Faculte des Etudes Superieures de l'Universite de Montreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058096] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Diabete Quebec; Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM); Faculte des Etudes Superieures de l'Universite de Montreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (R01DK58096 to VP). VP holds the Canada Research Chair in Diabetes and Pancreatic Beta-cell Function. JA and MS are supported by a training award from the Fonds de la Recherche en Sante du Quebec and received support from Diabete Quebec, the Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM) and the Faculte des Etudes Superieures de l'Universite de Montreal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PD, 2007, J CLIN ENDOCR METAB, V92, P2272, DOI 10.1210/jc.2006-2545; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Cha-Molstad H, 2007, MOL IMMUNOL, V44, P2933, DOI 10.1016/j.molimm.2007.01.015; Chang I, 2003, DIABETES, V52, P1169, DOI 10.2337/diabetes.52.5.1169; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Davis JE, 2008, OBESITY, V16, P1248, DOI 10.1038/oby.2008.210; DOCHERTY K, 1994, FASEB J, V8, P20, DOI 10.1096/fasebj.8.1.8299887; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fontes G, 2009, DIABETES, V58, P2048, DOI 10.2337/db08-0579; Garay-Malpartida HM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-18; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hammar EB, 2005, J BIOL CHEM, V280, P30630, DOI 10.1074/jbc.M502493200; He B, 2004, BIOCHEM BIOPH RES CO, V321, P13, DOI 10.1016/j.bbrc.2004.06.101; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hutton MJH, 2010, ISLETS, V2, P104, DOI 10.4161/isl.2.2.11209; Iype T, 2005, J BIOL CHEM, V280, P16798, DOI 10.1074/jbc.M414381200; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Kiely A, 2009, J ENDOCRINOL, V202, P365, DOI 10.1677/JOE-09-0160; Kim S, 2007, P NATL ACAD SCI USA, V104, P1913, DOI 10.1073/pnas.0610690104; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lawrence MC, 2005, J BIOL CHEM, V280, P26751, DOI 10.1074/jbc.M503158200; Lee SM, 2011, MOL CELL BIOCHEM, V354, P207, DOI 10.1007/s11010-011-0820-7; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Lin Y, 2000, J BIOL CHEM, V275, P24255, DOI 10.1074/jbc.M002137200; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Nilsen N, 2004, J BIOL CHEM, V279, P39727, DOI 10.1074/jbc.M405027200; Norlin S, 2005, DIABETES, V54, P125, DOI 10.2337/diabetes.54.1.125; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Poitout V, 2004, INT TXB DIABETES MEL; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulthess FT, 2009, CELL METAB, V9, P125, DOI 10.1016/j.cmet.2009.01.003; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Suganami T, 2007, BIOCHEM BIOPH RES CO, V354, P45, DOI 10.1016/j.bbrc.2006.12.190; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Vives-Pi M, 2003, CLIN EXP IMMUNOL, V133, P208, DOI 10.1046/j.1365-2249.2003.02211.x; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200; Zwergal A, 2006, J IMMUNOL, V177, P665, DOI 10.4049/jimmunol.177.1.665	61	91	109	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36200	10.1371/journal.pone.0036200	http://dx.doi.org/10.1371/journal.pone.0036200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558381	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000153
J	Gao, CH; Yang, M; He, ZG				Gao, Chun-hui; Yang, Min; He, Zheng-Guo			Characterization of a Novel ArsR-Like Regulator Encoded by Rv2034 in Mycobacterium tuberculosis	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORS; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; SMTB REPRESSOR; PROTEIN; FAMILY; SITES; VIRULENCE; SEQUENCE; OPERON	The genome of Mycobacterium tuberculosis, the causative agent of tuberculosis, encodes a large number of putative transcriptional regulators. However, the identity and target genes of only a few of them have been clearly identified to date. In a recent study, the ArsR family regulator Rv2034 was characterized as a novel positive regulator of phoP. In the current study, we characterized the auto-repressive capabilities of Rv2034 and identified several residues in the protein critical for its DNA binding activities. We also provide evidence that Rv2034 forms dimers in vitro. Furthermore, by using DNaseI footprinting assays, a palindromic sequence was identified as its binding site. Notably, we found that the dosR promoter region contains the binding motif for Rv2034, and that Rv2034 positively regulates the expression of the dosR gene. The potential roles of Rv2034 in the regulation of lipid metabolism and hypoxic adaptation are discussed.	[Gao, Chun-hui; Yang, Min; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan, Peoples R China.	he.zhengguo@hotmail.com	Gao, Chun-Hui/B-3667-2016; Gao, Chun-Hui/B-4111-2008; He, Zheng-Guo/P-3647-2014	Gao, Chun-Hui/0000-0002-1445-7939; Gao, Chun-Hui/0000-0002-1445-7939; Yang, Min/0000-0003-2924-5717	National Natural Science Foundation of China [30930003, 31025002]; Fundamental Research Funds for the Central Universities [2011PY140]; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hubei Chutian Scholar Program	This work is supported by the National Natural Science Foundation of China (30930003 and 31025002), the Fundamental Research Funds for the Central Universities (2011PY140) and Hubei Chutian Scholar Program (to Z.-G.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunkumar AI, 2009, P NATL ACAD SCI USA, V106, P18177, DOI 10.1073/pnas.0905558106; Barbosa RL, 2007, J BACTERIOL, V189, P6185, DOI 10.1128/JB.00331-07; Campbell DR, 2007, J BIOL CHEM, V282, P32298, DOI 10.1074/jbc.M703451200; Canneva F, 2005, J BACTERIOL, V187, P5837, DOI 10.1128/JB.187.16.5837-5840.2005; Cave JS, 2002, J BIOL CHEM, V277, P38441, DOI 10.1074/jbc.M207677200; Cavet JS, 2003, J BIOL CHEM, V278, P44560, DOI 10.1074/jbc.M307877200; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chauhan S, 2009, FEBS J, V276, P3428, DOI 10.1111/j.1742-4658.2009.07066.x; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Gao CH, 2011, BIOCHEM BIOPH RES CO, V411, P726, DOI 10.1016/j.bbrc.2011.07.014; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Korch SB, 2009, J BACTERIOL, V191, P1618, DOI 10.1128/JB.01318-08; Lee JH, 2007, J MICROBIOL, V45, P146; Liu M, 2007, INFECT IMMUN, V75, P3282, DOI 10.1128/IAI.00045-07; Liu W, 2007, J MOL BIOL, V369, P474, DOI 10.1016/j.jmb.2007.03.044; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Miller JH., 1972, EXPT MOL GENETICS; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Murphy JN, 2009, J BACTERIOL, V191, P6722, DOI 10.1128/JB.00801-09; O'Rourke KP, 2010, J BACTERIOL, V192, P1433, DOI 10.1128/JB.01161-09; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Summers AO, 2009, CURR OPIN MICROBIOL, V12, P138, DOI 10.1016/j.mib.2009.02.003; TIMM JL, 1994, J BACTERIOL, V176, P6749, DOI 10.1128/JB.176.21.6749-6753.1994; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; World Health Organization, 2010, GLOB TUB CONTR WHO R; WU J, 1991, MOL MICROBIOL, V5, P1331, DOI 10.1111/j.1365-2958.1991.tb00779.x; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Zhao HY, 2010, MICROBIOL-SGM, V156, P385, DOI 10.1099/mic.0.033548-0	41	34	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36255	10.1371/journal.pone.0036255	http://dx.doi.org/10.1371/journal.pone.0036255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558408	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000172
J	Luiz, OC; Gianini, RJ; Goncalves, FT; Francisco, G; Festa-Neto, C; Sanches, JA; Gattas, GJF; Chammas, R; Eluf-Neto, J				Luiz, Olinda C.; Gianini, Reinaldo Jose; Goncalves, Fernanda T.; Francisco, Guilherme; Festa-Neto, Cyro; Sanches, Jose Antonio; Gattas, Gilka J. F.; Chammas, Roger; Eluf-Neto, Jose			Ethnicity and Cutaneous Melanoma in the City of Sao Paulo, Brazil: A Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; REPAIR GENES; EUROPEAN ANCESTRY; UV INDEX; POLYMORPHISMS; POPULATION; SKIN; PIGMENTATION; EPIDEMIOLOGY; LATITUDE	Background: Over the last century the incidence of cutaneous melanoma has increased worldwide, a trend that has also been observed in Brazil. The identified risk factors for melanoma include the pattern of sun exposure, family history, and certain phenotypic features. In addition, the incidence of melanoma might be influenced by ethnicity. Like many countries, Brazil has high immigration rates and consequently a heterogenous population. However, Brazil is unique among such countries in that the ethnic heterogeneity of its population is primarily attributable to admixture. This study aimed to evaluate the contribution of European ethnicity to the risk of cutaneous melanoma in Brazil. Methodology/Principal Findings: We carried out a hospital-based case-control study in the metropolitan area of Sao Paulo, Brazil. We evaluated 424 hospitalized patients (202 melanoma patients and 222 control patients) regarding phenotypic features, sun exposure, and number of grandparents born in Europe. Through multivariate logistic regression analysis, we found the following variables to be independently associated with melanoma: grandparents born in Europe-Spain (OR = 3.01, 95% CI: 1.03-8.77), Italy (OR = 3.47, 95% CI: 1.41-8.57), a Germanic/Slavic country (OR = 3.06, 95% CI: 1.05-8.93), or >= 2 European countries (OR = 2.82, 95% CI: 1.06-7.47); eye color-light brown (OR = 1.99, 95% CI: 1.14-3.84) and green/blue (OR = 4.62; 95% CI 2.22-9.58); pigmented lesion removal (OR = 3.78; 95% CI: 2.21-6.49); no lifetime sunscreen use (OR = 3.08; 95% CI: 1.03-9.22); and lifetime severe sunburn (OR = 1.81; 95% CI: 1.03-3.19). Conclusions: Our results indicate that European ancestry is a risk factor for cutaneous melanoma. Such risk appears to be related not only to skin type, eye color, and tanning capacity but also to others specific characteristics of European populations introduced in the New World by European immigrants.	[Luiz, Olinda C.; Eluf-Neto, Jose] Univ Sao Paulo, Fac Med, Lab Epidemiol & Imunobiol LIM38, Dept Prevent Med, Sao Paulo, Brazil; [Gianini, Reinaldo Jose] Univ Sao Paulo, Fac Med, Lab Processamento Dados Biomed LIM39, Dept Prevent Med, Sao Paulo, Brazil; [Gianini, Reinaldo Jose] Pontificia Univ Catolica Sao Paulo, Sorocaba, Brazil; [Goncalves, Fernanda T.; Gattas, Gilka J. F.] Univ Sao Paulo, Fac Med, Lab Imunohematol & Hematol Forense LIM40, Dept Med Legal Etica Med Med Social & Trabalho, Sao Paulo, Brazil; [Francisco, Guilherme; Chammas, Roger] Univ Sao Paulo, Fac Med, Lab Oncol Expt LIM24, Dept Radiol, Sao Paulo, Brazil; [Festa-Neto, Cyro; Sanches, Jose Antonio] Univ Sao Paulo, Fac Med, Dept Dermatol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Pontificia Universidade Catolica de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Luiz, OC (corresponding author), Univ Sao Paulo, Fac Med, Lab Epidemiol & Imunobiol LIM38, Dept Prevent Med, Sao Paulo, Brazil.	olinda@usp.br	Luiz, Olinda do Carmo/C-6075-2012; Gianini, Reinaldo/G-2475-2012; SANCHES, JOSE ANTONIO/B-3250-2011; Chammas, Roger/A-8004-2011; Gattas, Gilka JF/H-4846-2013; Eluf-Neto, Jose/B-2522-2009	Luiz, Olinda do Carmo/0000-0002-2596-3626; SANCHES, JOSE ANTONIO/0000-0002-5709-092X; Chammas, Roger/0000-0003-0342-8726; Eluf-Neto, Jose/0000-0001-7504-2115	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [06-52041-9, 5-56069-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq [478239/03-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (process 06-52041-9, 5-56069-2) www.fapesp.br. 2. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (National Counsel of Technological and Scientific Development - Brazil) - CNPq (process no478239/03-3)- www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Acton RT, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-47; Bakos L, 2009, J EUR ACAD DERMATOL, V23, P304, DOI 10.1111/j.1468-3083.2008.03027.x; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Breslow NE, 1980, IARC SCI PUBL, V32; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; CLARK WH, 1969, CANCER RES, V29, P705; Correa MD, 2010, PHOTOCHEM PHOTOBIOL, V86, P438, DOI 10.1111/j.1751-1097.2009.00659.x; Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307; de Vries E, 2005, EUR J CANCER, V41, P2150, DOI 10.1016/j.ejca.2005.04.042; Eide MJ, 2005, ARCH DERMATOL, V141, P477, DOI 10.1001/archderm.141.4.477; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003; Gruber F, 2008, COLLEGIUM ANTROPOL, V32, P147; Hu S, 2004, ARCH DERMATOL, V140, P819, DOI 10.1001/archderm.140.7.819; IBGE, 2012, BRAS 500 AN POV; Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469; Lascano AR, 2004, MEDICINA-BUENOS AIRE, V64, P504; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Loria D, 2001, INT J DERMATOL, V40, P108, DOI 10.1046/j.1365-4362.2001.01132.x; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Mendes GLQ, 2010, J TOXICOL ENV HEAL A, V73, P850, DOI 10.1080/15287391003744757; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Nijsten T, 2005, J EUR ACAD DERMATOL, V19, P332, DOI 10.1111/j.1468-3083.2005.01196.x; Ou-Yang H, 2004, J INVEST DERMATOL, V122, P492, DOI 10.1046/j.0022-202X.2004.22247.x; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Swan MC, 2003, MELANOMA RES, V13, P415, DOI 10.1097/00008390-200308000-00012; Tomescu D, 2001, CARCINOGENESIS, V22, P403, DOI 10.1093/carcin/22.3.403; Trotti A., 2010, AJCC AM JOINT COMMIT	33	11	12	0	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36348	10.1371/journal.pone.0036348	http://dx.doi.org/10.1371/journal.pone.0036348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558444	Green Published, gold			2022-12-27	WOS:000305336000194
J	Tran, K; Cimon, K; Severn, M; Pessoa-Silva, CL; Conly, J				Khai Tran; Cimon, Karen; Severn, Melissa; Pessoa-Silva, Carmem L.; Conly, John			Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review	PLOS ONE			English	Review							SARS; PATHOGENS; INFLUENZA; LESSONS	Aerosol generating procedures (AGPs) may expose health care workers (HCWs) to pathogens causing acute respiratory infections (ARIs), but the risk of transmission of ARIs from AGPs is not fully known. We sought to determine the clinical evidence for the risk of transmission of ARIs to HCWs caring for patients undergoing AGPs compared with the risk of transmission to HCWs caring for patients not undergoing AGPs. We searched PubMed, EMBASE, MEDLINE, CINAHL, the Cochrane Library, University of York CRD databases, EuroScan, LILACS, Indian Medlars, Index Medicus for SE Asia, international health technology agencies and the Internet in all languages for articles from 01/01/1990 to 22/10/2010. Independent reviewers screened abstracts using pre-defined criteria, obtained full-text articles, selected relevant studies, and abstracted data. Disagreements were resolved by consensus. The outcome of interest was risk of ARI transmission. The quality of evidence was rated using the GRADE system. We identified 5 case-control and 5 retrospective cohort studies which evaluated transmission of SARS to HCWs. Procedures reported to present an increased risk of transmission included [n; pooled OR(95%CI)] tracheal intubation [n = 4 cohort; 6.6 (2.3, 18.9), and n = 4 case- control; 6.6 (4.1, 10.6)], non-invasive ventilation [n = 2 cohort; OR 3.1(1.4, 6.8)], tracheotomy [n = 1 case- control; 4.2 (1.5, 11.5)] and manual ventilation before intubation [n = 1 cohort; OR 2.8 (1.3, 6.4)]. Other intubation associated procedures, endotracheal aspiration, suction of body fluids, bronchoscopy, nebulizer treatment, administration of O2, high flow O2, manipulation of O2 mask or BiPAP mask, defibrillation, chest compressions, insertion of nasogastric tube, and collection of sputum were not significant. Our findings suggest that some procedures potentially capable of generating aerosols have been associated with increased risk of SARS transmission to HCWs or were a risk factor for transmission, with the most consistent association across multiple studies identified with tracheal intubation.	[Khai Tran; Cimon, Karen; Severn, Melissa] CADTH, Ottawa, ON, Canada; [Pessoa-Silva, Carmem L.; Conly, John] WHO, CH-1211 Geneva, Switzerland; [Conly, John] Univ Calgary, Dept Med, Fac Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Fac Med, Dept Microbiol, Calgary, AB, Canada; [Conly, John] Univ Calgary, Fac Med, Dept Immunol & Infect Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, Fac Med, Dept Pathol & Lab Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Fac Med, Calvin Phoebe & Joan Synder Inst Infect Immun & I, Calgary, AB, Canada	World Health Organization; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Tran, K (corresponding author), CADTH, Ottawa, ON, Canada.	khait@cadth.ca			Canadian federal, provincial and territorial governments	Canadian federal, provincial and territorial governments	This research was supported through a financial contribution from Canadian federal, provincial and territorial governments to the Canadian Agency for Drugs and Technologies in Health (CADTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Health and Wellness, 2004, ALB SARS RESP INF PR; Betsy Lehman Center for Patient Safety and Medical Error Reduction JSI Research and Training Institute Inc. Massachusetts Department of Public Health, 2008, PREV CONTR HEALTHC 1; British Thoracic Society British Infection Society Health Protection Agency, 2004, BRIT THOR SOC HOSP M; Carlson AL, 2010, CURR OPIN INFECT DIS, V23, P293, DOI 10.1097/QCO.0b013e32833bb804; Centers for Disease Control and Prevention, 2005, PUBL HLTH GUID CO S1; Chen WQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-81; College of Respiratory Therapists of Ontario, 2008, INF PREV CONTR CLIN; Davies A., 2009, Journal of Infection Prevention, V10, P122, DOI 10.1177/1757177409106456; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Fowler RA, 2004, AM J RESP CRIT CARE, V169, P1198, DOI 10.1164/rccm.200305-715OC; Gamage B, 2005, AM J INFECT CONTROL, V33, P114, DOI 10.1016/j.ajic.2004.12.002; Higgins JP, 2008, COCHRANE HDB SYST RE; Hui DSC, 2010, INFECT DIS CLIN N AM, V24, P619, DOI 10.1016/j.idc.2010.04.009; Liu W, 2009, TROP MED INT HEALTH, V14, P52, DOI 10.1111/j.1365-3156.2009.02255.x; Loeb M, 2004, EMERG INFECT DIS, V10, P251, DOI 10.3201/eid1002.030838; Ma Huai-jian, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P741; Moore D, 2005, AM J INFECT CONTROL, V33, P88, DOI 10.1016/j.ajic.2004.11.003; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pei Li-ying, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P271; Raboud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010717; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525; Sepkowitz KA, 1996, ANN INTERN MED, V125, P826, DOI 10.7326/0003-4819-125-10-199611150-00007; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Ter Chee VW, 2004, ANESTHESIOLOGY, V100, P1394, DOI 10.1097/00000542-200406000-00010; Weber DJ, 2010, CRIT CARE MED, V38, pS306, DOI 10.1097/CCM.0b013e3181e69ebd; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; World Health Organization (WHO), 2008, EP PAND PRON AC RESP; Zimmerman JL, 2010, INTENS CARE MED, V36, pS65, DOI 10.1007/s00134-010-1766-z	29	1085	1124	6	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35797	10.1371/journal.pone.0035797	http://dx.doi.org/10.1371/journal.pone.0035797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563403	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100030
J	Lopez-Castejon, G; Corbett, D; Goldrick, M; Roberts, IS; Brough, D				Lopez-Castejon, Gloria; Corbett, David; Goldrick, Marie; Roberts, Ian S.; Brough, David			Inhibition of Calpain Blocks the Phagosomal Escape of Listeria monocytogenes	PLOS ONE			English	Article							MACROPHAGES; ACTIN; GENE; CASPASE-1; INFECTION; VIRULENCE; CELLS; INFLAMMASOME; ACTIVATION; MATURATION	Listeria monocytogenes is a Gram-positive facultative intracellular bacterium responsible for the food borne infection listeriosis, affecting principally the immunocompromised, the old, neonates and pregnant women. Following invasion L. monocytogenes escapes the phagosome and replicates in the cytoplasm. Phagosome escape is central to L. monocytogenes virulence and is required for initiating innate host-defence responses such as the secretion of the cytokine interleukin-1. Phagosome escape of L. monocytogenes is reported to depend upon host proteins such as gamma-interferon-inducible lysosomal thiol reductase and the cystic fibrosis transmembrane conductance regulator. The host cytosolic cysteine protease calpain is required in the life cycle of numerous pathogens, and previous research reports an activation of calpain by L. monocytogenes infection. Thus we sought to determine whether host calpain was required for the virulence of L. monocytogenes. Treatment of macrophages with calpain inhibitors blocked escape of L. monocytogenes from the phagosome and consequently its proliferation within the cytosol. This was independent of any direct effect on the production of bacterial virulence factors or of a bactericidal effect. Furthermore, the secretion of interleukin-1 beta, a host cytokine whose secretion induced by L. monocytogenes depends upon phagosome escape, was also blocked by calpain inhibition. These data indicate that L. monocytogenes co-opts host calpain to facilitate its escape from the phagosome, and more generally, that calpain may represent a cellular Achilles heel exploited by pathogens.	[Lopez-Castejon, Gloria; Corbett, David; Goldrick, Marie; Roberts, Ian S.; Brough, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Lopez-Castejon, G (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.brough@manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015	Lopez-Castejon, Gloria/0000-0002-8585-3381; Brough, David/0000-0002-2250-2381	Wellcome Trust; Medical Research Council; MRC [G0601205] Funding Source: UKRI; Medical Research Council [G0601205] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Lopez-Castejon and Brough are supported by the Wellcome Trust. Corbett was supported by a Medical Research Council grant to Roberts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPUCHEARANDA CM, 1995, INFECT IMMUN, V63, P4456, DOI 10.1128/IAI.63.11.4456-4462.1995; Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Baron C, 2010, CURR OPIN MICROBIOL, V13, P100, DOI 10.1016/j.mib.2009.12.003; Bozym RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001135; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Corbett D, 2011, MOL MICROBIOL, V81, P457, DOI 10.1111/j.1365-2958.2011.07705.x; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; Dewamitta SR, 2010, INFECT IMMUN, V78, P1884, DOI 10.1128/IAI.01143-09; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goldfine H, 2002, MICROBES INFECT, V4, P1335, DOI 10.1016/S1286-4579(02)00011-4; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HARTFORD T, 1993, INT J SYST BACTERIOL, V43, P26, DOI 10.1099/00207713-43-1-26; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Perez-Cordon G, 2011, MICROBES INFECT, V13, P103, DOI 10.1016/j.micinf.2010.10.007; Radtke AL, 2011, P NATL ACAD SCI USA, V108, P1633, DOI 10.1073/pnas.1013262108; Ray K, 2009, NAT REV MICROBIOL, V7, P333, DOI 10.1038/nrmicro2112; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Sorimachi H, 2010, EXP ANIM TOKYO, V59, P549, DOI 10.1538/expanim.59.549; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Warren SE, 2008, J IMMUNOL, V180, P7558, DOI 10.4049/jimmunol.180.11.7558; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; WUENSCHER MD, 1991, MOL GEN GENET, V228, P177, DOI 10.1007/BF00282463	40	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35936	10.1371/journal.pone.0035936	http://dx.doi.org/10.1371/journal.pone.0035936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563421	Green Submitted, gold, Green Published			2022-12-27	WOS:000305349100047
J	Math, RK; Jin, HM; Kim, JM; Hahn, Y; Park, W; Madsen, EL; Jeon, CO				Math, Renukaradhya K.; Jin, Hyun Mi; Kim, Jeong Myeong; Hahn, Yoonsoo; Park, Woojun; Madsen, Eugene L.; Jeon, Che Ok			Comparative Genomics Reveals Adaptation by Alteromonas sp SN2 to Marine Tidal-Flat Conditions: Cold Tolerance and Aromatic Hydrocarbon Metabolism	PLOS ONE			English	Article							PROVIDES ACQUIRED-RESISTANCE; HORIZONTAL GENE-TRANSFER; CODON USAGE BIAS; OPEN SOFTWARE; NAG GENES; DI-GMP; SEA; MACLEODII; COMMUNITY; SEDIMENT	Alteromonas species are globally distributed copiotrophic bacteria in marine habitats. Among these, sea-tidal flats are distinctive: undergoing seasonal temperature and oxygen-tension changes, plus periodic exposure to petroleum hydrocarbons. Strain SN2 of the genus Alteromonas was isolated from hydrocarbon-contaminated sea-tidal flat sediment and has been shown to metabolize aromatic hydrocarbons there. Strain SN2's genomic features were analyzed bioinformatically and compared to those of Alteromonas macleodii ecotypes: AltDE and ATCC 27126. Strain SN2's genome differs from that of the other two strains in: size, average nucleotide identity value, tRNA genes, noncoding RNAs, dioxygenase gene content, signal transduction genes, and the degree to which genes collected during the Global Ocean Sampling project are represented. Patterns in genetic characteristics (e.g., GC content, GC skew, Karlin signature, CRISPR gene homology) indicate that strain SN2's genome architecture has been altered via horizontal gene transfer (HGT). Experiments proved that strain SN2 was far more cold tolerant, especially at 5 degrees C, than the other two strains. Consistent with the HGT hypothesis, a total of 15 genomic islands in strain SN2 likely confer ecological fitness traits (especially membrane transport, aromatic hydrocarbon metabolism, and fatty acid biosynthesis) specific to the adaptation of strain SN2 to its seasonally cold sea-tidal flat habitat.	[Math, Renukaradhya K.; Jin, Hyun Mi; Kim, Jeong Myeong; Hahn, Yoonsoo; Jeon, Che Ok] Chung Ang Univ, Sch Biol Sci, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea; [Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Seoul, South Korea; [Madsen, Eugene L.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Chung Ang University; Korea University; Cornell University	Math, RK (corresponding author), Chung Ang Univ, Sch Biol Sci, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea.	cojeon@cau.ac.kr	Math, Renukaradhya K/C-8175-2013	HAHN, YOONSOO/0000-0003-4273-9842	Ministry for Agriculture, Forestry and Fisheries; Next-Generation BioGreen 21 Program [SSAC2011- PJ008220]; Rural Development Administration, Republic of Korea; NSF [DEB-0841999]	Ministry for Agriculture, Forestry and Fisheries(Ministry of Agriculture Forestry & Fisheries - Japan); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); NSF(National Science Foundation (NSF))	These efforts were supported by the Technology Development Program for Agriculture and Forestry (TDPAF) of the Ministry for Agriculture, Forestry and Fisheries and by the Next-Generation BioGreen 21 Program (No. SSAC2011- PJ008220), Rural Development Administration, Republic of Korea. ELM was supported by NSF grant no. DEB-0841999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; Angellotti MC, 2007, NUCLEIC ACIDS RES, V35, pW132, DOI 10.1093/nar/gkm392; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; Banat IM, 1998, ENVIRON INT, V24, P109, DOI 10.1016/S0160-4120(97)00127-X; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BAUMANN L, 1972, J BACTERIOL, V110, P402, DOI 10.1128/JB.110.1.402-429.1972; BAUMANN P, 1984, INT J SYST BACTERIOL, V34, P145, DOI 10.1099/00207713-34-2-145; Corsaro MM, 2008, CHEM-EUR J, V14, P9368, DOI 10.1002/chem.200800117; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; Darling AE, 2010, PLOS ONE, V5; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eppinger M, 2004, NAT REV MICROBIOL, V2, P872, DOI 10.1038/nrmicro1024; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Gao S, 2008, FEBS J, V275, P5201, DOI 10.1111/j.1742-4658.2008.06651.x; Garcia-Martinez J, 2002, ENVIRON MICROBIOL, V4, P42, DOI 10.1046/j.1462-2920.2002.00255.x; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Hsiao W, 2003, BIOINFORMATICS, V19, P418, DOI 10.1093/bioinformatics/btg004; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jeon CO, 2006, APPL ENVIRON MICROB, V72, P1086, DOI 10.1128/AEM.72.2.1086-1095.2006; Jin HM, 2012, ENV SCI TECHNO UNPUB; Jin HM, 2011, J BACTERIOL, V193, P4292, DOI 10.1128/JB.05252-11; Kim BS, 2004, J MICROBIOL BIOTECHN, V14, P205; Kim JM, 2010, INT J SYST EVOL MICR, V60, P1828, DOI 10.1099/ijs.0.016246-0; Kim J, 2008, MICROBIOL-SGM, V154, P3905, DOI 10.1099/mic.0.2008/020362-0; Kim M, 2010, MAR POLLUT BULL, V60, P383, DOI 10.1016/j.marpolbul.2009.10.015; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANG H, 1995, BIOCHEM BIOPH RES CO, V208, P927, DOI 10.1006/bbrc.1995.1423; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; Lobry JR, 2003, J APPL GENET, V44, P235; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Medigue C, 2005, GENOME RES, V15, P1325, DOI 10.1101/gr.4126905; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Park MJ, 2007, APPL ENVIRON MICROB, V73, P5146, DOI 10.1128/AEM.00782-07; Pumphrey GM, 2007, MICROBIOL-SGM, V153, P3730, DOI 10.1099/mic.0.2007/010728-0; Qin QL, 2011, ISME J, V5, P274, DOI 10.1038/ismej.2010.103; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2009, J BACTERIOL, V191, P4697, DOI 10.1128/JB.00651-09; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Russell NJ, 1999, MICROBIOL-UK, V145, P767, DOI 10.1099/13500872-145-4-767; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sass AM, 2001, APPL ENVIRON MICROB, V67, P5392, DOI 10.1128/AEM.67.12.5392-5402.2001; Satapathy SS, 2010, MICROBIOL RES, V165, P609, DOI 10.1016/j.micres.2009.12.003; Sledjeski DD, 1996, EMBO J, V15, P3993, DOI 10.1002/j.1460-2075.1996.tb00773.x; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Sohma A, 2008, ECOL MODEL, V215, P10, DOI 10.1016/j.ecolmodel.2008.02.027; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stevens H, 2005, FEMS MICROBIOL ECOL, V54, P351, DOI 10.1016/j.femsec.2005.04.008; Stevens H, 2007, ENVIRON MICROBIOL, V9, P1810, DOI 10.1111/j.1462-2920.2007.01302.x; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Temperton B, 2009, ISME J, V3, P792, DOI 10.1038/ismej.2009.32; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Webler T, 2010, ENVIRON MANAGE, V45, P723, DOI 10.1007/s00267-010-9447-9; Winberg PC, 2007, BIOL CONSERV, V134, P310, DOI 10.1016/j.biocon.2006.07.019; Xu K, 2007, GENE, V397, P136, DOI 10.1016/j.gene.2007.04.023; Yagi JM, 2009, ENVIRON MICROBIOL, V11, P2253, DOI 10.1111/j.1462-2920.2009.01947.x; Yim JH, 2005, KEY ENG MAT, V277-279, P155, DOI 10.4028/www.scientific.net/KEM.277-279.155; Zaidi BR, 2003, MAR POLLUT BULL, V46, P418, DOI 10.1016/S0025-326X(02)00479-4; Zaidi BR, 1999, MAR POLLUT BULL, V38, P737, DOI 10.1016/S0025-326X(99)00037-5; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	75	76	78	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35784	10.1371/journal.pone.0035784	http://dx.doi.org/10.1371/journal.pone.0035784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563400	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100028
J	Pang, Y; Xiao, R; Liu, X; Li, QW				Pang, Yue; Xiao, Rong; Liu, Xin; Li, Qingwei			Identification and Characterization of the Lamprey High-Mobility Group Box 1 Gene	PLOS ONE			English	Article							BUCCAL GLAND SECRETION; VARIABLE LYMPHOCYTE RECEPTORS; LAMPETRA-JAPONICA; CYTOKINE ACTIVITY; DENDRITIC CELLS; CONCANAVALIN-A; HMGB PROTEINS; DNA; ACTIVATION; STIMULATION	High-mobility group box 1 (HMGB1), a highly conserved DNA-binding protein, plays an important role in maintaining nucleosome structures, transcription, and inflammation. We identified a homolog of HMGB1 in the Japanese lamprey (Lampetra japonica). The Lampetra japonica HMGB1 gene (Lj-HMGB1) has over 70% sequence identity with its homologs in jawed vertebrates. Despite the reasonably high sequence identity with other HMGB1 proteins, Lj-HMGB1 did not group together with these proteins in a phylogenetic analysis. We examined Lj-HMGB1 expression in lymphocyte-like cells, and the kidneys, heart, gills, and intestines of lampreys before and after the animals were challenged with lipopolysaccharide (LPS) and concanavalin A (ConA). Lj-HMGB1 was initially expressed at a higher level in the heart, but after treatment with LPS and ConA only the gills demonstrated a significant up-regulation of expression. The recombinant Lj-HMGB1 (rLj-HMGB1) protein bound double-stranded DNA and induced the proliferation of human adenocarcinoma cells to a similar extent as human HMGB1. We further revealed that Lj-HMGB1 was able to induce the production of tumor necrosis factor-alpha (TNF-alpha), a pro-inflammatory mediator, in activated human acute monocytic leukemia cells. These results suggest that lampreys use HMGB1 to activate their innate immunity for the purpose of pathogen defense.	[Pang, Yue; Xiao, Rong; Liu, Xin; Li, Qingwei] Liaoning Normal Univ, Inst Marine Genom & Prote, Dalian, Peoples R China; [Pang, Yue] Dalian Univ, Coll Life Sci & Technol, Dalian, Peoples R China	Liaoning Normal University; Dalian University	Pang, Y (corresponding author), Liaoning Normal Univ, Inst Marine Genom & Prote, Dalian, Peoples R China.	liqw@263.net			National Natural Science Foundation of China [31071991]; Science and Technology Project of Dalian [2011J21DW016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Dalian	This work was jointly supported by the National Natural Science Foundation of China (No. 31071991, http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html) and the Science and Technology Project of Dalian (No. 2011J21DW016, http://kjjh.dlinfo.gov.cn/login.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Amemiya CT, 2007, CURR OPIN IMMUNOL, V19, P535, DOI 10.1016/j.coi.2007.08.003; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bassi R, 2008, J NEURO-ONCOL, V87, P23, DOI 10.1007/s11060-007-9488-y; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Chi SP, 2009, PFLUG ARCH EUR J PHY, V458, P537, DOI 10.1007/s00424-008-0631-1; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Craig DGN, 2011, LIVER INT, V31, P1127, DOI 10.1111/j.1478-3231.2011.02528.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Dumitriu IE, 2007, J LEUKOCYTE BIOL, V81, P84, DOI 10.1189/jlb.0306171; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Huang HQ, 2011, J BIOL CHEM, V286, P36739, DOI 10.1074/jbc.M111.245944; Ishii A, 2007, J IMMUNOL, V178, P397, DOI 10.4049/jimmunol.178.1.397; Ito N, 2007, BIOCHEM BIOPH RES CO, V358, P35, DOI 10.1016/j.bbrc.2007.04.065; Kadowaki T, 2009, FISH SHELLFISH IMMUN, V27, P585, DOI 10.1016/j.fsi.2008.12.006; Krauss S, 1999, BBA-BIOENERGETICS, V1412, P129, DOI 10.1016/S0005-2728(99)00058-4; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu XJ, 2009, DEV COMP IMMUNOL, V33, P257, DOI 10.1016/j.dci.2008.09.008; Mahoney JA, 2005, CURR OPIN IMMUNOL, V17, P583, DOI 10.1016/j.coi.2005.09.018; Maroso M, 2011, J INTERN MED, V270, P319, DOI 10.1111/j.1365-2796.2011.02431.x; Messmer D, 2004, J IMMUNOL, V173, P307, DOI 10.4049/jimmunol.173.1.307; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ronchetti A, 1999, J IMMUNOL, V163, P130; Sharman AC, 1997, GENE, V184, P99, DOI 10.1016/S0378-1119(96)00580-X; Shen XK, 2009, ONCOL REP, V22, P535, DOI 10.3892/or_00000468; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; Sparatore B, 2002, BIOCHEM J, V363, P529, DOI 10.1042/0264-6021:3630529; Stott K, 2006, J MOL BIOL, V360, P90, DOI 10.1016/j.jmb.2006.04.059; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Sun J, 2008, BIOCHIMIE, V90, P1760, DOI 10.1016/j.biochi.2008.08.002; Sun Nian-Kang, 2005, Chang Gung Med J, V28, P673; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Topalova D, 2008, INT J BIOCHEM CELL B, V40, P1536, DOI 10.1016/j.biocel.2007.11.014; Tsutsui S, 2007, IMMUNOGENETICS, V59, P873, DOI 10.1007/s00251-007-0254-2; Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480; Xiao R, 2007, BIOCHIMIE, V89, P383, DOI 10.1016/j.biochi.2006.09.002; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zhao X, 2011, J BIOL CHEM, V286, P23200, DOI 10.1074/jbc.M111.223834	50	23	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35755	10.1371/journal.pone.0035755	http://dx.doi.org/10.1371/journal.pone.0035755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563397	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349100025
J	Rouzeau, S; Cordelieres, FP; Buhagiar-Labarchede, G; Hurbain, I; Onclercq-Delic, R; Gemble, S; Magnaghi-Jaulin, L; Jaulin, C; Amor-Gueret, M				Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Hurbain, Ilse; Onclercq-Delic, Rosine; Gemble, Simon; Magnaghi-Jaulin, Laura; Jaulin, Christian; Amor-Gueret, Mounira			Bloom's Syndrome and PICH Helicases Cooperate with Topoisomerase II alpha in Centromere Disjunction before Anaphase	PLOS ONE			English	Article							BLM HELICASE; DNA THREADS; DECATENATION; EPIGENETICS; INSTABILITY; CHECKPOINT; CANCER; CELLS	Centromeres are specialized chromosome domains that control chromosome segregation during mitosis, but little is known about the mechanisms underlying the maintenance of their integrity. Centromeric ultrafine anaphase bridges are physiological DNA structures thought to contain unresolved DNA catenations between the centromeres separating during anaphase. BLM and PICH helicases colocalize at these ultrafine anaphase bridges and promote their resolution. As PICH is detectable at centromeres from prometaphase onwards, we hypothesized that BLM might also be located at centromeres and that the two proteins might cooperate to resolve DNA catenations before the onset of anaphase. Using immunofluorescence analyses, we demonstrated the recruitment of BLM to centromeres from G2 phase to mitosis. With a combination of fluorescence in situ hybridization, electron microscopy, RNA interference, chromosome spreads and chromatin immunoprecipitation, we showed that both BLM-deficient and PICH-deficient prometaphase cells displayed changes in centromere structure. These cells also had a higher frequency of centromeric non disjunction in the absence of cohesin, suggesting the persistence of catenations. Both proteins were required for the correct recruitment to the centromere of active topoisomerase II alpha, an enzyme specialized in the catenation/decatenation process. These observations reveal the existence of a functional relationship between BLM, PICH and topoisomerase II alpha in the centromere decatenation process. They indicate that the higher frequency of centromeric ultrafine anaphase bridges in BLM-deficient cells and in cells treated with topoisomerase IIa inhibitors is probably due not only to unresolved physiological ultrafine anaphase bridges, but also to newly formed ultrafine anaphase bridges. We suggest that BLM and PICH cooperate in rendering centromeric catenates accessible to topoisomerase IIa, thereby facilitating correct centromere disjunction and preventing the formation of supernumerary centromeric ultrafine anaphase bridges.	[Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Onclercq-Delic, Rosine; Gemble, Simon; Amor-Gueret, Mounira] Ctr Univ, Ctr Rech, Inst Curie, Bat Orsay, France; [Rouzeau, Sebastien; Cordelieres, Fabrice P.; Buhagiar-Labarchede, Geraldine; Onclercq-Delic, Rosine; Gemble, Simon; Amor-Gueret, Mounira] CNRS, UMR3348, F-91405 Orsay, France; [Cordelieres, Fabrice P.] Ctr Univ, Ctr Rech Plateforme Imagerie Cellulaire & Tissula, Inst Curie, Bat Orsay, France; [Hurbain, Ilse] Ctr Rech, Inst Curie, Paris, France; [Hurbain, Ilse] CNRS, UMR144, Plateforme Imagerie Cellulaire & Tissulaire IBiSA, Paris, France; [Magnaghi-Jaulin, Laura; Jaulin, Christian] Univ Rennes 1, CNRS, UMR 6290, Inst Genet & Dev, Rennes, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Rouzeau, S (corresponding author), Ctr Univ, Ctr Rech, Inst Curie, Bat Orsay, France.	mounira.amor@curie.fr	Jaulin, Christian/L-9126-2018; Cordelières, Fabrice P/G-3574-2017	Cordelières, Fabrice P/0000-0002-5383-5816	Institut Curie (PIC); Centre National de la Recherche Scientifique (CNRS); Canceropole/Region Ilede-France; Ligue contre le Cancer Grand-Ouest; Association pour la Recherche sur le Cancer [1071]; Agence Nationale de la Recherche (EpiCentr); Ministere delegue de l'Enseignement Superieur et de la Recherche; Ligue Nationale contre le Cancer	Institut Curie (PIC); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Canceropole/Region Ilede-France(Region Ile-de-France); Ligue contre le Cancer Grand-Ouest; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche (EpiCentr)(French National Research Agency (ANR)); Ministere delegue de l'Enseignement Superieur et de la Recherche; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Institut Curie (PIC), the Centre National de la Recherche Scientifique (CNRS), the Canceropole/Region Ilede-France, the Ligue contre le Cancer Grand-Ouest, the Association pour la Recherche sur le Cancer (1071), the Agence Nationale de la Recherche (EpiCentr) and by fellowships from the Ministere delegue de l'Enseignement Superieur et de la Recherche and from the Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababou M, 2002, CELL CYCLE, V1, P262, DOI 10.4161/cc.1.4.136; Agostinho M, 2004, MOL BIOL CELL, V15, P2388, DOI 10.1091/mbc.E03-08-0558; Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Batram C, 2008, J STRUCT BIOL, V164, P293, DOI 10.1016/j.jsb.2008.09.002; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Bennani-Belhaj KL, 2010, MOL CANCER RES, V8, P385, DOI 10.1158/1541-7786.MCR-09-0534; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; Chan KL, 2011, SEMIN CELL DEV BIOL, V22, P906, DOI 10.1016/j.semcdb.2011.07.001; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Diaz-Martinez LA, 2008, J CELL SCI, V121, P2107, DOI 10.1242/jcs.029132; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Guo RB, 2007, NUCLEIC ACIDS RES, V35, P6297, DOI 10.1093/nar/gkm536; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Ke YW, 2011, EMBO J, V30, P3309, DOI 10.1038/emboj.2011.226; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Sano K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004103; Savino TM, 2001, J CELL BIOL, V153, P1097, DOI 10.1083/jcb.153.5.1097; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255; WARBURTON PE, 1991, GENOMICS, V11, P324, DOI 10.1016/0888-7543(91)90139-6; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yuen KWY, 2005, CURR OPIN CELL BIOL, V17, P576, DOI 10.1016/j.ceb.2005.09.012	31	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e33905	10.1371/journal.pone.0033905	http://dx.doi.org/10.1371/journal.pone.0033905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563370	Green Published, gold			2022-12-27	WOS:000305349100001
J	Bettinger, JC; Leung, K; Bolling, MH; Goldsmith, AD; Davies, AG				Bettinger, Jill C.; Leung, Kapo; Bolling, Mia H.; Goldsmith, Andrew D.; Davies, Andrew G.			Lipid Environment Modulates the Development of Acute Tolerance to Ethanol in Caenorhabditis elegans	PLOS ONE			English	Article							ACUTE FUNCTIONAL TOLERANCE; C-ELEGANS; GENETIC-DIFFERENCES; NEUROPEPTIDE-Y; BK CHANNELS; H-RAS; ALCOHOL; RECEPTOR; PROTEIN; CHOLESTEROL	The development of tolerance to a drug at the level of the neuron reflects a homeostatic mechanism by which neurons respond to perturbations of their function by external stimuli. Acute functional tolerance (AFT) to ethanol is a fast compensatory response that develops within a single drug session and normalizes neuronal function despite the continued presence of the drug. We performed a genetic screen to identify genes required for the development of acute functional tolerance to ethanol in the nematode C. elegans. We identified mutations affecting multiple genes in a genetic pathway known to regulate levels of triacylglycerols (TAGs) via the lipase LIPS-7, indicating that there is an important role for TAGs in the development of tolerance. Genetic manipulation of lips-7 expression, up or down, produced opposing effects on ethanol sensitivity and on the rate of development of AFT. Further, decreasing cholesterol levels through environmental manipulation mirrored the effects of decreased TAG levels. Finally, we found that genetic alterations in the levels of the TAG lipase LIPS-7 can modify the phenotype of gain-of-function mutations in the ethanol-inducible ion channel SLO-1, the voltage-and calcium-sensitive BK channel. This study demonstrates that the lipid milieu modulates neuronal responses to ethanol that include initial sensitivity and the development of acute tolerance. These results lend new insight into studies of alcohol dependence, and suggest a model in which TAG levels are important for the development of AFT through alterations of the action of ethanol on membrane proteins.	[Bettinger, Jill C.; Leung, Kapo; Bolling, Mia H.; Davies, Andrew G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA; [Bettinger, Jill C.; Davies, Andrew G.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Bettinger, Jill C.; Davies, Andrew G.] Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA USA; [Bettinger, Jill C.; Goldsmith, Andrew D.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Bettinger, JC (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA.	jcbettinger@vcu.edu	Davies, Andrew G/AAY-3567-2020		National Institutes of Health (NIH) [R01AA016837]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by the National Institutes of Health (NIH) (R01AA016837 to JCB). The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Alcohol Abuse and Alcoholism or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; AVDULOV NA, 1994, ALCOHOL CLIN EXP RES, V18, P53, DOI 10.1111/j.1530-0277.1994.tb00880.x; BRENNER S, 1974, GENETICS, V77, P71; Bukiya AN, 2011, J GEN PHYSIOL, V137, P93, DOI 10.1085/jgp.201010519; Cai T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000447; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Ghare S, 2011, ALCOHOL CLIN EXP RES, V35, P1435, DOI 10.1111/j.1530-0277.2011.01479.x; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; GOLDSTEIN DB, 1984, ANNU REV PHARMACOL, V24, P43, DOI 10.1146/annurev.pa.24.040184.000355; Harris R A, 1981, Curr Alcohol, V8, P379; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Heath AC, 1999, PSYCHOL MED, V29, P1069, DOI 10.1017/S0033291799008909; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Lin MW, 2006, CHINESE J PHYSIOL, V49, P1; Lind PA, 2010, TWIN RES HUM GENET, V13, P10, DOI 10.1375/twin.13.1.10; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Nicholas HR, 2008, J MOL BIOL, V375, P1, DOI 10.1016/j.jmb.2007.10.041; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Ponomarev I, 2002, J PHARMACOL EXP THER, V302, P257, DOI 10.1124/jpet.302.1.257; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Suvarna N, 2005, J BIOL CHEM, V280, P31450, DOI 10.1074/jbc.M504120200; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Thiele TE, 2000, PHARMACOL BIOCHEM BE, V67, P683, DOI 10.1016/S0091-3057(00)00413-5; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Wallace MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P127, DOI 10.1038/sj.npp.1301059; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Yuan C, 2008, J BIOL CHEM, V283, P5090, DOI 10.1074/jbc.M708214200; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Yuan CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027572	44	28	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35192	10.1371/journal.pone.0035192	http://dx.doi.org/10.1371/journal.pone.0035192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574115	Green Published, gold			2022-12-27	WOS:000305349800011
J	Wei, JH; Xue, Y; Wu, L; Ma, J; Yi, XL; Zhang, JR; Lu, B; Li, CY; Shi, DS; Shi, ST; Feng, XH; Cai, T				Wei, Jianhua; Xue, Yang; Wu, Lian; Ma, Jie; Yi, Xiuli; Zhang, Junrui; Lu, Bin; Li, Chunying; Shi, Dashuang; Shi, Songtao; Feng, Xinghua; Cai, Tao			Analysis of Large Phenotypic Variability of EEC and SHFM4 Syndromes Caused by K193E Mutation of the TP63 Gene	PLOS ONE			English	Article							SPLIT-HAND/SPLIT-FOOT; DNA-BINDING DOMAIN; P63 GENE; CLEFT-LIP; HAND/FOOT MALFORMATION; ECTODERMAL DYSPLASIA; CHINESE FAMILY; HAND; INHERITANCE; PALATE	EEC (ectrodactyly, ectodermal dysplasia, clefting; OMIM 604292) is an autosomal dominant developmental disorder resulting mainly from pathogenic mutations of the DNA-binding domain (DBD) of the TP63 gene. In this study, we showed that K193E mutation in nine affected individuals of a four-generation kindred with a large degree of phenotypic variability causes four different syndromes or TP63-related disorders: EEC, Ectrodactyly-ectodermal dysplasia (EE), isolated ectodermal dysplasia, and isolated Split Hand/Foot Malformation type 4 (SHFM4). Genotype-phenotype and DBD structural modeling analysis showed that the K193-located loop L2-A is associated with R280 through hydrogen bonding interactions, while R280 mutations also often cause large phenotypic variability of EEC and SHFM4. Thus, we speculate that K193 and several other DBD mutation-associated syndromes may share similar pathogenic mechanisms, particularly in the case of the same mutation with different phenotypes. Our study and others also suggest that the phenotypic variability of EEC is attributed, at least partially, to genetic and/or epigenetic modifiers.	[Wei, Jianhua; Ma, Jie; Zhang, Junrui; Lu, Bin; Feng, Xinghua; Cai, Tao] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Xue, Yang; Li, Chunying] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Wu, Lian] Fourth Mil Med Univ, Sch Stomatol, Dept Paediat Dent, Xian 710032, Shaanxi Provinc, Peoples R China; [Yi, Xiuli] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Shaanxi Provinc, Peoples R China; [Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC USA; [Shi, Dashuang] George Washington Univ, Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC USA; [Shi, Songtao] Univ So Calif, Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA 90089 USA; [Cai, Tao] Natl Inst Dent & Craniofacial Res, Oral Infect & Immun Branch, Natl Inst Hlth, Bethesda, MD USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Children's National Health System; George Washington University; Children's National Health System; George Washington University; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Wei, JH (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi Provinc, Peoples R China.	fengxh@fmmu.edu.cn; tcai@dir.nidcr.nih.gov	cai, tao/C-5060-2011	Cai, Tao/0000-0002-2877-8637; Shi, Dashuang/0000-0002-5491-1104	Fourth Military Medical University (FMMU), China	Fourth Military Medical University (FMMU), China	This research was partially supported by the Genetic Disease Research Fund (2011) at the Fourth Military Medical University (FMMU), China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellomaria A, 2010, CELL CYCLE, V9, P3730, DOI 10.4161/cc.9.18.12933; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen C, 2011, P NATL ACAD SCI USA, V108, P6456, DOI 10.1073/pnas.1013657108; Clements SE, 2010, BRIT J DERMATOL, V162, P201, DOI 10.1111/j.1365-2133.2009.09496.x; Dai Li, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P379, DOI 10.3760/cma.j.issn.1003-9406.2011.04.004; Duijf PHG, 2003, HUM MOL GENET, V12, pR51, DOI 10.1093/hmg/ddg090; Elliott AM, 2006, AM J MED GENET A, V140A, P1419, DOI 10.1002/ajmg.a.31244; Ergin H, 2010, TURKISH J PEDIATR, V52, P529; Huang YP, 2004, CELL CYCLE, V3, P1587, DOI 10.4161/cc.3.12.1290; Ianakiev P, 2000, AM J HUM GENET, V67, P59, DOI 10.1086/302972; Jindal Geetanjali, 2009, Indian J Hum Genet, V15, P140, DOI 10.4103/0971-6866.60191; Kantaputra PN, 2011, AM J MED GENET A, V155A, P1432, DOI 10.1002/ajmg.a.34011; Kantaputra PN, 2011, AM J MED GENET A; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; Leoyklang P, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036442; Lopardo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002715; Luo TX, 2008, MUTAT RES-FUND MOL M, V637, P182, DOI 10.1016/j.mrfmmm.2007.08.010; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Pozzi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005008; Ray AK, 2004, CLIN GENET, V66, P217, DOI 10.1111/j.1399-0004.2004.00287.x; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rinne T, 2006, AM J MED GENET A, V140A, P1396, DOI 10.1002/ajmg.a.31271; Roelfsema NM, 1996, CLIN DYSMORPHOL, V5, P115, DOI 10.1097/00019605-199604000-00003; Romano RA, 2012, J DENT RES, V91, P125, DOI 10.1177/0022034511411302; Rossi M, 2006, CELL CYCLE, V5, P1816, DOI 10.4161/cc.5.16.2861; Sorasio L, 2009, CLIN EXP DERMATOL, V34, pE726, DOI 10.1111/j.1365-2230.2009.03451.x; SPRANGER M, 1988, EUR J PEDIATR, V147, P202, DOI 10.1007/BF00442225; Ugur SA, 2008, HUM MOL GENET, V17, P2644, DOI 10.1093/hmg/ddn164; van Bokhoven H, 2001, AM J HUM GENET, V69, P481, DOI 10.1086/323123; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Vanbokhoven H, 2011, J INVEST DERMATOL, V131, P1196, DOI 10.1038/jid.2011.84; Witters I, 2001, PRENATAL DIAG, V21, P1119, DOI 10.1002/pd.181; Yin W, 2010, J DENT RES, V89, P813, DOI 10.1177/0022034510366804	33	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35337	10.1371/journal.pone.0035337	http://dx.doi.org/10.1371/journal.pone.0035337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574117	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800013
J	Bier, C; Hecht, R; Kunst, L; Scheiding, S; Wunsch, D; Goesswein, D; Schneider, G; Kramer, OH; Knauer, SK; Stauber, RH				Bier, Carolin; Hecht, Rouven; Kunst, Lena; Scheiding, Sabine; Wuensch, Desiree; Goesswein, Dorothee; Schneider, Guenter; Kraemer, Oliver H.; Knauer, Shirley K.; Stauber, Roland H.			Overexpression of the Catalytically Impaired Taspase1(T234V) or Taspase1(D233A) Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; FUSION PROTEIN; LIVING CELLS; MLL; COMPLEX; LOCALIZATION; ACTIVATION; EXPRESSION; INHIBITORS; STABILITY	Background: The chromosomal translocation t(4;11)(q21;q23) is associated with high-risk acute lymphoblastic leukemia of infants. The resulting AF4.MLL oncoprotein becomes activated by Taspase1 hydrolysis and is considered to promote oncogenic transcriptional activation. Hence, Taspase1's proteolytic activity is a critical step in AF4.MLL pathophysiology. The Taspase1 proenzyme is autoproteolytically processed in its subunits and is assumed to assemble into an alpha beta beta alpha-heterodimer, the active protease. Therefore, we investigated here whether overexpression of catalytically inactive Taspase1 variants are able to interfere with the proteolytic activity of the wild type enzyme in AF4.MLL model systems. Methodology/Findings: The consequences of overexpressing the catalytically dead Taspase1 mutant, Taspase1(T234V), or the highly attenuated variant, Taspase1(D233A), on Taspase1's processing of AF4.MLL and of other Taspase1 targets was analyzed in living cancer cells employing an optimized cell-based assay. Notably, even a nine-fold overexpression of the respective Taspase1 mutants neither inhibited Taspase1's cis- nor trans-cleavage activity in vivo. Likewise, enforced expression of the alpha- or beta-subunits showed no trans-dominant effect against the ectopically or endogenously expressed enzyme. Notably, co-expression of the individual alpha- and beta-subunits did not result in their assembly into an enzymatically active protease complex. Probing Taspase1 multimerization in living cells by a translocation-based protein interaction assay as well as by biochemical methods indicated that the inactive Taspase1 failed to assemble into stable heterocomplexes with the wild type enzyme. Conclusions: Collectively, our results demonstrate that inefficient heterodimerization appears to be the mechanism by which inactive Taspase1 variants fail to inhibit wild type Taspase1's activity in trans. Our work favours strategies targeting Taspase1's catalytic activity rather than attempts to block the formation of active Taspase1 dimers to interfere with the pathobiological function of AF4.MLL.	[Bier, Carolin; Wuensch, Desiree; Goesswein, Dorothee; Stauber, Roland H.] Univ Hosp Mainz, MSC, Mainz, Germany; [Hecht, Rouven; Kunst, Lena; Knauer, Shirley K.] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Inst Mol Biol, Essen, Germany; [Scheiding, Sabine; Kraemer, Oliver H.] Univ Jena, Inst Biochem & Biophys, Ctr Mol Biomed, Jena, Germany; [Schneider, Guenter] Tech Univ Munich, Dept Internal Med 2, D-8000 Munich, Germany	University Hospital Mainz; University of Duisburg Essen; Friedrich Schiller University of Jena; Technical University of Munich	Bier, C (corresponding author), Univ Hosp Mainz, MSC, Mainz, Germany.	bier@uni-mainz.de; shirley.knauer@uni-due.de; rstauber@uni-mainz.de	Knauer, Shirley K/E-7931-2012; Krämer, Oliver H/L-9266-2015; Gül, Désirée/AAB-5965-2022	Knauer, Shirley K/0000-0003-4321-0924; Krämer, Oliver H/0000-0003-3973-045X; Guel, Desiree/0000-0002-2446-5756; Stauber, Roland/0000-0002-1341-4523	German Cancer Aid [FKZ102362]; Head and Neck Cancer Foundation; Rheinland-Pfalz fur Innovationen; Mainz Screening Center; DFG [KN973/1-1, INST371/5-1FUGG]; Inneruniversity Funds; MAIFOR Mainz Support Program	German Cancer Aid(Deutsche Krebshilfe); Head and Neck Cancer Foundation; Rheinland-Pfalz fur Innovationen; Mainz Screening Center; DFG(German Research Foundation (DFG)); Inneruniversity Funds; MAIFOR Mainz Support Program	Grant support: German Cancer Aid (FKZ102362), Head and Neck Cancer Foundation (CB), donation by R. Patzke, Rheinland-Pfalz fur Innovationen, Mainz Screening Center, DFG KN973/1-1 and DFG INST371/5-1FUGG, and the Inneruniversity Funds and MAIFOR Mainz Support Program (RS and SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Benedikt A, 2011, LEUKEMIA, V25, P135, DOI 10.1038/leu.2010.249; Bier C, 2011, TRAFFIC, V12, P703, DOI 10.1111/j.1600-0854.2011.01191.x; Bier C, 2011, J BIOL CHEM, V286, P3007, DOI 10.1074/jbc.M110.161646; Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Bursen A, 2010, BLOOD, V115, P3570, DOI 10.1182/blood-2009-06-229542; Heger P, 1999, ONCOGENE, V18, P4080, DOI 10.1038/sj.onc.1202762; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200; Khan JA, 2005, STRUCTURE, V13, P1443, DOI 10.1016/j.str.2005.07.006; Knauer SK, 2007, CELL CYCLE, V6, P1502; Knauer SK, 2006, EMBO REP, V7, P1259, DOI 10.1038/sj.embor.7400824; Knauer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018253; Knauer SK, 2005, ANAL CHEM, V77, P4815, DOI 10.1021/ac050413o; Knauer SK, 2005, TRAFFIC, V6, P594, DOI 10.1111/j.1600-0854.2005.00298.x; Knauer SK, 2005, MOL CELL BIOL, V25, P2573, DOI 10.1128/MCB.25.7.2573-2582.2005; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Marschalek R, 2010, FEBS J, V277, P1822, DOI 10.1111/j.1742-4658.2010.07608.x; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Montes R, 2011, BLOOD, V117, P4746, DOI 10.1182/blood-2010-12-322230; Pless B, 2011, LEUKEMIA, V25, P663, DOI 10.1038/leu.2010.308; Schlingemann J, 2005, LAB INVEST, V85, P1024, DOI 10.1038/labinvest.3700293; Srinivasan RS, 2004, LEUKEMIA, V18, P1364, DOI 10.1038/sj.leu.2403415; Stauber RH, 1998, VIROLOGY, V251, P38, DOI 10.1006/viro.1998.9295; Tanaka T, 2008, CELL CYCLE, V7, P1569, DOI 10.4161/cc.7.11.6061; Tenzer S, 2011, ACS NANO; Weber L, 2010, EXPERT OPIN THER PAT, V20, P179, DOI 10.1517/13543770903514129; Wichmann C, 2007, CANCER RES, V67, P2280, DOI 10.1158/0008-5472.CAN-06-3360; Yokoyama A, 2002, BLOOD, V100, P3710, DOI 10.1182/blood-2002-04-1015	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e34142	10.1371/journal.pone.0034142	http://dx.doi.org/10.1371/journal.pone.0034142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570686	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400002
J	Rauschhuber, C; Ehrhardt, A				Rauschhuber, Christina; Ehrhardt, Anja			RNA Interference Is Responsible for Reduction of Transgene Expression after Sleeping Beauty Transposase Mediated Somatic Integration	PLOS ONE			English	Article							TOMBUSVIRUS-ENCODED P19; NUCLEAR EXPORT; FACTOR-IX; VECTOR; DNA; MICRORNA; IDENTIFICATION; TRANSCRIPTION; SUPPRESSION; VIRUSES	Background: Integrating non-viral vectors based on transposable elements are widely used for genetically engineering mammalian cells in functional genomics and therapeutic gene transfer. For the Sleeping Beauty (SB) transposase system it was demonstrated that convergent transcription driven by the SB transposase inverted repeats (IRs) in eukaryotic cells occurs after somatic integration. This could lead to formation of double-stranded RNAs potentially presenting targets for the RNA interference (RNAi) machinery and subsequently resulting into silencing of the transgene. Therefore, we aimed at investigating transgene expression upon transposition under RNA interference knockdown conditions. Principal Findings: To establish RNAi knockdown cell lines we took advantage of the P19 protein, which is derived from the tomato bushy stunt virus. P19 binds and inhibits 21 nucleotides long, small-interfering RNAs and was shown to sufficiently suppress RNAi. We found that transgene expression upon SB mediated transposition was enhanced, resulting into a 3.2-fold increased amount of colony forming units (CFU) after transposition. In contrast, if the transgene cassette is insulated from the influence of chromosomal position effects by the chicken-derived cHS4 insulating sequences or when applying the Forg Prince transposon system, that displays only negligible transcriptional activity, similar numbers of CFUs were obtained. Conclusion: In summary, we provide evidence for the first time that after somatic integration transposon derived transgene expression is regulated by the endogenous RNAi machinery. In the future this finding will help to further improve the molecular design of the SB transposase vector system.	[Rauschhuber, Christina; Ehrhardt, Anja] Univ Munich, Dept Virol, Max Von Pettenkofer Inst, Munich, Germany; [Ehrhardt, Anja] Univ Witten Herdecke, Dept Human Med, Inst Microbiol & Virol, Ctr Biomed Educ & Res,Fac Hlth, Witten, Germany	University of Munich; Witten Herdecke University	Rauschhuber, C (corresponding author), Univ Munich, Dept Virol, Max Von Pettenkofer Inst, Munich, Germany.	anja.ehrhardt@uni-wh.de			German Research Foundation (DFG) [SFB 455, EH 192/5-1, EH 192/4-1]; EU	German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This work was supported in part by the German Research Foundation (DFG) grants SFB 455, EH 192/5-1, EH 192/4-1 (Heisenberg-Programme) and EU Framework Programme 7 (Persistent Transgenesis) to A. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Calero-Nieto FJ, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-3; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Doherty JE, 2011, HUM GENE THER; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2004, J VIROL, V78, P2301, DOI 10.1128/JVI.78.5.2301-2309.2004; Ehrhardt A, 2005, MOL THER, V11, P695, DOI 10.1016/j.ymthe.2005.01.010; Ehrhardt A, 2002, BLOOD, V99, P3923, DOI 10.1182/blood.V99.11.3923; Ehrhardt A, 2007, MOL THER, V15, P146, DOI 10.1038/sj.mt.6300011; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Garrison BS, 2007, MOL CELL BIOL, V27, P8824, DOI 10.1128/MCB.00498-07; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Li CL, 2008, GENE THER, V15, P49, DOI 10.1038/sj.gt.3303009; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miskey C, 2003, NUCLEIC ACIDS RES, V31, P6873, DOI 10.1093/nar/gkg910; Moldt B, 2007, HUM GENE THER, V18, P1193, DOI 10.1089/hum.2007.099; Morris K, 2005, CELL MOL LIFE SCI, V62, P3057, DOI 10.1007/s00018-005-5182-4; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mutskov VJ, 2002, GENE DEV, V16, P1540, DOI 10.1101/gad.988502; Nakazawa Y, 2011, MOL THER; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Omarov R, 2006, J VIROL, V80, P3000, DOI 10.1128/JVI.80.6.3000-3008.2006; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pinto MGV, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-165; Robert VJP, 2004, COLD SPRING HARB SYM, V69, P397, DOI 10.1101/sqb.2004.69.397; Scholthof HB, 2006, NAT REV MICROBIOL, V4, P405, DOI 10.1038/nrmicro1395; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824	56	5	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35389	10.1371/journal.pone.0035389	http://dx.doi.org/10.1371/journal.pone.0035389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570690	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400006
J	Fox, C; Crugel, M; Maidment, I; Auestad, BH; Coulton, S; Treloar, A; Ballard, C; Boustani, M; Katona, C; Livingston, G				Fox, Chris; Crugel, Monica; Maidment, Ian; Auestad, Bjorn Henrik; Coulton, Simon; Treloar, Adrian; Ballard, Clive; Boustani, Malaz; Katona, Cornelius; Livingston, Gill			Efficacy of Memantine for Agitation in Alzheimer's Dementia: A Randomised Double-Blind Placebo Controlled Trial	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; PSYCHOLOGICAL SYMPTOMS; ATYPICAL ANTIPSYCHOTICS; BEHAVIORAL SYMPTOMS; DISEASE; PREVALENCE; MANAGEMENT; CARE	Background: Agitation in Alzheimer's disease (AD) is common and associated with poor patient life-quality and carer distress. The best evidence-based pharmacological treatments are antipsychotics which have limited benefits with increased morbidity and mortality. There are no memantine trials in clinically significant agitation but post-hoc analyses in other populations found reduced agitation. We tested the primary hypothesis, memantine is superior to placebo for clinically significant agitation, in patients with moderate-to-severe AD. Methods and Findings: We recruited 153 participants with AD and clinically significant agitation from care-homes or hospitals for a double-blind randomised-controlled trial and 149 people started the trial of memantine versus placebo. The primary outcome was 6 weeks mixed model autoregressive analysis of Cohen-Mansfield Agitation Inventory (CMAI). Secondary outcomes were: 12 weeks CMAI; 6 and 12 weeks Neuropsychiatric symptoms (NPI), Clinical Global Impression Change (CGI-C), Standardised Mini Mental State Examination, Severe Impairment Battery. Using a mixed effects model we found no significant differences in the primary outcome, 6 weeks CMAI, between memantine and placebo (memantine lower -3.0; -8.3 to 2.2, p = 0.26); or 12 weeks CMAI; or CGI-C or adverse events at 6 or 12 weeks. NPI mean difference favoured memantine at weeks 6 (-6.9; -12.2 to -1.6; p = 0.012) and 12 (-9.6; -15.0 to -4.3 p = 0.0005). Memantine was significantly better than placebo for cognition. The main study limitation is that it still remains to be determined whether memantine has a role in milder agitation in AD. Conclusions: Memantine did not improve significant agitation in people with in moderate-to-severe AD. Future studies are urgently needed to test other pharmacological candidates in this group and memantine for neuropsychiatric symptoms.	[Fox, Chris] Univ E Anglia, Dept Psychiat, Norwich NR4 7TJ, Norfolk, England; [Crugel, Monica] Oxleas NHS Fdn Trust, Dept Old Age Psychiat, London, England; [Coulton, Simon] Univ Kent, Ctr Hlth Serv Studies, Canterbury CT2 7NZ, Kent, England; [Maidment, Ian] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Auestad, Bjorn Henrik] Univ Stavanger, Dept Math & Nat Sci, Stavanger, Norway; [Treloar, Adrian] Oxleas NHS Fdn Trust Mem Hosp, Dept Old Age Psychiat, London, England; [Ballard, Clive] Kings Coll London, Neurodegenerat Grp, London WC2R 2LS, England; [Boustani, Malaz] Indiana Univ Sch Med, Indiana Univ Ctr Aging Res, Indianapolis, IN USA; [Katona, Cornelius; Livingston, Gill] UCL, Mental Hlth Sci Unit, London, England	University of East Anglia; University of Kent; Aston University; Universitetet i Stavanger; University of London; King's College London; Indiana University System; Indiana University Bloomington; University of London; University College London	Fox, C (corresponding author), Univ E Anglia, Dept Psychiat, Norwich NR4 7TJ, Norfolk, England.	Chris.Fox@uea.ac.uk	Boustani, Malaz/Q-3850-2019; Livingston, G/C-7081-2008	Boustani, Malaz/0000-0003-0330-677X; Ballard, Clive/0000-0003-0022-5632; Maidment, Ian/0000-0003-4152-9704; Katona, Cornelius/0000-0001-7451-0167; Fox, Chris/0000-0001-9480-5704; Livingston, Gill/0000-0001-6741-5516; Coulton, Simon/0000-0002-7704-3274	Lundbeck; Pfizer; Eisai; Novartis; Shires; Lilly; Schwarz; Forest; East Kent Hospitals University NHS foundation trust; Alzheimer's Society; National Institute for Health Research, through the Dementia and Neurodegenerative Research Network (DeNDRoN); National Institute for Health Research, through the Mental Health Research Network; National Institute for Health Research, through the Comprehensive Research Network	Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); Eisai(Eisai Co Ltd); Novartis(Novartis); Shires; Lilly(Eli Lilly); Schwarz; Forest; East Kent Hospitals University NHS foundation trust; Alzheimer's Society; National Institute for Health Research, through the Dementia and Neurodegenerative Research Network (DeNDRoN); National Institute for Health Research, through the Mental Health Research Network; National Institute for Health Research, through the Comprehensive Research Network	This work was funded by Lundbeck. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. CF has received speaker's fees and support from Pfizer, Eisai, Novartis, Shires, and Lilly. MC was the research fellow for the MAGD study. IM has received consultancy fees and honoraria from pharmaceutical companies that include Lundbeck, Lilly, Schwarz, Pfizer, Shires, and Novartis. AT has received funding to attend educational meetings and conferences from Eisai and Pfizer and research grant from Pfizer. CB has received research grants, honoraria and consultancy fees from Lundbeck, and has received honoraria from Novartis. MB has received research funding from Forest, research funding and honoraria for advisory board membership from Novartis, and speaker's fees and honoraria for advisory board membership from Pfizer and Eisai. CK's institution has received research funding from Lundbeck; he has received honoraria, support for travel, lecture fees, and payment from advisory board membership from Lundbeck and Lilly and payment for preparation of educational material from Lundbeck. GL has received research funding and educational support from Lundbeck and research funding from Pfizer. SC declares no conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We are grateful to the participants, families and care staff who participated in this trial. We thank the sponsor of this trial, East Kent Hospitals University NHS foundation trust. We thank the Alzheimer's Society for support and CB's involvement in this study. This study would not have been possible without support from the National Institute for Health Research, through the Dementia and Neurodegenerative Research Network (DeNDRoN), Mental Health Research Network, and the Comprehensive Research Network.	Ballard C, 2005, BMJ-BRIT MED J, V330, P874, DOI 10.1136/bmj.38369.459988.8F; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard C, 2011, EXPERT OPIN DRUG SAF, V10, P35, DOI 10.1517/14740338.2010.506711; Ballard C, 2009, CURR OPIN PSYCHIATR, V22, P532, DOI 10.1097/YCO.0b013e32833111f9; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P711, DOI 10.1111/j.1532-5415.1986.tb04302.x; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Ferrara M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-93; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Francis P T, 2009, Curr Mol Pharmacol, V2, P77; Gauthier S, 2008, INT J GERIATR PSYCH, V23, P537, DOI 10.1002/gps.1949; Guy W, ECDEU ASSESSMENT MAN, P218; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Howard R, 2010, INT J GERIATR PSYCH, V16, P16; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Hurt C, 2008, DEMENT GERIATR COGN, V26, P138, DOI 10.1159/000149584; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Livingston G, 2005, AM J PSYCHIAT, V162, P1996, DOI 10.1176/appi.ajp.162.11.1996; Livingston G, 2010, DEMENTIA; Maidment ID, 2008, ANN PHARMACOTHER, V42, P32, DOI 10.1345/aph.1K372; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; R Development Core Team R. R, 2011, LANG ENV STAT COMP; Ryu SH, 2005, AM J GERIAT PSYCHIAT, V13, P976, DOI 10.1176/appi.ajgp.13.11.976; Saxton J, 1990, PSYCHOL ASSESS, V2, P298, DOI DOI 10.1037/1040-3590.2.3.298; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Wilcock GK, 2008, J CLIN PSYCHIAT, V69, P341, DOI 10.4088/JCP.v69n0302; Wilmo A., 2010, WORLD ALZHEIMERS REP; Zuidema SU, 2010, INT J GERIATR PSYCH, V26, P127	32	92	93	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35185	10.1371/journal.pone.0035185	http://dx.doi.org/10.1371/journal.pone.0035185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567095	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305341500013
J	Kim, DY; Hao, JW; Liu, RL; Turner, G; Shi, FD; Rho, JM				Kim, Do Young; Hao, Junwei; Liu, Ruolan; Turner, Gregory; Shi, Fu-Dong; Rho, Jong M.			Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COGNITIVE DYSFUNCTION; CEREBROSPINAL-FLUID; T-CELLS; EXPRESSION; ATROPHY; RATS; INTERLEUKIN-6; ACCUMULATION; PATHOGENESIS	A prominent clinical symptom in multiple sclerosis (MS), a progressive disorder of the central nervous system (CNS) due to heightened neuro-inflammation, is learning and memory dysfunction. Here, we investigated the effects of a ketogenic diet (KD) on memory impairment and CNS-inflammation in a murine model of experimental autoimmune encephalomyelitis (EAE), using electrophysiological, behavioral, biochemical and in vivo imaging approaches. Behavioral spatial learning deficits were associated with motor disability in EAE mice, and were observed concurrently with brain inflammation. The KD improved motor disability in the EAE model, as well as CA1 hippocampal synaptic plasticity (long-term potentiation) and spatial learning and memory (assessed with the Morris Water Maze). Moreover, hippocampal atrophy and periventricular lesions in EAE mice were reversed in KD-treated EAE mice. Finally, we found that the increased expression of inflammatory cytokines and chemokines, as well as the production of reactive oxygen species (ROS), in our EAE model were both suppressed by the KD. Collectively, our findings indicate that brain inflammation in EAE mice is associated with impaired spatial learning and memory function, and that KD treatment can exert protective effects, likely via attenuation of the robust immune response and increased oxidative stress seen in these animals.	[Kim, Do Young; Hao, Junwei; Liu, Ruolan; Shi, Fu-Dong; Rho, Jong M.] St Josephs Hosp, Barrow Neurol Inst, Med Ctr, Phoenix, AZ 85013 USA; [Hao, Junwei; Shi, Fu-Dong] Tianjin Med Univ Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Turner, Gregory] Barrow Neurol Inst, Keller Ctr Imaging Innovat, Phoenix, AZ 85013 USA; [Rho, Jong M.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Rho, Jong M.] Univ Calgary, Dept Clin Neurosci, Alberta Childrens Hosp, Calgary, AB, Canada	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Tianjin Medical University; Barrow Neurological Institute; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Kim, DY (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Med Ctr, Phoenix, AZ 85013 USA.	fshi@chw.edu; jong.rho@albertahealthservices.ca		Hao, Junwei/0000-0002-3075-5434	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Institutes of Health [R01AI083294]; National Natural Science Foundation of China [31170864, 81100887]; Program for New Century Excellent Talents in University of China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083294] Funding Source: NIH RePORTER	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the Barrow Neurological Foundation (Dr. Rho), the Arizona Biomedical Research Commission (Dr. Kim), the National Institutes of Health (R01AI083294 to Dr. Shi), National Natural Science Foundation of China (31170864 to Dr. Shi and 81100887 to Dr. Hao), and Program for New Century Excellent Talents in University of China (Dr. Hao). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to submit for publication, or preparation of the manuscript.	Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, J NEUROL, V253, P1054, DOI 10.1007/s00415-006-0161-8; BO L, 1994, ANN NEUROL, V36, P778, DOI 10.1002/ana.410360515; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Dastur OK, 1963, NUTR METAB, P59; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Farinotti M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004192.pub2; Giuliani F, 2009, BRAIN RES BULL, V80, P302, DOI 10.1016/j.brainresbull.2009.07.009; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Honors MA, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-46; Jana M, 2005, FREE RADICAL BIO MED, V39, P823, DOI 10.1016/j.freeradbiomed.2005.05.014; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Kamsler A, 2003, J NEUROSCI, V23, P269; Kang Jing X., 2008, V49, P133, DOI 10.1007/978-1-4020-8831-5_5; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kocer B, 2008, NEUROL SCI, V29, P435, DOI 10.1007/s10072-008-1020-4; LEVINE SM, 1992, MED HYPOTHESES, V39, P271, DOI 10.1016/0306-9877(92)90121-R; Liu RL, 2008, EXP NEUROL, V211, P14, DOI 10.1016/j.expneurol.2007.11.004; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Mattsson N, 2007, NEUROSCI LETT, V414, P233, DOI 10.1016/j.neulet.2006.12.044; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Mohamed HE, 2010, J CLIN NEUROSCI, V17, P899, DOI 10.1016/j.jocn.2009.11.005; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Papadopoulos D, 2009, BRAIN PATHOL, V19, P238, DOI 10.1111/j.1750-3639.2008.00177.x; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Shinto L, 2009, PROSTAG LEUKOTR ESS, V80, P131, DOI 10.1016/j.plefa.2008.12.001; Sicotte NL, 2008, BRAIN, V131, P1134, DOI 10.1093/brain/awn030; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Tiemann L, 2009, MULT SCLER J, V15, P1164, DOI 10.1177/1352458509106853; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Wada-Isoe K, 2004, ACTA NEUROL SCAND, V110, P124, DOI 10.1111/j.1600-0404.2004.00286.x; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Yadav V, 2010, EXPERT REV CLIN IMMU, V6, P381, DOI [10.1586/eci.10.12, 10.1586/ECI.10.12]; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Ziehn MO, 2010, LAB INVEST, V90, P774, DOI 10.1038/labinvest.2010.6; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	48	116	120	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35476	10.1371/journal.pone.0035476	http://dx.doi.org/10.1371/journal.pone.0035476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567104	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341500022
J	Winerdal, M; Winerdal, ME; Kinn, J; Urmaliya, V; Winqvist, O; Aden, U				Winerdal, Max; Winerdal, Malin Elisabeth; Kinn, Johan; Urmaliya, Vijay; Winqvist, Ola; Aden, Ulrika			Long Lasting Local and Systemic Inflammation after Cerebral Hypoxic ischemia in Newborn Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; T-CELLS; EXPERIMENTAL STROKE; BRAIN-DAMAGE; LYMPHOCYTES; EXPRESSION; MICROGLIA; ANTIBODY; INFANTS; INJURY	A Background: Hypoxic ischemia (HI) is an important cause of neonatal brain injury and subsequent inflammation affects neurological outcome. In this study we performed investigations of systemic and local activation states of inflammatory cells from innate and adaptive immunity at different time points after neonatal HI brain injury in mice. Methodology/Principal Findings: We developed a multiplex flow cytometry based method combined with immunohistochemistry to investigate cellular immune responses in the brain 24 h to 7 months after HI brain injury. In addition, functional studies of ex vivo splenocytes after cerebral hypoxic ischemia were performed. Both central and peripheral activation of CD11b(+) and CD11c(+) antigen presenting cells were seen with expression of the costimulatory molecule CD86 and MHC-II, indicating active antigen presentation in the damaged hemisphere and in the spleen. After one week, naive CD45rb(+) T-lymphocytes were demonstrated in the damaged brain hemisphere. In a second phase after three months, pronounced activation of CD45rb(-) T-lymphocytes expressing CD69 and CD25 was seen in the damaged hemisphere. Brain homogenate induced proliferation in splenocytes after HI but not in controls. Conclusions/Significance: Our findings demonstrate activation of both local and systemic immune responses months after hypoxic ischemic neonatal brain injury. The long term immune activation observed is of general importance for future studies of the inflammatory response after brain injury as most previous studies have focused on the first few weeks after damage, while the effects of the late inflammation phase may be missed. Furthermore, the self-reactive component raises the question if there is a correlation with development of autoimmune brain disease later in life.	[Winerdal, Max; Aden, Ulrika] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden; [Winerdal, Malin Elisabeth; Kinn, Johan; Winqvist, Ola] Karolinska Inst, Dept Med, Unit Translat Immunol, Stockholm, Sweden; [Urmaliya, Vijay] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Winerdal, M (corresponding author), Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden.	max.winerdal@ki.se		winqvist, Ola/0000-0003-0842-4441	Stockholm County Council and Karolinska Institutet; Swedish Cancer Foundation; Soderberg's Foundation Stockholm, Sweden; John Hedin Cancer Research Foundation, Stockholm, Sweden; Japanese-Swedish Research Foundation, Stockholm, Sweden; Wallenberg Foundation, Stockholm, Sweden, VR [2006-6151]; Linnea and Josef Carlsson's foundation; Brain Foundation; Free Mason Foundation; Jerring Foundation	Stockholm County Council and Karolinska Institutet; Swedish Cancer Foundation; Soderberg's Foundation Stockholm, Sweden; John Hedin Cancer Research Foundation, Stockholm, Sweden; Japanese-Swedish Research Foundation, Stockholm, Sweden; Wallenberg Foundation, Stockholm, Sweden, VR; Linnea and Josef Carlsson's foundation; Brain Foundation; Free Mason Foundation; Jerring Foundation	This work was supported by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, the Swedish Cancer Foundation, Soderberg's Foundation Stockholm, Sweden, the John Hedin Cancer Research Foundation, Stockholm, Sweden, the Japanese-Swedish Research Foundation, Stockholm, Sweden Wallenberg Foundation, Stockholm, Sweden, VR grant 2006-6151, Linnea and Josef Carlsson's foundation, the Brain Foundation, the Free Mason Foundation, and the Jerring Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden U, 2002, STROKE, V33, P1405, DOI 10.1161/01.STR.0000014608.78503.DB; ASHMORE LM, 1989, J IMMUNOL METHODS, V118, P209, DOI 10.1016/0022-1759(89)90008-2; BARTEN DM, 1995, J IMMUNOL, V155, P5409; Becker K, 2001, STROKE, V32, P206, DOI 10.1161/01.STR.32.1.206; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Bornstein NM, 2001, NEUROLOGY, V56, P529, DOI 10.1212/WNL.56.4.529; Brait VH, 2012, J CEREB BLOOD FLOW M; Careaga M, 2010, NEUROTHERAPEUTICS, V7, P283, DOI 10.1016/j.nurt.2010.05.003; Chan WY, 2007, BRAIN RES REV, V53, P344, DOI 10.1016/j.brainresrev.2006.11.002; CLARK WM, 1991, J NEUROSURG, V75, P623, DOI 10.3171/jns.1991.75.4.0623; COSTELLO AMD, 1994, ARCH DIS CHILD-FETAL, V71, pF1, DOI 10.1136/fn.71.1.F1; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x; Felger JC, 2009, BRAIN BEHAV IMMUN; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Grange C, 2011, J IMMUNOL METHODS, V372, P119, DOI 10.1016/j.jim.2011.07.002; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Hug A, 2011, STROKE, V42, P3580, DOI 10.1161/STROKEAHA.111.620948; Hurn PD, 2007, J CEREBR BLOOD F MET, V27, P1798, DOI 10.1038/sj.jcbfm.9600482; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; JENSEN MA, 1992, J NEUROIMMUNOL, V38, P255, DOI 10.1016/0165-5728(92)90018-G; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin SJ, 2002, CLIN LAB HAEMATOL, V24, P353, DOI 10.1046/j.1365-2257.2002.00462.x; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; MUNSCHAUER FE, 1993, J CLIN IMMUNOL, V13, P113, DOI 10.1007/BF00919267; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Parel Y, 2004, AUTOIMMUN REV, V3, P215, DOI 10.1016/j.autrev.2003.09.001; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Saliba E, 2001, BIOL NEONATE, V79, P224; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Vogelgesang A, 2011, J NEUROIMMUNOL, V231, P105, DOI 10.1016/j.jneuroim.2010.09.023; Vogelgesang A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008718; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WANG WZ, 1992, CLIN EXP IMMUNOL, V88, P157; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	39	67	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36422	10.1371/journal.pone.0036422	http://dx.doi.org/10.1371/journal.pone.0036422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567156	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500075
J	Allen, BL; Leung, LKP				Allen, Benjamin L.; Leung, Luke K. -P.			Assessing Predation Risk to Threatened Fauna from their Prevalence in Predator Scats: Dingoes and Rodents in Arid Australia	PLOS ONE			English	Article							CANIS-LUPUS-DINGO; POPULATION-DYNAMICS; WESTERN-AUSTRALIA; EXTINCTION; PREY; CONSERVATION; PATTERNS; DECLINE; VERTEBRATES; COMPETITION	The prevalence of threatened species in predator scats has often been used to gauge the risks that predators pose to threatened species, with the infrequent occurrence of a given species often considered indicative of negligible predation risks. In this study, data from 4087 dingo (Canis lupus dingo and hybrids) scats were assessed alongside additional information on predator and prey distribution, dingo control effort and predation rates to evaluate whether or not the observed frequency of threatened species in dingo scats warrants more detailed investigation of dingo predation risks to them. Three small rodents (dusky hopping-mice Notomys fuscus; fawn hopping-mice Notomys cervinus; plains mice Pseudomys australis) were the only threatened species detected in <8% of dingo scats from any given site, suggesting that dingoes might not threaten them. However, consideration of dingo control effort revealed that plains mice distribution has largely retracted to the area where dingoes have been most heavily subjected to lethal control. Assessing the hypothetical predation rates of dingoes on dusky hopping-mice revealed that dingo predation alone has the potential to depopulate local hopping-mice populations within a few months. It was concluded that the occurrence of a given prey species in predator scats may be indicative of what the predator ate under the prevailing conditions, but in isolation, such data can have a poor ability to inform predation risk assessments. Some populations of threatened fauna assumed to derive a benefit from the presence of dingoes may instead be susceptible to dingo-induced declines under certain conditions.	[Allen, Benjamin L.; Leung, Luke K. -P.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia	University of Queensland	Allen, BL (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia.	benjamin.allen@dpi.nsw.gov.au	Allen, Benjamin L./H-3066-2019	Allen, Benjamin L./0000-0002-1533-0163; Leung, Luke/0000-0002-8829-4925				Allen B., 2011, Australian Mammalogy, V33, P68, DOI 10.1071/AM10032; Allen BL, 2012, WILDLIFE RES, V39, P35, DOI 10.1071/WR11128; Allen B. L., 2011, GLOVEBOX GUIDE MANAG; Allen B. L., 2012, WOLVES BIOL CONSERVA; Allen Benjamin L., 2011, Ecological Management & Restoration, V12, P26, DOI 10.1111/j.1442-8903.2011.00571.x; Allen Benjamin L., 2010, Australian Mammalogy, V32, P207, DOI 10.1071/AM10012; Allen BL, AUSTR MAMMA IN PRESS, Vxx, pxx; Allen L. R., 2009, TECHNICAL HIGHLIGHTS, P61; Allen LR, RANGELAND J IN PRESS, Vxx, pxx; Barrett G.W., 2003, NEW ATLAS AUSTR BIRD; Brook LA, 2011, RANGELAND J, V33, P79, DOI 10.1071/RJ10052; Brunner, 2002, HAIR ID INTERACTIVE; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Burnett S, 1995, PROJECT GONDWANA DIS; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CAUGHLEY G, 1980, AUST WILDLIFE RES, V7, P1, DOI 10.1071/WR9800001; Claridge Andrew W., 2010, Australian Mammalogy, V32, P117, DOI 10.1071/AM09038; Cogger H, 2000, REPTILES AMPHIBIANS; Corbett L. K., 2001, DINGO AUSTR ASIA; CORBETT LK, 1987, OECOLOGIA, V74, P215, DOI 10.1007/BF00379362; Courchamp F, 2000, J ANIM ECOL, V69, P154, DOI 10.1046/j.1365-2656.2000.00383.x; Coutts-Smith A.J., 2007, THREAT POSED PEST AN; Cupples JB, 2011, J MAMMAL, V92, P590, DOI 10.1644/10-MAMM-A-164.1; Davies KF, 2010, BIOL CONSERV, V143, P78, DOI 10.1016/j.biocon.2009.09.006; DEH, 2009, 2010 COMM KANG HARV; Dickman Chris R., 2009, P238, DOI 10.1002/9781444312034.ch11; Fleming P., 2001, MANAGING IMPACTS DIN; Fleming PJS, 2012, AUST MAMMAL, V34, P119, DOI 10.1071/AM11012; Glen AS, 2008, J APPL ECOL, V45, P700, DOI 10.1111/j.1365-2664.2007.01449.x; Glen AS, 2007, AUSTRAL ECOL, V32, P492, DOI 10.1111/j.1442-9993.2007.01721.x; HOLMES JC, 1995, WILDLIFE RES, V22, P11, DOI 10.1071/WR9950011; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; James CD, 1999, J ARID ENVIRON, V41, P87, DOI 10.1006/jare.1998.0467; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Kutsche F, 2003, FIELD GUIDE PLANTS O; Landsberg J., 1997, EFFECTS ARTIFICIAL S; Lee A., 1995, ACTION PLAN AUSTR RO; Letnic M, 2009, ANIM CONSERV, V12, P302, DOI 10.1111/j.1469-1795.2009.00250.x; Letnic M, 2000, BIODIVERS CONSERV, V9, P295, DOI 10.1023/A:1008913826686; Letnic M, 2006, BIODIVERS CONSERV, V15, P3847, DOI 10.1007/s10531-005-0601-2; Letnic M, 2012, BIOL REV, V87, P390, DOI 10.1111/j.1469-185X.2011.00203.x; Letnic M, 2009, P ROY SOC B-BIOL SCI, V276, P3249, DOI 10.1098/rspb.2009.0574; Lundie-Jenkins G., 2005, RECOVERY PLAN BRIDLE; Lunney D, 2001, RANGELAND J, V23, P44, DOI 10.1071/RJ01014; MCILROY JC, 1981, AUST WILDLIFE RES, V8, P369; McKenzie NL, 2007, J BIOGEOGR, V34, P597, DOI 10.1111/j.1365-2699.2006.01639.x; Moseby K., 1998, STUDY DAVENPORT RANG; Moseby KE, 2006, WILDLIFE RES, V33, P223, DOI 10.1071/WR05034; Moseby KE, 2011, BIOL CONSERV, V144, P2863, DOI 10.1016/j.biocon.2011.08.003; Moseby KE, 2009, AUSTRAL ECOL, V34, P156, DOI 10.1111/j.1442-9993.2008.01916.x; Moseby KE, 2011, RECOVERY PL IN PRESS; Newsome AE, 2001, RANGELAND J, V23, P71, DOI 10.1071/RJ01015; Newsome AE, 1975, RODENTS DESERT ENV; Newsome T.M., 2011, ECOLOGY DINGO CANIS; O'Neill Adam, 2008, PERSISTENCE ENDANGER; Paltridge R, 2002, WILDLIFE RES, V29, P389, DOI 10.1071/WR00010; Papenfus, 1992, RANGELAND J, V14, P107, DOI DOI 10.1071/RJ9920107; Pavey CR, 2008, J MAMMAL, V89, P674, DOI 10.1644/07-MAMM-A-168R.1; Saetre P, 2004, MOL BRAIN RES, V126, P198, DOI 10.1016/j.molbrainres.2004.05.003; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Sinclair ARE, 1998, CONSERV BIOL, V12, P564, DOI 10.1046/j.1523-1739.1998.97030.x; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; THOMSON PC, 1992, WILDLIFE RES, V19, P585, DOI 10.1071/WR9920585; Triggs B., 2004, TRACKS SCATS OTHER T; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Van Dyck S., 2008, MAMMALS AUSTR; Wallach AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006861; West P., 2008, ASSESSING INVASIVE A; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Yelland L., 2012, HOLDING LINE HIST S	72	48	52	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36426	10.1371/journal.pone.0036426	http://dx.doi.org/10.1371/journal.pone.0036426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563498	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305340700047
J	Peterson, JE; Vittore, CP				Peterson, Joseph E.; Vittore, Christopher P.			Cranial Pathologies in a Specimen of Pachycephalosaurus	PLOS ONE			English	Article							OPEN FRACTURES; NORTH-AMERICA; BONE; ORNITHISCHIA; DINOSAURS; INFECTION; EVOLUTION; INJURIES; BEHAVIOR	Background: A frontoparietal dome of a large pachycephalosaurid collected from the Upper Cretaceous Hell Creek Formation in 2001 is identified as Pachycephalosaurus wyomingensis. The specimen features two large oval depressions on the dorsal surface, accompanied by numerous circular pits on the margin and inner surface of the larger depressions. Methodology/Principal Findings: In order to identify the origin of these structures, computed tomography (CT) data and morphological characteristics of the specimen are analyzed and compared with similar osteological structures in fossil and extant archosaurs caused by taphonomic processes, non-pathologic bone resorption, and traumatic infection/inflammatory origins. The results of these analyses suggest that the structures are pathologic lesions likely resulting from a traumatic injury and followed by secondary infection at the site. Conclusions/Significance: The presence of lesions on a frontoparietal dome, and the exclusivity of their distribution along the dorsal dome surface, offers further insight into frontoparietal dome function and supports previously hypothesized agonistic behavior in pachycephalosaurids.	[Peterson, Joseph E.] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Vittore, Christopher P.] Rockford Mem Hosp, Dept Radiol, Rockford, IL USA	University of Wisconsin System	Peterson, JE (corresponding author), Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA.	petersoj@uwosh.edu		Vittore, Christopher/0000-0003-4399-3615	Dinosaur Research Institute	Dinosaur Research Institute	This research was funded by the Dinosaur Research Institute (http://www.dinosaurresearch.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RT, 2006, NEW MEXICO MUSEUM NA, V35, P331; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Blanco G, 1997, J RAPTOR RES, V31, P77; Carpenter Kenneth, 1997, Contributions to Geology University of Wyoming, V32, P19; Chure Daniel J., 2000, Gaia (Lisboa), V15, P227; CIERNY G, 1984, ORTHOPEDICS, V7, P1557, DOI 10.3928/0147-7447-19841001-07; Colbert E.H., 1955, EVOLUTION VERTEBRATE; GALTON P M, 1970, Discovery (New Haven), V6, P23; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; GUSTILO RB, 1990, J BONE JOINT SURG AM, V72A, P299, DOI 10.2106/00004623-199072020-00023; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; JOHNSON KR, 2002, GEOLOGICAL SOC AM SP, V361, P503; Kalin J.A., 1936, Z F R MORPHOLOGIE OE, V32, P327; Kemp A., 1995, HORNBILLS BUCEROTIFO; KLEM D, 1990, J FIELD ORNITHOL, V61, P115; Kofron CP, 1999, J ZOOL, V249, P375, DOI 10.1111/j.1469-7998.1999.tb01206.x; Lang J.W., 1989, P102; Lehman TM, 2010, J VERTEBR PALEONTOL, V30, P786, DOI 10.1080/02724631003763532; Longrich NR, 2010, CRETACEOUS RES, V31, P274, DOI 10.1016/j.cretres.2009.12.002; LYMAN RL, 1989, J ARCHAEOL SCI, V16, P293, DOI 10.1016/0305-4403(89)90007-1; Maryanska T., 1990, P564; Maryanska T, 1974, ACTA PALAEONTOLOGICA, V30, P45; Maryanska T, 2004, DINOSAURIA, 2ND EDITION, P464; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Peterson JE, 2011, PALAIOS, V26, P81, DOI 10.2110/palo.2010.p10-080r; Resnick D., 1981, DIAGNOSIS BONE JOINT, V3, P2058; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Rothschild Bruce, 2001, P331; Seeley HG, 1887, BRIT ASS ADV SCI MAN, V57, P698; Sereno Paul C., 2000, P480; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Snively E., 2008, PALAEONTOL ELECTRON, V11, P17; Snively E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021422; Sternberg C. M., 1945, JOUR PALEONTOL, V19, P534; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, NEW MEXICO MUSEUM NA, V35, P347; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; Tanke Darren H., 2010, P355; Tanke Darren H., 2007, P319; TAPPEN M, 1994, J ARCHAEOL SCI, V21, P667, DOI 10.1006/jasc.1994.1066; TIEMEIER OTTO W., 1941, AUK, V58, P350; WEBB GJW, 1977, AUST WILDLIFE RES, V4, P311; WHITE EM, 1983, AM ANTIQUITY, V48, P316, DOI 10.2307/280453; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; [No title captured]	50	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36227	10.1371/journal.pone.0036227	http://dx.doi.org/10.1371/journal.pone.0036227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558394	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200053
J	Andreozzi, F; Presta, I; Mannino, GC; Scarpelli, D; Di Silvestre, S; Di Pietro, N; Succurro, E; Sciacqua, A; Pandolfi, A; Consoli, A; Hribal, ML; Perticone, F; Sesti, G				Andreozzi, Francesco; Presta, Ivan; Mannino, Gaia Chiara; Scarpelli, Daniela; Di Silvestre, Sara; Di Pietro, Natalia; Succurro, Elena; Sciacqua, Angela; Pandolfi, Assunta; Consoli, Agostino; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio			A Functional Variant of the Dimethylarginine Dimethylaminohydrolase-2 Gene Is Associated with Insulin Sensitivity	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; NITRIC-OXIDE SYNTHESIS; STAGE RENAL-DISEASE; ENDOTHELIAL DYSFUNCTION; ASYMMETRIC DIMETHYLARGININE; ESSENTIAL-HYPERTENSION; GLUCOSE-TOLERANCE; PLASMA-CONCENTRATIONS; SYNTHASE INHIBITOR; RISK-FACTORS	Background: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of endothelial nitric oxide synthase, which was associated with insulin resistance. Dimethylarginine dimethylaminohydrolase (DDAH) is the major determinant of plasma ADMA. Examining data from the DIAGRAM+ (Diabetes Genetics Replication And Meta-analysis), we identified a variant (rs9267551) in the DDAH2 gene nominally associated with type 2 diabetes (P = 3 x 10(-5)). Methodology/Principal Findings: initially, we assessed the functional impact of rs9267551 in human endothelial cells (HUVECs), observing that the G allele had a lower transcriptional activity resulting in reduced expression of DDAH2 and decreased NO production in primary HUVECs naturally carrying it. We then proceeded to investigate whether this variant is associated with insulin sensitivity in vivo. To this end, two cohorts of nondiabetic subjects of European ancestry were studied. In sample 1 (n = 958) insulin sensitivity was determined by the insulin sensitivity index (ISI), while in sample 2 (n = 527) it was measured with a euglycemic-hyperinsulinemic clamp. In sample 1, carriers of the GG genotype had lower ISI than carriers of the C allele (67 +/- 33 vs.79 +/- 44; P=0.003 after adjusting for age, gender, and BMI). ADMA levels were higher in subjects carrying the GG genotype than in carriers of the C allele (0.68 +/- 0.14 vs. 0.57 +/- 0.14 mu mol/l; P=0.04). In sample 2, glucose disposal was lower in GG carriers as compared with C carriers (9.3 +/- 4.1 vs. 11.0 +/- 4.2 mgxKg(-1) free fat massxmin(-1); P=0.009). Conclusions/Significance: A functional polymorphism of the DDAH2 gene may confer increased risk for type 2 diabetes by affecting insulin sensitivity throughout increased ADMA levels.	[Andreozzi, Francesco; Presta, Ivan; Mannino, Gaia Chiara; Scarpelli, Daniela; Succurro, Elena; Sciacqua, Angela; Hribal, Marta Letizia; Perticone, Francesco; Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Consoli, Agostino] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Di Silvestre, Sara; Di Pietro, Natalia; Pandolfi, Assunta; Consoli, Agostino] Univ G dAnnunzio, Aging Res Ctr CeSI, Chieti, Italy	Magna Graecia University of Catanzaro; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Andreozzi, F (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Succurro, Elena/K-4138-2016; Mannino, Gaia C/K-1580-2016; Presta, Ivan/AAG-9461-2019; Perticone, Francesco/I-4260-2017; Consoli, Agostino/J-8027-2018; Di Pietro, Natalia/K-1604-2016; pandolfi, assunta/K-4595-2016; Sesti, Giorgio/B-1509-2012; Andreozzi, Francesco/J-4073-2018	Succurro, Elena/0000-0003-2578-692X; Mannino, Gaia C/0000-0002-6341-4572; Presta, Ivan/0000-0003-2668-6381; Consoli, Agostino/0000-0002-1885-451X; Di Pietro, Natalia/0000-0001-9720-2116; pandolfi, assunta/0000-0003-4135-7631; Andreozzi, Francesco/0000-0001-9375-1513; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of Instruction, Research and University (MIUR) [2009FATXW3_005]	Italian Ministry of Instruction, Research and University (MIUR)(Ministry of Education, Universities and Research (MIUR))	Grant received by the Italian Ministry of Instruction, Research and University (MIUR) as Research Project of National Interest (PRIN) no2009FATXW3_005 to F.A. (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Abhary S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009462; Andreozzi F, 2008, ARTERIOSCL THROM VAS, V28, P1355, DOI 10.1161/ATVBAHA.108.162883; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Bai YY, 2009, CLIN SCI, V117, P273, DOI 10.1042/CS20090005; Baron AD, 1999, AM J CARDIOL, V84, p25J; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; Cardellini M, 2005, DIABETES CARE, V28, P2007, DOI 10.2337/diacare.28.8.2007; Ceravolo R, 2003, J AM COLL CARDIOL, V41, P1753, DOI 10.1016/S0735-1097(03)00295-X; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Hribal ML, 2011, DIABETOLOGIA, V54, P795, DOI 10.1007/s00125-010-2038-8; Jones LC, 2003, BIOCHEM BIOPH RES CO, V310, P836, DOI 10.1016/j.bbrc.2003.09.097; Kielstein JT, 1999, J AM SOC NEPHROL, V10, P594; Laakso M, 2008, DIABETOLOGIA, V51, P502, DOI 10.1007/s00125-007-0899-2; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; Leiper JM, 1999, BIOCHEM J, V343, P209, DOI 10.1042/0264-6021:3430209; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Marini MA, 2003, J CLIN ENDOCR METAB, V88, P3368, DOI 10.1210/jc.2002-021716; McLaughlin T, 2006, J CLIN ENDOCR METAB, V91, P1896, DOI 10.1210/jc.2005-1441; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Miyazaki H, 1999, CIRCULATION, V99, P1141, DOI 10.1161/01.CIR.99.9.1141; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; OGAWA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P526, DOI 10.1016/0003-9861(87)90060-9; OGAWA T, 1989, J BIOL CHEM, V264, P10205; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Perticone F, 2005, J AM COLL CARDIOL, V46, P518, DOI 10.1016/j.jacc.2005.04.040; Perticone F, 2008, DIABETES, V57, P167, DOI 10.2337/db07-1189; Perticone F, 2010, INT J CARDIOL, V142, P236, DOI 10.1016/j.ijcard.2008.12.131; Pinkney JH, 1997, DIABETES, V46, pS9, DOI 10.2337/diab.46.2.S9; Quyyumi Arshed A., 1998, American Journal of Medicine, V105, p32S, DOI 10.1016/S0002-9343(98)00209-5; Rossi R, 2005, DIABETES CARE, V28, P702, DOI 10.2337/diacare.28.3.702; Sciacqua A, 2003, DIABETES CARE, V26, P1673, DOI 10.2337/diacare.26.6.1673; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stuhlinger MC, 2002, JAMA-J AM MED ASSOC, V287, P1420, DOI 10.1001/jama.287.11.1420; Sydow K, 2008, ARTERIOSCL THROM VAS, V28, P692, DOI 10.1161/ATVBAHA.108.162073; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; VALLANCE P, 1992, LANCET, V339, P572; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	45	17	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36224	10.1371/journal.pone.0036224	http://dx.doi.org/10.1371/journal.pone.0036224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558392	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000161
J	Bhadauria, V; Banniza, S; Vandenberg, A; Selvaraj, G; Wei, YD				Bhadauria, Vijai; Banniza, Sabine; Vandenberg, Albert; Selvaraj, Gopalan; Wei, Yangdou			Peroxisomal Alanine: Glyoxylate Aminotransferase AGT1 Is Indispensable for Appressorium Function of the Rice Blast Pathogen, Magnaporthe oryzae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SUBCELLULAR-DISTRIBUTION; TURGOR GENERATION; MAP KINASE; INFECTION; PROTEIN; GENE; PENETRATION; GRISEA; YEAST	The role of beta-oxidation and the glyoxylate cycle in fungal pathogenesis is well documented. However, an ambiguity still remains over their interaction in peroxisomes to facilitate fungal pathogenicity and virulence. In this report, we characterize a gene encoding an alanine, glyoxylate aminotransferase 1 (AGT1) in Magnaporthe oryzae, the causative agent of rice blast disease, and demonstrate that AGT1 is required for pathogenicity of M. oryzae. Targeted deletion of AGT1 resulted in the failure of penetration via appressoria; therefore, mutants lacking the gene were unable to induce blast symptoms on the hosts rice and barley. This penetration failure may be associated with a disruption in lipid mobilization during conidial germination as turgor generation in the appressorium requires mobilization of lipid reserves from the conidium. Analysis of enhanced green fluorescent protein expression using the transcriptional and translational fusion with the AGT1 promoter and open reading frame, respectively, revealed that AGT1 expressed constitutively in all in vitro grown cell types and during in planta colonization, and localized in peroxisomes. Peroxisomal localization was further confirmed by colocalization with red fluorescent protein fused with the peroxisomal targeting signal 1. Surprisingly, conidia produced by the Delta agt1 mutant were unable to form appressoria on artificial inductive surfaces, even after prolonged incubation. When supplemented with nicotinamide adenine dinucleotide (NAD(+))+pyruvate, appressorium formation was restored on an artificial inductive surface. Taken together, our data indicate that AGT1-dependent pyruvate formation by transferring an amino group of alanine to glyoxylate, an intermediate of the glyoxylate cycle is required for lipid mobilization and utilization. This pyruvate can be converted to non-fermentable carbon sources, which may require reoxidation of NADH generated by the beta-oxidation of fatty acids to NAD(+) in peroxisomes. Therefore, it may provide a means to maintain redox homeostasis in appressoria.	[Bhadauria, Vijai; Wei, Yangdou] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada; [Bhadauria, Vijai; Banniza, Sabine; Vandenberg, Albert] Univ Saskatchewan, Ctr Crop Dev, Saskatoon, SK S7N 0W0, Canada; [Selvaraj, Gopalan] Natl Res Council Canada, Inst Plant Biotechnol, Saskatoon, SK S7N 0W9, Canada	University of Saskatchewan; University of Saskatchewan; National Research Council Canada	Bhadauria, V (corresponding author), Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada.	sabine.banniza@usask.ca; yangdou.wei@usask.ca		Vandenberg, Albert/0000-0001-6177-1392	NSERC-CRD; Saskatchewan Pulse Growers	NSERC-CRD(Natural Sciences and Engineering Research Council of Canada (NSERC)); Saskatchewan Pulse Growers	This work was supported by NSERC-CRD and the Saskatchewan Pulse Growers grants to SB, AV and YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Danpure CJ, 1997, BIOESSAYS, V19, P317, DOI 10.1002/bies.950190409; DANPURE CJ, 1994, EUR J CELL BIOL, V64, P295; DANPURE CJ, 1990, J CELL SCI, V97, P669; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Hettema EH, 1999, BBA-MOL CELL RES, V1451, P17, DOI 10.1016/S0167-4889(99)00087-7; HONDRED D, 1985, PLANT PHYSIOL, V79, P95, DOI 10.1104/pp.79.1.95; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; HOWARD RJ, 1994, RICE BLAST DISEASE, P3; Kankanala P, 2007, PLANT CELL, V19, P706, DOI 10.1105/tpc.106.046300; Kato A, 1996, PLANT CELL, V8, P1601, DOI 10.1105/tpc.8.9.1601; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; KUNAU WH, 1988, BIOCHEM SOC T, V16, P418, DOI 10.1042/bst0160418; KURIHARA T, 1992, EUR J BIOCHEM, V210, P999, DOI 10.1111/j.1432-1033.1992.tb17505.x; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LU SW, 1994, P NATL ACAD SCI USA, V91, P12649, DOI 10.1073/pnas.91.26.12649; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Ou SH, 1985, RICE DIS; Park G, 2004, MOL MICROBIOL, V53, P1695, DOI 10.1111/j.1365-2958.2004.04220.x; PENG YL, 1988, CAN J BOT, V66, P730, DOI 10.1139/b88-107; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; REHFELD DW, 1972, J BIOL CHEM, V247, P4803; Sambrook J., 2001, MOL CLONING LAB MANU; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; SCHMALIX W, 1993, J BIOL CHEM, V268, P27428; Smith JJ, 2000, J BIOL CHEM, V275, P20168, DOI 10.1074/jbc.M909285199; Soanes DM, 2005, MOL PLANT PATHOL, V6, P503, DOI [10.1111/j.1364-3703.2005.00298.x, 10.1111/J.1364-3703.2005.00298.X]; Talbot NJ, 2001, ADV BOT RES, V34, P263, DOI 10.1016/S0065-2296(01)34011-9; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Wang ZY, 2003, MOL MICROBIOL, V47, P1601, DOI 10.1046/j.1365-2958.2003.03412.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Wilkins Thea A., 1996, P21; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116	36	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36266	10.1371/journal.pone.0036266	http://dx.doi.org/10.1371/journal.pone.0036266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558413	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000174
J	Dosoo, DK; Kayan, K; Adu-Gyasi, D; Kwara, E; Ocran, J; Osei-Kwakye, K; Mahama, E; Amenga-Etego, S; Bilson, P; Asante, KP; Koram, KA; Owusu-Agyei, S				Dosoo, David K.; Kayan, Kingsley; Adu-Gyasi, Dennis; Kwara, Evans; Ocran, Josephine; Osei-Kwakye, Kingsley; Mahama, Emmanuel; Amenga-Etego, Stephen; Bilson, Philip; Asante, Kwaku P.; Koram, Kwadwo A.; Owusu-Agyei, Seth			Haematological and Biochemical Reference Values for Healthy Adults in the Middle Belt of Ghana	PLOS ONE			English	Article							IMMUNOHEMATOLOGICAL REFERENCE RANGES; IMMUNOLOGICAL REFERENCE VALUES; POPULATION; CHILDREN; COUNT	Background: Reference values are very important in clinical management of patients, screening participants for enrolment into clinical trials and for monitoring the onset of adverse events during these trials. The aim of this was to establish gender-specific haematological and biochemical reference values for healthy adults in the central part of Ghana. Methods: A total of 691 adults between 18 and 59 years resident in the Kintampo North Municipality and South District in the central part of Ghana were randomly selected using the Kintampo Health and Demographic Surveillance System and enrolled in this cross-sectional survey. Out of these, 625 adults made up of 316 males and 309 females were assessed by a clinician to be healthy. Median values and nonparametric 95% reference values for 16 haematology and 22 biochemistry parameters were determined for this population based on the Clinical Laboratory and Standards Institute guidelines. Values established in this study were compared with the Caucasian values being used currently by our laboratory as reference values and also with data from other African and western countries. Results: Reference values established include: haemoglobin 113-164 g/L for males and 88-144 g/L for females; total white blood cell count 3.4-9.2 x 10(9)/L; platelet count 88-352 x 10(9)/L for males and 89-403 x 10(9)/L for females; alanine aminotransferase 8-54 U/L for males and 6-51 U/L for females; creatinine 56-119 mu mol/L for males and 53-106 mu mol/L for females. Using the haematological reference values based on the package inserts would have screened out up to 53% of potential trial participants and up to 25% of the population using the biochemical parameters. Conclusion: We have established a panel of locally relevant reference parameters for commonly used haematological and biochemical tests. This is important as it will help in the interpretation of laboratory results both for clinical management of patients and safety monitoring during a trial.	[Dosoo, David K.; Kayan, Kingsley; Adu-Gyasi, Dennis; Kwara, Evans; Osei-Kwakye, Kingsley; Mahama, Emmanuel; Amenga-Etego, Stephen; Bilson, Philip; Asante, Kwaku P.; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Ocran, Josephine; Koram, Kwadwo A.] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana	Kintampo Health Research Centre; University of Ghana	Dosoo, DK (corresponding author), Kintampo Hlth Res Ctr, Kintampo, Ghana.	seth.owusu-agyei@kintampo-hrc.org		Adu-Gyasi, Dennis/0000-0002-9449-2565; Owusu-Agyei, Seth/0000-0002-0807-1781	Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) of the U.S.A. [HHSN266200400016C]	Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) of the U.S.A.	This study was funded by the Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) of the U.S.A. Contract No. HHSN266200400016C awarded to Noguchi Memorial Institute for Medical Research, Ghana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABX, 2003, US MAN MICR 60 OS OT; Adetifa IMO, 2009, INT J LAB HEMATOL, V31, P615, DOI 10.1111/j.1751-553X.2008.01087.x; Asante KP, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/529583; AZIKIWE AN, 1984, E AFR MED J, V61, P482; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Buchanan AM, 2010, TROP MED INT HEALTH, V15, P1011, DOI 10.1111/j.1365-3156.2010.02585.x; CLSI, 2008, DEF EST VER REF INT; El-Hazmi MAF, 2001, ANN SAUDI MED, V21, P165, DOI 10.5144/0256-4947.2001.165; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Furruqh Sultana, 2004, Indian J Clin Biochem, V19, P72, DOI 10.1007/BF02894260; GILL GV, 1979, T ROY SOC TROP MED H, V73, P111, DOI 10.1016/0035-9203(79)90142-1; Hoffbrand AV., 2006, ESSENTIAL HAEMATOLOG, V5th ed; Horn PS, 2002, CLIN CHEM, V48, P1802; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kaya H, 2000, Turk J Haematol, V17, P123; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Koram Ka, 2007, Ghana Med J, V41, P160; Kratz A, 2004, NEW ENGL J MED, V351, P1548, DOI 10.1056/NEJMcpc049016; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Menard D, 2003, CLIN DIAGN LAB IMMUN, V10, P443, DOI 10.1128/CDLI.10.3.443-445.2003; Nkrumah B, 2011, Ghana Med J, V45, P97; Owusu-Agyei S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007302; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Quinto L, 2006, TROP MED INT HEALTH, V11, P1741, DOI 10.1111/j.1365-3156.2006.01764.x; Rao ArifAshfaq., 2007, PAK J PHYSL, V3, P19; Saathoff E, 2008, TROP MED INT HEALTH, V13, P612, DOI 10.1111/j.1365-3156.2008.02047.x; Sarkodie F, 2001, VOX SANG, V80, P142, DOI 10.1046/j.1423-0410.2001.00023.x; SCOTT TG, 1982, J CLIN PATHOL, V35, P69, DOI 10.1136/jcp.35.1.69; SOLBERG HE, 1987, J CLIN CHEM CLIN BIO, V25, P337; Stevens W, 2003, Qual Assur, V10, P83; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Wakeman L, 2007, INT J LAB HEMATOL, V29, P279, DOI 10.1111/j.1365-2257.2006.00883.x	33	54	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36308	10.1371/journal.pone.0036308	http://dx.doi.org/10.1371/journal.pone.0036308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558429	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000305336000184
J	Lin, LH; Qu, YF; Li, H; Zhou, KY; Ji, X				Lin, Long-Hui; Qu, Yan-Fu; Li, Hong; Zhou, Kai-Ya; Ji, Xiang			Genetic Structure and Demographic History Should Inform Conservation: Chinese Cobras Currently Treated as Homogenous Show Population Divergence	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NAJA-ATRA; PHYLOGENETIC-RELATIONSHIPS; SPECIES COMPLEX; PHYLOGEOGRAPHY; SOFTWARE; PROGRAM; DIFFERENTIATION; GROWTH; SNAKE	An understanding of population structure and genetic diversity is crucial for wildlife conservation and for determining the integrity of wildlife populations. The vulnerable Chinese cobra (Naja atra) has a distribution from the mouth of the Yangtze River down to northern Vietnam and Laos, within which several large mountain ranges and water bodies may influence population structure. We combined 12 microsatellite loci and 1117 bp of the mitochondrial cytochrome b gene to explore genetic structure and demographic history in this species, using 269 individuals from various localities in Mainland China and Vietnam. High levels of genetic variation were identified for both mtDNA and microsatellites. mtDNA data revealed two main (Vietnam + southern China + southwestern China; eastern + southeastern China) and one minor (comprising only two individuals from the westernmost site) clades. Microsatellite data divided the eastern + southeastern China clade further into two genetic clusters, which include individuals from the eastern and southeastern regions, respectively. The Luoxiao and Nanling Mountains may be important barriers affecting the diversification of lineages. In the haplotype network of cytchrome b, many haplotypes were represented within a "star" cluster and this and other tests suggest recent expansion. However, microsatellite analyses did not yield strong evidence for a recent bottleneck for any population or genetic cluster. The three main clusters identified here should be considered as independent management units for conservation purposes. The release of Chinese cobras into the wild should cease unless their origin can be determined, and this will avoid problems arising from unnatural homogenization.	[Lin, Long-Hui; Qu, Yan-Fu; Li, Hong; Zhou, Kai-Ya; Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Lin, Long-Hui] Hangzhou Normal Univ, Sch Life Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Nanjing Normal University; Hangzhou Normal University	Lin, LH (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	xji@mail.hz.zj.cn			Natural Science Foundation of China [3077038, 31070339]; Zhejiang Provincial Foundation of Natural Science [Z3090461]; Hangzhou Bureau of Science and Technology [20100332T20]; Zhejiang Department of Science and Technology for Innovation Teams [2010R50039-26]; Nanjing Normal University [0319PM0902]; Priority Academic Program Development of Jiangsu Higher Education Institutions [CXLX11_0885]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Foundation of Natural Science(Natural Science Foundation of Zhejiang Province); Hangzhou Bureau of Science and Technology; Zhejiang Department of Science and Technology for Innovation Teams; Nanjing Normal University; Priority Academic Program Development of Jiangsu Higher Education Institutions	The work was supported by grants from the Natural Science Foundation of China (3077038 and 31070339), the Zhejiang Provincial Foundation of Natural Science (Z3090461), Hangzhou Bureau of Science and Technology (20100332T20), Zhejiang Department of Science and Technology for Innovation Teams (2010R50039-26), Innovative Team Project of Nanjing Normal University (0319PM0902) and Priority Academic Program Development of Jiangsu Higher Education Institutions (CXLX11_0885). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BIRKY CW, 1983, GENETICS, V103, P513; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Butantan-British IBothrops/I Systematics Project, 2002, P111; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Chen XD, 1988, J TROP OCEANOGR, V7, P39; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Cornuet JM, 1996, GENETICS, V144, P2001; Ding L, 2011, MOL ECOL, V20, P1905, DOI 10.1111/j.1365-294X.2011.05060.x; Epperson BK, 2003, GEOGRAPHICAL GENETIC, V38; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fu JZ, 2005, MOL PHYLOGENET EVOL, V37, P202, DOI 10.1016/j.ympev.2005.03.023; Fu YX, 1997, GENETICS, V147, P915; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Huang Song, 2003, Acta Zoologica Sinica, V49, P854; Huang S, 2007, MOL PHYLOGENET EVOL, V44, P942, DOI 10.1016/j.ympev.2007.05.019; Huang S, 2009, MOL PHYLOGENET EVOL, V51, P438, DOI 10.1016/j.ympev.2009.02.013; Ineich Ivan, 1996, Bulletin de la Societe Herpetologique de France, V75-76, P7; Ji X, 2005, BIOL J LINN SOC, V85, P27, DOI 10.1111/j.1095-8312.2005.00470.x; Ji Xiang, 2002, Acta Zoologica Sinica, V48, P591; [李吉均 Li Jijun], 2004, [冰川冻土, Journal of Glaciology and Geocryology], V26, P235; Lin HC, 2008, CONSERV GENET, V9, P1089, DOI 10.1007/s10592-007-9418-8; Lin LH, 2008, J THERM BIOL, V33, P193, DOI 10.1016/j.jtherbio.2007.12.003; Lin LH, 2011, INT J MOL SCI, V12, P4435, DOI 10.3390/ijms12074435; Lin LH, 2010, MOL PHYLOGENET EVOL, V56, P601, DOI 10.1016/j.ympev.2010.04.032; Lin LH, 2008, ZOOL SCI, V25, P888, DOI 10.2108/zsj.25.888; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Lukoschek V, 2008, MOL ECOL, V17, P3062, DOI 10.1111/j.1365-294X.2008.03815.x; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Minton S.A., 1986, P3; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2004, DOCUMENTATION STRUCT; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sallaberry-Pincheira N, 2011, DIVERS DISTRIB, V17, P152, DOI 10.1111/j.1472-4642.2010.00729.x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szaro RC, 2008, INTEGR ZOOL, V3, P75, DOI 10.1111/j.1749-4877.2008.00075.x; SZYNDLAR Z, 1990, Amphibia-Reptilia, V11, P385, DOI 10.1163/156853890X00078; TAJIMA F, 1989, GENETICS, V123, P585; Tammeleht E, 2010, MOL ECOL, V19, P5359, DOI 10.1111/j.1365-294X.2010.04885.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan QY, 2009, J SNAKE, V21, P183; Tzika AC, 2009, CONSERV GENET, V10, P69, DOI 10.1007/s10592-008-9519-z; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wallach V, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2236.1.2; Wang J, 1980, ACTA GEOGRAPHICA SIN, V35, P299; WILLIAM J, 1995, TRENDS ECOL EVOL, V10, P485, DOI 10.1016/S0169-5347(00)89195-8; Wuster W, 1997, TOXICON, V35, P319, DOI 10.1016/S0041-0101(96)00152-3; WUSTER W, 1992, HERPETOLOGICA, V48, P69; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Zhao EM, 1998, CHINA RED DATA BOOK, P274; Zhao HT, 1999, GEOMORPHOLOGY ENV S	71	17	18	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36334	10.1371/journal.pone.0036334	http://dx.doi.org/10.1371/journal.pone.0036334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558439	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000191
J	Sergeev, M; Godin, AG; Kao, LY; Abuladze, N; Wiseman, PW; Kurtz, I				Sergeev, Mikhail; Godin, Antoine G.; Kao, Liyo; Abuladze, Natalia; Wiseman, Paul W.; Kurtz, Ira			Determination of Membrane Protein Transporter Oligomerization in Native Tissue Using Spatial Fluorescence Intensity Fluctuation Analysis	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; CORRELATION SPECTROSCOPY; PROXIMAL TUBULE; COTRANSPORTER; EXPRESSION; KIDNEY; NBCE1-A; CELLS; RAT; IMMUNOLOCALIZATION	Membrane transporter proteins exist in a complex dynamic equilibrium between various oligomeric states that include monomers, dimers, dimer of dimers and higher order oligomers. Given their sub-optical microscopic resolution size, the oligomerization state of membrane transporters is difficult to quantify without requiring tissue disruption and indirect biochemical methods. Here we present the application of a fluorescence measurement technique which combines fluorescence image moment analysis and spatial intensity distribution analysis (SpIDA) to determine the oligomerization state of membrane proteins in situ. As a model system we analyzed the oligomeric state(s) of the electrogenic sodium bicarbonate cotransporter NBCe1-A in cultured cells and in rat kidney. The approaches that we describe offer for the first time the ability to investigate the oligomeric state of membrane transporter proteins in their native state.	[Sergeev, Mikhail; Godin, Antoine G.; Wiseman, Paul W.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada; [Kao, Liyo; Abuladze, Natalia; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	McGill University; McGill University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Sergeev, M (corresponding author), McGill Univ, Dept Phys, Montreal, PQ, Canada.	ikurtz@mednet.ucla.edu		Godin, Antoine/0000-0003-2417-2563; Sergeev, Mikhail/0000-0001-7047-2378	Canadian Institutes of Health Research (CIHR); National Institutes of Health [DK077162, DK058563]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058563, R01DK077162] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	AGG was supported by Fellowships from the Canadian Institutes of Health Research (CIHR) Neurophysics Strategic Training Program Grant. IK is supported in part by National Institutes of Health grants DK077162 and DK058563. PWW is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the CIHR. PWW also acknowledges equipment funding from the Canadian Foundation for Innovation (CFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze N, 1998, AM J PHYSIOL-RENAL, V274, pF628, DOI 10.1152/ajprenal.1998.274.3.F628; Bok D, 2001, AM J PHYSIOL-RENAL, V281, pF920, DOI 10.1152/ajprenal.2001.281.5.F920; Brandes A, 2007, AM J PHYSIOL-REG I, V293, pR2400, DOI 10.1152/ajpregu.00208.2007; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Hess ST, 2002, BIOCHEMISTRY-US, V41, P697, DOI 10.1021/bi0118512; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kask P, 1999, P NATL ACAD SCI USA, V96, P13756, DOI 10.1073/pnas.96.24.13756; Kucik DF, 1999, BIOPHYS J, V76, P314, DOI 10.1016/S0006-3495(99)77198-5; Lee SH, 2005, ACTA OTO-LARYNGOL, V125, P745, DOI 10.1080/00016480510028519; MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705; Maunsbach AB, 2000, J AM SOC NEPHROL, V11, P2179, DOI 10.1681/ASN.V11122179; Meckel T, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600002; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Muller JD, 2004, BIOPHYS J, V86, P3981, DOI 10.1529/biophysj.103.037887; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Schmitt BM, 1999, AM J PHYSIOL-RENAL, V276, pF27, DOI 10.1152/ajprenal.1999.276.1.F27; Sergeev M, 2011, BIOPHYSICAL CHEM; Sergeev M, 2006, BIOPHYS J, V91, P3884, DOI 10.1529/biophysj.106.091181; SHOTTON D, 1978, J CELL BIOL, V76, P512, DOI 10.1083/jcb.76.2.512; Starchev K, 1999, J COLLOID INTERF SCI, V213, P479, DOI 10.1006/jcis.1999.6128; Swift JL, 2011, P NATL ACAD SCI USA, V108, P7016, DOI 10.1073/pnas.1018280108; Tatishchev S, 2003, BIOCHEMISTRY-US, V42, P755, DOI 10.1021/bi026826q; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Unruh JR, 2008, BIOPHYS J, V95, P5385, DOI 10.1529/biophysj.108.130310; Usui T, 2001, J CLIN INVEST, V108, P107, DOI 10.1172/JCI11869; Veenhoff LM, 2002, TRENDS BIOCHEM SCI, V27, P242, DOI 10.1016/S0968-0004(02)02077-7; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhu QS, 2010, J BIOL CHEM, V285, P37178, DOI 10.1074/jbc.M110.169201; Zhu QS, 2010, J BIOL CHEM, V285, P13416, DOI 10.1074/jbc.M109.093286	40	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36215	10.1371/journal.pone.0036215	http://dx.doi.org/10.1371/journal.pone.0036215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558387	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000158
J	Tu, WJ; He, J; Chen, H; Shi, XD; Li, Y				Tu, Wen-Jun; He, Jian; Chen, Hui; Shi, Xiao-Dong; Li, Ying			Psychological Effects of False-Positive Results in Expanded Newborn Screening in China	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CYSTIC-FIBROSIS; PEDIATRIC RESIDENTS; CLINICAL-RESEARCH; SWEAT-TEST; PARENTS; COMMUNICATION; TESTS; EXPERIENCE; DISORDERS	Objectives: As more families participate expanded newborn screening for metabolic disorders in China, the overall number of false positives increases. Our goal was to assess the potential impact on parental stress, perceptions of the child's health, and family relationships. Methods: Parents of 49 infants with false-positive screening results for metabolic disorders in the expanded newborn screening panel were compared with parents of 42 children with normal screening results. Parents first completed structured interview using likert scales, closed and open questions. Parents also completed the parenting stress index. Results: A total of 88 mothers and 41 fathers were interviewed. More mothers in the false-positive group reported that their children required extra parental care (21%), compared with 5% of mothers in the normal-screened group (P<0.001). 39% of mothers in the false-positive group reported that they worry about their child's future development, compared with 10% of mothers in the normal-screened group (P<0.001). Fathers in the false-positive group did not differ from fathers in the normal-screened group in reporting worry about their child's extra care requirements, and their child's future development. Children with false-positive results compared with children with normal results were triple as likely to experience hospitalization (27%vs 9%, respectively; P<0.001). Conclusions: The results showing false-positive screening results may affect parental stress and the parent-child relationship. Parental stress and anxiety can be reduced with improved education and communication to parents about false-positive results.	[Tu, Wen-Jun; He, Jian] Chinese Acad Med Sci, Ctr Clin Lab Dev, Beijing 100730, Peoples R China; [Tu, Wen-Jun; He, Jian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Hui; Shi, Xiao-Dong] China Rehabil Res Ctr, Beijing, Peoples R China; [Li, Ying] Beijing Haidian Maternal & Child Hlth Hosp, Dept Pediat, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Tu, WJ (corresponding author), Chinese Acad Med Sci, Ctr Clin Lab Dev, Beijing 100730, Peoples R China.	twjun8387@163.com	Tu, Wen-Jun/AAC-5696-2019	Tu, Wen-Jun/0000-0002-1703-1802				Abidin RR., 1995, PSYCHOL ASSESSMENT R; Allen EC, 2004, PEDIATRICS, V113, P267, DOI 10.1542/peds.113.2.267; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Beucher J, 2010, J PEDIATR-US, V156, P771, DOI 10.1016/j.jpeds.2009.12.003; Bodegard G, 1983, Acta Paediatr Scand Suppl, V304, P1; Burgess E, 2003, ARCH DIS CHILD-FETAL, V88, P280; Chappuy H, 2006, ARCH DIS CHILD, V91, P112, DOI 10.1136/adc.2005.076141; Fant KE, 2005, PEDIATRICS, V115, P1268, DOI 10.1542/peds.2004-0834; Farrell MH, 2005, PEDIATRICS, V116, P1492, DOI 10.1542/peds.2004-2611; Farrell MH, 2003, J PEDIATR-US, V143, P707, DOI 10.1016/j.jpeds.2003.09.022; Farrell M, 2008, PEDIATRICS, V122, P243, DOI 10.1542/peds.2007-2160; FYRO K, 1987, ACTA PAEDIATR SCAND, V76, P107, DOI 10.1111/j.1651-2227.1987.tb10424.x; Gennaccaro M, 2005, J INHERIT METAB DIS, V28, P819, DOI 10.1007/s10545-005-0135-5; Green JM, 2004, HEALTH TECHNOL ASSES, V8, P1; Green M, 1986, Pediatr Rev, V8, P75, DOI 10.1542/pir.8-3-75; Gurian EA, 2006, PEDIATRICS, V117, P1915, DOI 10.1542/peds.2005-2294; Hewlett J, 2006, J INHERIT METAB DIS, V29, P677, DOI 10.1007/s10545-006-0381-1; Janicke DM, 2001, MED CARE, V39, P990, DOI 10.1097/00005650-200109000-00009; Janicke DM, 2003, J PEDIATR PSYCHOL, V28, P547, DOI 10.1093/jpepsy/jsg045; Khairi MDM, 2011, INT J PEDIATR OTORHI, V75, P513, DOI 10.1016/j.ijporl.2011.01.009; La Pean A, 2005, PEDIATRICS, V116, P1499, DOI 10.1542/peds.2005-0449; Lang CW, 2011, PEDIATRICS, V127, P276, DOI 10.1542/peds.2010-2284; Leslie L K, 1996, Pediatr Rev, V17, P323, DOI 10.1542/pir.17-9-323; Levy HL, 2000, ANNU REV GENOM HUM G, V1, P139, DOI 10.1146/annurev.genom.1.1.139; Lipstein EA, 2009, GENET MED, V11, P716, DOI 10.1097/GIM.0b013e3181b3a61e; Matern D, 2007, J INHERIT METAB DIS, V30, P585, DOI 10.1007/s10545-007-0691-y; Prosser LA, 2008, ARCH PEDIAT ADOL MED, V162, P870, DOI 10.1001/archpediatrics.2008.1; ROTHENBERG MB, 1968, J AMER ACAD CHILD PS, V7, P689, DOI 10.1016/S0002-7138(09)62188-9; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Slaughter JL, 2010, PEDIATRICS, V126, P910, DOI 10.1542/peds.2010-0943; SORENSON JR, 1984, PEDIATRICS, V73, P183; Stenson BJ, 2004, ARCH DIS CHILD-FETAL, V89, pF321, DOI 10.1136/adc.2002.021931; Tarini BA, 2010, PUBLIC HEALTH GENOM, V13, P125, DOI 10.1159/000228724; Tarini BA, 2006, PEDIATRICS, V118, P448, DOI 10.1542/peds.2005-2026; Tluczek A, 2005, PEDIATRICS, V115, P1692, DOI 10.1542/peds.2004-0275; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564	36	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36235	10.1371/journal.pone.0036235	http://dx.doi.org/10.1371/journal.pone.0036235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TJ	22558398	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000165
J	Nam, JM; Davidson, EH				Nam, Jongmin; Davidson, Eric H.			Barcoded DNA-Tag Reporters for Multiplex Cis-Regulatory Analysis	PLOS ONE			English	Article							SEA-URCHIN EMBRYO; GENE NETWORK; CLONED DNA; EXPRESSION; SPECIFICATION; ENDOMESODERM; FUSION; MICROMERES; NODE; PCR	Cis-regulatory DNA sequences causally mediate patterns of gene expression, but efficient experimental analysis of these control systems has remained challenging. Here we develop a new version of "barcoded'' DNA-tag reporters, "Nanotags'' that permit simultaneous quantitative analysis of up to 130 distinct cis-regulatory modules (CRMs). The activities of these reporters are measured in single experiments by the NanoString RNA counting method and other quantitative procedures. We demonstrate the efficiency of the Nanotag method by simultaneously measuring hourly temporal activities of 126 CRMs from 46 genes in the developing sea urchin embryo, otherwise a virtually impossible task. Nanotags are also used in gene perturbation experiments to reveal cis-regulatory responses of many CRMs at once. Nanotag methodology can be applied to many research areas, ranging from gene regulatory networks to functional and evolutionary genomics.	[Nam, Jongmin; Davidson, Eric H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Nam, JM (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jn322@camden.rutgers.edu; davidson@caltech.edu			American Recovery and Reinvestment Act (ARRA) from the National Human Genome Research Institute, National Institute of Health [RC1 HG005332]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005332] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act (ARRA) from the National Human Genome Research Institute, National Institute of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project was supported by American Recovery and Reinvestment Act (ARRA) funds through grant number RC1 HG005332 to (E.H.D.) from the National Human Genome Research Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; De-Leon SBT, 2010, P NATL ACAD SCI USA, V107, P10103, DOI 10.1073/pnas.1004824107; FLYTZANIS CN, 1987, P NATL ACAD SCI USA, V84, P151, DOI 10.1073/pnas.84.1.151; FRANKS RR, 1988, DEVELOPMENT, V102, P287; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Kenny AP, 2003, DEV BIOL, V261, P412, DOI 10.1016/S0012-1606(03)00331-2; Lee PY, 2007, DEV BIOL, V307, P434, DOI 10.1016/j.ydbio.2007.05.005; LIVANT DL, 1991, DEVELOPMENT, V113, P385; Logan CY, 1999, DEVELOPMENT, V126, P345; Materna SC, 2010, GENE EXPR PATTERNS, V10, P177, DOI 10.1016/j.gep.2010.04.002; Materna SC, 2008, NAT PROTOC, V3, P1876, DOI 10.1038/nprot.2008.187; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; Minokawa T, 2005, DEV BIOL, V288, P545, DOI 10.1016/j.ydbio.2005.09.047; Nag A, 2006, RNA, V12, P1534, DOI 10.1261/rna.103206; Nam J, 2007, DEV BIOL, V306, P860, DOI 10.1016/j.ydbio.2007.03.033; Nam JM, 2010, P NATL ACAD SCI USA, V107, P3930, DOI 10.1073/pnas.1000147107; Peter IS, 2011, NATURE, V474, P635, DOI 10.1038/nature10100; Ransick A, 2002, DEV BIOL, V246, P132, DOI 10.1006/dbio.2002.0607; Revilla-i-Domingo R, 2004, DEV BIOL, V274, P438, DOI 10.1016/j.ydbio.2004.07.008; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Smith J, 2008, DEV BIOL, V313, P863, DOI 10.1016/j.ydbio.2007.10.042; Smith J, 2008, P NATL ACAD SCI USA, V105, P20089, DOI 10.1073/pnas.0806442105; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Wahl ME, 2009, DEV BIOL, V335, P428, DOI 10.1016/j.ydbio.2009.08.005; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	27	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35934	10.1371/journal.pone.0035934	http://dx.doi.org/10.1371/journal.pone.0035934			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563420	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100046
J	Tilghman, MW; May, S; Perez-Santiago, J; Ignacio, CC; Little, SJ; Richman, DD; Smith, DM				Tilghman, Myres W.; May, Susanne; Perez-Santiago, Josue; Ignacio, Caroline C.; Little, Susan J.; Richman, Douglas D.; Smith, Davey M.			A Combined Screening Platform for HIV Treatment Failure and Resistance	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT FAILURE; DRUG-RESISTANCE; INFECTION; VIREMIA	Background: To develop a low cost method to screen for virologic failure of antiretroviral therapy (ART) and HIV-1 drug resistance, we performed a retrospective evaluation of a screening assay using serial dilutions of HIV-1 RNA-spiked blood plasma and samples from patients receiving >6 months of first-line ART. Methods: Serial dilution testing was used to assess sensitivity of a simple PCR-based assay (targeted at >= 1,000 HIV RNA copies/mL). We created blood plasma minipools of five samples, extracted HIV RNA from the pools, PCR amplified the reverse transcriptase (RT) coding region of the HIV-1 pol gene from extracted RNA, sequenced PCR product of positive pools, and used sequences to determine drug resistance. Sensitivity, specificity, and predictive values were determined for different levels of virologic failure based on maximum viral loads of individual samples within a pool. Results: Of 295 samples analyzed, 43 (15%) had virologic failure at >= 50 copies/mL (range 50-10,500 copies/mL, four at >= 1,000 copies/mL). The assay demonstrated 100% sensitivity to detect virus from these four samples, requiring only one round of PCR, and 56% and 89% sensitivity to detect samples with >= 50 and >= 500 copies/mL using two rounds. Amplified PCR products of all positive pools were successfully sequenced and 30% harbored >= 1 major resistance mutation. This method would have cost 10% of the combined costs of individual viral load and resistance testing. Conclusions: We present a novel method that can screen for both virologic failure of first-line ART and drug resistance. The method is much less expensive than current methods, which may offer sustainability in resource-limited settings.	[Tilghman, Myres W.; Ignacio, Caroline C.; Little, Susan J.; Richman, Douglas D.; Smith, Davey M.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Richman, Douglas D.; Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [May, Susanne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Perez-Santiago, Josue] Univ Calif San Diego, Dept Bioinformat & Syst Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego	Tilghman, MW (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mtilghman@ucsd.edu; davey@ucsd.edu	Little, Susan/AAA-6116-2019	Smith, Davey/0000-0003-3603-1733	National Institutes of Health [AI69432, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353]; James B. Pendleton Charitable Trust; San Diego Veterans Affairs Healthcare System; California HIV Research Program [RN07-SD-702]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R21AI080353, UM1AI069432, R56AI047745, U01AI043638, P01AI074621, R21AI047745, R24AI106039, U01AI069432, R01AI047745, R21AI077304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062512, R01MH083552] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; San Diego Veterans Affairs Healthcare System; California HIV Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (AI69432, AI043638, MH62512, MH083552, AI077304, AI36214, AI047745, AI74621, AI080353), and by the James B. Pendleton Charitable Trust, the San Diego Veterans Affairs Healthcare System, and the California HIV Research Program RN07-SD-702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Gunthard HF, 1998, J VIROL, V72, P2422; Gunthard HF, 1998, AIDS RES HUM RETROV, V14, P869, DOI 10.1089/aid.1998.14.869; Martinez V, 2005, AIDS, V19, P1065, DOI 10.1097/01.aids.0000174453.55627.de; May S, 2010, JAIDS-J ACQ IMM DEF, V53, P194, DOI 10.1097/QAI.0b013e3181ba37a7; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Smith DM, 2009, AIDS, V23, P2151, DOI 10.1097/QAD.0b013e3283313ca9; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tilghman MW, 2011, JAIDS-J ACQ IMM DEF, V56, pE70, DOI 10.1097/QAI.0b013e3181ff63d7; van Zyl GU, 2011, CLIN INFECT DIS, V52, P264, DOI 10.1093/cid/ciq084	11	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35401	10.1371/journal.pone.0035401	http://dx.doi.org/10.1371/journal.pone.0035401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563383	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100012
J	Sanchez, LM; Wong, WR; Riener, RM; Schulze, CJ; Linington, RG				Sanchez, Laura M.; Wong, Weng Ruh; Riener, Romina M.; Schulze, Christopher J.; Linington, Roger G.			Examining the Fish Microbiome: Vertebrate-Derived Bacteria as an Environmental Niche for the Discovery of Unique Marine Natural Products	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; GUT MICROBIOTA; DIVERSITY; COMMUNITY	Historically, marine invertebrates have been a prolific source of unique natural products, with a diverse array of biological activities. Recent studies of invertebrate-associated microbial communities are revealing microorganisms as the true producers of many of these compounds. Inspired by the human microbiome project, which has highlighted the human intestine as a unique microenvironment in terms of microbial diversity, we elected to examine the bacterial communities of fish intestines (which we have termed the fish microbiome) as a new source of microbial and biosynthetic diversity for natural products discovery. To test the hypothesis that the fish microbiome contains microorganisms with unique capacity for biosynthesizing natural products, we examined six species of fish through a combination of dissection and culture-dependent evaluation of intestinal microbial communities. Using isolation media designed to enrich for marine Actinobacteria, we have found three main clades that show taxonomic divergence from known strains, several of which are previously uncultured. Extracts from these strains exhibit a wide range of activities against both Gram-positive and Gram-negative human pathogens, as well as several fish pathogens. Exploration of one of these extracts has identified the novel bioactive lipid sebastenoic acid as an anti-microbial agent, with activity against Staphylococcus aureus, Bacillus subtilis, Enterococcus faecium, and Vibrio mimicus.	[Sanchez, Laura M.; Wong, Weng Ruh; Riener, Romina M.; Schulze, Christopher J.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sanchez, LM (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu	Sanchez, Laura/AAT-8338-2020; Linington, Roger/ABD-5582-2021	Sanchez, Laura/0000-0001-9223-7977; Linington, Roger/0000-0003-1818-4971	NIH [ICBG FIC TW006634, 2R25GM05803-12]; UCSC Committee on Research Special Research Grant; Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program; NSF; FOGARTY INTERNATIONAL CENTER [U01TW006634] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSC Committee on Research Special Research Grant; Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program; NSF(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by NIH grant ICBG FIC TW006634, UCSC Committee on Research Special Research Grant, NIH grant for Undergraduate Research 2R25GM05803-12, the Malaysia Biotechnology Corporation under the QB3-Malaysia Postdoctoral Fellowship program (WW) and an NSF graduate research fellowship (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Blunt JW, 2011, NAT PROD REP, V28, P196, DOI 10.1039/c005001f; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Davies J, 2011, CURR OPIN CHEM BIOL, V15, P5, DOI 10.1016/j.cbpa.2010.11.001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gomez GD, 2008, FEMS IMMUNOL MED MIC, V52, P145, DOI 10.1111/j.1574-695X.2007.00343.x; Gulder TAM, 2009, CURR OPIN MICROBIOL, V12, P252, DOI 10.1016/j.mib.2009.05.002; Hauff S, 2010, LIPIDS, V45, P357, DOI 10.1007/s11745-010-3400-9; Hong K, 2009, MAR DRUGS, V7, P495, DOI 10.3390/md7040495; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughes CC, 2010, CHEM-EUR J, V16, P12512, DOI 10.1002/chem.201001279; Jensen PR, 2005, ENVIRON MICROBIOL, V7, P1039, DOI 10.1111/j.1462-2920.2005.00785.x; Khan ST, 2009, INT J SYST EVOL MICR, V59, P2094, DOI 10.1099/ijs.0.007666-0; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kim TK, 2005, ENVIRON MICROBIOL, V7, P509, DOI 10.1111/j.1462-2920.2005.00716.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITAHARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P78, DOI 10.1271/bbb.59.78; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Lin Z, 2011, J MED CHEM, V54, P3746, DOI 10.1021/jm101621u; Lin ZJ, 2010, J NAT PROD, V73, P1922, DOI 10.1021/np100588c; Murray PR, 2007, MAUNAL CLIN MICROBIO; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Noga EJ, 2010, FISH DIS DIAGNOSIS T, V2nd, P193; Oh DC, 2011, ORG LETT, V13, P752, DOI 10.1021/ol102991d; Peraud O, 2009, APPL ENVIRON MICROB, V75, P6820, DOI 10.1128/AEM.01238-09; Poulsen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016763; Quang DN, 2004, J NAT PROD, V67, P1152, DOI 10.1021/np040063l; Radjasa OK, 2011, BIOORGAN MED CHEM, V19, P6658, DOI 10.1016/j.bmc.2011.07.017; Reid HI, 2009, AQUACULTURE, V288, P36, DOI 10.1016/j.aquaculture.2008.11.022; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sheeja M.S., 2011, Middle-East Journal of Scientific Research, V7, P327; Smriga S, 2010, FEMS MICROBIOL ECOL, V73, P31, DOI 10.1111/j.1574-6941.2010.00879.x; Sonnenburg JL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001626; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornburg CC, 2010, J NAT PROD, V73, P489, DOI 10.1021/np900662k; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Ward NL, 2009, EXTREMOPHILES, V13, P679, DOI 10.1007/s00792-009-0252-4; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2	51	57	59	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35398	10.1371/journal.pone.0035398	http://dx.doi.org/10.1371/journal.pone.0035398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574119	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800015
J	Park, JE; Son, AI; Hua, R; Wang, LQ; Zhang, X; Zhou, RP				Park, Jeong Eun; Son, Alexander I.; Hua, Rui; Wang, Lianqing; Zhang, Xue; Zhou, Renping			Human Cataract Mutations in EPHA2 SAM Domain Alter Receptor Stability and Function	PLOS ONE			English	Article							DOMINANT CONGENITAL CATARACT; TYROSINE KINASE; CELL-MIGRATION; ECTODERMAL DYSPLASIA; MISSENSE MUTATION; CORTICAL CATARACT; ALPHA-CRYSTALLIN; CHROMOSOME 1P; RAPP-HODGKIN; GENE	The cellular and molecular mechanisms underlying the pathogenesis of cataracts leading to visual impairment remain poorly understood. In recent studies, several mutations in the cytoplasmic sterile-alpha-motif (SAM) domain of human EPHA2 on chromosome 1p36 have been associated with hereditary cataracts in several families. Here, we have investigated how these SAM domain mutations affect EPHA2 activity. We showed that the SAM domain mutations dramatically destabilized the EPHA2 protein in a proteasome-dependent pathway, as evidenced by the increase of EPHA2 receptor levels in the presence of the proteasome inhibitor MG132. In addition, the expression of wild-type EPHA2 promoted the migration of the mouse lens epithelial alpha TN4-1 cells in the absence of ligand stimulation, whereas the mutants exhibited significantly reduced activity. In contrast, stimulation of EPHA2 with its ligand ephrin-A5 eradicates the enhancement of cell migration accompanied by Akt activation. Taken together, our studies suggest that the SAM domain of the EPHA2 protein plays critical roles in enhancing the stability of EPHA2 by modulating the proteasome-dependent process. Furthermore, activation of Akt switches EPHA2 from promoting to inhibiting cell migration upon ephrin-A5 binding. Our results provide the first report of multiple EPHA2 cataract mutations contributing to the destabilization of the receptor and causing the loss of cell migration activity.	[Park, Jeong Eun; Son, Alexander I.; Zhou, Renping] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Hua, Rui; Wang, Lianqing; Zhang, Xue] Chinese Acad Med Sci, Inst Basic Med Sci, McKusick Zhang Ctr Genet Med, State Key Lab Med Mol Biol,Peking Union Med Coll, Beijing 100730, Peoples R China	Rutgers State University New Brunswick; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Park, JE (corresponding author), Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA.	rzhou@rci.rutgers.edu	Wang, Lianqing/AAX-5278-2020	Wang, Lianqing/0000-0002-7161-4718	National Institutes of Health (NIH) [1RO1EY019012]; National Natural Science Foundation of China (NSFC) [30973276]; NATIONAL EYE INSTITUTE [R01EY019012] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by the National Institutes of Health (NIH) grant (1RO1EY019012) to Dr. Zhou, and the National Natural Science Foundation of China (NSFC) grant (30973276) to Dr. Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Brannan JM, 2009, CANCER PREV RES, V2, P1039, DOI 10.1158/1940-6207.CAPR-09-0212; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Brantley-Sieders DM, 2004, J CELL SCI, V117, P2037, DOI 10.1242/jcs.01061; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chai A, 2008, HUM MOL GENET, V17, P266, DOI 10.1093/hmg/ddm303; Chang Q, 2008, BRIT J CANCER, V99, P1074, DOI 10.1038/sj.bjc.6604676; Cicero DO, 2006, CELL BIOCHEM BIOPHYS, V44, P475, DOI 10.1385/CBB:44:3:475; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Dufour A, 2006, DEVELOPMENT, V133, P4415, DOI 10.1242/dev.02623; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V320, P1096, DOI 10.1016/j.bbrc.2004.06.054; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Goichberg P, 2011, CIRC RES, V108, P1071, DOI 10.1161/CIRCRESAHA.110.239459; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Heon E, 1999, AM J HUM GENET, V65, P1261, DOI 10.1086/302619; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Huang WC, 2004, EUR J BIOCHEM, V271, P4114, DOI 10.1111/j.1432-1033.2004.04349.x; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kannabiran C, 1998, Mol Vis, V4, P21; Kantaputra PN, 2011, AM J MED GENET A, V155A, P1432, DOI 10.1002/ajmg.a.34011; Kantaputra PN, 2003, J DENT RES, V82, P433, DOI 10.1177/154405910308200606; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Kaul H, 2010, MOL VIS, V16, P511; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; Mackay DS, 2002, AM J HUM GENET, V71, P1216, DOI 10.1086/344212; McCarty CA, 2001, INVEST OPHTH VIS SCI, V42, P1677; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; McKay JD, 2005, BRIT J OPHTHALMOL, V89, P831, DOI 10.1136/bjo.2004.058495; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Pande A, 2010, BIOCHEMISTRY-US, V49, P6122, DOI 10.1021/bi100664s; Park EK, 2004, MOL BIOL CELL, V15, P1647, DOI 10.1091/mbc.E03-09-0674; Parri M, 2005, J BIOL CHEM, V280, P34008, DOI 10.1074/jbc.M502879200; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qiao F, 2005, SCI STKE, P286; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Sahin MT, 2004, CLIN EXP DERMATOL, V29, P486, DOI 10.1111/j.1365-2230.2004.01584.x; SanGiovanni JP, 2002, ARCH OPHTHALMOL-CHIC, V120, P1559, DOI 10.1001/archopht.120.11.1559; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Shiels A, 2008, MOL VIS, V14, P2042; Smalla M, 1999, PROTEIN SCI, V8, P1954, DOI 10.1110/ps.8.10.1954; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Sun H, 2005, J MED GENET, V42, P706, DOI 10.1136/jmg.2004.028274; Tan W, 2011, MOL VIS, V17, P1553; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Tognon CE, 2004, MOL CELL BIOL, V24, P4636, DOI 10.1128/MCB.24.11.4636-4650.2004; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Winer IS, 2006, J BIOL CHEM, V281, P26181, DOI 10.1074/jbc.M604217200; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Xu J., 2005, CURR PROT MOL BIOL, V28, P28; YAMADA T, 1990, CURR EYE RES, V9, P31, DOI 10.3109/02713689009000052; Yamazaki T, 2009, J CELL SCI, V122, P243, DOI 10.1242/jcs.036467; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yue X, 2008, DEV NEUROBIOL, V68, P1269, DOI 10.1002/dneu.20657; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995; Zhuang GL, 2007, J BIOL CHEM, V282, P2683, DOI 10.1074/jbc.M608509200	72	24	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36564	10.1371/journal.pone.0036564	http://dx.doi.org/10.1371/journal.pone.0036564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570727	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343400043
J	Singh, RK; Gonzalez, M; Kabbaj, MHM; Gunjan, A				Singh, Rakesh Kumar; Gonzalez, Melanie; Kabbaj, Marie-Helene Miquel; Gunjan, Akash			Novel E3 Ubiquitin Ligases That Regulate Histone Protein Levels in the Budding Yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							CELL-CYCLE; S-PHASE; GLOBAL ANALYSIS; RBR FAMILY; DEGRADATION; PHOSPHORYLATION; REVEALS; DISEASE; COMPLEX; DNA	Core histone proteins are essential for packaging the genomic DNA into chromatin in all eukaryotes. Since multiple genes encode these histone proteins, there is potential for generating more histones than what is required for chromatin assembly. The positively charged histones have a very high affinity for negatively charged molecules such as DNA, and any excess of histone proteins results in deleterious effects on genomic stability and cell viability. Hence, histone levels are known to be tightly regulated via transcriptional, posttranscriptional and posttranslational mechanisms. We have previously elucidated the posttranslational regulation of histone protein levels by the ubiquitin-proteasome pathway involving the E2 ubiquitin conjugating enzymes Ubc4/5 and the HECT (Homologous to E6-AP C-Terminus) domain containing E3 ligase Tom1 in the budding yeast. Here we report the identification of four additional E3 ligases containing the RING (Really Interesting New Gene) finger domains that are involved in the ubiquitylation and subsequent degradation of excess histones in yeast. These E3 ligases are Pep5, Snt2 as well as two previously uncharacterized Open Reading Frames (ORFs) YKR017C and YDR266C that we have named Hel1 and Hel2 (for Histone E3 Ligases) respectively. Mutants lacking these E3 ligases are sensitive to histone overexpression as they fail to degrade excess histones and accumulate high levels of endogenous histones on histone chaperones. Co-immunoprecipitation assays showed that these E3 ligases interact with the major E2 enzyme Ubc4 that is involved in the degradation related ubiquitylation of histones. Using mutagenesis we further demonstrate that the RING domains of Hel1, Hel2 and Snt2 are required for histone regulation. Lastly, mutants corresponding to Hel1, Hel2 and Pep5 are sensitive to replication inhibitors. Overall, our results highlight the importance of posttranslational histone regulatory mechanisms that employ multiple E3 ubiquitin ligases to ensure excess histone degradation and thus contribute to the maintenance of genomic stability.	[Singh, Rakesh Kumar; Gonzalez, Melanie; Kabbaj, Marie-Helene Miquel; Gunjan, Akash] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Singh, RK (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	rakesh.singh@med.fsu.edu; akash.gunjan@med.fsu.edu		Gunjan, Akash/0000-0001-8478-3978				Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Alibhoy Abbas A, 2011, World J Biol Chem, V2, P239, DOI 10.4331/wjbc.v2.i11.239; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Ardley HC, 2004, NEURODEGENER DIS, V1, P71, DOI 10.1159/000080048; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Ciechanover A, 2003, BIOCHEM SOC T, V31, P474, DOI 10.1042/BST0310474; Ciechanover A, 2002, HEPATOLOGY, V35, P3, DOI 10.1053/jhep.2002.30316; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dingwall C, 1990, Semin Cell Biol, V1, P11; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; HAAS AL, 1982, J BIOL CHEM, V257, P2543; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Hatakeyama S, 2003, BIOCHEM BIOPH RES CO, V302, P635, DOI 10.1016/S0006-291X(03)00245-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Huizing M, 2001, GENE, V264, P241, DOI 10.1016/S0378-1119(01)00333-X; JONES EW, 1977, GENETICS, V85, P23; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liang D, 2012, NUCL ACIDS IN PRESS; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Morillo-Huesca M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000964; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Scheffner M, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S6; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shieh HL, 2001, J BIOL CHEM, V276, P10398, DOI 10.1074/jbc.M001767200; Singh RK, 2010, CELL CYCLE, V9, P4236, DOI 10.4161/cc.9.20.13636; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Singh RK, 2009, FRONT BIOSCI-LANDMRK, V14, P3145, DOI 10.2741/3441; Srivastava A, 2000, GENETICS, V156, P105; Sutton A, 2001, GENETICS, V158, P587; Van der Reijden BA, 1999, PROTEIN SCI, V8, P1557, DOI 10.1110/ps.8.7.1557; van Holde K.E., 1988, CHROMATIN; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wolffe A., 1995, CHROMATIN STRUCTURE; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Yang Y, 2010, CELL RES, V20, P1276, DOI 10.1038/cr.2010.146; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	69	39	45	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36295	10.1371/journal.pone.0036295	http://dx.doi.org/10.1371/journal.pone.0036295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570702	Green Submitted, Green Published, gold			2022-12-27	WOS:000305343400018
J	Van Vaerenbergh, J; Baeyen, S; De Vos, P; Maes, M				Van Vaerenbergh, Johan; Baeyen, Steve; De Vos, Paul; Maes, Martine			Sequence Diversity in the Dickeya fliC Gene: Phylogeny of the Dickeya Genus and TaqMan (R) PCR for 'D. solani', New Biovar 3 Variant on Potato in Europe	PLOS ONE			English	Article							ERWINIA-CHRYSANTHEMI; BACTERIAL FLAGELLIN; SENSITIVE DETECTION; PLANT; STRAINS; RECA; PECTOBACTERIUM; CLADE; RFLP	Worldwide, Dickeya (formerly Erwinia chrysanthemi) is causing soft rot diseases on a large diversity of crops and ornamental plants. Strains affecting potato are mainly found in D. dadantii, D. dianthicola and D. zeae, which appear to have a marked geographical distribution. Furthermore, a few Dickeya isolates from potato are attributed to D. chrysanthemi and D. dieffenbachiae. In Europe, isolates of Erwinia chrysanthemi biovar 1 and biovar 7 from potato are now classified in D. dianthicola. However, in the past few years, a new Dickeya biovar 3 variant, tentatively named 'Dickeya solani', has emerged as a common major threat, in particular in seed potatoes. Sequences of a fliC gene fragment were used to generate a phylogeny of Dickeya reference strains from culture collections and with this reference backbone, to classify pectinolytic isolates, i.e. Dickeya spp. from potato and ornamental plants. The reference strains of the currently recognized Dickeya species and 'D. solani' were unambiguously delineated in the fliC phylogram. D. dadantii, D. dianthicola and 'D. solani' displayed unbranched clades, while D. chrysanthemi, D. zeae and D. dieffenbachiae branched into subclades and lineages. Moreover, Dickeya isolates from diagnostic samples, in particular biovar 3 isolates from greenhouse ornamentals, formed several new lineages. Most of these isolates were positioned between the clade of 'D. solani' and D. dadantii as transition variants. New lineages also appeared in D. dieffenbachiae and in D. zeae. The strains and isolates of D. dianthicola and 'D. solani' were differentiated by a fliC sequence useful for barcode identification. A fliC TaqMan (R) real-time PCR was developed for 'D. solani' and the assay was provisionally evaluated in direct analysis of diagnostic potato samples. This molecular tool can support the efforts to control this particular phytopathogen in seed potato certification.	[Van Vaerenbergh, Johan; Baeyen, Steve; Maes, Martine] Inst Agr & Fisheries Res ILVO, Unit Plant Sci Crop Protect, Merelbeke, Belgium; [De Vos, Paul] Univ Ghent, Microbiol Lab, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium	Institute For Agricultural & Fisheries Research; Ghent University	Van Vaerenbergh, J (corresponding author), Inst Agr & Fisheries Res ILVO, Unit Plant Sci Crop Protect, Merelbeke, Belgium.	johan.vanvaerenbergh@ilvo.vlaanderen.be	Baeyen, Steve/R-1869-2019; De Vos, Paul/J-5392-2013	Baeyen, Steve/0000-0002-7192-2403; 	Government of Flanders	Government of Flanders	The research was performed with funds of the Government of Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amhaz JMK, 2004, FEMS MICROBIOL LETT, V235, P259, DOI 10.1016/j.femsle.2004.04.044; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; Bellingham NF, 2001, SYST APPL MICROBIOL, V24, P157, DOI 10.1078/0723-2020-00031; Brady C.L., 2011, INT J SYST EVOL MICR, V62, P1592, DOI DOI 10.1099/IJS.0.035055-0; DARRASSE A, 1994, APPL ENVIRON MICROB, V60, P1437, DOI 10.1128/AEM.60.5.1437-1443.1994; DICKEY RS, 1984, PHYTOPATHOLOGY, V74, P1388, DOI 10.1094/Phyto-74-1388; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Felsenstein J., 2004, INFERRING PHYLOGENIE; Haque M, 2006, BANGLADESH J MICROBI, V25, P36; Hossein MM, 2005, PHYSIOL MOL PLANT P, V17, P943; Jahn CE, 2008, MOL PLANT MICROBE IN, V21, P1431, DOI 10.1094/MPMI-21-11-1431; JANSE JD, 1988, PHYTOPATHOLOGY, V78, P800, DOI 10.1094/Phyto-78-800; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Lee YA, 2006, J MICROBIOL METH, V64, P200, DOI 10.1016/j.mimet.2005.04.031; Ma B, 2007, PHYTOPATHOLOGY, V97, P1150, DOI 10.1094/PHYTO-97-9-1150; MULHOLLAND V, 1993, MOL MICROBIOL, V9, P343, DOI 10.1111/j.1365-2958.1993.tb01695.x; Nassar A, 1996, APPL ENVIRON MICROB, V62, P2228, DOI 10.1128/AEM.62.7.2228-2235.1996; Nei M., 2000, MOL EVOLUTION PHYLOG; Paiva JB, 2009, BRAZ J POULTRY SCI, V11, P271, DOI 10.1590/S1516-635X2009000400009; PARISH CR, 1969, BIOCHEM J, V113, P501, DOI 10.1042/bj1130501; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P2388, DOI 10.1099/ijs.0.009258-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Samson R., 1978, Proceedings of the IVth International Conference on Plant Pathogenic Bacteria. Vol. II., P547; Samson R., 1987, EPPO B, V17, P11, DOI [10.1111/j.1365-2338.1987.tb00002.x, DOI 10.1111/J.1365-2338.1987.TB00002.X]; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Schonfeld J, 2003, APPL ENVIRON MICROB, V69, P7248, DOI 10.1128/AEM.69.12.7248-7256.2003; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Waleron M, 2002, MICROBIOL-SGM, V148, P583, DOI 10.1099/00221287-148-2-583; Wang L, 2003, J BACTERIOL, V185, P2936, DOI 10.1128/JB.185.9.2936-2943.2003; Wang QF, 2005, EMBO J, V24, P2034, DOI 10.1038/sj.emboj.7600668; Winstanley C, 1999, J MED MICROBIOL, V48, P657, DOI 10.1099/00222615-48-7-657; Winstanley C, 1997, MICROBIOL-SGM, V143, P3071, DOI 10.1099/00221287-143-10-3071; YAKRUS M, 1979, PHYTOPATHOLOGY, V69, P517, DOI 10.1094/Phyto-69-517; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; Young JM, 2007, SYST APPL MICROBIOL, V30, P343, DOI 10.1016/j.syapm.2007.03.002; Zhang S, 1997, J PHYTOPATHOL, V145, P267, DOI 10.1111/j.1439-0434.1997.tb00398.x	43	23	25	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35738	10.1371/journal.pone.0035738	http://dx.doi.org/10.1371/journal.pone.0035738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570692	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400008
J	Pasco, MY; Leopold, P				Pasco, Matthieu Y.; Leopold, Pierre			High Sugar-Induced Insulin Resistance in Drosophila Relies on the Lipocalin Neural Lazarillo	PLOS ONE			English	Article							HEPATIC STEATOSIS; RETINOL-BINDING-PROTEIN-4; GROWTH; GENE; MICE; PEPTIDES; RECEPTOR; OBESITY; CELLS; CARBOXYLASE-2	In multicellular organisms, insulin/IGF signaling (IIS) plays a central role in matching energy needs with uptake and storage, participating in functions as diverse as metabolic homeostasis, growth, reproduction and ageing. In mammals, this pleiotropy of action relies in part on a dichotomy of action of insulin, IGF-I and their respective membrane-bound receptors. In organisms with simpler IIS, this functional separation is questionable. In Drosophila IIS consists of several insulin-like peptides called Dilps, activating a unique membrane receptor and its downstream signaling cascade. During larval development, IIS is involved in metabolic homeostasis and growth. We have used feeding conditions (high sugar diet, HSD) that induce an important change in metabolic homeostasis to monitor possible effects on growth. Unexpectedly we observed that HSD-fed animals exhibited severe growth inhibition as a consequence of peripheral Dilp resistance. Dilp-resistant animals present several metabolic disorders similar to those observed in type II diabetes (T2D) patients. By exploring the molecular mechanisms involved in Drosophila Dilp resistance, we found a major role for the lipocalin Neural Lazarillo (NLaz), a target of JNK signaling. NLaz expression is strongly increased upon HSD and animals heterozygous for an NLaz null mutation are fully protected from HSD-induced Dilp resistance. NLaz is a secreted protein homologous to the Retinol-Binding Protein 4 involved in the onset of T2D in human and mice. These results indicate that insulin resistance shares common molecular mechanisms in flies and human and that Drosophila could emerge as a powerful genetic system to study some aspects of this complex syndrome.	[Pasco, Matthieu Y.; Leopold, Pierre] Univ Nice, CNRS, UMR 7707, INSERM UMR 1091,iBV, F-06034 Nice, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Pasco, MY (corresponding author), Univ Nice, CNRS, UMR 7707, INSERM UMR 1091,iBV, F-06034 Nice, France.	leopold@unice.fr	Pasco, Matthieu/K-1243-2014	Pasco, Matthieu/0000-0002-8073-5896	ANR [Blan07-2 192851]; FRM; Centre National de la Recherche Scientifique; Institut National de la Sante et de la Recherche Medicale	ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	The work was supported by the following funding agencies: ANR Blan07-2 192851 "CoGroDro'', http://www.agence-nationale-recherche.fr/; and FRM Equipe 2009 "Etude du controle de la Croissance'', http://www.frm.org/. P. L. was supported by the Centre National de la Recherche Scientifique and the Institut National de la Sante et de la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Brankatschk M, 2010, J NEUROSCI, V30, P10441, DOI 10.1523/JNEUROSCI.5943-09.2010; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Erikstrup C, 2006, NEW ENGL J MED, V355, P1393; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gross LS, 2004, AM J CLIN NUTR, V79, P774; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hull-Thompson J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000460; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kim JJ, 2002, GROWTH HORM IGF RES, V12, P84, DOI 10.1054/ghir.2002.0265; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mohan V, 2009, BRIT J NUTR, V102, P1498, DOI 10.1017/S0007114509990468; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Musselman LP, 2011, DIS MODEL MECH; Neschen S, 2005, CELL METAB, V2, P55, DOI 10.1016/j.cmet.2005.06.006; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Oh J, 2006, NEW ENGL J MED, V355, P1394; Polonsky KS, 2006, NEW ENGL J MED, V354, P2596, DOI 10.1056/NEJMe068091; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Sheard NF, 2004, DIABETES CARE, V27, P2266, DOI 10.2337/diacare.27.9.2266; Takashima N, 2006, NEW ENGL J MED, V355, P1392; van Dam RM, 2007, CLIN CHEM, V53, P5, DOI 10.1373/clinchem.2006.080432; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wu Q, 2006, ANNU REV ENTOMOL, V51, P1, DOI 10.1146/annurev.ento.51.110104.151011; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600; Zinke I, 1999, DEVELOPMENT, V126, P5275	39	138	141	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36583	10.1371/journal.pone.0036583	http://dx.doi.org/10.1371/journal.pone.0036583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567167	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500087
J	Sawaya, MA; Stetz, JB; Clevenger, AP; Gibeau, ML; Kalinowski, ST				Sawaya, Michael A.; Stetz, Jeffrey B.; Clevenger, Anthony P.; Gibeau, Michael L.; Kalinowski, Steven T.			Estimating Grizzly and Black Bear Population Abundance and Trend in Banff National Park Using Noninvasive Genetic Sampling	PLOS ONE			English	Article							CAPTURE-MARK-RECAPTURE; URSUS-AMERICANUS; DNA; DEMOGRAPHY; MANAGEMENT; SURVIVAL; PROGRAM; CONSERVATION; MOUNTAINS; ECOSYSTEM	We evaluated the potential of two noninvasive genetic sampling methods, hair traps and bear rub surveys, to estimate population abundance and trend of grizzly (Ursus arctos) and black bear (U. americanus) populations in Banff National Park, Alberta, Canada. Using Huggins closed population mark-recapture models, we obtained the first precise abundance estimates for grizzly bears ((N) over cap = 73.5, 95% CI = 64-94 in 2006; (N) over cap = 50.4, 95% CI = 49-59 in 2008) and black bears ((N) over cap = 62.6, 95% CI = 51-89 in 2006; (N) over cap = 81.8, 95% CI = 72-102 in 2008) in the Bow Valley. Hair traps had high detection rates for female grizzlies, and male and female black bears, but extremely low detection rates for male grizzlies. Conversely, bear rubs had high detection rates for male and female grizzlies, but low rates for black bears. We estimated realized population growth rates, lambda, for grizzly bear males (lambda = 0.93, 95% CI = 0.74-1.17) and females (lambda = 0.90, 95% CI = 0.67-1.20) using Pradel open population models with three years of bear rub data. Lambda estimates are supported by abundance estimates from combined hair trap/bear rub closed population models and are consistent with a system that is likely driven by high levels of human-caused mortality. Our results suggest that bear rub surveys would provide an efficient and powerful means to inventory and monitor grizzly bear populations in the Central Canadian Rocky Mountains.	[Sawaya, Michael A.; Clevenger, Anthony P.] Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA; [Sawaya, Michael A.; Kalinowski, Steven T.] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Stetz, Jeffrey B.] Sinopah Wildlife Res Associates, Missoula, MT USA; [Gibeau, Michael L.] Pk Canada, Mt Natl Pk, Lake Louise, AB, Canada	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Sawaya, MA (corresponding author), Montana State Univ, Western Transportat Inst, Bozeman, MT 59717 USA.	sawaya.mike@gmail.com		Clevenger, Anthony P/0000-0003-0380-6272	Parks Canada; Western Transportation Institute-Montana State University (WTI); Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	Parks Canada; Western Transportation Institute-Montana State University (WTI); Woodcock Foundation; Henry P. Kendall Foundation; Wilburforce Foundation; National Fish and Wildlife Foundation; Alberta Conservation Association; Calgary Foundation; Mountain Equipment Cooperative	This project was generously supported by Parks Canada, the Western Transportation Institute-Montana State University (WTI), the Woodcock Foundation, the Henry P. Kendall Foundation, and the Wilburforce Foundation. Other support was provided by the National Fish and Wildlife Foundation, Alberta Conservation Association, Calgary Foundation, and the Mountain Equipment Cooperative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: they received a small amount of funding from a commercial source, the Mountain Equipment Cooperative. Two of the authors have recently become affiliated with a commercial company, Sinopah Wildlife Research Associates. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; [Anonymous], 1987, BEARS BIOL MANAG; Benn B, 2002, URSUS, V13, P213; Bertch B., 2009, GRIZZLY BEAR MONITOR; Boulanger J, 2004, CAN J ZOOL, V82, P1267, DOI 10.1139/Z04-100; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2002, URSUS, V13, P137; Boulanger J, 2001, CAN J ZOOL, V79, P642, DOI 10.1139/cjz-79-4-642; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2008, J WILDLIFE MANAGE, V72, P589, DOI 10.2193/2006-447; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Brodie JF, 2007, URSUS, V18, P137, DOI 10.2192/1537-6176(2007)18[137:BBPTFD]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clark JD, 2010, J WILDLIFE MANAGE, V74, P1448, DOI 10.2193/2009-529; Clevenger AP, 2010, ECOL SOC, V15; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Coen G.M., 1983, ALBERTA I PEDOLOGY P, VI; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Dreher BP, 2007, J WILDLIFE MANAGE, V71, P2684, DOI 10.2193/2006-398; ENNIS S, 1994, ANIM GENET, V25, P425, DOI 10.1111/j.1365-2052.1994.tb00533.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Garshelis DL, 2006, J WILDLIFE MANAGE, V70, P1634, DOI 10.2193/0022-541X(2006)70[1634:DBIALS]2.0.CO;2; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Gibeau ML, 2001, URSUS-SERIES, V12, P121; Harris RB, 2011, URSUS, V22, P24, DOI 10.2192/URSUS-D-10-00028.1; Hayward MW, 2009, BIODIVERS CONSERV, V18, P765, DOI 10.1007/s10531-008-9436-y; Hebblewhite M, 2003, BIOL CONSERV, V112, P415, DOI 10.1016/S0006-3207(02)00341-5; Herrero S, 2001, URSUS-SERIES, V12, P161; Herrero S., 2005, BIOL DEMOGRAPHY ECOL; HOLCROFT AC, 1991, CAN FIELD NAT, V105, P335; HOLROYD G.L., 1983, ECOLOGICAL BIOPHYSIC, VIII; Hristienko H, 2007, URSUS, V18, P72, DOI 10.2192/1537-6176(2007)18[72:GITSCA]2.0.CO;2; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Kansas JL, 1989, ECOLOGICAL STUDIES B; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall WL, 1997, ECOLOGY, V78, P563; KNIGHT RR, 1985, ECOLOGY, V66, P323, DOI 10.2307/1940382; Latham E, 2011, INVESTIGATING EFFECT; Long RA, 2008, NONINVASIVE SURVEY M; Mace RD, 1998, CONSERV BIOL, V12, P1005, DOI 10.1046/j.1523-1739.1998.97031.x; Mattson DJ, 2005, URSUS, V16, P11, DOI 10.2192/1537-6176(2005)016[0011:ABBAFI]2.0.CO;2; McCALL B.S, 2009, THESIS U MONTANA MIS; McGuire TM, 2000, CAN J CIVIL ENG, V27, P523, DOI 10.1139/cjce-27-3-523; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; McLellan BN, 1989, NATALITY RATE INCREA, V67, P1865; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pilgrim KL, 2005, MOL ECOL NOTES, V5, P60, DOI 10.1111/j.1471-8286.2004.00831.x; Pollock KH, 1990, WILD MONOGR, V107; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; Proctor M, 2010, URSUS, V21, P169, DOI 10.2192/1537-6176-21.2.169; Ruth TK, 2011, J WILDLIFE MANAGE, V75, P1381, DOI 10.1002/jwmg.190; Sawaya MA, 2010, P 2009 INT C EC TRAN; Sawaya MA, 2011, J WILDLIFE MANAGE, V75, P612, DOI 10.1002/jwmg.92; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Stetz JB, 2011, J FISH WILDL MANAG, V2, P216, DOI 10.3996/082011-JFWM-048; Stetz JB, 2010, J WILDLIFE MANAGE, V74, P860, DOI 10.2193/2008-435; van der Putten WH, 2004, BASIC APPL ECOL, V5, P487, DOI 10.1016/j.baae.2004.09.003; Waits JL, 2000, ANIM CONSERV, V3, P191, DOI 10.1017/S1367943000000901; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woods JG, 1999, WILDLIFE SOC B, V27, P616; [No title captured]	72	61	62	9	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e34777	10.1371/journal.pone.0034777	http://dx.doi.org/10.1371/journal.pone.0034777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567089	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500007
J	Sobral, D; Schwarz, S; Bergonier, D; Brisabois, A; Fessler, AT; Gilbert, FB; Kadlec, K; Lebeau, B; Loisy-Hamon, F; Treilles, M; Pourcel, C; Vergnaud, G				Sobral, Daniel; Schwarz, Stefan; Bergonier, Dominique; Brisabois, Anne; Fessler, Andrea T.; Gilbert, Florence B.; Kadlec, Kristina; Lebeau, Benoit; Loisy-Hamon, Fabienne; Treilles, Michael; Pourcel, Christine; Vergnaud, Gilles			High Throughput Multiple Locus Variable Number of Tandem Repeat Analysis (MLVA) of Staphylococcus aureus from Human, Animal and Food Sources	PLOS ONE			English	Article							METHICILLIN-RESISTANT; LEGIONELLA-PNEUMOPHILA; GENETIC-VARIATION; STRAINS; BOVINE; DIVERSITY; POULTRY; ST398; MILK; SUSCEPTIBILITY	Staphylococcus aureus is a major human pathogen, a relevant pathogen in veterinary medicine, and a major cause of food poisoning. Epidemiological investigation tools are needed to establish surveillance of S. aureus strains in humans, animals and food. In this study, we investigated 145 S. aureus isolates recovered from various animal species, disease conditions, food products and food poisoning events. Multiple Locus Variable Number of Tandem Repeat (VNTR) analysis (MLVA), known to be highly efficient for the genotyping of human S. aureus isolates, was used and shown to be equally well suited for the typing of animal S. aureus isolates. MLVA was improved by using sixteen VNTR loci amplified in two multiplex PCRs and analyzed by capillary electrophoresis ensuring a high throughput and high discriminatory power. The isolates were assigned to twelve known clonal complexes (CCs) and -a few singletons. Half of the test collection belonged to four CCs (CC9, CC97, CC133, CC398) previously described as mostly associated with animals. The remaining eight CCs (CC1, CC5, CC8, CC15, CC25, CC30, CC45, CC51), representing 46% of the animal isolates, are common in humans. Interestingly, isolates responsible for food poisoning show a CC distribution signature typical of human isolates and strikingly different from animal isolates, suggesting a predominantly human origin.	[Sobral, Daniel; Pourcel, Christine; Vergnaud, Gilles] Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Sobral, Daniel; Pourcel, Christine; Vergnaud, Gilles] CNRS, F-91405 Orsay, France; [Sobral, Daniel; Lebeau, Benoit; Loisy-Hamon, Fabienne] CEERAM, La Chapelle Sur Erdre, France; [Schwarz, Stefan; Fessler, Andrea T.; Kadlec, Kristina] Inst Farm Anim Genet, FLI, Neustadt, Germany; [Bergonier, Dominique] INRA, IHAP, UMR1225, F-31931 Toulouse, France; [Bergonier, Dominique] Univ Toulouse, INP, ENVT, IHAP,UMR1225, Toulouse, France; [Brisabois, Anne] ANSES, European Union Community Reference Lab Coagulase, Maisons Alfort, France; [Gilbert, Florence B.] INRA, IASP UR1282, F-37380 Nouzilly, France; [Treilles, Michael] Lab Dept Anal la Manche, St Lo, France; [Vergnaud, Gilles] DGA MRIS, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Friedrich Loeffler Institute; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); INRAE	Sobral, D (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France.	gilles.vergnaud@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020	Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X	European Defense Agency; German Federal Ministry of Education; Research (BMBF) through the German Aerospace Center (DLR) [01KI1014D]; association Vaincre La Mucoviscidose [RC0630]; French Direction Generale de l'Armement	European Defense Agency; German Federal Ministry of Education(Federal Ministry of Education & Research (BMBF)); Research (BMBF) through the German Aerospace Center (DLR); association Vaincre La Mucoviscidose; French Direction Generale de l'Armement(French National Research Agency (ANR))	Work by GV is part of the European Biodefense Laboratory Network (EBLN) project "Database of B-agents" supported by the European Defense Agency. The contribution of SS, ATF and KK is financially supported by the German Federal Ministry of Education and Research (BMBF) through the German Aerospace Center (DLR), grant number 01KI1014D (MedVet-Staph). This study also benefited from the support of the association Vaincre La Mucoviscidose (Grant No RC0630). The development of tools for the surveillance of bacterial pathogens is supported by the French Direction Generale de l'Armement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Argudin MA, 2011, J MED MICROBIOL, V60, P172, DOI 10.1099/jmm.0.021758-0; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Boundy S, 2012, J CLIN MICROBIOL, V50, P469, DOI 10.1128/JCM.01063-11; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; Porrero MC, 2012, VET MICROBIOL, V156, P157, DOI 10.1016/j.vetmic.2011.10.015; Cookson BD, 2007, J CLIN MICROBIOL, V45, P1830, DOI 10.1128/JCM.02402-06; Cramton SE, 2000, INFECT IMMUN, V68, P2344, DOI 10.1128/IAI.68.4.2344-2348.2000; de Almeida LM, 2011, J DAIRY RES, V78, P373, DOI 10.1017/S0022029911000379; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fessler AT, 2011, APPL ENVIRON MICROB, V77, P7151, DOI 10.1128/AEM.00561-11; Gilbert FB, 2006, VET MICROBIOL, V117, P297, DOI 10.1016/j.vetmic.2006.04.029; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Hardy KJ, 2006, J CLIN MICROBIOL, V44, P271, DOI 10.1128/JCM.44.1.271-273.2006; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Jorgensen HJ, 2005, APPL ENVIRON MICROB, V71, P8352, DOI 10.1128/AEM.71.12.8352-8361.2005; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kehrenberg C, 2009, ANTIMICROB AGENTS CH, V53, P779, DOI 10.1128/AAC.01376-08; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Le Loir Yves, 2003, Genet Mol Res, V2, P63; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rich M, 2005, BRIT J BIOMED SCI, V62, P98, DOI 10.1080/09674845.2005.11732694; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x; Sabat A, 2003, J CLIN MICROBIOL, V41, P1801, DOI 10.1128/JCM.41.4.1801-1804.2003; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schwarz S, 2008, J ANTIMICROB CHEMOTH, V61, P282, DOI 10.1093/jac/dkm487; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Sieber S, 2011, MICROB DRUG RESIST, V17, P471, DOI 10.1089/mdr.2010.0188; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Vainio A, 2011, EUR J CLIN MICROBIOL, V30, P789, DOI 10.1007/s10096-011-1158-5; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Vu-Thien H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-24; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wattinger L, 2012, EUR J CLIN MICROBIOL, V31, P455, DOI 10.1007/s10096-011-1330-y; Witt RT, 2010, EUR J CLIN MICROBIOL, V29, P295, DOI 10.1007/s10096-009-0856-8	54	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e33967	10.1371/journal.pone.0033967	http://dx.doi.org/10.1371/journal.pone.0033967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567085	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500003
J	Vazquez-Cintron, EJ; Monu, NR; Burns, JC; Blum, R; Chen, G; Lopez, P; Ma, J; Radoja, S; Frey, AB				Vazquez-Cintron, Edwin J.; Monu, Ngozi R.; Burns, Jeremy C.; Blum, Roy; Chen, Gregory; Lopez, Peter; Ma, Jennifer; Radoja, Sasa; Frey, Alan B.			Protocadherin-18 Is a Novel Differentiation Marker and an Inhibitory Signaling Receptor for CD8(+) Effector Memory T Cells	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; LYTIC FUNCTION; ANTIGEN; LYMPHOCYTES; EXPRESSION; ADHESION; ACTIVATION; EXHAUSTION; TOLERANCE; MECHANISM	CD8(+) tumor infiltrating T cells (TIL) lack effector-phase functions due to defective proximal TCR-mediated signaling previously shown to result from inactivation of p56(lck) kinase. We identify a novel interacting partner for p56(lck) in nonlytic TIL, Protocadherin-18 ('pcdh18'), and show that pcdh18 is transcribed upon in vitro or in vivo activation of all CD8+ central memory T cells (CD44(+) CD62L(hi) CD127(+)) coincident with conversion into effector memory cells (CD44(+) CD62L(lo) CD127(+)). Expression of pcdh18 in primary CD8(+) effector cells induces the phenotype of nonlytic TIL: defective proximal TCR signaling, cytokine secretion, and cytolysis, and enhanced AICD. pcdh18 contains a motif (centered at Y842) shared with src kinases (QGQYQP) that is required for the inhibitory phenotype. Thus, pcdh18 is a novel activation marker of CD8+ memory T cells that can function as an inhibitory signaling receptor and restrict the effector phase.	[Vazquez-Cintron, Edwin J.; Burns, Jeremy C.; Chen, Gregory; Frey, Alan B.] NYU, Dept Cell Biol, Langone Sch Med New York, New York, NY 10016 USA; [Monu, Ngozi R.; Blum, Roy; Frey, Alan B.] NYU, Langone Sch Med New York, New York Univ Canc Inst, New York, NY USA; [Lopez, Peter] NYU, Dept Pathol, Langone Sch Med New York, New York, NY 10016 USA; [Ma, Jennifer; Radoja, Sasa] Childrens Natl Med Ctr, Childrens Res Inst, Sheikh Zayed Inst Pediat Surg Innovat, Ctr Canc & Immunol Res, Washington, DC 20010 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Children's National Health System	Vazquez-Cintron, EJ (corresponding author), NYU, Dept Cell Biol, Langone Sch Med New York, 550 1St Ave, New York, NY 10016 USA.	alan.frey@nyumc.org	Lopez, Peter/AAP-7234-2020	Blum, Roy/0000-0002-3987-7198; Lopez, Peter/0000-0002-8587-7148; Burns, Jeremy/0000-0003-3853-0237; frey, alan/0000-0003-4151-561X; Vazquez-Cintron, Edwin/0000-0002-4397-3713	National Institutes of Health [F31 CA136164, F31 CA162875, R01 CA108573, 5P30CA016087-33]; NATIONAL CANCER INSTITUTE [R01CA108573, P30CA016087, F31CA136164, F31CA162875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (grants F31 CA136164 to EJV-C, F31 CA162875 to CB, R01 CA108573 to ABF, and 5P30CA016087-33 in support of the NYUMC Cytometry Core). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamar E, 2008, DEV BIOL, V318, P335, DOI 10.1016/j.ydbio.2008.03.040; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Frey AB, 2006, J LEUKOCYTE BIOL, V79, P652, DOI 10.1189/jlb.1105628; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Homayouni R, 2001, BIOCHEM BIOPH RES CO, V289, P539, DOI 10.1006/bbrc.2001.5998; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Koneru M, 2005, J IMMUNOL, V174, P1830, DOI 10.4049/jimmunol.174.4.1830; Koneru M, 2006, J IMMUNOL, V176, P6103, DOI 10.4049/jimmunol.176.10.6103; Ma JSY, 2007, J IMMUNOL, V178, P7814, DOI 10.4049/jimmunol.178.12.7814; Monu N, 2007, CANCER RES, V67, P11447, DOI 10.1158/0008-5472.CAN-07-1441; Newman DK, 2001, BLOOD, V97, P2351, DOI 10.1182/blood.V97.8.2351; Penna G, 2005, BLOOD, V106, P3490, DOI 10.1182/blood-2005-05-2044; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Radoja S, 2001, J IMMUNOL, V167, P5042, DOI 10.4049/jimmunol.167.9.5042; Radoja S, 2001, J IMMUNOL, V166, P6074, DOI 10.4049/jimmunol.166.10.6074; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sharan R, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P307; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zippelius A, 2004, CANCER RES, V64, P2865, DOI 10.1158/0008-5472.CAN-03-3066; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	29	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36101	10.1371/journal.pone.0036101	http://dx.doi.org/10.1371/journal.pone.0036101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567129	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500047
J	van Rikxoort, M; Michaelis, M; Wolschek, M; Muster, T; Egorov, A; Seipelt, J; Doerr, HW; Cinatl, J				van Rikxoort, Marijke; Michaelis, Martin; Wolschek, Markus; Muster, Thomas; Egorov, Andrej; Seipelt, Joachim; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.			Oncolytic Effects of a Novel Influenza A Virus Expressing Interleukin-15 from the NS Reading Frame	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VIVO; CANCER-CELLS; TUMOR-CELLS; PROTEIN; APOPTOSIS; MELANOMA; SENSITIVITY; ACTIVATION; RESISTANCE	Oncolytic influenza A viruses with deleted NS1 gene (delNS1) replicate selectively in tumour cells with defective interferon response and/or activated Ras/Raf/MEK/ERK signalling pathway. To develop a delNS1 virus with specific immunostimulatory properties, we used an optimised technology to insert the interleukin-15 (IL-15) coding sequence into the viral NS gene segment (delNS1-IL-15). DelNS1 and delNS1-IL-15 exerted similar oncolytic effects. Both viruses replicated and caused caspase-dependent apoptosis in interferon-defective melanoma cells. Virus replication was required for their oncolytic activity. Cisplatin enhanced the oncolytic activity of delNS1 viruses. The cytotoxic drug increased delNS1 replication and delNS1-induced caspase-dependent apoptosis. Interference with MEK/ERK signalling by RNAi-mediated depletion or the MEK inhibitor U0126 did not affect the oncolytic effects of the delNS1 viruses. In oncolysis sensitive melanoma cells, delNS1-IL-15 (but not delNS1) infection resulted in the production of IL-15 levels ranging from 70 to 1140 pg/mL in the cell culture supernatants. The supernatants of delNS1-IL-15-infected (but not of delNS1-infected) melanoma cells induced primary human natural killer cell-mediated lysis of non-infected tumour cells. In conclusion, we constructed a novel oncolytic influenza virus that combines the oncolytic activity of delNS1 viruses with immunostimulatory properties through production of functional IL-15. Moreover, we showed that the oncolytic activity of delNS1 viruses can be enhanced in combination with cytotoxic anti-cancer drugs.	[van Rikxoort, Marijke; Michaelis, Martin; Doerr, Hans Wilhelm; Cinatl, Jindrich, Jr.] Univ Frankfurt Klinikum, Inst Med Virol, D-6000 Frankfurt, Germany; [Wolschek, Markus; Muster, Thomas; Egorov, Andrej; Seipelt, Joachim] AVIR Green Hills Biotechnol, Vienna, Austria	Goethe University Frankfurt; Goethe University Frankfurt Hospital	van Rikxoort, M (corresponding author), Univ Frankfurt Klinikum, Inst Med Virol, D-6000 Frankfurt, Germany.	Cinatl@em.uni-frankfurt.de		Michaelis, Martin/0000-0002-5710-5888; Seipelt, Joachim/0000-0001-9865-814X	Hilfe fur krebskranke Kinder, Frankfurt/Main e.V.; Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.; European Commission [512864, 512054]	Hilfe fur krebskranke Kinder, Frankfurt/Main e.V.; Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the organization "Hilfe fur krebskranke Kinder, Frankfurt/Main e.V." (http://www.hilfe-fuer-krebskranke-kinder.de/), by the foundation "Frankfurter Stiftung fur krebskranke Kinder der Hilfe fur krebskranke Kinder Frankfurt e.V.'' (http://www.kinderkrebsstiftung-frankfurt.de/), and by the European Commission-funded Co-operative Research and SpeciWc Targeted Research Projects; COOP-CT-2004, Contract Nr. 512864 and LSHBCT-2004, Contract Nr. 512054, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 2001, CANCER RES, V61, P8188; Droebner K, 2011, ANTIVIR RES, V92, P195, DOI 10.1016/j.antiviral.2011.08.002; Efferson CL, 2006, J VIROL, V80, P383, DOI 10.1128/JVI.80.1.383-394.2006; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hwang TH, 2011, MOL THER, V19, P1913, DOI 10.1038/mt.2011.132; Jackson D, 2010, VIROLOGY, V396, P94, DOI 10.1016/j.virol.2009.10.004; Kaufman HL, 2010, ANN SURG ONCOL, V17, P718, DOI 10.1245/s10434-009-0809-6; Kaur B, 2009, CURR GENE THER, V9, P341, DOI 10.2174/156652309789753329; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Lev DC, 2004, J CLIN ONCOL, V22, P2092, DOI 10.1200/JCO.2004.11.070; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Meyer P, 2003, INT J CANCER, V106, P78, DOI 10.1002/ijc.11199; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Michaelis M, 2009, INVEST OPHTH VIS SCI, V50, P5419, DOI 10.1167/iovs.09-3752; Muster T, 2004, INT J CANCER, V110, P15, DOI 10.1002/ijc.20078; Ogbomo H, 2006, BIOCHEM BIOPH RES CO, V339, P375, DOI 10.1016/j.bbrc.2005.11.025; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Roychowdhury S, 2004, CANCER RES, V64, P8062, DOI 10.1158/0008-5472.CAN-04-1860; Stephenson KB, 2012, CANCER GENE THER, V19, P238, DOI 10.1038/cgt.2011.81; Sturlan S, 2010, CANCER BIOL THER, V10, P592, DOI 10.4161/cbt.10.6.12565; Tamai H, 2011, BLOOD           1024; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XD, 2010, BIOCHEM BIOPH RES CO, V395, P141, DOI 10.1016/j.bbrc.2010.03.160; Wolschek M, 2011, J VIROL, V85, P2469, DOI 10.1128/JVI.01650-10; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zhang CF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-181; Zhirnov O, 2003, VIROLOGY, V313, P198, DOI 10.1016/S0042-6822(03)00264-2; Zhirnov OP, 2002, J VIROL, V76, P1617, DOI 10.1128/JVI.76.4.1617-1625.2002; Zito CR, 2012, J CELL BIOCHEM, V113, P725, DOI 10.1002/jcb.23402	36	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36506	10.1371/journal.pone.0036506	http://dx.doi.org/10.1371/journal.pone.0036506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563505	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700054
J	Wu, JQ; Wang, X; Beveridge, NJ; Tooney, PA; Scott, RJ; Carr, VJ; Cairns, MJ				Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Carr, Vaughan J.; Cairns, Murray J.			Transcriptome Sequencing Revealed Significant Alteration of Cortical Promoter Usage and Splicing in Schizophrenia	PLOS ONE			English	Article							DOUBLECORTIN-LIKE KINASE; DORSOLATERAL PREFRONTAL CORTEX; DIFFERENTIAL GENE-EXPRESSION; MYELINATION-RELATED GENES; SUPERIOR TEMPORAL GYRUS; UP-REGULATION; RNA-SEQ; MICROARRAY ANALYSIS; OLIGODENDROGLIAL ABNORMALITIES; CINGULATE CORTEX	Background: While hybridization based analysis of the cortical transcriptome has provided important insight into the neuropathology of schizophrenia, it represents a restricted view of disease-associated gene activity based on predetermined probes. By contrast, sequencing technology can provide un-biased analysis of transcription at nucleotide resolution. Here we use this approach to investigate schizophrenia-associated cortical gene expression. Methodology/Principal Findings: The data was generated from 76 bp reads of RNA-Seq, aligned to the reference genome and assembled into transcripts for quantification of exons, splice variants and alternative promoters in postmortem superior temporal gyrus (STG/BA22) from 9 male subjects with schizophrenia and 9 matched non-psychiatric controls. Differentially expressed genes were then subjected to further sequence and functional group analysis. The output, amounting to more than 38 Gb of sequence, revealed significant alteration of gene expression including many previously shown to be associated with schizophrenia. Gene ontology enrichment analysis followed by functional map construction identified three functional clusters highly relevant to schizophrenia including neurotransmission related functions, synaptic vesicle trafficking, and neural development. Significantly, more than 2000 genes displayed schizophrenia-associated alternative promoter usage and more than 1000 genes showed differential splicing (FDR<0.05). Both types of transcriptional isoforms were exemplified by reads aligned to the neurodevelopmentally significant doublecortin-like kinase 1 (DCLK1) gene. Conclusions: This study provided the first deep and un-biased analysis of schizophrenia-associated transcriptional diversity within the STG, and revealed variants with important implications for the complex pathophysiology of schizophrenia.	[Wu, Jing Qin; Beveridge, Natalie J.; Tooney, Paul A.; Carr, Vaughan J.; Cairns, Murray J.] Schizophrenia Res Inst, Sydney, NSW, Australia; [Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Cairns, Murray J.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr Translat Neurosci & Mental Hlth, Fac Hlth, Callaghan, NSW 2308, Australia; [Wu, Jing Qin; Wang, Xi; Beveridge, Natalie J.; Tooney, Paul A.; Scott, Rodney J.; Cairns, Murray J.] Hunter Med Res Inst, New Lambton, NSW, Australia; [Carr, Vaughan J.] Univ New S Wales, Res Unit Schizophrenia Epidemiol, Sch Psychiat, St Vincents Hosp, Darlinghurst, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; St Vincents Hospital Sydney; University of New South Wales Sydney	Wu, JQ (corresponding author), Schizophrenia Res Inst, Sydney, NSW, Australia.	murray.cairns@newcastle.edu.au	Scott, Rodney J/B-2827-2013; WANG, XI/G-8328-2013; Wang, Xi/N-9527-2014; TOONEY, PAUL ANTHONY/G-7280-2013; Wu, Jingqin/V-9319-2019	Scott, Rodney J/0000-0001-7724-3404; Wang, Xi/0000-0002-7572-6354; Wu, Jingqin/0000-0002-2052-3875; Cairns, Murray/0000-0003-2490-2538; Beveridge, Natalie/0000-0002-5696-0516; Tooney, Paul/0000-0003-3745-4367	Schizophrenia Research Institute; Neurobehavioral Genetics Unit; NSW Health; M.C. Ainsworth Research Fellowship in Epigenetics; NARSAD Young Investigator Award; Hunter Medical Research Institute; NHMRC [631057]; University of Sydney; National Health and Medical Research Council of Australia; National Institute of Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA012725, R28AA012725] Funding Source: NIH RePORTER	Schizophrenia Research Institute; Neurobehavioral Genetics Unit; NSW Health; M.C. Ainsworth Research Fellowship in Epigenetics; NARSAD Young Investigator Award(NARSAD); Hunter Medical Research Institute; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by the Schizophrenia Research Institute and the Neurobehavioral Genetics Unit, utilising funding from NSW Health and an M.C. Ainsworth Research Fellowship in Epigenetics (Dr. Cairns); a NARSAD Young Investigator Award; a Hunter Medical Research Institute project grant; an NHMRC project grant 631057 and an NHMRC postdoctoral training fellowship (Dr. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge David Montgomery and the Academic and Research Computing Service (ARCS) at the University of Newcastle, for technical help with the Linux server and installation/maintenance of academic software for sequencing analysis. Tissues were received from the Australian Brain Donor Program's NSW Tissue Resource Centre, supported by The University of Sydney, National Health and Medical Research Council of Australia, Schizophrenia Research Institute, and the National Institute of Alcohol Abuse and Alcoholism.	Aitken A, 2002, BIOCHEM SOC T, V30, P351, DOI 10.1042/bst0300351; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altar CA, 2009, NEUROPSYCHOPHARMACOL, V34, P18, DOI 10.1038/npp.2008.172; Altar CA, 2005, BIOL PSYCHIAT, V58, P85, DOI 10.1016/j.biopsych.2005.03.031; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Barakauskas VE, 2010, NEUROPSYCHOPHARMACOL, V35, P1226, DOI 10.1038/npp.2009.228; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2008, HUM MOL GENET, V17, P1156, DOI 10.1093/hmg/ddn005; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bowden NA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-199; Burgess HA, 1999, J NEUROSCI RES, V58, P567, DOI 10.1002/(SICI)1097-4547(19991115)58:4<567::AID-JNR9>3.3.CO;2-K; Burgess HA, 2000, MOL CELL NEUROSCI, V16, P529, DOI 10.1006/mcne.2000.0891; CARPENTER WT, 1994, NEW ENGL J MED, V330, P681, DOI 10.1056/NEJM199403103301006; Chana G, 2009, SCHIZOPHR RES, V113, P273, DOI 10.1016/j.schres.2009.05.015; Chung C, 2003, SYNAPSE, V50, P29, DOI 10.1002/syn.10228; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deng XD, 2011, AM J MED GENET B, V156B, P850, DOI 10.1002/ajmg.b.31233; Duncan CE, 2008, PSYCHIAT GENET, V18, P226, DOI 10.1097/YPG.0b013e3283053019; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Faludi G, 2011, INT J DEV NEUROSCI, V2011, P4; Ferreira A, 2002, CELL MOL LIFE SCI, V59, P589, DOI 10.1007/s00018-002-8451-5; Gabriel SM, 1997, ARCH GEN PSYCHIAT, V54, P559; Gow A, 1997, J NEUROSCI, V17, P181, DOI 10.1523/JNEUROSCI.17-01-00181.1997; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Haroutunian V, 2007, INT J NEUROPSYCHOPH, V10, P565, DOI 10.1017/S1461145706007310; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honer WG, 2002, CEREB CORTEX, V12, P349, DOI 10.1093/cercor/12.4.349; Horesh Y, 2011, EUR J NEUROL, V18, P410, DOI 10.1111/j.1468-1331.2010.03166.x; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jacobs EC, 2004, NEUROCHEM RES, V29, P997, DOI 10.1023/B:NERE.0000021244.38279.c4; Jahn O, 2009, MOL NEUROBIOL, V40, P55, DOI 10.1007/s12035-009-8071-2; Karson CN, 1999, MOL PSYCHIATR, V4, P39, DOI 10.1038/sj.mp.4000459; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Koizumi H, 2007, SEIKAGAKU, V79, P1134; Kontkanen O, 2002, J NEUROCHEM, V83, P1043, DOI 10.1046/j.1471-4159.2002.01213.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; MacDonald ML, 2006, BIPOLAR DISORD, V8, P255, DOI 10.1111/j.1399-5618.2006.00302.x; Marenco S, 2000, DEV PSYCHOPATHOL, V12, P501, DOI 10.1017/S0954579400003138; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; McCullumsmith RE, 2007, SCHIZOPHR RES, V90, P15, DOI 10.1016/j.schres.2006.11.017; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Middleton FA, 2002, J NEUROSCI, V22, P2718, DOI 10.1523/JNEUROSCI.22-07-02718.2002; Mimmack ML, 2002, P NATL ACAD SCI USA, V99, P4680, DOI 10.1073/pnas.032069099; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mudge J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003625; Mukaetova-Ladinska EB, 2002, NEUROSCI LETT, V317, P161, DOI 10.1016/S0304-3940(01)02458-2; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rajarethinam RP, 2000, SCHIZOPHR RES, V41, P303, DOI 10.1016/S0920-9964(99)00083-3; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Santarelli DM, 2011, BIOL PSYCHIAT, V69, P180, DOI 10.1016/j.biopsych.2010.09.030; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; Schwab SG, 2000, MOL PSYCHIATR, V5, P638, DOI 10.1038/sj.mp.4000791; Seiler F, 2009, FEBS LETT, V583, P2343, DOI 10.1016/j.febslet.2009.06.025; Sequeira PA, 2012, NEUROBIOL DIS, V45, P23, DOI 10.1016/j.nbd.2011.03.001; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sommer JU, 2010, EUR ARCH PSY CLIN N, V260, pS81, DOI 10.1007/s00406-010-0159-1; Sporkel O, 2002, GLIA, V37, P19, DOI 10.1002/glia.10014; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tkachev D, 2003, LANCET, V362, P798, DOI 10.1016/S0140-6736(03)14289-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uriu Y, 2010, J BIOL CHEM, V285, P21750, DOI 10.1074/jbc.M110.101311; Vawter MP, 2002, SCHIZOPHR RES, V58, P11, DOI 10.1016/S0920-9964(01)00377-2; Vawter MP, 2001, BRAIN RES BULL, V55, P641, DOI 10.1016/S0361-9230(01)00522-6; Verissimo CS, 2010, ENDOCR-RELAT CANCER, V17, P399, DOI 10.1677/ERC-09-0301; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Weidenhofer J, 2006, MOL CELL NEUROSCI, V31, P243, DOI 10.1016/j.mcn.2005.09.013; Young CE, 1998, CEREB CORTEX, V8, P261, DOI 10.1093/cercor/8.3.261; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zink M, 2004, SCHIZOPHR RES, V66, P151, DOI 10.1016/S0920-9964(03)00088-4	82	67	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36351	10.1371/journal.pone.0036351	http://dx.doi.org/10.1371/journal.pone.0036351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558445	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336000195
J	Xu, Y; Zhou, WW; Zhou, YJ; Wu, JX; Zhou, XP				Xu, Yi; Zhou, Wenwu; Zhou, Yijun; Wu, Jianxiang; Zhou, Xueping			Transcriptome and Comparative Gene Expression Analysis of Sogatella furcifera (Horvath) in Response to Southern Rice Black-Streaked Dwarf Virus	PLOS ONE			English	Article							HOMOPTERA DELPHACIDAE; SECRETORY PATHWAY; 26S PROTEASOME; PROTEIN; FIJIVIRUS; MIGRATION; IMMUNITY; DISEASE; BCL-6	Background: The white backed planthopper (WBPH), Sogatella furcifera (Horvath), causes great damage to many crops by direct feeding or transmitting plant viruses. Southern rice black-streaked dwarf virus (SRBSDV), transmitted by WBPH, has become a great threat to rice production in East Asia. Methodology/Principal Findings: By de novo transcriptome assembling and massive parallel pyrosequencing, we constructed two transcriptomes of WBPH and profiled the alternation of gene expression in response to SRBSDV infection in transcriptional level. Over 25 million reads of high-quality DNA sequences and 81388 different unigenes were generated using Illumina technology from both viruliferous and non-viruliferous WBPH. WBPH has a very similar gene ontological distribution to other two closely related rice planthoppers, Nilaparvata lugens and Laodelphax striatellus. 7291 microsatellite loci were also predicted which could be useful for further evolutionary analysis. Furthermore, comparative analysis of the two transcriptomes generated from viruliferous and non-viruliferous WBPH provided a list of candidate transcripts that potentially were elicited as a response to viral infection. Pathway analyses of a subset of these transcripts indicated that SRBSDV infection may perturb primary metabolism and the ubiquitin-proteasome pathways. In addition, 5.5% (181 out of 3315) of the genes in cell cytoskeleton organization pathway showed obvious changes. Our data also demonstrated that SRBSDV infection activated the immunity regulatory systems of WBPH, such as RNA interference, autophagy and antimicrobial peptide production. Conclusions/Significance: We employed massively parallel pyrosequencing to collect ESTs from viruliferous and non-viruliferous samples of WBPH. 81388 different unigenes have been obtained. We for the first time described the direct effects of a Reoviridae family plant virus on global gene expression profiles of its insect vector using high-throughput sequencing. Our study will provide a road map for future investigations of the fascinating interactions between Reoviridae viruses and their insect vectors, and provide new strategies for crop protection.	[Xu, Yi; Wu, Jianxiang; Zhou, Xueping] Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Wenwu] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Zhejiang University; Jiangsu Academy of Agricultural Sciences	Wu, JX (corresponding author), Zhejiang Univ, State Key Lab Rice Biol, Inst Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	wujx@zju.edu.cn; zzhou@zju.edu.cn		Zhou, Wenwu/0000-0002-0727-8086	Program for Changjiang Scholars and Innovative Research Team in University [IRT0943]; National Key Basic Research and Development Program of China [2010CB126200]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Basic Research and Development Program of China(National Basic Research Program of China)	This work was supported by grants from the Program for Changjiang Scholars and Innovative Research Team in University (IRT0943) and the National Key Basic Research and Development Program of China (2010CB126200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Banks L, 2003, TRENDS BIOCHEM SCI, V28, P452, DOI 10.1016/S0968-0004(03)00141-5; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Denno RF, 1994, PLANTHOPPERS THEIR E; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Emmett Stevan R., 2004, V296, P197; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fauquet CM, 2005, 8 REP INT COMM TAX V, P534; Fenard D, 1999, J CLIN INVEST, V104, P611, DOI 10.1172/JCI6915; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROPPE K, 1995, APPL ENVIRON MICROB, V61, P3943, DOI 10.1128/AEM.61.11.3943-3949.1995; Harries PA, 2010, MOL PLANT MICROBE IN, V23, P1381, DOI 10.1094/MPMI-05-10-0121; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Hiroyuki H, 1996, ANNU REV PHYTOPATHOL, V34, P249; Huang SH, 2010, APPL ENTOMOL ZOOL, V45, P521, DOI 10.1303/aez.2010.521; Ikeda M, 1999, VIROLOGY, V258, P176, DOI 10.1006/viro.1999.9706; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Laporte C, 2003, PLANT CELL, V15, P2058, DOI 10.1105/tpc.013896; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liang MF, 2010, VIROL J, V7, p[42, 99]; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Liu Y, 2011, ARCH VIROL, V156, P1729, DOI 10.1007/s00705-011-1041-9; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Mills AP, 1996, B ENTOMOL RES, V86, P683, DOI 10.1017/S0007485300039201; Otuka A, 2008, APPL ENTOMOL ZOOL, V43, P527, DOI 10.1303/aez.2008.527; Otuka A, 2009, APPL ENTOMOL ZOOL, V44, P379, DOI 10.1303/aez.2009.379; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Rutter JF, 1998, B ENTOMOL RES, V88, P189, DOI 10.1017/S000748530002575X; Schoelz JE, 2011, MOL PLANT, V4, P813, DOI 10.1093/mp/ssr070; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; Spencer CM, 2011, J VIROL, V85, P5814, DOI 10.1128/JVI.02630-10; Stahnke S, 2011, VIROLOGY, V409, P77, DOI 10.1016/j.virol.2010.09.025; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan SL, 2004, CURR OPIN PHARMACOL, V4, P465, DOI 10.1016/j.coph.2004.07.003; Turnell AS, 2000, EMBO J, V19, P4759, DOI 10.1093/emboj/19.17.4759; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang QA, 2010, J PHYTOPATHOL, V158, P733, DOI 10.1111/j.1439-0434.2010.01679.x; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wei TY, 2006, J VIROL, V80, P8593, DOI 10.1128/JVI.00537-06; Wei TY, 2009, J VIROL, V83, P10830, DOI 10.1128/JVI.01067-09; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan ZJ, 2011, VIRUS RES, V159, P62, DOI 10.1016/j.virusres.2011.04.023; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang HM, 2008, ARCH VIROL, V153, P1893, DOI 10.1007/s00705-008-0209-4; Zhang ZH, 2011, PLANT CELL, V23, P273, DOI 10.1105/tpc.110.081695; Zhou GH, 2008, CHINESE SCI BULL, V53, P3677, DOI 10.1007/s11434-008-0467-2	64	54	59	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36238	10.1371/journal.pone.0036238	http://dx.doi.org/10.1371/journal.pone.0036238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558400	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000167
J	Garcia, J; Traulsen, A				Garcia, Julian; Traulsen, Arne			The Structure of Mutations and the Evolution of Cooperation	PLOS ONE			English	Article							REPEATED PRISONERS-DILEMMA; FINITE POPULATIONS; PUBLIC-GOODS; GAMES; DYNAMICS; STABILITY; SELECTION; PUNISHMENT; EMERGENCE; STRATEGY	Evolutionary game dynamics in finite populations assumes that all mutations are equally likely, i.e., if there are n strategies a single mutation can result in any strategy with probability 1/n. However, in biological systems it seems natural that not all mutations can arise from a given state. Certain mutations may be far away, or even be unreachable given the current composition of an evolving population. These distances between strategies (or genotypes) define a topology of mutations that so far has been neglected in evolutionary game theory. In this paper we re-evaluate classic results in the evolution of cooperation departing from the assumption of uniform mutations. We examine two cases: the evolution of reciprocal strategies in a repeated prisoner's dilemma, and the evolution of altruistic punishment in a public goods game. In both cases, alternative but reasonable mutation kernels shift known results in the direction of less cooperation. We therefore show that assuming uniform mutations has a substantial impact on the fate of an evolving population. Our results call for a reassessment of the "model-less" approach to mutations in evolutionary dynamics.	[Garcia, Julian; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Theory, Plon, Germany	Max Planck Society	Garcia, J (corresponding author), Max Planck Inst Evolutionary Biol, Res Grp Evolutionary Theory, Plon, Germany.	garcia@evolbio.mpg.de	Traulsen, Arne/A-4955-2009	Traulsen, Arne/0000-0002-0669-5267; Garcia, Julian/0000-0001-9639-489X				Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Back Thomas, 1997, HDB EVOLUTIONARY COM, V1st; Bergin J, 1996, ECONOMETRICA, V64, P943, DOI 10.2307/2171851; Binmore K, 2011, J THEOR BIOL, V278, P63, DOI 10.1016/j.jtbi.2011.02.024; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; BOMZE IM, 1995, GAME ECON BEHAV, V11, P146, DOI 10.1006/game.1995.1047; BOYD R, 1987, NATURE, V327, P58, DOI 10.1038/327058a0; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; De Silva H, 2010, J EVOL ECON, V20, P203, DOI 10.1007/s00191-009-0162-8; FARRELL J, 1989, THEOR POPUL BIOL, V36, P161, DOI 10.1016/0040-5809(89)90027-0; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Fudenberg D, 2006, THEOR POPUL BIOL, V70, P352, DOI 10.1016/j.tpb.2006.07.006; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Hauert Christoph, 2008, Biology Theory, V3, P114, DOI 10.1162/biot.2008.3.2.114; HOFBAUER J, 1985, J MATH BIOL, V23, P41, DOI 10.1007/BF00276557; Hofbauer J., 1990, APPL MATH LETT, V3, P75, DOI [10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C, DOI 10.1016/0893-9659(90)90051-C)]; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Imhof LA, 2010, P ROY SOC B-BIOL SCI, V277, P463, DOI 10.1098/rspb.2009.1171; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; LIPMAN DJ, 1991, P ROY SOC B-BIOL SCI, V245, P7, DOI 10.1098/rspb.1991.0081; MESZENA G, 2001, SELECTION, V2, P193, DOI [DOI 10.1556/SELECT.2.2001.1-2.14, 10.1556/select.2.2001.1-2.14]; Moran P., 1962, STAT PROCESSES EVOLU; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2011, J THEOR BIOL, V274, P30, DOI 10.1016/j.jtbi.2011.01.004; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Traulsen A., 2009, REV NONLINEAR DYN CO, V2, P25, DOI DOI 10.1007/978-3-642-01284-6_12; Traulsen A, 2008, B MATH BIOL, V70, P1410, DOI 10.1007/s11538-008-9305-6; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011901; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Willensdorfer M, 2005, J THEOR BIOL, V237, P355, DOI 10.1016/j.jtbi.2005.04.020; Wu B, 2011, J NEUROSURG, V114, P1288, DOI [10.3171/2010.12.JNS10912, 10.1155/2011/464919]	47	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35287	10.1371/journal.pone.0035287	http://dx.doi.org/10.1371/journal.pone.0035287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563381	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100010
J	Lin, JT; Chen, PC; Goud, TV; Huang, BR; Lin, TC; Biellmann, JF; Chen, CS				Lin, Jing-Tang; Chen, Po-Chung; Goud, Thirumani Venkatshwar; Huang, Bor-Rong; Lin, Tzu-Chau; Biellmann, Jean-Francois; Chen, Chien-Sheng			A Sulfhydryl-Reactive Ruthenium (II) Complex and Its Conjugation to Protein G as a Universal Reagent for Fluorescent Immunoassays	PLOS ONE			English	Article							RADIOIMMUNOASSAY	To develop a fluorescent ruthenium complex for biosensing, we synthesized a novel sulfhydryl-reactive compound, 4-bromophenanthroline bis-2,2'-dipyridine Ruthenium bis (hexafluorophosphate). The synthesized Ru(II) complex was crosslinked with thiol-modified protein G to form a universal reagent for fluorescent immunoassays. The resulting Ru(II)-protein G conjugates were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The emission peak wavelength of the Ru(II)-protein G conjugate was 602 nm at the excitation of 452 nm which is similar to the spectra of the Ru(II) complex, indicating that Ru(II)-protein G conjugates still remain the same fluorescence after conjugation. To test the usefulness of the conjugate for biosensing, immunoglobulin G (IgG) binding assay was conducted. The result showed that Ru(II)-protein G conjugates were capable of binding IgG and the more cross-linkers to modify protein G, the higher conjugation efficiency. To demonstrate the feasibility of Ru(II)-protein G conjugates for fluorescent immunoassays, the detection of recombinant histidine-tagged protein using the conjugates and anti-histidine antibody was developed. The results showed that the histidine-tagged protein was successfully detected with dose-response, indicating that Ru(II)-protein G conjugate is a useful universal fluorescent reagent for quantitative immunoassays.	[Lin, Jing-Tang; Chen, Po-Chung; Biellmann, Jean-Francois; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Goud, Thirumani Venkatshwar] Acad Sinica, Inst Chem, Taipei, Taiwan; [Huang, Bor-Rong; Lin, Tzu-Chau] Natl Cent Univ, Dept Chem, Jhongli, Taiwan	National Central University; Academia Sinica - Taiwan; National Central University	Lin, JT (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	biellman@cc.ncu.edu.tw; cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022		National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan [100-2627-M-008-003-]; Ministry of Education, Taiwan	National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	The authors thank National Central University, Taiwan for the financial support. This work was also supported by Center for Dynamical Biomarkers and Translational Medicine (CDBTM), National Science Council, Taiwan under the grant 100-2627-M-008-003-, and by Ministry of Education, Taiwan under the grant Plan of Developing Top Universities And Research Centers as well as The Aim for the Top University Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTROM B, 1985, J IMMUNOL, V135, P2589; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; BJORCK L, 1984, J IMMUNOL, V133, P969; BLAKE C, 1982, CLIN CHEM, V28, P1469; CASE FH, 1951, J ORG CHEM, V16, P941, DOI 10.1021/jo01146a018; Chen CS, 2005, TALANTA, V67, P205, DOI 10.1016/j.talanta.2005.02.018; Chevalier Francois, 2007, V355, P145; Forster RJ, 2009, ANNU REV ANAL CHEM, V2, P359, DOI 10.1146/annurev-anchem-060908-155305; GILLIS TP, 1978, J CLIN MICROBIOL, V8, P351; Gizeli E, 1996, CURR OPIN BIOTECH, V7, P66, DOI 10.1016/S0958-1669(96)80097-8; GOW SM, 1986, CLIN CHEM, V32, P2191; GUTCHO S, 1977, CLIN CHEM, V23, P1609; Herman L, 2008, J PHYS ORG CHEM, V21, P670, DOI 10.1002/poc.1355; Lee KW, 2003, PHYS CHEM CHEM PHYS, V5, P2706, DOI 10.1039/b302119j; Lin HH, 2011, J MATER CHEM, V21, P3170, DOI 10.1039/c0jm02942d; Liu GD, 2004, ANAL CHEM, V76, P7126, DOI 10.1021/ac049107l; Miao WJ, 2008, CHEM REV, V108, P2506, DOI 10.1021/cr068083a; PACHMANN K, 1976, J IMMUNOL METHODS, V12, P67, DOI 10.1016/0022-1759(76)90097-1; Richter MM, 2004, CHEM REV, V104, P3003, DOI 10.1021/cr020373d; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; SIDKI AM, 1985, THER DRUG MONIT, V7, P101, DOI 10.1097/00007691-198503000-00018; Steinberg TH, 2000, ELECTROPHORESIS, V21, P486, DOI 10.1002/(SICI)1522-2683(20000201)21:3<486::AID-ELPS486>3.0.CO;2-Q; Tokarski C, 2006, ELECTROPHORESIS, V27, P1407, DOI 10.1002/elps.200500426; WIANS FH, 1986, CLIN CHEM, V32, P887; Xiang MH, 2009, J APPL ELECTROCHEM, V39, P921, DOI 10.1007/s10800-008-9742-9; Yousouf SJ, 2007, POLYHEDRON, V26, P318, DOI 10.1016/j.poly.2006.06.004	26	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36086	10.1371/journal.pone.0036086	http://dx.doi.org/10.1371/journal.pone.0036086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563441	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100066
J	van Luijn, MM; de Loosdrecht, AAV; Lampen, MH; van Veelen, PA; Zevenbergen, A; Kester, MGD; de Ru, AH; Ossenkoppele, GJ; van Hall, T; van Ham, SM				van Luijn, Marvin M.; de Loosdrecht, Arjan A. van; Lampen, Margit H.; van Veelen, Peter A.; Zevenbergen, Adri; Kester, Michel G. D.; de Ru, Arnoud H.; Ossenkoppele, Gert J.; van Hall, Thorbald; van Ham, S. Marieke			Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells	PLOS ONE			English	Article							MHC CLASS-I; CD4(+) T-LYMPHOCYTES; COMPLEX CLASS-I; CROSS-PRESENTATION; DENDRITIC CELLS; ANTIGEN PRESENTATION; ENDOGENOUS ANTIGEN; ESCAPE VARIANTS; ASSOCIATION; TRANSPORT	Antigen presentation by HLA class I (HLA-I) and HLA class II (HLA-II) complexes is achieved by proteins that are specific for their respective processing pathway. The invariant chain (Ii)-derived peptide CLIP is required for HLA-II-mediated antigen presentation by stabilizing HLA-II molecules before antigen loading through transient and promiscuous binding to different HLA-II peptide grooves. Here, we demonstrate alternative binding of CLIP to surface HLA-I molecules on leukemic cells. In HLA-II-negative AML cells, we found plasma membrane display of the CLIP peptide. Silencing Ii in AML cells resulted in reduced HLA-I cell surface display, which indicated a direct role of CLIP in the HLA-I antigen presentation pathway. In HLA-I-specific peptide eluates from B-LCLs, five Ii-derived peptides were identified, of which two were from the CLIP region. In vitro peptide binding assays strikingly revealed that the eluted CLIP peptide RMATPLLMQALPM efficiently bound to four distinct HLA-I supertypes (-A2, -B7, -A3, -B40). Furthermore, shorter length variants of this CLIP peptide also bound to these four supertypes, although in silico algorithms only predicted binding to HLA-A2 or -B7. Immunization of HLA-A2 transgenic mice with these peptides did not induce CTL responses. Together these data show a remarkable promiscuity of CLIP for binding to a wide variety of HLA-I molecules. The found participation of CLIP in the HLA-I antigen presentation pathway could reflect an aberrant mechanism in leukemic cells, but might also lead to elucidation of novel processing pathways or immune escape mechanisms.	[van Luijn, Marvin M.; de Loosdrecht, Arjan A. van; Zevenbergen, Adri; Ossenkoppele, Gert J.] Vrije Univ Amsterdam, Med Ctr, VU Inst Canc & Immunol, Dept Hematol,Canc Ctr Amesterdam, Amsterdam, Netherlands; [van Luijn, Marvin M.; van Ham, S. Marieke] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Lampen, Margit H.; van Hall, Thorbald] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands; [van Veelen, Peter A.; de Ru, Arnoud H.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [Kester, Michel G. D.] Leiden Univ, Med Ctr, Dept Hematol, Lab Expt Hematol, Leiden, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Luijn, MM (corresponding author), Vrije Univ Amsterdam, Med Ctr, VU Inst Canc & Immunol, Dept Hematol,Canc Ctr Amesterdam, Amsterdam, Netherlands.	m.luijn@vumc.nl	Lampen, Margit/K-1839-2012; van Hall, Thorbald/Y-5651-2018	Lampen, Margit/0000-0001-5435-1568; van Veelen, Peter/0000-0002-7898-9408; van Hall, Thorbald/0000-0002-9115-558X	Stichting Vanderes [125]; Dutch Cancer Society [UL2007-3879]	Stichting Vanderes; Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported in part by research funding from Stichting Vanderes (grant 125) and the Dutch Cancer Society (grant UL2007-3879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; Armstrong TD, 1997, P NATL ACAD SCI USA, V94, P6886, DOI 10.1073/pnas.94.13.6886; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Basha G, 2012, NAT IMMUNOL, V13, P237, DOI 10.1038/ni.2225; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Dissanayake SK, 2004, CANCER RES, V64, P1867, DOI 10.1158/0008-5472.CAN-03-2634; ELLIOTT EA, 1994, J EXP MED, V179, P681, DOI 10.1084/jem.179.2.681; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; FLING SP, 1994, NATURE, V368, P554, DOI 10.1038/368554a0; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Harris PE, 1996, BLOOD, V87, P5104, DOI 10.1182/blood.V87.12.5104.bloodjournal87125104; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Kessler JH, 2003, HUM IMMUNOL, V64, P245, DOI 10.1016/S0198-8859(02)00787-5; Koch J, 2006, CELL MOL LIFE SCI, V63, P653, DOI 10.1007/s00018-005-5462-z; Lampen MH, 2010, J IMMUNOL, V185, P6508, DOI 10.4049/jimmunol.1001774; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Ly LV, 2010, CANCER RES, V70, P8339, DOI 10.1158/0008-5472.CAN-10-2288; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; MOLLER P, 1991, INT J CANCER, P155; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Newberg MH, 1996, J IMMUNOL, V156, P2473; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PIETERS J, 1993, J CELL SCI, V106, P831; Powis SJ, 2006, FEBS LETT, V580, P3112, DOI 10.1016/j.febslet.2006.04.060; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reber AJ, 2002, IMMUNOGENETICS, V54, P74, DOI 10.1007/s00251-002-0446-8; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Seidel UJE, 2012, CANCER IMMUNOL IMMUN, V61, P119, DOI 10.1007/s00262-011-1160-x; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SUGITA M, 1995, J BIOL CHEM, V270, P1443, DOI 10.1074/jbc.270.3.1443; Thompson JA, 2006, CANCER RES, V66, P1147, DOI 10.1158/0008-5472.CAN-05-2289; Thompson JA, 2008, CANCER IMMUNOL IMMUN, V57, P389, DOI 10.1007/s00262-007-0381-5; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; van Luijn MM, 2011, CANCER RES, V71, P2507, DOI 10.1158/0008-5472.CAN-10-3689; van Luijn MM, 2010, CANCER IMMUNOL IMMUN, V59, P1825, DOI 10.1007/s00262-010-0908-z; van Luijn MM, 2010, HAEMATOL-HEMATOL J, V95, P485, DOI 10.3324/haematol.2009.010595; Veenstra H, 1996, CELL IMMUNOL, V171, P68, DOI 10.1006/cimm.1996.0174; Vigna JL, 1996, J IMMUNOL, V157, P4503; Weenink SM, 1997, INT IMMUNOL, V9, P317, DOI 10.1093/intimm/9.2.317; Zwart W, 2010, J CELL SCI, V123, P3817, DOI 10.1242/jcs.068510	47	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e34649	10.1371/journal.pone.0034649	http://dx.doi.org/10.1371/journal.pone.0034649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563374	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100004
J	Xin, H; Cartmell, J; Bailey, JJ; Dziadek, S; Bundle, DR; Cutler, JE				Xin, Hong; Cartmell, Jonathan; Bailey, Justin J.; Dziadek, Sebastian; Bundle, David R.; Cutler, Jim E.			Self-Adjuvanting Glycopeptide Conjugate Vaccine against Disseminated Candidiasis	PLOS ONE			English	Article							IGG3 MONOCLONAL-ANTIBODY; ENHANCE MOUSE RESISTANCE; IMMUNE-RESPONSES; CRYPTOCOCCUS-NEOFORMANS; LINKER METHODOLOGY; PEPTIDE EPITOPES; SIDE-CHAIN; ALBICANS; PROTECTION; INFECTION	Our research on pathogenesis of disseminated candidiasis led to the discovery that antibodies specific for Candida albicans cell surface beta-1, 2-mannotriose [beta-(Man)(3)] protect mice. A 14 mer peptide Fba, which derived from the N-terminal portion of the C. albicans cytosolic/cell surface protein fructose-bisphosphate aldolase, was used as the glycan carrier and resulted in a novel synthetic glycopeptide vaccine beta-(Man)(3)-Fba. By a dendritic cell-based immunization approach, this conjugate induced protective antibody responses against both the glycan and peptide parts of the vaccine. In this report, we modified the beta-(Man)(3)-Fba conjugate by coupling it to tetanus toxoid (TT) in order to improve immunogenicity and allow for use of an adjuvant suitable for human use. By new immunization procedures entirely compatible with human use, the modified beta-(Man)(3)-Fba-TT was administered either alone or as a mixture made with alum or monophosphoryl lipid A (MPL) adjuvants and given to mice by a subcutaneous (s.c.) route. Mice vaccinated with or, surprisingly, without adjuvant responded well by making robust antibody responses. The immunized groups showed a high degree of protection against a lethal challenge with C. albicans as evidenced by increased survival times and reduced kidney fungal burden as compared to control groups that received only adjuvant or DPBS buffer prior to challenge. To confirm that induced antibodies were protective, sera from mice immunized against the beta-(Man)(3)-Fba-TT conjugate transferred protection against disseminated candidiasis to naive mice, whereas C. albicans-absorbed immune sera did not. Similar antibody responses and protection induced by the beta-(Man)(3)-Fba-TT vaccine was observed in inbred BALB/c and outbred Swiss Webster mice. We conclude that addition of TT to the glycopeptide conjugate results in a self-adjuvanting vaccine that promotes robust antibody responses without the need for additional adjuvant, which is novel and represents a major step forward in vaccine design against disseminated candidiasis.	[Xin, Hong; Cutler, Jim E.] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Xin, Hong; Cutler, Jim E.] Childrens Hosp, Res Inst Children, New Orleans, LA USA; [Cartmell, Jonathan; Bailey, Justin J.; Dziadek, Sebastian; Bundle, David R.] Univ Alberta, Dept Chem, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB, Canada	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Alberta	Xin, H (corresponding author), Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70112 USA.	hxin@chnola-research.org	Cartmell, Jonathan/GPS-4523-2022		Research Institute for Children (RIC) at Children's Hospital in New Orleans; Alberta Innovates Centre for Carbohydrate Science; Natural Science and Engineering Research Council of Canada	Research Institute for Children (RIC) at Children's Hospital in New Orleans; Alberta Innovates Centre for Carbohydrate Science; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research Institute for Children (RIC) at Children's Hospital in New Orleans supported the authors' research. This work was also supported by the Alberta Innovates Centre for Carbohydrate Science and the Natural Science and Engineering Research Council of Canada. SD now works in Roche Diagnostics GmbH, but all the work he contributed to this study was done when he was supported by the Alberta Innovates Centre for Carbohydrate Science and the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMAN RB, 1990, IMMUNOL CELL BIOL, V68, P179, DOI 10.1038/icb.1990.25; Ashman RB, 1997, FEMS IMMUNOL MED MIC, V19, P183, DOI 10.1111/j.1574-695X.1997.tb01087.x; Bromuro C, 2010, VACCINE, V28, P2615, DOI 10.1016/j.vaccine.2010.01.012; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Casadevall A, 2007, INFECT IMMUN, V75, P5074, DOI 10.1128/IAI.01001-07; Cassone A, 2005, CURR MOL MED, V5, P377, DOI 10.2174/1566524054022549; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; COOPER LJN, 1991, J IMMUNOL, V146, P2659; Cutler JE, 2005, CURR MOL MED, V5, P383, DOI 10.2174/1566524054022576; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Cutler JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022030; DeBernardis F, 1997, INFECT IMMUN, V65, P3399, DOI 10.1128/IAI.65.8.3399-3405.1997; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Dziadek S, 2008, CHEM-EUR J, V14, P5908, DOI 10.1002/chem.200800065; Fotin-Mleczek M, 2011, J IMMUNOTHER, V34, P1, DOI 10.1097/CJI.0b013e3181f7dbe8; GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329; Goins TL, 2000, J CLIN MICROBIOL, V38, P2862, DOI 10.1128/JCM.38.8.2862-2869.2000; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; HAN YM, 1995, INFECT IMMUN, V63, P2714, DOI 10.1128/IAI.63.7.2714-2719.1995; Han YM, 1997, J INFECT DIS, V175, P1169, DOI 10.1086/516455; Han YM, 2001, J IMMUNOL, V167, P1550, DOI 10.4049/jimmunol.167.3.1550; Han YM, 1998, INFECT IMMUN, V66, P5771, DOI 10.1128/IAI.66.12.5771-5776.1998; HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Hsu FC, 2009, J MICROBIOL IMMUNOL, V42, P378; KANBE T, 1994, INFECT IMMUN, V62, P1662, DOI 10.1128/IAI.62.5.1662-1668.1994; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOBAYASHI H, 1994, INFECT IMMUN, V62, P615, DOI 10.1128/IAI.62.2.615-622.1994; Krcmery V, 2002, J HOSP INFECT, V50, P243, DOI 10.1053/jhin.2001.1151; Kuroda E, 2000, J IMMUNOL, V164, P2386, DOI 10.4049/jimmunol.164.5.2386; Maitta RW, 2004, INFECT IMMUN, V72, P196, DOI 10.1128/IAI.72.1.196-208.2004; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; Mochon AB, 2005, MED MYCOL, V43, P97, DOI 10.1080/13693780500035979; Moyle PM, 2008, CURR MED CHEM, V15, P506, DOI 10.2174/092986708783503249; Nitz M, 2002, J BIOL CHEM, V277, P3440, DOI 10.1074/jbc.M109274200; Nussbaum G, 1996, J EXP MED, V183, P1905, DOI 10.1084/jem.183.4.1905; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; PINCUS SH, 1988, J IMMUNOL, V140, P2779; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Shibata N, 1996, J BIOL CHEM, V271, P9259, DOI 10.1074/jbc.271.16.9259; Suzuki A, 1997, J BIOL CHEM, V272, P16822, DOI 10.1074/jbc.272.27.16822; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251, DOI 10.1146/annurev.iy.06.040188.001343; Wu XY, 2007, ORG BIOMOL CHEM, V5, P3477, DOI 10.1039/b709912f; Wu XY, 2005, J ORG CHEM, V70, P7381, DOI 10.1021/jo051065t; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; Xin H, 2011, CLIN VACCINE IMMUNOL, V18, P1656, DOI 10.1128/CVI.05215-11; Yang Q, 2005, VACCINE, V23, P4088, DOI 10.1016/j.vaccine.2004.07.005; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	52	52	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35106	10.1371/journal.pone.0035106	http://dx.doi.org/10.1371/journal.pone.0035106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563378	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100007
J	Tynan, CJ; Clarke, DT; Coles, BC; Rolfe, DJ; Martin-Fernandez, ML; Webb, SED				Tynan, Christopher J.; Clarke, David T.; Coles, Benjamin C.; Rolfe, Daniel J.; Martin-Fernandez, Marisa L.; Webb, Stephen E. D.			Multicolour Single Molecule Imaging in Cells with Near Infra-Red Dyes	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENCE MICROSCOPY; PROBES; FLUOROPHORES; PROTEINS; BIOLOGY; BRIGHT	Background: The autofluorescence background of biological samples impedes the detection of single molecules when imaging. The most common method of reducing the background is to use evanescent field excitation, which is incompatible with imaging beyond the surface of biological samples. An alternative would be to use probes that can be excited in the near infra-red region of the spectrum, where autofluorescence is low. Such probes could also increase the number of labels that can be imaged in multicolour single molecule microscopes. Despite being widely used in ensemble imaging, there is a currently a shortage of information available for selecting appropriate commercial near infra-red dyes for single molecule work. It is therefore important to characterise available near infra-red dyes relevant to multicolour single molecule imaging. Methodology/Principal Findings: A range of commercially available near infra-red dyes compatible with multi-colour imaging was screened to find the brightest and most photostable candidates. Image series of immobilised samples of the brightest dyes (Alexa 700, IRDye 700DX, Alexa 790 and IRDye 800CW) were analysed to obtain the mean intensity of single dye molecules, their photobleaching rates and long period blinking kinetics. Using the optimum dye pair, we have demonstrated for the first time widefield, multi-colour, near infra-red single molecule imaging using a supercontinuum light source in MCF-7 cells. Conclusions/Significance: We have demonstrated that near infra-red dyes can be used to avoid autofluorescence background in samples where restricting the illumination volume of visible light fails or is inappropriate. We have also shown that supercontinuum sources are suited to single molecule multicolour imaging throughout the 470-1000 nm range. Our measurements of near infra-red dye properties will enable others to select optimal dyes for single molecule imaging.	[Tynan, Christopher J.; Clarke, David T.; Coles, Benjamin C.; Rolfe, Daniel J.; Martin-Fernandez, Marisa L.; Webb, Stephen E. D.] Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Didcot, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Tynan, CJ (corresponding author), Sci & Technol Facil Council, Rutherford Appleton Lab, Cent Laser Facil, Res Complex Harwell, Didcot, Oxon, England.	stephen.webb@stfc.ac.uk	Webb, Stephen E D/G-5682-2010	Webb, Stephen E D/0000-0002-6304-1702; Bateman, Benji/0000-0003-4580-4662; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300; Tynan, Christopher/0000-0002-4553-7018; Clarke, David/0000-0002-8776-1341	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; Science & Technology Facilities Council; BBSRC [BB/G006911/1, BB/G007160/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science & Technology Facilities Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was received from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant award BB/G006911/1, and from the Science & Technology Facilities Council (www.stfc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aswathy RG, 2010, ANAL BIOANAL CHEM, V397, P1417, DOI 10.1007/s00216-010-3643-6; Axelrod D, 2001, TRAFFIC, V2, P764, DOI 10.1034/j.1600-0854.2001.21104.x; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Dalgarno HIC, 2011, J R SOC INTERFACE, V8, P942, DOI 10.1098/rsif.2010.0508; Dave R, 2009, BIOPHYS J, V96, P2371, DOI 10.1016/j.bpj.2008.11.061; de Keijzer Sandra, 2008, V12, P107; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; DeRocco VC, 2010, BIOTECHNIQUES, V49, P807, DOI 10.2144/000113551; Eggeling C, 2006, J PHYS CHEM A, V110, P2979, DOI 10.1021/jp054581w; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Holtzer L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437066; Hou XM, 2012, BIOMED OPT EXPRESS, V3, P340, DOI 10.1364/BOE.3.000340; Kapanidis AN, 2002, J CHEM PHYS, V117, P10953, DOI 10.1063/1.1521158; Kobayashi H, 2007, ACS NANO, V1, P258, DOI 10.1021/nn700062z; Lavis LD, 2008, ACS CHEM BIOL, V3, P142, DOI 10.1021/cb700248m; Lee J, 2010, ANGEW CHEM INT EDIT, V49, P9922, DOI 10.1002/anie.201005402; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012270; Lin MZ, 2011, NAT METHODS, V8, P726, DOI 10.1038/nmeth.1678; Marras Salvatore A. E., 2006, V335, P3; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Peng XZ, 2006, PROC SPIE, V6097, DOI 10.1117/12.669173; Peng XX, 2009, ANAL BIOCHEM, V388, P220, DOI 10.1016/j.ab.2009.02.024; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rurack K, 2011, ANAL CHEM, V83, P1232, DOI 10.1021/ac101329h; Sabanayagam CR, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2136157; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Webb SED, 2012, BIOMED OPT EXPRESS, V3, P400, DOI 10.1364/BOE.3.000400; Yanagida T., 2009, SINGLE MOL DYNAMICS	33	22	25	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e36265	10.1371/journal.pone.0036265	http://dx.doi.org/10.1371/journal.pone.0036265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22558412	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345200120
J	Miller-Coleman, RL; Dodsworth, JA; Ross, CA; Shock, EL; Williams, AJ; Hartnett, HE; McDonald, AI; Havig, JR; Hedlund, BP				Miller-Coleman, Robin L.; Dodsworth, Jeremy A.; Ross, Christian A.; Shock, Everett L.; Williams, Amanda J.; Hartnett, Hilairy E.; McDonald, Austin I.; Havig, Jeff R.; Hedlund, Brian P.			Korarchaeota Diversity, Biogeography, and Abundance in Yellowstone and Great Basin Hot Springs and Ecological Niche Modeling Based on Machine Learning	PLOS ONE			English	Article							EAST PACIFIC RISE; NATIONAL-PARK; ARCHAEAL DIVERSITY; PHYLOGENETIC DIVERSITY; BACTERIAL COMMUNITIES; HYDROTHERMAL SYSTEM; MICROBIAL DIVERSITY; AQUEOUS-SOLUTION; THERMAL SPRINGS; METAL-IONS	Over 100 hot spring sediment samples were collected from 28 sites in 12 areas/regions, while recording as many coincident geochemical properties as feasible (>60 analytes). PCR was used to screen samples for Korarchaeota 16S rRNA genes. Over 500 Korarchaeota 16S rRNA genes were screened by RFLP analysis and 90 were sequenced, resulting in identification of novel Korarchaeota phylotypes and exclusive geographical variants. Korarchaeota diversity was low, as in other terrestrial geothermal systems, suggesting a marine origin for Korarchaeota with subsequent niche-invasion into terrestrial systems. Korarchaeota endemism is consistent with endemism of other terrestrial thermophiles and supports the existence of dispersal barriers. Korarchaeota were found predominantly in >55 degrees C springs at pH 4.7-8.5 at concentrations up to 6.6x10(6) 16S rRNA gene copies g(-1) wet sediment. In Yellowstone National Park (YNP), Korarchaeota were most abundant in springs with a pH range of 5.7 to 7.0. High sulfate concentrations suggest these fluids are influenced by contributions from hydrothermal vapors that may be neutralized to some extent by mixing with water from deep geothermal sources or meteoric water. In the Great Basin (GB), Korarchaeota were most abundant at spring sources of pH, 7.2 with high particulate C content and high alkalinity, which are likely to be buffered by the carbonic acid system. It is therefore likely that at least two different geological mechanisms in YNP and GB springs create the neutral to mildly acidic pH that is optimal for Korarchaeota. A classification support vector machine (C-SVM) trained on single analytes, two analyte combinations, or vectors from non-metric multidimensional scaling models was able to predict springs as Korarchaeota-optimal or sub-optimal habitats with accuracies up to 95%. To our knowledge, this is the most extensive analysis of the geochemical habitat of any high-level microbial taxon and the first application of a C-SVM to microbial ecology.	[Miller-Coleman, Robin L.; Dodsworth, Jeremy A.; Ross, Christian A.; Williams, Amanda J.; McDonald, Austin I.; Hedlund, Brian P.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Shock, Everett L.; Hartnett, Hilairy E.; Havig, Jeff R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Shock, Everett L.; Hartnett, Hilairy E.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Miller-Coleman, RL (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	brian.hedlund@unlv.edu		Hedlund, Brian/0000-0001-8530-0448; Dodsworth, Jeremy/0000-0003-2014-5488; McDonald, Austin/0000-0002-3161-5388; Havig, Jeff/0000-0002-1326-3382; Hartnett, Hilairy/0000-0003-0736-7844; Shock, Everett/0000-0002-4283-0163; Ross, Paige/0000-0002-4157-3951	National Science Foundation [EPS-9977809, MCB-0546865]; start-up funds from the University of Nevada Las Vegas; National Institutes of Health from the National Center for Research Resources, a component of the National Institutes of Health [_P20 RR016464_]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; Office Of Internatl Science &Engineering [0968421] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); start-up funds from the University of Nevada Las Vegas; National Institutes of Health from the National Center for Research Resources, a component of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Science Foundation Grant Numbers EPS-9977809, MCB-0546865, and start-up funds from the University of Nevada Las Vegas to BPH. CAR, AIM and the Nevada Genomics Center were supported by National Institutes of Health Grant Number_P20 RR016464_ from the National Center for Research Resources, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, BROCK BIOL MICROORGA; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Auchtung TA, 2006, APPL ENVIRON MICROB, V72, P5077, DOI 10.1128/AEM.00052-06; Auchtung TA, 2011, EXTREMOPHILES, V15, P105, DOI 10.1007/s00792-010-0340-5; Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Boyd ES, 2010, ISME J, V4, P1485, DOI 10.1038/ismej.2010.76; Brock T.D., 1966, PRINCIPLES MICROBIAL; BROCK TD, 1971, GEOL SOC AM BULL, V82, P1393, DOI 10.1130/0016-7606(1971)82[1393:BDOPVO]2.0.CO;2; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Burggraf S, 1997, NATURE, V385, P780, DOI 10.1038/385780a0; Byvatov E, 2003, J CHEM INF COMP SCI, V43, P1882, DOI 10.1021/ci0341161; Chang C.-C., LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Dyer JA, 1998, ENVIRON PROG, V17, P1, DOI 10.1002/ep.670170112; Ehrhardt CJ, 2007, ENVIRON MICROBIOL, V9, P900, DOI 10.1111/j.1462-2920.2006.01211.x; Elkins JG, 2008, P NATL ACAD SCI USA, V105, P8102, DOI 10.1073/pnas.0801980105; FARRAR CD, 1995, NATURE, V376, P675, DOI 10.1038/376675a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRY B, 1992, ANAL CHEM, V64, P288, DOI 10.1021/ac00027a009; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Goni MA, 2006, ESTUAR COAST SHELF S, V69, P225, DOI 10.1016/j.ecss.2006.04.012; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; HEDLUND BP, 2003, MICROBIAL DIVERSITY, P225; Hirayama H, 2007, APPL ENVIRON MICROB, V73, P7642, DOI 10.1128/AEM.01258-07; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Johnson DB, 2001, ENVIRON MICROBIOL, V3, P630, DOI 10.1046/j.1462-2920.2001.00234.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marteinsson VT, 2001, APPL ENVIRON MICROB, V67, P827, DOI 10.1128/AEM.67.2.827-833.2001; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Nakagawa S, 2005, FEMS MICROBIOL ECOL, V54, P141, DOI 10.1016/j.femsec.2005.03.007; Nakagawa T, 2004, FEMS MICROBIOL LETT, V232, P145, DOI 10.1016/S0378-1097(04)00044-8; Navarro J, 2009, MICROB ECOL, V57, P307, DOI 10.1007/s00248-008-9426-3; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; Nordstrom DK, 2009, APPL GEOCHEM, V24, P191, DOI 10.1016/j.apgeochem.2008.11.019; Palumbo AV, 2004, APPL ENVIRON MICROB, V70, P6525, DOI 10.1128/AEM.70.11.6525-6534.2004; Reigstad LJ, 2010, ISME J, V4, P346, DOI 10.1038/ismej.2009.126; Reysenbach AL, 2000, EXTREMOPHILES, V4, P61, DOI 10.1007/s007920050008; Rha SY, 2009, INT J ONCOL, V34, P837, DOI 10.3892/ijo_00000210; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rogers KL, 2005, GEOBIOLOGY, V3, P319, DOI 10.1111/j.1472-4669.2006.00064.x; Ross C, 2006, PLANT MOL BIOL, V62, P233, DOI 10.1007/s11103-006-9017-y; Schramm A, 2009, CANCER LETT, V282, P55, DOI 10.1016/j.canlet.2009.02.052; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shock EL, 2010, GEOCHIM COSMOCHIM AC, V74, P4005, DOI 10.1016/j.gca.2009.08.036; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; SMITH AE, 1973, ANALYST, V98, P65, DOI 10.1039/an9739800065; SMITH AE, 1973, ANALYST, V98, P209, DOI 10.1039/an9739800209; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Takacs-Vesbach C, 2008, ENVIRON MICROBIOL, V10, P1681, DOI 10.1111/j.1462-2920.2008.01584.x; Takai K, 1999, FEMS MICROBIOL ECOL, V28, P177, DOI 10.1111/j.1574-6941.1999.tb00573.x; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Zehner R.E., 2006, GEOTHERMAL RESOURCES, V30, P117	65	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35964	10.1371/journal.pone.0035964	http://dx.doi.org/10.1371/journal.pone.0035964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574130	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800026
J	Paraskevopoulos, E; Kuchenbuch, A; Herholz, SC; Pantev, C				Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Herholz, Sibylle C.; Pantev, Christo			Evidence for Training-Induced Plasticity in Multisensory Brain Structures: An MEG Study	PLOS ONE			English	Article							MISMATCH-NEGATIVITY MMN; AUDITORY-CORTEX; MUSIC; NEUROSCIENCE; INFORMATION; PERCEPTION; SPEECH	Multisensory learning and resulting neural brain plasticity have recently become a topic of renewed interest in human cognitive neuroscience. Music notation reading is an ideal stimulus to study multisensory learning, as it allows studying the integration of visual, auditory and sensorimotor information processing. The present study aimed at answering whether multisensory learning alters uni-sensory structures, interconnections of uni-sensory structures or specific multisensory areas. In a short-term piano training procedure musically naive subjects were trained to play tone sequences from visually presented patterns in a music notation-like system [Auditory-Visual-Somatosensory group (AVS)], while another group received audio-visual training only that involved viewing the patterns and attentively listening to the recordings of the AVS training sessions [Auditory-Visual group (AV)]. Training-related changes in cortical networks were assessed by pre- and post-training magnetoencephalographic (MEG) recordings of an auditory, a visual and an integrated audio-visual mismatch negativity (MMN). The two groups (AVS and AV) were differently affected by the training. The results suggest that multisensory training alters the function of multisensory structures, and not the uni-sensory ones along with their interconnections, and thus provide an answer to an important question presented by cognitive models of multisensory training.	[Paraskevopoulos, Evangelos; Kuchenbuch, Anja; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Herholz, Sibylle C.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	University of Munster; McGill University	Paraskevopoulos, E (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de		Paraskevopoulos, Evangelos/0000-0003-4063-4182	Deutsche Forschungsgemeinschaft [PA392/12-2, HE6067-1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [PA392/12-2 and HE6067-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1999, PSYCHOPHYSIOLOGY, V36, P737, DOI 10.1111/1469-8986.3660737; Bocquillon P, 2011, CLIN NEUROPHYSIOLOGY; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Koelsch S, 2002, NEUROIMAGE, V17, P956, DOI 10.1016/S1053-8119(02)91154-7; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Lappe C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021493; Lee H, 2011, P NATL ACAD SCI USA, V108, pE1441, DOI 10.1073/pnas.1115267108; Marco-Pallares J, 2005, NEUROIMAGE, V25, P471, DOI 10.1016/j.neuroimage.2004.11.028; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1995, EAR HEARING, V16, P6; Naatanen R, 2008, INT J AUDIOL, V47, pS16, DOI 10.1080/14992020802340116; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park HJ, 2002, HUM BRAIN MAPP, V17, P168, DOI 10.1002/hbm.10059; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pekkola J, 2005, NEUROREPORT, V16, P125, DOI 10.1097/00001756-200502080-00010; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; Schon D, 2005, J COGNITIVE NEUROSCI, V17, P694, DOI 10.1162/0898929053467532; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Shams L, 2008, TRENDS COGN SCI, V12, P411, DOI 10.1016/j.tics.2008.07.006; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tervaniemi M, 2003, BRAIN RES REV, V43, P231, DOI 10.1016/j.brainresrev.2003.08.004; Urakawa T, 2010, PSYCHOPHYSIOLOGY, V47, P905, DOI 10.1111/j.1469-8986.2010.00987.x; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; Waberski TD, 2001, NEUROSCI LETT, V308, P107, DOI 10.1016/S0304-3940(01)01988-7; Widmann A, 2004, PSYCHOPHYSIOLOGY, V41, P709, DOI 10.1111/j.1469-8986.2004.00208.x; Woldorff MG, 1997, HUM BRAIN MAPP, V5, P280, DOI 10.1002/(SICI)1097-0193(1997)5:4<280::AID-HBM13>3.0.CO;2-I; Yumoto M, 2005, NEUROREPORT, V16, P1175, DOI 10.1097/00001756-200508010-00008; Yumoto M, 2005, NEUROREPORT, V16, P803, DOI 10.1097/00001756-200505310-00005; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	39	30	31	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36534	10.1371/journal.pone.0036534	http://dx.doi.org/10.1371/journal.pone.0036534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VF	22570723	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400039
J	Junqueira, C; Guerrero, AT; Galvao, B; Andrade, WA; Salgado, APC; Cunha, TM; Ropert, C; Campos, MA; Penido, MLO; Mendonca-Previato, L; Previato, JO; Ritter, G; Cunha, FQ; Gazzinelli, RT				Junqueira, Caroline; Guerrero, Ana Tereza; Galvao-Filho, Bruno; Andrade, Warrison A.; Salgado, Ana Paula C.; Cunha, Thiago M.; Ropert, Catherine; Campos, Marco Antonio; Penido, Marcus L. O.; Mendonca-Previato, Lucia; Previato, Jose Oswaldo; Ritter, Gerd; Cunha, Fernando Q.; Gazzinelli, Ricardo T.			Trypanosoma cruzi Adjuvants Potentiate T Cell-Mediated Immunity Induced by a NY-ESO-1 Based Antitumor Vaccine	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; REDUCING INJECTION PAIN; TOLL-LIKE RECEPTORS; HOST-RESISTANCE; INNATE IMMUNITY; PROINFLAMMATORY CYTOKINES; ADAPTIVE IMMUNITY; INTERFERON-GAMMA; DENDRITIC CELLS; TLR9 AGONISTS	Immunological adjuvants that induce T cell-mediate immunity (TCMI) with the least side effects are needed for the development of human vaccines. Glycoinositolphospholipids (GIPL) and CpGs oligodeoxynucleotides (CpG ODNs) derived from the protozoa parasite Trypanosoma cruzi induce potent pro-inflammatory reaction through activation of Toll-Like Receptor (TLR) 4 and TLR9, respectively. Here, using mouse models, we tested the T. cruzi derived TLR agonists as immunological adjuvants in an antitumor vaccine. For comparison, we used well-established TLR agonists, such as the bacterial derived monophosphoryl lipid A (MPL), lipopeptide (Pam3Cys), and CpG ODN. All tested TLR agonists were comparable to induce antibody responses, whereas significant differences were noticed in their ability to elicit CD4(+) T and CD8(+) T cell responses. In particular, both GIPLs (GTH, and GY) and CpG ODNs (B344, B297 and B128) derived from T. cruzi elicited interferon-gamma (IFN-gamma) production by CD4(+) T cells. On the other hand, the parasite derived CpG ODNs, but not GIPLs, elicited a potent IFN-gamma response by CD8(+) T lymphocytes. The side effects were also evaluated by local pain (hypernociception). The intensity of hypernociception induced by vaccination was alleviated by administration of an analgesic drug without affecting protective immunity. Finally, the level of protective immunity against the NY-ESO-1 expressing melanoma was associated with the magnitude of both CD4+ T and CD8+ T cell responses elicited by a specific immunological adjuvant.	[Junqueira, Caroline; Galvao-Filho, Bruno; Andrade, Warrison A.; Salgado, Ana Paula C.; Ropert, Catherine; Campos, Marco Antonio; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Junqueira, Caroline; Galvao-Filho, Bruno; Andrade, Warrison A.; Penido, Marcus L. O.; Gazzinelli, Ricardo T.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guerrero, Ana Tereza] Fundacao Oswaldo Cruz, Inst Cerrado Pantanal, Campo Grande, Brazil; [Andrade, Warrison A.; Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA; [Cunha, Thiago M.; Cunha, Fernando Q.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Ribeirao Preto, Brazil; [Mendonca-Previato, Lucia; Previato, Jose Oswaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ctr Ciencias Saude, Rio De Janeiro, Brazil; [Ritter, Gerd] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Junqueira, C (corresponding author), Fundacao Oswaldo Cruz, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	ritoga@cpqrr.fiocruz.br	junqueira, caroline/B-4750-2010; Cunha, Fernando Q/M-3090-2014; Ropert, Catherine/G-2463-2012; Campos, Marco A/C-4000-2013; Junqueira, Caroline/GVR-8109-2022; Campos, Marco Antonio/AAU-6229-2021; Ropert, Catherine/AAL-7302-2021; Andrade, Warrison Athanasio/P-7722-2015; Cunha, Thiago M/B-7729-2012	Campos, Marco A/0000-0003-4683-0176; Campos, Marco Antonio/0000-0003-4683-0176; Ropert, Catherine/0000-0002-3077-714X; Andrade, Warrison Athanasio/0000-0003-2709-6463; Cunha, Thiago M/0000-0003-1084-0065; Cunha, Fernando Queiroz/0000-0003-4755-1670; Junqueira, Caroline/0000-0003-0545-0986; Mendonca Previato, Lucia/0000-0003-3927-3244; Previato, Jose Osvaldo/0000-0002-9233-9954; Gazzinelli, Ricardo/0000-0003-2427-7699	Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG	Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from The Atlantic Philanthropies/Ludwig Institute for Cancer Research (LICR) - Clinical Discovery Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq) - Instituto Nacional de Ciencia e Tecnologia de Vacinas; and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, IMMUNOTHERAPY-UK, V1, P949, DOI [10.2217/imt.09.70, 10.2217/IMT.09.70]; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Aliberti JCS, 1996, INFECT IMMUN, V64, P1961, DOI 10.1128/IAI.64.6.1961-1967.1996; Almeida IC, 2000, EMBO J, V19, P1476, DOI 10.1093/emboj/19.7.1476; Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Aoki M, 2009, VACCINE, V27, P6854, DOI 10.1016/j.vaccine.2009.09.018; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Caetano BC, 2011, J IMMUNOL, V187, P1903, DOI 10.4049/jimmunol.1003911; Camargo MM, 1997, J IMMUNOL, V158, P5890; Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Carroll MW, 1997, VACCINE, V15, P387, DOI 10.1016/S0264-410X(96)00195-8; Chen PW, 1996, J IMMUNOL, V156, P224; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018; Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gazzinelli RT, 2006, NAT REV IMMUNOL, V6, P895, DOI 10.1038/nri1978; Gazzinelli RT, 2004, IMMUNOL REV, V201, P9, DOI 10.1111/j.0105-2896.2004.00174.x; Gnjatic S, 2009, CLIN CANCER RES, V15, P2130, DOI 10.1158/1078-0432.CCR-08-2632; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Melief CJM, 2002, IMMUNOL REV, V188, P177, DOI 10.1034/j.1600-065X.2002.18816.x; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nishikawa H, 2008, BLOOD, V111, P1404, DOI 10.1182/blood-2007-09-113761; Nishikawa H, 2006, J CLIN INVEST, V116, P1946, DOI 10.1172/JCI28045; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Parada CA, 2003, P NATL ACAD SCI USA, V100, P2923, DOI 10.1073/pnas.252777799; PARKER KC, 1994, J IMMUNOL, V152, P163; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; PREVIATO JO, 1990, J BIOL CHEM, V265, P2518; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shah V, 2009, CLIN THER, V31, pS104, DOI 10.1016/j.clinthera.2009.08.001; Singh R, 2011, HUM VACCIN, V7; Su L, 2000, J Epidemiol Biostat, V5, P359; Taddio A, 2009, CLIN THER, V31, pS48, DOI 10.1016/j.clinthera.2009.07.024; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; Wang RF, 1998, J IMMUNOL, V161, P3596; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335; Zarour HM, 2002, CANCER RES, V62, P213; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	59	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36245	10.1371/journal.pone.0036245	http://dx.doi.org/10.1371/journal.pone.0036245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567144	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500063
J	Ricciardi, M; Malpeli, G; Bifari, F; Bassi, G; Pacelli, L; Kamdje, AHN; Chilosi, M; Krampera, M				Ricciardi, Mario; Malpeli, Giorgio; Bifari, Francesco; Bassi, Giulio; Pacelli, Luciano; Kamdje, Armel Herve Nwabo; Chilosi, Marco; Krampera, Mauro			Comparison of Epithelial Differentiation and Immune Regulatory Properties of Mesenchymal Stromal Cells Derived from Human Lung and Bone Marrow	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; RETINOIC ACID; FIBROBLASTS; APOPTOSIS; PATHOGENESIS; TRANSITIONS; MECHANISMS; EXPRESSION	Mesenchymal stromal cells (MSCs) reside in many organs including lung, as shown by their isolation from fetal lung tissues, bronchial stromal compartment, bronchial-alveolar lavage and transplanted lung tissues. It is still controversial whether lung MSCs can undergo mesenchymal-to-epithelial-transition (MET) and possess immune regulatory properties. To this aim, we isolated, expanded and characterized MSCs from normal adult human lung (lung-hMSCs) and compared with human bone marrow-derived MSCs (BM-hMSCs). Our results show that lung-MSCs reside at the perivascular level and do not significantly differ from BM-hMSCs in terms of immunophenotype, stemness gene profile, mesodermal differentiation potential and modulation of T, B and NK cells. However, lung-hMSCs express higher basal level of the stemness-related marker nestin and show, following in vitro treatment with retinoic acid, higher epithelial cell polarization, which is anyway partial when compared to a control epithelial bronchial cell line. Although these results question the real capability of acquiring epithelial functions by MSCs and the feasibility of MSC-based therapeutic approaches to regenerate damaged lung tissues, the characterization of this lung-hMSC population may be useful to study the involvement of stromal cell compartment in lung diseases in which MET plays a role, such as in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.	[Ricciardi, Mario; Bifari, Francesco; Bassi, Giulio; Pacelli, Luciano; Kamdje, Armel Herve Nwabo; Krampera, Mauro] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy; [Malpeli, Giorgio; Chilosi, Marco] Univ Verona, Dept Pathol & Diagnost, Sect Pathol Anat, I-37100 Verona, Italy	University of Verona; University of Verona	Ricciardi, M (corresponding author), Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Italy.	mauro.krampera@univr.it	Bifari, Francesco/M-3430-2014; CHILOSI, MARCO/ABB-8028-2021; KRAMPERA, MAURO/K-5596-2018	Bifari, Francesco/0000-0003-2028-3012; KRAMPERA, Mauro/0000-0002-7280-2040; Ricciardi, Mario/0000-0003-3694-8218; Malpeli, Giorgio/0000-0002-2996-2903	Regione del Veneto; Italian Ministry of University and Scientific Research; Fondazione CARIVERONA	Regione del Veneto(Regione Veneto); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIVERONA(Fondazione Cariverona)	This work was supported by the grant "Ricerca Sanitaria Finalizzata per l'anno 2009'' from "Regione del Veneto" and by the Italian Ministry of University and Scientific Research (PRIN 2007) and Fondazione CARIVERONA, Bando 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Badri L, 2011, AM J RESP CELL MOL, V45, P809, DOI 10.1165/rcmb.2010-0446OC; Baraldo S, 2008, EUR RESPIR J, V31, P486, DOI 10.1183/09031936.00000608; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Bozyk PD, 2011, STEM CELLS DEV, V20, P1995, DOI 10.1089/scd.2010.0494; Brzoska M, 2005, BIOCHEM BIOPH RES CO, V330, P142, DOI 10.1016/j.bbrc.2005.02.141; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Chilosi M, 2010, SARCOIDOSIS VASC DIF, V27, P7; Conese M, 2006, J CYST FIBROS, V5, P141, DOI 10.1016/j.jcf.2006.02.001; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dickman ED, 1997, DEVELOPMENT, V124, P3111; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Geiser T, 2003, SWISS MED WKLY, V133, P405; GUDAS LJ, 1994, J BIOL CHEM, V269, P15399; Hua JL, 2009, TISSUE CELL, V41, P448, DOI 10.1016/j.tice.2009.05.004; Jarvinen L, 2008, J IMMUNOL, V181, P4389, DOI 10.4049/jimmunol.181.6.4389; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kaza AK, 2001, ANN THORAC SURG, V71, P1645, DOI 10.1016/S0003-4975(01)02478-X; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Koshiol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007380; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Lane MA, 1999, P NATL ACAD SCI USA, V96, P13524, DOI 10.1073/pnas.96.23.13524; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Loi R, 2006, AM J RESP CRIT CARE, V173, P171, DOI 10.1164/rccm.200502-309OC; MacNee William, 2009, Proc Am Thorac Soc, V6, P527, DOI 10.1513/pats.200905-027DS; Maden M, 2004, PHILOS T R SOC B, V359, P799, DOI 10.1098/rstb.2004.1470; Malpel S, 2000, DEVELOPMENT, V127, P3057; Massaro D, 2010, NEW ENGL J MED, V362, P1829, DOI 10.1056/NEJMe1002366; MASUYAMA H, 1995, BIOL NEONATE, V67, P264, DOI 10.1159/000244174; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Mochizuki T, 2006, ARTHRITIS RHEUM-US, V54, P843, DOI 10.1002/art.21651; Muller KC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-32; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Plateroti M, 1997, J CELL SCI, V110, P1227; PROCKOP DJ, 1997, SCIENCE, V276, P71, DOI [DOI 10.1126/SCIENCE.276.5309.71, 10.1126/science.276.5309.71]; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Strieter RM, 2009, CHEST, V136, P1364, DOI 10.1378/chest.09-0510; Tabata C, 2006, AM J PHYSIOL-LUNG C, V290, pL597, DOI 10.1152/ajplung.00282.2005; Tabata C, 2006, AM J RESP CRIT CARE, V174, P1352, DOI 10.1164/rccm.200606-862OC; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Wolbach SB, 1933, J EXP MED, V57, P511, DOI 10.1084/jem.57.3.511; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	57	53	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35639	10.1371/journal.pone.0035639	http://dx.doi.org/10.1371/journal.pone.0035639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567106	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500024
J	Hagemann, S; Kuck, D; Stresemann, C; Prinz, F; Brueckner, B; Mund, C; Mumberg, D; Sommer, A				Hagemann, Sabine; Kuck, Dirk; Stresemann, Carlo; Prinz, Florian; Brueckner, Bodo; Mund, Cora; Mumberg, Dominik; Sommer, Anette			Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; DE-NOVO METHYLATION; COLORECTAL-CANCER; INTESTINAL NEOPLASIA; CELL-SURVIVAL; DNMT3B; GENES; EXPRESSION; HYPERMETHYLATION; LYMPHOMAGENESIS	Silencing of genes by hypermethylation contributes to cancer progression and has been shown to occur with increased frequency at specific genomic loci. However, the precise mechanisms underlying the establishment and maintenance of aberrant methylation marks are still elusive. The de novo DNA methyltransferase 3B (DNMT3B) has been suggested to play an important role in the generation of cancer-specific methylation patterns. Previous studies have shown that a reduction of DNMT3B protein levels induces antiproliferative effects in cancer cells that were attributed to the demethylation and reactivation of tumor suppressor genes. However, methylation changes have not been analyzed in detail yet. Using RNA interference we reduced DNMT3B protein levels in colon cancer cell lines. Our results confirm that depletion of DNMT3B specifically reduced the proliferation rate of DNMT3B-overexpressing colon cancer cell lines. However, genome-scale DNA methylation profiling failed to reveal methylation changes at putative DNMT3B target genes, even in the complete absence of DNMT3B. These results show that DNMT3B is dispensable for the maintenance of aberrant DNA methylation patterns in human colon cancer cells and they have important implications for the development of targeted DNA methyltransferase inhibitors as epigenetic cancer drugs.	[Hagemann, Sabine; Kuck, Dirk; Brueckner, Bodo] German Canc Res Ctr, Div Epigenet, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany; [Kuck, Dirk; Stresemann, Carlo; Prinz, Florian; Mund, Cora; Mumberg, Dominik; Sommer, Anette] Bayer Healthcare Pharmaceut, Global Drug Discovery, Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Bayer AG; Bayer Healthcare Pharmaceuticals	Hagemann, S (corresponding author), German Canc Res Ctr, Div Epigenet, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	anette.sommer@bayer.com	Sommer, Anette/T-7674-2019; Stresemann, Carlo/AAF-6643-2020	Sommer, Anette/0000-0002-1576-3110; 				Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Choi SH, 2011, NUCLEIC ACIDS RES, V39, P104, DOI 10.1093/nar/gkq774; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Egner U, 2005, CHEMBIOCHEM, V6, P468, DOI 10.1002/cbic.200400158; Esteller M, 2001, CANCER RES, V61, P3225; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Hlady RA, 2012, J CLIN INVEST, V122, P163, DOI 10.1172/JCI57292; Ibrahim AEK, 2011, GUT, V60, P499, DOI 10.1136/gut.2010.223602; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang ES, 2001, BIOCHEM BIOPH RES CO, V289, P862, DOI 10.1006/bbrc.2001.6057; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin HJ, 2006, MOL CELL BIOL, V26, P2976, DOI 10.1128/MCB.26.8.2976-2983.2006; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Milutinovic S, 2003, J BIOL CHEM, V278, P14985, DOI 10.1074/jbc.M213219200; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Rasband W., 2006, IMAGEJ; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shah MY, 2010, CANCER RES, V70, P5840, DOI 10.1158/0008-5472.CAN-10-0847; Shi HD, 2003, CANCER RES, V63, P2164; Simo-Riudalbas L, 2011, GENE CHROMOSOME CANC, V50, P527, DOI 10.1002/gcc.20877; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Steine EJ, 2011, J CLIN INVEST, V121, P1748, DOI 10.1172/JCI43169; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Team R. D. C, 2011, R LANG ENV STAT COMP; Teodoridis JM, 2008, CANCER LETT, V268, P177, DOI 10.1016/j.canlet.2008.03.022; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Unterberger A, 2006, MOL CELL BIOL, V26, P7575, DOI 10.1128/MCB.01887-05; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13	44	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36125	10.1371/journal.pone.0036125	http://dx.doi.org/10.1371/journal.pone.0036125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563479	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700028
J	Lin, AHM; Nichols, BL; Quezada-Calvillo, R; Avery, SE; Sim, L; Rose, DR; Naim, HY; Hamaker, BR				Lin, Amy Hui-Mei; Nichols, Buford L.; Quezada-Calvillo, Roberto; Avery, Stephen E.; Sim, Lyann; Rose, David R.; Naim, Hassan Y.; Hamaker, Bruce R.			Unexpected High Digestion Rate of Cooked Starch by the Ct-Maltase-Glucoamylase Small Intestine Mucosal alpha-Glucosidase Subunit	PLOS ONE			English	Article							ENZYME-RESISTANT STARCH; SUCRASE-ISOMALTASE; SUBSITE AFFINITIES; SUBSTRATE BRAKE; FOODS; HYDROLYSIS; DISACCHARIDASES; CLASSIFICATION; CHROMATOGRAPHY; ONTOGENY	For starch digestion to glucose, two luminal alpha-amylases and four gut mucosal alpha-glucosidase subunits are employed. The aim of this research was to investigate, for the first time, direct digestion capability of individual mucosal alpha-glucosidases on cooked (gelatinized) starch. Gelatinized normal maize starch was digested with N- and C-terminal subunits of recombinant mammalian maltase-glucoamylase (MGAM) and sucrase-isomaltase (SI) of varying amounts and digestion periods. Without the aid of alpha-amylase, Ct-MGAM demonstrated an unexpected rapid and high digestion degree near 80%, while other subunits showed 20 to 30% digestion. These findings suggest that Ct-MGAM assists alpha-amylase in digesting starch molecules and potentially may compensate for developmental or pathological amylase deficiencies.	[Lin, Amy Hui-Mei; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto; Avery, Stephen E.] Baylor Coll Med, USDA, ARS, Childrens Nutr Res Ctr,Dept Pediat, Houston, TX 77030 USA; [Sim, Lyann] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Sim, Lyann] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Naim, Hassan Y.] Univ Vet Med Hannover, Inst Physiol Chem, Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Waterloo; University of Veterinary Medicine Hannover, Foundation	Lin, AHM (corresponding author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, Smith Hall, W Lafayette, IN 47907 USA.	hamakerb@purdue.edu			internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.); USDA, Agricultural Research Service, under Cooperative Agreement [58-6250-1-003]	internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.); USDA, Agricultural Research Service, under Cooperative Agreement(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by internal sources from the Whistler Center for Carbohydrate Research at Purdue University (West Lafayette, IN, U.S.A.) and, for one collaborator (BLN), USDA, Agricultural Research Service, under Cooperative Agreement no. 58-6250-1-003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg A, 1998, J CEREAL SCI, V28, P71, DOI 10.1006/jcrs.1997.0173; Akerberg AKE, 1998, J NUTR, V128, P651; Ao Z, 2007, FEBS LETT, V581, P2381, DOI 10.1016/j.febslet.2007.04.035; Chung HJ, 2006, J CEREAL SCI, V43, P353, DOI 10.1016/j.jcs.2005.12.001; DAHLQVIST A, 1969, BIOCHEM J, V111, P139, DOI 10.1042/bj1110139; DAHLQVIST A, 1963, J CLIN INVEST, V42, P556, DOI 10.1172/JCI104744; DAHLQVIST A, 1962, J CLIN INVEST, V41, P463, DOI 10.1172/JCI104499; EERLINGEN RC, 1993, CEREAL CHEM, V70, P339; EERLINGEN RC, 1993, CEREAL CHEM, V70, P345; ENGLYST H, 1982, ANALYST, V107, P307, DOI 10.1039/an9820700307; Englyst HN, 1996, FOOD CHEM, V57, P15, DOI 10.1016/0308-8146(96)00056-8; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Faraj A, 2004, FOOD RES INT, V37, P517, DOI 10.1016/j.foodres.2003.09.015; French D., 1984, STARCH CHEM TECHNOLO, V2, P183, DOI DOI 10.1016/B978-0-12-746270-7.50013-6; Goni I, 1996, FOOD CHEM, V56, P445, DOI 10.1016/0308-8146(95)00222-7; Gunther S, 1996, ARCH BIOCHEM BIOPHYS, V327, P295, DOI 10.1006/abbi.1996.0125; Gunther S, 1998, ARCH BIOCHEM BIOPHYS, V354, P111, DOI 10.1006/abbi.1998.0684; HENNING SJ, 1985, ANNU REV PHYSIOL, V47, P231; HENNING SJ, 1979, ENVIRON HEALTH PERSP, V33, P9, DOI 10.2307/3429067; HEYMANN H, 1995, BIOL CHEM H-S, V376, P249; HEYMANN H, 1994, BIOL CHEM H-S, V375, P451, DOI 10.1515/bchm3.1994.375.7.451; HIROMI K, 1973, BIOCHIM BIOPHYS ACTA, V302, P362, DOI 10.1016/0005-2744(73)90164-2; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; LARNER J, 1955, J BIOL CHEM, V215, P723; Layer P, 1999, J CLIN GASTROENTEROL, V28, P3, DOI 10.1097/00004836-199901000-00002; LEBENTHAL E, 1980, PEDIATRICS, V66, P556; Lin AHM, 2010, FASEB J, V24; MCCLEAN P, 1993, ARCH DIS CHILD-FETAL, V68, P62, DOI 10.1136/adc.68.1_Spec_No.62; McCleary BV, 2002, J AOAC INT, V85, P1103; MCMICHAEL HB, 1971, P NUTR SOC, V30, P248, DOI 10.1079/PNS19710048; Megazyme, 2008, RES STARCH ASS PROC; MUIR JG, 1992, AM J CLIN NUTR, V56, P123, DOI 10.1093/ajcn/56.1.123; Nichols BL, 1998, J BIOL CHEM, V273, P3076, DOI 10.1074/jbc.273.5.3076; Nichols BL, 2003, P NATL ACAD SCI USA, V100, P1432, DOI 10.1073/pnas.0237170100; Nichols BL, 2009, J NUTR, V139, P684, DOI 10.3945/jn.108.098434; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; Segrest J P, 1971, Biochem Biophys Res Commun, V44, P390; Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x; SAURACALIXTO F, 1993, J FOOD SCI, V58, P642, DOI 10.1111/j.1365-2621.1993.tb04346.x; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SEMENZA G, 1991, INDIAN J BIOCHEM BIO, V28, P331; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; SORENSEN SH, 1982, EUR J BIOCHEM, V126, P559, DOI 10.1111/j.1432-1033.1982.tb06817.x; TRINDER P., 1969, Journal of Clinical Pathology, V22, P158, DOI 10.1136/jcp.22.2.158; UGOLEV AM, 1965, PHYSIOL REV, V45, P555, DOI 10.1152/physrev.1965.45.3.555; UGOLEV AM, 1973, BIOCHIM BIOPHYS ACTA, V300, P105, DOI 10.1016/0304-4157(73)90001-4; VANBEERS EH, 1995, CRIT REV BIOCHEM MOL, V30, P197, DOI 10.3109/10409239509085143	49	38	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35473	10.1371/journal.pone.0035473	http://dx.doi.org/10.1371/journal.pone.0035473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563462	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700011
J	Lang, MF; Yang, S; Zhao, CN; Sun, GQ; Murai, K; Wu, XW; Wang, JH; Gao, HL; Brown, CE; Liu, XX; Zhou, JH; Peng, L; Rossi, JJ; Shi, YH				Lang, Ming-Fei; Yang, Su; Zhao, Chunnian; Sun, Guoqiang; Murai, Kiyohito; Wu, Xiwei; Wang, Jinhui; Gao, Hanlin; Brown, Christine E.; Liu, Xiaoxuan; Zhou, Jiehua; Peng, Ling; Rossi, John J.; Shi, Yanhong			Genome-Wide Profiling Identified a Set of miRNAs that Are Differentially Expressed in Glioblastoma Stem Cells and Normal Neural Stem Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR TLX; HEPATOCELLULAR-CARCINOMA; REGULATORY LOOP; MICRORNAS; PROLIFERATION; CANCER; GLIOMA; GROWTH; NEUROGENESIS; PATTERNS	A major challenge in cancer research field is to define molecular features that distinguish cancer stem cells from normal stem cells. In this study, we compared microRNA (miRNA) expression profiles in human glioblastoma stem cells and normal neural stem cells using combined microarray and deep sequencing analyses. These studies allowed us to identify a set of 10 miRNAs that are considerably up-regulated or down-regulated in glioblastoma stem cells. Among them, 5 miRNAs were further confirmed to have altered expression in three independent lines of glioblastoma stem cells by real-time RT-PCR analysis. Moreover, two of the miRNAs with increased expression in glioblastoma stem cells also exhibited elevated expression in glioblastoma patient tissues examined, while two miRNAs with decreased expression in glioblastoma stem cells displayed reduced expression in tumor tissues. Furthermore, we identified two oncogenes, NRAS and PIM3, as downstream targets of miR-124, one of the down-regulated miRNAs; and a tumor suppressor, CSMD1, as a downstream target of miR-10a and miR-10b, two of the up-regulated miRNAs. In summary, this study led to the identification of a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. Characterizing the role of these miRNAs in glioblastoma stem cells may lead to the development of miRNA-based therapies that specifically target tumor stem cells, but spare normal stem cells.	[Lang, Ming-Fei; Yang, Su; Zhao, Chunnian; Sun, Guoqiang; Murai, Kiyohito; Shi, Yanhong] Beckman Res Inst City Hope, Dept Neurosci, Ctr Gene Express & Drug Discovery, Ctr Canc, Duarte, CA 91010 USA; [Yang, Su; Rossi, John J.; Shi, Yanhong] Beckman Res Inst City Hope, Irell & Manella Grad Sch Biol Sci, Duarte, CA USA; [Wu, Xiwei] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA USA; [Wang, Jinhui; Gao, Hanlin] Beckman Res Inst City Hope, DNA Sequencing Solexa Core, Duarte, CA USA; [Brown, Christine E.] Beckman Res Inst City Hope, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA; [Liu, Xiaoxuan; Peng, Ling] Aix Marseille Univ, CNRS UMR 7325, Ctr Interdisciplinaire Nanosci Marseille, Marseille, France; [Zhou, Jiehua; Rossi, John J.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; City of Hope; Beckman Research Institute of City of Hope	Lang, MF (corresponding author), Beckman Res Inst City Hope, Dept Neurosci, Ctr Gene Express & Drug Discovery, Ctr Canc, Duarte, CA 91010 USA.	yshi@coh.org	PENG, Ling/A-6366-2019; zhou, Jiehua/B-4045-2010	PENG, Ling/0000-0003-3990-5248; Brown, Christine/0000-0003-4915-8207; Shi, Yanhong/0000-0002-3938-5839	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) [R01 NS059546, RC1 NS068370]; California Institute for Regenerative medicine [TR2-01832]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068370, R01NS059546] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); California Institute for Regenerative medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH NINDS) R01 NS059546, RC1 NS068370 (http://www.ninds.nih.gov/) and California Institute for Regenerative medicine TR2-01832 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asadi-Moghaddam K, 2010, EXPERT REV ANTICANC, V10, P1753, DOI [10.1586/era.10.168, 10.1586/ERA.10.168]; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Brown CE, 2009, CANCER RES, V69, P8886, DOI 10.1158/0008-5472.CAN-09-2687; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Clayton PE, 2011, NAT REV ENDOCRINOL, V7, P11, DOI 10.1038/nrendo.2010.171; Conti A, 2009, J NEURO-ONCOL, V93, P325, DOI 10.1007/s11060-009-9797-4; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fowler A, 2011, EUR J CANCER, V47, P953, DOI 10.1016/j.ejca.2010.11.026; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Rao SAM, 2010, MODERN PATHOL, V23, P1404, DOI 10.1038/modpathol.2010.135; Roth P, 2011, J NEUROCHEM, V118, P449, DOI 10.1111/j.1471-4159.2011.07307.x; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Wu Y, 2010, ONCOGENE, V29, P2228, DOI 10.1038/onc.2009.504; Xia H, 2012, J BIOL CHEM; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c; Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207	46	84	90	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36248	10.1371/journal.pone.0036248	http://dx.doi.org/10.1371/journal.pone.0036248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558405	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340200056
J	Leon, A; Elgueda, D; Silva, MA; Hamame, CM; Delano, PH				Leon, Alex; Elgueda, Diego; Silva, Maria A.; Hamame, Carlos M.; Delano, Paul H.			Auditory Cortex Basal Activity Modulates Cochlear Responses in Chinchillas	PLOS ONE			English	Article							INFERIOR COLLICULUS; CORTICOFUGAL MODULATION; ELECTRICAL-STIMULATION; CONTRALATERAL SUPPRESSION; ACETYLCHOLINE-RECEPTOR; OLIVOCOCHLEAR NEURONS; NERVE ACTIVITY; GUINEA-PIG; INACTIVATION; PROJECTIONS	Background: The auditory efferent system has unique neuroanatomical pathways that connect the cerebral cortex with sensory receptor cells. Pyramidal neurons located in layers V and VI of the primary auditory cortex constitute descending projections to the thalamus, inferior colliculus, and even directly to the superior olivary complex and to the cochlear nucleus. Efferent pathways are connected to the cochlear receptor by the olivocochlear system, which innervates outer hair cells and auditory nerve fibers. The functional role of the cortico-olivocochlear efferent system remains debated. We hypothesized that auditory cortex basal activity modulates cochlear and auditory-nerve afferent responses through the efferent system. Methodology/Principal Findings: Cochlear microphonics (CM), auditory-nerve compound action potentials (CAP) and auditory cortex evoked potentials (ACEP) were recorded in twenty anesthetized chinchillas, before, during and after auditory cortex deactivation by two methods: lidocaine microinjections or cortical cooling with cryoloops. Auditory cortex deactivation induced a transient reduction in ACEP amplitudes in fifteen animals (deactivation experiments) and a permanent reduction in five chinchillas (lesion experiments). We found significant changes in the amplitude of CM in both types of experiments, being the most common effect a CM decrease found in fifteen animals. Concomitantly to CM amplitude changes, we found CAP increases in seven chinchillas and CAP reductions in thirteen animals. Although ACEP amplitudes were completely recovered after ninety minutes in deactivation experiments, only partial recovery was observed in the magnitudes of cochlear responses. Conclusions/Significance: These results show that blocking ongoing auditory cortex activity modulates CM and CAP responses, demonstrating that cortico-olivocochlear circuits regulate auditory nerve and cochlear responses through a basal efferent tone. The diversity of the obtained effects suggests that there are at least two functional pathways from the auditory cortex to the cochlea.	[Leon, Alex; Elgueda, Diego; Silva, Maria A.; Hamame, Carlos M.; Delano, Paul H.] Univ Chile, Fac Med, Lab Neurobiol Audic, Programa Fisiol & Biofis,ICBM, Santiago 7, Chile; [Elgueda, Diego] Univ Maryland, Inst Syst Res & Neurosci, College Pk, MD 20742 USA; [Elgueda, Diego] Univ Maryland, Cognit Sci Program, College Pk, MD 20742 USA; [Hamame, Carlos M.] CNRS, INSERM, Lyon Neurosci Res Ctr, Brain Dynam & Cognit Team,U1028,UMR5292, Lyon, France; [Delano, Paul H.] Univ Chile, Serv Otorrinolaringol, Hosp Clin, Santiago, Chile	Universidad de Chile; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universidad de Chile	Leon, A (corresponding author), Univ Chile, Fac Med, Lab Neurobiol Audic, Programa Fisiol & Biofis,ICBM, Santiago 7, Chile.	pdelano@med.uchile.cl	Delano, Paul/I-1030-2013; Elgueda, Diego/P-7239-2019	Delano, Paul/0000-0003-2588-4757; Elgueda, Diego/0000-0003-3542-9483	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11080033]; Sociedad Chilena de Otorrinolaringologia (SOCHIORL) [2008]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Sociedad Chilena de Otorrinolaringologia (SOCHIORL)	Supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 11080033 and Sociedad Chilena de Otorrinolaringologia (SOCHIORL) 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes FM, 2011, J NEUROSCI, V31, P17306, DOI 10.1523/JNEUROSCI.1915-11.2011; Bajo VM, 2005, J COMP NEUROL, V486, P101, DOI 10.1002/cne.20542; Coomber B, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00053; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; daCosta DL, 1997, EXP BRAIN RES, V116, P259, DOI 10.1007/PL00005754; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; De Boer J, 2007, HEARING RES, V233, P117, DOI 10.1016/j.heares.2007.08.002; De Venecia RK, 2005, J COMP NEUROL, V487, P345, DOI 10.1002/cne.20550; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Doucet JR, 2002, BRAIN RES, V925, P28, DOI 10.1016/S0006-8993(01)03248-6; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Elgueda D, 2011, JARO-J ASSOC RES OTO, V12, P317, DOI 10.1007/s10162-011-0260-9; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; EYBALIN M, 1993, PHYSIOL REV, V73, P309, DOI 10.1152/physrev.1993.73.2.309; FELICIANO M, 1995, J NEUROCHEM, V65, P1348; Fenoy AJ, 2006, BRAIN RES, V1118, P75, DOI 10.1016/j.brainres.2006.08.013; FEX J, 1959, Acta Otolaryngol, V50, P540, DOI 10.3109/00016485909129230; FROEHLICH P, 1990, BRAIN RES, V508, P286, DOI 10.1016/0006-8993(90)90408-4; GALAMBOS R, 1956, J NEUROPHYSIOL, V19, P424, DOI 10.1152/jn.1956.19.5.424; GIFFORD ML, 1987, HEARING RES, V29, P179, DOI 10.1016/0378-5955(87)90166-3; Groff JA, 2003, J NEUROPHYSIOL, V90, P3178, DOI 10.1152/jn.00537.2003; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Harel N, 1997, HEARING RES, V110, P25, DOI 10.1016/S0378-5955(97)00061-0; Harel N, 2000, NEUROIMAGE, V11, P302, DOI 10.1006/nimg.1999.0537; Harrison RV, 1996, HEARING RES, V100, P157, DOI 10.1016/0378-5955(96)00120-7; Hatzopoulos S, 2002, HEARING RES, V170, P12, DOI 10.1016/S0378-5955(02)00448-3; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; HUNT CC, 1951, J PHYSIOL-LONDON, V113, P283, DOI 10.1113/jphysiol.1951.sp004572; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; KUFFLER SW, 1951, J NEUROPHYSIOL, V14, P29, DOI 10.1152/jn.1951.14.1.29; Le Prell CG, 2005, JARO-J ASSOC RES OTO, V6, P48, DOI 10.1007/s10162-004-5009-2; Le Prell CG, 2003, JARO-J ASSOC RES OTO, V4, P276, DOI 10.1007/s10162-002-3018-6; Liu XP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013021; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; Lomber SG, 2010, NAT NEUROSCI, V13, P1421, DOI 10.1038/nn.2653; Luebke AE, 2002, J NEUROSCI, V22, P4241, DOI 10.1523/JNEUROSCI.22-10-04241.2002; Luo F, 2008, J NEUROSCI, V28, P11615, DOI 10.1523/JNEUROSCI.3972-08.2008; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Malmierca MS, 2011, AUDITORY CORTEX, P189, DOI 10.1007/978-1-4419-0074-6_9; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; Mulders WHAM, 2005, EXP BRAIN RES, V160, P235, DOI 10.1007/s00221-004-2003-1; Mulders WHAM, 2002, HEARING RES, V167, P206, DOI 10.1016/S0378-5955(02)00395-7; Nakamoto KT, 2010, J NEUROPHYSIOL, V103, P2050, DOI 10.1152/jn.00451.2009; Perrot X, 2006, CEREB CORTEX, V16, P941, DOI 10.1093/cercor/bhj035; Riga M, 2007, OTOL NEUROTOL, V28, P185, DOI 10.1097/MAO.0b013e31802e2a14; Robles L, 2008, EFFERENT SYSTEM SENS, P413; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; Ryugo D.K., 2010, INTRO EFFERENT SYSTE, P1; Schofield B.R., 2010, CENTRAL DESCENDING A, P261; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; Tehovnik EJ, 1997, J NEUROSCI METH, V74, P17, DOI 10.1016/S0165-0270(97)02229-2; THOMPSON AM, 1993, J COMP NEUROL, V335, P402, DOI 10.1002/cne.903350309; VELLUTI R, 1989, HEARING RES, V39, P203, DOI 10.1016/0378-5955(89)90091-9; WARR WB, 1979, BRAIN RES, V173, P152, DOI 10.1016/0006-8993(79)91104-1; Winer JA, 2005, HEARING RES, V207, P1, DOI 10.1016/j.heares.2005.06.007; Xiao ZJ, 2005, P NATL ACAD SCI USA, V102, P19162, DOI 10.1073/pnas.0509761102; Xiao ZJ, 2002, P NATL ACAD SCI USA, V99, P15743, DOI 10.1073/pnas.242606699; Xiao ZJ, 2002, NAT NEUROSCI, V5, P57, DOI 10.1038/nn786; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang W, 2006, BRAIN RES, V1081, P138, DOI 10.1016/j.brainres.2006.01.049; Zheng XY, 2000, HEARING RES, V143, P14, DOI 10.1016/S0378-5955(99)00217-8	63	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36203	10.1371/journal.pone.0036203	http://dx.doi.org/10.1371/journal.pone.0036203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558383	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340200049
J	Suzuki, S; Fukasawa, H; Misaki, T; Togawa, A; Ohashi, N; Kitagawa, K; Kotake, Y; Liu, N; Niida, H; Nakayama, K; Nakayama, KI; Yamamoto, T; Kitagawa, M				Suzuki, Sayuri; Fukasawa, Hirotaka; Misaki, Taro; Togawa, Akashi; Ohashi, Naro; Kitagawa, Kyoko; Kotake, Yojiro; Liu, Ning; Niida, Hiroyuki; Nakayama, Keiko; Nakayama, Keiichi I.; Yamamoto, Tatsuo; Kitagawa, Masatoshi			The Amelioration of Renal Damage in Skp2-Deficient Mice Canceled by p27 (Kip1) Deficiency in Skp2(-/-) p27(-/-) Mice	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITOR; MESENCHYMAL TRANSITION; UBIQUITIN LIGASE; C-MYC; DEGRADATION; P27(KIP1); SKP2; PROTEIN; SCFSKP2; PROLIFERATION	SCF-Skp2 E3 ubiquitin ligase (Skp2 hereafter) targets several cell cycle regulatory proteins for degradation via the ubiquitin-dependent pathway. However, the target-specific physiological functions of Skp2 have not been fully elucidated in kidney diseases. We previously reported an increase in Skp2 in progressive nephropathy and amelioration of unilateral ureteral obstruction (UUO) renal injury associated with renal accumulation of p27 in Skp2(-/-) mice. However, it remains unclear whether the amelioration of renal injury in Skp2(-/-) mice is solely caused by p27 accumulation, since Skp2 targets several other proteins. Using Skp2(-/-) p27(-/-) mice, we investigated whether Skp2 specifically targets p27 in the progressive nephropathy mediated by UUO. In contrast to the marked suppression of UUO renal injury in Skp2(-/-) mice, progression of tubular dilatation associated with tubular epithelial cell proliferation and tubulointerstitial fibrosis with increased expression of collagen and alpha-smooth muscle actin were observed in the obstructed kidneys in Skp2(-/-) p27(-/-) mice. No significant increases in other Skp2 target proteins including p57, p130, TOB1, cyclin A and cyclin D1 were noted in the UUO kidney in Skp2(-/-) mice, while p21, c-Myc, b-Myb and cyclin E were slightly increased. Contrary to the ameliorated UUO renal injure by Skp2-deficiency, the amelioration was canceled by the additional p27-deficiency in Skp2(-/-) p27(-/-) mice. These findings suggest a pathogenic role of the reduction in p27 targeted by Skp2 in the progression of nephropathy in UUO mice.	[Suzuki, Sayuri; Kitagawa, Kyoko; Kotake, Yojiro; Liu, Ning; Niida, Hiroyuki; Kitagawa, Masatoshi] Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka 4313192, Japan; [Fukasawa, Hirotaka; Misaki, Taro; Togawa, Akashi; Ohashi, Naro; Yamamoto, Tatsuo] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan; [Nakayama, Keiko] Tohoku Univ, Div Dev Genet, Ctr Translat & Adv Anim Res Human Dis, Grad Sch Med, Sendai, Miyagi 980, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan; [Yamamoto, Tatsuo] Numazu City Hosp, Dept Med 2, Numazu, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Tohoku University; Kyushu University	Suzuki, S (corresponding author), Hamamatsu Univ Sch Med, Dept Mol Biol, Hamamatsu, Shizuoka 4313192, Japan.	kitamasa@hama-med.ac.jp	Misaki, Taro/HHY-7358-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [22790310, 19057005, 21590062]; Grants-in-Aid for Scientific Research [24659130, 24700975] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant number: Grant-in-Aid for Young Scientists (B) 22790310 (S. Suzuki) and Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan 19057005 (M. Kitagawa) and 21590062 (K. Kitagawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gerth JH, 2002, KIDNEY INT, V61, P68, DOI 10.1046/j.1523-1755.2002.00111.x; GOBE GC, 1987, LAB INVEST, V56, P273; HAY ED, 1995, AM J KIDNEY DIS, V26, P678, DOI 10.1016/0272-6386(95)90610-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiramatsu Y, 2006, CANCER RES, V66, P8477, DOI 10.1158/0008-5472.CAN-06-1603; Hughes J, 1999, AM J PHYSIOL, V277, P948; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KAMB A, 1995, TRENDS GENET, V11, P136, DOI 10.1016/S0168-9525(00)89027-7; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morrissey JJ, 1996, KIDNEY INT, V50, pS84; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Ophascharoensuk V, 1998, NAT MED, V4, P575, DOI 10.1038/nm0598-575; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Shankland SJ, 1997, KIDNEY INT, V51, P1088, DOI 10.1038/ki.1997.151; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sicari BM, 2012, ENDOCRINOLOGY, V153, P861, DOI 10.1210/en.2011-1590; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Suzuki S, 2007, AM J PATHOL, V171, P473, DOI 10.2353/ajpath.2007.070279; Suzuki S, 2011, GENES CELLS, V16, P1110, DOI 10.1111/j.1365-2443.2011.01553.x; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; WALTON G, 1992, J UROLOGY, V148, P510, DOI 10.1016/S0022-5347(17)36641-7; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	37	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36249	10.1371/journal.pone.0036249	http://dx.doi.org/10.1371/journal.pone.0036249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558406	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000170
J	Yang, XF; Yang, Y; Lian, YT; Wang, ZH; Li, XW; Cheng, LX; Liu, JP; Wang, YF; Gao, X; Liao, YH; Wang, M; Zeng, QT; Liu, K				Yang, Xiao-Fang; Yang, Yong; Lian, Yi-Tian; Wang, Zhao-Hui; Li, Xiao-Wei; Cheng, Long-Xian; Liu, Jin-Ping; Wang, Yan-Fu; Gao, Xiang; Liao, Yu-Hua; Wang, Min; Zeng, Qiu-Tang; Liu, Kun			The Antibody Targeting the E314 Peptide of Human Kv1.3 Pore Region Serves as a Novel, Potent and Specific Channel Blocker	PLOS ONE			English	Article							GATED POTASSIUM CHANNEL; MEMORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; QT-INTERVAL PROLONGATION; MULTIPLE-SCLEROSIS; K+ CHANNELS; ION CHANNELS; THERAPEUTIC TARGET; TOXIN; EXPRESSION	Selective blockade of Kv1.3 channels in effector memory T (T-EM) cells was validated to ameliorate autoimmune or autoimmune-associated diseases. We generated the antibody directed against one peptide of human Kv1.3 (hKv1.3) extracellular loop as a novel and possible Kv1.3 blocker. One peptide of hKv1.3 extracellular loop E3 containing 14 amino acids (E314) was chosen as an antigenic determinant to generate the E314 antibody. The E314 antibody specifically recognized 63.8KD protein stably expressed in hKv1.3-HEK 293 cell lines, whereas it did not recognize or cross-react to human Kv1.1(hKv1.1), Kv1.2(hKv1.2), Kv1.4(hKv1.4), Kv1.5(hKv1.5), KCa3.1(hKCa3.1), HERG, hKCNQ1/hKCNE1, Nav1.5 and Cav1.2 proteins stably expressed in HEK 293 cell lines or in human atrial or ventricular myocytes by Western blotting analysis and immunostaining detection. By the technique of whole-cell patch clamp, the E314 antibody was shown to have a directly inhibitory effect on hKv1.3 currents expressed in HEK 293 or Jurkat T cells and the inhibition showed a concentration-dependence. However, it exerted no significant difference on hKv1.1, hKv1.2, hKv1.4, hKv1.5, hKCa3.1, HERG, hKCNQ1/hKCNE1, L-type Ca2+ or voltage-gated Na+ currents. The present study demonstrates that the antibody targeting the E314 peptide of hKv1.3 pore region could be a novel, potent and specific hKv1.3 blocker without affecting a variety of closely related K(v)1 channels, KCa3.1 channels and functional cardiac ion channels underlying central nervous systerm (CNS) disorders or drug-acquired arrhythmias, which is required as a safe clinic-promising channel blocker.	[Yang, Xiao-Fang; Yang, Yong; Lian, Yi-Tian; Cheng, Long-Xian; Liao, Yu-Hua; Wang, Min; Zeng, Qiu-Tang; Liu, Kun] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Wuhan 430074, Peoples R China; [Wang, Zhao-Hui] Huazhong Univ Sci & Technol, Dept Geriatr, Union Hosp, Wuhan 430074, Peoples R China; [Li, Xiao-Wei] Tianjin Chest Hosp, Dept Cardiol, Tianjin, Peoples R China; [Liu, Jin-Ping] Huazhong Univ Sci & Technol, Dept Cardiovasc Surg, Union Hosp, Wuhan 430074, Peoples R China; [Gao, Xiang] Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, XF (corresponding author), Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Wuhan 430074, Peoples R China.	zengqiutang@163.com; liukun@mail.hust.edu.cn			National Natural Science Foundation of China [30700747/C08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No, 30700747/C08) http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, J IMMUNOL, V166, P936, DOI 10.4049/jimmunol.166.2.936; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BELMONTE MA, 1986, J RHEUMATOL, V13, P477; Bodendiek SB, 2009, EUR J MED CHEM, V44, P1838, DOI 10.1016/j.ejmech.2008.10.033; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Cahalan MD, 1997, CURR OPIN BIOTECH, V8, P749, DOI 10.1016/S0958-1669(97)80130-9; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Chandy KG, 2001, TOXICON, V39, P1269, DOI 10.1016/S0041-0101(01)00120-9; Chiang AY, 2010, J PHARMACOL TOXICOL, V62, P143, DOI 10.1016/j.vascn.2010.05.013; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Darpo B, 2006, J CLIN PHARMACOL, V46, P498, DOI 10.1177/0091270006286436; Decher N, 2004, J BIOL CHEM, V279, P394, DOI 10.1074/jbc.M307411200; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; Donner BC, 2011, BASIC RES CARDIOL, V106, P75, DOI 10.1007/s00395-010-0128-x; Dorner Thomas, 2002, Autoimmun Rev, V1, P119, DOI 10.1016/S1568-9972(02)00029-0; Drici MD, 2000, THERAPIE, V55, P185; Ehling Petra, 2010, Exp Transl Stroke Med, V2, P14, DOI 10.1186/2040-7378-2-14; Ellis CN, 2001, NEW ENGL J MED, V345, P248, DOI 10.1056/NEJM200107263450403; Fasth AER, 2004, SCAND J IMMUNOL, V60, P199, DOI 10.1111/j.0300-9475.2004.01464.x; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; GARDINER PVG, 1990, BRIT MED J, V300, P125, DOI 10.1136/bmj.300.6717.125; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haegele KF, 2007, J NEUROIMMUNOL, V183, P168, DOI 10.1016/j.jneuroim.2006.09.008; Hanson DC, 1999, BRIT J PHARMACOL, V126, P1707, DOI 10.1038/sj.bjp.0702480; Harvey AJ, 2006, J MED CHEM, V49, P1433, DOI 10.1021/jm050839v; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Roman AJ, 2012, REV ESP CARDIOL, V65, P292, DOI [10.1016/j.recesp.2011.05.014, 10.1016/j.rec.2011.05.018]; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kivisakk P, 2004, ANN NEUROL, V55, P627, DOI 10.1002/ana.20049; Krakauer M, 2006, J NEUROIMMUNOL, V181, P157, DOI 10.1016/j.jneuroim.2006.09.006; Lanigan MD, 2002, BIOCHEMISTRY-US, V41, P11963, DOI 10.1021/bi026400b; LEWIS RS, 1995, ANNU REV IMMUNOL, V13, P623, DOI 10.1146/annurev.iy.13.040195.003203; Li EC, 2010, PHARMACOTHERAPY, V30, P684, DOI 10.1592/phco.30.7.684; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI12516; Matsushita Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1079, DOI 10.1152/ajpcell.00668.2008; Otten MH, 2011, J RHEUMATOL, V38, P2258, DOI 10.3899/jrheum.110145; Panyi G, 2006, CURR PHARM DESIGN, V12, P2199, DOI 10.2174/138161206777585120; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Peter M, 2001, J MEMBRANE BIOL, V179, P13, DOI 10.1007/s002320010033; Poulopoulou C, 2008, ARTHRITIS RHEUM, V58, P1445, DOI 10.1002/art.23446; Rangaraju S, 2009, EXPERT OPIN THER TAR, V13, P909, DOI 10.1517/14728220903018957; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Schmitz A, 2005, MOL PHARMACOL, V68, P1254, DOI 10.1124/mol.105.015669; Schonland SO, 2003, P NATL ACAD SCI USA, V100, P13471, DOI 10.1073/pnas.2233561100; Shah RR, 2005, DRUG SAFETY, V28, P115, DOI 10.2165/00002018-200528020-00003; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Smolen JS, 2011, ARTHRITIS RES THER, V13, DOI [10.1186/ar3094, 10.1186/1478-6354-13-S1-S2]; Srairi-Abid N, 2008, FEBS J, V275, P4641, DOI 10.1111/j.1742-4658.2008.06607.x; Toldi G, 2010, IMMUNOL LETT, V133, P35, DOI 10.1016/j.imlet.2010.06.009; Uyttenhove C, 2007, ANN NY ACAD SCI, V1110, P330, DOI 10.1196/annals.1423.035; Varga Z, 2010, IMMUNOL LETT, V130, P19, DOI 10.1016/j.imlet.2009.12.015; Vasheghani-Farahani A, 2011, J NEUROL SCI, V309, P75, DOI 10.1016/j.jns.2011.07.018; Vennekamp J, 2004, MOL PHARMACOL, V65, P1364, DOI 10.1124/mol.65.6.1364; Viglietta V, 2002, J CLIN INVEST, V109, P895, DOI 10.1172/JCI14114; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Yamashita K, 2004, BLOOD, V103, P3986, DOI 10.1182/blood-2003-09-3286; Zhou BY, 1998, J GEN PHYSIOL, V111, P555, DOI 10.1085/jgp.111.4.555	70	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36379	10.1371/journal.pone.0036379	http://dx.doi.org/10.1371/journal.pone.0036379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558454	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000201
J	Belisle, JM; Levin, LA; Costantino, S				Belisle, Jonathan M.; Levin, Leonard A.; Costantino, Santiago			High-Content Neurite Development Study Using Optically Patterned Substrates	PLOS ONE			English	Article							GROWTH CONE GUIDANCE; MOLECULAR-MECHANISMS; CORTICAL-NEURONS; AXON GUIDANCE; GRADIENTS; LAMININ; OUTGROWTH; BEHAVIOR; CELLS	The study of neurite guidance in vitro relies on the ability to reproduce the distribution of attractive and repulsive guidance molecules normally expressed in vivo. The identification of subtle variations in the neurite response to changes in the spatial distribution of extracellular molecules can be achieved by monitoring the behavior of cells on protein gradients. To do this, automated high-content screening assays are needed to quantify the morphological changes resulting from growth on gradients of guidance molecules. Here, we present the use of laser-assisted protein adsorption by photobleaching (LAPAP) to allow the fabrication of large-scale substrate-bound laminin-1 gradients to study neurite extension. We produced thousands of gradients of different slopes and analyzed the variations in neurite attraction of neuron-like cells (RGC-5). An image analysis algorithm processed bright field microscopy images, detecting each cell and quantifying the soma centroid and the initiation, terminal and turning angles of the longest neurite.	[Belisle, Jonathan M.; Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada; [Belisle, Jonathan M.; Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada; [Levin, Leonard A.; Costantino, Santiago] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Belisle, JM (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp, Montreal, PQ, Canada.	santiago.costantino@umontreal.ca	Costantino, Santiago/ABD-5472-2020	Costantino, Santiago/0000-0002-2454-2635	National Science and Engineering Research Council (NSERC); Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante; Canadian Institutes of Health Research and Canada Research Chairs	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante; Canadian Institutes of Health Research and Canada Research Chairs(Canadian Institutes of Health Research (CIHR))	Support is acknowledged for SC from the National Science and Engineering Research Council (NSERC), Fonds de Recherche du Quebec Nature et Technologie and Fonds de Recherche du Quebec Sante. For LAL from Canadian Institutes of Health Research and Canada Research Chairs. For JMB from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075; Aletti G, 2008, IET SYST BIOL, V2, P150, DOI 10.1049/iet-syb:20070059; Belisle JM, 2009, LAB CHIP, V9, P3580, DOI 10.1039/b911967a; Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d; Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4; COHEN J, 1991, J CELL SCI, P1; Costantino S, 2008, J NEUROSCI METH, V171, P165, DOI 10.1016/j.jneumeth.2008.02.009; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Goodhill GJ, 1998, NEURAL COMPUT, V10, P521, DOI 10.1162/089976698300017638; GUNDERSEN RW, 1979, SCIENCE, V206, P1079, DOI 10.1126/science.493992; Gupton SL, 2010, DEV CELL, V18, P725, DOI [10.1016/j.devcel.2010.02.017, 10.1016/j.devce1.2010.02.017]; Halfter W, 1996, J NEUROSCI, V16, P4389; Hu M, 2007, BRAIN RES, V1151, P227, DOI 10.1016/j.brainres.2007.03.051; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Keenan TM, 2006, J NEUROSCI METH, V151, P232, DOI 10.1016/j.jneumeth.2005.07.010; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Lang S, 2008, ANAL BIOANAL CHEM, V390, P809, DOI 10.1007/s00216-007-1363-3; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; MCKENNA MP, 1988, DEV BIOL, V130, P232, DOI 10.1016/0012-1606(88)90429-0; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Paulus JD, 2006, DEV DYNAM, V235, P213, DOI 10.1002/dvdy.20604; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Randlett O, 2011, NEURON, V70, P266, DOI 10.1016/j.neuron.2011.03.013; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Wang CJ, 2008, LAB CHIP, V8, P227, DOI 10.1039/b713945d; Wang DD, 2010, J BIOMOL SCREEN, V15, P1165, DOI 10.1177/1087057110382894; Xiang Y, 2002, NAT NEUROSCI, V5, P843, DOI 10.1038/nn899; Yao L, 2009, J BIOMED MATER RES, V92, P484; Zheng JQ, 1996, J NEUROSCI, V16, P1140; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	40	12	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35911	10.1371/journal.pone.0035911	http://dx.doi.org/10.1371/journal.pone.0035911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563416	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100042
J	Riccombeni, A; Vidanes, G; Proux-Wera, E; Wolfe, KH; Butler, G				Riccombeni, Alessandro; Vidanes, Genevieve; Proux-Wera, Estelle; Wolfe, Kenneth H.; Butler, Geraldine			Sequence and Analysis of the Genome of the Pathogenic Yeast Candida orthopsilosis	PLOS ONE			English	Article							HORIZONTAL-GENE-TRANSFER; BLOOD-STREAM INFECTIONS; POPULATION-BASED SURVEILLANCE; ANTIFUNGAL SUSCEPTIBILITY; SACCHAROMYCES-CEREVISIAE; DIFFERENTIAL REGULATION; PHYLOGENETIC ANALYSIS; BIOFILM PRODUCTION; HYPOXIC RESPONSE; AZOLE RESISTANCE	Candida orthopsilosis is closely related to the fungal pathogen Candida parapsilosis. However, whereas C. parapsilosis is a major cause of disease in immunosuppressed individuals and in premature neonates, C. orthopsilosis is more rarely associated with infection. We sequenced the C. orthopsilosis genome to facilitate the identification of genes associated with virulence. Here, we report the de novo assembly and annotation of the genome of a Type 2 isolate of C. orthopsilosis. The sequence was obtained by combining data from next generation sequencing (454 Life Sciences and Illumina) with paired-end Sanger reads from a fosmid library. The final assembly contains 12.6 Mb on 8 chromosomes. The genome was annotated using an automated pipeline based on comparative analysis of genomes of Candida species, together with manual identification of introns. We identified 5700 protein-coding genes in C. orthopsilosis, of which 5570 have an ortholog in C. parapsilosis. The time of divergence between C. orthopsilosis and C. parapsilosis is estimated to be twice as great as that between Candida albicans and Candida dubliniensis. There has been an expansion of the Hyr/Iff family of cell wall genes and the JEN family of monocarboxylic transporters in C. parapsilosis relative to C. orthopsilosis. We identified one gene from a Maltose/Galactoside O-acetyltransferase family that originated by horizontal gene transfer from a bacterium to the common ancestor of C. orthopsilosis and C. parapsilosis. We report that TFB3, a component of the general transcription factor TFIIH, undergoes alternative splicing by intron retention in multiple Candida species. We also show that an intein in the vacuolar ATPase gene VMA1 is present in C. orthopsilosis but not C. parapsilosis, and has a patchy distribution in Candida species. Our results suggest that the difference in virulence between C. parapsilosis and C. orthopsilosis may be associated with expansion of gene families.	[Riccombeni, Alessandro; Vidanes, Genevieve; Butler, Geraldine] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland; [Proux-Wera, Estelle; Wolfe, Kenneth H.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland	University College Dublin; Trinity College Dublin	Riccombeni, A (corresponding author), Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin 2, Ireland.	gbutler@ucd.ie	Proux-Wéra, Estelle/G-4786-2015; Proux-Wéra, Estelle/AAC-8874-2019	Proux-Wéra, Estelle/0000-0003-3752-1806; Proux-Wéra, Estelle/0000-0003-3752-1806; Wolfe, Kenneth/0000-0003-4992-4979; Butler, Geraldine/0000-0002-1770-5301	Science Foundation Ireland [08/N1B1865, 07/IN.1.B911]; Irish Research Council for Science, Engineering and Technology	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR)	This work was supported by Science Foundation Ireland (08/N1B1865 and 07/IN.1.B911) and by a studentship to AR from the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Almirante B, 2006, J CLIN MICROBIOL, V44, P1681, DOI 10.1128/JCM.44.5.1681-1685.2006; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Barchiesi F, 2000, ANTIMICROB AGENTS CH, V44, P1578, DOI 10.1128/AAC.44.6.1578-1584.2000; Bates S, 2007, INFECT IMMUN, V75, P2922, DOI 10.1128/IAI.00102-07; Borghi E, 2011, EUR J CLIN MICROBIOL, V30, P1437, DOI 10.1007/s10096-011-1242-x; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Canton E, 2010, ANTIMICROB AGENTS CH, V54, P2194, DOI 10.1128/AAC.01538-09; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Clark TA, 2004, J CLIN MICROBIOL, V42, P4468, DOI 10.1128/JCM.42.10.4468-4472.2004; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124; de Toro M, 2011, CLIN MICROBIOL INFEC, V17, P418, DOI 10.1111/j.1469-0691.2010.03302.x; Ding C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028151; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dunkel N, 2008, MOL MICROBIOL, V69, P827, DOI 10.1111/j.1365-2958.2008.06309.x; Dunkel N, 2008, EUKARYOT CELL, V7, P1180, DOI 10.1128/EC.00103-08; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Feaver WJ, 1997, J BIOL CHEM, V272, P19319, DOI 10.1074/jbc.272.31.19319; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fitzgerald D., 2010, P INT C DIGITAL AUDI, V13, P1; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Fitzpatrick DA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-181; Gacser A, 2007, FUNGAL GENET BIOL, V44, P1336, DOI 10.1016/j.fgb.2007.02.002; Garcia-Effron G, 2008, ANTIMICROB AGENTS CH, V52, P2305, DOI 10.1128/AAC.00262-08; Gaur M, 2005, J MOL MICROB BIOTECH, V9, P3, DOI 10.1159/000088141; Gaur M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-579; GIMBLE FS, 1992, NATURE, V357, P301, DOI 10.1038/357301a0; Gogarten JP, 2002, ANNU REV MICROBIOL, V56, P263, DOI 10.1146/annurev.micro.56.012302.160741; Gomez-Lopez A, 2008, ANTIMICROB AGENTS CH, V52, P1506, DOI 10.1128/AAC.01595-07; Gordon JL, 2011, P NATL ACAD SCI USA, V108, P20024, DOI 10.1073/pnas.1112808108; Gordon JL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002190; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hall C, 2007, GENETICS, V177, P2293, DOI 10.1534/genetics.107.074963; Hernendez-Castro R, 2010, EUR J PEDIATR, V169, P783, DOI 10.1007/s00431-009-1109-7; HIRATA R, 1990, J BIOL CHEM, V265, P6726; Holesova Z, 2011, MICROBIOL-SGM, V157, P2152, DOI 10.1099/mic.0.048215-0; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Huang YC, 1998, SCAND J INFECT DIS, V30, P137, DOI 10.1080/003655498750003519; Iida Soji, 2005, Nihon Ishinkin Gakkai Zasshi, V46, P133, DOI 10.3314/jjmm.46.133; Jackson AP, 2009, GENOME RES, V19, P2231, DOI 10.1101/gr.097501.109; Jona G, 2002, J BIOL CHEM, V277, P39409, DOI 10.1074/jbc.M202733200; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kosa P, 2006, NUCLEIC ACIDS RES, V34, P2472, DOI 10.1093/nar/gkl327; Koufopanou V, 2005, MOL BIOL EVOL, V22, P1535, DOI 10.1093/molbev/msi149; Koufopanou V, 2002, MOL BIOL EVOL, V19, P239, DOI 10.1093/oxfordjournals.molbev.a004077; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Lasker BA, 2006, J CLIN MICROBIOL, V44, P750, DOI 10.1128/JCM.44.3.750-759.2006; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; LEHMANN PF, 1992, J CLIN MICROBIOL, V30, P3249, DOI 10.1128/JCM.30.12.3249-3254.1992; LIN DM, 1995, J CLIN MICROBIOL, V33, P1815, DOI 10.1128/JCM.33.7.1815-1821.1995; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P2659, DOI 10.1128/JCM.00803-08; Lockhart SR, 2008, J CLIN MICROBIOL, V46, P374, DOI 10.1128/JCM.01790-07; Lodi T, 2007, FEMS YEAST RES, V7, P646, DOI 10.1111/j.1567-1364.2007.00245.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lupetti A, 2002, J CLIN MICROBIOL, V40, P2363, DOI 10.1128/JCM.40.7.2363-2369.2002; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marr KA, 2001, ANTIMICROB AGENTS CH, V45, P52, DOI 10.1128/AAC.45.1.52-59.2001; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Melo AS, 2011, MED MYCOL, V49, P253, DOI 10.3109/13693786.2010.530032; Miranda-Zapico I, 2011, J ANTIMICROB CHEMOTH, V66, P2315, DOI 10.1093/jac/dkr298; Mirhendi H, 2010, J MED MICROBIOL, V59, P414, DOI 10.1099/jmm.0.017293-0; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Moran GP, 2007, MOL MICROBIOL, V66, P915, DOI 10.1111/j.1365-2958.2007.05965.x; Morschhauser J, 2010, FUNGAL GENET BIOL, V47, P94, DOI 10.1016/j.fgb.2009.08.002; Nguyen NH, 2006, MYCOL RES, V110, P1232, DOI 10.1016/j.mycres.2006.07.002; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Orsi CF, 2010, MED MYCOL, V48, P1024, DOI 10.3109/13693786.2010.489233; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Pfaller MA, 2011, INT J ANTIMICROB AG, V38, P65, DOI 10.1016/j.ijantimicag.2011.02.016; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V68, P278, DOI 10.1016/j.diagmicrobio.2010.06.015; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Silva ATPE, 2009, FEMS YEAST RES, V9, P626, DOI 10.1111/j.1567-1364.2009.00508.x; Posey KL, 2004, NUCLEIC ACIDS RES, V32, P3947, DOI 10.1093/nar/gkh734; Poulter RTM, 2007, FUNGAL GENET BIOL, V44, P153, DOI 10.1016/j.fgb.2006.07.012; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reiss E, 2008, INFECT GENET EVOL, V8, P103, DOI 10.1016/j.meegid.2007.10.007; Roderick SL, 2005, CR BIOL, V328, P568, DOI 10.1016/j.crvi.2005.03.005; Rossignol T, 2007, ANTIMICROB AGENTS CH, V51, P2304, DOI [10.1128/AAC.01438.06, 10.1128/AAC.01438-06]; Rossignol T, 2009, EUKARYOT CELL, V8, P550, DOI 10.1128/EC.00350-08; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sabino R, 2010, J CLIN MICROBIOL, V48, P1677, DOI 10.1128/JCM.02151-09; Sai SX, 2011, EUKARYOT CELL, V10, P578, DOI 10.1128/EC.00276-10; San Miguel LG, 2004, DIAGN MICR INFEC DIS, V49, P189, DOI 10.1016/j.diagmicrobio.2004.03.017; SANTOS MAS, 1995, NUCLEIC ACIDS RES, V23, P1481, DOI 10.1093/nar/23.9.1481; Sasse C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025623; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silva AP, 2011, ANTIMICROB AGENTS CH, V55, P3546, DOI 10.1128/AAC.01127-10; Silva AP, 2009, J CLIN MICROBIOL, V47, P2392, DOI 10.1128/JCM.02379-08; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Song JW, 2005, MED MYCOL, V43, P657, DOI 10.1080/13693780500294915; Stokes C, 2007, FUNGAL GENET BIOL, V44, P920, DOI 10.1016/j.fgb.2006.11.014; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tavanti A, 2007, J CLIN MICROBIOL, V45, P1455, DOI 10.1128/JCM.00243-07; Tay ST, 2009, J MED MICROBIOL, V58, P185, DOI 10.1099/jmm.0.004242-0; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; Theodoro RC, 2011, FUNGAL GENET BIOL, V48, P80, DOI 10.1016/j.fgb.2010.07.010; van Asbeck EC, 2009, MYCOSES, V52, P493, DOI 10.1111/j.1439-0507.2008.01649.x; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Weissman Z, 2004, MOL MICROBIOL, V53, P1209, DOI 10.1111/j.1365-2958.2004.04199.x; Weissman Z, 2008, MOL MICROBIOL, V69, P201, DOI 10.1111/j.1365-2958.2008.06277.x; Wohlbach DJ, 2011, P NATL ACAD SCI USA, V108, P13212, DOI 10.1073/pnas.1103039108; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zancope-Oliveira RM, 2000, EUR J CLIN MICROBIOL, V19, P514, DOI 10.1007/s100960000307; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256; Zordan RE, 2006, P NATL ACAD SCI USA, V103, P12807, DOI 10.1073/pnas.0605138103	126	48	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35750	10.1371/journal.pone.0035750	http://dx.doi.org/10.1371/journal.pone.0035750			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563396	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100024
J	Tidten-Luksch, N; Grimaldi, R; Torrie, LS; Frearson, JA; Hunter, WN; Brenk, R				Tidten-Luksch, Naomi; Grimaldi, Raffaella; Torrie, Leah S.; Frearson, Julie A.; Hunter, William N.; Brenk, Ruth			IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening	PLOS ONE			English	Article							NON-MEVALONATE PATHWAY; SMALL-MOLECULE INHIBITORS; ISOPRENOID BIOSYNTHESIS; CRYSTAL-STRUCTURE; PROTEIN FLEXIBILITY; ESCHERICHIA-COLI; KINASE ISPE; DOCKING; LIGAND; GENES	CDP-ME kinase (IspE) contributes to the non-mevalonate or deoxy-xylulose phosphate (DOXP) pathway for isoprenoid precursor biosynthesis found in many species of bacteria and apicomplexan parasites. IspE has been shown to be essential by genetic methods and since it is absent from humans it constitutes a promising target for antimicrobial drug development. Using in silico screening directed against the substrate binding site and in vitro high-throughput screening directed against both, the substrate and co-factor binding sites, non-substrate-like IspE inhibitors have been discovered and structure-activity relationships were derived. The best inhibitors in each series have high ligand efficiencies and favourable physico-chemical properties rendering them promising starting points for drug discovery. Putative binding modes of the ligands were suggested which are consistent with established structure-activity relationships. The applied screening methods were complementary in discovering hit compounds, and a comparison of both approaches highlights their strengths and weaknesses. It is noteworthy that compounds identified by virtual screening methods provided the controls for the biochemical screens.	[Tidten-Luksch, Naomi; Grimaldi, Raffaella; Torrie, Leah S.; Frearson, Julie A.; Hunter, William N.; Brenk, Ruth] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland	University of Dundee	Tidten-Luksch, N (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee, Scotland.	w.n.hunter@dundee.ac.uk; r.brenk@dundee.ac.uk	Hunter, William/AAE-3947-2019	Brenk, Ruth/0000-0002-6204-5488	Wellcome Trust [WT082596, WT083481]; German Academic Exchange Service (DAAD)	Wellcome Trust(Wellcome TrustEuropean Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the Wellcome Trust (grants WT082596 and WT083481) and a fellowship from the German Academic Exchange Service (DAAD) to NTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; B-Rao C, 2009, DRUG DISCOV TODAY, V14, P394, DOI 10.1016/j.drudis.2009.01.003; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Brenk R, 2005, J BIOMOL SCREEN, V10, P667, DOI 10.1177/1087057105281047; Brenk R, 2008, CHEMMEDCHEM, V3, P435, DOI 10.1002/cmdc.200700139; Campbell TL, 2002, J BACTERIOL, V184, P5609, DOI 10.1128/JB.184.20.5609-5618.2002; Chen Y, 2009, NAT CHEM BIOL, V5, P358, DOI 10.1038/nchembio.155; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Crane CM, 2008, CHEMMEDCHEM, V3, P91, DOI 10.1002/cmdc.200700208; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Edwards BS, 2005, MOL PHARMACOL, V68, P1301, DOI 10.1124/mol.105.014068; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Englert L, 2010, CHEMMEDCHEM, V5, P930, DOI 10.1002/cmdc.201000084; Erickson JA, 2004, J MED CHEM, V47, P45, DOI 10.1021/jm030209y; Evensen E, 2003, J MED CHEM, V46, P5125, DOI 10.1021/jm025618t; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Friedman R, 2009, CHEMMEDCHEM, V4, P1317, DOI 10.1002/cmdc.200900078; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Hawkins G.D., 2003, AMSOL VERSION 7 0; Hirsch AKH, 2008, ORG BIOMOL CHEM, V6, P2719, DOI 10.1039/b804375b; Hirsch AKH, 2007, CHEMMEDCHEM, V2, P806, DOI 10.1002/cmdc.200700014; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Jenkins JL, 2003, PROTEINS, V50, P81, DOI 10.1002/prot.10270; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kuzuyama T, 2002, BIOSCI BIOTECH BIOCH, V66, P1619, DOI 10.1271/bbb.66.1619; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Liao JJL, 2007, J MED CHEM, V50, P409, DOI 10.1021/jm0608107; Lisurek M, 2010, MOL DIVERS, V14, P401, DOI 10.1007/s11030-009-9187-z; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Miallau L, 2003, P NATL ACAD SCI USA, V100, P9173, DOI 10.1073/pnas.1533425100; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; Mukherjee S, 2010, J CHEM INF MODEL, V50, P1986, DOI 10.1021/ci1001982; Muthas D, 2008, J MOL GRAPH MODEL, V26, P1237, DOI 10.1016/j.jmgm.2007.11.005; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nilakantan R, 2003, DRUG DISCOV TODAY, V8, P668, DOI 10.1016/S1359-6446(03)02793-4; Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67, DOI 10.1016/S0167-4838(00)00262-4; Pierce AC, 2002, PROTEINS, V49, P567, DOI 10.1002/prot.10259; Polgar T, 2005, J MED CHEM, V48, P7946, DOI 10.1021/jm050504d; Rarey M, 1998, J COMPUT AID MOL DES, V12, P471, DOI 10.1023/A:1008068904628; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Rohmer M., 1999, COMPREH NATL PROD CH, V2, P45; Ruda GF, 2010, BIOORGAN MED CHEM, V18, P5056, DOI 10.1016/j.bmc.2010.05.077; Sgraja T, 2008, FEBS J, V275, P2779, DOI 10.1111/j.1742-4658.2008.06418.x; Shan S, 2011, FASEB J, V25, P1577, DOI 10.1096/fj.10-175786; Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g; Singh U, 2006, J BIOMOL SCREEN, V11, P1035, DOI 10.1177/1087057106292798; Tang M, 2011, BIOORGAN MED CHEM, V19, P5886, DOI 10.1016/j.bmc.2011.08.012; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Wada T, 2003, J BIOL CHEM, V278, P30022, DOI 10.1074/jbc.M304339200; Walters WP, 2003, NAT REV DRUG DISCOV, V2, P259, DOI 10.1038/nrd1063; Wierenga KJ, 2008, J BIOMOL SCREEN, V13, P415, DOI 10.1177/1087057108318331; Zalacain M, 2003, J MOL MICROB BIOTECH, V6, P109, DOI 10.1159/000076741	66	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e35792	10.1371/journal.pone.0035792	http://dx.doi.org/10.1371/journal.pone.0035792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VP	22563402	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345200078
J	Fritsche, M; Reinholdt, LG; Lessard, M; Handel, MA; Bewersdorf, J; Heermann, DW				Fritsche, Miriam; Reinholdt, Laura G.; Lessard, Mark; Handel, Mary Ann; Bewersdorf, Joerg; Heermann, Dieter W.			The Impact of Entropy on the Spatial Organization of Synaptonemal Complexes within the Cell Nucleus	PLOS ONE			English	Article							MEIOTIC CHROMOSOMES; POLYMER-CHAIN; LENGTH; MICROSCOPY; STIFFNESS; CROSSOVER; PROTEINS; PROPHASE; MEIOSIS	We employ 4Pi-microscopy to study SC organization in mouse spermatocyte nuclei allowing for the three-dimensional reconstruction of the SC's backbone arrangement. Additionally, we model the SCs in the cell nucleus by confined, self-avoiding polymers, whose chain ends are attached to the envelope of the confining cavity and diffuse along it. This work helps to elucidate the role of entropy in shaping pachytene SC organization. The framework provided by the complex interplay between SC polymer rigidity, tethering and confinement is able to qualitatively explain features of SC organization, such as mean squared end-to-end distances, mean squared center-of-mass distances, or SC density distributions. However, it fails in correctly assessing SC entanglement within the nucleus. In fact, our analysis of the 4Pi-microscopy images reveals a higher ordering of SCs within the nuclear volume than what is expected by our numerical model. This suggests that while effects of entropy impact SC organization, the dedicated action of proteins or actin cables is required to fine-tune the spatial ordering of SCs within the cell nucleus.	[Fritsche, Miriam; Heermann, Dieter W.] Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany; [Reinholdt, Laura G.; Lessard, Mark; Handel, Mary Ann; Bewersdorf, Joerg; Heermann, Dieter W.] Jackson Lab, Bar Harbor, ME 04609 USA; [Heermann, Dieter W.] Interdisciplinary Ctr Sci Comp, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Jackson Laboratory; Ruprecht Karls University Heidelberg	Fritsche, M (corresponding author), Heidelberg Univ, Inst Theoret Phys, Heidelberg, Germany.	fritsche@tphys.uni-heidelberg.de; Joerg.Bewersdorf@yale.edu		Lessard, Mark/0000-0002-1927-2204; Bewersdorf, Joerg/0000-0002-4085-7020	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp); W. M. Keck Foundation; National Science Foundation [DBI-0421007]; National Institutes of Health [HD48998]; Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wuerttemberg; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033816] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048998] Funding Source: NIH RePORTER	Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp); W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry for Education and Research; Ministry for Science, Research and Arts Baden-Wuerttemberg; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	MF gratefully acknowledges funding from the Heidelberg Graduate School of Mathematical and Computational Methods for the Sciences (HGS MathComp). Funding for the 4Pi confocal laser scanning microscope was provided by the W. M. Keck Foundation and National Science Foundation Grant DBI-0421007. Additional funding was provided by National Institutes of Health HD48998 (to MAH, LGR). For this work, bwGRiD parallel computing facilities (http://www.bw-grid.de), member of the German D-Grid initiative, funded by the Ministry for Education and Research and the Ministry for Science, Research and Arts Baden-Wuerttemberg, as well as the high performance PC cluster HELICS II at the Interdisciplinary Center for Scientific Computing (IWR) were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsheimer M, 1999, MOL BIOL CELL, V10, P1235, DOI 10.1091/mbc.10.4.1235; ARTECA GA, 1994, PHYS REV E, V49, P2417, DOI 10.1103/PhysRevE.49.2417; Binder K, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-03163-2; Carlton PM, 2008, CHROMOSOME RES, V16, P351, DOI 10.1007/s10577-008-1231-9; CARMESIN I, 1988, MACROMOLECULES, V21, P2819, DOI 10.1021/ma00187a030; Codina-Pascual M, 2006, MOL HUM REPROD, V12, P123, DOI 10.1093/molehr/gal007; Colby R.H., 2003, POLYM PHYS; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; CREMER C, 1978, MICROSC ACTA, V81, P31; Diesinger PM, 2008, EUR PHYS J B, V62, P209, DOI 10.1140/epjb/e2008-00145-6; Dresser M, 2008, PLOS GENET, V4, P1; Fritsche M, 2011, NUCLEIC ACIDS RES, P1; Fritsche M, 2011, SOFT MATTER, V7, P6906, DOI 10.1039/c1sm05445g; Fritsche M, 2010, MACROMOL THEOR SIMUL, V19, P440, DOI 10.1002/mats.201000025; Gugel H, 2004, BIOPHYS J, V87, P4146, DOI 10.1529/biophysj.104.045815; HALPERIN A, 1992, ADV POLYM SCI, V100, P31; HELL SW, 1994, OPT LETT, V19, P222, DOI 10.1364/OL.19.000222; HOLM PB, 1982, MUTAT RES, V95, P45, DOI 10.1016/0027-5107(82)90065-3; Hsu HP, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/28003; Hsu HP, 2010, MACROMOLECULES, V43, P3094, DOI 10.1021/ma902715e; Jahn D, 2010, NUCLEUS-PHILA, V1, P273, DOI 10.4161/nucl.1.3.11800; Jun S, 2010, NAT REV MICROBIOL, V8, P600, DOI 10.1038/nrmicro2391; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klenin K, 2000, BIOPOLYMERS, V54, P307, DOI 10.1002/1097-0282(20001015)54:5<307::AID-BIP20>3.0.CO;2-Y; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Liu Y, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026004; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; MOENS PB, 1990, J CELL SCI, V97, P1; MOSES MJ, 1969, GENETICS, V61, P41; Nicodemi M, 2008, GENETICS, V179, P717, DOI 10.1534/genetics.107.083154; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; RASMUSSEN SW, 1986, CARLSBERG RES COMMUN, V51, P401, DOI 10.1007/BF02907315; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rother D, 2008, IEEE ACM T COMPUT BI, V5, P42, DOI 10.1109/TCBB.2007.1061; Scherthan H, 2011, CHROMOSOMA, V120, P151, DOI 10.1007/s00412-010-0295-4; Sokal AD, 1997, FUNCTIONAL INTEGRATI; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; VANRENSBURG EJJ, 1992, J PHYS A-MATH GEN, V25, P6557, DOI 10.1088/0305-4470/25/24/010; Vranis NM, 2010, GENES-BASEL, V1, P505, DOI 10.3390/genes1030505; Wang CJR, 2009, GENETICS, V183, P905, DOI 10.1534/genetics.109.108688; Watts FZ, 2011, BIOESSAYS, V33, P529, DOI 10.1002/bies.201100002; White EJ, 2004, GENETICS, V167, P51, DOI 10.1534/genetics.167.1.51; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Wilhelm J, 1996, PHYS REV LETT, V77, P2581, DOI 10.1103/PhysRevLett.77.2581; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	47	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36282	10.1371/journal.pone.0036282	http://dx.doi.org/10.1371/journal.pone.0036282			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574147	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800043
J	Li, YY; Bao, YL; Song, ZB; Sun, LG; Wu, P; Zhang, Y; Fan, C; Huang, YX; Wu, Y; Yu, CL; Sun, Y; Zheng, LH; Wang, GN; Li, YX				Li, Yu-Yin; Bao, Yong-Li; Song, Zhen-Bo; Sun, Lu-Guo; Wu, Ping; Zhang, Yu; Fan, Cong; Huang, Yan-Xin; Wu, Yin; Yu, Chun-Lei; Sun, Ying; Zheng, Li-Hua; Wang, Guan-Nan; Li, Yu-Xin			The Threonine Protease Activity of Testes-Specific Protease 50 (TSP50) Is Essential for Its Function in Cell Proliferation	PLOS ONE			English	Article							NF-KAPPA-B; SELF-RENEWAL; I-TASSER; CLONOGENIC CELLS; APOPTOSIS; INFLAMMATION; ACTIVATION; IMMUNITY; SYSTEM; GROWTH	Background: Testes-specific protease 50 (TSP50), a newly discovered threonine enzyme, has similar amino acid sequences and enzymatic structures to those of many serine proteases. It may be an oncogene. TSP50 is up-regulated in breast cancer epithelial cells, and ectopic expression of TSP50 in TSP50-deficient Chinese hamster ovary (CHO) cells has been found to promote cell proliferation. However, the mechanisms by which TSP50 exerts its growth-promoting effects are not yet fully understood. Methodology/Principal Findings: To delineate whether the threonine protease activity of TSP50 is essential to its function in cell proliferation, we constructed and characterized a mutant TSP50, called TSP50 T310A, which was identified as a protease-dead mutant of TSP50. By a series of proliferation analyses, colony formation assays and apoptosis analyses, we showed that T310A mutation significantly depresses TSP50-induced cell proliferation in vitro. Next, the CHO stable cell line expressing either wild-type or T310A mutant TSP50 was injected subcutaneously into nude mice. We found that the T310A mutation could abolish the tumorigenicity of TSP50 in vivo. A mechanism investigation revealed that the T310A mutation prevented interaction between TSP50 and the NF-kappa BI kappa B alpha complex, which is necessary for TSP50 to perform its function in cell proliferation. Conclusion: Our data highlight the importance of threonine 310, the most critical protease catalytic site in TSP50, to TSP50-induced cell proliferation and tumor formation.	[Li, Yu-Yin; Bao, Yong-Li; Song, Zhen-Bo; Sun, Lu-Guo; Wu, Ping; Huang, Yan-Xin; Yu, Chun-Lei] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Li, Yu-Yin; Zhang, Yu; Fan, Cong; Wu, Yin; Yu, Chun-Lei; Li, Yu-Xin] NE Normal Univ, Res Ctr Agr & Med Gene Engn, Minist Educ, Changchun, Peoples R China; [Sun, Lu-Guo; Sun, Ying; Zheng, Li-Hua; Wang, Guan-Nan; Li, Yu-Xin] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China	Li, YY (corresponding author), NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China.	baoyl800@nenu.edu.cn; liyx486@nenu.edu.cn	Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; zhang, yu/J-6095-2014; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022		National Natural Science Foundation of China [30672068]; China Postdoctoral Science Foundation [20090451122]; Fundamental Research Funds for the Central Universities; Ministry of Science and Technology [2011ZX09401-305-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Natural Science Foundation of China (grant number 30672068), the China Postdoctoral Science Foundation (grant number 20090451122), the Fundamental Research Funds for the Central Universities, and the National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (grant number 2011ZX09401-305-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; BUICK RN, 1981, BRIT J CANCER, V44, P349, DOI 10.1038/bjc.1981.191; Cheng HC, 1998, J BIOL CHEM, V273, P24207, DOI 10.1074/jbc.273.37.24207; Cheng JD, 2002, CANCER RES, V62, P4767; Cui HJ, 2006, J BIOL CHEM, V281, P34696, DOI 10.1074/jbc.M604009200; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Fiore M, 1999, EXP CELL RES, V251, P102, DOI 10.1006/excr.1999.4542; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; HEDSTROM L, 2002, CURR PROTOC PROTEIN, pCH21; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Majdalawieh A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823821; MCLEMORE TL, 1988, CANCER RES, V48, P2880; NELSEN B, 1988, MOL CELL BIOL, V8, P3526, DOI 10.1128/MCB.8.8.3526; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SCHREINER C, 1991, CANCER RES, V51, P1738; Shan JD, 2002, CANCER RES, V62, P290; Song ZB, 2011, BIOCHEM J, V436, P457, DOI 10.1042/BJ20101780; THOMSON SP, 1982, CANCER RES, V42, P4606; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wlodawer A, 2003, ACTA BIOCHIM POL, V50, P81; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008; Yuan LM, 1999, CANCER RES, V59, P3215; Zhang J, 2006, CHEM RES CHINESE U, V22, P308, DOI 10.1016/S1005-9040(06)60104-9; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171; Zheng L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022203; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	40	21	21	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35030	10.1371/journal.pone.0035030	http://dx.doi.org/10.1371/journal.pone.0035030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574111	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349800007
J	Chen, FK; Zhang, ZY; Lin, K; Qian, TL; Zhang, Y; You, DL; He, XY; Wang, ZJ; Liang, JD; Deng, ZX; Wu, G				Chen, Fukun; Zhang, Zhenyi; Lin, Kui; Qian, Tianle; Zhang, Yan; You, Delin; He, Xinyi; Wang, Zhijun; Liang, Jingdan; Deng, Zixin; Wu, Geng			Crystal Structure of the Cysteine Desulfurase DndA from Streptomyces lividans Which Is Involved in DNA Phosphorothioation	PLOS ONE			English	Article							ESCHERICHIA-COLI COUNTERPART; NIFS-LIKE PROTEIN; CLUSTER; SULFUR; GENE; CSDB; PURIFICATION; HOMOLOG	DNA phosphorothioation is widespread among prokaryotes, and might function to restrict gene transfer among different kinds of bacteria. There has been little investigation into the structural mechanism of the DNA phosphorothioation process. DndA is a cysteine desulfurase which is involved in the first step of DNA phosphorothioation. In this study, we determined the crystal structure of Streptomyces lividans DndA in complex with its covalently bound cofactor PLP, to a resolution of 2.4 angstrom. Our structure reveals the molecular mechanism that DndA employs to recognize its cofactor PLP, and suggests the potential binding site for the substrate L-cysteine on DndA. In contrast to previously determined structures of cysteine desulfurases, the catalytic cysteine of DndA was found to reside on a beta strand. This catalytic cysteine is very far away from the presumable location of the substrate, suggesting that a conformational change of DndA is required during the catalysis process to bring the catalytic cysteine close to the substrate cysteine. Moreover, our in vitro enzymatic assay results suggested that this conformational change is unlikely to be a simple result of random thermal motion, since moving the catalytic cysteine two residues forward or backward in the primary sequence completely disabled the cysteine desulfurase activity of DndA.	[Chen, Fukun; Zhang, Zhenyi; Lin, Kui; Qian, Tianle; Zhang, Yan; You, Delin; He, Xinyi; Wang, Zhijun; Liang, Jingdan; Deng, Zixin; Wu, Geng] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, FK (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	klin@sjtu.edu.cn; geng.wu@sjtu.edu.cn			National Natural Science Foundation of China [30900225, 30821005, 90919021]; Innovation Program of Shanghai Municipal Education Commission [09ZZ23]; "Dawn" Program of Shanghai Education Commission [08SG11]; Shanghai Pujiang Program [09PJ1405500]; Key Project of Chinese Ministry of Education [109060]; Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX09301-007]; State Key Laboratory of Bioorganic; Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); "Dawn" Program of Shanghai Education Commission; Shanghai Pujiang Program(Shanghai Pujiang Program); Key Project of Chinese Ministry of Education(Ministry of Education, China); Program for Professor of Special Appointment at Shanghai Institutions of Higher Learning; National Comprehensive Technology Platforms for Innovative Drug RD; State Key Laboratory of Bioorganic; Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China)	This work was supported by grants from National Natural Science Foundation of China (grant numbers 30900225, 30821005, and 90919021), Innovation Program of Shanghai Municipal Education Commission (grant number 09ZZ23), the "Dawn" Program of Shanghai Education Commission (grant number 08SG11), Shanghai Pujiang Program (grant number 09PJ1405500), the Key Project of Chinese Ministry of Education (grant number 109060), the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, the National Comprehensive Technology Platforms for Innovative Drug R&D (2009ZX09301-007), the State Key Laboratory of Bioorganic and Natural Products Chemistry, Shanghai Institute of Organic Chemistry (Shanghai, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen FK, 2011, ACTA CRYSTALLOGR F, V67, P1440, DOI 10.1107/S1744309111036694; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Liu GA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001253; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mihara H, 1999, J BIOL CHEM, V274, P14768, DOI 10.1074/jbc.274.21.14768; Mueller EG, 2006, NAT CHEM BIOL, V2, P185, DOI 10.1038/nchembio779; Ou HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005132; Patzer SI, 1999, J BACTERIOL, V181, P3307, DOI 10.1128/JB.181.10.3307-3309.1999; Tirupati B, 2004, BIOCHEMISTRY-US, V43, P12210, DOI 10.1021/bi0491447; Wang LR, 2011, P NATL ACAD SCI USA, V108, P2963, DOI 10.1073/pnas.1017261108; Xu TG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-41; You DL, 2007, BIOCHEMISTRY-US, V46, P6126, DOI 10.1021/bi602615k; ZHENG LM, 1993, P NATL ACAD SCI USA, V90, P2754, DOI 10.1073/pnas.90.7.2754; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; ZHOU XF, 1988, NUCLEIC ACIDS RES, V16, P4341, DOI 10.1093/nar/16.10.4341; Zhou XF, 2005, MOL MICROBIOL, V57, P1428, DOI 10.1111/j.1365-2958.2005.04764.x	22	3	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36635	10.1371/journal.pone.0036635	http://dx.doi.org/10.1371/journal.pone.0036635			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570733	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400049
J	Faassen, EJ; Gillissen, F; Lurling, M				Faassen, Elisabeth J.; Gillissen, Frits; Luerling, Miquel			A Comparative Study on Three Analytical Methods for the Determination of the Neurotoxin BMAA in Cyanobacteria	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; NONPROTEIN AMINO-ACIDS; LIQUID-CHROMATOGRAPHY; NEURODEGENERATIVE DISEASE; 2,4-DIAMINOBUTYRIC ACID; MASS-SPECTROMETRY; CHAMORRO PEOPLE; FLYING FOXES; GUAM; ALS	The cyanobacterial neurotoxin beta-N-methylamino-L-alanine (BMAA) has been considered a serious health threat because of its putative role in multiple neurodegenerative diseases. First reports on BMAA concentrations in cyanobacteria were alarming: nearly all cyanobacteria were assumed to contain high BMAA concentrations, implying ubiquitous exposure. Recent studies however question this presence of high BMAA concentrations in cyanobacteria. To assess the real risk of BMAA to human health, this discrepancy must be resolved. We therefore tested whether the differences found could be caused by the analytical methods used in different studies. Eight cyanobacterial samples and two control samples were analyzed by three commonly used methods: HPLC-FLD analysis and LC-MS/MS analysis of both derivatized and underivatized samples. In line with published results, HPLC-FLD detected relatively high BMAA concentrations in some cyanobacterial samples, while both LC-MS/MS methods only detected BMAA in the positive control (cycad seed sarcotesta). Because we could eliminate the use of different samples and treatments as causal factors, we demonstrate that the observed differences were caused by the analytical methods. We conclude that HPLC-FLD overestimated BMAA concentrations in some cyanobacterial samples due to its low selectivity and propose that BMAA might be present in (some) cyanobacteria, but in the low mu g/g or ng/g range instead of the high mu g/g range as sometimes reported before. We therefore recommend to use only selective and sensitive analytical methods like LC-MS/MS for BMAA analysis. Although possibly present in low concentrations in cyanobacteria, BMAA can still form a health risk. Recent evidence on BMAA accumulation in aquatic food chains suggests human exposure through consumption of fish and shellfish which expectedly exceeds exposure through cyanobacteria.	[Faassen, Elisabeth J.; Gillissen, Frits; Luerling, Miquel] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands	Wageningen University & Research	Faassen, EJ (corresponding author), Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands.	Els.Faassen@wur.nl	Faassen, Elisabeth/P-5411-2015	Faassen, Elisabeth/0000-0001-9098-8662	The Netherlands Organization for Scientific Research (NWO) [817.02.019]	The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	EJF was supported by grant 817.02.019 from The Netherlands Organization for Scientific Research (NWO, www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2010, TOXICON, V56, P868, DOI 10.1016/j.toxicon.2010.06.006; Banack SA, 2006, J ETHNOPHARMACOL, V106, P97, DOI 10.1016/j.jep.2005.12.032; Banack SA, 2007, MAR DRUGS, V5, P180, DOI 10.3390/md20070014; Baptista MS, 2011, TOXICON, V58, P410, DOI 10.1016/j.toxicon.2011.08.007; Bell EA, 2009, AMYOTROPH LATERAL SC, V10, P21, DOI 10.3109/17482960903268700; Bell EA, 2003, J AGR FOOD CHEM, V51, P2854, DOI 10.1021/jf020880w; Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Codd GA, 1999, EUR J PHYCOL, V34, P405, DOI 10.1080/09670269910001736462; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2002, NEUROLOGY, V58, P956, DOI 10.1212/WNL.58.6.956; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Downing S, 2011, TOXICON, V58, P187, DOI 10.1016/j.toxicon.2011.05.017; DUNCAN MW, 1990, NEUROLOGY, V40, P767, DOI 10.1212/WNL.40.5.767; Eriksson J, 2009, AMINO ACIDS, V36, P43, DOI 10.1007/s00726-007-0023-4; Esterhuizen M, 2008, ECOTOX ENVIRON SAFE, V71, P309, DOI 10.1016/j.ecoenv.2008.04.010; Esterhuizen-Londt M, 2011, WATER SA, V37, P133; Faassen EJ, 2009, AMYOTROPH LATERAL SC, V10, P79, DOI 10.3109/17482960903272967; ICH, 1996, GUID IND Q2B VAL AN; ICH, 1994, TEXT VAL AN PROC Q2A; Johnson HE, 2008, J ETHNOPHARMACOL, V118, P159, DOI 10.1016/j.jep.2008.04.008; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; Kaspar H, 2009, ANAL BIOANAL CHEM, V393, P445, DOI 10.1007/s00216-008-2421-1; Kruger T, 2010, TOXICON, V55, P547, DOI 10.1016/j.toxicon.2009.10.009; Li AF, 2010, TOXICON, V55, P947, DOI 10.1016/j.toxicon.2009.09.023; Lobner D, 2007, NEUROBIOL DIS, V25, P360, DOI 10.1016/j.nbd.2006.10.002; Lurling M, 2006, ANN LIMNOL-INT J LIM, V42, P65, DOI 10.1051/limn/2006010; Lurling M, 2011, J PLANKTON RES, V33, P333, DOI 10.1093/plankt/fbq130; Metcalf JS, 2008, ENVIRON MICROBIOL, V10, P702, DOI 10.1111/j.1462-2920.2007.01492.x; Moura S, 2009, TOXICON, V53, P578, DOI 10.1016/j.toxicon.2008.12.013; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Rosen J, 2008, ANALYST, V133, P1785, DOI 10.1039/b809231a; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Spacil Z, 2010, ANALYST, V135, P127, DOI 10.1039/b921048b; VEGA A, 1967, PHYTOCHEMISTRY, V6, P759, DOI 10.1016/S0031-9422(00)86018-5; Waters Corporation, 1993, WAT ACCQ TAG CHEM PA	39	66	69	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36667	10.1371/journal.pone.0036667	http://dx.doi.org/10.1371/journal.pone.0036667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570736	Green Published, gold, Green Submitted			2022-12-27	WOS:000305343400052
J	Javaheri, B; Sunters, A; Zaman, G; Suswillo, RFL; Saxon, LK; Lanyon, LE; Price, JS				Javaheri, Behzad; Sunters, Andrew; Zaman, Gul; Suswillo, Rosemary F. L.; Saxon, Leanne K.; Lanyon, Lance E.; Price, Joanna S.			Lrp5 Is Not Required for the Proliferative Response of Osteoblasts to Strain but Regulates Proliferation and Apoptosis in a Cell Autonomous Manner	PLOS ONE			English	Article							HIGH-BONE-MASS; ESTROGEN-RECEPTOR-ALPHA; OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; MARROW STROMAL CELLS; BETA-CATENIN LEVELS; AGE-RELATED-CHANGES; MECHANICAL STRAIN; IN-VITRO; TRANSGENIC MICE; WNT CORECEPTOR	Although Lrp5 is known to be an important contributor to the mechanisms regulating bone mass, its precise role remains unclear. The aim of this study was to establish whether mutations in Lrp5 are associated with differences in the growth and/or apoptosis of osteoblast-like cells and their proliferative response to mechanical strain in vitro. Primary osteoblast-like cells were derived from cortical bone of adult mice lacking functional Lrp5 (Lrp5(-/-)), those heterozygous for the human G171V High Bone Mass (HBM) mutation (LRP5(G171V)) and their WT littermates (WTLrp5, WTHBM). Osteoblast proliferation over time was significantly higher in cultures of cells from LRP5(G171V) mice compared to their WTHBM littermates, and lower in Lrp5(-/-) cells. Cells from female LRP5(G171V) mice grew more rapidly than those from males, whereas cells from female Lrp5(-/-) mice grew more slowly than those from males. Apoptosis induced by serum withdrawal was significantly higher in cultures from Lrp5(-/-) mice than in those from WTHBM or LRP5(G171V) mice. Exposure to a single short period of dynamic mechanical strain was associated with a significant increase in cell number but this response was unaffected by genotype which also did not change the 'threshold' at which cells responded to strain. In conclusion, the data presented here suggest that Lrp5 loss and gain of function mutations result in cell-autonomous alterations in osteoblast proliferation and apoptosis but do not alter the proliferative response of osteoblasts to mechanical strain in vitro.	[Javaheri, Behzad] UMKC Sch Dent, Dept Oral Biol, Kansas City, MO USA; [Sunters, Andrew; Zaman, Gul; Suswillo, Rosemary F. L.; Saxon, Leanne K.; Lanyon, Lance E.] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England; [Price, Joanna S.] Bristol Vet Sch, Bristol, Avon, England	University of Missouri System; University of Missouri Kansas City; University of London; University of London Royal Veterinary College; University of Bristol	Javaheri, B (corresponding author), UMKC Sch Dent, Dept Oral Biol, Kansas City, MO USA.	javaherib@umkc.edu	Javaheri, Behzad/AAF-1784-2019; Javaheri, Behzad/L-5997-2018	Javaheri, Behzad/0000-0001-7941-3104; Javaheri, Behzad/0000-0001-7941-3104	Biotechnology and Biological Sciences Research Council (BBSRC); Wellcome Trust	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter MP, 2004, BONE, V35, P162, DOI 10.1016/j.bone.2004.02.018; Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Battmann A, 1997, EXP CLIN ENDOCR DIAB, V105, P98, DOI 10.1055/s-0029-1211734; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bergman RJ, 1996, J BONE MINER RES, V11, P568; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boutahar N, 2004, J BIOL CHEM, V279, P30588, DOI 10.1074/jbc.M313244200; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brighton CT, 1996, J BONE JOINT SURG AM, V78A, P1337, DOI 10.2106/00004623-199609000-00007; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Cheng MZ, 1999, J BONE MINER RES, V14, P1742, DOI 10.1359/jbmr.1999.14.10.1742; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Cullen DM, 2004, J BONE MINER RES, V19, pS396; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; FEDARKO NS, 1995, J BONE MINER RES, V10, P1705; FEDARKO NS, 1992, J CELL PHYSIOL, V151, P215, DOI 10.1002/jcp.1041510202; Fermor B, 1998, BONE, V22, P637, DOI 10.1016/S8756-3282(98)00047-7; FRONTALI M, 1985, AM J MED GENET, V22, P35, DOI 10.1002/ajmg.1320220104; GILADI M, 1991, AM J SPORT MED, V19, P647, DOI 10.1177/036354659101900617; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; JIANG DZ, 1992, EXP HEMATOL, V20, P1216; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kamel MA, 2010, BONE, V47, P872, DOI 10.1016/j.bone.2010.08.007; Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2; Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; KOSHIHARA Y, 1991, J GERONTOL, V46, pB201, DOI 10.1093/geronj/46.5.B201; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; RAWLINSON SCF, 1991, J BONE MINER RES, V6, P1345; Rawlinson SCF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008358; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Saxon LK, 2011, BONE, V49, P184, DOI 10.1016/j.bone.2011.03.683; Shen LX, 2009, J CELL BIOCHEM, V106, P337, DOI 10.1002/jcb.22010; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sunters A, 2010, J BIOL CHEM, V285, P8743, DOI 10.1074/jbc.M109.027086; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yudoh K, 2001, J BONE MINER RES, V16, P1453, DOI 10.1359/jbmr.2001.16.8.1453; Zaman G, 1997, J BONE MINER RES, V12, P769, DOI 10.1359/jbmr.1997.12.5.769; Zha LB, 2008, J GENET GENOMICS, V35, P525, DOI 10.1016/S1673-8527(08)60072-7; Zhuang HM, 1996, BIOCHEM BIOPH RES CO, V229, P449, DOI 10.1006/bbrc.1996.1824	53	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35726	10.1371/journal.pone.0035726	http://dx.doi.org/10.1371/journal.pone.0035726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567110	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500028
J	Talos, DM; Sun, HY; Zhou, XP; Fitzgerald, EC; Jackson, MC; Klein, PM; Lan, VJ; Joseph, A; Jensen, FE				Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Fitzgerald, Erin C.; Jackson, Michele C.; Klein, Peter M.; Lan, Victor J.; Joseph, Annelise; Jensen, Frances E.			The Interaction between Early Life Epilepsy and Autistic-Like Behavioral Consequences: A Role for the Mammalian Target of Rapamycin (mTOR) Pathway	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; LONG-TERM POTENTIATION; TEMPORAL-LOBE EPILEPSY; RECEPTOR SUBUNIT EXPRESSION; INDUCED NEONATAL SEIZURES; MESSENGER-RNA EXPRESSION; HIPPOCAMPAL CA1 NEURONS; CEREBRAL WHITE-MATTER; FRAGILE-X-SYNDROME; MOUSE MODEL	Early life seizures can result in chronic epilepsy, cognitive deficits and behavioral changes such as autism, and conversely epilepsy is common in autistic children. We hypothesized that during early brain development, seizures could alter regulators of synaptic development and underlie the interaction between epilepsy and autism. The mammalian Target of Rapamycin (mTOR) modulates protein translation and is dysregulated in Tuberous Sclerosis Complex, a disorder characterized by epilepsy and autism. We used a rodent model of acute hypoxia-induced neonatal seizures that results in long term increases in neuronal excitability, seizure susceptibility, and spontaneous seizures, to determine how seizures alter mTOR Complex 1 (mTORC1) signaling. We hypothesized that seizures occurring at a developmental stage coinciding with a critical period of synaptogenesis will activate mTORC1, contributing to epileptic networks and autistic-like behavior in later life. Here we show that in the rat, baseline mTORC1 activation peaks during the first three postnatal weeks, and induction of seizures at postnatal day 10 results in further transient activation of its downstream targets phospho-4E-BP1 (Thr37/46), phospho-p70S6K (Thr389) and phospho-S6 (Ser235/236), as well as rapid induction of activity-dependent upstream signaling molecules, including BDNF, phospho-Akt (Thr308) and phospho-ERK (Thr202/Tyr204). Furthermore, treatment with the mTORC1 inhibitor rapamycin immediately before and after seizures reversed early increases in glutamatergic neurotransmission and seizure susceptibility and attenuated later life epilepsy and autistic-like behavior. Together, these findings suggest that in the developing brain the mTORC1 signaling pathway is involved in epileptogenesis and altered social behavior, and that it may be a target for development of novel therapies that eliminate the progressive effects of neonatal seizures.	[Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Fitzgerald, Erin C.; Jackson, Michele C.; Klein, Peter M.; Lan, Victor J.; Joseph, Annelise; Jensen, Frances E.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Talos, Delia M.; Sun, Hongyu; Zhou, Xiangping; Jensen, Frances E.] Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; [Jensen, Frances E.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Talos, DM (corresponding author), NYU, Med Ctr, Dept Neurol, New York, NY 10016 USA.	frances.jensen@childrens.harvard.edu	Sun, Hongyu/O-2853-2013	Sun, Hongyu/0000-0002-6816-842X; Klein, Peter/0000-0002-3232-3387	United States National Institutes of Health [RO1 NS 31718, DP1 OD003347]; Mental Retardation Developmental Disorders Research Center [P30 HD18655]; Tuberous Sclerosis Alliance; Ruth L. Kirschstein National Research Service Award [T32HD007466]; Canadian Institutes of Health Research [MFE-115462]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS031718, R01NS031718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003347] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mental Retardation Developmental Disorders Research Center; Tuberous Sclerosis Alliance; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by United States National Institutes of Health (NIH, www.nih.gov) Grants RO1 NS 31718 (to F.E.J.) and DP1 OD003347 (from the Office of the Director) (to F.E.J.), Mental Retardation Developmental Disorders Research Center Grant P30 HD18655 (National Institute of Child Health and Human Development, www.nichd.nih.gov) (to F.E.J.), Tuberous Sclerosis Alliance (www.tsalliance.org) (to D. M. T.), Ruth L. Kirschstein National Research Service Award (NRSA, grants.nih.gov/training/nrsa.htm) T32HD007466 (to X.Z.), and Canadian Institutes of Health Research (www.cihr-irsc.gc.ca) MFE-115462 (to H. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekinschtein P, 2007, NEURON, V53, P261, DOI 10.1016/j.neuron.2006.11.025; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Bolton PF, 2002, BRAIN, V125, P1247, DOI 10.1093/brain/awf124; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brooks-Kayal A, 2010, BRAIN DEV-JPN, V32, P731, DOI 10.1016/j.braindev.2010.04.010; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Carter MD, 2011, AUTISM RES, V4, P57, DOI 10.1002/aur.180; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Connor SA, 2011, LEARN MEMORY, V18, P207, DOI 10.1101/lm.2043811; Ehninger D, 2009, J INTELL DISABIL RES, V53, P838, DOI 10.1111/j.1365-2788.2009.01208.x; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Huang CH, 2010, BRAIN RES, V1326, P143, DOI 10.1016/j.brainres.2010.02.033; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; ISACKSON PJ, 1991, NEURON, V6, P937, DOI 10.1016/0896-6273(91)90234-Q; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; JENSEN FE, 1991, ANN NEUROL, V29, P629, DOI 10.1002/ana.410290610; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Jensen FE, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2010.02904.x; Kanamori K, 2011, BRAIN RES, V1371, P180, DOI 10.1016/j.brainres.2010.11.064; Karouni M, 2010, EUR J CLIN PHARMACOL, V66, P1151, DOI 10.1007/s00228-010-0861-y; Kelleher RJ, 2004, NEURON, V44, P59, DOI 10.1016/j.neuron.2004.09.013; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Koh S, 2004, EPILEPSIA, V45, P569, DOI 10.1111/j.0013-9580.2004.69103.x; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee CC, 2005, J BIOL CHEM, V280, P18543, DOI 10.1074/jbc.M414112200; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Mikati MA, 2005, DEV BRAIN RES, V157, P98, DOI 10.1016/j.devbrainres.2005.03.007; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; O'Reilly T, 2010, TRANSL ONCOL, V3, P65, DOI 10.1593/tlo.09277; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Rakhade SN, 2008, J NEUROSCI, V28, P7979, DOI 10.1523/JNEUROSCI.1734-08.2008; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Ronen GM, 2007, NEUROLOGY, V69, P1816, DOI 10.1212/01.wnl.0000279335.85797.2c; Rosner M, 2010, AMINO ACIDS, V38, P223, DOI 10.1007/s00726-008-0230-7; Ruegg S, 2007, EPILEPSY RES, V77, P85, DOI 10.1016/j.eplepsyres.2007.09.009; Schneider A, 2008, NEOPLASIA, V10, P1295, DOI 10.1593/neo.08586; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shaw FZ, 2007, J NEUROPHYSIOL, V97, P238, DOI 10.1152/jn.00340.2006; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Talos DM, 2006, J COMP NEUROL, V497, P61, DOI 10.1002/cne.20978; Talos DM, 2006, J COMP NEUROL, V497, P42, DOI 10.1002/cne.20972; Tandon P, 1999, NEUROSCIENCE, V91, P293, DOI 10.1016/S0306-4522(98)00609-5; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tekgul H, 2006, PEDIATRICS, V117, P1270, DOI 10.1542/peds.2005-1178; Trifilieff P, 2007, NEUROBIOL LEARN MEM, V88, P424, DOI 10.1016/j.nlm.2007.05.004; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; Tuchman R, 2011, CURR NEUROL NEUROSCI, V11, P428, DOI 10.1007/s11910-011-0195-x; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Wiebe S, 2007, EPILEPSY CURR, V7, P145; Winterkorn EB, 2007, NEUROLOGY, V68, P62, DOI 10.1212/01.wnl.0000250330.44291.54; Wirrell EC, 2011, EPILEPSY RES, V95, P110, DOI 10.1016/j.eplepsyres.2011.03.009; Wong M, 2010, EPILEPSIA, V51, P27, DOI 10.1111/j.1528-1167.2009.02341.x; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang B, 2012, EPILEPSIA, V53, P506, DOI 10.1111/j.1528-1167.2011.03384.x; Zhou CW, 2011, J NEUROSCI, V31, P18211, DOI 10.1523/JNEUROSCI.4838-11.2011; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	92	136	141	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35885	10.1371/journal.pone.0035885	http://dx.doi.org/10.1371/journal.pone.0035885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567115	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341500033
J	Bauer, E; Gebhardt, H; Ruprecht, C; Gallhofer, B; Sammer, G				Bauer, Eva; Gebhardt, Helge; Ruprecht, Christoph; Gallhofer, Bernd; Sammer, Gebhard			Neuroimaging Evidence for Processes Underlying Repetition of Ignored Stimuli	PLOS ONE			English	Article							ATTENTIONAL SELECTION; INHIBITORY MECHANISMS; PREFRONTAL CORTEX; COGNITIVE CONTROL; LOCATION; RETRIEVAL; IDENTITY; MEMORY; DISSOCIATION; RECOGNITION	Prolonged response times are observed with targets having been presented as distractors immediately before, called negative priming effect. Among others, inhibitory and retrieval processes have been suggested underlying this behavioral effect. As those processes would involve different neural activation patterns, a functional magnetic resonance imaging (fMRI) study including 28 subjects was conducted. Two tasks were used to investigate stimulus repetition effects. One task focused on target location, the other on target identity. Both tasks are known to elicit the expected response time effects. However, there is less agreement about the relationship of those tasks with the explanatory accounts under consideration. Based on within-subject comparisons we found clear differences between the experimental repetition conditions and the neutral control condition on neural level for both tasks. Hemodynamic fronto-striatal activation patterns occurred for the location-based task favoring the selective inhibition account. Hippocampal activation found for the identity-based task suggests an assignment to the retrieval account; however, this task lacked a behavioral effect.	[Bauer, Eva; Gebhardt, Helge; Ruprecht, Christoph; Gallhofer, Bernd; Sammer, Gebhard] Univ Giessen, Cognit Neuro Sci Ctr Psychiat, Giessen, Germany	Justus Liebig University Giessen	Bauer, E (corresponding author), Univ Giessen, Cognit Neuro Sci Ctr Psychiat, Giessen, Germany.	eva.bauer@psychiat.med.uni-giessen.de			Robert Sommer Research Society (Giessen, Germany)	Robert Sommer Research Society (Giessen, Germany)	The research was funded by the Robert Sommer Research Society (Giessen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva HA, 2002, J CLIN EXP NEUROPSYC, V24, P503, DOI 10.1076/jcen.24.4.503.1034; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buckolz E, 2002, CAN J EXP PSYCHOL, V56, P273, DOI 10.1037/h0087403; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 2001, CLIN NEUROSCI RES, V1, P267, DOI 10.1016/S1566-2772(01)00013-5; Christie J, 2001, CAN J EXP PSYCHOL, V55, P24, DOI 10.1037/h0087350; Cools R, 2006, J COGNITIVE NEUROSCI, V18, P1973, DOI 10.1162/jocn.2006.18.12.1973; Cropley VL, 2006, BIOL PSYCHIAT, V59, P898, DOI 10.1016/j.biopsych.2006.03.004; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Egner T, 2005, J COGNITIVE NEUROSCI, V17, P1774, DOI 10.1162/089892905774589226; Eldridge LL, 2005, J NEUROSCI, V25, P3280, DOI 10.1523/JNEUROSCI.3420-04.2005; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Fischer R, 2006, PSYCHOL RES-PSYCH FO, V70, P317, DOI 10.1007/s00426-005-0220-2; Frings C, 2007, BRAIN RES, V1176, P82, DOI 10.1016/j.brainres.2007.07.093; Frings C, 2011, J EXP PSYCHOL HUMAN, V37, P72, DOI 10.1037/a0020673; Gibbons H, 2006, MEM COGNITION, V34, P172, DOI 10.3758/BF03193396; Gibbons H, 2006, J PSYCHOPHYSIOL, V20, P170, DOI 10.1027/0269-8803.20.3.170; Gibbons H, 2010, INT J PSYCHOPHYSIOL, V75, P339, DOI 10.1016/j.ijpsycho.2010.01.004; Guy S, 2007, PSYCHOL RES-PSYCH FO, V71, P178, DOI 10.1007/s00426-005-0003-9; Henson R, 2005, Q J EXP PSYCHOL-A, V58, P193, DOI 10.1080/02724980443000502; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; Houghton G, 1996, BRAIN COGNITION, V30, P20, DOI 10.1006/brcg.1996.0003; Houghton George, 1994, P53; Kathmann N, 2006, NEUROSCI LETT, V394, P53, DOI 10.1016/j.neulet.2005.10.001; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Krueger F, 2007, BRAIN RES, V1174, P110, DOI 10.1016/j.brainres.2007.08.016; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lancaster JL, 1997, NEUROIMAGE, V5, pS633; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MAY CP, 1995, PSYCHOL BULL, V118, P35, DOI 10.1037/0033-2909.118.1.35; Mayr S, 2003, COGNITION, V90, pB11, DOI 10.1016/S0010-0277(03)00142-2; Mayr S, 2007, Z PSYCHOL, V215, P35, DOI 10.1027/0044-3409.215.1.35; Michael GA, 2006, BEHAV NEUROSCI, V120, P447, DOI 10.1037/0735-7044.120.2.447; Milliken B, 2000, PERCEPT PSYCHOPHYS, V62, P1280, DOI 10.3758/BF03212130; Neill W. T., 2007, INHIBITION COGNITION, P63, DOI DOI 10.1037/11587-004; Neill WT, 1997, J EXP PSYCHOL LEARN, V23, P1291, DOI 10.1037/0278-7393.23.6.1291; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P993, DOI 10.1037/0278-7393.18.5.993; NEILL WT, 1992, J EXP PSYCHOL LEARN, V18, P565, DOI 10.1037/0278-7393.18.3.565; Robbins TW, 2007, PHILOS T R SOC B, V362, P917, DOI 10.1098/rstb.2007.2097; Rothermund K, 2005, J EXP PSYCHOL LEARN, V31, P482, DOI 10.1037/0278-7393.31.3.482; Rugg MD, 2003, NEUROPSYCHOLOGIA, V41, P40, DOI 10.1016/S0028-3932(02)00129-X; Stadler MA, 1996, PSYCHON B REV, V3, P87, DOI 10.3758/BF03210745; Steel C, 2001, NEUROREPORT, V12, P3619, DOI 10.1097/00001756-200111160-00049; Stolz JA, 2001, CAN J EXP PSYCHOL, V55, P219, DOI 10.1037/h0087368; SULLIVAN MP, 1995, NEUROPSYCHOLOGY, V9, P537, DOI 10.1037/0894-4105.9.4.537; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; Talairach I., 1988, COPLANAR STEREOTACTI; Tipper S. P, 1990, ADV PSYCHOL, V69, P197, DOI DOI 10.1016/S0166-4115(08)60457-4; Tipper SP, 2001, Q J EXP PSYCHOL-A, V54, P321, DOI 10.1080/02724980042000183; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; TIPPER SP, 1991, B PSYCHONOMIC SOC, V29, P45; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Troche SJ, 2006, NEUROPSYCHOLOGIA, V44, P1811, DOI 10.1016/j.neuropsychologia.2006.03.005; Troche SJ, 2009, J NEUROPSYCHOL, V3, P147, DOI 10.1348/174866408X306872; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Vink M, 2005, NEUROIMAGE, V25, P1168, DOI 10.1016/j.neuroimage.2004.12.042; Wright CI, 2006, NEUROIMAGE, V30, P983, DOI 10.1016/j.neuroimage.2005.10.015; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	64	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36089	10.1371/journal.pone.0036089	http://dx.doi.org/10.1371/journal.pone.0036089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UN	22563478	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700027
J	Dhananjaneyulu, V; Sagar, PVN; Kumar, G; Viswanathan, GA				Dhananjaneyulu, Venkata; Sagar, Vidya Nanda P.; Kumar, Gopalakrishnan; Viswanathan, Ganesh A.			Noise Propagation in Two-Step Series MAPK Cascade	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; STOCHASTIC GENE-EXPRESSION; STEADY-STATE ASSUMPTION; DYNAMICS; TIME; AMPLIFICATION; FLUCTUATIONS; BISTABILITY; VARIABILITY; SENSITIVITY	Series MAPK enzymatic cascades, ubiquitously found in signaling networks, act as signal amplifiers and play a key role in processing information during signal transduction in cells. In activated cascades, cell-to-cell variability or noise is bound to occur and thereby strongly affects the cellular response. Commonly used linearization method (LM) applied to Langevin type stochastic model of the MAPK cascade fails to accurately predict intrinsic noise propagation in the cascade. We prove this by using extensive stochastic simulations for various ranges of biochemical parameters. This failure is due to the fact that the LM ignores the nonlinear effects on the noise. However, LM provides a good estimate of the extrinsic noise propagation. We show that the correct estimate of intrinsic noise propagation in signaling networks that contain at least one enzymatic step can be obtained only through stochastic simulations. Noise propagation in the cascade depends on the underlying biochemical parameters which are often unavailable. Based on a combination of global sensitivity analysis (GSA) and stochastic simulations, we developed a systematic methodology to characterize noise propagation in the cascade. GSA predicts that noise propagation in MAPK cascade is sensitive to the total number of upstream enzyme molecules and the total number of molecules of the two substrates involved in the cascade. We argue that the general systematic approach proposed and demonstrated on MAPK cascade must accompany noise propagation studies in biological networks.	[Dhananjaneyulu, Venkata; Sagar, Vidya Nanda P.; Kumar, Gopalakrishnan; Viswanathan, Ganesh A.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Dhananjaneyulu, V (corresponding author), Vignan Univ, Sch Chem Engn, Vadlamudi Guntur, Andhra Pradesh, India.	ganesh@che.iitb.ac.in		Viswanathan, Ganesh A/0000-0001-6424-0765	Department of Science and Technology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India))	This research was supported by a grant from Department of Science and Technology, Government of India. The funders had no role to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Alon U., 2007, MATH COMPUTATIONAL B, V10; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Detwiler PB, 2000, BIOPHYS J, V79, P2801, DOI 10.1016/S0006-3495(00)76519-2; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; English JM, 2002, TRENDS PHARMACOL SCI, V23, P40, DOI 10.1016/S0165-6147(00)01865-4; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gardiner C. W., 1990, HDB STOCHASTIC METHO; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Higham DJ, 2001, SIAM REV, V43, P525, DOI 10.1137/S0036144500378302; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P1749, DOI 10.1080/03610928008827996; JACHIMOWSKI CJ, 1964, BIOCHEMISTRY-US, V3, P1732, DOI 10.1021/bi00899a025; Jia J.F., 2007, IEEE 1 INT C BIOINF, V1, P442; JimenezAquino JI, 1997, PHYSICA A, V237, P113, DOI 10.1016/S0378-4371(96)00412-8; JimenezAquino JI, 1996, PHYSICA A, V229, P444, DOI 10.1016/0378-4371(96)00030-1; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Lan Y, 2006, J CHEM PHYS, V125; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ruf F, 2007, BIOPHYS J, V93, P4474, DOI 10.1529/biophysj.107.115170; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; SEGEL LA, 1988, B MATH BIOL, V50, P579, DOI 10.1007/BF02460092; SEYDEL R, 1987, CHEM ENG SCI, V42, P1281, DOI 10.1016/0009-2509(87)85001-7; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Van Kampen NG, 1992, STOCHASTIC PROCESSES; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Viswanathan G, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/4/046002; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zhang Y, 2007, CELL MOL LIFE SCI, V64, P2771, DOI 10.1007/s00018-007-7012-3; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20	59	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e35958	10.1371/journal.pone.0035958	http://dx.doi.org/10.1371/journal.pone.0035958			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563473	Green Published, gold			2022-12-27	WOS:000305340700022
J	Zvi, A; Rotem, S; Cohen, O; Shafferman, A				Zvi, Anat; Rotem, Shahar; Cohen, Ofer; Shafferman, Avigdor			Clusters versus Affinity-Based Approaches in F. tularensis Whole Genome Search of CTL Epitopes	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; TULAREMIA VACCINES; PREDICTION; IDENTIFICATION; MECHANISMS; RESPONSES; PEPTIDES; MOUSE; MICE	Deciphering the cellular immunome of a bacterial pathogen is challenging due to the enormous number of putative peptidic determinants. State-of-the-art prediction methods developed in recent years enable to significantly reduce the number of peptides to be screened, yet the number of remaining candidates for experimental evaluation is still in the range of ten-thousands, even for a limited coverage of MHC alleles. We have recently established a resource-efficient approach for down selection of candidates and enrichment of true positives, based on selection of predicted MHC binders located in high density "hotspots" of putative epitopes. This cluster-based approach was applied to an unbiased, whole genome search of Francisella tularensis CTL epitopes and was shown to yield a 17-25 fold higher level of responders as compared to randomly selected predicted epitopes tested in Kb/Db C57BL/6 mice. In the present study, we further evaluate the cluster-based approach (down to a lower density range) and compare this approach to the classical affinity-based approach by testing putative CTL epitopes with predicted IC50 values of <10 nM. We demonstrate that while the percent of responders achieved by both approaches is similar, the profile of responders is different, and the predicted binding affinity of most responders in the cluster-based approach is relatively low (geometric mean of 170 nM), rendering the two approaches complimentary. The cluster-based approach is further validated in BALB/c F. tularensis immunized mice belonging to another allelic restriction (Kd/Dd) group. To date, the cluster-based approach yielded over 200 novel F. tularensis peptides eliciting a cellular response, all were verified as MHC class I binders, thereby substantially increasing the F. tularensis dataset of known CTL epitopes. The generality and power of the high density cluster-based approach suggest that it can be a valuable tool for identification of novel CTLs in proteomes of other bacterial pathogens.	[Zvi, Anat; Rotem, Shahar; Cohen, Ofer; Shafferman, Avigdor] Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel		Zvi, A (corresponding author), Israel Inst Biol Res, Dept Biochem & Mol Genet, IL-70450 Ness Ziona, Israel.	avigdors@iibr.gov.il			Prime Minister office/IIBR research funds	Prime Minister office/IIBR research funds	The study was funded by the Prime Minister office/IIBR research funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry EM, 2009, HUM VACCINES, V5, P832, DOI 10.4161/hv.10297; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Conlan JW, 2011, FUTURE MICROBIOL, V6, P391, DOI [10.2217/FMB.11.22, 10.2217/fmb.11.22]; CONLAN JW, 1994, INFECT IMMUN, V62, P5603, DOI 10.1128/IAI.62.12.5603-5607.1994; Conlan W, 2010, NOVEL LIVE VACCINE C, P213; Gregory SH, 2009, VACCINE, V27, P5299, DOI 10.1016/j.vaccine.2009.06.101; Griffin KF, 2007, FEMS IMMUNOL MED MIC, V49, P315, DOI 10.1111/j.1574-695X.2007.00219.x; Hepburn MJ, 2008, EXPERT REV ANTI-INFE, V6, P231, DOI 10.1586/14787210.6.2.231; Kovjazin R, 2011, MOL IMMUNOL, V48, P1009, DOI 10.1016/j.molimm.2011.01.006; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lund O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026494; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Lundegaard C, 2012, EXPERT REV VACCINES, V11, P43, DOI [10.1586/erv.11.160, 10.1586/ERV.11.160]; Lundegaard C, 2011, J IMMUNOL METHODS, V374, P26, DOI 10.1016/j.jim.2010.10.011; Mann BJ, 2009, EXPERT REV VACCINES, V8, P877, DOI [10.1586/erv.09.51, 10.1586/ERV.09.51]; McMurry JA, 2007, CURR MOL MED, V7, P351, DOI 10.2174/156652407780831584; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; McMurry Julie A, 2007, Med Health R I, V90, P311; Moise L, 2008, HUM VACCINES, V4, P219, DOI 10.4161/hv.4.3.5394; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; SETTE A, 1994, J IMMUNOL, V153, P5586; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zvi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020050	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36440	10.1371/journal.pone.0036440	http://dx.doi.org/10.1371/journal.pone.0036440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563500	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340700049
J	Torres, J; Prieto, J; Durupt, FC; Broad, S; Watt, FM				Torres, Josema; Prieto, Javier; Durupt, Fabrice C.; Broad, Simon; Watt, Fiona M.			Efficient Differentiation of Embryonic Stem Cells into Mesodermal Precursors by BMP, Retinoic Acid and Notch Signalling	PLOS ONE			English	Article							MESENCHYMAL STEM; FATE DECISIONS; MOUSE; INDUCTION; GENERATION; NEURONS	The ability to direct differentiation of mouse embryonic stem (ES) cells into specific lineages not only provides new insights into the pathways that regulate lineage selection but also has translational applications, for example in drug discovery. We set out to develop a method of differentiating ES cells into mesodermal cells at high efficiency without first having to induce embryoid body formation. ES cells were plated on a feeder layer of PA6 cells, which have membrane-associated stromal-derived inducing activity (SDIA), the molecular basis of which is currently unknown. Stimulation of ES/PA6 co-cultures with Bone Morphogenetic Protein 4 (BMP4) both favoured self-renewal of ES cells and induced differentiation into a Desmin and Nestin double positive cell population. Combined stimulation with BMP4 and all-trans Retinoic Acid (RA) inhibited self-renewal and resulted in 90% of cells expressing Desmin and Nestin. Quantitative reverse transcription-polymerase chain reaction (qPCR) analysis confirmed that the cells were of mesodermal origin and expressed markers of mesenchymal and smooth muscle cells. BMP4 activation of a MAD-homolog (Smad)-dependent reporter in undifferentiated ES cells was attenuated by co-stimulation with RA and co-culture with PA6 cells. The Notch ligand Jag1 was expressed in PA6 cells and inhibition of Notch signalling blocked the differentiation inducing activity of PA6 cells. Our data suggest that mesodermal differentiation is regulated by the level of Smad activity as a result of inputs from BMP4, RA and the Notch pathway.	[Torres, Josema; Prieto, Javier; Durupt, Fabrice C.] Univ Valencia, Dept Biol Celular, Burjassot, Comunidad Valen, Spain; [Torres, Josema; Broad, Simon; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	University of Valencia; University of Cambridge	Torres, J (corresponding author), Univ Valencia, Dept Biol Celular, Burjassot, Comunidad Valen, Spain.	Josema.torres@uv.es; Fiona.watt@cancer.org.uk	Watt, Fiona/AHB-0226-2022; Torres, Josema/F-7070-2013	Watt, Fiona/0000-0001-9151-5154; Torres, Josema/0000-0001-6906-7164; Prieto, Javier/0000-0001-9317-3688	Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs); Fondo de Investigacion Sanitaria (Health Research Fund); EU; Wellcome Trust; Medical Research Council (MRC); Ramon y Cajal investigator award from Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology)	Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs); Fondo de Investigacion Sanitaria (Health Research Fund); EU(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ramon y Cajal investigator award from Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology)	This work was supported by grants from Spanish Ministerio de Sanidad y Consumo (Ministry of Health and Consumer Affairs), Fondo de Investigacion Sanitaria (Health Research Fund) (http://www.isciii.es/) to JT and grants from the EU (http://cordis.europa.eu/fp7/sis/), Wellcome Trust (http://www.wellcome.ac.uk/) and Medical Research Council (MRC) (http://www.mrc.ac.uk/index.htm) to FMW. JT is the recipient of a Ramon y Cajal investigator award from the former Spanish Ministerio de Ciencia y Tecnologia (Spanish Ministry for Science and Technology) (http://www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Chiba S, 2008, STEM CELLS, V26, P2810, DOI 10.1634/stemcells.2008-0085; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Goldman DC, 2009, BLOOD, V114, P4393, DOI 10.1182/blood-2009-02-206433; Gritti A, 1999, J NEUROSCI, V19, P3287; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Ishii S, 2010, J NEUROSCI RES, V88, P722, DOI 10.1002/jnr.22250; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kennedy KAM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-67; KODAMA HA, 1986, J CELL PHYSIOL, V129, P20, DOI 10.1002/jcp.1041290104; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakayama N, 2000, BLOOD, V95, P2275, DOI 10.1182/blood.V95.7.2275.007k30_2275_2283; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Schneider MD, 2003, CYTOKINE GROWTH F R, V14, P1, DOI 10.1016/S1359-6101(02)00053-9; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Shimizu N, 2008, INT J HEMATOL, V87, P239, DOI 10.1007/s12185-008-0048-9; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Yamazoe H, 2005, BIOMATERIALS, V26, P5746, DOI 10.1016/j.biomaterials.2005.02.021; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028856; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	46	28	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36405	10.1371/journal.pone.0036405	http://dx.doi.org/10.1371/journal.pone.0036405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558462	gold, Green Submitted, Green Published			2022-12-27	WOS:000305340200076
J	Farkas, IJ; Szanto-Varnagy, A; Korcsmaros, T				Farkas, Illes J.; Szanto-Varnagy, Adam; Korcsmaros, Tamas			Linking Proteins to Signaling Pathways for Experiment Design and Evaluation	PLOS ONE			English	Article							COMPREHENSIVE RESOURCE; GENE; WEB; NETWORKS; DATABASE; CANCER	Biomedical experimental work often focuses on altering the functions of selected proteins. These changes can hit signaling pathways, and can therefore unexpectedly and non-specifically affect cellular processes. We propose PathwayLinker, an online tool that can provide a first estimate of the possible signaling effects of such changes, e.g., drug or microRNA treatments. PathwayLinker minimizes the users' efforts by integrating protein-protein interaction and signaling pathway data from several sources with statistical significance tests and clear visualization. We demonstrate through three case studies that the developed tool can point out unexpected signaling bias in normal laboratory experiments and identify likely novel signaling proteins among the interactors of known drug targets. In our first case study we show that knockdown of the Caenorhabditis elegans gene cdc-25.1 (meant to avoid progeny) may globally affect the signaling system and unexpectedly bias experiments. In the second case study we evaluate the loss-of-function phenotypes of a less known C. elegans gene to predict its function. In the third case study we analyze GJA1, an anti-cancer drug target protein in human, and predict for this protein novel signaling pathway memberships, which may be sources of side effects. Compared to similar services, a major advantage of PathwayLinker is that it drastically reduces the necessary amount of manual literature searches and can be used without a computational background. PathwayLinker is available at http://PathwayLinker.org. Detailed documentation and source code are available at the website.	[Farkas, Illes J.] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary; [Szanto-Varnagy, Adam] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Korcsmaros, Tamas] Eotvos Lorand Univ, Dept Genet, Budapest, Hungary	Hungarian Academy of Sciences; Eotvos Lorand University; Eotvos Lorand University	Farkas, IJ (corresponding author), Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary.	fij@elte.hu	Korcsmaros, Tamas/C-3526-2015; Farkas, Illes/C-1504-2008	Korcsmaros, Tamas/0000-0003-1717-996X; Farkas, Illes/0000-0001-5341-5582	European Research Council [FP6-518230, TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Hungarian Scientific Research Fund [K75334]; Hungarian Research and Technology Office [5LET-08-2-2009-0041]	European Research Council(European Research Council (ERC)European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Research and Technology Office	Funding was provided by the European Research Council (http://erc.europa.eu) Grants FP6-518230 and TAMOP 4.2.1./B-09/1/KMR-2010-0003; Hungarian Scientific Research Fund (http://www.otka.hu/?set_lang=991) Grant K75334; and Hungarian Research and Technology Office (http://www.nkth.gov.hu/english) Grant 5LET-08-2-2009-0041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Ashcroft NR, 1999, DEV BIOL, V206, P15, DOI 10.1006/dbio.1998.9135; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Boutet Emmanuel, 2007, V406, P89; Brohee S, 2008, NUCLEIC ACIDS RES, V36, pW444, DOI 10.1093/nar/gkn336; Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Hornberg JJ, 2006, BIOSYSTEMS, V83, P81, DOI 10.1016/j.biosystems.2005.05.014; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-219; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li J, 2007, ONCOGENE, V26, P2860, DOI 10.1038/sj.onc.1210086; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Owen RP, 2008, HUM MUTAT, V29, P456, DOI 10.1002/humu.20731; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Wishart DS, 2008, PHARMACOGENOMICS, V9, P1155, DOI 10.2217/14622416.9.8.1155; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	27	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36202	10.1371/journal.pone.0036202	http://dx.doi.org/10.1371/journal.pone.0036202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558382	gold, Green Published			2022-12-27	WOS:000305336000154
J	Moffat, CS; Ingle, RA; Wathugala, DL; Saunders, NJ; Knight, H; Knight, MR				Moffat, Caroline S.; Ingle, Robert A.; Wathugala, Deepthi L.; Saunders, Nigel J.; Knight, Heather; Knight, Marc R.			ERF5 and ERF6 Play Redundant Roles as Positive Regulators of JA/Et-Mediated Defense against Botrytis cinerea in Arabidopsis	PLOS ONE			English	Article							DNA-BINDING PROTEINS; TRANSCRIPTION FACTORS; SALICYLIC-ACID; DISEASE RESISTANCE; RESPONSE PATHWAYS; GCC-BOX; ETHYLENE; JASMONATE; GENE; EXPRESSION	The ethylene response factor (ERF) family in Arabidopsis thaliana comprises 122 members in 12 groups, yet the biological functions of the majority remain unknown. Of the group IX ERFs, the IXc subgroup has been studied the most, and includes ERF1, ERF14 and ORA59, which play roles in plant innate immunity. Here we investigate the biological functions of two members of the less studied IXb subgroup: ERF5 and ERF6. In order to identify potential targets of these transcription factors, microarray analyses were performed on plants constitutively expressing either ERF5 or ERF6. Expression of defense genes, JA/Et-responsive genes and genes containing the GCC box promoter motif were significantly upregulated in both ERF5 and ERF6 transgenic plants, suggesting that ERF5 and ERF6 may act as positive regulators of JA-mediated defense and potentially overlap in their function. Since defense against necrotrophic pathogens is generally mediated through JA/Et-signalling, resistance against the fungal necrotroph Botrytis cinerea was examined. Constitutive expression of ERF5 or ERF6 resulted in significantly increased resistance. Although no significant difference in susceptibility to B. cinerea was observed in either erf5 or erf6 mutants, the erf5 erf6 double mutant showed a significant increase in susceptibility, which was likely due to compromised JA-mediated gene expression, since JA-induced gene expression was reduced in the double mutant. Taken together these data suggest that ERF5 and ERF6 play positive but redundant roles in defense against B. cinerea. Since mutual antagonism between JA/Et and salicylic acid (SA) signalling is well known, the UV-C inducibility of an SA-inducible gene, PR-1, was examined. Reduced inducibilty in both ERF5 and ERF6 constitutive overexepressors was consistent with suppression of SA-mediated signalling, as was an increased susceptibility to avirulent Pseudomonas syringae. These data suggest that ERF5 and ERF6 may also play a role in the antagonistic crosstalk between the JA/Et and SA signalling pathways.	[Moffat, Caroline S.; Wathugala, Deepthi L.; Knight, Heather; Knight, Marc R.] Univ Durham, Durham Ctr Crop Improvement Technol, Sch Biol & Biomed Sci, Durham, England; [Moffat, Caroline S.] Curtin Univ Technol, Australian Ctr Necrotroph Fungal Pathogens, Dept Environm & Agr, Perth, WA, Australia; [Ingle, Robert A.] Univ Cape Town, Dept Mol & Cell Biol, ZA-7700 Rondebosch, South Africa; [Wathugala, Deepthi L.] Univ Ruhuna, Dept Crop Sci, Kamburupitiya, Sri Lanka; [Saunders, Nigel J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Durham University; Curtin University; University of Cape Town; University Ruhuna; University of Oxford	Moffat, CS (corresponding author), Univ Durham, Durham Ctr Crop Improvement Technol, Sch Biol & Biomed Sci, Durham, England.	m.r.knight@durham.ac.uk	Moffat, Caroline S/I-1058-2014; Saunders, Nigel J/W-6745-2019; Lakmini, Deepthi/AAJ-1967-2020; Ingle, Robert A/C-5599-2008	Moffat, Caroline S/0000-0002-6360-1933; Ingle, Robert A/0000-0002-8362-3777; Knight, Marc/0000-0002-4830-8608; Saunders, Nigel/0000-0002-0160-4573; Knight, Heather/0000-0003-2047-6084	Biotechnology and Biological Sciences Research Council (BBSRC) UK [BBS/S/B/2003/12908, BBS/S/K/2003/10126]; Durham University; National Research Foundation, South Africa	Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Durham University; National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) UK (studentship BBS/S/B/2003/12908 and BBS/S/K/2003/10126) (http://www.bbsrc.ac.uk/PA/grants/AwardDetails.aspx?FundingReference=BBS%2fS%2fB%2f2003%2f12908; http://www.bbsrc.ac.uk/PA/grants/AwardDetails.aspx?FundingReference =BBS%2fS%2fK%2f2003%2f10126). The authors also thank Durham University's Project Sri Lanka for funding DLW and the National Research Foundation, South Africa for funding RAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Camehl I, 2010, NEW PHYTOL, V185, P1062, DOI 10.1111/j.1469-8137.2009.03149.x; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Goda H, 2008, PLANT J, V55, P526, DOI [10.1111/j.1365-313X.2008.03510.x, 10.1111/j.0960-7412.2008.03510.x]; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Laluk KaM T, 2010, NECROTROPH ATTACKS P, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Mulema JM, 2011, MOL BIOL REPORTS; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Saal LH, 2002, GENOME BIOL, V3; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; van der Graaff E, 2000, DEVELOPMENT, V127, P4971; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; van Wees SCM, 2003, PLANT PHYSIOL, V132, P606, DOI 10.1104/pp.103.022186; Verhage A, 2010, PLANT PHYSIOL, V154, P536, DOI 10.1104/pp.110.161570; Wehner N, 2011, PLANT J, V68, P560, DOI 10.1111/j.1365-313X.2011.04704.x; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Zarei A, 2011, PLANT MOL BIOL, V75, P321, DOI 10.1007/s11103-010-9728-y	49	161	178	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35995	10.1371/journal.pone.0035995	http://dx.doi.org/10.1371/journal.pone.0035995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563431	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305349100057
J	Truax, AD; Thakkar, M; Greer, SF				Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.			Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CREB BINDING-PROTEIN; T-CELLS; MHC2TA TRANSCRIPTION; ANTIGEN EXPRESSION; UVEAL MELANOMA; ATPASE SUG1; IFN-GAMMA; TUMOR; GENES	One mechanism frequently utilized by tumor cells to escape immune system recognition and elimination is suppression of cell surface expression of Major Histocompatibility Class II (MHC II) molecules. Expression of MHC II is regulated primarily at the level of transcription by the Class II Transactivator, CIITA, and decreased CIITA expression is observed in multiple tumor types. We investigate here contributions of epigenetic modifications to transcriptional silencing of CIITA in variants of the human breast cancer cell line MDA MB 435. Significant increases in histone H3 lysine 27 trimethylation upon IFN-gamma stimulation correlate with reductions in transcription factor recruitment to the interferon-gamma inducible CIITA promoter, CIITApIV, and with significantly increased CIITApIV occupancy by the histone methyltransferase enhancer of zeste homolog 2 (EZH2). Most compelling is evidence that decreased expression of EZH2 in MDA MB 435 variants results in significant increases in CIITA and HLA-DRA mRNA expression, even in the absence of interferon-gamma stimulation, as well as increased cell surface expression of MHC II. Together, these data add mechanistic insight to prior observations of increased EZH2 expression and decreased CIITA expression in multiple tumor types.	[Truax, Agnieszka D.; Thakkar, Meghna; Greer, Susanna F.] Georgia State Univ, Dept Biol, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Truax, AD (corresponding author), Georgia State Univ, Dept Biol, Div Cellular & Mol Biol & Physiol, Atlanta, GA 30302 USA.	sgreer@gsu.edu			American Cancer Society [RSG-09-067-01-L1B]	American Cancer Society(American Cancer Society)	This work was funded by the American Cancer Society, RSG-09-067-01-L1B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Beresford GW, 2001, NAT IMMUNOL, V2, P652, DOI 10.1038/89810; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Boss JM, 1997, CURR OPIN IMMUNOL, V9, P107, DOI 10.1016/S0952-7915(97)80166-5; BROCKER EB, 1984, J INVEST DERMATOL, V82, P244, DOI 10.1111/1523-1747.ep12260181; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan HM, 2001, J CELL SCI, V114, P2363; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; Concha A, 1991, Semin Cancer Biol, V2, P47; Croce M, 2003, ONCOGENE, V22, P7848, DOI 10.1038/sj.onc.1207054; DADMARZ R, 1995, CANCER IMMUNOL IMMUN, V40, P1; DEWAARDSIEBINGA I, 1995, HUM IMMUNOL, V44, P111, DOI 10.1016/0198-8859(95)00083-G; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Fontes JD, 1997, NUCLEIC ACIDS RES, V25, P2522, DOI 10.1093/nar/25.12.2522; Fontes JD, 1999, MOL CELL BIOL, V19, P941; FUJIWARA H, 1984, J IMMUNOL, V133, P1671; Garrido F, 1991, Semin Cancer Biol, V2, P3; GORELIK E, 1993, CLIN EXP METASTAS, V11, P439, DOI 10.1007/BF00054935; GREENBERG PD, 1981, J EXP MED, V154, P952, DOI 10.1084/jem.154.3.952; HOCK H, 1991, J EXP MED, V174, P1291, DOI 10.1084/jem.174.6.1291; Holen I, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2769; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; Holling TM, 2006, BIOCHEM PHARMACOL, V72, P1570, DOI 10.1016/j.bcp.2006.06.034; Humphreys J S, 2000, Aust J Rural Health, V8, P120; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kretsovali A, 1998, MOL CELL BIOL, V18, P6777, DOI 10.1128/MCB.18.11.6777; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; Langlade-Demoyen P, 2003, EUR J IMMUNOL, V33, P720, DOI 10.1002/eji.200323287; LAURITZSEN GF, 1994, P NATL ACAD SCI USA, V91, P5700, DOI 10.1073/pnas.91.12.5700; Lennon AM, 1997, IMMUNOGENETICS, V45, P266, DOI 10.1007/s002510050202; Mahanta SK, 1997, P NATL ACAD SCI USA, V94, P6324, DOI 10.1073/pnas.94.12.6324; MAIORANA A, 1995, CLIN EXP METASTAS, V13, P43, DOI 10.1007/BF00144017; Mehta NT, 2011, EPIGENETICS, V6; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Morris AC, 2000, J IMMUNOL, V164, P4143, DOI 10.4049/jimmunol.164.8.4143; Muhlethaler-Mottet A, 2004, J BIOL CHEM, V279, P40529, DOI 10.1074/jbc.M406585200; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ni ZY, 2005, P NATL ACAD SCI USA, V102, P14611, DOI 10.1073/pnas.0503070102; Pai RK, 2002, J IMMUNOL, V169, P1326, DOI 10.4049/jimmunol.169.3.1326; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; PRICE JE, 1990, CANCER-AM CANCER SOC, V66, P1313, DOI 10.1002/1097-0142(19900915)66:14+<1313::AID-CNCR2820661403>3.0.CO;2-4; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Reijm EA, BREAST CANC RES TREA; RUIZCABELLO F, 1991, IMMUNOL LETT, V29, P181, DOI 10.1016/0165-2478(91)90168-A; Rybtsova N, 2007, NUCLEIC ACIDS RES, V35, P3431, DOI 10.1093/nar/gkm214; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; Shi B, 2006, INT J BIOCHEM CELL B, V38, P544, DOI 10.1016/j.biocel.2005.07.012; Sotiriadou R, 2001, BRIT J CANCER, V85, P1527, DOI 10.1054/bjoc.2001.2089; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Truax AD, 2012, METHODS MOL BIOL, V809, P175, DOI 10.1007/978-1-61779-376-9_12; Truax AD, 2010, J MOL BIOL, V395, P254, DOI 10.1016/j.jmb.2009.10.035; van den Elsen PJ, 2001, J REPROD IMMUNOL, V52, P129, DOI 10.1016/S0165-0378(01)00115-2; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Walter W, 2000, BRIT J CANCER, V83, P1192, DOI 10.1054/bjoc.2000.1415; Warabi M, 2000, PATHOL RES PRACT, V196, P807, DOI 10.1016/S0344-0338(00)80080-1; Wong AW, 2002, J IMMUNOL, V169, P3112, DOI 10.4049/jimmunol.169.6.3112; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Xiao Y, 2011, INT J BIOCH CELL BIO; Yan X, 2006, INT J BIOCHEM CELL B, V38, P2102, DOI 10.1016/j.biocel.2006.06.002; ZHANG RD, 1991, INVAS METAST, V11, P204; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	72	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36013	10.1371/journal.pone.0036013	http://dx.doi.org/10.1371/journal.pone.0036013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563434	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349100060
J	Leppiniemi, J; Gronroos, T; Maatta, JAE; Johnson, MS; Kulomaa, MS; Hytonen, VP; Airenne, TT				Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Johnson, Mark S.; Kulomaa, Markku S.; Hytonen, Vesa P.; Airenne, Tomi T.			Structure of Bradavidin - C-Terminal Residues Act as Intrinsic Ligands	PLOS ONE			English	Article							AVIDIN PROTEIN FAMILY; STREPTAVIDIN-BINDING PEPTIDE; TAG II PEPTIDE; BIOTIN-BINDING; CHICKEN AVIDIN; STREP-TAG; RECOMBINANT PROTEINS; AFFINITY PEPTIDE; BRADYRHIZOBIUM-JAPONICUM; CORE STREPTAVIDIN	Bradavidin is a homotetrameric biotin-binding protein from Bradyrhizobium japonicum, a nitrogen fixing and root nodule-forming symbiotic bacterium of the soybean. Wild-type (wt) bradavidin has 138 amino acid residues, whereas the C-terminally truncated core-bradavidin has only 118 residues. We have solved the X-ray structure of wt bradavidin and found that the C-terminal amino acids of each subunit were uniquely bound to the biotin-binding pocket of an adjacent subunit. The biotin-binding pocket occupying peptide (SEKLSNTK) was named "Brad-tag" and it serves as an intrinsic stabilizing ligand in wt bradavidin. The binding of Brad-tag to core-bradavidin was analysed by isothermal titration calorimetry and a binding affinity of similar to 25 mu M was measured. In order to study the potential of Brad-tag, a green fluorescent protein tagged with Brad-tag was prepared and successfully concentrated from a bacterial cell lysate using core-bradavidin-functionalized Sepharose resin.	[Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Leppiniemi, Jenni; Gronroos, Toni; Maatta, Juha A. E.; Kulomaa, Markku S.; Hytonen, Vesa P.] BioMediTech, Tampere, Finland; [Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Dept Biosci, Turku, Finland	Tampere University; Tampere University Hospital; Abo Akademi University	Leppiniemi, J (corresponding author), Univ Tampere, Tampere Univ Hosp, Inst Biomed Technol, FIN-33101 Tampere, Finland.	tomi.airenne@abo.fi	Leppiniemi, Jenni/S-6262-2019; Määttä, Juha/A-6629-2016; Kulomaa, Markku S/C-9063-2014; Leppiniemi, Jenni/A-6641-2016; Hytonen, Vesa P./E-8855-2013	Leppiniemi, Jenni/0000-0002-7225-1648; Määttä, Juha/0000-0003-3885-6149; Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Gronroos, Toni/0000-0002-2830-8192	Academy of Finland [115976, 121236]; ISB (National Graduate School in Informational and Structural Biology); TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology); Institute of Biomedical Technology; Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation; Tampere University Hospital [9M019, 9M042]; Joe, Pentti and Tor Borg Memorial Fund; European Community; Academy of Finland	Academy of Finland(Academy of Finland); ISB (National Graduate School in Informational and Structural Biology); TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology); Institute of Biomedical Technology; Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital; Joe, Pentti and Tor Borg Memorial Fund; European Community(European Commission); Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland [projects 115976 and 121236], ISB (National Graduate School in Informational and Structural Biology), TGPBB (Tampere Graduate Program in Biomedicine and Biotechnology), the Institute of Biomedical Technology, the Foundation of Abo Akademi (Centre of Excellence in Cell Stress and Aging), the Sigrid Juselius Foundation, the Competitive Research Funding of the Tampere University Hospital [Grants 9M019 and 9M042], and the Joe, Pentti and Tor Borg Memorial Fund. The authors acknowledge support by the European Community - Research Infrastructure Action under the FP6 "Structuring the European Research Area" Programme and FIRI infrastructure support for structural biology from the Academy of Finland. Biocenter Finland is acknowledged for the infrastructure support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER EA, 1989, BIOCHEM J, V259, P369, DOI 10.1042/bj2590369; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Byron A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001827; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farres J, 2005, BIOCHEMISTRY-US, V44, P4125, DOI 10.1021/bi047389d; Gaj T, 2007, PROTEIN EXPRES PURIF, V56, P54, DOI 10.1016/j.pep.2007.06.010; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; Helppolainen SH, 2007, BIOCHEM J, V405, P397, DOI 10.1042/BJ20070076; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Hytonen VP, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-28; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2003, BIOCHEM J, V372, P219, DOI 10.1042/BJ20021531; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; KORPELA JK, 1981, EXPERIENTIA, V37, P1065, DOI 10.1007/BF02085010; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2002, BIOCHEM J, V363, P609, DOI 10.1042/0264-6021:3630609; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Maatta JAE, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-63; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meir A, 2009, J MOL BIOL, V386, P379, DOI 10.1016/j.jmb.2008.11.061; Meyer SC, 2006, CHEM BIOL DRUG DES, V68, P3, DOI 10.1111/j.1747-0285.2006.00401.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, J BIOL CHEM, V280, P13250, DOI 10.1074/jbc.M414336200; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; Rosebrough SF, 1996, J NUCL MED, V37, P1380; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANO T, 1995, J BIOL CHEM, V270, P28204; Sardo A, 2011, PROTEIN EXPRES PURIF, V77, P131, DOI 10.1016/j.pep.2011.01.003; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; SCHMIDT TGM, 1993, PROTEIN ENG, V6, P109, DOI 10.1093/protein/6.1.109; Schrodinger L., 2020, PYMOL; Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9; Takahashi S, 2012, ANAL BIOANAL CHEM, V402, P1749, DOI 10.1007/s00216-011-5317-4; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; Wilchek M, 2006, IMMUNOL LETT, V103, P27, DOI 10.1016/j.imlet.2005.10.022; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xie H, 2009, MOL BIOTECHNOL, V42, P135, DOI 10.1007/s12033-009-9148-x; Zhou M, 2007, BIOPOLYMERS, V88, P325, DOI 10.1002/bip.20655	72	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e35962	10.1371/journal.pone.0035962	http://dx.doi.org/10.1371/journal.pone.0035962			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574129	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800025
J	Barclay, RMR				Barclay, Robert M. R.			Variable Variation: Annual and Seasonal Changes in Offspring Sex Ratio in a Bat	PLOS ONE			English	Article							EPTESICUS-FUSCUS; BROWN BAT; REPRODUCTIVE-BIOLOGY; GROUND-SQUIRRELS; POPULATION; CHIROPTERA; ADJUSTMENT; SURVIVAL; HYPOTHESIS; ALLOCATION	Many organisms produce offspring with sex-ratios that deviate from equal numbers of males and females, and numerous adaptive explanations have been proposed. In some species, offspring sex-ratio varies across the reproductive season, again with several explanations as to why this might be adaptive. However, patterns for birds and mammals are inconsistent, and multiple factors are likely involved. Long-term studies on a variety of species may help untangle the complexity. I analyzed a long-term data set on the variation in offspring sex-ratio of the big brown bat, Eptesicus fuscus, a temperate-zone, insectivorous species. Sex ratio varied seasonally, but only in some years. Births early in the season were significantly female biased in years in which parturition occurred relatively early, but not in years with late parturition. Survival of female pups increased with earlier median birth date for the colony, and early-born females were more likely to survive and reproduce as one-year olds, compared to later-born pups. I argue that, due to the unusual timing of reproductive activities in male and female bats that hibernate, producing female offspring early in the year increases their probability of reproducing as one year olds, but this is not the case for male offspring. Thus, mothers that can give birth early in the year, benefit most by producing a female pup. The relative benefit of producing female or male offspring varies depending on the length of the growing season and thus the time available for female pups to reach sexual maturity. This suggests that not only does sex-ratio vary seasonally and among years, depending on the condition of the mother and the environment, but also likely varies geographically due to differences in season length.	Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Barclay, RMR (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	barclay@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada [DG 39695]; University of Calgary Research Grants Committee	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Calgary Research Grants Committee	Funding for this project was received from the Natural Sciences and Engineering Research Council of Canada through Discovery Grants to the author (DG 39695), and scholarships to graduate students. Further funding was provided by the University of Calgary Research Grants Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeta R, 2012, BIOL LETTERS, V8, P401, DOI 10.1098/rsbl.2011.1009; Bain J.R., 1986, Florida Scientist, V49, P22; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Brunet-Rossinni Anja K., 2009, P315; BURNETT C D, 1983, Annals of Carnegie Museum, V52, P139; BURNETT CD, 1983, J MAMMAL, V64, P437, DOI 10.2307/1380356; CAGLE FR, 1950, J MAMMAL, V31, P400, DOI 10.2307/1375106; Cagnacci A, 2005, FERTIL STERIL, V84, P246, DOI 10.1016/j.fertnstert.2004.12.054; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; CHARNOV E L, 1982; Chaverri G, 2006, J ZOOL, V270, P650, DOI 10.1111/j.1469-7998.2006.00171.x; CHRISTIAN JOHN J., 1956, AMER MIDLAND NAT, V55, P66, DOI 10.2307/2422322; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; CLUTTONBROCK TH, 1986, Q REV BIOL, V61, P339, DOI 10.1086/415033; Cockburn A, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P266, DOI 10.1017/CBO9780511542053.014; Daan S, 1996, BEHAV ECOL, V7, P426, DOI 10.1093/beheco/7.4.426; DIJKSTRA C, 1990, FUNCT ECOL, V4, P143, DOI 10.2307/2389333; Entwistle AC, 2000, J ZOOL, V252, P11, DOI 10.1017/S095283690000902X; Fisher RA, 1930, GENETICAL THEORY NAT; Freed LA, 2009, EVOL ECOL RES, V11, P731; French AR, 2000, LIFE IN THE COLD, P111; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Garroway CJ, 2007, J MAMMAL, V88, P1305, DOI 10.1644/06-MAMM-A-212R2.1; GRIFFIN DONALD R., 1940, JOUR MAMMAL, V21, P181, DOI 10.2307/1374974; GRINEVITCH L, 1995, J ZOOL, V235, P301, DOI 10.1111/j.1469-7998.1995.tb05146.x; HITCHCOCK HAROLD B., 1965, CAN FIELD NATUR, V79, P4; Holand O, 2006, P ROY SOC B-BIOL SCI, V273, P293, DOI 10.1098/rspb.2005.3330; Holroyd SL, 1993, THESIS U CALGARY; Hood WR, 2002, J ZOOL, V258, P355, DOI 10.1017/S0952836902001504; KRACKOW S, 1995, BIOL REV, V70, P225, DOI 10.1111/j.1469-185X.1995.tb01066.x; Kruger O, 2005, P ROY SOC B-BIOL SCI, V272, P375, DOI 10.1098/rspb.2004.2943; KUNZ TH, 1974, J MAMMAL, V55, P1, DOI 10.2307/1379252; KURTA A, 1990, Mammalian Species, P1, DOI 10.2307/3504258; Lerchl A, 1998, HUM REPROD, V13, P1401, DOI 10.1093/humrep/13.5.1401; Martin JGA, 2011, ECOLOGY, V92, P441, DOI 10.1890/09-2413.1; Mensing-Solick YR, 2003, ACTA CHIROPTEROL, V5, P91, DOI 10.3161/001.005.0108; MICHENER GR, 1985, J MAMMAL, V66, P280, DOI 10.2307/1381240; MILLER ROLAND E., 1939, JOUR MORPH, V64, P267, DOI 10.1002/jmor.1050640205; Millesi E, 1999, ETHOLOGY, V105, P163, DOI 10.1046/j.1439-0310.1999.00379.x; MILLIGAN BN, 1993, CAN J ZOOL, V71, P937, DOI 10.1139/z93-122; MILLS RS, 1975, J MAMMAL, V56, P591, DOI 10.2307/1379471; Monadjem A, 2005, BELG J ZOOL, V135, P103; MURIE JO, 1982, J MAMMAL, V63, P431, DOI 10.2307/1380440; Navara KJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P127, DOI 10.1086/648487; O'Donnell CFJ, 2002, J ZOOL, V257, P311, DOI 10.1017/S0952836902000912; O'Shea TJ, 2010, J MAMMAL, V91, P418, DOI 10.1644/08-MAMM-A-295.1; Racey P.A., 1973, Journal Reprod Fert, V19, P175; RACEY PA, 1981, J REPROD FERTIL, V61, P123; Racey Paul A., 2009, P249; RANSOME RD, 1994, ZOOL J LINN SOC-LOND, V112, P337, DOI 10.1006/zjls.1994.1046; RANSOME RD, 1973, PERIOD BIOL, V75, P169; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Robert KA, 2011, MAMMAL REV, V41, P1, DOI 10.1111/j.1365-2907.2010.00168.x; Sakisaka Y, 2000, MOL ECOL, V9, P1711, DOI 10.1046/j.1365-294x.2000.01038.x; SCHOWALTER DB, 1979, CAN FIELD NAT, V93, P48; Sheldon BC, 2004, AM NAT, V163, P40, DOI 10.1086/381003; STIRLING I, 1971, J MAMMAL, V52, P842, DOI 10.2307/1378943; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Tuttle M.D., 1982, P105; Veeroja R, 2010, J ANIM ECOL, V79, P169, DOI 10.1111/j.1365-2656.2009.01599.x; Vonhof MJ, 2006, MOL ECOL, V15, P241, DOI 10.1111/j.1365-294X.2005.02801.x; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WRIGHT DD, 1995, AM NAT, V145, P133, DOI 10.1086/285732; ZIJLSTRA M, 1992, FUNCT ECOL, V6, P553, DOI 10.2307/2390052	68	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36344	10.1371/journal.pone.0036344	http://dx.doi.org/10.1371/journal.pone.0036344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570704	gold, Green Published, Green Submitted			2022-12-27	WOS:000305343400020
J	Schiffer, AM; Ahlheim, C; Wurm, MF; Schubotz, RI				Schiffer, Anne-Marike; Ahlheim, Christiane; Wurm, Moritz F.; Schubotz, Ricarda I.			Surprised at All the Entropy: Hippocampal, Caudate and Midbrain Contributions to Learning from Prediction Errors	PLOS ONE			English	Article							NEOCORTICAL CONTRIBUTIONS; STIMULUS REPRESENTATION; RECOGNITION MEMORY; INFORMATION-THEORY; DORSAL STRIATUM; BASAL GANGLIA; SYSTEMS; UNCERTAINTY; SUBSTRATE; DOPAMINE	Influential concepts in neuroscientific research cast the brain a predictive machine that revises its predictions when they are violated by sensory input. This relates to the predictive coding account of perception, but also to learning. Learning from prediction errors has been suggested for take place in the hippocampal memory system as well as in the basal ganglia. The present fMRI study used an action-observation paradigm to investigate the contributions of the hippocampus, caudate nucleus and midbrain dopaminergic system to different types of learning: learning in the absence of prediction errors, learning from prediction errors, and responding to the accumulation of prediction errors in unpredictable stimulus configurations. We conducted analyses of the regions of interests' BOLD response towards these different types of learning, implementing a bootstrapping procedure to correct for false positives. We found both, caudate nucleus and the hippocampus to be activated by perceptual prediction errors. The hippocampal responses seemed to relate to the associative mismatch between a stored representation and current sensory input. Moreover, its response was significantly influenced by the average information, or Shannon entropy of the stimulus material. In accordance with earlier results, the habenula was activated by perceptual prediction errors. Lastly, we found that the substantia nigra was activated by the novelty of sensory input. In sum, we established that the midbrain dopaminergic system, the hippocampus, and the caudate nucleus were to different degrees significantly involved in the three different types of learning: acquisition of new information, learning from prediction errors and responding to unpredictable stimulus developments. We relate learning from perceptual prediction errors to the concept of predictive coding and related information theoretic accounts.	[Schiffer, Anne-Marike] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Schiffer, Anne-Marike; Ahlheim, Christiane; Wurm, Moritz F.; Schubotz, Ricarda I.] Max Planck Inst Neurol Res, Motor Cognit Grp, D-50931 Cologne, Germany; [Ahlheim, Christiane; Schubotz, Ricarda I.] Univ Munster, Inst Psychol, Munster, Germany; [Wurm, Moritz F.] Univ Trento, Ctr Mind Brain Sci, Mattarello, Italy	University of Oxford; Max Planck Society; University of Munster; University of Trento	Schiffer, AM (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	anne-marike.schiffer@psy.ox.ac.uk	Schubotz, Ricarda/B-2871-2013; Wurm, Moritz/AAB-2603-2019	Wurm, Moritz/0000-0003-4358-9815; Schubotz, Ricarda/0000-0001-5802-6869; Schiffer, Marike/0000-0002-7102-4064	Max Planck Institute	Max Planck Institute(Foundation CELLEX)	The Max Planck Institute financed the fMRI study (http://www.nf.mpg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Atallah HE, 2004, NEUROBIOL LEARN MEM, V82, P253, DOI 10.1016/j.nlm.2004.06.004; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Bubic A, 2010, FRONTIERS HUMAN NEUR; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Colder B, 2011, FRONTIERS HUMAN NEUR; Crapse TB, 2008, PROG BRAIN RES, V171, P383, DOI 10.1016/S0079-6123(08)00656-0; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Davis T, J EXP PSYCH IN PRESS; den Ouden HEJ, 2010, J NEUROSCI, V30, P11177; Devan BD, 1999, J NEUROSCI, V19, P2789; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Doya K., 2007, BAYESIAN BRAIN PROBA, P3, DOI [10.7551/mitpress/9780262042383.003.0001, DOI 10.7551/MITPRESS/9780262042383.003.0001]; Dusek JA, 1997, P NATL ACAD SCI USA, V94, P7109, DOI 10.1073/pnas.94.13.7109; Duzel E, 2003, J NEUROSCI, V23, P9439; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2002, PROG NEUROBIOL, V68, P113, DOI 10.1016/S0301-0082(02)00076-X; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; GLUCK MA, 1993, HIPPOCAMPUS, V3, P491, DOI 10.1002/hipo.450030410; Gluck MA, 2005, NEURAL NETWORKS, V18, P1265, DOI 10.1016/j.neunet.2005.08.003; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Harrison LM, 2006, NEURAL NETWORKS, V19, P535, DOI 10.1016/j.neunet.2005.11.002; Hikosaka O, 2008, CURR OPIN NEUROBIOL, V18, P203, DOI 10.1016/j.conb.2008.07.002; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kersten D, 2011, OBJECT PERCEPTION BA; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kumaran D, 2008, NEURON, V60, P197, DOI 10.1016/j.neuron.2008.10.007; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2009, PHILOS T R SOC B, V364, P1193, DOI 10.1098/rstb.2008.0316; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Luce RD, 2003, REV GEN PSYCHOL, V7, P183, DOI 10.1037/1089-2680.7.2.183; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty J, 2003, CURRENT OPINION NEUR, V14, P769; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rugg MD, 2008, PROG BRAIN RES, V169, P339, DOI 10.1016/S0079-6123(07)00021-0; Schiffer AM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00038; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schutz-Bosbach Simone, 2007, Cogn Process, V8, P93, DOI 10.1007/s10339-007-0167-x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shohamy D, 2010, TRENDS COGN SCI, V14, P464, DOI 10.1016/j.tics.2010.08.002; Spicer J, 2007, NEUROIMAGE, V34, P455, DOI 10.1016/j.neuroimage.2006.09.012; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Summerfield C, 2006, SCIENCE, V314, P1311, DOI 10.1126/science.1132028; Talairach J., 1988, COPLANAR STEREOTAXIC; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Turk-Browne NB, 2010, J NEUROSCI, V30, P11177, DOI 10.1523/JNEUROSCI.0858-10.2010; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	68	39	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36445	10.1371/journal.pone.0036445	http://dx.doi.org/10.1371/journal.pone.0036445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570715	gold, Green Published			2022-12-27	WOS:000305343400031
J	Whelly, S; Johnson, S; Powell, J; Borchardt, C; Hastert, MC; Cornwall, GA				Whelly, Sandra; Johnson, Seethal; Powell, Jonathan; Borchardt, Clinton; Hastert, Mary Catherine; Cornwall, Gail A.			Nonpathological Extracellular Amyloid Is Present during Normal Epididymal Sperm Maturation	PLOS ONE			English	Article							CYSTATIN-C; FIBRILS; OLIGOMERS; PROTEIN; CRES	Amyloids are aggregated proteins characterized by a specific cross-beta-sheet structure and are typically associated with neurodegenerative diseases including Alzheimer's disease. Recently, however, several nonpathological amyloids have been found in intracellular organelles of normal mammalian tissues suggesting that amyloid may also carry out biological functions. We previously have shown that the epididymal cystatin CRES (cystatin-related epididymal spermatogenic), cst8, a reproductive-specific member of the cystatin superfamily of cysteine protease inhibitors, forms amyloid in vitro suggesting that CRES amyloid may also form in vivo within the epididymal lumen. Here we show that amyloid structures containing CRES are a component of the normal mouse epididymal lumen without any apparent cytotoxic effects on spermatozoa and that these structures change along the length of the tubule. These studies suggest the presence of a functional amyloid structure that may carry out roles in sperm maturation or maintenance of the luminal milieu and which itself may undergo maturational changes along the epididymis. In contrast to previous examples of functional amyloid which were intracellular, our studies now show that nonpathological/functional amyloid can also be extracellular. The presence of an extracellular and nonpathological amyloid in the epididymis suggests that similar amyloid structures may be present in other organ systems and may carry out distinctive tissue-specific functions.	[Whelly, Sandra; Johnson, Seethal; Powell, Jonathan; Borchardt, Clinton; Cornwall, Gail A.] Texas Tech Univ Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA; [Hastert, Mary Catherine] Texas Tech Univ, Dept Biol, Imaging Ctr, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University	Whelly, S (corresponding author), Texas Tech Univ Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79409 USA.	gail.cornwall@ttuhsc.edu			National Institutes of Health (NIH) [HD56182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056182] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health (NIH) HD56182 to G. A. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; CORNWALL GA, 1995, MOL REPROD DEV, V41, P37, DOI 10.1002/mrd.1080410107; Cornwall GA, 2007, GENETICS OF MALE INFERTILITY, P211, DOI 10.1007/978-1-59745-176-5_13; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; EANES ED, 1968, J HISTOCHEM CYTOCHEM, V16, P673, DOI 10.1177/16.11.673; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Lane A, 2003, CLIN CHEM, V49, P1774, DOI 10.1373/49.10.1774; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Parent AD, 2011, J ANDROL, V32, P444, DOI 10.2164/jandrol.110.010694; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Sabate R, 2008, J STRUCT BIOL, V162, P387, DOI 10.1016/j.jsb.2008.02.002; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Turner TT, 2007, ASIAN J ANDROL, V9, P565, DOI 10.1111/j.1745-7262.2007.00302.x; van Rooijen BD, 2010, CURR PROTEIN PEPT SC, V11, P334; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wang X, 2008, PRION, V2, P57, DOI 10.4161/pri.2.2.6746	24	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36394	10.1371/journal.pone.0036394	http://dx.doi.org/10.1371/journal.pone.0036394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570708	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400024
J	Lefebvre, KA; Frame, ER; Gulland, F; Hansen, JD; Kendrick, PS; Beyer, RP; Bammler, TK; Farin, FM; Hiolski, EM; Smith, DR; Marcinek, DJ				Lefebvre, Kathi A.; Frame, Elizabeth R.; Gulland, Frances; Hansen, John D.; Kendrick, Preston S.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Hiolski, Emma M.; Smith, Donald R.; Marcinek, David J.			A Novel Antibody-Based Biomarker for Chronic Algal Toxin Exposure and Sub-Acute Neurotoxicity	PLOS ONE			English	Article							CALIFORNIA SEA LIONS; DOMOIC ACID TOXICITY; ZALOPHUS-CALIFORNIANUS; CLINICAL SIGNS; SPECIFICITY; MORTALITY; INNATE; BRAIN; CELLS; SELF	The neurotoxic amino acid, domoic acid (DA), is naturally produced by marine phytoplankton and presents a significant threat to the health of marine mammals, seabirds and humans via transfer of the toxin through the foodweb. In humans, acute exposure causes a neurotoxic illness known as amnesic shellfish poisoning characterized by seizures, memory loss, coma and death. Regular monitoring for high DA levels in edible shellfish tissues has been effective in protecting human consumers from acute DA exposure. However, chronic low-level DA exposure remains a concern, particularly in coastal and tribal communities that subsistence harvest shellfish known to contain low levels of the toxin. Domoic acid exposure via consumption of planktivorous fish also has a profound health impact on California sea lions (Zalophus californianus) affecting hundreds of animals yearly. Due to increasing algal toxin exposure threats globally, there is a critical need for reliable diagnostic tests for assessing chronic DA exposure in humans and wildlife. Here we report the discovery of a novel DA-specific antibody response that is a signature of chronic low-level exposure identified initially in a zebrafish exposure model and confirmed in naturally exposed wild sea lions. Additionally, we found that chronic exposure in zebrafish caused increased neurologic sensitivity to DA, revealing that repetitive exposure to DA well below the threshold for acute behavioral toxicity has underlying neurotoxic consequences. The discovery that chronic exposure to low levels of a small, water-soluble single amino acid triggers a detectable antibody response is surprising and has profound implications for the development of diagnostic tests for exposure to other pervasive environmental toxins.	[Lefebvre, Kathi A.; Frame, Elizabeth R.; Kendrick, Preston S.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Gulland, Frances] Marine Mammal Ctr, Sausalito, CA USA; [Hansen, John D.] US Geol Survey, Western Fisheries Res Ctr, Seattle, WA USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Hiolski, Emma M.; Smith, Donald R.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Marcinek, David J.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Marcinek, David J.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lefebvre, KA (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	Kathi.Lefebvre@noaa.gov		Marcinek, David/0000-0001-5187-2149	NOAA-ECOHAB program; UW NIEHS [P30ES07033]; NIH [AG036606]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021930, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036606] Funding Source: NIH RePORTER	NOAA-ECOHAB program(National Oceanic Atmospheric Admin (NOAA) - USA); UW NIEHS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this research was provided by the NOAA-ECOHAB program. This work was also supported in part by the UW NIEHS sponsored Center for Ecogenetics & Environmental Health (P30ES07033) and NIH AG036606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA K, 1984, J IMMUNOL, V133, P3286; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Colvocoresses JA, CHARACTERIZATION HUM; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goldstein T, 2008, P ROY SOC B-BIOL SCI, V275, P267, DOI 10.1098/rspb.2007.1221; Grattan LM, 2009, 5 S HARMF ALG US C P; Gulland FMD, 2002, VET REC, V150, P475; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HENKART PA, 1977, J EXP MED, V146, P1068, DOI 10.1084/jem.146.4.1068; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JANEWAY CA, 1978, J EXP MED, V147, P1065, DOI 10.1084/jem.147.4.1065; Kirkham PA, 2011, AM J RESP CRIT CARE, V184, P796, DOI 10.1164/rccm.201010-1605OC; Lefebvre KA, 1999, NAT TOXINS, V7, P85, DOI 10.1002/(SICI)1522-7189(199905/06)7:3<85::AID-NT39>3.0.CO;2-Q; Lefebvre KA, 2010, TOXICON, V56, P218, DOI 10.1016/j.toxicon.2009.05.034; Lefebvre KA, 2009, TOXICOL SCI, V107, P65, DOI 10.1093/toxsci/kfn207; MARTIN S, 1995, EUR J IMMUNOL, V25, P2788, DOI 10.1002/eji.1830251012; McGeer PL, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00077; Montie EW, 2010, DIS AQUAT ORGAN, V91, P243, DOI 10.3354/dao02259; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Silvagni PA, 2005, VET PATHOL, V42, P184, DOI 10.1354/vp.42-2-184; Skuljec J, 2011, CELL IMMUNOL, V270, P164, DOI 10.1016/j.cellimm.2011.05.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; TODD ECD, 1993, J FOOD PROTECT, V56, P69, DOI 10.4315/0362-028X-56.1.69; TRUELOVE J, 1994, B ENVIRON CONTAM TOX, V52, P479; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Wekell JC, 2004, J SHELLFISH RES, V23, P927; Wekell John C., 1994, Natural Toxins, V2, P197, DOI 10.1002/nt.2620020408; YOSHIDA T, 1970, J IMMUNOL, V105, P306	32	26	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36213	10.1371/journal.pone.0036213	http://dx.doi.org/10.1371/journal.pone.0036213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567140	Green Published, gold			2022-12-27	WOS:000305341500059
J	Ma, Z; Zhang, H; Yi, L; Fan, HJ; Lu, CP				Ma, Zhe; Zhang, Hui; Yi, Li; Fan, Hongjie; Lu, Chengping			Microarray Analysis of the Effect of Streptococcus equi subsp zooepidemicus M-Like Protein in Infecting Porcine Pulmonary Alveolar Macrophage	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION DATA; IMMUNE-RESPONSES; PHAGOCYTOSIS; ACTIVATION; PATHWAY; CELLS; MENINGITIS; SECRETION	Streptococcus equi subsp. zooepidemicus (S. zooepidemicus), which belongs to Lancefield group C streptococci, is an important pathogen of domesticated species, causing septicemia, meningitis and mammitis. M-like protein (SzP) is an important virulence factor of S. zooepidemicus and contributes to bacterial infection and antiphagocytosis. To increase our knowledge of the mechanism of SzP in infection, we profiled the response of porcine pulmonary alveolar macrophage (PAM) to infection with S. zooepidemicus ATCC35246 wild strain (WD) and SzP-knockout strain (KO) using the Roche NimbleGen Porcine Genome Expression Array. We found SzP contributed to differential expression of 446 genes, with upregulation of 134 genes and downregulation of 312 genes. Gene Ontology category and KEGG pathway were analyzed for relationships among differentially expressed genes. These genes were represented in a variety of functional categories, including genes involved in immune response, regulation of chemokine production, signal transduction and regulation of apoptosis. The reliability of the data obtained from the microarray was verified by performing quantitative real-time PCR on 12 representative genes. The data will contribute to understanding of SzP mediated mechanisms of S. zooepidemicus pathogenesis.	[Ma, Zhe; Zhang, Hui; Yi, Li; Fan, Hongjie; Lu, Chengping] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Ma, Z (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	fhj@njau.edu.cn			Program for New Century Excellent Talents (NCET) at the University of China [NCET-08-0794]; National Transgenic Major Program [2009ZX08009-154B]; Key Technology Program, Jiangsu [R65286D, BE2009388]; Fundamental Research Funds for the Central Universities [KYT 201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions	Program for New Century Excellent Talents (NCET) at the University of China(Program for New Century Excellent Talents in University (NCET)); National Transgenic Major Program; Key Technology Program, Jiangsu; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was supported by the Program for New Century Excellent Talents (NCET) at the University of China (NCET-08-0794), the National Transgenic Major Program (2009ZX08009-154B), the Key Technology Program (R65286D), Jiangsu (BE2009388), the Fundamental Research Funds for the Central Universities (KYT 201003), and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Barichello T, 2009, NEUROSCI LETT, V467, P217, DOI 10.1016/j.neulet.2009.10.039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISNO AL, 1979, INFECT IMMUN, V26, P1172, DOI 10.1128/IAI.26.3.1172-1176.1979; CAMPO RE, 1995, J INFECT DIS, V171, P601, DOI 10.1093/infdis/171.3.601; Chae P, 2002, INFECT IMMUN, V70, P3164, DOI 10.1128/IAI.70.6.3164-3169.2002; Dey R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005188; Ernst JD, 2000, CELL MICROBIOL, V2, P379, DOI 10.1046/j.1462-5822.2000.00075.x; Eyre DW, 2010, EUR J CLIN MICROBIOL; Fan HJ, 2009, VACCINE, V27, P56, DOI 10.1016/j.vaccine.2008.10.037; Feng ZG., 1977, ANIM HUSBANDRY VET M, V2, P7; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Heras AL, 2002, J CLIN MICROBIOL, V40, P1106, DOI 10.1128/JCM.40.3.1106-1108.2002; Hess DJ, 2009, J SURG RES, V155, P217, DOI 10.1016/j.jss.2008.07.022; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Ichinose S, 2006, INT J ONCOL, V29, P349; Jovanovic M, 2008, J MED MICROBIOL, V57, P373, DOI 10.1099/jmm.0.47487-0; Liu ML, 2011, VET MICROBIOL, V150, P126, DOI 10.1016/j.vetmic.2010.12.014; Liu PeiHong, 2001, Chinese Journal of Veterinary Science, V21, P42; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032099; Marodi L, 2000, INFECT IMMUN, V68, P2167, DOI 10.1128/IAI.68.4.2167-2170.2000; MOORE BO, 1969, J AM VET MED ASSOC, V155, P416; Mostefaoui Y, 2004, CELL MICROBIOL, V6, P1085, DOI 10.1111/j.1462-5822.2004.00420.x; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soedarmanto I, 1996, J CLIN MICROBIOL, V34, P2201, DOI 10.1128/JCM.34.9.2201-2204.1996; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; TIMONEY JF, 1995, INFECT IMMUN, V63, P1440, DOI 10.1128/IAI.63.4.1440-1445.1995; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Ural O, 2003, SCAND J INFECT DIS, V35, P206, DOI 10.1080/00365540310000076; Vallejo JG, 2000, J IMMUNOL, V165, P419, DOI 10.4049/jimmunol.165.1.419; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Xu H, 2007, BIOCHEM BIOPH RES CO, V353, P812, DOI 10.1016/j.bbrc.2006.12.108; YOON IJ, 1992, J VET DIAGN INVEST, V4, P139, DOI 10.1177/104063879200400204; You YO, 2004, J ETHNOPHARMACOL, V92, P331, DOI 10.1016/j.jep.2004.03.023; Zheng H, 2011, VET MICROBIOL	41	4	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36452	10.1371/journal.pone.0036452	http://dx.doi.org/10.1371/journal.pone.0036452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567158	Green Published, gold			2022-12-27	WOS:000305341500077
J	Mitra, R; Sapolsky, RM				Mitra, Rupshi; Sapolsky, Robert M.			Short-Term Enrichment Makes Male Rats More Attractive, More Defensive and Alters Hypothalamic Neurons	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; FACTOR MESSENGER-RNA; FREELY MOVING RATS; ELEVATED PLUS-MAZE; ENVIRONMENTAL ENRICHMENT; SYNAPTIC-TRANSMISSION; NEURAL PLASTICITY; SEXUAL SELECTION; RECEPTOR-BINDING; CHRONIC STRESS	Innate behaviors are shaped by contingencies built during evolutionary history. On the other hand, environmental stimuli play a significant role in shaping behavior. In particular, a short period of environmental enrichment can enhance cognitive behavior, modify effects of stress on learned behaviors and induce brain plasticity. It is unclear if modulation by environment can extend to innate behaviors which are preserved by intense selection pressure. In the present report we investigate this issue by studying effects of relatively short (14-days) environmental enrichment on two prominent innate behaviors in rats, avoidance of predator odors and ability of males to attract mates. We show that enrichment has strong effects on both the innate behaviors: a) enriched males were more avoidant of a predator odor than non-enriched controls, and had a greater rise in corticosterone levels in response to the odor; and b) had higher testosterone levels and were more attractive to females. Additionally, we demonstrate decrease in dendritic length of neurons of ventrolateral nucleus of hypothalamus, important for reproductive mate-choice and increase in the same in dorsomedial nucleus, important for defensive behavior. Thus, behavioral and hormonal observations provide evidence that a short period of environmental manipulation can alter innate behaviors, providing a good example of gene-environment interaction.	[Mitra, Rupshi] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Mitra, Rupshi] Nanyang Technol Univ, Div Psychol, Singapore, Singapore; [Sapolsky, Robert M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Stanford University	Mitra, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	rupshi@gmail.com	Mitra, Rupshi/B-5055-2008	Mitra, Rupshi/0000-0003-1440-8931	National Institutes of Health, USA [RO1 AGO 20633]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, USA, (RO1 AGO 20633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able DJ, 1996, P NATL ACAD SCI USA, V93, P2229, DOI 10.1073/pnas.93.5.2229; Adamec RE, 2006, NEUROSCI BIOBEHAV R, V30, P356, DOI 10.1016/j.neubiorev.2005.04.004; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bakker J, 1996, PHYSIOL BEHAV, V60, P489, DOI 10.1016/S0031-9384(96)80023-0; Barreca S, 2003, BRAIN INJURY, V17, P1065, DOI 10.1080/0269905031000110535; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Blanchard RJ, 1998, PHYSIOL BEHAV, V65, P201, DOI 10.1016/S0031-9384(98)00012-2; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; BROWN TJ, 1994, MOL CELL NEUROSCI, V5, P549, DOI 10.1006/mcne.1994.1067; Buchhold B, 2007, RESTOR NEUROL NEUROS, V25, P467; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; COOPER RM, 1958, CAN J PSYCHOLOGY, V12, P159, DOI 10.1037/h0083747; Correll CM, 2005, BIOL PSYCHIAT, V58, P382, DOI 10.1016/j.biopsych.2005.04.009; DENENBERG VH, 1968, J COMP PHYSIOL PSYCH, V66, P533, DOI 10.1037/h0026345; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; Dielenberg RA, 1999, J COMP PSYCHOL, V113, P376, DOI 10.1037/0735-7036.113.4.376; Dielenberg RA, 2001, NEUROSCIENCE, V104, P1085, DOI 10.1016/S0306-4522(01)00150-6; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; FERNANDEZTERUEL A, 1992, NEUROSCI LETT, V137, P185, DOI 10.1016/0304-3940(92)90400-2; Friske JE, 2005, PHYSIOL BEHAV, V85, P187, DOI 10.1016/j.physbeh.2005.03.022; Gelfo F, 2009, NEUROBIOL LEARN MEM, V91, P353, DOI 10.1016/j.nlm.2009.01.010; Gortz N, 2008, BEHAV BRAIN RES, V191, P43, DOI 10.1016/j.bbr.2008.03.006; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAMMER RP, 1992, PHARMACOL BIOCHEM BE, V42, P25, DOI 10.1016/0091-3057(92)90440-Q; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Imanaka A, 2008, BEHAV BRAIN RES, V186, P91, DOI 10.1016/j.bbr.2007.07.039; Irvine GI, 2006, HIPPOCAMPUS, V16, P149, DOI 10.1002/hipo.20142; Irvine GI, 2005, NEUROSCI LETT, V391, P32, DOI 10.1016/j.neulet.2005.08.031; Iwata E, 2007, PHYSIOL BEHAV, V91, P318, DOI 10.1016/j.physbeh.2007.03.013; Johansson BB, 2000, STROKE, V31, P223, DOI 10.1161/01.STR.31.1.223; Jones AG, 2009, P NATL ACAD SCI USA, V106, P10001, DOI 10.1073/pnas.0901129106; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kolber BJ, 2008, P NATL ACAD SCI USA, V105, P12004, DOI 10.1073/pnas.0803216105; Korte SM, 2003, EUR J PHARMACOL, V463, P163, DOI 10.1016/S0014-2999(03)01279-2; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; LEVINE S, 1957, SCIENCE, V126, P405, DOI 10.1126/science.126.3270.405; Lores-Arnaiz S, 2006, BEHAV BRAIN RES, V169, P294, DOI 10.1016/j.bbr.2006.01.016; Magalhaes A, 2004, ANN NY ACAD SCI, V1025, P619, DOI 10.1196/annals.1316.077; MCEWEN BS, 1991, J STEROID BIOCHEM, V39, P223, DOI 10.1016/0960-0760(91)90067-F; Mitra R, EXPERT OPIN BIOL THE, V10, P1289; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Mitra R, 2009, BEHAV BRAIN RES, V205, P535, DOI 10.1016/j.bbr.2009.08.014; Mitra R, 2009, STRESS, V12, P305, DOI 10.1080/10253890802379955; Mong JA, 1999, J NEUROBIOL, V40, P602, DOI 10.1002/(SICI)1097-4695(19990915)40:4<602::AID-NEU14>3.0.CO;2-O; Moriceau S, 2006, J NEUROSCI, V26, P6737, DOI 10.1523/JNEUROSCI.0499-06.2006; Moriceau S, 2009, J NEUROSCI, V29, P15745, DOI 10.1523/JNEUROSCI.4106-09.2009; Papes F, CELL, V141, P692; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Ponmanickam P, GEN COMP ENDOCRINOL, V167, P35; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rema V, 2006, NEUROSCIENCE, V140, P659, DOI 10.1016/j.neuroscience.2006.02.043; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Ribeiro-Barbosa ER, 2005, NEUROSCI BIOBEHAV R, V29, P1255, DOI 10.1016/j.neubiorev.2005.04.006; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Sa SI, 2005, NEUROSCIENCE, V133, P919, DOI 10.1016/j.neuroscience.2005.02.033; Saucier DM, 2007, BRAIN RES, V1170, P31, DOI 10.1016/j.brainres.2007.07.020; Savioz A, 2009, BRAIN RES BULL, V80, P309, DOI 10.1016/j.brainresbull.2009.06.006; Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; Sztainberg Y, 2010, MOL PSYCHIATR, V15, P905, DOI 10.1038/mp.2009.151; TAYLOR GT, 1983, J ENDOCRINOL, V96, P43, DOI 10.1677/joe.0.0960043; TAYLOR GT, 1982, PHYSIOL BEHAV, V28, P953, DOI 10.1016/0031-9384(82)90159-7; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Vyas A, 2002, J NEUROSCI, V22, P6810; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449; Zewail-Foote M, 2009, PHYSIOL BEHAV, V96, P98, DOI 10.1016/j.physbeh.2008.09.007; Zhao LR, 2000, NEUROSCIENCE, V97, P177, DOI 10.1016/S0306-4522(00)00023-3; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	79	29	29	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36092	10.1371/journal.pone.0036092	http://dx.doi.org/10.1371/journal.pone.0036092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567125	Green Published, gold			2022-12-27	WOS:000305341500043
J	Rodriguez, KA; Edrey, YH; Osmulski, P; Gaczynska, M; Buffenstein, R				Rodriguez, Karl A.; Edrey, Yael H.; Osmulski, Pawel; Gaczynska, Maria; Buffenstein, Rochelle			Altered Composition of Liver Proteasome Assemblies Contributes to Enhanced Proteasome Activity in the Exceptionally Long-Lived Naked Mole-Rat	PLOS ONE			English	Article							SISTER-CHROMATID SEPARATION; NF-KAPPA-B; OXIDATIVE-STRESS; 20S PROTEASOME; LIVING RODENT; PROTEIN-DEGRADATION; IMMUNOPROTEASOME; LONGEVITY; MECHANISMS; RESISTANCE	The longest-lived rodent, the naked mole-rat (Bathyergidae; Heterocephalus glaber), maintains robust health for at least 75% of its 32 year lifespan, suggesting that the decline in genomic integrity or protein homeostasis routinely observed during aging, is either attenuated or delayed in this extraordinarily long-lived species. The ubiquitin proteasome system (UPS) plays an integral role in protein homeostasis by degrading oxidatively-damaged and misfolded proteins. In this study, we examined proteasome activity in naked mole-rats and mice in whole liver lysates as well as three subcellular fractions to probe the mechanisms behind the apparently enhanced effectiveness of UPS. We found that when compared with mouse samples, naked mole-rats had significantly higher chymotrypsin-like (ChT-L) activity and a two-fold increase in trypsin-like (T-L) in both whole lysates as well as cytosolic fractions. Native gel electrophoresis of the whole tissue lysates showed that the 20S proteasome was more active in the longer-lived species and that 26S proteasome was both more active and more populous. Western blot analyses revealed that both 19S subunits and immunoproteasome catalytic subunits are present in greater amounts in the naked mole-rat suggesting that the observed higher specific activity may be due to the greater proportion of immunoproteasomes in livers of healthy young adults. It thus appears that proteasomes in this species are primed for the efficient removal of stress-damaged proteins. Further characterization of the naked mole-rat proteasome and its regulation could lead to important insights on how the cells in these animals handle increased stress and protein damage to maintain a longer health in their tissues and ultimately a longer life.	[Rodriguez, Karl A.; Edrey, Yael H.; Osmulski, Pawel; Gaczynska, Maria; Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Sam & Ann Barshop Inst Aging & Longev Studies, San Antonio, TX USA; [Rodriguez, Karl A.; Edrey, Yael H.; Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA; [Osmulski, Pawel; Gaczynska, Maria] Univ Texas San Antonio, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX USA; [Buffenstein, Rochelle] Univ Texas San Antonio, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio	Rodriguez, KA (corresponding author), Univ Texas San Antonio, Hlth Sci Ctr, Sam & Ann Barshop Inst Aging & Longev Studies, San Antonio, TX USA.	Buffenstein@uthscsa.edu	Rodriguez, Karl A/F-2689-2012; Osmulski, Pawel/C-7751-2019	Osmulski, Pawel/0000-0002-5359-9200	Institutional Postdoctoral Fellow Training Grant [T32 AG021890-08]; Ellison Medical Foundation [AGSS-178006]; Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING [T32AG021890, R01AG022891, R21AG043912] Funding Source: NIH RePORTER	Institutional Postdoctoral Fellow Training Grant; Ellison Medical Foundation(Lawrence Ellison Foundation); Glenn Foundation for Medical Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	T32 AG021890-08 (NIA) Institutional Postdoctoral Fellow Training Grant (KR), AGSS-178006 (RB is PI) Ellison Medical Foundation (Genomic Stability in the Naked Mole-Rat: A Role for Cancer Resistance and Extended Longevity) (http://www.ellisonfoundation.org/), and Glenn Foundation for Medical Research (RB is PI). (Comparative biological mechanisms of aging, insights from the longest lived rodent, the naked mole-rat) (http://glennfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Arendt CS, 1997, P NATL ACAD SCI USA, V94, P7156, DOI 10.1073/pnas.94.14.7156; Bajorek M, 2004, CELL MOL LIFE SCI, V61, P1579, DOI 10.1007/s00018-004-4131-y; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dasuri K, 2009, FREE RADICAL RES, V43, P28, DOI 10.1080/10715760802534812; Dasuri K, 2010, FREE RADICAL BIO MED, V49, P1290, DOI 10.1016/j.freeradbiomed.2010.07.014; de Magalhaes JP, 2007, J GERONTOL A-BIOL, V62, P149; Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Enenkel C, 1998, EMBO J, V17, P6144, DOI 10.1093/emboj/17.21.6144; Ferrington DA, 2008, J NEUROCHEM, V106, P158, DOI 10.1111/j.1471-4159.2008.05345.x; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Gaczynska M, 2005, METHOD ENZYMOL, V398, P425, DOI 10.1016/S0076-6879(05)98035-X; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; HENDIL KB, 1993, ENZYME PROTEIN, V47, P232, DOI 10.1159/000468682; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x; Ikeno Y, 2005, J GERONTOL A-BIOL, V60, P1510, DOI 10.1093/gerona/60.12.1510; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kapahi P, 1999, FREE RADICAL BIO MED, V26, P495, DOI 10.1016/S0891-5849(98)00323-2; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Lam YA, 2002, NATURE, V416, P763, DOI 10.1038/416763a; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Lewis KN, 2010, INTEGR COMP BIOL, V50, P829, DOI 10.1093/icb/icq034; Li J, 2011, FASEB J, V25, P883, DOI 10.1096/fj.10-160895; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rodgers KJ, 2003, INT J BIOCHEM CELL B, V35, P716, DOI 10.1016/S1357-2725(02)00391-6; Rodriguez KA, 2010, MECH AGEING DEV, V131, P144, DOI 10.1016/j.mad.2010.01.002; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Wang JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001048; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Yanagida M, 2000, GENES CELLS, V5, P1, DOI 10.1046/j.1365-2443.2000.00306.x; Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	65	77	83	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35890	10.1371/journal.pone.0035890	http://dx.doi.org/10.1371/journal.pone.0035890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567116	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500034
J	Wegiel, J; Frackowiak, J; Mazur-Kolecka, B; Schanen, NC; Cook, EH; Sigman, M; Brown, WT; Kuchna, I; Wegiel, J; Nowicki, K; Imaki, H; Ma, SY; Chauhan, A; Chauhan, V; Miller, DL; Mehta, PD; Flory, M; Cohen, IL; London, E; Reisberg, B; de Leon, MJ; Wisniewski, T				Wegiel, Jerzy; Frackowiak, Janusz; Mazur-Kolecka, Bozena; Schanen, N. Carolyn; Cook, Edwin H., Jr.; Sigman, Marian; Brown, W. Ted; Kuchna, Izabela; Wegiel, Jarek; Nowicki, Krzysztof; Imaki, Humi; Ma, Shuang Yong; Chauhan, Abha; Chauhan, Ved; Miller, David L.; Mehta, Pankaj D.; Flory, Michael; Cohen, Ira L.; London, Eric; Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas			Abnormal Intracellular Accumulation and Extracellular A beta Deposition in Idiopathic and Dup15q11.2-q13 Autism Spectrum Disorders	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; DIFFUSE PLAQUES; MONOCLONAL-ANTIBODIES; LIPID-PEROXIDATION; OXIDATIVE STRESS; BRAIN-INJURY; PATHOGENESIS; APP	Background: It has been shown that amyloid beta (A beta), a product of proteolytic cleavage of the amyloid beta precursor protein (APP), accumulates in neuronal cytoplasm in non-affected individuals in a cell type-specific amount. Methodology/Principal Findings: In the present study, we found that the percentage of amyloid-positive neurons increases in subjects diagnosed with idiopathic autism and subjects diagnosed with duplication 15q11.2-q13 (dup15) and autism spectrum disorder (ASD). In spite of interindividual differences within each examined group, levels of intraneuronal A beta load were significantly greater in the dup(15) autism group than in either the control or the idiopathic autism group in 11 of 12 examined regions (p<0.0001 for all comparisons; Kruskall-Wallis test). In eight regions, intraneuronal A beta load differed significantly between idiopathic autism and control groups (p<0.0001). The intraneuronal A beta was mainly N-terminally truncated. Increased intraneuronal accumulation of A beta(17-40/42) in children and adults suggests a life-long enhancement of APP processing with alpha-secretase in autistic subjects. A beta accumulation in neuronal endosomes, autophagic vacuoles, Lamp1-positive lysosomes and lipofuscin, as revealed by confocal microscopy, indicates that products of enhanced alpha-secretase processing accumulate in organelles involved in proteolysis and storage of metabolic remnants. Diffuse plaques containing A beta(1-40/42) detected in three subjects with ASD, 39 to 52 years of age, suggest that there is an age-associated risk of alterations of APP processing with an intraneuronal accumulation of a short form of A beta and an extracellular deposition of full-length A beta in nonfibrillar plaques. Conclusions/Significance: The higher prevalence of excessive A beta accumulation in neurons in individuals with early onset of intractable seizures, and with a high risk of sudden unexpected death in epilepsy in autistic subjects with dup(15) compared to subjects with idiopathic ASD, supports the concept of mechanistic and functional links between autism, epilepsy and alterations of APP processing leading to neuronal and astrocytic A beta accumulation and diffuse plaque formation.	[Wegiel, Jerzy; Frackowiak, Janusz; Mazur-Kolecka, Bozena; Kuchna, Izabela; Wegiel, Jarek; Nowicki, Krzysztof; Imaki, Humi; Ma, Shuang Yong; Mehta, Pankaj D.; Wisniewski, Thomas] NYS Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA; [Schanen, N. Carolyn] DuPont Hosp Children, Wilmington, DE USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Sigman, Marian] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Brown, W. Ted] NYS Inst Basic Res Dev Disabil, Dept Human Genet, Staten Isl, NY USA; [Chauhan, Abha; Chauhan, Ved] NYS Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY USA; [Miller, David L.] NYS Inst Basic Res Dev Disabil, Dept Mol Biol, Staten Isl, NY USA; [Flory, Michael; Cohen, Ira L.; London, Eric] NYS Inst Basic Res Dev Disabil, Dept Psychol, Staten Isl, NY USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Dept Neurol, Sch Med, New York, NY 10016 USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Reisberg, Barry; de Leon, Mony J.; Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA	Nemours Alfred I. duPont Hospital for Children; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California Los Angeles; New York University; New York University; New York University	Wegiel, J (corresponding author), NYS Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA.	Jerzy.Wegiel@opwdd.ny.gov	Wisniewski, Thomas/Q-6525-2019; de Leon, Mony/AAP-7890-2021; Brown, William/GXN-2777-2022	Wisniewski, Thomas/0000-0002-3379-8966; Reisberg, Barry/0000-0002-9104-7423; Cook, Edwin/0000-0002-5848-5114; de Leon, Mony/0000-0003-2245-4380	New York State Office for People with Developmental Disabilities; U.S. Department of Defense [AS073234]; Autism Speaks (Princeton, NJ); National Institutes of Health, National Institute of Child Health and Human Development [R01 HD43960]; NIH [U19 HD35470]; PHS [R24-MH 068855]; National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043960, U19HD035470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG012101, R01AG022374] Funding Source: NIH RePORTER	New York State Office for People with Developmental Disabilities; U.S. Department of Defense(United States Department of Defense); Autism Speaks (Princeton, NJ); National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by funds from the New York State Office for People with Developmental Disabilities, a grant from the U.S. Department of Defense Autism Spectrum Disorders Research Program (AS073234, Program Project; Jerzy Wegiel, TW, AC), a grant from Autism Speaks (Princeton, NJ; Jerzy Wegiel), and grant R01 HD43960 (Jerzy Wegiel) from the National Institutes of Health, National Institute of Child Health and Human Development. Clinical and molecular investigations of the subjects with chromosome 15 duplication were supported by the Collaborative Programs for Excellence in Autism Research (NIH U19 HD35470; NCS) and Nemours Biomedical Research, duPont Hospital for Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; The authors thank Maureen Marlow for editorial corrections, Elaine Marchi for help in laboratory work coordination, and Jadwiga Wegiel, Cathy Wang and En Wu Zhang for histology and immunocytochemistry. Tissue and clinical records acquisition was coordinated by the Autism Tissue Program, Autism Speaks (Princeton, NJ; Directors: Jane Pickett, Ph.D. and Daniel Lightfoot, Ph.D.). Carolyn Komich Hare provided results of post-mortem application of ADI-R. The tissue was obtained from the Harvard Brain Tissue Resource Center, Belmont, MA, supported in part by PHS grant number R24-MH 068855; the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore, MD; and the Brain Bank and Tissue Bank for Developmental Disabilities and Aging of the New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY. We are deeply indebted to the Dup15q Alliance for supporting this project and to the families of the tissue donors who have made this study possible.	Akyol O, 2002, PROG NEURO-PSYCHOPH, V26, P995, DOI 10.1016/S0278-5846(02)00220-8; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bailey AR, 2008, INT J CLIN EXP MED, V1, P338; BANCHER C, 1989, NEUROBIOL AGING, V10, P125, DOI 10.1016/0197-4580(89)90021-3; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; BRODY H, 1960, J GERONTOL, V15, P258, DOI 10.1093/geronj/15.3.258; BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N; Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan V, 2010, AUTISM: OXIDATIVE STRESS, INFLAMMATION, AND IMMUNE ABNORMALITIES, P177; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Frackowiak J, 2003, J NEUROPATH EXP NEUR, V62, P685, DOI 10.1093/jnen/62.6.685; Frackowiak J, 2004, BRAIN RES, V1002, P67, DOI 10.1016/j.brainres.2003.12.015; Funato H, 1998, AM J PATHOL, V152, P983; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GORDON PB, 1992, BIOCHEM J, V283, P361, DOI 10.1042/bj2830361; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; GOWING E, 1994, J BIOL CHEM, V269, P10987; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Gyure KA, 2001, ARCH PATHOL LAB MED, V125, P489; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Herken H, 2001, MOL PSYCHIATR, V6, P66, DOI 10.1038/sj.mp.4000789; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; IQBAL K, 1993, J HISTOTECHNOL, V16, P335, DOI 10.1179/his.1993.16.4.335; IVERSEN LL, 1995, BIOCHEM J, V311, P1; JELLINGER K, 1988, ACTA NEUROPATHOL, V76, P142, DOI 10.1007/BF00688098; Kent L, 1999, DEV MED CHILD NEUROL, V41, P153, DOI 10.1017/S001216229900033X; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KIM KS, 1990, NEUROSCI RES COMMUN, V7, P113; KITAMOTO T, 1987, LAB INVEST, V57, P230; Lalowski M, 1996, J BIOL CHEM, V271, P33623, DOI 10.1074/jbc.271.52.33623; Lopez-Hurtado E., 2008, AM J BIOCH BIOTECHNO, V4, P130, DOI DOI 10.3844/AJBBSP.2008.130.145; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; MANN DMA, 1989, NEUROPATH APPL NEURO, V15, P317, DOI 10.1111/j.1365-2990.1989.tb01232.x; Mann SM, 2004, HUM GENET, V115, P104, DOI 10.1007/s00439-004-1127-5; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller DL, 2011, J ALZHEIMERS DIS, V23, P293, DOI 10.3233/JAD-2010-101341; Miller DL, 2003, BIOCHEMISTRY-US, V42, P11682, DOI 10.1021/bi030100s; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Moechars D, 1996, EMBO J, V15, P1265, DOI 10.1002/j.1460-2075.1996.tb00468.x; Murakami N, 1998, J NEUROTRAUM, V15, P993, DOI 10.1089/neu.1998.15.993; NODA T, 1992, J CELL BIOL, V119, P85, DOI 10.1083/jcb.119.1.85; OHM TG, 1995, NEUROSCIENCE, V64, P209, DOI 10.1016/0306-4522(95)90397-P; Pigino G, 2003, J NEUROSCI, V23, P4499; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; PROBST A, 1991, ACTA NEUROPATHOL, V83, P21, DOI 10.1007/BF00294426; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Rineer S, 1998, AM J MED GENET, V81, P428, DOI 10.1002/(SICI)1096-8628(19980907)81:5<428::AID-AJMG12>3.0.CO;2-E; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROZEMULLER JM, 1989, J NEUROPATH EXP NEUR, V48, P674, DOI 10.1097/00005072-198911000-00009; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sheikh AM, 2010, NEUROSCIENCE, V165, P363, DOI 10.1016/j.neuroscience.2009.10.035; SIEGEL S, 1988, NONPARAMETRIC STAT, P206; Simon EW, 2000, AM J MED GENET, V96, P432, DOI 10.1002/1096-8628(20000612)96:3<432::AID-AJMG39>3.0.CO;2-T; SOHAL RS, 1989, ADV EXP MED BIOL, V266, P17; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Sokol DK, 2006, J CHILD NEUROL, V21, P444, DOI 10.1177/08830738060210062201; Tagliavini F, 1989, Prog Clin Biol Res, V317, P1001; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Terman A, 2004, INT J BIOCHEM CELL B, V36, P1400, DOI 10.1016/j.biocel.2003.08.009; Thal DR, 1999, CLIN NEUROPATHOL, V18, P226; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Wegiel J., 1999, NEUROSCIENCE NEWS, V2, P34; Wegiel J, 2012, J NEUROPATH IN PRESS; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Westmark CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026549; Westmark CJ, 2010, INT J CLIN EXP PATHO, V3, P56; Westmark CJ, 2008, INT J CLIN EXP PATHO, V1, P157; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Wisniewski HM, 1996, NEUROPATH APPL NEURO, V22, P3, DOI 10.1046/j.1365-2990.1996.1698016.x; Wisniewski HM, 1998, J NEUROPATH EXP NEUR, V57, P674, DOI 10.1097/00005072-199807000-00004; Yamaguchi H, 1998, ACTA NEUROPATHOL, V95, P217, DOI 10.1007/s004010050790; Yanik M, 2004, EUR ARCH PSY CLIN N, V254, P43, DOI 10.1007/s00406-004-0453-x	90	37	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35414	10.1371/journal.pone.0035414	http://dx.doi.org/10.1371/journal.pone.0035414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567102	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341500020
J	Hu, G; Xu, XH; Wang, YL; Lu, G; Feeley, KJ; Yu, MJ				Hu, Guang; Xu, Xuehong; Wang, Yuling; Lu, Gao; Feeley, Kenneth J.; Yu, Mingjian			Regeneration of Different Plant Functional Types in a Masson Pine Forest Following Pine Wilt Disease	PLOS ONE			English	Article							SHADE TOLERANCE; STAND STRUCTURE; WESTERN JAPAN; DISTURBANCE; TRAITS; VEGETATION; SEEDLINGS; NEMATODE; FIRE; ECOSYSTEMS	Pine wilt disease is a severe threat to the native pine forests in East Asia. Understanding the natural regeneration of the forests disturbed by pine wilt disease is thus critical for the conservation of biodiversity in this realm. We studied the dynamics of composition and structure within different plant functional types (PFTs) in Masson pine forests affected by pine wilt disease (PWD). Based on plant traits, all species were assigned to four PFTs: evergreen woody species (PFT1), deciduous woody species (PFT2), herbs (PFT3), and ferns (PFT4). We analyzed the changes in these PFTs during the initial disturbance period and during post-disturbance regeneration. The species richness, abundance and basal area, as well as life-stage structure of the PFTs changed differently after pine wilt disease. The direction of plant community regeneration depended on the differential response of the PFTs. PFT1, which has a higher tolerance to disturbances, became dominant during the post-disturbance regeneration, and a young evergreen-broad-leaved forest developed quickly after PWD. Results also indicated that the impacts of PWD were dampened by the feedbacks between PFTs and the microclimate, in which PFT4 played an important ecological role. In conclusion, we propose management at the functional type level instead of at the population level as a promising approach in ecological restoration and biodiversity conservation.	[Hu, Guang; Yu, Mingjian] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Xuehong] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Wang, Yuling] State Forestry Adm, Gen Stn Forest Pest Management, Shenyang, Peoples R China; [Lu, Gao] Xiangshan Forest Pest Control & Quarantine Stn, Xianshan, Peoples R China; [Feeley, Kenneth J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA	Zhejiang University; Chinese Academy of Sciences; Institute of Botany, CAS; State University System of Florida; Florida International University	Hu, G (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Hu, Guang/AAF-1689-2020; Feeley, Kenneth James/A-7631-2009	Feeley, Kenneth James/0000-0002-3618-1144; Hu, Guang/0000-0002-4390-6166	National Key Basic Research Project of China [2000046803]; Science and Technology Project of Zhejiang Province [2007C22084]	National Key Basic Research Project of China(National Basic Research Program of China); Science and Technology Project of Zhejiang Province	The funders "National Key Basic Research Project of China (No. 2000046803)" and "Science and Technology Project of Zhejiang Province (2007C22084)" supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman DMJS, 2005, AUST J BOT, V53, P379, DOI 10.1071/BT05022; Chineses National Forestry Bureau, 2011, ANN CHIN NAT FOR BUR, P2011; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Department of Forestry of Zhejiang Province, 2002, NAT RES ZHEJ FOR; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Drever CR, 2006, FOREST ECOL MANAG, V231, P27, DOI 10.1016/j.foreco.2006.04.039; Drobyshev I, 2008, FOREST ECOL MANAG, V256, P1723, DOI 10.1016/j.foreco.2008.05.017; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Editorial Committee of Flora of Zhejiang, 1993, FLOR ZHEJ; ENDA N, 1997, FOREST PESTS, V46, P182; Eviner VT, 2004, ECOLOGY, V85, P2215, DOI 10.1890/03-0405; Ewers BE, 2008, PLANT ECOL, V194, P67, DOI 10.1007/s11258-007-9275-z; Fujihara M, 1996, J VEG SCI, V7, P729, DOI 10.2307/3236384; Fujihara M, 2002, FOREST ECOL MANAG, V170, P55, DOI 10.1016/S0378-1127(01)00779-4; Fujihara M., 1995, NAT HIST RES, V3, P161; Fujihara M, 1997, NATURAL HIST RES, V4, P113; Futai K, 2003, MASS DIEBACK PINE TR; GREENBERG CH, 1995, AM MIDL NAT, V133, P149, DOI 10.2307/2426356; Ke G, 1999, ACTA OECOL, V20, P579, DOI 10.1016/S1146-609X(99)00103-4; Khan A, 1991, PAKISTAN J NEMATOL, V9, P57; Kleyer M, 1999, J VEG SCI, V10, P697, DOI 10.2307/3237084; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Korner K, 2008, ECOL MODEL, V210, P287, DOI 10.1016/j.ecolmodel.2007.08.002; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lindenmayer DB, 1997, CONSERV BIOL, V11, P1053, DOI 10.1046/j.1523-1739.1997.96150.x; Mamiya U, 1986, FOREST PEST, V35, P145; McIntyre S, 1999, J VEG SCI, V10, P604, DOI 10.1111/j.1654-1103.1999.tb00103.x; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Moghaddas EEY, 2007, FOREST ECOL MANAG, V250, P156, DOI 10.1016/j.foreco.2007.05.011; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nakagoshi N., 1987, ROLE FIRE ECOLOGICAL, P91; Navarro T, 2006, J ARID ENVIRON, V64, P298, DOI 10.1016/j.jaridenv.2005.05.005; NOBLE IR, 1980, VEGETATIO, V43, P5, DOI 10.1007/BF00121013; Noble IR, 1996, J VEG SCI, V7, P337; Olsen MF, 1989, ASPECTS ECOLOGY PHYS; Pausas JG, 1999, J VEG SCI, V10, P717, DOI 10.2307/3237086; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Rusch GM, 2003, J VEG SCI, V14, P307, DOI 10.1658/1100-9233(2003)014[0307:PFTIRT]2.0.CO;2; Sakamoto K., 1995, J JAP SOC REVEGET TE, V21, P18; Shi J, 2007, J INTEGR PLANT BIOL, V49, P1763, DOI 10.1111/j.1744-7909.2007.00613.x; Shibuya M, 2004, ECOL RES, V19, P301, DOI 10.1111/j.1440-1703.2004.00639.x; Shimizu Y, 2005, ECOL RES, V20, P708, DOI 10.1007/s11284-005-0087-0; TAODA H, 1988, Hikobia, V10, P119; Toyohara G, 1998, APPL VEG SCI, V1, P259, DOI 10.2307/1478956; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Walters MB, 1996, ECOLOGY, V77, P841, DOI 10.2307/2265505; Xue L, 2008, ECOL RES, V23, P689, DOI 10.1007/s11284-007-0427-3; Yu MJ, 2011, BIOL INVASIONS, V13, P1283, DOI 10.1007/s10530-010-9889-2; Zhang QF, 1999, CAN J FOREST RES, V29, P106, DOI 10.1139/cjfr-29-1-106	49	9	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36432	10.1371/journal.pone.0036432	http://dx.doi.org/10.1371/journal.pone.0036432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563499	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340700048
J	Nganou-Makamdop, K; van Gemert, GJ; Arens, T; Hermsen, CC; Sauerwein, RW				Nganou-Makamdop, Krystelle; van Gemert, Geert-Jan; Arens, Theo; Hermsen, Cornelus C.; Sauerwein, Robert W.			Long Term Protection after Immunization with P. berghei Sporozoites Correlates with Sustained IFN gamma Responses of Hepatic CD8+Memory T Cells	PLOS ONE			English	Article							ATTENUATED PLASMODIUM-BERGHEI; MALARIA LIVER STAGE; BLOOD-STAGE; PROTRACTED PROTECTION; VACCINE; IMMUNITY; PARASITE; MICE; INOCULATION	Protection against P. berghei malaria can successfully be induced in mice by immunization with both radiation attenuated sporozoites (RAS) arresting early during liver stage development, or sporozoites combined with chloroquine chemoprophylaxis (CPS), resulting in complete intra-hepatic parasite development before killing of blood-stages by chloroquine takes place. We assessed the longevity of protective cellular immune responses by RAS and CPS P. berghei immunization of C57BL/6j mice. Strong effector and memory (T-EM) CD8+ T cell responses were induced predominantly in the liver of both RAS and CPS immunized mice while CD4+ T cells with memory phenotype remained at base line levels. Compared to unprotected naive mice, we found high sporozoite-specific IFN gamma ex vivo responses that associated with induced levels of in vivo CD8+ TEM cells in the liver but not spleen. Long term evaluation over a period of 9 months showed a decline of malaria-specific IFN gamma responses in RAS and CPS mice that significantly correlated with loss of protection (r(2) = 0.60, p<0.0001). The reducing IFN gamma response by hepatic memory CD8+ T cells could be boosted by re-exposure to wildtype sporozoites. Our data show that sustainable protection against malaria associates with distinct intra-hepatic immune responses characterized by strong IFN gamma producing CD8+ memory T cells.	[Nganou-Makamdop, Krystelle; van Gemert, Geert-Jan; Arens, Theo; Hermsen, Cornelus C.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Nganou-Makamdop, K (corresponding author), Radboud Univ Nijmegen, Dept Med Microbiol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	r.sauerwein@mmb.umcn.nl	Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013		NWO-Mozaiek (The Netherlands Organisation for Scientific Research) [017.005.011]	NWO-Mozaiek (The Netherlands Organisation for Scientific Research)	Financial support for this study was provided by NWO-Mozaiek (The Netherlands Organisation for Scientific Research) grant No. 017.005.011 (K. Nganou-Makamdop recipient). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoura T, 2012, VACCINE, V30, P2662, DOI 10.1016/j.vaccine.2012.02.010; Belnoue E, 2004, J IMMUNOL, V172, P2487, DOI 10.4049/jimmunol.172.4.2487; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Berenzon D, 2003, J IMMUNOL, V171, P2024, DOI 10.4049/jimmunol.171.4.2024; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Friesen J, 2011, VACCINE, V29, P7002, DOI 10.1016/j.vaccine.2011.07.034; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Jobe O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005075; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McCall MBB, 2010, J LEUKOCYTE BIOL, V88, P1131, DOI 10.1189/jlb.0310137; McCarthy JS, 2010, HUM VACCINES, V6, P114, DOI 10.4161/hv.6.1.10394; ORJIH AU, 1985, CLIN EXP IMMUNOL, V61, P67; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SCHELLER LF, 1995, J PARASITOL, V81, P58, DOI 10.2307/3284006; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; Sedegah M, 2007, PARASITE IMMUNOL, V29, P559, DOI 10.1111/j.1365-3024.2007.00976.x; Teirlinck AC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002389; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Vaughan AM, 2010, HUM VACCINES, V6, P107, DOI 10.4161/hv.6.1.9654; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515	25	54	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36508	10.1371/journal.pone.0036508	http://dx.doi.org/10.1371/journal.pone.0036508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563506	Green Published, gold, Green Submitted			2022-12-27	WOS:000305340700055
J	Bee, C; Abdiche, YN; Stone, DM; Collier, S; Lindquist, KC; Pinkerton, AC; Pons, J; Rajpal, A				Bee, Christine; Abdiche, Yasmina N.; Stone, Donna M.; Collier, Sierra; Lindquist, Kevin C.; Pinkerton, Alanna C.; Pons, Jaume; Rajpal, Arvind			Exploring the Dynamic Range of the Kinetic Exclusion Assay in Characterizing Antigen-Antibody Interactions	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; BINDING-PROPERTIES; CHELATE COMPLEXES; AFFINITY; ASSOCIATION; TECHNOLOGY; BIACORE; PROTEIN; FAMILY	Therapeutic antibodies are often engineered or selected to have high on-target binding affinities that can be challenging to determine precisely by most biophysical methods. Here, we explore the dynamic range of the kinetic exclusion assay (KinExA) by exploiting the interactions of an anti-DKK antibody with a panel of DKK antigens as a model system. By tailoring the KinExA to each studied antigen, we obtained apparent equilibrium dissociation constants (K-D values) spanning six orders of magnitude, from approximately 100 fM to 100 nM. Using a previously calibrated antibody concentration and working in a suitable concentration range, we show that a single experiment can yield accurate and precise values for both the apparent K-D and the apparent active concentration of the antigen, thereby increasing the information content of an assay and decreasing sample consumption. Orthogonal measurements obtained on Biacore and Octet label-free biosensor platforms further validated our KinExA-derived affinity and active concentration determinations. We obtained excellent agreement in the apparent affinities obtained across platforms and within the KinExA method irrespective of the assay orientation employed or the purity of the recombinant or native antigens.	[Bee, Christine; Abdiche, Yasmina N.; Stone, Donna M.; Collier, Sierra; Lindquist, Kevin C.; Pinkerton, Alanna C.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat, San Francisco, CA 94080 USA	Pfizer	Bee, C (corresponding author), Pfizer Inc, Rinat, San Francisco, CA 94080 USA.	Yasmina.Abdiche@pfizer.com		Lindquist, Kevin/0000-0001-6059-7425				Blake DA, 1996, J BIOL CHEM, V271, P27677, DOI 10.1074/jbc.271.44.27677; Blake RC, 1999, ANAL BIOCHEM, V272, P123, DOI 10.1006/abio.1999.4176; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Fleury D, 2008, PROTEIN EXPRES PURIF, V60, P74, DOI 10.1016/j.pep.2008.03.023; Glass TR, 2004, ANAL CHIM ACTA, V517, P161, DOI 10.1016/j.aca.2004.04.038; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; Khosraviani M, 2000, BIOCONJUGATE CHEM, V11, P267, DOI 10.1021/bc9901548; Kostenuik PJ, 2009, J BONE MINER RES, V24, P182, DOI [10.1359/jbmr.081112, 10.1359/JBMR.081112]; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Navratilova I, 2005, ANAL BIOCHEM, V344, P295, DOI 10.1016/j.ab.2005.05.025; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Owyang AM, 2011, MABS-AUSTIN, V3, P49, DOI 10.4161/mabs.3.1.13989; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Rathanaswami P, 2011, ANAL BIOCHEM, V414, P7, DOI 10.1016/j.ab.2011.02.034; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Sigmundsson K, 2002, BIOCHEMISTRY-US, V41, P8263, DOI 10.1021/bi020099h; Xie L, 2005, J IMMUNOL METHODS, V304, P1, DOI 10.1016/j.jim.2005.04.009	22	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36261	10.1371/journal.pone.0036261	http://dx.doi.org/10.1371/journal.pone.0036261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558410	gold, Green Published, Green Submitted			2022-12-27	WOS:000305340200057
J	Namdar, M; Gebhard, C; Studiger, R; Shi, Y; Mocharla, P; Schmied, C; Brugada, P; Luscher, TF; Camici, GG				Namdar, Mehdi; Gebhard, Catherine; Studiger, Rafael; Shi, Yi; Mocharla, Pavani; Schmied, Christian; Brugada, Pedro; Luescher, Thomas F.; Camici, Giovanni G.			Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease	PLOS ONE			English	Article							DEPENDENT CONTRACTIONS; ENZYME REPLACEMENT; ADHESION MOLECULE-1; OXIDATIVE STRESS; KNOCKOUT MOUSE; MICE; ATHEROSCLEROSIS; EXPRESSION; GLOBOTRIAOSYLCERAMIDE; HYPERTENSION	Background: Fabry disease (FD) is caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (GLA) resulting in the accumulation of globotriaosylsphingosine (Gb3) in a variety of tissues. While GLA deficiency was always considered as the fulcrum of the disease, recent attention shifted towards studying the mechanisms through which Gb3 accumulation in vascular cells leads to endothelial dysfunction and eventually multiorgan failure. In addition to the well-described macrovascular disease, FD is also characterized by abnormalities of microvascular function, which have been demonstrated by measurements of myocardial blood flow and coronary flow reserve. To date, the relative importance of Gb3 accumulation versus GLA deficiency in causing endothelial dysfunction is not fully understood; furthermore, its differential effects on cardiac micro-and macrovascular endothelial cells are not known. Methods and Results: In order to assess the effects of Gb3 accumulation versus GLA deficiency, human macro-and microvascular cardiac endothelial cells (ECs) were incubated with Gb3 or silenced by siRNA to GLA. Gb3 loading caused deregulation of several key endothelial pathways such as eNOS, iNOS, COX-1 and COX-2, while GLA silencing showed no effects. Cardiac microvascular ECs showed a greater susceptibility to Gb3 loading as compared to macrovascular ECs. Conclusions: Deregulation of key endothelial pathways as observed in FD vasculopathy is likely caused by intracellular Gb3 accumulation rather than deficiency of GLA. Human microvascular ECs, as opposed to macrovascular ECs, seem to be affected earlier and more severely by Gb3 accumulation and this notion may prove fundamental for future progresses in early diagnosis and management of FD patients.	[Namdar, Mehdi; Brugada, Pedro] Heart Rhythm Management Ctr UZB, Brussels, Belgium; [Namdar, Mehdi; Gebhard, Catherine; Schmied, Christian; Luescher, Thomas F.] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Gebhard, Catherine; Studiger, Rafael; Shi, Yi; Mocharla, Pavani; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Studiger, Rafael; Luescher, Thomas F.; Camici, Giovanni G.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Namdar, M (corresponding author), Heart Rhythm Management Ctr UZB, Brussels, Belgium.	giovannic@access.uzh.ch	Shi, Yi/GXG-2318-2022; Gebhard, Catherine/AAT-7060-2020; Camici, Giovanni/H-1631-2018	Gebhard, Catherine/0000-0001-7240-5822; Camici, Giovanni/0000-0002-0523-0695; Shi, Yi/0000-0003-3005-9655; Namdar, Mehdi/0000-0002-5779-7431	Genzyme; Swiss National Science Foundation [310030_130500]	Genzyme(Sanofi-AventisGenzyme Corporation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a research grant from Genzyme and by the Swiss National Science Foundation (grant no. 310030_130500 to GGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Altarescu G, 2001, STROKE, V32, P1559, DOI 10.1161/01.STR.32.7.1559; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; Bodary PF, 2005, CIRCULATION, V111, P629, DOI 10.1161/01.CIR.0000154550.15963.80; Bulut D, 2003, J HYPERTENS, V21, P1663, DOI 10.1097/00004872-200309000-00015; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Crutchfield KE, 1998, NEUROLOGY, V50, P1746, DOI 10.1212/WNL.50.6.1746; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Demuth K, 2002, ACTA PAEDIATR, V91, P57, DOI 10.1080/080352502762457941; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eitzman DT, 2003, J AM SOC NEPHROL, V14, P298, DOI 10.1097/01.ASN.0000043901.45141.D4; Elliott PM, 2006, HEART, V92, P357, DOI 10.1136/hrt.2004.054015; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Gebhard C, 2010, BASIC RES CARDIOL, V105, P349, DOI 10.1007/s00395-009-0060-0; GREWAL RP, 1994, J NEUROL, V241, P153; Hartford M, 2007, J INTERN MED, V262, P526, DOI 10.1111/j.1365-2796.2007.01862.x; Kalliokoski RJ, 2005, J INHERIT METAB DIS, V28, P563, DOI 10.1007/s10545-005-0563-2; Kanda A, 2000, VIRCHOWS ARCH, V436, P36, DOI 10.1007/PL00008196; Kuhlencordt PJ, 2001, CIRCULATION, V103, P3099, DOI 10.1161/01.CIR.103.25.3099; Merat S, 2000, J GERONTOL A-BIOL, V55, pB85; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Moore DF, 2001, CIRCULATION, V104, P1506, DOI 10.1161/hc3801.096352; Park JL, 2008, CLIN EXP PHARMACOL P, V35, P1156, DOI 10.1111/j.1440-1681.2008.04984.x; Park JL, 2009, AM J PHYSIOL-HEART C, V296, pH1133, DOI 10.1152/ajpheart.00929.2008; Ries M, 2007, J CLIN PHARMACOL, V47, P1222, DOI 10.1177/0091270007305299; Rombach SM, 2010, MOL GENET METAB, V99, P99, DOI 10.1016/j.ymgme.2009.10.004; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Shu LM, 2009, J AM SOC NEPHROL, V20, P1975, DOI 10.1681/ASN.2008111190; Szerafin T, 2006, CIRC RES, V99, pE12, DOI 10.1161/01.RES.0000241051.83067.62; Tang EHC, 2007, BRIT J PHARMACOL, V151, P15, DOI 10.1038/sj.bjp.0707190; Tang EHC, 2005, J CARDIOVASC PHARM, V46, P761, DOI 10.1097/01.fjc.0000187174.67661.67; Thomaidis T, 2009, KIDNEY INT, V75, P399, DOI 10.1038/ki.2008.576; Vanhoutte PM, 2005, BRIT J PHARMACOL, V144, P449, DOI 10.1038/sj.bjp.0706042; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; Yang D, 2002, BRIT J PHARMACOL, V136, P104, DOI 10.1038/sj.bjp.0704669; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	38	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36373	10.1371/journal.pone.0036373	http://dx.doi.org/10.1371/journal.pone.0036373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558451	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305340200072
J	Barbieri, M; Di Filippo, C; Esposito, A; Marfella, R; Rizzo, MR; D'Amico, M; Ferraraccio, F; Di Ronza, C; Duan, SZ; Mortensen, RM; Rossi, F; Paolisso, G				Barbieri, Michelangela; Di Filippo, Clara; Esposito, Antonietta; Marfella, Raffaele; Rizzo, Maria Rosaria; D'Amico, Michele; Ferraraccio, Franca; Di Ronza, Cristina; Duan, Sheng Zhong; Mortensen, Richard M.; Rossi, Francesco; Paolisso, Giuseppe			Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-gamma - Knockout (CM-PGKO) Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; QUANTITATIVE-ANALYSIS; LIPID-ACCUMULATION; HEART; HYPERTROPHY; EXPRESSION; ROSIGLITAZONE; PIOGLITAZONE	Understanding the molecular regulatory mechanisms controlling for myocardial lipid metabolism is of critical importance for the development of new therapeutic strategies for heart diseases. The role of PPAR gamma and thiazolidinediones in regulation of myocardial lipid metabolism is controversial. The aim of our study was to assess the role of PPAR gamma on myocardial lipid metabolism and function and differentiate local/from systemic actions of PPARs agonists using cardiomyocyte-specific PPAR gamma -knockout (CM-PGKO) mice. To this aim, the effect of PPAR gamma, PPAR gamma/PPAR alpha and PPAR alpha agonists on cardiac function, intra-myocyte lipid accumulation and myocardial expression profile of genes and proteins, affecting lipid oxidation, uptake, synthesis, and storage (CD36, CPT1MIIA, AOX, FAS, SREBP1-c and ADPR) was evaluated in cardiomyocyte-specific PPAR gamma -knockout (CM-PGKO) and littermate control mice undergoing standard and high fat diet (HFD). At baseline, protein levels and mRNA expression of genes involved in lipid uptake, oxidation, synthesis, and accumulation of CM-PGKO mice were not significantly different from those of their littermate controls. At baseline, no difference in myocardial lipid content was found between CM-PGKO and littermate controls. In standard condition, pioglitazone and rosiglitazone do not affect myocardial metabolism while, fenofibrate treatment significantly increased CD36 and CPT1MIIA gene expression. In both CM-PGKO and control mice submitted to HFD, six weeks of treatment with rosiglitazone, fenofibrate and pioglitazone lowered myocardial lipid accumulation shifting myocardial substrate utilization towards greater contribution of glucose. In conclusion, at baseline, PPAR gamma does not play a crucial role in regulating cardiac metabolism in mice, probably due to its low myocardial expression. PPARs agonists, indirectly protect myocardium from lipotoxic damage likely reducing fatty acids delivery to the heart through the actions on adipose tissue. Nevertheless a direct non- PPAR gamma mediated mechanism of PPAR gamma agonist could not be ruled out.	[Barbieri, Michelangela; Esposito, Antonietta; Marfella, Raffaele; Rizzo, Maria Rosaria; Paolisso, Giuseppe] Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy; [Di Filippo, Clara; D'Amico, Michele; Di Ronza, Cristina; Rossi, Francesco] Univ Naples 2, Sect Pharmacol L Donatelli, Dept Expt Med, Naples, Italy; [Ferraraccio, Franca] Univ Naples 2, Dept Prevent Med, Naples, Italy; [Duan, Sheng Zhong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Metab Endocrinol & Diabet Div, Ann Arbor, MI USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Metab Endocrinol & Diabet Div, Ann Arbor, MI 48109 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Metab Endocrinol & Diabet Div, Ann Arbor, MI USA	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Barbieri, M (corresponding author), Univ Naples 2, Dept Geriatr Med & Metab Dis, Naples, Italy.	giuseppe.paolisso@unina2.it	Rizzo, Maria Rosaria/AHH-3649-2022; Rizzo, Maria/HGD-6576-2022; Marfella, Raffaele/AAH-2595-2019; paolisso, giuseppe/AAP-8516-2020; Barbieri, Michelangela/K-2192-2016; rizzo, maria rosaria R/J-1968-2016	Rizzo, Maria Rosaria/0000-0002-1023-4260; Marfella, Raffaele/0000-0003-3960-9270; paolisso, giuseppe/0000-0002-2137-455X; Barbieri, Michelangela/0000-0002-9223-5792; rizzo, maria rosaria R/0000-0002-1023-4260; d'amico, michele/0000-0002-6899-0595; duan, sheng zhong/0000-0001-5399-7252	NIDDK NIH HHS [P30 DK020572] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel ED, 1999, J CLIN INVEST, V104, P1703, DOI 10.1172/JCI7605; Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Baranowski M, 2008, ARCH BIOCHEM BIOPHYS, V477, P86, DOI 10.1016/j.abb.2008.05.015; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Birnbaum Y, 2011, BASIC RES CARDIOL, V106, P431, DOI 10.1007/s00395-011-0162-3; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Chaggar PS, 2009, DIABETES VASC DIS RE, V6, P146, DOI 10.1177/1479164109338772; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Ding GL, 2007, CARDIOVASC RES, V76, P269, DOI 10.1016/j.cardiores.2007.06.027; Ding GL, 2007, J MOL CELL CARDIOL, V43, P73, DOI 10.1016/j.yjmcc.2007.04.014; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Erdmann E, 2010, J DIABETES, V2, P212, DOI 10.1111/j.1753-0407.2010.00082.x; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Fang XP, 2010, AM J PHYSIOL-ENDOC M, V299, pE721, DOI 10.1152/ajpendo.00086.2010; Frantz S, 2004, BRIT J PHARMACOL, V141, P9, DOI 10.1038/sj.bjp.0705585; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Gurnell M, 2003, CLIN ENDOCRINOL, V59, P267, DOI 10.1046/j.1365-2265.2003.01767.x; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Luo JW, 2011, AM J TRANSL RES, V3, P61; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Mehrabi MR, 2003, EUR J HEART FAIL, V5, P733, DOI 10.1016/S1388-9842(03)00148-X; Mughal RS, 2009, CLIN EXP PHARMACOL P, V36, P478, DOI 10.1111/j.1440-1681.2008.05088.x; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Patel D, 2011, JACC-CARDIOVASC INTE, V4, P353, DOI 10.1016/j.jcin.2010.10.016; Ren LQ, 2010, CELL BIOCHEM FUNCT, V28, P58, DOI 10.1002/cbf.1621; Ren YS, 2009, VASC PHARMACOL, V51, P169, DOI 10.1016/j.vph.2009.06.004; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Vikramadithyan RK, 2005, J PHARMACOL EXP THER, V313, P586, DOI 10.1124/jpet.104.080259; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Yamamoto K, 2001, CIRCULATION, V104, P1670, DOI 10.1161/hc4001.097186; Yue TL, 2001, CIRCULATION, V104, P2588, DOI 10.1161/hc4601.099403; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zhu PL, 2000, CIRCULATION, V101, P1165, DOI 10.1161/01.CIR.101.10.1165	40	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35999	10.1371/journal.pone.0035999	http://dx.doi.org/10.1371/journal.pone.0035999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563432	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349100058
J	Dong, YW; Wang, HS; Han, GD; Ke, CH; Zhan, X; Nakano, T; Williams, GA				Dong, Yun-wei; Wang, Hai-shan; Han, Guo-Dong; Ke, Cai-huan; Zhan, Xin; Nakano, Tomoyuki; Williams, Gray A.			The Impact of Yangtze River Discharge, Ocean Currents and Historical Events on the Biogeographic Pattern of Cellana toreuma along the China Coast	PLOS ONE			English	Article							ROCKY INTERTIDAL INVERTEBRATES; POPULATION GENETIC-STRUCTURE; LATITUDINAL GRADIENT; MARINE GASTROPODS; LARVAL DISPERSAL; NEW-ZEALAND; DNA; PHYLOGEOGRAPHY; LIMPETS; PACIFIC	Aim: Genetic data were used to measure the phylogeographic distribution of the limpet, Cellana toreuma along the China coast in order to acsertain impacts of historic events, ocean currents and especially freshwater discharge from the Yangtze River on the connectivity of intertidal species with limited larval dispersal capability. Methodology/Principal Findings: Genetic variation in 15 populations of C. toreuma (n = 418), ranging from the Yellow Sea (YS), East China Sea (ECS) and South China Sea (SCS), were determined from partial mitochondrial cytochrome c oxidase subunit I gene. Genetic diversity and divergence based on haplotype frequencies were analyzed using CONTRIB, and AMOVA was used to examine genetic population structure. Historic demographic expansions were evaluated from both neutrality tests and mismatch distribution tests. Among the 30 haplotypes identified, a dominant haplotype No. 1 (H1) existed in all the populations, and a relatively abundant private haplotype (H2) in YS. Pairwise F-ST values between YS and the other two groups were relatively high and the percentage of variation among groups was 10.9%. Conclusions: The high nucleotide and gene diversity in the YS, with large pairwise genetic distances and relatively high percentages of variation among groups, suggests that this group was relatively isolated from ECS and SCS. This is likely driven by historic events, ocean currents, and demographic expansion. We propose that freshwater discharge from the Yangtze River, which may act as physical barrier limiting the southward dispersal of larvae from northern populations, is especially important in determining the separation of the YS group from the rest of the Chinese populations of C. toreuma.	[Dong, Yun-wei; Wang, Hai-shan; Han, Guo-Dong; Ke, Cai-huan; Zhan, Xin] Xiamen Univ, State Key Lab Marine Environm Sci, Coll Oceanog & Earth Sci, Xiamen, Peoples R China; [Dong, Yun-wei] Xiamen Univ, Marine Biodivers & Global Change Lab, Xiamen, Peoples R China; [Nakano, Tomoyuki] Kyoto Univ, Field Sci Educ & Res Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Williams, Gray A.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Williams, Gray A.] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	Xiamen University; Xiamen University; Kyoto University; University of Hong Kong; University of Hong Kong	Dong, YW (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Coll Oceanog & Earth Sci, Xiamen, Peoples R China.	dongyw@xmu.edu.cn	Ke, CH/G-4635-2010; Dong, Yunwei/C-4617-2011; HUANG, Shuiying/C-3117-2014; zhan, xin/G-2472-2011	Dong, Yunwei/0000-0003-4550-2322; zhan, xin/0000-0001-5873-3141	Natural Science Foundation for National Natural Science Foundation of China [41076083]; Distinguished Young Scholars of Fujian Province, China [2011J06017]; Fundamental Research Funds for the Central Universities [201012028]	Natural Science Foundation for National Natural Science Foundation of China; Distinguished Young Scholars of Fujian Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Natural Science Foundation for National Natural Science Foundation of China (41076083), Distinguished Young Scholars of Fujian Province, China (2011J06017) and the Fundamental Research Funds for the Central Universities (201012028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BEARDSLEY RC, 1985, CONT SHELF RES, V4, P57, DOI 10.1016/0278-4343(85)90022-6; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; BOUCHET P, 2006, EXPLORATION MARINE B, P32; Branch G.M., 1981, Oceanography and Marine Biology an Annual Review, V19, P235; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; CARLTON JT, 1995, MAR BIOL, V121, P721, DOI 10.1007/BF00349308; Chan BKK, 2008, B MAR SCI, V83, P315; Cheang CC, 2010, MOL ECOL, V19, P2933, DOI 10.1111/j.1365-294X.2010.04685.x; COE WR, 1953, ECOLOGY, V34, P225, DOI 10.2307/1930330; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; Espinosa F, 2006, J ZOOL SYST EVOL RES, V44, P8, DOI 10.1111/j.1439-0469.2005.00348.x; Espinosa F, 2011, MAR ECOL-EVOL PERSP, V32, P1, DOI 10.1111/j.1439-0485.2010.00410.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fang Juanjuan, 2011, Water Resources and Power, V29, P9; FENG S.Z., 1999, INTRO MARINE SCI; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaine MC, 2010, P ROY SOC B-BIOL SCI, V277, P2829, DOI 10.1098/rspb.2010.0412; Fu YX, 1996, GENETICS, V143, P557; GAINES S, 1985, OECOLOGIA, V67, P267, DOI 10.1007/BF00384297; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Goldstien SJ, 2009, MAR ECOL PROG SER, V388, P111, DOI 10.3354/meps08046; Goldstien SJ, 2006, MOL PHYLOGENET EVOL, V38, P261, DOI 10.1016/j.ympev.2005.09.002; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hidas EZ, 2007, MAR FRESHWATER RES, V58, P835, DOI 10.1071/MF06235; Hu ZM, 2011, MOL ECOL, V20, P3894, DOI 10.1111/j.1365-294X.2011.05220.x; Huang ZG., 2008, MARINE SPECIES THEIR; JIANG C.B., 2006, PERODICAL OCEAN U CH, V36, P147; Kyle CJ, 2000, MAR BIOL, V137, P835, DOI 10.1007/s002270000412; Li YL, 2009, AFR J BIOTECHNOL, V8, P1193; [林军 Lin Jun], 2011, [水产学报, Journal of Fisheries of China], V35, P74; [刘兴泉 LIU XingQuan], 2008, [海洋与湖沼, Oceanologia et Limnologia Sinica], V39, P312; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; Nakano T, 2004, J MOLLUS STUD, V70, P31, DOI 10.1093/mollus/70.1.31; Nakano T, 2007, J MOLLUS STUD, V73, P79, DOI 10.1093/mollus/eym001; Nakano T, 2010, ZOOL SCI, V27, P811, DOI 10.2108/zsj.27.811; Ohgaki S, 2005, ARGONAUTA NEWSLET KA, V11, P27; Palmer MA, 1996, TRENDS ECOL EVOL, V11, P322, DOI 10.1016/0169-5347(96)10038-0; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Reid DG, 1996, PHILOS T R SOC B, V351, P877, DOI 10.1098/rstb.1996.0082; Ribeiro PA, 2010, J BIOGEOGR, V37, P1782, DOI 10.1111/j.1365-2699.2010.02330.x; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sa-Pinto A, 2005, J EXP MAR BIOL ECOL, V325, P95, DOI 10.1016/j.jembe.2005.04.025; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Sagarin RD, 2002, J BIOGEOGR, V29, P985, DOI 10.1046/j.1365-2699.2002.00705.x; SCHELTEM.RS, 1968, NATURE, V217, P1159, DOI 10.1038/2171159a0; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Shanks AL, 2003, ECOL APPL, V13, pS159; Shih HT, 2008, ZOOL STUD, V47, P114; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOLUTION; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsang LM, 2008, MAR ECOL PROG SER, V364, P107, DOI 10.3354/meps07476; WANG PX, 1994, CATENA, V23, P341; Wang YongQing, 2001, Chinese Journal of Zoology, V36, P27; Wang Z.Z., 2000, J ZHEJIANG OCEAN U, V19, P316; Wu Z-Y, 2010, B MAR SCI, V12, P1; York KL, 2008, MOL ECOL, V17, P1948, DOI 10.1111/j.1365-294X.2008.03735.x	76	30	31	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e36178	10.1371/journal.pone.0036178	http://dx.doi.org/10.1371/journal.pone.0036178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563446	Green Published, gold			2022-12-27	WOS:000305349100071
J	Huang, TR; Watanabe, T				Huang, Tsung-Ren; Watanabe, Takeo			Task Attention Facilitates Learning of Task-Irrelevant Stimuli	PLOS ONE			English	Article							LOAD; MOTION; PERCEPTION; FIELD; MODEL	Attention plays a fundamental role in visual learning and memory. One highly established principle of visual attention is that the harder a central task is, the more attentional resources are used to perform the task and the smaller amount of attention is allocated to peripheral processing because of limited attention capacity. Here we show that this principle holds true in a dual-task setting but not in a paradigm of task-irrelevant perceptual learning. In Experiment 1, eight participants were asked to identify either bright or dim number targets at the screen center and to remember concurrently presented scene backgrounds. Their recognition performances for scenes paired with dim/hard targets were worse than those for scenes paired with bright/easy targets. In Experiment 2, eight participants were asked to identify either bright or dim letter targets at the screen center while a task-irrelevant coherent motion was concurrently presented in the background. After five days of training on letter identification, participants improved their motion sensitivity to the direction paired with hard/dim targets improved but not to the direction paired with easy/bright targets. Taken together, these results suggest that task-irrelevant stimuli are not subject to the attentional control mechanisms that task-relevant stimuli abide.	[Huang, Tsung-Ren; Watanabe, Takeo] Boston Univ, Dept Psychol, Boston, MA 02215 USA	Boston University	Huang, TR (corresponding author), Boston Univ, Dept Psychol, 64 Cummington St, Boston, MA 02215 USA.	tren@bu.edu		Huang, Tsung-Ren/0000-0003-4396-7943	National Institutes of Health (NIH) [EY015980, EY019466]; NATIONAL EYE INSTITUTE [R01EY019466, R01EY015980] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health (NIH) R01 grants EY015980 and EY019466. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHISSAR M, 1993, P NATL ACAD SCI USA, V90, P5718, DOI 10.1073/pnas.90.12.5718; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CASTIELLO U, 1990, ACTA PSYCHOL, V73, P195, DOI 10.1016/0001-6918(90)90022-8; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Choi Hoon, 2009, Learn Percept, V1, P89; Duncan Susan, 1999, MIT ENCY COGNITIVE S, P39; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Grossberg S, 2009, J VISION, V9, DOI 10.1167/9.4.6; Gutnisky DA, 2009, CURR BIOL, V19, P555, DOI 10.1016/j.cub.2009.01.063; Huang TR, 2010, PSYCHOL REV, V117, P1080, DOI 10.1037/a0020664; IKEDA M, 1975, PERCEPT PSYCHOPHYS, V18, P255, DOI 10.3758/BF03199371; Kahneman D., 1973, ATTENTION EFFORT; LABERGE D, 1983, J EXP PSYCHOL HUMAN, V9, P371, DOI 10.1037/0096-1523.9.3.371; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Lin JY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000337; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; Pilly PK, 2009, VISION RES, V49, P1599, DOI 10.1016/j.visres.2009.03.019; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Robbins TW, 1997, BIOL PSYCHOL, V45, P57, DOI 10.1016/S0301-0511(96)05222-2; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Seitz AR, 2003, NATURE, V422, P36, DOI 10.1038/422036a; Swallow KM, 2010, COGNITION, V115, P118, DOI 10.1016/j.cognition.2009.12.003; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; Wickens C.D., 1991, MULTIPLE TASK PERFOR, V1991, P3, DOI [10.1201/9781003069447-2, DOI 10.1201/9781003069447-2]; Yi DJ, 2004, NAT NEUROSCI, V7, P992, DOI 10.1038/nn1294	33	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35946	10.1371/journal.pone.0035946	http://dx.doi.org/10.1371/journal.pone.0035946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959WQ	22563424	gold, Green Submitted, Green Published			2022-12-27	WOS:000305349100050
J	Scholz-Starke, J; Cesca, F; Schiavo, G; Benfenati, F; Baldelli, P				Scholz-Starke, Joachim; Cesca, Fabrizia; Schiavo, Giampietro; Benfenati, Fabio; Baldelli, Pietro			Kidins220/ARMS Is a Novel Modulator of Short-Term Synaptic Plasticity in Hippocampal GABAergic Neurons	PLOS ONE			English	Article							PAIRED-PULSE DEPRESSION; MEMBRANE-SPANNING PROTEIN; AMPA RECEPTORS; RELEASE; NEUROTROPHIN; STABILITY; TRANSMISSION; INVOLVEMENT; ACTIVATION; SUBSTRATE	Kidins220 (Kinase D interacting substrate of 220 kDa)/ARMS (Ankyrin Repeat-rich Membrane Spanning) is a scaffold protein highly expressed in the nervous system. Previous work on neurons with altered Kidins220/ARMS expression suggested that this protein plays multiple roles in synaptic function. In this study, we analyzed the effects of Kidins220/ARMS ablation on basal synaptic transmission and on a variety of short-term plasticity paradigms in both excitatory and inhibitory synapses using a recently described Kidins220 full knockout mouse. Hippocampal neuronal cultures prepared from embryonic Kidins220(-/-) (KO) and wild type (WT) littermates were used for whole-cell patch-clamp recordings of spontaneous and evoked synaptic activity. Whereas glutamatergic AMPA receptor-mediated responses were not significantly affected in KO neurons, specific differences were detected in evoked GABAergic transmission. The recovery from synaptic depression of inhibitory post-synaptic currents in WT cells showed biphasic kinetics, both in response to paired-pulse and long-lasting train stimulation, while in KO cells the respective slow components were strongly reduced. We demonstrate that the slow recovery from synaptic depression in WT cells is caused by a transient reduction of the vesicle release probability, which is absent in KO neurons. These results suggest that Kidins220/ARMS is not essential for basal synaptic transmission and various forms of short-term plasticity, but instead plays a novel role in the mechanisms regulating the recovery of synaptic strength in GABAergic synapses.	[Scholz-Starke, Joachim; Cesca, Fabrizia; Benfenati, Fabio; Baldelli, Pietro] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schiavo, Giampietro] Canc Res UK London Res Inst, Mol Neuropathobiol Lab, London, England; [Benfenati, Fabio; Baldelli, Pietro] Univ Genoa, Dept Expt Med, Genoa, Italy; [Benfenati, Fabio; Baldelli, Pietro] Natl Inst Neurosci, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; Cancer Research UK; University of Genoa	Scholz-Starke, J (corresponding author), CNR, Inst Biophys, Genoa, Italy.	joachim.scholzstarke@iit.it	Baldelli, Pietro/AAA-6298-2020; Baldelli, Pietro/AAH-2493-2021; Scholz-Starke, Joachim/A-2944-2014	Baldelli, Pietro/0000-0001-9599-3436; Cesca, Fabrizia/0000-0003-2190-6314; Scholz-Starke, Joachim/0000-0002-7376-6635; Schiavo, Giampietro/0000-0002-4319-8745	Compagnia di San Paolo, Torino; Italian Ministry of Health; Italian Ministry of Education, University and Research; Cancer Research UK; Telethon, Italy [GGP05134, GGP09134, GGP09066]	Compagnia di San Paolo, Torino(Compagnia di San Paolo); Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Cancer Research UK(Cancer Research UK); Telethon, Italy(Fondazione Telethon)	Work in the authors' laboratories was supported by research grants from the Compagnia di San Paolo, Torino (to PB and FB), the Italian Ministry of Health (to PB), the Italian Ministry of Education, University and Research (to FB), and Cancer Research UK (GS). The support of Telethon, Italy (grants GGP05134 and GGP09134 to FB and grant GGP09066 to PB) is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Arevalo JC, 2010, MOL CELL NEUROSCI, V45, P92, DOI 10.1016/j.mcn.2010.06.002; Cesca F, 2012, CELL DEATH DIFFER, V19, P194, DOI 10.1038/cdd.2011.141; Cesca F, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.108; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Cortes RY, 2007, DEV NEUROBIOL, V67, P1687, DOI 10.1002/dneu.20542; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gottmann K, 2009, EXP BRAIN RES, V199, P203, DOI 10.1007/s00221-009-1994-z; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Kirischuk S, 2002, J PHYSIOL-LONDON, V543, P99, DOI 10.1113/jphysiol.2002.021576; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Park HJ, 2010, MOL CELLS, V30, P143, DOI 10.1007/s10059-010-0099-7; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Sutachan JJ, 2010, J NEUROSCI RES, V88, P3447, DOI 10.1002/jnr.22513; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu SH, 2010, J BIOL CHEM, V285, P40472, DOI 10.1074/jbc.M110.171371; Wu SH, 2009, DEV NEUROBIOL, V69, P547, DOI 10.1002/dneu.20723; Xu JY, 2009, EXP NEUROL, V216, P243, DOI 10.1016/j.expneurol.2008.11.013; Yang YM, 2010, NEURON, V67, P100, DOI 10.1016/j.neuron.2010.06.003; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35785	10.1371/journal.pone.0035785	http://dx.doi.org/10.1371/journal.pone.0035785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563401	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349100029
J	Hervella, M; Izagirre, N; Alonso, S; Fregel, R; Alonso, A; Cabrera, VM; de la Rua, C				Hervella, Montserrat; Izagirre, Neskuts; Alonso, Santos; Fregel, Rosa; Alonso, Antonio; Cabrera, Vicente M.; de la Rua, Concepcion			Ancient DNA from Hunter-Gatherer and Farmer Groups from Northern Spain Supports a Random Dispersion Model for the Neolithic Expansion into Europe	PLOS ONE			English	Article							MITOCHONDRIAL GENE POOL; NEAR-EASTERN; DEMIC DIFFUSION; BASQUE COUNTRY; CANARY-ISLANDS; HUMAN MTDNA; LINEAGES; SEQUENCES; POPULATIONS; PHYLOGEOGRAPHY	Background/Principal Findings: The phenomenon of Neolithisation refers to the transition of prehistoric populations from a hunter-gatherer to an agro-pastoralist lifestyle. Traditionally, the spread of an agro-pastoralist economy into Europe has been framed within a dichotomy based either on an acculturation phenomenon or on a demic diffusion. However, the nature and speed of this transition is a matter of continuing scientific debate in archaeology, anthropology, and human population genetics. In the present study, we have analyzed the mitochondrial DNA diversity in hunter-gatherers and first farmers from Northern Spain, in relation to the debate surrounding the phenomenon of Neolithisation in Europe. Methodology/Significance: Analysis of mitochondrial DNA was carried out on 54 individuals from Upper Paleolithic and Early Neolithic, which were recovered from nine archaeological sites from Northern Spain (Basque Country, Navarre and Cantabria). In addition, to take all necessary precautions to avoid contamination, different authentication criteria were applied in this study, including: DNA quantification, cloning, duplication (51% of the samples) and replication of the results (43% of the samples) by two independent laboratories. Statistical and multivariate analyses of the mitochondrial variability suggest that the genetic influence of Neolithisation did not spread uniformly throughout Europe, producing heterogeneous genetic consequences in different geographical regions, rejecting the traditional models that explain the Neolithisation in Europe. Conclusion: The differences detected in the mitochondrial DNA lineages of Neolithic groups studied so far (including these ones of this study) suggest different genetic impact of Neolithic in Central Europe, Mediterranean Europe and the Cantabrian fringe. The genetic data obtained in this study provide support for a random dispersion model for Neolithic farmers. This random dispersion had a different impact on the various geographic regions, and thus contradicts the more simplistic total acculturation and replacement models proposed so far to explain Neolithisation.	[Hervella, Montserrat; Izagirre, Neskuts; Alonso, Santos; de la Rua, Concepcion] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Bizkaia, Spain; [Fregel, Rosa; Cabrera, Vicente M.] Univ La Laguna, Dept Genet, E-38207 San Cristobal la Laguna, Santa Cruz De T, Spain; [Alonso, Antonio] Natl Inst Toxicol & Forens Sci, Dept Biol, Madrid, Spain	University of Basque Country; Universidad de la Laguna	Hervella, M (corresponding author), Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Bizkaia, Spain.	conchi.delarua@ehu.es	Fregel, Rosa/H-4942-2015; Alonso, Santos/L-8316-2014; Afonso, Montse Hervella/X-4520-2019	Fregel, Rosa/0000-0002-2951-6508; Alonso, Santos/0000-0003-0221-4048; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020; HERVELLA AFONSO, MONTSERRAT/0000-0003-4594-2950	Spanish Ministry of Science and Innovation [CGL-2004-03300, CGL-2007-65515, BES-2005-6925]; Basque Government for Research Groups in the Basque University System [IT542-10]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government for Research Groups in the Basque University System	This work was partly supported by grants CGL-2004-03300, CGL-2007-65515, and a FPI pre-doctoral fellowship for MH (BES-2005-6925) from the Spanish Ministry of Science and Innovation; and grant IT542-10 from the Basque Government for Research Groups in the Basque University System. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alday A, 1995, RUBICATUM, V1, P745; Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Alonso A, 2003, INT CONGR SER, V1239, P585, DOI 10.1016/S0531-5131(02)00401-6; Altuna J., 1989, MUNIBE, V41, P23; Alzualde A, 2007, CURR ANTHROPOL, V48, P155, DOI 10.1086/510464; Alzualde A, 2005, ANN HUM GENET, V69, P665, DOI 10.1046/j.1529-8817.2005.00170.x; Alzualde A, 2006, AM J PHYS ANTHROPOL, V130, P394, DOI 10.1002/ajpa.20375; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Balaresque P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000285; BARBUJANI G, 1995, AM J PHYS ANTHROPOL, V96, P109, DOI 10.1002/ajpa.1330960202; Basabe JM, 1971, MUNIBE, V23, P105; Basabe JM, 1983, ESTUDIOS ARQUEOLOGIA, V11, P77; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; CavalliSforza LL, 1997, AM J HUM GENET, V61, P247, DOI 10.1016/S0002-9297(07)64303-1; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Collins MJ, 2009, P BIOL SCI, V1669, P2971; Cooper A, 2000, SCIENCE, V289, P1139; Crespillo M, 2000, INT J LEGAL MED, V114, P130, DOI 10.1007/s004140000158; de la Rua C., 2001, ANEJOS VELEIA SERIES, V10, P363; de la Rua C., 1985, MUNIBE, V37, P195; Deguilloux MF, 2011, AM J PHYS ANTHROPOL, V144, P108, DOI 10.1002/ajpa.21376; DENNELL RW, 1985, SCIENCE, V227, P1331, DOI 10.1126/science.227.4692.1331; Fregel R, 2009, EUR J HUM GENET, V17, P1314, DOI 10.1038/ejhg.2009.46; Fregel R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-181; Garcia O, 2011, HEREDITY, V106, P37, DOI 10.1038/hdy.2010.47; Garcia-Gazolaz J, 2007, TIERRA SEA LEVE ARQU, P49; Gilbert M Thomas P, 2006, Med Secoli, V18, P701; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; Gonzalez-Echegaray P.J., 1963, EXCAVACIONES ARQUEOL, V26, P43; Gonzalez-Echegaray PJ, 1952, AMPURIAS, P43; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; Handt O, 1996, AM J HUM GENET, V59, P368; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Izagirre N, 2005, HUM BIOL, V77, P443, DOI 10.1353/hub.2005.0064; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Larruga JM, 2001, EUR J HUM GENET, V9, P708, DOI 10.1038/sj.ejhg.5200693; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meyer S, 2003, MOL BIOL EVOL, V20, P182, DOI 10.1093/molbev/msg019; Meyer S, 1999, GENETICS, V152, P1103; Nei M., 1987, MOL EVOLUTIONARY GEN; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 1996, AM J HUM GENET, V59, P185; Richards M, 2003, DOCUMENTA PRAEHIS 30, V10, P159; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Schneider S, 1999, GENETICS, V152, P1079; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Zvelebil L, 2000, EUR J ARCHAEOL, V8, P183	65	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 25	2012	7	4							e34417	10.1371/journal.pone.0034417	http://dx.doi.org/10.1371/journal.pone.0034417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959VP	22563371	gold, Green Published			2022-12-27	WOS:000305345200008
J	Bojakowski, K; Dzabic, M; Kurzejamska, E; Styczynski, G; Andziak, P; Gaciong, Z; Soderberg-Naucler, C; Religa, P				Bojakowski, Krzysztof; Dzabic, Mensur; Kurzejamska, Ewa; Styczynski, Grzegorz; Andziak, Piotr; Gaciong, Zbigniew; Soderberg-Naucler, Cecilia; Religa, Piotr			A High Red Blood Cell Distribution Width Predicts Failure of Arteriovenous Fistula	PLOS ONE			English	Article							C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; HEART-FAILURE; PROGNOSTIC MARKER; CORONARY-DISEASE; ACCESS; INTERLEUKIN-6; DYSFUNCTION; THROMBOSIS; MORTALITY	In hemodialysis patients, a native arteriovenous fistula (AVF) is the preferred form of permanent vascular access. Despite recent improvements, vascular access dysfunction remains an important cause of morbidity in these patients. In this prospective observational cohort study, we evaluated potential risk factors for native AVF dysfunction. We included 68 patients with chronic renal disease stage 5 eligible for AVF construction at the Department of General and Vascular Surgery, Central Clinical Hospital Ministry of Internal Affairs, Warsaw, Poland. Patient characteristics and biochemical parameters associated with increased risk for AVF failure were identified using Cox proportional hazards models. Vessel biopsies were analyzed for inflammatory cells and potential associations with biochemical parameters. In multivariable analysis, independent predictors of AVF dysfunction were the number of white blood cells (hazard ratio [HR] 1.67; 95% confidence interval [CI] 1.24 to 2.25; p<0.001), monocyte number (HR 0.02; 95% CI 0.00 to 0.21; p = 0.001), and red blood cell distribution width (RDW) (HR 1.44; 95% CI 1.17 to 1.78; p<0.001). RDW was the only significant factor in receiver operating characteristic curve analysis (area under the curve 0.644; CI 0.51 to 0.76; p = 0.046). RDW>16.2% was associated with a significantly reduced AVF patency frequency 24 months after surgery. Immunohistochemical analysis revealed CD45-positive cells in the artery/vein of 39% of patients and CD68-positive cells in 37%. Patients with CD68-positive cells in the vessels had significantly higher white blood cell count. We conclude that RDW, a readily available laboratory value, is a novel prognostic marker for AVF failure. Further studies are warranted to establish the mechanistic link between high RDW and AVF failure.	[Bojakowski, Krzysztof; Andziak, Piotr] Warsaw Univ Med, Dept Gen Vasc & Oncol Surg, Warsaw, Poland; [Dzabic, Mensur; Kurzejamska, Ewa; Soderberg-Naucler, Cecilia; Religa, Piotr] Karolinska Inst, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Bojakowski, Krzysztof; Styczynski, Grzegorz; Gaciong, Zbigniew] Warsaw Univ Med, Dept Internal Med & Hypertens, Warsaw, Poland	Karolinska Institutet	Bojakowski, K (corresponding author), Warsaw Univ Med, Dept Gen Vasc & Oncol Surg, Warsaw, Poland.	mensur.dzabic@ki.se; piotr.religa@ki.se	styczynski, grzegorz/V-6257-2018	styczynski, grzegorz/0000-0002-4547-1522; Andziak, Piotr/0000-0003-0041-357X; Religa, Piotr/0000-0002-3884-2954; Bojakowski, Krzysztof/0000-0001-6899-8741; Kurzejamska, Ewa/0000-0002-8050-6516	Science Research Committee MNiSW [2 P05C 010 30, PBZ/MEiN/01/2006]; Swedish Heart and Lung Foundation; Karolinska Institutet; Foundation for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Society of Medicine; Karolinska Institute's M.D./Ph.D. program	Science Research Committee MNiSW; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Karolinska Institutet(Karolinska Institutet); Foundation for Geriatric Research; Stiftelsen Gamla Tjanarinnor; Swedish Society of Medicine; Karolinska Institute's M.D./Ph.D. program	This study was supported by the Science Research Committee MNiSW grants 2 P05C 010 30, PBZ/MEiN/01/2006, the Swedish Heart and Lung Foundation, Karolinska Institutet, Foundation for Geriatric Research, Stiftelsen Gamla Tjanarinnor and the Swedish Society of Medicine. MD is supported by the Karolinska Institute's M.D./Ph.D. program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Andrews D A, 1999, Curr Opin Hematol, V6, P76, DOI 10.1097/00062752-199903000-00004; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Baron M, 2010, J AM COLL NUTR, V29, P144, DOI 10.1080/07315724.2010.10719828; Barshtein Gregory, 2007, Expert Rev Cardiovasc Ther, V5, P743, DOI 10.1586/14779072.5.4.743; Casserly LF, 2003, SEMIN DIALYSIS, V16, P245, DOI 10.1046/j.1525-139X.2003.16048.x; Cavusoglu E, 2010, INT J CARDIOL, V141, P141, DOI 10.1016/j.ijcard.2008.11.187; Chang CJ, 2005, KIDNEY INT, V68, P1312, DOI 10.1111/j.1523-1755.2005.00529.x; Chou CY, 2006, BLOOD PURIFICAT, V24, P342, DOI 10.1159/000092558; DeMarchi S, 1996, J AM SOC NEPHROL, V7, P1169; Durante W, 2008, KIDNEY INT, V74, P9, DOI 10.1038/ki.2008.127; Dzabic M, 2012, CLIN MICROBIOL INFEC, V18, pE5, DOI 10.1111/j.1469-0691.2011.03691.x; Eknoyan G, 1997, CURR OPIN NEPHROL HY, V6, P520, DOI 10.1097/00041552-199711000-00003; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Feldman HI, 1996, J AM SOC NEPHROL, V7, P523; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Gagliardi GM, 2011, J VASC ACCESS, V12, P57, DOI 10.5301/JVA.2010.5831; Grandaliano G, 2003, KIDNEY INT, V64, P715, DOI 10.1046/j.1523-1755.2003.00120.x; Grant PJ, 2007, J INTERN MED, V262, P157, DOI 10.1111/j.1365-2796.2007.01824.x; Hampole CV, 2009, AM J CARDIOL, V104, P868, DOI 10.1016/j.amjcard.2009.05.016; Huber TS, 2003, J VASC SURG, V38, P1005, DOI 10.1016/S0741-5214(03)00426-9; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Lappe JM, 2011, CLIN CHIM ACTA, V412, P2094, DOI 10.1016/j.cca.2011.07.018; Lemkes BA, 2010, J THROMB HAEMOST; Lin CC, 2009, J CHIN MED ASSOC, V72, P109, DOI 10.1016/S1726-4901(09)70035-8; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; Roy-Chaudhury P, 2006, J AM SOC NEPHROL, V17, P1112, DOI 10.1681/ASN.2005050615; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; van Kimmenade RRJ, 2010, EUR J HEART FAIL, V12, P129, DOI 10.1093/eurjhf/hfp179; Wali Mahmoud A., 2003, Journal of Smooth Muscle Research, V39, P95, DOI 10.1540/jsmr.39.95; Wang ZB, 2003, J SURG RES, V111, P261, DOI 10.1016/S0022-4804(03)00087-8	32	23	26	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36482	10.1371/journal.pone.0036482	http://dx.doi.org/10.1371/journal.pone.0036482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574168	Green Published, Green Submitted, gold			2022-12-27	WOS:000305349800064
J	Herold, C; Joshi, I; Chehadi, O; Hollmann, M; Gunturkun, O				Herold, Christina; Joshi, Illah; Chehadi, Omar; Hollmann, Michael; Guentuerkuen, Onur			Plasticity in D1-Like Receptor Expression Is Associated with Different Components of Cognitive Processes	PLOS ONE			English	Article							PREFRONTAL CORTEX; WORKING-MEMORY; DOPAMINE D1; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; BASAL GANGLIA; NEURONS; D-1; BRAIN; LOCALIZATION	Dopamine D1-like receptors consist of D1 (D1A) and D5 (D1B) receptors and play a key role in working memory. However, their possibly differential contribution to working memory is unclear. We combined a working memory training protocol with a stepwise increase of cognitive subcomponents and real-time RT-PCR analysis of dopamine receptor expression in pigeons to identify molecular changes that accompany training of isolated cognitive subfunctions. In birds, the D1-like receptor family is extended and consists of the D1A, D1B, and D1D receptors. Our data show that D1B receptor plasticity follows a training that includes active mental maintenance of information, whereas D1A and D1D receptor plasticity in addition accompanies learning of stimulus-response associations. Plasticity of D1-like receptors plays no role for processes like response selection and stimulus discrimination. None of the tasks altered D2 receptor expression. Our study shows that different cognitive components of working memory training have distinguishable effects on D1-like receptor expression.	[Herold, Christina; Chehadi, Omar; Guentuerkuen, Onur] Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Fac Psychol, Bochum, Germany; [Joshi, Illah; Hollmann, Michael] Ruhr Univ Bochum, Fac Chem & Biochem, Dept Biochem Receptor Biochem 1, Bochum, Germany; [Herold, Christina] Univ Dusseldorf, C&O Vogt Inst Brain Res, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Ruhr University Bochum; Heinrich Heine University Dusseldorf	Herold, C (corresponding author), Ruhr Univ Bochum, Inst Cognit Neurosci, Dept Biopsychol, Fac Psychol, Univ Str 150, Bochum, Germany.	Christina.Herold@uni-duesseldorf.de	Chehadi, Omar/ABE-9469-2020	Chehadi, Omar/0000-0003-2458-0356; Hollmann, Michael/0000-0001-8000-7787; Gunturkun, Onur/0000-0003-4173-5233	fellowship of the Wilhelm; Gunter Esser Stiftung; DFG grant [SFB874]; fellowship of the Deutsche Forschungsgemeinschaft Graduate School [736]	fellowship of the Wilhelm; Gunter Esser Stiftung; DFG grant(German Research Foundation (DFG)); fellowship of the Deutsche Forschungsgemeinschaft Graduate School(German Research Foundation (DFG))	This work was supported by a fellowship of the Wilhelm and Gunter Esser Stiftung to C. H. and a DFG grant to O.G. via the SFB874. I.J. was supported by a fellowship of the Deutsche Forschungsgemeinschaft Graduate School 736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Ahn S, 2002, J NEUROSCI, V22, P10958; Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Bassareo V, 1997, J NEUROSCI, V17, P851; Bast T, 2002, J COMP NEUROL, V446, P58, DOI 10.1002/cne.10187; Bergson C, 1995, J NEUROSCI, V15, P7821; Bordelon-Glausier JR, 2008, J COMP NEUROL, V508, P893, DOI 10.1002/cne.21710; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Castner SA, 2007, BRAIN COGNITION, V63, P94, DOI 10.1016/j.bandc.2006.11.002; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Diekamp B, 2002, J NEUROSCI, V22, P9573; Diekamp B, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0002.2002; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Durstewitz D, 1999, PROG NEUROBIOL, V59, P161, DOI 10.1016/S0301-0082(98)00100-2; Durstewitz D, 1998, NEUROSCIENCE, V83, P763, DOI 10.1016/S0306-4522(97)00450-8; Durstewitz D, 2006, NEUROSCIENCE, V139, P119, DOI 10.1016/j.neuroscience.2005.06.094; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; El-Ghundi M, 1999, EUR J PHARMACOL, V383, P95, DOI 10.1016/S0014-2999(99)00573-7; Fisher BE, 2004, J NEUROSCI RES, V77, P378, DOI 10.1002/jnr.20162; FUNAHASHI S, 1994, NEUROSCI RES, V21, P1, DOI 10.1016/0168-0102(94)90063-9; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Glausier JR, 2009, CEREB CORTEX, V19, P1820, DOI 10.1093/cercor/bhn212; GOLDMANRAKIC PS, 1989, P NATL ACAD SCI USA, V86, P9015, DOI 10.1073/pnas.86.22.9015; Gunturkun O, 2005, CURR OPIN NEUROBIOL, V15, P686, DOI 10.1016/j.conb.2005.10.003; GUNTURKUN O, 2001, BRAIN EVOLUTION COGN, P431; He Y, 2009, NEUROSCI BULL, V25, P43, DOI 10.1007/s12264-009-0107-0; Herold C, 2008, BEHAV BRAIN RES; Herold C, 2011, BRAIN STRUCT FUNCT, V216, P239, DOI 10.1007/s00429-011-0301-5; Herold C, 2010, BEHAV NEUROSCI, V124, P381, DOI 10.1037/a0019504; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Karakuyu D, 2007, EUR J NEUROSCI, V26, P2293, DOI 10.1111/j.1460-9568.2007.05840.x; Karten H.J., 1967, STEREOTAXIC ATLAS BR; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kroner S, 1999, J COMP NEUROL, V407, P228, DOI 10.1002/(SICI)1096-9861(19990503)407:2<228::AID-CNE6>3.0.CO;2-2; Kroner S, 2002, NEUROSCIENCE, V110, P459, DOI 10.1016/S0306-4522(01)00506-1; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Phillips AG, 2004, J NEUROSCI, V24, P547, DOI 10.1523/JNEUROSCI.4653-03.2004; QUINTANA J, 1988, BRAIN RES, V474, P211, DOI 10.1016/0006-8993(88)90436-2; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Reiner A, 2005, BRAIN RES BULL, V66, P317, DOI 10.1016/j.brainresbull.2005.05.007; Reiner A, 2002, BRAIN RES BULL, V57, P513, DOI 10.1016/S0361-9230(01)00667-0; Rose J, 2005, PLOS BIOL, V3, P1139, DOI 10.1371/journal.pbio.0030190; Rose J, 2010, NEUROSCIENCE, V167, P232, DOI 10.1016/j.neuroscience.2010.02.004; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; Schnabel R, 1997, J COMP NEUROL, V388, P146, DOI 10.1002/(SICI)1096-9861(19971110)388:1<146::AID-CNE10>3.0.CO;2-T; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Soiza-Reilly M, 2004, BRAIN RES, V1004, P217, DOI 10.1016/j.brainres.2004.01.050; Sun ZQ, 2000, J CHEM NEUROANAT, V19, P211, DOI 10.1016/S0891-0618(00)00069-7; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; WALDMANN C, 1993, BRAIN RES, V600, P225, DOI 10.1016/0006-8993(93)91377-5; Wang M, 2008, MOL CELLS, V25, P149; Watanabe M, 1997, J NEUROPHYSIOL, V78, P2795, DOI 10.1152/jn.1997.78.5.2795; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Yao WD, 2008, BIOCHEM PHARMACOL, V75, P2055, DOI 10.1016/j.bcp.2008.01.018	68	17	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e36484	10.1371/journal.pone.0036484	http://dx.doi.org/10.1371/journal.pone.0036484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574169	Green Submitted, Green Published, gold			2022-12-27	WOS:000305349800065
J	Bock, M; Ogishima, S; Tanaka, H; Kramer, S; Kaderali, L				Boeck, Matthias; Ogishima, Soichi; Tanaka, Hiroshi; Kramer, Stefan; Kaderali, Lars			Hub-Centered Gene Network Reconstruction Using Automatic Relevance Determination	PLOS ONE			English	Article							REGULATORY NETWORKS; MODELS; ORGANIZATION; ANALYZE	Network inference deals with the reconstruction of biological networks from experimental data. A variety of different reverse engineering techniques are available; they differ in the underlying assumptions and mathematical models used. One common problem for all approaches stems from the complexity of the task, due to the combinatorial explosion of different network topologies for increasing network size. To handle this problem, constraints are frequently used, for example on the node degree, number of edges, or constraints on regulation functions between network components. We propose to exploit topological considerations in the inference of gene regulatory networks. Such systems are often controlled by a small number of hub genes, while most other genes have only limited influence on the network's dynamic. We model gene regulation using a Bayesian network with discrete, Boolean nodes. A hierarchical prior is employed to identify hub genes. The first layer of the prior is used to regularize weights on edges emanating from one specific node. A second prior on hyperparameters controls the magnitude of the former regularization for different nodes. The net effect is that central nodes tend to form in reconstructed networks. Network reconstruction is then performed by maximization of or sampling from the posterior distribution. We evaluate our approach on simulated and real experimental data, indicating that we can reconstruct main regulatory interactions from the data. We furthermore compare our approach to other state-of-the art methods, showing superior performance in identifying hubs. Using a large publicly available dataset of over 800 cell cycle regulated genes, we are able to identify several main hub genes. Our method may thus provide a valuable tool to identify interesting candidate genes for further study. Furthermore, the approach presented may stimulate further developments in regularization methods for network reconstruction from data.	[Boeck, Matthias; Kaderali, Lars] Heidelberg Univ, ViroQuant Res Grp Modeling, Heidelberg, Germany; [Boeck, Matthias; Kramer, Stefan] Tech Univ Munich, Inst Informat I12, D-8046 Garching, Germany; [Ogishima, Soichi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Kramer, Stefan] Johannes Gutenberg Univ Mainz, Inst Informat, Mainz, Germany; [Kaderali, Lars] Tech Univ Dresden, Inst Med Informat & Biometry, D-01062 Dresden, Germany	Ruprecht Karls University Heidelberg; Technical University of Munich; Tokyo Medical & Dental University (TMDU); Johannes Gutenberg University of Mainz; Technische Universitat Dresden	Bock, M (corresponding author), Heidelberg Univ, ViroQuant Res Grp Modeling, BioQuant BQ26, Heidelberg, Germany.	lars.kaderali@tu-dresden.de		Kaderali, Lars/0000-0002-2359-2294	German Federal Ministry for Education and Research (BMBF) [0313923, 0315523A]; European Commission [260429]; Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems" [GRK 1563]; Grants-in-Aid for Scientific Research [22700311] Funding Source: KAKEN	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems"(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge funding from the German Federal Ministry for Education and Research (BMBF), grant numbers 0313923 (Forsys/ViroQuant) and 0315523A (SysTec) and from the European Commission in the Seventh Framework Program, grant 260429 (SysPatho). SK and MB received funding from the Deutsche Forschungsgemeinschaft (DFG) International Research Training Group "Regulation and Evolution of Cellular Systems" (GRK 1563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone MI, 1997, DEVELOPMENT, V124, P1851; Bernard A, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P459; Bishop C., 1998, NIPS, P382; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Chen T, 1999, Pac Symp Biocomput, P29; Chen T, 2001, PARALLEL COMPUT, V27, P141, DOI 10.1016/S0167-8191(00)00092-2; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Csardi ~ G, 2006, INTERJ COMP SYST, V1695; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DUANE S, 1987, PHYS LETT B, V195, P216, DOI 10.1016/0370-2693(87)91197-X; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Guthke R, 2005, BIOINFORMATICS, V21, P1626, DOI 10.1093/bioinformatics/bti226; Hartemink AJ, 2002, IEEE INTELL SYST, V17, P37, DOI 10.1109/MIS.2002.999218; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Harvey I, 1997, FROM ANIM ANIMAT, P67; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KADERALI L, 2006, HIERARCHICAL BAYESIA; Kaderali L, 2009, BIOINFORMATICS, V25, P2229, DOI 10.1093/bioinformatics/btp375; Kaderali Lars, 2008, V94, P33; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Liang S, 1998, Pac Symp Biocomput, P18; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Neal RM, 1996, LECT NOTES STAT, V118; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sales G, 2011, BIOINFORMATICS, V27, P1876, DOI 10.1093/bioinformatics/btr274; Shmulevich I, 2002, P IEEE, V90, P1778, DOI 10.1109/JPROC.2002.804686; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spiegelhalter DJ, 1996, BAYESIAN STAT, V5; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tan VYF, 2009, SPARS09 SIGNAL PROCE, P1; Van Someren E, 2001, P 2 INT C SYST BIOL, P222; Woolf PJ, 2000, PHYSIOL GENOMICS, V3, P9, DOI 10.1152/physiolgenomics.2000.3.1.9	45	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e35077	10.1371/journal.pone.0035077	http://dx.doi.org/10.1371/journal.pone.0035077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570688	Green Published, gold			2022-12-27	WOS:000305343400004
J	Sun, FF; Dai, CY; Xie, JS; Hu, X				Sun, Feifei; Dai, Chunyan; Xie, Jiansheng; Hu, Xun			Biochemical Issues in Estimation of Cytosolic Free NAD/NADH Ratio	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; AUGMENTS BLOOD-FLOW; REDOX STATE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; FREE-RADICALS; LIVER; NADH; LACTATE; METABOLISM	Cytosolic free NAD/NADH ratio is fundamentally important in maintaining cellular redox homeostasis but current techniques cannot distinguish between protein-bound and free NAD/NADH. Williamson et al reported a method to estimate this ratio by cytosolic lactate/pyruvate (L/P) based on the principle of chemical equilibrium. Numerous studies used L/P ratio to estimate the cytosolic free NAD/NADH ratio by assuming that the conversion in cells was at near-equilibrium but not verifying how near it was. In addition, it seems accepted that cytosolic free NAD/NADH ratio was a dependent variable responding to the change of L/P ratio. In this study, we show (1) that the change of lactate/glucose (percentage of glucose that converts to lactate by cells) and L/P ratio could measure the status of conversion between pyruvate + NADH and lactate + NAD that tends to or gets away from equilibrium; (2) that cytosolic free NAD/NADH could be accurately estimated by L/P only when the conversion is at or very close to equilibrium otherwise a calculation error by one order of magnitude could be introduced; (3) that cytosolic free NAD/NADH is stable and L/P is highly labile, that the highly labile L/P is crucial to maintain the homeostasis of NAD/NADH; (4) that cytosolic free NAD/NADH is dependent on oxygen levels. Our study resolved the key issues regarding accurate estimation of cytosolic free NAD/NADH ratio and the relationship between NAD/NADH and L/P.	[Sun, Feifei; Dai, Chunyan; Xie, Jiansheng; Hu, Xun] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Inst Canc,China Natl Minist Educ,Key Lab Canc Int, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Sun, FF (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Inst Canc,China Natl Minist Educ,Key Lab Canc Int, Hangzhou 310003, Zhejiang, Peoples R China.	huxun@zju.edu.cn			National 863 project [2007AA02Z143]; China Natural Sciences Foundation [30772544, 81071802]; National Ministry of Education, China	National 863 project(National High Technology Research and Development Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); National Ministry of Education, China(Ministry of Education, China)	This work was supported in part by National 863 project (2007AA02Z143); China Natural Sciences Foundation projects (30772544, 81071802); and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China, all to Dr. Hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ARIEFF AI, 1976, METABOLISM, V25, P307, DOI 10.1016/0026-0495(76)90088-3; BACHELARD HS, 1974, J NEUROCHEM, V22, P395, DOI 10.1111/j.1471-4159.1974.tb07605.x; Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Barron JT, 2000, AM J PHYSIOL-HEART C, V279, pH2872, DOI 10.1152/ajpheart.2000.279.6.H2872; Bassenge E, 2000, AM J PHYSIOL-HEART C, V279, pH2431, DOI 10.1152/ajpheart.2000.279.5.H2431; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bisswanger H, 2002, ENZYME KINETICS PRIN; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; David L. N., 2008, LEHNINGER PRINCIPLES; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GIBSON GE, 1976, J NEUROCHEM, V27, P37, DOI 10.1111/j.1471-4159.1976.tb01540.x; GRANHOLM L, 1969, ACTA PHYSIOL SCAND, V77, P179, DOI 10.1111/j.1748-1716.1969.tb04562.x; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu B., 1974, METHODS ENZYMATIC AN; Ido Y, 1997, DIABETOLOGIA, V40, pS115, DOI 10.1007/s001250051422; Ido Y, 2004, P NATL ACAD SCI USA, V101, P653, DOI 10.1073/pnas.0307458100; KATZ A, 1987, ACTA PHYSIOL SCAND, V131, P119, DOI 10.1111/j.1748-1716.1987.tb08213.x; Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Mazurek S, 1997, J BIOL CHEM, V272, P4941, DOI 10.1074/jbc.272.8.4941; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; NITTA N, 1988, RES EXP MED, V188, P341, DOI 10.1007/BF01851202; Obrosova IG, 2001, FASEB J, V15, P123, DOI 10.1096/fj.01-0603fje; SAUER LA, 1985, J BIOL CHEM, V260, P7496; SCHWARTZ JP, 1974, J BIOL CHEM, V249, P4138; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; Swierczynski J, 2001, POL J PHARMACOL, V53, P125; TANAKA J, 1982, J SURG RES, V33, P49, DOI 10.1016/0022-4804(82)90008-7; Vary TC, 1998, MOL CELL BIOCHEM, V178, P81, DOI 10.1023/A:1006826331115; VEECH RL, 1970, BIOCHEM J, V117, P499, DOI 10.1042/bj1170499; WARBURG O, 1956, SCIENCE, V124, P269; WARD LD, 1983, BIOCHEM J, V215, P685, DOI 10.1042/bj2150685; Wasserman K, 1990, CIRCULATION S2, V81, P1114; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; YAGER JY, 1991, AM J PHYSIOL, V261, pH1102, DOI 10.1152/ajpheart.1991.261.4.H1102; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang QH, 2006, P NATL ACAD SCI USA, V103, P9029, DOI 10.1073/pnas.0603269103; Ziegler M, 2005, FEBS J, V272, P4561, DOI 10.1111/j.1742-4658.2005.04893.x	49	89	90	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e34525	10.1371/journal.pone.0034525	http://dx.doi.org/10.1371/journal.pone.0034525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22570687	Green Published, Green Submitted, gold			2022-12-27	WOS:000305343400003
J	Bryant, B				Bryant, Barbara			Chromatin Computation	PLOS ONE			English	Article							HISTONE MODIFICATIONS; DNA METHYLATION; MOLECULAR COMPUTATION; REGULATORY NETWORKS; ESCHERICHIA-COLI; EPIGENETIC CODE; GENE-EXPRESSION; GENOME; EPIGENOMICS	In living cells, DNA is packaged along with protein and RNA into chromatin. Chemical modifications to nucleotides and histone proteins are added, removed and recognized by multi-functional molecular complexes. Here I define a new computational model, in which chromatin modifications are information units that can be written onto a one-dimensional string of nucleosomes, analogous to the symbols written onto cells of a Turing machine tape, and chromatin-modifying complexes are modeled as read-write rules that operate on a finite set of adjacent nucleosomes. I illustrate the use of this "chromatin computer" to solve an instance of the Hamiltonian path problem. I prove that chromatin computers are computationally universal - and therefore more powerful than the logic circuits often used to model transcription factor control of gene expression. Features of biological chromatin provide a rich instruction set for efficient computation of nontrivial algorithms in biological time scales. Modeling chromatin as a computer shifts how we think about chromatin function, suggests new approaches to medical intervention, and lays the groundwork for the engineering of a new class of biological computing machines.	Constellat Pharmaceut, Bioinformat Dept, Cambridge, MA USA		Bryant, B (corresponding author), Constellat Pharmaceut, Bioinformat Dept, Cambridge, MA USA.	barbara.bryant@constellationpharma.com		Bryant, Barbara/0000-0003-2707-1186				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Barbuti R, 2007, LECT NOTES COMPUT SC, V4860, P54; Beaver, 1995, UNIVERSAL MOL COMPUT, P29; Benayoun BA, 2009, TRENDS CELL BIOL, V19, P189, DOI 10.1016/j.tcb.2009.02.003; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Eiben AE, 2002, INFORM PROCESS LETT, V82, P1, DOI 10.1016/S0020-0190(02)00204-1; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Feeney AJ, 2011, CURR OPIN IMMUNOL, V23, P171, DOI 10.1016/j.coi.2010.12.008; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hartmann L, 2011, SCI ANN COMPUT SCI, V21, P73; Haynes KA, 2011, J BIOL CHEM; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivega I, 2011, CURR OPIN GENET DEV; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Madhani HD, 2008, SCIENCE, V322, P43, DOI 10.1126/science.322.5898.43b; Mario Coppo FD, 2010, QUANTITATIVE ASPECTS, P82; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Ptashne M, 2010, NATURE, V464, P487, DOI 10.1038/464487c; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Razin SV, 2011, NUCLEIC ACIDS RES, V39, P9085, DOI 10.1093/nar/gkr683; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Regev A, 2004, THEOR COMPUT SCI, V325, P141, DOI 10.1016/j.tcs.2004.03.061; Regev A, 2001, Pac Symp Biocomput, P459; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a; Rooss D., 1996, POWER BIOCOMPUTERS; Rothemund P. W. K, 1995, DNA BASED COMPUTERS, P75; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sakamoto K, 2000, SCIENCE, V288, P1223, DOI 10.1126/science.288.5469.1223; Smith W. D, 1995, DNA BASED COMPUTERS, P121; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Turing A.M, 1948, TECH REP; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Weiss R., 2003, Natural Computing, V2, P47, DOI 10.1023/A:1023307812034; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35703	10.1371/journal.pone.0035703	http://dx.doi.org/10.1371/journal.pone.0035703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567109	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500027
J	Pausch, H; Wang, XL; Jung, S; Krogmeier, D; Edel, C; Emmerling, R; Gotz, KU; Fries, R				Pausch, Hubert; Wang, Xiaolong; Jung, Simone; Krogmeier, Dieter; Edel, Christian; Emmerling, Reiner; Goetz, Kay-Uwe; Fries, Ruedi			Identification of QTL for UV-Protective Eye Area Pigmentation in Cattle by Progeny Phenotyping and Genome-Wide Association Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; DAIRY-CATTLE; MELANOCYTE DEVELOPMENT; SKIN PIGMENTATION; HEREFORD CATTLE; MILK-PRODUCTION; COMPLEX TRAITS; HUMAN HEIGHT; COMMON SNPS; BOS-TAURUS	Pigmentation patterns allow for the differentiation of cattle breeds. A dominantly inherited white head is characteristic for animals of the Fleckvieh (FV) breed. However, a minority of the FV animals exhibits peculiar pigmentation surrounding the eyes (ambilateral circumocular pigmentation, ACOP). In areas where animals are exposed to increased solar ultraviolet radiation, ACOP is associated with a reduced susceptibility to bovine ocular squamous cell carcinoma (BOSCC, eye cancer). Eye cancer is the most prevalent malignant tumour affecting cattle. Selection for animals with ACOP rapidly reduces the incidence of BOSCC. To identify quantitative trait loci (QTL) underlying ACOP, we performed a genome-wide association study using 658,385 single nucleotide polymorphisms (SNPs). The study population consisted of 3579 bulls of the FV breed with a total of 320,186 progeny with phenotypes for ACOP. The proportion of progeny with ACOP was used as a quantitative trait with high heritability (h(2) = 0.79). A variance component based approach to account for population stratification uncovered twelve QTL regions on seven chromosomes. The identified QTL point to MCM6, PAX3, ERBB3, KITLG, LEF1, DKK2, KIT, CRIM1, ATRN, GSDMC, MITF and NBEAL2 as underlying genes for eye area pigmentation in cattle. The twelve QTL regions explain 44.96% of the phenotypic variance of the proportion of daughters with ACOP. The chromosomes harbouring significantly associated SNPs account for 54.13% of the phenotypic variance, while another 19.51% of the phenotypic variance is attributable to chromosomes without identified QTL. Thus, the missing heritability amounts to 7% only. Our results support a polygenic inheritance pattern of ACOP in cattle and provide the basis for efficient genomic selection of animals that are less susceptible to serious eye diseases.	[Pausch, Hubert; Wang, Xiaolong; Jung, Simone; Fries, Ruedi] Tech Univ Munich, Lehrstuhl Tierzucht, Freising Weihenstephan, Germany; [Krogmeier, Dieter; Edel, Christian; Emmerling, Reiner; Goetz, Kay-Uwe] Bayer Landesanstalt Landwirtschaft, Inst Tierzucht, Poing, Germany	Technical University of Munich	Pausch, H (corresponding author), Tech Univ Munich, Lehrstuhl Tierzucht, Freising Weihenstephan, Germany.	hubert.pausch@tierzucht.tum.de	Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Gotz, Kay-Uwe/0000-0001-5495-7738; Fries, Ruedi/0000-0002-4657-1787	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr [0315527B]; FUGATO-plus GenoTrack [0315134A, 0315134D]	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr(Federal Ministry of Education & Research (BMBF)); FUGATO-plus GenoTrack	This research was funded by the German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de) within the AgroClustEr "Synbreed Synergistic plant and animal breeding (http://www.synbreed.tum.de)'' (grant number 0315527B) and as part of the project FUGATO-plus GenoTrack (grant numbers 0315134A and 0315134D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; ANDERSON DE, 1991, J HERED, V82, P21, DOI 10.1093/jhered/82.1.21; ANDERSON DE, 1963, ANN NY ACAD SCI, V108, P948, DOI 10.1111/j.1749-6632.1963.tb13432.x; ANDERSON DE, 1957, J ANIM SCI, V16, P1007, DOI 10.2527/jas1957.1641007x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; BARLOW R, 1980, AUST J AGR RES, V31, P417, DOI 10.1071/AR9800417; Baxter LL, 2009, WIRES SYST BIOL MED, V1, P359, DOI 10.1002/wsbm.20; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Buac K, 2009, PIGM CELL MELANOMA R, V22, P773, DOI 10.1111/j.1755-148X.2009.00616.x; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chamberlain AJ, 2007, GENETICS, V177, P1117, DOI 10.1534/genetics.107.077784; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; CLARK P, 1981, ANN HUM BIOL, V8, P529, DOI 10.1080/03014468100005371; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; David Clifford PM, 2006, R NEWS, P6; DENOTTER W, 1995, AM J VET RES, V56, P1440; Druet T, 2010, J DAIRY SCI, V93, P5443, DOI 10.3168/jds.2010-3255; Faigle W, 2000, PROTOPLASMA, V210, P117, DOI 10.1007/BF01276851; FINCH VA, 1977, ECOLOGY, V58, P1384, DOI 10.2307/1935090; FRISANCHO AR, 1981, AM J PHYS ANTHROPOL, V55, P203, DOI 10.1002/ajpa.1330550207; Furumura M, 1998, P NATL ACAD SCI USA, V95, P7374, DOI 10.1073/pnas.95.13.7374; Gage PJ, 2008, DEV BIOL, V317, P310, DOI 10.1016/j.ydbio.2008.02.030; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; GUILBERT HR, 1948, J ANIM SCI, V7, P426; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; He L, 2001, NAT GENET, V27, P40, DOI 10.1038/83741; HEENEY JL, 1985, CAN J COMP MED, V49, P21; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Klein RJ, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-58; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lovicu FJ, 2000, MECH DEVELOP, V94, P261, DOI 10.1016/S0925-4773(00)00292-6; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; McRae AF, 2008, GENOME RES, V18, P911, DOI 10.1101/gr.074872.107; Newton R, 1996, LANCET, V347, P1450, DOI 10.1016/S0140-6736(96)91685-2; NISHIMURA H, 1977, AUST J EXP AGR, V17, P709, DOI 10.1071/EA9770709; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; RUSSELL WC, 1976, J ANIM SCI, V43, P1156, DOI 10.2527/jas1976.4361156x; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Song YS, 2010, GENETICS, V186, P1467, DOI 10.1534/genetics.110.119008; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; VOGT DW, 1963, J ANIM SCI, V22, P762, DOI 10.2527/jas1963.223762x; WARD JK, 1979, J ANIM SCI, V49, P361, DOI 10.2527/jas1979.492361x; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	65	39	40	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e36346	10.1371/journal.pone.0036346	http://dx.doi.org/10.1371/journal.pone.0036346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567150	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500069
J	Xie, YC; Chen, SB; Murphy, T				Xie, Yicheng; Chen, Shangbin; Murphy, Timothy			Dendritic Spines and Pre-Synaptic Boutons Are Stable Despite Local Deep Hypothermic Challenge and Re-Warming In Vivo	PLOS ONE			English	Article							THERAPEUTIC HYPOTHERMIA; PROLONGED HYPOTHERMIA; CIRCULATORY ARREST; BLOOD-FLOW; PLASTICITY; TEMPERATURE; ANEURYSMS; TURNOVER; MODERATE; ONSET	Background and Purpose: Deep hypothermia to 20 degrees C is used clinically for major pediatric and adult surgical procedures. In particular, it is used in the "standstill operation" where blood flow is stopped for up to 30 min. Patients recovering from these procedures can exhibit neurological deficits. Such deficits could arise from changes to dendritic spines and plasticity-induced changes in network function as a result of cooling and/or re-warming. In the brain, each dendritic spine represents a single excitatory synapse and their number can be reflective of injury or plasticity-induced changes in network function. This research sought to determine whether deep hypothermia and re-warming have detrimental effects on synaptic stability and network function. Methods: In vivo 2-photon (2-P) imaging in green/yellow fluorescent protein (GFP/YFP)-expressing transgenic mice was performed to determine whether 4 hours of deep hypothermia and 2 hours of re-warming can have relatively covert effects on dendritic spine and presynaptic bouton stability. At the same time, electroencephalographic (EEG) activity was recorded to evaluate network function during deep hypothermia and re-warming. Results: We report that deep hypothermia and subsequent re-warming did not change the stability of dendritic spines or presynaptic boutons in mouse somatosensory cortex measured over 8 hours. As expected, deep hypothermia attenuated ongoing EEG activity over 0.1-80 Hz frequencies. The effects on EEG activity were fully reversible following re-warming. Conclusion: These results are consistent with deep hypothermia being a safe treatment which could be applied clinically to those undergoing major elective surgical procedures.	[Xie, Yicheng; Chen, Shangbin; Murphy, Timothy] Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada; [Xie, Yicheng; Chen, Shangbin; Murphy, Timothy] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Xie, YC (corresponding author), Univ British Columbia, Dept Psychiat, Kinsmen Lab Neurol Res, Vancouver, BC V6T 1W5, Canada.	thmurphy@mail.ubc.ca	Murphy, Timothy H/I-4982-2014; Murphy, Timothy/AAW-1975-2021	Murphy, Timothy H/0000-0002-0093-4490; Murphy, Timothy/0000-0002-0093-4490	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research (CIHR) [MOP-111009]; University of British Columbia	Heart and Stroke Foundation of British Columbia; Yukon; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of British Columbia	This work was supported by a grant in aid from the Heart and Stroke Foundation of British Columbia and the Yukon and a Canadian Institutes of Health Research (CIHR) operating grant MOP-111009 to TM and a Four Year Fellowship from the University of British Columbia to YX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; BAKER CJ, 1991, SURG NEUROL, V36, P175, DOI 10.1016/0090-3019(91)90109-M; Brown CE, 2007, J NEUROSCI, V27, P4101, DOI 10.1523/JNEUROSCI.4295-06.2007; Clark DL, 2007, J CEREBR BLOOD F MET, V27, P115, DOI 10.1038/sj.jcbfm.9600327; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DELEON S, 1990, ANN THORAC SURG, V50, P714, DOI 10.1016/0003-4975(90)90668-V; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Engelman RM, 1996, J THORAC CARDIOV SUR, V112, P1622, DOI 10.1016/S0022-5223(96)70021-1; Enomoto S, 1996, ANESTHESIOLOGY, V84, P1392, DOI 10.1097/00000542-199606000-00016; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gao TM, 1998, NEUROSCIENCE, V87, P371, DOI 10.1016/S0306-4522(98)00150-X; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guyton RA, 1996, J THORAC CARDIOV SUR, V112, P1632; Kim JH, 2011, RECENT PATENTS INFLA, V5, P155, DOI 10.2174/187221311795399219; Kirov SA, 2004, NEUROSCIENCE, V127, P69, DOI 10.1016/j.neuroscience.2004.04.053; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kurth CD, 1999, J THORAC CARDIOV SUR, V118, P1068, DOI 10.1016/S0022-5223(99)70103-0; Liu LP, 2007, FRONT BIOSCI-LANDMRK, V12, P816, DOI 10.2741/2104; Mack WJ, 2007, NEUROSURGERY, V60, P815, DOI 10.1227/01.NEU.0000255452.20602.C9; MacLellan CL, 2009, J NEUROTRAUM, V26, P313, DOI 10.1089/neu.2008.0580; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; MOSER E, 1993, SCIENCE, V259, P1324, DOI 10.1126/science.8446900; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; POPOV VI, 1992, NEUROSCIENCE, V48, P53, DOI 10.1016/0306-4522(92)90337-2; POPOV VI, 1992, NEUROSCIENCE, V48, P45, DOI 10.1016/0306-4522(92)90336-Z; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; SILVERBERG GD, 1981, J NEUROSURG, V55, P337, DOI 10.3171/jns.1981.55.3.0337; STEEN PA, 1979, STROKE, V10, P522, DOI 10.1161/01.STR.10.5.522; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tran S, 2012, J CEREBR BLOOD F MET, V32, P437, DOI 10.1038/jcbfm.2011.178; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2012	7	5							e36305	10.1371/journal.pone.0036305	http://dx.doi.org/10.1371/journal.pone.0036305			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UN	22563488	Green Published, Green Submitted, gold			2022-12-27	WOS:000305340700037
J	Ma, Q; Fan, JB; Zhou, Z; Zhou, BR; Meng, SR; Hu, JY; Chen, J; Liang, Y				Ma, Qian; Fan, Jun-Bao; Zhou, Zheng; Zhou, Bing-Rui; Meng, Sheng-Rong; Hu, Ji-Ying; Chen, Jie; Liang, Yi			The Contrasting Effect of Macromolecular Crowding on Amyloid Fibril Formation	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; PROTEIN AGGREGATION; TAU-PROTEIN; PRION; MUTATIONS; STABILITY; LYSOZYME; RESIDUES; FRAGMENT; DISEASE	Background: Amyloid fibrils associated with neurodegenerative diseases can be considered biologically relevant failures of cellular quality control mechanisms. It is known that in vivo human Tau protein, human prion protein, and human copper, zinc superoxide dismutase (SOD1) have the tendency to form fibril deposits in a variety of tissues and they are associated with different neurodegenerative diseases, while rabbit prion protein and hen egg white lysozyme do not readily form fibrils and are unlikely to cause neurodegenerative diseases. In this study, we have investigated the contrasting effect of macromolecular crowding on fibril formation of different proteins. Methodology/Principal Findings: As revealed by assays based on thioflavin T binding and turbidity, human Tau fragments, when phosphorylated by glycogen synthase kinase-3 beta, do not form filaments in the absence of a crowding agent but do form fibrils in the presence of a crowding agent, and the presence of a strong crowding agent dramatically promotes amyloid fibril formation of human prion protein and its two pathogenic mutants E196K and D178N. Such an enhancing effect of macromolecular crowding on fibril formation is also observed for a pathological human SOD1 mutant A4V. On the other hand, rabbit prion protein and hen lysozyme do not form amyloid fibrils when a crowding agent at 300 g/l is used but do form fibrils in the absence of a crowding agent. Furthermore, aggregation of these two proteins is remarkably inhibited by Ficoll 70 and dextran 70 at 200 g/l. Conclusions/Significance: We suggest that proteins associated with neurodegenerative diseases are more likely to form amyloid fibrils under crowded conditions than in dilute solutions. By contrast, some of the proteins that are not neurodegenerative disease-associated are unlikely to misfold in crowded physiological environments. A possible explanation for the contrasting effect of macromolecular crowding on these two sets of proteins (amyloidogenic proteins and non-amyloidogenic proteins) has been proposed.	[Ma, Qian; Fan, Jun-Bao; Zhou, Zheng; Zhou, Bing-Rui; Meng, Sheng-Rong; Hu, Ji-Ying; Chen, Jie; Liang, Yi] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Wuhan University	Ma, Q (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	liangyi@whu.edu.cn	Zhou, Zheng/AAK-2669-2021; Liang, Yi/V-1396-2017; Fan, Jun-bao/E-7155-2012; Zhou, Bing-Rui/D-4766-2009	Zhou, Zheng/0000-0002-3124-6041; Liang, Yi/0000-0002-7349-8300; Fan, Junbao/0000-0002-1709-3659; Zhou, Bing-Rui/0000-0002-5375-7977	National Key Basic Research Foundation of China [2012CB911003]; National Natural Science Foundation of China [30970599, 31170744]; Fundamental Research Funds for the Central Universities of China [1104006]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by National Key Basic Research Foundation of China (http://www.most.gov.cn/, Grant no. 2012CB911003, to YL), National Natural Science Foundation of China (http://www.nsfc.gov.cn/, grant nos. 30970599 and 31170744, to YL), and Fundamental Research Funds for the Central Universities of China (http://www.moe.edu.cn/, grant no. 1104006, to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Arnaudov LN, 2005, BIOPHYS J, V88, P515, DOI 10.1529/biophysj.104.048819; Barghorn Stefan, 2004, V299, P35; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Capellari S, 2011, ACTA NEUROPATHOL, V121, P21, DOI 10.1007/s00401-010-0760-4; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Ip P, 2011, J MOL BIOL, V409, P839, DOI 10.1016/j.jmb.2011.04.027; Jiao M, 2010, BIOPHYS J, V99, P914, DOI 10.1016/j.bpj.2010.05.013; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; MANDELKOW E, 1995, NEUROBIOL AGING, V16, P347, DOI 10.1016/0197-4580(95)00026-B; Meiering EM, 2008, PLOS BIOL, V6, P1383, DOI 10.1371/journal.pbio.0060193; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; PEOCH, 2000, HUM MUTAT, V15, P482; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Spitzer J, 2011, MICROBIOL MOL BIOL R, V75, P491, DOI 10.1128/MMBR.00010-11; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Sun Y, 2008, J MOL BIOL, V376, P1155, DOI 10.1016/j.jmb.2007.12.053; Swaminathan R, 2011, ADV PROTEIN CHEM STR, V84, P63, DOI 10.1016/B978-0-12-386483-3.00003-3; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; van der Kamp MW, 2009, PROTEIN ENG DES SEL, V22, P461, DOI 10.1093/protein/gzp039; Vassall KA, 2011, P NATL ACAD SCI USA, V108, P2210, DOI 10.1073/pnas.0913021108; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Zhou BR, 2004, J BIOL CHEM, V279, P55109, DOI 10.1074/jbc.M409086200; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832; Zhu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025020; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	48	63	65	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36288	10.1371/journal.pone.0036288	http://dx.doi.org/10.1371/journal.pone.0036288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558423	Green Submitted, Green Published, gold			2022-12-27	WOS:000305340200063
J	Belanger, CL				Belanger, Christina L.			Individual to Community-Level Faunal Responses to Environmental Change from a Marine Fossil Record of Early Miocene Global Warming	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; CLIMATE-CHANGE; REGIME SHIFTS; BENTHIC FORAMINIFERA; POPULATION-DYNAMICS; BODY-SIZE; TEMPERATURE; EUTROPHICATION; GROWTH; EVOLUTIONARY	Modern climate change has a strong potential to shift earth systems and biological communities into novel states that have no present-day analog, leaving ecologists with no observational basis to predict the likely biotic effects. Fossil records contain long time-series of past environmental changes outside the range of modern observation, which are vital for predicting future ecological responses, and are capable of (a) providing detailed information on rates of ecological change, (b) illuminating the environmental drivers of those changes, and (c) recording the effects of environmental change on individual physiological rates. Outcrops of Early Miocene Newport Member of the Astoria Formation (Oregon) provide one such time series. This record of benthic foraminiferal and molluscan community change from continental shelf depths spans a past interval environmental change (similar to 20.3-16.7 mya) during which the region warmed 2.1-4.5 degrees C, surface productivity and benthic organic carbon flux increased, and benthic oxygenation decreased, perhaps driven by intensified upwelling as on the modern Oregon coast. The Newport Member record shows that (a) ecological responses to natural environmental change can be abrupt, (b) productivity can be the primary driver of faunal change during global warming, (c) molluscs had a threshold response to productivity change while foraminifera changed gradually, and (d) changes in bivalve body size and growth rates parallel changes in taxonomic composition at the community level, indicating that, either directly or indirectly through some other biological parameter, the physiological tolerances of species do influence community change. Ecological studies in modern and fossil records that consider multiple ecological levels, environmental parameters, and taxonomic groups can provide critical information for predicting future ecological change and evaluating species vulnerability.	Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Belanger, CL (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	belanger@uchicago.edu		Belanger, Christina/0000-0002-1582-7647	National Science Foundation [0910026]; Cushman Foundation; Conchologists of America Research Award; Sigma Xi Grants-in-Aid of Research; Frank H. and Eva B. Buck Foundation	National Science Foundation(National Science Foundation (NSF)); Cushman Foundation; Conchologists of America Research Award; Sigma Xi Grants-in-Aid of Research; Frank H. and Eva B. Buck Foundation	This material is based upon work supported by the National Science Foundation under Grant No. 0910026, the William V. Sliter award from the Cushman Foundation, Conchologists of America Research Award, and Sigma Xi Grants-in-Aid of Research. CLB was also supported by the National Science Foundation Graduate Research Fellowship and the Frank H. and Eva B. Buck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT WO, 1970, PALAEOGEOGR PALAEOCL, V8, P287, DOI 10.1016/0031-0182(70)90103-3; Allmon WD, 2001, PALAEOGEOGR PALAEOCL, V166, P9, DOI 10.1016/S0031-0182(00)00199-1; Alve E, 2010, J SEA RES, V63, P36, DOI 10.1016/j.seares.2009.09.003; AMANO K, 1994, PALAEOGEOGR PALAEOCL, V108, P369, DOI 10.1016/0031-0182(94)90243-7; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; [Anonymous], 2010, R LANG ENV STAT COMP; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bakun A, 2010, GLOBAL CHANGE BIOL, V16, P1213, DOI 10.1111/j.1365-2486.2009.02094.x; Belanger CL, 2011, PALAIOS, V26, P767, DOI 10.2110/palo.2011.p11-032r; Belanger CL, 2011, MAR MICROPALEONTOL, V80, P101, DOI 10.1016/j.marmicro.2011.06.004; BORGESE TA, 1987, COMP BIOCHEM PHYS B, V86, P155, DOI 10.1016/0305-0491(87)90191-X; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; CLARKE A, 1993, PALEOBIOLOGY, V19, P499, DOI 10.1017/S0094837300014111; Collie JS, 2004, PROG OCEANOGR, V60, P281, DOI 10.1016/j.pocean.2004.02.013; CUMMINS H, 1986, PALAEONTOLOGY, V29, P495; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEBENAY JP, 1994, J MOLLUS STUD, V60, P113, DOI 10.1093/mollus/60.2.113; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dietl GP, 2011, TRENDS ECOL EVOL, V26, P30, DOI 10.1016/j.tree.2010.09.010; Dumas S, 2006, GEOLOGY, V34, P1073, DOI 10.1130/G22930A.1; ERSKIAN MG, 1987, J FORAMIN RES, V17, P240, DOI 10.2113/gsjfr.17.3.240; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; FURSICH FT, 1990, LETHAIA, V23, P143, DOI 10.1111/j.1502-3931.1990.tb01355.x; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Gilbert D, 2010, BIOGEOSCIENCES, V7, P2283, DOI 10.5194/bg-7-2283-2010; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Goewert AE, 2008, GEO-MAR LETT, V28, P327, DOI 10.1007/s00367-008-0113-7; Goldstein ST, 2011, MAR ECOL PROG SER, V437, P1, DOI 10.3354/meps09296; Grall J, 2002, GLOBAL CHANGE BIOL, V8, P813, DOI 10.1046/j.1365-2486.2002.00519.x; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Greene CH, 2008, ECOLOGY, V89, pS24, DOI 10.1890/07-0550.1; Grunert P, 2010, GEOL CARPATH, V61, P129, DOI 10.2478/v10096-010-0006-3; Hall C.A., 2002, GEOL SOC AM SPEC PAP, V357, P1, DOI DOI 10.1130/0-8137-2357-4.1); Hallam A., 1965, Palaeontology, V8, P132; HALLAM A, 1967, PALAEONTOLOGY, V10, P25; HALLOCK P, 1985, PALEOBIOLOGY, V11, P195, DOI 10.1017/S0094837300011507; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; Hunt G, 2008, PALEOBIOLOGY, V34, P360, DOI 10.1666/07073.1; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; JONES DS, 1989, MAR BIOL, V102, P225, DOI 10.1007/BF00428284; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kender S, 2009, GEOLOGY, V37, P699, DOI 10.1130/G30070A.1; Kidwell SM, 2001, SCIENCE, V294, P1091, DOI 10.1126/science.1064539; Kidwell SM, 2002, GEOBIOS MEMOIRE SPEC; Kidwell SM, 2010, PALEOBIOLOGY, V36, P615, DOI 10.1666/09004.1; Kirby MX, 2005, ESTUAR COAST SHELF S, V62, P679, DOI 10.1016/j.ecss.2004.10.004; Knowlton N, 2004, PROG OCEANOGR, V60, P387, DOI 10.1016/j.pocean.2004.02.011; Kosnik MA, 2006, PALAIOS, V21, P588, DOI 10.2110/palo.2006.p06-012r; Kowalewski Michal, 2003, Journal of Taphonomy, V1, P43; Levin LA, 2009, BIOGEOSCIENCES, V6, P2063, DOI 10.5194/bg-6-2063-2009; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; LI Q, 1994, AUST J EARTH SCI, V41, P593, DOI 10.1080/08120099408728169; Lillebo AI, 1999, ACTA OECOL, V20, P289, DOI 10.1016/S1146-609X(99)00137-X; Marincovich LJ, 1992, US GEOLOGICAL SURVEY, V199, P163; Martel P, 2003, ENVIRON POLLUT, V124, P471, DOI 10.1016/S0269-7491(03)00011-3; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McNamara K.J., 2001, P180, DOI 10.1002/9780470999295.ch38; Metcalfe B, 2011, PALAEOGEOGR PALAEOCL, V308, P171, DOI 10.1016/j.palaeo.2010.09.011; Miles EL, 2009, ANNU REV ENV RESOUR, V34, P17, DOI 10.1146/annurev.environ.33.041707.110117; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Moore E. J., 1963, Professional Papers US Geological Survey, V419, P1; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Murray J. W., 1991, ECOLOGY PALEOECOLOGY; MURRAY JW, 1983, J FORAMIN RES, V13, P1, DOI 10.2113/gsjfr.13.1.1; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; Murray JW, 2001, MAR MICROPALEONTOL, V41, P1, DOI 10.1016/S0377-8398(00)00057-8; Niem W.A., 1992, GEOLOGY N AM G, P314; NRC, 2005, GEOL REC EC DYN UND; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Oksanen J., 2016, R PACKAG; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Petersen JK, 2008, ECOL APPL, V18, P497, DOI 10.1890/07-0752.1; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; SAVRDA CE, 1987, NATURE, V327, P54, DOI 10.1038/327054a0; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Shepherd AS, 2007, MAR MICROPALEONTOL, V65, P54, DOI 10.1016/j.marmicro.2007.06.001; Smith JR, 2006, ECOLOGY, V87, P1153, DOI 10.1890/0012-9658(2006)87[1153:DDIMBC]2.0.CO;2; Snavely P. D., 1964, Ore Bin, V26, P133; Thomas CD, 2005, RECENT EVOLUTIONARY, P75; Tomasovych A, 2011, PALEOBIOLOGY, V37, P332, DOI 10.1666/09506.1; Twitchett RJ, 2007, PALAEOGEOGR PALAEOCL, V252, P132, DOI 10.1016/j.palaeo.2006.11.038; Urbanek Adam, 1993, Historical Biology, V7, P29; Valentine J. W., 1961, Bulletin Department Geology University California, V34, P309; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeineddine M, 2009, EVOLUTION, V63, P1498, DOI 10.1111/j.1558-5646.2009.00630.x	99	5	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36290	10.1371/journal.pone.0036290	http://dx.doi.org/10.1371/journal.pone.0036290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558424	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000180
J	Lanza, AM; Blazeck, JJ; Crook, NC; Alper, HS				Lanza, Amanda M.; Blazeck, John J.; Crook, Nathan C.; Alper, Hal S.			Linking Yeast Gcn5p Catalytic Function and Gene Regulation Using a Quantitative, Graded Dominant Mutant Approach	PLOS ONE			English	Article							PROBE LEVEL DATA; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLATION; GENOME-WIDE; NEGATIVE MUTATIONS; IN-VIVO; PROMOTER; TRANSCRIPTION; EXPLORATION; EXPRESSION	Establishing causative links between protein functional domains and global gene regulation is critical for advancements in genetics, biotechnology, disease treatment, and systems biology. This task is challenging for multifunctional proteins when relying on traditional approaches such as gene deletions since they remove all domains simultaneously. Here, we describe a novel approach to extract quantitative, causative links by modulating the expression of a dominant mutant allele to create a function-specific competitive inhibition. Using the yeast histone acetyltransferase Gcn5p as a case study, we demonstrate the utility of this approach and (1) find evidence that Gcn5p is more involved in cell-wide gene repression, instead of the accepted gene activation associated with HATs, (2) identify previously unknown gene targets and interactions for Gcn5p-based acetylation, (3) quantify the strength of some Gcn5p-DNA associations, (4) demonstrate that this approach can be used to correctly identify canonical chromatin modifications, (5) establish the role of acetyltransferase activity on synthetic lethal interactions, and (6) identify new functional classes of genes regulated by Gcn5p acetyltransferase activity-all six of these major conclusions were unattainable by using standard gene knockout studies alone. We recommend that a graded dominant mutant approach be utilized in conjunction with a traditional knockout to study multifunctional proteins and generate higher-resolution data that more accurately probes protein domain function and influence.	[Lanza, Amanda M.; Blazeck, John J.; Crook, Nathan C.; Alper, Hal S.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Alper, Hal S.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lanza, AM (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	halper@che.utexas.edu		Crook, Nathan/0000-0001-6165-1972				Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Alper H, 2006, SCIENCE, V314, P1565, DOI 10.1126/science.1131969; Barbaric S, 2003, MOL CELL BIOL, V23, P3468, DOI 10.1128/MCB.23.10.3468-3476.2003; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Byun HM, 2008, CANCER LETT, V266, P238, DOI 10.1016/j.canlet.2008.02.069; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GREENBERG ML, 1986, MOL CELL BIOL, V6, P1820, DOI 10.1128/MCB.6.5.1820; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; HAGUENAUERTSAPIS R, 1984, MOL CELL BIOL, V4, P2668, DOI 10.1128/MCB.4.12.2668; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Imoberdorf RM, 2006, MOL CELL BIOL, V26, P1610, DOI 10.1128/MCB.26.5.1610-1616.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen G, 2002, METHOD ENZYMOL, V344, P82; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Lanza AM, 2012, CURR OPIN BIOTECH, DOI [10.1016/j.cop-bio.2011.12.026, DOI 10.1016/J.COP-BIO.2011.12.026]; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; O'Connor TR, 2007, BIOINFORMATICS, V23, P1828, DOI 10.1093/bioinformatics/btm236; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tornoe J, 2002, GENE, V297, P21, DOI 10.1016/S0378-1119(02)00878-8; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Xue-Franzen Y, 2010, BMC GENOMICS, V11; Yan Z, 2009, GENETICS, V182, P623, DOI 10.1534/genetics.109.103036	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36193	10.1371/journal.pone.0036193	http://dx.doi.org/10.1371/journal.pone.0036193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558379	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336000151
J	Nightingale, CM; Krishnaveni, GV; Rudnicka, AR; Owen, CG; Veena, SR; Hill, JC; Cook, DG; Fall, CHD; Whincup, PH				Nightingale, Claire M.; Krishnaveni, Ghattu V.; Rudnicka, Alicja R.; Owen, Christopher G.; Veena, Sargoor R.; Hill, Jacqueline C.; Cook, Derek G.; Fall, Caroline H. D.; Whincup, Peter H.			Cardiometabolic Risk Markers in Indian Children: Comparison with UK Indian and White European Children	PLOS ONE			English	Article							BLOOD-PRESSURE-MEASUREMENT; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; ETHNIC-DIFFERENCES; VASCULAR MORTALITY; PHYSICAL-ACTIVITY; INDIVIDUAL DATA; BLACK-AFRICAN; HEART; ENGLAND	Objective: UK Indian adults have higher risks of coronary heart disease and type 2 diabetes than Indian and UK European adults. With growing evidence that these diseases originate in early life, we compared cardiometabolic risk markers in Indian, UK Indian and white European children. Methods: Comparisons were based on the Mysore Parthenon Birth Cohort Study (MPBCS), India and the Child Heart Health Study in England (CHASE), which studied 9-10 year-old children (538 Indian, 483 UK Indian, 1375 white European) using similar methods. Analyses adjusted for study differences in age and sex. Results: Compared with Mysore Indians, UK Indians had markedly higher BMI (% difference 21%, 95%CI 18 to 24%), skinfold thickness (% difference 34%, 95%CI 26 to 42%), LDL-cholesterol (mean difference 0.48, 95%CI 0.38 to 0.57 mmol/L), systolic BP (mean difference 10.3, 95% CI 8.9 to 11.8 mmHg) and fasting insulin (% difference 145%, 95%CI 124 to 168%). These differences (similar in both sexes and little affected by adiposity adjustment) were larger than those between UK Indians and white Europeans. Compared with white Europeans, UK Indians had higher skinfold thickness (% difference 6.0%, 95% CI 1.5 to 10.7%), fasting insulin (% difference 31%, 95% CI 22 to 40%), triglyceride (% difference 13%, 95% CI 8 to 18%) and LDL-cholesterol (mean difference 0.12 mmol/L, 95% CI 0.04 to 0.19 mmol/L). Conclusions: UK Indian children have an adverse cardiometabolic risk profile, especially compared to Indian children. These differences, not simply reflecting greater adiposity, emphasize the need for prevention strategies starting in childhood or earlier.	[Nightingale, Claire M.; Rudnicka, Alicja R.; Owen, Christopher G.; Cook, Derek G.; Whincup, Peter H.] St Georges Univ London, Div Populat Hlth Sci & Educ, London, England; [Krishnaveni, Ghattu V.; Veena, Sargoor R.] CSI Holdsworth Mem Hosp, Epidemiol Res Unit, Mysore, Karnataka, India; [Hill, Jacqueline C.; Fall, Caroline H. D.] Southampton Gen Hosp, Med Res Council Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England	St Georges University London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Southampton	Nightingale, CM (corresponding author), St Georges Univ London, Div Populat Hlth Sci & Educ, London, England.	cnightin@sgul.ac.uk	Cook, Derek G/C-3271-2008	Krishnaveni, Ghattu V/0000-0002-6532-8272; Whincup, Peter/0000-0002-5589-4107; Rudnicka, Alicja R/0000-0003-0369-8574; Nightingale, Claire/0000-0002-4803-7617; Fall, Caroline/0000-0003-4402-5552; Owen, Christopher/0000-0003-1135-5977; Cook, Derek/0000-0002-9723-5759; Nightingale, Claire/0000-0003-2408-757X	NIHR; Wellcome Trust; Parthenon Trust; Medical Research Council; Medical Research Council [MC_U147585821, MC_UP_A620_1016] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-101] Funding Source: researchfish; MRC [MC_UP_A620_1016, MC_U147585821] Funding Source: UKRI	NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Parthenon Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Claire Nightingale was supported by an NIHR Doctoral Fellowship. CHASE was supported by the Wellcome Trust and MPBCS by Parthenon Trust, Medical Research Council and the Wellcome Trust. The study sponsors had no role in the collection, analysis and interpretation of the data or in the writing of the report or in the decision to submit this paper for publication.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; BARKER DJP, 1993, BRIT HEART J, V69, P195; Barker ME, 2000, PAEDIATR PERINAT EP, V14, P179, DOI 10.1046/j.1365-3016.2000.00250.x; BHATNAGAR D, 1995, LANCET, V345, P405; CLASEY J, 2007, OBESITY, V15, pA127; Donin AS, 2010, AM J CLIN NUTR, V92, P776, DOI 10.3945/ajcn.2010.29533; Ehtisham S, 2005, J CLIN ENDOCR METAB, V90, P3963, DOI 10.1210/jc.2004-2001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gupta R, 2006, INT J CARDIOL, V108, P291, DOI 10.1016/j.ijcard.2005.05.044; Hypponen E, 2003, DIABETES CARE, V26, P2512, DOI 10.2337/diacare.26.9.2512; *INF CTR, 2006, HLTH SURV ENGL 2004; International Institute for Population Sciences Macro International, 2007, NAT FAM HLTH SURV 3, VI; Jin RZ, 2001, J PAEDIATR CHILD H, V37, P545, DOI 10.1046/j.1440-1754.2001.00752.x; Kehoe SH, 2011, EUR J CLIN NUTR; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; Krishnaveni GV, 2005, DIABETES CARE, V28, P2919, DOI 10.2337/diacare.28.12.2919; Kuh D, 1997, LIFE COURSE APPROACH; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Nightingale CM, 2011, INT J EPIDEMIOL, V40, P33, DOI 10.1093/ije/dyq180; Ostchega Y, 2010, J CLIN HYPERTENS, V12, P22, DOI 10.1111/j.1751-7176.2009.00199.x; Owen CG, 2010, DIABETOLOGIA, V53, P1620, DOI 10.1007/s00125-010-1781-1; Owen CG, 2009, INT J EPIDEMIOL, V38, P1082, DOI 10.1093/ije/dyp176; Park MK, 2001, ARCH PEDIAT ADOL MED, V155, P50, DOI 10.1001/archpedi.155.1.50; Patel JV, 2006, ATHEROSCLEROSIS, V185, P297, DOI 10.1016/j.atherosclerosis.2005.06.005; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Thomas C, 2012, PLOS ONE IN PRESS; Whincup PH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000263; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Whincup PH, 2005, DIABETIC MED, V22, P1275, DOI 10.1111/j.1464-5491.2005.01587.x; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WHO, 2004, LANCET, V363, P902; WHO, 2011, WHO GLOB INFOBASE; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36236	10.1371/journal.pone.0036236	http://dx.doi.org/10.1371/journal.pone.0036236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558399	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305336000166
J	Wortham, M; Jin, GL; Sun, JL; Bigner, DD; He, YP; Yan, H				Wortham, Matthew; Jin, Genglin; Sun, Julia Lailai; Bigner, Darell D.; He, Yiping; Yan, Hai			Aberrant Otx2 Expression Enhances Migration and Induces Ectopic Proliferation of Hindbrain Neuronal Progenitor Cells	PLOS ONE			English	Article							CEREBELLAR-VERMIS-DEFECT; TRANSGENIC MICE; STEM-CELLS; MEDULLOBLASTOMA; DIFFERENTIATION; RAT	Dysregulation of Otx2 is a hallmark of the pediatric brain tumor medulloblastoma, yet its functional significance in the establishment of these tumors is unknown. Here we have sought to determine the functional consequences of Otx2 overexpression in the mouse hindbrain to characterize its potential role in medulloblastoma tumorigenesis and identify the cell types responsive to this lineage-specific oncogene. Expression of Otx2 broadly in the mouse hindbrain resulted in the accumulation of proliferative clusters of cells in the cerebellar white matter and dorsal brainstem of postnatal mice. We found that brainstem ectopia were derived from neuronal progenitors of the rhombic lip and that cerebellar ectopia were derived from granule neuron precursors (GNPs) that had migrated inwards from the external granule layer (EGL). These hyperplasias exhibited various characteristics of medulloblastoma precursor cells identified in animal models of Shh or Wnt group tumors, including aberrant localization and altered spatiotemporal control of proliferation. However, ectopia induced by Otx2 differentiated and dispersed as the animals reached adulthood, indicating that factors restricting proliferative lifespan were a limiting factor to full transformation of these cells. These studies implicate a role for Otx2 in altering the dynamics of neuronal progenitor cell proliferation.	[Wortham, Matthew] Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC USA	Duke University; Duke University	Wortham, M (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Pediat Brain Tumor Fdn Inst, Durham, NC 27710 USA.	hai.yan@dm.duke.edu			NIH [R01CA118822]; Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE [R01CA118822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01CA118822 (http://www.nih.gov) and the Pediatric Brain Tumor Foundation (www.pbtfus.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DC, 2010, CANCER RES, V70, P181, DOI 10.1158/0008-5472.CAN-09-2331; Altman J, 1997, DEV CEREBELLAR SYSTE; Boon K, 2002, P NATL ACAD SCI USA, V99, P11287, DOI 10.1073/pnas.152324199; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Bunt J, 2011, INT J CANC IN PRESS; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Choi Y, 2005, J NEUROSCI, V25, P10437, DOI 10.1523/JNEUROSCI.1559-05.2005; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; FRANTZ GD, 1994, J NEUROSCI, V14, P5725; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Kuramoto T, 2004, MOL BRAIN RES, V122, P103, DOI 10.1016/j.molbrainres.2003.12.003; KUWAMURA M, 1994, DEV BRAIN RES, V83, P294, DOI 10.1016/0165-3806(94)00167-7; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Louis P, WHO CLASSIFICATIONS; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Omodei D, 2008, DEVELOPMENT, V135, P3459, DOI 10.1242/dev.027003; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Puelles E, 2006, J NEUROSCI, V26, P5955, DOI 10.1523/JNEUROSCI.1097-06.2006; Shakhova O, 2006, CANCER RES, V66, P5190, DOI 10.1158/0008-5472.CAN-05-3545; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36211	10.1371/journal.pone.0036211	http://dx.doi.org/10.1371/journal.pone.0036211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558385	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336000156
J	Lautenbach, S; Seppelt, R; Liebscher, J; Dormann, CF				Lautenbach, Sven; Seppelt, Ralf; Liebscher, Juliane; Dormann, Carsten F.			Spatial and Temporal Trends of Global Pollination Benefit	PLOS ONE			English	Article							LAND-USE INTENSITY; ECOSYSTEM SERVICES; LANDSCAPE STRUCTURE; CROP POLLINATION; NATIVE BEES; BIODIVERSITY; HABITAT; CONSERVATION; DIVERSITY; DECLINES	Pollination is a well-studied and at the same time a threatened ecosystem service. A significant part of global crop production depends on or profits from pollination by animals. Using detailed information on global crop yields of 60 pollination dependent or profiting crops, we provide a map of global pollination benefits on a 5' by 5' latitude-longitude grid. The current spatial pattern of pollination benefits is only partly correlated with climate variables and the distribution of cropland. The resulting map of pollination benefits identifies hot spots of pollination benefits at sufficient detail to guide political decisions on where to protect pollination services by investing in structural diversity of land use. Additionally, we investigated the vulnerability of the national economies with respect to potential decline of pollination services as the portion of the (agricultural) economy depending on pollination benefits. While the general dependency of the agricultural economy on pollination seems to be stable from 1993 until 2009, we see increases in producer prices for pollination dependent crops, which we interpret as an early warning signal for a conflict between pollination service and other land uses at the global scale. Our spatially explicit analysis of global pollination benefit points to hot spots for the generation of pollination benefits and can serve as a base for further planning of land use, protection sites and agricultural policies for maintaining pollination services.	[Lautenbach, Sven; Seppelt, Ralf; Liebscher, Juliane; Dormann, Carsten F.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany; [Lautenbach, Sven] Univ Bonn, Dept Urban Planning & Real Estate Management, Inst Geodesy & Geoinformat IGG, Bonn, Germany; [Liebscher, Juliane] Tech Univ Dresden, Dept Geog, Dresden, Germany; [Dormann, Carsten F.] Univ Freiburg, D-79106 Freiburg, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bonn; Technische Universitat Dresden; University of Freiburg	Lautenbach, S (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany.	sven.lautenbach@ufz.de	Lautenbach, Sven/C-1235-2010; BITOUN, RACHEL Elisabeth/AAC-9538-2021; Seppelt, Ralf/E-6056-2010	Lautenbach, Sven/0000-0003-1825-9996; BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Seppelt, Ralf/0000-0002-2723-7150; Dormann, Carsten/0000-0002-9835-1794	German Ministry of Research and Technology [01LG0801A, 01LL0901A]; Helmholtz-University-Group 'Biotic Ecosystem Services [VH-NG-247]; Helmholtz Programme 'Terrestrial Environmental Research'	German Ministry of Research and Technology; Helmholtz-University-Group 'Biotic Ecosystem Services; Helmholtz Programme 'Terrestrial Environmental Research'	The work was funded by grants 01LG0801Aand 01LL0901A (German Ministry of Research and Technology), the Helmholtz-University-Group 'Biotic Ecosystem Services' (VH-NG-247) and the Helmholtz Programme 'Terrestrial Environmental Research'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Asquith NM, 2008, ECOL ECON, V65, P675, DOI 10.1016/j.ecolecon.2007.12.014; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Carvalheiro LG, 2011, ECOL LETT, V14, P251, DOI 10.1111/j.1461-0248.2010.01579.x; Chapagain AK, 2007, ECOL ECON, V64, P109, DOI 10.1016/j.ecolecon.2007.02.022; Chiang AY, 2007, TECHNOMETRICS, V49, P360; Committee on the Status of Pollinators in North America, 2006, STAT POLL N AM; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; De la Rua P, 2009, APIDOLOGIE, V40, P263, DOI 10.1051/apido/2009027; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dormann CF, 2008, ECOL LETT, V11, P235, DOI 10.1111/j.1461-0248.2007.01142.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Erb KH, 2007, J LAND USE SCI, V2, P191, DOI 10.1080/17474230701622981; FAO, 2011, STAT DAT; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Fisher B, 2008, ECOL APPL, V18, P2050, DOI 10.1890/07-1537.1; Franke G, NUTZPFLANZEN TROPEN, V3, P18; Freitas BM, 2009, APIDOLOGIE, V40, P332, DOI 10.1051/apido/2009012; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Greenleaf SS, 2006, BIOL CONSERV, V133, P81, DOI 10.1016/j.biocon.2006.05.025; Gruber B, 2011, APIDOLOGIE, V42, P564, DOI 10.1007/s13592-011-0059-z; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Heston Alan, 2011, PENN WORLD TABLE VER; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2011, RASTER GEOGRAPHIC AN; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Jaffe R, 2010, CONSERV BIOL, V24, P583, DOI 10.1111/j.1523-1739.2009.01331.x; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kevan PG, 1997, J APPL ECOL, V34, P1122, DOI 10.2307/2405226; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, J APPL ECOL, V40, P837, DOI 10.1046/j.1365-2664.2003.00847.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Lautenbach S, 2011, ECOL INDIC, V11, P676, DOI 10.1016/j.ecolind.2010.09.007; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; MEA, 2005, ECOSYSTEMS HUMAN WEL; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Ne'eman G, 2010, BIOL REV, V85, P435, DOI 10.1111/j.1469-185X.2009.00108.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pinillos V, 2008, BIOTECH HISTOCHEM, V83, P15, DOI 10.1080/10520290801987204; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Potts SG, 2006, BIOL CONSERV, V129, P519, DOI 10.1016/j.biocon.2005.11.019; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Priess JA, 2007, ECOL APPL, V17, P407, DOI 10.1890/05-1795; R Core Team, 2016, R FDN STAT COMP; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; Schweiger O, 2010, BIOL REV, V85, P777, DOI 10.1111/j.1469-185X.2010.00125.x; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2003, BIODIVERS CONSERV, V12, P1953, DOI 10.1023/A:1024199513365; Stout JC, 2009, APIDOLOGIE, V40, P388, DOI 10.1051/apido/2009023; SUMNER D. A., 2006, AGR RESOURCE EC UPDA, V9, P9; TEEB, 2010, EC EC BIOD MAINSTR E; Thomson DM, 2006, OIKOS, V114, P407, DOI 10.1111/j.2006.0030-1299.14604.x; Vaissieere BE, 2011, PROTOCOLL DETECT ASE; Westerkamp C, 2000, CROP SCI, V40, P1209, DOI 10.2135/cropsci2000.4051209x; Williams PH, 2007, BIOL CONSERV, V138, P493, DOI 10.1016/j.biocon.2007.06.001; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Winfree R, 2011, ECOL ECON, V71, P80, DOI 10.1016/j.ecolecon.2011.08.001; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; World bank, 2011, INFL GDP DEFL; World bank, 2011, DAT CAT; Wossink A, 2007, ECOL ECON, V64, P297, DOI 10.1016/j.ecolecon.2007.07.003	84	211	221	9	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35954	10.1371/journal.pone.0035954	http://dx.doi.org/10.1371/journal.pone.0035954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563427	gold, Green Published, Green Submitted			2022-12-27	WOS:000305349100053
J	Monteiro, CA; Serrao, EA; Pearson, GA				Monteiro, Carla A.; Serrao, Ester A.; Pearson, Gareth A.			Prezygotic Barriers to Hybridization in Marine Broadcast Spawners: Reproductive Timing and Mating System Variation	PLOS ONE			English	Article							SUCCESSFUL EXTERNAL FERTILIZATION; FUCUS-VESICULOSUS; GAMETE RELEASE; FUCOID ALGAE; SELF-FERTILIZATION; INTERTIDAL ALGA; NATURAL-POPULATIONS; GENETIC DIVERSITY; LOW TIDE; PHAEOPHYCEAE	Sympatric assemblages of congeners with incomplete reproductive barriers offer the opportunity to study the roles that ecological and non-ecological factors play in reproductive isolation. While interspecific asynchrony in gamete release and gametic incompatibility are known prezygotic barriers to hybridization, the role of mating system variation has been emphasized in plants. Reproductive isolation between the sibling brown algal species Fucus spiralis, Fucus guiryi (selfing hermaphrodite) and Fucus vesiculosus (dioecious) was studied because they form hybrids in parapatry in the rocky intertidal zone, maintain species integrity over a broad geographic range, and have contrasting mating systems. We compared reproductive synchrony (spawning overlap) between the three species at several temporal scales (yearly/seasonal, semilunar/tidal, and hourly during single tides). Interspecific patterns of egg release were coincident at seasonal (single peak in spring to early summer) to semilunar timescales. Synthesis of available data indicated that spawning is controlled by semidiurnal tidal and daily light-dark cues, and not directly by semilunar cycles. Importantly, interspecific shifts in timing detected at the hourly scale during single tides were consistent with a partial ecological prezygotic hybridization barrier. The species displayed patterns of gamete release consistent with a power law distribution, indicating a high degree of reproductive synchrony, while the hypothesis of weaker selective constraints for synchrony in selfing versus outcrossing species was supported by observed spawning in hermaphrodites over a broader range of tidal phase than in outcrossers. Synchronous gamete release is critical to the success of external fertilization, while high-energy intertidal environments may offer only limited windows of reproductive opportunity. Within these windows, however, subtle variations in reproductive timing have evolved with the potential to form ecological barriers to hybridization.	[Monteiro, Carla A.; Serrao, Ester A.; Pearson, Gareth A.] Univ Algarve, CCMAR CIMAR, Faro, Portugal	Universidade do Algarve	Monteiro, CA (corresponding author), Univ Algarve, CCMAR CIMAR, Faro, Portugal.	gpearson@ualg.pt	Serrao, Ester A/C-6686-2012; Monteiro, Carla/M-6078-2013; Pearson, Gareth/J-3911-2013	Serrao, Ester A/0000-0003-1316-658X; Monteiro, Carla/0000-0002-8410-2092; Pearson, Gareth/0000-0002-0768-464X	Portuguese Science Foundation; FEDER (ERDF, European Regional Development Fund); FCT; ESF (European Social Fund)	Portuguese Science Foundation(Portuguese Foundation for Science and Technology); FEDER (ERDF, European Regional Development Fund); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); ESF (European Social Fund)(European Social Fund (ESF))	This work was supported by projects from the Portuguese Science Foundation (http://www.fct.pt) co-sponsored by FEDER (ERDF, European Regional Development Fund), and an FCT and ESF (European Social Fund) PhD fellowship to CAM. The European Union Network of Excellence MARBEF-Marine Biodiversity and Ecosystem Function and the NSF (USA) CORONA network provided opportunities for interesting insights and discussions on the topic of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Berndt ML, 2002, MAR ECOL PROG SER, V226, P273, DOI 10.3354/meps226273; Billard E, 2005, EUR J PHYCOL, V40, P397, DOI 10.1080/09670260500334354; Billard E, 2005, J PHYCOL, V41, P900, DOI 10.1111/j.0022-3646.2005.04221.x; Billard E, 2010, MAR ECOL PROG SER, V405, P163, DOI 10.3354/meps08517; BRAWLEY SH, 1992, MAR BIOL, V113, P145, DOI 10.1007/BF00367648; Brawley SH, 1999, AM ZOOL, V39, P218; Canovas FG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-371; Clifton KE, 1997, SCIENCE, V275, P1116, DOI 10.1126/science.275.5303.1116; Coleman MA, 2005, MAR ECOL PROG SER, V300, P63, DOI 10.3354/meps300063; Coleman MA, 2005, J PHYCOL, V41, P753, DOI 10.1111/j.0022-3646.2005.04136.x; Coyne J.A., 2004, SPECIATION; DENNY M, 1992, BIOL BULL, V183, P220, DOI 10.2307/1542209; DENNY MW, 1989, AM NAT, V134, P859, DOI 10.1086/285018; Dudgeon S, 2001, ECOLOGY, V82, P991, DOI 10.1890/0012-9658(2001)082[0991:SDRADO]2.0.CO;2; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Engel CR, 2005, MOL ECOL, V14, P2033, DOI 10.1111/j.1365-294X.2005.02558.x; Forgarty ND, 2012, PLOS ONE, V7; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; Johnson LE, 1998, OECOLOGIA, V117, P517, DOI 10.1007/s004420050688; Knowlton N, 1997, MAR BIOL, V127, P705, DOI 10.1007/s002270050061; Ladah L, 2003, MAR ECOL PROG SER, V262, P173, DOI 10.3354/meps262173; Ladah LB, 2008, MAR BIOL, V155, P583, DOI 10.1007/s00227-008-1054-4; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Luning K, 1990, SEAWEEDS THEIR ENV B; Marshall DJ, 2004, MAR ECOL PROG SER, V266, P135, DOI 10.3354/meps266135; Marshall DJ, 2002, MAR ECOL PROG SER, V236, P113, DOI 10.3354/meps236113; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; MEAD KS, 1995, BIOL BULL-US, V188, P46, DOI 10.2307/1542066; Moalic Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-33; MULLER DG, 1977, Z PFLANZENPHYSIOL, V84, P85; ORTON JH, 1956, J MAR BIOL ASSOC UK, V35, P149, DOI 10.1017/S0025315400009036; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; Pearson GA, 1998, ECOLOGY, V79, P1725; Pearson GA, 1998, PLANT PHYSIOL, V118, P305, DOI 10.1104/pp.118.1.305; Pearson GA, 2006, INTEGR COMP BIOL, V46, P587, DOI 10.1093/icb/icl030; Perrin C, 2007, EUR J PHYCOL, V42, P219, DOI 10.1080/09670260701336554; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Rundle HD, 2001, EVOLUTION, V55, P198; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Serrao EA, 1999, J PHYCOL, V35, P382, DOI 10.1046/j.1529-8817.1999.3520382.x; Serrao EA, 2009, ECOL STU AN, P149; SERRAO EA, 1996, THESIS U MAINE; SERRAO EA, 1997, PHYCOLOGIA S, V36, P101; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Takebayashi N, 2001, AM J BOT, V88, P1143, DOI 10.2307/3558325; Tomaiuolo M, 2007, EVOLUTION, V61, P2584, DOI 10.1111/j.1558-5646.2007.00218.x; Yamahira K, 2004, FUNCT ECOL, V18, P4, DOI 10.1046/j.0269-8463.2004.00795.x; Zardi GI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019402	52	20	20	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 26	2012	7	4							e35978	10.1371/journal.pone.0035978	http://dx.doi.org/10.1371/journal.pone.0035978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WQ	22563429	gold, Green Published			2022-12-27	WOS:000305349100055
J	Han, YL; Li, YL; Jia, LX; Cheng, JZ; Qi, YF; Zhang, HJ; Du, J				Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie			Reciprocal Interaction between Macrophages and T cells Stimulates IFN-gamma and MCP-1 Production in Ang II-induced Cardiac Inflammation and Fibrosis	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; ANGIOTENSIN-II; INTERFERON-GAMMA; FIBROBLAST PRECURSORS; CYTOKINE PROFILES; MYOCARDITIS; HYPERTENSION; EXPRESSION; SYSTEM	Background: The inflammatory response plays a critical role in hypertension-induced cardiac remodeling. We aimed to study how interaction among inflammatory cells causes inflammatory responses in the process of hypertensive cardiac fibrosis. Methodology/Principal Findings: Infusion of angiotensin II (Ang II, 1500 ng/kg/min) in mice rapidly induced the expression of interferon gamma (IFN-gamma) and leukocytes infiltration into the heart. To determine the role of IFN-gamma on cardiac inflammation and remodeling, both wild-type (WT) and IFN-gamma-knockout (KO) mice were infused Ang II for 7 days, and were found an equal blood pressure increase. However, knockout of IFN-gamma prevented Ang II-induced: 1) infiltration of macrophages and T cells into cardiac tissue; 2) expression of tumor necrosis factor a and monocyte chemoattractant protein 1 (MCP-1), and 3) cardiac fibrosis, including the expression of alpha-smooth muscle actin and collagen I (all p<0.05). Cultured T cells or macrophages alone expressed very low level of IFN-gamma, however, co-culture of T cells and macrophages increased IFN-gamma expression by 19.860.95 folds ( vs. WT macrophage, p<0.001) and 20.9 +/- 2.09 folds (vs. WT T cells, p<0.001). In vitro co-culture studies using T cells and macrophages from WT or IFN-gamma KO mice demonstrated that T cells were primary source for IFN-gamma production. Co-culture of WT macrophages with WT T cells, but not with IFN-gamma-knockout T cells, increased IFN-gamma production (p<0.01). Moreover, IFN-gamma produced by T cells amplified MCP-1 expression in macrophages and stimulated macrophage migration. Conclusions/Significance: Reciprocal interaction between macrophages and T cells in heart stimulates IFN-gamma expression, leading to increased MCP-1 expression in macrophages, which results a forward-feed recruitment of macrophages, thus contributing to Ang II-induced cardiac inflammation and fibrosis.	[Han, Ya-lei; Li, Yu-lin; Jia, Li-xin; Cheng, Ji-zhong; Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China; [Qi, Yong-fen; Zhang, Hong-jia; Du, Jie] Inst Heart Lung & Blood Vessel Dis, Minist Educ, Key Lab Remodeling Related Cardiovasc Dis, Beijing, Peoples R China	Capital Medical University	Han, YL (corresponding author), Capital Med Univ, Beijing An Zhen Hosp, Beijing, Peoples R China.	jdu@bcm.edu	Li, yulin/AGZ-5611-2022	Han, Ying/0000-0001-8591-7894; Zhu, Guo-Qing/0000-0002-3132-9592	Chinese Ministry of Science and Technology [2012CB517802, 2012CB945104]; National Science Foundation of China [30888004, 31090363]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grants from the Chinese Ministry of Science and Technology (2012CB517802 and 2012CB945104) and from the National Science Foundation of China (30888004 and 31090363). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva M, 2005, P NATL ACAD SCI USA, V102, P180, DOI 10.1073/pnas.0408241102; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Brands MW, 2010, HYPERTENSION, V56, P879, DOI 10.1161/HYPERTENSIONAHA.110.158071; Cheng JZ, 2007, ARTERIOSCL THROM VAS, V27, P1744, DOI 10.1161/ATVBAHA.107.147371; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Coelho PS, 2002, J LEUKOCYTE BIOL, V71, P837; Fairweather D, 2004, AM J PATHOL, V165, P1883, DOI 10.1016/S0002-9440(10)63241-5; Fairweather D, 2003, J IMMUNOL, V170, P4731, DOI 10.4049/jimmunol.170.9.4731; Fauvel JP, 2003, HYPERTENSION, V42, P1112, DOI 10.1161/01.HYP.0000102862.93418.EE; Finckenberg P, 2003, AM J PATHOL, V163, P355, DOI 10.1016/S0002-9440(10)63659-0; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Hilgers KF, 2000, KIDNEY INT, V58, P2408, DOI 10.1046/j.1523-1755.2000.00424.x; Hochrein H, 2001, J IMMUNOL, V166, P5448, DOI 10.4049/jimmunol.166.9.5448; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kawai C, 1999, CIRCULATION, V99, P1091, DOI 10.1161/01.CIR.99.8.1091; Lin AA, 2009, J VIROL, V83, P8604, DOI 10.1128/JVI.02477-08; Marchesi C, 2008, TRENDS PHARMACOL SCI, V29, P367, DOI 10.1016/j.tips.2008.05.003; Mazzolai L, 2004, HYPERTENSION, V44, P277, DOI 10.1161/01.HYP.0000140269.55873.7b; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Munder M, 1998, J EXP MED, V187, P2103, DOI 10.1084/jem.187.12.2103; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Ponomarev ED, 2004, J IMMUNOL, V173, P1587, DOI 10.4049/jimmunol.173.3.1587; Pore D, 2012, J BIOL CHEM IN PRESS; Puddu P, 1997, J IMMUNOL, V159, P3490; Qi GM, 2011, CARDIOVASC TOXICOL, V11, P157, DOI 10.1007/s12012-011-9109-z; Ren JY, 2011, AM J HYPERTENS, V24, P701, DOI 10.1038/ajh.2011.42; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Shao J, 2003, HYPERTENSION, V42, P31, DOI 10.1161/01.HYP.0000075082.06183.4E; Sturgis LC, 2009, AM J PHYSIOL-REG I, V297, pR1742, DOI 10.1152/ajpregu.90995.2008; Takahashi M, 2008, AM J PHYSIOL-HEART C, V294, pH2879, DOI 10.1152/ajpheart.91406.2007; Tang PCY, 2005, FASEB J, V19, P1528, DOI 10.1096/fj.05-3671fje; Valentincic NV, 2011, MOL VIS, V17, P2003; Vinh A, 2010, CIRCULATION, V122, P2529, DOI 10.1161/CIRCULATIONAHA.109.930446; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	43	83	87	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35506	10.1371/journal.pone.0035506	http://dx.doi.org/10.1371/journal.pone.0035506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567105	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341500023
J	Yang, SY; Keshavmurthy, S; Obura, D; Sheppard, CRC; Visram, S; Chen, CA				Yang, Sung-Yin; Keshavmurthy, Shashank; Obura, David; Sheppard, Charles R. C.; Visram, Shakil; Chen, Chaolun Allen			Diversity and Distribution of Symbiodinium Associated with Seven Common Coral Species in the Chagos Archipelago, Central Indian Ocean	PLOS ONE			English	Article							SYMBIOTIC ALGAE; CLIMATE-CHANGE; SCLERACTINIAN CORALS; MOLECULAR DIVERSITY; REEF CORALS; ZOOXANTHELLAE; HOST; PATTERNS; IDENTIFICATION; COMMUNITIES	The Chagos Archipelago designated as a no-take marine protected area in 2010, lying about 500 km south of the Maldives in the Indian Ocean, has a high conservation priority, particularly because of its fast recovery from the ocean-wide massive coral mortality following the 1998 coral bleaching event. The aims of this study were to examine Symbiodinium diversity and distribution associated with scleractinian corals in five atolls of the Chagos Archipelago, spread over 10,000 km(-2). Symbiodinium clade diversity in 262 samples of seven common coral species, Acropora muricata, Isopora palifera, Pocillopora damicornis, P. verrucosa, P. eydouxi, Seriatopora hystrix, and Stylophora pistillata were determined using PCR-SSCP of the ribosomal internal transcribed spacer 1 (ITS1), PCR-DDGE of ITS2, and phylogenetic analyses. The results indicated that Symbiodinium in clade C were the dominant symbiont group in the seven coral species. Our analysis revealed types of Symbiodinium clade C specific to coral species. Types C1 and C3 (with C3z and C3i variants) were dominant in Acroporidae and C1 and C1c were the dominant types in Pocilloporidae. We also found 2 novel ITS2 types in S. hystrix and 1 novel ITS2 type of Symbiodinium in A. muricata. Some colonies of A. muricata and I. palifera were also associated with Symbiodinium A1. These results suggest that corals in the Chagos Archipelago host different assemblages of Symbiodinium types then their conspecifics from other locations in the Indian Ocean; and that future research will show whether these patterns in Symbiodinium genotypes may be due to local adaptation to specific conditions in the Chagos.	[Yang, Sung-Yin; Keshavmurthy, Shashank; Visram, Shakil; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Obura, David; Visram, Shakil] CORDIO, Mombasa, Kenya; [Obura, David; Sheppard, Charles R. C.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Chen, Chaolun Allen] Natl Taiwan Univ, Taipei 10764, Taiwan	Academia Sinica - Taiwan; University of Warwick; National Taiwan University	Yang, SY (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	cac@gate.sinica.edu.tw	Chen, Yu/Y-3292-2019; Keshavmurthy, Shashank/C-3672-2013; Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Xiao, Yonghong/AFS-9054-2022; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; Matz, Mikhail/0000-0001-5453-9819; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Rao, Xiaoquan/0000-0001-7316-4530; Obura, David/0000-0003-2256-6649	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship	Academia Sinica Thematic Grants; CORDIO; Chagos Conservation Trust; National Science Council postdoctoral fellowship; Academia Sinica postdoctoral fellowship(Academia Sinica - Taiwan)	This study was partly funded by Academia Sinica Thematic Grants (2005-2010), CORDIO and Chagos Conservation Trust. SK was supported by National Science Council postdoctoral fellowship (2008-2010) and Academia Sinica postdoctoral fellowship (2010-2012), SV by Academia Sinica postdoctoral fellowship (2007-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baker AC, 2004, CORAL HEALTH AND DISEASE, P177; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CA, 2005, CORAL REEFS, V24, P11, DOI 10.1007/s00338-004-0389-7; Chen CA, 2003, ZOOL STUD, V42, P540; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Garren M, 2006, CORAL REEFS, V25, P503, DOI 10.1007/s00338-006-0146-1; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Goulet TL, 2003, MAR BIOL, V142, P233, DOI 10.1007/s00227-002-0936-0; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2004, MAR ECOL PROG SER, V284, P147, DOI 10.3354/meps284147; LaJeunesse TC, 2003, LIMNOL OCEANOGR, V48, P2046, DOI 10.4319/lo.2003.48.5.2046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; LaJeunesse TC, 2000, BIOL BULL, V199, P126, DOI 10.2307/1542872; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Lien YT, 2007, CORAL REEFS, V26, P35, DOI 10.1007/s00338-006-0185-7; Loh WKW, 2001, MAR ECOL PROG SER, V222, P97, DOI 10.3354/meps222097; Magalon H, 2007, CORAL REEFS, V26, P551, DOI 10.1007/s00338-007-0215-0; Mangi S, 2010, WORKSH HELD 7 JAN 20; McPhaden MJ, 2009, B AM METEOROL SOC, V90, P459, DOI 10.1175/2008BAMS2608.1; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1991, MAR ECOL PROG SER, V77, P233, DOI 10.3354/meps077233; Oliver TA, 2009, MAR ECOL PROG SER, V378, P93, DOI 10.3354/meps07871; Pochon X, 2004, MAR BIOL, V146, P17, DOI 10.1007/s00227-004-1427-2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1998, J PHYCOL, V34, P407, DOI 10.1046/j.1529-8817.1998.340407.x; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sampayo EM, 2009, MOL ECOL, V18, P500, DOI 10.1111/j.1365-294X.2008.04037.x; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard C, 2006, CONSERV BIOL SER, P264; Sheppard Charles R.C., 2000, P3; Sheppard CRC, 1999, AMBIO, V28, P472; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Sheppard CRC, 2012, MAR FRESHWATER RES, DOI [10.1002/aqc.1248, DOI 10.1002/AQC.1248]; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Stat M, 2008, CORAL REEFS, V27, P763, DOI 10.1007/s00338-008-0412-5; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen Madeleine J. H., 2009, V205, P83; Van Woesik Robert, 2009, Galaxea - Tokyo, V11, P53; Visram S, 2006, J MAR BIOL ASSOC UK, V86, P1281, DOI 10.1017/S0025315406014299; Visram S, 2006, CORAL REEFS, V25, P172, DOI 10.1007/s00338-005-0079-0; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x	67	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2012	7	5							e35836	10.1371/journal.pone.0035836	http://dx.doi.org/10.1371/journal.pone.0035836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959US	22567113	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341500031
J	Santos, ARC; Corredor, RG; Obeso, BA; Trakhtenberg, EF; Wang, Y; Ponmattam, J; Dvoriantchikova, G; Ivanov, D; Shestopalov, VI; Goldberg, JL; Fini, ME; Bajenaru, ML				Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia			beta 1 Integrin-Focal Adhesion Kinase (FAK) Signaling Modulates Retinal Ganglion Cell (RGC) Survival	PLOS ONE			English	Article							NEURITE OUTGROWTH; EXTRACELLULAR-MATRIX; AXONAL REGENERATION; LINKED KINASE; UP-REGULATION; BRAIN-INJURY; OPTIC-NERVE; IN-VITRO; ISCHEMIA; PATHWAY	Extracellular matrix (ECM) integrity in the central nervous system (CNS) is essential for neuronal homeostasis. Signals from the ECM are transmitted to neurons through integrins, a family of cell surface receptors that mediate cell attachment to ECM. We have previously established a causal link between the activation of the matrix metalloproteinase-9 (MMP-9), degradation of laminin in the ECM of retinal ganglion cells (RGCs), and RGC death in a mouse model of retinal ischemia-reperfusion injury (RIRI). Here we investigated the role of laminin-integrin signaling in RGC survival in vitro, and after ischemia in vivo. In purified primary rat RGCs, stimulation of the beta 1 integrin receptor with laminin, or agonist antibodies enhanced RGC survival in correlation with activation of beta 1 integrin's major downstream regulator, focal adhesion kinase (FAK). Furthermore, beta 1 integrin binding and FAK activation were required for RGCs' survival response to laminin. Finally, in vivo after RIRI, we observed an up-regulation of MMP-9, proteolytic degradation of laminin, decreased RGC expression of beta 1 integrin, FAK and Akt dephosphorylation, and reduced expression of the pro-survival molecule bcl-xL in the period preceding RGC apoptosis. RGC death was prevented, in the context of laminin degradation, by maintaining beta 1 integrin activation with agonist antibodies. Thus, disruption of homeostatic RGC-laminin interaction and signaling leads to cell death after retinal ischemia, and maintaining integrin activation may be a therapeutic approach to neuroprotection.	[Santos, Andrea Rachelle C.; Corredor, Raul G.; Obeso, Betty Albo; Trakhtenberg, Ephraim F.; Wang, Ying; Ponmattam, Jamie; Dvoriantchikova, Galina; Ivanov, Dmitry; Shestopalov, Valery I.; Goldberg, Jeffrey L.; Fini, Mary Elizabeth; Bajenaru, Michaela Livia] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Neurosci Program, Miami, FL 33136 USA; [Fini, Mary Elizabeth] Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Southern California	Bajenaru, ML (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	lbajenaru@med.miami.edu	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	American Heart Association (AHA) [09SDG2280555, 0735014B, 11PRE7310069]; National Institutes of Health (NIH) [EY12651]; NIH [EY020913, NS061348, R21EY020613, EY017991, T32 NS007492, 5 P30-EY014801-08]; Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Foundation (TGF); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	The authors acknowledge support from American Heart Association (http://www.heart.org/HEARTORG/) Scientist Development Grant (AHA SDG) 09SDG2280555 to M.L.B.; National Institutes of Health (http://www.nih.gov/) (NIH) grant EY12651, Walter G. Ross Distinguished Chair in Ophthalmic Research to M.E.F.; NIH grant EY020913, NS061348, and Walter G. Ross Distinguished Chair in Ophthalmic Research to J.L.G; NIH grant R21EY020613, American Heart Association (AHA) 0735014B to D.I.; NIH grant EY017991, The Glaucoma Foundation (http://www.glaucomafoundation.org/) (TGF) grant, Research to Prevent Blindness (https://www.rpbusa.org/rpb/)(RPB) Career Development Award to V.I.S.; NIH grant T32 NS007492, American Heart Association (AHA) 11PRE7310069 to E.F.T. Bascom Palmer is also supported by NIH core center grant 5 P30-EY014801-08, and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin AE, 1998, PHARMACOL REV, V50, P197; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Asahi M, 2001, NEUROREPORT, V12, P3003, DOI 10.1097/00001756-200109170-00050; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Barros CS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005108; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; BREM RB, 1994, INVEST OPHTH VIS SCI, V35, P3466; Brocco MA, 1999, DEV BRAIN RES, V118, P23, DOI 10.1016/S0165-3806(99)00120-0; BUCHI ER, 1991, OPHTHALMOLOGICA, V203, P138; Cabodi S, 2010, ADV EXP MED BIOL, V674, P43; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Clegg DO, 2003, FRONT BIOSCI-LANDMRK, V8, pD723, DOI 10.2741/1020; COHEN S, 1987, IN VITRO CELL DEV B, V23, P239; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Condic ML, 1997, NATURE, V389, P852, DOI 10.1038/39878; DECURTIS I, 1993, DEVELOPMENT, V118, P377; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; DRAZBA J, 1990, DEV BIOL, V138, P82, DOI 10.1016/0012-1606(90)90178-L; Dreixler JC, 2009, EXP EYE RES, V88, P512, DOI 10.1016/j.exer.2008.11.013; Finnemann SC, 2003, EMBO J, V22, P4143, DOI 10.1093/emboj/cdg416; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gardiner NJ, 2005, MOL CELL NEUROSCI, V28, P229, DOI 10.1016/j.mcn.2004.08.017; Gary DS, 2003, J NEUROCHEM, V84, P878, DOI 10.1046/j.1471-4159.2003.01579.x; Gary DS, 2001, J NEUROCHEM, V76, P1485, DOI 10.1046/j.1471-4159.2001.00173.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gibson RM, 2005, MOL CELL NEUROSCI, V28, P588, DOI 10.1016/j.mcn.2004.11.004; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grimpe B, 2002, J NEUROSCI, V22, P3144, DOI 10.1523/JNEUROSCI.22-08-03144.2002; Gu ZZ, 2005, J NEUROSCI, V25, P6401, DOI 10.1523/JNEUROSCI.1563-05.2005; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Guo SZ, 2008, P NATL ACAD SCI USA, V105, P7582, DOI 10.1073/pnas.0801105105; Halfter W, 2008, EYE, V22, P1207, DOI 10.1038/eye.2008.19; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Ivins JK, 2004, J NEUROSCI, V24, P1212, DOI 10.1523/JNEUROSCI.4689-03.2004; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Ju WK, 2003, EXP EYE RES, V77, P137, DOI 10.1016/S0014-4835(03)00128-3; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Kaneda K, 1999, BRAIN RES, V815, P11, DOI 10.1016/S0006-8993(98)01074-9; Kermer P, 2000, J NEUROSCI, V20, P722, DOI 10.1523/JNEUROSCI.20-02-00722.2000; Kretz A, 2005, MOL CELL NEUROSCI, V29, P569, DOI 10.1016/j.mcn.2005.04.009; Kunzevitzky NJ, 2010, INVEST OPHTH VIS SCI, V51, P3800, DOI 10.1167/iovs.09-4540; Lam TT, 1999, INVEST OPHTH VIS SCI, V40, P967; Lemons ML, 2006, EXP NEUROL, V202, P324, DOI 10.1016/j.expneurol.2006.06.008; Lemons ML, 2008, EXP NEUROL, V209, P343, DOI 10.1016/j.expneurol.2007.05.027; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Libby R T, 2000, Results Probl Cell Differ, V31, P115; Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000; Limb GA, 2002, AM J PATHOL, V160, P1847, DOI 10.1016/S0002-9440(10)61131-5; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Manabe S, 2005, INVEST OPHTH VIS SCI, V46, P4747, DOI 10.1167/iovs.05-0128; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; McDonald PC, 2008, J CELL SCI, V121, P3121, DOI 10.1242/jcs.017996; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Molina A, 2005, J AM SOC NEPHROL, V16, P374, DOI 10.1681/ASN.2004070528; Morissette N, 1995, J NEUROSCI, V15, P8067; Neufeld AH, 2002, EXP EYE RES, V75, P521, DOI 10.1006/exer.2002.2042; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; Otsuka K, 1997, J Nihon Univ Sch Dent, V39, P182; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Plantman S, 2005, NEUROREPORT, V16, P709, DOI 10.1097/00001756-200505120-00011; Robles E, 2006, NAT NEUROSCI, V9, P1274, DOI 10.1038/nn1762; SARTHY PV, 1990, J CELL BIOL, V110, P2099, DOI 10.1083/jcb.110.6.2099; Savitz SI, 2006, BRAIN RES, V1118, P168, DOI 10.1016/j.brainres.2006.05.060; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Tagami Y, 2009, JPN J OPHTHALMOL, V53, P257, DOI 10.1007/s10384-009-0657-8; Tan CL, 2011, J NEUROSCI, V31, P6289, DOI 10.1523/JNEUROSCI.0008-11.2011; Tonges L, 2011, J NEUROCHEM, V117, P892, DOI 10.1111/j.1471-4159.2011.07257.x; Vachon P. H., 2011, J SIGNAL TRANSDUCT, V2011; WEAVER CD, 1995, J NEUROSCI, V15, P5275; Yu WM, 2005, J NEUROSCI, V25, P4463, DOI 10.1523/JNEUROSCI.5032-04.2005; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang X, 2004, INVEST OPHTH VIS SCI, V45, P2374, DOI 10.1167/iovs.03-1239; Zhang Y, 2005, INVEST OPHTH VIS SCI, V46, P2133, DOI 10.1167/iovs.04-1235; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	89	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48332	10.1371/journal.pone.0048332	http://dx.doi.org/10.1371/journal.pone.0048332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	22558402	gold, Green Submitted, Green Published			2022-12-27	WOS:000310600500108
J	Yang, SG; Cao, B; Liang, LR; Li, XL; Xiao, YH; Cao, ZX; Jia, HY; Yu, HJ; Xu, Z; Gu, L; Yang, YD; Chen, Y; Du, WB; Yan, XX; Liang, ZA; Zhang, W; Zhang, CL; Chen, W; Guo, CP; Jiang, XL; Yang, M; Deng, GM; Yu, KJ; Hu, K; Zou, Q; Li, LJ; Wang, C				Yang, Shi-gui; Cao, Bin; Liang, Li-rong; Li, Xiao-li; Xiao, Yong-hong; Cao, Zhi-xin; Jia, Hong-yu; Yu, Hong-jie; Xu, Zhen; Gu, Li; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Yan, Xi-xin; Liang, Zong-an; Zhang, Wei; Zhang, Chang-le; Chen, Wei; Guo, Cai-ping; Jiang, Xun-liang; Yang, Ming; Deng, Guang-ming; Yu, Kai-jiang; Hu, Ke; Zou, Qi; Li, Lan-juan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Antiviral Therapy and Outcomes of Patients with Pneumonia Caused by Influenza A Pandemic (H1N1) Virus	PLOS ONE			English	Article							NEURAMINIDASE INHIBITORS; RISK-FACTORS; HOSPITALIZATION; OSELTAMIVIR; A(H1N1)	Background: There is limited data on the clinical outcome of patients with pandemic H1N1 (pH1N1) pneumonia who received oseltamivir treatment, especially when the treatment was administered more than 48 hours after symptom onset. Methods: During the pandemic in 2009, a cohort of pH1N1 influenza pneumonia was built in China, and their clinical information was collected systematically, and analyzed with Cox models. Results: 920 adults and 541 children with pneumonia who didn't receive corticosteroids were analyzed. In-hospital mortality was higher in adults who did not receive antiviral therapy (18.2%) than those with who received oseltamivir <= 2days (2.9%), between 2-5 days (4.6%) and >5 days after illness onset (4.9%), p<0.01. A similar trend was observed in pediatric patients. Cox regression showed that at 60 days after symptoms onset, 11 patients (10.8%) who did not receive antivirals died versus 4 (1.8%), 18 (3.3%), and 23 (3.7%) patients whose oseltamivir treatment was started <= 2days, between 2-5days, and >5 days, respectively. For males patients, aged >= 14 years and baseline PaO2/FiO(2)<200, oseltamivir administration reduced the mortality risk by 92.1%, 88% and 83.5%, respectively. Higher doses of oseltamivir (>3.8 mg/kg/d) did not improve clinical outcome (mortality, higher dose 2.5% vs standard dose 2.8%, p>0.05). Conclusions: Antiviral therapy might reduce mortality of patients with pH1N1 pneumonia, even when initiated more than 48 hours after onset of illness. Greater protective effects might be in males, patients aged 14-60 years, and patients with PaO2/FiO(2)<200.	[Yang, Shi-gui; Xiao, Yong-hong; Jia, Hong-yu; Yang, Yi-da; Chen, Yu; Du, Wei-bo; Li, Lan-juan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Bin; Liang, Li-rong; Li, Xiao-li; Cao, Zhi-xin; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Chao Yang Hosp, Beijing Inst Resp Med, Beijing Key Lab Resp & Pulm Circulat, Beijing, Peoples R China; [Yu, Hong-jie; Xu, Zhen] Chinese Ctr Dis Control & Prevent, Dis Control & Emergency Response Off, Beijing, Peoples R China; [Yan, Xi-xin] Hebei Med Univ, Dept Resp Med, Hosp 2, Shijiazhuang, Peoples R China; [Liang, Zong-an] Sichuan Univ, W China Hosp, Chengdu 610064, Peoples R China; [Zhang, Wei] Nanchang Univ, Affiliated Hosp 1, Nanchang, Peoples R China; [Zhang, Chang-le] Wenzhou 2 Peoples Hosp, Wenzhou, Peoples R China; [Chen, Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Guo, Cai-ping] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China; [Jiang, Xun-liang] Childrens Hosp Hunan Prov, Changsha, Hunan, Peoples R China; [Yang, Ming] Beijing Childrens Hosp, Beijing, Peoples R China; [Deng, Guang-ming] Shaoyang Cent Hosp, Shaoyang, Peoples R China; [Yu, Kai-jiang] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China; [Hu, Ke] Wuhan Univ, Remin Hosp, Wuhan 430072, Peoples R China; [Zou, Qi] Fujian Med Univ, Union Hosp, Fuzhou, Peoples R China	Zhejiang University; Capital Medical University; Chinese Center for Disease Control & Prevention; Hebei Medical University; Sichuan University; Nanchang University; China Medical University; Capital Medical University; Capital Medical University; Harbin Medical University; Wuhan University; Fujian Medical University	Yang, SG (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis,Key Lab, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn; cyh-birm@263.net	Chen, Yu/Y-3292-2019; Keshavmurthy, Shashank/C-3672-2013; Chen, Yi/HIR-2608-2022; Yu, Hongjie/GZK-5351-2022; Xiao, Yonghong/AFS-9054-2022; Matz, Mikhail/K-4392-2017	Keshavmurthy, Shashank/0000-0002-2235-9132; Matz, Mikhail/0000-0001-5453-9819; sheppard, charles/0000-0002-2579-5124; Yang, Sung-Yin/0000-0001-7431-406X; Wang, Dao Wen/0000-0002-9774-3980; Rao, Xiaoquan/0000-0001-7316-4530; Obura, David/0000-0003-2256-6649	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology [Z09000700090903]; Major State Basic Research Development Program [2009CB522107]; Mega-projects of Science Research for the 11th Five-Year Plan of China [2009ZX10004-901, 2009ZX10004-210]; National Natural Science Foundation of China [81001271]	Ministry of Health of People's Republic of China; World Health Organization on clinical study for the influenza A pandemic A; Beijing Science Technology; Major State Basic Research Development Program(National Basic Research Program of China); Mega-projects of Science Research for the 11th Five-Year Plan of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the Ministry of Health of People's Republic of China and the World Health Organization on clinical study for the influenza A pandemic A (H1N1) 2009, grants from the Beijing Science & Technology (Z09000700090903), and Major State Basic Research Development Program (2009CB522107), Mega-projects of Science Research for the 11th Five-Year Plan of China (2009ZX10004-901, 2009ZX10004-210), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PAND INFL H1N1 2009; [Anonymous], 2010, H1N1 2009 UPD 94; Bai L, 2011, CHEST, V139, P1156, DOI 10.1378/chest.10-1036; *CDCP, 2009, CDC EST 2009 H1N1 IN; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Slopen M. E., 2010, Morbidity and Mortality Weekly Report, V58, P1436; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Weinstock DM, 2003, NEW ENGL J MED, V348, P867, DOI 10.1056/NEJM200302273480923; WHO, CDC PROT REALT RTPCR; WHO, 2009, WHO GUID PHARM MAN P; Writing Committee of the WHO Consultation on Pandemic (H1N1), 2009, NEW ENGL J MED, V362, P1708	30	115	121	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e29652	10.1371/journal.pone.0029652	http://dx.doi.org/10.1371/journal.pone.0029652			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22567113	Green Published, gold, Green Submitted			2022-12-27	WOS:000301568100014
J	Santos, AM; Lopez-Sanchez, N; Martin-Oliva, D; de la Villa, P; Cuadros, MA; Frade, JM				Santos, Ana M.; Lopez-Sanchez, Noelia; Martin-Oliva, David; de la Villa, Pedro; Cuadros, Miguel A.; Frade, Jose M.			Sortilin Participates in Light-dependent Photoreceptor Degeneration in Vivo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; CELL-DEATH; NEUROTROPHIC FACTOR; NEURONAL APOPTOSIS; RECEPTOR SORTILIN; INHIBITORY FACTOR; PRONGF; P75; EXPRESSION; P75(NTR)	Both proNGF and the neurotrophin receptor p75 (p75(NTR)) are known to regulate photoreceptor cell death caused by exposure of albino mice to intense illumination. ProNGF-induced apoptosis requires the participation of sortilin as a necessary p75(NTR) co-receptor, suggesting that sortilin may participate in the photoreceptor degeneration triggered by intense lighting. We report here that light-exposed albino mice showed sortilin, p75(NTR), and proNGF expression in the outer nuclear layer, the retinal layer where photoreceptor cell bodies are located. In addition, cone progenitor-derived 661W cells subjected to intense illumination expressed sortilin and p75(NTR) and released proNGF into the culture medium. Pharmacological blockade of sortilin with either neurotensin or the "pro'' domain of proNGF (pro-peptide) favored the survival of 661W cells subjected to intense light. In vivo, the pro-peptide attenuated retinal cell death in light-exposed albino mice. We propose that an auto/paracrine proapoptotic mechanism based on the interaction of proNGF with the receptor complex p75(NTR)/sortilin participates in intense light-dependent photoreceptor cell death. We therefore propose sortilin as a putative target for intervention in hereditary retinal dystrophies.	[Santos, Ana M.; Martin-Oliva, David; Cuadros, Miguel A.] Univ Granada, Dept Cell Biol, Granada, Spain; [Lopez-Sanchez, Noelia; Frade, Jose M.] IC CSIC, Inst Cajal, Madrid, Spain; [de la Villa, Pedro] Univ Alcala De Henares, Dept Physiol, Sch Med, Madrid, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Universidad de Alcala	Santos, AM (corresponding author), Univ Granada, Dept Cell Biol, Granada, Spain.	frade@cajal.csic.es	Santos, Ana M./AAB-6302-2019; López-Sánchez, Noelia/F-5533-2010; Frade, Jose M/E-7913-2013; Martín-Oliva, David/L-8472-2014; de la Villa, Pedro/G-2322-2016; Shestopalov, Valery/AAE-9838-2020; Cuadros, Miguel A/L-3954-2014	Santos, Ana M./0000-0002-9540-2226; Frade, Jose M/0000-0001-7067-2505; Martín-Oliva, David/0000-0002-8095-5442; de la Villa, Pedro/0000-0001-9856-6616; Cuadros, Miguel A/0000-0003-4259-1649; Goldberg, Jeffrey/0000-0002-1390-7360; Shestopalov, Valery/0000-0002-1568-6637; Lopez-Sanchez, Noelia/0000-0003-3095-3438; Ivanov, Dmitry/0000-0002-5573-4402	Ministerio de Ciencia e Innovacion [BFU2009-07671, BFU2007-61659]; Fundacion Lucha contra la Ceguera [FUNDALUCE-2008]; Junta de Andalucia [P07-CVI-03008]; University of Granada (GREIB)	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Lucha contra la Ceguera; Junta de Andalucia(Junta de Andalucia); University of Granada (GREIB)	This study was supported by grants from the "Ministerio de Ciencia e Innovacion'' (BFU2009-07671) and from "Fundacion Lucha contra la Ceguera'' (FUNDALUCE-2008) to JMF, as well as from "Ministerio de Ciencia e Innovacion'' (BFU2007-61659), from "Junta de Andalucia'' (P07-CVI-03008), and from "University of Granada'' (2011 GREIB incentive) to MAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Al-Shawi R, 2007, ANN NY ACAD SCI, V1119, P208, DOI 10.1196/annals.1404.024; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; Andersen OS, 2010, J BIOL CHEM, V285, P12210, DOI 10.1074/jbc.M109.062364; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Chen LW, 2008, CNS NEUROL DISORD-DR, V7, P512, DOI 10.2174/187152708787122923; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; deKozak Y, 1997, OCUL IMMUNOL INFLAMM, V5, P85, DOI 10.3109/09273949709085056; Dicou E, 2004, J NEUROSCI RES, V78, P92, DOI 10.1002/jnr.20231; Dimaras H, 2006, MOL CARCINOGEN, V45, P333, DOI 10.1002/mc.20179; Dobrowsky RT, 2000, J NEUROSCI RES, V61, P237, DOI 10.1002/1097-4547(20000801)61:3<237::AID-JNR1>3.0.CO;2-M; Domeniconi M, 2007, MOL CELL NEUROSCI, V34, P271, DOI 10.1016/j.mcn.2006.11.005; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Frade JM, 1996, NATURE, V383, P166; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kanan Y, 2010, ADV EXP MED BIOL, V664, P3, DOI 10.1007/978-1-4419-1399-9_1; KORSCHING S, 1987, METHOD ENZYMOL, V147, P167; Larsen JV, 2010, MOL CELL BIOL, V30, P4175, DOI 10.1128/MCB.00274-10; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nakamura K, 2007, CELL DEATH DIFFER, V14, P1552, DOI 10.1038/sj.cdd.4402173; NOELL WK, 1980, VISION RES, V20, P1163, DOI 10.1016/0042-6989(80)90055-3; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Provenzano MJ, 2008, LARYNGOSCOPE, V118, P87, DOI 10.1097/MLG.0b013e31814b8d9f; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Rohrer B, 2003, EXP EYE RES, V76, P125, DOI 10.1016/S0014-4835(02)00258-0; Santos AM, 2010, J COMP NEUROL, V518, P477, DOI 10.1002/cne.22227; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Sheedlo HJ, 2002, MOL BRAIN RES, V103, P71, DOI 10.1016/S0169-328X(02)00185-7; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Srinivasan B, 2004, J BIOL CHEM, V279, P41839, DOI 10.1074/jbc.M402872200; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Stoica G, 2008, BRAIN RES, V1208, P204, DOI 10.1016/j.brainres.2008.02.085; Stone J, 1999, PROG RETIN EYE RES, V18, P689, DOI 10.1016/S1350-9462(98)00032-9; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ueki Y, 2009, P NATL ACAD SCI USA, V106, P21389, DOI 10.1073/pnas.0906156106; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Wei Y, 2007, NEUROSCI LETT, V429, P169, DOI 10.1016/j.neulet.2007.10.012; Xu FF, 2009, NEUROSCI LETT, V454, P81, DOI 10.1016/j.neulet.2009.02.036; YAMATO S, 1984, STAIN TECHNOL, V59, P113, DOI 10.3109/10520298409113840; Yang LP, 2007, MOL VIS, V13, P2048; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118	59	53	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 27	2012	7	4							e36243	10.1371/journal.pone.0036243	http://dx.doi.org/10.1371/journal.pone.0036243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TJ	22558402	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336000169
J	Zhang, X; Lynch, AI; Davis, BR; Ford, CE; Boerwinkle, E; Eckfeldt, JH; Leiendecker-Foster, C; Arnett, DK				Zhang, Xue; Lynch, Amy I.; Davis, Barry R.; Ford, Charles E.; Boerwinkle, Eric; Eckfeldt, John H.; Leiendecker-Foster, Catherine; Arnett, Donna K.			Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; GENE POLYMORPHISM; GLU298ASP POLYMORPHISM; COMMON VARIANT; RISK-FACTOR; ENOS; SUSCEPTIBILITY	Nitric oxide synthase 3 (NOS3) catalyzes production of NO in the endothelium and may play a role in cardiovascular disease (CVD). We assessed the pharmacogenetic associations of three NOS3 polymorphisms and three antihypertensive drugs with CVD outcomes. Hypertensive subjects (n = 30,280) from a multi-center, double-blind clinical trial were randomized to chlorthalidone, amlodipine, or lisinopril treatment (mean follow up, 4.9 years). Outcomes included coronary heart disease (CHD: fatal CHD and nonfatal myocardial infarction); stroke; heart failure (fatal, requiring hospitalization, or outpatient treatment); all-cause mortality; and end-stage renal disease (ESRD). Main effects of NOS3 variants on outcome and genotype-treatment interactions were tested. For NOS3 2690 C>T (rs3918226), a higher hazard ratio (HR) was found in minor allele carriers for CHD (CC = 1.00, CT+TT = 1.12 (95% confidence interval (CI) = 1.00-1.26), P = 0.048). For NOS3 2922 A>G (rs1800779), a higher HR was found in minor allele carriers for heart failure (AA = 1.00, AG+GG = 1.10 (CI = 1.00-1.21), P = 0.046). Significant pharmacogenetic findings were observed for stroke and all-cause mortality. For 2690 C>T, a lower HR was observed for stroke in minor allele carriers when treated with amlodipine versus lisinopril (CC = 0.85 (CI = 0.73-0.99), CT+TT = 0.49 (CI = 0.31-0.80), P = 0.04). For glu298asp G>T (rs1799983), a lower HR was observed for all-cause mortality in minor allele carriers when treated with amlodipine versus lisinopril (GG = 1.01 (CI = 0.91-1.13), GT+TT = 0.85 (CI = 0.75-0.97), P = 0.04). We observed significant associations with NOS3 variants and CHD and heart failure and significant pharmacogenetic effects for stroke and all cause mortality. This suggests that NOS3 variants may potentially provide useful clinical information with respect to treatment decisions in the future.	[Zhang, Xue] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Lynch, Amy I.; Eckfeldt, John H.; Leiendecker-Foster, Catherine] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Davis, Barry R.; Ford, Charles E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Boerwinkle, Eric] Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Cincinnati Children's Hospital Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham	Zhang, X (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.	arnett@uab.edu		Haile, Colin/0000-0001-8293-7291	National Heart, Lung and Blood Institute [HL63082, N01-HC-35130]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083498, R01HL063082] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute grants HL63082 (GenHAT - Genetics of Hypertension Associated Treatments: ClinicalTrials.gov, NCT00006294, http://clinicaltrials.gov/ct2/show/NCT00006294) and N01-HC-35130 (ALLHAT - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: ClinicalTrials.gov, NCT00000542, http://clinicaltrials.gov/ct2/show/NCT00000542). The National Heart, Lung, and Blood Institute had a contributing role in the analysis and interpretation of the ALLHAT data.	Arnett D. K., 2002, Pharmacogenomics Journal, V2, P309; Arnett DK, 2006, VASC PHARMACOL, V44, P107, DOI 10.1016/j.vph.2005.09.010; Asakimori Y, 2004, AM J KIDNEY DIS, V44, P112, DOI 10.1053/j.ajkd.2004.03.034; Augeri Amanda L, 2009, Atherosclerosis, V204, pe28, DOI 10.1016/j.atherosclerosis.2008.12.015; Benjafield AV, 2000, AM J HYPERTENS, V13, P994, DOI 10.1016/S0895-7061(00)00282-X; Bhandary UV, 2008, NEPHROLOGY, V13, P348, DOI 10.1111/j.1440-1797.2008.00925.x; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Chang KY, 2003, CORONARY ARTERY DIS, V14, P293, DOI 10.1097/01.mca.0000073080.69657.71; Cherney DZI, 2009, KIDNEY INT, V75, P327, DOI 10.1038/ki.2008.574; Chobanian AV, 2001, NEW ENGL J MED, V345, P534, DOI 10.1056/NEJM200108163450709; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; Colombo MG, 2002, HEART, V87, P525, DOI 10.1136/heart.87.6.525; Cooke GE, 2007, PHARMACOGENOMICS, V8, P1723, DOI 10.2217/14622416.8.12.1723; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; Dell'Omo G, 2007, J HYPERTENS, V25, P1389, DOI 10.1097/HJH.0b013e3281268548; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Howard TD, 2005, STROKE, V36, P1848, DOI 10.1161/01.STR.0000177978.97428.53; Jachymova M, 2001, BIOCHEM BIOPH RES CO, V284, P426, DOI 10.1006/bbrc.2001.5007; Joshi MS, 2008, ACTA BIOCH BIOPH SIN, V40, P47, DOI 10.1111/j.1745-7270.2008.00369.x; Kullo IJ, 2008, ATHEROSCLEROSIS, V196, P905, DOI 10.1016/j.atherosclerosis.2007.02.008; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Lenasi H, 2003, CARDIOVASC RES, V59, P844, DOI 10.1016/S0008-6363(03)00505-4; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Markus HS, 1998, STROKE, V29, P1908, DOI 10.1161/01.STR.29.9.1908; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; Moe KT, 2006, J HUM HYPERTENS, V20, P956, DOI 10.1038/sj.jhh.1002096; Mollsten A, 2006, ANN MED, V38, P522, DOI 10.1080/07853890600969213; Nagase S, 2003, MOL CELL BIOCHEM, V244, P113, DOI 10.1023/A:1022473405275; Noiri E, 2002, HYPERTENSION, V40, P535, DOI 10.1161/01.HYP.0000033974.57407.82; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Rossi GP, 2006, J AM COLL CARDIOL, V48, P1166, DOI 10.1016/j.jacc.2006.05.046; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Suzuki H, 2000, CLIN CHEM, V46, P1858; Tangurek B, 2006, HEART VESSELS, V21, P285, DOI 10.1007/s00380-005-0902-0; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Thaha M, 2008, CLIN NEPHROL, V70, P144; Wang XL, 2000, MOL GENET METAB, V70, P241, DOI 10.1006/mgme.2000.3033; Xin Y, 2009, CLIN SCI, V117, P67, DOI 10.1042/CS20080476	45	42	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34217	10.1371/journal.pone.0034217	http://dx.doi.org/10.1371/journal.pone.0034217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470539	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000078
J	Chen, YX; Zheng, SP; Qi, D; Zheng, SJ; Guo, JL; Zhang, SL; Weng, ZH				Chen, Yixiong; Zheng, Shaoping; Qi, Dan; Zheng, Shaojiang; Guo, Junli; Zhang, Shuling; Weng, Zhihong			Inhibition of Notch Signaling by a gamma-Secretase Inhibitor Attenuates Hepatic Fibrosis in Rats	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; STELLATE CELLS; MAMMALIAN NOTCH; LIVER FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; PLASMINOGEN-ACTIVATOR; GENE-EXPRESSION; DEFICIENT MICE; PATHWAY	Notch signaling is essential to the regulation of cell differentiation, and aberrant activation of this pathway is implicated in human fibrotic diseases, such as pulmonary, renal, and peritoneal fibrosis. However, the role of Notch signaling in hepatic fibrosis has not been fully investigated. In the present study, we show Notch signaling to be highly activated in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4), as indicated by increased expression of Jagged1, Notch3, and Hes1. Blocking Notch signaling activation by a gamma-secretase inhibitor, DAPT, significantly attenuated liver fibrosis and decreased the expression of snail, vimentin, and TGF-beta 1 in association with the enhanced expression of E-cadherin. The study in vitro revealed that DAPT treatment could suppress the EMT process of rat hepatic stellate cell line (HSC-T6). Interestingly, DAPT treatment was found not to affect hepatocyte proliferation in vivo. In contrast, DAPT can inhibit hepatocyte apoptosis to some degree. Our study provides the first evidence that Notch signaling is implicated in hepatic fibrogenesis and DAPT treatment has a protective effect on hepatocytes and ameliorates liver fibrosis. These findings suggest that the inhibition of Notch signaling might present a novel therapeutic approach for hepatic fibrosis.	[Chen, Yixiong; Qi, Dan; Zhang, Shuling; Weng, Zhihong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China; [Zheng, Shaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Ultrasonog, Wuhan 430074, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Dept Pathol, Haikou, Peoples R China; [Zheng, Shaojiang; Guo, Junli] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hainan Medical University; Hainan Medical University	Weng, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China.	wzh941@126.com	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	National Natural Science Foundation of China [30900663]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Natural Science Foundation of China (30900663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi-Ikeda K, 2011, AM J RESP CELL MOL, V45, P136, DOI 10.1165/rcmb.2010-0140OC; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; BETTENHAUSEN B, 1995, GENOMICS, V28, P436, DOI 10.1006/geno.1995.1172; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Chen SW, 2008, GENE THER, V15, P1424, DOI 10.1038/gt.2008.93; Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dumortier A, 2006, MOL CELL BIOL, V26, P209, DOI 10.1128/MCB.26.1.209-220.2006; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kinoshita K, 2007, GUT, V56, P396, DOI 10.1136/gut.2005.085704; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lin Y, 2005, LIVER INT, V25, P796, DOI 10.1111/j.1478-3231.2005.01098.x; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nijjar SS, 2002, AM J PATHOL, V160, P1695, DOI 10.1016/S0002-9440(10)61116-9; Nijjar SS, 2001, HEPATOLOGY, V34, P1184, DOI 10.1053/jhep.2001.29399; Pan Q, 2007, DIGEST DIS SCI, V52, P2591, DOI 10.1007/s10620-006-9676-1; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; Sawitza I, 2009, HEPATOLOGY, V50, P1617, DOI 10.1002/hep.23184; Shawber C, 1996, DEVELOPMENT, V122, P3765; Sheahan S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-191; Shimizu M, 2001, HEPATOLOGY, V33, P569, DOI 10.1053/jhep.2001.22650; Teng YQ, 2007, J CLIN INVEST, V117, P304, DOI 10.1172/JCI31200; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Wei P, 2010, MOL CANCER THER, V9, P1618, DOI 10.1158/1535-7163.MCT-10-0034; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhu FX, 2010, AM J PATHOL, V176, P650, DOI 10.2353/ajpath.2010.090447	50	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46512	10.1371/journal.pone.0046512	http://dx.doi.org/10.1371/journal.pone.0046512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	22276200	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000052
J	Chen, YP; Xiao, XM; Li, J; Reichetzeder, C; Wang, ZN; Hocher, B				Chen, You-Peng; Xiao, Xiao-Min; Li, Jian; Reichetzeder, Christoph; Wang, Zi-Neng; Hocher, Berthold			Paternal Body Mass Index (BMI) Is Associated with Offspring Intrauterine Growth in a Gender Dependent Manner	PLOS ONE			English	Article							HIGH-FAT DIET; IMPAIRED GLUCOSE-TOLERANCE; BIRTH-WEIGHT; FOOD-INTAKE; METABOLIC SYNDROME; SEX-DIFFERENCES; DEVELOPMENTAL ORIGINS; BLOOD-PRESSURE; PROTEIN-DIET; PREGNANCY	Background: Environmental alternations leading to fetal programming of cardiovascular diseases in later life have been attributed to maternal factors. However, animal studies showed that paternal obesity may program cardio-metabolic diseases in the offspring. In the current study we tested the hypothesis that paternal BMI may be associated with fetal growth. Methods and Results: We analyzed the relationship between paternal body mass index (BMI) and birth weight, ultrasound parameters describing the newborn's body shape as well as parameters describing the newborns endocrine system such as cortisol, aldosterone, renin activity and fetal glycated serum protein in a birth cohort of 899 father/mother/child triplets. Since fetal programming is an offspring sex specific process, male and female offspring were analyzed separately. Multivariable regression analyses considering maternal BMI, paternal and maternal age, hypertension during pregnancy, maternal total glycated serum protein, parity and either gestational age (for birth weight) or time of ultrasound investigation (for ultrasound parameters) as confounding showed that paternal BMI is associated with growth of the male but not female offspring. Paternal BMI correlated with birth parameters of male offspring only: birth weight; biparietal diameter, head circumference; abdominal diameter, abdominal circumference; and pectoral diameter. Cortisol was likewise significantly correlated with paternal BMI in male newborns only. Conclusions: Paternal BMI affects growth of the male but not female offspring. Paternal BMI may thus represent a risk factor for cardiovascular diseases of male offspring in later life. It remains to be demonstrated whether this is linked to an offspring sex specific paternal programming of cortisol secretion.	[Chen, You-Peng; Hocher, Berthold] Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Xiao, Xiao-Min; Li, Jian; Wang, Zi-Neng] Jinan Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Reichetzeder, Christoph; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Nuthetal Potsdam, Germany; [Reichetzeder, Christoph; Hocher, Berthold] Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany	Jinan University; Jinan University; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, YP (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579; Kassis, Judith/0000-0001-9268-3213	Hoffmann La Roche Ltd, Basel, Switzerland	Hoffmann La Roche Ltd, Basel, Switzerland(Hoffmann-La Roche)	This study was supported by a grant from Hoffmann La Roche Ltd, Basel, Switzerland to Dr. B. Hocher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Augustyniak RA, 2010, AM J PHYSIOL-REG I, V298, pR1375, DOI 10.1152/ajpregu.00848.2009; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Brunton PJ, 2010, J NEUROENDOCRINOL, V22, P1198, DOI 10.1111/j.1365-2826.2010.02067.x; Clausen JO, 1997, AM J EPIDEMIOL, V146, P23, DOI 10.1093/oxfordjournals.aje.a009188; Cooper R, 2010, AM J CLIN NUTR, V92, P946, DOI 10.3945/ajcn.2010.29477; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gabory A, 2009, MOL CELL ENDOCRINOL, V304, P8, DOI 10.1016/j.mce.2009.02.015; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUO F, 1995, PHYSIOL BEHAV, V57, P681, DOI 10.1016/0031-9384(94)00342-4; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; Hocher B, 2000, LANCET, V355, P1241, DOI 10.1016/S0140-6736(00)02094-8; Hocher B, 2007, J PHYSIOL-LONDON, V579, P287, DOI 10.1113/jphysiol.2007.127738; Hogberg U, 2000, GYNECOL OBSTET INVES, V49, P160, DOI 10.1159/000010239; Jahan-Mihan A, 2011, NUTR RES, V31, P644, DOI 10.1016/j.nutres.2011.08.003; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Leon DA, 2005, CIRCULATION, V112, P3478, DOI 10.1161/CIRCULATIONAHA.104.497610; Li J, 2012, NEUROSCI BIOBEHAV R, V36, P1085, DOI 10.1016/j.neubiorev.2011.12.006; Li J, 2011, J HYPERTENS, V29, P1712, DOI 10.1097/HJH.0b013e328349a2e6; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288; Manabe M, 2005, PEDIATR INT, V47, P60, DOI 10.1111/j.1442-200x.2004.02002.x; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; Murphy SK, 2012, GENE, V494, P36, DOI 10.1016/j.gene.2011.11.062; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Szeto IMY, 2008, AM J PHYSIOL-REG I, V295, pR575, DOI 10.1152/ajpregu.90354.2008; Tang C, 2010, CHIN J BIRTH HLTH HE, P4; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WIDDOWSON EM, 1975, PEDIATR RES, V9, P154, DOI 10.1203/00006450-197503000-00010; Xie Y, 2007, PROG OBSTET GYNECOL, V16, P440; Yazbek SN, 2010, HUM MOL GENET, V19, P4134, DOI 10.1093/hmg/ddq332; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	45	180	195	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2012	7	5							e36329	10.1371/journal.pone.0036329	http://dx.doi.org/10.1371/journal.pone.0036329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VF	22276200	Green Published, gold			2022-12-27	WOS:000305343400019
J	Li, CF; Zhou, DN; Kou, ZK; Zhang, ZS; Wang, JP; Cai, ML; Cao, CG				Li Cheng-Fang; Zhou Dan-Na; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui			Effects of Tillage and Nitrogen Fertilizers on CH4 and CO2 Emissions and Soil Organic Carbon in Paddy Fields of Central China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LONG-TERM APPLICATION; RICE FIELDS; NO-TILLAGE; METHANE EMISSIONS; CHEMICAL FERTILIZER; SYSTEMS; SEQUESTRATION; FLUXES; DIOXIDE	Quantifying carbon (C) sequestration in paddy soils is necessary to help better understand the effect of agricultural practices on the C cycle. The objective of the present study was to assess the effects of tillage practices [conventional tillage (CT) and no-tillage (NT)] and the application of nitrogen (N) fertilizer (0 and 210 kg N ha(-1)) on fluxes of CH4 and CO2, and soil organic C (SOC) sequestration during the 2009 and 2010 rice growing seasons in central China. Application of N fertilizer significantly increased CH4 emissions by 13%-66% and SOC by 21%-94% irrespective of soil sampling depths, but had no effect on CO2 emissions in either year. Tillage significantly affected CH4 and CO2 emissions, where NT significantly decreased CH4 emissions by 10%-36% but increased CO2 emissions by 22%-40% in both years. The effects of tillage on the SOC varied with the depth of soil sampling. NT significantly increased the SOC by 7%-48% in the 0-5 cm layer compared with CT. However, there was no significant difference in the SOC between NT and CT across the entire 0-20 cm layer. Hence, our results suggest that the potential of SOC sequestration in NT paddy fields may be overestimated in central China if only surface soil samples are considered.	[Li Cheng-Fang; Kou Zhi-Kui; Zhang Zhi-Sheng; Wang Jin-Ping; Cai Ming-Li; Cao Cou-Gui] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhou Dan-Na] Hubei Acad Agr Sci, Inst Anim Husb & Vet Sci, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Hubei Academy of Agricultural Sciences	Li, CF (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	ccgui@mail.hzau.edu.cn		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	National Technology Project for High Food Yield of China [2011BAD16B02]; National Natural Science Foundation of China [31100319]; Fundamental Research Funds for the Central Universities [2010QC032]; Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding [2011ZD152]	National Technology Project for High Food Yield of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding	The study was supported by the National Technology Project for High Food Yield of China (2011BAD16B02), National Natural Science Foundation of China (31100319), Fundamental Research Funds for the Central Universities (2010QC032) and the Foundation of Hubei Key Laboratory of Animal Embryo Engineering and Molecular Breeding (2011ZD152). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz JJ, 2009, SOIL TILL RES, V104, P134, DOI 10.1016/j.still.2009.02.003; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Ball BC, 1999, SOIL TILL RES, V53, P29, DOI 10.1016/S0167-1987(99)00074-4; BAO SD, 2000, ANAL SOIL AGR CHEM, P42; Burton AJ, 2004, GLOBAL CHANGE BIOL, V10, P1080, DOI 10.1111/j.1365-2486.2004.00737.x; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Causarano HJ, 2006, J ENVIRON QUAL, V35, P1374, DOI 10.2134/jeq2005.0150; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P330, DOI 10.1016/j.soilbio.2006.08.003; Crill PM, 1988, GLOBAL BIOGEOCHEM CY, V2, P371, DOI 10.1029/GB002i004p00371; Deen W, 2003, SOIL TILL RES, V74, P143, DOI 10.1016/S0167-1987(03)00162-4; DeForest JL, 2004, SOIL SCI SOC AM J, V68, P132, DOI 10.2136/sssaj2004.1320; DeLuca TH, 2011, FRONT ECOL ENVIRON, V9, P407, DOI 10.1890/100063; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Drury CF, 2006, SOIL SCI SOC AM J, V70, P570, DOI 10.2136/sssaj2005.0042; Gao YJ, 2000, SOIL ENV SCI, V9, P27; GREEN CJ, 1995, SOIL SCI SOC AM J, V59, P453, DOI 10.2136/sssaj1995.03615995005900020026x; Guo JP, 2007, AGR FOREST METEOROL, V142, P270, DOI 10.1016/j.agrformet.2006.03.029; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Harada H, 2007, SOIL SCI PLANT NUTR, V53, P668, DOI 10.1111/j.1747-0765.2007.00174.x; He YingYing, 2010, Journal of Agro-Environment Science, V29, P200; Hutsch BW, 1998, BIOL FERT SOILS, V27, P284, DOI 10.1007/s003740050435; IPCC, 2007, CONTRIBUTION WORKING; Iqbal J, 2009, AGR ECOSYST ENVIRON, V131, P292, DOI 10.1016/j.agee.2009.02.001; [IRRI] International Rice Research Institute, 2004, RIC STAT DAT; Khan SA, 2007, J ENVIRON QUAL, V36, P1821, DOI 10.2134/jeq2007.0099; 郑循华, 1998, Advances in Atmospheric Sciences, V15, P569; Kroon PS, 2008, NUTR CYCL AGROECOSYS, V82, P175, DOI 10.1007/s10705-008-9179-x; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee DK, 2007, SOIL BIOL BIOCHEM, V39, P178, DOI 10.1016/j.soilbio.2006.07.004; Li CF, 2010, ATMOS ENVIRON, V44, P2696, DOI 10.1016/j.atmosenv.2010.04.045; Li CF, 2009, ARCH ENVIRON CON TOX, V56, P21, DOI 10.1007/s00244-008-9159-9; Li JT, 2007, PEDOSPHERE, V17, P568, DOI 10.1016/S1002-0160(07)60067-8; Liang W, 2007, PEDOSPHERE, V17, P630, DOI 10.1016/S1002-0160(07)60075-7; LINDAU CW, 1993, SOIL SCI, V156, P42, DOI 10.1097/00010694-199307000-00006; Liu XJ, 2006, PLANT SOIL, V280, P177, DOI 10.1007/s11104-005-2950-8; Lopez-Bellido RJ, 2010, AGRON J, V102, P310, DOI 10.2134/agronj2009.0165; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lou YS, 2003, WATER AIR SOIL POLL, V149, P281, DOI 10.1023/A:1025727504841; Lu F, 2009, GLOBAL CHANGE BIOL, V15, P281, DOI 10.1111/j.1365-2486.2008.01743.x; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; MINAMI K, 1995, FERT RES, V40, P71, DOI 10.1007/BF00749864; Mitra S, 2005, SOIL SCI SOC AM J, V69, P563, DOI 10.2136/sssaj2005.0563; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Nayak P, 2009, NUTR CYCL AGROECOSYS, V83, P259, DOI 10.1007/s10705-008-9217-8; Neue HU, 2000, ATMOSPHERIC METHANE, P134; Nyamadzawo G, 2008, NUTR CYCL AGROECOSYS, V81, P85, DOI 10.1007/s10705-007-9154-y; OECD, 2000, ENV IND AGR METH AGR; Omonode RA, 2007, SOIL TILL RES, V95, P182, DOI 10.1016/j.still.2006.12.004; Oorts K, 2007, SOIL TILL RES, V95, P133, DOI 10.1016/j.still.2006.12.002; Pan GX, 2009, AGR ECOSYST ENVIRON, V131, P274, DOI 10.1016/j.agee.2009.01.020; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PARKINSON KJ, 1981, J APPL ECOL, V18, P221, DOI 10.2307/2402491; Paustian K., 1997, SOIL ORGANIC MATTER; Reicosky DC, 1997, SOIL TILL RES, V41, P105, DOI 10.1016/S0167-1987(96)01080-X; Roberson T, 2008, J ENVIRON QUAL, V37, P535, DOI 10.2134/jeq2006.0386; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Tang Xiao-hong, 2007, Yingyong Shengtai Xuebao, V18, P1027; Tong CL, 2009, SOIL TILL RES, V106, P8, DOI 10.1016/j.still.2009.09.003; Ussiri DAN, 2009, SOIL TILL RES, V104, P247, DOI 10.1016/j.still.2009.03.001; Wang CJ, 2010, SCI CHINA LIFE SCI, V53, P858, DOI 10.1007/s11427-010-4028-y; Wang MX, 2002, NUTR CYCL AGROECOSYS, V64, P43, DOI 10.1023/A:1021183706235; Wang SX, 2012, J ZHEJIANG UNIV-SC B, V13, P274, DOI 10.1631/jzus.B1100145; WASSMANN R, 1993, BIOGEOCHEMISTRY, V20, P83, DOI 10.1007/BF00004136; Wassmann R, 2000, BIOL FERT SOILS, V31, P20, DOI 10.1007/s003740050619; Wilson HM, 2008, APPL SOIL ECOL, V39, P264, DOI 10.1016/j.apsoil.2007.12.013; Wright AL, 2005, BIOL FERT SOILS, V41, P95, DOI 10.1007/s00374-004-0819-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xiao Y, 2005, AGR ECOSYST ENVIRON, V109, P273, DOI 10.1016/j.agee.2005.03.016; Xu H, 2000, NUTR CYCL AGROECOSYS, V58, P12, DOI DOI 10.1023/A:1009823425806; Zhan M, 2011, NUTR CYCL AGROECOSYS, V89, P1, DOI 10.1007/s10705-010-9371-7	78	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2012	7	5							e34642	10.1371/journal.pone.0034642	http://dx.doi.org/10.1371/journal.pone.0034642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WV	22574109	Green Published, gold, Green Submitted			2022-12-27	WOS:000305349800005
J	Li, CY; Harper, A; Puddick, J; Wang, WY; McMahon, C				Li, Chunyi; Harper, Anne; Puddick, Jonathan; Wang, Wenying; McMahon, Chris			Proteomes and Signalling Pathways of Antler Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; PROTEIN S100A4; EMBRYONAL CARCINOMA; DEER ANTLER; C-MYC; EXPRESSION; GENE; REGENERATION; GROWTH; PEDICLE	As the only known example of complete organ regeneration in mammals, deer antler in the growing or velvet phase is of major interest in developmental biology. This regeneration event initiates from self-renewing antler stem cells that exhibit pluripotency. At present, it remains unclear how the activation and quiescence of antler stem cells are regulated. Therefore, in the present study proteins that were differentially expressed between the antler stem cells and somatic cells (facial periosteum) were identified by a gel-based proteomic technique, and analysed using Ingenuity Pathway Analysis software. Several molecular pathways (PI3K/Akt, ERK/MAPK, p38 MAPK, etc.) were found to be activated during proliferation. Also expressed were the transcription factors POU5F1, SOX2, NANOG and MYC, which are key markers of embryonic stem cells. Expression of these proteins was confirmed in both cultured cells and fresh tissues by Western blot analysis. Therefore, the molecular pathways and transcription factors identified in the current study are common to embryonic and adult stem cells. However, expression of embryonic stem cell transcription factors would suggest that antler stem cells are, potentially, an intermediary stem cell type between embryonic and the more specialized tissue-specific stem cells like those residing in muscle, fat or from a hematopoietic origin. The retention of this embryonic, pluripotent lineage may be of fundamental importance for the subsequent regenerative capacity of antlers.	[Li, Chunyi; Harper, Anne; Wang, Wenying] AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand; [Li, Chunyi] State Key Lab Mol Biol Special Econ Anim, Changchun, Peoples R China; [Puddick, Jonathan] Univ Waikato, Waikato Mass Spectrometry Facil, Hamilton, New Zealand; [McMahon, Chris] AgResearch Ltd, Dev Biol Grp, Ruakura Agr Ctr, Hamilton, New Zealand	AgResearch - New Zealand; University of Waikato; AgResearch - New Zealand	Li, CY (corresponding author), AgResearch Ltd, Dev Biol Grp, Invermay Agr Ctr, Mosgiel, New Zealand.	chris.mcmahon@agresearch.co.nz		Li, Chaozheng/0000-0001-7639-7831; Yu, Xiao-Qiang/0000-0003-1419-9009; Puddick, Jonathan/0000-0001-7000-9180	Foundation for Research, Science and Technology, New Zealand [C10X0207]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology)	The work was funded by Foundation for Research, Science and Technology, New Zealand (C10X0207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Banks WJ, 1982, LIGHT MICROSCOPIC ST, P231; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Berg DK, 2007, BIOL REPROD, V77, P384, DOI 10.1095/biolreprod.106.058172; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Brown R.D., 1982, ANTLER DEV CERVIDAE, P61; Bubenik GA, 1982, ENDOCRINE REGULATION, P73; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Clark DE, 2006, ANAT REC PART A, V288A, P1281, DOI 10.1002/ar.a.20393; Colitti M, 2005, J ANAT, V207, P339, DOI 10.1111/j.1469-7580.2005.00464.x; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Freemantle SJ, 2002, ONCOGENE, V21, P2880, DOI 10.1038/sj.onc.1205408; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Giguere V, 1990, MOL CLONING CDNA ENC, P6233; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Gilbert SF, 2003, DEV BIOL, P143; Goss R.J., 1983, DEER ANTLERS REGENER; GOSS RJ, 1985, J EXP ZOOL, V235, P359, DOI 10.1002/jez.1402350307; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Gyurjan I, 2007, MOL GENET GENOMICS, V277, P221, DOI 10.1007/s00438-006-0190-0; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Horie H, 1999, J NEUROSCI, V19, P9964; Kamal AM, 2005, MEM I OSWALDO CRUZ, V100, P39, DOI 10.1590/S0074-02762005000900008; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kierdorf U, 2003, ANAT REC PART A, V273A, P741, DOI 10.1002/ar.a.10082; Kierdorf U, 2007, J MORPHOL, V268, P726, DOI 10.1002/jmor.10546; Klingelhofer J, 1997, DEV DYNAM, V210, P87, DOI 10.1002/(SICI)1097-0177(199710)210:2<87::AID-AJA2>3.0.CO;2-5; Kriajevska M, 2002, J BIOL CHEM, V277, P5229, DOI 10.1074/jbc.M110976200; Lai AKW, 2007, TISSUE CELL, V39, P35, DOI 10.1016/j.tice.2007.01.001; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Li C., 2003, European Journal of Morphology, V41, P23, DOI 10.1076/ejom.41.1.23.28106; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Li C, 2006, RECENT PROGR ANTLER; Li CY, 2007, CELL TISSUE RES, V328, P65, DOI 10.1007/s00441-006-0333-y; Li CY, 2009, CURR STEM CELL RES T, V4, P237, DOI 10.2174/157488809789057446; LI CY, 1994, ANAT REC, V239, P198, DOI 10.1002/ar.1092390211; Li CY, 2005, ANAT REC PART A, V282A, P163, DOI 10.1002/ar.a.20148; Li CY, 2002, ANAT REC, V268, P125, DOI 10.1002/ar.10120; Li CY, 2001, ANAT EMBRYOL, V204, P375, DOI 10.1007/s004290100204; Li CY, 1999, J EXP ZOOL, V284, P82, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;82::AID-JEZ11&gt;3.0.CO;2-K; Li ZH, 2006, CANCER RES, V66, P5173, DOI 10.1158/0008-5472.CAN-05-3087; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; LINCOLN GA, 1973, J EMBRYOL EXP MORPH, V29, P431; LINCOLN GA, 1976, J EXP ZOOL, V195, P247, DOI 10.1002/jez.1401950209; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Louro ID, 2002, CANCER RES, V62, P5867; Lu Y, 2000, BBA-GENE STRUCT EXPR, V1491, P13, DOI 10.1016/S0167-4781(00)00055-5; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Melnikova VO, 2006, PIGM CELL RES, V19, P395, DOI 10.1111/j.1600-0749.2006.00331.x; Molnar A, 2007, MOL GENET GENOMICS, V277, P237, DOI 10.1007/s00438-006-0193-x; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Park HJ, 2004, PROTEOMICS, V4, P3642, DOI 10.1002/pmic.200401027; Phan E, 2007, MED SCI MONITOR, V13, pRA25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; Rolf HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002064; Rosenkilde MM, 2004, APMIS, V112, P481, DOI 10.1111/j.1600-0463.2004.apm11207-0808.x; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Stocum DL, 2006, REGENERATIVE BIOL ME; SUTTIE JM, 1995, J EXP ZOOL, V271, P120, DOI 10.1002/jez.1402710207; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WATANABE Y, 1993, FEBS LETT, V324, P51, DOI 10.1016/0014-5793(93)81530-D; Welstead GG, 2008, CURR OPIN GENET DEV, V18, P123, DOI 10.1016/j.gde.2008.01.013	71	180	206	28	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2012	7	1							e30026	10.1371/journal.pone.0030026	http://dx.doi.org/10.1371/journal.pone.0030026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	885IH	22574109	gold, Green Submitted, Green Published			2022-12-27	WOS:000299771900039
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22558416	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22558416	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2020, R LANG ENV STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22558416	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	22558416	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	22558416	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200040
